Citrus Sinensis ID: 000859
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 1251 | 2.2.26 [Sep-21-2011] | |||||||
| C0LGQ5 | 1249 | LRR receptor-like serine/ | yes | no | 0.980 | 0.981 | 0.688 | 0.0 | |
| Q9FIZ3 | 1252 | LRR receptor-like serine/ | no | no | 0.986 | 0.985 | 0.635 | 0.0 | |
| Q9LVP0 | 1102 | Probable leucine-rich rep | no | no | 0.782 | 0.888 | 0.402 | 0.0 | |
| Q9SHI2 | 1101 | Leucine-rich repeat recep | no | no | 0.792 | 0.900 | 0.383 | 0.0 | |
| O49318 | 1124 | Probable leucine-rich rep | no | no | 0.784 | 0.872 | 0.383 | 0.0 | |
| Q9LHP4 | 1141 | Receptor-like protein kin | no | no | 0.764 | 0.837 | 0.378 | 1e-173 | |
| C0LGV1 | 1135 | LRR receptor-like serine/ | no | no | 0.763 | 0.841 | 0.376 | 1e-168 | |
| Q9FZ59 | 1088 | Leucine-rich repeat recep | no | no | 0.770 | 0.886 | 0.372 | 1e-165 | |
| Q9LP24 | 1120 | Probable leucine-rich rep | no | no | 0.793 | 0.886 | 0.369 | 1e-164 | |
| Q8VZG8 | 1045 | Probable LRR receptor-lik | no | no | 0.737 | 0.883 | 0.360 | 1e-160 |
| >sp|C0LGQ5|GSO1_ARATH LRR receptor-like serine/threonine-protein kinase GSO1 OS=Arabidopsis thaliana GN=GSO1 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 1698 bits (4398), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 854/1240 (68%), Positives = 1012/1240 (81%), Gaps = 14/1240 (1%)
Query: 17 CFS----PGFVLCKDEELSVLLEIKKSFTADP--ENVLHAWNQSNQNLCTWRGITCGSSS 70
CFS PG + + +L LLE+KKS +P ++ L WN N N C+W G+TC ++
Sbjct: 13 CFSGLGQPGII---NNDLQTLLEVKKSLVTNPQEDDPLRQWNSDNINYCSWTGVTCDNTG 69
Query: 71 A-RVVSLNLSGLSLAGSISPSLGRLQSLIHLDLSSNSLTGPIPTALSNLSSLESLLLFSN 129
RV++LNL+GL L GSISP GR +LIHLDLSSN+L GPIPTALSNL+SLESL LFSN
Sbjct: 70 LFRVIALNLTGLGLTGSISPWFGRFDNLIHLDLSSNNLVGPIPTALSNLTSLESLFLFSN 129
Query: 130 QLAGTIPTQLGSLTSLRVMRIGDNWLSGSIPTSFGNLVNLGTLGLASCSLSGPIPPQFGQ 189
QL G IP+QLGSL ++R +RIGDN L G IP + GNLVNL L LASC L+GPIP Q G+
Sbjct: 130 QLTGEIPSQLGSLVNIRSLRIGDNELVGDIPETLGNLVNLQMLALASCRLTGPIPSQLGR 189
Query: 190 LSQLEELILQQNQLQGPIPAELGNCSSLSIFTAAENNLNGSIPAALGRLQNLQLLNLGNN 249
L +++ LILQ N L+GPIPAELGNCS L++FTAAEN LNG+IPA LGRL+NL++LNL NN
Sbjct: 190 LVRVQSLILQDNYLEGPIPAELGNCSDLTVFTAAENMLNGTIPAELGRLENLEILNLANN 249
Query: 250 SLSGEIPSELGELSQLGYLNLMGNRLEGAIPRSFAKMGNLQSLDLSMNRLTGGIPEEFGN 309
SL+GEIPS+LGE+SQL YL+LM N+L+G IP+S A +GNLQ+LDLS N LTG IPEEF N
Sbjct: 250 SLTGEIPSQLGEMSQLQYLSLMANQLQGLIPKSLADLGNLQTLDLSANNLTGEIPEEFWN 309
Query: 310 MGQLVFLVLSNNNISGSIPRRICTNATSLEHLILAEIQLSGEIPVELSQCQSLKQLDLSN 369
M QL+ LVL+NN++SGS+P+ IC+N T+LE L+L+ QLSGEIPVELS+CQSLKQLDLSN
Sbjct: 310 MSQLLDLVLANNHLSGSLPKSICSNNTNLEQLVLSGTQLSGEIPVELSKCQSLKQLDLSN 369
Query: 370 NTLNGTIPVELFQLVALTHLYLHNNSLVGSISPFVANLSNLQELALYHNNFQGSLPREIG 429
N+L G+IP LF+LV LT LYLHNN+L G++SP ++NL+NLQ L LYHNN +G LP+EI
Sbjct: 370 NSLAGSIPEALFELVELTDLYLHNNTLEGTLSPSISNLTNLQWLVLYHNNLEGKLPKEIS 429
Query: 430 MLVKLELLYLYDNHLSGQIPSEVGNCSSLKWIDFFGNSFTGEIPTSIGRLKDLNFLHLRQ 489
L KLE+L+LY+N SG+IP E+GNC+SLK ID FGN F GEIP SIGRLK+LN LHLRQ
Sbjct: 430 ALRKLEVLFLYENRFSGEIPQEIGNCTSLKMIDMFGNHFEGEIPPSIGRLKELNLLHLRQ 489
Query: 490 NELVGQIPASLGNCHQLIILDLADNKLSGGVPASFGFLQALEQLMLYNNSLEGNLPGSLI 549
NELVG +PASLGNCHQL ILDLADN+LSG +P+SFGFL+ LEQLMLYNNSL+GNLP SLI
Sbjct: 490 NELVGGLPASLGNCHQLNILDLADNQLSGSIPSSFGFLKGLEQLMLYNNSLQGNLPDSLI 549
Query: 550 NLRNLTRINFSKNRLNGRIATLCSSHSFLSFDVTNNEFDHEIPPQLGNSPSLERLRLGNN 609
+LRNLTRIN S NRLNG I LC S S+LSFDVTNN F+ EIP +LGNS +L+RLRLG N
Sbjct: 550 SLRNLTRINLSHNRLNGTIHPLCGSSSYLSFDVTNNGFEDEIPLELGNSQNLDRLRLGKN 609
Query: 610 KFIGKIPWTFGKIRELSLLDLSGNSLTGPIPTQLLMCKKLSHIDLNNNLLSGAVPSWLGT 669
+ GKIPWT GKIRELSLLD+S N+LTG IP QL++CKKL+HIDLNNN LSG +P WLG
Sbjct: 610 QLTGKIPWTLGKIRELSLLDMSSNALTGTIPLQLVLCKKLTHIDLNNNFLSGPIPPWLGK 669
Query: 670 LPQLGELKLSFNQFVGFLPRELFNCSKLLVLSLDGNMLNGSLPNEVGNLASLNVLTLSGN 729
L QLGELKLS NQFV LP ELFNC+KLLVLSLDGN LNGS+P E+GNL +LNVL L N
Sbjct: 670 LSQLGELKLSSNQFVESLPTELFNCTKLLVLSLDGNSLNGSIPQEIGNLGALNVLNLDKN 729
Query: 730 LLSGPIPPAIGRLSKLYELRLSNNSLNGVIPLEIGQLQNLQSILDLSHNNFTGQIPPSMG 789
SG +P A+G+LSKLYELRLS NSL G IP+EIGQLQ+LQS LDLS+NNFTG IP ++G
Sbjct: 730 QFSGSLPQAMGKLSKLYELRLSRNSLTGEIPVEIGQLQDLQSALDLSYNNFTGDIPSTIG 789
Query: 790 TLAKLEVLNLSHNQLVGELPSQLGEMSSLGKLNLSYNDLQGKLSKQFSHWPAEAFEGNLH 849
TL+KLE L+LSHNQL GE+P +G+M SLG LN+S+N+L GKL KQFS WPA++F GN
Sbjct: 790 TLSKLETLDLSHNQLTGEVPGSVGDMKSLGYLNVSFNNLGGKLKKQFSRWPADSFLGNTG 849
Query: 850 LCGSPLDHCNGLVSNQHQSTISVSLVVAISVISTLSAIALLIAVVTLFVKRKREFLRKSS 909
LCGSPL CN + SN Q +S VV IS IS L+AI L+I V+ LF K++ +F +K
Sbjct: 850 LCGSPLSRCNRVRSNNKQQGLSARSVVIISAISALTAIGLMILVIALFFKQRHDFFKKVG 909
Query: 910 Q--VNYTSSSSSSQAQRRLLFQ-AAAKRDFRWEDIMGATNNLSDEFIIGSGGSGTVYKAE 966
YTSSSSSSQA + LF+ A+K D RWEDIM AT+NLS+EF+IGSGGSG VYKAE
Sbjct: 910 HGSTAYTSSSSSSQATHKPLFRNGASKSDIRWEDIMEATHNLSEEFMIGSGGSGKVYKAE 969
Query: 967 LANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIYEY 1026
L NG TVAVKKI KDD + NKSF+REVKTLGRIRHRHLVKLMG+C +K G NLLIYEY
Sbjct: 970 LENGETVAVKKILWKDDLMSNKSFSREVKTLGRIRHRHLVKLMGYCSSKSEGLNLLIYEY 1029
Query: 1027 MENGSVWDWLHK-QPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSN 1085
M+NGS+WDWLH+ +PV K +K LDWEARL+IAVGLAQGVEYLHHDCVP I+HRDIKSSN
Sbjct: 1030 MKNGSIWDWLHEDKPVLEKKKKLLDWEARLRIAVGLAQGVEYLHHDCVPPIVHRDIKSSN 1089
Query: 1086 ILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSM 1145
+LLDSNMEAHLGDFGLAK L E+ ++NT+SNTWFA SYGYIAPEYAYSLKATEK DVYSM
Sbjct: 1090 VLLDSNMEAHLGDFGLAKVLTENCDTNTDSNTWFACSYGYIAPEYAYSLKATEKSDVYSM 1149
Query: 1146 GIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSAREELLDDQMKPLLPGEECAAYQ 1205
GIVLME+V+GKMPTD+ FG EMDMVRWVE H+E++GSAR++L+D ++KPLLP EE AA Q
Sbjct: 1150 GIVLMEIVTGKMPTDSVFGAEMDMVRWVETHLEVAGSARDKLIDPKLKPLLPFEEDAACQ 1209
Query: 1206 VLEIALQCTKTSPQERPSSRQVCDLLLNVFNNRIVDFDKL 1245
VLEIALQCTKTSPQERPSSRQ CD LL+V+NNR + KL
Sbjct: 1210 VLEIALQCTKTSPQERPSSRQACDSLLHVYNNRTAGYKKL 1249
|
Together with GSO2, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9FIZ3|GSO2_ARATH LRR receptor-like serine/threonine-protein kinase GSO2 OS=Arabidopsis thaliana GN=GSO2 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 1555 bits (4025), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 792/1246 (63%), Positives = 970/1246 (77%), Gaps = 12/1246 (0%)
Query: 11 LLLLLLCFSPGF---VLCKDEELSVLLEIKKSFTADP--ENVLHAWNQSNQNLCTWRGIT 65
L L LCFS G + ++L LLE+K SF +P E+VL WN + + C W G+T
Sbjct: 8 LALFFLCFSSGLGSGQPGQRDDLQTLLELKNSFITNPKEEDVLRDWNSGSPSYCNWTGVT 67
Query: 66 CGSSSARVVSLNLSGLSLAGSISPSLGRLQSLIHLDLSSNSLTGPIPTALSNLSSLESLL 125
CG ++ LNLSGL L GSISPS+GR +LIH+DLSSN L GPIPT LSNLSS L
Sbjct: 68 CGGR--EIIGLNLSGLGLTGSISPSIGRFNNLIHIDLSSNRLVGPIPTTLSNLSSSLESL 125
Query: 126 LFS-NQLAGTIPTQLGSLTSLRVMRIGDNWLSGSIPTSFGNLVNLGTLGLASCSLSGPIP 184
N L+G IP+QLGSL +L+ +++GDN L+G+IP +FGNLVNL L LASC L+G IP
Sbjct: 126 HLFSNLLSGDIPSQLGSLVNLKSLKLGDNELNGTIPETFGNLVNLQMLALASCRLTGLIP 185
Query: 185 PQFGQLSQLEELILQQNQLQGPIPAELGNCSSLSIFTAAENNLNGSIPAALGRLQNLQLL 244
+FG+L QL+ LILQ N+L+GPIPAE+GNC+SL++F AA N LNGS+PA L RL+NLQ L
Sbjct: 186 SRFGRLVQLQTLILQDNELEGPIPAEIGNCTSLALFAAAFNRLNGSLPAELNRLKNLQTL 245
Query: 245 NLGNNSLSGEIPSELGELSQLGYLNLMGNRLEGAIPRSFAKMGNLQSLDLSMNRLTGGIP 304
NLG+NS SGEIPS+LG+L + YLNL+GN+L+G IP+ ++ NLQ+LDLS N LTG I
Sbjct: 246 NLGDNSFSGEIPSQLGDLVSIQYLNLIGNQLQGLIPKRLTELANLQTLDLSSNNLTGVIH 305
Query: 305 EEFGNMGQLVFLVLSNNNISGSIPRRICTNATSLEHLILAEIQLSGEIPVELSQCQSLKQ 364
EEF M QL FLVL+ N +SGS+P+ IC+N TSL+ L L+E QLSGEIP E+S CQSLK
Sbjct: 306 EEFWRMNQLEFLVLAKNRLSGSLPKTICSNNTSLKQLFLSETQLSGEIPAEISNCQSLKL 365
Query: 365 LDLSNNTLNGTIPVELFQLVALTHLYLHNNSLVGSISPFVANLSNLQELALYHNNFQGSL 424
LDLSNNTL G IP LFQLV LT+LYL+NNSL G++S ++NL+NLQE LYHNN +G +
Sbjct: 366 LDLSNNTLTGQIPDSLFQLVELTNLYLNNNSLEGTLSSSISNLTNLQEFTLYHNNLEGKV 425
Query: 425 PREIGMLVKLELLYLYDNHLSGQIPSEVGNCSSLKWIDFFGNSFTGEIPTSIGRLKDLNF 484
P+EIG L KLE++YLY+N SG++P E+GNC+ L+ ID++GN +GEIP+SIGRLKDL
Sbjct: 426 PKEIGFLGKLEIMYLYENRFSGEMPVEIGNCTRLQEIDWYGNRLSGEIPSSIGRLKDLTR 485
Query: 485 LHLRQNELVGQIPASLGNCHQLIILDLADNKLSGGVPASFGFLQALEQLMLYNNSLEGNL 544
LHLR+NELVG IPASLGNCHQ+ ++DLADN+LSG +P+SFGFL ALE M+YNNSL+GNL
Sbjct: 486 LHLRENELVGNIPASLGNCHQMTVIDLADNQLSGSIPSSFGFLTALELFMIYNNSLQGNL 545
Query: 545 PGSLINLRNLTRINFSKNRLNGRIATLCSSHSFLSFDVTNNEFDHEIPPQLGNSPSLERL 604
P SLINL+NLTRINFS N+ NG I+ LC S S+LSFDVT N F+ +IP +LG S +L+RL
Sbjct: 546 PDSLINLKNLTRINFSSNKFNGSISPLCGSSSYLSFDVTENGFEGDIPLELGKSTNLDRL 605
Query: 605 RLGNNKFIGKIPWTFGKIRELSLLDLSGNSLTGPIPTQLLMCKKLSHIDLNNNLLSGAVP 664
RLG N+F G+IP TFGKI ELSLLD+S NSL+G IP +L +CKKL+HIDLNNN LSG +P
Sbjct: 606 RLGKNQFTGRIPRTFGKISELSLLDISRNSLSGIIPVELGLCKKLTHIDLNNNYLSGVIP 665
Query: 665 SWLGTLPQLGELKLSFNQFVGFLPRELFNCSKLLVLSLDGNMLNGSLPNEVGNLASLNVL 724
+WLG LP LGELKLS N+FVG LP E+F+ + +L L LDGN LNGS+P E+GNL +LN L
Sbjct: 666 TWLGKLPLLGELKLSSNKFVGSLPTEIFSLTNILTLFLDGNSLNGSIPQEIGNLQALNAL 725
Query: 725 TLSGNLLSGPIPPAIGRLSKLYELRLSNNSLNGVIPLEIGQLQNLQSILDLSHNNFTGQI 784
L N LSGP+P IG+LSKL+ELRLS N+L G IP+EIGQLQ+LQS LDLS+NNFTG+I
Sbjct: 726 NLEENQLSGPLPSTIGKLSKLFELRLSRNALTGEIPVEIGQLQDLQSALDLSYNNFTGRI 785
Query: 785 PPSMGTLAKLEVLNLSHNQLVGELPSQLGEMSSLGKLNLSYNDLQGKLSKQFSHWPAEAF 844
P ++ TL KLE L+LSHNQLVGE+P Q+G+M SLG LNLSYN+L+GKL KQFS W A+AF
Sbjct: 786 PSTISTLPKLESLDLSHNQLVGEVPGQIGDMKSLGYLNLSYNNLEGKLKKQFSRWQADAF 845
Query: 845 EGNLHLCGSPLDHCNGLVSNQHQSTISVSLVVAISVISTLSAIALLIAVVTLFVKRKREF 904
GN LCGSPL HCN +++Q ++S VV IS IS+L+AIAL++ V+ LF K+ +
Sbjct: 846 VGNAGLCGSPLSHCN-RAGSKNQRSLSPKTVVIISAISSLAAIALMVLVIILFFKQNHDL 904
Query: 905 LRKSSQVNYTSSSSSSQAQRRLLFQAAAKRDFRWEDIMGATNNLSDEFIIGSGGSGTVYK 964
+K N SS+SS +Q L AK D +W+DIM AT+ L++EF+IGSGGSG VYK
Sbjct: 905 FKKVRGGNSAFSSNSSSSQAPLFSNGGAKSDIKWDDIMEATHYLNEEFMIGSGGSGKVYK 964
Query: 965 AELANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIY 1024
AEL NG T+AVKKI KDD + NKSF REVKTLG IRHRHLVKLMG+C +K G NLLIY
Sbjct: 965 AELKNGETIAVKKILWKDDLMSNKSFNREVKTLGTIRHRHLVKLMGYCSSKADGLNLLIY 1024
Query: 1025 EYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSS 1084
EYM NGSVWDWLH N K ++ L WE RLKIA+GLAQGVEYLH+DCVP I+HRDIKSS
Sbjct: 1025 EYMANGSVWDWLHANE-NTKKKEVLGWETRLKIALGLAQGVEYLHYDCVPPIVHRDIKSS 1083
Query: 1085 NILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYS 1144
N+LLDSN+EAHLGDFGLAK L +Y++NTESNT FAGSYGYIAPEYAYSLKATEK DVYS
Sbjct: 1084 NVLLDSNIEAHLGDFGLAKILTGNYDTNTESNTMFAGSYGYIAPEYAYSLKATEKSDVYS 1143
Query: 1145 MGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEM--SGSAREELLDDQMKPLLPGEECA 1202
MGIVLME+V+GKMPT+A F E DMVRWVE ++ ARE+L+D ++K LLP EE A
Sbjct: 1144 MGIVLMEIVTGKMPTEAMFDEETDMVRWVETVLDTPPGSEAREKLIDSELKSLLPCEEEA 1203
Query: 1203 AYQVLEIALQCTKTSPQERPSSRQVCDLLLNVFNNRIVDFDKLHID 1248
AYQVLEIALQCTK+ PQERPSSRQ + LLNVFNNR + ++ D
Sbjct: 1204 AYQVLEIALQCTKSYPQERPSSRQASEYLLNVFNNRAASYREMQTD 1249
|
Together with GSO1, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Involved in the nuclear division phase of megagametogenesis. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LVP0|Y5639_ARATH Probable leucine-rich repeat receptor-like protein kinase At5g63930 OS=Arabidopsis thaliana GN=At5g63930 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 667 bits (1722), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 411/1022 (40%), Positives = 585/1022 (57%), Gaps = 43/1022 (4%)
Query: 227 LNGSIPAALGRLQNLQLLNLGNNSLSGEIPSELGELSQLGYLNLMGNRLEGAIPRSFAKM 286
L+G + ++G L +L+ L+L N LSG+IP E+G S L L L N+ +G IP K+
Sbjct: 85 LSGKLSPSIGGLVHLKQLDLSYNGLSGKIPKEIGNCSSLEILKLNNNQFDGEIPVEIGKL 144
Query: 287 GNLQSLDLSMNRLTGGIPEEFGNMGQLVFLVLSNNNISGSIPRRICTNATSLEHLILAEI 346
+L++L + NR++G +P E GN+ L LV +NNISG +PR I N L +
Sbjct: 145 VSLENLIIYNNRISGSLPVEIGNLLSLSQLVTYSNNISGQLPRSI-GNLKRLTSFRAGQN 203
Query: 347 QLSGEIPVELSQCQSLKQLDLSNNTLNGTIPVELFQLVALTHLYLHNNSLVGSISPFVAN 406
+SG +P E+ C+SL L L+ N L+G +P E+ L L+ + L N G I ++N
Sbjct: 204 MISGSLPSEIGGCESLVMLGLAQNQLSGELPKEIGMLKKLSQVILWENEFSGFIPREISN 263
Query: 407 LSNLQELALYHNNFQGSLPREIGMLVKLELLYLYDNHLSGQIPSEVGNCSSLKWIDFFGN 466
++L+ LALY N G +P+E+G L LE LYLY N L+G IP E+GN S IDF N
Sbjct: 264 CTSLETLALYKNQLVGPIPKELGDLQSLEFLYLYRNGLNGTIPREIGNLSYAIEIDFSEN 323
Query: 467 SFTGEIPTSIGRLKDLNFLHLRQNELVGQIPASLGNCHQLIILDLADNKLSGGVPASFGF 526
+ TGEIP +G ++ L L+L +N+L G IP L L LDL+ N L+G +P F +
Sbjct: 324 ALTGEIPLELGNIEGLELLYLFENQLTGTIPVELSTLKNLSKLDLSINALTGPIPLGFQY 383
Query: 527 LQALEQLMLYNNSLEGNLPGSLINLRNLTRINFSKNRLNGRIAT-LCSSHSFLSFDVTNN 585
L+ L L L+ NSL G +P L +L ++ S N L+GRI + LC + + ++ N
Sbjct: 384 LRGLFMLQLFQNSLSGTIPPKLGWYSDLWVLDMSDNHLSGRIPSYLCLHSNMIILNLGTN 443
Query: 586 EFDHEIPPQLGNSPSLERLRLGNNKFIGKIPWTFGKIRELSLLDLSGNSLTGPIPTQLLM 645
IP + +L +LRL N +G+ P K ++ ++L N G IP ++
Sbjct: 444 NLSGNIPTGITTCKTLVQLRLARNNLVGRFPSNLCKQVNVTAIELGQNRFRGSIPREVGN 503
Query: 646 CKKLSHIDLNNNLLSGAVPSWLGTLPQLGELKLSFNQFVGFLPRELFNCSKLLVLSLDGN 705
C L + L +N +G +P +G L QLG L +S N+ G +P E+FNC L L + N
Sbjct: 504 CSALQRLQLADNGFTGELPREIGMLSQLGTLNISSNKLTGEVPSEIFNCKMLQRLDMCCN 563
Query: 706 MLNGSLPNEVGNLASLNVLTLSGNLLSGPIPPAIGRLSKLYELRLSNNSLNGVIPLEIGQ 765
+G+LP+EVG+L L +L LS N LSG IP A+G LS+L EL++ N NG IP E+G
Sbjct: 564 NFSGTLPSEVGSLYQLELLKLSNNNLSGTIPVALGNLSRLTELQMGGNLFNGSIPRELGS 623
Query: 766 LQNLQSILDLSHNNFTGQIPPSMGTLAKLEVLNLSHNQLVGELPSQLGEMSSLGKLNLSY 825
L LQ L+LS+N TG+IPP + L LE L L++N L GE+PS +SSL N SY
Sbjct: 624 LTGLQIALNLSYNKLTGEIPPELSNLVMLEFLLLNNNNLSGEIPSSFANLSSLLGYNFSY 683
Query: 826 NDLQGKLSKQFSHWPAEAFEGNLHLCGSPLDHCNGLVSNQ----HQST-----ISVSLVV 876
N L G + + +F GN LCG PL+ C + Q QST + S ++
Sbjct: 684 NSLTGPI-PLLRNISMSSFIGNEGLCGPPLNQC---IQTQPFAPSQSTGKPGGMRSSKII 739
Query: 877 AISVISTLSAIALLIAVVTLFVKRKREFLRKSSQVNYTSSSSSSQAQRRLLFQAAAKRDF 936
AI+ +LIA++ ++R + S+Q S S L K F
Sbjct: 740 AITAAVIGGVSLMLIALIVYLMRRPVRTVASSAQDGQPSEMS-------LDIYFPPKEGF 792
Query: 937 RWEDIMGATNNLSDEFIIGSGGSGTVYKAELANGATVAVKKISCK----DDHLLNKSFTR 992
++D++ AT+N + F++G G GTVYKA L G T+AVKK++ +++ ++ SF
Sbjct: 793 TFQDLVAATDNFDESFVVGRGACGTVYKAVLPAGYTLAVKKLASNHEGGNNNNVDNSFRA 852
Query: 993 EVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWE 1052
E+ TLG IRHR++VKL G C ++ GSNLL+YEYM GS+ + LH N LDW
Sbjct: 853 EILTLGNIRHRNIVKLHGFCNHQ--GSNLLLYEYMPKGSLGEILHDPSCN------LDWS 904
Query: 1053 ARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSN 1112
R KIA+G AQG+ YLHHDC P+I HRDIKS+NILLD EAH+GDFGLAK + +
Sbjct: 905 KRFKIALGAAQGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPH--- 961
Query: 1113 TESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRW 1172
++S + AGSYGYIAPEYAY++K TEK D+YS G+VL+EL++GK P D+V W
Sbjct: 962 SKSMSAIAGSYGYIAPEYAYTMKVTEKSDIYSYGVVLLELLTGKAPVQP-IDQGGDVVNW 1020
Query: 1173 VEMHMEMSGSAREELLDDQMKPLLPGEECAAYQ--VLEIALQCTKTSPQERPSSRQVCDL 1230
V ++ + +LD ++ L E ++ VL+IAL CT SP RPS RQV +
Sbjct: 1021 VRSYIRRD-ALSSGVLDARLT--LEDERIVSHMLTVLKIALLCTSVSPVARPSMRQVVLM 1077
Query: 1231 LL 1232
L+
Sbjct: 1078 LI 1079
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SHI2|Y1723_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase At1g17230 OS=Arabidopsis thaliana GN=At1g17230 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 649 bits (1674), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 398/1037 (38%), Positives = 578/1037 (55%), Gaps = 46/1037 (4%)
Query: 214 CSSLSIFTAAE---NNLNGSIPAALGRLQNLQLLNLGNNSLSGEIPSELGELSQLGYLNL 270
C+ L T+ + NL+G++ + +L L+ LN+ N +SG IP +L L L+L
Sbjct: 63 CTHLRTVTSVDLNGMNLSGTLSPLICKLHGLRKLNVSTNFISGPIPQDLSLCRSLEVLDL 122
Query: 271 MGNRLEGAIPRSFAKMGNLQSLDLSMNRLTGGIPEEFGNMGQLVFLVLSNNNISGSIPRR 330
NR G IP + L+ L L N L G IP + GN+ L LV+ +NN++G IP
Sbjct: 123 CTNRFHGVIPIQLTMIITLKKLYLCENYLFGSIPRQIGNLSSLQELVIYSNNLTGVIPPS 182
Query: 331 ICTNATSLEHLILAEIQLSGEIPVELSQCQSLKQLDLSNNTLNGTIPVELFQLVALTHLY 390
+ L + SG IP E+S C+SLK L L+ N L G++P +L +L LT L
Sbjct: 183 M-AKLRQLRIIRAGRNGFSGVIPSEISGCESLKVLGLAENLLEGSLPKQLEKLQNLTDLI 241
Query: 391 LHNNSLVGSISPFVANLSNLQELALYHNNFQGSLPREIGMLVKLELLYLYDNHLSGQIPS 450
L N L G I P V N+S L+ LAL+ N F GS+PREIG L K++ LYLY N L+G+IP
Sbjct: 242 LWQNRLSGEIPPSVGNISRLEVLALHENYFTGSIPREIGKLTKMKRLYLYTNQLTGEIPR 301
Query: 451 EVGNCSSLKWIDFFGNSFTGEIPTSIGRLKDLNFLHLRQNELVGQIPASLGNCHQLIILD 510
E+GN IDF N TG IP G + +L LHL +N L+G IP LG L LD
Sbjct: 302 EIGNLIDAAEIDFSENQLTGFIPKEFGHILNLKLLHLFENILLGPIPRELGELTLLEKLD 361
Query: 511 LADNKLSGGVPASFGFLQALEQLMLYNNSLEGNLPGSLINLRNLTRINFSKNRLNGRI-A 569
L+ N+L+G +P FL L L L++N LEG +P + N + ++ S N L+G I A
Sbjct: 362 LSINRLNGTIPQELQFLPYLVDLQLFDNQLEGKIPPLIGFYSNFSVLDMSANSLSGPIPA 421
Query: 570 TLCSSHSFLSFDVTNNEFDHEIPPQLGNSPSLERLRLGNNKFIGKIPWTFGKIRELSLLD 629
C + + + +N+ IP L SL +L LG+N+ G +P ++ L+ L+
Sbjct: 422 HFCRFQTLILLSLGSNKLSGNIPRDLKTCKSLTKLMLGDNQLTGSLPIELFNLQNLTALE 481
Query: 630 LSGNSLTGPIPTQLLMCKKLSHIDLNNNLLSGAVPSWLGTLPQLGELKLSFNQFVGFLPR 689
L N L+G I L K L + L NN +G +P +G L ++ +S NQ G +P+
Sbjct: 482 LHQNWLSGNISADLGKLKNLERLRLANNNFTGEIPPEIGNLTKIVGFNISSNQLTGHIPK 541
Query: 690 ELFNCSKLLVLSLDGNMLNGSLPNEVGNLASLNVLTLSGNLLSGPIPPAIGRLSKLYELR 749
EL +C + L L GN +G + E+G L L +L LS N L+G IP + G L++L EL+
Sbjct: 542 ELGSCVTIQRLDLSGNKFSGYIAQELGQLVYLEILRLSDNRLTGEIPHSFGDLTRLMELQ 601
Query: 750 LSNNSLNGVIPLEIGQLQNLQSILDLSHNNFTGQIPPSMGTLAKLEVLNLSHNQLVGELP 809
L N L+ IP+E+G+L +LQ L++SHNN +G IP S+G L LE+L L+ N+L GE+P
Sbjct: 602 LGGNLLSENIPVELGKLTSLQISLNISHNNLSGTIPDSLGNLQMLEILYLNDNKLSGEIP 661
Query: 810 SQLGEMSSLGKLNLSYNDLQGKL--SKQFSHWPAEAFEGNLHLCGSPLDHCNGLV----- 862
+ +G + SL N+S N+L G + + F + F GN LC S HC LV
Sbjct: 662 ASIGNLMSLLICNISNNNLVGTVPDTAVFQRMDSSNFAGNHGLCNSQRSHCQPLVPHSDS 721
Query: 863 -------SNQHQSTISVSLVVAISVISTLSAIALLIAVVTLFVKRKREFLRKSSQVNYTS 915
+Q Q ++++ +V SV + + + +R+ F+ Q
Sbjct: 722 KLNWLINGSQRQKILTITCIVIGSVF-----LITFLGLCWTIKRREPAFVALEDQTKPDV 776
Query: 916 SSSSSQAQRRLLFQAAAKRDFRWEDIMGATNNLSDEFIIGSGGSGTVYKAELANGATVAV 975
S K+ F ++ ++ AT N S++ ++G G GTVYKAE++ G +AV
Sbjct: 777 MDS----------YYFPKKGFTYQGLVDATRNFSEDVVLGRGACGTVYKAEMSGGEVIAV 826
Query: 976 KKISCKDDHL-LNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIYEYMENGSVWD 1034
KK++ + + + SF E+ TLG+IRHR++VKL G C ++ SNLL+YEYM GS+ +
Sbjct: 827 KKLNSRGEGASSDNSFRAEISTLGKIRHRNIVKLYGFCYHQ--NSNLLLYEYMSKGSLGE 884
Query: 1035 WLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEA 1094
L + N LDW AR +IA+G A+G+ YLHHDC P+I+HRDIKS+NILLD +A
Sbjct: 885 QLQRGEKNCL----LDWNARYRIALGAAEGLCYLHHDCRPQIVHRDIKSNNILLDERFQA 940
Query: 1095 HLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS 1154
H+GDFGLAK + Y ++S + AGSYGYIAPEYAY++K TEKCD+YS G+VL+EL++
Sbjct: 941 HVGDFGLAKLIDLSY---SKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT 997
Query: 1155 GKMPTDATFGVEMDMVRWVEMHMEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCT 1214
GK P D+V WV + + E+ D ++ VL+IAL CT
Sbjct: 998 GKPPVQP-LEQGGDLVNWVRRSIR-NMIPTIEMFDARLDTNDKRTVHEMSLVLKIALFCT 1055
Query: 1215 KTSPQERPSSRQVCDLL 1231
SP RP+ R+V ++
Sbjct: 1056 SNSPASRPTMREVVAMI 1072
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49318|Y2317_ARATH Probable leucine-rich repeat receptor-like protein kinase At2g33170 OS=Arabidopsis thaliana GN=At2g33170 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 643 bits (1659), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 395/1031 (38%), Positives = 578/1031 (56%), Gaps = 50/1031 (4%)
Query: 226 NLNGSIPAALGRLQNLQLLNLGNNSLSGEIPSELGELSQLGYLNLMGNRLEGAIPRSFAK 285
NL+G + ++G L NL LNL N+L+G+IP E+G S+L + L N+ G+IP K
Sbjct: 96 NLSGIVSPSIGGLVNLVYLNLAYNALTGDIPREIGNCSKLEVMFLNNNQFGGSIPVEINK 155
Query: 286 MGNLQSLDLSMNRLTGGIPEEFGNMGQLVFLVLSNNNISGSIPRRICTNATSLEHLILAE 345
+ L+S ++ N+L+G +PEE G++ L LV NN++G +PR + N L +
Sbjct: 156 LSQLRSFNICNNKLSGPLPEEIGDLYNLEELVAYTNNLTGPLPRSL-GNLNKLTTFRAGQ 214
Query: 346 IQLSGEIPVELSQCQSLKQLDLSNNTLNGTIPVELFQLVALTHLYLHNNSLVGSISPFVA 405
SG IP E+ +C +LK L L+ N ++G +P E+ LV L + L N G I +
Sbjct: 215 NDFSGNIPTEIGKCLNLKLLGLAQNFISGELPKEIGMLVKLQEVILWQNKFSGFIPKDIG 274
Query: 406 NLSNLQELALYHNNFQGSLPREIGMLVKLELLYLYDNHLSGQIPSEVGNCSSLKWIDFFG 465
NL++L+ LALY N+ G +P EIG + L+ LYLY N L+G IP E+G S + IDF
Sbjct: 275 NLTSLETLALYGNSLVGPIPSEIGNMKSLKKLYLYQNQLNGTIPKELGKLSKVMEIDFSE 334
Query: 466 NSFTGEIPTSIGRLKDLNFLHLRQNELVGQIPASLGNCHQLIILDLADNKLSGGVPASFG 525
N +GEIP + ++ +L L+L QN+L G IP L L LDL+ N L+G +P F
Sbjct: 335 NLLSGEIPVELSKISELRLLYLFQNKLTGIIPNELSKLRNLAKLDLSINSLTGPIPPGFQ 394
Query: 526 FLQALEQLMLYNNSLEGNLPGSLINLRNLTRINFSKNRLNGRIAT-LCSSHSFLSFDVTN 584
L ++ QL L++NSL G +P L L ++FS+N+L+G+I +C + + ++ +
Sbjct: 395 NLTSMRQLQLFHNSLSGVIPQGLGLYSPLWVVDFSENQLSGKIPPFICQQSNLILLNLGS 454
Query: 585 NEFDHEIPPQLGNSPSLERLRLGNNKFIGKIPWTFGKIRELSLLDLSGNSLTGPIPTQLL 644
N IPP + SL +LR+ N+ G+ P K+ LS ++L N +GP+P ++
Sbjct: 455 NRIFGNIPPGVLRCKSLLQLRVVGNRLTGQFPTELCKLVNLSAIELDQNRFSGPLPPEIG 514
Query: 645 MCKKLSHIDLNNNLLSGAVPSWLGTLPQLGELKLSFNQFVGFLPRELFNCSKLLVLSLDG 704
C+KL + L N S +P+ + L L +S N G +P E+ NC L L L
Sbjct: 515 TCQKLQRLHLAANQFSSNLPNEISKLSNLVTFNVSSNSLTGPIPSEIANCKMLQRLDLSR 574
Query: 705 NMLNGSLPNEVGNLASLNVLTLSGNLLSGPIPPAIGRLSKLYELRLSNNSLNGVIPLEIG 764
N GSLP E+G+L L +L LS N SG IP IG L+ L EL++ N +G IP ++G
Sbjct: 575 NSFIGSLPPELGSLHQLEILRLSENRFSGNIPFTIGNLTHLTELQMGGNLFSGSIPPQLG 634
Query: 765 QLQNLQSILDLSHNNFTGQIPPSMGTLAKLEVLNLSHNQLVGELPSQLGEMSSLGKLNLS 824
L +LQ ++LS+N+F+G+IPP +G L L L+L++N L GE+P+ +SSL N S
Sbjct: 635 LLSSLQIAMNLSYNDFSGEIPPEIGNLHLLMYLSLNNNHLSGEIPTTFENLSSLLGCNFS 694
Query: 825 YNDLQGKL--SKQFSHWPAEAFEGNLHLCGSPLDHCNGLVSNQHQSTISVSLVVAISV-- 880
YN+L G+L ++ F + +F GN LCG L C+ H S +S + A S
Sbjct: 695 YNNLTGQLPHTQIFQNMTLTSFLGNKGLCGGHLRSCDP----SHSSWPHISSLKAGSARR 750
Query: 881 --------ISTLSAIALLIAVVTLFVKRKREFLRKSSQVNYTSSSSSSQAQRRLLFQAAA 932
LLIA+V F++ E Y + + F
Sbjct: 751 GRIIIIVSSVIGGISLLLIAIVVHFLRNPVE-----PTAPYVHDKEPFFQESDIYF--VP 803
Query: 933 KRDFRWEDIMGATNNLSDEFIIGSGGSGTVYKAELANGATVAVKKIS------CKDDHLL 986
K F +DI+ AT D +I+G G GTVYKA + +G T+AVKK+ + +
Sbjct: 804 KERFTVKDILEATKGFHDSYIVGRGACGTVYKAVMPSGKTIAVKKLESNREGNNNNSNNT 863
Query: 987 NKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMR 1046
+ SF E+ TLG+IRHR++V+L C ++G+ SNLL+YEYM GS+ + LH
Sbjct: 864 DNSFRAEILTLGKIRHRNIVRLYSFCYHQGSNSNLLLYEYMSRGSLGELLHG-----GKS 918
Query: 1047 KSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALV 1106
S+DW R IA+G A+G+ YLHHDC P+I+HRDIKS+NIL+D N EAH+GDFGLAK +
Sbjct: 919 HSMDWPTRFAIALGAAEGLAYLHHDCKPRIIHRDIKSNNILIDENFEAHVGDFGLAKVID 978
Query: 1107 EDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVE 1166
++S + AGSYGYIAPEYAY++K TEKCD+YS G+VL+EL++GK P
Sbjct: 979 MPL---SKSVSAVAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELLTGKAPVQP-LEQG 1034
Query: 1167 MDMVRWVEMHMEMSGSAREELLDDQMKPLLPGEECAA-----YQVLEIALQCTKTSPQER 1221
D+ W H+ S E+LD P L E V +IA+ CTK+SP +R
Sbjct: 1035 GDLATWTRNHIR-DHSLTSEILD----PYLTKVEDDVILNHMITVTKIAVLCTKSSPSDR 1089
Query: 1222 PSSRQVCDLLL 1232
P+ R+V +L+
Sbjct: 1090 PTMREVVLMLI 1100
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LHP4|RCH2_ARATH Receptor-like protein kinase 2 OS=Arabidopsis thaliana GN=RCH2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 609 bits (1570), Expect = e-173, Method: Compositional matrix adjust.
Identities = 389/1028 (37%), Positives = 572/1028 (55%), Gaps = 72/1028 (7%)
Query: 230 SIPAALGRLQNLQLLNLGNNSLSGEIPSELGELSQLGYLNLMGNRLEGAIPRSFAKMGNL 289
S+P L ++LQ L + +L+G +P LG+ L L+L N L G IP S +K+ NL
Sbjct: 96 SLPKNLPAFRSLQKLTISGANLTGTLPESLGDCLGLKVLDLSSNGLVGDIPWSLSKLRNL 155
Query: 290 QSLDLSMNRLTGGIPEEFGNMGQLVFLVLSNNNISGSIPRRICTNATSLEHL-ILAEIQL 348
++L L+ N+LTG IP + +L L+L +N ++GSIP + + LE + I ++
Sbjct: 156 ETLILNSNQLTGKIPPDISKCSKLKSLILFDNLLTGSIPTEL-GKLSGLEVIRIGGNKEI 214
Query: 349 SGEIPVELSQCQSLKQLDLSNNTLNGTIPVELFQLVALTHLYLHNNSLVGSISPFVANLS 408
SG+IP E+ C +L L L+ +++G +P L +L L L ++ + G I + N S
Sbjct: 215 SGQIPSEIGDCSNLTVLGLAETSVSGNLPSSLGKLKKLETLSIYTTMISGEIPSDLGNCS 274
Query: 409 NLQELALYHNNFQGSLPREIGMLVKLELLYLYDNHLSGQIPSEVGNCSSLKWIDFFGNSF 468
L +L LY N+ GS+PREIG L KLE L+L+ N L G IP E+GNCS+LK ID N
Sbjct: 275 ELVDLFLYENSLSGSIPREIGQLTKLEQLFLWQNSLVGGIPEEIGNCSNLKMIDLSLNLL 334
Query: 469 TGEIPTSIGRLKDLNFLHLRQNELVGQIPASLGNCHQLIILDLADNKLSGGVPASFGFLQ 528
+G IP+SIGRL L + N+ G IP ++ NC L+ L L N++SG +P+ G L
Sbjct: 335 SGSIPSSIGRLSFLEEFMISDNKFSGSIPTTISNCSSLVQLQLDKNQISGLIPSELGTLT 394
Query: 529 ALEQLMLYNNSLEGNLPGSLINLRNLTRINFSKNRLNGRIAT-LCSSHSFLSFDVTNNEF 587
L ++N LEG++P L + +L ++ S+N L G I + L + + +N
Sbjct: 395 KLTLFFAWSNQLEGSIPPGLADCTDLQALDLSRNSLTGTIPSGLFMLRNLTKLLLISNSL 454
Query: 588 DHEIPPQLGNSPSLERLRLGNNKFIGKIPWTFGKIRELSLLDLSGNSLTGPIPTQLLMCK 647
IP ++GN SL RLRLG N+ G+IP G +++++ LD S N L G +P ++ C
Sbjct: 455 SGFIPQEIGNCSSLVRLRLGFNRITGEIPSGIGSLKKINFLDFSSNRLHGKVPDEIGSCS 514
Query: 648 KLSHIDLNNNLLSGAVPSWLGTLPQLGELKLSFNQFVGFLPRELFNCSKLLVLSLDGNML 707
+L IDL+NN L G++P+ + +L L L +S NQF
Sbjct: 515 ELQMIDLSNNSLEGSLPNPVSSLSGLQVLDVSANQF------------------------ 550
Query: 708 NGSLPNEVGNLASLNVLTLSGNLLSGPIPPAIGRLSKLYELRLSNNSLNGVIPLEIGQLQ 767
+G +P +G L SLN L LS NL SG IP ++G S L L L +N L+G IP E+G ++
Sbjct: 551 SGKIPASLGRLVSLNKLILSKNLFSGSIPTSLGMCSGLQLLDLGSNELSGEIPSELGDIE 610
Query: 768 NLQSILDLSHNNFTGQIPPSMGTLAKLEVLNLSHNQLVGELPSQLGEMSSLGKLNLSYND 827
NL+ L+LS N TG+IP + +L KL +L+LSHN L G+L + L + +L LN+SYN
Sbjct: 611 NLEIALNLSSNRLTGKIPSKIASLNKLSILDLSHNMLEGDL-APLANIENLVSLNISYNS 669
Query: 828 LQGKL--SKQFSHWPAEAFEGNLHLCGSPLDHC-------NGLVSNQHQSTISVSLVVAI 878
G L +K F + EGN LC S D C NGL + S +
Sbjct: 670 FSGYLPDNKLFRQLSPQDLEGNKKLCSSTQDSCFLTYRKGNGLGDDGDASRTRKLRLTLA 729
Query: 879 SVISTLSAIALLIAVVTLFVKRKREFLRKSSQVNYTSSSSSSQAQRRLLFQAAAKRDFRW 938
+I+ + +L AV + +R + R S++ T + F K +F
Sbjct: 730 LLITLTVVLMILGAVAVIRARRNIDNER-DSELGET---------YKWQFTPFQKLNFSV 779
Query: 939 EDIMGATNNLSDEFIIGSGGSGTVYKAELANGATVAVKKI------SCKDDHLLN--KSF 990
+ I+ L + +IG G SG VY+A++ NG +AVKK+ D+ N SF
Sbjct: 780 DQIIRC---LVEPNVIGKGCSGVVYRADVDNGEVIAVKKLWPAMVNGGHDEKTKNVRDSF 836
Query: 991 TREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLD 1050
+ EVKTLG IRH+++V+ +G C N+ + LL+Y+YM NGS+ LH+ + SLD
Sbjct: 837 SAEVKTLGTIRHKNIVRFLGCCWNR--NTRLLMYDYMPNGSLGSLLHE-----RRGSSLD 889
Query: 1051 WEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYN 1110
W+ R +I +G AQG+ YLHHDC+P I+HRDIK++NIL+ + E ++ DFGLAK LV++ +
Sbjct: 890 WDLRYRILLGAAQGLAYLHHDCLPPIVHRDIKANNILIGLDFEPYIADFGLAK-LVDEGD 948
Query: 1111 SNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMV 1170
SNT AGSYGYIAPEY YS+K TEK DVYS G+V++E+++GK P D T + +V
Sbjct: 949 IGRCSNT-VAGSYGYIAPEYGYSMKITEKSDVYSYGVVVLEVLTGKQPIDPTVPEGIHLV 1007
Query: 1171 RWVEMHMEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDL 1230
WV + GS E+LD ++ E QVL AL C +SP ERP+ + V +
Sbjct: 1008 DWVRQN---RGSL--EVLDSTLRSRTEAEADEMMQVLGTALLCVNSSPDERPTMKDVAAM 1062
Query: 1231 LLNVFNNR 1238
L + R
Sbjct: 1063 LKEIKQER 1070
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGV1|RCH1_ARATH LRR receptor-like serine/threonine-protein kinase RCH1 OS=Arabidopsis thaliana GN=RCH1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 594 bits (1531), Expect = e-168, Method: Compositional matrix adjust.
Identities = 386/1024 (37%), Positives = 567/1024 (55%), Gaps = 69/1024 (6%)
Query: 232 PAALGRLQNLQLLNLGNNSLSGEIPSELGELSQLGYLNLMGNRLEGAIPRSFAKMGNLQS 291
P + +LQ L + N +L+G I SE+G+ S+L ++L N L G IP S K+ NLQ
Sbjct: 99 PPNISSFTSLQKLVISNTNLTGAISSEIGDCSELIVIDLSSNSLVGEIPSSLGKLKNLQE 158
Query: 292 LDLSMNRLTGGIPEEFGNMGQLVFLVLSNNNISGSIPRRICTNATSLEHLILAEIQLSGE 351
L L+ N LTG IP E G+ L L + +N +S ++P + +T +LSG+
Sbjct: 159 LCLNSNGLTGKIPPELGDCVSLKNLEIFDNYLSENLPLELGKISTLESIRAGGNSELSGK 218
Query: 352 IPVELSQCQSLKQLDLSNNTLNGTIPVELFQLVALTHLYLHNNSLVGSISPFVANLSNLQ 411
IP E+ C++LK L L+ ++G++PV L QL L L +++ L G I + N S L
Sbjct: 219 IPEEIGNCRNLKVLGLAATKISGSLPVSLGQLSKLQSLSVYSTMLSGEIPKELGNCSELI 278
Query: 412 ELALYHNNFQGSLPREIGMLVKLELLYLYDNHLSGQIPSEVGNCSSLKWIDFFGNSFTGE 471
L LY N+ G+LP+E+G L LE + L+ N+L G IP E+G SL ID N F+G
Sbjct: 279 NLFLYDNDLSGTLPKELGKLQNLEKMLLWQNNLHGPIPEEIGFMKSLNAIDLSMNYFSGT 338
Query: 472 IPTSIGRLKDLNFLHLRQNELVGQIPASLGNCHQLIILDLADNKLSGGVPASFGFLQALE 531
IP S G L +L L L N + G IP+ L NC +L+ + N++SG +P G L+ L
Sbjct: 339 IPKSFGNLSNLQELMLSSNNITGSIPSILSNCTKLVQFQIDANQISGLIPPEIGLLKELN 398
Query: 532 QLMLYNNSLEGNLPGSLINLRNLTRINFSKNRLNGRI-ATLCSSHSFLSFDVTNNEFDHE 590
+ + N LEGN+P L +NL ++ S+N L G + A L + + +N
Sbjct: 399 IFLGWQNKLEGNIPDELAGCQNLQALDLSQNYLTGSLPAGLFQLRNLTKLLLISNAISGV 458
Query: 591 IPPQLGNSPSLERLRLGNNKFIGKIPWTFGKIRELSLLDLSGNSLTGPIPTQLLMCKKLS 650
IP ++GN SL RLRL NN+ G+IP G ++ LS LDLS N+L+GP+P ++ C++L
Sbjct: 459 IPLEIGNCTSLVRLRLVNNRITGEIPKGIGFLQNLSFLDLSENNLSGPVPLEISNCRQLQ 518
Query: 651 HIDLNNNLLSGAVPSWLGTLPQLGELKLSFNQFVGFLPRELFNCSKLLVLSLDGNMLNGS 710
++L+NN L G+LP L + +KL VL + N L G
Sbjct: 519 MLNLSNNTLQ------------------------GYLPLSLSSLTKLQVLDVSSNDLTGK 554
Query: 711 LPNEVGNLASLNVLTLSGNLLSGPIPPAIGRLSKLYELRLSNNSLNGVIPLEIGQLQNLQ 770
+P+ +G+L SLN L LS N +G IP ++G + L L LS+N+++G IP E+ +Q+L
Sbjct: 555 IPDSLGHLISLNRLILSKNSFNGEIPSSLGHCTNLQLLDLSSNNISGTIPEELFDIQDLD 614
Query: 771 SILDLSHNNFTGQIPPSMGTLAKLEVLNLSHNQLVGELPSQLGEMSSLGKLNLSYNDLQG 830
L+LS N+ G IP + L +L VL++SHN L G+L S L + +L LN+S+N G
Sbjct: 615 IALNLSWNSLDGFIPERISALNRLSVLDISHNMLSGDL-SALSGLENLVSLNISHNRFSG 673
Query: 831 KL--SKQFSHWPAEAFEGNLHLCGSPLDHCNGLVSNQHQSTI-----SVSLVVAISVIST 883
L SK F EGN LC C VSN Q T S L +AI ++ +
Sbjct: 674 YLPDSKVFRQLIGAEMEGNNGLCSKGFRSC--FVSNSSQLTTQRGVHSHRLRIAIGLLIS 731
Query: 884 LSAIALLIAVVTLFVKRKREFLRKSSQVNYTSSSSSSQAQRRLLFQAAAKRDFRWEDIMG 943
++A+ ++ V L V R ++ +R + S + + F K +F E ++
Sbjct: 732 VTAVLAVLGV--LAVIRAKQMIRDDND------SETGENLWTWQFTPFQKLNFTVEHVLK 783
Query: 944 ATNNLSDEFIIGSGGSGTVYKAELANGATVAVKKISCKDDHLLNK---------SFTREV 994
L + +IG G SG VYKAE+ N +AVKK+ LN+ SF+ EV
Sbjct: 784 C---LVEGNVIGKGCSGIVYKAEMPNREVIAVKKLWPVTVPNLNEKTKSSGVRDSFSAEV 840
Query: 995 KTLGRIRHRHLVKLMGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEAR 1054
KTLG IRH+++V+ +G C NK + LL+Y+YM NGS+ LH++ SL WE R
Sbjct: 841 KTLGSIRHKNIVRFLGCCWNK--NTRLLMYDYMSNGSLGSLLHER----SGVCSLGWEVR 894
Query: 1055 LKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTE 1114
KI +G AQG+ YLHHDCVP I+HRDIK++NIL+ + E ++GDFGLAK LV+D +
Sbjct: 895 YKIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPDFEPYIGDFGLAK-LVDDGDFARS 953
Query: 1115 SNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVE 1174
SNT AGSYGYIAPEY YS+K TEK DVYS G+V++E+++GK P D T + +V WV+
Sbjct: 954 SNT-IAGSYGYIAPEYGYSMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGLHIVDWVK 1012
Query: 1175 MHMEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNV 1234
++ +++D ++ E Q L +AL C P++RP+ + V +L +
Sbjct: 1013 KIRDI------QVIDQGLQARPESEVEEMMQTLGVALLCINPIPEDRPTMKDVAAMLSEI 1066
Query: 1235 FNNR 1238
R
Sbjct: 1067 CQER 1070
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FZ59|PEPR2_ARATH Leucine-rich repeat receptor-like protein kinase PEPR2 OS=Arabidopsis thaliana GN=PEPR2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 582 bits (1500), Expect = e-165, Method: Compositional matrix adjust.
Identities = 380/1019 (37%), Positives = 561/1019 (55%), Gaps = 55/1019 (5%)
Query: 227 LNGSIPAALGRLQNLQLLNLGNNSLSGEIPSELGELSQLGYLNLMGNRLEGAIPRSFAKM 286
L+G + + +G L++L L+L NS SG +PS LG + L YL+L N G +P F +
Sbjct: 88 LSGQLGSEIGELKSLVTLDLSLNSFSGLLPSTLGNCTSLEYLDLSNNDFSGEVPDIFGSL 147
Query: 287 GNLQSLDLSMNRLTGGIPEEFGNMGQLVFLVLSNNNISGSIPRRICTNATSLEHLILAEI 346
NL L L N L+G IP G + +LV L +S NN+SG+IP + N + LE+L L
Sbjct: 148 QNLTFLYLDRNNLSGLIPASVGGLIELVDLRMSYNNLSGTIPE-LLGNCSKLEYLALNNN 206
Query: 347 QLSGEIPVELSQCQSLKQLDLSNNTLNGTIPVELFQLVALTHLYLHNNSLVGSISPFVAN 406
+L+G +P L ++L +L +SNN+L G + L L L N G + P + N
Sbjct: 207 KLNGSLPASLYLLENLGELFVSNNSLGGRLHFGSSNCKKLVSLDLSFNDFQGGVPPEIGN 266
Query: 407 LSNLQELALYHNNFQGSLPREIGMLVKLELLYLYDNHLSGQIPSEVGNCSSLKWIDFFGN 466
S+L L + N G++P +GML K+ ++ L DN LSG IP E+GNCSSL+ + N
Sbjct: 267 CSSLHSLVMVKCNLTGTIPSSMGMLRKVSVIDLSDNRLSGNIPQELGNCSSLETLKLNDN 326
Query: 467 SFTGEIPTSIGRLKDLNFLHLRQNELVGQIPASLGNCHQLIILDLADNKLSGGVPASFGF 526
GEIP ++ +LK L L L N+L G+IP + L + + +N L+G +P
Sbjct: 327 QLQGEIPPALSKLKKLQSLELFFNKLSGEIPIGIWKIQSLTQMLVYNNTLTGELPVEVTQ 386
Query: 527 LQALEQLMLYNNSLEGNLPGSLINLRNLTRINFSKNRLNGRIAT-LCSSHSFLSFDVTNN 585
L+ L++L L+NN G++P SL R+L ++ NR G I LC F + +N
Sbjct: 387 LKHLKKLTLFNNGFYGDIPMSLGLNRSLEEVDLLGNRFTGEIPPHLCHGQKLRLFILGSN 446
Query: 586 EFDHEIPPQLGNSPSLERLRLGNNKFIGKIPWTFGKIRELSLLDLSGNSLTGPIPTQLLM 645
+ +IP + +LER+RL +NK G +P F + LS ++L NS G IP L
Sbjct: 447 QLHGKIPASIRQCKTLERVRLEDNKLSGVLP-EFPESLSLSYVNLGSNSFEGSIPRSLGS 505
Query: 646 CKKLSHIDLNNNLLSGAVPSWLGTLPQLGELKLSFNQFVGFLPRELFNCSKLLVLSLDGN 705
CK L IDL+ N L+G +P LG L LG L LS N G LP +L C++LL + N
Sbjct: 506 CKNLLTIDLSQNKLTGLIPPELGNLQSLGLLNLSHNYLEGPLPSQLSGCARLLYFDVGSN 565
Query: 706 MLNGSLPNEVGNLASLNVLTLSGNLLSGPIPPAIGRLSKLYELRLSNNSLNGVIPLEIGQ 765
LNGS+P+ + SL+ L LS N G IP + L +L +LR++ N+ G IP +G
Sbjct: 566 SLNGSIPSSFRSWKSLSTLVLSDNNFLGAIPQFLAELDRLSDLRIARNAFGGKIPSSVGL 625
Query: 766 LQNLQSILDLSHNNFTGQIPPSMGTLAKLEVLNLSHNQLVGELPSQLGEMSSLGKLNLSY 825
L++L+ LDLS N FTG+IP ++G L LE LN+S+N+L G L S L + SL ++++SY
Sbjct: 626 LKSLRYGLDLSANVFTGEIPTTLGALINLERLNISNNKLTGPL-SVLQSLKSLNQVDVSY 684
Query: 826 NDLQGKLSKQFSHWPAEAFEGNLHLCGSPLDHCNGLVSNQHQS-----TISVSLVVAISV 880
N G + + F GN LC + ++ + +S +S + I+
Sbjct: 685 NQFTGPIPVNLLS-NSSKFSGNPDLCIQASYSVSAIIRKEFKSCKGQVKLSTWKIALIAA 743
Query: 881 ISTLSAIALLIAVVTLFVKRKREFLRKSSQVNYTSSSSSSQAQRRLLFQAAAKRDFRWED 940
S+LS +ALL A+ + + KR K+ N + S LL
Sbjct: 744 GSSLSVLALLFALFLVLCRCKRG--TKTEDANILAEEGLS-----LLLNK---------- 786
Query: 941 IMGATNNLSDEFIIGSGGSGTVYKAELANGATVAVKKISCKDDHLLNKSFTREVKTLGRI 1000
++ AT+NL D++IIG G G VY+A L +G AVKK+ + N++ RE++T+G +
Sbjct: 787 VLAATDNLDDKYIIGRGAHGVVYRASLGSGEEYAVKKLIFAEHIRANQNMKREIETIGLV 846
Query: 1001 RHRHLVKLMGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVG 1060
RHR+L++L K G L++Y+YM NGS+ D LH+ + LDW AR IA+G
Sbjct: 847 RHRNLIRLERFWMRKEDG--LMLYQYMPNGSLHDVLHRGN---QGEAVLDWSARFNIALG 901
Query: 1061 LAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFA 1120
++ G+ YLHHDC P I+HRDIK NIL+DS+ME H+GDFGLA+ L + +T S
Sbjct: 902 ISHGLAYLHHDCHPPIIHRDIKPENILMDSDMEPHIGDFGLARIL----DDSTVSTATVT 957
Query: 1121 GSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWV------- 1173
G+ GYIAPE AY +++ DVYS G+VL+ELV+GK D +F ++++V WV
Sbjct: 958 GTTGYIAPENAYKTVRSKESDVYSYGVVLLELVTGKRALDRSFPEDINIVSWVRSVLSSY 1017
Query: 1174 EMHMEMSG-----SAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQV 1227
E + +G +ELLD +++ A QV ++AL+CT P+ RPS R V
Sbjct: 1018 EDEDDTAGPIVDPKLVDELLDTKLRE-------QAIQVTDLALRCTDKRPENRPSMRDV 1069
|
Acts as a receptor for PEP defense peptides. Unlike typical immune receptors, senses an endogenous elicitor that potentiates PAMP-inducible plant responses. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LP24|Y1571_ARATH Probable leucine-rich repeat receptor-like protein kinase At1g35710 OS=Arabidopsis thaliana GN=At1g35710 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 578 bits (1491), Expect = e-164, Method: Compositional matrix adjust.
Identities = 391/1058 (36%), Positives = 560/1058 (52%), Gaps = 65/1058 (6%)
Query: 187 FGQLSQLEELILQQNQLQGPIPAELGNCSSLSIFTAAENNLNGSIPAALGRLQNLQLLNL 246
F LS L + L N L G IP + GN S L F + N+L G I +LG L+NL +L L
Sbjct: 98 FISLSNLAYVDLSMNLLSGTIPPQFGNLSKLIYFDLSTNHLTGEISPSLGNLKNLTVLYL 157
Query: 247 GNNSLSGEIPSELGELSQLGYLNLMGNRLEGAIPRSFAKMGNLQSLDLSMNRLTGGIPEE 306
N L+ IPSELG + + L L N+L G+IP S + NL L L N LTG IP E
Sbjct: 158 HQNYLTSVIPSELGNMESMTDLALSQNKLTGSIPSSLGNLKNLMVLYLYENYLTGVIPPE 217
Query: 307 FGNMGQLVFLVLSNNNISGSIPRRICTNATSLEHLILAEIQLSGEIPVELSQCQSLKQLD 366
GNM + L LS N ++GSIP + N +L L L E L+G IP E+ +S+ L
Sbjct: 218 LGNMESMTDLALSQNKLTGSIPSTLG-NLKNLMVLYLYENYLTGVIPPEIGNMESMTNLA 276
Query: 367 LSNNTLNGTIPVELFQLVALTHLYLHNNSLVGSISPFVANLSNLQELALYHNNFQGSLPR 426
LS N L G+IP L L LT L L N L G I P + N+ ++ +L L +N GS+P
Sbjct: 277 LSQNKLTGSIPSSLGNLKNLTLLSLFQNYLTGGIPPKLGNIESMIDLELSNNKLTGSIPS 336
Query: 427 EIGMLVKLELLYLYDNHLSGQIPSEVGNCSSLKWIDFFGNSFTGEIPTSIGRLKDLNFLH 486
+G L L +LYLY+N+L+G IP E+GN S+ + N TG IP+S G LK+L +L+
Sbjct: 337 SLGNLKNLTILYLYENYLTGVIPPELGNMESMIDLQLNNNKLTGSIPSSFGNLKNLTYLY 396
Query: 487 LRQNELVGQIPASLGNCHQLIILDLADNKLSGGVPASFGFLQALEQLMLYNNSLEGNLPG 546
L N L G IP LGN +I LDL+ NKL+G VP SFG LE L L N L G +P
Sbjct: 397 LYLNYLTGVIPQELGNMESMINLDLSQNKLTGSVPDSFGNFTKLESLYLRVNHLSGAIPP 456
Query: 547 SLINLRNLTRINFSKNRLNGRI-ATLCSSHSFLSFDVTNNEFDHEIPPQLGNSPSLERLR 605
+ N +LT + N G T+C + + N + IP L + SL R R
Sbjct: 457 GVANSSHLTTLILDTNNFTGFFPETVCKGRKLQNISLDYNHLEGPIPKSLRDCKSLIRAR 516
Query: 606 LGNNKFIGKIPWTFGKIRELSLLDLSGNSLTGPIPTQLLMCKKLSHIDLNNNLLSGAVPS 665
NKF G I FG +L+ +D S N G I + KL + ++NN ++GA+P+
Sbjct: 517 FLGNKFTGDIFEAFGIYPDLNFIDFSHNKFHGEISSNWEKSPKLGALIMSNNNITGAIPT 576
Query: 666 WLGTLPQLGELKLSFNQFVGFLPRELFNCSKLLVLSLDGNMLNGSLPNEVGNLASLNVLT 725
+ + QL EL LS N G LP + N + L L L+GN L+G +P + L +L L
Sbjct: 577 EIWNMTQLVELDLSTNNLFGELPEAIGNLTNLSRLRLNGNQLSGRVPAGLSFLTNLESLD 636
Query: 726 LSGNLLSGPIPPAIGRLSKLYELRLSNNSLNGVIPLEIGQLQNLQSILDLSHNNFTGQIP 785
LS N S IP KL+++ LS N +G IP + +L L LDLSHN G+IP
Sbjct: 637 LSSNNFSSEIPQTFDSFLKLHDMNLSRNKFDGSIP-RLSKLTQLTQ-LDLSHNQLDGEIP 694
Query: 786 PSMGTLAKLEVLNLSHNQLVGELPSQLGEMSSLGKLNLSYNDLQGKL--SKQFSHWPAEA 843
+ +L L+ L+LSHN L G +P+ M +L +++S N L+G L + F A+A
Sbjct: 695 SQLSSLQSLDKLDLSHNNLSGLIPTTFEGMIALTNVDISNNKLEGPLPDTPTFRKATADA 754
Query: 844 FEGNLHLCGS----PLDHCNGLVSNQHQSTISVSLVVAISVISTLSAIALLIAVVTLFVK 899
E N+ LC + L C L + + V ++V I + L +++ T ++
Sbjct: 755 LEENIGLCSNIPKQRLKPCRELKKPKKNGNLVVWILVPI--LGVLVILSICANTFTYCIR 812
Query: 900 RKREFLRKSSQVNYTSSSSSSQAQRRLLFQAAAKRDFRWEDIMGATNNLSDEFIIGSGGS 959
+++ + ++ + +F K F+++DI+ +TN +IG+GG
Sbjct: 813 KRK--------LQNGRNTDPETGENMSIFSVDGK--FKYQDIIESTNEFDPTHLIGTGGY 862
Query: 960 GTVYKAELANGATVAVKKISCKDDHLLNK-----SFTREVKTLGRIRHRHLVKLMGHCCN 1014
VY+A L + +AVK++ D ++K F EVK L IRHR++VKL G C +
Sbjct: 863 SKVYRANLQD-TIIAVKRLHDTIDEEISKPVVKQEFLNEVKALTEIRHRNVVKLFGFCSH 921
Query: 1015 KGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVP 1074
+ LIYEYME GS L+K N + K L W R+ + G+A + Y+HHD +
Sbjct: 922 RR--HTFLIYEYMEKGS----LNKLLANDEEAKRLTWTKRINVVKGVAHALSYMHHDRIT 975
Query: 1075 KILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTW--FAGSYGYIAPEYAY 1132
I+HRDI S NILLD++ A + DFG AK L T+S+ W AG+YGY+APE+AY
Sbjct: 976 PIVHRDISSGNILLDNDYTAKISDFGTAKLL------KTDSSNWSAVAGTYGYVAPEFAY 1029
Query: 1133 SLKATEKCDVYSMGIVLMELVSGKMPTDATFGV-----EMDMVRWV--EMHMEMSGSARE 1185
++K TEKCDVYS G++++EL+ GK P D + E +R + E +E G RE
Sbjct: 1030 TMKVTEKCDVYSFGVLILELIIGKHPGDLVSSLSSSPGEALSLRSISDERVLEPRGQNRE 1089
Query: 1186 ELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPS 1223
+LL +++E+AL C + +P+ RP+
Sbjct: 1090 KLL----------------KMVEMALLCLQANPESRPT 1111
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8VZG8|Y4885_ARATH Probable LRR receptor-like serine/threonine-protein kinase At4g08850 OS=Arabidopsis thaliana GN=At4g08850 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 565 bits (1456), Expect = e-160, Method: Compositional matrix adjust.
Identities = 350/972 (36%), Positives = 535/972 (55%), Gaps = 49/972 (5%)
Query: 268 LNLMGNRLEGAIPR-SFAKMGNLQSLDLSMNRLTGGIPEEFGNMGQLVFLVLSNNNISGS 326
LNL +EG F+ + NL +DLSMNR +G I +G +L + LS N + G
Sbjct: 98 LNLTNTGIEGTFEDFPFSSLPNLTFVDLSMNRFSGTISPLWGRFSKLEYFDLSINQLVGE 157
Query: 327 IPRRICTNATSLEHLILAEIQLSGEIPVELSQCQSLKQLDLSNNTLNGTIPVELFQLVAL 386
IP + + ++L+ L L E +L+G IP E+ + + ++ + +N L G IP L L
Sbjct: 158 IPPELG-DLSNLDTLHLVENKLNGSIPSEIGRLTKVTEIAIYDNLLTGPIPSSFGNLTKL 216
Query: 387 THLYLHNNSLVGSISPFVANLSNLQELALYHNNFQGSLPREIGMLVKLELLYLYDNHLSG 446
+LYL NSL GSI + NL NL+EL L NN G +P G L + LL +++N LSG
Sbjct: 217 VNLYLFINSLSGSIPSEIGNLPNLRELCLDRNNLTGKIPSSFGNLKNVTLLNMFENQLSG 276
Query: 447 QIPSEVGNCSSLKWIDFFGNSFTGEIPTSIGRLKDLNFLHLRQNELVGQIPASLGNCHQL 506
+IP E+GN ++L + N TG IP+++G +K L LHL N+L G IP LG +
Sbjct: 277 EIPPEIGNMTALDTLSLHTNKLTGPIPSTLGNIKTLAVLHLYLNQLNGSIPPELGEMESM 336
Query: 507 IILDLADNKLSGGVPASFGFLQALEQLMLYNNSLEGNLPGSLINLRNLTRINFSKNRLNG 566
I L++++NKL+G VP SFG L ALE L L +N L G +P + N LT + N G
Sbjct: 337 IDLEISENKLTGPVPDSFGKLTALEWLFLRDNQLSGPIPPGIANSTELTVLQLDTNNFTG 396
Query: 567 RIA-TLCSSHSFLSFDVTNNEFDHEIPPQLGNSPSLERLRLGNNKFIGKIPWTFGKIREL 625
+ T+C + + +N F+ +P L + SL R+R N F G I FG L
Sbjct: 397 FLPDTICRGGKLENLTLDDNHFEGPVPKSLRDCKSLIRVRFKGNSFSGDISEAFGVYPTL 456
Query: 626 SLLDLSGNSLTGPIPTQLLMCKKLSHIDLNNNLLSGAVPSWLGTLPQLGELKLSFNQFVG 685
+ +DLS N+ G + +KL L+NN ++GA+P + + QL +L LS N+ G
Sbjct: 457 NFIDLSNNNFHGQLSANWEQSQKLVAFILSNNSITGAIPPEIWNMTQLSQLDLSSNRITG 516
Query: 686 FLPRELFNCSKLLVLSLDGNMLNGSLPNEVGNLASLNVLTLSGNLLSGPIPPAIGRLSKL 745
LP + N +++ L L+GN L+G +P+ + L +L L LS N S IPP + L +L
Sbjct: 517 ELPESISNINRISKLQLNGNRLSGKIPSGIRLLTNLEYLDLSSNRFSSEIPPTLNNLPRL 576
Query: 746 YELRLSNNSLNGVIPLEIGQLQNLQSILDLSHNNFTGQIPPSMGTLAKLEVLNLSHNQLV 805
Y + LS N L+ IP + +L LQ +LDLS+N G+I +L LE L+LSHN L
Sbjct: 577 YYMNLSRNDLDQTIPEGLTKLSQLQ-MLDLSYNQLDGEISSQFRSLQNLERLDLSHNNLS 635
Query: 806 GELPSQLGEMSSLGKLNLSYNDLQGKL--SKQFSHWPAEAFEGNLHLCGSPLDHCNGL-- 861
G++P +M +L +++S+N+LQG + + F + P +AFEGN LCGS ++ GL
Sbjct: 636 GQIPPSFKDMLALTHVDVSHNNLQGPIPDNAAFRNAPPDAFEGNKDLCGS-VNTTQGLKP 694
Query: 862 --VSNQHQSTISVSLVVAISVISTLSAIALLIAVVTLFVKRKREFLRKSSQVN-YTSSSS 918
+++ +S +L++ I ++ + AI +L +F+ F +++ Q+ +T S S
Sbjct: 695 CSITSSKKSHKDRNLIIYI-LVPIIGAIIILSVCAGIFIC----FRKRTKQIEEHTDSES 749
Query: 919 SSQAQRRLLFQAAAKRDFRWEDIMGATNNLSDEFIIGSGGSGTVYKAELANGATVAVKKI 978
+ F R+++I+ AT +++IG+GG G VYKA+L N A +AVKK+
Sbjct: 750 GGETLSIFSFDGKV----RYQEIIKATGEFDPKYLIGTGGHGKVYKAKLPN-AIMAVKKL 804
Query: 979 SCKDDHLLN-----KSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIYEYMENGSVW 1033
+ D ++ + F E++ L IRHR++VKL G C ++ + L+YEYME GS
Sbjct: 805 NETTDSSISNPSTKQEFLNEIRALTEIRHRNVVKLFGFCSHRR--NTFLVYEYMERGS-- 860
Query: 1034 DWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNME 1093
L K N K LDW R+ + G+A + Y+HHD P I+HRDI S NILL + E
Sbjct: 861 --LRKVLENDDEAKKLDWGKRINVVKGVAHALSYMHHDRSPAIVHRDISSGNILLGEDYE 918
Query: 1094 AHLGDFGLAKALVEDYNSNTESNTW--FAGSYGYIAPEYAYSLKATEKCDVYSMGIVLME 1151
A + DFG AK L D S+ W AG+YGY+APE AY++K TEKCDVYS G++ +E
Sbjct: 919 AKISDFGTAKLLKPD------SSNWSAVAGTYGYVAPELAYAMKVTEKCDVYSFGVLTLE 972
Query: 1152 LVSGKMPTDATFGVEMDMVRWVEMHMEMSGSAREELLDDQMKPLLPGEECAAYQVLEIAL 1211
++ G+ P D+V + + + + + D ++ P + ++L++AL
Sbjct: 973 VIKGEHPG--------DLVSTLSSSPPDATLSLKSISDHRLPEPTPEIKEEVLEILKVAL 1024
Query: 1212 QCTKTSPQERPS 1223
C + PQ RP+
Sbjct: 1025 LCLHSDPQARPT 1036
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 1251 | ||||||
| 224057908 | 1253 | predicted protein [Populus trichocarpa] | 0.997 | 0.996 | 0.746 | 0.0 | |
| 224072399 | 1254 | predicted protein [Populus trichocarpa] | 0.997 | 0.995 | 0.751 | 0.0 | |
| 255578513 | 1257 | Leucine-rich repeat receptor protein kin | 0.980 | 0.975 | 0.749 | 0.0 | |
| 449454947 | 1261 | PREDICTED: LRR receptor-like serine/thre | 0.990 | 0.982 | 0.702 | 0.0 | |
| 449473884 | 1261 | PREDICTED: LRR receptor-like serine/thre | 0.990 | 0.982 | 0.702 | 0.0 | |
| 356510820 | 1268 | PREDICTED: LRR receptor-like serine/thre | 0.989 | 0.976 | 0.713 | 0.0 | |
| 42566982 | 1249 | LRR receptor-like serine/threonine-prote | 0.980 | 0.981 | 0.688 | 0.0 | |
| 356528160 | 1272 | PREDICTED: LRR receptor-like serine/thre | 0.988 | 0.971 | 0.708 | 0.0 | |
| 297804124 | 1252 | hypothetical protein ARALYDRAFT_354732 [ | 0.988 | 0.988 | 0.677 | 0.0 | |
| 2982431 | 1232 | leucine rich repeat-like protein [Arabid | 0.966 | 0.981 | 0.682 | 0.0 |
| >gi|224057908|ref|XP_002299384.1| predicted protein [Populus trichocarpa] gi|222846642|gb|EEE84189.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1826 bits (4730), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 938/1256 (74%), Positives = 1072/1256 (85%), Gaps = 8/1256 (0%)
Query: 1 MVMFKQVLLGLLLLLLCFSPGFVLCKDEELSVLLEIKKSFTADPENVLHAWNQSNQNLCT 60
M + KQVLL + +L+CFS GFVLC+++ELSVLLE+KKSF DPE VLH WN+SN N CT
Sbjct: 1 MGVPKQVLLLFVAILVCFSFGFVLCQNQELSVLLEVKKSFEGDPEKVLHDWNESNPNSCT 60
Query: 61 WRGITCG----SSSARVVSLNLSGLSLAGSISPSLGRLQSLIHLDLSSNSLTGPIPTALS 116
W G+TCG S +VVSLNLS SL+GSISPSLG L+ L+HLDLSSNSLTGPIPT LS
Sbjct: 61 WTGVTCGLNSVDGSVQVVSLNLSDSSLSGSISPSLGSLKYLLHLDLSSNSLTGPIPTTLS 120
Query: 117 NLSSLESLLLFSNQLAGTIPTQLGSLTSLRVMRIGDNWLSGSIPTSFGNLVNLGTLGLAS 176
NLSSLE+LLLFSNQL G IP QLGS+TSL VMRIGDN LSG +P SFGNLVNL TLGLAS
Sbjct: 121 NLSSLETLLLFSNQLTGPIPIQLGSITSLLVMRIGDNGLSGPVPASFGNLVNLVTLGLAS 180
Query: 177 CSLSGPIPPQFGQLSQLEELILQQNQLQGPIPAELGNCSSLSIFTAAENNLNGSIPAALG 236
CSL+GPIPPQ GQLSQ++ LILQQNQL+G IPAELGNCSSL++FT A NNLNGSIP LG
Sbjct: 181 CSLTGPIPPQLGQLSQVQNLILQQNQLEGLIPAELGNCSSLTVFTVALNNLNGSIPGELG 240
Query: 237 RLQNLQLLNLGNNSLSGEIPSELGELSQLGYLNLMGNRLEGAIPRSFAKMGNLQSLDLSM 296
RLQNLQ+LNL NNSLSGEIP++LGE+SQL YLN MGN L G+IP+S AKMG+LQ+LDLSM
Sbjct: 241 RLQNLQILNLANNSLSGEIPTQLGEMSQLVYLNFMGNHLGGSIPKSLAKMGSLQNLDLSM 300
Query: 297 NRLTGGIPEEFGNMGQLVFLVLSNNNISGSIPRRICTNATSLEHLILAEIQLSGEIPVEL 356
N LTGG+PEE G M QLVFLVLSNNN+SG IP +C+N T+LE LIL+EIQLSG IP EL
Sbjct: 301 NMLTGGVPEELGRMAQLVFLVLSNNNLSGVIPTSLCSNNTNLESLILSEIQLSGPIPKEL 360
Query: 357 SQCQSLKQLDLSNNTLNGTIPVELFQLVALTHLYLHNNSLVGSISPFVANLSNLQELALY 416
C SL QLDLSNN+LNG+IP E+++ V LTHLYLHNNSLVGSISP +ANLSNL+ELALY
Sbjct: 361 RLCPSLMQLDLSNNSLNGSIPNEIYESVQLTHLYLHNNSLVGSISPLIANLSNLKELALY 420
Query: 417 HNNFQGSLPREIGMLVKLELLYLYDNHLSGQIPSEVGNCSSLKWIDFFGNSFTGEIPTSI 476
HNN G+LP+EIGML LE+LYLYDN LSG+IP E+GNCS+L+ IDF+GN F+GEIP +I
Sbjct: 421 HNNLLGNLPKEIGMLGNLEVLYLYDNLLSGEIPMEIGNCSNLQMIDFYGNHFSGEIPVTI 480
Query: 477 GRLKDLNFLHLRQNELVGQIPASLGNCHQLIILDLADNKLSGGVPASFGFLQALEQLMLY 536
GRLK LN LHLRQNEL G IPA+LGNCHQL ILDLADN LSGG+P +FGFL ALEQLMLY
Sbjct: 481 GRLKGLNLLHLRQNELFGHIPATLGNCHQLTILDLADNGLSGGIPVTFGFLHALEQLMLY 540
Query: 537 NNSLEGNLPGSLINLRNLTRINFSKNRLNGRIATLCSSHSFLSFDVTNNEFDHEIPPQLG 596
NNSLEGNLP SL NLRNLTRIN SKNR+NG I+ LC S SFLSFDVT+N F +EIP LG
Sbjct: 541 NNSLEGNLPDSLTNLRNLTRINLSKNRINGSISALCGSSSFLSFDVTSNAFGNEIPALLG 600
Query: 597 NSPSLERLRLGNNKFIGKIPWTFGKIRELSLLDLSGNSLTGPIPTQLLMCKKLSHIDLNN 656
NSPSLERLRLGNN+F GKIPWT G+IRELSLLDLSGN LTG IP QL++CKKL H+DLNN
Sbjct: 601 NSPSLERLRLGNNRFTGKIPWTLGQIRELSLLDLSGNLLTGQIPAQLMLCKKLEHVDLNN 660
Query: 657 NLLSGAVPSWLGTLPQLGELKLSFNQFVGFLPRELFNCSKLLVLSLDGNMLNGSLPNEVG 716
NLL G+VPSWLG LPQLGELKL NQF G LPRELFNCSKLLVLSLD N LNG+LP EVG
Sbjct: 661 NLLYGSVPSWLGNLPQLGELKLFSNQFTGSLPRELFNCSKLLVLSLDANFLNGTLPVEVG 720
Query: 717 NLASLNVLTLSGNLLSGPIPPAIGRLSKLYELRLSNNSLNGVIPLEIGQLQNLQSILDLS 776
NL SLNVL L+ N LSG IP ++G+LSKLYELRLSNNS +G IP E+GQLQNLQSILDLS
Sbjct: 721 NLESLNVLNLNQNQLSGSIPLSLGKLSKLYELRLSNNSFSGEIPSELGQLQNLQSILDLS 780
Query: 777 HNNFTGQIPPSMGTLAKLEVLNLSHNQLVGELPSQLGEMSSLGKLNLSYNDLQGKLSKQF 836
+NN GQIPPS+GTL+KLE L+LSHN LVG +P ++G +SSLGKLNLS+N+LQGKL KQF
Sbjct: 781 YNNLGGQIPPSIGTLSKLEALDLSHNCLVGAVPPEVGSLSSLGKLNLSFNNLQGKLDKQF 840
Query: 837 SHWPAEAFEGNLHLCGSPLDHCNGLVSNQHQSTISVSLVVAISVISTLSAIALLIAVVTL 896
SHWP EAFEGNL LCG+PL+ C+ ++S+Q QS +S VV IS I++L+AIALL + L
Sbjct: 841 SHWPPEAFEGNLQLCGNPLNRCS-ILSDQ-QSGLSELSVVVISAITSLAAIALLALGLAL 898
Query: 897 FVKRKREFLRKSSQVNYTSSSSSSQAQRRLLF-QAAAKRDFRWEDIMGATNNLSDEFIIG 955
F KR+REFL++ S+ N SSSSSQAQR+ F + AKRD+RW+D+M ATNNLSDEFIIG
Sbjct: 899 FFKRRREFLKRVSEGNCICSSSSSQAQRKTPFLRGTAKRDYRWDDLMEATNNLSDEFIIG 958
Query: 956 SGGSGTVYKAELANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNK 1015
SGGSGT+Y+AE +G TVAVKKI KD+ LLNKSF REVKTLGRIRHR+LVKL+G+C NK
Sbjct: 959 SGGSGTIYRAEFQSGETVAVKKILWKDEFLLNKSFAREVKTLGRIRHRNLVKLIGYCSNK 1018
Query: 1016 GAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPK 1075
GAG NLLIYEYMENGS+WDWLH+QPVN K R+SLDWEARLKI VGLAQGVEYLHHDCVPK
Sbjct: 1019 GAGCNLLIYEYMENGSLWDWLHQQPVNSKQRQSLDWEARLKIGVGLAQGVEYLHHDCVPK 1078
Query: 1076 ILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLK 1135
I+HRDIKSSN+LLDSNMEAHLGDFGLAKAL E+Y+SNTES++WFAGSYGYIAPE+AYS K
Sbjct: 1079 IMHRDIKSSNVLLDSNMEAHLGDFGLAKALEENYDSNTESHSWFAGSYGYIAPEHAYSFK 1138
Query: 1136 ATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSAREELLDDQMKPL 1195
ATEK DVYSMGIVLMELVSGK PTDATFGV+MDMVRWVE H EM G + EL+D +KPL
Sbjct: 1139 ATEKSDVYSMGIVLMELVSGKTPTDATFGVDMDMVRWVEKHTEMQGESARELIDPALKPL 1198
Query: 1196 LPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNVFNNRIVDFDKLHIDPYA 1251
+P EE AAYQ+LEIALQCTKT+PQERPSSR CD LL+++ NR+VDFD ++IDP A
Sbjct: 1199 VPYEEYAAYQMLEIALQCTKTTPQERPSSRHACDQLLHLYKNRMVDFD-MNIDPNA 1253
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224072399|ref|XP_002303717.1| predicted protein [Populus trichocarpa] gi|222841149|gb|EEE78696.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1798 bits (4657), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 945/1257 (75%), Positives = 1075/1257 (85%), Gaps = 9/1257 (0%)
Query: 1 MVMFKQVLLGLLLLLLCFSPGFVLCKDEELSVLLEIKKSFTADPENVLHAWNQSNQNLCT 60
M + K+VLL LL CFS GFVLC+++ELS LLE+KKSF DPE VL WN+SN N CT
Sbjct: 1 MAVPKRVLLLFAALLFCFSFGFVLCQNQELSSLLEVKKSFEGDPEKVLLDWNESNPNFCT 60
Query: 61 WRGITCG----SSSARVVSLNLSGLSLAGSISPSLGRLQSLIHLDLSSNSLTGPIPTALS 116
W G+ CG S +VVSLNLS SL+GSI PSLG LQ L+ LDLSSNSLTGPIP LS
Sbjct: 61 WTGVICGLNSVDGSVQVVSLNLSDSSLSGSIPPSLGSLQKLLQLDLSSNSLTGPIPATLS 120
Query: 117 NLSSLESLLLFSNQLAGTIPTQLGSLTSLRVMRIGDNWLSGSIPTSFGNLVNLGTLGLAS 176
NLSSLESLLLFSNQL G IPTQLGSL SL+V+RIGDN LSG IP SFGNLVNL TLGLAS
Sbjct: 121 NLSSLESLLLFSNQLTGPIPTQLGSLKSLQVLRIGDNGLSGPIPASFGNLVNLVTLGLAS 180
Query: 177 CSLSGPIPPQFGQLSQLEELILQQNQLQGPIPAELGNCSSLSIFTAAENNLNGSIPAALG 236
CSL+GPIPPQ GQLSQ++ LILQQNQL+GPIPAELGNCSSL++FT A NNLNGSIP ALG
Sbjct: 181 CSLTGPIPPQLGQLSQVQSLILQQNQLEGPIPAELGNCSSLTVFTVAVNNLNGSIPGALG 240
Query: 237 RLQNLQLLNLGNNSLSGEIPSELGELSQLGYLNLMGNRLEGAIPRSFAKMGNLQSLDLSM 296
RLQNLQ LNL NNSLSGEIPS+LGELSQL YLN MGN+L+G IP+S AKM NLQ+LDLSM
Sbjct: 241 RLQNLQTLNLANNSLSGEIPSQLGELSQLVYLNFMGNQLQGPIPKSLAKMSNLQNLDLSM 300
Query: 297 NRLTGGIPEEFGNMGQLVFLVLSNNNISGSIPRRICTNATSLEHLILAEIQLSGEIPVEL 356
N LTGG+PEEFG+M QL+++VLSNNN+SG IPR +CTN T+LE LIL+E QLSG IP+EL
Sbjct: 301 NMLTGGVPEEFGSMNQLLYMVLSNNNLSGVIPRSLCTNNTNLESLILSETQLSGPIPIEL 360
Query: 357 SQCQSLKQLDLSNNTLNGTIPVELFQLVALTHLYLHNNSLVGSISPFVANLSNLQELALY 416
C SL QLDLSNN+LNG+IP E+++ + LTHLYLHNNSLVGSISP +ANLSNL+ELALY
Sbjct: 361 RLCPSLMQLDLSNNSLNGSIPTEIYESIQLTHLYLHNNSLVGSISPLIANLSNLKELALY 420
Query: 417 HNNFQGSLPREIGMLVKLELLYLYDNHLSGQIPSEVGNCSSLKWIDFFGNSFTGEIPTSI 476
HN+ QG+LP+EIGML LE+LYLYDN LSG+IP E+GNCS+LK +DFFGN F+GEIP SI
Sbjct: 421 HNSLQGNLPKEIGMLGNLEVLYLYDNQLSGEIPMEIGNCSNLKMVDFFGNHFSGEIPVSI 480
Query: 477 GRLKDLNFLHLRQNELVGQIPASLGNCHQLIILDLADNKLSGGVPASFGFLQALEQLMLY 536
GRLK LN LHLRQNEL G IPA+LGNCHQL ILDLADN LSGG+P +FGFLQALEQLMLY
Sbjct: 481 GRLKGLNLLHLRQNELGGHIPAALGNCHQLTILDLADNGLSGGIPVTFGFLQALEQLMLY 540
Query: 537 NNSLEGNLPGSLINLRNLTRINFSKNRLNGRIATLCSSHSFLSFDVTNNEFDHEIPPQLG 596
NNSLEGNLP SL NLR+LTRIN SKNR NG IA LCSS SFLSFDVT+N F +EIP QLG
Sbjct: 541 NNSLEGNLPYSLTNLRHLTRINLSKNRFNGSIAALCSSSSFLSFDVTSNSFANEIPAQLG 600
Query: 597 NSPSLERLRLGNNKFIGKIPWTFGKIRELSLLDLSGNSLTGPIPTQLLMCKKLSHIDLNN 656
NSPSLERLRLGNN+F G +PWT GKIRELSLLDLSGN LTGPIP QL++CKKL+HIDLNN
Sbjct: 601 NSPSLERLRLGNNQFTGNVPWTLGKIRELSLLDLSGNLLTGPIPPQLMLCKKLTHIDLNN 660
Query: 657 NLLSGAVPSWLGTLPQLGELKLSFNQFVGFLPRELFNCSKLLVLSLDGNMLNGSLPNEVG 716
NLLSG +PS LG LPQLGELKLS NQF G LP ELFNCSKLLVLSLDGN+LNG+LP EVG
Sbjct: 661 NLLSGPLPSSLGNLPQLGELKLSSNQFSGSLPSELFNCSKLLVLSLDGNLLNGTLPVEVG 720
Query: 717 NLASLNVLTLSGNLLSGPIPPAIGRLSKLYELRLSNNSLNGVIPLEIGQLQNLQSILDLS 776
L LNVL L N LSG IP A+G+LSKLYEL+LS+NS +G IP E+GQLQNLQSILDL
Sbjct: 721 KLEFLNVLNLEQNQLSGSIPAALGKLSKLYELQLSHNSFSGEIPFELGQLQNLQSILDLG 780
Query: 777 HNNFTGQIPPSMGTLAKLEVLNLSHNQLVGELPSQLGEMSSLGKLNLSYNDLQGKLSKQF 836
+NN +GQIP S+G L+KLE L+LSHNQLVG +P ++G+MSSLGKLNLS+N+LQGKL +QF
Sbjct: 781 YNNLSGQIPSSIGKLSKLEALDLSHNQLVGAVPPEVGDMSSLGKLNLSFNNLQGKLGEQF 840
Query: 837 SHWPAEAFEGNLHLCGSPLDHCNGLVSNQHQSTISVSLVVAISVISTLSAIALLIAVVTL 896
SHWP EAFEGNL LCGSPLDHC+ VS+Q +S +S S VV IS I+TL+A+ALL + L
Sbjct: 841 SHWPTEAFEGNLQLCGSPLDHCS--VSSQ-RSGLSESSVVVISAITTLTAVALLALGLAL 897
Query: 897 FVKRKREFLRKSSQVNYTSSSSSSQAQRRLLF-QAAAKRDFRWEDIMGATNNLSDEFIIG 955
F+K + EFLR+ S+V SSSSSQAQR+ LF + AKRD+RW+DIM ATNNLSDEFIIG
Sbjct: 898 FIKHRLEFLRRVSEVKCIYSSSSSQAQRKPLFRKGTAKRDYRWDDIMAATNNLSDEFIIG 957
Query: 956 SGGSGTVYKAELANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNK 1015
SGGSGT+Y+ E +G TVAVKKI KD+ LLNKSF REVKTLGRIRHRHLVKL+G+C ++
Sbjct: 958 SGGSGTIYRTEFQSGETVAVKKILWKDEFLLNKSFAREVKTLGRIRHRHLVKLIGYCSSE 1017
Query: 1016 GAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPK 1075
GAG NLLIYEYMENGS+WDWL +QPVNIK R+SLDWE RLKI +GLAQGVEYLHHDCVPK
Sbjct: 1018 GAGCNLLIYEYMENGSLWDWLRQQPVNIKKRQSLDWETRLKIGLGLAQGVEYLHHDCVPK 1077
Query: 1076 ILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLK 1135
I+HRDIKSSNILLDS MEAHLGDFGLAKAL E+Y+SNTES++WFAGSYGYIAPEYAY+LK
Sbjct: 1078 IIHRDIKSSNILLDSTMEAHLGDFGLAKALEENYDSNTESHSWFAGSYGYIAPEYAYTLK 1137
Query: 1136 ATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGS-AREELLDDQMKP 1194
ATEK DVYSMGIVLMELVSGKMPTDA+FGV+MDMVRWVE HMEM G REEL+D +KP
Sbjct: 1138 ATEKSDVYSMGIVLMELVSGKMPTDASFGVDMDMVRWVEKHMEMQGGCGREELIDPALKP 1197
Query: 1195 LLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNVFNNRIVDFDKLHIDPYA 1251
LLP EE AAYQ+LEIALQCTKT+PQERPSSRQ CD LL+++ NR+VDFDK++ DPY+
Sbjct: 1198 LLPCEESAAYQLLEIALQCTKTTPQERPSSRQACDQLLHLYKNRMVDFDKMNNDPYS 1254
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255578513|ref|XP_002530120.1| Leucine-rich repeat receptor protein kinase EXS precursor, putative [Ricinus communis] gi|223530374|gb|EEF32264.1| Leucine-rich repeat receptor protein kinase EXS precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1795 bits (4649), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 923/1231 (74%), Positives = 1065/1231 (86%), Gaps = 5/1231 (0%)
Query: 24 LCKDEELSVLLEIKKSFTADPENVLHAWNQSNQNLCTWRGITCG----SSSARVVSLNLS 79
+C+ +LSVLLE+KKSF DPEN+LH WN+SN N CTWRG+TCG S +VSLNLS
Sbjct: 24 VCQTHDLSVLLEVKKSFIDDPENILHDWNESNPNFCTWRGVTCGLNSGDGSVHLVSLNLS 83
Query: 80 GLSLAGSISPSLGRLQSLIHLDLSSNSLTGPIPTALSNLSSLESLLLFSNQLAGTIPTQL 139
SL+GS+SP LGRL +LIHLDLSSNSLTGPIPT LSNLS LESLLLFSN+L G+IPTQL
Sbjct: 84 DSSLSGSVSPFLGRLHNLIHLDLSSNSLTGPIPTTLSNLSLLESLLLFSNELTGSIPTQL 143
Query: 140 GSLTSLRVMRIGDNWLSGSIPTSFGNLVNLGTLGLASCSLSGPIPPQFGQLSQLEELILQ 199
GSL SLRVMRIGDN L+G IP SF NL +L TLGLASCSL+GPIPPQ G+L ++E LILQ
Sbjct: 144 GSLASLRVMRIGDNALTGPIPASFANLAHLVTLGLASCSLTGPIPPQLGRLGRVENLILQ 203
Query: 200 QNQLQGPIPAELGNCSSLSIFTAAENNLNGSIPAALGRLQNLQLLNLGNNSLSGEIPSEL 259
QNQL+GPIPAELGNCSSL++FTAA NNLNGSIP LGRLQNLQ+LNL NNSLSG IPS++
Sbjct: 204 QNQLEGPIPAELGNCSSLTVFTAAVNNLNGSIPGELGRLQNLQILNLANNSLSGYIPSQV 263
Query: 260 GELSQLGYLNLMGNRLEGAIPRSFAKMGNLQSLDLSMNRLTGGIPEEFGNMGQLVFLVLS 319
E++QL Y+NL+GN++EG IP S AK+ NLQ+LDLSMNRL G IPEEFGNM QLV+LVLS
Sbjct: 264 SEMTQLIYMNLLGNQIEGPIPGSLAKLANLQNLDLSMNRLAGSIPEEFGNMDQLVYLVLS 323
Query: 320 NNNISGSIPRRICTNATSLEHLILAEIQLSGEIPVELSQCQSLKQLDLSNNTLNGTIPVE 379
NNN+SG IPR IC+NAT+L LIL+E QLSG IP EL QC SL+QLDLSNNTLNG++P E
Sbjct: 324 NNNLSGVIPRSICSNATNLVSLILSETQLSGPIPKELRQCPSLQQLDLSNNTLNGSLPNE 383
Query: 380 LFQLVALTHLYLHNNSLVGSISPFVANLSNLQELALYHNNFQGSLPREIGMLVKLELLYL 439
+F++ LTHLYLHNNSLVGSI P +ANLSNL+ELALYHNN QG+LP+EIGML LE+LYL
Sbjct: 384 IFEMTQLTHLYLHNNSLVGSIPPLIANLSNLKELALYHNNLQGNLPKEIGMLGNLEILYL 443
Query: 440 YDNHLSGQIPSEVGNCSSLKWIDFFGNSFTGEIPTSIGRLKDLNFLHLRQNELVGQIPAS 499
YDN SG+IP E+ NCSSL+ +DFFGN F+GEIP +IGRLK LN LHLRQNELVG+IPAS
Sbjct: 444 YDNQFSGEIPMEIVNCSSLQMVDFFGNHFSGEIPFAIGRLKGLNLLHLRQNELVGEIPAS 503
Query: 500 LGNCHQLIILDLADNKLSGGVPASFGFLQALEQLMLYNNSLEGNLPGSLINLRNLTRINF 559
LGNCHQL ILDLADN LSGG+PA+FGFLQ+LEQLMLYNNSLEGN+P SL NLRNLTRIN
Sbjct: 504 LGNCHQLTILDLADNHLSGGIPATFGFLQSLEQLMLYNNSLEGNIPDSLTNLRNLTRINL 563
Query: 560 SKNRLNGRIATLCSSHSFLSFDVTNNEFDHEIPPQLGNSPSLERLRLGNNKFIGKIPWTF 619
S+NRLNG IA LCSS SFLSFDVT+N FD EIPPQLGNSPSLERLRLGNNKF GKIPW
Sbjct: 564 SRNRLNGSIAALCSSSSFLSFDVTDNAFDQEIPPQLGNSPSLERLRLGNNKFTGKIPWAL 623
Query: 620 GKIRELSLLDLSGNSLTGPIPTQLLMCKKLSHIDLNNNLLSGAVPSWLGTLPQLGELKLS 679
GKIR+LSLLDLSGN LTGPIP +L++CK+L+HIDLN+NLLSG +P WLG L QLGELKLS
Sbjct: 624 GKIRQLSLLDLSGNMLTGPIPAELMLCKRLTHIDLNSNLLSGPIPLWLGRLSQLGELKLS 683
Query: 680 FNQFVGFLPRELFNCSKLLVLSLDGNMLNGSLPNEVGNLASLNVLTLSGNLLSGPIPPAI 739
NQF+G LP +L NCSKLLVLSLD N LNG+LP E+G L SLNVL L N LSGPIP +
Sbjct: 684 SNQFLGSLPPQLCNCSKLLVLSLDRNSLNGTLPVEIGKLESLNVLNLERNQLSGPIPHDV 743
Query: 740 GRLSKLYELRLSNNSLNGVIPLEIGQLQNLQSILDLSHNNFTGQIPPSMGTLAKLEVLNL 799
G+LSKLYELRLS+NS + IP E+GQLQNLQS+L+LS+NN TG IP S+GTL+KLE L+L
Sbjct: 744 GKLSKLYELRLSDNSFSSEIPFELGQLQNLQSMLNLSYNNLTGPIPSSIGTLSKLEALDL 803
Query: 800 SHNQLVGELPSQLGEMSSLGKLNLSYNDLQGKLSKQFSHWPAEAFEGNLHLCGSPLDHCN 859
SHNQL GE+P Q+G MSSLGKLNLSYN+LQGKL KQF HWPA+AFEGNL LCGSPLD+CN
Sbjct: 804 SHNQLEGEVPPQVGSMSSLGKLNLSYNNLQGKLGKQFLHWPADAFEGNLKLCGSPLDNCN 863
Query: 860 GLVSNQHQSTISVSLVVAISVISTLSAIALLIAVVTLFVKRKREFLRKSSQVNYTSSSSS 919
G S +S +S S+VV +S ++TL A++LL AV+ LF+K KRE L++ +++N SSSS
Sbjct: 864 GYGSENKRSGLSESMVVVVSAVTTLVALSLLAAVLALFLKYKREALKRENELNLIYSSSS 923
Query: 920 SQAQRRLLFQ-AAAKRDFRWEDIMGATNNLSDEFIIGSGGSGTVYKAELANGATVAVKKI 978
S+AQR+ LFQ AK+DFRWEDIM AT+NLSD FIIGSGGSGT+Y+AEL G TVAVK+I
Sbjct: 924 SKAQRKPLFQNGVAKKDFRWEDIMKATDNLSDAFIIGSGGSGTIYRAELHTGETVAVKRI 983
Query: 979 SCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIYEYMENGSVWDWLHK 1038
KDD+LLNKSFTREVKTLGRIRHRHLVKL+G+C N+GAGSNLLIYEYMENGSVWDWLH+
Sbjct: 984 LWKDDYLLNKSFTREVKTLGRIRHRHLVKLLGYCTNRGAGSNLLIYEYMENGSVWDWLHQ 1043
Query: 1039 QPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGD 1098
+PVN KM+KSL+WEARLKIAVGLAQGVEYLHHDCVP ++HRDIKSSN+LLDSNMEAHLGD
Sbjct: 1044 KPVNSKMKKSLEWEARLKIAVGLAQGVEYLHHDCVPMLIHRDIKSSNVLLDSNMEAHLGD 1103
Query: 1099 FGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMP 1158
FGLAKA+VED+ SNTESN+WFAGSYGYIAPEYAYS KATEK DVYSMGIVLMELV+GKMP
Sbjct: 1104 FGLAKAMVEDFESNTESNSWFAGSYGYIAPEYAYSFKATEKSDVYSMGIVLMELVTGKMP 1163
Query: 1159 TDATFGVEMDMVRWVEMHMEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSP 1218
TDA FGV MDMVRWVE H+EM GS EEL+D +++PLLPGEE AAYQVLEIALQCTKTSP
Sbjct: 1164 TDAFFGVNMDMVRWVEKHIEMQGSGPEELIDPELRPLLPGEESAAYQVLEIALQCTKTSP 1223
Query: 1219 QERPSSRQVCDLLLNVFNNRIVDFDKLHIDP 1249
ERPSSRQ CD+LL++F+NR+VD +++++DP
Sbjct: 1224 PERPSSRQACDILLHLFHNRMVDSEEMNLDP 1254
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449454947|ref|XP_004145215.1| PREDICTED: LRR receptor-like serine/threonine-protein kinase GSO1-like [Cucumis sativus] gi|449525844|ref|XP_004169926.1| PREDICTED: LRR receptor-like serine/threonine-protein kinase GSO1-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1759 bits (4555), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 880/1252 (70%), Positives = 1041/1252 (83%), Gaps = 13/1252 (1%)
Query: 12 LLLLLCF-----SPGFVLCKDE-ELSVLLEIKKSFTADPENVLHAWNQSNQNLCTWRGIT 65
+L+LCF G V C D L+VLLEI+KSF DPENVL W++SN N C WRG++
Sbjct: 11 FVLVLCFFVWSVQYGVVFCDDGLSLNVLLEIRKSFVDDPENVLEDWSESNPNFCKWRGVS 70
Query: 66 CGSSSA----RVVSLNLSGLSLAGSISPSLGRLQSLIHLDLSSNSLTGPIPTALSNLSSL 121
C S SA VV LNLS SL GSISP+LGRL +L+HLDLSSN L GPIPT LS L SL
Sbjct: 71 CVSDSAGGSVSVVGLNLSDSSLGGSISPALGRLHNLLHLDLSSNGLMGPIPTNLSQLHSL 130
Query: 122 ESLLLFSNQLAGTIPTQLGSLTSLRVMRIGDNWLSGSIPTSFGNLVNLGTLGLASCSLSG 181
ESLLLFSNQL G+IPT+LGS++SLRVMRIGDN L+G IP+SFGNLVNL TLGLASCSLSG
Sbjct: 131 ESLLLFSNQLNGSIPTELGSMSSLRVMRIGDNGLTGPIPSSFGNLVNLVTLGLASCSLSG 190
Query: 182 PIPPQFGQLSQLEELILQQNQLQGPIPAELGNCSSLSIFTAAENNLNGSIPAALGRLQNL 241
IPP+ GQLS++E+++LQQNQL+GP+P ELGNCSSL +FTAA N+LNGSIP LGRL+NL
Sbjct: 191 LIPPELGQLSRVEDMVLQQNQLEGPVPGELGNCSSLVVFTAAGNSLNGSIPKQLGRLENL 250
Query: 242 QLLNLGNNSLSGEIPSELGELSQLGYLNLMGNRLEGAIPRSFAKMGNLQSLDLSMNRLTG 301
Q+LNL NN+LSGEIP ELGEL QL YLNLMGN+L+G+IP S A++GNLQ+LDLSMN+LTG
Sbjct: 251 QILNLANNTLSGEIPVELGELGQLLYLNLMGNQLKGSIPVSLAQLGNLQNLDLSMNKLTG 310
Query: 302 GIPEEFGNMGQLVFLVLSNNNISGSIPRRICTNATSLEHLILAEIQLSGEIPVELSQCQS 361
GIPEE GNMG L FLVLSNN +SG IP ++C+NA+SL+HL++++IQ+SGEIPVEL QC++
Sbjct: 311 GIPEELGNMGSLEFLVLSNNPLSGVIPSKLCSNASSLQHLLISQIQISGEIPVELIQCRA 370
Query: 362 LKQLDLSNNTLNGTIPVELFQLVALTHLYLHNNSLVGSISPFVANLSNLQELALYHNNFQ 421
L Q+DLSNN+LNG+IP E ++L +LT + LHNNSLVGSISP +ANLSNL+ LALYHNN Q
Sbjct: 371 LTQMDLSNNSLNGSIPDEFYELRSLTDILLHNNSLVGSISPSIANLSNLKTLALYHNNLQ 430
Query: 422 GSLPREIGMLVKLELLYLYDNHLSGQIPSEVGNCSSLKWIDFFGNSFTGEIPTSIGRLKD 481
G LPREIGML +LE+LYLYDN SG+IP E+GNCS L+ IDFFGN F+GEIP S+GRLK+
Sbjct: 431 GDLPREIGMLGELEILYLYDNQFSGKIPFELGNCSKLQMIDFFGNRFSGEIPVSLGRLKE 490
Query: 482 LNFLHLRQNELVGQIPASLGNCHQLIILDLADNKLSGGVPASFGFLQALEQLMLYNNSLE 541
LNF+HLRQNEL G+IPA+LGNC +L LDLADN+LSG +P++FGFL ALE LMLYNNSLE
Sbjct: 491 LNFIHLRQNELEGKIPATLGNCRKLTTLDLADNRLSGVIPSTFGFLGALELLMLYNNSLE 550
Query: 542 GNLPGSLINLRNLTRINFSKNRLNGRIATLCSSHSFLSFDVTNNEFDHEIPPQLGNSPSL 601
GNLP SLINL L RIN SKNRLNG IA LC+S FLSFD+TNN FD EIPPQLGNS SL
Sbjct: 551 GNLPRSLINLAKLQRINLSKNRLNGSIAPLCASPFFLSFDITNNRFDGEIPPQLGNSSSL 610
Query: 602 ERLRLGNNKFIGKIPWTFGKIRELSLLDLSGNSLTGPIPTQLLMCKKLSHIDLNNNLLSG 661
ERLRLGNN+F G+IP GKIRELSLLDLSGNSLTG IP +L +CKKL+H+DLNNN SG
Sbjct: 611 ERLRLGNNQFFGEIPPALGKIRELSLLDLSGNSLTGSIPAELSLCKKLTHLDLNNNNFSG 670
Query: 662 AVPSWLGTLPQLGELKLSFNQFVGFLPRELFNCSKLLVLSLDGNMLNGSLPNEVGNLASL 721
++P WLG LPQLGE+KLSFNQF G LP ELFNCSKL+VLSL+ N+LNG+LP E+GNL SL
Sbjct: 671 SLPMWLGGLPQLGEIKLSFNQFTGPLPLELFNCSKLIVLSLNENLLNGTLPMEIGNLRSL 730
Query: 722 NVLTLSGNLLSGPIPPAIGRLSKLYELRLSNNSLNGVIPLEIGQLQNLQSILDLSHNNFT 781
N+L L N SGPIP IG +SKL+ELR+S N L+G IP EI QLQNLQS+LDLS+NN T
Sbjct: 731 NILNLDANRFSGPIPSTIGTISKLFELRMSRNGLDGEIPAEISQLQNLQSVLDLSYNNLT 790
Query: 782 GQIPPSMGTLAKLEVLNLSHNQLVGELPSQLGEMSSLGKLNLSYNDLQGKLSKQFSHWPA 841
G+IP + L+KLE L+LSHN+L GE+PS + +MSSLGKLNL+YN L+GKL K+FSHWP
Sbjct: 791 GEIPSFIALLSKLEALDLSHNELSGEVPSDISKMSSLGKLNLAYNKLEGKLEKEFSHWPI 850
Query: 842 EAFEGNLHLCGSPLDHCNGLVSNQHQSTISVSLVVAISVISTLSAIALLIAVVTLFVKRK 901
F+GNL LCG PLD CN S+ S++S + V+AIS +STL+ +A+L+ VTL K K
Sbjct: 851 SVFQGNLQLCGGPLDRCN-EASSSESSSLSEAAVIAISAVSTLAGMAILVLTVTLLYKHK 909
Query: 902 REFLRKSSQVNYTSSSSSSQAQRRLLFQ-AAAKRDFRWEDIMGATNNLSDEFIIGSGGSG 960
E ++ +VN SSSSSQAQRR LF RDF WE+IM TNNLSD+FIIGSGGSG
Sbjct: 910 LETFKRWGEVNCVYSSSSSQAQRRPLFHNPGGNRDFHWEEIMEVTNNLSDDFIIGSGGSG 969
Query: 961 TVYKAELANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSN 1020
T+Y+AEL G TVAVKKISCKDD L N+SF REVKTLGRI+HRHLVKL+G+C N+G GSN
Sbjct: 970 TIYRAELLTGETVAVKKISCKDDLLSNRSFIREVKTLGRIKHRHLVKLLGYCMNRGDGSN 1029
Query: 1021 LLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRD 1080
LLIY+YMENGSVWDWLH+QP+N K +K LDWEAR +IAVGLAQG+EYLHHDC+PKI+HRD
Sbjct: 1030 LLIYDYMENGSVWDWLHQQPINGKKKKKLDWEARFRIAVGLAQGLEYLHHDCLPKIVHRD 1089
Query: 1081 IKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKC 1140
IK+SNILLDSNMEAHLGDFGLAKALVE+Y+++TES TWFAGSYGYIAPEYAYSL+ATEK
Sbjct: 1090 IKTSNILLDSNMEAHLGDFGLAKALVENYDTDTESKTWFAGSYGYIAPEYAYSLRATEKS 1149
Query: 1141 DVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEM-SGSAREELLDDQMKPLLPGE 1199
DVYSMGIVLMEL+SGKMPTD FGV+MDMVRWVE +EM S + RE L+D +KPLLP E
Sbjct: 1150 DVYSMGIVLMELISGKMPTDEAFGVDMDMVRWVETRIEMQSLTDREGLIDPCLKPLLPDE 1209
Query: 1200 ECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNVFNNRIVDFDKLHIDPYA 1251
E AA+QVLEIALQCTKT+PQERP+SR+VCD LL+V+N R V +DK+ DPY+
Sbjct: 1210 ESAAFQVLEIALQCTKTAPQERPTSRRVCDQLLHVYNPRTVGYDKMKTDPYS 1261
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449473884|ref|XP_004154011.1| PREDICTED: LRR receptor-like serine/threonine-protein kinase GSO1-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1758 bits (4554), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 880/1252 (70%), Positives = 1041/1252 (83%), Gaps = 13/1252 (1%)
Query: 12 LLLLLCF-----SPGFVLCKDE-ELSVLLEIKKSFTADPENVLHAWNQSNQNLCTWRGIT 65
+L+LCF G V C D L+VLLEI+KSF DPENVL W++SN N C WRG++
Sbjct: 11 FVLVLCFFVWSVQYGVVFCDDGLSLNVLLEIRKSFVDDPENVLEDWSESNPNFCKWRGVS 70
Query: 66 CGSSSA----RVVSLNLSGLSLAGSISPSLGRLQSLIHLDLSSNSLTGPIPTALSNLSSL 121
C S SA VV LNLS SL GSISP+LGRL +L+HLDLSSN L GPIPT LS L SL
Sbjct: 71 CVSDSAGGSVSVVGLNLSDSSLGGSISPALGRLHNLLHLDLSSNGLMGPIPTNLSQLHSL 130
Query: 122 ESLLLFSNQLAGTIPTQLGSLTSLRVMRIGDNWLSGSIPTSFGNLVNLGTLGLASCSLSG 181
ESLLLFSNQL G+IPT+LGS++SLRVMRIGDN L+G IP+SFGNLVNL TLGLASCSLSG
Sbjct: 131 ESLLLFSNQLNGSIPTELGSMSSLRVMRIGDNGLTGPIPSSFGNLVNLVTLGLASCSLSG 190
Query: 182 PIPPQFGQLSQLEELILQQNQLQGPIPAELGNCSSLSIFTAAENNLNGSIPAALGRLQNL 241
IPP+ GQLS++E+++LQQNQL+GP+P ELGNCSSL +FTAA N+LNGSIP LGRL+NL
Sbjct: 191 LIPPELGQLSRVEDMVLQQNQLEGPVPGELGNCSSLVVFTAAGNSLNGSIPKQLGRLENL 250
Query: 242 QLLNLGNNSLSGEIPSELGELSQLGYLNLMGNRLEGAIPRSFAKMGNLQSLDLSMNRLTG 301
Q+LNL NN+LSGEIP ELGEL QL YLNLMGN+L+G+IP S A++GNLQ+LDLSMN+LTG
Sbjct: 251 QILNLANNTLSGEIPVELGELGQLLYLNLMGNQLKGSIPVSLAQLGNLQNLDLSMNKLTG 310
Query: 302 GIPEEFGNMGQLVFLVLSNNNISGSIPRRICTNATSLEHLILAEIQLSGEIPVELSQCQS 361
GIPEE GNMG L FLVLSNN +SG IP ++C+NA+SL+HL++++IQ+SGEIPVEL QC++
Sbjct: 311 GIPEELGNMGSLEFLVLSNNPLSGVIPSKLCSNASSLQHLLISQIQISGEIPVELIQCRA 370
Query: 362 LKQLDLSNNTLNGTIPVELFQLVALTHLYLHNNSLVGSISPFVANLSNLQELALYHNNFQ 421
L Q+DLSNN+LNG+IP E ++L +LT + LHNNSLVGSISP +ANLSNL+ LALYHNN Q
Sbjct: 371 LTQMDLSNNSLNGSIPDEFYELRSLTDILLHNNSLVGSISPSIANLSNLKTLALYHNNLQ 430
Query: 422 GSLPREIGMLVKLELLYLYDNHLSGQIPSEVGNCSSLKWIDFFGNSFTGEIPTSIGRLKD 481
G LPREIGML +LE+LYLYDN SG+IP E+GNCS L+ IDFFGN F+GEIP S+GRLK+
Sbjct: 431 GDLPREIGMLGELEILYLYDNQFSGKIPFELGNCSKLQMIDFFGNRFSGEIPVSLGRLKE 490
Query: 482 LNFLHLRQNELVGQIPASLGNCHQLIILDLADNKLSGGVPASFGFLQALEQLMLYNNSLE 541
LNF+HLRQNEL G+IPA+LGNC +L LDLADN+LSG +P++FGFL ALE LMLYNNSLE
Sbjct: 491 LNFIHLRQNELEGKIPATLGNCRKLTTLDLADNRLSGVIPSTFGFLGALELLMLYNNSLE 550
Query: 542 GNLPGSLINLRNLTRINFSKNRLNGRIATLCSSHSFLSFDVTNNEFDHEIPPQLGNSPSL 601
GNLP SLINL L RIN SKNRLNG IA LC+S FLSFD+TNN FD EIPPQLGNS SL
Sbjct: 551 GNLPRSLINLAKLQRINLSKNRLNGSIAPLCASPFFLSFDITNNRFDGEIPPQLGNSSSL 610
Query: 602 ERLRLGNNKFIGKIPWTFGKIRELSLLDLSGNSLTGPIPTQLLMCKKLSHIDLNNNLLSG 661
ERLRLGNN+F G+IP GKIRELSLLDLSGNSLTG IP +L +CKKL+H+DLNNN SG
Sbjct: 611 ERLRLGNNQFFGEIPPALGKIRELSLLDLSGNSLTGSIPAELSLCKKLTHLDLNNNNFSG 670
Query: 662 AVPSWLGTLPQLGELKLSFNQFVGFLPRELFNCSKLLVLSLDGNMLNGSLPNEVGNLASL 721
++P WLG LPQLGE+KLSFNQF G LP ELFNCSKL+VLSL+ N+LNG+LP E+GNL SL
Sbjct: 671 SLPMWLGGLPQLGEIKLSFNQFTGPLPLELFNCSKLIVLSLNENLLNGTLPMEIGNLRSL 730
Query: 722 NVLTLSGNLLSGPIPPAIGRLSKLYELRLSNNSLNGVIPLEIGQLQNLQSILDLSHNNFT 781
N+L L N SGPIP IG +SKL+ELR+S N L+G IP EI QLQNLQS+LDLS+NN T
Sbjct: 731 NILNLDANRFSGPIPSTIGTISKLFELRMSRNGLDGEIPAEISQLQNLQSVLDLSYNNLT 790
Query: 782 GQIPPSMGTLAKLEVLNLSHNQLVGELPSQLGEMSSLGKLNLSYNDLQGKLSKQFSHWPA 841
G+IP + L+KLE L+LSHN+L GE+PS + +MSSLGKLNL+YN L+GKL K+FSHWP
Sbjct: 791 GEIPSFIALLSKLEALDLSHNELSGEVPSDISKMSSLGKLNLAYNKLEGKLEKEFSHWPI 850
Query: 842 EAFEGNLHLCGSPLDHCNGLVSNQHQSTISVSLVVAISVISTLSAIALLIAVVTLFVKRK 901
F+GNL LCG PLD CN S+ S++S + V+AIS +STL+ +A+L+ VTL K K
Sbjct: 851 SVFQGNLQLCGGPLDRCN-EASSSESSSLSEAAVLAISAVSTLAGMAILVLTVTLLYKHK 909
Query: 902 REFLRKSSQVNYTSSSSSSQAQRRLLFQ-AAAKRDFRWEDIMGATNNLSDEFIIGSGGSG 960
E ++ +VN SSSSSQAQRR LF RDF WE+IM TNNLSD+FIIGSGGSG
Sbjct: 910 LETFKRWGEVNCVYSSSSSQAQRRPLFHNPGGNRDFHWEEIMEVTNNLSDDFIIGSGGSG 969
Query: 961 TVYKAELANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSN 1020
T+Y+AEL G TVAVKKISCKDD L N+SF REVKTLGRI+HRHLVKL+G+C N+G GSN
Sbjct: 970 TIYRAELLTGETVAVKKISCKDDLLSNRSFIREVKTLGRIKHRHLVKLLGYCMNRGDGSN 1029
Query: 1021 LLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRD 1080
LLIY+YMENGSVWDWLH+QP+N K +K LDWEAR +IAVGLAQG+EYLHHDC+PKI+HRD
Sbjct: 1030 LLIYDYMENGSVWDWLHQQPINGKKKKKLDWEARFRIAVGLAQGLEYLHHDCLPKIVHRD 1089
Query: 1081 IKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKC 1140
IK+SNILLDSNMEAHLGDFGLAKALVE+Y+++TES TWFAGSYGYIAPEYAYSL+ATEK
Sbjct: 1090 IKTSNILLDSNMEAHLGDFGLAKALVENYDTDTESKTWFAGSYGYIAPEYAYSLRATEKS 1149
Query: 1141 DVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEM-SGSAREELLDDQMKPLLPGE 1199
DVYSMGIVLMEL+SGKMPTD FGV+MDMVRWVE +EM S + RE L+D +KPLLP E
Sbjct: 1150 DVYSMGIVLMELISGKMPTDEAFGVDMDMVRWVETRIEMQSLTDREGLIDPCLKPLLPDE 1209
Query: 1200 ECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNVFNNRIVDFDKLHIDPYA 1251
E AA+QVLEIALQCTKT+PQERP+SR+VCD LL+V+N R V +DK+ DPY+
Sbjct: 1210 ESAAFQVLEIALQCTKTAPQERPTSRRVCDQLLHVYNPRTVGYDKMKTDPYS 1261
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356510820|ref|XP_003524132.1| PREDICTED: LRR receptor-like serine/threonine-protein kinase GSO1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1758 bits (4552), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 899/1260 (71%), Positives = 1040/1260 (82%), Gaps = 22/1260 (1%)
Query: 12 LLLLLCFSPGFVLC------KDEELSVLLEIKKSFTADPENVLHAWNQSNQNLCTWRGIT 65
++ LLCFS ++ + L VLLE+KKSF DP+NVL W++ N + C+WRG++
Sbjct: 9 IVFLLCFSSMLLVLGQVNSDSESTLRVLLEVKKSFVEDPQNVLGDWSEDNTDYCSWRGVS 68
Query: 66 C----------GSSSARVVSLNLSGLSLAGSISPSLGRLQSLIHLDLSSNSLTGPIPTAL 115
C S VV+LNLS SL GSISPSLGRLQ+L+HLDLSSNSL GPIP L
Sbjct: 69 CELNSNSNTLDSDSVQVVVALNLSDSSLTGSISPSLGRLQNLLHLDLSSNSLMGPIPPNL 128
Query: 116 SNLSSLESLLLFSNQLAGTIPTQLGSLTSLRVMRIGDNWLSGSIPTSFGNLVNLGTLGLA 175
SNL+SLESLLLFSNQL G IPT+ GSLTSLRVMR+GDN L+G+IP S GNLVNL LGLA
Sbjct: 129 SNLTSLESLLLFSNQLTGHIPTEFGSLTSLRVMRLGDNALTGTIPASLGNLVNLVNLGLA 188
Query: 176 SCSLSGPIPPQFGQLSQLEELILQQNQLQGPIPAELGNCSSLSIFTAAENNLNGSIPAAL 235
SC ++G IP Q GQLS LE LILQ N+L GPIP ELGNCSSL++FTAA N LNGSIP+ L
Sbjct: 189 SCGITGSIPSQLGQLSLLENLILQYNELMGPIPTELGNCSSLTVFTAASNKLNGSIPSEL 248
Query: 236 GRLQNLQLLNLGNNSLSGEIPSELGELSQLGYLNLMGNRLEGAIPRSFAKMGNLQSLDLS 295
GRL NLQ+LNL NNSLS +IPS+L ++SQL Y+N MGN+LEGAIP S A++GNLQ+LDLS
Sbjct: 249 GRLGNLQILNLANNSLSWKIPSQLSKMSQLVYMNFMGNQLEGAIPPSLAQLGNLQNLDLS 308
Query: 296 MNRLTGGIPEEFGNMGQLVFLVLSNNNISGSIPRRICTNATSLEHLILAEIQLSGEIPVE 355
MN+L+GGIPEE GNMG L +LVLS NN++ IPR IC+NATSLEHL+L+E L GEIP E
Sbjct: 309 MNKLSGGIPEELGNMGDLAYLVLSGNNLNCVIPRTICSNATSLEHLMLSESGLHGEIPAE 368
Query: 356 LSQCQSLKQLDLSNNTLNGTIPVELFQLVALTHLYLHNNSLVGSISPFVANLSNLQELAL 415
LSQCQ LKQLDLSNN LNG+IP+EL+ L+ LT L L+NN+LVGSISPF+ NLS LQ LAL
Sbjct: 369 LSQCQQLKQLDLSNNALNGSIPLELYGLLGLTDLLLNNNTLVGSISPFIGNLSGLQTLAL 428
Query: 416 YHNNFQGSLPREIGMLVKLELLYLYDNHLSGQIPSEVGNCSSLKWIDFFGNSFTGEIPTS 475
+HNN +GSLPREIGML KLE+LYLYDN LSG IP E+GNCSSL+ +DFFGN F+GEIP +
Sbjct: 429 FHNNLEGSLPREIGMLGKLEILYLYDNQLSGAIPMEIGNCSSLQMVDFFGNHFSGEIPIT 488
Query: 476 IGRLKDLNFLHLRQNELVGQIPASLGNCHQLIILDLADNKLSGGVPASFGFLQALEQLML 535
IGRLK+LNFLHLRQNELVG+IP++LG+CH+L ILDLADN+LSG +P +F FL+AL+QLML
Sbjct: 489 IGRLKELNFLHLRQNELVGEIPSTLGHCHKLNILDLADNQLSGAIPETFEFLEALQQLML 548
Query: 536 YNNSLEGNLPGSLINLRNLTRINFSKNRLNGRIATLCSSHSFLSFDVTNNEFDHEIPPQL 595
YNNSLEGNLP LIN+ NLTR+N SKNRLNG IA LCSS SFLSFDVT+NEFD EIP Q+
Sbjct: 549 YNNSLEGNLPHQLINVANLTRVNLSKNRLNGSIAALCSSQSFLSFDVTDNEFDGEIPSQM 608
Query: 596 GNSPSLERLRLGNNKFIGKIPWTFGKIRELSLLDLSGNSLTGPIPTQLLMCKKLSHIDLN 655
GNSPSL+RLRLGNNKF GKIP T GKI ELSLLDLSGNSLTGPIP +L +C KL++IDLN
Sbjct: 609 GNSPSLQRLRLGNNKFSGKIPRTLGKILELSLLDLSGNSLTGPIPAELSLCNKLAYIDLN 668
Query: 656 NNLLSGAVPSWLGTLPQLGELKLSFNQFVGFLPRELFNCSKLLVLSLDGNMLNGSLPNEV 715
+NLL G +PSWL LPQLGELKLS N F G LP LF CSKLLVLSL+ N LNGSLP+ +
Sbjct: 669 SNLLFGQIPSWLENLPQLGELKLSSNNFSGPLPLGLFKCSKLLVLSLNDNSLNGSLPSNI 728
Query: 716 GNLASLNVLTLSGNLLSGPIPPAIGRLSKLYELRLSNNSLNGVIPLEIGQLQNLQSILDL 775
G+LA LNVL L N SGPIPP IG+LSKLYELRLS NS +G +P EIG+LQNLQ ILDL
Sbjct: 729 GDLAYLNVLRLDHNKFSGPIPPEIGKLSKLYELRLSRNSFHGEMPAEIGKLQNLQIILDL 788
Query: 776 SHNNFTGQIPPSMGTLAKLEVLNLSHNQLVGELPSQLGEMSSLGKLNLSYNDLQGKLSKQ 835
S+NN +GQIPPS+GTL+KLE L+LSHNQL GE+P +GEMSSLGKL+LSYN+LQGKL KQ
Sbjct: 789 SYNNLSGQIPPSVGTLSKLEALDLSHNQLTGEVPPHVGEMSSLGKLDLSYNNLQGKLDKQ 848
Query: 836 FSHWPAEAFEGNLHLCGSPLDHCNGLVSNQHQSTISVSLVVAISVISTLSAIALLIAVVT 895
FS W EAFEGNLHLCGSPL+ C + ++ S V IS +STL+ IALLI V
Sbjct: 849 FSRWSDEAFEGNLHLCGSPLERCRR-DDASGSAGLNESSVAIISSLSTLAVIALLIVAVR 907
Query: 896 LFVKRKREFLRKSSQVNYTSSSSSSQAQRRLLFQ--AAAKRDFRWEDIMGATNNLSDEFI 953
+F K K+EF RK S+VNY SSSSSQAQRR LFQ AA KRDFRWE IM ATNNLSD+F+
Sbjct: 908 IFSKNKQEFCRKGSEVNYVYSSSSSQAQRRPLFQLNAAGKRDFRWEHIMDATNNLSDDFM 967
Query: 954 IGSGGSGTVYKAELANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCC 1013
IGSGGSG +YKAELA G TVAVKKIS KD+ LLNKSF REVKTLGRIRHRHLVKL+G+C
Sbjct: 968 IGSGGSGKIYKAELATGETVAVKKISSKDEFLLNKSFLREVKTLGRIRHRHLVKLIGYCT 1027
Query: 1014 --NKGAGSNLLIYEYMENGSVWDWLHKQPVNI-KMRKSLDWEARLKIAVGLAQGVEYLHH 1070
NK AG NLLIYEYMENGSVWDWLH +P K+++ +DWE R KIAVGLAQGVEYLHH
Sbjct: 1028 NRNKEAGWNLLIYEYMENGSVWDWLHGKPAKASKVKRRIDWETRFKIAVGLAQGVEYLHH 1087
Query: 1071 DCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEY 1130
DCVP+I+HRDIKSSN+LLDS MEAHLGDFGLAKAL E+Y+SNTESN+WFAGSYGYIAPEY
Sbjct: 1088 DCVPRIIHRDIKSSNVLLDSKMEAHLGDFGLAKALTENYDSNTESNSWFAGSYGYIAPEY 1147
Query: 1131 AYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSAREELLDD 1190
AYSL+ATEK DVYSMGI+LMELVSGKMPT FG EMDMVRWVEMHM+M GS REEL+D
Sbjct: 1148 AYSLQATEKSDVYSMGILLMELVSGKMPTSEFFGAEMDMVRWVEMHMDMHGSGREELIDS 1207
Query: 1191 QMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNVFNNRIVDFDKLHIDPY 1250
++KPLLPGEE AA+QVLEIALQCTKT+P ERPSSR+ CDLLL+VFNNR+V F+K++++ Y
Sbjct: 1208 ELKPLLPGEEFAAFQVLEIALQCTKTTPLERPSSRKACDLLLHVFNNRMVKFEKMNLNHY 1267
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|42566982|ref|NP_193747.2| LRR receptor-like serine/threonine-protein kinase GSO1 [Arabidopsis thaliana] gi|263430760|sp|C0LGQ5.1|GSO1_ARATH RecName: Full=LRR receptor-like serine/threonine-protein kinase GSO1; AltName: Full=Protein GASSHO 1; Flags: Precursor gi|224589614|gb|ACN59340.1| leucine-rich repeat receptor-like protein kinase [Arabidopsis thaliana] gi|332658879|gb|AEE84279.1| LRR receptor-like serine/threonine-protein kinase GSO1 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 1698 bits (4398), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 854/1240 (68%), Positives = 1012/1240 (81%), Gaps = 14/1240 (1%)
Query: 17 CFS----PGFVLCKDEELSVLLEIKKSFTADP--ENVLHAWNQSNQNLCTWRGITCGSSS 70
CFS PG + + +L LLE+KKS +P ++ L WN N N C+W G+TC ++
Sbjct: 13 CFSGLGQPGII---NNDLQTLLEVKKSLVTNPQEDDPLRQWNSDNINYCSWTGVTCDNTG 69
Query: 71 A-RVVSLNLSGLSLAGSISPSLGRLQSLIHLDLSSNSLTGPIPTALSNLSSLESLLLFSN 129
RV++LNL+GL L GSISP GR +LIHLDLSSN+L GPIPTALSNL+SLESL LFSN
Sbjct: 70 LFRVIALNLTGLGLTGSISPWFGRFDNLIHLDLSSNNLVGPIPTALSNLTSLESLFLFSN 129
Query: 130 QLAGTIPTQLGSLTSLRVMRIGDNWLSGSIPTSFGNLVNLGTLGLASCSLSGPIPPQFGQ 189
QL G IP+QLGSL ++R +RIGDN L G IP + GNLVNL L LASC L+GPIP Q G+
Sbjct: 130 QLTGEIPSQLGSLVNIRSLRIGDNELVGDIPETLGNLVNLQMLALASCRLTGPIPSQLGR 189
Query: 190 LSQLEELILQQNQLQGPIPAELGNCSSLSIFTAAENNLNGSIPAALGRLQNLQLLNLGNN 249
L +++ LILQ N L+GPIPAELGNCS L++FTAAEN LNG+IPA LGRL+NL++LNL NN
Sbjct: 190 LVRVQSLILQDNYLEGPIPAELGNCSDLTVFTAAENMLNGTIPAELGRLENLEILNLANN 249
Query: 250 SLSGEIPSELGELSQLGYLNLMGNRLEGAIPRSFAKMGNLQSLDLSMNRLTGGIPEEFGN 309
SL+GEIPS+LGE+SQL YL+LM N+L+G IP+S A +GNLQ+LDLS N LTG IPEEF N
Sbjct: 250 SLTGEIPSQLGEMSQLQYLSLMANQLQGLIPKSLADLGNLQTLDLSANNLTGEIPEEFWN 309
Query: 310 MGQLVFLVLSNNNISGSIPRRICTNATSLEHLILAEIQLSGEIPVELSQCQSLKQLDLSN 369
M QL+ LVL+NN++SGS+P+ IC+N T+LE L+L+ QLSGEIPVELS+CQSLKQLDLSN
Sbjct: 310 MSQLLDLVLANNHLSGSLPKSICSNNTNLEQLVLSGTQLSGEIPVELSKCQSLKQLDLSN 369
Query: 370 NTLNGTIPVELFQLVALTHLYLHNNSLVGSISPFVANLSNLQELALYHNNFQGSLPREIG 429
N+L G+IP LF+LV LT LYLHNN+L G++SP ++NL+NLQ L LYHNN +G LP+EI
Sbjct: 370 NSLAGSIPEALFELVELTDLYLHNNTLEGTLSPSISNLTNLQWLVLYHNNLEGKLPKEIS 429
Query: 430 MLVKLELLYLYDNHLSGQIPSEVGNCSSLKWIDFFGNSFTGEIPTSIGRLKDLNFLHLRQ 489
L KLE+L+LY+N SG+IP E+GNC+SLK ID FGN F GEIP SIGRLK+LN LHLRQ
Sbjct: 430 ALRKLEVLFLYENRFSGEIPQEIGNCTSLKMIDMFGNHFEGEIPPSIGRLKELNLLHLRQ 489
Query: 490 NELVGQIPASLGNCHQLIILDLADNKLSGGVPASFGFLQALEQLMLYNNSLEGNLPGSLI 549
NELVG +PASLGNCHQL ILDLADN+LSG +P+SFGFL+ LEQLMLYNNSL+GNLP SLI
Sbjct: 490 NELVGGLPASLGNCHQLNILDLADNQLSGSIPSSFGFLKGLEQLMLYNNSLQGNLPDSLI 549
Query: 550 NLRNLTRINFSKNRLNGRIATLCSSHSFLSFDVTNNEFDHEIPPQLGNSPSLERLRLGNN 609
+LRNLTRIN S NRLNG I LC S S+LSFDVTNN F+ EIP +LGNS +L+RLRLG N
Sbjct: 550 SLRNLTRINLSHNRLNGTIHPLCGSSSYLSFDVTNNGFEDEIPLELGNSQNLDRLRLGKN 609
Query: 610 KFIGKIPWTFGKIRELSLLDLSGNSLTGPIPTQLLMCKKLSHIDLNNNLLSGAVPSWLGT 669
+ GKIPWT GKIRELSLLD+S N+LTG IP QL++CKKL+HIDLNNN LSG +P WLG
Sbjct: 610 QLTGKIPWTLGKIRELSLLDMSSNALTGTIPLQLVLCKKLTHIDLNNNFLSGPIPPWLGK 669
Query: 670 LPQLGELKLSFNQFVGFLPRELFNCSKLLVLSLDGNMLNGSLPNEVGNLASLNVLTLSGN 729
L QLGELKLS NQFV LP ELFNC+KLLVLSLDGN LNGS+P E+GNL +LNVL L N
Sbjct: 670 LSQLGELKLSSNQFVESLPTELFNCTKLLVLSLDGNSLNGSIPQEIGNLGALNVLNLDKN 729
Query: 730 LLSGPIPPAIGRLSKLYELRLSNNSLNGVIPLEIGQLQNLQSILDLSHNNFTGQIPPSMG 789
SG +P A+G+LSKLYELRLS NSL G IP+EIGQLQ+LQS LDLS+NNFTG IP ++G
Sbjct: 730 QFSGSLPQAMGKLSKLYELRLSRNSLTGEIPVEIGQLQDLQSALDLSYNNFTGDIPSTIG 789
Query: 790 TLAKLEVLNLSHNQLVGELPSQLGEMSSLGKLNLSYNDLQGKLSKQFSHWPAEAFEGNLH 849
TL+KLE L+LSHNQL GE+P +G+M SLG LN+S+N+L GKL KQFS WPA++F GN
Sbjct: 790 TLSKLETLDLSHNQLTGEVPGSVGDMKSLGYLNVSFNNLGGKLKKQFSRWPADSFLGNTG 849
Query: 850 LCGSPLDHCNGLVSNQHQSTISVSLVVAISVISTLSAIALLIAVVTLFVKRKREFLRKSS 909
LCGSPL CN + SN Q +S VV IS IS L+AI L+I V+ LF K++ +F +K
Sbjct: 850 LCGSPLSRCNRVRSNNKQQGLSARSVVIISAISALTAIGLMILVIALFFKQRHDFFKKVG 909
Query: 910 Q--VNYTSSSSSSQAQRRLLFQ-AAAKRDFRWEDIMGATNNLSDEFIIGSGGSGTVYKAE 966
YTSSSSSSQA + LF+ A+K D RWEDIM AT+NLS+EF+IGSGGSG VYKAE
Sbjct: 910 HGSTAYTSSSSSSQATHKPLFRNGASKSDIRWEDIMEATHNLSEEFMIGSGGSGKVYKAE 969
Query: 967 LANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIYEY 1026
L NG TVAVKKI KDD + NKSF+REVKTLGRIRHRHLVKLMG+C +K G NLLIYEY
Sbjct: 970 LENGETVAVKKILWKDDLMSNKSFSREVKTLGRIRHRHLVKLMGYCSSKSEGLNLLIYEY 1029
Query: 1027 MENGSVWDWLHK-QPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSN 1085
M+NGS+WDWLH+ +PV K +K LDWEARL+IAVGLAQGVEYLHHDCVP I+HRDIKSSN
Sbjct: 1030 MKNGSIWDWLHEDKPVLEKKKKLLDWEARLRIAVGLAQGVEYLHHDCVPPIVHRDIKSSN 1089
Query: 1086 ILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSM 1145
+LLDSNMEAHLGDFGLAK L E+ ++NT+SNTWFA SYGYIAPEYAYSLKATEK DVYSM
Sbjct: 1090 VLLDSNMEAHLGDFGLAKVLTENCDTNTDSNTWFACSYGYIAPEYAYSLKATEKSDVYSM 1149
Query: 1146 GIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSAREELLDDQMKPLLPGEECAAYQ 1205
GIVLME+V+GKMPTD+ FG EMDMVRWVE H+E++GSAR++L+D ++KPLLP EE AA Q
Sbjct: 1150 GIVLMEIVTGKMPTDSVFGAEMDMVRWVETHLEVAGSARDKLIDPKLKPLLPFEEDAACQ 1209
Query: 1206 VLEIALQCTKTSPQERPSSRQVCDLLLNVFNNRIVDFDKL 1245
VLEIALQCTKTSPQERPSSRQ CD LL+V+NNR + KL
Sbjct: 1210 VLEIALQCTKTSPQERPSSRQACDSLLHVYNNRTAGYKKL 1249
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356528160|ref|XP_003532673.1| PREDICTED: LRR receptor-like serine/threonine-protein kinase GSO1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1693 bits (4384), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 894/1262 (70%), Positives = 1038/1262 (82%), Gaps = 26/1262 (2%)
Query: 14 LLLCFSPGFVLC----KDEE--LSVLLEIKKSFTADPENVLHAWNQSNQNLCTWRGITC- 66
LLCFS ++ D E L +LLE+KKSF D +NVL W++ N + C+WRG++C
Sbjct: 11 FLLCFSSMLLVLGQVNSDSESILRLLLEVKKSFVQDQQNVLSDWSEDNTDYCSWRGVSCE 70
Query: 67 -------------GSSSARVVSLNLSGLSLAGSISPSLGRLQSLIHLDLSSNSLTGPIPT 113
S VV LNLS SL GSISPSLG LQ+L+HLDLSSNSL GPIP
Sbjct: 71 LNSNSNSISNTLDSDSVQVVVGLNLSDSSLTGSISPSLGLLQNLLHLDLSSNSLMGPIPP 130
Query: 114 ALSNLSSLESLLLFSNQLAGTIPTQLGSLTSLRVMRIGDNWLSGSIPTSFGNLVNLGTLG 173
LSNL+SL+SLLLFSNQL G IPT+LGSLTSLRVMR+GDN L+G IP S GNLVNL LG
Sbjct: 131 NLSNLTSLQSLLLFSNQLTGHIPTELGSLTSLRVMRLGDNTLTGKIPASLGNLVNLVNLG 190
Query: 174 LASCSLSGPIPPQFGQLSQLEELILQQNQLQGPIPAELGNCSSLSIFTAAENNLNGSIPA 233
LASC L+G IP + G+LS LE LILQ N+L GPIP ELGNCSSL+IFTAA N LNGSIP+
Sbjct: 191 LASCGLTGSIPRRLGKLSLLENLILQDNELMGPIPTELGNCSSLTIFTAANNKLNGSIPS 250
Query: 234 ALGRLQNLQLLNLGNNSLSGEIPSELGELSQLGYLNLMGNRLEGAIPRSFAKMGNLQSLD 293
LG+L NLQ+LN NNSLSGEIPS+LG++SQL Y+N MGN+LEGAIP S A++GNLQ+LD
Sbjct: 251 ELGQLSNLQILNFANNSLSGEIPSQLGDVSQLVYMNFMGNQLEGAIPPSLAQLGNLQNLD 310
Query: 294 LSMNRLTGGIPEEFGNMGQLVFLVLSNNNISGSIPRRICTNATSLEHLILAEIQLSGEIP 353
LS N+L+GGIPEE GNMG+L +LVLS NN++ IP+ IC+NATSLEHL+L+E L G+IP
Sbjct: 311 LSTNKLSGGIPEELGNMGELAYLVLSGNNLNCVIPKTICSNATSLEHLMLSESGLHGDIP 370
Query: 354 VELSQCQSLKQLDLSNNTLNGTIPVELFQLVALTHLYLHNNSLVGSISPFVANLSNLQEL 413
ELSQCQ LKQLDLSNN LNG+I +EL+ L+ LT L L+NNSLVGSISPF+ NLS LQ L
Sbjct: 371 AELSQCQQLKQLDLSNNALNGSINLELYGLLGLTDLLLNNNSLVGSISPFIGNLSGLQTL 430
Query: 414 ALYHNNFQGSLPREIGMLVKLELLYLYDNHLSGQIPSEVGNCSSLKWIDFFGNSFTGEIP 473
AL+HNN QG+LPREIGML KLE+LYLYDN LS IP E+GNCSSL+ +DFFGN F+G+IP
Sbjct: 431 ALFHNNLQGALPREIGMLGKLEILYLYDNQLSEAIPMEIGNCSSLQMVDFFGNHFSGKIP 490
Query: 474 TSIGRLKDLNFLHLRQNELVGQIPASLGNCHQLIILDLADNKLSGGVPASFGFLQALEQL 533
+IGRLK+LNFLHLRQNELVG+IPA+LGNCH+L ILDLADN+LSG +PA+FGFL+AL+QL
Sbjct: 491 ITIGRLKELNFLHLRQNELVGEIPATLGNCHKLNILDLADNQLSGAIPATFGFLEALQQL 550
Query: 534 MLYNNSLEGNLPGSLINLRNLTRINFSKNRLNGRIATLCSSHSFLSFDVTNNEFDHEIPP 593
MLYNNSLEGNLP LIN+ NLTR+N SKNRLNG IA LCSS SFLSFDVT NEFD EIP
Sbjct: 551 MLYNNSLEGNLPHQLINVANLTRVNLSKNRLNGSIAALCSSQSFLSFDVTENEFDGEIPS 610
Query: 594 QLGNSPSLERLRLGNNKFIGKIPWTFGKIRELSLLDLSGNSLTGPIPTQLLMCKKLSHID 653
Q+GNSPSL+RLRLGNNKF G+IP T KIRELSLLDLSGNSLTGPIP +L +C KL++ID
Sbjct: 611 QMGNSPSLQRLRLGNNKFSGEIPRTLAKIRELSLLDLSGNSLTGPIPAELSLCNKLAYID 670
Query: 654 LNNNLLSGAVPSWLGTLPQLGELKLSFNQFVGFLPRELFNCSKLLVLSLDGNMLNGSLPN 713
LN+NLL G +PSWL LP+LGELKLS N F G LP LF CSKLLVLSL+ N LNGSLP+
Sbjct: 671 LNSNLLFGQIPSWLEKLPELGELKLSSNNFSGPLPLGLFKCSKLLVLSLNDNSLNGSLPS 730
Query: 714 EVGNLASLNVLTLSGNLLSGPIPPAIGRLSKLYELRLSNNSLNGVIPLEIGQLQNLQSIL 773
++G+LA LNVL L N SGPIPP IG+LSK+YEL LS N+ N +P EIG+LQNLQ IL
Sbjct: 731 DIGDLAYLNVLRLDHNKFSGPIPPEIGKLSKIYELWLSRNNFNAEMPPEIGKLQNLQIIL 790
Query: 774 DLSHNNFTGQIPPSMGTLAKLEVLNLSHNQLVGELPSQLGEMSSLGKLNLSYNDLQGKLS 833
DLS+NN +GQIP S+GTL KLE L+LSHNQL GE+P +GEMSSLGKL+LSYN+LQGKL
Sbjct: 791 DLSYNNLSGQIPSSVGTLLKLEALDLSHNQLTGEVPPHIGEMSSLGKLDLSYNNLQGKLD 850
Query: 834 KQFSHWPAEAFEGNLHLCGSPLDHCNGLVSNQHQSTISVSLVVAISVISTLSAIALLIAV 893
KQFS WP EAFEGNL LCGSPL+ C +++ + ++ SLV IS ISTL+AIALLI
Sbjct: 851 KQFSRWPDEAFEGNLQLCGSPLERCRRDDASR-SAGLNESLVAIISSISTLAAIALLILA 909
Query: 894 VTLFVKRKREFLRKSSQVNYTSSSSSSQAQRRLLFQ--AAAKRDFRWEDIMGATNNLSDE 951
V +F K K+EF K S+VNY SSSSSQAQRR LFQ AA KRDFRWEDIM ATNNLSD+
Sbjct: 910 VRIFSKNKQEFCWKGSEVNYVYSSSSSQAQRRPLFQLNAAGKRDFRWEDIMDATNNLSDD 969
Query: 952 FIIGSGGSGTVYKAELANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGH 1011
F+IGSGGSG +YKAELA G TVAVKKIS KD+ LLNKSF REVKTLGRIRHRHLVKL+G+
Sbjct: 970 FMIGSGGSGKIYKAELATGETVAVKKISSKDEFLLNKSFIREVKTLGRIRHRHLVKLIGY 1029
Query: 1012 CCNKG--AGSNLLIYEYMENGSVWDWLHKQPVNI-KMRKSLDWEARLKIAVGLAQGVEYL 1068
C NK AG NLLIYEYMENGSVW+WLH +P K+++S+DWE R KIAVGLAQGVEYL
Sbjct: 1030 CTNKNKEAGWNLLIYEYMENGSVWNWLHGKPAKANKVKRSIDWETRFKIAVGLAQGVEYL 1089
Query: 1069 HHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAP 1128
HHDCVP+I+HRDIKSSN+LLD+ MEAHLGDFGLAKAL E+ +SNTESN+WFAGSYGYIAP
Sbjct: 1090 HHDCVPRIIHRDIKSSNVLLDTKMEAHLGDFGLAKALTENCDSNTESNSWFAGSYGYIAP 1149
Query: 1129 EYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSAREELL 1188
EYAY L ATEK DVYSMGIVLMELVSGKMPT+ FG EMDMVRWVEMHM++ GSAREEL+
Sbjct: 1150 EYAYLLHATEKSDVYSMGIVLMELVSGKMPTNDFFGAEMDMVRWVEMHMDIHGSAREELI 1209
Query: 1189 DDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNVFNNRIVDFDKLHID 1248
D ++KPLLPGEE AA+QVLEIALQCTKT+PQERPSSR+ CD LL+VFNNR V+F+K+++D
Sbjct: 1210 DPELKPLLPGEEFAAFQVLEIALQCTKTTPQERPSSRKACDRLLHVFNNRTVNFEKMNLD 1269
Query: 1249 PY 1250
Y
Sbjct: 1270 HY 1271
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297804124|ref|XP_002869946.1| hypothetical protein ARALYDRAFT_354732 [Arabidopsis lyrata subsp. lyrata] gi|297315782|gb|EFH46205.1| hypothetical protein ARALYDRAFT_354732 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 1682 bits (4355), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 850/1254 (67%), Positives = 1009/1254 (80%), Gaps = 17/1254 (1%)
Query: 6 QVLLGLLLLLLCFS-------PGFVLCKDEELSVLLEIKKSFTADP--ENVLHAWNQSNQ 56
Q L+ L+L +LC S PG + + + LLE+KKSF P ++ L WN N
Sbjct: 2 QPLVLLVLFILCSSLESGSGQPGII---NNDFQTLLEVKKSFVTTPQEDDPLRQWNSVNV 58
Query: 57 NLCTWRGITCGSSSA-RVVSLNLSGLSLAGSISPSLGRLQSLIHLDLSSNSLTGPIPTAL 115
N C+W G+TC + RV++LNL+GL L GSISP GR +LIHLDLSSN+L GPIPTAL
Sbjct: 59 NYCSWTGVTCDDTGLFRVIALNLTGLGLTGSISPWFGRFDNLIHLDLSSNNLVGPIPTAL 118
Query: 116 SNLSSLESLLLFSNQLAGTIPTQLGSLTSLRVMRIGDNWLSGSIPTSFGNLVNLGTLGLA 175
SNL+SLESL LFSNQL G IP+QLGSL +LR +RIGDN L G+IP + GNLVN+ L LA
Sbjct: 119 SNLTSLESLFLFSNQLTGEIPSQLGSLVNLRSLRIGDNELVGAIPETLGNLVNIQMLALA 178
Query: 176 SCSLSGPIPPQFGQLSQLEELILQQNQLQGPIPAELGNCSSLSIFTAAENNLNGSIPAAL 235
SC L+GPIP Q G+L +++ LILQ N L+G IP ELGNCS L++FTAAEN LNG+IPA L
Sbjct: 179 SCRLTGPIPSQLGRLVRVQSLILQDNYLEGLIPVELGNCSDLTVFTAAENMLNGTIPAEL 238
Query: 236 GRLQNLQLLNLGNNSLSGEIPSELGELSQLGYLNLMGNRLEGAIPRSFAKMGNLQSLDLS 295
GRL +L++LNL NNSL+GEIPS+LGE+SQL YL+LM N+L+G IP+S A + NLQ+LDLS
Sbjct: 239 GRLGSLEILNLANNSLTGEIPSQLGEMSQLQYLSLMANQLQGFIPKSLADLRNLQTLDLS 298
Query: 296 MNRLTGGIPEEFGNMGQLVFLVLSNNNISGSIPRRICTNATSLEHLILAEIQLSGEIPVE 355
N LTG IPEE NM QL+ LVL+NN++SGS+P+ IC+N T+LE LIL+ QLSGEIPVE
Sbjct: 299 ANNLTGEIPEEIWNMSQLLDLVLANNHLSGSLPKSICSNNTNLEQLILSGTQLSGEIPVE 358
Query: 356 LSQCQSLKQLDLSNNTLNGTIPVELFQLVALTHLYLHNNSLVGSISPFVANLSNLQELAL 415
LS+CQSLKQLDLSNN+L G+IP LFQLV LT LYLHNN+L G +SP ++NL+NLQ L L
Sbjct: 359 LSKCQSLKQLDLSNNSLVGSIPEALFQLVELTDLYLHNNTLEGKLSPSISNLTNLQWLVL 418
Query: 416 YHNNFQGSLPREIGMLVKLELLYLYDNHLSGQIPSEVGNCSSLKWIDFFGNSFTGEIPTS 475
YHNN +G+LP+EI L KLE+L+LY+N SG+IP E+GNC+SLK ID FGN F GEIP S
Sbjct: 419 YHNNLEGTLPKEISTLEKLEVLFLYENRFSGEIPKEIGNCTSLKMIDLFGNHFEGEIPPS 478
Query: 476 IGRLKDLNFLHLRQNELVGQIPASLGNCHQLIILDLADNKLSGGVPASFGFLQALEQLML 535
IGRLK LN LHLRQNELVG +P SLGNCHQL ILDLADN+L G +P+SFGFL+ LEQLML
Sbjct: 479 IGRLKVLNLLHLRQNELVGGLPTSLGNCHQLKILDLADNQLLGSIPSSFGFLKGLEQLML 538
Query: 536 YNNSLEGNLPGSLINLRNLTRINFSKNRLNGRIATLCSSHSFLSFDVTNNEFDHEIPPQL 595
YNNSL+GNLP SLI+LRNLTRIN S NRLNG I LC S S+LSFDVTNNEF+ EIP +L
Sbjct: 539 YNNSLQGNLPDSLISLRNLTRINLSHNRLNGTIHPLCGSSSYLSFDVTNNEFEDEIPLEL 598
Query: 596 GNSPSLERLRLGNNKFIGKIPWTFGKIRELSLLDLSGNSLTGPIPTQLLMCKKLSHIDLN 655
GNS +L+RLRLG N+F G+IPWT GKIRELSLLD+S NSLTG IP QL++CKKL+HIDLN
Sbjct: 599 GNSQNLDRLRLGKNQFTGRIPWTLGKIRELSLLDISSNSLTGTIPLQLVLCKKLTHIDLN 658
Query: 656 NNLLSGAVPSWLGTLPQLGELKLSFNQFVGFLPRELFNCSKLLVLSLDGNMLNGSLPNEV 715
NN LSG +P WLG L QLGELKLS NQFV LP ELFNC+KLLVLSLDGN+LNGS+P E+
Sbjct: 659 NNFLSGPIPPWLGKLSQLGELKLSSNQFVESLPTELFNCTKLLVLSLDGNLLNGSIPQEI 718
Query: 716 GNLASLNVLTLSGNLLSGPIPPAIGRLSKLYELRLSNNSLNGVIPLEIGQLQNLQSILDL 775
GNL +LNVL L N SG +P A+G+LSKLYELRLS NS G IP+EIGQLQ+LQS LDL
Sbjct: 719 GNLGALNVLNLDKNQFSGSLPQAMGKLSKLYELRLSRNSFTGEIPIEIGQLQDLQSALDL 778
Query: 776 SHNNFTGQIPPSMGTLAKLEVLNLSHNQLVGELPSQLGEMSSLGKLNLSYNDLQGKLSKQ 835
S+NNFTG IP ++GTL+KLE L+LSHNQL GE+P +G+M SLG LNLS+N+L GKL KQ
Sbjct: 779 SYNNFTGDIPSTIGTLSKLETLDLSHNQLTGEVPGAVGDMKSLGYLNLSFNNLGGKLKKQ 838
Query: 836 FSHWPAEAFEGNLHLCGSPLDHCNGLVSNQHQSTISVSLVVAISVISTLSAIALLIAVVT 895
FS WPA++F GN LCGSPL CN + SN Q +S VV IS IS L AI L+I V+
Sbjct: 839 FSRWPADSFVGNTGLCGSPLSRCNRVGSNNKQQGLSARSVVIISAISALIAIGLMILVIA 898
Query: 896 LFVKRKREFLRK--SSQVNYTSSSSSSQAQRRLLFQ-AAAKRDFRWEDIMGATNNLSDEF 952
LF K++ +F +K Y+SSSSSSQA + LF+ A+K D +WEDIM AT+NLS+EF
Sbjct: 899 LFFKQRHDFFKKVGDGSTAYSSSSSSSQATHKPLFRTGASKSDIKWEDIMEATHNLSEEF 958
Query: 953 IIGSGGSGTVYKAELANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHC 1012
+IGSGGSG VYKAEL NG TVAVKKI KDD + NKSF+REVKTLGRIRHRHLVKLMG+C
Sbjct: 959 MIGSGGSGKVYKAELDNGETVAVKKILWKDDLMSNKSFSREVKTLGRIRHRHLVKLMGYC 1018
Query: 1013 CNKGAGSNLLIYEYMENGSVWDWLHKQ-PVNIKMRKSLDWEARLKIAVGLAQGVEYLHHD 1071
+K G NLLIYEYM+NGS+WDWLH++ PV K K +DWEARL+IAVGLAQGVEYLHHD
Sbjct: 1019 SSKSEGLNLLIYEYMKNGSIWDWLHEEKPVLEKKTKLIDWEARLRIAVGLAQGVEYLHHD 1078
Query: 1072 CVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYA 1131
CVP I+HRDIKSSN+LLDSNMEAHLGDFGLAK L E+ ++NT+SNTWFA SYGYIAPEYA
Sbjct: 1079 CVPPIVHRDIKSSNVLLDSNMEAHLGDFGLAKVLTENCDTNTDSNTWFACSYGYIAPEYA 1138
Query: 1132 YSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSAREELLDDQ 1191
YSLKATEK DVYSMGIVLME+V+GKMPT++ FG EMDMVRWVE H+E++GS R++L+D +
Sbjct: 1139 YSLKATEKSDVYSMGIVLMEIVTGKMPTESVFGAEMDMVRWVETHLEIAGSVRDKLIDPK 1198
Query: 1192 MKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNVFNNRIVDFDKL 1245
+KPLLP EE AAY VLEIALQCTKTSPQERPSSRQ CD LL+V+NNR + KL
Sbjct: 1199 LKPLLPFEEDAAYHVLEIALQCTKTSPQERPSSRQACDSLLHVYNNRTAGYKKL 1252
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|2982431|emb|CAA18239.1| leucine rich repeat-like protein [Arabidopsis thaliana] gi|7268809|emb|CAB79014.1| leucine rich repeat-like protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 1678 bits (4345), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 846/1240 (68%), Positives = 1003/1240 (80%), Gaps = 31/1240 (2%)
Query: 17 CFS----PGFVLCKDEELSVLLEIKKSFTADP--ENVLHAWNQSNQNLCTWRGITCGSSS 70
CFS PG + + +L LLE+KKS +P ++ L WN N N C+W G+TC ++
Sbjct: 13 CFSGLGQPGII---NNDLQTLLEVKKSLVTNPQEDDPLRQWNSDNINYCSWTGVTCDNTG 69
Query: 71 A-RVVSLNLSGLSLAGSISPSLGRLQSLIHLDLSSNSLTGPIPTALSNLSSLESLLLFSN 129
RV++LNL+GL L GSISP GR +LIHLDLSSN+L GPIPTALSNL+SLESL LFSN
Sbjct: 70 LFRVIALNLTGLGLTGSISPWFGRFDNLIHLDLSSNNLVGPIPTALSNLTSLESLFLFSN 129
Query: 130 QLAGTIPTQLGSLTSLRVMRIGDNWLSGSIPTSFGNLVNLGTLGLASCSLSGPIPPQFGQ 189
QL G IP+QLGSL ++R +RIGDN L G IP + GNLVNL L LASC L+GPIP Q G+
Sbjct: 130 QLTGEIPSQLGSLVNIRSLRIGDNELVGDIPETLGNLVNLQMLALASCRLTGPIPSQLGR 189
Query: 190 LSQLEELILQQNQLQGPIPAELGNCSSLSIFTAAENNLNGSIPAALGRLQNLQLLNLGNN 249
L +++ LILQ N L+GPIPAELGNCS L++FTAAEN LNG+IPA LGRL+NL++LNL NN
Sbjct: 190 LVRVQSLILQDNYLEGPIPAELGNCSDLTVFTAAENMLNGTIPAELGRLENLEILNLANN 249
Query: 250 SLSGEIPSELGELSQLGYLNLMGNRLEGAIPRSFAKMGNLQSLDLSMNRLTGGIPEEFGN 309
SL+GEIPS+LGE+SQL YL+LM N+L+G IP+S A +GNLQ+LDLS N LTG IPEEF N
Sbjct: 250 SLTGEIPSQLGEMSQLQYLSLMANQLQGLIPKSLADLGNLQTLDLSANNLTGEIPEEFWN 309
Query: 310 MGQLVFLVLSNNNISGSIPRRICTNATSLEHLILAEIQLSGEIPVELSQCQSLKQLDLSN 369
M QL+ LVL+NN++SGS+P+ IC+N T+LE L+L+ QLSGEIPVELS+CQSLKQLDLSN
Sbjct: 310 MSQLLDLVLANNHLSGSLPKSICSNNTNLEQLVLSGTQLSGEIPVELSKCQSLKQLDLSN 369
Query: 370 NTLNGTIPVELFQLVALTHLYLHNNSLVGSISPFVANLSNLQELALYHNNFQGSLPREIG 429
N+L G+IP LF+LV LT LYLHNN+L G++SP ++NL+NLQ L LYHNN +G LP+EI
Sbjct: 370 NSLAGSIPEALFELVELTDLYLHNNTLEGTLSPSISNLTNLQWLVLYHNNLEGKLPKEIS 429
Query: 430 MLVKLELLYLYDNHLSGQIPSEVGNCSSLKWIDFFGNSFTGEIPTSIGRLKDLNFLHLRQ 489
L KLE+L+LY+N SG+IP E+GNC+SLK ID FGN F GEIP SIGRLK+LN LHLRQ
Sbjct: 430 ALRKLEVLFLYENRFSGEIPQEIGNCTSLKMIDMFGNHFEGEIPPSIGRLKELNLLHLRQ 489
Query: 490 NELVGQIPASLGNCHQLIILDLADNKLSGGVPASFGFLQALEQLMLYNNSLEGNLPGSLI 549
NELVG +PASLGNCHQL ILDLADN+LSG +P+SFGFL+ LEQLMLYNNSL+GNLP SLI
Sbjct: 490 NELVGGLPASLGNCHQLNILDLADNQLSGSIPSSFGFLKGLEQLMLYNNSLQGNLPDSLI 549
Query: 550 NLRNLTRINFSKNRLNGRIATLCSSHSFLSFDVTNNEFDHEIPPQLGNSPSLERLRLGNN 609
+LRNLTRIN S NRLNG I LC S S+LSFDVTNN F+ EIP +LGNS +L+RLRLG N
Sbjct: 550 SLRNLTRINLSHNRLNGTIHPLCGSSSYLSFDVTNNGFEDEIPLELGNSQNLDRLRLGKN 609
Query: 610 KFIGKIPWTFGKIRELSLLDLSGNSLTGPIPTQLLMCKKLSHIDLNNNLLSGAVPSWLGT 669
+ GKIPWT GKIRELSLLD+S N+LTG IP QL++CKKL+HIDLNNN LSG +P WLG
Sbjct: 610 QLTGKIPWTLGKIRELSLLDMSSNALTGTIPLQLVLCKKLTHIDLNNNFLSGPIPPWLGK 669
Query: 670 LPQLGELKLSFNQFVGFLPRELFNCSKLLVLSLDGNMLNGSLPNEVGNLASLNVLTLSGN 729
L QLGELKLS NQFV LP ELFNC+KLLVLSLDGN LNGS+P E+GNL +LNVL L N
Sbjct: 670 LSQLGELKLSSNQFVESLPTELFNCTKLLVLSLDGNSLNGSIPQEIGNLGALNVLNLDKN 729
Query: 730 LLSGPIPPAIGRLSKLYELRLSNNSLNGVIPLEIGQLQNLQSILDLSHNNFTGQIPPSMG 789
SG +P A+G+LSKLYELRLS NSL G IP+EIGQLQ+LQS LDLS+NNFTG IP ++G
Sbjct: 730 QFSGSLPQAMGKLSKLYELRLSRNSLTGEIPVEIGQLQDLQSALDLSYNNFTGDIPSTIG 789
Query: 790 TLAKLEVLNLSHNQLVGELPSQLGEMSSLGKLNLSYNDLQGKLSKQFSHWPAEAFEGNLH 849
TL+KLE L+LSHNQL GE+P +G+M SLG LN+S+N+L GKL KQFS WPA++F GN
Sbjct: 790 TLSKLETLDLSHNQLTGEVPGSVGDMKSLGYLNVSFNNLGGKLKKQFSRWPADSFLGNTG 849
Query: 850 LCGSPLDHCNGLVSNQHQSTISVSLVVAISVISTLSAIALLIAVVTLFVKRKREFLRKSS 909
LCGSPL CN + IS L+AI L+I V+ LF K++ +F +K
Sbjct: 850 LCGSPLSRCN-----------------RVRTISALTAIGLMILVIALFFKQRHDFFKKVG 892
Query: 910 Q--VNYTSSSSSSQAQRRLLFQ-AAAKRDFRWEDIMGATNNLSDEFIIGSGGSGTVYKAE 966
YTSSSSSSQA + LF+ A+K D RWEDIM AT+NLS+EF+IGSGGSG VYKAE
Sbjct: 893 HGSTAYTSSSSSSQATHKPLFRNGASKSDIRWEDIMEATHNLSEEFMIGSGGSGKVYKAE 952
Query: 967 LANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIYEY 1026
L NG TVAVKKI KDD + NKSF+REVKTLGRIRHRHLVKLMG+C +K G NLLIYEY
Sbjct: 953 LENGETVAVKKILWKDDLMSNKSFSREVKTLGRIRHRHLVKLMGYCSSKSEGLNLLIYEY 1012
Query: 1027 MENGSVWDWLHK-QPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSN 1085
M+NGS+WDWLH+ +PV K +K LDWEARL+IAVGLAQGVEYLHHDCVP I+HRDIKSSN
Sbjct: 1013 MKNGSIWDWLHEDKPVLEKKKKLLDWEARLRIAVGLAQGVEYLHHDCVPPIVHRDIKSSN 1072
Query: 1086 ILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSM 1145
+LLDSNMEAHLGDFGLAK L E+ ++NT+SNTWFA SYGYIAPEYAYSLKATEK DVYSM
Sbjct: 1073 VLLDSNMEAHLGDFGLAKVLTENCDTNTDSNTWFACSYGYIAPEYAYSLKATEKSDVYSM 1132
Query: 1146 GIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSAREELLDDQMKPLLPGEECAAYQ 1205
GIVLME+V+GKMPTD+ FG EMDMVRWVE H+E++GSAR++L+D ++KPLLP EE AA Q
Sbjct: 1133 GIVLMEIVTGKMPTDSVFGAEMDMVRWVETHLEVAGSARDKLIDPKLKPLLPFEEDAACQ 1192
Query: 1206 VLEIALQCTKTSPQERPSSRQVCDLLLNVFNNRIVDFDKL 1245
VLEIALQCTKTSPQERPSSRQ CD LL+V+NNR + KL
Sbjct: 1193 VLEIALQCTKTSPQERPSSRQACDSLLHVYNNRTAGYKKL 1232
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 1251 | ||||||
| TAIR|locus:2120362 | 1249 | GSO1 "GASSHO1" [Arabidopsis th | 0.980 | 0.981 | 0.632 | 0.0 | |
| TAIR|locus:2156349 | 1252 | GSO2 "GASSHO 2" [Arabidopsis t | 0.981 | 0.980 | 0.585 | 0.0 | |
| TAIR|locus:2160791 | 1102 | AT5G63930 [Arabidopsis thalian | 0.503 | 0.571 | 0.383 | 2.4e-179 | |
| TAIR|locus:2020417 | 1101 | AT1G17230 [Arabidopsis thalian | 0.517 | 0.588 | 0.378 | 7.5e-174 | |
| TAIR|locus:2046525 | 1124 | AT2G33170 [Arabidopsis thalian | 0.505 | 0.563 | 0.365 | 1.1e-172 | |
| TAIR|locus:2007918 | 1088 | PEPR2 "PEP1 receptor 2" [Arabi | 0.498 | 0.572 | 0.366 | 3e-157 | |
| TAIR|locus:2011339 | 1120 | AT1G35710 [Arabidopsis thalian | 0.516 | 0.576 | 0.383 | 1.3e-154 | |
| TAIR|locus:2154344 | 1135 | AT5G48940 [Arabidopsis thalian | 0.441 | 0.486 | 0.390 | 1.3e-152 | |
| TAIR|locus:2085949 | 1141 | AT3G24240 [Arabidopsis thalian | 0.513 | 0.562 | 0.349 | 4.5e-152 | |
| TAIR|locus:2138268 | 1045 | AT4G08850 [Arabidopsis thalian | 0.466 | 0.558 | 0.377 | 1.9e-151 |
| TAIR|locus:2120362 GSO1 "GASSHO1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 3988 (1408.9 bits), Expect = 0., P = 0.
Identities = 784/1240 (63%), Positives = 923/1240 (74%)
Query: 17 CFS----PGFVLCKDEELSVLLEIKKSFTADPE--NVLHAWNQSNQNLCTWRGITCGSSS 70
CFS PG + + +L LLE+KKS +P+ + L WN N N C+W G+TC ++
Sbjct: 13 CFSGLGQPGII---NNDLQTLLEVKKSLVTNPQEDDPLRQWNSDNINYCSWTGVTCDNTG 69
Query: 71 A-RVVXXXXXXXXXXXXXXXXXXRLQSLIHLDLSSNSLTGPIPTAXXXXXXXXXXXXXXX 129
RV+ R +LIHLDLSSN+L GPIPTA
Sbjct: 70 LFRVIALNLTGLGLTGSISPWFGRFDNLIHLDLSSNNLVGPIPTALSNLTSLESLFLFSN 129
Query: 130 XXAGTIPTQLGSLTSLRVMRIGDNWLSGSIPTSFGNLVNLGTLGLASCSLSGPIPPQFGX 189
G IP+QLGSL ++R +RIGDN L G IP + GNLVNL L LASC L+GPIP Q G
Sbjct: 130 QLTGEIPSQLGSLVNIRSLRIGDNELVGDIPETLGNLVNLQMLALASCRLTGPIPSQLGR 189
Query: 190 XXXXXXXXXXXXXXXGPIPAELGNCSSLSIFTAAENNLNGSIPAALGRXXXXXXXXXXXX 249
GPIPAELGNCS L++FTAAEN LNG+IPA LGR
Sbjct: 190 LVRVQSLILQDNYLEGPIPAELGNCSDLTVFTAAENMLNGTIPAELGRLENLEILNLANN 249
Query: 250 XXXXEIPSELGELSQLGYLNLMGNRLEGAIPRSFAKMGNLQSLDLSMNRLTGGIPEEFGN 309
EIPS+LGE+SQL YL+LM N+L+G IP+S A +GNLQ+LDLS N LTG IPEEF N
Sbjct: 250 SLTGEIPSQLGEMSQLQYLSLMANQLQGLIPKSLADLGNLQTLDLSANNLTGEIPEEFWN 309
Query: 310 MGQLVFLVLSNNNISGSIPRRICTNATSLEHLILAEIQLSGEIPVELSQCQSLKQLDLSN 369
M QL+ LVL+NN++SGS+P+ IC+N T+LE L+L+ QLSGEIPVELS+CQSLKQLDLSN
Sbjct: 310 MSQLLDLVLANNHLSGSLPKSICSNNTNLEQLVLSGTQLSGEIPVELSKCQSLKQLDLSN 369
Query: 370 NTLNGTIPVELFQLVALTHLYLHNNSLVGSISPFVANLSNLQELALYHNNFQGSLPREIG 429
N+L G+IP LF+LV LT LYLHNN+L G++SP ++NL+NLQ L LYHNN +G LP+EI
Sbjct: 370 NSLAGSIPEALFELVELTDLYLHNNTLEGTLSPSISNLTNLQWLVLYHNNLEGKLPKEIS 429
Query: 430 MLVKLELLYLYDNHLSGQIPSEVGNCSSLKWIDFFGNSFTGEIPTSIGRLKDLNFLHLRQ 489
L KLE+L+LY+N SG+IP E+GNC+SLK ID FGN F GEIP SIGRLK+LN LHLRQ
Sbjct: 430 ALRKLEVLFLYENRFSGEIPQEIGNCTSLKMIDMFGNHFEGEIPPSIGRLKELNLLHLRQ 489
Query: 490 NELVGQIPASLGNCHQLIILDLADNKLSGGVPASFGFLQALEQLMLYNNSLEGNLPGSLI 549
NELVG +PASLGNCHQL ILDLADN+LSG +P+SFGFL+ LEQLMLYNNSL+GNLP SLI
Sbjct: 490 NELVGGLPASLGNCHQLNILDLADNQLSGSIPSSFGFLKGLEQLMLYNNSLQGNLPDSLI 549
Query: 550 NLRNLTRINFSKNRLNGRIATLCSSHSFLSFDVTNNEFDHEIPPQLGNSPSLERLRLGNN 609
+LRNLTRIN S NRLNG I LC S S+LSFDVTNN F+ EIP +LGNS +L+RLRLG N
Sbjct: 550 SLRNLTRINLSHNRLNGTIHPLCGSSSYLSFDVTNNGFEDEIPLELGNSQNLDRLRLGKN 609
Query: 610 KFIGKIPWTFGKIRELSLLDLSGNSLTGPIPTQLLMCKKLSHIDLNNNLLSGAVPSWLGT 669
+ GKIPWT GKIRELSLLD+S N+LTG IP QL++CKKL+HIDLNNN LSG +P WLG
Sbjct: 610 QLTGKIPWTLGKIRELSLLDMSSNALTGTIPLQLVLCKKLTHIDLNNNFLSGPIPPWLGK 669
Query: 670 LPQLGELKLSFNQFVGFLPRELFNCSKLLVLSLDGNMLNGSLPNEVGNLASLNVLTLSGN 729
L QLGELKLS NQFV LP ELFNC+KLLVLSLDGN LNGS+P E+GNL +LNVL L N
Sbjct: 670 LSQLGELKLSSNQFVESLPTELFNCTKLLVLSLDGNSLNGSIPQEIGNLGALNVLNLDKN 729
Query: 730 LLSGPIPPAIGRLSKLYELRLSNNSLNGVIPLEIGQLQNLQSILDLSHNNFTGQIPPSMG 789
SG +P A+G+LSKLYELRLS NSL G IP+EIGQLQ+LQS LDLS+NNFTG IP ++G
Sbjct: 730 QFSGSLPQAMGKLSKLYELRLSRNSLTGEIPVEIGQLQDLQSALDLSYNNFTGDIPSTIG 789
Query: 790 TLAKLEVLNLSHNQLVGELPSQLGEMSSLGKLNLSYNDLQGKLSKQFSHWPAEAFEGNLH 849
TL+KLE L+LSHNQL GE+P +G+M SLG LN+S+N+L GKL KQFS WPA++F GN
Sbjct: 790 TLSKLETLDLSHNQLTGEVPGSVGDMKSLGYLNVSFNNLGGKLKKQFSRWPADSFLGNTG 849
Query: 850 LCGSPLDHCNGLVSNQHQXXXXXXXXXXXXXXXXXXXXXXXXXXXXXFVKRKREFLRK-- 907
LCGSPL CN + SN Q F K++ +F +K
Sbjct: 850 LCGSPLSRCNRVRSNNKQQGLSARSVVIISAISALTAIGLMILVIALFFKQRHDFFKKVG 909
Query: 908 SSQVNYTXXXXXXXXXXX-XXXXXXXKRDFRWEDIMGATNNLSDEFIIGSGGSGTVYKAE 966
YT K D RWEDIM AT+NLS+EF+IGSGGSG VYKAE
Sbjct: 910 HGSTAYTSSSSSSQATHKPLFRNGASKSDIRWEDIMEATHNLSEEFMIGSGGSGKVYKAE 969
Query: 967 LANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIYEY 1026
L NG TVAVKKI KDD + NKSF+REVKTLGRIRHRHLVKLMG+C +K G NLLIYEY
Sbjct: 970 LENGETVAVKKILWKDDLMSNKSFSREVKTLGRIRHRHLVKLMGYCSSKSEGLNLLIYEY 1029
Query: 1027 MENGSVWDWLHK-QPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSN 1085
M+NGS+WDWLH+ +PV K +K LDWEARL+IAVGLAQGVEYLHHDCVP I+HRDIKSSN
Sbjct: 1030 MKNGSIWDWLHEDKPVLEKKKKLLDWEARLRIAVGLAQGVEYLHHDCVPPIVHRDIKSSN 1089
Query: 1086 ILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSM 1145
+LLDSNMEAHLGDFGLAK L E+ ++NT+SNTWFA SYGYIAPEYAYSLKATEK DVYSM
Sbjct: 1090 VLLDSNMEAHLGDFGLAKVLTENCDTNTDSNTWFACSYGYIAPEYAYSLKATEKSDVYSM 1149
Query: 1146 GIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSAREELLDDQMKPLLPGEECAAYQ 1205
GIVLME+V+GKMPTD+ FG EMDMVRWVE H+E++GSAR++L+D ++KPLLP EE AA Q
Sbjct: 1150 GIVLMEIVTGKMPTDSVFGAEMDMVRWVETHLEVAGSARDKLIDPKLKPLLPFEEDAACQ 1209
Query: 1206 VLEIALQCTKTSPQERPSSRQVCDLLLNVFNNRIVDFDKL 1245
VLEIALQCTKTSPQERPSSRQ CD LL+V+NNR + KL
Sbjct: 1210 VLEIALQCTKTSPQERPSSRQACDSLLHVYNNRTAGYKKL 1249
|
|
| TAIR|locus:2156349 GSO2 "GASSHO 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 3684 (1301.9 bits), Expect = 0., P = 0.
Identities = 726/1240 (58%), Positives = 888/1240 (71%)
Query: 17 CFSPGFVLCKD---EELSVLLEIKKSFTADP--ENVLHAWNQSNQNLCTWRGITCGSSSA 71
CFS G + ++L LLE+K SF +P E+VL WN + + C W G+TCG
Sbjct: 14 CFSSGLGSGQPGQRDDLQTLLELKNSFITNPKEEDVLRDWNSGSPSYCNWTGVTCGGRE- 72
Query: 72 RVVXXXXXXXXXXXXXXXXXXRLQSLIHLDLSSNSLTGPIPTAXXXXXXXXXXXXXXXXX 131
++ R +LIH+DLSSN L GPIPT
Sbjct: 73 -IIGLNLSGLGLTGSISPSIGRFNNLIHIDLSSNRLVGPIPTTLSNLSSSLESLHLFSNL 131
Query: 132 -AGTIPTQLGSLTSLRVMRIGDNWLSGSIPTSFGNLVNLGTLGLASCSLSGPIPPQFGXX 190
+G IP+QLGSL +L+ +++GDN L+G+IP +FGNLVNL L LASC L+G IP +FG
Sbjct: 132 LSGDIPSQLGSLVNLKSLKLGDNELNGTIPETFGNLVNLQMLALASCRLTGLIPSRFGRL 191
Query: 191 XXXXXXXXXXXXXXGPIPAELGNCSSLSIFTAAENNLNGSIPAALGRXXXXXXXXXXXXX 250
GPIPAE+GNC+SL++F AA N LNGS+PA L R
Sbjct: 192 VQLQTLILQDNELEGPIPAEIGNCTSLALFAAAFNRLNGSLPAELNRLKNLQTLNLGDNS 251
Query: 251 XXXEIPSELGELSQLGYLNLMGNRLEGAIPRSFAKMGNLQSLDLSMNRLTGGIPEEFGNM 310
EIPS+LG+L + YLNL+GN+L+G IP+ ++ NLQ+LDLS N LTG I EEF M
Sbjct: 252 FSGEIPSQLGDLVSIQYLNLIGNQLQGLIPKRLTELANLQTLDLSSNNLTGVIHEEFWRM 311
Query: 311 GQLVFLVLSNNNISGSIPRRICTNATSLEHLILAEIQLSGEIPVELSQCQSLKQLDLSNN 370
QL FLVL+ N +SGS+P+ IC+N TSL+ L L+E QLSGEIP E+S CQSLK LDLSNN
Sbjct: 312 NQLEFLVLAKNRLSGSLPKTICSNNTSLKQLFLSETQLSGEIPAEISNCQSLKLLDLSNN 371
Query: 371 TLNGTIPVELFQLVALTHLYLHNNSLVGSISPFVANLSNLQELALYHNNFQGSLPREIGM 430
TL G IP LFQLV LT+LYL+NNSL G++S ++NL+NLQE LYHNN +G +P+EIG
Sbjct: 372 TLTGQIPDSLFQLVELTNLYLNNNSLEGTLSSSISNLTNLQEFTLYHNNLEGKVPKEIGF 431
Query: 431 LVKLELLYLYDNHLSGQIPSEVGNCSSLKWIDFFGNSFTGEIPTSIGRLKDLNFLHLRQN 490
L KLE++YLY+N SG++P E+GNC+ L+ ID++GN +GEIP+SIGRLKDL LHLR+N
Sbjct: 432 LGKLEIMYLYENRFSGEMPVEIGNCTRLQEIDWYGNRLSGEIPSSIGRLKDLTRLHLREN 491
Query: 491 ELVGQIPASLGNCHQLIILDLADNKLSGGVPASFGFLQALEQLMLYNNSLEGNLPGSLIN 550
ELVG IPASLGNCHQ+ ++DLADN+LSG +P+SFGFL ALE M+YNNSL+GNLP SLIN
Sbjct: 492 ELVGNIPASLGNCHQMTVIDLADNQLSGSIPSSFGFLTALELFMIYNNSLQGNLPDSLIN 551
Query: 551 LRNLTRINFSKNRLNGRIATLCSSHSFLSFDVTNNEFDHEIPPQLGNSPSLERLRLGNNK 610
L+NLTRINFS N+ NG I+ LC S S+LSFDVT N F+ +IP +LG S +L+RLRLG N+
Sbjct: 552 LKNLTRINFSSNKFNGSISPLCGSSSYLSFDVTENGFEGDIPLELGKSTNLDRLRLGKNQ 611
Query: 611 FIGKIPWTFGKIRELSLLDLSGNSLTGPIPTQLLMCKKLSHIDLNNNLLSGAVPSWLGTL 670
F G+IP TFGKI ELSLLD+S NSL+G IP +L +CKKL+HIDLNNN LSG +P+WLG L
Sbjct: 612 FTGRIPRTFGKISELSLLDISRNSLSGIIPVELGLCKKLTHIDLNNNYLSGVIPTWLGKL 671
Query: 671 PQLGELKLSFNQFVGFLPRELFNCSKLLVLSLDGNMLNGSLPNEVGNLASLNVLTLSGNL 730
P LGELKLS N+FVG LP E+F+ + +L L LDGN LNGS+P E+GNL +LN L L N
Sbjct: 672 PLLGELKLSSNKFVGSLPTEIFSLTNILTLFLDGNSLNGSIPQEIGNLQALNALNLEENQ 731
Query: 731 LSGPIPPAIGRLSKLYELRLSNNSLNGVIPLEIGQLQNLQSILDLSHNNFTGQIPPSMGT 790
LSGP+P IG+LSKL+ELRLS N+L G IP+EIGQLQ+LQS LDLS+NNFTG+IP ++ T
Sbjct: 732 LSGPLPSTIGKLSKLFELRLSRNALTGEIPVEIGQLQDLQSALDLSYNNFTGRIPSTIST 791
Query: 791 LAKLEVLNLSHNQLVGELPSQLGEMSSLGKLNLSYNDLQGKLSKQFSHWPAEAFEGNLHL 850
L KLE L+LSHNQLVGE+P Q+G+M SLG LNLSYN+L+GKL KQFS W A+AF GN L
Sbjct: 792 LPKLESLDLSHNQLVGEVPGQIGDMKSLGYLNLSYNNLEGKLKKQFSRWQADAFVGNAGL 851
Query: 851 CGSPLDHCNGLVSNQHQXXXXXXXXXXXXXXXXXXXXXXXXXXXXXFVKRKREFLRKSSQ 910
CGSPL HCN +++Q F K+ + +K
Sbjct: 852 CGSPLSHCNR-AGSKNQRSLSPKTVVIISAISSLAAIALMVLVIILFFKQNHDLFKKVRG 910
Query: 911 VNYTXXXXXXXXXXXXXXXXXXKRDFRWEDIMGATNNLSDEFIIGSGGSGTVYKAELANG 970
N K D +W+DIM AT+ L++EF+IGSGGSG VYKAEL NG
Sbjct: 911 GNSAFSSNSSSSQAPLFSNGGAKSDIKWDDIMEATHYLNEEFMIGSGGSGKVYKAELKNG 970
Query: 971 ATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIYEYMENG 1030
T+AVKKI KDD + NKSF REVKTLG IRHRHLVKLMG+C +K G NLLIYEYM NG
Sbjct: 971 ETIAVKKILWKDDLMSNKSFNREVKTLGTIRHRHLVKLMGYCSSKADGLNLLIYEYMANG 1030
Query: 1031 SVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDS 1090
SVWDWLH N K ++ L WE RLKIA+GLAQGVEYLH+DCVP I+HRDIKSSN+LLDS
Sbjct: 1031 SVWDWLHANE-NTKKKEVLGWETRLKIALGLAQGVEYLHYDCVPPIVHRDIKSSNVLLDS 1089
Query: 1091 NMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLM 1150
N+EAHLGDFGLAK L +Y++NTESNT FAGSYGYIAPEYAYSLKATEK DVYSMGIVLM
Sbjct: 1090 NIEAHLGDFGLAKILTGNYDTNTESNTMFAGSYGYIAPEYAYSLKATEKSDVYSMGIVLM 1149
Query: 1151 ELVSGKMPTDATFGVEMDMVRWVEMHMEMS-GS-AREELLDDQMKPLLPGEECAAYQVLE 1208
E+V+GKMPT+A F E DMVRWVE ++ GS ARE+L+D ++K LLP EE AAYQVLE
Sbjct: 1150 EIVTGKMPTEAMFDEETDMVRWVETVLDTPPGSEAREKLIDSELKSLLPCEEEAAYQVLE 1209
Query: 1209 IALQCTKTSPQERPSSRQVCDLLLNVFNNRIVDFDKLHID 1248
IALQCTK+ PQERPSSRQ + LLNVFNNR + ++ D
Sbjct: 1210 IALQCTKSYPQERPSSRQASEYLLNVFNNRAASYREMQTD 1249
|
|
| TAIR|locus:2160791 AT5G63930 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1095 (390.5 bits), Expect = 2.4e-179, Sum P(2) = 2.4e-179
Identities = 243/633 (38%), Positives = 349/633 (55%)
Query: 227 LNGSIPAALGRXXXXXXXXXXXXXXXXEIPSELGELSQLGYLNLMGNRLEGAIPRSFAKM 286
L+G + ++G +IP E+G S L L L N+ +G IP K+
Sbjct: 85 LSGKLSPSIGGLVHLKQLDLSYNGLSGKIPKEIGNCSSLEILKLNNNQFDGEIPVEIGKL 144
Query: 287 GNLQSLDLSMNRLTGGIPEEFGNMGQLVFLVLSNNNISGSIPRRICTNATSLEHLILAEI 346
+L++L + NR++G +P E GN+ L LV +NNISG +PR I N L +
Sbjct: 145 VSLENLIIYNNRISGSLPVEIGNLLSLSQLVTYSNNISGQLPRSI-GNLKRLTSFRAGQN 203
Query: 347 QLSGEIPVELSQCQSLKQLDLSNNTLNGTIPVELFQLVALTHLYLHNNSLVGSISPFVAN 406
+SG +P E+ C+SL L L+ N L+G +P E+ L L+ + L N G I ++N
Sbjct: 204 MISGSLPSEIGGCESLVMLGLAQNQLSGELPKEIGMLKKLSQVILWENEFSGFIPREISN 263
Query: 407 LSNLQELALYHNNFQGSLPREIGMLVKLELLYLYDNHLSGQIPSEVGNCSSLKWIDFFGN 466
++L+ LALY N G +P+E+G L LE LYLY N L+G IP E+GN S IDF N
Sbjct: 264 CTSLETLALYKNQLVGPIPKELGDLQSLEFLYLYRNGLNGTIPREIGNLSYAIEIDFSEN 323
Query: 467 SFTGEIPTSIGRLKDLNFLHLRQNELVGQIPASLGNCHQLIILDLADNKLSGGVPASFGF 526
+ TGEIP +G ++ L L+L +N+L G IP L L LDL+ N L+G +P F +
Sbjct: 324 ALTGEIPLELGNIEGLELLYLFENQLTGTIPVELSTLKNLSKLDLSINALTGPIPLGFQY 383
Query: 527 LQALEQLMLYNNSLEGNLPGSLINLRNLTRINFSKNRLNGRIAT-LCSSHSFLSFDVTNN 585
L+ L L L+ NSL G +P L +L ++ S N L+GRI + LC + + ++ N
Sbjct: 384 LRGLFMLQLFQNSLSGTIPPKLGWYSDLWVLDMSDNHLSGRIPSYLCLHSNMIILNLGTN 443
Query: 586 EFDHEIPPQLGNSPSLERLRLGNNKFIGKIPWTFGKIRELSLLDLSGNSLTGPIPTQLLM 645
IP + +L +LRL N +G+ P K ++ ++L N G IP ++
Sbjct: 444 NLSGNIPTGITTCKTLVQLRLARNNLVGRFPSNLCKQVNVTAIELGQNRFRGSIPREVGN 503
Query: 646 CKKLSHIDLNNNLLSGAVPSWLGTLPQLGELKLSFNQFVGFLPRELFNCSKLLVLSLDGN 705
C L + L +N +G +P +G L QLG L +S N+ G +P E+FNC L L + N
Sbjct: 504 CSALQRLQLADNGFTGELPREIGMLSQLGTLNISSNKLTGEVPSEIFNCKMLQRLDMCCN 563
Query: 706 MLNGSLPNEVGNLASLNVLTLSGNLLSGPIPPAIGRLSKLYELRLSNNSLNGVIPLEIGQ 765
+G+LP+EVG+L L +L LS N LSG IP A+G LS+L EL++ N NG IP E+G
Sbjct: 564 NFSGTLPSEVGSLYQLELLKLSNNNLSGTIPVALGNLSRLTELQMGGNLFNGSIPRELGS 623
Query: 766 LQNLQSILDLSHNNFTGQIPPSMGTLAKLEVLNLSHNQLVGELPSQLGEMSSLGKLNLSY 825
L LQ L+LS+N TG+IPP + L LE L L++N L GE+PS +SSL N SY
Sbjct: 624 LTGLQIALNLSYNKLTGEIPPELSNLVMLEFLLLNNNNLSGEIPSSFANLSSLLGYNFSY 683
Query: 826 NDLQGKLSKQFSHWPAEAFEGNLHLCGSPLDHC 858
N L G + + +F GN LCG PL+ C
Sbjct: 684 NSLTGPIPL-LRNISMSSFIGNEGLCGPPLNQC 715
|
|
| TAIR|locus:2020417 AT1G17230 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1064 (379.6 bits), Expect = 7.5e-174, Sum P(2) = 7.5e-174
Identities = 248/655 (37%), Positives = 355/655 (54%)
Query: 214 CSSLSIFTAAE-N--NLNGSIPAALGRXXXXXXXXXXXXXXXXEIPSELGELSQLGYLNL 270
C+ L T+ + N NL+G++ + + IP +L L L+L
Sbjct: 63 CTHLRTVTSVDLNGMNLSGTLSPLICKLHGLRKLNVSTNFISGPIPQDLSLCRSLEVLDL 122
Query: 271 MGNRLEGAIPRSFAKMGNLQSLDLSMNRLTGGIPEEFGNMGQLVFLVLSNNNISGSIPRR 330
NR G IP + L+ L L N L G IP + GN+ L LV+ +NN++G IP
Sbjct: 123 CTNRFHGVIPIQLTMIITLKKLYLCENYLFGSIPRQIGNLSSLQELVIYSNNLTGVIPPS 182
Query: 331 ICTNATSLEHLILAEIQLSGEIPVELSQCQSLKQLDLSNNTLNGTIPVELFQLVALTHLY 390
+ L + SG IP E+S C+SLK L L+ N L G++P +L +L LT L
Sbjct: 183 MA-KLRQLRIIRAGRNGFSGVIPSEISGCESLKVLGLAENLLEGSLPKQLEKLQNLTDLI 241
Query: 391 LHNNSLVGSISPFVANLSNLQELALYHNNFQGSLPREIGMLVKLELLYLYDNHLSGQIPS 450
L N L G I P V N+S L+ LAL+ N F GS+PREIG L K++ LYLY N L+G+IP
Sbjct: 242 LWQNRLSGEIPPSVGNISRLEVLALHENYFTGSIPREIGKLTKMKRLYLYTNQLTGEIPR 301
Query: 451 EVGNCSSLKWIDFFGNSFTGEIPTSIGRLKDLNFLHLRQNELVGQIPASLGNCHQLIILD 510
E+GN IDF N TG IP G + +L LHL +N L+G IP LG L LD
Sbjct: 302 EIGNLIDAAEIDFSENQLTGFIPKEFGHILNLKLLHLFENILLGPIPRELGELTLLEKLD 361
Query: 511 LADNKLSGGVPASFGFLQALEQLMLYNNSLEGNLPGSLINLRNLTRINFSKNRLNGRI-A 569
L+ N+L+G +P FL L L L++N LEG +P + N + ++ S N L+G I A
Sbjct: 362 LSINRLNGTIPQELQFLPYLVDLQLFDNQLEGKIPPLIGFYSNFSVLDMSANSLSGPIPA 421
Query: 570 TLCSSHSFLSFDVTNNEFDHEIPPQLGNSPSLERLRLGNNKFIGKIPWTFGKIRELSLLD 629
C + + + +N+ IP L SL +L LG+N+ G +P ++ L+ L+
Sbjct: 422 HFCRFQTLILLSLGSNKLSGNIPRDLKTCKSLTKLMLGDNQLTGSLPIELFNLQNLTALE 481
Query: 630 LSGNSLTGPIPTQLLMCKKLSHIDLNNNLLSGAVPSWLGTLPQLGELKLSFNQFVGFLPR 689
L N L+G I L K L + L NN +G +P +G L ++ +S NQ G +P+
Sbjct: 482 LHQNWLSGNISADLGKLKNLERLRLANNNFTGEIPPEIGNLTKIVGFNISSNQLTGHIPK 541
Query: 690 ELFNCSKLLVLSLDGNMLNGSLPNEVGNLASLNVLTLSGNLLSGPIPPAIGRLSKLYELR 749
EL +C + L L GN +G + E+G L L +L LS N L+G IP + G L++L EL+
Sbjct: 542 ELGSCVTIQRLDLSGNKFSGYIAQELGQLVYLEILRLSDNRLTGEIPHSFGDLTRLMELQ 601
Query: 750 LSNNSLNGVIPLEIGQLQNLQSILDLSHNNFTGQIPPSMGTLAKLEVLNLSHNQLVGELP 809
L N L+ IP+E+G+L +LQ L++SHNN +G IP S+G L LE+L L+ N+L GE+P
Sbjct: 602 LGGNLLSENIPVELGKLTSLQISLNISHNNLSGTIPDSLGNLQMLEILYLNDNKLSGEIP 661
Query: 810 SQLGEMSSLGKLNLSYNDLQGKL--SKQFSHWPAEAFEGNLHLCGSPLDHCNGLV 862
+ +G + SL N+S N+L G + + F + F GN LC S HC LV
Sbjct: 662 ASIGNLMSLLICNISNNNLVGTVPDTAVFQRMDSSNFAGNHGLCNSQRSHCQPLV 716
|
|
| TAIR|locus:2046525 AT2G33170 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1048 (374.0 bits), Expect = 1.1e-172, Sum P(2) = 1.1e-172
Identities = 233/637 (36%), Positives = 354/637 (55%)
Query: 226 NLNGSIPAALGRXXXXXXXXXXXXXXXXEIPSELGELSQLGYLNLMGNRLEGAIPRSFAK 285
NL+G + ++G +IP E+G S+L + L N+ G+IP K
Sbjct: 96 NLSGIVSPSIGGLVNLVYLNLAYNALTGDIPREIGNCSKLEVMFLNNNQFGGSIPVEINK 155
Query: 286 MGNLQSLDLSMNRLTGGIPEEFGNMGQLVFLVLSNNNISGSIPRRICTNATSLEHLILAE 345
+ L+S ++ N+L+G +PEE G++ L LV NN++G +PR + N L +
Sbjct: 156 LSQLRSFNICNNKLSGPLPEEIGDLYNLEELVAYTNNLTGPLPRSL-GNLNKLTTFRAGQ 214
Query: 346 IQLSGEIPVELSQCQSLKQLDLSNNTLNGTIPVELFQLVALTHLYLHNNSLVGSISPFVA 405
SG IP E+ +C +LK L L+ N ++G +P E+ LV L + L N G I +
Sbjct: 215 NDFSGNIPTEIGKCLNLKLLGLAQNFISGELPKEIGMLVKLQEVILWQNKFSGFIPKDIG 274
Query: 406 NLSNLQELALYHNNFQGSLPREIGMLVKLELLYLYDNHLSGQIPSEVGNCSSLKWIDFFG 465
NL++L+ LALY N+ G +P EIG + L+ LYLY N L+G IP E+G S + IDF
Sbjct: 275 NLTSLETLALYGNSLVGPIPSEIGNMKSLKKLYLYQNQLNGTIPKELGKLSKVMEIDFSE 334
Query: 466 NSFTGEIPTSIGRLKDLNFLHLRQNELVGQIPASLGNCHQLIILDLADNKLSGGVPASFG 525
N +GEIP + ++ +L L+L QN+L G IP L L LDL+ N L+G +P F
Sbjct: 335 NLLSGEIPVELSKISELRLLYLFQNKLTGIIPNELSKLRNLAKLDLSINSLTGPIPPGFQ 394
Query: 526 FLQALEQLMLYNNSLEGNLPGSLINLRNLTRINFSKNRLNGRIAT-LCSSHSFLSFDVTN 584
L ++ QL L++NSL G +P L L ++FS+N+L+G+I +C + + ++ +
Sbjct: 395 NLTSMRQLQLFHNSLSGVIPQGLGLYSPLWVVDFSENQLSGKIPPFICQQSNLILLNLGS 454
Query: 585 NEFDHEIPPQLGNSPSLERLRLGNNKFIGKIPWTFGKIRELSLLDLSGNSLTGPIPTQLL 644
N IPP + SL +LR+ N+ G+ P K+ LS ++L N +GP+P ++
Sbjct: 455 NRIFGNIPPGVLRCKSLLQLRVVGNRLTGQFPTELCKLVNLSAIELDQNRFSGPLPPEIG 514
Query: 645 MCKKLSHIDLNNNLLSGAVPSWLGTLPQLGELKLSFNQFVGFLPRELFNCSKLLVLSLDG 704
C+KL + L N S +P+ + L L +S N G +P E+ NC L L L
Sbjct: 515 TCQKLQRLHLAANQFSSNLPNEISKLSNLVTFNVSSNSLTGPIPSEIANCKMLQRLDLSR 574
Query: 705 NMLNGSLPNEVGNLASLNVLTLSGNLLSGPIPPAIGRLSKLYELRLSNNSLNGVIPLEIG 764
N GSLP E+G+L L +L LS N SG IP IG L+ L EL++ N +G IP ++G
Sbjct: 575 NSFIGSLPPELGSLHQLEILRLSENRFSGNIPFTIGNLTHLTELQMGGNLFSGSIPPQLG 634
Query: 765 QLQNLQSILDLSHNNFTGQIPPSMGTLAKLEVLNLSHNQLVGELPSQLGEMSSLGKLNLS 824
L +LQ ++LS+N+F+G+IPP +G L L L+L++N L GE+P+ +SSL N S
Sbjct: 635 LLSSLQIAMNLSYNDFSGEIPPEIGNLHLLMYLSLNNNHLSGEIPTTFENLSSLLGCNFS 694
Query: 825 YNDLQGKL--SKQFSHWPAEAFEGNLHLCGSPLDHCN 859
YN+L G+L ++ F + +F GN LCG L C+
Sbjct: 695 YNNLTGQLPHTQIFQNMTLTSFLGNKGLCGGHLRSCD 731
|
|
| TAIR|locus:2007918 PEPR2 "PEP1 receptor 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 979 (349.7 bits), Expect = 3.0e-157, Sum P(2) = 3.0e-157
Identities = 230/628 (36%), Positives = 337/628 (53%)
Query: 225 NNLNGSIPAALGRXXXXXXXXXXXXXXXXEIPSELGELSQLGYLNLMGNRLEGAIPRSFA 284
+ L+G + + +G +PS LG + L YL+L N G +P F
Sbjct: 86 SGLSGQLGSEIGELKSLVTLDLSLNSFSGLLPSTLGNCTSLEYLDLSNNDFSGEVPDIFG 145
Query: 285 KMGNLQSLDLSMNRLTGGIPEEFGNMGQLVFLVLSNNNISGSIPRRICTNATSLEHLILA 344
+ NL L L N L+G IP G + +LV L +S NN+SG+IP + N + LE+L L
Sbjct: 146 SLQNLTFLYLDRNNLSGLIPASVGGLIELVDLRMSYNNLSGTIPE-LLGNCSKLEYLALN 204
Query: 345 EIQLSGEIPVELSQCQSLKQLDLSNNTLNGTIPVELFQLVALTHLYLHNNSLVGSISPFV 404
+L+G +P L ++L +L +SNN+L G + L L L N G + P +
Sbjct: 205 NNKLNGSLPASLYLLENLGELFVSNNSLGGRLHFGSSNCKKLVSLDLSFNDFQGGVPPEI 264
Query: 405 ANLSNLQELALYHNNFQGSLPREIGMLVKLELLYLYDNHLSGQIPSEVGNCSSLKWIDFF 464
N S+L L + N G++P +GML K+ ++ L DN LSG IP E+GNCSSL+ +
Sbjct: 265 GNCSSLHSLVMVKCNLTGTIPSSMGMLRKVSVIDLSDNRLSGNIPQELGNCSSLETLKLN 324
Query: 465 GNSFTGEIPTSIGRLKDLNFLHLRQNELVGQIPASLGNCHQLIILDLADNKLSGGVPASF 524
N GEIP ++ +LK L L L N+L G+IP + L + + +N L+G +P
Sbjct: 325 DNQLQGEIPPALSKLKKLQSLELFFNKLSGEIPIGIWKIQSLTQMLVYNNTLTGELPVEV 384
Query: 525 GFLQALEQLMLYNNSLEGNLPGSLINLRNLTRINFSKNRLNGRIAT-LCSSHSFLSFDVT 583
L+ L++L L+NN G++P SL R+L ++ NR G I LC F +
Sbjct: 385 TQLKHLKKLTLFNNGFYGDIPMSLGLNRSLEEVDLLGNRFTGEIPPHLCHGQKLRLFILG 444
Query: 584 NNEFDHEIPPQLGNSPSLERLRLGNNKFIGKIPWTFGKIRELSLLDLSGNSLTGPIPTQL 643
+N+ +IP + +LER+RL +NK G +P F + LS ++L NS G IP L
Sbjct: 445 SNQLHGKIPASIRQCKTLERVRLEDNKLSGVLP-EFPESLSLSYVNLGSNSFEGSIPRSL 503
Query: 644 LMCKKLSHIDLNNNLLSGAVPSWLGTLPQLGELKLSFNQFVGFLPRELFNCSKLLVLSLD 703
CK L IDL+ N L+G +P LG L LG L LS N G LP +L C++LL +
Sbjct: 504 GSCKNLLTIDLSQNKLTGLIPPELGNLQSLGLLNLSHNYLEGPLPSQLSGCARLLYFDVG 563
Query: 704 GNMLNGSLPNEVGNLASLNVLTLSGNLLSGPIPPAIGRLSKLYELRLSNNSLNGVIPLEI 763
N LNGS+P+ + SL+ L LS N G IP + L +L +LR++ N+ G IP +
Sbjct: 564 SNSLNGSIPSSFRSWKSLSTLVLSDNNFLGAIPQFLAELDRLSDLRIARNAFGGKIPSSV 623
Query: 764 GQLQNLQSILDLSHNNFTGQIPPSMGTLAKLEVLNLSHNQLVGELPSQLGEMSSLGKLNL 823
G L++L+ LDLS N FTG+IP ++G L LE LN+S+N+L G L S L + SL ++++
Sbjct: 624 GLLKSLRYGLDLSANVFTGEIPTTLGALINLERLNISNNKLTGPL-SVLQSLKSLNQVDV 682
Query: 824 SYNDLQGKLSKQFSHWPAEAFEGNLHLC 851
SYN G + + F GN LC
Sbjct: 683 SYNQFTGPIPVNLLS-NSSKFSGNPDLC 709
|
|
| TAIR|locus:2011339 AT1G35710 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1041 (371.5 bits), Expect = 1.3e-154, Sum P(2) = 1.3e-154
Identities = 250/652 (38%), Positives = 342/652 (52%)
Query: 205 GPIPAELGNCSSLSIFTAAENNLNGSIPAALGRXXXXXXXXXXXXXXXXEIPSELGELSQ 264
G IP + GN S L F + N+L G I +LG IPSELG +
Sbjct: 116 GTIPPQFGNLSKLIYFDLSTNHLTGEISPSLGNLKNLTVLYLHQNYLTSVIPSELGNMES 175
Query: 265 LGYLNLMGNRLEGAIPRSFAKMGNLQSLDLSMNRLTGGIPEEFGNMGQLVFLVLSNNNIS 324
+ L L N+L G+IP S + NL L L N LTG IP E GNM + L LS N ++
Sbjct: 176 MTDLALSQNKLTGSIPSSLGNLKNLMVLYLYENYLTGVIPPELGNMESMTDLALSQNKLT 235
Query: 325 GSIPRRICTNATSLEHLILAEIQLSGEIPVELSQCQSLKQLDLSNNTLNGTIPVELFQLV 384
GSIP + N +L L L E L+G IP E+ +S+ L LS N L G+IP L L
Sbjct: 236 GSIPSTL-GNLKNLMVLYLYENYLTGVIPPEIGNMESMTNLALSQNKLTGSIPSSLGNLK 294
Query: 385 ALTHLYLHNNSLVGSISPFVANLSNLQELALYHNNFQGSLPREIGMLVKLELLYLYDNHL 444
LT L L N L G I P + N+ ++ +L L +N GS+P +G L L +LYLY+N+L
Sbjct: 295 NLTLLSLFQNYLTGGIPPKLGNIESMIDLELSNNKLTGSIPSSLGNLKNLTILYLYENYL 354
Query: 445 SGQIPSEVGNCSSLKWIDFFGNSFTGEIPTSIGRLKDLNFLHLRQNELVGQIPASLGNCH 504
+G IP E+GN S+ + N TG IP+S G LK+L +L+L N L G IP LGN
Sbjct: 355 TGVIPPELGNMESMIDLQLNNNKLTGSIPSSFGNLKNLTYLYLYLNYLTGVIPQELGNME 414
Query: 505 QLIILDLADNKLSGGVPASFGFLQALEQLMLYNNSLEGNLPGSLINLRNLTRINFSKNRL 564
+I LDL+ NKL+G VP SFG LE L L N L G +P + N +LT + N
Sbjct: 415 SMINLDLSQNKLTGSVPDSFGNFTKLESLYLRVNHLSGAIPPGVANSSHLTTLILDTNNF 474
Query: 565 NGRIA-TLCSSHSFLSFDVTNNEFDHEIPPQLGNSPSLERLRLGNNKFIGKIPWTFGKIR 623
G T+C + + N + IP L + SL R R NKF G I FG
Sbjct: 475 TGFFPETVCKGRKLQNISLDYNHLEGPIPKSLRDCKSLIRARFLGNKFTGDIFEAFGIYP 534
Query: 624 ELSLLDLSGNSLTGPIPTQLLMCKKLSHIDLNNNLLSGAVPSWLGTLPQLGELKLSFNQF 683
+L+ +D S N G I + KL + ++NN ++GA+P+ + + QL EL LS N
Sbjct: 535 DLNFIDFSHNKFHGEISSNWEKSPKLGALIMSNNNITGAIPTEIWNMTQLVELDLSTNNL 594
Query: 684 VGFLPRELFNCSKLLVLSLDGNMLNGSLPNEVGNLASLNVLTLSGNLLSGPIPPAIGRLS 743
G LP + N + L L L+GN L+G +P + L +L L LS N S IP
Sbjct: 595 FGELPEAIGNLTNLSRLRLNGNQLSGRVPAGLSFLTNLESLDLSSNNFSSEIPQTFDSFL 654
Query: 744 KLYELRLSNNSLNGVIPLEIGQLQNLQSILDLSHNNFTGQIPPSMGTLAKLEVLNLSHNQ 803
KL+++ LS N +G IP + +L L LDLSHN G+IP + +L L+ L+LSHN
Sbjct: 655 KLHDMNLSRNKFDGSIP-RLSKLTQLTQ-LDLSHNQLDGEIPSQLSSLQSLDKLDLSHNN 712
Query: 804 LVGELPSQLGEMSSLGKLNLSYNDLQGKL--SKQFSHWPAEAFEGNLHLCGS 853
L G +P+ M +L +++S N L+G L + F A+A E N+ LC +
Sbjct: 713 LSGLIPTTFEGMIALTNVDISNNKLEGPLPDTPTFRKATADALEENIGLCSN 764
|
|
| TAIR|locus:2154344 AT5G48940 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 928 (331.7 bits), Expect = 1.3e-152, Sum P(2) = 1.3e-152
Identities = 218/558 (39%), Positives = 316/558 (56%)
Query: 255 IPSELGELSQLGYLNLMGNRLEGAIPRSFAKMGNLQSLDLSMNRLTGGIPEEFGNMGQLV 314
I SE+G+ S+L ++L N L G IP S K+ NLQ L L+ N LTG IP E G+ L
Sbjct: 122 ISSEIGDCSELIVIDLSSNSLVGEIPSSLGKLKNLQELCLNSNGLTGKIPPELGDCVSLK 181
Query: 315 FLVLSNNNISGSIPRRICTNATSLEHLILA-EIQLSGEIPVELSQCQSLKQLDLSNNTLN 373
L + +N +S ++P + +T LE + +LSG+IP E+ C++LK L L+ ++
Sbjct: 182 NLEIFDNYLSENLPLELGKIST-LESIRAGGNSELSGKIPEEIGNCRNLKVLGLAATKIS 240
Query: 374 GTIPVELFQLVALTHLYLHNNSLVGSISPFVANLSNLQELALYHNNFQGSLPREIGMLVK 433
G++PV L QL L L +++ L G I + N S L L LY N+ G+LP+E+G L
Sbjct: 241 GSLPVSLGQLSKLQSLSVYSTMLSGEIPKELGNCSELINLFLYDNDLSGTLPKELGKLQN 300
Query: 434 LELLYLYDNHLSGQIPSEVGNCSSLKWIDFFGNSFTGEIPTSIGRLKDLNFLHLRQNELV 493
LE + L+ N+L G IP E+G SL ID N F+G IP S G L +L L L N +
Sbjct: 301 LEKMLLWQNNLHGPIPEEIGFMKSLNAIDLSMNYFSGTIPKSFGNLSNLQELMLSSNNIT 360
Query: 494 GQIPASLGNCHQLIILDLADNKLSGGVPASFGFLQALEQLMLYNNSLEGNLPGSLINLRN 553
G IP+ L NC +L+ + N++SG +P G L+ L + + N LEGN+P L +N
Sbjct: 361 GSIPSILSNCTKLVQFQIDANQISGLIPPEIGLLKELNIFLGWQNKLEGNIPDELAGCQN 420
Query: 554 LTRINFSKNRLNGRI-ATLCSSHSFLSFDVTNNEFDHEIPPQLGNSPSLERLRLGNNKFI 612
L ++ S+N L G + A L + + +N IP ++GN SL RLRL NN+
Sbjct: 421 LQALDLSQNYLTGSLPAGLFQLRNLTKLLLISNAISGVIPLEIGNCTSLVRLRLVNNRIT 480
Query: 613 GKIPWTFGKIRELSLLDLSGNSLTGPIPTQLLMCKKLSHIDLNNNLLSGAVPSWLGTLPQ 672
G+IP G ++ LS LDLS N+L+GP+P ++ C++L ++L+NN L G +P L +L +
Sbjct: 481 GEIPKGIGFLQNLSFLDLSENNLSGPVPLEISNCRQLQMLNLSNNTLQGYLPLSLSSLTK 540
Query: 673 LGELKLSFNQFVGFLPRELFNCSKLLVLSLDGNMLNGSLPNEVGNLASLNVLTLSGNLLS 732
L L +S N G +P L + L L L N NG +P+ +G+ +L +L LS N +S
Sbjct: 541 LQVLDVSSNDLTGKIPDSLGHLISLNRLILSKNSFNGEIPSSLGHCTNLQLLDLSSNNIS 600
Query: 733 GPIPPAIGRLSKL-YELRLSNNSLNGVIPLEIGQLQNLQSILDLSHNNFTGQIPPSMGTL 791
G IP + + L L LS NSL+G IP I L L S+LD+SHN +G + G L
Sbjct: 601 GTIPEELFDIQDLDIALNLSWNSLDGFIPERISALNRL-SVLDISHNMLSGDLSALSG-L 658
Query: 792 AKLEVLNLSHNQLVGELP 809
L LN+SHN+ G LP
Sbjct: 659 ENLVSLNISHNRFSGYLP 676
|
|
| TAIR|locus:2085949 AT3G24240 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 908 (324.7 bits), Expect = 4.5e-152, Sum P(2) = 4.5e-152
Identities = 229/655 (34%), Positives = 329/655 (50%)
Query: 17 CFSPGFVLCKDEELSVLLEIKKSFTADPENV-LHAWNQSNQNLCT-WRGITCGSSSARVV 74
CFS ++ E S+L S + P ++ L WN + C W ITC SS +
Sbjct: 27 CFSLSDAE-QNPEASILYSWLHSSSPTPSSLSLFNWNSIDNTPCNNWTFITC-SSQGFIT 84
Query: 75 XXXXXXXXXXXXXXXXXXRLQSLIHLDLSSNSLTGPIPTAXXXXXXXXXXXXXXXXXAGT 134
+SL L +S +LTG +P + G
Sbjct: 85 DIDIESVPLQLSLPKNLPAFRSLQKLTISGANLTGTLPESLGDCLGLKVLDLSSNGLVGD 144
Query: 135 IPTQLGSLTSLRVMRIGDNWLSGSIPTSFGNLVNLGTLGLASCSLSGPIPPQFGXXXXXX 194
IP L L +L + + N L+G IP L +L L L+G IP + G
Sbjct: 145 IPWSLSKLRNLETLILNSNQLTGKIPPDISKCSKLKSLILFDNLLTGSIPTELGKLSGLE 204
Query: 195 XXXXXXXXX-XGPIPAELGNCSSLSIFTAAENNLNGSIPAALGRXXXXXXXXXXXXXXXX 253
G IP+E+G+CS+L++ AE +++G++P++LG+
Sbjct: 205 VIRIGGNKEISGQIPSEIGDCSNLTVLGLAETSVSGNLPSSLGKLKKLETLSIYTTMISG 264
Query: 254 EIPSELGELSQLGYLNLMGNRLEGAIPRSFAKMGNLQSLDLSMNRLTGGIPEEFGNMGQL 313
EIPS+LG S+L L L N L G+IPR ++ L+ L L N L GGIPEE GN L
Sbjct: 265 EIPSDLGNCSELVDLFLYENSLSGSIPREIGQLTKLEQLFLWQNSLVGGIPEEIGNCSNL 324
Query: 314 VFLVLSNNNISGSIPRRICTNATSLEHLILAEIQLSGEIPVELSQCQSLKQLDLSNNTLN 373
+ LS N +SGSIP I + LE ++++ + SG IP +S C SL QL L N ++
Sbjct: 325 KMIDLSLNLLSGSIPSSI-GRLSFLEEFMISDNKFSGSIPTTISNCSSLVQLQLDKNQIS 383
Query: 374 GTIPVELFQLVALTHLYLHNNSLVGSISPFVANLSNLQELALYHNNFQGSLPREIGMLVK 433
G IP EL L LT + +N L GSI P +A+ ++LQ L L N+ G++P + ML
Sbjct: 384 GLIPSELGTLTKLTLFFAWSNQLEGSIPPGLADCTDLQALDLSRNSLTGTIPSGLFMLRN 443
Query: 434 LELLYLYDNHLSGQIPSEVGNCSSLKWIDFFGNSFTGEIPTSIGRLKDLNFLHLRQNELV 493
L L L N LSG IP E+GNCSSL + N TGEIP+ IG LK +NFL N L
Sbjct: 444 LTKLLLISNSLSGFIPQEIGNCSSLVRLRLGFNRITGEIPSGIGSLKKINFLDFSSNRLH 503
Query: 494 GQIPASLGNCHQLIILDLADNKLSGGVPASFGFLQALEQLMLYNNSLEGNLPGSLINLRN 553
G++P +G+C +L ++DL++N L G +P L L+ L + N G +P SL L +
Sbjct: 504 GKVPDEIGSCSELQMIDLSNNSLEGSLPNPVSSLSGLQVLDVSANQFSGKIPASLGRLVS 563
Query: 554 LTRINFSKNRLNGRIAT---LCSSHSFLSFDVTNNEFDHEIPPQLGNSPSLE-RLRLGNN 609
L ++ SKN +G I T +CS L D+ +NE EIP +LG+ +LE L L +N
Sbjct: 564 LNKLILSKNLFSGSIPTSLGMCSGLQLL--DLGSNELSGEIPSELGDIENLEIALNLSSN 621
Query: 610 KFIGKIPWTFGKIRELSLLDLSGNSLTGPIPTQLLMCKKLSHIDLNNNLLSGAVP 664
+ GKIP + +LS+LDLS N L G + L + L ++++ N SG +P
Sbjct: 622 RLTGKIPSKIASLNKLSILDLSHNMLEGDL-APLANIENLVSLNISYNSFSGYLP 675
|
|
| TAIR|locus:2138268 AT4G08850 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 997 (356.0 bits), Expect = 1.9e-151, Sum P(2) = 1.9e-151
Identities = 223/590 (37%), Positives = 330/590 (55%)
Query: 268 LNLMGNRLEGAIPR-SFAKMGNLQSLDLSMNRLTGGIPEEFGNMGQLVFLVLSNNNISGS 326
LNL +EG F+ + NL +DLSMNR +G I +G +L + LS N + G
Sbjct: 98 LNLTNTGIEGTFEDFPFSSLPNLTFVDLSMNRFSGTISPLWGRFSKLEYFDLSINQLVGE 157
Query: 327 IPRRICTNATSLEHLILAEIQLSGEIPVELSQCQSLKQLDLSNNTLNGTIPVELFQLVAL 386
IP + + ++L+ L L E +L+G IP E+ + + ++ + +N L G IP L L
Sbjct: 158 IPPEL-GDLSNLDTLHLVENKLNGSIPSEIGRLTKVTEIAIYDNLLTGPIPSSFGNLTKL 216
Query: 387 THLYLHNNSLVGSISPFVANLSNLQELALYHNNFQGSLPREIGMLVKLELLYLYDNHLSG 446
+LYL NSL GSI + NL NL+EL L NN G +P G L + LL +++N LSG
Sbjct: 217 VNLYLFINSLSGSIPSEIGNLPNLRELCLDRNNLTGKIPSSFGNLKNVTLLNMFENQLSG 276
Query: 447 QIPSEVGNCSSLKWIDFFGNSFTGEIPTSIGRLKDLNFLHLRQNELVGQIPASLGNCHQL 506
+IP E+GN ++L + N TG IP+++G +K L LHL N+L G IP LG +
Sbjct: 277 EIPPEIGNMTALDTLSLHTNKLTGPIPSTLGNIKTLAVLHLYLNQLNGSIPPELGEMESM 336
Query: 507 IILDLADNKLSGGVPASFGFLQALEQLMLYNNSLEGNLPGSLINLRNLTRINFSKNRLNG 566
I L++++NKL+G VP SFG L ALE L L +N L G +P + N LT + N G
Sbjct: 337 IDLEISENKLTGPVPDSFGKLTALEWLFLRDNQLSGPIPPGIANSTELTVLQLDTNNFTG 396
Query: 567 RIA-TLCSSHSFLSFDVTNNEFDHEIPPQLGNSPSLERLRLGNNKFIGKIPWTFGKIREL 625
+ T+C + + +N F+ +P L + SL R+R N F G I FG L
Sbjct: 397 FLPDTICRGGKLENLTLDDNHFEGPVPKSLRDCKSLIRVRFKGNSFSGDISEAFGVYPTL 456
Query: 626 SLLDLSGNSLTGPIPTQLLMCKKLSHIDLNNNLLSGAVPSWLGTLPQLGELKLSFNQFVG 685
+ +DLS N+ G + +KL L+NN ++GA+P + + QL +L LS N+ G
Sbjct: 457 NFIDLSNNNFHGQLSANWEQSQKLVAFILSNNSITGAIPPEIWNMTQLSQLDLSSNRITG 516
Query: 686 FLPRELFNCSKLLVLSLDGNMLNGSLPNEVGNLASLNVLTLSGNLLSGPIPPAIGRLSKL 745
LP + N +++ L L+GN L+G +P+ + L +L L LS N S IPP + L +L
Sbjct: 517 ELPESISNINRISKLQLNGNRLSGKIPSGIRLLTNLEYLDLSSNRFSSEIPPTLNNLPRL 576
Query: 746 YELRLSNNSLNGVIPLEIGQLQNLQSILDLSHNNFTGQIPPSMGTLAKLEVLNLSHNQLV 805
Y + LS N L+ IP + +L LQ +LDLS+N G+I +L LE L+LSHN L
Sbjct: 577 YYMNLSRNDLDQTIPEGLTKLSQLQ-MLDLSYNQLDGEISSQFRSLQNLERLDLSHNNLS 635
Query: 806 GELPSQLGEMSSLGKLNLSYNDLQGKL--SKQFSHWPAEAFEGNLHLCGS 853
G++P +M +L +++S+N+LQG + + F + P +AFEGN LCGS
Sbjct: 636 GQIPPSFKDMLALTHVDVSHNNLQGPIPDNAAFRNAPPDAFEGNKDLCGS 685
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| C0LGQ5 | GSO1_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.6887 | 0.9800 | 0.9815 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.991 |
| 3rd Layer | 2.7.11 | 0.976 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | fgenesh4_pm.C_LG_I000244 | hypothetical protein (1253 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 1251 | |||
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-146 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-105 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-98 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-89 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-51 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-45 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-44 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-40 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 9e-38 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 4e-36 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-35 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 7e-35 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-32 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 3e-31 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-30 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-29 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 8e-28 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 8e-28 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-27 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-27 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 6e-27 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-26 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-25 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-25 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-24 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-24 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 3e-24 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 5e-24 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 7e-24 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-23 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-23 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 3e-23 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 4e-23 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 5e-23 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-22 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-22 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-22 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 4e-22 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 4e-22 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-21 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 7e-21 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 8e-21 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 9e-21 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-20 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-20 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-20 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-20 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 3e-20 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 3e-20 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-20 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 3e-20 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 4e-20 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-19 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 3e-19 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 4e-19 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 5e-19 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 5e-19 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 5e-19 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 7e-19 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 8e-19 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-18 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-18 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-18 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-18 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-18 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 3e-18 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 5e-18 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 5e-18 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 7e-18 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-17 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-17 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-17 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-17 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 3e-17 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 3e-17 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 4e-17 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 4e-17 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 6e-17 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 8e-17 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 9e-17 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-16 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-16 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-16 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 3e-16 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 3e-16 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 4e-16 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 4e-16 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 4e-16 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 5e-16 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 5e-16 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 5e-16 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 5e-16 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 6e-16 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 7e-16 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-15 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-15 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-15 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-15 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-15 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-15 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-15 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-15 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 3e-15 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 3e-15 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 3e-15 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 4e-15 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 4e-15 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 4e-15 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 6e-15 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 7e-15 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 9e-15 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 9e-15 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-14 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-14 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-14 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-14 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-14 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-14 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-14 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-14 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 5e-14 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 7e-14 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 7e-14 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 8e-14 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-13 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-13 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-13 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-13 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-13 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-13 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-13 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-13 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-13 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-13 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-13 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 3e-13 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 3e-13 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 3e-13 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 4e-13 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 4e-13 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 5e-13 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 5e-13 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 5e-13 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 5e-13 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 5e-13 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 7e-13 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 9e-13 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-12 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-12 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-12 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-12 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-12 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-12 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-12 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-12 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 3e-12 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 3e-12 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 3e-12 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 3e-12 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 3e-12 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 3e-12 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 4e-12 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 4e-12 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 5e-12 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 6e-12 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 6e-12 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 7e-12 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 7e-12 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 7e-12 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 7e-12 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 7e-12 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 8e-12 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 8e-12 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-11 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-11 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 1e-11 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-11 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-11 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-11 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-11 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-11 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-11 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-11 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-11 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-11 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 3e-11 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 3e-11 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 3e-11 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 3e-11 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 3e-11 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 3e-11 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 3e-11 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 4e-11 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 5e-11 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 5e-11 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 5e-11 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 5e-11 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 6e-11 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 8e-11 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 8e-11 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 9e-11 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-10 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-10 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-10 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-10 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-10 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-10 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-10 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 3e-10 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 3e-10 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 3e-10 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 4e-10 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 4e-10 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 4e-10 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 4e-10 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 5e-10 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 5e-10 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 7e-10 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 7e-10 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 9e-10 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-09 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 1e-09 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-09 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-09 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-09 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-09 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-09 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-09 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-09 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-09 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-09 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-09 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-09 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-09 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-09 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-09 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-09 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 3e-09 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 3e-09 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 3e-09 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 3e-09 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 3e-09 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 3e-09 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 4e-09 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 4e-09 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 5e-09 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 5e-09 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 5e-09 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 5e-09 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 5e-09 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 6e-09 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 7e-09 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 7e-09 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 8e-09 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 9e-09 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 1e-08 | |
| pfam08263 | 42 | pfam08263, LRRNT_2, Leucine rich repeat N-terminal | 1e-08 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-08 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-08 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-08 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-08 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-08 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-08 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-08 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-08 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-08 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 3e-08 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 3e-08 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 3e-08 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 3e-08 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 3e-08 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 5e-08 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 6e-08 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 6e-08 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 7e-08 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 7e-08 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 7e-08 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 9e-08 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-07 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-07 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-07 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-07 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-07 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 2e-07 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-07 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-07 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-07 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 2e-07 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 2e-07 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 2e-07 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-07 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-07 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 3e-07 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 3e-07 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 3e-07 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 3e-07 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 3e-07 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 3e-07 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 3e-07 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 4e-07 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 4e-07 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 4e-07 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 4e-07 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 4e-07 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 5e-07 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 5e-07 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 7e-07 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 8e-07 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 8e-07 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 9e-07 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-06 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 1e-06 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 2e-06 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-06 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-06 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-06 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-06 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-06 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 3e-06 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 3e-06 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 4e-06 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 5e-06 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 5e-06 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 6e-06 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 6e-06 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 7e-06 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 7e-06 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 2e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-05 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 3e-05 | |
| COG5238 | 388 | COG5238, RNA1, Ran GTPase-activating protein (RanG | 3e-05 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 4e-05 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 6e-05 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 9e-05 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 1e-04 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 1e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 2e-04 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 2e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 3e-04 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 6e-04 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 6e-04 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 7e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.001 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.001 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 0.001 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.002 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.003 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 0.003 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 465 bits (1199), Expect = e-146
Identities = 339/1030 (32%), Positives = 489/1030 (47%), Gaps = 167/1030 (16%)
Query: 213 NCSSLSIFTAAENNLNGSIPAALGRLQNLQLLNLGNNSLSGEIPSELGELS-QLGYLNLM 271
N S + + N++G I +A+ RL +Q +NL NN LSG IP ++ S L YLNL
Sbjct: 67 NSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLS 126
Query: 272 GNRLEGAIPRSFAKMGNLQSLDLSMNRLTGGIPEEFGNMGQLVFLVLSNNNISGSIPRRI 331
N G+IPR NL++LDLS N L+G IP + G+ L L L N + G IP +
Sbjct: 127 NNNFTGSIPRGSIP--NLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSL 184
Query: 332 CTNATSLEHLILAEIQLSGEIPVELSQCQSLKQLDLSNNTLNGTIPVELFQLVALTHLYL 391
TN TSLE L LA QL G+IP EL Q +SLK + L N L+G IP E+ L +L HL L
Sbjct: 185 -TNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDL 243
Query: 392 HNNSLVGSISPFVANLSNLQELALYHNNFQGSLPREIGMLVKLELLYLYDNHLSGQIPSE 451
N+L G I + NL NLQ L LY N G +P I L KL L L DN LSG+IP
Sbjct: 244 VYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPEL 303
Query: 452 VGNCSSLKWIDFFGNSFTGEIPTSIGRLKDLNFLHLRQNELVGQIPASLGNCHQLIILDL 511
V +L+ + F N+FTG+IP ++ L L L L N+ G+IP +LG + L +LDL
Sbjct: 304 VIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDL 363
Query: 512 ADNKLSGGVPASFGFLQALEQLMLYNNSLEGNLPGSLINLRNLTRINFSKNRLNGRIATL 571
+ N L+G +P L +L+L++NSLEG
Sbjct: 364 STNNLTGEIPEGLCSSGNLFKLILFSNSLEG----------------------------- 394
Query: 572 CSSHSFLSFDVTNNEFDHEIPPQLGNSPSLERLRLGNNKFIGKIPWTFGKIRELSLLDLS 631
EIP LG SL R+RL +N F G++P F K+ + LD+S
Sbjct: 395 ------------------EIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDIS 436
Query: 632 GNSLTGPIPTQLLMCKKLSHIDLNNNLLSGAVPSWLGTLPQLGELKLSFNQFVGFLPREL 691
N+L G I ++ W +P L L L+ N+F G LP +
Sbjct: 437 NNNLQGRINSR----------------------KW--DMPSLQMLSLARNKFFGGLP-DS 471
Query: 692 FNCSKLLVLSLDGNMLNGSLPNEVGNLASLNVLTLSGNLLSGPIPPAIGRLSKLYELRLS 751
F +L L LS N SG +P +G LS+L +L+LS
Sbjct: 472 FGSKRL------------------------ENLDLSRNQFSGAVPRKLGSLSELMQLKLS 507
Query: 752 NNSLNGVIPLEIGQLQNLQSILDLSHNNFTGQIPPSMGTLAKLEVLNLSHNQLVGELPSQ 811
N L+G IP E+ + L S LDLSHN +GQIP S + L L+LS NQL GE+P
Sbjct: 508 ENKLSGEIPDELSSCKKLVS-LDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKN 566
Query: 812 LGEMSSLGKLNLSYNDLQGKL--SKQFSHWPAEAFEGNLHLCG----SPLDHCNGLVSNQ 865
LG + SL ++N+S+N L G L + F A A GN+ LCG S L C +
Sbjct: 567 LGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVRKTP 626
Query: 866 HQSTISVSLVVAISVISTLSAIALLIAVVTLFVKRKREF-LRKSSQVNYTSSSSSSQAQR 924
+ A V+ L+A +F++ + L++ + T
Sbjct: 627 SWWFYITCTLGAFLVL-------ALVAFGFVFIRGRNNLELKRVENEDGTWEL------- 672
Query: 925 RLLFQAAAKRDFRWEDIMGATNNLSDEFIIGSGGSGTVYKAE-LANGATVAVKKISCKDD 983
F + + DI+ + +E +I G G YK + + NG VK+I D
Sbjct: 673 -QFFDSKVSKSITINDILSSLK---EENVISRGKKGASYKGKSIKNGMQFVVKEI--NDV 726
Query: 984 HLLNKSFTREVKTLGRIRHRHLVKLMGHC-CNKGAGSNLLIYEYMENGSVWDWLHKQPVN 1042
+ + S + +G+++H ++VKL+G C KGA LI+EY+E ++ + L
Sbjct: 727 NSIPSSEIAD---MGKLQHPNIVKLIGLCRSEKGA---YLIHEYIEGKNLSEVL------ 774
Query: 1043 IKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLA 1102
++L WE R KIA+G+A+ + +LH C P ++ ++ I++D E HL L
Sbjct: 775 ----RNLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHL-RLSLP 829
Query: 1103 KALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDAT 1162
L D S Y+APE + TEK D+Y G++L+EL++GK P DA
Sbjct: 830 GLLCTDTKCFISS--------AYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAE 881
Query: 1163 FGVEMDMVRWV-----EMHMEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTS 1217
FGV +V W + H++M +D ++ + + +V+ +AL CT T
Sbjct: 882 FGVHGSIVEWARYCYSDCHLDM-------WIDPSIRGDVSVNQNEIVEVMNLALHCTATD 934
Query: 1218 PQERPSSRQV 1227
P RP + V
Sbjct: 935 PTARPCANDV 944
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 354 bits (909), Expect = e-105
Identities = 238/655 (36%), Positives = 340/655 (51%), Gaps = 77/655 (11%)
Query: 11 LLLLLLCFSPGFVLCKDEELSVLLEIKKSFTADPENVLHAWNQSNQNLCTWRGITCGSSS 70
L+ +L F + EEL +LL K S DP L WN S ++C W+GITC +SS
Sbjct: 12 LIFMLFFLFLNFSMLHAEELELLLSFKSSIN-DPLKYLSNWNSSA-DVCLWQGITCNNSS 69
Query: 71 ARVVSLNLSGLSLAGSISPSLGRLQSLIHLDLSSNSLTGPIPTALSNLSSLESLLLFSNQ 130
RVVS++LSG +++G IS ++ RL + ++LS+N L+GPIP + SS
Sbjct: 70 -RVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSS---------- 118
Query: 131 LAGTIPTQLGSLTSLRVMRIGDNWLSGSIPTSFGNLVNLGTLGLASCSLSGPIPPQFGQL 190
SLR + + +N +GSIP G++ NL TL L++ LSG IP G
Sbjct: 119 -------------SLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSF 163
Query: 191 SQLEELILQQNQLQGPIPAELGNCSSLSIFTAAENNLNGSIPAALGRLQNLQLLNLGNNS 250
S L+ L L N L G IP L N +SL T A N L G IP LG++++L+ + LG N+
Sbjct: 164 SSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNN 223
Query: 251 LSGEIPSELGELSQLGYLNLMGNRLEGAIPRSFAKMGNLQSLDLSMNRLTGGIPEEFGNM 310
LSGEIP E+G L+ L +L+L+ N L G IP S + NLQ L L N+L+G IP ++
Sbjct: 224 LSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSL 283
Query: 311 GQLVFLVLSNNNISGSIPRRICTNATSLEHLILAEIQLSGEIPVELSQCQSLKQLDLSNN 370
+L+ L LS+N+ LSGEIP + Q Q+L+ L L +N
Sbjct: 284 QKLISLDLSDNS-------------------------LSGEIPELVIQLQNLEILHLFSN 318
Query: 371 TLNGTIPVELFQLVALTHLYLHNNSLVGSISPFVANLSNLQELALYHNNFQGSLPREIGM 430
G IPV L L L L L +N G I + +NL L L NN G +P +
Sbjct: 319 NFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCS 378
Query: 431 LVKLELLYLYDNHLSGQIPSEVGNCSSLKWIDFFGNSFTGEIPTSIGRLKDLNFLHLRQN 490
L L L+ N L G+IP +G C SL+ + NSF+GE+P+ +L + FL + N
Sbjct: 379 SGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNN 438
Query: 491 ELVGQIPASLGNCHQLIILDLADNKLSGGVPASFGFLQALEQLMLYNNSLEGNLPGSLIN 550
L G+I + + L +L LA NK GG+P SFG + LE L L N G +P L +
Sbjct: 439 NLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGSKR-LENLDLSRNQFSGAVPRKLGS 497
Query: 551 LRNLTRINFSKNRLNGRIATLCSSHSFLSFDVTNNEFDHEIPPQLGNSPSLERLRLGNNK 610
L L ++ S+N+L+G EIP +L + L L L +N+
Sbjct: 498 LSELMQLKLSENKLSG-----------------------EIPDELSSCKKLVSLDLSHNQ 534
Query: 611 FIGKIPWTFGKIRELSLLDLSGNSLTGPIPTQLLMCKKLSHIDLNNNLLSGAVPS 665
G+IP +F ++ LS LDLS N L+G IP L + L +++++N L G++PS
Sbjct: 535 LSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPS 589
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 337 bits (865), Expect = 1e-98
Identities = 210/566 (37%), Positives = 303/566 (53%), Gaps = 29/566 (5%)
Query: 165 NLVNLGTLGLASCSLSGPIPPQFGQLSQLEELILQQNQLQGPIPAEL-GNCSSLSIFTAA 223
N + ++ L+ ++SG I +L ++ + L NQL GPIP ++ SSL +
Sbjct: 67 NSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLS 126
Query: 224 ENNLNGSIPAALGRLQNLQLLNLGNNSLSGEIPSELGELSQLGYLNLMGNRLEGAIPRSF 283
NN GSIP G + NL+ L+L NN LSGEIP+++G S L L+L GN L G IP S
Sbjct: 127 NNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSL 184
Query: 284 AKMGNLQSLDLSMNRLTGGIPEEFGNMGQLVFLVLSNNNISGSIPRRICTNATSLEHLIL 343
+ +L+ L L+ N+L G IP E G M L ++ L NN+SG IP I TSL HL L
Sbjct: 185 TNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEI-GGLTSLNHLDL 243
Query: 344 AEIQLSGEIPVELSQCQSLKQLDLSNNTLNGTIPVELFQLVALTHLYLHNNSLVGSISPF 403
L+G IP L ++L+ L L N L+G IP +F L L L L +NSL G I
Sbjct: 244 VYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPEL 303
Query: 404 VANLSNLQELALYHNNFQGSLPREIGMLVKLELLYLYDNHLSGQIPSEVGNCSSLKWIDF 463
V L NL+ L L+ NNF G +P + L +L++L L+ N SG+IP +G ++L +D
Sbjct: 304 VIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDL 363
Query: 464 FGNSFTGEIPTSIGRLKDLNFLHLRQNELVGQIPASLGNCHQLIILDLADNKLSGGVPAS 523
N+ TGEIP + +L L L N L G+IP SLG C L + L DN SG +P+
Sbjct: 364 STNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSE 423
Query: 524 FGFLQALEQLMLYNNSLEGNLPGSLINLRNLTRINFSKNRLNGRIATLCSSHSFLSFDVT 583
F L + L + NN+L+G + ++ +L ++ ++N+ G +
Sbjct: 424 FTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGL--------------- 468
Query: 584 NNEFDHEIPPQLGNSPSLERLRLGNNKFIGKIPWTFGKIRELSLLDLSGNSLTGPIPTQL 643
P S LE L L N+F G +P G + EL L LS N L+G IP +L
Sbjct: 469 ---------PDSFGSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDEL 519
Query: 644 LMCKKLSHIDLNNNLLSGAVPSWLGTLPQLGELKLSFNQFVGFLPRELFNCSKLLVLSLD 703
CKKL +DL++N LSG +P+ +P L +L LS NQ G +P+ L N L+ +++
Sbjct: 520 SSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNIS 579
Query: 704 GNMLNGSLPNEVGNLASLNVLTLSGN 729
N L+GSLP+ G ++N ++GN
Sbjct: 580 HNHLHGSLPS-TGAFLAINASAVAGN 604
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 310 bits (795), Expect = 5e-89
Identities = 187/476 (39%), Positives = 268/476 (56%), Gaps = 5/476 (1%)
Query: 52 NQSNQNLCTWRGITCGSSSARVVSLNLSGLSLAGSISPSLGRLQSLIHLDLSSNSLTGPI 111
N SN N G S + +L+LS L+G I +G SL LDL N L G I
Sbjct: 124 NLSNNNFT---GSIPRGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKI 180
Query: 112 PTALSNLSSLESLLLFSNQLAGTIPTQLGSLTSLRVMRIGDNWLSGSIPTSFGNLVNLGT 171
P +L+NL+SLE L L SNQL G IP +LG + SL+ + +G N LSG IP G L +L
Sbjct: 181 PNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNH 240
Query: 172 LGLASCSLSGPIPPQFGQLSQLEELILQQNQLQGPIPAELGNCSSLSIFTAAENNLNGSI 231
L L +L+GPIP G L L+ L L QN+L GPIP + + L ++N+L+G I
Sbjct: 241 LDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEI 300
Query: 232 PAALGRLQNLQLLNLGNNSLSGEIPSELGELSQLGYLNLMGNRLEGAIPRSFAKMGNLQS 291
P + +LQNL++L+L +N+ +G+IP L L +L L L N+ G IP++ K NL
Sbjct: 301 PELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTV 360
Query: 292 LDLSMNRLTGGIPEEFGNMGQLVFLVLSNNNISGSIPRRICTNATSLEHLILAEIQLSGE 351
LDLS N LTG IPE + G L L+L +N++ G IP+ + SL + L + SGE
Sbjct: 361 LDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGA-CRSLRRVRLQDNSFSGE 419
Query: 352 IPVELSQCQSLKQLDLSNNTLNGTIPVELFQLVALTHLYLHNNSLVGSISPFVANLSNLQ 411
+P E ++ + LD+SNN L G I + + +L L L N G + P L+
Sbjct: 420 LPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGL-PDSFGSKRLE 478
Query: 412 ELALYHNNFQGSLPREIGMLVKLELLYLYDNHLSGQIPSEVGNCSSLKWIDFFGNSFTGE 471
L L N F G++PR++G L +L L L +N LSG+IP E+ +C L +D N +G+
Sbjct: 479 NLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQ 538
Query: 472 IPTSIGRLKDLNFLHLRQNELVGQIPASLGNCHQLIILDLADNKLSGGVPASFGFL 527
IP S + L+ L L QN+L G+IP +LGN L+ ++++ N L G +P++ FL
Sbjct: 539 IPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFL 594
|
Length = 968 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 182 bits (464), Expect = 1e-51
Identities = 84/279 (30%), Positives = 135/279 (48%), Gaps = 32/279 (11%)
Query: 953 IIGSGGSGTVYKA-ELANGATVAVKKIS-CKDDHLLNKSFTREVKTLGRIRHRHLVKLMG 1010
+GSG GTVYKA G VAVK + + +++ RE++ L R+ H ++V+L+
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65
Query: 1011 HCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHH 1070
+K L+ EY E G ++D+L + L + KIA+ + +G+EYLH
Sbjct: 66 AFEDKD--HLYLVMEYCEGGDLFDYLSR-------GGPLSEDEAKKIALQILRGLEYLHS 116
Query: 1071 DCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPE- 1129
+ I+HRD+K NILLD N + DFGLAK L ++ S T F G+ Y+APE
Sbjct: 117 N---GIIHRDLKPENILLDENGVVKIADFGLAKKL----LKSSSSLTTFVGTPWYMAPEV 169
Query: 1130 YAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSAREELLD 1189
K DV+S+G++L EL++GK P ++ + + L
Sbjct: 170 LLGGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQL----QLIRRILGP----PLEF 221
Query: 1190 DQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVC 1228
D+ K EE ++ +C P +RP++ ++
Sbjct: 222 DEPKWSSGSEEA-----KDLIKKCLNKDPSKRPTAEEIL 255
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 164 bits (417), Expect = 2e-45
Identities = 70/209 (33%), Positives = 102/209 (48%), Gaps = 22/209 (10%)
Query: 953 IIGSGGSGTVYKA-ELANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGH 1011
+G G G VY A + G VA+K I K + RE+K L +++H ++V+L
Sbjct: 6 KLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDV 65
Query: 1012 CCNKGAGSNL-LIYEYMENGSVWDWLHKQPVNIKMRKSLD-WEARLKIAVGLAQGVEYLH 1069
++ L L+ EY E G ++D L K R L EAR + +EYLH
Sbjct: 66 FEDED---KLYLVMEYCEGGDLFDLLKK-------RGRLSEDEAR-FYLRQILSALEYLH 114
Query: 1070 HDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPE 1129
I+HRD+K NILLD + L DFGLA+ L T F G+ Y+APE
Sbjct: 115 SK---GIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTT-----FVGTPEYMAPE 166
Query: 1130 YAYSLKATEKCDVYSMGIVLMELVSGKMP 1158
+ D++S+G++L EL++GK P
Sbjct: 167 VLLGKGYGKAVDIWSLGVILYELLTGKPP 195
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 160 bits (408), Expect = 1e-44
Identities = 71/202 (35%), Positives = 105/202 (51%), Gaps = 18/202 (8%)
Query: 954 IGSGGSGTVYKAE-LANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHC 1012
+G GG GTVY A G VA+K I +D L + RE++ L ++ H ++VKL G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYG-- 58
Query: 1013 CNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDC 1072
+ L+ EY E GS+ D L + L + L+I + + +G+EYLH +
Sbjct: 59 VFEDENHLYLVMEYCEGGSLKDLLKENE------GKLSEDEILRILLQILEGLEYLHSN- 111
Query: 1073 VPKILHRDIKSSNILLDS-NMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPE-Y 1130
I+HRD+K NILLDS N + L DFGL+K S+ G+ Y+APE
Sbjct: 112 --GIIHRDLKPENILLDSDNGKVKLADFGLSK----LLTSDKSLLKTIVGTPAYMAPEVL 165
Query: 1131 AYSLKATEKCDVYSMGIVLMEL 1152
+EK D++S+G++L EL
Sbjct: 166 LGKGYYSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 150 bits (382), Expect = 1e-40
Identities = 78/295 (26%), Positives = 131/295 (44%), Gaps = 60/295 (20%)
Query: 954 IGSGGSGTVYKAEL-----ANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKL 1008
+G G G VYK L VAVK + + F E + ++ H ++V+L
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66
Query: 1009 MGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYL 1068
+G C +G ++ EYM G + D+L K + ++ L++A+ +A+G+EYL
Sbjct: 67 LG-VCTQG-EPLYIVTEYMPGGDLLDFLRKHGEKLTLKD------LLQMALQIAKGMEYL 118
Query: 1069 H-HDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNT-----WFAGS 1122
+ V HRD+ + N L+ N+ + DFGL++ + ED W
Sbjct: 119 ESKNFV----HRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKW---- 170
Query: 1123 YGYIAPEYAYSLKA---TEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMVRWVEMHME 1178
+APE SLK T K DV+S G++L E+ + G+ P + M
Sbjct: 171 ---MAPE---SLKDGKFTSKSDVWSFGVLLWEIFTLGEQP-------------YPGMSN- 210
Query: 1179 MSGSAREELLD--DQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLL 1231
EE+L+ + L E C ++ E+ LQC P++RP+ ++ + L
Sbjct: 211 ------EEVLELLEDGYRLPRPENCPD-ELYELMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 142 bits (360), Expect = 9e-38
Identities = 73/291 (25%), Positives = 128/291 (43%), Gaps = 43/291 (14%)
Query: 953 IIGSGGSGTVYKAEL----ANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKL 1008
+G G G VYK +L VAVK + K F +E + + ++ H ++V+L
Sbjct: 2 KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRL 61
Query: 1009 MGHCCNKGAGSNLLIYEYMENGSVWDWL--HKQPVNIKMRKSLDWEARLKIAVGLAQGVE 1066
+G C + L+ EYME G + D+L + + +L + L A+ +A+G+E
Sbjct: 62 LG-VCTEE-EPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGME 119
Query: 1067 YLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNT-----WFAG 1121
YL K +HRD+ + N L+ ++ + DFGL++ + +D ++ W
Sbjct: 120 YLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWM-- 174
Query: 1122 SYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMVRWVEMHMEMS 1180
APE T K DV+S G++L E+ + G P + E+
Sbjct: 175 -----APESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPG--------LSNEEVL---- 217
Query: 1181 GSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLL 1231
E L + P E C ++ E+ L C + P++RP+ ++ + L
Sbjct: 218 -----EYLRKGYRLPKP-EYCPD-ELYELMLSCWQLDPEDRPTFSELVERL 261
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 137 bits (348), Expect = 4e-36
Identities = 75/290 (25%), Positives = 126/290 (43%), Gaps = 49/290 (16%)
Query: 953 IIGSGGSGTVYKAEL-----ANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVK 1007
+G G G VYK +L VAVK + + F RE + + ++ H ++VK
Sbjct: 6 KLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVK 65
Query: 1008 LMGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEY 1067
L+G C + ++ EYME G + +L K + + L A+ +A+G+EY
Sbjct: 66 LLGVCTEEEPL--YIVMEYMEGGDLLSYLRKNRPKLSLSD------LLSFALQIARGMEY 117
Query: 1068 LH-HDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKAL-VEDYNSNTESN---TWFAGS 1122
L + + HRD+ + N L+ N+ + DFGL++ L +DY W
Sbjct: 118 LESKNFI----HRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWM--- 170
Query: 1123 YGYIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMVRWVEMHMEMSG 1181
APE K T K DV+S G++L E+ + G+ P + MS
Sbjct: 171 ----APESLKEGKFTSKSDVWSFGVLLWEIFTLGEQP-----------------YPGMSN 209
Query: 1182 SAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLL 1231
E L + + P C + ++ LQC P++RP+ ++ ++L
Sbjct: 210 EEVLEYLKNGYRLPQP-PNCPPE-LYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 135 bits (343), Expect = 2e-35
Identities = 72/286 (25%), Positives = 130/286 (45%), Gaps = 41/286 (14%)
Query: 953 IIGSGGSGTVYKA-ELANGATVAVKKISCKDDHLLN-KSFTREVKTLGRIRHRHLVKLMG 1010
++G G G+VY A + G +AVK + D ++ RE++ L ++H ++V+ G
Sbjct: 7 LLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYG 66
Query: 1011 HCCNKGAGSNLLIY-EYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVG-LAQGVEYL 1068
++ + L I+ EY+ GS+ +K L E ++ + +G+ YL
Sbjct: 67 SERDE-EKNTLNIFLEYVSGGSLSSL-------LKKFGKLP-EPVIRKYTRQILEGLAYL 117
Query: 1069 H-HDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIA 1127
H + I+HRDIK +NIL+DS+ L DFG AK L + E G+ ++A
Sbjct: 118 HSN----GIVHRDIKGANILVDSDGVVKLADFGCAKRLGD--IETGEGTGSVRGTPYWMA 171
Query: 1128 PEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSAREEL 1187
PE + D++S+G ++E+ +GK P + E+ + SG
Sbjct: 172 PEVIRGEEYGRAADIWSLGCTVIEMATGKPP----WS-ELGNPMAALYKIGSSGEP---- 222
Query: 1188 LDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLN 1233
P +P E + + + +C + P++RP++ + LL
Sbjct: 223 ------PEIP--EHLSEEAKDFLRKCLRRDPKKRPTADE----LLQ 256
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 133 bits (338), Expect = 7e-35
Identities = 77/289 (26%), Positives = 125/289 (43%), Gaps = 46/289 (15%)
Query: 953 IIGSGGSGTVYKAEL-----ANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVK 1007
+G G G VYK L VAVK + + F RE + + ++ H ++VK
Sbjct: 6 KLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVK 65
Query: 1008 LMGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEY 1067
L+G C + +++ EYM G + D+L K K L L A+ +A+G+EY
Sbjct: 66 LLGVCTEEEPL--MIVMEYMPGGDLLDYLRKNR-----PKELSLSDLLSFALQIARGMEY 118
Query: 1068 LHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKAL-VEDYNSNTESN---TWFAGSY 1123
L +HRD+ + N L+ N+ + DFGL++ L +DY W
Sbjct: 119 LESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWM---- 171
Query: 1124 GYIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMVRWVEMHMEMSGS 1182
APE K T K DV+S G++L E+ + G+ P + MS +
Sbjct: 172 ---APESLKEGKFTSKSDVWSFGVLLWEIFTLGEEP-----------------YPGMSNA 211
Query: 1183 AREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLL 1231
E L + P C + ++ LQC P++RP+ ++ ++L
Sbjct: 212 EVLEYLKKGYRLPKP-PNCPPE-LYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 127 bits (320), Expect = 2e-32
Identities = 82/281 (29%), Positives = 133/281 (47%), Gaps = 38/281 (13%)
Query: 954 IGSGGSGTVYKAE-LANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHC 1012
+G+G SG V K G +AVK I + + + K RE+ L + ++V G
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF 68
Query: 1013 CNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDC 1072
N G S + EYM+ GS+ D + K+ ++ + KIAV + +G+ YLH
Sbjct: 69 YNNGDIS--ICMEYMDGGSL-DKILKE-----VQGRIPERILGKIAVAVLKGLTYLHEKH 120
Query: 1073 VPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAY 1132
KI+HRD+K SNIL++S + L DFG++ LV N+ + T F G+ Y+APE
Sbjct: 121 --KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLV-----NSLAKT-FVGTSSYMAPERIQ 172
Query: 1133 SLKATEKCDVYSMGIVLMELVSGKMPTDA-TFGVEMDMVRWVEMHMEMSGSAREELLD-- 1189
+ K D++S+G+ L+EL +G+ P + ELL
Sbjct: 173 GNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIF----------------ELLQYI 216
Query: 1190 -DQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCD 1229
++ P LP + + + L K P+ERPS +++ +
Sbjct: 217 VNEPPPRLPSGKFSPDFQDFVNLCLIK-DPRERPSYKELLE 256
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 3e-31
Identities = 88/281 (31%), Positives = 134/281 (47%), Gaps = 45/281 (16%)
Query: 954 IGSGGSGTVYKAEL-ANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHC 1012
+G G SG VYK G A+KKI D K RE+KTL ++VK G
Sbjct: 9 LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAF 68
Query: 1013 CNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLK-IAVGLAQGVEYLHHD 1071
+G S ++ EYM+ GS+ D L K+ I E L IA + +G++YLH
Sbjct: 69 YKEGEIS--IVLEYMDGGSLAD-LLKKVGKIP-------EPVLAYIARQILKGLDYLHTK 118
Query: 1072 CVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPE-- 1129
I+HRDIK SN+L++S E + DFG++K L N+ + NT F G+ Y++PE
Sbjct: 119 --RHIIHRDIKPSNLLINSKGEVKIADFGISKVLE---NTLDQCNT-FVGTVTYMSPERI 172
Query: 1130 ----YAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSARE 1185
Y+Y+ D++S+G+ L+E GK P + E+ M +
Sbjct: 173 QGESYSYA------ADIWSLGLTLLECALGKFPFLPP-----GQPSFFEL-M-------Q 213
Query: 1186 ELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQ 1226
+ D P LP EE + + + C + P++RPS+ +
Sbjct: 214 AICDGP-PPSLPAEEFSP-EFRDFISACLQKDPKKRPSAAE 252
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 2e-30
Identities = 67/210 (31%), Positives = 102/210 (48%), Gaps = 26/210 (12%)
Query: 954 IGSGGSGTVYKAE-LANGATVAVKKI---SCKDDHLLNKSFTREVKTLGRIRHRHLVKLM 1009
IG GG G VYKA G VA+K I S + + E++ L + +H ++VK
Sbjct: 8 IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKI----INEIQILKKCKHPNIVKYY 63
Query: 1010 G-HCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYL 1068
G + ++ E+ GS+ D L + + A + L +G+EYL
Sbjct: 64 GSYLKK---DELWIVMEFCSGGSLKDLLK----STNQTLTESQIA--YVCKELLKGLEYL 114
Query: 1069 HHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAP 1128
H + I+HRDIK++NILL S+ E L DFGL+ L S+T++ G+ ++AP
Sbjct: 115 HSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQL-----SDTKARNTMVGTPYWMAP 166
Query: 1129 EYAYSLKATEKCDVYSMGIVLMELVSGKMP 1158
E K D++S+GI +EL GK P
Sbjct: 167 EVINGKPYDYKADIWSLGITAIELAEGKPP 196
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 2e-29
Identities = 81/294 (27%), Positives = 128/294 (43%), Gaps = 41/294 (13%)
Query: 954 IGSGGSGTVYKAELAN-----GATVAVK--KISCKDDHLLNKSFTREVKTLGRIRHRHLV 1006
+G G G V G VAVK S ++ H F RE++ L + H ++V
Sbjct: 12 LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHR--SDFEREIEILRTLDHENIV 69
Query: 1007 KLMGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVE 1066
K G C G S LI EY+ +GS+ D+L + I K L L + + +G++
Sbjct: 70 KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQIN-LKRL-----LLFSSQICKGMD 123
Query: 1067 YLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVED---YNSNTESNT---WFA 1120
YL + +HRD+ + NIL++S + DFGLAK L ED Y + W+
Sbjct: 124 YLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY- 179
Query: 1121 GSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTD---ATFGVEMDMVRWVEMHM 1177
APE + K + DV+S G+ L EL + P+ A F + + + +
Sbjct: 180 ------APECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVT 233
Query: 1178 EMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLL 1231
+ ELL + LP +V ++ C + PQ+RPS + ++
Sbjct: 234 RLL-----ELLKE--GERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIV 280
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 8e-28
Identities = 80/291 (27%), Positives = 129/291 (44%), Gaps = 63/291 (21%)
Query: 953 IIGSGGSGTVYKAE-LANGATVAVKKISCKDDHLLN-KSFTREVKTLGRIRHRHLVKLMG 1010
+IG G G VYK L G VA+K+IS + KS +E+ L ++H ++VK +G
Sbjct: 7 LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIG 66
Query: 1011 HCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQ---GVEY 1067
+ + S +I EY ENGS+ + K +SL +AV + Q G+ Y
Sbjct: 67 SI--ETSDSLYIILEYAENGSLRQIIKK---FGPFPESL-------VAVYVYQVLQGLAY 114
Query: 1068 LHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIA 1127
LH ++HRDIK++NIL + L DFG+A L N ++ + G+ ++A
Sbjct: 115 LHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKL----NDVSKDDASVVGTPYWMA 167
Query: 1128 PEYAYSLKATEKCDVYSMGIVLMELVSGK--------MPTDATFGVEMDMVRWVEMHMEM 1179
PE A+ D++S+G ++EL++G M + R V+
Sbjct: 168 PEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAA---------LFRIVQ----- 213
Query: 1180 SGSAREELLDDQMKPLLPG--EECAAYQVLEIALQCTKTSPQERPSSRQVC 1228
D PL G E + +QC + P RP+++Q+
Sbjct: 214 ----------DDHPPLPEGISPELKDF-----LMQCFQKDPNLRPTAKQLL 249
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 8e-28
Identities = 69/216 (31%), Positives = 99/216 (45%), Gaps = 24/216 (11%)
Query: 954 IGSGGSGTVYKAE-LANGATVAVKKISCKDDHLLNKSFT-REVKTLGRIRHRHLVKLMGH 1011
IG G G VY ++G +K+I + + EVK L ++ H +++K
Sbjct: 8 IGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYES 67
Query: 1012 CCNKGAGSNLLI-YEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHH 1070
KG L I EY + G + + KQ K K E L V L ++YLH
Sbjct: 68 FEEKG---KLCIVMEYADGGDLSQKIKKQ---KKEGKPFPEEQILDWFVQLCLALKYLHS 121
Query: 1071 DCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPE- 1129
KILHRDIK NI L SN LGDFG++K L +S + G+ Y++PE
Sbjct: 122 R---KILHRDIKPQNIFLTSNGLVKLGDFGISKVL----SSTVDLAKTVVGTPYYLSPEL 174
Query: 1130 ---YAYSLKATEKCDVYSMGIVLMELVSGKMPTDAT 1162
Y+ K+ D++S+G VL EL + K P +
Sbjct: 175 CQNKPYNYKS----DIWSLGCVLYELCTLKHPFEGE 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 1e-27
Identities = 69/208 (33%), Positives = 106/208 (50%), Gaps = 15/208 (7%)
Query: 953 IIGSGGSGTVYKAELANGATV-AVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGH 1011
+G G G+V K L N + A+K I+ + L K RE++ + ++VK G
Sbjct: 8 RLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGA 67
Query: 1012 CCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARL-KIAVGLAQGVEYLHH 1070
++ + S + EY E GS+ D ++K +K R E L KIA + +G+ YLH
Sbjct: 68 FLDESSSSIGIAMEYCEGGSL-DSIYK---KVKKRGGRIGEKVLGKIAESVLKGLSYLHS 123
Query: 1071 DCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEY 1130
KI+HRDIK SNILL + L DFG++ LV N+ + T F G+ Y+APE
Sbjct: 124 R---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELV-----NSLAGT-FTGTSFYMAPER 174
Query: 1131 AYSLKATEKCDVYSMGIVLMELVSGKMP 1158
+ DV+S+G+ L+E+ + P
Sbjct: 175 IQGKPYSITSDVWSLGLTLLEVAQNRFP 202
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 115 bits (288), Expect = 2e-27
Identities = 78/282 (27%), Positives = 126/282 (44%), Gaps = 27/282 (9%)
Query: 954 IGSGGSGTVYKAELANGATVAVKKISCK--DDHLLNKSFTREVKTLGRIRH-RHLVKLMG 1010
+G G G VY A + VA+K ++ K + F RE++ L + H ++VKL
Sbjct: 8 LGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYD 65
Query: 1011 HCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHH 1070
+ GS L+ EY++ GS+ D L K + +S L I + +EYLH
Sbjct: 66 FF--QDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESE----ALFILAQILSALEYLHS 119
Query: 1071 DCVPKILHRDIKSSNILLDSN-MEAHLGDFGLAKALVEDYNSNTESNTW--FAGSYGYIA 1127
I+HRDIK NILLD + L DFGLAK L + ++++ G+ GY+A
Sbjct: 120 KG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMA 176
Query: 1128 PEYAYSL---KATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSAR 1184
PE L A+ D++S+GI L EL++G P + + +++ +E+ +
Sbjct: 177 PEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEG-EKNSSATSQTLKIILELPTPSL 235
Query: 1185 EELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQ 1226
L L+ ++ + P+ R SS
Sbjct: 236 ASPLSPSNPELISKA------ASDLLKKLLAKDPKNRLSSSS 271
|
Length = 384 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (281), Expect = 6e-27
Identities = 75/224 (33%), Positives = 110/224 (49%), Gaps = 46/224 (20%)
Query: 953 IIGSGGSGTVYKAE-LANGATVAVKKISCKDDHLLNKSFT----REVKTLGRIRHRHLVK 1007
IG G G VYKA G VA+KKI +++ + F RE+K L ++RH ++V+
Sbjct: 6 QIGEGTYGQVYKARNKKTGELVALKKIRMENEK---EGFPITAIREIKLLQKLRHPNIVR 62
Query: 1008 LMGHCCNKGAGSNLLIYEYME---NGSVWDWLHKQPVNIKMRKSLDWEARLK-IAVGLAQ 1063
L +KG GS +++EYM+ G L P +K E+++K L +
Sbjct: 63 LKEIVTSKGKGSIYMVFEYMDHDLTG-----LLDSP-EVKFT-----ESQIKCYMKQLLE 111
Query: 1064 GVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNT------ 1117
G++YLH + ILHRDIK SNIL++++ L DFGLA+ N+ T
Sbjct: 112 GLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYT---KRNSADYTNRVITL 165
Query: 1118 WFAGSYGYIAPEYAYSLKAT---EKCDVYSMGIVLMELVSGKMP 1158
W Y PE L AT + D++S+G +L EL GK
Sbjct: 166 W------YRPPELL--LGATRYGPEVDMWSVGCILAELFLGKPI 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 3e-26
Identities = 76/284 (26%), Positives = 122/284 (42%), Gaps = 58/284 (20%)
Query: 954 IGSGGSGTVYKAELANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCC 1013
IG G G V + G VAVK + KDD ++F E + +RH +LV+L+G
Sbjct: 14 IGKGEFGDVMLGDYR-GQKVAVKCL--KDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVL 70
Query: 1014 NKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCV 1073
++ EYM GS+ D+L + R + +L A+ + +G+EYL
Sbjct: 71 QGN--PLYIVTEYMAKGSLVDYLRS-----RGRAVITLAQQLGFALDVCEGMEYLEEK-- 121
Query: 1074 PKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESN----TWFAGSYGYIAPE 1129
+HRD+ + N+L+ ++ A + DFGLAK + + +S W APE
Sbjct: 122 -NFVHRDLAARNVLVSEDLVAKVSDFGLAK----EASQGQDSGKLPVKW-------TAPE 169
Query: 1130 YAYSLKATEKCDVYSMGIVLMELVS------GKMPTDATFGVEMDMVRWVEMHMEMSGSA 1183
K + K DV+S GI+L E+ S ++P D+V VE M
Sbjct: 170 ALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK-------DVVPHVEKGYRME--- 219
Query: 1184 REELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQV 1227
E C +V ++ C + P +RP+ +Q+
Sbjct: 220 -------------APEGCPP-EVYKVMKDCWELDPAKRPTFKQL 249
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 2e-25
Identities = 63/217 (29%), Positives = 106/217 (48%), Gaps = 39/217 (17%)
Query: 953 IIGSGGSGTVYKA-ELANGATVAVKKI-SCKDDHLLNKSFTREVKTLGRIRHRHLVKLMG 1010
+G G G VYKA + G VA+KKI ++ + + RE+ L ++H ++VKL+
Sbjct: 6 KLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLD 65
Query: 1011 HCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMR--KSLDWEARLKIAVGLAQGVEYL 1068
+ L++EY + + +L K+P + KS+ ++ L +G+ Y
Sbjct: 66 VIHTER--KLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQ--------LLRGLAYC 114
Query: 1069 HHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNT-ESNT-WFAGSYGYI 1126
H +ILHRD+K NIL++ + L DFGLA+A + T E T W Y
Sbjct: 115 HSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTLW------YR 165
Query: 1127 APE-------YAYSLKATEKCDVYSMGIVLMELVSGK 1156
APE Y+ ++ D++S+G + E+++GK
Sbjct: 166 APEILLGSKHYSTAV------DIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 75/272 (27%), Positives = 124/272 (45%), Gaps = 37/272 (13%)
Query: 954 IGSGGSGTVYKAELANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCC 1013
+GSG G V++ N VA+K + DD L + F +EV+ L R+RH+HL+ L C
Sbjct: 14 LGSGYFGEVWEGLWKNRVRVAIKILK-SDDLLKQQDFQKEVQALKRLRHKHLISLFAVC- 71
Query: 1014 NKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCV 1073
+I E ME GS+ +L + L + + +A +A+G+ YL
Sbjct: 72 -SVGEPVYIITELMEKGSLLAFL-----RSPEGQVLPVASLIDMACQVAEGMAYLEEQ-- 123
Query: 1074 PKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYS 1133
+HRD+ + NIL+ ++ + DFGLA+ + ED +++ Y + APE A
Sbjct: 124 -NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI----PYKWTAPEAASH 178
Query: 1134 LKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMVRWVEMHMEMSGSAREELLDDQM 1192
+ K DV+S GI+L E+ + G++P G E+ D
Sbjct: 179 GTFSTKSDVWSFGILLYEMFTYGQVPYP--------------------GMNNHEVYDQIT 218
Query: 1193 KPL-LPGEECAAYQVLEIALQCTKTSPQERPS 1223
+P ++ +I L+C P++RPS
Sbjct: 219 AGYRMPCPAKCPQEIYKIMLECWAAEPEDRPS 250
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 65/210 (30%), Positives = 102/210 (48%), Gaps = 16/210 (7%)
Query: 954 IGSGGSGTVYKA-ELANGATVAVKKISCKD-DHLLNKSFTREVKTLGRIRHRHLVKLMGH 1011
IG G G V+K A+ A+K+I + + E + L ++ ++++
Sbjct: 8 IGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYES 67
Query: 1012 CCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHD 1071
+KG + ++ EY ENG + L Q + + W ++I +GLA +LH
Sbjct: 68 FLDKGKLN--IVMEYAENGDLHKLLKMQ-RGRPLPEDQVWRFFIQILLGLA----HLHSK 120
Query: 1072 CVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYA 1131
KILHRDIKS N+ LD+ +GD G+AK L + NT G+ Y++PE
Sbjct: 121 ---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLL----SDNTNFANTIVGTPYYLSPELC 173
Query: 1132 YSLKATEKCDVYSMGIVLMELVSGKMPTDA 1161
EK DV+++G+VL E +GK P DA
Sbjct: 174 EDKPYNEKSDVWALGVVLYECCTGKHPFDA 203
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 69/211 (32%), Positives = 106/211 (50%), Gaps = 27/211 (12%)
Query: 953 IIGSGGSGTVYKA-ELANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGH 1011
+G G G+VYKA G VA+K + ++D + +E+ L + ++VK G
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVVPVEED---LQEIIKEISILKQCDSPYIVKYYGS 66
Query: 1012 CCNKGAGSNLLI-YEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQ---GVEY 1067
++L I EY GSV D + I K+L E +IA L Q G+EY
Sbjct: 67 YFKN---TDLWIVMEYCGAGSVSDI-----MKI-TNKTLTEE---EIAAILYQTLKGLEY 114
Query: 1068 LHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIA 1127
LH + K +HRDIK+ NILL+ +A L DFG++ L ++ + NT G+ ++A
Sbjct: 115 LHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLT---DTMAKRNT-VIGTPFWMA 167
Query: 1128 PEYAYSLKATEKCDVYSMGIVLMELVSGKMP 1158
PE + K D++S+GI +E+ GK P
Sbjct: 168 PEVIQEIGYNNKADIWSLGITAIEMAEGKPP 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 3e-24
Identities = 61/213 (28%), Positives = 94/213 (44%), Gaps = 32/213 (15%)
Query: 954 IGSGGSGTVYKA-ELANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHC 1012
IG G SG VYKA + A G VA+KK+ + + + E+ + +H ++V
Sbjct: 27 IGEGASGEVYKATDRATGKEVAIKKMRLRKQNK--ELIINEILIMKDCKHPNIVDYYD-- 82
Query: 1013 CNKGAGSNLLIYEYMENGSVWDWLHKQPVNIK-------MRKSLDWEARLKIAVGLAQGV 1065
++ EYM+ GS+ D + + V + R+ L QG+
Sbjct: 83 SYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVL-------------QGL 129
Query: 1066 EYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGY 1125
EYLH ++HRDIKS NILL + L DFG A L G+ +
Sbjct: 130 EYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQL----TKEKSKRNSVVGTPYW 182
Query: 1126 IAPEYAYSLKATEKCDVYSMGIVLMELVSGKMP 1158
+APE K D++S+GI+ +E+ G+ P
Sbjct: 183 MAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 5e-24
Identities = 81/282 (28%), Positives = 125/282 (44%), Gaps = 41/282 (14%)
Query: 954 IGSGGSGTVYKA-ELANGATVAVKKISCKD-DHLLNKSFTREVKTLGRIRHRHLVKLMG- 1010
IG G G VY A L G +AVK+I +D D K E+K L ++H +LVK G
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGV 67
Query: 1011 --HCCNKGAGSNLLIY-EYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEY 1067
H + I+ EY G++ + L + LD + L +G+ Y
Sbjct: 68 EVH------REKVYIFMEYCSGGTLEELLE-------HGRILDEHVIRVYTLQLLEGLAY 114
Query: 1068 LHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIA 1127
LH I+HRDIK +NI LD N LGDFG A L + + E AG+ Y+A
Sbjct: 115 LHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMA 171
Query: 1128 PEYAYSLKATEK---CDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSAR 1184
PE K D++S+G V++E+ +GK P E+D + H+
Sbjct: 172 PEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWS-----ELDNEFQIMFHVGA----- 221
Query: 1185 EELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQ 1226
KP +P + + + +C ++ P++RP++ +
Sbjct: 222 ------GHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASE 257
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 7e-24
Identities = 77/277 (27%), Positives = 126/277 (45%), Gaps = 47/277 (16%)
Query: 954 IGSGGSGTVYKAELANGAT-VAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHC 1012
+G+G G V++ L N T VAVK + K + K F E + + ++RH L++L C
Sbjct: 14 LGAGQFGEVWEG-LWNNTTPVAVKTL--KPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVC 70
Query: 1013 CNKGAGSNLLIYEYMENGSVWDWLHKQPV-NIKMRKSLDWEARLKIAVGLAQGVEYLHHD 1071
+ ++ E M+ GS+ ++L +K+ + +D +A +A G+ YL
Sbjct: 71 TLEE--PIYIVTELMKYGSLLEYLQGGAGRALKLPQLID------MAAQVASGMAYLEAQ 122
Query: 1072 CVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVED-YNSNTESN---TWFAGSYGYIA 1127
+HRD+ + N+L+ N + DFGLA+ + ED Y + + W A
Sbjct: 123 ---NYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKW-------TA 172
Query: 1128 PEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMVRWVEMHMEMSGSAREE 1186
PE A + + K DV+S GI+L E+V+ G+MP E +++ V+ M
Sbjct: 173 PEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE--VLQQVDQGYRM------- 223
Query: 1187 LLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPS 1223
P PG Y I L C K P +RP+
Sbjct: 224 -------PCPPGCPKELYD---IMLDCWKEDPDDRPT 250
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 81/281 (28%), Positives = 132/281 (46%), Gaps = 55/281 (19%)
Query: 954 IGSGGSGTVYKAELANGAT-VAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHC 1012
+G+G G V+ NG T VAVK + K + ++F +E + + ++RH LV+L C
Sbjct: 14 LGAGQFGEVWMG-TWNGTTKVAVKTL--KPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVC 70
Query: 1013 CNKGAGSNLLIY---EYMENGSVWDWLHKQP-VNIKMRKSLDWEARLKIAVGLAQGVEYL 1068
+ IY EYM GS+ D+L +++ + +D +A +A+G+ YL
Sbjct: 71 SEEEP-----IYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVD------MAAQIAEGMAYL 119
Query: 1069 HHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVED--YNSNTESN---TWFAGSY 1123
+HRD+ + NIL+ N+ + DFGLA+ L+ED Y + + W
Sbjct: 120 ESR---NYIHRDLAARNILVGENLVCKIADFGLAR-LIEDDEYTAREGAKFPIKW----- 170
Query: 1124 GYIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMVRWVEMHMEMSGS 1182
APE A + T K DV+S GI+L E+V+ G++P E ++ VE M
Sbjct: 171 --TAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNRE--VLEQVERGYRMP-- 224
Query: 1183 AREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPS 1223
+P C ++ ++ LQC P+ERP+
Sbjct: 225 ----------RP----PNCPE-ELYDLMLQCWDKDPEERPT 250
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 63/219 (28%), Positives = 105/219 (47%), Gaps = 21/219 (9%)
Query: 953 IIGSGGSGTVYKA-ELANGATVAVKKIS------CKDDHLLNKSFTREVKTLGRIRHRHL 1005
IG G GTV K ++G + K+I + L++ EV L ++H ++
Sbjct: 7 TIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVS-----EVNILRELKHPNI 61
Query: 1006 VKLMGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGV 1065
V+ ++ + ++ EY E G + + K K RK ++ E +I L +
Sbjct: 62 VRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKC---KKERKYIEEEFIWRILTQLLLAL 118
Query: 1066 EYLHHDCVPK--ILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSY 1123
H+ P +LHRD+K +NI LD+N LGDFGLAK L D +S ++ + G+
Sbjct: 119 YECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHD-SSFAKT---YVGTP 174
Query: 1124 GYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDAT 1162
Y++PE + EK D++S+G ++ EL + P A
Sbjct: 175 YYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTAR 213
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 3e-23
Identities = 81/296 (27%), Positives = 140/296 (47%), Gaps = 35/296 (11%)
Query: 954 IGSGGSGTVYKAE-LANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHC 1012
+G+G G+V K + + G +A K + + K RE++ + R ++V G
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72
Query: 1013 CNKGAGSNLLIYEYMENGSVWDWLHKQ--PVNIKMRKSLDWEARLKIAVGLAQGVEYLHH 1070
N+ + E+M+ GS+ D ++K+ P+ + E KIAV + +G+ YL++
Sbjct: 73 LNENNIC--MCMEFMDCGSL-DRIYKKGGPIPV--------EILGKIAVAVVEGLTYLYN 121
Query: 1071 DCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEY 1130
V +I+HRDIK SNIL++S + L DFG++ L+ N+ ++T F G+ Y++PE
Sbjct: 122 --VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELI-----NSIADT-FVGTSTYMSPER 173
Query: 1131 AYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSAREELLD- 1189
K T K DV+S+GI ++EL GK P + + + +LL
Sbjct: 174 IQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDD---------DGQDDPMGILDLLQQ 224
Query: 1190 --DQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNVFNNRIVDFD 1243
+ P LP + + C P ERP+ +Q+C + + R + D
Sbjct: 225 IVQEPPPRLPSSDFPEDLRDFVDA-CLLKDPTERPTPQQLCAMPPFIQALRASNVD 279
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 4e-23
Identities = 80/274 (29%), Positives = 121/274 (44%), Gaps = 54/274 (19%)
Query: 970 GATVAVKKIS-CKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIYEYME 1028
G VAVKK+ +HL + F RE++ L ++H ++VK G C + G + L+ EY+
Sbjct: 33 GEVVAVKKLQHSTAEHL--RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLP 90
Query: 1029 NGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILL 1088
GS+ D+L K R+ LD L A + +G+EYL + +HRD+ + NIL+
Sbjct: 91 YGSLRDYL------QKHRERLDHRKLLLYASQICKGMEYLG---SKRYVHRDLATRNILV 141
Query: 1089 DSNMEAHLGDFGLAKALVED--YNSNTESNT----WFAGSYGYIAPEYAYSLKATEKCDV 1142
+S +GDFGL K L +D Y E W+ APE K + DV
Sbjct: 142 ESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWY-------APESLTESKFSVASDV 194
Query: 1143 YSMGIVLMELVS----GKMPTDATFGVEMDMVRWVEMHMEMSGSARE---------ELLD 1189
+S G+VL EL + P M M G+ ++ ELL
Sbjct: 195 WSFGVVLYELFTYSDKSCSPP--------------AEFMRMMGNDKQGQMIVYHLIELLK 240
Query: 1190 DQMKPLLPGEECAAYQVLEIALQCTKTSPQERPS 1223
+ + LP ++ I +C P +RPS
Sbjct: 241 NNGR--LPAPPGCPAEIYAIMKECWNNDPSQRPS 272
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.5 bits (249), Expect = 5e-23
Identities = 63/210 (30%), Positives = 97/210 (46%), Gaps = 23/210 (10%)
Query: 954 IGSGGSGTVYKA-ELANGATVAVKKIS---CKDDHLLNKSFTREVKTLGRIRHRHLVKLM 1009
+G G G V + G A+K + + + T E L RI H +VKL
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLT-ERNILSRINHPFIVKL- 58
Query: 1010 GHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLH 1069
H + L+ EY G ++ L K+ + + AR A + +EYLH
Sbjct: 59 -HYAFQTEEKLYLVLEYAPGGELFSHLSKE------GRFSEERARF-YAAEIVLALEYLH 110
Query: 1070 -HDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAP 1128
I++RD+K NILLD++ L DFGLAK E + + +NT F G+ Y+AP
Sbjct: 111 SLG----IIYRDLKPENILLDADGHIKLTDFGLAK---ELSSEGSRTNT-FCGTPEYLAP 162
Query: 1129 EYAYSLKATEKCDVYSMGIVLMELVSGKMP 1158
E + D +S+G++L E+++GK P
Sbjct: 163 EVLLGKGYGKAVDWWSLGVLLYEMLTGKPP 192
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 98.6 bits (246), Expect = 1e-22
Identities = 63/214 (29%), Positives = 102/214 (47%), Gaps = 25/214 (11%)
Query: 954 IGSGGSGTVYKAE-LANGATVAVKKIS---CKD--DHLLNKSFTREVKTLGRIRHRHLVK 1007
IG G + VY A L N VA+K+I C+ D L +EV+ + + H ++VK
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELR-----KEVQAMSQCNHPNVVK 63
Query: 1008 LMGHCCNKGAGSNL-LIYEYMENGSVWDWL-HKQPVNIKMRKSLDWEARLKIAVGLAQGV 1065
+ + G L L+ Y+ GS+ D + P R LD + + +G+
Sbjct: 64 ---YYTSFVVGDELWLVMPYLSGGSLLDIMKSSYP-----RGGLDEAIIATVLKEVLKGL 115
Query: 1066 EYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGY 1125
EYLH + +HRDIK+ NILL + + DFG++ +L + + + F G+ +
Sbjct: 116 EYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCW 172
Query: 1126 IAPEYAYSLKA-TEKCDVYSMGIVLMELVSGKMP 1158
+APE + K D++S GI +EL +G P
Sbjct: 173 MAPEVMEQVHGYDFKADIWSFGITAIELATGAAP 206
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 1e-22
Identities = 87/302 (28%), Positives = 138/302 (45%), Gaps = 72/302 (23%)
Query: 954 IGSGGSGTVYKA-ELANGATVAVKKISCKDDHLLNKS----FTREVKTLGRIRHRHLVKL 1008
+GSG G+VY+ L +G AVK++S DD + +E+ L +++H ++V+
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 1009 MGHCCNKGAGSNLLIY-EYMENGSVWDWLHK-----QPVNIKM--RKSLDWEARLKIAVG 1060
+G + NL I+ E + GS+ L K +PV I++ R+ L
Sbjct: 68 LG---TEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPV-IRLYTRQILL---------- 113
Query: 1061 LAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFA 1120
G+EYLH +HRDIK +NIL+D+N L DFG+AK +VE S +S F
Sbjct: 114 ---GLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVE--FSFAKS---FK 162
Query: 1121 GSYGYIAPEY-----AYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEM 1175
GS ++APE Y L A D++S+G ++E+ +GK P GV
Sbjct: 163 GSPYWMAPEVIAQQGGYGLAA----DIWSLGCTVLEMATGKPPWSQLEGVA------AVF 212
Query: 1176 HMEMSGSARE--ELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLN 1233
+ S + L D+ K + L+C + P RP++ + LL +
Sbjct: 213 KIGRSKELPPIPDHLSDEAKDFI--------------LKCLQRDPSLRPTAAE---LLEH 255
Query: 1234 VF 1235
F
Sbjct: 256 PF 257
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 98.1 bits (244), Expect = 2e-22
Identities = 77/272 (28%), Positives = 127/272 (46%), Gaps = 38/272 (13%)
Query: 954 IGSGGSGTVYKAELANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCC 1013
IGSG G V+ VA+K I ++ + + F E + + ++ H LV+L G C
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTI--REGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCT 69
Query: 1014 NKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCV 1073
+ L++E+ME+G + D+L Q R E L + + + +G+ YL V
Sbjct: 70 ERSP--ICLVFEFMEHGCLSDYLRAQ------RGKFSQETLLGMCLDVCEGMAYLESSNV 121
Query: 1074 PKILHRDIKSSNILLDSNMEAHLGDFGLAKALVED-YNSNTESNTWFAGSYGYIAPEYAY 1132
+HRD+ + N L+ N + DFG+ + +++D Y S+T T F + +PE
Sbjct: 122 ---IHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSST--GTKFPVKWS--SPEVFS 174
Query: 1133 SLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMVRWVEMHMEMSGSAREELLDDQ 1191
K + K DV+S G+++ E+ S GK P + E+ VE ++ R
Sbjct: 175 FSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEV-----VE---TINAGFR------L 220
Query: 1192 MKPLLPGEECAAYQVLEIALQCTKTSPQERPS 1223
KP L A+ V E+ C K P++RPS
Sbjct: 221 YKPRL-----ASQSVYELMQHCWKERPEDRPS 247
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 97.5 bits (243), Expect = 4e-22
Identities = 78/301 (25%), Positives = 128/301 (42%), Gaps = 58/301 (19%)
Query: 954 IGSGGSGTVYKAELANG------ATVAVK--KISCKDDHLLNKSFTREVKTLGRIRHRHL 1005
+G G G V+ E + VAVK K + +D K F RE + L +H ++
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASND--ARKDFEREAELLTNFQHENI 70
Query: 1006 VKLMGHCCNKGAGSNLLIYEYMENGSVWDWL--HKQPVNIKMR-----KSLDWEARLKIA 1058
VK G C ++++EYME+G + +L H L L+IA
Sbjct: 71 VKFYGVCTE--GDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIA 128
Query: 1059 VGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVE-DY----NSNT 1113
V +A G+ YL +HRD+ + N L+ ++ +GDFG+++ + DY
Sbjct: 129 VQIASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTM 185
Query: 1114 ESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMVRW 1172
W + PE K T + DV+S G+VL E+ + GK P W
Sbjct: 186 LPIRW-------MPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP-------------W 225
Query: 1173 VEMHMEMSGSAREELLD--DQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDL 1230
+ + EE+++ Q + L C + +V +I L C K PQ+R + + + +
Sbjct: 226 YGL-------SNEEVIECITQGRLLQRPRTCPS-EVYDIMLGCWKRDPQQRINIKDIHER 277
Query: 1231 L 1231
L
Sbjct: 278 L 278
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 97.7 bits (243), Expect = 4e-22
Identities = 83/298 (27%), Positives = 136/298 (45%), Gaps = 41/298 (13%)
Query: 954 IGSGGSGTV--YKAELAN---GATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKL 1008
+G G G V Y + AN G VAVK + + + +E+ L + H ++VK
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71
Query: 1009 MGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKI-AVGLAQGVEY 1067
G C +G LI EY+ GS+ D+L K +N+ A+L + A + +G+ Y
Sbjct: 72 KGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNL---------AQLLLFAQQICEGMAY 122
Query: 1068 LHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDY-----NSNTESNT-WFAG 1121
LH +HRD+ + N+LLD++ +GDFGLAKA+ E + + +S W+
Sbjct: 123 LHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-- 177
Query: 1122 SYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS---GKMPTDATFGVEMDMVRWVEMHME 1178
A E K + DV+S G+ L EL++ K F EM + +
Sbjct: 178 -----AVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKF-EEMIGPK----QGQ 227
Query: 1179 MSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNVFN 1236
M+ ELL+ M+ LP + +V + C +T + RP+ R + +L + +
Sbjct: 228 MTVVRLIELLERGMR--LPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMHH 283
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 95.3 bits (237), Expect = 2e-21
Identities = 72/290 (24%), Positives = 135/290 (46%), Gaps = 50/290 (17%)
Query: 953 IIGSGGSGTVYKA-ELANGATVAVKKIS-CK----DDHLLNKSFTREVKTLGRIRHRHLV 1006
+G+G + Y+A ++ G +AVK+++ + + + ++ +E++ + R+ H H++
Sbjct: 7 QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66
Query: 1007 KLMGHCCNKGAGSNLLIYEYMENGSVWDWLHK-----QPVNIKMRKSLDWEARLKIAVGL 1061
+++G C NL + E+M GSV L K + V I + L
Sbjct: 67 RMLGATCEDS-HFNLFV-EWMAGGSVSHLLSKYGAFKEAVIINYTEQL------------ 112
Query: 1062 AQGVEYLHHDCVPKILHRDIKSSNILLDSN-MEAHLGDFGLAKALVEDYNSNTESNTWFA 1120
+G+ YLH + +I+HRD+K +N+L+DS + DFG A L E
Sbjct: 113 LRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLL 169
Query: 1121 GSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEM- 1179
G+ ++APE + CDV+S+G V++E+ + K P +A H+ +
Sbjct: 170 GTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEK---------HSNHLALI 220
Query: 1180 --SGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQV 1227
SA P +P E + + ++ L+C + P++RP SR++
Sbjct: 221 FKIASATT-------APSIP--EHLSPGLRDVTLRCLELQPEDRPPSREL 261
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 93.2 bits (232), Expect = 7e-21
Identities = 74/290 (25%), Positives = 124/290 (42%), Gaps = 47/290 (16%)
Query: 954 IGSGGSGTVYKAELANGA----TVAVKKISCKDDHLLN--KSFTREVKTLGRIRHRHLVK 1007
+G G G V + E + VAVK + K D L + F +E + + H +L++
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCL--KSDKLSDIMDDFLKEAAIMHSLDHENLIR 60
Query: 1008 LMGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSL-DWEARLKIAVGLAQGVE 1066
L G +++ E GS+ D L K + + +L D+ AV +A G+
Sbjct: 61 LYGVVLTH---PLMMVTELAPLGSLLDRLRKDALGHFLISTLCDY------AVQIANGMR 111
Query: 1067 YLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVED---YNSNTESNTWFAGSY 1123
YL + +HRD+ + NILL S+ + +GDFGL +AL ++ Y FA
Sbjct: 112 YLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFA--- 165
Query: 1124 GYIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMVRWVEMHMEMSGS 1182
+ APE + + DV+ G+ L E+ + G+ P W +SGS
Sbjct: 166 -WCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEP-------------WA----GLSGS 207
Query: 1183 AREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLL 1232
+ +D + L E + + LQC +P +RP+ + + L
Sbjct: 208 QILKKIDKE-GERLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.5 bits (233), Expect = 8e-21
Identities = 69/215 (32%), Positives = 101/215 (46%), Gaps = 36/215 (16%)
Query: 954 IGSGGSGTVYKA-ELANGATVAVKKI---SCKDDHLLNKSFTREVKTLGRIRHRHLVKLM 1009
IG G G VYKA + VA+K I +D+ +E++ L + R ++ K
Sbjct: 9 IGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIED---IQQEIQFLSQCRSPYITKYY 65
Query: 1010 GHCCNKGAGSNL-LIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQ---GV 1065
G GS L +I EY GS D L ++ IA L + G+
Sbjct: 66 GSFLK---GSKLWIIMEYCGGGSCLDLLKPGKLDET-----------YIAFILREVLLGL 111
Query: 1066 EYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTES--NTWFAGSY 1123
EYLH + +HRDIK++NILL + L DFG++ L ++T S NT F G+
Sbjct: 112 EYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQL-----TSTMSKRNT-FVGTP 162
Query: 1124 GYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMP 1158
++APE EK D++S+GI +EL G+ P
Sbjct: 163 FWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPP 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 93.4 bits (233), Expect = 9e-21
Identities = 60/229 (26%), Positives = 99/229 (43%), Gaps = 38/229 (16%)
Query: 953 IIGSGGSGTVYKA-ELANGATVAVKKISCKDDHLL--NK--SFTREVKTLGRI-RHRHLV 1006
IIG G TV A E A+K + + L+ K E + L R+ H ++
Sbjct: 8 IIGEGSFSTVVLAKEKETNKEYAIKILDKR--QLIKEKKVKYVKIEKEVLTRLNGHPGII 65
Query: 1007 KLMGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVE 1066
KL + + + + EY NG + ++ K SLD + A + +E
Sbjct: 66 KL--YYTFQDEENLYFVLEYAPNGELLQYIRK-------YGSLDEKCTRFYAAEILLALE 116
Query: 1067 YLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTW-------- 1118
YLH I+HRD+K NILLD +M + DFG AK L + +S +
Sbjct: 117 YLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVL-DPNSSPESNKGDATNIDSQI 172
Query: 1119 ---------FAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMP 1158
F G+ Y++PE A + D++++G ++ ++++GK P
Sbjct: 173 EKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 97.6 bits (243), Expect = 1e-20
Identities = 59/164 (35%), Positives = 85/164 (51%), Gaps = 15/164 (9%)
Query: 748 LRLSNNSLNGVIPLEIGQLQNLQSILDLSHNNFTGQIPPSMGTLAKLEVLNLSHNQLVGE 807
L L N L G IP +I +L++LQSI +LS N+ G IPPS+G++ LEVL+LS+N G
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSI-NLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGS 481
Query: 808 LPSQLGEMSSLGKLNLSYNDLQGKLSKQFS----HWPAEAFEGNLHLCGSP-LDHCNGLV 862
+P LG+++SL LNL+ N L G++ H + F N LCG P L C
Sbjct: 482 IPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPGLRACG--- 538
Query: 863 SNQHQSTISVSLVVAISVISTLSAIALLIAVVTLFVKRKREFLR 906
+SV + I+ A L+ + KR++ LR
Sbjct: 539 -----PHLSVGAKIGIA-FGVSVAFLFLVICAMCWWKRRQNILR 576
|
Length = 623 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.2 bits (232), Expect = 1e-20
Identities = 62/210 (29%), Positives = 98/210 (46%), Gaps = 27/210 (12%)
Query: 954 IGSGGSGTVYKA-ELANGATVAVKKISCK-DDHLLNKSFTREVKTLGRIRHRHLVKLMGH 1011
IG G G VYKA + G VA+KKI + + + K+ RE+K L + H +++KL+
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 1012 CCNKGAGSNL-LIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLK-IAVGLAQGVEYLH 1069
+L L++E+M+ IK R+ E+ +K L QG+ + H
Sbjct: 67 F---RHKGDLYLVFEFMD--------TDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH 115
Query: 1070 HDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTE--SNTWFAGSYGYIA 1127
ILHRD+K N+L+++ L DFGLA++ T W Y A
Sbjct: 116 SH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRW------YRA 166
Query: 1128 PEYAYSLKA-TEKCDVYSMGIVLMELVSGK 1156
PE K + D++S+G + EL+S +
Sbjct: 167 PELLLGDKGYSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 2e-20
Identities = 82/312 (26%), Positives = 136/312 (43%), Gaps = 55/312 (17%)
Query: 935 DFRWEDIMGATNNLSDEFIIGSGGSGTVYKAELANG-------ATVAVKKISCKDDHLLN 987
D +WE NNLS +G+G G V +A A G VAVK +
Sbjct: 27 DLKWE---FPRNNLSFGKTLGAGAFGKVVEAT-AYGLSKSDAVMKVAVKMLKPTAHSSER 82
Query: 988 KSFTREVKTLGRI-RHRHLVKLMGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMR 1046
++ E+K + + H ++V L+G C G G L+I EY G + ++L + K
Sbjct: 83 EALMSELKIMSHLGNHENIVNLLG-ACTIG-GPILVITEYCCYGDLLNFLRR-----KRE 135
Query: 1047 KSLDWEARLKIAVGLAQGVEYL-HHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKAL 1105
L E L + +A+G+ +L +C+ HRD+ + N+LL + DFGLA+ +
Sbjct: 136 SFLTLEDLLSFSYQVAKGMAFLASKNCI----HRDLAARNVLLTHGKIVKICDFGLARDI 191
Query: 1106 VEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS------GKMPT 1159
+ D N + N ++APE ++ T + DV+S GI+L E+ S MP
Sbjct: 192 MNDSNYVVKGNARL--PVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPV 249
Query: 1160 DATFGVEMDMVRWVEMHMEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQ 1219
D+ F +L+ + + P E A ++ +I C P
Sbjct: 250 DSKF---------------------YKLIKEGYRMAQP--EHAPAEIYDIMKTCWDADPL 286
Query: 1220 ERPSSRQVCDLL 1231
+RP+ +Q+ L+
Sbjct: 287 KRPTFKQIVQLI 298
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.0 bits (229), Expect = 2e-20
Identities = 80/287 (27%), Positives = 127/287 (44%), Gaps = 46/287 (16%)
Query: 954 IGSGGSGTVYKA--ELANGA--TVAVKKISCKDDHLLN--KSFTREVKTLGRIRHRHLVK 1007
+G G G+V K + +G VAVK + K +H+ K F RE + ++ H +V+
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTL--KQEHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 1008 LMGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEY 1067
L+G C KG +L+ E G + +L K+ I + + A +A G+ Y
Sbjct: 61 LIGVC--KGEPL-MLVMELAPLGPLLKYLKKRR-EIPVSDLKEL------AHQVAMGMAY 110
Query: 1068 LHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALV--EDYNSNTESNTWFAGSYGY 1125
L +HRD+ + N+LL + +A + DFG+++AL DY T + W Y
Sbjct: 111 LESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWY-- 165
Query: 1126 IAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMVRWVEMHMEMSGSAR 1184
APE K + K DV+S G+ L E S G P + EM G+
Sbjct: 166 -APECINYGKFSSKSDVWSYGVTLWEAFSYGAKP-----------------YGEMKGAEV 207
Query: 1185 EELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLL 1231
+L + + L EEC + I L C K P++RP+ ++
Sbjct: 208 IAML-ESGERLPRPEECPQE-IYSIMLSCWKYRPEDRPTFSELESTF 252
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 3e-20
Identities = 76/280 (27%), Positives = 133/280 (47%), Gaps = 42/280 (15%)
Query: 953 IIGSGGSGTVYKAELANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHC 1012
IIG G G V + E G VAVK I C + ++F E + ++ H++LV+L+G
Sbjct: 13 IIGEGEFGAVLQGEYT-GQKVAVKNIKCD---VTAQAFLEETAVMTKLHHKNLVRLLGVI 68
Query: 1013 CNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDC 1072
+ G ++ E M G++ ++L + R + L+ ++ +A+G+EYL
Sbjct: 69 LHNGL---YIVMELMSKGNLVNFLRT-----RGRALVSVIQLLQFSLDVAEGMEYLESK- 119
Query: 1073 VPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAY 1132
K++HRD+ + NIL+ + A + DFGLA+ +++ W APE
Sbjct: 120 --KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVKW-------TAPEALK 170
Query: 1133 SLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMVRWVEMHMEMSGSAREELLDDQ 1191
K + K DV+S G++L E+ S G+ P + +MS +E ++
Sbjct: 171 HKKFSSKSDVWSYGVLLWEVFSYGRAP-----------------YPKMSLKEVKECVEKG 213
Query: 1192 MKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLL 1231
+ + P E C A V + C +T P++RPS ++ + L
Sbjct: 214 YR-MEPPEGCPA-DVYVLMTSCWETEPKKRPSFHKLREKL 251
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.6 bits (228), Expect = 3e-20
Identities = 66/215 (30%), Positives = 100/215 (46%), Gaps = 32/215 (14%)
Query: 954 IGSGGSGTVYKA-ELANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHC 1012
IGSG G VYKA ++A G VA+K I + + +E+ L RH ++V G
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDF-EIIQQEISMLKECRHPNIVAYFG-- 67
Query: 1013 CNKGAGSNLLI-YEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIA---VGLAQGVEYL 1068
+ L I EY GS+ D R L + L+IA +G+ YL
Sbjct: 68 -SYLRRDKLWIVMEYCGGGSLQDIYQV------TRGPL---SELQIAYVCRETLKGLAYL 117
Query: 1069 HHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTES--NTWFAGSYGYI 1126
H +HRDIK +NILL + + L DFG++ L + T + + F G+ ++
Sbjct: 118 HET---GKIHRDIKGANILLTEDGDVKLADFGVSAQL-----TATIAKRKS-FIGTPYWM 168
Query: 1127 APEYAYSLKA---TEKCDVYSMGIVLMELVSGKMP 1158
APE A + KCD++++GI +EL + P
Sbjct: 169 APEVAAVERKGGYDGKCDIWALGITAIELAELQPP 203
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 91.9 bits (228), Expect = 3e-20
Identities = 81/278 (29%), Positives = 131/278 (47%), Gaps = 34/278 (12%)
Query: 953 IIGSGGSGTVYKA-ELANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGH 1011
I+G G GTVYKA L +AVK I L K E++ L + +++ G
Sbjct: 8 ILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGA 67
Query: 1012 CCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHD 1071
+ S + E+M+ GS+ D K P ++ R IAV + +G+ YL
Sbjct: 68 FFVENRIS--ICTEFMDGGSL-DVYRKIPEHVLGR----------IAVAVVKGLTYLWS- 113
Query: 1072 CVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYA 1131
KILHRD+K SN+L+++ + L DFG++ LV N+ + T + G+ Y+APE
Sbjct: 114 --LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLV-----NSIAKT-YVGTNAYMAPERI 165
Query: 1132 YSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSAREELLDDQ 1191
+ DV+S+GI MEL G+ P + + M +++ + + D+
Sbjct: 166 SGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSL-----MPLQLL-----QCIVDE 215
Query: 1192 MKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCD 1229
P+LP + + V I QC + P+ERP+ + D
Sbjct: 216 DPPVLPVGQFSEKFVHFIT-QCMRKQPKERPAPENLMD 252
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.0 bits (229), Expect = 3e-20
Identities = 78/293 (26%), Positives = 122/293 (41%), Gaps = 40/293 (13%)
Query: 954 IGSGGSGTVYKA-ELANGATVAVKKI-SCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGH 1011
+G G G V K A G VA+KK +DD + K+ REVK L ++RH ++V L
Sbjct: 9 VGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEA 68
Query: 1012 CCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHD 1071
+ G L++EY+E ++ + L P L +A L Q + Y H
Sbjct: 69 F--RRKGRLYLVFEYVER-TLLELLEASP------GGLPPDAVRSYIWQLLQAIAYCHSH 119
Query: 1072 CVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSN-TE--SNTWFAGSYGYIAP 1128
I+HRDIK NIL+ + L DFG A+AL S T+ + W Y AP
Sbjct: 120 ---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRW------YRAP 170
Query: 1129 EYAYSLKATE---KCDVYSMGIVLMELVS------GKMPTDATFGVEMDMVRWVEMHMEM 1179
E + T DV+++G ++ EL+ G D + ++ + H E+
Sbjct: 171 ELL--VGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQEL 228
Query: 1180 SGS----AREELLD-DQMKPLLPGEECA-AYQVLEIALQCTKTSPQERPSSRQ 1226
S A + Q + L + L+ C + P+ER + +
Sbjct: 229 FSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDE 281
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 4e-20
Identities = 69/281 (24%), Positives = 125/281 (44%), Gaps = 38/281 (13%)
Query: 954 IGSGGSGTVYKAELANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCC 1013
+GSG G V+ + VA+K I ++ + F E K + ++ H +LV+L G C
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMI--REGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCT 69
Query: 1014 NKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCV 1073
+ ++ EYM NG + ++L ++ + E L + + + +EYL +
Sbjct: 70 KQR--PIFIVTEYMANGCLLNYLRERKGKLGT------EWLLDMCSDVCEAMEYLESNGF 121
Query: 1074 PKILHRDIKSSNILLDSNMEAHLGDFGLAKALVED-YNSNTESNTWFAGSYGYIAPEYAY 1132
+HRD+ + N L+ + + DFGLA+ +++D Y S+ T F + PE
Sbjct: 122 ---IHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQ--GTKFPVKWA--PPEVFD 174
Query: 1133 SLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMVRWVEMHMEMSGSAREELLDDQ 1191
+ + K DV+S G+++ E+ S GKMP + R+ S E +
Sbjct: 175 YSRFSSKSDVWSFGVLMWEVFSEGKMPYE----------RF---------SNSEVVESVS 215
Query: 1192 MKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLL 1232
L + A +V I C P++RP+ +++ L
Sbjct: 216 AGYRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQLT 256
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 2e-19
Identities = 74/280 (26%), Positives = 119/280 (42%), Gaps = 51/280 (18%)
Query: 954 IGSGGSGTVYKAELANGATVAVKKISCKDD--HLLNKSFTREVKTLGRIRHRHLVKLMGH 1011
IG G G VYK L VAVK +C+ L + F +E + L + H ++VKL+G
Sbjct: 3 IGKGNFGDVYKGVLKGNTEVAVK--TCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGV 60
Query: 1012 CCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHD 1071
C K ++ E + GS+ +L K+ + ++K L++++ A G+EYL
Sbjct: 61 CVQK--QPIYIVMELVPGGSLLTFLRKKKNRLTVKK------LLQMSLDAAAGMEYLESK 112
Query: 1072 CVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYG------- 1124
+HRD+ + N L+ N + DFG+ S E + S G
Sbjct: 113 NC---IHRDLAARNCLVGENNVLKISDFGM---------SREEEGGIYTVSDGLKQIPIK 160
Query: 1125 YIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMVRWVEMHMEMSGSA 1183
+ APE + T + DV+S GI+L E S G P + MS
Sbjct: 161 WTAPEALNYGRYTSESDVWSYGILLWETFSLGDTP-----------------YPGMSNQQ 203
Query: 1184 REELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPS 1223
E ++ + +P + ++ + LQC P+ RPS
Sbjct: 204 TRERIESGYR--MPAPQLCPEEIYRLMLQCWAYDPENRPS 241
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 89.0 bits (220), Expect = 3e-19
Identities = 78/279 (27%), Positives = 134/279 (48%), Gaps = 38/279 (13%)
Query: 947 NLSDEFIIGSGGSGTVYKAELANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLV 1006
+L E +G G G V+ VA+K + K + ++F +E + + ++RH LV
Sbjct: 7 SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL--KPGTMSPEAFLQEAQVMKKLRHEKLV 64
Query: 1007 KLMGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVN-IKMRKSLDWEARLKIAVGLAQGV 1065
+L + ++ EYM GS+ D+L + +++ + +D A +IA G+A V
Sbjct: 65 QLYAVVSEEPI---YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAA--QIASGMAY-V 118
Query: 1066 EYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGY 1125
E +++ +HRD++++NIL+ N+ + DFGLA+ L+ED F +
Sbjct: 119 ERMNY------VHRDLRAANILVGENLVCKVADFGLAR-LIEDNEYTARQGAKF--PIKW 169
Query: 1126 IAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMVRWVEMHMEMSGSAR 1184
APE A + T K DV+S GI+L EL + G++P V +++ VE M
Sbjct: 170 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM--VNREVLDQVERGYRM----- 222
Query: 1185 EELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPS 1223
P P EC + ++ QC + P+ERP+
Sbjct: 223 ---------PCPP--ECPE-SLHDLMCQCWRKEPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 89.2 bits (222), Expect = 4e-19
Identities = 66/229 (28%), Positives = 103/229 (44%), Gaps = 62/229 (27%)
Query: 954 IGSGGSGTVYKAE-LANGATVAVKKISC----KDDHLLNKSFTREVKTLGRIRHRHLVKL 1008
+G G VYKA G VA+KKI + +N + RE+K L ++H +++ L
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGL 67
Query: 1009 M---GHCCNKGAGSNL-LIYEYMENGSVWDWLHK---------QPVNIK--MRKSLDWEA 1053
+ GH SN+ L++E+ME D L K P +IK M +L
Sbjct: 68 LDVFGH------KSNINLVFEFME----TD-LEKVIKDKSIVLTPADIKSYMLMTL---- 112
Query: 1054 RLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNT 1113
+G+EYLH + ILHRD+K +N+L+ S+ L DFGLA++ + N
Sbjct: 113 ---------RGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFG---SPNR 157
Query: 1114 ESNT-----WFAGSYGYIAPEYAYSLKA-TEKCDVYSMGIVLMELVSGK 1156
+ W Y APE + + D++S+G + EL+
Sbjct: 158 KMTHQVVTRW------YRAPELLFGARHYGVGVDMWSVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 88.6 bits (220), Expect = 5e-19
Identities = 70/222 (31%), Positives = 103/222 (46%), Gaps = 25/222 (11%)
Query: 946 NNLSDEFIIGSGGSGTVYKAELANGATV-AVKKISCKDDHLLNKSFTREVKTLGRIRH-R 1003
+L D IG G GTV K T+ AVK+I D K ++ + R
Sbjct: 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCP 63
Query: 1004 HLVKLMGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQ 1063
++VK G +G + E M+ D +K V ++ + E KIAV +
Sbjct: 64 YIVKFYGALFREG--DCWICMELMD--ISLDKFYKY-VYEVLKSVIPEEILGKIAVATVK 118
Query: 1064 GVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSY 1123
+ YL + KI+HRD+K SNILLD N L DFG++ LV ++ + T AG
Sbjct: 119 ALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLV-----DSIAKTRDAGCR 171
Query: 1124 GYIAPEY-------AYSLKATEKCDVYSMGIVLMELVSGKMP 1158
Y+APE Y +++ DV+S+GI L E+ +GK P
Sbjct: 172 PYMAPERIDPSARDGYDVRS----DVWSLGITLYEVATGKFP 209
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 5e-19
Identities = 77/272 (28%), Positives = 128/272 (47%), Gaps = 38/272 (13%)
Query: 954 IGSGGSGTVYKAELANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCC 1013
+G+G G V+ VAVK + K + +SF E + + ++RH LV+L
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTL--KPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS 71
Query: 1014 NKGAGSNLLIYEYMENGSVWDWLHK-QPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDC 1072
+ ++ EYM GS+ D+L + +K+ +D A ++A G+A +E +++
Sbjct: 72 EEPI---YIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAA--QVAAGMAY-IERMNY-- 123
Query: 1073 VPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAY 1132
+HRD++S+NIL+ + + DFGLA+ L+ED F + APE A
Sbjct: 124 ----IHRDLRSANILVGDGLVCKIADFGLAR-LIEDNEYTARQGAKF--PIKWTAPEAAL 176
Query: 1133 SLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMVRWVEMHMEMSGSAREELLDDQ 1191
+ T K DV+S GI+L ELV+ G++P + RE L +
Sbjct: 177 YGRFTIKSDVWSFGILLTELVTKGRVPYPGM-------------------NNREVLEQVE 217
Query: 1192 MKPLLPGEECAAYQVLEIALQCTKTSPQERPS 1223
+P + + E+ LQC K P+ERP+
Sbjct: 218 RGYRMPCPQDCPISLHELMLQCWKKDPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 5e-19
Identities = 64/211 (30%), Positives = 102/211 (48%), Gaps = 18/211 (8%)
Query: 953 IIGSGGSGTVYKA-ELANGATVAVKKIS-CKDDHLLNK---SFTREVKTLGRIRHRHLVK 1007
++G G G VY ++ G +AVK++ D K + E++ L ++H +V+
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68
Query: 1008 LMGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEY 1067
G C + + + EYM GSV D +K +L K + +GVEY
Sbjct: 69 YYG--CLRDDETLSIFMEYMPGGSVKD-------QLKAYGALTETVTRKYTRQILEGVEY 119
Query: 1068 LHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIA 1127
LH + I+HRDIK +NIL DS LGDFG +K L +S T + G+ +++
Sbjct: 120 LHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKS-VTGTPYWMS 175
Query: 1128 PEYAYSLKATEKCDVYSMGIVLMELVSGKMP 1158
PE K DV+S+G ++E+++ K P
Sbjct: 176 PEVISGEGYGRKADVWSVGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 7e-19
Identities = 78/287 (27%), Positives = 136/287 (47%), Gaps = 42/287 (14%)
Query: 954 IGSGGSGTVYKAELAN-GATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHC 1012
+G G G VY+ TVAVK + K+D + + F +E + I+H +LV+L+G C
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTL--KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 71
Query: 1013 CNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDC 1072
+ +I E+M G++ D+L + R+ ++ L +A ++ +EYL
Sbjct: 72 TREPP--FYIITEFMTYGNLLDYLRECN-----RQEVNAVVLLYMATQISSAMEYLEKK- 123
Query: 1073 VPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGS---YGYIAPE 1129
+HRD+ + N L+ N + DFGL++ + D + T AG+ + APE
Sbjct: 124 --NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD------TYTAHAGAKFPIKWTAPE 175
Query: 1130 -YAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSAREELL 1188
AY+ K + K DV++ G++L E+ AT+G M +++ S ELL
Sbjct: 176 SLAYN-KFSIKSDVWAFGVLLWEI--------ATYG--MSPYPGIDL------SQVYELL 218
Query: 1189 DDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNVF 1235
+ + P E C +V E+ C + +P +RPS ++ +F
Sbjct: 219 EKGYRMERP-EGCPP-KVYELMRACWQWNPSDRPSFAEIHQAFETMF 263
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 87.4 bits (217), Expect = 8e-19
Identities = 54/212 (25%), Positives = 86/212 (40%), Gaps = 26/212 (12%)
Query: 953 IIGSGGSGTVYKAELANGATVAVKKISCKDDHLLNKS---FTREVKTLGRIRHRHLVKLM 1009
+IG G G V + + + K K + S E + L + H LV L
Sbjct: 7 VIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLW 66
Query: 1010 GHCCNKGAGSNL-LIYEYMENGSV-WDWLHKQPVNIKMRKSLDWEARLKI-AVGLAQGVE 1066
+ N+ L+ + + G + + K + E ++K + +E
Sbjct: 67 YSFQD---EENMYLVVDLLLGGDLRYHLSQKVKFS---------EEQVKFWICEIVLALE 114
Query: 1067 YLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYI 1126
YLH I+HRDIK NILLD H+ DF +A + D + + S G+ GY+
Sbjct: 115 YLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTS-----GTPGYM 166
Query: 1127 APEYAYSLKATEKCDVYSMGIVLMELVSGKMP 1158
APE + D +S+G+ E + GK P
Sbjct: 167 APEVLCRQGYSVAVDWWSLGVTAYECLRGKRP 198
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 1e-18
Identities = 73/274 (26%), Positives = 127/274 (46%), Gaps = 42/274 (15%)
Query: 954 IGSGGSGTVYKAELANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCC 1013
+G+G G V+ A VAVK + K + ++F E + ++H LVKL
Sbjct: 14 LGAGQFGEVWMATYNKHTKVAVKTM--KPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT 71
Query: 1014 NKGAGSNLLIYEYMENGSVWDWLHKQPVN-IKMRKSLDWEARLKIAVGLAQGVEYLHHDC 1072
+ +I E+M GS+ D+L + + K +D+ A++ A+G+ ++
Sbjct: 72 KEPI---YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQI------AEGMAFIEQR- 121
Query: 1073 VPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAY 1132
+HRD++++NIL+ +++ + DFGLA+ ++ED F + APE
Sbjct: 122 --NYIHRDLRAANILVSASLVCKIADFGLAR-VIEDNEYTAREGAKF--PIKWTAPEAIN 176
Query: 1133 SLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMVRWVE--MHMEMSGSAREELLD 1189
T K DV+S GI+LME+V+ G++P E ++R +E M + EEL +
Sbjct: 177 FGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE--VIRALERGYRMPRPENCPEELYN 234
Query: 1190 DQMKPLLPGEECAAYQVLEIALQCTKTSPQERPS 1223
I ++C K P+ERP+
Sbjct: 235 -------------------IMMRCWKNRPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 1e-18
Identities = 75/287 (26%), Positives = 116/287 (40%), Gaps = 60/287 (20%)
Query: 953 IIGSGGSGTVYKA-ELANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRH---RHLVKL 1008
+IG G G VY+ + G VA+K I+ REV L ++R ++ K
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67
Query: 1009 MGHCCNKGAGSNL-LIYEYMENGSVWDWLHKQPVNIK-----MRKSLDWEARLKIAVGLA 1062
G G L +I EY E GSV + P+ K +R+ L
Sbjct: 68 YGSYLK---GPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVL------------- 111
Query: 1063 QGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGS 1122
++Y+H ++HRDIK++NIL+ + L DFG+A L N N+ + F G+
Sbjct: 112 VALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALL----NQNSSKRSTFVGT 164
Query: 1123 YGYIAPEY-----AYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHM 1177
++APE Y KA D++S+GI + E+ +G P V+
Sbjct: 165 PYWMAPEVITEGKYYDTKA----DIWSLGITIYEMATGNPPYSD-----------VDAFR 209
Query: 1178 EMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSS 1224
M L+ P L + + E C P+ER S+
Sbjct: 210 AM------MLIPKSKPPRLEDNGYSK-LLREFVAACLDEEPKERLSA 249
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 1e-18
Identities = 64/223 (28%), Positives = 101/223 (45%), Gaps = 26/223 (11%)
Query: 953 IIGSGGSGTVYKA----ELANGAT-VAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVK 1007
++GSG GTVYK E VA+K + + NK E + + H H+V+
Sbjct: 14 VLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVR 73
Query: 1008 LMGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEY 1067
L+G C + LI + M G + D++ NI + L+W V +A+G+ Y
Sbjct: 74 LLGICLSS---QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNW------CVQIAKGMSY 124
Query: 1068 LHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGS---YG 1124
L +++HRD+ + N+L+ + + DFGLAK L D E G
Sbjct: 125 LEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVD-----EKEYHAEGGKVPIK 176
Query: 1125 YIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVE 1166
++A E T K DV+S G+ + EL++ G P + VE
Sbjct: 177 WMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE 219
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 1e-18
Identities = 84/281 (29%), Positives = 126/281 (44%), Gaps = 48/281 (17%)
Query: 954 IGSGGSGTVYKA-ELANGATVAVKKISCKDDHLLNK--SFTREVKTLGRIRHRHLVKLMG 1010
IG G G VY A ++ VA+KK+S K +EV+ L ++RH + ++ G
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKG 82
Query: 1011 HCCNKGAGSNLLIYEYMENGSVWDWL--HKQPVNIKMRKSLDWEARLKIAVGLAQGVEYL 1068
C + L+ EY GS D L HK+P+ + ++ A I G QG+ YL
Sbjct: 83 --CYLREHTAWLVMEYCL-GSASDILEVHKKPL-----QEVEIAA---ICHGALQGLAYL 131
Query: 1069 HHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAP 1128
H +HRDIK+ NILL L DFG A +LV NS F G+ ++AP
Sbjct: 132 HSHER---IHRDIKAGNILLTEPGTVKLADFGSA-SLVSPANS-------FVGTPYWMAP 180
Query: 1129 EYAYSL---KATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSARE 1185
E ++ + K DV+S+GI +EL K P M+ + + H+ + S
Sbjct: 181 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPL-----FNMNAMSAL-YHIAQNDS--- 231
Query: 1186 ELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQ 1226
P L + + Y + C + PQ+RPSS +
Sbjct: 232 --------PTLSSNDWSDYFRNFVDS-CLQKIPQDRPSSEE 263
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.6 bits (215), Expect = 2e-18
Identities = 71/217 (32%), Positives = 98/217 (45%), Gaps = 23/217 (10%)
Query: 953 IIGSGGSGTVYKA-ELANGATVAVKKISCKDDHLLNKSFTREVKTLGRI-RHRHLVKLMG 1010
+IG G G VYKA G VA+K + +D + E L + H ++ G
Sbjct: 13 VIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDE--EEEIKEEYNILRKYSNHPNIATFYG 70
Query: 1011 HCCNK---GAGSNL-LIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVE 1066
K G L L+ E GSV D L K R +W A I +G+
Sbjct: 71 AFIKKNPPGNDDQLWLVMELCGGGSVTD-LVKGLRKKGKRLKEEWIAY--ILRETLRGLA 127
Query: 1067 YLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYI 1126
YLH + K++HRDIK NILL N E L DFG++ L ++ NT F G+ ++
Sbjct: 128 YLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLD---STLGRRNT-FIGTPYWM 180
Query: 1127 APEY---AYSLKAT--EKCDVYSMGIVLMELVSGKMP 1158
APE A+ + DV+S+GI +EL GK P
Sbjct: 181 APEVIACDEQPDASYDARSDVWSLGITAIELADGKPP 217
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 3e-18
Identities = 62/217 (28%), Positives = 109/217 (50%), Gaps = 30/217 (13%)
Query: 954 IGSGGSGTVYKAE-LANGATVAVKKISCKDDHLLNK----SFTREVKTLGRIRHRHLVKL 1008
+G G G+VYK + L++ A+K++ D +++ E++ L + H +++
Sbjct: 8 LGKGSYGSVYKVKRLSDNQFYALKEV---DLGSMSQKEREDAVNEIRILASVNHPNII-- 62
Query: 1009 MGHCCNKGA---GSNLLI-YEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQG 1064
K A G+ L I EY G + + K+ K RK + + +I + L +G
Sbjct: 63 ----SYKEAFLDGNKLCIVMEYAPFGDLSKAISKRK---KKRKLIPEQEIWRIFIQLLRG 115
Query: 1065 VEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYG 1124
++ LH KILHRD+KS+NILL +N +GD G++K L ++ + T+ T
Sbjct: 116 LQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKNM-AKTQIGTPH----- 166
Query: 1125 YIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDA 1161
Y+APE + K D++S+G +L E+ + P +A
Sbjct: 167 YMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEA 203
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 86.4 bits (215), Expect = 5e-18
Identities = 72/225 (32%), Positives = 107/225 (47%), Gaps = 48/225 (21%)
Query: 953 IIGSGGSGTVYKAE-LANGATVAVKKISCKDDHLLN-KSFTREVKTLGRIRHRHLVKLMG 1010
IGSG G V A G VA+KKIS D L++ K RE+K L +RH +++ L+
Sbjct: 7 PIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLL- 65
Query: 1011 HCCNKGAGSNLL----------IY---EYMENGSVWDWLHKQPVNIKMRKSLDWEARLKI 1057
++L +Y E ME D LHK V IK + L +
Sbjct: 66 ---------DILRPPSPEDFNDVYIVTELMET----D-LHK--V-IKSPQPLTDDHIQYF 108
Query: 1058 AVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSN---TE 1114
+ +G++YLH ++HRD+K SNIL++SN + + DFGLA+ + D + TE
Sbjct: 109 LYQILRGLKYLHS---ANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTE 165
Query: 1115 --SNTWFAGSYGYIAPEYAYSLKA-TEKCDVYSMGIVLMELVSGK 1156
W Y APE S T+ D++S+G + EL++ K
Sbjct: 166 YVVTRW------YRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 85.4 bits (212), Expect = 5e-18
Identities = 69/216 (31%), Positives = 104/216 (48%), Gaps = 27/216 (12%)
Query: 954 IGSGGSGTVYKAE-LANGATVAVKKISCKDDHLLNKSFTREVKT----LGRIRHRHLVKL 1008
I G G V+ A+ + G A+K I D ++ K+ +V T L + + ++VKL
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKAD--MIRKNQVDQVLTERDILSQAQSPYVVKL 58
Query: 1009 MGHCCNKGAGSNL-LIYEYMENGSVWDWLHKQPVNIKMRKSLDWE-ARLKIAVGLAQGVE 1066
K NL L+ EY+ G + L SLD + AR+ IA + +E
Sbjct: 59 YYSFQGK---KNLYLVMEYLPGGDLASLLE-------NVGSLDEDVARIYIA-EIVLALE 107
Query: 1067 YLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKA-LVE---DYNSNTESNTWFAGS 1122
YLH + I+HRD+K NIL+DSN L DFGL+K LV + N + + + G+
Sbjct: 108 YLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGT 164
Query: 1123 YGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMP 1158
YIAPE ++ D +S+G +L E + G P
Sbjct: 165 PDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPP 200
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 85.4 bits (212), Expect = 7e-18
Identities = 61/217 (28%), Positives = 100/217 (46%), Gaps = 42/217 (19%)
Query: 954 IGSGGSGTVYKA-ELANGATVAVKKISCKDDHLLNK------SFTREVKTLGRIRHRHLV 1006
IG G G V+KA + G TVA+KK+ L RE+K L +H ++V
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKV-----ALRRLEGGIPNQALREIKALQACQHPYVV 62
Query: 1007 KLM-----GHCCNKGAGSNLLIYEYMENGSVWDWLHK--QPVNIKMRKSLDWEARLKIAV 1059
KL+ G +L+ EYM + + L +P+ KS R+
Sbjct: 63 KLLDVFPHGSGF-------VLVMEYMP-SDLSEVLRDEERPLPEAQVKSY---MRM---- 107
Query: 1060 GLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWF 1119
L +GV Y+H + I+HRD+K +N+L+ ++ + DFGLA+ E+ +
Sbjct: 108 -LLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEE---EPRLYSHQ 160
Query: 1120 AGSYGYIAPEYAY-SLKATEKCDVYSMGIVLMELVSG 1155
+ Y APE Y + K D++++G + EL++G
Sbjct: 161 VATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNG 197
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 1e-17
Identities = 75/276 (27%), Positives = 119/276 (43%), Gaps = 40/276 (14%)
Query: 953 IIGSGGSGTVYKAELANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHC 1012
IG G G V + G VAVK C + ++F E + ++RH +LV+L+G
Sbjct: 13 TIGKGEFGDVMLGDY-RGNKVAVK---CIKNDATAQAFLAEASVMTQLRHSNLVQLLGVI 68
Query: 1013 CNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDC 1072
+ G ++ EYM GS+ D+L + R L + LK ++ + + +EYL +
Sbjct: 69 VEE-KGGLYIVTEYMAKGSLVDYLRS-----RGRSVLGGDCLLKFSLDVCEAMEYLEAN- 121
Query: 1073 VPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAY 1132
+HRD+ + N+L+ + A + DFGL K ++ W APE
Sbjct: 122 --NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKW-------TAPEALR 172
Query: 1133 SLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMVRWVEMHMEMSGSAREELLDDQ 1191
K + K DV+S GI+L E+ S G++P D+V VE +M D
Sbjct: 173 EKKFSTKSDVWSFGILLWEIYSFGRVPYPRI--PLKDVVPRVEKGYKMDAP-------DG 223
Query: 1192 MKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQV 1227
P+ V ++ QC RPS Q+
Sbjct: 224 CPPV----------VYDVMKQCWHLDAATRPSFLQL 249
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 83.8 bits (208), Expect = 1e-17
Identities = 71/219 (32%), Positives = 101/219 (46%), Gaps = 42/219 (19%)
Query: 954 IGSGGSGTVYKAELAN-GATVAVKKISCKDDHLLNKSFT----REVKTLGRIRHRHLVKL 1008
+G GG G V ++ + T A+K + K H++ E + L H +VKL
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCV--KKRHIVETGQQEHIFSEKEILEECNHPFIVKL 58
Query: 1009 MGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLD-WEARLKIA-VGLAQGVE 1066
+ K ++ EY G +W L R D + AR IA V LA E
Sbjct: 59 --YRTFKDKKYIYMLMEYCLGGELWTILRD-------RGLFDEYTARFYIACVVLA--FE 107
Query: 1067 YLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTW-FAGSYGY 1125
YLH+ I++RD+K N+LLDSN L DFG AK L + TW F G+ Y
Sbjct: 108 YLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKL---KSGQ---KTWTFCGTPEY 158
Query: 1126 IAPE------YAYSLKATEKCDVYSMGIVLMELVSGKMP 1158
+APE Y +S D +S+GI+L EL++G+ P
Sbjct: 159 VAPEIILNKGYDFS------VDYWSLGILLYELLTGRPP 191
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 1e-17
Identities = 63/219 (28%), Positives = 113/219 (51%), Gaps = 27/219 (12%)
Query: 953 IIGSGGSGTVYKAELA-NGATVAVKKI--------SCKDDHLLNKSFTREVKTLGRIRHR 1003
+IGSG G+VY A +G +AVK++ S + + RE+ L ++H
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 1004 HLVKLMGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAV-GLA 1062
++V+ +G + A + EY+ GSV L+ + + E ++ V +
Sbjct: 67 NIVQYLG--SSLDADHLNIFLEYVPGGSVAALLN-------NYGAFE-ETLVRNFVRQIL 116
Query: 1063 QGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTW---F 1119
+G+ YLH+ I+HRDIK +NIL+D+ + DFG++K +E + +T++N
Sbjct: 117 KGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKK-LEANSLSTKTNGARPSL 172
Query: 1120 AGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMP 1158
GS ++APE T K D++S+G +++E+++GK P
Sbjct: 173 QGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 2e-17
Identities = 78/298 (26%), Positives = 132/298 (44%), Gaps = 51/298 (17%)
Query: 946 NNLSDEFIIGSGGSGTVYKAELANGA----TVAVK--KISCKDDHLLNKSFTREVKTLGR 999
+ ++ E +IG G G V + L VA+K K D L+ F E +G+
Sbjct: 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLD--FLTEASIMGQ 61
Query: 1000 IRHRHLVKLMGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAV 1059
H ++++L G K ++I EYMENGS+ +L + + +
Sbjct: 62 FDHPNIIRLEG-VVTKSR-PVMIITEYMENGSLDKFLREN------DGKFTVGQLVGMLR 113
Query: 1060 GLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWF 1119
G+A G++YL +HRD+ + NIL++SN+ + DFGL++ +ED + +
Sbjct: 114 GIASGMKYLSEMNY---VHRDLAARNILVNSNLVCKVSDFGLSR-RLEDSEATYTTKG-- 167
Query: 1120 AGSYGYI-----APEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMVRWV 1173
G I APE K T DV+S GIV+ E++S G+ P
Sbjct: 168 ----GKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERP--------------- 208
Query: 1174 EMHMEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLL 1231
+ +MS + ++D + L P +C + + ++ L C + ERP+ Q+ L
Sbjct: 209 --YWDMSNQDVIKAVEDGYR-LPPPMDCPS-ALYQLMLDCWQKDRNERPTFSQIVSTL 262
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 3e-17
Identities = 71/272 (26%), Positives = 123/272 (45%), Gaps = 37/272 (13%)
Query: 954 IGSGGSGTVYKAELANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCC 1013
+G+G G V+ N VAVK + K + ++F E + ++H LV+L +
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTL--KPGTMSVQAFLEEANLMKTLQHDKLVRL--YAV 69
Query: 1014 NKGAGSNLLIYEYMENGSVWDWLHKQP-VNIKMRKSLDWEARLKIAVGLAQGVEYLHHDC 1072
+I EYM GS+ D+L + + K +D+ A++ A+G+ Y+
Sbjct: 70 VTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQI------AEGMAYIERK- 122
Query: 1073 VPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAY 1132
+HRD++++N+L+ ++ + DFGLA+ ++ED F + APE
Sbjct: 123 --NYIHRDLRAANVLVSESLMCKIADFGLAR-VIEDNEYTAREGAKF--PIKWTAPEAIN 177
Query: 1133 SLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMVRWVEMHMEMSGSAREELLDDQ 1191
T K DV+S GI+L E+V+ GK+P + MS S + + Q
Sbjct: 178 FGSFTIKSDVWSFGILLYEIVTYGKIP-----------------YPGMSNS--DVMSALQ 218
Query: 1192 MKPLLPGEECAAYQVLEIALQCTKTSPQERPS 1223
+P E ++ +I C K +ERP+
Sbjct: 219 RGYRMPRMENCPDELYDIMKTCWKEKAEERPT 250
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 3e-17
Identities = 75/273 (27%), Positives = 126/273 (46%), Gaps = 40/273 (14%)
Query: 954 IGSGGSGTVYKAELANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCC 1013
+G+G G V+ VA+K S K + ++F E + +++H LV+L
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIK--SLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT 71
Query: 1014 NKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMR--KSLDWEARLKIAVGLAQGVEYLHHD 1071
+ +I EYMENGS+ D+L K P IK+ K +D A++ A+G+ ++
Sbjct: 72 QEPI---YIITEYMENGSLVDFL-KTPEGIKLTINKLIDMAAQI------AEGMAFIE-- 119
Query: 1072 CVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYA 1131
+HRD++++NIL+ + + DFGLA+ L+ED F + APE
Sbjct: 120 -RKNYIHRDLRAANILVSETLCCKIADFGLAR-LIEDNEYTAREGAKF--PIKWTAPEAI 175
Query: 1132 YSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMVRWVEMHMEMSGSAREELLDD 1190
T K DV+S GI+L E+V+ G++P E +++ +E M
Sbjct: 176 NYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE--VIQNLERGYRM----------- 222
Query: 1191 QMKPLLPGEECAAYQVLEIALQCTKTSPQERPS 1223
P + ++ E+ C K P+ERP+
Sbjct: 223 ------PRPDNCPEELYELMRLCWKEKPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 4e-17
Identities = 77/292 (26%), Positives = 132/292 (45%), Gaps = 38/292 (13%)
Query: 946 NNLSDEFIIGSGGSGTVYKAELA----NGATVAVKKISCKDDHLLNKSFTREVKTLGRIR 1001
++++ + +IG+G G V++ L VA+K + + F E +G+
Sbjct: 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFS 64
Query: 1002 HRHLVKLMGHCCN-KGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVG 1060
H ++++L G K A ++I EYMENG++ +L S L+ G
Sbjct: 65 HHNIIRLEGVVTKFKPA---MIITEYMENGALDKYLRDHDGEFS---SYQLVGMLR---G 115
Query: 1061 LAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFA 1120
+A G++YL +HRD+ + NIL++SN+E + DFGL++ L ED T + +
Sbjct: 116 IAAGMKYLSD---MNYVHRDLAARNILVNSNLECKVSDFGLSRVL-EDDPEGTYTTSGGK 171
Query: 1121 GSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMVRWVEMHMEM 1179
+ APE K T DV+S GIV+ E++S G+ P + +M
Sbjct: 172 IPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERP-----------------YWDM 214
Query: 1180 SGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLL 1231
S + ++D + LP V ++ LQC + RP + +LL
Sbjct: 215 SNHEVMKAINDGFR--LPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLL 264
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 4e-17
Identities = 85/324 (26%), Positives = 126/324 (38%), Gaps = 90/324 (27%)
Query: 954 IGSGGSGTVYKAELANGATV-AVKKISCKDDHLLNKSFTRE-------------VKTLGR 999
IGSG G VYK V AVK++ + NK + VK G
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGY 82
Query: 1000 IRHRHLVK----LMGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARL 1055
V LM C +K LL + P+ E L
Sbjct: 83 FITDSDVFICMELMSTCLDK-----LLK------------RIQGPIP---------EDIL 116
Query: 1056 -KIAVGLAQGVEYL--HHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSN 1112
K+ V + + + YL H ++HRD+K SNILLD++ L DFG++ LV D +
Sbjct: 117 GKMTVAIVKALHYLKEKHG----VIHRDVKPSNILLDASGNVKLCDFGISGRLV-DSKAK 171
Query: 1113 TESNTWFAGSYGYIAPEY--------AYSLKATEKCDVYSMGIVLMELVSGKMPTDATFG 1164
T S AG Y+APE Y ++A DV+S+GI L+EL +G+ P
Sbjct: 172 TRS----AGCAAYMAPERIDPPDPNPKYDIRA----DVWSLGISLVELATGQFPYK---N 220
Query: 1165 VEMDMVRWVEMHMEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSS 1224
+ + E+ ++ +EE P LP E + C ++RP
Sbjct: 221 CKTEF----EV---LTKILQEEP------PSLPPNEGFSPDFCSFVDLCLTKDHRKRPKY 267
Query: 1225 RQVCDLLLNVFNNRIVDFDKLHID 1248
R+ LL + F I ++ +D
Sbjct: 268 RE---LLQHPF---IRRYETAEVD 285
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 6e-17
Identities = 75/279 (26%), Positives = 131/279 (46%), Gaps = 38/279 (13%)
Query: 947 NLSDEFIIGSGGSGTVYKAELANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLV 1006
+L + +G G G V+ VA+K + K ++ ++F +E + + ++RH LV
Sbjct: 7 SLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTL--KPGTMMPEAFLQEAQIMKKLRHDKLV 64
Query: 1007 KLMGHCCNKGAGSNLLIYEYMENGSVWDWLHK-QPVNIKMRKSLDWEARLKIAVGLAQGV 1065
L + ++ E+M GS+ D+L + +K+ + +D A +IA G+A +
Sbjct: 65 PLYAVVSEEPI---YIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAA--QIADGMAY-I 118
Query: 1066 EYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGY 1125
E +++ +HRD++++NIL+ N+ + DFGLA+ L+ED F +
Sbjct: 119 ERMNY------IHRDLRAANILVGDNLVCKIADFGLAR-LIEDNEYTARQGAKF--PIKW 169
Query: 1126 IAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMVRWVEMHMEMSGSAR 1184
APE A + T K DV+S GI+L ELV+ G++P V +++ VE M
Sbjct: 170 TAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGM--VNREVLEQVERGYRM----- 222
Query: 1185 EELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPS 1223
P + + E+ C K P ERP+
Sbjct: 223 ------------PCPQGCPESLHELMKLCWKKDPDERPT 249
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 8e-17
Identities = 63/214 (29%), Positives = 106/214 (49%), Gaps = 21/214 (9%)
Query: 953 IIGSGGSGTVYKAELAN-GATVAVKK-ISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMG 1010
++G G G V K + G VA+KK + +DD ++ K RE++ L ++RH +LV L+
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67
Query: 1011 HCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHH 1070
K L++E++++ +V D L K P LD K + +G+E+ H
Sbjct: 68 VFRRKK--RLYLVFEFVDH-TVLDDLEKYP------NGLDESRVRKYLFQILRGIEFCHS 118
Query: 1071 DCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEY 1130
I+HRDIK NIL+ + L DFG A+ L + E T + + Y APE
Sbjct: 119 H---NIIHRDIKPENILVSQSGVVKLCDFGFARTL----AAPGEVYTDYVATRWYRAPEL 171
Query: 1131 AY-SLKATEKCDVYSMGIVLMELVSGK--MPTDA 1161
K D++++G ++ E+++G+ P D+
Sbjct: 172 LVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDS 205
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 9e-17
Identities = 73/298 (24%), Positives = 132/298 (44%), Gaps = 43/298 (14%)
Query: 947 NLSDEFIIGSGGSGTVYKA-----ELANGAT-VAVKKISCKDDHLLNKSFTREVKTLGRI 1000
NL + +G G G V+ A E G T V VK + D L F RE+ ++
Sbjct: 6 NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKL 65
Query: 1001 RHRHLVKLMGHCCNKGAGSNLLIYEYMENGSVWDWL--HKQPVNIKMRKSLDWEARLKIA 1058
H+++V+L+G C + A + +I EY + G + +L K L + ++ +
Sbjct: 66 SHKNVVRLLGLC--REAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALC 123
Query: 1059 VGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSN--TESN 1116
+A G+++L + + +HRD+ + N L+ S E + L+K + YNS N
Sbjct: 124 TQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSK---DVYNSEYYKLRN 177
Query: 1117 TWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMVRWVEM 1175
++APE + K DV+S G+++ E+ + G++P
Sbjct: 178 ALI--PLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELP----------------- 218
Query: 1176 HMEMSGSAREELLDD-QMKPL-LPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLL 1231
+S EE+L+ Q L LP E ++ ++ +C +P++RPS ++ L
Sbjct: 219 FYGLSD---EEVLNRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSAL 273
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 81.6 bits (202), Expect = 1e-16
Identities = 62/216 (28%), Positives = 99/216 (45%), Gaps = 41/216 (18%)
Query: 954 IGSGGSGTVYKA-ELANGATVAVKK-ISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMG- 1010
IG G G V+K G VA+KK + +DD ++ K RE++ L +++H +LV L+
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEV 68
Query: 1011 -------HCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQ 1063
H L++EY ++ +V + L K P + + KI Q
Sbjct: 69 FRRKRKLH----------LVFEYCDH-TVLNELEKNP------RGVPEHLIKKIIWQTLQ 111
Query: 1064 GVEYLH-HDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALV--EDYNSNTESNTWFA 1120
V + H H+C+ HRD+K NIL+ + L DFG A+ L D ++ + W
Sbjct: 112 AVNFCHKHNCI----HRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRW-- 165
Query: 1121 GSYGYIAPEYAY-SLKATEKCDVYSMGIVLMELVSG 1155
Y APE + DV+++G V EL++G
Sbjct: 166 ----YRAPELLVGDTQYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 1e-16
Identities = 57/209 (27%), Positives = 99/209 (47%), Gaps = 19/209 (9%)
Query: 954 IGSGGSGTVYKAELANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCC 1013
+G+G G V + VA+K I K+ + F E K + ++ H LV+L G C
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMI--KEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCT 69
Query: 1014 NKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCV 1073
+ ++ EYM NG + ++L + K L++ + +G+ YL
Sbjct: 70 KQRP--IYIVTEYMSNGCLLNYLRE------HGKRFQPSQLLEMCKDVCEGMAYLESK-- 119
Query: 1074 PKILHRDIKSSNILLDSNMEAHLGDFGLAKALVED-YNSNTESNTWFAGSYGYIAPEYAY 1132
+ +HRD+ + N L+D + DFGL++ +++D Y S+ S S PE
Sbjct: 120 -QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWS----PPEVLL 174
Query: 1133 SLKATEKCDVYSMGIVLMELVS-GKMPTD 1160
K + K DV++ G+++ E+ S GKMP +
Sbjct: 175 YSKFSSKSDVWAFGVLMWEVYSLGKMPYE 203
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 2e-16
Identities = 39/89 (43%), Positives = 57/89 (64%)
Query: 172 LGLASCSLSGPIPPQFGQLSQLEELILQQNQLQGPIPAELGNCSSLSIFTAAENNLNGSI 231
LGL + L G IP +L L+ + L N ++G IP LG+ +SL + + N+ NGSI
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 232 PAALGRLQNLQLLNLGNNSLSGEIPSELG 260
P +LG+L +L++LNL NSLSG +P+ LG
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 3e-16
Identities = 72/275 (26%), Positives = 124/275 (45%), Gaps = 38/275 (13%)
Query: 953 IIGSGGSGTVYKAE-LANGATVAVKKISCKDDHLLNKSFTR-EVKTLGRIRHRHLVKLMG 1010
IG G G +Y A+ ++ +K+I + K ++ EV L +++H ++V
Sbjct: 7 KIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFA 66
Query: 1011 HCCNKGAGSNLLIYEYMENGSVWDWLHKQP-VNIKMRKSLDWEARLKIAVGLAQGVEYLH 1069
+ G ++ EY + G + +++Q V + L W V ++ G++++H
Sbjct: 67 SF--QENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSW------FVQISLGLKHIH 118
Query: 1070 HDCVPKILHRDIKSSNILLDSN-MEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAP 1128
KILHRDIKS NI L N M A LGDFG+A+ L N + E G+ Y++P
Sbjct: 119 DR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQL----NDSMELAYTCVGTPYYLSP 171
Query: 1129 EYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSAREELL 1188
E + K D++S+G VL EL + K P + ++ + ++
Sbjct: 172 EICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVL----------------KIC 215
Query: 1189 DDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPS 1223
P+ P + + + Q K SP++RPS
Sbjct: 216 QGYFAPISPN---FSRDLRSLISQLFKVSPRDRPS 247
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 3e-16
Identities = 74/279 (26%), Positives = 122/279 (43%), Gaps = 45/279 (16%)
Query: 954 IGSGGSGTVYKA-ELANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHC 1012
IG G G V+K + VA+K I ++ + +E+ L + ++ K G
Sbjct: 12 IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 1013 CNKGAGSNL-LIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQ---GVEYL 1068
G+ L +I EY+ GS D L P + +IA L + G++YL
Sbjct: 72 LK---GTKLWIIMEYLGGGSALDLLRAGPFD-----------EFQIATMLKEILKGLDYL 117
Query: 1069 HHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAP 1128
H + K +HRDIK++N+LL + L DFG+A L + + + NT F G+ ++AP
Sbjct: 118 HSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD---TQIKRNT-FVGTPFWMAP 170
Query: 1129 EYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSAREELL 1188
E K D++S+GI +EL G+ P +M +R V + +
Sbjct: 171 EVIQQSAYDSKADIWSLGITAIELAKGEPPNS-----DMHPMR-VLFLIPKNNP------ 218
Query: 1189 DDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQV 1227
P L GE ++ E C P RP+++++
Sbjct: 219 -----PTLTGEFSKPFK--EFIDACLNKDPSFRPTAKEL 250
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 4e-16
Identities = 65/218 (29%), Positives = 109/218 (50%), Gaps = 26/218 (11%)
Query: 953 IIGSGGSGTVYKA-ELANGATV----AVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVK 1007
++GSG GTVYK + G TV A+K ++ N F E + + H HLV+
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73
Query: 1008 LMGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEY 1067
L+G C + + L+ + M +G + D++H+ NI + L+W V +A+G+ Y
Sbjct: 74 LLGVCLSP---TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNW------CVQIAKGMMY 124
Query: 1068 LHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVED---YNSNTESNTWFAGSYG 1124
L +++HRD+ + N+L+ S + DFGLA+ L D YN++
Sbjct: 125 LEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKM-----PIK 176
Query: 1125 YIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDA 1161
++A E + K T + DV+S G+ + EL++ G P D
Sbjct: 177 WMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDG 214
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 4e-16
Identities = 63/208 (30%), Positives = 105/208 (50%), Gaps = 19/208 (9%)
Query: 954 IGSGGSGTV----YKAELAN-GATVAVK--KISCKDDHLLNKSFTREVKTLGRIRHRHLV 1006
+G G G V Y E N G VAVK K +H+ + +E++ L + H ++V
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIAD--LKKEIEILRNLYHENIV 69
Query: 1007 KLMGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVE 1066
K G C G LI E++ +GS+ ++L + I +++ +LK AV + +G++
Sbjct: 70 KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQ------QLKYAVQICKGMD 123
Query: 1067 YLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYI 1126
YL + +HRD+ + N+L++S + +GDFGL KA+ D T + + + Y
Sbjct: 124 YLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWY- 179
Query: 1127 APEYAYSLKATEKCDVYSMGIVLMELVS 1154
APE K DV+S G+ L EL++
Sbjct: 180 APECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 4e-16
Identities = 71/276 (25%), Positives = 124/276 (44%), Gaps = 46/276 (16%)
Query: 954 IGSGGSGTVYKAELANGATVAVKKIS----CKDDHLLNKSFTREVKTLGRIRHRHLVKLM 1009
+GSG G V+ + VA+K I+ ++D F E K + ++ H LV+L
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEED------FIEEAKVMMKLSHPKLVQLY 65
Query: 1010 GHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLH 1069
G C + ++ E+MENG + ++L ++ + L + L + + +G+EYL
Sbjct: 66 GVCTQQK--PLYIVTEFMENGCLLNYLRQR------QGKLSKDMLLSMCQDVCEGMEYLE 117
Query: 1070 HDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVED-YNSNTESNTWFAGSYGYIAP 1128
+ +HRD+ + N L+ S + DFG+ + +++D Y S+ S F + P
Sbjct: 118 RN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSS--SGAKFPVKWS--PP 170
Query: 1129 EYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMVRWVEMHMEMSGSAREEL 1187
E K + K DV+S G+++ E+ + GKMP + E+ VEM R +L
Sbjct: 171 EVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEV-----VEMISRGFRLYRPKL 225
Query: 1188 LDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPS 1223
A+ V E+ C P+ RP+
Sbjct: 226 --------------ASMTVYEVMYSCWHEKPEGRPT 247
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 5e-16
Identities = 35/85 (41%), Positives = 49/85 (57%)
Query: 244 LNLGNNSLSGEIPSELGELSQLGYLNLMGNRLEGAIPRSFAKMGNLQSLDLSMNRLTGGI 303
L L N L G IP+++ +L L +NL GN + G IP S + +L+ LDLS N G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 304 PEEFGNMGQLVFLVLSNNNISGSIP 328
PE G + L L L+ N++SG +P
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVP 507
|
Length = 623 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 5e-16
Identities = 58/175 (33%), Positives = 87/175 (49%), Gaps = 32/175 (18%)
Query: 1068 LHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAK---ALVEDYNSNTESNTWFAGSYG 1124
+HH ++HRDIKS+NILL SN LGDFG +K A V D T F G+
Sbjct: 156 VHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRT-----FCGTPY 210
Query: 1125 YIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSAR 1184
Y+APE ++K D++S+G++L EL++ K P D G M+ V MH ++G R
Sbjct: 211 YVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFD---GENMEEV----MHKTLAG--R 261
Query: 1185 EELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQ-----VCDLLLNV 1234
+ L + P ++ EI + P+ RPSS + +C L ++
Sbjct: 262 YDPLPPSISP----------EMQEIVTALLSSDPKRRPSSSKLLNMPICKLFISG 306
|
Length = 496 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 5e-16
Identities = 80/288 (27%), Positives = 125/288 (43%), Gaps = 52/288 (18%)
Query: 954 IGSGGSGTVYKA-ELANGATVAVKKISCKDDHLLNK--SFTREVKTLGRIRHRHLVKLMG 1010
IG G G VY A ++ N VA+KK+S K +EV+ L ++RH + ++ G
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 1011 HCCNKGAGSNLLIYEYMENGSVWDWL--HKQPVNIKMRKSLDWEARLKIAVGLAQGVEYL 1068
C + L+ EY GS D L HK+P+ + ++ A + G QG+ YL
Sbjct: 83 --CYLREHTAWLVMEYCL-GSASDLLEVHKKPL-----QEVEIAA---VTHGALQGLAYL 131
Query: 1069 HHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAP 1128
H ++HRD+K+ NILL LGDFG A +++ N F G+ ++AP
Sbjct: 132 HSH---NMIHRDVKAGNILLSEPGLVKLGDFGSA-SIMAPANX-------FVGTPYWMAP 180
Query: 1129 EYAYSLKATE---KCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSARE 1185
E ++ + K DV+S+GI +EL K P M+ +
Sbjct: 181 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPL-----------------FNMNAMSAL 223
Query: 1186 ELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLN 1233
+ P L + Y C + PQ+RP+S ++LL
Sbjct: 224 YHIAQNESPALQSGHWSEY-FRNFVDSCLQKIPQDRPTS----EVLLK 266
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 5e-16
Identities = 87/323 (26%), Positives = 149/323 (46%), Gaps = 60/323 (18%)
Query: 946 NNLSDEFIIGSGGSGTVYKAEL------ANGATVAVKKISCKDDHLLNKSFTREVKTLGR 999
N++ + +IG G G V KA + + A +K+ + KDDH + F E++ L +
Sbjct: 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDH---RDFAGELEVLCK 63
Query: 1000 I-RHRHLVKLMGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPV---------NIKMRKSL 1049
+ H +++ L+G C ++G L EY +G++ D+L K V +L
Sbjct: 64 LGHHPNIINLLGACEHRG--YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTL 121
Query: 1050 DWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDY 1109
+ L A +A+G++YL + +HRD+ + NIL+ N A + DFGL++ E Y
Sbjct: 122 SSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQ-EVY 177
Query: 1110 NSNTESN---TWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGV 1165
T W A YS+ T DV+S G++L E+VS G P
Sbjct: 178 VKKTMGRLPVRWMA------IESLNYSVYTTNS-DVWSYGVLLWEIVSLGGTPYCG---- 226
Query: 1166 EMDMVRWVEMHMEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSR 1225
+ E++ ++ R E KPL +E V ++ QC + P ERPS
Sbjct: 227 ----MTCAELYEKLPQGYRLE------KPLNCDDE-----VYDLMRQCWREKPYERPSFA 271
Query: 1226 QVCDLLLNVFNNRIVDFDKLHID 1248
Q+ L+++ NR+++ K +++
Sbjct: 272 QI---LVSL--NRMLEERKTYVN 289
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 6e-16
Identities = 40/108 (37%), Positives = 58/108 (53%), Gaps = 4/108 (3%)
Query: 61 WRGITC---GSSSARVVS-LNLSGLSLAGSISPSLGRLQSLIHLDLSSNSLTGPIPTALS 116
W G C + + L L L G I + +L+ L ++LS NS+ G IP +L
Sbjct: 404 WSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLG 463
Query: 117 NLSSLESLLLFSNQLAGTIPTQLGSLTSLRVMRIGDNWLSGSIPTSFG 164
+++SLE L L N G+IP LG LTSLR++ + N LSG +P + G
Sbjct: 464 SITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 7e-16
Identities = 63/218 (28%), Positives = 102/218 (46%), Gaps = 29/218 (13%)
Query: 953 IIGSGGSGTVYKAELANGATVAVKKISCKDDHLLN-----KSFTREVKTLGRIRHRHLVK 1007
++G G GTVY G +AVK++ ++L + EV L ++H ++V+
Sbjct: 7 VLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66
Query: 1008 LMGHCCNKGAGSNLLIYEYMENGSVWDWLHK-----QPVNIKMRKSLDWEARLKIAVGLA 1062
+G C + S + E++ GS+ L++ +PV K K +
Sbjct: 67 YLGTCLDDNTIS--IFMEFVPGGSISSILNRFGPLPEPVFCKYTKQI------------L 112
Query: 1063 QGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTW--FA 1120
GV YLH++CV +HRDIK +N++L N L DFG A+ L T SN
Sbjct: 113 DGVAYLHNNCV---VHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMH 169
Query: 1121 GSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMP 1158
G+ ++APE K D++S+G + E+ +GK P
Sbjct: 170 GTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPP 207
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 79.0 bits (194), Expect = 1e-15
Identities = 76/296 (25%), Positives = 131/296 (44%), Gaps = 44/296 (14%)
Query: 954 IGSGGSGTVYKAELAN------GATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVK 1007
+G G G V+ AE N VAVK + D+ K F RE + L ++H H+VK
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNA-RKDFHREAELLTNLQHEHIVK 71
Query: 1008 LMGHCCNKGAGSNLLIYEYMENGSVWDWLHKQ-PVNIKMRK-----SLDWEARLKIAVGL 1061
G C ++++EYM++G + +L P + M + L L IA +
Sbjct: 72 FYGVCVE--GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQI 129
Query: 1062 AQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAG 1121
A G+ YL +HRD+ + N L+ N+ +GDFG+++ + +T
Sbjct: 130 AAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTML-- 184
Query: 1122 SYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMVRWVEMHMEMS 1180
++ PE K T + DV+S+G+VL E+ + GK P W ++
Sbjct: 185 PIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP-------------WYQL----- 226
Query: 1181 GSAREELLD--DQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNV 1234
+ E+++ Q + L C +V ++ L C + P R + +++ LL N+
Sbjct: 227 --SNNEVIECITQGRVLQRPRTCPK-EVYDLMLGCWQREPHMRLNIKEIHSLLQNL 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.9 bits (195), Expect = 1e-15
Identities = 62/227 (27%), Positives = 98/227 (43%), Gaps = 49/227 (21%)
Query: 954 IGSGGSGTVYKAELANGAT---VAVKKISCKDDHL--LNKSFTREVKTLGRIRHRHLVKL 1008
IG G G VYKA+ NG A+KK + +++S RE+ L ++H ++V L
Sbjct: 8 IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSL 67
Query: 1009 MGHCCNKGAGSNLLIYEYMENGSVWDWLH---------KQPVNIKMRKSLDWEARLKIAV 1059
+ S L+++Y E+ D + + M KSL W+
Sbjct: 68 VEVFLEHADKSVYLLFDYAEH----DLWQIIKFHRQAKRVSIPPSMVKSLLWQ------- 116
Query: 1060 GLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAH----LGDFGLA----KALVEDYNS 1111
+ GV YLH + +LHRD+K +NIL+ +GD GLA L +
Sbjct: 117 -ILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADL 172
Query: 1112 NTESNT-WFAGSYGYIAPEYAYSLKA---TEKCDVYSMGIVLMELVS 1154
+ T W Y APE L A T+ D++++G + EL++
Sbjct: 173 DPVVVTIW------YRAPELL--LGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 1e-15
Identities = 83/310 (26%), Positives = 136/310 (43%), Gaps = 62/310 (20%)
Query: 938 WEDIMGATNNLSDEFIIGSGGSGTVYKAELA------NGATVAVKKISCKDDHLLNKSFT 991
WEDI E +IG G G V +A + N A +K+ + ++DH + F
Sbjct: 1 WEDI-------KFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDH---RDFA 50
Query: 992 REVKTLGRI-RHRHLVKLMGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPV--------- 1041
E++ L ++ H +++ L+G C N+G + EY G++ D+L K V
Sbjct: 51 GELEVLCKLGHHPNIINLLGACENRG--YLYIAIEYAPYGNLLDFLRKSRVLETDPAFAK 108
Query: 1042 NIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGL 1101
+L + L+ A +A G++YL + +HRD+ + N+L+ N+ + + DFGL
Sbjct: 109 EHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGL 165
Query: 1102 AKALVEDYNSNTESN---TWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKM 1157
++ E Y T W A YS+ T K DV+S G++L E+VS G
Sbjct: 166 SRG-EEVYVKKTMGRLPVRWMA------IESLNYSVYTT-KSDVWSFGVLLWEIVSLGGT 217
Query: 1158 PTDATFGVEMDMVRWVEMHMEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTS 1217
P + E++ ++ R E KP C +V E+ QC +
Sbjct: 218 PYCG--------MTCAELYEKLPQGYRME------KP----RNCDD-EVYELMRQCWRDR 258
Query: 1218 PQERPSSRQV 1227
P ERP Q+
Sbjct: 259 PYERPPFAQI 268
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 2e-15
Identities = 62/212 (29%), Positives = 98/212 (46%), Gaps = 18/212 (8%)
Query: 953 IIGSGGSGTVYKA-ELANGATVAVKKI----SCKDDHLLNKSFTREVKTLGRIRHRHLVK 1007
++G G G VY + G +AVK++ ++ + E++ L +RH +V+
Sbjct: 9 LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68
Query: 1008 LMGHCCNKGAGSNLLIY-EYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVE 1066
G C L I+ EYM GS+ D L K +L + + QGV
Sbjct: 69 YYG-CLRDPEEKKLSIFVEYMPGGSIKDQL-------KAYGALTENVTRRYTRQILQGVS 120
Query: 1067 YLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYI 1126
YLH + I+HRDIK +NIL DS LGDFG +K + S T + G+ ++
Sbjct: 121 YLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKS-VTGTPYWM 176
Query: 1127 APEYAYSLKATEKCDVYSMGIVLMELVSGKMP 1158
+PE K DV+S+ ++E+++ K P
Sbjct: 177 SPEVISGEGYGRKADVWSVACTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 78.9 bits (195), Expect = 2e-15
Identities = 63/210 (30%), Positives = 102/210 (48%), Gaps = 24/210 (11%)
Query: 953 IIGSGGSGTVYKA-ELANGATVAVKKIS-CKDDHLLNKSFTREVKTLGRIRHRHLVKLMG 1010
IGSG G V A + +G VA+KKI D L K RE+K L +H +++ +
Sbjct: 12 NIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRD 71
Query: 1011 HCCNKGA-GSNL-LIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYL 1068
GA ++ ++ + ME+ LH I + L E L +G++Y+
Sbjct: 72 ILRPPGADFKDVYVVMDLMESD-----LHHI---IHSDQPLTEEHIRYFLYQLLRGLKYI 123
Query: 1069 HHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSY----G 1124
H V +HRD+K SN+L++ + E +GDFG+A+ L S+ + +F Y
Sbjct: 124 HSANV---IHRDLKPSNLLVNEDCELRIGDFGMARGLS----SSPTEHKYFMTEYVATRW 176
Query: 1125 YIAPEYAYSL-KATEKCDVYSMGIVLMELV 1153
Y APE SL + T D++S+G + E++
Sbjct: 177 YRAPELLLSLPEYTTAIDMWSVGCIFAEML 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 2e-15
Identities = 74/303 (24%), Positives = 135/303 (44%), Gaps = 54/303 (17%)
Query: 945 TNNLSDEFIIGSGGSGTVYKA-ELANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHR 1003
+ + ++G G G VY A +L+ +A+K+I +D + + E+ ++HR
Sbjct: 7 YDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYV-QPLHEEIALHSYLKHR 65
Query: 1004 HLVKLMGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKI-AVGLA 1062
++V+ +G ++ G + E + GS+ L K D E + +
Sbjct: 66 NIVQYLG-SDSEN-GFFKIFMEQVPGGSLSALLRS-----KWGPLKDNEQTIIFYTKQIL 118
Query: 1063 QGVEYLHHDCVPKILHRDIKSSNILLDS-NMEAHLGDFGLAKALVEDYNSNTESNTWFAG 1121
+G++YLH + +I+HRDIK N+L+++ + + DFG +K L N TE+ F G
Sbjct: 119 EGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA-GINPCTET---FTG 171
Query: 1122 SYGYIAPEY------AYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEM 1175
+ Y+APE Y A D++S+G ++E+ +GK P ++E+
Sbjct: 172 TLQYMAPEVIDKGPRGYGAPA----DIWSLGCTIVEMATGKPP-------------FIEL 214
Query: 1176 HMEMSGSAREELLDDQM---KPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLL 1232
G + + M P +P A + L+C + P +R S+ DLL
Sbjct: 215 -----GEPQAAMFKVGMFKIHPEIPESLSAEAK--NFILRCFEPDPDKRASAH---DLLQ 264
Query: 1233 NVF 1235
+ F
Sbjct: 265 DPF 267
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 2e-15
Identities = 56/213 (26%), Positives = 104/213 (48%), Gaps = 31/213 (14%)
Query: 953 IIGSGGSGTVYKA-ELANGAT----VAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVK 1007
++GSG GTV+K + G + VA+K I + + T + +G + H ++V+
Sbjct: 14 LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVR 73
Query: 1008 LMGHCCNKGAGSNL-LIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVE 1066
L+G C G++L L+ + GS+ D + + ++ ++ L+W V +A+G+
Sbjct: 74 LLGIC----PGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNW------CVQIAKGMY 123
Query: 1067 YLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVED-----YNSNTESNTWFAG 1121
YL ++HR++ + NILL S+ + DFG+A L D Y+ + W
Sbjct: 124 YLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKW--- 177
Query: 1122 SYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS 1154
+A E + T + DV+S G+ + E++S
Sbjct: 178 ----MALESILFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 2e-15
Identities = 59/219 (26%), Positives = 109/219 (49%), Gaps = 28/219 (12%)
Query: 953 IIGSGGSGTVYKA-ELANGATVAVKK------ISCKDDHLLN---KSFTREVKTLGRIRH 1002
+IG G G VY A + G +AVK+ I+ + D K+ E++TL + H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 1003 RHLVKLMGHCCNKGAGSNLLIYEYMENGSVWDWLHKQ-PVNIKMRKSLDWEARLKIAVGL 1061
++V+ +G + EY+ GS+ L ++ + + +
Sbjct: 68 LNIVQYLG--FETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQ--------V 117
Query: 1062 AQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAG 1121
+G+ YLH ILHRD+K+ N+L+D++ + DFG++K +D N ++ + G
Sbjct: 118 LEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGISKK-SDDIYDNDQNMS-MQG 172
Query: 1122 SYGYIAPE--YAYSLKATEKCDVYSMGIVLMELVSGKMP 1158
S ++APE ++YS + K D++S+G V++E+ +G+ P
Sbjct: 173 SVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 3e-15
Identities = 81/298 (27%), Positives = 134/298 (44%), Gaps = 51/298 (17%)
Query: 954 IGSGGSGTVYKAELANGAT------VAVKKISCKDDHL-LNKSFTREVKTLGRIRHRHLV 1006
+G G G V+ AE N + VAVK + KD L K F RE + L ++H H+V
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKAL--KDPTLAARKDFQREAELLTNLQHEHIV 70
Query: 1007 KLMGHCCNKGAGSNL-LIYEYMENGSVWDWLHK-----------QPVNIKMRKSLDWEAR 1054
K G C G G L +++EYM++G + +L QP + + L
Sbjct: 71 KFYGVC---GDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQP--RQAKGELGLSQM 125
Query: 1055 LKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTE 1114
L IA +A G+ YL +HRD+ + N L+ +N+ +GDFG+++ +
Sbjct: 126 LHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVG 182
Query: 1115 SNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMVRWV 1173
+T ++ PE K T + DV+S G++L E+ + GK P W
Sbjct: 183 GHTML--PIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP-------------W- 226
Query: 1174 EMHMEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLL 1231
++S + E + Q + L C +V +I L C + PQ+R + +++ +L
Sbjct: 227 ---FQLSNTEVIECI-TQGRVLERPRVCPK-EVYDIMLGCWQREPQQRLNIKEIYKIL 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 3e-15
Identities = 86/296 (29%), Positives = 129/296 (43%), Gaps = 51/296 (17%)
Query: 948 LSDEFIIGSGGSGTVYKA-ELANGATVAVKKISCKDDHLLNK--SFTREVKTLGRIRHRH 1004
+D IG G G VY A ++ VA+KK+S K +EVK L RI+H +
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 1005 LVKLMGHCCNKGAGSNLLIYEYMENGSVWDWL--HKQPVNIKMRKSLDWEARLKIAVGLA 1062
++ G C + L+ EY GS D L HK+P+ + ++ A I G
Sbjct: 87 SIEYKG--CYLREHTAWLVMEYCL-GSASDLLEVHKKPL-----QEVEIAA---ITHGAL 135
Query: 1063 QGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGS 1122
QG+ YLH ++HRDIK+ NILL + L DFG A ++ NS F G+
Sbjct: 136 QGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSA-SIASPANS-------FVGT 184
Query: 1123 YGYIAPEYAYSLKATE---KCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEM 1179
++APE ++ + K DV+S+GI +EL K P M
Sbjct: 185 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL-----------------FNM 227
Query: 1180 SGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNVF 1235
+ + + P L E + Y C + PQ+RP+S + LL ++F
Sbjct: 228 NAMSALYHIAQNESPTLQSNEWSDY-FRNFVDSCLQKIPQDRPTSEE---LLKHMF 279
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 3e-15
Identities = 72/281 (25%), Positives = 123/281 (43%), Gaps = 49/281 (17%)
Query: 954 IGSGGSGTVYKA-ELANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHC 1012
IG G G VYK + VA+K I ++ + +E+ L + ++ + G
Sbjct: 12 IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY 71
Query: 1013 CNKGAGSNL-LIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARL-KIAVGLAQGVEYLHH 1070
G+ L +I EY+ GS D L P+ E + I + +G++YLH
Sbjct: 72 LK---GTKLWIIMEYLGGGSALDLLKPGPLE---------ETYIATILREILKGLDYLHS 119
Query: 1071 DCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEY 1130
+ + +HRDIK++N+LL + L DFG+A L + + + NT F G+ ++APE
Sbjct: 120 E---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD---TQIKRNT-FVGTPFWMAPEV 172
Query: 1131 ----AYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSAREE 1186
AY KA D++S+GI +EL G+ P + +
Sbjct: 173 IKQSAYDFKA----DIWSLGITAIELAKGEPPNSDLHPMRVLF----------------- 211
Query: 1187 LLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQV 1227
L+ P L G+ ++ E C P+ RP+++++
Sbjct: 212 LIPKNSPPTLEGQYSKPFK--EFVEACLNKDPRFRPTAKEL 250
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 4e-15
Identities = 61/224 (27%), Positives = 101/224 (45%), Gaps = 51/224 (22%)
Query: 1030 GSVW----------DWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHR 1079
G VW D +K+ + + D KIAV + + +EYLH ++HR
Sbjct: 73 GDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILG--KIAVSIVKALEYLHSKL--SVIHR 128
Query: 1080 DIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPE--------YA 1131
D+K SN+L++ N + L DFG++ LV ++ + T AG Y+APE
Sbjct: 129 DVKPSNVLINRNGQVKLCDFGISGYLV-----DSVAKTIDAGCKPYMAPERINPELNQKG 183
Query: 1132 YSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSAREELLDDQ 1191
Y +K+ DV+S+GI ++EL +G+ P D W ++ E
Sbjct: 184 YDVKS----DVWSLGITMIELATGRFPYD----------SWKTPFQQLKQVVEEP----- 224
Query: 1192 MKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNVF 1235
P LP E+ + + + +C K + +ERP+ + LL + F
Sbjct: 225 -SPQLPAEKFSP-EFQDFVNKCLKKNYKERPNYPE---LLQHPF 263
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 4e-15
Identities = 72/305 (23%), Positives = 126/305 (41%), Gaps = 61/305 (20%)
Query: 953 IIGSGGSGTVYKAEL------ANGATVAVK--KISCKDDHLLNKSFTREVKTLGRI-RHR 1003
+G G G V KAE +TVAVK K + L + E++ + I +H+
Sbjct: 19 PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSD--LVSEMEMMKMIGKHK 76
Query: 1004 HLVKLMGHCCNKGAGSNLLIYEYMENGSVWDWLH-KQPVNIKMRKSLDWEARLKI----- 1057
+++ L+G C G ++ EY +G++ D+L ++P +
Sbjct: 77 NIINLLGVC--TQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDL 134
Query: 1058 ---AVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVE-DYNSNT 1113
A +A+G+E+L K +HRD+ + N+L+ + + DFGLA+ + DY T
Sbjct: 135 VSFAYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKT 191
Query: 1114 ESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMVRW 1172
+ ++APE + T + DV+S G++L E+ + G P
Sbjct: 192 TNGRL---PVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSP-------------- 234
Query: 1173 VEMHMEMSGSAREELLD-----DQM-KPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQ 1226
G EEL +M KP +E + + C P +RP+ +Q
Sbjct: 235 ------YPGIPVEELFKLLKEGYRMEKPQNCTQE-----LYHLMRDCWHEVPSQRPTFKQ 283
Query: 1227 VCDLL 1231
+ + L
Sbjct: 284 LVEDL 288
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.9 bits (190), Expect = 4e-15
Identities = 65/220 (29%), Positives = 99/220 (45%), Gaps = 46/220 (20%)
Query: 953 IIGSGGSGTVYKA-ELANGATVAVKKIS-CKDDHLLNKSFTREV---KTLGRIRHRHLVK 1007
IG G GTVYKA +L G VA+KK+ + + S RE+ K L H ++V+
Sbjct: 6 EIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVR 65
Query: 1008 LMGHCCNKGAGSNL---LIYEYMENGSVWD---WLHKQPVNIKMRKSLDWEARLKIAVGL 1061
L+ C L L++E+++ D +L K P + L E + L
Sbjct: 66 LLDVCHGPRTDRELKLTLVFEHVD----QDLATYLSKCP-----KPGLPPETIKDLMRQL 116
Query: 1062 AQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTES---NTW 1118
+GV++LH I+HRD+K NIL+ S+ + + DFGLA+ + + S W
Sbjct: 117 LRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR--IYSFEMALTSVVVTLW 171
Query: 1119 FAGSYGYIAPE------YAYSLKATEKCDVYSMGIVLMEL 1152
Y APE YA D++S+G + EL
Sbjct: 172 ------YRAPEVLLQSSYATP------VDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 6e-15
Identities = 64/214 (29%), Positives = 101/214 (47%), Gaps = 31/214 (14%)
Query: 953 IIGSGGSGTVYKA-ELANGATVAVKKISC---KDDHLLNKSFTREVKTLGRIRHRHLVKL 1008
IG G G VY+A + +G VA+KK+ +D + S RE+ L +RH ++V+L
Sbjct: 14 RIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDG--IPISSLREITLLLNLRHPNIVEL 71
Query: 1009 MGHCCNKGAGSNLLIYEYMEN--GSVWDWLHKQPVNIKMRKSLDWEARLK-IAVGLAQGV 1065
K S L+ EY E S+ D + P + E+++K + + L +G+
Sbjct: 72 KEVVVGKHLDSIFLVMEYCEQDLASLLDNM-PTPFS---------ESQVKCLMLQLLRGL 121
Query: 1066 EYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTES--NTWFAGSY 1123
+YLH + I+HRD+K SN+LL + DFGLA+ T W
Sbjct: 122 QYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLW----- 173
Query: 1124 GYIAPEYAY-SLKATEKCDVYSMGIVLMELVSGK 1156
Y APE T D++++G +L EL++ K
Sbjct: 174 -YRAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 7e-15
Identities = 71/275 (25%), Positives = 123/275 (44%), Gaps = 48/275 (17%)
Query: 954 IGSGGSGTVYKAE-LANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHC 1012
+G+G G V K + +G +A K I + + RE++ L ++V G
Sbjct: 13 LGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72
Query: 1013 CNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDC 1072
+ G S + E+M+ GS+ L K K + E K+++ + +G+ YL
Sbjct: 73 YSDGEIS--ICMEHMDGGSLDQVL-------KEAKRIPEEILGKVSIAVLRGLAYLREK- 122
Query: 1073 VPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAY 1132
+I+HRD+K SNIL++S E L DFG++ L+ D +N+ F G+ Y++PE
Sbjct: 123 -HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI-DSMANS-----FVGTRSYMSPERLQ 175
Query: 1133 SLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSAREELLDDQM 1192
+ + D++SMG+ L+EL G+ P E++ +
Sbjct: 176 GTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFG-------------------- 215
Query: 1193 KPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQV 1227
+P++ GEE + + SP+ RP R V
Sbjct: 216 RPVVDGEEGEPHSI----------SPRPRPPGRPV 240
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 9e-15
Identities = 60/228 (26%), Positives = 111/228 (48%), Gaps = 46/228 (20%)
Query: 954 IGSGGSGTVYKAELANGA------TVAVKKISCKDDHL--LNKSFTREVKTLGRIRHRHL 1005
+G G G VYK EL +VA+K + K++ + + F +E + + ++H ++
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIK--TLKENAEPKVQQEFRQEAELMSDLQHPNI 70
Query: 1006 VKLMGHCCNKGAGSNLLIYEYMENGSVWDWL-----HKQP----VNIKMRKSLDWEARLK 1056
V L+G C + +++EY+ +G + ++L H + ++ SLD L
Sbjct: 71 VCLLGVCTKEQP--TCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLH 128
Query: 1057 IAVGLAQGVEYL--HHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSN-- 1112
IA+ +A G+EYL HH +HRD+ + N L+ + + DFGL++ + Y+++
Sbjct: 129 IAIQIAAGMEYLSSHH-----FVHRDLAARNCLVGEGLTVKISDFGLSR---DIYSADYY 180
Query: 1113 -TESNT-----WFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS 1154
+S + W + PE K T + D++S G+VL E+ S
Sbjct: 181 RVQSKSLLPVRW-------MPPEAILYGKFTTESDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 9e-15
Identities = 70/213 (32%), Positives = 104/213 (48%), Gaps = 30/213 (14%)
Query: 954 IGSGGSGTVYKAELAN-GATVAVKKISC--KDDHLLNKSFTREVKTLGRIRHRHLVKLMG 1010
IG G G VY A ++ VAVKK+S K + + +EVK L +++H + ++ G
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 1011 HCCNKGAGSNLLIYEYMENGSVWDWL--HKQPVNIKMRKSLDWEARLKIAVGLAQGVEYL 1068
C + L+ EY GS D L HK+P+ + ++ A I G QG+ YL
Sbjct: 89 --CYLKEHTAWLVMEYCL-GSASDLLEVHKKPL-----QEVEIAA---ITHGALQGLAYL 137
Query: 1069 HHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAP 1128
H ++HRDIK+ NILL + L DFG A + NS F G+ ++AP
Sbjct: 138 HSHN---MIHRDIKAGNILLTEPGQVKLADFGSA-SKSSPANS-------FVGTPYWMAP 186
Query: 1129 EYAYSLKATE---KCDVYSMGIVLMELVSGKMP 1158
E ++ + K DV+S+GI +EL K P
Sbjct: 187 EVILAMDEGQYDGKVDVWSLGITCIELAERKPP 219
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 1e-14
Identities = 39/90 (43%), Positives = 59/90 (65%), Gaps = 1/90 (1%)
Query: 700 LSLDGNMLNGSLPNEVGNLASLNVLTLSGNLLSGPIPPAIGRLSKLYELRLSNNSLNGVI 759
L LD L G +PN++ L L + LSGN + G IPP++G ++ L L LS NS NG I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 760 PLEIGQLQNLQSILDLSHNNFTGQIPPSMG 789
P +GQL +L+ IL+L+ N+ +G++P ++G
Sbjct: 483 PESLGQLTSLR-ILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 1e-14
Identities = 64/252 (25%), Positives = 120/252 (47%), Gaps = 24/252 (9%)
Query: 954 IGSGGSGTVYK-AELANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHC 1012
+G+G G V+K + +G +A K I + + RE++ L ++V G
Sbjct: 13 LGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72
Query: 1013 CNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDC 1072
+ G S + E+M+ GS+ L K + + K+++ + +G+ YL
Sbjct: 73 YSDGEIS--ICMEHMDGGSLDQVLKKA-------GRIPEQILGKVSIAVIKGLTYLREK- 122
Query: 1073 VPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAY 1132
KI+HRD+K SNIL++S E L DFG++ L+ D +N+ F G+ Y++PE
Sbjct: 123 -HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI-DSMANS-----FVGTRSYMSPERLQ 175
Query: 1133 SLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSAREELLDDQM 1192
+ + D++SMG+ L+E+ G+ P E++++ + + + S +
Sbjct: 176 GTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAES------ETSP 229
Query: 1193 KPLLPGEECAAY 1204
+P PG ++Y
Sbjct: 230 RPRPPGRPLSSY 241
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 75.7 bits (187), Expect = 1e-14
Identities = 67/220 (30%), Positives = 101/220 (45%), Gaps = 38/220 (17%)
Query: 951 EFI--IGSGGSGTVYKA-ELANGATVAVKKISCKD-------DHLLNKSFTREVKTLGRI 1000
EFI +G+G G V +G A+K +S +H+LN E + L I
Sbjct: 4 EFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLN-----EKRILQSI 58
Query: 1001 RHRHLVKLMGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIA-V 1059
RH LV L G + + L+ EY+ G ++ L K R AR A V
Sbjct: 59 RHPFLVNLYGS--FQDDSNLYLVMEYVPGGELFSHLRK-----SGRFPEPV-ARFYAAQV 110
Query: 1060 GLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTW- 1118
LA +EYLH I++RD+K N+LLDS+ + DFG AK + T+
Sbjct: 111 VLA--LEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG--------RTYT 157
Query: 1119 FAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMP 1158
G+ Y+APE S + D +++GI++ E+++G P
Sbjct: 158 LCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 1e-14
Identities = 71/275 (25%), Positives = 114/275 (41%), Gaps = 37/275 (13%)
Query: 954 IGSGGSGTVYKA-ELANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHC 1012
IG G G V+K + VA+K I ++ + +E+ L + ++ K G
Sbjct: 12 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 1013 CNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDC 1072
+I EY+ GS D L P LD I + +G++YLH +
Sbjct: 72 LKDT--KLWIIMEYLGGGSALDLLEPGP--------LDETQIATILREILKGLDYLHSE- 120
Query: 1073 VPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAY 1132
K +HRDIK++N+LL + E L DFG+A L + + + N F G+ ++APE
Sbjct: 121 --KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD---TQIKRN-TFVGTPFWMAPEVIK 174
Query: 1133 SLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSAREELLDDQM 1192
K D++S+GI +EL G+ P H E+ L+
Sbjct: 175 QSAYDSKADIWSLGITAIELAKGEPP-----------------HSELHPMKVLFLIPKNN 217
Query: 1193 KPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQV 1227
P L G + E C P RP+++++
Sbjct: 218 PPTLEGNYSKPLK--EFVEACLNKEPSFRPTAKEL 250
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 2e-14
Identities = 59/211 (27%), Positives = 98/211 (46%), Gaps = 16/211 (7%)
Query: 953 IIGSGGSGTVYKA-ELANGATVAVKKISCKDDHLLNK----SFTREVKTLGRIRHRHLVK 1007
++G G G VY ++ G +A K++ + + E++ L ++H +V+
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQ 68
Query: 1008 LMGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEY 1067
G ++ + + EYM GSV D L K +L K + +G+ Y
Sbjct: 69 YYGCLRDRAEKTLTIFMEYMPGGSVKDQL-------KAYGALTESVTRKYTRQILEGMSY 121
Query: 1068 LHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIA 1127
LH + I+HRDIK +NIL DS LGDFG +K L S T + G+ +++
Sbjct: 122 LHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRS-VTGTPYWMS 177
Query: 1128 PEYAYSLKATEKCDVYSMGIVLMELVSGKMP 1158
PE K DV+S+G ++E+++ K P
Sbjct: 178 PEVISGEGYGRKADVWSLGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 2e-14
Identities = 70/299 (23%), Positives = 123/299 (41%), Gaps = 54/299 (18%)
Query: 954 IGSGGSGTVYKAELAN------GATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVK 1007
+G G G VY+ VA+K ++ F E + H+V+
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 1008 LMGHCCNKGAGSNLLIYEYMENGSVWDWLHKQ---PVNIKMRKSLDWEARLKIAVGLAQG 1064
L+G + G + L++ E M G + +L + N + +++A +A G
Sbjct: 74 LLG-VVSTGQPT-LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADG 131
Query: 1065 VEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVE-DYNSNTESNTWFAGSY 1123
+ YL K +HRD+ + N ++ ++ +GDFG+ + + E DY + G
Sbjct: 132 MAYLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDY--------YRKGGK 180
Query: 1124 G-----YIAPEYAYSLKA---TEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEM 1175
G ++APE SLK T K DV+S G+VL E+ AT +
Sbjct: 181 GLLPVRWMAPE---SLKDGVFTTKSDVWSFGVVLWEM--------ATLAEQ--------- 220
Query: 1176 HMEMSGSAREELLDDQMK-PLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLN 1233
G + EE+L + L E ++LE+ C + +P+ RP+ ++ L +
Sbjct: 221 --PYQGLSNEEVLKFVIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 2e-14
Identities = 63/222 (28%), Positives = 105/222 (47%), Gaps = 33/222 (14%)
Query: 951 EFIIGSGGSGTVYKAELANGA----TVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLV 1006
E +IG+G G V + L VA+K + + F E +G+ H +++
Sbjct: 9 EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNII 68
Query: 1007 KLMGHCCNKGAGSNLLIYEYMENGSVWDWLHK---QPVNIKMRKSLDWEARLKIAVGLAQ 1063
L G + ++I E+MENG++ +L + Q I++ L G+A
Sbjct: 69 HLEGVVTK--SRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLR---------GIAA 117
Query: 1064 GVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSY 1123
G++YL +HRD+ + NIL++SN+ + DFGL++ L +D S+ + S
Sbjct: 118 GMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD-----TSDPTYTSSL 169
Query: 1124 G------YIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMP 1158
G + APE K T DV+S GIV+ E++S G+ P
Sbjct: 170 GGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 75.0 bits (185), Expect = 3e-14
Identities = 63/231 (27%), Positives = 97/231 (41%), Gaps = 50/231 (21%)
Query: 954 IGSGGSGTVYKA-ELANGATVAVKKI---SCKDDHLLNKSFTREVKTLGRIRHRHLVKLM 1009
+G G G VYKA ++ G VA+KKI + KD + RE+K L +++H ++V L+
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVALKKILMHNEKD--GFPITALREIKILKKLKHPNVVPLI 73
Query: 1010 GHCCNKGA------GSNLLIYEYM--------ENGSVWDWLHKQPVNIK--MRKSLDWEA 1053
+ GS ++ YM EN SV IK M + L+
Sbjct: 74 DMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSV----KLTESQIKCYMLQLLE--- 126
Query: 1054 RLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNT 1113
G+ YLH + ILHRDIK++NIL+D+ + DFGLA+ +
Sbjct: 127 ----------GINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPK 173
Query: 1114 ESNTWFAGSYG-------YIAPEYAYSLKA-TEKCDVYSMGIVLMELVSGK 1156
Y Y PE + T D++ +G V E+ + +
Sbjct: 174 GGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 5e-14
Identities = 82/290 (28%), Positives = 135/290 (46%), Gaps = 40/290 (13%)
Query: 954 IGSGGSGTVYKA-ELANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHC 1012
+G+G G V K +G +A K I + + RE+K L ++V G
Sbjct: 9 LGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAF 68
Query: 1013 CNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARL-KIAVGLAQGVEYLHHD 1071
+ G S + E+M+ GS+ D + K+ I E L KI++ + +G+ YL
Sbjct: 69 YSDGEISICM--EHMDGGSL-DQVLKKAGRIP-------ENILGKISIAVLRGLTYLRE- 117
Query: 1072 CVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYA 1131
KI+HRD+K SNIL++S E L DFG++ L+ D +N+ F G+ Y++PE
Sbjct: 118 -KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI-DSMANS-----FVGTRSYMSPERL 170
Query: 1132 YSLKATEKCDVYSMGIVLMELVSGKMPT--------DATFGVEMDMVRWVEMHMEMSGSA 1183
T + D++S+G+ L+E+ G+ P +A FG + E H +SG
Sbjct: 171 QGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHP 230
Query: 1184 RE--------ELLD---DQMKPLLPGEECAAYQVLEIALQCTKTSPQERP 1222
+ ELLD ++ P LP + + + +C K +P+ER
Sbjct: 231 PDSPRPMAIFELLDYIVNEPPPKLPSGAFSD-EFQDFVDKCLKKNPKERA 279
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 7e-14
Identities = 64/228 (28%), Positives = 101/228 (44%), Gaps = 48/228 (21%)
Query: 953 IIGSGGSGTVYKA-ELANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGH 1011
IGSG GTVYK G A+K I + + + RE++ L + H ++VK H
Sbjct: 81 RIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKC--H 138
Query: 1012 CCNKGAGSNLLIYEYMENGS-----VWDWLHKQPVNIKMRKSLDWEARLK-IAVGLAQGV 1065
G ++ E+M+ GS + D E L +A + G+
Sbjct: 139 DMFDHNGEIQVLLEFMDGGSLEGTHIAD-----------------EQFLADVARQILSGI 181
Query: 1066 EYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGY 1125
YLH I+HRDIK SN+L++S + DFG+++ L + + S G+ Y
Sbjct: 182 AYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSS----VGTIAY 234
Query: 1126 IAPEY--------AYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGV 1165
++PE AY A D++S+G+ ++E G+ P FGV
Sbjct: 235 MSPERINTDLNHGAYDGYAG---DIWSLGVSILEFYLGRFP----FGV 275
|
Length = 353 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 7e-14
Identities = 68/281 (24%), Positives = 119/281 (42%), Gaps = 52/281 (18%)
Query: 954 IGSGGSGTVYKAEL-ANGATVAVKKISCKDD--HLLNKSFTREVKTLGRIRHRHLVKLMG 1010
IG G G V+ L A+ VAVK SC++ L F +E + L + H ++V+L+G
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVK--SCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 60
Query: 1011 HCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHH 1070
C K ++ E ++ G +L + +K+++ +++ A G+EYL
Sbjct: 61 VCTQK--QPIYIVMELVQGGDFLTFLRTEGPRLKVKE------LIQMVENAAAGMEYLES 112
Query: 1071 DCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYG------ 1124
+HRD+ + N L+ + DFG+ S E + +A + G
Sbjct: 113 KHC---IHRDLAARNCLVTEKNVLKISDFGM---------SREEEDGVYASTGGMKQIPV 160
Query: 1125 -YIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMVRWVEMHMEMSGS 1182
+ APE + + + DV+S GI+L E S G +P + +S
Sbjct: 161 KWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVP-----------------YANLSNQ 203
Query: 1183 AREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPS 1223
E ++ ++ L E C V + +C + P +RPS
Sbjct: 204 QTREAIEQGVR-LPCPELCPD-AVYRLMERCWEYDPGQRPS 242
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 8e-14
Identities = 57/211 (27%), Positives = 101/211 (47%), Gaps = 29/211 (13%)
Query: 954 IGSGGSGTVYKA-ELANGATVAVKKISCKD----DHLLNKSFTREVKTLGRIRHRHLVKL 1008
IG G SGTVY A ++A G VA+K+++ + + ++N E+ + +H ++V
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIIN-----EILVMRENKHPNIVNY 81
Query: 1009 MGHCCNKGAGSNL-LIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEY 1067
+ G L ++ EY+ GS+ D + +D + Q +E+
Sbjct: 82 LDSYL---VGDELWVVMEYLAGGSLTD--------VVTETCMDEGQIAAVCRECLQALEF 130
Query: 1068 LHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIA 1127
LH + +++HRDIKS NILL + L DFG + + + + G+ ++A
Sbjct: 131 LHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST----MVGTPYWMA 183
Query: 1128 PEYAYSLKATEKCDVYSMGIVLMELVSGKMP 1158
PE K D++S+GI+ +E+V G+ P
Sbjct: 184 PEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 1e-13
Identities = 40/104 (38%), Positives = 55/104 (52%), Gaps = 7/104 (6%)
Query: 470 GEIPTSIGRLKDLNFLHLRQNELVGQIPASLGNCHQLIILDLADNKLSGGVPASFGFLQA 529
G IP I +L+ L ++L N + G IP SLG+ L +LDL+ N +G +P S G L +
Sbjct: 432 GFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTS 491
Query: 530 LEQLMLYNNSLEGNLPGSL-INLRNLTRINFSKNRLNGRIATLC 572
L L L NSL G +P +L L + NF+ N A LC
Sbjct: 492 LRILNLNGNSLSGRVPAALGGRLLHRASFNFTDN------AGLC 529
|
Length = 623 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 1e-13
Identities = 57/217 (26%), Positives = 97/217 (44%), Gaps = 34/217 (15%)
Query: 954 IGSGGSGTVYKAELAN-GATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHC 1012
+G G G VYKA+ G A K I + + L + F E+ L +H ++V L
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEEL-EDFMVEIDILSECKHPNIVGLYEAY 71
Query: 1013 CNKGAGSNLLIY-EYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHD 1071
+ L I E+ + G++ + +++ + L + + + + +LH
Sbjct: 72 FYEN---KLWILIEFCDGGALDS------IMLELERGLTEPQIRYVCRQMLEALNFLHSH 122
Query: 1072 CVPKILHRDIKSSNILLDSNMEAHLGDFGL-AKALVEDYNSNTESNTWFAGSYGYIAPEY 1130
K++HRD+K+ NILL + + L DFG+ AK +T F G+ ++APE
Sbjct: 123 ---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT-----FIGTPYWMAPEV 174
Query: 1131 ---------AYSLKATEKCDVYSMGIVLMELVSGKMP 1158
Y KA D++S+GI L+EL + P
Sbjct: 175 VACETFKDNPYDYKA----DIWSLGITLIELAQMEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 1e-13
Identities = 67/233 (28%), Positives = 106/233 (45%), Gaps = 34/233 (14%)
Query: 946 NNLSDEFIIGSGGSGTVYKAELANG-------ATVAVKKISCKDDHLLNKSFTREVKTLG 998
NN+ IG G G V++A A G VAVK + + + F RE +
Sbjct: 5 NNIEYVRDIGQGAFGRVFQAR-APGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMA 63
Query: 999 RIRHRHLVKLMGHCCNKGAGSNL-LIYEYMENGSVWDWL-HKQPVNIKMRKSLDWEAR-- 1054
H ++VKL+G C G + L++EYM G + ++L H+ P AR
Sbjct: 64 EFDHPNIVKLLGVC---AVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKC 120
Query: 1055 ------------LKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLA 1102
L IA +A G+ YL K +HRD+ + N L+ NM + DFGL+
Sbjct: 121 GLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLS 177
Query: 1103 KAL-VEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS 1154
+ + DY +E++ A ++ PE + + T + DV++ G+VL E+ S
Sbjct: 178 RNIYSADYYKASEND---AIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 1e-13
Identities = 73/307 (23%), Positives = 124/307 (40%), Gaps = 58/307 (18%)
Query: 953 IIGSGGSGTVYKA-ELANGAT----VAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVK 1007
++GSG GTVYK + G VA+K++ NK E + + + H+ +
Sbjct: 14 VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 73
Query: 1008 LMGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEY 1067
L+G C LI + M G + D++ + NI + L+W V +A+G+ Y
Sbjct: 74 LLGICLTSTVQ---LITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNY 124
Query: 1068 LHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGS----Y 1123
L +++HRD+ + N+L+ + + DFGLAK L + + A
Sbjct: 125 LEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL------GADEKEYHAEGGKVPI 175
Query: 1124 GYIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMVRWVEMHMEMSGS 1182
++A E T + DV+S G+ + EL++ G P D E+ + +
Sbjct: 176 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI--------LEKG 227
Query: 1183 AREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNVFNNRIVDF 1242
R LP V I ++C RP R++ I++F
Sbjct: 228 ER-----------LPQPPICTIDVYMIMVKCWMIDADSRPKFREL-----------IIEF 265
Query: 1243 DKLHIDP 1249
K+ DP
Sbjct: 266 SKMARDP 272
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 1e-13
Identities = 60/210 (28%), Positives = 99/210 (47%), Gaps = 21/210 (10%)
Query: 958 GSGTVYKAELA----NGATVAVKKIS-CKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHC 1012
G G+ KA L +G +K+I+ K + +EV L ++H ++V+
Sbjct: 9 GEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESF 68
Query: 1013 CNKGAGSNLLIYEYMENGSVWDWLHKQP-VNIKMRKSLDWEARLKIAVGLAQGVEYLHHD 1071
+ G+ ++ +Y E G ++ ++ Q V + LDW ++ +A L H
Sbjct: 69 --EENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLA---------LKHV 117
Query: 1072 CVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYA 1131
KILHRDIKS NI L + LGDFG+A+ L NS E G+ Y++PE
Sbjct: 118 HDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVL----NSTVELARTCIGTPYYLSPEIC 173
Query: 1132 YSLKATEKCDVYSMGIVLMELVSGKMPTDA 1161
+ K D++++G VL E+ + K +A
Sbjct: 174 ENRPYNNKSDIWALGCVLYEMCTLKHAFEA 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 2e-13
Identities = 56/218 (25%), Positives = 102/218 (46%), Gaps = 27/218 (12%)
Query: 954 IGSGGSGTVYKA-ELANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHC 1012
+G G +G V+ A + VAVKKI D + K RE+K + R+ H ++VK+
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSV-KHALREIKIIRRLDHDNIVKVYEVL 71
Query: 1013 CNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWE------ARLKIAVGLAQGVE 1066
G+ + E SV+ + ++ + + L+ ARL L +G++
Sbjct: 72 GPSGSDLTEDVGSLTELNSVY--IVQEYMETDLANVLEQGPLSEEHARL-FMYQLLRGLK 128
Query: 1067 YLHHDCVPKILHRDIKSSNILLDS-NMEAHLGDFGLAKALVEDYN-----SNTESNTWFA 1120
Y+H +LHRD+K +N+ +++ ++ +GDFGLA+ + Y+ S W
Sbjct: 129 YIHS---ANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKW-- 183
Query: 1121 GSYGYIAPEYAYSLKA-TEKCDVYSMGIVLMELVSGKM 1157
Y +P S T+ D+++ G + E+++GK
Sbjct: 184 ----YRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKP 217
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 2e-13
Identities = 69/244 (28%), Positives = 112/244 (45%), Gaps = 30/244 (12%)
Query: 954 IGSGGSGTVYKA-ELANGATVAVKKISCKDDHLLNKSFT-REVKTLGRIRHRHLVKL--- 1008
IG G G V A VA+KKI+ D+ ++ T RE+K L + H +++ +
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDI 72
Query: 1009 MGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYL 1068
M + ++YE M+ LH+ I+ ++L + L +G++Y+
Sbjct: 73 MPPPHREAFNDVYIVYELMDTD-----LHQI---IRSSQTLSDDHCQYFLYQLLRGLKYI 124
Query: 1069 HHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTE--SNTWFAGSYGYI 1126
H +LHRD+K SN+LL++N + + DFGLA+ E + TE W Y
Sbjct: 125 HS---ANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRW------YR 175
Query: 1127 APEYAYSL-KATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSARE 1185
APE + + T DV+S+G + EL+ K D V +++ E+ GS E
Sbjct: 176 APELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGK-----DYVHQLKLITELLGSPSE 230
Query: 1186 ELLD 1189
E L
Sbjct: 231 EDLG 234
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 2e-13
Identities = 57/216 (26%), Positives = 103/216 (47%), Gaps = 30/216 (13%)
Query: 950 DEFI-IGSGGSGTVYKA-ELANGATVAVKKISCKDDH----LLNKSFTREVKTLGRIRHR 1003
D F+ IG G +G V A + + G VAVKK+ + L N EV + +H
Sbjct: 22 DNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFN-----EVVIMRDYQHP 76
Query: 1004 HLVKLMGHCCNKGAGSNL-LIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLA 1062
++V++ + G L ++ E++E G++ D I ++ E + + +
Sbjct: 77 NIVEMYS---SYLVGDELWVVMEFLEGGALTD--------IVTHTRMNEEQIATVCLAVL 125
Query: 1063 QGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGS 1122
+ + +LH ++HRDIKS +ILL S+ L DFG + ++ G+
Sbjct: 126 KALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE----VPRRKSLVGT 178
Query: 1123 YGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMP 1158
++APE L + D++S+GI+++E+V G+ P
Sbjct: 179 PYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 2e-13
Identities = 68/275 (24%), Positives = 117/275 (42%), Gaps = 41/275 (14%)
Query: 973 VAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIYEYMENGSV 1032
VAVK + + F +EVK L R+ ++ +L+G C +I EYMENG +
Sbjct: 49 VAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVD--PPLCMIMEYMENGDL 106
Query: 1033 WDWLHK---QPVNIKM-RKSLDWEARLKIAVGLAQGVEYL-HHDCVPKILHRDIKSSNIL 1087
+L K + + KSL + L +A +A G+ YL + V HRD+ + N L
Sbjct: 107 NQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFV----HRDLATRNCL 162
Query: 1088 LDSNMEAHLGDFGLAKALVE-DYNSNTESNT-----WFAGSYGYIAPEYAYSLKATEKCD 1141
+ N + DFG+++ L DY + W +A E K T K D
Sbjct: 163 VGKNYTIKIADFGMSRNLYSSDY-YRVQGRAPLPIRW-------MAWESVLLGKFTTKSD 214
Query: 1142 VYSMGIVLMELVS--GKMPTDATFGVEMDMVRWVEMHMEM-SGSAREELLDDQMKPLLPG 1198
V++ G+ L E+++ + P + + + +E R+ L P P
Sbjct: 215 VWAFGVTLWEILTLCREQPYE-----HLTDQQVIENAGHFFRDDGRQIYLP--RPPNCPK 267
Query: 1199 EECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLN 1233
+ + E+ L+C + ++RP+ R++ L
Sbjct: 268 D------IYELMLECWRRDEEDRPTFREIHLFLQR 296
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 2e-13
Identities = 76/296 (25%), Positives = 130/296 (43%), Gaps = 46/296 (15%)
Query: 946 NNLSDEFIIGSGGSGTVYKAELA----NGATVAVKKISCKDDHLLNKSFTREVKTLGRIR 1001
+ + E +IG+G G V L VA+K + + F E +G+
Sbjct: 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFD 63
Query: 1002 HRHLVKLMGHCCNKGAGSNLLIYEYMENGSVWDWLHK---QPVNIKMRKSLDWEARLKIA 1058
H +++ L G + +++ EYMENGS+ +L K Q I++ + +
Sbjct: 64 HPNIIHLEGVVTK--SKPVMIVTEYMENGSLDAFLRKHDGQFTVIQL---------VGML 112
Query: 1059 VGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTW 1118
G+A G++YL +HRD+ + NIL++SN+ + DFGL++ L ED +
Sbjct: 113 RGIASGMKYLSD---MGYVHRDLAARNILVNSNLVCKVSDFGLSRVL-EDDPEAAYTTRG 168
Query: 1119 FAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMVRWVEMHM 1177
+ APE K T DV+S GIV+ E++S G+ P +
Sbjct: 169 GKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP-----------------YW 211
Query: 1178 EMSGSAREELLDDQMKPLLPGEECAA--YQVLEIALQCTKTSPQERPSSRQVCDLL 1231
EMS + +++ + L +C A +Q++ L C + ERP Q+ +L
Sbjct: 212 EMSNQDVIKAIEEGYR-LPAPMDCPAALHQLM---LDCWQKDRNERPKFEQIVSIL 263
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 3e-13
Identities = 34/89 (38%), Positives = 55/89 (61%)
Query: 365 LDLSNNTLNGTIPVELFQLVALTHLYLHNNSLVGSISPFVANLSNLQELALYHNNFQGSL 424
L L N L G IP ++ +L L + L NS+ G+I P + ++++L+ L L +N+F GS+
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 425 PREIGMLVKLELLYLYDNHLSGQIPSEVG 453
P +G L L +L L N LSG++P+ +G
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 3e-13
Identities = 59/244 (24%), Positives = 103/244 (42%), Gaps = 56/244 (22%)
Query: 947 NLSDEFIIGSGGSGTVYKAE------LANGATVAVKKISCKDDHLLNKSFTREVKTLGRI 1000
NL +G G G V KA A TVAVK + + E L ++
Sbjct: 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV 60
Query: 1001 RHRHLVKLMGHCCNKGAGSNLLIYEYMENGSVWDWLH----------------------- 1037
H H++KL G C G LLI EY + GS+ +L
Sbjct: 61 NHPHVIKLYGACSQDGP--LLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDN 118
Query: 1038 --KQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAH 1095
++ + + S W+ +++G++YL K++HRD+ + N+L+ +
Sbjct: 119 PDERALTMGDLISFAWQ--------ISRGMQYLAE---MKLVHRDLAARNVLVAEGRKMK 167
Query: 1096 LGDFGLAKALVEDYNSNTESNTWFAGSYG-----YIAPEYAYSLKATEKCDVYSMGIVLM 1150
+ DFGL++ + E+ +++ S G ++A E + T + DV+S G++L
Sbjct: 168 ISDFGLSRDVYEE-------DSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLW 220
Query: 1151 ELVS 1154
E+V+
Sbjct: 221 EIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 3e-13
Identities = 61/213 (28%), Positives = 102/213 (47%), Gaps = 24/213 (11%)
Query: 955 GSGGSGTVYKAELANGATVAVKKISCKDDHLLNKSFTR----EVKTLGRIRHRHLVKLMG 1010
G+ G T+Y+ + + V K+++ L++ R E+ L ++H +++
Sbjct: 11 GAFGEATLYRRT-EDDSLVVWKEVNLTR---LSEKERRDALNEIVILSLLQHPNIIAYYN 66
Query: 1011 HCCNKGAGSNLLI-YEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLH 1069
H + LLI EY G+++D + +Q + + E L + V Y+H
Sbjct: 67 HFMDDNT---LLIEMEYANGGTLYDKIVRQKGQL-----FEEEMVLWYLFQIVSAVSYIH 118
Query: 1070 HDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPE 1129
ILHRDIK+ NI L LGDFG++K L +Y S E+ G+ Y++PE
Sbjct: 119 KA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY-SMAET---VVGTPYYMSPE 171
Query: 1130 YAYSLKATEKCDVYSMGIVLMELVSGKMPTDAT 1162
+K K D++++G VL EL++ K DAT
Sbjct: 172 LCQGVKYNFKSDIWALGCVLYELLTLKRTFDAT 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.2 bits (175), Expect = 3e-13
Identities = 64/219 (29%), Positives = 101/219 (46%), Gaps = 44/219 (20%)
Query: 954 IGSGGSGTVYKA-ELANGATVAVKKISCK-DDHLLNKSFTREVKTLGRIRHRHLVKLMG- 1010
IG G G VYKA + G VA+KKI + +D + + RE+ L + H ++V+L+
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDV 66
Query: 1011 -HCCNKGAGSNL-LIYEY--MENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVE 1066
H + L L++E+ ++ D ++ + KS ++ L QG+
Sbjct: 67 VHS-----ENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQ--------LLQGIA 113
Query: 1067 YLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKAL---VEDYNSNTESNT-WFAGS 1122
Y H ++LHRD+K N+L+D L DFGLA+A V Y E T W
Sbjct: 114 YCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTH--EVVTLW---- 164
Query: 1123 YGYIAPEY-----AYSLKATEKCDVYSMGIVLMELVSGK 1156
Y APE YS D++S+G + E+V+ +
Sbjct: 165 --YRAPEILLGSRQYSTPV----DIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 4e-13
Identities = 59/208 (28%), Positives = 99/208 (47%), Gaps = 26/208 (12%)
Query: 953 IIGSGGSGTVYKAELANGATVAVKKISCKDD--HLLNKSFTREVKTLGRIRHRHLVKLMG 1010
++G G G V+K L + VAVK +CK+D L F E + L + H ++VKL+G
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVK--TCKEDLPQELKIKFLSEARILKQYDHPNIVKLIG 59
Query: 1011 HCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLH- 1069
C + ++ E + G +L K+ +K ++ +K A+ A G+ YL
Sbjct: 60 VCTQRQ--PIYIVMELVPGGDFLSFLRKKKDELKTKQ------LVKFALDAAAGMAYLES 111
Query: 1070 HDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVED---YNSNTESNTWFAGSYGYI 1126
+C+ HRD+ + N L+ N + DFG+++ ED Y+S+ +
Sbjct: 112 KNCI----HRDLAARNCLVGENNVLKISDFGMSRQ--EDDGIYSSSGLKQI----PIKWT 161
Query: 1127 APEYAYSLKATEKCDVYSMGIVLMELVS 1154
APE + + + DV+S GI+L E S
Sbjct: 162 APEALNYGRYSSESDVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 71.8 bits (177), Expect = 4e-13
Identities = 70/228 (30%), Positives = 110/228 (48%), Gaps = 57/228 (25%)
Query: 954 IGSGGSGTVYKA-ELANGATVAVKKI-----SCKDDHLLNKSFTREVKTLGRIR-HRHLV 1006
+G G G V+KA + VA+KKI + D ++F RE+ L + H ++V
Sbjct: 15 LGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQ---RTF-REIMFLQELGDHPNIV 70
Query: 1007 KLMGHCCNKGAGSN----LLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLK------ 1056
KL+ N N L++EYME D LH V +R ++ L+
Sbjct: 71 KLL----NVIKAENDKDIYLVFEYMET----D-LHA--V---IRANI-----LEDVHKRY 111
Query: 1057 IAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSN---- 1112
I L + ++Y+H ++HRD+K SNILL+S+ L DFGLA++L E +
Sbjct: 112 IMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPV 168
Query: 1113 -TE--SNTWFAGSYGYIAPEYAY-SLKATEKCDVYSMGIVLMELVSGK 1156
T+ + W Y APE S + T+ D++S+G +L E++ GK
Sbjct: 169 LTDYVATRW------YRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 5e-13
Identities = 32/82 (39%), Positives = 50/82 (60%)
Query: 227 LNGSIPAALGRLQNLQLLNLGNNSLSGEIPSELGELSQLGYLNLMGNRLEGAIPRSFAKM 286
L G IP + +L++LQ +NL NS+ G IP LG ++ L L+L N G+IP S ++
Sbjct: 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQL 489
Query: 287 GNLQSLDLSMNRLTGGIPEEFG 308
+L+ L+L+ N L+G +P G
Sbjct: 490 TSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 5e-13
Identities = 38/86 (44%), Positives = 47/86 (54%), Gaps = 1/86 (1%)
Query: 441 DNH-LSGQIPSEVGNCSSLKWIDFFGNSFTGEIPTSIGRLKDLNFLHLRQNELVGQIPAS 499
DN L G IP+++ L+ I+ GNS G IP S+G + L L L N G IP S
Sbjct: 426 DNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPES 485
Query: 500 LGNCHQLIILDLADNKLSGGVPASFG 525
LG L IL+L N LSG VPA+ G
Sbjct: 486 LGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 5e-13
Identities = 56/213 (26%), Positives = 102/213 (47%), Gaps = 32/213 (15%)
Query: 954 IGSGGSGTVYKAE-LANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMG-- 1010
+G G TVYK G VA+K+I + + RE+ + ++H ++V+L
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVI 67
Query: 1011 HCCNKGAGSNLLIYEYMENGSVWDWL----HKQPVNIKMRKSLDWEARLKIAVGLAQGVE 1066
H NK +L++EYM+ + ++ + ++ KS ++ L +G+
Sbjct: 68 HTENK----LMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQ--------LLKGIA 114
Query: 1067 YLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYN--SNTESNTWFAGSYG 1124
+ H + ++LHRD+K N+L++ E L DFGLA+A N SN W
Sbjct: 115 FCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLW------ 165
Query: 1125 YIAPEYAY-SLKATEKCDVYSMGIVLMELVSGK 1156
Y AP+ S + D++S+G ++ E+++G+
Sbjct: 166 YRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 5e-13
Identities = 82/295 (27%), Positives = 132/295 (44%), Gaps = 55/295 (18%)
Query: 953 IIGSGGSGTVYKAELA------NGATVAVKKISCKDDHLLNKSFTREVKTLGRI-RHRHL 1005
+IG G G V KA + + A +K+ + KDDH + F E++ L ++ H ++
Sbjct: 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDH---RDFAGELEVLCKLGHHPNI 58
Query: 1006 VKLMGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPV---------NIKMRKSLDWEARLK 1056
+ L+G C ++G L EY +G++ D+L K V +L + L
Sbjct: 59 INLLGACEHRG--YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 116
Query: 1057 IAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESN 1116
A +A+G++YL + +HRD+ + NIL+ N A + DFGL++ E Y T
Sbjct: 117 FAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRG-QEVYVKKTMGR 172
Query: 1117 ---TWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMVRW 1172
W A YS+ T DV+S G++L E+VS G P +
Sbjct: 173 LPVRWMA------IESLNYSVYTT-NSDVWSYGVLLWEIVSLGGTPYCG--------MTC 217
Query: 1173 VEMHMEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQV 1227
E++ ++ R E KPL +E V ++ QC + P ERPS Q+
Sbjct: 218 AELYEKLPQGYRLE------KPLNCDDE-----VYDLMRQCWREKPYERPSFAQI 261
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 5e-13
Identities = 56/224 (25%), Positives = 97/224 (43%), Gaps = 38/224 (16%)
Query: 954 IGSGGSGTVYKA-ELANGATVAVKKISCKD-------DHLLNKSFTREVKTLGRIRHRHL 1005
+G+G G V+ + + A+K ++ + H+ N E + L + H +
Sbjct: 9 VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHN-----EKRVLKEVSHPFI 63
Query: 1006 VKLMGHCCNKGAGSNL-LIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQG 1064
++L + L ++ EY+ G ++ +L + L A +
Sbjct: 64 IRLF---WTEHDQRFLYMLMEYVPGGELFSYL-------RNSGRFSNSTGLFYASEIVCA 113
Query: 1065 VEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTW-FAGSY 1123
+EYLH +I++RD+K NILLD L DFG AK L + TW G+
Sbjct: 114 LEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD--------RTWTLCGTP 162
Query: 1124 GYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMP--TDATFGV 1165
Y+APE S + D +++GI++ E++ G P D FG+
Sbjct: 163 EYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGI 206
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 7e-13
Identities = 68/288 (23%), Positives = 125/288 (43%), Gaps = 49/288 (17%)
Query: 953 IIGSGGSGTVYKAELANGAT----VAVKKISCKDDHLLN--KSFTREVKTLGRIRHRHLV 1006
I+G G G+V + +L+ VAVK + D H + + F E + H +++
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKL-DIHTYSEIEEFLSEAACMKDFDHPNVM 64
Query: 1007 KLMGHCCN----KGAGSNLLIYEYMENGSVWDWL-----HKQPVNIKMRKSLDWEARLKI 1057
KL+G C + ++I +M++G + +L P + ++ LK
Sbjct: 65 KLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQT------LLKF 118
Query: 1058 AVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALV-EDYNSNTESN 1116
V +A G+EYL + +HRD+ + N +L +M + DFGL+K + DY
Sbjct: 119 MVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIA 175
Query: 1117 TWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMVRWVEM 1175
+IA E T K DV++ G+ + E+ + G+ P GVE E+
Sbjct: 176 KM---PVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYP---GVENH-----EI 224
Query: 1176 HMEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPS 1223
+ + R + +P E+C ++ ++ C + P++RP+
Sbjct: 225 YDYLRHGNRLK------QP----EDCLD-ELYDLMYSCWRADPKDRPT 261
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 9e-13
Identities = 40/114 (35%), Positives = 55/114 (48%), Gaps = 13/114 (11%)
Query: 1048 SLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVE 1107
DW A+ IA + GVE LH I+HRDIK N+L+D L DFGL++
Sbjct: 95 PEDW-AKQYIA-EVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSR---- 145
Query: 1108 DYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDA 1161
N N F G+ Y+APE + + D +S+G V+ E + G P A
Sbjct: 146 ----NGLENKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHA 195
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 1e-12
Identities = 59/211 (27%), Positives = 103/211 (48%), Gaps = 22/211 (10%)
Query: 954 IGSGGSGTVYKAE-LANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHC 1012
+G G G VYKA+ GA A K I K + L + + E++ L H ++VKL+G
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEEL-EDYMVEIEILATCNHPYIVKLLGAF 78
Query: 1013 CNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDC 1072
G ++ E+ G+V + +++ + L I + + ++YLH
Sbjct: 79 YWDGKLW--IMIEFCPGGAV------DAIMLELDRGLTEPQIQVICRQMLEALQYLHSM- 129
Query: 1073 VPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAY 1132
KI+HRD+K+ N+LL + + L DFG++ V+ + F G+ ++APE
Sbjct: 130 --KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVK----TLQRRDSFIGTPYWMAPEVVM 183
Query: 1133 --SLKATE---KCDVYSMGIVLMELVSGKMP 1158
++K T K D++S+GI L+E+ + P
Sbjct: 184 CETMKDTPYDYKADIWSLGITLIEMAQIEPP 214
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 1e-12
Identities = 59/215 (27%), Positives = 105/215 (48%), Gaps = 27/215 (12%)
Query: 954 IGSGGSGTVYKA-ELANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHC 1012
+G G G+VYK G T+A+K+I + D E+ L + ++V G
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68
Query: 1013 CNKGAGSNLLIY---EYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLH 1069
+GA +Y EYM+ GS+ D L+ V + + + +I + +G+++L
Sbjct: 69 FIEGA-----VYMCMEYMDAGSL-DKLYAGGVATE---GIPEDVLRRITYAVVKGLKFLK 119
Query: 1070 HDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPE 1129
+ I+HRD+K +N+L++ N + L DFG++ LV S ++N G Y+APE
Sbjct: 120 EE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVA---SLAKTNI---GCQSYMAPE 171
Query: 1130 YAYSLKATE------KCDVYSMGIVLMELVSGKMP 1158
S + + DV+S+G+ ++E+ G+ P
Sbjct: 172 RIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYP 206
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 2e-12
Identities = 60/221 (27%), Positives = 98/221 (44%), Gaps = 25/221 (11%)
Query: 954 IGSGGSGTVYKAELAN------GATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVK 1007
+G G G V+ AE N VAVK + + + F RE + L ++H+H+V+
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESA-RQDFQREAELLTVLQHQHIVR 71
Query: 1008 LMGHCCNKGAGSNLL-IYEYMENGSVWDWLHKQPVNIKMRKS--------LDWEARLKIA 1058
G C G LL ++EYM +G + +L + K+ L L IA
Sbjct: 72 FYGVCTE---GRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIA 128
Query: 1059 VGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTW 1118
+A G+ YL +HRD+ + N L+ + +GDFG+++ + T
Sbjct: 129 SQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTM 185
Query: 1119 FAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMP 1158
++ PE K T + D++S G+VL E+ + GK P
Sbjct: 186 L--PIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 2e-12
Identities = 77/296 (26%), Positives = 122/296 (41%), Gaps = 43/296 (14%)
Query: 953 IIGSGGSGTVY----KAELANGA---TVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHL 1005
+GSG G VY L G+ VAVK + K F +E + H ++
Sbjct: 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNI 61
Query: 1006 VKLMGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGV 1065
VKL+G C +I E ME G + +L V L + L I + +A+G
Sbjct: 62 VKLLGVCLLN--EPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGC 119
Query: 1066 EYLHHDCVPKILHRDIKSSNILL-----DSNMEAHLGDFGLAKALVED--YNSNTESNTW 1118
YL +HRD+ + N L+ D++ +GDFGLA+ + + Y E
Sbjct: 120 VYLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLL- 175
Query: 1119 FAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMVRWVEMHM 1177
++APE K T + DV+S G+++ E+++ G+ P A E V H+
Sbjct: 176 ---PVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE------VLQHV 226
Query: 1178 EMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLN 1233
G Q P + YQ++ C P ERP+ ++ ++L N
Sbjct: 227 TAGGRL-------QKPENCPDK---IYQLM---TNCWAQDPSERPTFDRIQEILQN 269
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 2e-12
Identities = 59/220 (26%), Positives = 102/220 (46%), Gaps = 21/220 (9%)
Query: 945 TNNLSDEFIIGSGGSGTVYKAE-LANGATVAVKKISCKD--DHLLNKSFTREVKTLGRIR 1001
N E IG G VYKA L +G VA+KK+ + D + +E+ L ++
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 1002 HRHLVKLMGHCCNKGAGSNLLI--YEYMENGSVWDWLHKQPVNIKMRKSLDWEARL-KIA 1058
H +++K + +N L E + G L + + K +K L E + K
Sbjct: 61 HPNVIKYLASFIE----NNELNIVLELADAGD----LSRMIKHFKKQKRLIPERTIWKYF 112
Query: 1059 VGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTW 1118
V L +E++H +I+HRDIK +N+ + + LGD GL + ++S T +
Sbjct: 113 VQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRF----FSSKTTAAHS 165
Query: 1119 FAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMP 1158
G+ Y++PE + K D++S+G +L E+ + + P
Sbjct: 166 LVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 2e-12
Identities = 76/287 (26%), Positives = 129/287 (44%), Gaps = 48/287 (16%)
Query: 953 IIGSGGSGTVYKAELANGAT----VAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKL 1008
+IG G G VY L + AVK ++ D + F +E + H +++ L
Sbjct: 2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSL 61
Query: 1009 MGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGL--AQGVE 1066
+G C GS L++ YM++G + +++ + N + K L I GL A+G+E
Sbjct: 62 LGICLPS-EGSPLVVLPYMKHGDLRNFIRSETHNPTV-KDL-------IGFGLQVAKGME 112
Query: 1067 YLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYI 1126
YL K +HRD+ + N +LD + + DFGLA+ + + + ++T ++
Sbjct: 113 YLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWM 169
Query: 1127 APEYAYSLKATEKCDVYSMGIVLMELVSGKMP----TDATFGVEMDMVRWVEMHMEMSGS 1182
A E + K T K DV+S G++L EL++ P D+ D+ +
Sbjct: 170 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS-----FDITVY---------- 214
Query: 1183 AREELLDDQMKPLLPGEEC--AAYQVLEIALQCTKTSPQERPSSRQV 1227
LL Q + LL E C Y+V+ L C P+ RP+ ++
Sbjct: 215 ----LL--QGRRLLQPEYCPDPLYEVM---LSCWHPKPEMRPTFSEL 252
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.6 bits (171), Expect = 2e-12
Identities = 67/224 (29%), Positives = 106/224 (47%), Gaps = 32/224 (14%)
Query: 947 NLSDEF----IIGSGGSGTVYKA-ELANGATVAVKKISCKDDHLLNKSFTREVKTLGRIR 1001
++ + IG G G V A G VA+KKIS + + RE+K L R +
Sbjct: 2 DVGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFK 61
Query: 1002 HRHLVKLMGHCCNKGAGSNLLIY---EYMENGSVWDWLHKQPVNIKMRK-SLDWEARLKI 1057
H +++ ++ S +Y E ME L+K IK + S D I
Sbjct: 62 HENIIGILDIIRPPSFESFNDVYIVQELMETD-----LYKL---IKTQHLSND-----HI 108
Query: 1058 AVGLAQ---GVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNS-NT 1113
L Q G++Y+H V LHRD+K SN+LL++N + + DFGLA+ + D +T
Sbjct: 109 QYFLYQILRGLKYIHSANV---LHRDLKPSNLLLNTNCDLKICDFGLAR--IADPEHDHT 163
Query: 1114 ESNTWFAGSYGYIAPEYAYSLKA-TEKCDVYSMGIVLMELVSGK 1156
T + + Y APE + K T+ D++S+G +L E++S +
Sbjct: 164 GFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 69.0 bits (168), Expect = 2e-12
Identities = 55/211 (26%), Positives = 101/211 (47%), Gaps = 29/211 (13%)
Query: 954 IGSGGSGTVYKA-ELANGATVAVKKISC----KDDHLLNKSFTREVKTLGRIRHRHLVKL 1008
IG G SGTVY A ++A G VA+++++ K + ++N E+ + ++ ++V
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIIN-----EILVMRENKNPNIVNY 82
Query: 1009 MGHCCNKGAGSNL-LIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEY 1067
+ G L ++ EY+ GS+ D + +D + Q +E+
Sbjct: 83 LDSYL---VGDELWVVMEYLAGGSLTD--------VVTETCMDEGQIAAVCRECLQALEF 131
Query: 1068 LHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIA 1127
LH + +++HRDIKS NILL + L DFG + + + + G+ ++A
Sbjct: 132 LHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST----MVGTPYWMA 184
Query: 1128 PEYAYSLKATEKCDVYSMGIVLMELVSGKMP 1158
PE K D++S+GI+ +E++ G+ P
Sbjct: 185 PEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 3e-12
Identities = 79/246 (32%), Positives = 120/246 (48%), Gaps = 10/246 (4%)
Query: 207 IPAELGNCSSLSIFTAAENNLNGSIPAALGRLQNLQLLNLGNNSLSGEIPSELGELSQLG 266
+P+ L SL + + + + L L L L+L N L I SEL EL+ L
Sbjct: 62 LPSSLSRLLSLDLLSPSGISSLDGSEN-LLNLLPLPSLDLNLNRLRSNI-SELLELTNLT 119
Query: 267 YLNLMGNRLEGAIPRSFAKMGNLQSLDLSMNRLTGGIPEEFGNMGQLVFLVLSNNNISGS 326
L+L N + P NL+ LDLS N++ +P N+ L L LS N++S
Sbjct: 120 SLDLDNNNITDIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-D 177
Query: 327 IPRRICTNATSLEHLILAEIQLSGEIPVELSQCQSLKQLDLSNNTLNGTIPVELFQLVAL 386
+P+ + N ++L +L L+ ++S ++P E+ +L++LDLSNN++ + L L L
Sbjct: 178 LPKLLS-NLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNL 234
Query: 387 THLYLHNNSLVGSISPFVANLSNLQELALYHNNFQGSLPREIGMLVKLELLYLYDNHLSG 446
+ L L NN L + NLSNL+ L L +N Q S +G L L L L N LS
Sbjct: 235 SGLELSNNKLEDLPES-IGNLSNLETLDLSNN--QISSISSLGSLTNLRELDLSGNSLSN 291
Query: 447 QIPSEV 452
+P
Sbjct: 292 ALPLIA 297
|
Length = 394 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 3e-12
Identities = 62/215 (28%), Positives = 104/215 (48%), Gaps = 29/215 (13%)
Query: 954 IGSGGSGTVYKA---ELANGATVAVKKISCK-DDHLLNKSFTREVKTLGRIRHRHLVKLM 1009
+GSG GTV K + TVAVK + +D L RE + ++ + ++V+++
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 1010 GHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLH 1069
G C A S +L+ E E G + +L K K + + ++ ++ G++YL
Sbjct: 63 GIC---EAESWMLVMELAELGPLNKFLQKN-------KHVTEKNITELVHQVSMGMKYLE 112
Query: 1070 HDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYG----- 1124
+HRD+ + N+LL + A + DFGL+KAL D N + A ++G
Sbjct: 113 ET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGAD------ENYYKAKTHGKWPVK 163
Query: 1125 YIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMP 1158
+ APE K + K DV+S G+++ E S G+ P
Sbjct: 164 WYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.3 bits (168), Expect = 3e-12
Identities = 59/227 (25%), Positives = 97/227 (42%), Gaps = 61/227 (26%)
Query: 954 IGSGGSGTVYKA-ELANGATVAVKKISCKDDHLLNKSFT--------REVKTLGRI-RHR 1003
+G G G+VY A G VA+KK + K F REVK+L ++ H
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKK--------MKKKFYSWEECMNLREVKSLRKLNEHP 58
Query: 1004 HLVKLM------GHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKS--LDWEARL 1055
++VKL ++EYME L++ +K RK E+ +
Sbjct: 59 NIVKLKEVFRENDELY--------FVFEYMEGN-----LYQL---MKDRKGKPFS-ESVI 101
Query: 1056 K-IAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTE 1114
+ I + QG+ ++H HRD+K N+L+ + DFGLA+ + T+
Sbjct: 102 RSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLARE-IRSRPPYTD 157
Query: 1115 --SNTWFAGSYGYIAPEYAYSLKATE---KCDVYSMGIVLMELVSGK 1156
S W Y APE L++T D++++G ++ EL + +
Sbjct: 158 YVSTRW------YRAPEIL--LRSTSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 3e-12
Identities = 66/216 (30%), Positives = 104/216 (48%), Gaps = 29/216 (13%)
Query: 954 IGSGGSGTVYKA---ELANGATVAVKKIS-CKDDHLLNKSFTREVKTLGRIR-HRHLVKL 1008
+G G G V A E + TVA+KKI+ +L K RE+K L R H+++ L
Sbjct: 8 LGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCL 67
Query: 1009 MG-HCCNKGAGSNLLIY-EYMENGSVWDWLHK-----QPVNIKMRKSLDWEARLKIAVGL 1061
G + L +Y E ME LH+ QP+ +S ++ +
Sbjct: 68 YDMDIVFPGNFNELYLYEELMEAD-----LHQIIRSGQPLTDAHFQSFIYQ--------I 114
Query: 1062 AQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAG 1121
G++Y+H V LHRD+K N+L++++ E + DFGLA+ E+ N T +
Sbjct: 115 LCGLKYIHSANV---LHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVA 171
Query: 1122 SYGYIAPEYAYSLKA-TEKCDVYSMGIVLMELVSGK 1156
+ Y APE S ++ T+ DV+S+G +L EL+ K
Sbjct: 172 TRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 68.4 bits (168), Expect = 3e-12
Identities = 61/215 (28%), Positives = 98/215 (45%), Gaps = 35/215 (16%)
Query: 954 IGSGGSGTVYKA-ELANGATVAVKKISCKDDHLLNKSFT--REVKTLGRIRHRHLVKLMG 1010
I G G VY+A + G VA+KK+ + T RE+ L +++H ++V +
Sbjct: 13 IEEGTYGVVYRARDKKTGEIVALKKLKM-EKEKEGFPITSLREINILLKLQHPNIVTVKE 71
Query: 1011 HCCNKGAGSNLLIYEYMENG--SVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYL 1068
++ EY+E+ S+ + KQP K L + L GV +L
Sbjct: 72 VVVGSNLDKIYMVMEYVEHDLKSLME-TMKQPFLQSEVKCL--------MLQLLSGVAHL 122
Query: 1069 HHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNT------WFAGS 1122
H + ILHRD+K+SN+LL++ + DFGLA+ +Y S + T W
Sbjct: 123 HDN---WILHRDLKTSNLLLNNRGILKICDFGLAR----EYGSPLKPYTQLVVTLW---- 171
Query: 1123 YGYIAPEYAYSLKA-TEKCDVYSMGIVLMELVSGK 1156
Y APE K + D++S+G + EL++ K
Sbjct: 172 --YRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 3e-12
Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 22/211 (10%)
Query: 954 IGSGGSGTVYKA-ELANGATVAVKKISCK-DDHLLNKSFTREVKTLGRIR---HRHLVKL 1008
IG G GTVYKA + +G VA+K + + ++ L S REV L R+ H ++V+L
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 1009 MGHCCNKGAGSNL---LIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGV 1065
M C L++E+++ + +L K P L E + +G+
Sbjct: 68 MDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPP-----PGLPAETIKDLMRQFLRGL 121
Query: 1066 EYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGY 1125
++LH +C I+HRD+K NIL+ S + L DFGLA+ S + T + Y
Sbjct: 122 DFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIY-----SCQMALTPVVVTLWY 173
Query: 1126 IAPEYAYSLKATEKCDVYSMGIVLMELVSGK 1156
APE D++S+G + E+ K
Sbjct: 174 RAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 4e-12
Identities = 56/211 (26%), Positives = 102/211 (48%), Gaps = 29/211 (13%)
Query: 954 IGSGGSGTVYKA-ELANGATVAVKKISC----KDDHLLNKSFTREVKTLGRIRHRHLVKL 1008
IG G SGTV+ A ++A G VA+K+I+ K + ++N E+ + +++ ++V
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIIN-----EILVMKELKNPNIVNF 81
Query: 1009 MGHCCNKGAGSNL-LIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEY 1067
+ G L ++ EY+ GS+ D + +D + Q +E+
Sbjct: 82 LDSFL---VGDELFVVMEYLAGGSLTD--------VVTETCMDEAQIAAVCRECLQALEF 130
Query: 1068 LHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIA 1127
LH + +++HRDIKS N+LL + L DFG + + + + G+ ++A
Sbjct: 131 LHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRST----MVGTPYWMA 183
Query: 1128 PEYAYSLKATEKCDVYSMGIVLMELVSGKMP 1158
PE K D++S+GI+ +E+V G+ P
Sbjct: 184 PEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 4e-12
Identities = 68/232 (29%), Positives = 101/232 (43%), Gaps = 58/232 (25%)
Query: 953 IIGSGGSGTVYKA-ELANGATVAVKKISCKDDHLLNKSF----TREVKTLGRIRHRHLVK 1007
IG G G VYKA + G VA+KK+ ++ + F RE+K L ++ HR++V
Sbjct: 14 QIGEGTYGQVYKARDKDTGELVALKKVRLDNE---KEGFPITAIREIKILRQLNHRNIVN 70
Query: 1008 LMGHCCN--------KGAGSNLLIYEYM--------ENGSVWDWLHKQPVNIKMRKSLDW 1051
L + K G+ L++EYM E+G V + + M++ L+
Sbjct: 71 LKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLV-HFSEDHIKSF-MKQLLE- 127
Query: 1052 EARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYN- 1110
G+ Y H LHRDIK SNILL++ + L DFGLA+ + +
Sbjct: 128 ------------GLNYCHKK---NFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESR 172
Query: 1111 --SNTESNTWFAGSYGYIAPEYAYSLKATEK----CDVYSMGIVLMELVSGK 1156
+N W Y PE L E+ DV+S G +L EL + K
Sbjct: 173 PYTNKVITLW------YRPPEL---LLGEERYGPAIDVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 5e-12
Identities = 36/92 (39%), Positives = 52/92 (56%)
Query: 649 LSHIDLNNNLLSGAVPSWLGTLPQLGELKLSFNQFVGFLPRELFNCSKLLVLSLDGNMLN 708
+ + L+N L G +P+ + L L + LS N G +P L + + L VL L N N
Sbjct: 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFN 479
Query: 709 GSLPNEVGNLASLNVLTLSGNLLSGPIPPAIG 740
GS+P +G L SL +L L+GN LSG +P A+G
Sbjct: 480 GSIPESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 6e-12
Identities = 61/215 (28%), Positives = 102/215 (47%), Gaps = 24/215 (11%)
Query: 953 IIGSGGSGTVYKAE-LANGATVAVKKIS----CKDDHLLNKSFTREVKTLGRIRHRHLVK 1007
++G G G V+ A+ V +K+I KD+ L + E + L + H ++++
Sbjct: 7 VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERL---AAQNECQVLKLLSHPNIIE 63
Query: 1008 LMGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEY 1067
+ A +++ EY G++ +++ K+ LD + L V Q +
Sbjct: 64 YYENFLEDKA--LMIVMEYAPGGTLAEYIQKR-----CNSLLDEDTILHFFV---QILLA 113
Query: 1068 LHHDCVPKILHRDIKSSNILLDSN-MEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYI 1126
LHH ILHRD+K+ NILLD + M +GDFG++K L + T G+ YI
Sbjct: 114 LHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT-----VVGTPCYI 168
Query: 1127 APEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDA 1161
+PE +K D++++G VL EL S K +A
Sbjct: 169 SPELCEGKPYNQKSDIWALGCVLYELASLKRAFEA 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 6e-12
Identities = 63/232 (27%), Positives = 103/232 (44%), Gaps = 36/232 (15%)
Query: 953 IIGSGGSGTVYKA-ELANGATVAVKKI--SCKDDHLLNKSFTREVKTLGRIRHRHLVKLM 1009
+IG GG G VY A + VA+KKI ++ LL K F RE K + H +V +
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68
Query: 1010 GHCCNKGAGSNLLIYE--YMEN-------GSVWDWLHKQPVNIKMRKSLDWEARLKIAVG 1060
C + + + Y Y+E SVW K+ ++ ++ + A L I
Sbjct: 69 SICSD----GDPVYYTMPYIEGYTLKSLLKSVW---QKESLSKELAEKTSVGAFLSIFHK 121
Query: 1061 LAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKAL-----VEDYNSNTES 1115
+ +EY+H +LHRD+K NILL E + D+G A E
Sbjct: 122 ICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDER 178
Query: 1116 NTWFA---------GSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMP 1158
N ++ G+ Y+APE + A+E D+Y++G++L ++++ P
Sbjct: 179 NICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230
|
Length = 932 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 7e-12
Identities = 61/212 (28%), Positives = 97/212 (45%), Gaps = 18/212 (8%)
Query: 953 IIGSGGSGTVYKA-ELANGATVAVKKISCKDDHLLN----KSFTREVKTLGRIRHRHLVK 1007
++G G G VY + G +AVK++ + + E++ L + H +V+
Sbjct: 9 LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68
Query: 1008 LMGHCCNKGAGSNLLIY-EYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVE 1066
G C L I+ E+M GS+ D L K +L K + +GV
Sbjct: 69 YYG-CLRDPMERTLSIFMEHMPGGSIKDQL-------KSYGALTENVTRKYTRQILEGVS 120
Query: 1067 YLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYI 1126
YLH + I+HRDIK +NIL DS LGDFG +K L S T + G+ ++
Sbjct: 121 YLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKS-VTGTPYWM 176
Query: 1127 APEYAYSLKATEKCDVYSMGIVLMELVSGKMP 1158
+PE K D++S+G ++E+++ K P
Sbjct: 177 SPEVISGEGYGRKADIWSVGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 7e-12
Identities = 61/225 (27%), Positives = 99/225 (44%), Gaps = 44/225 (19%)
Query: 954 IGSGGSGTVYKAE-LANGATVAVKKISCK-DDHLLNKSFTREVKTLGRIRHRHLVKLMG- 1010
IG G G VYKA G VA+KKI + + + RE+ L + H ++VKL+
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 67
Query: 1011 -HCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLA------- 1062
H NK L++E++ + ++K +D I + L
Sbjct: 68 IHTENK----LYLVFEFL--------------HQDLKKFMDASPLSGIPLPLIKSYLFQL 109
Query: 1063 -QGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTES--NTWF 1119
QG+ + H ++LHRD+K N+L+++ L DFGLA+A + T W
Sbjct: 110 LQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLW- 165
Query: 1120 AGSYGYIAPEYAYSLK-ATEKCDVYSMGIVLMELVSGK--MPTDA 1161
Y APE K + D++S+G + E+V+ + P D+
Sbjct: 166 -----YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 205
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 7e-12
Identities = 71/236 (30%), Positives = 106/236 (44%), Gaps = 21/236 (8%)
Query: 936 FRWEDIMGATNNLSD-----EFI--IGSGGSGTVYK-AELANGATVAVKKISCKDDHLLN 987
F + M +L D E I IG G G VYK +G+ AVK + D ++
Sbjct: 5 FPYNSSMLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD--VD 62
Query: 988 KSFTREVKTLGRI-RHRHLVKLMG--HCCNKGAGSNL-LIYEYMENGSVWDWLHKQPVNI 1043
+ E L + H ++VK G + +K G L L+ E GSV + + +
Sbjct: 63 EEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGL---L 119
Query: 1044 KMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAK 1103
+ LD I G G+++LH++ +I+HRD+K +NILL + L DFG++
Sbjct: 120 ICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSA 176
Query: 1104 ALVED-YNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMP 1158
L NT T F + IA E Y +CDV+S+GI +EL G P
Sbjct: 177 QLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPP 232
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 7e-12
Identities = 50/165 (30%), Positives = 80/165 (48%), Gaps = 24/165 (14%)
Query: 953 IIGSGGSGTVYKA-ELANGATVAVKKISCKDDHLLNKSFT----REVKTLGRIRHRHLVK 1007
IG G G V+KA VA+KK+ +++ + F RE+K L ++H ++V
Sbjct: 19 KIGQGTFGEVFKARHKKTKQIVALKKVLMENE---KEGFPITALREIKILQLLKHENVVN 75
Query: 1008 LMGHCCNKGAGSN------LLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGL 1061
L+ C K N L++E+ E+ L N ++ +L K+ L
Sbjct: 76 LIEICRTKATPYNRYKGSFYLVFEFCEHD-----LAGLLSNKNVKFTL--SEIKKVMKML 128
Query: 1062 AQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALV 1106
G+ Y+H + KILHRD+K++NIL+ + L DFGLA+A
Sbjct: 129 LNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARAFS 170
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 7e-12
Identities = 60/211 (28%), Positives = 101/211 (47%), Gaps = 19/211 (9%)
Query: 953 IIGSGGSGTVYKA-ELANGATVAVKKISCKDDHLLNKS-FTREVKTLGRIRHRHLVK--- 1007
+IG G G V A + G VA+KKI+ +H+ + + RE+K L +RH +V+
Sbjct: 7 VIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKH 66
Query: 1008 LMGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEY 1067
+M + +++E ME+ LH+ IK L E L + ++Y
Sbjct: 67 IMLPPSRREFKDIYVVFELMESD-----LHQV---IKANDDLTPEHHQFFLYQLLRALKY 118
Query: 1068 LHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIA 1127
+H + HRD+K NIL +++ + + DFGLA+ D + + A + Y A
Sbjct: 119 IH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRW-YRA 174
Query: 1128 PEYAYSL--KATEKCDVYSMGIVLMELVSGK 1156
PE S K T D++S+G + E+++GK
Sbjct: 175 PELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 8e-12
Identities = 39/89 (43%), Positives = 50/89 (56%)
Query: 100 LDLSSNSLTGPIPTALSNLSSLESLLLFSNQLAGTIPTQLGSLTSLRVMRIGDNWLSGSI 159
L L + L G IP +S L L+S+ L N + G IP LGS+TSL V+ + N +GSI
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 160 PTSFGNLVNLGTLGLASCSLSGPIPPQFG 188
P S G L +L L L SLSG +P G
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 8e-12
Identities = 35/89 (39%), Positives = 53/89 (59%)
Query: 413 LALYHNNFQGSLPREIGMLVKLELLYLYDNHLSGQIPSEVGNCSSLKWIDFFGNSFTGEI 472
L L + +G +P +I L L+ + L N + G IP +G+ +SL+ +D NSF G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 473 PTSIGRLKDLNFLHLRQNELVGQIPASLG 501
P S+G+L L L+L N L G++PA+LG
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 1e-11
Identities = 35/68 (51%), Positives = 43/68 (63%)
Query: 75 SLNLSGLSLAGSISPSLGRLQSLIHLDLSSNSLTGPIPTALSNLSSLESLLLFSNQLAGT 134
S+NLSG S+ G+I PSLG + SL LDLS NS G IP +L L+SL L L N L+G
Sbjct: 446 SINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGR 505
Query: 135 IPTQLGSL 142
+P LG
Sbjct: 506 VPAALGGR 513
|
Length = 623 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 1e-11
Identities = 59/212 (27%), Positives = 99/212 (46%), Gaps = 22/212 (10%)
Query: 950 DEFI-IGSGGSGTVYKA-ELANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVK 1007
D FI IG G +G V A E G VAVKK+ + F EV + H ++V
Sbjct: 25 DSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFN-EVVIMRDYHHENVVD 83
Query: 1008 LMGHCCNKGAGSNL-LIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVE 1066
+ G L ++ E++E G++ D I ++ E + + + + +
Sbjct: 84 MYNSYL---VGDELWVVMEFLEGGALTD--------IVTHTRMNEEQIATVCLSVLRALS 132
Query: 1067 YLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYI 1126
YLH+ V +HRDIKS +ILL S+ L DFG + ++ G+ ++
Sbjct: 133 YLHNQGV---IHRDIKSDSILLTSDGRIKLSDFGFCAQVSKE----VPKRKSLVGTPYWM 185
Query: 1127 APEYAYSLKATEKCDVYSMGIVLMELVSGKMP 1158
APE L + D++S+GI+++E++ G+ P
Sbjct: 186 APEVISRLPYGTEVDIWSLGIMVIEMIDGEPP 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 66.7 bits (162), Expect = 1e-11
Identities = 56/211 (26%), Positives = 101/211 (47%), Gaps = 29/211 (13%)
Query: 954 IGSGGSGTVYKA-ELANGATVAVKKISC----KDDHLLNKSFTREVKTLGRIRHRHLVKL 1008
IG G SGTVY A ++A G VA+K+++ K + ++N E+ + ++ ++V
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIIN-----EILVMRENKNPNIVNY 81
Query: 1009 MGHCCNKGAGSNL-LIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEY 1067
+ G L ++ EY+ GS+ D + +D + Q +++
Sbjct: 82 LDSYL---VGDELWVVMEYLAGGSLTD--------VVTETCMDEGQIAAVCRECLQALDF 130
Query: 1068 LHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIA 1127
LH + +++HRDIKS NILL + L DFG + + + + G+ ++A
Sbjct: 131 LHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST----MVGTPYWMA 183
Query: 1128 PEYAYSLKATEKCDVYSMGIVLMELVSGKMP 1158
PE K D++S+GI+ +E+V G+ P
Sbjct: 184 PEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-11
Identities = 69/220 (31%), Positives = 99/220 (45%), Gaps = 43/220 (19%)
Query: 954 IGSGGSGTVYKA-ELANGATVAVK--KISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMG 1010
+GSG G VYKA L G AVK K+ DD L +E+ + +H ++V G
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSL---IQQEIFMVKECKHCNIVAYFG 73
Query: 1011 HCCNKGAGSNLLI-YEYMENGSVWDWLH-KQPVNIKMRKSLDWEARLKIAV---GLAQGV 1065
++ L I EY GS+ D H P+ + L+IA QG+
Sbjct: 74 SYLSR---EKLWICMEYCGGGSLQDIYHVTGPL-----------SELQIAYVCRETLQGL 119
Query: 1066 EYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGY 1125
YLH +HRDIK +NILL N + L DFG+A + + F G+ +
Sbjct: 120 AYLHSKGK---MHRDIKGANILLTDNGDVKLADFGVAAKI----TATIAKRKSFIGTPYW 172
Query: 1126 IAPEYAYSLKATEK-------CDVYSMGIVLMELVSGKMP 1158
+APE A A EK CD++++GI +EL + P
Sbjct: 173 MAPEVA----AVEKNGGYNQLCDIWAVGITAIELAELQPP 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 2e-11
Identities = 33/83 (39%), Positives = 51/83 (61%), Gaps = 1/83 (1%)
Query: 201 NQ-LQGPIPAELGNCSSLSIFTAAENNLNGSIPAALGRLQNLQLLNLGNNSLSGEIPSEL 259
NQ L+G IP ++ L + N++ G+IP +LG + +L++L+L NS +G IP L
Sbjct: 427 NQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESL 486
Query: 260 GELSQLGYLNLMGNRLEGAIPRS 282
G+L+ L LNL GN L G +P +
Sbjct: 487 GQLTSLRILNLNGNSLSGRVPAA 509
|
Length = 623 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 2e-11
Identities = 57/212 (26%), Positives = 99/212 (46%), Gaps = 22/212 (10%)
Query: 950 DEFI-IGSGGSGTVYKAEL-ANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVK 1007
D FI IG G +G V A + ++G VAVKK+ + F EV + +H ++V+
Sbjct: 23 DNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFN-EVVIMRDYQHENVVE 81
Query: 1008 LMGHCCNKGAGSNL-LIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVE 1066
+ G L ++ E++E G++ D I ++ E + + + + +
Sbjct: 82 MYNSYL---VGDELWVVMEFLEGGALTD--------IVTHTRMNEEQIAAVCLAVLKALS 130
Query: 1067 YLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYI 1126
LH V +HRDIKS +ILL + L DFG + + G+ ++
Sbjct: 131 VLHAQGV---IHRDIKSDSILLTHDGRVKLSDFGFCAQV----SKEVPRRKSLVGTPYWM 183
Query: 1127 APEYAYSLKATEKCDVYSMGIVLMELVSGKMP 1158
APE L + D++S+GI+++E+V G+ P
Sbjct: 184 APELISRLPYGPEVDIWSLGIMVIEMVDGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 2e-11
Identities = 60/223 (26%), Positives = 95/223 (42%), Gaps = 37/223 (16%)
Query: 953 IIGSGGSGTVYKAE-LANGATVAVKKISCKDDHLLNKSFTREVKTLGRI-RHRHLVKLMG 1010
++G+G G VYK + G A+K + +D + E+ L + HR++ G
Sbjct: 23 VVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDE--EEEIKLEINMLKKYSHHRNIATYYG 80
Query: 1011 HCCNKGAGSN----LLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVE 1066
K + L+ E+ GSV D + N DW A I + +G+
Sbjct: 81 AFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKE---DWIAY--ICREILRGLA 135
Query: 1067 YLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYI 1126
+LH K++HRDIK N+LL N E L DFG++ L + F G+ ++
Sbjct: 136 HLH---AHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL----DRTVGRRNTFIGTPYWM 188
Query: 1127 APE-----------YAYSLKATEKCDVYSMGIVLMELVSGKMP 1158
APE Y Y + D++S+GI +E+ G P
Sbjct: 189 APEVIACDENPDATYDY------RSDIWSLGITAIEMAEGAPP 225
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 2e-11
Identities = 62/215 (28%), Positives = 101/215 (46%), Gaps = 24/215 (11%)
Query: 953 IIGSGGSGTVYKAELANGATVAVKKISCKD----DHLLNKSFT-REVKTLGRIRHRHLVK 1007
++G G G V AEL V K+ KD D ++ + T + + L +H L
Sbjct: 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAA-KHPFLTA 60
Query: 1008 LMGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIA-VGLAQGVE 1066
L HCC + + EY+ G + + + RK + +R A V LA +
Sbjct: 61 L--HCCFQTKDRLFFVMEYVNGGDLMFQIQRS------RKFDEPRSRFYAAEVTLA--LM 110
Query: 1067 YLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYI 1126
+LH V ++RD+K NILLD+ L DFG+ K E + + T F G+ YI
Sbjct: 111 FLHRHGV---IYRDLKLDNILLDAEGHCKLADFGMCK---EGILNGVTTTT-FCGTPDYI 163
Query: 1127 APEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDA 1161
APE L+ D +++G+++ E+++G+ P +A
Sbjct: 164 APEILQELEYGPSVDWWALGVLMYEMMAGQPPFEA 198
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 2e-11
Identities = 60/217 (27%), Positives = 96/217 (44%), Gaps = 25/217 (11%)
Query: 953 IIGSGGSGTVYKAE-LANGATVAVKKISCKDDHLLNKSFTREVKTLGRI-RHRHLVKLMG 1010
++G+G G VYK + G A+K + D + +E+ L + HR++ G
Sbjct: 13 LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE--EEEIKQEINMLKKYSHHRNIATYYG 70
Query: 1011 HCCNK---GAGSNL-LIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVE 1066
K G L L+ E+ GSV D + N +L E I + +G+
Sbjct: 71 AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGN-----TLKEEWIAYICREILRGLS 125
Query: 1067 YLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYI 1126
+LH K++HRDIK N+LL N E L DFG++ L + F G+ ++
Sbjct: 126 HLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL----DRTVGRRNTFIGTPYWM 178
Query: 1127 APEYAYSLKATE-----KCDVYSMGIVLMELVSGKMP 1158
APE + + K D++S+GI +E+ G P
Sbjct: 179 APEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 215
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 2e-11
Identities = 56/201 (27%), Positives = 95/201 (47%), Gaps = 27/201 (13%)
Query: 959 SGTVYKAELANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAG 1018
+G +Y ++ AT+ V+ D + K E L + H +VKL H + G
Sbjct: 23 AGQLYAMKVLKKATLKVR------DRVRTK---MERDILAEVNHPFIVKL--HYAFQTEG 71
Query: 1019 SNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVG-LAQGVEYLHHDCVPKIL 1077
LI +++ G ++ L K+ + E +K + LA +++LH I+
Sbjct: 72 KLYLILDFLRGGDLFTRLSKE--------VMFTEEDVKFYLAELALALDHLHS---LGII 120
Query: 1078 HRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKAT 1137
+RD+K NILLD L DFGL+K + D+ S F G+ Y+APE T
Sbjct: 121 YRDLKPENILLDEEGHIKLTDFGLSKESI-DHEKKAYS---FCGTVEYMAPEVVNRRGHT 176
Query: 1138 EKCDVYSMGIVLMELVSGKMP 1158
+ D +S G+++ E+++G +P
Sbjct: 177 QSADWWSFGVLMFEMLTGSLP 197
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 2e-11
Identities = 49/139 (35%), Positives = 75/139 (53%), Gaps = 17/139 (12%)
Query: 1022 LIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLH-HDCVPKILHRD 1080
L+ +YM G ++ W H Q K + + A+ IA L +E+LH +D I++RD
Sbjct: 73 LVTDYMSGGELF-W-HLQ----KEGRFSEDRAKFYIA-ELVLALEHLHKYD----IVYRD 121
Query: 1081 IKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKA-TEK 1139
+K NILLD+ L DFGL+KA + N +NT F G+ Y+APE K T+
Sbjct: 122 LKPENILLDATGHIALCDFGLSKA---NLTDNKTTNT-FCGTTEYLAPEVLLDEKGYTKH 177
Query: 1140 CDVYSMGIVLMELVSGKMP 1158
D +S+G+++ E+ G P
Sbjct: 178 VDFWSLGVLVFEMCCGWSP 196
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 2e-11
Identities = 59/242 (24%), Positives = 105/242 (43%), Gaps = 45/242 (18%)
Query: 946 NNLSDEFI-----IGSGGSGTVYKAE-LANGATVAVKKIS-CKDDHLLNKS--------- 989
++S+ +I +G G G V KA G VA+KK+ + + + K
Sbjct: 4 FSISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGI 63
Query: 990 -FT--REVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMR 1046
FT RE+K + I+H +++ L+ + L+ + M + K+ V+ K+R
Sbjct: 64 HFTTLRELKIMNEIKHENIMGLVDVYVEGDFIN--LVMDIMASDL------KKVVDRKIR 115
Query: 1047 KSLDWEARLK-IAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKAL 1105
+ E+++K I + + G+ LH +HRD+ +NI ++S + DFGLA+
Sbjct: 116 LT---ESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKIADFGLARRY 169
Query: 1106 VED----------YNSNTESNTWFAGSYGYIAPEYAY-SLKATEKCDVYSMGIVLMELVS 1154
E T + Y APE + K D++S+G + EL++
Sbjct: 170 GYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLT 229
Query: 1155 GK 1156
GK
Sbjct: 230 GK 231
|
Length = 335 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 3e-11
Identities = 75/287 (26%), Positives = 130/287 (45%), Gaps = 37/287 (12%)
Query: 75 SLNLSGLSLAGSISPSLGRLQSLIHLDLSSNSLTGPIPTALSNL-SSLESLLLFSNQLAG 133
SL+L+ L +IS L L +L LDL +N++T IP + L S+L+ L L N++
Sbjct: 97 SLDLNLNRLRSNISE-LLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE- 153
Query: 134 TIPTQLGSLTSLRVMRIGDNWLSGSIPTSFGNLVNLGTLGLASCSLSGPIPPQFGQLSQL 193
++P+ L +L +L+ + + N LS +P NL N L
Sbjct: 154 SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSN------------------------L 188
Query: 194 EELILQQNQLQGPIPAELGNCSSLSIFTAAENNLNGSIPAALGRLQNLQLLNLGNNSLSG 253
L L N++ +P E+ S+L + N++ + ++L L+NL L L NN L
Sbjct: 189 NNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE- 245
Query: 254 EIPSELGELSQLGYLNLMGNRLEGAIPRSFAKMGNLQSLDLSMNRLTGGIPEEFGNMGQL 313
++P +G LS L L+L N++ S + NL+ LDLS N L+ +P L
Sbjct: 246 DLPESIGNLSNLETLDLSNNQIS--SISSLGSLTNLRELDLSGNSLSNALPLIAL--LLL 301
Query: 314 VFLVLSNNNISG-SIPRRICTNATSLEHLILAEIQLSGEIPVELSQC 359
+ +L N ++ ++ ++ + + L E + + S
Sbjct: 302 LLELLLNLLLTLKALELKLNSILLNNNILSNGETSSPEALSILESLN 348
|
Length = 394 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 3e-11
Identities = 58/219 (26%), Positives = 102/219 (46%), Gaps = 22/219 (10%)
Query: 943 GATNNLSDEFI-IGSGGSGTVYKA-ELANGATVAVKKISCKDDHLLNKSFTREVKTLGRI 1000
G +L + +I IG G +G V A E +G VAVK + + F EV +
Sbjct: 17 GDPRSLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFN-EVVIMRDY 75
Query: 1001 RHRHLVKLMGHCCNKGAGSNL-LIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAV 1059
+H+++V++ G L ++ E+++ G++ +I + L+ E +
Sbjct: 76 QHQNVVEMYKSYL---VGEELWVLMEFLQGGAL--------TDIVSQTRLNEEQIATVCE 124
Query: 1060 GLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWF 1119
+ Q + YLH V +HRDIKS +ILL + L DFG + +D
Sbjct: 125 SVLQALCYLHSQGV---IHRDIKSDSILLTLDGRVKLSDFGFCAQISKD----VPKRKSL 177
Query: 1120 AGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMP 1158
G+ ++APE + D++S+GI+++E+V G+ P
Sbjct: 178 VGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 3e-11
Identities = 69/280 (24%), Positives = 124/280 (44%), Gaps = 33/280 (11%)
Query: 947 NLSDEFIIGSGGSGTVYKAE-LANGATVAVKKISCKD--DHLLNKSFTREVKTLGRIRHR 1003
N E IG G VY+A L + VA+KK+ + D + +E+ L ++ H
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 1004 HLVKLMGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARL-KIAVGLA 1062
+++K + + ++ E + G L + K +K L E + K V L
Sbjct: 63 NVIKYLDSFIEDNELN--IVLELADAGD----LSQMIKYFKKQKRLIPERTVWKYFVQLC 116
Query: 1063 QGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGS 1122
VE++H +++HRDIK +N+ + + LGD GL + ++S T + G+
Sbjct: 117 SAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRF----FSSKTTAAHSLVGT 169
Query: 1123 YGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGS 1182
Y++PE + K D++S+G +L E+ + + P +G +M++ S
Sbjct: 170 PYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP---FYGDKMNL---------FSLC 217
Query: 1183 AREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERP 1222
+ E D P LP E + ++ E+ C P +RP
Sbjct: 218 QKIEQCD---YPPLPTEHYSE-KLRELVSMCIYPDPDQRP 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 3e-11
Identities = 51/191 (26%), Positives = 87/191 (45%), Gaps = 36/191 (18%)
Query: 1048 SLDWEARLKIAVGLAQGVEYL-HHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALV 1106
+LD E L + +A+G+ +L +C+ HRD+ + NILL + DFGLA+ +
Sbjct: 210 ALDTEDLLSFSYQVAKGMSFLASKNCI----HRDLAARNILLTHGRITKICDFGLARDIR 265
Query: 1107 EDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS------GKMPTD 1160
D N + N ++APE ++ T + DV+S GI+L E+ S MP D
Sbjct: 266 NDSNYVVKGNARLP--VKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD 323
Query: 1161 ATFGVEMDMVRWVEMHMEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQE 1220
+ F +++ + + L P ECA ++ +I C P +
Sbjct: 324 SKF---------------------YKMIKEGYRMLSP--ECAPSEMYDIMKSCWDADPLK 360
Query: 1221 RPSSRQVCDLL 1231
RP+ +Q+ L+
Sbjct: 361 RPTFKQIVQLI 371
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 3e-11
Identities = 65/213 (30%), Positives = 100/213 (46%), Gaps = 26/213 (12%)
Query: 953 IIGSGGSGTVYKAELANG----ATVAVKK-ISCKDDHLLNKSFTREVKTLGRIRHRHLVK 1007
++G G G V AEL A A+KK + +DD + R V L H L
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAW-EHPFLTH 60
Query: 1008 LMGHCCNKGAGSNLL-IYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKI-AVGLAQGV 1065
L C +L + EY+ G D + +I+ D EAR + A + G+
Sbjct: 61 LF---CTFQTKEHLFFVMEYLNGG---DLMF----HIQSSGRFD-EARARFYAAEIICGL 109
Query: 1066 EYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGY 1125
++LH I++RD+K N+LLD + + DFG+ K E+ N +++T F G+ Y
Sbjct: 110 QFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCK---ENMNGEGKAST-FCGTPDY 162
Query: 1126 IAPEYAYSLKATEKCDVYSMGIVLMELVSGKMP 1158
IAPE K E D +S G++L E++ G+ P
Sbjct: 163 IAPEILKGQKYNESVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 3e-11
Identities = 70/288 (24%), Positives = 128/288 (44%), Gaps = 33/288 (11%)
Query: 947 NLSDEFIIGSGGSGTVYKAE-LANGATVAVKKISCKD--DHLLNKSFTREVKTLGRIRHR 1003
N E IG G VY+A L +G VA+KK+ D D +E+ L ++ H
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 1004 HLVKLMGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARL-KIAVGLA 1062
+++K + ++ E + G L + + K +K L E + K V L
Sbjct: 63 NVIKYYASFIEDNELN--IVLELADAGD----LSRMIKHFKKQKRLIPEKTVWKYFVQLC 116
Query: 1063 QGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGS 1122
+E++H +++HRDIK +N+ + + LGD GL + ++S T + G+
Sbjct: 117 SALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRF----FSSKTTAAHSLVGT 169
Query: 1123 YGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGS 1182
Y++PE + K D++S+G +L E+ + + P +G +M++ S
Sbjct: 170 PYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP---FYGDKMNL---------YSLC 217
Query: 1183 AREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDL 1230
+ E D P LP + + ++ ++ C P++RP V D+
Sbjct: 218 KKIEQCD---YPPLPSDHYSE-ELRQLVNMCINPDPEKRPDITYVYDV 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 3e-11
Identities = 71/290 (24%), Positives = 121/290 (41%), Gaps = 53/290 (18%)
Query: 953 IIGSGGSGTVYKA-ELANGAT----VAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVK 1007
++GSG GTVYK + +G VA+K + NK E + + ++ +
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73
Query: 1008 LMGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEY 1067
L+G C L+ + M G + D++ + I + L+W V +A+G+ Y
Sbjct: 74 LLGICLTSTVQ---LVTQLMPYGCLLDYVRENKDRIGSQDLLNW------CVQIAKGMSY 124
Query: 1068 LHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYG--- 1124
L +++HRD+ + N+L+ S + DFGLA+ L D T + G
Sbjct: 125 LEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDID-------ETEYHADGGKVP 174
Query: 1125 --YIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMVRWVEMHMEMSG 1181
++A E + T + DV+S G+ + EL++ G P D
Sbjct: 175 IKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGI------------------- 215
Query: 1182 SARE--ELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCD 1229
ARE +LL+ + LP V I ++C + RP R++ D
Sbjct: 216 PAREIPDLLEKGER--LPQPPICTIDVYMIMVKCWMIDSECRPRFRELVD 263
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 4e-11
Identities = 70/283 (24%), Positives = 121/283 (42%), Gaps = 53/283 (18%)
Query: 973 VAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIYEYMENGSV 1032
VAVK + + F +EVK L R++ ++++L+G C ++ +I EYMENG +
Sbjct: 49 VAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLC--MITEYMENGDL 106
Query: 1033 WDWLHKQPVNIKMRKSLD------------WEARLKIAVGLAQGVEYLHHDCVPKILHRD 1080
+L ++ K D + + L +A+ +A G++YL +HRD
Sbjct: 107 NQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRD 163
Query: 1081 IKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSY-----------GYIAPE 1129
+ + N L+ N+ + DFG+++ L +AG Y ++A E
Sbjct: 164 LATRNCLVGENLTIKIADFGMSRNL-------------YAGDYYRIQGRAVLPIRWMAWE 210
Query: 1130 YAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSAREELLD 1189
K T DV++ G+ L E++ + + +G D E +E +G E
Sbjct: 211 CILMGKFTTASDVWAFGVTLWEILM--LCKEQPYGELTD-----EQVIENAG----EFFR 259
Query: 1190 DQMKPLLPGEECAAYQVL-EIALQCTKTSPQERPSSRQVCDLL 1231
DQ + + Q L E+ LQC +ERPS + L
Sbjct: 260 DQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFL 302
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 5e-11
Identities = 35/100 (35%), Positives = 52/100 (52%), Gaps = 4/100 (4%)
Query: 628 LDLSGNSLTGPIPTQLLMCKKLSHIDLNNNLLSGAVPSWLGTLPQLGELKLSFNQFVGFL 687
L L L G IP + + L I+L+ N + G +P LG++ L L LS+N F G +
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 688 PRELFNCSKLLVLSLDGNMLNGSLPNEVGNL----ASLNV 723
P L + L +L+L+GN L+G +P +G AS N
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNF 522
|
Length = 623 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 64.6 bits (158), Expect = 5e-11
Identities = 60/219 (27%), Positives = 98/219 (44%), Gaps = 44/219 (20%)
Query: 953 IIGSGGSGT---VYKA-ELANGATVAVKKI--SCKDDHLLNKSFTREVKTLGRIR-HRHL 1005
I+G G GT V KA G A+K + K +N RE++ L R+ H ++
Sbjct: 3 ILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNL--REIQALRRLSPHPNI 60
Query: 1006 VKLMGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLK-IAVGLAQG 1064
++L+ ++ G L++E M+ ++++ IK RK E R+K L +
Sbjct: 61 LRLIEVLFDRKTGRLALVFELMD-MNLYEL-------IKGRKRPLPEKRVKSYMYQLLKS 112
Query: 1065 VEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTE--SNTWFAGS 1122
++++H + I HRDIK NIL+ + L DFG + + TE S W
Sbjct: 113 LDHMHRN---GIFHRDIKPENILIKDD-ILKLADFGSCRG-IYSKPPYTEYISTRW---- 163
Query: 1123 YGYIAPE-------YAYSLKATEKCDVYSMGIVLMELVS 1154
Y APE Y K D++++G V E++S
Sbjct: 164 --YRAPECLLTDGYYGP------KMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 5e-11
Identities = 67/258 (25%), Positives = 108/258 (41%), Gaps = 53/258 (20%)
Query: 981 KDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIYEYMENGSVWDWLHKQP 1040
DH + +F + ++ H+HLVKL G C N+++ EY++ G + +LH++
Sbjct: 39 GSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVRDE---NIMVEEYVKFGPLDVFLHREK 95
Query: 1041 VNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILL---DSNME---- 1093
N+ SL W +L +A LA + YL K++H ++ NIL+ N
Sbjct: 96 NNV----SLHW--KLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPF 146
Query: 1094 AHLGDFGLAK-ALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKA--TEKCDVYSMGIVLM 1150
L D G+ L + E W IAPE + +A T D +S G L+
Sbjct: 147 IKLSDPGIPITVLSREE--RVERIPW-------IAPECIRNGQASLTIAADKWSFGTTLL 197
Query: 1151 ELVS-GKMPTDATFGVEMDMVRWVEMHMEMSGSAREELLDDQMKPLLPGEECAAYQVLEI 1209
E+ S G+ P S+ E+ Q + LP +CA ++ +
Sbjct: 198 EICSNGEEPLSTL-------------------SSSEKERFYQDQHRLPMPDCA--ELANL 236
Query: 1210 ALQCTKTSPQERPSSRQV 1227
QC P +RPS R +
Sbjct: 237 INQCWTYDPTKRPSFRAI 254
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 5e-11
Identities = 48/170 (28%), Positives = 83/170 (48%), Gaps = 14/170 (8%)
Query: 992 REVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDW 1051
+E L +++H ++V + G ++ EY + G + Q + ++ K
Sbjct: 47 KEAVLLAKMKHPNIVAFKESF--EADGHLYIVMEYCDGGDLM-----QKIKLQRGKLFPE 99
Query: 1052 EARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNS 1111
+ L+ V + GV+++H ++LHRDIKS NI L N + LGDFG A+ L +
Sbjct: 100 DTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLT---SP 153
Query: 1112 NTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDA 1161
+ T+ Y Y+ PE ++ K D++S+G +L EL + K P A
Sbjct: 154 GAYACTYVGTPY-YVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQA 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 6e-11
Identities = 62/226 (27%), Positives = 104/226 (46%), Gaps = 45/226 (19%)
Query: 954 IGSGGSGTVYKA-ELANGATVAVKKISC-KDDHLLNKSFTREVKTLGRIRHRHLVKLMG- 1010
IG G G VYKA + T+A+KKI ++D + + RE+ L ++H ++V+L
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDV 69
Query: 1011 -HCCNKGAGSNLLIYEYMENGSVWDWLHKQ-------PVNIKMRKSLDWEARLKIAVGLA 1062
H + L++EY++ L K N ++ K+ ++ +
Sbjct: 70 VHSEKR----LYLVFEYLDLD-----LKKHMDSSPDFAKNPRLIKTYLYQ--------IL 112
Query: 1063 QGVEYLHHDCVPKILHRDIKSSNILLDSNMEA-HLGDFGLAKAL---VEDYNSNTESNTW 1118
+G+ Y H ++LHRD+K N+L+D A L DFGLA+A V + + W
Sbjct: 113 RGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVT-LW 168
Query: 1119 FAGSYGYIAPEYAY-SLKATEKCDVYSMGIVLMELVSGK--MPTDA 1161
Y APE S + D++S+G + E+V+ K P D+
Sbjct: 169 ------YRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDS 208
|
Length = 294 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 8e-11
Identities = 40/111 (36%), Positives = 53/111 (47%), Gaps = 23/111 (20%)
Query: 533 LMLYNNSLEGNLPGSLINLRNLTRINFSKNRLNGRIATLCSSHSFLSFDVTNNEFDHEIP 592
L L N L G +P + LR+L IN S N + G IP
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRG-----------------------NIP 459
Query: 593 PQLGNSPSLERLRLGNNKFIGKIPWTFGKIRELSLLDLSGNSLTGPIPTQL 643
P LG+ SLE L L N F G IP + G++ L +L+L+GNSL+G +P L
Sbjct: 460 PSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 8e-11
Identities = 58/216 (26%), Positives = 97/216 (44%), Gaps = 26/216 (12%)
Query: 953 IIGSGGSGTVYKAELANGATV-AVKKISCKDDHLLNKSFTREVKTLGRI-----RHRHLV 1006
++G G G V AEL + AVK K D +L T R+ +H L
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVK--VLKKDVILQDDDVECTMTEKRVLALAGKHPFLT 59
Query: 1007 KLMGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVE 1066
+L H C + + EY+ G + H Q + + + AR A + G++
Sbjct: 60 QL--HSCFQTKDRLFFVMEYVNGGDLM--FHIQ----RSGRFDEPRARF-YAAEIVLGLQ 110
Query: 1067 YLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAK-ALVEDYNSNTESNTWFAGSYGY 1125
+LH I++RD+K N+LLDS + DFG+ K ++ ++T F G+ Y
Sbjct: 111 FLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTST-----FCGTPDY 162
Query: 1126 IAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDA 1161
IAPE D +++G++L E+++G+ P +
Sbjct: 163 IAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEG 198
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 9e-11
Identities = 31/80 (38%), Positives = 51/80 (63%)
Query: 685 GFLPRELFNCSKLLVLSLDGNMLNGSLPNEVGNLASLNVLTLSGNLLSGPIPPAIGRLSK 744
GF+P ++ L ++L GN + G++P +G++ SL VL LS N +G IP ++G+L+
Sbjct: 432 GFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTS 491
Query: 745 LYELRLSNNSLNGVIPLEIG 764
L L L+ NSL+G +P +G
Sbjct: 492 LRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 1e-10
Identities = 38/97 (39%), Positives = 52/97 (53%), Gaps = 1/97 (1%)
Query: 155 LSGSIPTSFGNLVNLGTLGLASCSLSGPIPPQFGQLSQLEELILQQNQLQGPIPAELGNC 214
L G IP L +L ++ L+ S+ G IPP G ++ LE L L N G IP LG
Sbjct: 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQL 489
Query: 215 SSLSIFTAAENNLNGSIPAALG-RLQNLQLLNLGNNS 250
+SL I N+L+G +PAALG RL + N +N+
Sbjct: 490 TSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNA 526
|
Length = 623 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 1e-10
Identities = 61/211 (28%), Positives = 98/211 (46%), Gaps = 27/211 (12%)
Query: 954 IGSGGSGTVYKAE-LANGATVAVKKISCK-DDHLLNKSFTREVKTLGRIRHRHLVKLMGH 1011
IG G G VYK G VA+KKI + ++ + + RE+ L ++H ++V L
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV 67
Query: 1012 CCNKGAGSNL-LIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHH 1070
+ S L LI+E++ L K ++ + +D E + QG+ + H
Sbjct: 68 LMQE---SRLYLIFEFLSMD-----LKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHS 119
Query: 1071 DCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKAL---VEDYNSNTESNT-WFAGSYGYI 1126
++LHRD+K N+L+D+ L DFGLA+A V Y E T W Y
Sbjct: 120 R---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTH--EVVTLW------YR 168
Query: 1127 APEYAY-SLKATEKCDVYSMGIVLMELVSGK 1156
APE S + + D++S+G + E+ + K
Sbjct: 169 APEVLLGSPRYSTPVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 1e-10
Identities = 65/211 (30%), Positives = 90/211 (42%), Gaps = 14/211 (6%)
Query: 954 IGSGGSGTVYKA-ELANGATVAVKKISCKDDHLLNKSFTREVKTLGRIR-HRHLVKLMGH 1011
IG G G V+K NG+ AVK + H +++ E L + H ++VK G
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILD--PIHDIDEEIEAEYNILKALSDHPNVVKFYGM 83
Query: 1012 CCNKGA--GSNL-LIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYL 1068
K G L L+ E GSV D + K + IA L + + L
Sbjct: 84 YYKKDVKNGDQLWLVLELCNGGSVTDLVKG------FLKRGERMEEPIIAYILHEALMGL 137
Query: 1069 HHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVED-YNSNTESNTWFAGSYGYIA 1127
H V K +HRD+K +NILL + L DFG++ L NT T F + IA
Sbjct: 138 QHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIA 197
Query: 1128 PEYAYSLKATEKCDVYSMGIVLMELVSGKMP 1158
E +CDV+S+GI +EL G P
Sbjct: 198 CEQQLDSTYDARCDVWSLGITAIELGDGDPP 228
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 1e-10
Identities = 59/215 (27%), Positives = 99/215 (46%), Gaps = 23/215 (10%)
Query: 945 TNNLSDEFIIGSGGSGTVYKA-ELANGATVAVKKISCK-DDHLLNKSFTREVKTLGRIRH 1002
TN D +G G G V A + G VA+KKI +L K RE+K L +RH
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRH 68
Query: 1003 RHLVKLMGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLA 1062
+++ L S++ I + V + L + + L+ + +
Sbjct: 69 ENIISL----------SDIFISPLEDIYFVTELLGTDLHRLLTSRPLEKQFIQYFLYQIL 118
Query: 1063 QGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGS 1122
+G++Y+H V +HRD+K SNIL++ N + + DFGLA+ ++D T + +
Sbjct: 119 RGLKYVHSAGV---VHRDLKPSNILINENCDLKICDFGLAR--IQDPQM-----TGYVST 168
Query: 1123 YGYIAPEYAYSL-KATEKCDVYSMGIVLMELVSGK 1156
Y APE + K + D++S G + E++ GK
Sbjct: 169 RYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 60/214 (28%), Positives = 103/214 (48%), Gaps = 28/214 (13%)
Query: 954 IGSGGSGTVYKAE-LANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHC 1012
+G G G VYKA+ G A K I K + L + + E+ L H ++VKL+
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEEL-EDYMVEIDILASCDHPNIVKLLDAF 71
Query: 1013 CNKGAGSNLLIY-EYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLA-QGVEYLHH 1070
+ +NL I E+ G+V V +++ + L E ++++ + + YLH
Sbjct: 72 YYE---NNLWILIEFCAGGAV------DAVMLELERPLT-EPQIRVVCKQTLEALNYLHE 121
Query: 1071 DCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNT-ESNTWFAGSYGYIAPE 1129
+ KI+HRD+K+ NIL + + L DFG++ N+ T + F G+ ++APE
Sbjct: 122 N---KIIHRDLKAGNILFTLDGDIKLADFGVSAK-----NTRTIQRRDSFIGTPYWMAPE 173
Query: 1130 YAYSLKATE-----KCDVYSMGIVLMELVSGKMP 1158
+ + K DV+S+GI L+E+ + P
Sbjct: 174 VVMCETSKDRPYDYKADVWSLGITLIEMAQIEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 2e-10
Identities = 71/288 (24%), Positives = 116/288 (40%), Gaps = 52/288 (18%)
Query: 954 IGSGGSGTVYKAE---LANGAT---VAVKKI--SCKDDHLLNKSFTREVKTLGRIRHRHL 1005
+G G G VY+ A VAVK + SC + + F E + + H+++
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESD--FLMEALIMSKFNHQNI 71
Query: 1006 VKLMGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGV 1065
V+L+G + ++ E M G + +L + + SL + L A +A+G
Sbjct: 72 VRLIGVSFERL--PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGC 129
Query: 1066 EYLHHDCVPKILHRDIKSSNILLDS---NMEAHLGDFGLAKAL--VEDYNSNTESN---T 1117
+YL + +HRDI + N LL A + DFG+A+ + Y +
Sbjct: 130 KYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIK 186
Query: 1118 WFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVE-MDMVRWVEM 1175
W + PE T K DV+S G++L E+ S G MP E M+ V
Sbjct: 187 W-------MPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFV----- 234
Query: 1176 HMEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPS 1223
+G R + P + C V I C + +P++RP+
Sbjct: 235 ----TGGGRLD----------PPKGCPG-PVYRIMTDCWQHTPEDRPN 267
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 2e-10
Identities = 64/230 (27%), Positives = 95/230 (41%), Gaps = 30/230 (13%)
Query: 954 IGSGGSGTVYKAELAN-GATVAVKKISCKDDHLLNKSFTREVKT----LGRIRHRHLVKL 1008
+G GG G V+ A+ + G VA+K++ LN+ R V T L + LVKL
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNE--VRHVLTERDILTTTKSEWLVKL 66
Query: 1009 MGHCCNKGAGSNL-LIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEY 1067
+ + L L EY+ G L + + AR +A V+
Sbjct: 67 LYAFQDD---EYLYLAMEYVPGGDFRTLL------NNLGVLSEDHARFYMAEMFE-AVDA 116
Query: 1068 LHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIA 1127
LH +HRD+K N L+D++ L DFGL+K +V NS GS Y+A
Sbjct: 117 LHE---LGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANS-------VVGSPDYMA 166
Query: 1128 PEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEM--DMVRWVEM 1175
PE D +S+G +L E + G P + E ++ W E
Sbjct: 167 PEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKET 216
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 3e-10
Identities = 46/139 (33%), Positives = 69/139 (49%), Gaps = 16/139 (11%)
Query: 1022 LIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVG-LAQGVEYLHHDCVPKILHRD 1080
LI +Y+ G ++ L+ Q N E ++ G + +E+LH I++RD
Sbjct: 82 LILDYVSGGEMFTHLY-QRDNFS-------EDEVRFYSGEIILALEHLHK---LGIVYRD 130
Query: 1081 IKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKC 1140
IK NILLDS L DFGL+K + + T S F G+ Y+APE K
Sbjct: 131 IKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYS---FCGTIEYMAPEIIRGKGGHGKA 187
Query: 1141 -DVYSMGIVLMELVSGKMP 1158
D +S+GI++ EL++G P
Sbjct: 188 VDWWSLGILIFELLTGASP 206
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 3e-10
Identities = 61/214 (28%), Positives = 97/214 (45%), Gaps = 22/214 (10%)
Query: 953 IIGSGGSGTVYKAEL-ANGATVAVK----KISCKDDHLLNKSFTREVKTLGRIRHRHLVK 1007
++G G G V A L +G AVK + +DD + + + +L R H L +
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLAR-NHPFLTQ 60
Query: 1008 LMGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEY 1067
L +CC + + E++ G + H Q K R+ + AR A + + +
Sbjct: 61 L--YCCFQTPDRLFFVMEFVNGGDLM--FHIQ----KSRRFDEARARF-YAAEITSALMF 111
Query: 1068 LHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIA 1127
LH I++RD+K N+LLD L DFG+ K +N T S F G+ YIA
Sbjct: 112 LHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKE--GIFNGKTTST--FCGTPDYIA 164
Query: 1128 PEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDA 1161
PE + D ++MG++L E++ G P +A
Sbjct: 165 PEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEA 198
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 3e-10
Identities = 47/140 (33%), Positives = 69/140 (49%), Gaps = 17/140 (12%)
Query: 1022 LIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVG-LAQGVEYLHHDCVPKILHRD 1080
LI +Y+ G ++ L Q K E ++I G + +E+LH I++RD
Sbjct: 82 LILDYINGGELFTHL-SQRERFK-------EQEVQIYSGEIVLALEHLHK---LGIIYRD 130
Query: 1081 IKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKA--TE 1138
IK NILLDSN L DFGL+K ED S F G+ Y+AP+ +
Sbjct: 131 IKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYS---FCGTIEYMAPDIVRGGDGGHDK 187
Query: 1139 KCDVYSMGIVLMELVSGKMP 1158
D +SMG+++ EL++G P
Sbjct: 188 AVDWWSMGVLMYELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 4e-10
Identities = 34/85 (40%), Positives = 47/85 (55%), Gaps = 1/85 (1%)
Query: 129 NQ-LAGTIPTQLGSLTSLRVMRIGDNWLSGSIPTSFGNLVNLGTLGLASCSLSGPIPPQF 187
NQ L G IP + L L+ + + N + G+IP S G++ +L L L+ S +G IP
Sbjct: 427 NQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESL 486
Query: 188 GQLSQLEELILQQNQLQGPIPAELG 212
GQL+ L L L N L G +PA LG
Sbjct: 487 GQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 4e-10
Identities = 49/199 (24%), Positives = 88/199 (44%), Gaps = 23/199 (11%)
Query: 956 SGGSGTVYKAELANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNK 1015
G G V+ A V KI K L+ E L + H +++ M
Sbjct: 76 PGSEGRVFVATKPGQPDPVVLKIGQKGTTLI------EAMLLQNVNHPSVIR-MKDTLVS 128
Query: 1016 GAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPK 1075
GA + +++ Y + ++ +L K+ + + ++L I + +G+ YLH +
Sbjct: 129 GAITCMVLPHY--SSDLYTYLTKRSRPLPIDQAL------IIEKQILEGLRYLHAQ---R 177
Query: 1076 ILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLK 1135
I+HRD+K+ NI ++ + +GD G A+ + + AG+ APE K
Sbjct: 178 IIHRDVKTENIFINDVDQVCIGDLGAAQ-----FPVVAPAFLGLAGTVETNAPEVLARDK 232
Query: 1136 ATEKCDVYSMGIVLMELVS 1154
K D++S GIVL E+++
Sbjct: 233 YNSKADIWSAGIVLFEMLA 251
|
Length = 357 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 4e-10
Identities = 54/216 (25%), Positives = 92/216 (42%), Gaps = 30/216 (13%)
Query: 953 IIGSGGSGTVYKA--ELANGATVAVKKISCKDDHLLNKS--FTREVKTLGRIRHRHLVKL 1008
IG G G VY+ +AV +CK+ + F +E + + H H+VKL
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72
Query: 1009 MGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYL 1068
+G ++ E G + +L + SLD + + + L+ + YL
Sbjct: 73 IGVITENPV---WIVMELAPLGELRSYLQVN------KYSLDLASLILYSYQLSTALAYL 123
Query: 1069 HHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYG---- 1124
+ +HRDI + N+L+ S LGDFGL++ L E +++ S G
Sbjct: 124 ESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYL--------EDESYYKASKGKLPI 172
Query: 1125 -YIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMP 1158
++APE + T DV+ G+ + E++ G P
Sbjct: 173 KWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKP 208
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 4e-10
Identities = 56/222 (25%), Positives = 103/222 (46%), Gaps = 31/222 (13%)
Query: 954 IGSGGSGTVYKAEL--------ANGATVAVKKISCKDDHLLN--KSFTREVKTLGRI-RH 1002
+G G G V AE TVAVK + KDD E++ + I +H
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKML--KDDATEKDLSDLVSEMEMMKMIGKH 80
Query: 1003 RHLVKLMGHCCNKGAGSNLLIYEYMENGSVWDWLH-KQPVNIKMR--------KSLDWEA 1053
++++ L+G C G +I EY G++ ++L ++P ++ + + ++
Sbjct: 81 KNIINLLGACTQDG--PLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKD 138
Query: 1054 RLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVE-DYNSN 1112
+ +A+G+EYL K +HRD+ + N+L+ N + DFGLA+ + DY
Sbjct: 139 LVSCTYQVARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKK 195
Query: 1113 TESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS 1154
T + ++APE + T + DV+S G+++ E+ +
Sbjct: 196 TTNGRL---PVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 5e-10
Identities = 61/283 (21%), Positives = 121/283 (42%), Gaps = 58/283 (20%)
Query: 973 VAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIYEYMENGSV 1032
VAVK + F +E+K + R+++ ++++L+G C + +I EYMENG +
Sbjct: 47 VAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLC--MITEYMENGDL 104
Query: 1033 WDWLHKQPVNIKMRK-----SLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNIL 1087
+L ++ + S+ L +AV +A G++YL +HRD+ + N L
Sbjct: 105 NQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCL 161
Query: 1088 LDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSY-----------GYIAPEYAYSLKA 1136
+ ++ + DFG+++ L ++G Y ++A E K
Sbjct: 162 VGNHYTIKIADFGMSRNL-------------YSGDYYRIQGRAVLPIRWMAWESILLGKF 208
Query: 1137 TEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSAREELLDDQMK--- 1193
T DV++ G+ L E+ + + + + + D E +E +G E +Q +
Sbjct: 209 TTASDVWAFGVTLWEMFT--LCKEQPYSLLSD-----EQVIENTG----EFFRNQGRQIY 257
Query: 1194 ----PLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLL 1232
PL P V ++ ++C ++RP+ ++ L
Sbjct: 258 LSQTPLCPSP------VFKLMMRCWSRDIKDRPTFNKIHHFLR 294
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 5e-10
Identities = 63/212 (29%), Positives = 95/212 (44%), Gaps = 24/212 (11%)
Query: 953 IIGSGGSGTVYKAE-LANGATVAVKKISCKDDHLLNKSFTREVKT-----LGRIRHRHLV 1006
+IG G G V A+ A+G AVK + K +L K + + L ++H LV
Sbjct: 2 VIGKGSFGKVLLAKHKADGKFYAVKVLQKK--AILKKKEQKHIMAERNVLLKNVKHPFLV 59
Query: 1007 KLMGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVE 1066
L H + A + +Y+ G ++ L ++ R + AR A +A +
Sbjct: 60 GL--HYSFQTADKLYFVLDYVNGGELFFHLQRE------RSFPEPRARF-YAAEIASALG 110
Query: 1067 YLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYI 1126
YLH I++RD+K NILLDS L DFGL K E + ++T F G+ Y+
Sbjct: 111 YLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCK---EGIEHSKTTST-FCGTPEYL 163
Query: 1127 APEYAYSLKATEKCDVYSMGIVLMELVSGKMP 1158
APE D + +G VL E++ G P
Sbjct: 164 APEVLRKQPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 7e-10
Identities = 65/212 (30%), Positives = 96/212 (45%), Gaps = 24/212 (11%)
Query: 953 IIGSGGSGTVYKAEL-ANGATVAVKKISCKDDHLLNKSFTREVKT-----LGRIRHRHLV 1006
+IG G G V A+ ++G+ AVK + K +L K + L ++H LV
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKT--ILKKKEQNHIMAERNVLLKNLKHPFLV 59
Query: 1007 KLMGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVE 1066
L H + A + +Y+ G ++ H Q + R L+ AR A +A +
Sbjct: 60 GL--HYSFQTAEKLYFVLDYVNGGELF--FHLQ----RERCFLEPRARF-YAAEVASAIG 110
Query: 1067 YLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYI 1126
YLH I++RD+K NILLDS L DFGL K VE E+ + F G+ Y+
Sbjct: 111 YLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP----EETTSTFCGTPEYL 163
Query: 1127 APEYAYSLKATEKCDVYSMGIVLMELVSGKMP 1158
APE D + +G VL E++ G P
Sbjct: 164 APEVLRKEPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 7e-10
Identities = 59/222 (26%), Positives = 102/222 (45%), Gaps = 31/222 (13%)
Query: 954 IGSGGSGTVYKAELANGAT---VAVK--KIS-CKDDHLLNKSFTREVKTLGRIRHRHLVK 1007
+G G G+V + +L + VAVK KI+ C + + F E + H ++++
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEM--EDFLSEAVCMKEFDHPNVMR 64
Query: 1008 LMGHCC----NKGAGSNLLIYEYMENGSV-----WDWLHKQPVNIKMRKSLDWEARLKIA 1058
L+G C ++G S ++I +M++G + + L P L + +K
Sbjct: 65 LIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQ------YLPTQMLVKFM 118
Query: 1059 VGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTW 1118
+A G+EYL +HRD+ + N +L+ NM + DFGL+K + YN +
Sbjct: 119 TDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGLSKKI---YNGDYYRQGR 172
Query: 1119 FAG-SYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMP 1158
A +IA E T K DV+S G+ + E+ + G+ P
Sbjct: 173 IAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTP 214
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 9e-10
Identities = 34/103 (33%), Positives = 51/103 (49%), Gaps = 2/103 (1%)
Query: 485 LHLRQNELVGQIPASLGNCHQLIILDLADNKLSGGVPASFGFLQALEQLMLYNNSLEGNL 544
L L L G IP + L ++L+ N + G +P S G + +LE L L NS G++
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 545 PGSLINLRNLTRINFSKNRLNGRIATLCSSHSF--LSFDVTNN 585
P SL L +L +N + N L+GR+ SF+ T+N
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDN 525
|
Length = 623 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 1e-09
Identities = 30/71 (42%), Positives = 37/71 (52%)
Query: 601 LERLRLGNNKFIGKIPWTFGKIRELSLLDLSGNSLTGPIPTQLLMCKKLSHIDLNNNLLS 660
L+ + L N G IP + G I L +LDLS NS G IP L L ++LN N LS
Sbjct: 444 LQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLS 503
Query: 661 GAVPSWLGTLP 671
G VP+ LG
Sbjct: 504 GRVPAALGGRL 514
|
Length = 623 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 1e-09
Identities = 80/228 (35%), Positives = 112/228 (49%), Gaps = 15/228 (6%)
Query: 588 DHEIPPQLGNSPSLERLRLGNNKFIGKIPWTFGKIRELSL---LDLSGNSLTGPIPTQLL 644
+ L N L L L N+ I ++ EL+ LDL N++T P L
Sbjct: 82 SLDGSENLLNLLPLPSLDLNLNRLRSNIS----ELLELTNLTSLDLDNNNITDIPPLIGL 137
Query: 645 MCKKLSHIDLNNNLLSGAVPSWLGTLPQLGELKLSFNQFVGFLPRELFNCSKLLVLSLDG 704
+ L +DL++N + ++PS L LP L L LSFN + LP+ L N S L L L G
Sbjct: 138 LKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFND-LSDLPKLLSNLSNLNNLDLSG 195
Query: 705 NMLNGSLPNEVGNLASLNVLTLSGNLLSGPIPPAIGRLSKLYELRLSNNSLNGVIPLEIG 764
N ++ LP E+ L++L L LS N + + ++ L L L LSNN L +P IG
Sbjct: 196 NKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLED-LPESIG 252
Query: 765 QLQNLQSILDLSHNNFTGQIPPSMGTLAKLEVLNLSHNQLVGELPSQL 812
L NL++ LDLS+N S+G+L L L+LS N L LP
Sbjct: 253 NLSNLET-LDLSNNQ--ISSISSLGSLTNLRELDLSGNSLSNALPLIA 297
|
Length = 394 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 1e-09
Identities = 62/240 (25%), Positives = 113/240 (47%), Gaps = 27/240 (11%)
Query: 954 IGSGGSGTVYKA-ELANGATVAVKKISCKDDHLLNKSFT-REVKTLGRIRHRHLVKLMGH 1011
+GSG G+V A + VAVKK+S L++ T RE++ L ++H +++ L+
Sbjct: 23 VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDV 82
Query: 1012 CCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHD 1071
+ N + E V + + NI + L E + L +G++Y+H
Sbjct: 83 FTPATSIEN-----FNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHS- 136
Query: 1072 CVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYA 1131
I+HRD+K SN+ ++ + E + DFGLA+ + T + + Y APE
Sbjct: 137 --AGIIHRDLKPSNVAVNEDCELRILDFGLAR-------QADDEMTGYVATRWYRAPEIM 187
Query: 1132 YS-LKATEKCDVYSMGIVLMELVSGK--MPTDATFGVEMDMVRWVEMHMEMSGSAREELL 1188
+ + + D++S+G ++ EL+ GK P + D + ++ ME+ G+ E+L
Sbjct: 188 LNWMHYNQTVDIWSVGCIMAELLKGKALFPGN-------DYIDQLKRIMEVVGTPSPEVL 240
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 1e-09
Identities = 54/215 (25%), Positives = 92/215 (42%), Gaps = 32/215 (14%)
Query: 954 IGSGGSGTVYKAELAN-GATVAVKKISCK--------DDHLLNKSFTREVKTLGRIRHRH 1004
+G GG G V ++ N G A KK+ K LL K +V + + +
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 1005 LVKLMGHCCNKGAGSNLLIYEYMENGSV-WDWLHKQPVNIKMRKSLDWEARLKIAVGLAQ 1063
+ H C L+ M G + + + ++M + + + A++
Sbjct: 61 AFESKTHLC--------LVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQI------TC 106
Query: 1064 GVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSY 1123
G+ +LH I++RD+K N+LLD L D GLA L + ++ T AG+
Sbjct: 107 GILHLHS---MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG-----KTITQRAGTN 158
Query: 1124 GYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMP 1158
GY+APE + D ++MG + E+V+G+ P
Sbjct: 159 GYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 1e-09
Identities = 69/290 (23%), Positives = 125/290 (43%), Gaps = 53/290 (18%)
Query: 953 IIGSGGSGTVYKAEL----ANGATVAVK----KISCKDDHLLNKSFTREVKTLGRIRHRH 1004
++G G G+V +A+L + VAVK I D + F RE + H +
Sbjct: 6 MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSD---IEEFLREAACMKEFDHPN 62
Query: 1005 LVKLMGHCCNKGAGSNL----LIYEYMENGSVWDWL-----HKQPVNIKMRKSLDWEARL 1055
++KL+G A L +I +M++G + +L ++P + + + +
Sbjct: 63 VIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPL------QTLV 116
Query: 1056 KIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVE-DYNSNTE 1114
+ + +A G+EYL +HRD+ + N +L+ NM + DFGL+K + DY
Sbjct: 117 RFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGC 173
Query: 1115 SNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMVRWV 1173
++ ++A E T DV++ G+ + E+++ G+ P GVE
Sbjct: 174 ASKL---PVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYA---GVEN-----S 222
Query: 1174 EMHMEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPS 1223
E++ + R + +P +C V E+ QC P+ RPS
Sbjct: 223 EIYNYLIKGNRLK------QPP----DCLE-DVYELMCQCWSPEPKCRPS 261
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 1e-09
Identities = 58/211 (27%), Positives = 96/211 (45%), Gaps = 22/211 (10%)
Query: 953 IIGSGGSGTVYKAELANG----ATVAVKK-ISCKDDHLLNKSFTREVKTLGRIRHRHLVK 1007
++G G G V+ AEL A A+KK + DD + + V +L H L
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLA-WEHPFLTH 60
Query: 1008 LMGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEY 1067
L +C + + + EY+ G + +I+ D A + G+++
Sbjct: 61 L--YCTFQTKENLFFVMEYLNGGDLM-------FHIQSCHKFDLPRATFYAAEIICGLQF 111
Query: 1068 LHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIA 1127
LH I++RD+K NILLD++ + DFG+ K E+ + ++ T F G+ YIA
Sbjct: 112 LHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCK---ENMLGDAKTCT-FCGTPDYIA 164
Query: 1128 PEYAYSLKATEKCDVYSMGIVLMELVSGKMP 1158
PE K D +S G++L E++ G+ P
Sbjct: 165 PEILLGQKYNTSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 1e-09
Identities = 60/213 (28%), Positives = 96/213 (45%), Gaps = 29/213 (13%)
Query: 954 IGSGGSGTVYKAELAN-GATVAVKKISCKDDHLLNKSFT-REVKTLGRIRHRHLVKLMG- 1010
IG G GTV+KA+ VA+K++ DD S RE+ L ++H+++V+L
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67
Query: 1011 -HCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLH 1069
H K L++EY + L K + +D E L +G+ + H
Sbjct: 68 LHSDKK----LTLVFEYCDQD-----LKKYFDS--CNGDIDPEIVKSFMFQLLKGLAFCH 116
Query: 1070 HDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKAL---VEDYNSNTESNTWFAGSYGYI 1126
+LHRD+K N+L++ N E L DFGLA+A V Y++ + W Y
Sbjct: 117 SH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVVT-LW------YR 166
Query: 1127 APEYAYSLKA-TEKCDVYSMGIVLMELVSGKMP 1158
P+ + K + D++S G + EL + P
Sbjct: 167 PPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 2e-09
Identities = 66/221 (29%), Positives = 99/221 (44%), Gaps = 24/221 (10%)
Query: 953 IIGSGGSGTVYKAE-LANGATVAVKKISCKDDHLLNKSFTREVKT-----LGRIRHRHLV 1006
+IG G G V A A AVK + K +L K + + + L ++H LV
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKK--AILKKKEEKHIMSERNVLLKNVKHPFLV 59
Query: 1007 KLMGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVE 1066
L H + A + +Y+ G ++ L ++ R L+ AR A +A +
Sbjct: 60 GL--HFSFQTADKLYFVLDYINGGELFYHLQRE------RCFLEPRARF-YAAEIASALG 110
Query: 1067 YLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYI 1126
YLH I++RD+K NILLDS L DFGL K +E +N T + F G+ Y+
Sbjct: 111 YLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE-HNGTTST---FCGTPEYL 163
Query: 1127 APEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEM 1167
APE + D + +G VL E++ G P + EM
Sbjct: 164 APEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM 204
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 2e-09
Identities = 52/213 (24%), Positives = 97/213 (45%), Gaps = 27/213 (12%)
Query: 954 IGSGGSGTVYKAELANG---ATVAVKKI---SCKDDHLLNKSFTREVKTLGRIRHRHLVK 1007
IG+G G V E G A V VK++ + D+ LL F +EV+ + H ++++
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLL---FLQEVQPYRELNHPNVLQ 59
Query: 1008 LMGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEY 1067
+G C + LL+ E+ G + ++L + + + ++A +A G+ +
Sbjct: 60 CLGQCIE--SIPYLLVLEFCPLGDLKNYLRSNRGM--VAQMAQKDVLQRMACEVASGLLW 115
Query: 1068 LHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLA-KALVEDYNSNTESNTWFAGSYGYI 1126
LH +H D+ N L +++ +GD+GLA + EDY T+ ++
Sbjct: 116 LHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDY-YITKDCHAV--PLRWL 169
Query: 1127 APEYAYSL-------KATEKCDVYSMGIVLMEL 1152
APE T+K +++S+G+ + EL
Sbjct: 170 APELVEIRGQDLLPKDQTKKSNIWSLGVTMWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 2e-09
Identities = 58/209 (27%), Positives = 97/209 (46%), Gaps = 22/209 (10%)
Query: 954 IGSGGSGTVYKA-ELANGATVAVKKISCK-DDHLLNKSFTREVKTLGRIRHRHLVKLMG- 1010
IGSG G V A + G VAVKK+S + K RE+ L + H++++ L+
Sbjct: 29 IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNV 88
Query: 1011 HCCNKGAGSNLLIYEYME--NGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYL 1068
K +Y ME + ++ +H + LD E + + G+++L
Sbjct: 89 FTPQKSLEEFQDVYLVMELMDANLCQVIHME---------LDHERMSYLLYQMLCGIKHL 139
Query: 1069 HHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAP 1128
H I+HRD+K SNI++ S+ + DFGLA+ ++ T + + Y AP
Sbjct: 140 HS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNF-----MMTPYVVTRYYRAP 191
Query: 1129 EYAYSLKATEKCDVYSMGIVLMELVSGKM 1157
E + E D++S+G ++ ELV G +
Sbjct: 192 EVILGMGYKENVDIWSVGCIMGELVKGSV 220
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 2e-09
Identities = 56/212 (26%), Positives = 91/212 (42%), Gaps = 20/212 (9%)
Query: 953 IIGSGGSGTVYKAELANG----ATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKL 1008
+IG G V L A VKK DD ++ T + H LV L
Sbjct: 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 61
Query: 1009 MGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYL 1068
H C + + EY+ G + + +Q RK + AR A ++ + YL
Sbjct: 62 --HSCFQTESRLFFVIEYVNGGDLMFHMQRQ------RKLPEEHARFYSA-EISLALNYL 112
Query: 1069 HHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAP 1128
H I++RD+K N+LLDS L D+G+ K + ++ + F G+ YIAP
Sbjct: 113 HER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP----GDTTSTFCGTPNYIAP 165
Query: 1129 EYAYSLKATEKCDVYSMGIVLMELVSGKMPTD 1160
E D +++G+++ E+++G+ P D
Sbjct: 166 EILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.8 bits (148), Expect = 2e-09
Identities = 64/240 (26%), Positives = 102/240 (42%), Gaps = 52/240 (21%)
Query: 953 IIGSGGSGTVYKA-ELANGATVAVKKISCKDDHLLNKSFTREVKT----LGRIRHRHLVK 1007
+IG G G V+ + G A+K + K D ++ ++ V+ L +VK
Sbjct: 8 VIGRGAFGEVWLVRDKDTGQVYAMKVLR-KSD-MIKRNQIAHVRAERDILADADSPWIVK 65
Query: 1008 LMGHCCNKGAGSNL-LIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIA-VGLAQGV 1065
L + + +L L+ EYM G + + L I+ + AR IA + LA +
Sbjct: 66 L--YYSFQDE-EHLYLVMEYMPGGDLMNLL------IRKDVFPEETARFYIAELVLA--L 114
Query: 1066 EYLHHDCVPKI--LHRDIKSSNILLDSNMEAHLGDFGLAKALVED----YNSNTESNTWF 1119
+ +H K+ +HRDIK NIL+D++ L DFGL K + + Y N N F
Sbjct: 115 DSVH-----KLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLF 169
Query: 1120 ---------------------AGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMP 1158
G+ YIAPE +CD +S+G++L E++ G P
Sbjct: 170 RDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPP 229
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 2e-09
Identities = 54/206 (26%), Positives = 98/206 (47%), Gaps = 17/206 (8%)
Query: 953 IIGSGGSGTVYKAE-LANGATVAVKKIS-CKDDHLLNKSFTREVKTLGRIRHRHLVKLMG 1010
++G G G V K VA+KK +++ + ++ RE+K L ++ ++V+L
Sbjct: 8 VVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKE 67
Query: 1011 HCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHH 1070
+ G L++EY+E ++ + L + P + K + +L + + + H
Sbjct: 68 --AFRRRGKLYLVFEYVEK-NMLELLEEMPNGVPPEKVRSYIYQL------IKAIHWCHK 118
Query: 1071 DCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEY 1130
+ I+HRDIK N+L+ N L DFG A+ L E N+N T + + Y +PE
Sbjct: 119 N---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANY---TEYVATRWYRSPEL 172
Query: 1131 AYSLKATEKCDVYSMGIVLMELVSGK 1156
+ D++S+G +L EL G+
Sbjct: 173 LLGAPYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 2e-09
Identities = 61/222 (27%), Positives = 97/222 (43%), Gaps = 22/222 (9%)
Query: 953 IIGSGGSGTVYKAELANGATVAVKKISCKDDHLLNKS---FTREVKTLGRIRHRHLVKLM 1009
+IG G G V +L N V KI K + L F E L ++ + L
Sbjct: 8 VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTL- 66
Query: 1010 GHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLH 1069
H + + L+ +Y G + L K + + + A + IA+ V LH
Sbjct: 67 -HYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAI---DSVHQLH 122
Query: 1070 HDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPE 1129
+ +HRDIK NIL+D N L DFG L+ED T ++ G+ YI+PE
Sbjct: 123 Y------VHRDIKPDNILMDMNGHIRLADFGSCLKLMED---GTVQSSVAVGTPDYISPE 173
Query: 1130 YAYSLKATE-----KCDVYSMGIVLMELVSGKMPTDATFGVE 1166
+++ + +CD +S+G+ + E++ G+ P A VE
Sbjct: 174 ILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE 215
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 2e-09
Identities = 58/211 (27%), Positives = 94/211 (44%), Gaps = 25/211 (11%)
Query: 954 IGSGGSGTVYKAE-LANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHC 1012
IGSG G VYKA + G A+K I + +E+ + +H ++V G
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFA-VVQQEIIMMKDCKHSNIVAYFGSY 75
Query: 1013 CNKGAGSNLLI-YEYMENGSVWDWLH-KQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHH 1070
+ L I E+ GS+ D H P++ + + +R + QG+ YLH
Sbjct: 76 LRR---DKLWICMEFCGGGSLQDIYHVTGPLS---ESQIAYVSRETL-----QGLYYLHS 124
Query: 1071 DCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEY 1130
+HRDIK +NILL N L DFG++ + + F G+ ++APE
Sbjct: 125 K---GKMHRDIKGANILLTDNGHVKLADFGVSAQI----TATIAKRKSFIGTPYWMAPEV 177
Query: 1131 AYSLKA---TEKCDVYSMGIVLMELVSGKMP 1158
A + + CD++++GI +EL + P
Sbjct: 178 AAVERKGGYNQLCDIWAVGITAIELAELQPP 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 2e-09
Identities = 70/271 (25%), Positives = 113/271 (41%), Gaps = 43/271 (15%)
Query: 953 IIGSGGSGTVYKAELA-NGATVAVKKISCKDDHLLNKSFTREVKT-----LGRIRHRHLV 1006
+IG G G V A+ +G AVK + K +LN+ + + L ++H LV
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKI--VLNRKEQKHIMAERNVLLKNVKHPFLV 59
Query: 1007 KLMGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVE 1066
L H + + +++ G ++ L ++ R + AR A +A +
Sbjct: 60 GL--HYSFQTTEKLYFVLDFVNGGELFFHLQRE------RSFPEPRARFYAA-EIASALG 110
Query: 1067 YLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYI 1126
YLH I++RD+K NILLDS L DFGL K + + +++ T F G+ Y+
Sbjct: 111 YLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCKEGI----AQSDTTTTFCGTPEYL 163
Query: 1127 APEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEM-DMVRWVEMHMEMSGSARE 1185
APE D + +G VL E++ G P EM D + +H +
Sbjct: 164 APEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNI----LHKPLV----- 214
Query: 1186 ELLDDQMKPLLPGEECAAYQVLEIALQCTKT 1216
L PG A+ +LE L+ +
Sbjct: 215 ---------LRPGASLTAWSILEELLEKDRQ 236
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 2e-09
Identities = 40/140 (28%), Positives = 70/140 (50%), Gaps = 17/140 (12%)
Query: 1022 LIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVG-LAQGVEYLHHDCVPKILHRD 1080
LI +Y+ G ++ L++ R+ E+ +++ + + +++LH I++RD
Sbjct: 82 LILDYVNGGELFTHLYQ-------REHFT-ESEVRVYIAEIVLALDHLHQ---LGIIYRD 130
Query: 1081 IKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKA--TE 1138
IK NILLDS L DFGL+K + + E F G+ Y+APE +
Sbjct: 131 IKLENILLDSEGHVVLTDFGLSKEFLAE---EEERAYSFCGTIEYMAPEVIRGGSGGHDK 187
Query: 1139 KCDVYSMGIVLMELVSGKMP 1158
D +S+G++ EL++G P
Sbjct: 188 AVDWWSLGVLTFELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 3e-09
Identities = 60/223 (26%), Positives = 109/223 (48%), Gaps = 33/223 (14%)
Query: 954 IGSGGSGTVYKAELANG---------ATVAVK--KISCKDDHLLNKSFTREV-KTLGRIR 1001
+G G G V +AE A G TVAVK K + D L + E+ K +G+
Sbjct: 20 LGEGCFGQVVRAE-AYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGK-- 76
Query: 1002 HRHLVKLMGHCCNKGAGSNLLIYEYMENGSVWDWLH-KQP--------VNIKMRKSLDWE 1052
H++++ L+G C +G +I EY G++ ++L ++P + + L ++
Sbjct: 77 HKNIINLLGVCTQEG--PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFK 134
Query: 1053 ARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVE-DYNS 1111
+ A +A+G+EYL + +HRD+ + N+L+ + + DFGLA+ + + DY
Sbjct: 135 DLVSCAYQVARGMEYLESR---RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYK 191
Query: 1112 NTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS 1154
T + ++APE + T + DV+S GI++ E+ +
Sbjct: 192 KTSNGRL---PVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 3e-09
Identities = 61/256 (23%), Positives = 118/256 (46%), Gaps = 32/256 (12%)
Query: 954 IGSGGSGTVYKA-ELANGATVAVKKISCKDDHLLNKSFT-REVKTLGRIRHRHLVKLMGH 1011
+GSG G+V A + G VAVKK+S +++ T RE++ L ++H +++ L+
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD- 83
Query: 1012 CCNKGAGSNLLIYEYMENGSVWDWLHKQPVN--IKMRKSLDWEARLKIAVGLAQGVEYLH 1069
+ E + + L +N +K +K D + I + +G++Y+H
Sbjct: 84 -----VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIH 137
Query: 1070 HDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPE 1129
I+HRD+K SN+ ++ + E + DFGLA+ + T + + Y APE
Sbjct: 138 S---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPE 187
Query: 1130 YAYS-LKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSAREELL 1188
+ + + D++S+G ++ EL++G+ T D + +++ + + G+ ELL
Sbjct: 188 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT-----DHIDQLKLILRLVGTPGAELL 242
Query: 1189 DDQMKPLLPGEECAAY 1204
+ E Y
Sbjct: 243 KK-----ISSESARNY 253
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 3e-09
Identities = 56/217 (25%), Positives = 97/217 (44%), Gaps = 33/217 (15%)
Query: 954 IGSGGSGTVYKAEL-ANGATVAVKKISCKDDHLLNK-----SFTREVKTLGRIRHRHLVK 1007
+G GG G V ++ A G A KK++ K L K E + L ++ R +V
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKR---LKKRKGYEGAMVEKRILAKVHSRFIVS 57
Query: 1008 LMGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEY 1067
L + L+ M G + H V+ + + G+E+
Sbjct: 58 LA--YAFQTKTDLCLVMTIMNGGDLR--YHIYNVD-EENPGFPEPRACFYTAQIISGLEH 112
Query: 1068 LHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIA 1127
LH +I++RD+K N+LLD++ + D GLA L +D S T+ +AG+ G++A
Sbjct: 113 LHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVEL-KDGQSKTKG---YAGTPGFMA 165
Query: 1128 P------EYAYSLKATEKCDVYSMGIVLMELVSGKMP 1158
P EY +S+ D +++G+ L E+++ + P
Sbjct: 166 PELLQGEEYDFSV------DYFALGVTLYEMIAARGP 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 3e-09
Identities = 60/290 (20%), Positives = 123/290 (42%), Gaps = 42/290 (14%)
Query: 954 IGSGGSGTVYKAEL-----ANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKL 1008
+G G +YK L + VA+K + ++ F +E + + H ++V L
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72
Query: 1009 MGHCCNKGAGSNLLIYEYMENGSVWDWL-HKQP---------VNIKMRKSLDWEARLKIA 1058
+G + +++EY+ G + ++L + P + ++ SLD L IA
Sbjct: 73 LGVVTQEQPVC--MLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIA 130
Query: 1059 VGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTW 1118
+ +A G+EYL +H+D+ + NIL+ + + D GL++ + + +
Sbjct: 131 IQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSL 187
Query: 1119 FAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHME 1178
++ PE K + D++S G+VL E+ S FG++
Sbjct: 188 L--PIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS--------FGLQ-----------P 226
Query: 1179 MSGSAREELLDD-QMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQV 1227
G + +E+++ + + LLP E ++ + +C + P RP + +
Sbjct: 227 YYGFSNQEVIEMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDI 276
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 3e-09
Identities = 57/209 (27%), Positives = 95/209 (45%), Gaps = 28/209 (13%)
Query: 954 IGSGGSGTVYKAEL-ANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHC 1012
+G G TVYK + NG VA+K I +++ + RE L ++H ++V L H
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLL--HD 70
Query: 1013 CNKGAGSNLLIYEYMENGSVWDWLHKQPV-----NIKMRKSLDWEARLKIAVGLAQGVEY 1067
+ L++EY+ + ++ K P N+K+ L +G+ Y
Sbjct: 71 IIHTKETLTLVFEYVHT-DLCQYMDKHPGGLHPENVKL-----------FLFQLLRGLSY 118
Query: 1068 LHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIA 1127
+H ILHRD+K N+L+ E L DFGLA+A + S+T SN + Y
Sbjct: 119 IHQR---YILHRDLKPQNLLISDTGELKLADFGLARA--KSVPSHTYSNE--VVTLWYRP 171
Query: 1128 PEYAYSLKATEKC-DVYSMGIVLMELVSG 1155
P+ C D++ +G + +E++ G
Sbjct: 172 PDVLLGSTEYSTCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 3e-09
Identities = 59/217 (27%), Positives = 95/217 (43%), Gaps = 37/217 (17%)
Query: 954 IGSGGSGTVYKA-ELANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHC 1012
+G G TVYK G VA+K+I + + + RE L ++H ++V L H
Sbjct: 13 LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTL--HD 70
Query: 1013 CNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDC 1072
+ L++EY++ + ++ + M RL L +G+ Y H
Sbjct: 71 IIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHN-----VRL-FLFQLLRGLAYCHQR- 122
Query: 1073 VPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNT----WF------AGS 1122
++LHRD+K N+L+ E L DFGLA+A + S T SN W+ GS
Sbjct: 123 --RVLHRDLKPQNLLISERGELKLADFGLARA--KSVPSKTYSNEVVTLWYRPPDVLLGS 178
Query: 1123 YGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPT 1159
EY+ SL D++ +G + E+ +G P
Sbjct: 179 -----TEYSTSL------DMWGVGCIFYEMATG-RPL 203
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 4e-09
Identities = 67/236 (28%), Positives = 104/236 (44%), Gaps = 39/236 (16%)
Query: 954 IGSGGSGTVYKAELANGAT--VAVKKISC------KDDHLLNKSFTREVKTLGRI----R 1001
+GSG G VYK N +A+K+I+ KD +KS V + I R
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 1002 HRHLVKLMGHCCNKGAGSNLLIYEYME--NGSVWDWLHKQPVNIKMRKSLDWEARL-KIA 1058
H ++V+ K N +Y M+ G+ L + ++K +K E R+ I
Sbjct: 68 HPNIVRYY-----KTFLENDRLYIVMDLIEGAP---LGEHFNSLKEKKQRFTEERIWNIF 119
Query: 1059 VGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESN-T 1117
V + + YLH + +I+HRD+ +NI+L + + + DFGLAK ES T
Sbjct: 120 VQMVLALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAK------QKQPESKLT 171
Query: 1118 WFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELV-------SGKMPTDATFGVE 1166
G+ Y PE + EK DV++ G +L ++ S M + AT VE
Sbjct: 172 SVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVE 227
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 4e-09
Identities = 58/209 (27%), Positives = 97/209 (46%), Gaps = 26/209 (12%)
Query: 954 IGSGGSGTVYKA-ELANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHC 1012
+G G TVYK NG VA+K IS K + + + RE L ++H ++V L H
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLL--HD 70
Query: 1013 CNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDC 1072
+ ++EYM + ++ + P + + RL L +G+ Y+H
Sbjct: 71 IIHTKETLTFVFEYMHT-DLAQYMIQHPGGLH-----PYNVRL-FMFQLLRGLAYIHGQ- 122
Query: 1073 VPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNT----WFAGSYGYI-A 1127
ILHRD+K N+L+ E L DFGLA+A + S T S+ W+ + A
Sbjct: 123 --HILHRDLKPQNLLISYLGELKLADFGLARA--KSIPSQTYSSEVVTLWYRPPDVLLGA 178
Query: 1128 PEYAYSLKATEKCDVYSMGIVLMELVSGK 1156
+Y+ +L D++ G + +E++ G+
Sbjct: 179 TDYSSAL------DIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 5e-09
Identities = 34/95 (35%), Positives = 53/95 (55%), Gaps = 7/95 (7%)
Query: 1064 GVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSY 1123
G+++LH I++RD+K N++LD + + DFG+ K V + N S F G+
Sbjct: 108 GLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENV--FGDNRAST--FCGTP 160
Query: 1124 GYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMP 1158
YIAPE LK T D +S G++L E++ G+ P
Sbjct: 161 DYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 5e-09
Identities = 85/348 (24%), Positives = 142/348 (40%), Gaps = 96/348 (27%)
Query: 954 IGSGGSGTVYKAEL------ANGATVAVKKISCKDDHLLNKSFTREVKTLGRI-RHRHLV 1006
+G G G V +A A+ TVAVK + K+ E+K L I H ++V
Sbjct: 15 LGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVV 74
Query: 1007 KLMGHCCNKGAGSNLLIYEYMENGSVWDWLH-------------------KQPVNIKMR- 1046
L+G C G G ++I EY + G++ ++L KQ K R
Sbjct: 75 NLLGACTKPG-GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRL 133
Query: 1047 -----------------KSLD-----------WEARLKI------AVGLAQGVEYLHHDC 1072
KSL ++ L + + +A+G+E+L
Sbjct: 134 DSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASR- 192
Query: 1073 VPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVE--DYNSNTESNTWFAGSYGYIAPEY 1130
K +HRD+ + NILL N + DFGLA+ + + DY ++ ++APE
Sbjct: 193 --KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL----PLKWMAPES 246
Query: 1131 AYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMVRWVEMHMEMSGSAREEL-- 1187
+ T + DV+S G++L E+ S G P GV++D EE
Sbjct: 247 IFDKVYTTQSDVWSFGVLLWEIFSLGASPYP---GVQID----------------EEFCR 287
Query: 1188 -LDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNV 1234
L + + P E A ++ I L C +P++RP+ ++ ++L ++
Sbjct: 288 RLKEGTRMRAP--EYATPEIYSIMLDCWHNNPEDRPTFSELVEILGDL 333
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 5e-09
Identities = 58/222 (26%), Positives = 103/222 (46%), Gaps = 31/222 (13%)
Query: 954 IGSGGSGTVYKAEL--------ANGATVAVKKISCKDDHLLN--KSFTREVKTLGRI-RH 1002
+G G G V AE TVAVK + KDD E++ + I +H
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKML--KDDATDKDLSDLVSEMEMMKMIGKH 77
Query: 1003 RHLVKLMGHCCNKGAGSNLLIYEYMENGSVWDWLH-KQPVNIKM--------RKSLDWEA 1053
++++ L+G C G L+ EY G++ ++L ++P + + L ++
Sbjct: 78 KNIINLLGACTQDGPLYVLV--EYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKD 135
Query: 1054 RLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVE-DYNSN 1112
+ A +A+G+EYL K +HRD+ + N+L+ + + DFGLA+ + DY
Sbjct: 136 LVSCAYQVARGMEYLASQ---KCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKK 192
Query: 1113 TESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS 1154
T + ++APE + T + DV+S G++L E+ +
Sbjct: 193 TTNGRL---PVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 5e-09
Identities = 56/211 (26%), Positives = 96/211 (45%), Gaps = 29/211 (13%)
Query: 954 IGSGGSGTVYKA-ELANGAT-VAVKKISCK-DDHLLNKSFTREVKTLGRIR---HRHLVK 1007
IG G G V+KA +L NG VA+K++ + + + S REV L + H ++V+
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 1008 LMGHCCNKGAGSNL---LIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQG 1064
L C L++E+++ + +L K P + E + L +G
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVP-----EPGVPTETIKDMMFQLLRG 122
Query: 1065 VEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTES---NTWFAG 1121
+++LH +++HRD+K NIL+ S+ + L DFGLA+ + + S W
Sbjct: 123 LDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLAR--IYSFQMALTSVVVTLW--- 174
Query: 1122 SYGYIAPEYAYSLKATEKCDVYSMGIVLMEL 1152
Y APE D++S+G + E+
Sbjct: 175 ---YRAPEVLLQSSYATPVDLWSVGCIFAEM 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 5e-09
Identities = 48/179 (26%), Positives = 85/179 (47%), Gaps = 26/179 (14%)
Query: 1055 LKIAVGLAQGVEYL-HHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNT 1113
L +A+G+E+L +CV HRD+ + N+LL + DFGLA+ ++ D N +
Sbjct: 240 LSFTYQVARGMEFLASKNCV----HRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVS 295
Query: 1114 ESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMVRW 1172
+ +T+ ++APE + T DV+S GI+L E+ S G P V+
Sbjct: 296 KGSTFL--PVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMI-VDSTFYNK 352
Query: 1173 VEMHMEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLL 1231
++ M+ KP + A +V +I ++C + P++RPS + D++
Sbjct: 353 IKSGYRMA------------KP-----DHATQEVYDIMVKCWNSEPEKRPSFLHLSDIV 394
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 6e-09
Identities = 56/216 (25%), Positives = 91/216 (42%), Gaps = 28/216 (12%)
Query: 953 IIGSGGSGTVYKA-ELANGATVAVKKI-SCKDDHLLNKSFTREVKTLGRIRHR-HLVKLM 1009
IG G G VYKA + G VA+KK D+ + + RE+ L + ++V+L+
Sbjct: 8 KIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLL 67
Query: 1010 G--HCCNKGAGSNL-LIYEYMENGSVWDWLHKQPVNIKMRKS---LDWEARLKIAVGLAQ 1063
H K +L L++EY+++ K+ ++ R L + L +
Sbjct: 68 DVEHVEEKNGKPSLYLVFEYLDSDL------KKFMDSNGRGPGRPLPAKTIKSFMYQLLK 121
Query: 1064 GVEYLHHDCVPKILHRDIKSSNILLD-SNMEAHLGDFGLAKALVEDYNSNTES--NTWFA 1120
GV + H V +HRD+K N+L+D + D GL +A S T W
Sbjct: 122 GVAHCHKHGV---MHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLW-- 176
Query: 1121 GSYGYIAPEYAY-SLKATEKCDVYSMGIVLMELVSG 1155
Y APE S + D++S+G + E+
Sbjct: 177 ----YRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 7e-09
Identities = 41/150 (27%), Positives = 73/150 (48%), Gaps = 14/150 (9%)
Query: 1011 HCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHH 1070
H C + L+ EY+ G + + +Q RK + AR A + + +LH
Sbjct: 62 HSCFQTTSRLFLVIEYVNGGDLMFHMQRQ------RKLPEEHARF-YAAEICIALNFLHE 114
Query: 1071 DCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEY 1130
I++RD+K N+LLD++ L D+G+ K E ++T F G+ YIAPE
Sbjct: 115 R---GIIYRDLKLDNVLLDADGHIKLTDYGMCK---EGLGPGDTTST-FCGTPNYIAPEI 167
Query: 1131 AYSLKATEKCDVYSMGIVLMELVSGKMPTD 1160
+ D +++G+++ E+++G+ P D
Sbjct: 168 LRGEEYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 7e-09
Identities = 67/276 (24%), Positives = 116/276 (42%), Gaps = 42/276 (15%)
Query: 954 IGSGGSGTV----YKAELANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLM 1009
+GSG G V YK VA+K + +++ + RE + + ++ + ++V+++
Sbjct: 3 LGSGNFGCVKKGVYKMR-KKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 1010 GHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLH 1069
G C A + +L+ E G L+K K ++ L V + G++YL
Sbjct: 62 GVC---EAEALMLVMEMASGGP----LNKFLSGKKDEITVSNVVELMHQVSM--GMKYLE 112
Query: 1070 HDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVED--YNSNTESNTWFAGSYGYIA 1127
+HRD+ + N+LL + A + DFGL+KAL D Y + W Y A
Sbjct: 113 GK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWY---A 166
Query: 1128 PEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMVRWVEMHMEMSGSAREE 1186
PE K + + DV+S GI + E S G+ P G E ++ ++E + A
Sbjct: 167 PECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE--VMSFIEQGKRLDCPA--- 221
Query: 1187 LLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERP 1222
EC ++ + C ++RP
Sbjct: 222 -------------ECPP-EMYALMKDCWIYKWEDRP 243
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 8e-09
Identities = 36/110 (32%), Positives = 59/110 (53%), Gaps = 8/110 (7%)
Query: 1063 QGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGS 1122
+G++YLH ILHRDIK N+L++SN + DFGLA+ VE+ + +
Sbjct: 114 RGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLAR--VEEPDESKHMTQEVVTQ 168
Query: 1123 YGYIAPEYAY-SLKATEKCDVYSMGIVLMELVSGKMPTDATFGVE-MDMV 1170
Y Y APE S T D++S+G + EL+ ++ A ++ +D++
Sbjct: 169 Y-YRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLI 217
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 58.1 bits (141), Expect = 9e-09
Identities = 48/231 (20%), Positives = 85/231 (36%), Gaps = 46/231 (19%)
Query: 955 GSGGSGTVYKAELANGATVAVKKISCKDDHLLNKSFTR---EVKTLGRIRHRHLVKLMGH 1011
+ K + VAVKKI+ + E+ T +++H +++ +
Sbjct: 11 EDLMIVHLAKHK-PTNTLVAVKKINLDSCS--KEDLKLLQQEIITSRQLQHPNILPYVT- 66
Query: 1012 CCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAV---GLAQGVEYL 1068
++ M GS D L K + + IA + ++Y+
Sbjct: 67 -SFIVDSELYVVSPLMAYGSCED-LLKTHFPEGLPELA-------IAFILKDVLNALDYI 117
Query: 1069 HH-DCVPKILHRDIKSSNILLDSNMEAHLGDF---------GLAKALVEDYNSNTESN-T 1117
H + HR +K+S+ILL + + L G + +V D+ ++ N
Sbjct: 118 HSKGFI----HRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLP 173
Query: 1118 WFAGSYGYIAPEYAYS--LKATEKCDVYSMGIVLMELVSGKMP---TDATF 1163
W ++PE EK D+YS+GI EL +G +P AT
Sbjct: 174 W-------LSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ 217
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 1e-08
Identities = 71/199 (35%), Positives = 96/199 (48%), Gaps = 31/199 (15%)
Query: 628 LDLSGNSLTGPIPTQLLMCKKLSHIDLNNNLLSGAVPSWLGTLPQLGELKLSFNQFVGFL 687
LDL+ N L I LL L+ +DL+NN ++ P L EL LS N+ + L
Sbjct: 98 LDLNLNRLRSNISE-LLELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNK-IESL 155
Query: 688 PRELFNCSKLLVLSLDGNMLNGSLPNEVGNLASLNVLTLSGNLLSGPIPPAIGRLSKLYE 747
P L N L L L N L+ LP + NL++LN L LSGN +S +PP I LS L E
Sbjct: 156 PSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEE 213
Query: 748 LRLSNNSLNGVIPLEIGQLQNLQSILDLSHNNFTGQIPPSMGTLAKLEVLNLSHNQLVGE 807
L LSNNS+ ++ S+ L L L LS+N+L +
Sbjct: 214 LDLSNNSII--------------------------ELLSSLSNLKNLSGLELSNNKLE-D 246
Query: 808 LPSQLGEMSSLGKLNLSYN 826
LP +G +S+L L+LS N
Sbjct: 247 LPESIGNLSNLETLDLSNN 265
|
Length = 394 |
| >gnl|CDD|219766 pfam08263, LRRNT_2, Leucine rich repeat N-terminal domain | Back alignment and domain information |
|---|
Score = 51.9 bits (125), Expect = 1e-08
Identities = 15/40 (37%), Positives = 23/40 (57%)
Query: 27 DEELSVLLEIKKSFTADPENVLHAWNQSNQNLCTWRGITC 66
+++ LL K S DP L +WN S+ + C+W G+TC
Sbjct: 2 NDDRDALLAFKSSLNGDPSGALSSWNPSSSDPCSWTGVTC 41
|
Leucine Rich Repeats pfam00560 are short sequence motifs present in a number of proteins with diverse functions and cellular locations. Leucine Rich Repeats are often flanked by cysteine rich domains. This domain is often found at the N-terminus of tandem leucine rich repeats. Length = 42 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 1e-08
Identities = 56/215 (26%), Positives = 96/215 (44%), Gaps = 30/215 (13%)
Query: 953 IIGSGGSGTVYKAEL-ANGATVAVKKISCK-------DDHLLNKSFTREVKTLGRIRHRH 1004
++G GG G V ++ A G A KK+ K + LN E + L ++ R
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALN-----EKQILEKVNSRF 61
Query: 1005 LVKLMGHCCNKGAGSNLLIYEYMENGSV-WDWLHKQPVNIKMRKSLDWEARLKIAVGLAQ 1063
+V L K A L+ M G + + H + +++ + A +
Sbjct: 62 VVSLAYAYETKDALC--LVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEI------CC 113
Query: 1064 GVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSY 1123
G+E LH + +I++RD+K NILLD + + D GLA + E G+
Sbjct: 114 GLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR-----VGTV 165
Query: 1124 GYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMP 1158
GY+APE + + T D +++G +L E+++G+ P
Sbjct: 166 GYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 1e-08
Identities = 52/185 (28%), Positives = 86/185 (46%), Gaps = 26/185 (14%)
Query: 1049 LDWEARLKIAVGLAQGVEYL-HHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVE 1107
LD + L+ + +AQG+++L +C+ HRD+ + N+LL A + DFGLA+ ++
Sbjct: 209 LDLDDLLRFSSQVAQGMDFLASKNCI----HRDVAARNVLLTDGRVAKICDFGLARDIMN 264
Query: 1108 DYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVE 1166
D N + N ++APE + T + DV+S GI+L E+ S GK P V
Sbjct: 265 DSNYVVKGNARL--PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGIL-VN 321
Query: 1167 MDMVRWVEMHMEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQ 1226
+ V+ +MS +P + A ++ I C P ERP+ Q
Sbjct: 322 SKFYKMVKRGYQMS------------RP-----DFAPPEIYSIMKMCWNLEPTERPTFSQ 364
Query: 1227 VCDLL 1231
+ L+
Sbjct: 365 ISQLI 369
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 1e-08
Identities = 34/108 (31%), Positives = 54/108 (50%), Gaps = 9/108 (8%)
Query: 1052 EARLKI-AVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYN 1110
EAR A + G+E+LH +I++RD+K N+LLD + + D GLA L
Sbjct: 94 EARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVEL----- 145
Query: 1111 SNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMP 1158
+ AG+ GY+APE D +++G L E+++G+ P
Sbjct: 146 KGGKKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 1e-08
Identities = 46/140 (32%), Positives = 76/140 (54%), Gaps = 12/140 (8%)
Query: 1021 LLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLA--QGVEYLHHDCVPKILH 1078
LLI EY G L+KQ + ++++ L ++ + VGL Q V L K++H
Sbjct: 141 LLIMEYGSGGD----LNKQ-IKQRLKEHLPFQ---EYEVGLLFYQIVLALDEVHSRKMMH 192
Query: 1079 RDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATE 1138
RD+KS+NI L LGDFG +K + + + S+ F G+ Y+APE + ++
Sbjct: 193 RDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASS--FCGTPYYLAPELWERKRYSK 250
Query: 1139 KCDVYSMGIVLMELVSGKMP 1158
K D++S+G++L EL++ P
Sbjct: 251 KADMWSLGVILYELLTLHRP 270
|
Length = 478 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 1e-08
Identities = 58/210 (27%), Positives = 98/210 (46%), Gaps = 30/210 (14%)
Query: 954 IGSGGSGTVY----KAELANGATVAVKKISCKDDHLLNKSFT----REVKTLGRIRHRHL 1005
+G G GTVY K +A +K+I + LN + T +E + L ++ H +
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGE---LNPNETVQANQEAQLLSKLDHPAI 64
Query: 1006 VKLMGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKM---RKSLDWEARLKIAVGLA 1062
VK H + +I EY E + L + K + +W +L +
Sbjct: 65 VKF--HASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLL----- 117
Query: 1063 QGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGS 1122
GV Y+H +ILHRD+K+ NI L +N+ +GDFG+++ L+ + + T F G+
Sbjct: 118 -GVHYMH---QRRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLM----GSCDLATTFTGT 168
Query: 1123 YGYIAPEYAYSLKATEKCDVYSMGIVLMEL 1152
Y++PE K D++S+G +L E+
Sbjct: 169 PYYMSPEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 2e-08
Identities = 61/277 (22%), Positives = 117/277 (42%), Gaps = 47/277 (16%)
Query: 973 VAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIYEYMENGSV 1032
VAVK + + F +E+K + R++ ++++L+ C + +I EYMENG +
Sbjct: 49 VAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCIT--SDPLCMITEYMENGDL 106
Query: 1033 WDWLH----KQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILL 1088
+L ++ ++ + + +A +A G++YL +HRD+ + N L+
Sbjct: 107 NQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS---LNFVHRDLATRNCLV 163
Query: 1089 DSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSL-----------KAT 1137
N + DFG+++ L ++G Y I + K T
Sbjct: 164 GKNYTIKIADFGMSRNL-------------YSGDYYRIQGRAVLPIRWMSWESILLGKFT 210
Query: 1138 EKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWV-EMHMEMSGSAREELLDDQMKPL- 1195
DV++ G+ L E++ T E + E +E +G E DQ + +
Sbjct: 211 TASDVWAFGVTLWEIL--------TLCKEQPYSQLSDEQVIENTG----EFFRDQGRQVY 258
Query: 1196 LPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLL 1232
LP + ++ L C + + +ERPS +++ LL
Sbjct: 259 LPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 2e-08
Identities = 59/221 (26%), Positives = 96/221 (43%), Gaps = 50/221 (22%)
Query: 954 IGSGGSGTVYKAELA-NGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHC 1012
+G G TV+K VA+K+I + + + REV L ++H ++V L H
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTL--HD 70
Query: 1013 CNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARL------KIAV-GLAQGV 1065
L++EY+++ +++ LD L KI + L +G+
Sbjct: 71 IIHTERCLTLVFEYLDS--------------DLKQYLDNCGNLMSMHNVKIFMFQLLRGL 116
Query: 1066 EYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNT----WFA- 1120
Y H KILHRD+K N+L++ E L DFGLA+A + + T SN W+
Sbjct: 117 SYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARA--KSVPTKTYSNEVVTLWYRP 171
Query: 1121 -----GSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGK 1156
GS Y P D++ +G +L E+ +G+
Sbjct: 172 PDVLLGSTEYSTP-----------IDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 2e-08
Identities = 57/216 (26%), Positives = 91/216 (42%), Gaps = 31/216 (14%)
Query: 953 IIGSGGSGTVYKAELAN-GATVAVKKISCKDDHLLN------KSFTREVKTLGRIRHRHL 1005
++G G G V AE G A+K + K D + R +T RH L
Sbjct: 6 VLGRGHFGKVLLAEYKKTGELYAIKALK-KGDIIARDEVESLMCEKRIFETANSERHPFL 64
Query: 1006 VKLMGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKI-AVGLAQG 1064
V L C + + EY G + +H + E R A + G
Sbjct: 65 VNL--FACFQTEDHVCFVMEYAAGGDLMMHIHTDVFS---------EPRAVFYAACVVLG 113
Query: 1065 VEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVED--YNSNTESNTWFAGS 1122
++YLH + KI++RD+K N+LLD+ + DFGL K E + T + F G+
Sbjct: 114 LQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCK---EGMGFGDRTST---FCGT 164
Query: 1123 YGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMP 1158
++APE T D + +G+++ E++ G+ P
Sbjct: 165 PEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESP 200
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 2e-08
Identities = 58/216 (26%), Positives = 99/216 (45%), Gaps = 26/216 (12%)
Query: 953 IIGSGGSGTVYKAEL-ANGATVAVK----KISCKDDHLLNKSFTREVKTLGRIRHRHLVK 1007
++G G G V AE A+K + +DD + + V L + + L +
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLAL-QDKPPFLTQ 65
Query: 1008 LMGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPV-NIKMRKSLDWEARLKIAVGLAQGVE 1066
L H C + + EY+ G + H Q V K +++ + A +I+VGL
Sbjct: 66 L--HSCFQTVDRLYFVMEYVNGGDLM--YHIQQVGKFKEPQAVFYAA--EISVGLF---- 115
Query: 1067 YLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAK-ALVEDYNSNTESNTWFAGSYGY 1125
+LH I++RD+K N++LDS + DFG+ K +V+ + T F G+ Y
Sbjct: 116 FLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRT-----FCGTPDY 167
Query: 1126 IAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDA 1161
IAPE + D ++ G++L E+++G+ P D
Sbjct: 168 IAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDG 203
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 3e-08
Identities = 56/214 (26%), Positives = 92/214 (42%), Gaps = 29/214 (13%)
Query: 953 IIGSGGSGTVYKA-ELANGATVAVK-----KISCKDD--HLLNKSFTREVKTLGRIRHRH 1004
++G G G V E A+G A+K I KD+ H L +S + L RH
Sbjct: 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTES-----RVLKNTRHPF 56
Query: 1005 LVKLMGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQG 1064
L L K + EY+ G ++ L ++ V + R +
Sbjct: 57 LTSLKYSFQTKD--RLCFVMEYVNGGELFFHLSRERVFSEDRTRF-------YGAEIVSA 107
Query: 1065 VEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYG 1124
++YLH KI++RD+K N++LD + + DFGL K + D + F G+
Sbjct: 108 LDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITD----AATMKTFCGTPE 160
Query: 1125 YIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMP 1158
Y+APE D + +G+V+ E++ G++P
Sbjct: 161 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 3e-08
Identities = 49/182 (26%), Positives = 85/182 (46%), Gaps = 30/182 (16%)
Query: 1061 LAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFA 1120
+A+G+E+L K +HRD+ + NILL N + DFGLA+ + +D + + +
Sbjct: 183 VARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL- 238
Query: 1121 GSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMVRWVEMHMEM 1179
++APE + T + DV+S G++L E+ S G P GV+++
Sbjct: 239 -PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYP---GVQIN----------- 283
Query: 1180 SGSAREEL---LDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNVFN 1236
EE L D + P E A ++ I L C + P+ERP+ + ++L ++
Sbjct: 284 -----EEFCQRLKDGTRMRAP--ENATPEIYRIMLACWQGDPKERPTFSALVEILGDLLQ 336
Query: 1237 NR 1238
Sbjct: 337 EN 338
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 3e-08
Identities = 42/164 (25%), Positives = 83/164 (50%), Gaps = 18/164 (10%)
Query: 1001 RHRHLVKLMGHCCNKGAGSNLLIYEYMENGSVWDWLH-KQPVNIKM--------RKSLDW 1051
+H++++ L+G C G +I EY G++ ++L ++P ++ + L +
Sbjct: 82 KHKNIINLLGACTQDG--PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSF 139
Query: 1052 EARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVE-DYN 1110
+ + A +A+G+EYL K +HRD+ + N+L+ + + DFGLA+ + DY
Sbjct: 140 KDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY 196
Query: 1111 SNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS 1154
T + ++APE + T + DV+S G++L E+ +
Sbjct: 197 KKTTNGRL---PVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 3e-08
Identities = 69/293 (23%), Positives = 122/293 (41%), Gaps = 52/293 (17%)
Query: 951 EFIIGSGGSGTV--------YKAELANGATVAVKKI--SCKDDHLLNKSFTREVKTLGRI 1000
E I+G+G G + K EL VA+ + C D + F E TLG+
Sbjct: 10 ERILGTGRFGELCRGCLKLPSKRELP----VAIHTLRAGCSDKQ--RRGFLAEALTLGQF 63
Query: 1001 RHRHLVKLMGHCCNKGAGSNLLIY-EYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAV 1059
H ++V+L G G+ ++I EYM NG++ +L K + + + +
Sbjct: 64 DHSNIVRLEGVITR---GNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMG------MLP 114
Query: 1060 GLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWF 1119
GLA G++YL +H+ + + +L++S++ + F L ED + +
Sbjct: 115 GLASGMKYLSE---MGYVHKGLAAHKVLVNSDLVCKISGFR---RLQEDKSEAIYTTMSG 168
Query: 1120 AGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMVRWVEMHME 1178
+ APE + DV+S GIV+ E++S G+ P + +
Sbjct: 169 KSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERP-----------------YWD 211
Query: 1179 MSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLL 1231
MSG + ++D + LP + ++ L C + ERP Q+ +L
Sbjct: 212 MSGQDVIKAVEDGFR--LPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSIL 262
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 3e-08
Identities = 57/217 (26%), Positives = 104/217 (47%), Gaps = 40/217 (18%)
Query: 954 IGSGGSGTV-YKAELANGATVAVKKISCK-DDHLLNKSFTREVKTLGRIRHRHLVKLMGH 1011
+GSG GTV + GA VA+KK+ L K RE++ L ++H +++ L+
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDV 82
Query: 1012 CCNKGAGSNL-------LIYEYM--ENGSVWDWLHKQPVNIKMRKSLDWEARLKIAV-GL 1061
+L L+ +M + G + +K K E R++ V +
Sbjct: 83 FT---PDLSLDRFHDFYLVMPFMGTDLGKL----------MKHEKL--SEDRIQFLVYQM 127
Query: 1062 AQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESN-TWFA 1120
+G++Y+H I+HRD+K N+ ++ + E + DFGLA+ T+S T +
Sbjct: 128 LKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR--------QTDSEMTGYV 176
Query: 1121 GSYGYIAPEYAYS-LKATEKCDVYSMGIVLMELVSGK 1156
+ Y APE + + T+ D++S+G ++ E+++GK
Sbjct: 177 VTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 5e-08
Identities = 33/104 (31%), Positives = 51/104 (49%), Gaps = 9/104 (8%)
Query: 1061 LAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFA 1120
LA+ V +H +HRDIK N+L+D L DFG A L + N++
Sbjct: 108 LAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPV--- 164
Query: 1121 GSYGYIAPEYAYSLKATEK------CDVYSMGIVLMELVSGKMP 1158
G+ YIAPE ++ K CD +S+G++ E++ G+ P
Sbjct: 165 GTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSP 208
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 6e-08
Identities = 39/138 (28%), Positives = 62/138 (44%), Gaps = 17/138 (12%)
Query: 1019 SNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILH 1078
S L+ ++ E G +W + K +NI W A + +A+ + LH + I+
Sbjct: 59 SVFLVLQHAEGGKLWSHISKF-LNIPEECVKRWAAEMVVAL------DALHRE---GIVC 108
Query: 1079 RDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATE 1138
RD+ +NILLD L F + + + N Y APE + TE
Sbjct: 109 RDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM-------YCAPEVGGISEETE 161
Query: 1139 KCDVYSMGIVLMELVSGK 1156
CD +S+G +L EL++GK
Sbjct: 162 ACDWWSLGAILFELLTGK 179
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 6e-08
Identities = 51/211 (24%), Positives = 94/211 (44%), Gaps = 21/211 (9%)
Query: 953 IIGSGGSGTVYKAELANGATVAVKKISC--KDDHLLNKSFTREVKTLGRIRHRHLVKLMG 1010
+I ++YK N V ++ K +L E+K L RI +++K+ G
Sbjct: 27 LIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYG 85
Query: 1011 HCCNKGAG--SNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYL 1068
+ LI EY G + + L K+ K L ++ +L +A+ +G+ L
Sbjct: 86 FIIDIVDDLPRLSLILEYCTRGYLREVLDKE-------KDLSFKTKLDMAIDCCKGLYNL 138
Query: 1069 H-HDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIA 1127
+ + P ++++ S + L+ N + + GL K L N +F SY +
Sbjct: 139 YKYTNKP---YKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVNFMVYF--SYKMLN 193
Query: 1128 PEYAYSLKATEKCDVYSMGIVLMELVSGKMP 1158
++ + T K D+YS+G+VL E+ +GK+P
Sbjct: 194 DIFS---EYTIKDDIYSLGVVLWEIFTGKIP 221
|
Length = 283 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 7e-08
Identities = 33/105 (31%), Positives = 56/105 (53%), Gaps = 11/105 (10%)
Query: 1056 KIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTES 1115
+IA+GL +LH I++RD+K N++LD+ + DFG+ K E+ +
Sbjct: 109 EIAIGLF----FLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCK---ENIFGGKTT 158
Query: 1116 NTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTD 1160
T F G+ YIAPE + D ++ G++L E+++G+ P D
Sbjct: 159 RT-FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 7e-08
Identities = 60/219 (27%), Positives = 97/219 (44%), Gaps = 34/219 (15%)
Query: 953 IIGSGGSGTVYKAELANG----ATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKL 1008
+IG G V EL A +KK DD ++ T + H LV L
Sbjct: 2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGL 61
Query: 1009 MGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIA-VGLAQGVEY 1067
H C + + E++ G + H Q + RK + AR A + LA + +
Sbjct: 62 --HSCFQTESRLFFVIEFVSGGDLM--FHMQ----RQRKLPEEHARFYSAEISLA--LNF 111
Query: 1068 LHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIA 1127
LH I++RD+K N+LLD+ L D+G+ K + +T S F G+ YIA
Sbjct: 112 LHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP--GDTTST--FCGTPNYIA 164
Query: 1128 PE------YAYSLKATEKCDVYSMGIVLMELVSGKMPTD 1160
PE Y +S+ D +++G+++ E+++G+ P D
Sbjct: 165 PEILRGEDYGFSV------DWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 7e-08
Identities = 52/208 (25%), Positives = 96/208 (46%), Gaps = 20/208 (9%)
Query: 954 IGSGGSGTV---YKAELANGATVAVKKISCK-DDHLLNKSFTREVKTLGRIRHRHLVKLM 1009
IGSG G V Y A L VA+KK+S + K RE+ + + H++++ L+
Sbjct: 32 IGSGAQGIVCAAYDAILER--NVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 89
Query: 1010 GHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLH 1069
+ + + E+ + V + + + ++ LD E + + G+++LH
Sbjct: 90 NVFTPQKS-----LEEFQDVYIVMELMDANLCQV-IQMELDHERMSYLLYQMLCGIKHLH 143
Query: 1070 HDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPE 1129
I+HRD+K SNI++ S+ + DFGLA+ + T + Y APE
Sbjct: 144 S---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY-----YRAPE 195
Query: 1130 YAYSLKATEKCDVYSMGIVLMELVSGKM 1157
+ E D++S+G ++ E++ G +
Sbjct: 196 VILGMGYKENVDIWSVGCIMGEMIKGGV 223
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 9e-08
Identities = 76/350 (21%), Positives = 136/350 (38%), Gaps = 92/350 (26%)
Query: 954 IGSGGSGTVYKAE------LANGATVAVKKISCKDDHLLNKSFTREVKTLGRI-RHRHLV 1006
+G G G V +A+ A TVAVK + H +++ E+K L I H ++V
Sbjct: 15 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 74
Query: 1007 KLMGHCCNKGAGSNLLIYEYMENGSVWDWLHKQ------------------------PVN 1042
L+G C G G ++I E+ + G++ ++L + +
Sbjct: 75 NLLGACTKPG-GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISED 133
Query: 1043 IKMR------------------------------------KSLDWEARLKIAVGLAQGVE 1066
+K R K L E + + +A+G+E
Sbjct: 134 LKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGME 193
Query: 1067 YLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYI 1126
+L K +HRD+ + NILL N + DFGLA+ + +D + + + ++
Sbjct: 194 FLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL--PLKWM 248
Query: 1127 APEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMVRWVEMHMEMSGSARE 1185
APE + T + DV+S G++L E+ S G P GV++D E + R
Sbjct: 249 APETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP---GVKIDE----EFCRRLKEGTR- 300
Query: 1186 ELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNVF 1235
+ + ++ + L C P +RP+ ++ + L N+
Sbjct: 301 ----------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 340
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 1e-07
Identities = 30/93 (32%), Positives = 47/93 (50%), Gaps = 10/93 (10%)
Query: 1066 EYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGY 1125
EYLH I++RD+K N+LLD+ + DFG AK + + G+ Y
Sbjct: 132 EYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKV-------PDRTFTLCGTPEY 181
Query: 1126 IAPEYAYSLKATEKCDVYSMGIVLMELVSGKMP 1158
+APE S + D ++MG++L E ++G P
Sbjct: 182 LAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPP 214
|
Length = 329 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 1e-07
Identities = 52/172 (30%), Positives = 78/172 (45%), Gaps = 31/172 (18%)
Query: 1022 LIYEYMENGSVWDWL-HKQPVNIKMRKSLDWEARLKIA-VGLAQGVEYLHHDCVPKILHR 1079
++ EY+E G L + + + M AR+ A LA +EYLH+ I+HR
Sbjct: 78 MVMEYVEGGDCATLLKNIGALPVDM-------ARMYFAETVLA--LEYLHN---YGIVHR 125
Query: 1080 DIKSSNILLDSNMEAHLGDFGLAKALVED-----YNSNTESNT------WFAGSYGYIAP 1128
D+K N+L+ S L DFGL+K + Y + E +T G+ YIAP
Sbjct: 126 DLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAP 185
Query: 1129 EYAYSLKATEKCDVYSMGIVLMELVSGKMP-----TDATFG-VEMDMVRWVE 1174
E + D ++MGI+L E + G +P + FG V D + W E
Sbjct: 186 EVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPE 237
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 1e-07
Identities = 53/210 (25%), Positives = 100/210 (47%), Gaps = 27/210 (12%)
Query: 954 IGSGGSGTVYKA-ELANGATVAVKKISCK-DDHLLNKSFTREVKTLGRIRHRHLVKLMGH 1011
+GSG G+V A + G VA+KK+S + K RE+ L ++H +++ L+
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDV 82
Query: 1012 CCNKGAGSNL----LIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEY 1067
+ +G L+ YM+ L K M L + + + G++Y
Sbjct: 83 FTSAVSGDEFQDFYLVMPYMQTD-----LQK-----IMGHPLSEDKVQYLVYQMLCGLKY 132
Query: 1068 LHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIA 1127
+H I+HRD+K N+ ++ + E + DFGLA+ +++ E T + + Y A
Sbjct: 133 IHS---AGIIHRDLKPGNLAVNEDCELKILDFGLAR------HADAEM-TGYVVTRWYRA 182
Query: 1128 PEYAYS-LKATEKCDVYSMGIVLMELVSGK 1156
PE + + + D++S+G ++ E+++GK
Sbjct: 183 PEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 2e-07
Identities = 34/85 (40%), Positives = 46/85 (54%), Gaps = 1/85 (1%)
Query: 316 LVLSNNNISGSIPRRICTNATSLEHLILAEIQLSGEIPVELSQCQSLKQLDLSNNTLNGT 375
L L N + G IP I + L+ + L+ + G IP L SL+ LDLS N+ NG+
Sbjct: 423 LGLDNQGLRGFIPNDI-SKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGS 481
Query: 376 IPVELFQLVALTHLYLHNNSLVGSI 400
IP L QL +L L L+ NSL G +
Sbjct: 482 IPESLGQLTSLRILNLNGNSLSGRV 506
|
Length = 623 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 2e-07
Identities = 32/95 (33%), Positives = 50/95 (52%), Gaps = 8/95 (8%)
Query: 1077 LHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSL-- 1134
+HRDIK N+LLD N L DFG + +D T ++ G+ YI+PE ++
Sbjct: 124 VHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD---GTVQSSVAVGTPDYISPEILQAMED 180
Query: 1135 ---KATEKCDVYSMGIVLMELVSGKMPTDATFGVE 1166
K +CD +S+G+ + E++ G+ P A VE
Sbjct: 181 GMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE 215
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 53.7 bits (130), Expect = 2e-07
Identities = 46/175 (26%), Positives = 76/175 (43%), Gaps = 35/175 (20%)
Query: 1002 HRHLVKLMGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGL 1061
+ + +KL + ++LI +Y+++G ++D L K L KI L
Sbjct: 68 NPNFIKL--YYSVTTLKGHVLIMDYIKDGDLFDLL-------KKEGKLSEAEVKKIIRQL 118
Query: 1062 AQGVEYLH-HDCVPKILHRDIKSSNILLDSNME-AHLGDFGLAKALVEDYNSNTESNTWF 1119
+ + LH H I+H DIK N+L D + +L D+GL K T S +
Sbjct: 119 VEALNDLHKH----NIIHNDIKLENVLYDRAKDRIYLCDYGLCK------IIGTPSC--Y 166
Query: 1120 AGSYGYIAPE------YAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMD 1168
G+ Y +PE Y S D +++G++ EL++GK P E+D
Sbjct: 167 DGTLDYFSPEKIKGHNYDVSF------DWWAVGVLTYELLTGKHPFKEDEDEELD 215
|
Length = 267 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 2e-07
Identities = 46/171 (26%), Positives = 74/171 (43%), Gaps = 15/171 (8%)
Query: 988 KSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRK 1047
K+ RE+ L I HR ++ L+ H + +++ +Y +
Sbjct: 131 KTPGREIDILKTISHRAIINLI-HAYRWKSTVCMVMPKYK---------CDLFTYVDRSG 180
Query: 1048 SLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVE 1107
L E + I L + + YLH I+HRD+K+ NI LD A LGDFG A L
Sbjct: 181 PLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKL-- 235
Query: 1108 DYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMP 1158
D + +T ++G+ +PE K D++S G+VL E+ +
Sbjct: 236 DAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVT 286
|
Length = 392 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 54.2 bits (131), Expect = 2e-07
Identities = 52/211 (24%), Positives = 99/211 (46%), Gaps = 28/211 (13%)
Query: 954 IGSGGSGTVYKAELA-NGATVAVKKIS--CKDDHLLNKSFTREVKTLGRIRHRHLVKLMG 1010
+GSG G V A G VA+KK+S + +++ RE++ L + H +++ L+
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTY-RELRLLKHMDHENVIGLLD 81
Query: 1011 HCCNKGAGSNL----LIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVE 1066
+ + L+ M L+ +K +K D + + + +G++
Sbjct: 82 VFTPASSLEDFQDVYLVTHLMGAD-----LNNI---VKCQKLSDDHIQF-LVYQILRGLK 132
Query: 1067 YLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYI 1126
Y+H I+HRD+K SNI ++ + E + DFGLA+ + T + + Y
Sbjct: 133 YIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYR 182
Query: 1127 APEYAYS-LKATEKCDVYSMGIVLMELVSGK 1156
APE + + + D++S+G ++ EL++GK
Sbjct: 183 APEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 2e-07
Identities = 61/231 (26%), Positives = 98/231 (42%), Gaps = 32/231 (13%)
Query: 953 IIGSGGSGTVYKAEL-ANGATVAVKKISCK-------DDHLLNKSFTREVKTLGRIRHRH 1004
++G GG G V ++ A G A KK+ K + LN E + L ++ R
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALN-----EKRILEKVNSRF 61
Query: 1005 LVKLMGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQG 1064
+V L K A L+ M G + K + D + + A L G
Sbjct: 62 VVSLAYAYETKDALC--LVLTIMNGGDL-----KFHIYNMGNPGFDEQRAIFYAAELCCG 114
Query: 1065 VEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYG 1124
+E L + +I++RD+K NILLD + D GLA + E E+ G+ G
Sbjct: 115 LEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG-----ETVRGRVGTVG 166
Query: 1125 YIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEM 1175
Y+APE + K T D + +G ++ E++ G+ P F + V+ E+
Sbjct: 167 YMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSP----FRKRKERVKREEV 213
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 48.7 bits (117), Expect = 2e-07
Identities = 25/60 (41%), Positives = 31/60 (51%)
Query: 264 QLGYLNLMGNRLEGAIPRSFAKMGNLQSLDLSMNRLTGGIPEEFGNMGQLVFLVLSNNNI 323
L L+L NRL +F + NL+ LDLS N LT PE F + L L LS NN+
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 2e-07
Identities = 44/179 (24%), Positives = 66/179 (36%), Gaps = 46/179 (25%)
Query: 1053 ARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSN 1112
AR IA L +E +H +HRDIK NIL+D + L DFGL ++S
Sbjct: 103 ARFYIA-ELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 158
Query: 1113 -------------TESNTWFA--------------------------GSYGYIAPEYAYS 1133
S W G+ YIAPE
Sbjct: 159 YYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLR 218
Query: 1134 LKATEKCDVYSMGIVLMELVSGKMP--TDATFGVEMDMVRW-VEMHMEMSGSAREELLD 1189
T+ CD +S+G++L E++ G+ P D ++ ++ W +H+ E D
Sbjct: 219 TGYTQLCDWWSVGVILYEMLVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASD 277
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 2e-07
Identities = 72/286 (25%), Positives = 108/286 (37%), Gaps = 63/286 (22%)
Query: 954 IGSGGSGTVYKA-ELANGATVAVKKISCKDDHLLNK--SFTREVKTLGRIRHRHLVKLMG 1010
+G G G V A ++ A A+K + KD L N+ E L + +V+L
Sbjct: 9 LGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYY 68
Query: 1011 HCCNKGAGSNL-LIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLH 1069
+K NL + +Y+ G + L I+M + AR IA L VE +H
Sbjct: 69 SFQDK---DNLYFVMDYIPGGDMMSLL------IRMGIFPEDLARFYIA-ELTCAVESVH 118
Query: 1070 HDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTE-------------SN 1116
+HRDIK NIL+D + L DFGL ++S SN
Sbjct: 119 K---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSN 175
Query: 1117 TW------------------------------FAGSYGYIAPEYAYSLKATEKCDVYSMG 1146
W G+ YIAPE T+ CD +S+G
Sbjct: 176 EWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 235
Query: 1147 IVLMELVSGKMPTDATFGVE--MDMVRW-VEMHMEMSGSAREELLD 1189
++L E++ G+ P A +E M ++ W +H+ E D
Sbjct: 236 VILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASD 281
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 2e-07
Identities = 27/83 (32%), Positives = 45/83 (54%), Gaps = 4/83 (4%)
Query: 1076 ILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLK 1135
+++RD+K NILLD L DFGL K + + + F G+ Y+APE
Sbjct: 114 VIYRDLKPENILLDYQGHIALCDFGLCKLNM----KDDDKTNTFCGTPEYLAPELLLGHG 169
Query: 1136 ATEKCDVYSMGIVLMELVSGKMP 1158
T+ D +++G++L E+++G P
Sbjct: 170 YTKAVDWWTLGVLLYEMLTGLPP 192
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 2e-07
Identities = 54/213 (25%), Positives = 99/213 (46%), Gaps = 23/213 (10%)
Query: 953 IIGSGGSGTVYKAELANGAT---VAVKKISCKDDHLLNKSFTREVKT----LGRIRHRHL 1005
++G GG G V++ GA + K+ K + N+ T K L ++H +
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62
Query: 1006 VKLMGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGV 1065
V L + G LI EY+ G ++ L ++ + ++ + + + +A+
Sbjct: 63 VDL--IYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACF-YLSEISLAL------ 113
Query: 1066 EYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGY 1125
E+LH I++RD+K NILLD+ L DFGL K + + + T + F G+ Y
Sbjct: 114 EHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHE-GTVTHT---FCGTIEY 166
Query: 1126 IAPEYAYSLKATEKCDVYSMGIVLMELVSGKMP 1158
+APE + D +S+G ++ ++++G P
Sbjct: 167 MAPEILMRSGHGKAVDWWSLGALMYDMLTGAPP 199
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 3e-07
Identities = 35/112 (31%), Positives = 57/112 (50%), Gaps = 12/112 (10%)
Query: 1064 GVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSY 1123
G+E LH + +I++RD+K NILLD + D GLA + E E+ G+
Sbjct: 114 GLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG-----ETIRGRVGTV 165
Query: 1124 GYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEM 1175
GY+APE + + T D + +G ++ E++ GK P F + V+ E+
Sbjct: 166 GYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSP----FRQRKEKVKREEV 213
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 3e-07
Identities = 38/137 (27%), Positives = 66/137 (48%), Gaps = 14/137 (10%)
Query: 1022 LIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDI 1081
+ EY G ++ L ++ V + R AR A + +EYLH +++RDI
Sbjct: 72 FVMEYANGGELFFHLSRERVFTEER------ARFYGA-EIVSALEYLHSR---DVVYRDI 121
Query: 1082 KSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCD 1141
K N++LD + + DFGL K + S+ + F G+ Y+APE D
Sbjct: 122 KLENLMLDKDGHIKITDFGLCKEGI----SDGATMKTFCGTPEYLAPEVLEDNDYGRAVD 177
Query: 1142 VYSMGIVLMELVSGKMP 1158
+ +G+V+ E++ G++P
Sbjct: 178 WWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 3e-07
Identities = 57/209 (27%), Positives = 99/209 (47%), Gaps = 26/209 (12%)
Query: 954 IGSGGSGTVYK--AELANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGH 1011
+G G TVYK ++L + VA+K+I + + + REV L ++H ++V L H
Sbjct: 14 LGEGTYATVYKGRSKLTDN-LVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTL--H 70
Query: 1012 CCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAV-GLAQGVEYLHH 1070
S L++EY++ + +L +I M +K+ + L +G+ Y H
Sbjct: 71 DIIHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHN-------VKLFLFQLLRGLNYCHR 122
Query: 1071 DCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKA--LVEDYNSNTESNTWFAGSYGYIAP 1128
K+LHRD+K N+L++ E L DFGLA+A + SN W Y P
Sbjct: 123 R---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLW------YRPP 173
Query: 1129 EYAY-SLKATEKCDVYSMGIVLMELVSGK 1156
+ S + + D++ +G + E+ +G+
Sbjct: 174 DILLGSTDYSTQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 3e-07
Identities = 36/102 (35%), Positives = 54/102 (52%), Gaps = 6/102 (5%)
Query: 1055 LKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTE 1114
L I + + ++YLH + +I+HRDIK+ NI ++ + LGDFG A V D N+N +
Sbjct: 185 LAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPV-DINAN-K 239
Query: 1115 SNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGK 1156
W AG+ APE D++S GIVL E+ +
Sbjct: 240 YYGW-AGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 3e-07
Identities = 62/248 (25%), Positives = 93/248 (37%), Gaps = 62/248 (25%)
Query: 953 IIGSGGSGTVYKAELANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRH-------- 1004
+IG G G V + + V KI K D L E + +G IR
Sbjct: 8 VIGRGAFGEVRLVQKKDTGHVYAMKILRKADML-------EKEQVGHIRAERDILVEADS 60
Query: 1005 --LVKLMGHCCNKGAGSNL-LIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGL 1061
+VK+ +K NL LI E++ G + L K + +L E
Sbjct: 61 LWVVKMFYSFQDK---LNLYLIMEFLPGGDMMTLLMK-------KDTLTEEETQFYIAET 110
Query: 1062 AQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKAL---------------- 1105
++ +H +HRDIK N+LLDS L DFGL L
Sbjct: 111 VLAIDSIHQ---LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSL 167
Query: 1106 -----VEDYNSNTESNTW----------FAGSYGYIAPEYAYSLKATEKCDVYSMGIVLM 1150
++ NS ++ TW G+ YIAPE + CD +S+G+++
Sbjct: 168 PSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMY 227
Query: 1151 ELVSGKMP 1158
E++ G P
Sbjct: 228 EMLIGYPP 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 3e-07
Identities = 32/113 (28%), Positives = 48/113 (42%), Gaps = 31/113 (27%)
Query: 1077 LHRDIKSSNILLDSNMEAHLGDFGLAKAL---------------------VEDYNSNTES 1115
+HRDIK N+LLD+ L DFGL L ++ NS ++
Sbjct: 123 IHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKA 182
Query: 1116 NTW----------FAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMP 1158
TW G+ YIAPE + CD +S+G+++ E++ G P
Sbjct: 183 ETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 3e-07
Identities = 31/95 (32%), Positives = 49/95 (51%), Gaps = 8/95 (8%)
Query: 1064 GVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSY 1123
G+E LH + ++RD+K NILLD + D GLA + E ES G+
Sbjct: 114 GLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG-----ESIRGRVGTV 165
Query: 1124 GYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMP 1158
GY+APE + + T D + +G ++ E++ G+ P
Sbjct: 166 GYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 4e-07
Identities = 35/98 (35%), Positives = 50/98 (51%), Gaps = 14/98 (14%)
Query: 1077 LHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKA 1136
+HRDIK N+LLD N L DFG L+ D T + G+ YI+PE L+A
Sbjct: 124 VHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD---GTVQSNVAVGTPDYISPEI---LQA 177
Query: 1137 TE--------KCDVYSMGIVLMELVSGKMPTDATFGVE 1166
E +CD +S+G+ + E++ G+ P A VE
Sbjct: 178 MEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE 215
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 4e-07
Identities = 68/268 (25%), Positives = 111/268 (41%), Gaps = 54/268 (20%)
Query: 903 EFLRKSSQVNYTSSSSSSQAQRRLLFQAAAKRDFRWEDIMGATNNLSDEFI--IGSGGSG 960
+FL K+ Q++ S S++ +R K ++ED FI +G+G G
Sbjct: 2 QFL-KNLQLHKKKDSDSTKEPKR-------KNKMKYEDF---------NFIRTLGTGSFG 44
Query: 961 TVYKAELANG--ATVAVKKIS-CKD------DHLLNKSFTREVKTLGRIRHRHLVKLMGH 1011
V A N VA+K+ K DH+ + E K L I H V L G
Sbjct: 45 RVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFS-----ERKILNYINHPFCVNLYGS 99
Query: 1012 CCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHD 1071
K L+ E++ G + +L + K + A + EYL
Sbjct: 100 F--KDESYLYLVLEFVIGGEFFTFLRRN-------KRFPNDVGCFYAAQIVLIFEYLQS- 149
Query: 1072 CVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTW-FAGSYGYIAPEY 1130
I++RD+K N+LLD + + DFG AK + ++ T+ G+ YIAPE
Sbjct: 150 --LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV--------DTRTYTLCGTPEYIAPEI 199
Query: 1131 AYSLKATEKCDVYSMGIVLMELVSGKMP 1158
++ + D +++GI + E++ G P
Sbjct: 200 LLNVGHGKAADWWTLGIFIYEILVGCPP 227
|
Length = 340 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 4e-07
Identities = 66/285 (23%), Positives = 122/285 (42%), Gaps = 46/285 (16%)
Query: 954 IGSGGSGTVYKAELANGAT-------VAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLV 1006
+G G G VY+ +A G VA+K ++ F E + H+V
Sbjct: 14 LGQGSFGMVYEG-IAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 72
Query: 1007 KLMGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSL---DWEARLKIAVGLAQ 1063
+L+G ++G + L+I E M G + +L ++ + +++A +A
Sbjct: 73 RLLG-VVSQGQPT-LVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIAD 130
Query: 1064 GVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSY 1123
G+ YL+ + K +HRD+ + N ++ + +GDFG+ + + E++ + G
Sbjct: 131 GMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY-------ETDYYRKGGK 180
Query: 1124 G-----YIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHME 1178
G +++PE T DV+S G+VL E+ + + G+ + V +
Sbjct: 181 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT--LAEQPYQGMSNEQV----LRFV 234
Query: 1179 MSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPS 1223
M G LLD KP + C + E+ C + +P+ RPS
Sbjct: 235 MEGG----LLD---KP----DNCPD-MLFELMRMCWQYNPKMRPS 267
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 4e-07
Identities = 62/281 (22%), Positives = 123/281 (43%), Gaps = 42/281 (14%)
Query: 953 IIGSGGSGTVYKAE-LANGATVAVKKISCKD-DHLLNKSFTREVKTLGRIRHRHLVKLMG 1010
++G G G V +G +KK++ ++ K+ +E + L +++H ++V
Sbjct: 7 VVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYR- 65
Query: 1011 HCCNKGAGSNLLIYEYM---ENGSVWDWLHKQPVNIKM-RKSLDWEARLKIAVGLAQGVE 1066
G + L+Y M E G ++ L +Q + + ++W V +A ++
Sbjct: 66 ---ESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEW------FVQIAMALQ 116
Query: 1067 YLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYI 1126
YLH ILHRD+K+ N+ L +GD G+A+ L N ++T Y Y+
Sbjct: 117 YLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVL---ENQCDMASTLIGTPY-YM 169
Query: 1127 APEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSAREE 1186
+PE + K DV+++G + E+ + K +A DM S
Sbjct: 170 SPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAK-----DM-----------NSLVYR 213
Query: 1187 LLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQV 1227
+++ ++ P +P + + ++ E+ P++RPS + +
Sbjct: 214 IIEGKLPP-MPKD--YSPELGELIATMLSKRPEKRPSVKSI 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 4e-07
Identities = 32/104 (30%), Positives = 55/104 (52%), Gaps = 7/104 (6%)
Query: 1058 AVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNT 1117
A +A G+ +LH I++RD+K N++LDS + DFG+ K E+ + T
Sbjct: 107 AAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCK---ENMWDGVTTKT 160
Query: 1118 WFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDA 1161
F G+ YIAPE + D ++ G++L E+++G+ P +
Sbjct: 161 -FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG 203
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 53.2 bits (127), Expect = 5e-07
Identities = 53/208 (25%), Positives = 97/208 (46%), Gaps = 20/208 (9%)
Query: 954 IGSGGSGTV---YKAELANGATVAVKKISCK-DDHLLNKSFTREVKTLGRIRHRHLVKLM 1009
IGSG G V Y A L VA+KK+S + K RE+ + + H++++ L+
Sbjct: 25 IGSGAQGIVCAAYDAVLDR--NVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82
Query: 1010 GHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLH 1069
+ + + E+ + V + + + ++ LD E + + G+++LH
Sbjct: 83 NVFTPQKS-----LEEFQDVYLVMELMDANLCQV-IQMELDHERMSYLLYQMLCGIKHLH 136
Query: 1070 HDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPE 1129
I+HRD+K SNI++ S+ + DFGLA+ + T + + Y APE
Sbjct: 137 S---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF-----MMTPYVVTRYYRAPE 188
Query: 1130 YAYSLKATEKCDVYSMGIVLMELVSGKM 1157
+ E D++S+G ++ E+V K+
Sbjct: 189 VILGMGYKENVDIWSVGCIMGEMVRHKI 216
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 5e-07
Identities = 27/98 (27%), Positives = 52/98 (53%), Gaps = 6/98 (6%)
Query: 1061 LAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFA 1120
+ ++YLH + +++RD+K N++LD + + DFGL K ++D + F
Sbjct: 104 IVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD----GATMKTFC 157
Query: 1121 GSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMP 1158
G+ Y+APE D + +G+V+ E++ G++P
Sbjct: 158 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 7e-07
Identities = 53/210 (25%), Positives = 93/210 (44%), Gaps = 21/210 (10%)
Query: 954 IGSGGSGTVYKAELANG---ATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMG 1010
IG+G G V E+ +G A V VK++ F E + ++H +L++ +G
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 1011 HCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHH 1070
C LL+ E+ G + +L M + D ++A +A G+ +LH
Sbjct: 63 QCTE--VTPYLLVMEFCPLGDLKGYLRSCRKAELM--TPDPTTLQRMACEIALGLLHLHK 118
Query: 1071 DCVPKILHRDIKSSNILLDSNMEAHLGDFGLAK-ALVEDYNSNTESNTWFAGSYGYIAPE 1129
+ +H D+ N LL +++ +GD+GL+ EDY T W +IAPE
Sbjct: 119 N---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV-TPDQLWV--PLRWIAPE 172
Query: 1130 YAYSLKA-------TEKCDVYSMGIVLMEL 1152
+ T++ +V+S+G+ + EL
Sbjct: 173 LVDEVHGNLLVVDQTKESNVWSLGVTIWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.3 bits (126), Expect = 8e-07
Identities = 66/255 (25%), Positives = 99/255 (38%), Gaps = 67/255 (26%)
Query: 954 IGSGGSGTVYKAEL-ANGATVAVKKISCKDDHLLNK----SFTREVKTLGRIRHRHLVKL 1008
+G G G V+ L G A+K + K+ NK +E+ L + H L L
Sbjct: 9 LGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEI--LATLDHPFLPTL 66
Query: 1009 MG------HCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIA-VGL 1061
+ C L+ +Y G ++ L +QP + + AR A V L
Sbjct: 67 YASFQTETYLC--------LVMDYCPGGELFRLLQRQP----GKCLSEEVARFYAAEVLL 114
Query: 1062 AQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAK------------------ 1103
A +EYLH + I++RD+K NILL + L DF L+K
Sbjct: 115 A--LEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSR 169
Query: 1104 ----------ALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELV 1153
E+ + SN+ F G+ YIAPE D +++GI+L E++
Sbjct: 170 RSSVNSIPSETFSEE--PSFRSNS-FVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEML 226
Query: 1154 SGKMP-----TDATF 1163
G P D TF
Sbjct: 227 YGTTPFKGSNRDETF 241
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 8e-07
Identities = 28/94 (29%), Positives = 48/94 (51%), Gaps = 7/94 (7%)
Query: 1065 VEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYG 1124
+ YLH +++RD+K N++LD + + DFGL K E + T F G+
Sbjct: 108 LGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCK---EGISDGATMKT-FCGTPE 160
Query: 1125 YIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMP 1158
Y+APE D + +G+V+ E++ G++P
Sbjct: 161 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 9e-07
Identities = 50/218 (22%), Positives = 95/218 (43%), Gaps = 26/218 (11%)
Query: 954 IGSGGSGTVYKAELANGA------TVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVK 1007
+G G VYK L A VA+K + K + L + F E R++H ++V
Sbjct: 13 LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVC 72
Query: 1008 LMGHCCNKGAGSNLLIYEYMENGSVWDWL-HKQPV--------NIKMRKSLDWEARLKIA 1058
L+G + S +I+ Y + + ++L + P + ++ +L+ + I
Sbjct: 73 LLGVVTKEQPLS--MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIV 130
Query: 1059 VGLAQGVEYL--HHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESN 1116
+A G+E+L HH H+D+ + N+L+ + + D GL + + N
Sbjct: 131 TQIAAGMEFLSSHHVV-----HKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGN 185
Query: 1117 TWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS 1154
+ +++PE K + D++S G+VL E+ S
Sbjct: 186 SLL--PIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 1e-06
Identities = 50/200 (25%), Positives = 84/200 (42%), Gaps = 29/200 (14%)
Query: 970 GATVAVKKISCKDDHL----LNKSFTREVKTLGRIRHRHLVKLMGHCCNKG-AGSNLL-- 1022
G VA+K + + D F RE R+ H ++V L+ + G A LL
Sbjct: 3 GHEVAIKLL--RTDAPEEEHQRARFRRETALCARLYHPNIVALL----DSGEAPPGLLFA 56
Query: 1023 IYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIK 1082
++EY+ ++ + L RL + Q ++ L I+HRD+K
Sbjct: 57 VFEYVPGRTLREVLAADGA-----LPAGETGRL-----MLQVLDALACAHNQGIVHRDLK 106
Query: 1083 SSNILL---DSNMEAHLGDFGLAKAL--VEDYNSNTES-NTWFAGSYGYIAPEYAYSLKA 1136
NI++ A + DFG+ L V D + T + T G+ Y APE
Sbjct: 107 PQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPV 166
Query: 1137 TEKCDVYSMGIVLMELVSGK 1156
T D+Y+ G++ +E ++G+
Sbjct: 167 TPNSDLYAWGLIFLECLTGQ 186
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 1e-06
Identities = 47/175 (26%), Positives = 78/175 (44%), Gaps = 37/175 (21%)
Query: 993 EVKTLGRIRHRHLVKLMGHCCNKGAGSNLL-------IYEYMENGSVWDWLHKQPVNIKM 1045
E+ LGR+ H +++K+ A + ++ +Y +M + + DW K
Sbjct: 213 EILALGRLNHENILKIE-EILRSEANTYMITQKYDFDLYSFMYDEAF-DW--------KD 262
Query: 1046 RKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKAL 1105
R L + R I L VEY+H K++HRDIK NI L+ + + LGDFG A
Sbjct: 263 RPLL-KQTR-AIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCDGKIVLGDFGTA--- 314
Query: 1106 VEDYNSNTESNTWFAGSYGYI------APEYAYSLKATEKCDVYSMGIVLMELVS 1154
A YG++ +PE E D++S G++L++++S
Sbjct: 315 ------MPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 2e-06
Identities = 102/352 (28%), Positives = 147/352 (41%), Gaps = 41/352 (11%)
Query: 384 VALTHLYLHNNSLVGSISPFVANLSNLQELALYHNNFQGSL--PREIGMLVKLELLYLYD 441
VA+ L L+ +S + P ++LS L L L + SL + L+ L L L
Sbjct: 45 VAVNRLALNLSSNTLLLLP--SSLSRLLSLDLLSPSGISSLDGSENLLNLLPLPSLDLNL 102
Query: 442 NHLSGQIPSEVGNCSSLKWIDFFGNSFTGEIPTSIGRLKD-LNFLHLRQNELVGQIPASL 500
N L I + ++L +D N+ T +IP IG LK L L L N++ +P+ L
Sbjct: 103 NRLRSNISELLEL-TNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKI-ESLPSPL 159
Query: 501 GNCHQLIILDLADNKLSGGVPASFGFLQALEQLMLYNNSLEGNLPGSLINLRNLTRINFS 560
N L LDL+ N LS +P L L L L N + +LP + L L ++ S
Sbjct: 160 RNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLS 217
Query: 561 KNRLNGRIATLCSSHSFLSFDVTNNEFDHEIPPQLGNSPSLERLRLGNNKFIGKIPWTFG 620
N + E+ L N +L L L NNK +P + G
Sbjct: 218 NNSII------------------------ELLSSLSNLKNLSGLELSNNKLE-DLPESIG 252
Query: 621 KIRELSLLDLSGNSLTGPIPTQLLMCKKLSHIDLNNNLLSGAVPSWLGTLPQLGELKLSF 680
+ L LDLS N ++ + L L +DL+ N LS A+P + L L EL L+
Sbjct: 253 NLSNLETLDLSNNQIS--SISSLGSLTNLRELDLSGNSLSNALPL-IALLLLLLELLLNL 309
Query: 681 NQFVGFLPRELFNCSKLLVLSLDGNMLNGSLPNEVGNLASLNVLTLSGNLLS 732
+ L +L S LL ++ N S P + L SLN L N L
Sbjct: 310 LLTLKALELKL--NSILLNNNILSNGE-TSSPEALSILESLNNLWTLDNALD 358
|
Length = 394 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 2e-06
Identities = 56/215 (26%), Positives = 100/215 (46%), Gaps = 38/215 (17%)
Query: 954 IGSGGSGTVYK--AELANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGH 1011
+G G TV+K ++L VA+K+I + + + REV L ++H ++V L H
Sbjct: 14 LGEGTYATVFKGRSKLTEN-LVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTL--H 70
Query: 1012 CCNKGAGSNLLIYEYMEN---------GSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLA 1062
S L++EY++ G++ +H N+K+ +
Sbjct: 71 DIVHTDKSLTLVFEYLDKDLKQYMDDCGNIMS-MH----NVKI-----------FLYQIL 114
Query: 1063 QGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGS 1122
+G+ Y H K+LHRD+K N+L++ E L DFGLA+A + + T SN +
Sbjct: 115 RGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARA--KSVPTKTYSNE--VVT 167
Query: 1123 YGYIAPEYAY-SLKATEKCDVYSMGIVLMELVSGK 1156
Y P+ S + + + D++ +G + E+ SG+
Sbjct: 168 LWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 2e-06
Identities = 53/221 (23%), Positives = 100/221 (45%), Gaps = 34/221 (15%)
Query: 954 IGSGGSGTVYKAELANGAT---VAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMG 1010
+G G G VYKA+ +G A+K+I ++ S RE+ L ++H +++ L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG---ISMSACREIALLRELKHPNVISLQK 65
Query: 1011 HCCNKGAGSNLLIYEYMENGSVWDWL--------HKQPVNIK--MRKSLDWEARLKIAVG 1060
+ L+++Y E+ +W + +K+PV + M KSL ++
Sbjct: 66 VFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQ-------- 116
Query: 1061 LAQGVEYLHHDCVPKILHRDIKSSNILL----DSNMEAHLGDFGLAKALVEDYNSNTESN 1116
+ G+ YLH + V LHRD+K +NIL+ + D G A+ + +
Sbjct: 117 ILDGIHYLHANWV---LHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLD 173
Query: 1117 TWFAGSYGYIAPEYAYSLKA-TEKCDVYSMGIVLMELVSGK 1156
++ Y APE + T+ D++++G + EL++ +
Sbjct: 174 PVVV-TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 2e-06
Identities = 57/212 (26%), Positives = 100/212 (47%), Gaps = 30/212 (14%)
Query: 954 IGSGGSGTVYKA-ELANGATVAVKKISCKDDHLLN-KSFTREVKTLGRIRHRHLVKLMGH 1011
IGSG G V A + G VA+KK+S ++ + K RE+ + + H++++ L+
Sbjct: 24 IGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNV 83
Query: 1012 CCNKGAGSNL----LIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQ---G 1064
+ + L+ E M+ L + I+M LD E +++ L Q G
Sbjct: 84 FTPQKSLEEFQDVYLVMELMDAN-----LCQV---IQM--DLDHE---RMSYLLYQMLCG 130
Query: 1065 VEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYG 1124
+++LH I+HRD+K SNI++ S+ + DFGLA+ + T +
Sbjct: 131 IKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY----- 182
Query: 1125 YIAPEYAYSLKATEKCDVYSMGIVLMELVSGK 1156
Y APE + E D++S+G ++ E++ G
Sbjct: 183 YRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 2e-06
Identities = 33/100 (33%), Positives = 54/100 (54%), Gaps = 18/100 (18%)
Query: 1064 GVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSY 1123
G+E++H+ V ++RD+K +NILLD + + D GLA D++ + G++
Sbjct: 109 GLEHMHNRFV---VYRDLKPANILLDEHGHVRISDLGLAC----DFSKKKPHAS--VGTH 159
Query: 1124 GYIAPEY-----AYSLKATEKCDVYSMGIVLMELVSGKMP 1158
GY+APE AY A D +S+G +L +L+ G P
Sbjct: 160 GYMAPEVLQKGVAYDSSA----DWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 2e-06
Identities = 29/86 (33%), Positives = 43/86 (50%), Gaps = 7/86 (8%)
Query: 1077 LHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKA 1136
+HRD+K N+LLD + L DFG + D N +T G+ YI+PE S
Sbjct: 164 IHRDVKPDNMLLDKSGHLKLADFGTCMKM--DANGMVRCDT-AVGTPDYISPEVLKSQGG 220
Query: 1137 T----EKCDVYSMGIVLMELVSGKMP 1158
+CD +S+G+ L E++ G P
Sbjct: 221 DGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 3e-06
Identities = 31/96 (32%), Positives = 53/96 (55%), Gaps = 10/96 (10%)
Query: 1064 GVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSY 1123
G+E++H+ V ++RD+K +NILLD + + D GLA D++ + G++
Sbjct: 109 GLEHMHNRFV---VYRDLKPANILLDEHGHVRISDLGLAC----DFSKKKPHAS--VGTH 159
Query: 1124 GYIAPEYAYSLKATE-KCDVYSMGIVLMELVSGKMP 1158
GY+APE A + D +S+G +L +L+ G P
Sbjct: 160 GYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 3e-06
Identities = 53/215 (24%), Positives = 97/215 (45%), Gaps = 26/215 (12%)
Query: 954 IGSGGSGTVYKA---ELANG---ATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVK 1007
+G G G VY+ ++ G VAVK ++ F E + H+V+
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 1008 LMGHCCNKGAGSNLLIYEYMENGSVWDWLHK---QPVNIKMRKSLDWEARLKIAVGLAQG 1064
L+G +KG + L++ E M +G + +L + N R + +++A +A G
Sbjct: 74 LLG-VVSKGQPT-LVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 131
Query: 1065 VEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYG 1124
+ YL+ K +HRD+ + N ++ + +GDFG+ + + E++ + G G
Sbjct: 132 MAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIY-------ETDYYRKGGKG 181
Query: 1125 -----YIAPEYAYSLKATEKCDVYSMGIVLMELVS 1154
++APE T D++S G+VL E+ S
Sbjct: 182 LLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 4e-06
Identities = 51/210 (24%), Positives = 96/210 (45%), Gaps = 22/210 (10%)
Query: 954 IGSGGSGTVYKAELANGATVA---VKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMG 1010
IG+G G V +E+ VA VK++ F ++ ++H ++++ +G
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 1011 HCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHH 1070
C A LL++EY E G + +L ++ + + + L + ++A +A GV ++H
Sbjct: 63 QCVE--AIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQ---RMACEIAAGVTHMHK 117
Query: 1071 DCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKA-LVEDYNSNTESNTWFAGSYGYIAPE 1129
LH D+ N L S++ +GD+G+ + EDY TE + ++APE
Sbjct: 118 H---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDY-IETEDDKCVP--LRWLAPE 171
Query: 1130 YAYSLKA-------TEKCDVYSMGIVLMEL 1152
T+ +V+++G+ L EL
Sbjct: 172 LVGEFHGGLITAEQTKPSNVWALGVTLWEL 201
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 5e-06
Identities = 65/255 (25%), Positives = 96/255 (37%), Gaps = 42/255 (16%)
Query: 621 KIRELSLLDLSGNSLTGP----IPTQLLMCKKLSHIDLNNNLLSGAVPSW------LGTL 670
K+ L +L L GN+L + + L L + L+ N L
Sbjct: 21 KLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKG 80
Query: 671 PQLGELKLSFNQFVGFLPRELFNCSK---LLVLSLDGN--------MLNGSLPNEVGNLA 719
L EL LS N L + + L L L+ N +L L +
Sbjct: 81 CGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKD---LPP 137
Query: 720 SLNVLTLSGNLLSG----PIPPAIGRLSKLYELRLSNNSLNG----VIPLEIGQLQNLQS 771
+L L L N L G + A+ L EL L+NN + + + NL+
Sbjct: 138 ALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLE- 196
Query: 772 ILDLSHNNFT----GQIPPSMGTLAKLEVLNLSHNQL----VGELPSQL-GEMSSLGKLN 822
+LDL++N T + ++ +L LEVLNL N L L S L SL L+
Sbjct: 197 VLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLS 256
Query: 823 LSYNDLQGKLSKQFS 837
LS ND+ +K +
Sbjct: 257 LSCNDITDDGAKDLA 271
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 5e-06
Identities = 32/116 (27%), Positives = 46/116 (39%), Gaps = 34/116 (29%)
Query: 1077 LHRDIKSSNILLDSNMEAHLGDFGLAKAL--------VEDYNSNTESN------------ 1116
+HRDIK N+LLD+ L DFGL L + SN
Sbjct: 123 IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSK 182
Query: 1117 ----TW----------FAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMP 1158
TW G+ YIAPE ++CD +S+G+++ E++ G P
Sbjct: 183 RKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPP 238
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 6e-06
Identities = 52/221 (23%), Positives = 100/221 (45%), Gaps = 34/221 (15%)
Query: 954 IGSGGSGTVYKAELANGA---TVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMG 1010
+G G G VYKA+ +G A+K+I ++ S RE+ L ++H +++ L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG---ISMSACREIALLRELKHPNVIALQK 65
Query: 1011 HCCNKGAGSNLLIYEYMENGSVWDWL--------HKQPVNI--KMRKSLDWEARLKIAVG 1060
+ L+++Y E+ +W + +K+P+ + M KSL ++
Sbjct: 66 VFLSHSDRKVWLLFDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQ-------- 116
Query: 1061 LAQGVEYLHHDCVPKILHRDIKSSNILL----DSNMEAHLGDFGLAKALVEDYNSNTESN 1116
+ G+ YLH + V LHRD+K +NIL+ + D G A+ + +
Sbjct: 117 ILDGIHYLHANWV---LHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLD 173
Query: 1117 TWFAGSYGYIAPEYAYSLKA-TEKCDVYSMGIVLMELVSGK 1156
++ Y APE + T+ D++++G + EL++ +
Sbjct: 174 PVVV-TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 6e-06
Identities = 66/254 (25%), Positives = 99/254 (38%), Gaps = 64/254 (25%)
Query: 954 IGSGGSGTVYKA-ELANGATVAVKKISCKDDHLLNKSFTREVKT----LGRIRHRHLVKL 1008
+G G G V A ++ A A+K + KD +LN++ VK L + +VKL
Sbjct: 9 LGIGAFGEVCLACKVDTHALYAMKTLRKKD--VLNRNQVAHVKAERDILAEADNEWVVKL 66
Query: 1009 MGHCCNKGAGSNL-LIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEY 1067
+K NL + +Y+ G + L I+M + AR IA L +E
Sbjct: 67 YYSFQDK---DNLYFVMDYIPGGDMMSLL------IRMEVFPEVLARFYIA-ELTLAIES 116
Query: 1068 LHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSN-------------TE 1114
+H +HRDIK NIL+D + L DFGL +NS
Sbjct: 117 VHK---MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEP 173
Query: 1115 SNTW------------------------------FAGSYGYIAPEYAYSLKATEKCDVYS 1144
S+ W G+ YIAPE T+ CD +S
Sbjct: 174 SDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWS 233
Query: 1145 MGIVLMELVSGKMP 1158
+G++L E++ G+ P
Sbjct: 234 VGVILFEMLVGQPP 247
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 7e-06
Identities = 53/249 (21%), Positives = 109/249 (43%), Gaps = 37/249 (14%)
Query: 990 FTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIYEYMENGSVWDWLHK-QPVNIKMRKS 1048
+E L + H++++ + H C + ++Y YM G++ +L + + ++
Sbjct: 55 LLQESCLLYGLSHQNILPI-LHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQA 113
Query: 1049 LDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALV-E 1107
L + + +A+ +A G+ YLH ++H+DI + N ++D ++ + D L++ L
Sbjct: 114 LSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDLFPM 170
Query: 1108 DYNS--NTESN--TWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDAT 1162
DY+ + E+ W +A E + + + DV+S G++L EL++ G+ P
Sbjct: 171 DYHCLGDNENRPVKW-------MALESLVNKEYSSASDVWSFGVLLWELMTLGQTP---- 219
Query: 1163 FGVEMDMVRWVEMHMEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERP 1222
++E+ L D + P C ++ + C P+ERP
Sbjct: 220 -------------YVEIDPFEMAAYLKDGYRLAQP-INCPD-ELFAVMACCWALDPEERP 264
Query: 1223 SSRQVCDLL 1231
S Q+ L
Sbjct: 265 SFSQLVQCL 273
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.1 bits (119), Expect = 7e-06
Identities = 47/190 (24%), Positives = 83/190 (43%), Gaps = 33/190 (17%)
Query: 993 EVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWE 1052
EV + ++H+++V+ + NK ++ E+ + G + + K KM ++
Sbjct: 62 EVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQK---CYKMFGKIEEH 118
Query: 1053 ARLKIAVGLAQGVEYLHH----DCVPKILHRDIKSSNILLDSNME--------------- 1093
A + I L + Y H+ ++LHRD+K NI L + +
Sbjct: 119 AIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGR 178
Query: 1094 --AHLGDFGLAKALVEDYNSNTESNTWF-AGSYGYIAPEYAYSLKAT--EKCDVYSMGIV 1148
A +GDFGL+K N ES G+ Y +PE + +K D++++G +
Sbjct: 179 PIAKIGDFGLSK------NIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCI 232
Query: 1149 LMELVSGKMP 1158
+ EL SGK P
Sbjct: 233 IYELCSGKTP 242
|
Length = 1021 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 42.9 bits (102), Expect = 2e-05
Identities = 24/60 (40%), Positives = 33/60 (55%)
Query: 240 NLQLLNLGNNSLSGEIPSELGELSQLGYLNLMGNRLEGAIPRSFAKMGNLQSLDLSMNRL 299
NL+ L+L NN L+ L L L+L GN L P +F+ + +L+SLDLS N L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 2e-05
Identities = 30/95 (31%), Positives = 54/95 (56%), Gaps = 7/95 (7%)
Query: 1061 LAQGVEYL-HHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWF 1119
+A G+E+L +CV HRD+ + N+L+ + DFGLA+ ++ D N ++ +T+
Sbjct: 248 VANGMEFLASKNCV----HRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFL 303
Query: 1120 AGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS 1154
++APE ++ T DV+S GI+L E+ +
Sbjct: 304 --PLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 3e-05
Identities = 38/141 (26%), Positives = 60/141 (42%), Gaps = 18/141 (12%)
Query: 1022 LIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDI 1081
++ EYM G + + + V K K E L + + G ++HRD+
Sbjct: 120 MVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMG-----------LIHRDV 168
Query: 1082 KSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKAT---- 1137
K N+LLD + L DFG + D +T G+ YI+PE S
Sbjct: 169 KPDNMLLDKHGHLKLADFGTCMKM--DETGMVRCDT-AVGTPDYISPEVLKSQGGDGYYG 225
Query: 1138 EKCDVYSMGIVLMELVSGKMP 1158
+CD +S+G+ L E++ G P
Sbjct: 226 RECDWWSVGVFLFEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|227563 COG5238, RNA1, Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Signal transduction mechanisms / RNA processing and modification] | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 3e-05
Identities = 33/124 (26%), Positives = 52/124 (41%), Gaps = 17/124 (13%)
Query: 290 QSLDLSMNRLTGGIPEEFGNMGQLVFLVLSNNNISGSIPRRICTNATSLEHLILAEI--- 346
+ L L G+ EE M +LV + LS N I +C ++ +L +
Sbjct: 9 KKLKLETKEDVKGVVEELEMMDELVEVDLSGNTIGTEAMEELCNVIANVRNLRVVNFSDA 68
Query: 347 ---QLSGEIPVE-------LSQCQSLKQLDLSNNTLNGTIPVELFQLVA----LTHLYLH 392
+ E+ L +C L+++DLS+N P EL L++ L HL L+
Sbjct: 69 FTGRDKDELYSNLVMLLKALLKCPRLQKVDLSDNAFGSEFPEELGDLISSSTDLVHLKLN 128
Query: 393 NNSL 396
NN L
Sbjct: 129 NNGL 132
|
Length = 388 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 4e-05
Identities = 31/95 (32%), Positives = 48/95 (50%), Gaps = 5/95 (5%)
Query: 1057 IAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESN 1116
+A L ++Y+H + I+HRDIK+ N+L++ + LGDFG A S T +
Sbjct: 265 VARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFG-AACFARGSWS-TPFH 319
Query: 1117 TWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLME 1151
AG+ APE T D++S G+V+ E
Sbjct: 320 YGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 6e-05
Identities = 26/86 (30%), Positives = 43/86 (50%), Gaps = 7/86 (8%)
Query: 1077 LHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKA 1136
+HRD+K N+LLD + L DFG + ++ ++ G+ YI+PE S
Sbjct: 164 IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV---GTPDYISPEVLKSQGG 220
Query: 1137 T----EKCDVYSMGIVLMELVSGKMP 1158
+CD +S+G+ L E++ G P
Sbjct: 221 DGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 41.0 bits (97), Expect = 9e-05
Identities = 25/61 (40%), Positives = 29/61 (47%), Gaps = 1/61 (1%)
Query: 744 KLYELRLSNNSLNGVIPLEIGQLQNLQSILDLSHNNFTGQIPPSMGTLAKLEVLNLSHNQ 803
L L LSNN L + L NL+ LDLS NN T P + L L L+LS N
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKV-LDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59
Query: 804 L 804
L
Sbjct: 60 L 60
|
Length = 60 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 40.6 bits (96), Expect = 1e-04
Identities = 19/59 (32%), Positives = 26/59 (44%)
Query: 482 LNFLHLRQNELVGQIPASLGNCHQLIILDLADNKLSGGVPASFGFLQALEQLMLYNNSL 540
L L L N L + L +LDL+ N L+ P +F L +L L L N+L
Sbjct: 2 LKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 1e-04
Identities = 43/154 (27%), Positives = 68/154 (44%), Gaps = 17/154 (11%)
Query: 954 IGSGGSGTVYKAELANGATVAVKKISCKDDHLLNKSFTREVKT----LGRIRHRHLVKLM 1009
I G G VY N + + K+ K D ++NK+ +V+ L + +V L
Sbjct: 12 ISRGAFGKVYLGRKKNNSKLYAVKVVKKAD-MINKNMVHQVQAERDALALSKSPFIVHLY 70
Query: 1010 GHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLH 1069
+ A + L+ EY+ G V LH + D E +K +A ++YLH
Sbjct: 71 YSL--QSANNVYLVMEYLIGGDVKSLLH-------IYGYFDEEMAVKYISEVALALDYLH 121
Query: 1070 HDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAK 1103
I+HRD+K N+L+ + L DFGL+K
Sbjct: 122 RH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 39.8 bits (94), Expect = 2e-04
Identities = 19/60 (31%), Positives = 30/60 (50%)
Query: 505 QLIILDLADNKLSGGVPASFGFLQALEQLMLYNNSLEGNLPGSLINLRNLTRINFSKNRL 564
L LDL++N+L+ +F L L+ L L N+L P + L +L ++ S N L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 45.0 bits (107), Expect = 2e-04
Identities = 55/211 (26%), Positives = 85/211 (40%), Gaps = 29/211 (13%)
Query: 238 LQNLQLLNLGNNSLSGE----IPSELGELSQLGYLNLMGNRLE------GAIPRSFAKMG 287
L LQ+L L N+L E + S L L L L N ++ + K
Sbjct: 22 LLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGC 81
Query: 288 NLQSLDLSMNRLTGGIPEEFGNMGQLVFL---VLSNNNISGSIPRRICT----NATSLEH 340
LQ LDLS N L ++ + L L+NN + R + +LE
Sbjct: 82 GLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEK 141
Query: 341 LILAEIQLSGE----IPVELSQCQSLKQLDLSNNTLNG----TIPVELFQLVALTHLYLH 392
L+L +L G + L + LK+L+L+NN + + L L L L+
Sbjct: 142 LVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLN 201
Query: 393 NNSL----VGSISPFVANLSNLQELALYHNN 419
NN L +++ +A+L +L+ L L NN
Sbjct: 202 NNGLTDEGASALAETLASLKSLEVLNLGDNN 232
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 39.4 bits (93), Expect = 3e-04
Identities = 21/59 (35%), Positives = 24/59 (40%)
Query: 625 LSLLDLSGNSLTGPIPTQLLMCKKLSHIDLNNNLLSGAVPSWLGTLPQLGELKLSFNQF 683
L LDLS N LT L +DL+ N L+ P LP L L LS N
Sbjct: 2 LKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 6e-04
Identities = 56/172 (32%), Positives = 88/172 (51%), Gaps = 9/172 (5%)
Query: 75 SLNLSGLSLAGSISPSLGRLQSLIHLDLSSNSLTGPIPTALSNLSSLESLLLFSNQLAGT 134
+L+LSG ++ + P + L +L LDLS+NS+ + ++LSNL +L L L +N+L
Sbjct: 190 NLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-D 246
Query: 135 IPTQLGSLTSLRVMRIGDNWLSGSIPTSFGNLVNLGTLGLASCSLSGPIPPQFGQLSQLE 194
+P +G+L++L + + +N + S +S G+L NL L L+ SLS +P L LE
Sbjct: 247 LPESIGNLSNLETLDLSNNQI--SSISSLGSLTNLRELDLSGNSLSNALPLIALLLLLLE 304
Query: 195 ELILQQNQLQGPIPAELGNCSSLSIFTAAENNLNGSIPAALGRLQNLQLLNL 246
L+ L EL S L +N S P AL L++L L
Sbjct: 305 LLLNLLLTL---KALELKLNSILLNN-NILSNGETSSPEALSILESLNNLWT 352
|
Length = 394 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 6e-04
Identities = 58/215 (26%), Positives = 94/215 (43%), Gaps = 32/215 (14%)
Query: 953 IIGSGGSGTVYKAE-LANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGH 1011
IIG+G G VY+A + VA+KK+ +D N RE+ + + H +++ L +
Sbjct: 73 IIGNGSFGVVYEAICIDTSEKVAIKKV-LQDPQYKN----RELLIMKNLNHINIIFLKDY 127
Query: 1012 C---CNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKI------AVGLA 1062
C K N+ + ME Q V+ M+ L + + L
Sbjct: 128 YYTECFKKNEKNIFLNVVME-------FIPQTVHKYMKHYARNNHALPLFLVKLYSYQLC 180
Query: 1063 QGVEYLHHDCVPKILHRDIKSSNILLDSNMEA-HLGDFGLAKALVEDYNSNTESNTWFAG 1121
+ + Y+H I HRD+K N+L+D N L DFG AK L+ S + +
Sbjct: 181 RALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVS-----YIC 232
Query: 1122 SYGYIAPEYAY-SLKATEKCDVYSMGIVLMELVSG 1155
S Y APE + T D++S+G ++ E++ G
Sbjct: 233 SRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 7e-04
Identities = 34/125 (27%), Positives = 45/125 (36%), Gaps = 43/125 (34%)
Query: 1077 LHRDIKSSNILLDSNMEAHLGDFGLA-------------KALVEDYNSNTESN------- 1116
+HRDIK NIL+D L DFGL+ K L N N N
Sbjct: 123 IHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVD 182
Query: 1117 -------------TWFA----------GSYGYIAPEYAYSLKATEKCDVYSMGIVLMELV 1153
TW G+ YIAPE ++CD +S+G ++ E +
Sbjct: 183 SINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFECL 242
Query: 1154 SGKMP 1158
G P
Sbjct: 243 IGWPP 247
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 38.3 bits (90), Expect = 0.001
Identities = 20/42 (47%), Positives = 23/42 (54%)
Query: 90 SLGRLQSLIHLDLSSNSLTGPIPTALSNLSSLESLLLFSNQL 131
+ L +L LDLS N+LT P A S L SL SL L N L
Sbjct: 19 AFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 37.9 bits (89), Expect = 0.001
Identities = 20/60 (33%), Positives = 23/60 (38%)
Query: 648 KLSHIDLNNNLLSGAVPSWLGTLPQLGELKLSFNQFVGFLPRELFNCSKLLVLSLDGNML 707
L +DL+NN L+ LP L L LS N P L L L GN L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 0.001
Identities = 25/105 (23%), Positives = 46/105 (43%), Gaps = 6/105 (5%)
Query: 1057 IAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALV---EDYNSNT 1113
I + +EY+H I H DIK NI++D N ++ D+G+A + + +
Sbjct: 131 IMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSK 187
Query: 1114 ESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMP 1158
E G+ Y + T + D+ S+G +++ K+P
Sbjct: 188 EQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLP 232
|
Length = 294 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 37.1 bits (87), Expect = 0.002
Identities = 24/59 (40%), Positives = 30/59 (50%), Gaps = 2/59 (3%)
Query: 771 SILDLSHNNFTGQIPPSM-GTLAKLEVLNLSHNQLVGELPSQLGEMSSLGKLNLSYNDL 828
LDLS+N T IP L L+VL+LS N L P + SL L+LS N+L
Sbjct: 3 KSLDLSNNRLTV-IPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 37.1 bits (87), Expect = 0.003
Identities = 24/56 (42%), Positives = 29/56 (51%), Gaps = 1/56 (1%)
Query: 288 NLQSLDLSMNRLTGGIPEEFGNMGQLVFLVLSNNNISGSIPRRICTNATSLEHLIL 343
NL+SLDLS NRLT F + L L LS NN++ SI + SL L L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLT-SISPEAFSGLPSLRSLDL 55
|
Length = 60 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 40.8 bits (96), Expect = 0.003
Identities = 61/269 (22%), Positives = 92/269 (34%), Gaps = 52/269 (19%)
Query: 472 IPTSIGRLKDLNFLHLRQNEL------VGQIPASLGNCHQLIILDLADNKLSGGVPASFG 525
+ +++ L L L NE + + L L LDL+DN L
Sbjct: 43 LASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCGLQELDLSDNALGPDGCGVLE 102
Query: 526 FLQ---ALEQLMLYNNSLEGN----LPGSLINLR-NLTRINFSKNRLNGR----IATLCS 573
L +L++L L NN L L L +L L ++ +NRL G +A
Sbjct: 103 SLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALR 162
Query: 574 SHSFL-SFDVTNNEFDHE----IPPQLGNSPSLERLRLGNNKFIGKIPWTFGKIRELSLL 628
++ L ++ NN + L + +LE L L NN
Sbjct: 163 ANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGL----------------T 206
Query: 629 DLSGNSLTGPIPTQLLMCKKLSHIDLNNNLLSGA-----VPSWLGTLPQLGELKLSFNQF 683
D ++L + + K L ++L +N L+ A + L L L LS N
Sbjct: 207 DEGASALAETLASL----KSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDI 262
Query: 684 ----VGFLPRELFNCSKLLVLSLDGNMLN 708
L L LL L L GN
Sbjct: 263 TDDGAKDLAEVLAEKESLLELDLRGNKFG 291
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 1251 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.98 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.98 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.98 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.98 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.98 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.98 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.98 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.98 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.98 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.98 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.98 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.98 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.98 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.98 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.98 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.98 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.98 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.98 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.98 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.98 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.97 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.97 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.97 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.97 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.97 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.97 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.97 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.97 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.97 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.97 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.97 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.97 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.97 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.97 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.97 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.97 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.97 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.97 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.97 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.97 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.97 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.97 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.97 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.97 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.97 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.97 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.97 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.97 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.97 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.96 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.96 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.96 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.95 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.95 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.94 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.94 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.93 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.93 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.93 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.93 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.92 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.92 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.92 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.91 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.91 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.9 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.89 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.89 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.89 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.89 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.88 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.86 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.85 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.84 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.83 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.81 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.8 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.79 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.79 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.78 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.78 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.78 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.76 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.76 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.75 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.74 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.72 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.72 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.71 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.69 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.67 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.66 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.64 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.63 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.63 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.61 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.6 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.58 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.58 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.56 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.49 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.48 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.48 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.48 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.46 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.42 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.42 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.36 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.31 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.25 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.22 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.21 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.13 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.13 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.13 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.12 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.11 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.09 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.08 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.06 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.05 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.03 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.01 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.98 | |
| PF08263 | 43 | LRRNT_2: Leucine rich repeat N-terminal domain; In | 98.98 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.97 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 98.96 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 98.95 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.95 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.9 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.88 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.85 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.82 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.76 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.73 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.7 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.69 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.64 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.59 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.59 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.58 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.58 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.49 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.46 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.43 | |
| KOG2982 | 418 | consensus Uncharacterized conserved protein [Funct | 98.37 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.36 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-110 Score=1102.91 Aligned_cols=922 Identities=36% Similarity=0.595 Sum_probs=630.9
Q ss_pred CHHhHHHHHHHHHHcCCCCCCCCCCCCCCCCCCCccccEEEcCCCCeEEEeccCCccCCCCCCCCCCCCCcccEEEccCC
Q 000859 26 KDEELSVLLEIKKSFTADPENVLHAWNQSNQNLCTWRGITCGSSSARVVSLNLSGLSLAGSISPSLGRLQSLIHLDLSSN 105 (1251)
Q Consensus 26 ~~~~~~all~~k~~~~~~~~~~l~sW~~~~~~~c~w~gv~C~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~n 105 (1251)
.++|++||++||+++. ||.+.+.+|+. +.+||.|.||+|++ .++|+.|+|+++++.|.+++.+..+++|++|+|++|
T Consensus 27 ~~~~~~~l~~~~~~~~-~~~~~~~~w~~-~~~~c~w~gv~c~~-~~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~n 103 (968)
T PLN00113 27 HAEELELLLSFKSSIN-DPLKYLSNWNS-SADVCLWQGITCNN-SSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNN 103 (968)
T ss_pred CHHHHHHHHHHHHhCC-CCcccCCCCCC-CCCCCcCcceecCC-CCcEEEEEecCCCccccCChHHhCCCCCCEEECCCC
Confidence 6789999999999994 78888999975 46899999999985 468999999999999988888888999999999999
Q ss_pred CCCCCcCcccc-ccCcccEEecccccccCCCCcccCCCccccEEEeccCCCCCCCCCcccccccccccccccCCCCCCCC
Q 000859 106 SLTGPIPTALS-NLSSLESLLLFSNQLAGTIPTQLGSLTSLRVMRIGDNWLSGSIPTSFGNLVNLGTLGLASCSLSGPIP 184 (1251)
Q Consensus 106 ~l~~~~p~~l~-~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p 184 (1251)
.+.|.+|..+. ++++|++|+|++|.++|.+|. +.+++|++|+|++|.+++.+|..++++++|++|+|++|.+.+
T Consensus 104 ~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~--- 178 (968)
T PLN00113 104 QLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVG--- 178 (968)
T ss_pred ccCCcCChHHhccCCCCCEEECcCCccccccCc--cccCCCCEEECcCCcccccCChHHhcCCCCCEEECccCcccc---
Confidence 88888887655 788888888888888777764 345566666666666655555555555555555555555444
Q ss_pred CCcCcccccceeeeccccccCCCCcccCCCCCCceeeccccccCCCchhhhcccccCceeeccCccCCCCCCccccCCCc
Q 000859 185 PQFGQLSQLEELILQQNQLQGPIPAELGNCSSLSIFTAAENNLNGSIPAALGRLQNLQLLNLGNNSLSGEIPSELGELSQ 264 (1251)
Q Consensus 185 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~ 264 (1251)
.+|..|+++++|++|++++|++++.+|..++++++|++|+|++|.+++.+|..++++++
T Consensus 179 ---------------------~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~ 237 (968)
T PLN00113 179 ---------------------KIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTS 237 (968)
T ss_pred ---------------------cCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCCcCChhHhcCCC
Confidence 44555555555555555555555566666766777777777766665544443333333
Q ss_pred cceeeccCccccCcCCcccccCCCccEEEeccccccCCCCCccccccceEEEEccCccccCcccccccccccchhhhhcc
Q 000859 265 LGYLNLMGNRLEGAIPRSFAKMGNLQSLDLSMNRLTGGIPEEFGNMGQLVFLVLSNNNISGSIPRRICTNATSLEHLILA 344 (1251)
Q Consensus 265 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~i~~~~~~~l~~L~~L~L~ 344 (1251)
|++|++ ++|++++.+|..
T Consensus 238 L~~L~L------------------------~~n~l~~~~p~~-------------------------------------- 255 (968)
T PLN00113 238 LNHLDL------------------------VYNNLTGPIPSS-------------------------------------- 255 (968)
T ss_pred CCEEEC------------------------cCceeccccChh--------------------------------------
Confidence 333322 222222111111
Q ss_pred chhcccCCCcCccCCCCCceEEccCCcccCCccccccccccccEEEeecccccccccccccccccccEEEecccccCCCC
Q 000859 345 EIQLSGEIPVELSQCQSLKQLDLSNNTLNGTIPVELFQLVALTHLYLHNNSLVGSISPFVANLSNLQELALYHNNFQGSL 424 (1251)
Q Consensus 345 ~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 424 (1251)
++.+++|++|++++|
T Consensus 256 -----------l~~l~~L~~L~L~~n------------------------------------------------------ 270 (968)
T PLN00113 256 -----------LGNLKNLQYLFLYQN------------------------------------------------------ 270 (968)
T ss_pred -----------HhCCCCCCEEECcCC------------------------------------------------------
Confidence 111111222222211
Q ss_pred chhhhcccccchhhcccCcccccccCCcCCCCccceEeccCCcccCCCCCcccccCCCcEEeccCCccCCCcCccccccc
Q 000859 425 PREIGMLVKLELLYLYDNHLSGQIPSEVGNCSSLKWIDFFGNSFTGEIPTSIGRLKDLNFLHLRQNELVGQIPASLGNCH 504 (1251)
Q Consensus 425 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~ 504 (1251)
.+++.+|..+.++++|++|++++|++.+.+|..+.+++
T Consensus 271 ------------------------------------------~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~ 308 (968)
T PLN00113 271 ------------------------------------------KLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQ 308 (968)
T ss_pred ------------------------------------------eeeccCchhHhhccCcCEEECcCCeeccCCChhHcCCC
Confidence 11122333445566788999999999988999999999
Q ss_pred cCCeeecCCCcCcccCCcchhccchhhhhhccCCccccCCchhhhhhcCCCeeecccccccccccccccCccceeeeccc
Q 000859 505 QLIILDLADNKLSGGVPASFGFLQALEQLMLYNNSLEGNLPGSLINLRNLTRINFSKNRLNGRIATLCSSHSFLSFDVTN 584 (1251)
Q Consensus 505 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~l~~~~~l~~l~l~~ 584 (1251)
+|+.|++++|.+++..|..+..+++|+.|+|++|.+++.+|..+..+++|+.|++++|+++
T Consensus 309 ~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~------------------- 369 (968)
T PLN00113 309 NLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLT------------------- 369 (968)
T ss_pred CCcEEECCCCccCCcCChhHhcCCCCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeE-------------------
Confidence 9999999999998888887877777777777777777666666666666666666655553
Q ss_pred CccccCCCCCCCCcccCceeecccCccccccCcccccccccceEEccCCcccCCCCccccccCCccEEEcCCCccCCCCc
Q 000859 585 NEFDHEIPPQLGNSPSLERLRLGNNKFIGKIPWTFGKIRELSLLDLSGNSLTGPIPTQLLMCKKLSHIDLNNNLLSGAVP 664 (1251)
Q Consensus 585 n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~ 664 (1251)
+.+|..++.+++|+.|++++|++.+.+|..++.+++|+.|++++|++++..|
T Consensus 370 ----~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p------------------------ 421 (968)
T PLN00113 370 ----GEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELP------------------------ 421 (968)
T ss_pred ----eeCChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECC------------------------
Confidence 2344445555555555555555555555555555555555555555554444
Q ss_pred cccCCCcccccccccCccccCCCccccccccccceeeccCcccccccCcccCCCCCCceeccCCCcCCCCCCcccccccc
Q 000859 665 SWLGTLPQLGELKLSFNQFVGFLPRELFNCSKLLVLSLDGNMLNGSLPNEVGNLASLNVLTLSGNLLSGPIPPAIGRLSK 744 (1251)
Q Consensus 665 ~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~ 744 (1251)
..+..+++|+.|++++|++++..|..+..+++|+.|+|++|++.+.+|..+ ..++|+.|++++|++++.+|..+..+++
T Consensus 422 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~-~~~~L~~L~ls~n~l~~~~~~~~~~l~~ 500 (968)
T PLN00113 422 SEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSF-GSKRLENLDLSRNQFSGAVPRKLGSLSE 500 (968)
T ss_pred hhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCccc-ccccceEEECcCCccCCccChhhhhhhc
Confidence 444445555555555555555445445555555555555555555555544 2467777777777777777777777888
Q ss_pred cceeeccCcccccccchhhhchhhHHHHHhccCCcccCCCCCCcCccccccEEEccCCccccCCchhhhhccCCCcEeec
Q 000859 745 LYELRLSNNSLNGVIPLEIGQLQNLQSILDLSHNNFTGQIPPSMGTLAKLEVLNLSHNQLVGELPSQLGEMSSLGKLNLS 824 (1251)
Q Consensus 745 L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~ 824 (1251)
|+.|+|++|++.+.+|..++.+++|+. |+|++|+++|.+|..++.+++|+.|+|++|+++|.+|..+..+++|+.|+++
T Consensus 501 L~~L~Ls~N~l~~~~p~~~~~l~~L~~-L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls 579 (968)
T PLN00113 501 LMQLKLSENKLSGEIPDELSSCKKLVS-LDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNIS 579 (968)
T ss_pred cCEEECcCCcceeeCChHHcCccCCCE-EECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEecc
Confidence 888888888887788888888888854 8888888888888889999999999999999999999999999999999999
Q ss_pred cccCcCccC--cccCCCCCccccCCccCCCCCC----CCCCCccccCCCccceeeeeeehhHHHHHHHHHHHHHHhhhhh
Q 000859 825 YNDLQGKLS--KQFSHWPAEAFEGNLHLCGSPL----DHCNGLVSNQHQSTISVSLVVAISVISTLSAIALLIAVVTLFV 898 (1251)
Q Consensus 825 ~N~l~~~~~--~~~~~~~~~~~~~n~~~c~~~~----~~c~~~~~~~~~~~~~~~~iv~i~~~~~~~~~~l~~~~~~~~~ 898 (1251)
+|++.|.+| ++|..+.+.+|.||+..||.+. ..|... .....+ +++++++++++++++++++ +++++
T Consensus 580 ~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~~-----~~~~~~-~~~~~~~~~~~~~~~~~~~-~~~~~ 652 (968)
T PLN00113 580 HNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRV-----RKTPSW-WFYITCTLGAFLVLALVAF-GFVFI 652 (968)
T ss_pred CCcceeeCCCcchhcccChhhhcCCccccCCccccCCCCCccc-----ccccee-eeehhHHHHHHHHHHHHHH-HHHHH
Confidence 999999998 6888899999999999998653 234211 111112 2222223333333322222 22333
Q ss_pred hhhhhh-ccccccccccCCCCchHHHHHHHHHhhhcccCCHHHHHHhhcCCCcCceecccCCceEEEEEe-cCCcEEEEE
Q 000859 899 KRKREF-LRKSSQVNYTSSSSSSQAQRRLLFQAAAKRDFRWEDIMGATNNLSDEFIIGSGGSGTVYKAEL-ANGATVAVK 976 (1251)
Q Consensus 899 ~rk~~~-~~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK 976 (1251)
+|+++. .++..... . .. + ...+.......+.+++. ...+...+.||+|+||.||+|.. .++..||||
T Consensus 653 ~~~~~~~~~~~~~~~---~-~~---~-~~~~~~~~~~~~~~~~~---~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK 721 (968)
T PLN00113 653 RGRNNLELKRVENED---G-TW---E-LQFFDSKVSKSITINDI---LSSLKEENVISRGKKGASYKGKSIKNGMQFVVK 721 (968)
T ss_pred Hhhhccccccccccc---c-cc---c-ccccccccchhhhHHHH---HhhCCcccEEccCCCeeEEEEEECCCCcEEEEE
Confidence 322211 11111000 0 00 0 00011111122333443 34577788999999999999965 578999999
Q ss_pred EeccCCchhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEEEeecCCCChHHhhhcCCCCcccCCCCCHHHHHH
Q 000859 977 KISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLK 1056 (1251)
Q Consensus 977 ~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ 1056 (1251)
++..... ....|++++++++|||||+++|+|.+. ...++||||+++|+|.++++. ++|.++.+
T Consensus 722 ~~~~~~~-----~~~~~~~~l~~l~HpnIv~~~~~~~~~--~~~~lv~Ey~~~g~L~~~l~~----------l~~~~~~~ 784 (968)
T PLN00113 722 EINDVNS-----IPSSEIADMGKLQHPNIVKLIGLCRSE--KGAYLIHEYIEGKNLSEVLRN----------LSWERRRK 784 (968)
T ss_pred EccCCcc-----ccHHHHHHHhhCCCCCcceEEEEEEcC--CCCEEEEeCCCCCcHHHHHhc----------CCHHHHHH
Confidence 9864322 123568899999999999999998654 346999999999999999853 78999999
Q ss_pred HHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcccccccccccccCCCCcccceeecccceecccccccCCC
Q 000859 1057 IAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKA 1136 (1251)
Q Consensus 1057 i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 1136 (1251)
++.|+|+||+|||+.+.++|+||||||+||+++.++.+++. ||.+..... .....||+.|+|||++.+..+
T Consensus 785 i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~ 855 (968)
T PLN00113 785 IAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT--------DTKCFISSAYVAPETRETKDI 855 (968)
T ss_pred HHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc--------CCCccccccccCcccccCCCC
Confidence 99999999999996656699999999999999999988876 665533211 111367899999999999999
Q ss_pred CCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccchhhhhhhcccCCCCCCchHHHHHHHHHHHHHcccc
Q 000859 1137 TEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKT 1216 (1251)
Q Consensus 1137 ~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 1216 (1251)
+.++|||||||++|||+||+.||+..........+|...... ......+++....+..+.......++.+++.+||+.
T Consensus 856 ~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~ 933 (968)
T PLN00113 856 TEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYS--DCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTAT 933 (968)
T ss_pred CcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcC--ccchhheeCccccCCCCccHHHHHHHHHHHHhhCcC
Confidence 999999999999999999999997665555566666654322 222334444444333334445566789999999999
Q ss_pred CCCCCCCHHHHHHHHHhhcCCCcc
Q 000859 1217 SPQERPSSRQVCDLLLNVFNNRIV 1240 (1251)
Q Consensus 1217 dP~~RPs~~eil~~L~~~~~~~~~ 1240 (1251)
||++||||+||++.|+++.+....
T Consensus 934 ~P~~RPt~~evl~~L~~~~~~~~~ 957 (968)
T PLN00113 934 DPTARPCANDVLKTLESASRSSSS 957 (968)
T ss_pred CchhCcCHHHHHHHHHHhhccccc
Confidence 999999999999999999875443
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-58 Score=612.91 Aligned_cols=500 Identities=40% Similarity=0.619 Sum_probs=375.6
Q ss_pred ccceeeccCccccCcCCcccccCCCccEEEeccccccCCCCCcc-ccccceEEEEccCccccCcccccccccccchhhhh
Q 000859 264 QLGYLNLMGNRLEGAIPRSFAKMGNLQSLDLSMNRLTGGIPEEF-GNMGQLVFLVLSNNNISGSIPRRICTNATSLEHLI 342 (1251)
Q Consensus 264 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~-~~l~~L~~L~Ls~N~l~~~i~~~~~~~l~~L~~L~ 342 (1251)
+++.|+|++|.+++.++..|..+++|+.|+|++|++.+.+|..+ ..+++|++|+|++|++++.+|.
T Consensus 70 ~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~------------- 136 (968)
T PLN00113 70 RVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR------------- 136 (968)
T ss_pred cEEEEEecCCCccccCChHHhCCCCCCEEECCCCccCCcCChHHhccCCCCCEEECcCCccccccCc-------------
Confidence 45555555555555555555555555555555555554444332 2444444444444444432221
Q ss_pred ccchhcccCCCcCccCCCCCceEEccCCcccCCccccccccccccEEEeecccccccccccccccccccEEEecccccCC
Q 000859 343 LAEIQLSGEIPVELSQCQSLKQLDLSNNTLNGTIPVELFQLVALTHLYLHNNSLVGSISPFVANLSNLQELALYHNNFQG 422 (1251)
Q Consensus 343 L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 422 (1251)
+.+++|++|+|++|.+.+.+|. .+.++++|++|++++|.+.+
T Consensus 137 --------------~~l~~L~~L~Ls~n~~~~~~p~------------------------~~~~l~~L~~L~L~~n~l~~ 178 (968)
T PLN00113 137 --------------GSIPNLETLDLSNNMLSGEIPN------------------------DIGSFSSLKVLDLGGNVLVG 178 (968)
T ss_pred --------------cccCCCCEEECcCCcccccCCh------------------------HHhcCCCCCEEECccCcccc
Confidence 1234455555555555544444 44445555555555555555
Q ss_pred CCchhhhcccccchhhcccCcccccccCCcCCCCccceEeccCCcccCCCCCcccccCCCcEEeccCCccCCCcCccccc
Q 000859 423 SLPREIGMLVKLELLYLYDNHLSGQIPSEVGNCSSLKWIDFFGNSFTGEIPTSIGRLKDLNFLHLRQNELVGQIPASLGN 502 (1251)
Q Consensus 423 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~ 502 (1251)
..|..++.+++|++|+|++|.+++.+|..++++++|++|++++|.+++.+|..++++++|++|++++|++.+.+|..+++
T Consensus 179 ~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~ 258 (968)
T PLN00113 179 KIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGN 258 (968)
T ss_pred cCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCCcCChhHhcCCCCCEEECcCceeccccChhHhC
Confidence 55555555555555555555555555555666666666666666666666666666666666666666666666666666
Q ss_pred cccCCeeecCCCcCcccCCcchhccchhhhhhccCCccccCCchhhhhhcCCCeeecccccccccccccccCccceeeec
Q 000859 503 CHQLIILDLADNKLSGGVPASFGFLQALEQLMLYNNSLEGNLPGSLINLRNLTRINFSKNRLNGRIATLCSSHSFLSFDV 582 (1251)
Q Consensus 503 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~l~~~~~l~~l~l 582 (1251)
+++|+.|++++|++++..|..+..+++|++|+|++|.+.+.+|..+.++++|+.|++++|.+.
T Consensus 259 l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~----------------- 321 (968)
T PLN00113 259 LKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFT----------------- 321 (968)
T ss_pred CCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccC-----------------
Confidence 666666666666666666666666666666666666666666666667777777777666654
Q ss_pred ccCccccCCCCCCCCcccCceeecccCccccccCcccccccccceEEccCCcccCCCCccccccCCccEEEcCCCccCCC
Q 000859 583 TNNEFDHEIPPQLGNSPSLERLRLGNNKFIGKIPWTFGKIRELSLLDLSGNSLTGPIPTQLLMCKKLSHIDLNNNLLSGA 662 (1251)
Q Consensus 583 ~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ 662 (1251)
+.+|..++.+++|+.|++++|++.+.+|..++.+++|+.|++++|++++.+|..+..+.+|+.|++++|.+.+.
T Consensus 322 ------~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~ 395 (968)
T PLN00113 322 ------GKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGE 395 (968)
T ss_pred ------CcCChhHhcCCCCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEeccc
Confidence 34566677778888888888888888888888899999999999999988999999999999999999999999
Q ss_pred CccccCCCcccccccccCccccCCCccccccccccceeeccCcccccccCcccCCCCCCceeccCCCcCCCCCCcccccc
Q 000859 663 VPSWLGTLPQLGELKLSFNQFVGFLPRELFNCSKLLVLSLDGNMLNGSLPNEVGNLASLNVLTLSGNLLSGPIPPAIGRL 742 (1251)
Q Consensus 663 ~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l 742 (1251)
+|..++.+++|+.|++++|++++..|..+..++.|+.|++++|++++.+|..+..+++|+.|++++|++.+.+|..++ .
T Consensus 396 ~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~~-~ 474 (968)
T PLN00113 396 IPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFG-S 474 (968)
T ss_pred CCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCcccc-c
Confidence 999999999999999999999999999999999999999999999999999999999999999999999988888764 5
Q ss_pred cccceeeccCcccccccchhhhchhhHHHHHhccCCcccCCCCCCcCccccccEEEccCCccccCCchhhhhccCCCcEe
Q 000859 743 SKLYELRLSNNSLNGVIPLEIGQLQNLQSILDLSHNNFTGQIPPSMGTLAKLEVLNLSHNQLVGELPSQLGEMSSLGKLN 822 (1251)
Q Consensus 743 ~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~ 822 (1251)
++|+.|++++|++++.+|..+..+++|+. |+|++|++++.+|++++.+++|++|+|++|+++|.+|..+..+++|+.|+
T Consensus 475 ~~L~~L~ls~n~l~~~~~~~~~~l~~L~~-L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 553 (968)
T PLN00113 475 KRLENLDLSRNQFSGAVPRKLGSLSELMQ-LKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLD 553 (968)
T ss_pred ccceEEECcCCccCCccChhhhhhhccCE-EECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEE
Confidence 89999999999999999999999999965 99999999999999999999999999999999999999999999999999
Q ss_pred eccccCcCccCcccCCC
Q 000859 823 LSYNDLQGKLSKQFSHW 839 (1251)
Q Consensus 823 l~~N~l~~~~~~~~~~~ 839 (1251)
|++|+++|.+|..+.++
T Consensus 554 Ls~N~l~~~~p~~l~~l 570 (968)
T PLN00113 554 LSQNQLSGEIPKNLGNV 570 (968)
T ss_pred CCCCcccccCChhHhcC
Confidence 99999999999655544
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-46 Score=423.11 Aligned_cols=292 Identities=45% Similarity=0.764 Sum_probs=243.4
Q ss_pred hcccCCHHHHHHhhcCCCcCceecccCCceEEEEEecCCcEEEEEEeccCCchhhhHHHHHHHHHHHhccCCCccceece
Q 000859 932 AKRDFRWEDIMGATNNLSDEFIIGSGGSGTVYKAELANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGH 1011 (1251)
Q Consensus 932 ~~~~~~~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~ 1011 (1251)
....|++.++..+|++|+..+.||+|+||.||+|...+|+.||||++....... .++|..|++++.+++|||+|+++||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~-~~eF~~Ei~~ls~l~H~Nlv~LlGy 139 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG-EREFLNEVEILSRLRHPNLVKLLGY 139 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc-hhHHHHHHHHHhcCCCcCcccEEEE
Confidence 466799999999999999999999999999999999989999999886554432 4569999999999999999999999
Q ss_pred eeecCCCceeEEEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCC
Q 000859 1012 CCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSN 1091 (1251)
Q Consensus 1012 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~ 1091 (1251)
|.+.+. ..++|||||++|+|.++|+.... ..++|..|.+||.++|+||+|||+.+.++||||||||+|||+|++
T Consensus 140 C~e~~~-~~~LVYEym~nGsL~d~L~~~~~-----~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~ 213 (361)
T KOG1187|consen 140 CLEGGE-HRLLVYEYMPNGSLEDHLHGKKG-----EPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDED 213 (361)
T ss_pred EecCCc-eEEEEEEccCCCCHHHHhCCCCC-----CCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCC
Confidence 987654 46999999999999999988531 178999999999999999999999988899999999999999999
Q ss_pred CCeEEcccccccccccccCCCCccccee-ecccceecccccccCCCCCccceeehhHHHHHHhhCCCCCCCcc-ccchhH
Q 000859 1092 MEAHLGDFGLAKALVEDYNSNTESNTWF-AGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATF-GVEMDM 1169 (1251)
Q Consensus 1092 ~~~kl~DfG~a~~~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~-~~~~~~ 1169 (1251)
+.+||+|||+|+..... ....... .||.+|+|||+...+..++|+|||||||++.|++||+.|.+... ..+...
T Consensus 214 ~~aKlsDFGLa~~~~~~----~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l 289 (361)
T KOG1187|consen 214 FNAKLSDFGLAKLGPEG----DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSL 289 (361)
T ss_pred CCEEccCccCcccCCcc----ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccH
Confidence 99999999999654321 1111111 79999999999999999999999999999999999999987654 334457
Q ss_pred HHHHHHHHhccchhhhhhhcccCCC-CCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhcCC
Q 000859 1170 VRWVEMHMEMSGSAREELLDDQMKP-LLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNVFNN 1237 (1251)
Q Consensus 1170 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~ 1237 (1251)
.+|...... .....+++|..+.. ..+. ......+..++.+|++.+|.+||+|.||+++|+.+...
T Consensus 290 ~~w~~~~~~--~~~~~eiiD~~l~~~~~~~-~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 290 VEWAKPLLE--EGKLREIVDPRLKEGEYPD-EKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred HHHHHHHHH--CcchhheeCCCccCCCCCh-HHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence 777744443 23667777766552 2221 14666799999999999999999999999999666544
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-46 Score=395.08 Aligned_cols=254 Identities=31% Similarity=0.482 Sum_probs=214.6
Q ss_pred CCCcCceecccCCceEEEEEe-cCCcEEEEEEeccCCchhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEEEe
Q 000859 947 NLSDEFIIGSGGSGTVYKAEL-ANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIYE 1025 (1251)
Q Consensus 947 ~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv~E 1025 (1251)
+++....||+|..|+||++++ .+++.+|+|++....++...+++.+|++++++++||+||++||.|..... ...++||
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~-~isI~mE 158 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGE-EISICME 158 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCc-eEEeehh
Confidence 456677899999999999955 47889999999877788889999999999999999999999999987765 5799999
Q ss_pred ecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCCeeecCCCCCCeeecCCCCeEEcccccccc
Q 000859 1026 YMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHH-DCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKA 1104 (1251)
Q Consensus 1026 ~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~ 1104 (1251)
||++|+|.+++++ .+.+++....+||.+|++||.|||+ + +||||||||+|||+++.|.|||||||.++.
T Consensus 159 YMDgGSLd~~~k~-------~g~i~E~~L~~ia~~VL~GL~YLh~~~---~IIHRDIKPsNlLvNskGeVKicDFGVS~~ 228 (364)
T KOG0581|consen 159 YMDGGSLDDILKR-------VGRIPEPVLGKIARAVLRGLSYLHEER---KIIHRDIKPSNLLVNSKGEVKICDFGVSGI 228 (364)
T ss_pred hcCCCCHHHHHhh-------cCCCCHHHHHHHHHHHHHHHHHHhhcc---CeeeccCCHHHeeeccCCCEEeccccccHH
Confidence 9999999999987 3678999999999999999999996 6 999999999999999999999999999987
Q ss_pred cccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccchhh
Q 000859 1105 LVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSAR 1184 (1251)
Q Consensus 1105 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1184 (1251)
+... ....++||..|||||.+.+..|+.++||||||++++|+.+|+.||....+...+ |.+...
T Consensus 229 lvnS------~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~---~~~Ll~------- 292 (364)
T KOG0581|consen 229 LVNS------IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLD---IFELLC------- 292 (364)
T ss_pred hhhh------hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCC---HHHHHH-------
Confidence 6533 334479999999999999999999999999999999999999999765222222 222221
Q ss_pred hhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 000859 1185 EELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDL 1230 (1251)
Q Consensus 1185 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 1230 (1251)
.+++ ...|.+|.. .+++++..++..|+++||.+|||++|++++
T Consensus 293 -~Iv~-~ppP~lP~~-~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 293 -AIVD-EPPPRLPEG-EFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred -HHhc-CCCCCCCcc-cCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 1222 122333332 478889999999999999999999999864
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-46 Score=416.08 Aligned_cols=258 Identities=29% Similarity=0.485 Sum_probs=218.8
Q ss_pred CCCcCceecccCCceEEEEEecCCcEEEEEEeccCCchhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEEEee
Q 000859 947 NLSDEFIIGSGGSGTVYKAELANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIYEY 1026 (1251)
Q Consensus 947 ~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv~E~ 1026 (1251)
.+...+.||+|.||+||.|.|+....||||.++... ...++|.+|+++|++++|++||+++|+|..++ ..+|||||
T Consensus 207 ~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~--m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~--piyIVtE~ 282 (468)
T KOG0197|consen 207 ELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS--MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQE--PIYIVTEY 282 (468)
T ss_pred HHHHHHHhcCCccceEEEEEEcCCCcccceEEeccc--cChhHHHHHHHHHHhCcccCeEEEEEEEecCC--ceEEEEEe
Confidence 345566899999999999999977799999997543 34578999999999999999999999997654 57999999
Q ss_pred cCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcccccccccc
Q 000859 1027 MENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALV 1106 (1251)
Q Consensus 1027 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~ 1106 (1251)
|+.|+|.+||+... +..+...+.+.++.|||+||+||+++ ++|||||.++||||+++..|||+|||+|+...
T Consensus 283 m~~GsLl~yLr~~~-----~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~ 354 (468)
T KOG0197|consen 283 MPKGSLLDYLRTRE-----GGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIG 354 (468)
T ss_pred cccCcHHHHhhhcC-----CCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccC
Confidence 99999999998732 67789999999999999999999999 99999999999999999999999999999554
Q ss_pred cccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhh-CCCCCCCccccchhHHHHHHHHHhccchhhh
Q 000859 1107 EDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMVRWVEMHMEMSGSARE 1185 (1251)
Q Consensus 1107 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1185 (1251)
++.+... ....-+..|+|||.+....++.|||||||||++|||+| |+.||.++...+. ++..
T Consensus 355 d~~Y~~~---~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev-----~~~l--------- 417 (468)
T KOG0197|consen 355 DDEYTAS---EGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEV-----LELL--------- 417 (468)
T ss_pred CCceeec---CCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHH-----HHHH---------
Confidence 4333222 22344789999999999999999999999999999999 9999987744321 2111
Q ss_pred hhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhcCCC
Q 000859 1186 ELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNVFNNR 1238 (1251)
Q Consensus 1186 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~ 1238 (1251)
+ ...++|.+..|+++++++|..||+.+|++||||+.+...++++....
T Consensus 418 ---e--~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~~ 465 (468)
T KOG0197|consen 418 ---E--RGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTST 465 (468)
T ss_pred ---h--ccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhcc
Confidence 1 12356677779999999999999999999999999999999988654
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-45 Score=429.60 Aligned_cols=269 Identities=28% Similarity=0.449 Sum_probs=226.7
Q ss_pred hhcCCCcCceecccCCceEEEEEec------CCcEEEEEEeccCCchhhhHHHHHHHHHHHhccCCCccceeceeeecCC
Q 000859 944 ATNNLSDEFIIGSGGSGTVYKAELA------NGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGA 1017 (1251)
Q Consensus 944 ~~~~~~~~~~lG~G~fg~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~ 1017 (1251)
.+.+....+.||+|+||+||+|+.. +...||||.++.+++...+++|.+|++.++.++|||||+++|+|.+.++
T Consensus 484 ~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P 563 (774)
T KOG1026|consen 484 PRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDP 563 (774)
T ss_pred chhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCe
Confidence 4455667778999999999999653 3467999999988888899999999999999999999999999977655
Q ss_pred CceeEEEeecCCCChHHhhhcCCCCcc---c----CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecC
Q 000859 1018 GSNLLIYEYMENGSVWDWLHKQPVNIK---M----RKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDS 1090 (1251)
Q Consensus 1018 ~~~~lv~E~~~~gsL~~~l~~~~~~~~---~----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~ 1090 (1251)
.++|+|||+.|||.+||+.+..... . ...++..+.+.||.|||.||+||-++ .+||||+..+|+||.+
T Consensus 564 --~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge 638 (774)
T KOG1026|consen 564 --LCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGE 638 (774)
T ss_pred --eEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceecc
Confidence 5899999999999999976432111 1 34489999999999999999999999 9999999999999999
Q ss_pred CCCeEEcccccccccccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhh-CCCCCCCccccchhH
Q 000859 1091 NMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDM 1169 (1251)
Q Consensus 1091 ~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~t-g~~p~~~~~~~~~~~ 1169 (1251)
+..|||+|||+++.+...++......+ .-+.+|||||.+..++|+.+||||||||++||++| |+.||.+..+.+.
T Consensus 639 ~l~VKIsDfGLsRdiYssDYYk~~~~t--~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EV-- 714 (774)
T KOG1026|consen 639 NLVVKISDFGLSRDIYSSDYYKVRGNT--LLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEV-- 714 (774)
T ss_pred ceEEEecccccchhhhhhhhhcccCCc--eeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHH--
Confidence 999999999999987665555444344 34789999999999999999999999999999999 9999987755332
Q ss_pred HHHHHHHHhccchhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhcCCC
Q 000859 1170 VRWVEMHMEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNVFNNR 1238 (1251)
Q Consensus 1170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~ 1238 (1251)
.+.+.+ +..++.++.++.++++||..||+..|++||+++||-..|++.-...
T Consensus 715 --------------Ie~i~~---g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s 766 (774)
T KOG1026|consen 715 --------------IECIRA---GQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQAS 766 (774)
T ss_pred --------------HHHHHc---CCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcC
Confidence 111111 1336788889999999999999999999999999999998876543
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-45 Score=409.76 Aligned_cols=260 Identities=37% Similarity=0.583 Sum_probs=213.3
Q ss_pred CCcCceecccCCceEEEEEecCCcEEEEEEeccCC-chhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEEEee
Q 000859 948 LSDEFIIGSGGSGTVYKAELANGATVAVKKISCKD-DHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIYEY 1026 (1251)
Q Consensus 948 ~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv~E~ 1026 (1251)
+...+.+|+|+||+||+|.|+....||||++.... +....++|.+|+.+|++++|||||+++|+|.+... ..++||||
T Consensus 43 l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~-~~~iVtEy 121 (362)
T KOG0192|consen 43 LPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPG-SLCIVTEY 121 (362)
T ss_pred hhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC-ceEEEEEe
Confidence 34445699999999999999854449999997554 22236799999999999999999999999965432 57899999
Q ss_pred cCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCC-eeecCCCCCCeeecCCC-CeEEcccccccc
Q 000859 1027 MENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPK-ILHRDIKSSNILLDSNM-EAHLGDFGLAKA 1104 (1251)
Q Consensus 1027 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~-ivH~Dlkp~Nill~~~~-~~kl~DfG~a~~ 1104 (1251)
+++|+|.+++++. ..+.+++..+.++|.|||+||.|||++ + ||||||||+|||++.++ ++||+|||+++.
T Consensus 122 ~~~GsL~~~l~~~-----~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~ 193 (362)
T KOG0192|consen 122 MPGGSLSVLLHKK-----RKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSRE 193 (362)
T ss_pred CCCCcHHHHHhhc-----ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCcccee
Confidence 9999999999874 157899999999999999999999999 7 99999999999999998 999999999987
Q ss_pred cccccCCCCcccceeecccceecccccc--cCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccch
Q 000859 1105 LVEDYNSNTESNTWFAGSYGYIAPEYAY--SLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGS 1182 (1251)
Q Consensus 1105 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 1182 (1251)
..... ...+...||+.|||||++. ...|+.|+|||||||++|||+||+.||.+..+...
T Consensus 194 ~~~~~----~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~--------------- 254 (362)
T KOG0192|consen 194 KVISK----TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQV--------------- 254 (362)
T ss_pred ecccc----ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHH---------------
Confidence 54321 2233368999999999999 66999999999999999999999999987744111
Q ss_pred hhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhcCCC
Q 000859 1183 AREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNVFNNR 1238 (1251)
Q Consensus 1183 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~ 1238 (1251)
.........++..+ ..+++.+..+|.+||+.||++||++.+++..|+.+....
T Consensus 255 -~~~v~~~~~Rp~~p--~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~ 307 (362)
T KOG0192|consen 255 -ASAVVVGGLRPPIP--KECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHI 307 (362)
T ss_pred -HHHHHhcCCCCCCC--ccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhh
Confidence 11112222233333 337788999999999999999999999999999887633
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-46 Score=394.86 Aligned_cols=475 Identities=29% Similarity=0.426 Sum_probs=388.6
Q ss_pred ccchhhhhccchhcccCCCcCccCCCCCceEEccCCcccCCccccccccccccEEEeecccccccccccccccccccEEE
Q 000859 335 ATSLEHLILAEIQLSGEIPVELSQCQSLKQLDLSNNTLNGTIPVELFQLVALTHLYLHNNSLVGSISPFVANLSNLQELA 414 (1251)
Q Consensus 335 l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 414 (1251)
-..+..+.+++|.+.. +...+.++..|..|++++|++. ..|.+++++.+++.|+.+.|++. .+|+.+..+.+|+.|+
T Consensus 44 qv~l~~lils~N~l~~-l~~dl~nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~ 120 (565)
T KOG0472|consen 44 QVDLQKLILSHNDLEV-LREDLKNLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLD 120 (565)
T ss_pred hcchhhhhhccCchhh-ccHhhhcccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhh
Confidence 3568888999998874 4456778888899999999998 78888999999999999999988 6778888888999999
Q ss_pred ecccccCCCCchhhhcccccchhhcccCcccccccCCcCCCCccceEeccCCcccCCCCCcccccCCCcEEeccCCccCC
Q 000859 415 LYHNNFQGSLPREIGMLVKLELLYLYDNHLSGQIPSEVGNCSSLKWIDFFGNSFTGEIPTSIGRLKDLNFLHLRQNELVG 494 (1251)
Q Consensus 415 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 494 (1251)
+++|.+. .+|..++.+..|+.|+..+|+++ ..|+.+.++.+|..+++.+|+++ ..|+..-+++.|+.|+...|-++
T Consensus 121 ~s~n~~~-el~~~i~~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~-~l~~~~i~m~~L~~ld~~~N~L~- 196 (565)
T KOG0472|consen 121 CSSNELK-ELPDSIGRLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLK-ALPENHIAMKRLKHLDCNSNLLE- 196 (565)
T ss_pred cccccee-ecCchHHHHhhhhhhhccccccc-cCchHHHHHHHHHHhhccccchh-hCCHHHHHHHHHHhcccchhhhh-
Confidence 9999988 67788888889999999999998 78888888999999999999998 55555555889999999999888
Q ss_pred CcCccccccccCCeeecCCCcCcccCCcchhccchhhhhhccCCccccCCchhh-hhhcCCCeeeccccccccccccccc
Q 000859 495 QIPASLGNCHQLIILDLADNKLSGGVPASFGFLQALEQLMLYNNSLEGNLPGSL-INLRNLTRINFSKNRLNGRIATLCS 573 (1251)
Q Consensus 495 ~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l-~~l~~L~~L~l~~N~l~~~~~~l~~ 573 (1251)
.+|..++.+.+|..|+|..|+|. ..| .|.++..|.+|+++.|+|+ .+|... .++.+|..||+..|+++..|..+|-
T Consensus 197 tlP~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklke~Pde~cl 273 (565)
T KOG0472|consen 197 TLPPELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLKEVPDEICL 273 (565)
T ss_pred cCChhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeeccccccccCchHHHH
Confidence 68888999999999999999998 666 7889999999999999998 455554 4889999999999999999999998
Q ss_pred CccceeeecccCccccCCCCCCCCcccCceeecccCccccccCcccccc--cccceEEc--cCCccc---C---------
Q 000859 574 SHSFLSFDVTNNEFDHEIPPQLGNSPSLERLRLGNNKFIGKIPWTFGKI--RELSLLDL--SGNSLT---G--------- 637 (1251)
Q Consensus 574 ~~~l~~l~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l--~~L~~L~L--s~N~l~---~--------- 637 (1251)
..++.+||+|+|.|+ .+|..++++ .|+.|.+.+|.+..+-.+.+..= .-|++|.= ..-+++ +
T Consensus 274 LrsL~rLDlSNN~is-~Lp~sLgnl-hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs~~~~dglS~se~~~e~~~t~~ 351 (565)
T KOG0472|consen 274 LRSLERLDLSNNDIS-SLPYSLGNL-HLKFLALEGNPLRTIRREIISKGTQEVLKYLRSKIKDDGLSQSEGGTETAMTLP 351 (565)
T ss_pred hhhhhhhcccCCccc-cCCcccccc-eeeehhhcCCchHHHHHHHHcccHHHHHHHHHHhhccCCCCCCcccccccCCCC
Confidence 889999999999987 678888888 88999999998753322211110 11222211 001110 0
Q ss_pred -CCCccccccCCccEEEcCCCccCCCCccccCCCcc---cccccccCccccCCCccccccccccce-eeccCcccccccC
Q 000859 638 -PIPTQLLMCKKLSHIDLNNNLLSGAVPSWLGTLPQ---LGELKLSFNQFVGFLPRELFNCSKLLV-LSLDGNMLNGSLP 712 (1251)
Q Consensus 638 -~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~---L~~L~l~~N~l~~~~p~~~~~l~~L~~-L~L~~N~l~~~~p 712 (1251)
..-.....+.+.+.|++++-+++ .+|+.+..-.+ .+..+++.|++.+ +|..+..++.+.. +.+++|.+. -+|
T Consensus 352 ~~~~~~~~~~i~tkiL~~s~~qlt-~VPdEVfea~~~~~Vt~VnfskNqL~e-lPk~L~~lkelvT~l~lsnn~is-fv~ 428 (565)
T KOG0472|consen 352 SESFPDIYAIITTKILDVSDKQLT-LVPDEVFEAAKSEIVTSVNFSKNQLCE-LPKRLVELKELVTDLVLSNNKIS-FVP 428 (565)
T ss_pred CCcccchhhhhhhhhhcccccccc-cCCHHHHHHhhhcceEEEecccchHhh-hhhhhHHHHHHHHHHHhhcCccc-cch
Confidence 11123446778899999999999 66776655444 8889999999997 7988888877654 567777776 899
Q ss_pred cccCCCCCCceeccCCCcCCCCCCcccccccccceeeccCcccccccchhhhchhhHHHHHhccCCcccCCCCCC-cCcc
Q 000859 713 NEVGNLASLNVLTLSGNLLSGPIPPAIGRLSKLYELRLSNNSLNGVIPLEIGQLQNLQSILDLSHNNFTGQIPPS-MGTL 791 (1251)
Q Consensus 713 ~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~l~~N~l~~~~p~~-~~~l 791 (1251)
..++.+++|..|+|++|.+- .+|..++.+..|+.|+++.|+|. .+|..+..++.++ ++-.++|++. .+|++ +.+|
T Consensus 429 ~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lE-tllas~nqi~-~vd~~~l~nm 504 (565)
T KOG0472|consen 429 LELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLE-TLLASNNQIG-SVDPSGLKNM 504 (565)
T ss_pred HHHHhhhcceeeecccchhh-hcchhhhhhhhhheecccccccc-cchHHHhhHHHHH-HHHhcccccc-ccChHHhhhh
Confidence 99999999999999999987 79999999999999999999998 8999999888885 4556779998 56665 9999
Q ss_pred ccccEEEccCCccccCCchhhhhccCCCcEeeccccCc
Q 000859 792 AKLEVLNLSHNQLVGELPSQLGEMSSLGKLNLSYNDLQ 829 (1251)
Q Consensus 792 ~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~ 829 (1251)
++|..|||.+|.|. .+|+.+++|++|++|+|++|||.
T Consensus 505 ~nL~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr 541 (565)
T KOG0472|consen 505 RNLTTLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPFR 541 (565)
T ss_pred hhcceeccCCCchh-hCChhhccccceeEEEecCCccC
Confidence 99999999999998 89999999999999999999998
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=375.00 Aligned_cols=254 Identities=27% Similarity=0.362 Sum_probs=204.8
Q ss_pred hcCCCcCceecccCCceEEEE-EecCCcEEEEEEeccCCchh------hhHHHHHHHHHHHhccCCCccceeceeeecCC
Q 000859 945 TNNLSDEFIIGSGGSGTVYKA-ELANGATVAVKKISCKDDHL------LNKSFTREVKTLGRIRHRHLVKLMGHCCNKGA 1017 (1251)
Q Consensus 945 ~~~~~~~~~lG~G~fg~V~~~-~~~~~~~vavK~~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~ 1017 (1251)
...|...+.+|+|+||.|-+| ..++|+.||||++....... ......+|+++|++++|||||+++++|.. +
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~--~ 248 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEV--P 248 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeec--C
Confidence 345677789999999999999 67789999999997543211 12335699999999999999999999854 5
Q ss_pred CceeEEEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCC---CCe
Q 000859 1018 GSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSN---MEA 1094 (1251)
Q Consensus 1018 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~---~~~ 1094 (1251)
...|+||||++||+|.+++-. .+.+.++....+++|++.|+.|||+. ||+||||||+|||+..+ ..+
T Consensus 249 ds~YmVlE~v~GGeLfd~vv~-------nk~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~ll 318 (475)
T KOG0615|consen 249 DSSYMVLEYVEGGELFDKVVA-------NKYLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLL 318 (475)
T ss_pred CceEEEEEEecCccHHHHHHh-------ccccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEE
Confidence 567999999999999999976 35688888899999999999999999 99999999999999766 779
Q ss_pred EEcccccccccccccCCCCcccceeecccceecccccccCC---CCCccceeehhHHHHHHhhCCCCCCCccccchhHHH
Q 000859 1095 HLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLK---ATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVR 1171 (1251)
Q Consensus 1095 kl~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~ 1171 (1251)
||+|||+|+...+ .......+||+.|.|||++.... +..++|+||+||++|-+++|.+||.+..+...
T Consensus 319 KItDFGlAK~~g~-----~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~s---- 389 (475)
T KOG0615|consen 319 KITDFGLAKVSGE-----GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPS---- 389 (475)
T ss_pred Eecccchhhcccc-----ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCcc----
Confidence 9999999987642 33344479999999999988654 33478999999999999999999986644321
Q ss_pred HHHHHHhccchhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 000859 1172 WVEMHMEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDL 1230 (1251)
Q Consensus 1172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 1230 (1251)
..+.+....+.-..+.+...+.+..++|.+|+..||++|||+.|+++.
T Consensus 390 -----------l~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 390 -----------LKEQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred -----------HHHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 112222222222234456677889999999999999999999999864
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-46 Score=396.70 Aligned_cols=431 Identities=31% Similarity=0.430 Sum_probs=278.2
Q ss_pred CcCccCCCCCceEEccCCcccCCccccccccccccEEEeecccccccccccccccccccEEEecccccCCCCchhhhccc
Q 000859 353 PVELSQCQSLKQLDLSNNTLNGTIPVELFQLVALTHLYLHNNSLVGSISPFVANLSNLQELALYHNNFQGSLPREIGMLV 432 (1251)
Q Consensus 353 ~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 432 (1251)
|..++.+.+|+.|++++|.+. .+|++++.+..++.++..+|++. ..|+.+.++.+|..|++.+|++....|..+. ++
T Consensus 107 p~~i~s~~~l~~l~~s~n~~~-el~~~i~~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~l~~~~i~-m~ 183 (565)
T KOG0472|consen 107 PEQIGSLISLVKLDCSSNELK-ELPDSIGRLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLKALPENHIA-MK 183 (565)
T ss_pred cHHHhhhhhhhhhhcccccee-ecCchHHHHhhhhhhhccccccc-cCchHHHHHHHHHHhhccccchhhCCHHHHH-HH
Confidence 333444444444444444444 44444444444555555555544 2344444455555555555555533333332 55
Q ss_pred ccchhhcccCcccccccCCcCCCCccceEeccCCcccCCCCCcccccCCCcEEeccCCccCCCcCcccc-ccccCCeeec
Q 000859 433 KLELLYLYDNHLSGQIPSEVGNCSSLKWIDFFGNSFTGEIPTSIGRLKDLNFLHLRQNELVGQIPASLG-NCHQLIILDL 511 (1251)
Q Consensus 433 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~-~l~~L~~L~L 511 (1251)
.|++||..+|-++ .+|+.++.+.+|..|++..|+|. .+| +|.++..|++|+++.|+|+ .+|.... ++++|.+|||
T Consensus 184 ~L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDL 259 (565)
T KOG0472|consen 184 RLKHLDCNSNLLE-TLPPELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDL 259 (565)
T ss_pred HHHhcccchhhhh-cCChhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeec
Confidence 5555555555554 45555555555555555555555 445 4556666666666666665 3444443 6666666666
Q ss_pred CCCcCcccCCcchhccchhhhhhccCCccccCCchhhhhhcCCCeeecccccccccccccccCcc---ceeeec--ccCc
Q 000859 512 ADNKLSGGVPASFGFLQALEQLMLYNNSLEGNLPGSLINLRNLTRINFSKNRLNGRIATLCSSHS---FLSFDV--TNNE 586 (1251)
Q Consensus 512 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~l~~~~~---l~~l~l--~~n~ 586 (1251)
.+|+++ ..|+.+..+++|+.||+|+|.|+ .+|.+++++ .|+.|-+.||+++.+-..+.+... +.+|.- ....
T Consensus 260 RdNklk-e~Pde~clLrsL~rLDlSNN~is-~Lp~sLgnl-hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs~~~~dg 336 (565)
T KOG0472|consen 260 RDNKLK-EVPDEICLLRSLERLDLSNNDIS-SLPYSLGNL-HLKFLALEGNPLRTIRREIISKGTQEVLKYLRSKIKDDG 336 (565)
T ss_pred cccccc-cCchHHHHhhhhhhhcccCCccc-cCCcccccc-eeeehhhcCCchHHHHHHHHcccHHHHHHHHHHhhccCC
Confidence 666666 56666666666666666666666 456666666 677777777776654333322221 112110 0001
Q ss_pred cccCCCCCCCCcccCceeecccCccccccCcccccccccceEEccCCcccCCCCccccccCC---ccEEEcCCCccCCCC
Q 000859 587 FDHEIPPQLGNSPSLERLRLGNNKFIGKIPWTFGKIRELSLLDLSGNSLTGPIPTQLLMCKK---LSHIDLNNNLLSGAV 663 (1251)
Q Consensus 587 l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~---L~~L~l~~N~l~~~~ 663 (1251)
++.. + -.+-..-++. .+.. .....+.+.+.|++++=+++ .+|.+.....+ .+..+++.|++. ++
T Consensus 337 lS~s--e----~~~e~~~t~~----~~~~-~~~~~~i~tkiL~~s~~qlt-~VPdEVfea~~~~~Vt~VnfskNqL~-el 403 (565)
T KOG0472|consen 337 LSQS--E----GGTETAMTLP----SESF-PDIYAIITTKILDVSDKQLT-LVPDEVFEAAKSEIVTSVNFSKNQLC-EL 403 (565)
T ss_pred CCCC--c----ccccccCCCC----CCcc-cchhhhhhhhhhcccccccc-cCCHHHHHHhhhcceEEEecccchHh-hh
Confidence 1000 0 0000000000 0011 12345567888888888888 57776655554 788999999998 77
Q ss_pred ccccCCCccccc-ccccCccccCCCccccccccccceeeccCcccccccCcccCCCCCCceeccCCCcCCCCCCcccccc
Q 000859 664 PSWLGTLPQLGE-LKLSFNQFVGFLPRELFNCSKLLVLSLDGNMLNGSLPNEVGNLASLNVLTLSGNLLSGPIPPAIGRL 742 (1251)
Q Consensus 664 ~~~~~~l~~L~~-L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l 742 (1251)
|..+..+..+.. +++++|.+ ++.|..+..+++|..|+|++|.+. .+|.+++.+..|+.|++|.|++. .+|.++-.+
T Consensus 404 Pk~L~~lkelvT~l~lsnn~i-sfv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~l 480 (565)
T KOG0472|consen 404 PKRLVELKELVTDLVLSNNKI-SFVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYEL 480 (565)
T ss_pred hhhhHHHHHHHHHHHhhcCcc-ccchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheecccccccc-cchHHHhhH
Confidence 888877776655 55555554 578999999999999999999998 89999999999999999999998 799999888
Q ss_pred cccceeeccCcccccccchhhhchhhHHHHHhccCCcccCCCCCCcCccccccEEEccCCccccCCchhhh
Q 000859 743 SKLYELRLSNNSLNGVIPLEIGQLQNLQSILDLSHNNFTGQIPPSMGTLAKLEVLNLSHNQLVGELPSQLG 813 (1251)
Q Consensus 743 ~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~ 813 (1251)
..|+.+-.++|++..+.|..+..+.+|. +|||.+|.+. ++|+.+++|++|++|+|++|.+. .|....
T Consensus 481 q~lEtllas~nqi~~vd~~~l~nm~nL~-tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr--~Pr~~i 547 (565)
T KOG0472|consen 481 QTLETLLASNNQIGSVDPSGLKNMRNLT-TLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPFR--QPRHQI 547 (565)
T ss_pred HHHHHHHhccccccccChHHhhhhhhcc-eeccCCCchh-hCChhhccccceeEEEecCCccC--CCHHHH
Confidence 8888888888999988888899999995 5999999999 89999999999999999999998 455433
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-43 Score=391.54 Aligned_cols=249 Identities=26% Similarity=0.397 Sum_probs=210.7
Q ss_pred cCCCcCceecccCCceEEEEEe-cCCcEEEEEEeccCC--chhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeE
Q 000859 946 NNLSDEFIIGSGGSGTVYKAEL-ANGATVAVKKISCKD--DHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLL 1022 (1251)
Q Consensus 946 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~l 1022 (1251)
.+|...+.||+|||+.||+++. .+|+.||+|++..+. .....+...+|++|.++++|||||+++++|.+ ....|+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FED--s~nVYi 95 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFED--SNNVYI 95 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeec--CCceEE
Confidence 5688999999999999999966 889999999997643 44456788999999999999999999999954 456799
Q ss_pred EEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcccccc
Q 000859 1023 IYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLA 1102 (1251)
Q Consensus 1023 v~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a 1102 (1251)
|.|.|+.|+|.+++++ ++.+++.+++.+.+||+.|+.|||++ +|+|||+|..|++++++.+|||+|||+|
T Consensus 96 vLELC~~~sL~el~Kr-------rk~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLA 165 (592)
T KOG0575|consen 96 VLELCHRGSLMELLKR-------RKPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLA 165 (592)
T ss_pred EEEecCCccHHHHHHh-------cCCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEeccccee
Confidence 9999999999999985 57899999999999999999999999 9999999999999999999999999999
Q ss_pred cccccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccch
Q 000859 1103 KALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGS 1182 (1251)
Q Consensus 1103 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 1182 (1251)
..+..+ ...+...+||+.|.|||++....++..+||||+||++|-|+.|++||+...-.+.
T Consensus 166 t~le~~----~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vket--------------- 226 (592)
T KOG0575|consen 166 TQLEYD----GERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKET--------------- 226 (592)
T ss_pred eeecCc----ccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHH---------------
Confidence 887533 2344457999999999999999999999999999999999999999975411111
Q ss_pred hhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 000859 1183 AREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDL 1230 (1251)
Q Consensus 1183 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 1230 (1251)
........+..+...+.+..++|.++++.||.+|||+++|++.
T Consensus 227 -----y~~Ik~~~Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 227 -----YNKIKLNEYSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred -----HHHHHhcCcccccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 0000011222333456678899999999999999999999864
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-44 Score=405.01 Aligned_cols=274 Identities=26% Similarity=0.388 Sum_probs=229.6
Q ss_pred cCCHHHHHHhhcC---------CCcCceecccCCceEEEEEecC----CcEEEEEEeccCCchhhhHHHHHHHHHHHhcc
Q 000859 935 DFRWEDIMGATNN---------LSDEFIIGSGGSGTVYKAELAN----GATVAVKKISCKDDHLLNKSFTREVKTLGRIR 1001 (1251)
Q Consensus 935 ~~~~~~~~~~~~~---------~~~~~~lG~G~fg~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~ 1001 (1251)
.++|||...+..+ ..+.++||.|.||.||+|+++. ...||||.++....+..+.+|..|+.||.+++
T Consensus 609 P~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFd 688 (996)
T KOG0196|consen 609 PHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFD 688 (996)
T ss_pred CccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCC
Confidence 4556655444433 3567789999999999997642 45799999998888889999999999999999
Q ss_pred CCCccceeceeeecCCCceeEEEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCC
Q 000859 1002 HRHLVKLMGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDI 1081 (1251)
Q Consensus 1002 h~niv~l~g~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dl 1081 (1251)
||||+++.|+.... ...+||+|||++|+|..||+.+ .+.+++.+...|.++||.||.||.+. ++||||+
T Consensus 689 HPNIIrLEGVVTks--~PvMIiTEyMENGsLDsFLR~~------DGqftviQLVgMLrGIAsGMkYLsdm---~YVHRDL 757 (996)
T KOG0196|consen 689 HPNIIRLEGVVTKS--KPVMIITEYMENGSLDSFLRQN------DGQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDL 757 (996)
T ss_pred CCcEEEEEEEEecC--ceeEEEhhhhhCCcHHHHHhhc------CCceEeehHHHHHHHHHHHhHHHhhc---Cchhhhh
Confidence 99999999988654 4469999999999999999986 46799999999999999999999999 9999999
Q ss_pred CCCCeeecCCCCeEEcccccccccccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhh-CCCCCC
Q 000859 1082 KSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTD 1160 (1251)
Q Consensus 1082 kp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~t-g~~p~~ 1160 (1251)
.++||||+.+..+|++|||++|.+.++. ........-.-+.+|.|||.+..+.++.+||||||||++||.++ |..||.
T Consensus 758 AARNILVNsnLvCKVsDFGLSRvledd~-~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYW 836 (996)
T KOG0196|consen 758 AARNILVNSNLVCKVSDFGLSRVLEDDP-EAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYW 836 (996)
T ss_pred hhhheeeccceEEEeccccceeecccCC-CccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCccc
Confidence 9999999999999999999999775554 22222222334689999999999999999999999999999998 999998
Q ss_pred CccccchhHHHHHHHHHhccchhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhcCCCc
Q 000859 1161 ATFGVEMDMVRWVEMHMEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNVFNNRI 1239 (1251)
Q Consensus 1161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~ 1239 (1251)
++.+.+. .+. +.+ ...+|.+..|+..+++||..||++|-.+||.|.||+..|.+++.+..
T Consensus 837 dmSNQdV----------------Ika-Ie~--gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~ 896 (996)
T KOG0196|consen 837 DMSNQDV----------------IKA-IEQ--GYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPN 896 (996)
T ss_pred ccchHHH----------------HHH-HHh--ccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCch
Confidence 7754332 111 111 13567777899999999999999999999999999999999987654
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=370.14 Aligned_cols=205 Identities=31% Similarity=0.473 Sum_probs=179.4
Q ss_pred hcCCCcCceecccCCceEEEEEe-cCCcEEEEEEeccCC-chhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeE
Q 000859 945 TNNLSDEFIIGSGGSGTVYKAEL-ANGATVAVKKISCKD-DHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLL 1022 (1251)
Q Consensus 945 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~l 1022 (1251)
..+|...+.||+|+||+||+|++ +++.+||||.+..+. .....+-...|+++++.++|||||++++++.. ++..|+
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~--~~~i~l 86 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIED--DDFIYL 86 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEec--CCeEEE
Confidence 45678888899999999999954 468999999998765 55566778899999999999999999997643 557899
Q ss_pred EEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCC------CCeEE
Q 000859 1023 IYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSN------MEAHL 1096 (1251)
Q Consensus 1023 v~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~------~~~kl 1096 (1251)
|||||+||||.+|++. ++.++++.++.++.|+|.|+++||++ +||||||||+|||++.. -.+||
T Consensus 87 VMEyC~gGDLs~yi~~-------~~~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKI 156 (429)
T KOG0595|consen 87 VMEYCNGGDLSDYIRR-------RGRLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKI 156 (429)
T ss_pred EEEeCCCCCHHHHHHH-------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEe
Confidence 9999999999999998 45799999999999999999999999 99999999999999764 46899
Q ss_pred cccccccccccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhhCCCCCCCccccc
Q 000859 1097 GDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVE 1166 (1251)
Q Consensus 1097 ~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~ 1166 (1251)
+|||+|+.+.+ .......+|++-|||||+++..+|+.|+|+||+|+++|||++|+.||+.....+
T Consensus 157 ADFGfAR~L~~-----~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~e 221 (429)
T KOG0595|consen 157 ADFGFARFLQP-----GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKE 221 (429)
T ss_pred cccchhhhCCc-----hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHH
Confidence 99999998743 223334789999999999999999999999999999999999999998664433
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=358.43 Aligned_cols=260 Identities=24% Similarity=0.363 Sum_probs=210.3
Q ss_pred CCCcCceecccCCceEEEE-EecCCcEEEEEEeccCC-chhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEEE
Q 000859 947 NLSDEFIIGSGGSGTVYKA-ELANGATVAVKKISCKD-DHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIY 1024 (1251)
Q Consensus 947 ~~~~~~~lG~G~fg~V~~~-~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv~ 1024 (1251)
+|.+.++||.|.||+||++ +..+|..||.|.+.-.. +...+++...|+.+|++++|||||+++++-..+.....++||
T Consensus 20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivm 99 (375)
T KOG0591|consen 20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVM 99 (375)
T ss_pred HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHH
Confidence 4677789999999999999 66789999999997443 555678899999999999999999999965555555578999
Q ss_pred eecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCC--eeecCCCCCCeeecCCCCeEEcccccc
Q 000859 1025 EYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPK--ILHRDIKSSNILLDSNMEAHLGDFGLA 1102 (1251)
Q Consensus 1025 E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~Dlkp~Nill~~~~~~kl~DfG~a 1102 (1251)
|+++.|+|.++++.-. +.++.+++..+++++.|++.|+.++|.... . |+||||||.||+++.+|.||++|||++
T Consensus 100 E~c~~GDLsqmIk~~K---~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~-r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~ 175 (375)
T KOG0591|consen 100 ELCDAGDLSQMIKHFK---KQKRLIPEKTVWKYFVQLCRALYHCHSKIP-RGTVMHRDIKPANIFLTANGVVKLGDFGLG 175 (375)
T ss_pred HhhcccCHHHHHHHHH---hccccCchHHHHHHHHHHHHHHHHHhcccc-ccceeeccCcchheEEcCCCceeeccchhH
Confidence 9999999999997532 336789999999999999999999999432 5 999999999999999999999999999
Q ss_pred cccccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccch
Q 000859 1103 KALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGS 1182 (1251)
Q Consensus 1103 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 1182 (1251)
+.+... .......+|||.||+||.+.+..|+.+|||||+||++|||+.-++||.+. .+.+..+
T Consensus 176 r~l~s~----~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~-----n~~~L~~-------- 238 (375)
T KOG0591|consen 176 RFLSSK----TTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD-----NLLSLCK-------- 238 (375)
T ss_pred hHhcch----hHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc-----cHHHHHH--------
Confidence 987432 33334579999999999999999999999999999999999999999865 1111111
Q ss_pred hhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 000859 1183 AREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLL 1232 (1251)
Q Consensus 1183 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 1232 (1251)
.+.... .+.. +.+..+.++.+++..|+..||+.||+.-.++..+.
T Consensus 239 ---KI~qgd-~~~~-p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~ 283 (375)
T KOG0591|consen 239 ---KIEQGD-YPPL-PDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQ 283 (375)
T ss_pred ---HHHcCC-CCCC-cHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHH
Confidence 111111 1111 23668889999999999999999999544444433
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=419.18 Aligned_cols=272 Identities=26% Similarity=0.438 Sum_probs=227.9
Q ss_pred cCCCcCceecccCCceEEEEEecC--Cc----EEEEEEeccCCchhhhHHHHHHHHHHHhccCCCccceeceeeecCCCc
Q 000859 946 NNLSDEFIIGSGGSGTVYKAELAN--GA----TVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGS 1019 (1251)
Q Consensus 946 ~~~~~~~~lG~G~fg~V~~~~~~~--~~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 1019 (1251)
......+.||+|+||.||+|.+.+ |. .||||.++...+.....+|.+|+.+|++++|||||+++|+|.+. ..
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~--~~ 769 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDS--GP 769 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCC--CC
Confidence 345566789999999999997653 33 49999998888888999999999999999999999999999874 44
Q ss_pred eeEEEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEccc
Q 000859 1020 NLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDF 1099 (1251)
Q Consensus 1020 ~~lv~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 1099 (1251)
.++++|||++|||..||++.+........++..+...+|.|||+|+.||+++ ++|||||.++|+|++....|||+||
T Consensus 770 ~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaDF 846 (1025)
T KOG1095|consen 770 PLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIADF 846 (1025)
T ss_pred cEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEccc
Confidence 6999999999999999998866555677899999999999999999999999 9999999999999999999999999
Q ss_pred ccccccccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhh-CCCCCCCccccchhHHHHHHHHHh
Q 000859 1100 GLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMVRWVEMHME 1178 (1251)
Q Consensus 1100 G~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~ 1178 (1251)
|+|+.+....+...... ..-+.+|||||.+..+.++.|+|||||||++||++| |..||.+..+.+. ...
T Consensus 847 GlArDiy~~~yyr~~~~--a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v-----~~~--- 916 (1025)
T KOG1095|consen 847 GLARDIYDKDYYRKHGE--AMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEV-----LLD--- 916 (1025)
T ss_pred chhHhhhhchheeccCc--cccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHH-----HHH---
Confidence 99996544333322222 234679999999999999999999999999999999 9999987644322 110
Q ss_pred ccchhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhcCCCccccc
Q 000859 1179 MSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNVFNNRIVDFD 1243 (1251)
Q Consensus 1179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~~~~~ 1243 (1251)
+.. ...++.+..|+..++++|..||+.+|++||+|+.|++++.++.....-...
T Consensus 917 --------~~~---ggRL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~~~~ 970 (1025)
T KOG1095|consen 917 --------VLE---GGRLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALGTIY 970 (1025)
T ss_pred --------HHh---CCccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhccCcc
Confidence 111 125566777899999999999999999999999999999998876555433
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=343.34 Aligned_cols=266 Identities=24% Similarity=0.373 Sum_probs=205.7
Q ss_pred cCCCcCceecccCCceEEEEEe-cCCcEEEEEEeccCCc-hhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEE
Q 000859 946 NNLSDEFIIGSGGSGTVYKAEL-ANGATVAVKKISCKDD-HLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLI 1023 (1251)
Q Consensus 946 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv 1023 (1251)
+.|+...++|+|+||+||+++. .+|+.||||++....+ +...+-..+|++++++++|||+|.++.+|.. ....++|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrr--krklhLV 79 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRR--KRKLHLV 79 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHh--cceeEEE
Confidence 3577778999999999999965 4699999999976554 5666778899999999999999999999954 4557999
Q ss_pred EeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEccccccc
Q 000859 1024 YEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAK 1103 (1251)
Q Consensus 1024 ~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~ 1103 (1251)
+||++. ++.+-|.+.+ ..++.+.+.++.+|+++|+.|+|++ ++|||||||+||+++.+|.+|+||||+|+
T Consensus 80 FE~~dh-TvL~eLe~~p------~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR 149 (396)
T KOG0593|consen 80 FEYCDH-TVLHELERYP------NGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFAR 149 (396)
T ss_pred eeecch-HHHHHHHhcc------CCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhH
Confidence 999986 6666676653 5688999999999999999999999 99999999999999999999999999999
Q ss_pred ccccccCCCCcccceeecccceeccccccc-CCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccch
Q 000859 1104 ALVEDYNSNTESNTWFAGSYGYIAPEYAYS-LKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGS 1182 (1251)
Q Consensus 1104 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 1182 (1251)
.+.. .....+.++.|..|+|||.+.+ ..|+..+||||+||++.||++|.+-|.+... .+..-.+.........
T Consensus 150 ~L~~----pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SD--iDQLy~I~ktLG~L~p 223 (396)
T KOG0593|consen 150 TLSA----PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSD--IDQLYLIRKTLGNLIP 223 (396)
T ss_pred hhcC----CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcch--HHHHHHHHHHHcccCH
Confidence 8753 2233344678999999999887 6899999999999999999999999987643 2222222221111111
Q ss_pred hhhhhh------cccCCCCCCchHH-------HHHHHHHHHHHccccCCCCCCCHHHHHH
Q 000859 1183 AREELL------DDQMKPLLPGEEC-------AAYQVLEIALQCTKTSPQERPSSRQVCD 1229 (1251)
Q Consensus 1183 ~~~~~~------~~~~~~~~~~~~~-------~~~~l~~li~~cl~~dP~~RPs~~eil~ 1229 (1251)
....++ ....-|..+.++. ...-+.++++.|++.||++|++-+|++.
T Consensus 224 rhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 224 RHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred HHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 111111 1111122111111 3345789999999999999999999874
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=369.54 Aligned_cols=250 Identities=29% Similarity=0.495 Sum_probs=208.2
Q ss_pred ccCCHHHHHHhhcCCCcCceecccCCceEEEEEecCCcEEEEEEeccCCchhhhHHHHHHHHHHHhccCCCccceeceee
Q 000859 934 RDFRWEDIMGATNNLSDEFIIGSGGSGTVYKAELANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCC 1013 (1251)
Q Consensus 934 ~~~~~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~ 1013 (1251)
-.+.|+++ ...+-||.|+-|.||+|+.+ ++.||||+++. .-+.+++.|++++||||+.|.|+|.
T Consensus 119 WeiPFe~I-------sELeWlGSGaQGAVF~Grl~-netVAVKKV~e--------lkETdIKHLRkLkH~NII~FkGVCt 182 (904)
T KOG4721|consen 119 WEIPFEEI-------SELEWLGSGAQGAVFLGRLH-NETVAVKKVRE--------LKETDIKHLRKLKHPNIITFKGVCT 182 (904)
T ss_pred ccCCHHHh-------hhhhhhccCcccceeeeecc-CceehhHHHhh--------hhhhhHHHHHhccCcceeeEeeeec
Confidence 34555553 44567999999999999997 79999999852 2246899999999999999999996
Q ss_pred ecCCCceeEEEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCC
Q 000859 1014 NKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNME 1093 (1251)
Q Consensus 1014 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~ 1093 (1251)
. ...++||||||..|-|++.|+. +..++....+.+..+||.||.|||.+ +|||||+|.-||||+.+..
T Consensus 183 q--sPcyCIiMEfCa~GqL~~VLka-------~~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~ 250 (904)
T KOG4721|consen 183 Q--SPCYCIIMEFCAQGQLYEVLKA-------GRPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDV 250 (904)
T ss_pred C--CceeEEeeeccccccHHHHHhc-------cCccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccce
Confidence 4 3457999999999999999987 56788999999999999999999999 9999999999999999999
Q ss_pred eEEcccccccccccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHH
Q 000859 1094 AHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWV 1173 (1251)
Q Consensus 1094 ~kl~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~ 1173 (1251)
|||+|||-++...+. ..+..++||..|||||+++..+.++|+||||||||||||+||..||.+.....+-+
T Consensus 251 VKIsDFGTS~e~~~~-----STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIw---- 321 (904)
T KOG4721|consen 251 VKISDFGTSKELSDK-----STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIW---- 321 (904)
T ss_pred EEeccccchHhhhhh-----hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEE----
Confidence 999999998765332 22234799999999999999999999999999999999999999997653221100
Q ss_pred HHHHhccchhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 000859 1174 EMHMEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNV 1234 (1251)
Q Consensus 1174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 1234 (1251)
+.. .-.-.++.++.+++-+.-+++.||+..|..||||++|+..|..+
T Consensus 322 -------GVG-------sNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa 368 (904)
T KOG4721|consen 322 -------GVG-------SNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIA 368 (904)
T ss_pred -------ecc-------CCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence 000 01123566777888999999999999999999999999998654
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-41 Score=369.16 Aligned_cols=257 Identities=28% Similarity=0.365 Sum_probs=209.2
Q ss_pred HHhhcCCCcCceecccCCceEEEE-EecCCcEEEEEEeccCC--chhhhHHHHHHHHHHHhc-cCCCccceeceeeecCC
Q 000859 942 MGATNNLSDEFIIGSGGSGTVYKA-ELANGATVAVKKISCKD--DHLLNKSFTREVKTLGRI-RHRHLVKLMGHCCNKGA 1017 (1251)
Q Consensus 942 ~~~~~~~~~~~~lG~G~fg~V~~~-~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~ 1017 (1251)
.....+|...+.||+|+|++|++| +..++++||||++.++- .+...+.+.+|-.+|.++ .||.|++++-.|.+ +
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD--~ 146 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQD--E 146 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeec--c
Confidence 344567888889999999999999 56689999999986543 333446678899999999 89999999877754 5
Q ss_pred CceeEEEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEc
Q 000859 1018 GSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLG 1097 (1251)
Q Consensus 1018 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~ 1097 (1251)
...|+|+||+++|+|.+++++ -+.+++..++.+|.+|+.|++|||++ |||||||||+|||+|.||++||+
T Consensus 147 ~sLYFvLe~A~nGdll~~i~K-------~Gsfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikIT 216 (604)
T KOG0592|consen 147 ESLYFVLEYAPNGDLLDLIKK-------YGSFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKIT 216 (604)
T ss_pred cceEEEEEecCCCcHHHHHHH-------hCcchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEe
Confidence 568999999999999999998 46899999999999999999999999 99999999999999999999999
Q ss_pred ccccccccccccCC---------CCcccceeecccceecccccccCCCCCccceeehhHHHHHHhhCCCCCCCccccchh
Q 000859 1098 DFGLAKALVEDYNS---------NTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMD 1168 (1251)
Q Consensus 1098 DfG~a~~~~~~~~~---------~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~ 1168 (1251)
|||.|+.+.+.... ...+...++||..|.+||++.....+.++|+|+|||++|+|+.|++||.+......-
T Consensus 217 DFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliF 296 (604)
T KOG0592|consen 217 DFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIF 296 (604)
T ss_pred eccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHH
Confidence 99999987653322 111224589999999999999999999999999999999999999999876332110
Q ss_pred HHHHHHHHHhccchhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 000859 1169 MVRWVEMHMEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDL 1230 (1251)
Q Consensus 1169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 1230 (1251)
.+ ...++- ..++..++.+.+|+++.+..||.+|+|.++|.++
T Consensus 297 -qk-------------I~~l~y------~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 297 -QK-------------IQALDY------EFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred -HH-------------HHHhcc------cCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 00 001111 1222234668899999999999999999877654
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-41 Score=355.53 Aligned_cols=243 Identities=25% Similarity=0.386 Sum_probs=198.8
Q ss_pred hcCCCcCceecccCCceEEEEE-ecCCcEEEEEEeccCC--chhhhHHHHHHHHHHHhccCCCccceeceeeecCCCcee
Q 000859 945 TNNLSDEFIIGSGGSGTVYKAE-LANGATVAVKKISCKD--DHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNL 1021 (1251)
Q Consensus 945 ~~~~~~~~~lG~G~fg~V~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~ 1021 (1251)
..+|+..++||+|+||+||.++ .++++.+|+|+++++. ...+.+...+|..|+.+++||.||+++-.| +.+...|
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysF--Qt~~kLy 101 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSF--QTEEKLY 101 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEec--ccCCeEE
Confidence 3468999999999999999995 4578999999997654 223457788999999999999999998666 4456689
Q ss_pred EEEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEccccc
Q 000859 1022 LIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGL 1101 (1251)
Q Consensus 1022 lv~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~ 1101 (1251)
+|+||+.||.|...|.+ .+.++++.++-++..|+.||.|||++ +|||||+||+|||+|++|.++|+|||+
T Consensus 102 lVld~~~GGeLf~hL~~-------eg~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL 171 (357)
T KOG0598|consen 102 LVLDYLNGGELFYHLQR-------EGRFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGL 171 (357)
T ss_pred EEEeccCCccHHHHHHh-------cCCcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEecccc
Confidence 99999999999999987 46799999999999999999999999 999999999999999999999999999
Q ss_pred ccccccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccc
Q 000859 1102 AKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSG 1181 (1251)
Q Consensus 1102 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 1181 (1251)
++....+ ......++||+.|||||++.+..|+.++|+||+||++|||++|.+||.+... ..+.+
T Consensus 172 ~k~~~~~----~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~-----~~~~~------- 235 (357)
T KOG0598|consen 172 CKEDLKD----GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDV-----KKMYD------- 235 (357)
T ss_pred chhcccC----CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccH-----HHHHH-------
Confidence 9854322 2222337999999999999999999999999999999999999999986522 11111
Q ss_pred hhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCC
Q 000859 1182 SAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERP 1222 (1251)
Q Consensus 1182 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP 1222 (1251)
.+.... ....+...+.+..+++.+.++.||++|.
T Consensus 236 ----~I~~~k---~~~~p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 236 ----KILKGK---LPLPPGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred ----HHhcCc---CCCCCccCCHHHHHHHHHHhccCHHHhc
Confidence 111111 1112222455688999999999999995
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=353.72 Aligned_cols=276 Identities=26% Similarity=0.386 Sum_probs=208.4
Q ss_pred CCcCceecccCCceEEEEEecCCcEEEEEEeccCCchhhhHHHHHHHHHHHhc--cCCCccceeceeeecC--CCceeEE
Q 000859 948 LSDEFIIGSGGSGTVYKAELANGATVAVKKISCKDDHLLNKSFTREVKTLGRI--RHRHLVKLMGHCCNKG--AGSNLLI 1023 (1251)
Q Consensus 948 ~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~g~~~~~~--~~~~~lv 1023 (1251)
....+++|+|.||.||+|.+. ++.||||++. ....+.|..|-+|++.. +|+||++|+++-.... ...+++|
T Consensus 212 l~l~eli~~Grfg~V~KaqL~-~~~VAVKifp----~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLV 286 (534)
T KOG3653|consen 212 LQLLELIGRGRFGCVWKAQLD-NRLVAVKIFP----EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLV 286 (534)
T ss_pred hhhHHHhhcCccceeehhhcc-CceeEEEecC----HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEE
Confidence 344557999999999999986 6999999995 33457888888887765 8999999998543222 3357999
Q ss_pred EeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhc------CCCCeeecCCCCCCeeecCCCCeEEc
Q 000859 1024 YEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHD------CVPKILHRDIKSSNILLDSNMEAHLG 1097 (1251)
Q Consensus 1024 ~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~------~~~~ivH~Dlkp~Nill~~~~~~kl~ 1097 (1251)
+||.+.|+|.+||+.+ .++|.+..+|+..+++||+|||+. +.|+|+|||||.+||||.+|+++.|+
T Consensus 287 t~fh~kGsL~dyL~~n--------tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIa 358 (534)
T KOG3653|consen 287 TEFHPKGSLCDYLKAN--------TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIA 358 (534)
T ss_pred eeeccCCcHHHHHHhc--------cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEee
Confidence 9999999999999864 689999999999999999999986 34789999999999999999999999
Q ss_pred ccccccccccccCCCCcccceeecccceecccccccCC------CCCccceeehhHHHHHHhhCCCCCCC--ccccchhH
Q 000859 1098 DFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLK------ATEKCDVYSMGIVLMELVSGKMPTDA--TFGVEMDM 1169 (1251)
Q Consensus 1098 DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~sDiwSlGv~l~el~tg~~p~~~--~~~~~~~~ 1169 (1251)
|||+|..+..+.. .......+||.+|||||++.+.- .-.+.||||+|.|+|||+++..-++. ..+.....
T Consensus 359 DFGLAl~~~p~~~--~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpf 436 (534)
T KOG3653|consen 359 DFGLALRLEPGKP--QGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPF 436 (534)
T ss_pred ccceeEEecCCCC--CcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCch
Confidence 9999998864332 22333479999999999986542 22468999999999999998766532 22222222
Q ss_pred HHHHHHHHhccchhhhhhhcccCCCCCCch---HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhcCCCc
Q 000859 1170 VRWVEMHMEMSGSAREELLDDQMKPLLPGE---ECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNVFNNRI 1239 (1251)
Q Consensus 1170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~ 1239 (1251)
...+..++.. +.....++.++.+|.++.. ......+.+.+..||..||+.|.|+.=+.+.+.++.....
T Consensus 437 e~evG~hPt~-e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~ 508 (534)
T KOG3653|consen 437 EAEVGNHPTL-EEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWE 508 (534)
T ss_pred hHHhcCCCCH-HHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCC
Confidence 2222222211 2223334444555555421 1245678999999999999999999999999888775443
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-40 Score=357.15 Aligned_cols=267 Identities=28% Similarity=0.380 Sum_probs=211.5
Q ss_pred hcCCCcCceecccCCceEEEE-EecCCcEEEEEEeccCC-chhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeE
Q 000859 945 TNNLSDEFIIGSGGSGTVYKA-ELANGATVAVKKISCKD-DHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLL 1022 (1251)
Q Consensus 945 ~~~~~~~~~lG~G~fg~V~~~-~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~l 1022 (1251)
...|+..++||+|.||.||+| +..+|+.||+|+++.+. .+.......+||.||++++||||+++.+...+......|+
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 345777789999999999999 56789999999998665 3334456679999999999999999999988876677899
Q ss_pred EEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcccccc
Q 000859 1023 IYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLA 1102 (1251)
Q Consensus 1023 v~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a 1102 (1251)
|+|||+. ||..++... .-.+++.++..++.|++.||+|+|++ +|+|||||.+|||+|.+|.+||+|||+|
T Consensus 196 VFeYMdh-DL~GLl~~p------~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLA 265 (560)
T KOG0600|consen 196 VFEYMDH-DLSGLLSSP------GVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLA 265 (560)
T ss_pred EEecccc-hhhhhhcCC------CcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccce
Confidence 9999987 888888764 45799999999999999999999999 9999999999999999999999999999
Q ss_pred cccccccCCCCcccceeecccceecccccccC-CCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccc
Q 000859 1103 KALVEDYNSNTESNTWFAGSYGYIAPEYAYSL-KATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSG 1181 (1251)
Q Consensus 1103 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 1181 (1251)
+.+.... ....+..+-|..|+|||.+.+. .|+.++|+||.|||+.||++|++.|.+.... +..+......+
T Consensus 266 r~y~~~~---~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEv-----eQl~kIfklcG 337 (560)
T KOG0600|consen 266 RFYTPSG---SAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEV-----EQLHKIFKLCG 337 (560)
T ss_pred eeccCCC---CcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHH-----HHHHHHHHHhC
Confidence 9775432 2224456789999999998865 6999999999999999999999999876332 22333333334
Q ss_pred hhhhhhhc-------ccCCCCCCchH-------HHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 000859 1182 SAREELLD-------DQMKPLLPGEE-------CAAYQVLEIALQCTKTSPQERPSSRQVCD 1229 (1251)
Q Consensus 1182 ~~~~~~~~-------~~~~~~~~~~~-------~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1229 (1251)
...+..+. ..+++..+... ..+....+++..++..||++|.||.++++
T Consensus 338 SP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 338 SPTEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred CCChhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 43333222 11111111111 13456788999999999999999999874
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-41 Score=362.53 Aligned_cols=269 Identities=23% Similarity=0.302 Sum_probs=210.1
Q ss_pred hcCCCcCceecccCCceEEEE-EecCCcEEEEEEeccCCchhhhHHHHHHHHHHHhcc-CCCccceeceeeecCCCceeE
Q 000859 945 TNNLSDEFIIGSGGSGTVYKA-ELANGATVAVKKISCKDDHLLNKSFTREVKTLGRIR-HRHLVKLMGHCCNKGAGSNLL 1022 (1251)
Q Consensus 945 ~~~~~~~~~lG~G~fg~V~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~~~l 1022 (1251)
.++|...++||.|.||.||+| ...+|..||||+++.+-...+.-.-.||++.++++. |||||++..++.+... ..++
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~-~L~f 87 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDR-ILYF 87 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCc-eEee
Confidence 456788889999999999999 456799999999987665544455679999999998 9999999998876644 7899
Q ss_pred EEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcccccc
Q 000859 1023 IYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLA 1102 (1251)
Q Consensus 1023 v~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a 1102 (1251)
|||||+. +|++.++++ .+.+++..++.|+.||++||+|+|.+ |+.|||+||+|||+.....+||+|||+|
T Consensus 88 VfE~Md~-NLYqLmK~R------~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLA 157 (538)
T KOG0661|consen 88 VFEFMDC-NLYQLMKDR------NRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLA 157 (538)
T ss_pred eHHhhhh-hHHHHHhhc------CCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEecccccc
Confidence 9999975 999999876 57899999999999999999999999 9999999999999999999999999999
Q ss_pred cccccccCCCCcccceeecccceeccccc-ccCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhcc-
Q 000859 1103 KALVEDYNSNTESNTWFAGSYGYIAPEYA-YSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMS- 1180 (1251)
Q Consensus 1103 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~- 1180 (1251)
|.+.. ..+.+.++.|..|+|||++ +.+.|+.+.||||+||+++|+.+=++-|.+....+. +.+.++......
T Consensus 158 Rev~S-----kpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dq-i~KIc~VLGtP~~ 231 (538)
T KOG0661|consen 158 REVRS-----KPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQ-IYKICEVLGTPDK 231 (538)
T ss_pred ccccc-----CCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHH-HHHHHHHhCCCcc
Confidence 98643 3344557889999999976 466799999999999999999999999987644221 111111110000
Q ss_pred chhhh-hhhcccCCCCCCc---------hHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 000859 1181 GSARE-ELLDDQMKPLLPG---------EECAAYQVLEIALQCTKTSPQERPSSRQVCDL 1230 (1251)
Q Consensus 1181 ~~~~~-~~~~~~~~~~~~~---------~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 1230 (1251)
..+.+ .-+...+.-.+|. ...+..+..++|.+|+++||.+||||+|.+++
T Consensus 232 ~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 232 DSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred ccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 00000 1111111111111 11266788999999999999999999999875
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=367.23 Aligned_cols=267 Identities=31% Similarity=0.468 Sum_probs=212.4
Q ss_pred HHHHHhhcCCCcCceecccCCceEEEEEecCCcEEEEEEeccCC-chhhhHHHHHHHHHHHhccCCCccceeceeeecCC
Q 000859 939 EDIMGATNNLSDEFIIGSGGSGTVYKAELANGATVAVKKISCKD-DHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGA 1017 (1251)
Q Consensus 939 ~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~ 1017 (1251)
+++.+..+++.....||+|.||+||+|+|. -.||||++.... ..+..+.|..|+.++++-+|.||+-|+|||....
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~- 461 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPP- 461 (678)
T ss_pred cccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCc-
Confidence 445556666778889999999999999997 479999997554 3446789999999999999999999999996543
Q ss_pred CceeEEEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEc
Q 000859 1018 GSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLG 1097 (1251)
Q Consensus 1018 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~ 1097 (1251)
.+||+.||+|.+|+.+++-. +..+.+.+.+.||.|||+||.|||.+ +|||||+|..||++.++++|||+
T Consensus 462 --~AIiTqwCeGsSLY~hlHv~------etkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIg 530 (678)
T KOG0193|consen 462 --LAIITQWCEGSSLYTHLHVQ------ETKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIG 530 (678)
T ss_pred --eeeeehhccCchhhhhccch------hhhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEe
Confidence 38999999999999999875 46789999999999999999999999 99999999999999999999999
Q ss_pred ccccccccccccCCCCcccceeecccceeccccccc---CCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHH
Q 000859 1098 DFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYS---LKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVE 1174 (1251)
Q Consensus 1098 DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~ 1174 (1251)
|||++..-..- ..........|..-|||||+++. .+|++.+||||||+|+|||+||..||... ..+- .. |
T Consensus 531 DFGLatvk~~w--~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~-~~dq-Ii-f-- 603 (678)
T KOG0193|consen 531 DFGLATVKTRW--SGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQ-NRDQ-II-F-- 603 (678)
T ss_pred cccceeeeeee--ccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCC-Chhh-eE-E--
Confidence 99999653221 11112222457788999999874 46899999999999999999999999732 1110 00 0
Q ss_pred HHHhccchhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhcC
Q 000859 1175 MHMEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNVFN 1236 (1251)
Q Consensus 1175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~ 1236 (1251)
+.+ +.+. +.........++.++.+|+..||..++++||.+.+|+..|+.+..
T Consensus 604 ----mVG--rG~l----~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 604 ----MVG--RGYL----MPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred ----Eec--cccc----CccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 000 0000 111122334477789999999999999999999999999998887
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-40 Score=357.31 Aligned_cols=264 Identities=27% Similarity=0.441 Sum_probs=206.1
Q ss_pred cCCCcCceecccCCceEEEEEec-CCcEEEEEEeccCCchhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEEE
Q 000859 946 NNLSDEFIIGSGGSGTVYKAELA-NGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIY 1024 (1251)
Q Consensus 946 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv~ 1024 (1251)
.++...+.||+|+||+||++... +|+..|||.+....... .+.+.+|+.+|++++|||||+++|.........+++.|
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~-~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m 95 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT-SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM 95 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh-HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence 34666778999999999999654 58999999997664333 56789999999999999999999964433333578999
Q ss_pred eecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecC-CCCeEEccccccc
Q 000859 1025 EYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDS-NMEAHLGDFGLAK 1103 (1251)
Q Consensus 1025 E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~-~~~~kl~DfG~a~ 1103 (1251)
||+++|+|.+++.+.. +.+++..++++..||++|++|||++ |||||||||+|||++. ++.+||+|||.++
T Consensus 96 Ey~~~GsL~~~~~~~g------~~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~ 166 (313)
T KOG0198|consen 96 EYAPGGSLSDLIKRYG------GKLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAK 166 (313)
T ss_pred eccCCCcHHHHHHHcC------CCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCcccc
Confidence 9999999999998753 2799999999999999999999999 9999999999999999 7999999999998
Q ss_pred ccccccCCCCcccceeecccceecccccccC-CCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccch
Q 000859 1104 ALVEDYNSNTESNTWFAGSYGYIAPEYAYSL-KATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGS 1182 (1251)
Q Consensus 1104 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 1182 (1251)
.... ............||+.|||||++..+ ....++||||+||++.||+||+.||..... ...+.
T Consensus 167 ~~~~-~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~----~~~~~--------- 232 (313)
T KOG0198|consen 167 KLES-KGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFE----EAEAL--------- 232 (313)
T ss_pred cccc-ccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcc----hHHHH---------
Confidence 7643 11222223346899999999999853 344599999999999999999999875300 00000
Q ss_pred hhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhcCC
Q 000859 1183 AREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNVFNN 1237 (1251)
Q Consensus 1183 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~ 1237 (1251)
..+......| +.+...+++..+++.+|++.||++||||+++++.-....+.
T Consensus 233 --~~ig~~~~~P--~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~ 283 (313)
T KOG0198|consen 233 --LLIGREDSLP--EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNS 283 (313)
T ss_pred --HHHhccCCCC--CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhccc
Confidence 0000111112 22333667789999999999999999999999877654433
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-40 Score=361.12 Aligned_cols=268 Identities=25% Similarity=0.407 Sum_probs=221.8
Q ss_pred HHHhhcCCCcCceecccCCceEEEEEecC-CcEEEEEEeccCCchhhhHHHHHHHHHHHhccCCCccceeceeeecCCCc
Q 000859 941 IMGATNNLSDEFIIGSGGSGTVYKAELAN-GATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGS 1019 (1251)
Q Consensus 941 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 1019 (1251)
++-...+....++||.|.||.||.|.|+. .-.||||.++.+. ...++|.+|+.+|+.++|||+|+++|+|..+.+
T Consensus 262 WEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt--MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpP-- 337 (1157)
T KOG4278|consen 262 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPP-- 337 (1157)
T ss_pred hhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc--hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCC--
Confidence 33345567778899999999999998864 4679999996544 457899999999999999999999999977654
Q ss_pred eeEEEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEccc
Q 000859 1020 NLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDF 1099 (1251)
Q Consensus 1020 ~~lv~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 1099 (1251)
+|||+|||.+|+|.+||++.. +..++.-..++||.||+.||+||..+ .+||||+.++|+||.++..|||+||
T Consensus 338 FYIiTEfM~yGNLLdYLRecn-----r~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADF 409 (1157)
T KOG4278|consen 338 FYIITEFMCYGNLLDYLRECN-----RSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADF 409 (1157)
T ss_pred eEEEEecccCccHHHHHHHhc-----hhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeecc
Confidence 599999999999999999875 45677788899999999999999999 9999999999999999999999999
Q ss_pred ccccccccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhh-CCCCCCCccccchhHHHHHHHHHh
Q 000859 1100 GLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMVRWVEMHME 1178 (1251)
Q Consensus 1100 G~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~ 1178 (1251)
|+++.+..+.+.. +....-++.|.|||.+....++.|+|||+|||++||+.| |-.||.+. ++....+
T Consensus 410 GLsRlMtgDTYTA---HAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGi-----dlSqVY~---- 477 (1157)
T KOG4278|consen 410 GLSRLMTGDTYTA---HAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGI-----DLSQVYG---- 477 (1157)
T ss_pred chhhhhcCCceec---ccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCc-----cHHHHHH----
Confidence 9999876543322 222334689999999999999999999999999999999 99999765 2222111
Q ss_pred ccchhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhcCCCcccc
Q 000859 1179 MSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNVFNNRIVDF 1242 (1251)
Q Consensus 1179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~~~~ 1242 (1251)
++... .+...++.|++.++++|+.||++.|.+||+++|+-+.++.++...-+..
T Consensus 478 --------LLEkg--yRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~sSisd 531 (1157)
T KOG4278|consen 478 --------LLEKG--YRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSSSSISD 531 (1157)
T ss_pred --------HHhcc--ccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhccccccH
Confidence 11111 1234567789999999999999999999999999999999997665543
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=343.15 Aligned_cols=269 Identities=26% Similarity=0.436 Sum_probs=216.2
Q ss_pred hhcCCCcCceecccCCceEEEEEecCCcEEEEEEeccCCchhhhHHHHHHHHHHHhc--cCCCccceeceeeecCC--Cc
Q 000859 944 ATNNLSDEFIIGSGGSGTVYKAELANGATVAVKKISCKDDHLLNKSFTREVKTLGRI--RHRHLVKLMGHCCNKGA--GS 1019 (1251)
Q Consensus 944 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~g~~~~~~~--~~ 1019 (1251)
...+....+.||+|.||+||+|+|+ |+.||||++...+ ++.+.+|.+|++.+ +|+||+.|++.-..+.. .+
T Consensus 209 iarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srd----E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQ 283 (513)
T KOG2052|consen 209 IARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRD----ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQ 283 (513)
T ss_pred hhheeEEEEEecCccccceeecccc-CCceEEEEecccc----hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEE
Confidence 3456677789999999999999998 8999999996543 36778899998886 99999999985443322 24
Q ss_pred eeEEEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhc-----CCCCeeecCCCCCCeeecCCCCe
Q 000859 1020 NLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHD-----CVPKILHRDIKSSNILLDSNMEA 1094 (1251)
Q Consensus 1020 ~~lv~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-----~~~~ivH~Dlkp~Nill~~~~~~ 1094 (1251)
.|+|++|.+.|+|+|||.+ ..++.+.+.+++..+|.||+|||.. +.|.|+|||||..||||..++++
T Consensus 284 LwLvTdYHe~GSL~DyL~r--------~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C 355 (513)
T KOG2052|consen 284 LWLVTDYHEHGSLYDYLNR--------NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTC 355 (513)
T ss_pred EEEeeecccCCcHHHHHhh--------ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcE
Confidence 6999999999999999986 4689999999999999999999965 56889999999999999999999
Q ss_pred EEcccccccccccccCCCCcccceeecccceecccccccCC------CCCccceeehhHHHHHHhhC----------CCC
Q 000859 1095 HLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLK------ATEKCDVYSMGIVLMELVSG----------KMP 1158 (1251)
Q Consensus 1095 kl~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~sDiwSlGv~l~el~tg----------~~p 1158 (1251)
-|+|+|+|.....+...-.......+||.+|||||++...- .-..+||||||.|+||+..+ ++|
T Consensus 356 ~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~P 435 (513)
T KOG2052|consen 356 CIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLP 435 (513)
T ss_pred EEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCC
Confidence 99999999887666555555566689999999999976432 23469999999999999753 577
Q ss_pred CCCccccchhHHHHHHHHHhccchhhhhhhcccCCCCCCc---hHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhc
Q 000859 1159 TDATFGVEMDMVRWVEMHMEMSGSAREELLDDQMKPLLPG---EECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNVF 1235 (1251)
Q Consensus 1159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~ 1235 (1251)
|.+..+.+....+ .++-+..++.+|..|. ..++...+.++|+.||..+|..|-|+-.|.+.|.++.
T Consensus 436 yyd~Vp~DPs~ee-----------MrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~ 504 (513)
T KOG2052|consen 436 YYDVVPSDPSFEE-----------MRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLS 504 (513)
T ss_pred cccCCCCCCCHHH-----------HhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHh
Confidence 7666554443322 2233444555555543 3446677899999999999999999999999999987
Q ss_pred C
Q 000859 1236 N 1236 (1251)
Q Consensus 1236 ~ 1236 (1251)
+
T Consensus 505 ~ 505 (513)
T KOG2052|consen 505 N 505 (513)
T ss_pred c
Confidence 6
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=364.26 Aligned_cols=364 Identities=25% Similarity=0.248 Sum_probs=288.9
Q ss_pred cccccccCCCCCCCCCCcCcccccceeeeccccccCCCCcccCCCCCCceeeccccccCCCchhhhcccccCceeeccCc
Q 000859 170 GTLGLASCSLSGPIPPQFGQLSQLEELILQQNQLQGPIPAELGNCSSLSIFTAAENNLNGSIPAALGRLQNLQLLNLGNN 249 (1251)
Q Consensus 170 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N 249 (1251)
++|++++|.++..-+..|.++++|++++|.+|.++ .||...+-...|+.|+|.+|.|+..-.+.+..++.|+.||||.|
T Consensus 81 ~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLSrN 159 (873)
T KOG4194|consen 81 QTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLRHNLISSVTSEELSALPALRSLDLSRN 159 (873)
T ss_pred eeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEeeeccccccccHHHHHhHhhhhhhhhhhc
Confidence 45667777776666666777777777777777776 56666555666777777777777777788888888888888888
Q ss_pred cCCCCCCccccCCCccceeeccCccccCcCCcccccCCCccEEEeccccccCCCCCccccccceEEEEccCccccCcccc
Q 000859 250 SLSGEIPSELGELSQLGYLNLMGNRLEGAIPRSFAKMGNLQSLDLSMNRLTGGIPEEFGNMGQLVFLVLSNNNISGSIPR 329 (1251)
Q Consensus 250 ~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~i~~ 329 (1251)
.|+.+.-..|..-.++++|+|++|+|+.+....|.++.+|..|.|+.|+++...+..|.++++|+.|+|..|+|. .+..
T Consensus 160 ~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~ir-ive~ 238 (873)
T KOG4194|consen 160 LISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIR-IVEG 238 (873)
T ss_pred hhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCcccccCHHHhhhcchhhhhhcccccee-eehh
Confidence 888555556777778999999999998888888888889999999999998777788888999999999999886 5556
Q ss_pred cccccccchhhhhccchhcccCCCcCccCCCCCceEEccCCcccCCccccccccccccEEEeeccccccccccccccccc
Q 000859 330 RICTNATSLEHLILAEIQLSGEIPVELSQCQSLKQLDLSNNTLNGTIPVELFQLVALTHLYLHNNSLVGSISPFVANLSN 409 (1251)
Q Consensus 330 ~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~ 409 (1251)
..|.++++|+.|.|..|+++..-...|..|.++++|+|+.|++...-..++++++.|+.|+||+|.|..+.++.....++
T Consensus 239 ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~Wsftqk 318 (873)
T KOG4194|consen 239 LTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQK 318 (873)
T ss_pred hhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhccc
Confidence 67888888999999999888777888999999999999999998777788999999999999999999888888888899
Q ss_pred ccEEEecccccCCCCchhhhcccccchhhcccCcccccccCCcCCCCccceEeccCCcccCCCCC---cccccCCCcEEe
Q 000859 410 LQELALYHNNFQGSLPREIGMLVKLELLYLYDNHLSGQIPSEVGNCSSLKWIDFFGNSFTGEIPT---SIGRLKDLNFLH 486 (1251)
Q Consensus 410 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~---~~~~l~~L~~L~ 486 (1251)
|++|+|++|+|+...+..|..+..|++|.|++|.++..--..|..+++|++|||++|.++..+.+ .|..+++|+.|.
T Consensus 319 L~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~ 398 (873)
T KOG4194|consen 319 LKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLR 398 (873)
T ss_pred ceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhhee
Confidence 99999999999988888899999999999999999866566778888888888888887754433 355666666666
Q ss_pred ccCCccCCCcCccccccccCCeeecCCCcCcccCCcchhccchhhhhhcc
Q 000859 487 LRQNELVGQIPASLGNCHQLIILDLADNKLSGGVPASFGFLQALEQLMLY 536 (1251)
Q Consensus 487 L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 536 (1251)
|.+|+|..+.-.+|.++..|+.|||.+|.|..+.|++|..+ .|++|.+.
T Consensus 399 l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m-~Lk~Lv~n 447 (873)
T KOG4194|consen 399 LTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPM-ELKELVMN 447 (873)
T ss_pred ecCceeeecchhhhccCcccceecCCCCcceeecccccccc-hhhhhhhc
Confidence 66666665555566666666666666666666666666666 66666554
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=359.68 Aligned_cols=251 Identities=25% Similarity=0.398 Sum_probs=212.3
Q ss_pred hcCCCcCceecccCCceEEEE-EecCCcEEEEEEeccCCchhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEE
Q 000859 945 TNNLSDEFIIGSGGSGTVYKA-ELANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLI 1023 (1251)
Q Consensus 945 ~~~~~~~~~lG~G~fg~V~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv 1023 (1251)
...|....+||+|+.|.||.| +..+++.||||++.... ...++-+..|+.+|+..+|+|||.++..|... +..|+|
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~-Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~--deLWVV 348 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRK-QPKKELLLNEILVMRDLHHPNIVNFLDSYLVG--DELWVV 348 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEecc-CCchhhhHHHHHHHHhccchHHHHHHHHhccc--ceeEEE
Confidence 345777789999999999999 56678999999996543 33457788999999999999999999977665 457999
Q ss_pred EeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEccccccc
Q 000859 1024 YEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAK 1103 (1251)
Q Consensus 1024 ~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~ 1103 (1251)
||||+||+|.+.+... .+++.++..|+.++++||+|||.+ +|+|||||.+|||++.+|.+||+|||++.
T Consensus 349 MEym~ggsLTDvVt~~--------~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFca 417 (550)
T KOG0578|consen 349 MEYMEGGSLTDVVTKT--------RMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCA 417 (550)
T ss_pred EeecCCCchhhhhhcc--------cccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeee
Confidence 9999999999988763 489999999999999999999999 99999999999999999999999999998
Q ss_pred ccccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccchh
Q 000859 1104 ALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSA 1183 (1251)
Q Consensus 1104 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1183 (1251)
.+..... .....+||+.|||||++....|++++||||+|++++||+-|++||-...+. .
T Consensus 418 qi~~~~~----KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~Pl----r------------- 476 (550)
T KOG0578|consen 418 QISEEQS----KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPL----R------------- 476 (550)
T ss_pred ccccccC----ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChH----H-------------
Confidence 7654322 233468999999999999999999999999999999999999999643221 1
Q ss_pred hhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 000859 1184 REELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDL 1230 (1251)
Q Consensus 1184 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 1230 (1251)
..+.+...-.+.+..++..+..+.+++.+|++.||++||+++|+++.
T Consensus 477 AlyLIa~ng~P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 477 ALYLIATNGTPKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred HHHHHhhcCCCCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 11223344456666777788899999999999999999999999864
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=356.21 Aligned_cols=266 Identities=25% Similarity=0.369 Sum_probs=215.9
Q ss_pred hcCCCcCceecccCCceEEEEEecCCcEEEEEEeccCCchhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEEE
Q 000859 945 TNNLSDEFIIGSGGSGTVYKAELANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIY 1024 (1251)
Q Consensus 945 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv~ 1024 (1251)
......+++||+|-||.|..+....+..||||+++..+......+|.+|+++|.+++|||||+++|+|..+++ .++|+
T Consensus 537 Rs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DeP--icmI~ 614 (807)
T KOG1094|consen 537 RSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDP--LCMIT 614 (807)
T ss_pred hhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCc--hHHHH
Confidence 4455677899999999999999887899999999988877778999999999999999999999999987654 58999
Q ss_pred eecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcccccccc
Q 000859 1025 EYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKA 1104 (1251)
Q Consensus 1025 E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~ 1104 (1251)
|||++|+|.+|+.++.. .....+...+|+.||+.||+||.+. .+||||+.++|+|++.++++||+|||+++.
T Consensus 615 EYmEnGDLnqFl~ahea-----pt~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~ 686 (807)
T KOG1094|consen 615 EYMENGDLNQFLSAHEL-----PTAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRN 686 (807)
T ss_pred HHHhcCcHHHHHHhccC-----cccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccc
Confidence 99999999999987631 2234455678999999999999999 999999999999999999999999999997
Q ss_pred cccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhh--CCCCCCCccccchhHHHHHHHHHhccch
Q 000859 1105 LVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS--GKMPTDATFGVEMDMVRWVEMHMEMSGS 1182 (1251)
Q Consensus 1105 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~t--g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 1182 (1251)
+....+.. .....+-+.+|||||.+.-++++.+||||+|||++||+++ ...||....... .++...++.
T Consensus 687 lysg~yy~--vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~-----vven~~~~~-- 757 (807)
T KOG1094|consen 687 LYSGDYYR--VQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQ-----VVENAGEFF-- 757 (807)
T ss_pred cccCCcee--eecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHH-----HHHhhhhhc--
Confidence 65443322 2223466899999999999999999999999999999886 788987653321 122222111
Q ss_pred hhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 000859 1183 AREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNV 1234 (1251)
Q Consensus 1183 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 1234 (1251)
.++...-.++.+..++.+++++|.+||..|-++||+++++...|++.
T Consensus 758 -----~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 758 -----RDQGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred -----CCCCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 11111122334556888999999999999999999999999888764
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=366.68 Aligned_cols=264 Identities=25% Similarity=0.404 Sum_probs=212.4
Q ss_pred hhcCCCcCceecccCCceEEEEEecC--C---cEEEEEEecc--CCchhhhHHHHHHHHHHHhccCCCccceeceeeecC
Q 000859 944 ATNNLSDEFIIGSGGSGTVYKAELAN--G---ATVAVKKISC--KDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKG 1016 (1251)
Q Consensus 944 ~~~~~~~~~~lG~G~fg~V~~~~~~~--~---~~vavK~~~~--~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~ 1016 (1251)
...+....++||+|+||.||+|+++. + ..||||.... .......++|.+|+++|+.++|||||++||++..+.
T Consensus 155 ~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~ 234 (474)
T KOG0194|consen 155 SHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEE 234 (474)
T ss_pred eccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCC
Confidence 34445556899999999999996543 2 2389999874 245667789999999999999999999999987765
Q ss_pred CCceeEEEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEE
Q 000859 1017 AGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHL 1096 (1251)
Q Consensus 1017 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl 1096 (1251)
| .++|||+|+||+|.+||++.+ +.++..+..+++.+.|.||+|||++ +++||||.++|+|++.++.+||
T Consensus 235 P--l~ivmEl~~gGsL~~~L~k~~------~~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKI 303 (474)
T KOG0194|consen 235 P--LMLVMELCNGGSLDDYLKKNK------KSLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKI 303 (474)
T ss_pred c--cEEEEEecCCCcHHHHHHhCC------CCCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEe
Confidence 5 599999999999999999853 4699999999999999999999999 9999999999999999999999
Q ss_pred cccccccccccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhh-CCCCCCCccccchhHHHHHHH
Q 000859 1097 GDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMVRWVEM 1175 (1251)
Q Consensus 1097 ~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~ 1175 (1251)
+|||+++.-. .+ .. ......-+.+|+|||.+....|++++|||||||++||+++ |..||.+....+.
T Consensus 304 SDFGLs~~~~-~~-~~--~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v-------- 371 (474)
T KOG0194|consen 304 SDFGLSRAGS-QY-VM--KKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEV-------- 371 (474)
T ss_pred CccccccCCc-ce-ee--ccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHH--------
Confidence 9999987532 11 11 1111134689999999999999999999999999999999 8999987744311
Q ss_pred HHhccchhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhcCCCcc
Q 000859 1176 HMEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNVFNNRIV 1240 (1251)
Q Consensus 1176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~~ 1240 (1251)
...+.....+ .+.+...+.++..++.+||..||++||+|.++.+.++.+......
T Consensus 372 --------~~kI~~~~~r--~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 372 --------KAKIVKNGYR--MPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA 426 (474)
T ss_pred --------HHHHHhcCcc--CCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence 1111111111 122234567789999999999999999999999999999876554
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=320.12 Aligned_cols=264 Identities=23% Similarity=0.322 Sum_probs=203.3
Q ss_pred cCCCcCceecccCCceEEEE-EecCCcEEEEEEeccCCc-hhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEE
Q 000859 946 NNLSDEFIIGSGGSGTVYKA-ELANGATVAVKKISCKDD-HLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLI 1023 (1251)
Q Consensus 946 ~~~~~~~~lG~G~fg~V~~~-~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv 1023 (1251)
.+|...+++|+|.||.||+| +..+|+.||||+++.... +.......+|++.++.++|+||+.++++|... ....+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~--~~l~lV 79 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHK--SNLSLV 79 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCC--CceEEE
Confidence 35777889999999999999 567899999999975542 22345678999999999999999999998554 446899
Q ss_pred EeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEccccccc
Q 000859 1024 YEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAK 1103 (1251)
Q Consensus 1024 ~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~ 1103 (1251)
+|||+. +|...++.. ...++..++..++.++++|++|||++ .|+|||+||.|+|++++|.+||+|||+|+
T Consensus 80 fEfm~t-dLe~vIkd~------~i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr 149 (318)
T KOG0659|consen 80 FEFMPT-DLEVVIKDK------NIILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLAR 149 (318)
T ss_pred EEeccc-cHHHHhccc------ccccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchh
Confidence 999975 899999875 46789999999999999999999999 99999999999999999999999999999
Q ss_pred ccccccCCCCcccceeecccceecccccccC-CCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccch
Q 000859 1104 ALVEDYNSNTESNTWFAGSYGYIAPEYAYSL-KATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGS 1182 (1251)
Q Consensus 1104 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 1182 (1251)
.+....... +..+-|..|+|||.+.+. .|+..+||||.||++.||+-|.+-|.+... .+.... .....+.
T Consensus 150 ~f~~p~~~~----~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sD--idQL~~---If~~LGT 220 (318)
T KOG0659|consen 150 FFGSPNRIQ----THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSD--IDQLSK---IFRALGT 220 (318)
T ss_pred ccCCCCccc----ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCch--HHHHHH---HHHHcCC
Confidence 886543322 223679999999988865 599999999999999999999887766532 111111 1111111
Q ss_pred hhh-hh---------hcccCCCCCCc---hHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 000859 1183 ARE-EL---------LDDQMKPLLPG---EECAAYQVLEIALQCTKTSPQERPSSRQVCDL 1230 (1251)
Q Consensus 1183 ~~~-~~---------~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 1230 (1251)
... +| ..-...|..+. -..++.+..+++..++..||.+|+|++|++++
T Consensus 221 P~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 221 PTPDQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred CCcccCccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 111 11 01011111111 12245667899999999999999999999864
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-39 Score=344.02 Aligned_cols=266 Identities=23% Similarity=0.333 Sum_probs=210.3
Q ss_pred hcCCCcCceecccCCceEEEEE-ecCCcEEEEEEeccCCchhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEE
Q 000859 945 TNNLSDEFIIGSGGSGTVYKAE-LANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLI 1023 (1251)
Q Consensus 945 ~~~~~~~~~lG~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv 1023 (1251)
..+|+...+||.|..++||+|+ ...++.||||++..+......+.+.+|+..|+.++||||++++..|.. +...|+|
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv--~~~LWvV 102 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVV--DSELWVV 102 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEe--cceeEEe
Confidence 4568888999999999999994 557899999999877666667889999999999999999999877755 4557999
Q ss_pred EeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEccccccc
Q 000859 1024 YEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAK 1103 (1251)
Q Consensus 1024 ~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~ 1103 (1251)
|.||.+|++.+.++..- ...+.+..+..|.+++++||.|||++ |.||||||+.|||++++|.|||+|||.+.
T Consensus 103 mpfMa~GS~ldIik~~~-----~~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa 174 (516)
T KOG0582|consen 103 MPFMAGGSLLDIIKTYY-----PDGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSA 174 (516)
T ss_pred ehhhcCCcHHHHHHHHc-----cccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeee
Confidence 99999999999998743 45689999999999999999999999 99999999999999999999999999887
Q ss_pred ccccccCCCCcccceeecccceecccccc--cCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccc
Q 000859 1104 ALVEDYNSNTESNTWFAGSYGYIAPEYAY--SLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSG 1181 (1251)
Q Consensus 1104 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 1181 (1251)
.+.........+-..++||+.|||||++. ...|+.|+||||||++..|+.+|..||....+.++-+.......+..
T Consensus 175 ~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~-- 252 (516)
T KOG0582|consen 175 SLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTL-- 252 (516)
T ss_pred eecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCc--
Confidence 66543311111114578999999999955 34699999999999999999999999987755443222211100000
Q ss_pred hhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 000859 1182 SAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDL 1230 (1251)
Q Consensus 1182 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 1230 (1251)
..... ...........+.+++..|+++||.+|||++++++.
T Consensus 253 --~t~~~------~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 253 --LTSGL------DKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred --ccccC------ChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 00000 011122244578999999999999999999999763
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=353.76 Aligned_cols=248 Identities=27% Similarity=0.362 Sum_probs=206.8
Q ss_pred cCCCcCceecccCCceEEEE-EecCCcEEEEEEeccCC-chhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEE
Q 000859 946 NNLSDEFIIGSGGSGTVYKA-ELANGATVAVKKISCKD-DHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLI 1023 (1251)
Q Consensus 946 ~~~~~~~~lG~G~fg~V~~~-~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv 1023 (1251)
++|.+.+.||+|.||.|||| +..+.+.||+|.+.+.. .+.+.+.+.+|++|+++++|||||.++++|.. ....|+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt--~~~~~vV 79 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFET--SAHLWVV 79 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcc--cceEEEE
Confidence 46777788999999999999 45578999999986543 44566778999999999999999999998854 4457999
Q ss_pred EeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEccccccc
Q 000859 1024 YEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAK 1103 (1251)
Q Consensus 1024 ~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~ 1103 (1251)
+||+.| +|..++.. .+.++++.++.++.|++.|+.|||+. +|.|||+||+||+++..|.+|+||||+|+
T Consensus 80 te~a~g-~L~~il~~-------d~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar 148 (808)
T KOG0597|consen 80 TEYAVG-DLFTILEQ-------DGKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLAR 148 (808)
T ss_pred ehhhhh-hHHHHHHh-------ccCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhh
Confidence 999976 99999987 56899999999999999999999999 99999999999999999999999999998
Q ss_pred ccccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccchh
Q 000859 1104 ALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSA 1183 (1251)
Q Consensus 1104 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1183 (1251)
.+.. .....+...||+-|||||.+.+.+|+..+|+||+||++||+++|++||-... ....
T Consensus 149 ~m~~----~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s-----i~~L----------- 208 (808)
T KOG0597|consen 149 AMST----NTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS-----ITQL----------- 208 (808)
T ss_pred hccc----CceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH-----HHHH-----------
Confidence 7643 3444555789999999999999999999999999999999999999996431 1111
Q ss_pred hhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 000859 1184 REELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDL 1230 (1251)
Q Consensus 1184 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 1230 (1251)
.+.+.. .....+......+..++...+.+||.+|.|..+++..
T Consensus 209 v~~I~~----d~v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 209 VKSILK----DPVKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred HHHHhc----CCCCCcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 111111 1222333566788999999999999999999998753
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=369.91 Aligned_cols=269 Identities=27% Similarity=0.414 Sum_probs=209.2
Q ss_pred hcCCCcCceecccCCceEEEEEe------cCCcEEEEEEeccCCchhhhHHHHHHHHHHHhc-cCCCccceeceeeecCC
Q 000859 945 TNNLSDEFIIGSGGSGTVYKAEL------ANGATVAVKKISCKDDHLLNKSFTREVKTLGRI-RHRHLVKLMGHCCNKGA 1017 (1251)
Q Consensus 945 ~~~~~~~~~lG~G~fg~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~ 1017 (1251)
.++|++.++||+|+||.||+|.. .+++.||||++.........+.+.+|+++++++ +||||++++|+|... .
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~-~ 84 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKP-N 84 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCC-C
Confidence 45688899999999999999963 235689999997655555567889999999999 899999999987643 3
Q ss_pred CceeEEEeecCCCChHHhhhcCCCCc------------------------------------------------------
Q 000859 1018 GSNLLIYEYMENGSVWDWLHKQPVNI------------------------------------------------------ 1043 (1251)
Q Consensus 1018 ~~~~lv~E~~~~gsL~~~l~~~~~~~------------------------------------------------------ 1043 (1251)
...++||||+++|+|.+++.......
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 34689999999999999997542100
Q ss_pred -ccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcccccccccccccCCCCcccceeecc
Q 000859 1044 -KMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGS 1122 (1251)
Q Consensus 1044 -~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~gt 1122 (1251)
.....+++.++.+++.||++||+|||++ +|+||||||+||+++.++.+||+|||+++........ .......++
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~--~~~~~~~~~ 239 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY--VRKGSARLP 239 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcch--hcccCCCCC
Confidence 0023588899999999999999999999 9999999999999999999999999999765322111 111223457
Q ss_pred cceecccccccCCCCCccceeehhHHHHHHhh-CCCCCCCccccchhHHHHHHHHHhccchhhhhhhcccCCCCCCchHH
Q 000859 1123 YGYIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMVRWVEMHMEMSGSAREELLDDQMKPLLPGEEC 1201 (1251)
Q Consensus 1123 ~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1201 (1251)
..|+|||++.+..++.++|||||||++|||++ |..||.+....+. ..... .+. ... ..+..
T Consensus 240 ~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~----~~~~~-----------~~~-~~~--~~~~~ 301 (338)
T cd05102 240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE----FCQRL-----------KDG-TRM--RAPEN 301 (338)
T ss_pred ccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH----HHHHH-----------hcC-CCC--CCCCC
Confidence 88999999999999999999999999999997 9999976432211 00000 000 001 11223
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhcCC
Q 000859 1202 AAYQVLEIALQCTKTSPQERPSSRQVCDLLLNVFNN 1237 (1251)
Q Consensus 1202 ~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~ 1237 (1251)
.+.++.+++.+||+.||++|||+.|+++.|+++++.
T Consensus 302 ~~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~~ 337 (338)
T cd05102 302 ATPEIYRIMLACWQGDPKERPTFSALVEILGDLLQE 337 (338)
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 456789999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=362.64 Aligned_cols=367 Identities=25% Similarity=0.234 Sum_probs=212.0
Q ss_pred cccEEEccCCCCCCCcCccccccCcccEEecccccccCCCCcccCCCccccEEEeccCCCCCCCCCcccccccccccccc
Q 000859 96 SLIHLDLSSNSLTGPIPTALSNLSSLESLLLFSNQLAGTIPTQLGSLTSLRVMRIGDNWLSGSIPTSFGNLVNLGTLGLA 175 (1251)
Q Consensus 96 ~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~ 175 (1251)
.-+.||+|+|++...-+.+|.++++|+++++..|.++ .||...+...+|+.|+|.+|.++..-.+++..++.|+.|||+
T Consensus 79 ~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLS 157 (873)
T KOG4194|consen 79 QTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLRHNLISSVTSEELSALPALRSLDLS 157 (873)
T ss_pred ceeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEeeeccccccccHHHHHhHhhhhhhhhh
Confidence 3456777777777766777777777777777777776 666666666667777777777766556666666677777777
Q ss_pred cCCCCCCCCCCcCcccccceeeeccccccCCCCcccCCCCCCceeeccccccCCCchhhhcccccCceeeccCccCCCCC
Q 000859 176 SCSLSGPIPPQFGQLSQLEELILQQNQLQGPIPAELGNCSSLSIFTAAENNLNGSIPAALGRLQNLQLLNLGNNSLSGEI 255 (1251)
Q Consensus 176 ~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 255 (1251)
.|.|+..--++|..-.++++|+|++|+|+..--..|.++.+|..|.|++|+++...+..|.+|+.|+.|+|..|.|.-.-
T Consensus 158 rN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~irive 237 (873)
T KOG4194|consen 158 RNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVE 237 (873)
T ss_pred hchhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCcccccCHHHhhhcchhhhhhccccceeeeh
Confidence 77766555556655556666666666666555555665555555555555555555555555555555555555554222
Q ss_pred CccccCCCccceeeccCccccCcCCcccccCCCccEEEeccccccCCCCCccccccceEEEEccCccccCcccccccccc
Q 000859 256 PSELGELSQLGYLNLMGNRLEGAIPRSFAKMGNLQSLDLSMNRLTGGIPEEFGNMGQLVFLVLSNNNISGSIPRRICTNA 335 (1251)
Q Consensus 256 ~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~i~~~~~~~l 335 (1251)
--.|.++++|+.|.|..|.|...-.+.|..+.++++|+|+.|++...-..++.+ +
T Consensus 238 ~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfg-------------------------L 292 (873)
T KOG4194|consen 238 GLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFG-------------------------L 292 (873)
T ss_pred hhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccc-------------------------c
Confidence 234444555555555555444444444444444444444444444333333333 3
Q ss_pred cchhhhhccchhcccCCCcCccCCCCCceEEccCCcccCCccccccccccccEEEeecccccccccccccccccccEEEe
Q 000859 336 TSLEHLILAEIQLSGEIPVELSQCQSLKQLDLSNNTLNGTIPVELFQLVALTHLYLHNNSLVGSISPFVANLSNLQELAL 415 (1251)
Q Consensus 336 ~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 415 (1251)
++|++|++++|.|....+.....+++|++|+||+|+|+...+.. |..+..|++|+|
T Consensus 293 t~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~s------------------------f~~L~~Le~LnL 348 (873)
T KOG4194|consen 293 TSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGS------------------------FRVLSQLEELNL 348 (873)
T ss_pred chhhhhccchhhhheeecchhhhcccceeEeccccccccCChhH------------------------HHHHHHhhhhcc
Confidence 33333333333333344455555666666666666666444444 444445555555
Q ss_pred cccccCCCCchhhhcccccchhhcccCccccccc---CCcCCCCccceEeccCCcccCCCCCcccccCCCcEEeccCCcc
Q 000859 416 YHNNFQGSLPREIGMLVKLELLYLYDNHLSGQIP---SEVGNCSSLKWIDFFGNSFTGEIPTSIGRLKDLNFLHLRQNEL 492 (1251)
Q Consensus 416 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~---~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l 492 (1251)
++|.++..-...|..+++|++|||++|.|+..+- ..|.++++|+.|++.+|++..+.-.+|.++..|+.|+|.+|-|
T Consensus 349 s~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~Nai 428 (873)
T KOG4194|consen 349 SHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAI 428 (873)
T ss_pred cccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceeeecchhhhccCcccceecCCCCcc
Confidence 5555543333445555555555555555553332 3355566666666666666644445666666667777777766
Q ss_pred CCCcCccccccccCCeeecCC
Q 000859 493 VGQIPASLGNCHQLIILDLAD 513 (1251)
Q Consensus 493 ~~~~p~~l~~l~~L~~L~Ls~ 513 (1251)
..+.|++|..+ .|+.|-+..
T Consensus 429 aSIq~nAFe~m-~Lk~Lv~nS 448 (873)
T KOG4194|consen 429 ASIQPNAFEPM-ELKELVMNS 448 (873)
T ss_pred eeecccccccc-hhhhhhhcc
Confidence 66666666666 666665554
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=356.45 Aligned_cols=256 Identities=24% Similarity=0.382 Sum_probs=218.7
Q ss_pred CCCcCceecccCCceEEEEEecC---Cc--EEEEEEeccCCchhhhHHHHHHHHHHHhccCCCccceeceeeecCCCcee
Q 000859 947 NLSDEFIIGSGGSGTVYKAELAN---GA--TVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNL 1021 (1251)
Q Consensus 947 ~~~~~~~lG~G~fg~V~~~~~~~---~~--~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~ 1021 (1251)
.....++||+|-||.||+|.+.+ |+ .||||+-+.+......+.|.+|+.+|+.++|||||+++|+|.+. ..|
T Consensus 390 ~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~---P~W 466 (974)
T KOG4257|consen 390 LITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ---PMW 466 (974)
T ss_pred hccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc---cee
Confidence 34455689999999999996543 32 58999988777777789999999999999999999999999654 359
Q ss_pred EEEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEccccc
Q 000859 1022 LIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGL 1101 (1251)
Q Consensus 1022 lv~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~ 1101 (1251)
+|||.++.|.|..||+.. ...++......++.||+.||+|||+. ++|||||.++||||.+..-||++|||+
T Consensus 467 ivmEL~~~GELr~yLq~n------k~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGL 537 (974)
T KOG4257|consen 467 IVMELAPLGELREYLQQN------KDSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGL 537 (974)
T ss_pred EEEecccchhHHHHHHhc------cccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccch
Confidence 999999999999999876 46788999999999999999999999 999999999999999999999999999
Q ss_pred ccccccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhh-CCCCCCCccccchhHHHHHHHHHhcc
Q 000859 1102 AKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMVRWVEMHMEMS 1180 (1251)
Q Consensus 1102 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~ 1180 (1251)
++.+..+.+.... ...-+..|||||.+.-++++.+||||.|||.+||++. |..||.+..+.+.-.
T Consensus 538 SR~~ed~~yYkaS---~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~----------- 603 (974)
T KOG4257|consen 538 SRYLEDDAYYKAS---RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIG----------- 603 (974)
T ss_pred hhhccccchhhcc---ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEE-----------
Confidence 9987655444332 2244789999999999999999999999999999998 999998765433210
Q ss_pred chhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhcC
Q 000859 1181 GSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNVFN 1236 (1251)
Q Consensus 1181 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~ 1236 (1251)
.-.-..++|.++.|++.++.+|.+||..||.+||.+.++...|+++++
T Consensus 604 --------~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 604 --------HIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred --------EecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 011224677888899999999999999999999999999999999987
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=349.82 Aligned_cols=251 Identities=28% Similarity=0.408 Sum_probs=210.8
Q ss_pred hcCCCcCceecccCCceEEEE-EecCCcEEEEEEeccCCchhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEE
Q 000859 945 TNNLSDEFIIGSGGSGTVYKA-ELANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLI 1023 (1251)
Q Consensus 945 ~~~~~~~~~lG~G~fg~V~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv 1023 (1251)
...|+..+.||+|.||.||+| +.++++.||+|++.-...+.+.+++.+|+.++..++++||.++||.|... ...+++
T Consensus 12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g--~~Lwii 89 (467)
T KOG0201|consen 12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKG--TKLWII 89 (467)
T ss_pred ccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeec--ccHHHH
Confidence 345777789999999999999 66789999999998888777889999999999999999999999987653 456999
Q ss_pred EeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEccccccc
Q 000859 1024 YEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAK 1103 (1251)
Q Consensus 1024 ~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~ 1103 (1251)
|||+.||++.+.++.. ..+.+.++.-+.+++..|+.|||.+ +.+|||||+.||++..+|.||++|||.+.
T Consensus 90 Mey~~gGsv~~lL~~~-------~~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ 159 (467)
T KOG0201|consen 90 MEYCGGGSVLDLLKSG-------NILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAG 159 (467)
T ss_pred HHHhcCcchhhhhccC-------CCCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceee
Confidence 9999999999999863 3447777788999999999999999 99999999999999999999999999997
Q ss_pred ccccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccchh
Q 000859 1104 ALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSA 1183 (1251)
Q Consensus 1104 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1183 (1251)
.+..+ ......++||+.|||||++.+..|+.|+||||+|++.+||.+|.+|+....+...
T Consensus 160 ql~~~----~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrv---------------- 219 (467)
T KOG0201|consen 160 QLTNT----VKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRV---------------- 219 (467)
T ss_pred eeech----hhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceE----------------
Confidence 66433 2222457999999999999999999999999999999999999999987644211
Q ss_pred hhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 000859 1184 REELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDL 1230 (1251)
Q Consensus 1184 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 1230 (1251)
...+.....|.+.. .+.+.+.+++..|+++||+.||||+++++.
T Consensus 220 -lflIpk~~PP~L~~--~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 220 -LFLIPKSAPPRLDG--DFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred -EEeccCCCCCcccc--ccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 11222223333333 467779999999999999999999999864
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=356.30 Aligned_cols=248 Identities=24% Similarity=0.357 Sum_probs=208.4
Q ss_pred CCCcCceecccCCceEEEE-EecCCcEEEEEEeccCC--chhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEE
Q 000859 947 NLSDEFIIGSGGSGTVYKA-ELANGATVAVKKISCKD--DHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLI 1023 (1251)
Q Consensus 947 ~~~~~~~lG~G~fg~V~~~-~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv 1023 (1251)
-|...+.||.|+.|.|..| +..+|+.+|||++.+.. .......+.+|+.||+-+.||||+++|+++.. ....|+|
T Consensus 13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~--~~~lylv 90 (786)
T KOG0588|consen 13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWEN--KQHLYLV 90 (786)
T ss_pred ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeecc--CceEEEE
Confidence 4667778999999999999 45689999999997552 33345678899999999999999999998854 4557999
Q ss_pred EeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEccccccc
Q 000859 1024 YEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAK 1103 (1251)
Q Consensus 1024 ~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~ 1103 (1251)
.||+++|-|.+|+.+ ++.+++.++.++++||+.|+.|+|.. +|+|||+||+|+|+|..+.+||+|||+|.
T Consensus 91 lEyv~gGELFdylv~-------kG~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAs 160 (786)
T KOG0588|consen 91 LEYVPGGELFDYLVR-------KGPLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMAS 160 (786)
T ss_pred EEecCCchhHHHHHh-------hCCCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceee
Confidence 999999999999987 47899999999999999999999999 99999999999999999999999999996
Q ss_pred ccccccCCCCcccceeecccceecccccccCCCC-CccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccch
Q 000859 1104 ALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKAT-EKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGS 1182 (1251)
Q Consensus 1104 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 1182 (1251)
.-. ....-...+|+++|.|||++++.+|+ .++||||.|||+|.++||+.||++. ....
T Consensus 161 Le~-----~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDd-----Nir~----------- 219 (786)
T KOG0588|consen 161 LEV-----PGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDD-----NIRV----------- 219 (786)
T ss_pred ccc-----CCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCc-----cHHH-----------
Confidence 532 22233346899999999999999985 6899999999999999999999844 1111
Q ss_pred hhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 000859 1183 AREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLL 1231 (1251)
Q Consensus 1183 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L 1231 (1251)
++....++.+.++...+.+.++++.+|+..||++|.|++||.++-
T Consensus 220 ----LLlKV~~G~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP 264 (786)
T KOG0588|consen 220 ----LLLKVQRGVFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHP 264 (786)
T ss_pred ----HHHHHHcCcccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCc
Confidence 111222244556667788899999999999999999999998864
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=346.71 Aligned_cols=251 Identities=24% Similarity=0.298 Sum_probs=202.1
Q ss_pred hhcCCCcCceecccCCceEEEEE-ecCCcEEEEEEeccCC--chhhhHHHHHHHHHHHhccCCCccceeceeeecCCCce
Q 000859 944 ATNNLSDEFIIGSGGSGTVYKAE-LANGATVAVKKISCKD--DHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSN 1020 (1251)
Q Consensus 944 ~~~~~~~~~~lG~G~fg~V~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~ 1020 (1251)
..++|+...+||+|+||.||.|+ ..+|..+|+|++++.. .....+.+..|-.+|...++|.||++|-.| ++....
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsF--QD~~~L 216 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSF--QDKEYL 216 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEe--cCCCee
Confidence 56789999999999999999995 4579999999997654 223456778899999999999999998766 446678
Q ss_pred eEEEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcccc
Q 000859 1021 LLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFG 1100 (1251)
Q Consensus 1021 ~lv~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG 1100 (1251)
|+||||++|||+..+|.+ .+.++++.++.++.+++.||+.+|+. |||||||||+|+|||..|++||+|||
T Consensus 217 YLiMEylPGGD~mTLL~~-------~~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFG 286 (550)
T KOG0605|consen 217 YLIMEYLPGGDMMTLLMR-------KDTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFG 286 (550)
T ss_pred EEEEEecCCccHHHHHHh-------cCcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeecccc
Confidence 999999999999999987 46899999999999999999999999 99999999999999999999999999
Q ss_pred cccccccccC-------------------CCCc-----cc-------------------ceeecccceecccccccCCCC
Q 000859 1101 LAKALVEDYN-------------------SNTE-----SN-------------------TWFAGSYGYIAPEYAYSLKAT 1137 (1251)
Q Consensus 1101 ~a~~~~~~~~-------------------~~~~-----~~-------------------~~~~gt~~y~aPE~~~~~~~~ 1137 (1251)
++..+..... .... .. ...+|||.|||||++.+..|+
T Consensus 287 Ls~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~ 366 (550)
T KOG0605|consen 287 LSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYG 366 (550)
T ss_pred ccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCC
Confidence 9865432000 0000 00 015899999999999999999
Q ss_pred CccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccchhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccC
Q 000859 1138 EKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTS 1217 (1251)
Q Consensus 1138 ~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 1217 (1251)
..+|+||+|||+|||+.|.+||.+..+.+....- ..|+..+ .+|......++..++|.+|+. |
T Consensus 367 ~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI---------~nwr~~l-------~fP~~~~~s~eA~DLI~rll~-d 429 (550)
T KOG0605|consen 367 KECDWWSLGCIMYEMLVGYPPFCSETPQETYRKI---------VNWRETL-------KFPEEVDLSDEAKDLITRLLC-D 429 (550)
T ss_pred ccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---------HHHhhhc-------cCCCcCcccHHHHHHHHHHhc-C
Confidence 9999999999999999999999887665432110 1111111 123333445778899999999 9
Q ss_pred CCCCCC
Q 000859 1218 PQERPS 1223 (1251)
Q Consensus 1218 P~~RPs 1223 (1251)
|++|--
T Consensus 430 ~~~RLG 435 (550)
T KOG0605|consen 430 PENRLG 435 (550)
T ss_pred HHHhcC
Confidence 999976
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=356.30 Aligned_cols=249 Identities=26% Similarity=0.374 Sum_probs=203.0
Q ss_pred hhcCCCcCceecccCCceEEEE-EecCCcEEEEEEeccCC----chhhhHHHHHHHHHHHhcc-CCCccceeceeeecCC
Q 000859 944 ATNNLSDEFIIGSGGSGTVYKA-ELANGATVAVKKISCKD----DHLLNKSFTREVKTLGRIR-HRHLVKLMGHCCNKGA 1017 (1251)
Q Consensus 944 ~~~~~~~~~~lG~G~fg~V~~~-~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~ 1017 (1251)
....|...+.||+|+||+|+.| ...+++.||||++..+. .....+.+.+|+.++++++ ||||++++.++...
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~-- 92 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATP-- 92 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecC--
Confidence 4567888999999999999999 45678999999775531 1133456778999999998 99999999988654
Q ss_pred CceeEEEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCC-CCeEE
Q 000859 1018 GSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSN-MEAHL 1096 (1251)
Q Consensus 1018 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~-~~~kl 1096 (1251)
...++||||+.+|+|.+++.+ .+.+.+.++++++.|++.|++|+|++ +|+||||||+||+++.+ +.+||
T Consensus 93 ~~~~ivmEy~~gGdL~~~i~~-------~g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl 162 (370)
T KOG0583|consen 93 TKIYIVMEYCSGGDLFDYIVN-------KGRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKL 162 (370)
T ss_pred CeEEEEEEecCCccHHHHHHH-------cCCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEE
Confidence 448999999999999999987 46788899999999999999999999 99999999999999999 99999
Q ss_pred cccccccccccccCCCCcccceeecccceecccccccCC-CC-CccceeehhHHHHHHhhCCCCCCCccccchhHHHHHH
Q 000859 1097 GDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLK-AT-EKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVE 1174 (1251)
Q Consensus 1097 ~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~ 1174 (1251)
+|||++.... .........+||+.|+|||++.+.. |+ .++||||+||++|.|++|+.||++.........
T Consensus 163 ~DFG~s~~~~----~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~k---- 234 (370)
T KOG0583|consen 163 SDFGLSAISP----GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRK---- 234 (370)
T ss_pred eccccccccC----CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHH----
Confidence 9999997652 1222333468999999999999877 75 789999999999999999999987422111000
Q ss_pred HHHhccchhhhhhhcccCCCCCCchHHH-HHHHHHHHHHccccCCCCCCCHHHHH
Q 000859 1175 MHMEMSGSAREELLDDQMKPLLPGEECA-AYQVLEIALQCTKTSPQERPSSRQVC 1228 (1251)
Q Consensus 1175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~li~~cl~~dP~~RPs~~eil 1228 (1251)
.....+..+... +.++..++.+|+..||.+|+|+.+|+
T Consensus 235 ----------------i~~~~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 235 ----------------IRKGEFKIPSYLLSPEARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred ----------------HhcCCccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 111122222223 67789999999999999999999998
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=321.43 Aligned_cols=237 Identities=22% Similarity=0.338 Sum_probs=198.4
Q ss_pred cCCCcCceecccCCceEEEEEe-cCCcEEEEEEeccCC--chhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeE
Q 000859 946 NNLSDEFIIGSGGSGTVYKAEL-ANGATVAVKKISCKD--DHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLL 1022 (1251)
Q Consensus 946 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~l 1022 (1251)
.+|+..+.||.|+||+|..++. .+|..+|+|++.... .....+....|..+++.+.||.++++++.|.+ ....++
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d--~~~lym 121 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKD--NSNLYM 121 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeecc--CCeEEE
Confidence 4588888999999999999954 568999999997554 33345667789999999999999999987744 556799
Q ss_pred EEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcccccc
Q 000859 1023 IYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLA 1102 (1251)
Q Consensus 1023 v~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a 1102 (1251)
||||++||.|..++++ .+++++..++-+|.||+.|++|||+. +|++||+||+|||+|++|.+||+|||+|
T Consensus 122 vmeyv~GGElFS~Lrk-------~~rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFA 191 (355)
T KOG0616|consen 122 VMEYVPGGELFSYLRK-------SGRFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFA 191 (355)
T ss_pred EEeccCCccHHHHHHh-------cCCCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccce
Confidence 9999999999999998 46799999999999999999999999 9999999999999999999999999999
Q ss_pred cccccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccch
Q 000859 1103 KALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGS 1182 (1251)
Q Consensus 1103 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 1182 (1251)
+.+.. ..-..+||+.|+|||++....|..++|.|||||++|||+.|.+||.+..+..+
T Consensus 192 K~v~~-------rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~i--------------- 249 (355)
T KOG0616|consen 192 KRVSG-------RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQI--------------- 249 (355)
T ss_pred EEecC-------cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHH---------------
Confidence 87532 12237899999999999999999999999999999999999999986644211
Q ss_pred hhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCC
Q 000859 1183 AREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQER 1221 (1251)
Q Consensus 1183 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R 1221 (1251)
.+.++. ..+..+.....++.+++...++.|-.+|
T Consensus 250 -Y~KI~~----~~v~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 250 -YEKILE----GKVKFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred -HHHHHh----CcccCCcccCHHHHHHHHHHHhhhhHhh
Confidence 111111 2233344456678899999999999999
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=381.49 Aligned_cols=480 Identities=30% Similarity=0.369 Sum_probs=396.3
Q ss_pred ccCccccCcccccccccccchhhhhccchhcccCCCcCccCCCCCceEEccCCcccCCccccccccccccEEEeeccccc
Q 000859 318 LSNNNISGSIPRRICTNATSLEHLILAEIQLSGEIPVELSQCQSLKQLDLSNNTLNGTIPVELFQLVALTHLYLHNNSLV 397 (1251)
Q Consensus 318 Ls~N~l~~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~ 397 (1251)
.++..+. .||..++..-. +.+|++..|-+....-+.....-+|+.|||++|++. ..|..+..+.+|+.|+++.|.|.
T Consensus 5 ~s~~~l~-~ip~~i~~~~~-~~~ln~~~N~~l~~pl~~~~~~v~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i~ 81 (1081)
T KOG0618|consen 5 ASDEQLE-LIPEQILNNEA-LQILNLRRNSLLSRPLEFVEKRVKLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYIR 81 (1081)
T ss_pred cccccCc-ccchhhccHHH-HHhhhccccccccCchHHhhheeeeEEeeccccccc-cCCchhhhHHHHhhcccchhhHh
Confidence 3333333 44444443333 555555555544322223344555999999999998 89999999999999999999998
Q ss_pred ccccccccccccccEEEecccccCCCCchhhhcccccchhhcccCcccccccCCcCCCCccceEeccCCcccCCCCCccc
Q 000859 398 GSISPFVANLSNLQELALYHNNFQGSLPREIGMLVKLELLYLYDNHLSGQIPSEVGNCSSLKWIDFFGNSFTGEIPTSIG 477 (1251)
Q Consensus 398 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~ 477 (1251)
..|....++.+|++|.|.+|+++ ..|..+..+.+|++|+++.|++. .+|..+..++.+.++..++|..... ++
T Consensus 82 -~vp~s~~~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS~N~f~-~~Pl~i~~lt~~~~~~~s~N~~~~~----lg 154 (1081)
T KOG0618|consen 82 -SVPSSCSNMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDLSFNHFG-PIPLVIEVLTAEEELAASNNEKIQR----LG 154 (1081)
T ss_pred -hCchhhhhhhcchhheeccchhh-cCchhHHhhhcccccccchhccC-CCchhHHhhhHHHHHhhhcchhhhh----hc
Confidence 45678889999999999999998 88999999999999999999998 8899999999999999999933212 23
Q ss_pred ccCCCcEEeccCCccCCCcCccccccccCCeeecCCCcCcccCCcchhccchhhhhhccCCccccCCchhhhhhcCCCee
Q 000859 478 RLKDLNFLHLRQNELVGQIPASLGNCHQLIILDLADNKLSGGVPASFGFLQALEQLMLYNNSLEGNLPGSLINLRNLTRI 557 (1251)
Q Consensus 478 ~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L 557 (1251)
... ++.+++..|.+.+.++..+..++. .|||.+|.+. -..+..+.+|+.|+...|++.... ...++|+.|
T Consensus 155 ~~~-ik~~~l~~n~l~~~~~~~i~~l~~--~ldLr~N~~~---~~dls~~~~l~~l~c~rn~ls~l~----~~g~~l~~L 224 (1081)
T KOG0618|consen 155 QTS-IKKLDLRLNVLGGSFLIDIYNLTH--QLDLRYNEME---VLDLSNLANLEVLHCERNQLSELE----ISGPSLTAL 224 (1081)
T ss_pred ccc-chhhhhhhhhcccchhcchhhhhe--eeecccchhh---hhhhhhccchhhhhhhhcccceEE----ecCcchhee
Confidence 332 888999999999999988888877 8999999987 235778899999999999998432 245789999
Q ss_pred ecccccccccccccccCccceeeecccCccccCCCCCCCCcccCceeecccCccccccCcccccccccceEEccCCcccC
Q 000859 558 NFSKNRLNGRIATLCSSHSFLSFDVTNNEFDHEIPPQLGNSPSLERLRLGNNKFIGKIPWTFGKIRELSLLDLSGNSLTG 637 (1251)
Q Consensus 558 ~l~~N~l~~~~~~l~~~~~l~~l~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 637 (1251)
+.++|.+.. ...-+....++++++++|+++ .+|+|++.+++|+.+...+|+++ .+|..+...++|+.|++..|.++
T Consensus 225 ~a~~n~l~~-~~~~p~p~nl~~~dis~n~l~-~lp~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~- 300 (1081)
T KOG0618|consen 225 YADHNPLTT-LDVHPVPLNLQYLDISHNNLS-NLPEWIGACANLEALNANHNRLV-ALPLRISRITSLVSLSAAYNELE- 300 (1081)
T ss_pred eeccCccee-eccccccccceeeecchhhhh-cchHHHHhcccceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhhh-
Confidence 999999983 233345667899999999998 67799999999999999999996 78889999999999999999998
Q ss_pred CCCccccccCCccEEEcCCCccCCCCccccCCCcc-cccccccCccccCCCcc-ccccccccceeeccCcccccccCccc
Q 000859 638 PIPTQLLMCKKLSHIDLNNNLLSGAVPSWLGTLPQ-LGELKLSFNQFVGFLPR-ELFNCSKLLVLSLDGNMLNGSLPNEV 715 (1251)
Q Consensus 638 ~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~-L~~L~l~~N~l~~~~p~-~~~~l~~L~~L~L~~N~l~~~~p~~~ 715 (1251)
-+|+.....+.|++|+|..|.|...++..+..+.. |+.|+.+.|++.. .|. .=...+.|+.|++.+|.|+...-..+
T Consensus 301 yip~~le~~~sL~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~-lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l 379 (1081)
T KOG0618|consen 301 YIPPFLEGLKSLRTLDLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLST-LPSYEENNHAALQELYLANNHLTDSCFPVL 379 (1081)
T ss_pred hCCCcccccceeeeeeehhccccccchHHHhhhhHHHHHHhhhhccccc-cccccchhhHHHHHHHHhcCcccccchhhh
Confidence 68888888999999999999999665555555554 8999999999886 452 22346789999999999998887889
Q ss_pred CCCCCCceeccCCCcCCCCCCcccccccccceeeccCcccccccchhhhchhhHHHHHhccCCcccCCCCCCcCcccccc
Q 000859 716 GNLASLNVLTLSGNLLSGPIPPAIGRLSKLYELRLSNNSLNGVIPLEIGQLQNLQSILDLSHNNFTGQIPPSMGTLAKLE 795 (1251)
Q Consensus 716 ~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~l~~N~l~~~~p~~~~~l~~L~ 795 (1251)
.+...|++|+|++|+|.......+.++..|++|+||+|+|+ .+|.++..+..|+ +|..-+|++. .+| ++..+++|+
T Consensus 380 ~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~-tL~ahsN~l~-~fP-e~~~l~qL~ 455 (1081)
T KOG0618|consen 380 VNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLH-TLRAHSNQLL-SFP-ELAQLPQLK 455 (1081)
T ss_pred ccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhH-HHhhcCCcee-ech-hhhhcCcce
Confidence 99999999999999998544456789999999999999998 6899999999996 5999999999 788 789999999
Q ss_pred EEEccCCcccc-CCchhhhhccCCCcEeecccc
Q 000859 796 VLNLSHNQLVG-ELPSQLGEMSSLGKLNLSYND 827 (1251)
Q Consensus 796 ~L~l~~N~l~~-~~p~~l~~l~~L~~L~l~~N~ 827 (1251)
++|+|.|+|+- .+|..+.. ++|+.|||++|.
T Consensus 456 ~lDlS~N~L~~~~l~~~~p~-p~LkyLdlSGN~ 487 (1081)
T KOG0618|consen 456 VLDLSCNNLSEVTLPEALPS-PNLKYLDLSGNT 487 (1081)
T ss_pred EEecccchhhhhhhhhhCCC-cccceeeccCCc
Confidence 99999999985 45554443 899999999998
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=357.69 Aligned_cols=256 Identities=25% Similarity=0.406 Sum_probs=216.0
Q ss_pred CCcCceecccCCceEEEEEec-CC----cEEEEEEeccCCchhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeE
Q 000859 948 LSDEFIIGSGGSGTVYKAELA-NG----ATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLL 1022 (1251)
Q Consensus 948 ~~~~~~lG~G~fg~V~~~~~~-~~----~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~l 1022 (1251)
....++||+|+||+||+|.|- .| -+||||++.........+++.+|+-+|.+++|||+++++|+|.... ..+
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~---~ql 774 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST---LQL 774 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch---HHH
Confidence 445678999999999999663 33 4799999988877778899999999999999999999999997654 569
Q ss_pred EEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcccccc
Q 000859 1023 IYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLA 1102 (1251)
Q Consensus 1023 v~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a 1102 (1251)
|++||+.|+|.+|++.+ +..+.....+.+..|||+||.|||++ ++|||||.++||||.+...+||.|||+|
T Consensus 775 vtq~mP~G~LlDyvr~h------r~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla 845 (1177)
T KOG1025|consen 775 VTQLMPLGCLLDYVREH------RDNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLA 845 (1177)
T ss_pred HHHhcccchHHHHHHHh------hccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchh
Confidence 99999999999999986 46778889999999999999999999 9999999999999999999999999999
Q ss_pred cccccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhh-CCCCCCCccccchhHHHHHHHHHhccc
Q 000859 1103 KALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMVRWVEMHMEMSG 1181 (1251)
Q Consensus 1103 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 1181 (1251)
+....+...... ....-.+.|||-|.++.+.|+.++|||||||++||++| |..||++....++..
T Consensus 846 ~ll~~d~~ey~~--~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~d------------ 911 (1177)
T KOG1025|consen 846 KLLAPDEKEYSA--PGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPD------------ 911 (1177)
T ss_pred hccCcccccccc--cccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhH------------
Confidence 887654332221 12234688999999999999999999999999999999 999998774443311
Q ss_pred hhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhcC
Q 000859 1182 SAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNVFN 1236 (1251)
Q Consensus 1182 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~ 1236 (1251)
.+.. ..+++.+..++.+++.+|.+||..|+..||+|+++...+.++-+
T Consensus 912 -----lle~--geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ar 959 (1177)
T KOG1025|consen 912 -----LLEK--GERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMAR 959 (1177)
T ss_pred -----HHhc--cccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhc
Confidence 1111 12366777788899999999999999999999999999988764
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-37 Score=344.19 Aligned_cols=249 Identities=22% Similarity=0.304 Sum_probs=200.7
Q ss_pred ceecccCCceEEEEEecCCcEEEEEEeccCCc--hhhhHHHHHHHHHHHhccCCCccceeceeee--cCCCceeEEEeec
Q 000859 952 FIIGSGGSGTVYKAELANGATVAVKKISCKDD--HLLNKSFTREVKTLGRIRHRHLVKLMGHCCN--KGAGSNLLIYEYM 1027 (1251)
Q Consensus 952 ~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~~~~~lv~E~~ 1027 (1251)
..||+|++|.||+|.+ +|+.||||++..... ....+.+.+|++++++++|||||+++|++.+ ......++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 5799999999999988 589999999965432 2234678899999999999999999999876 4445678999999
Q ss_pred CCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEccccccccccc
Q 000859 1028 ENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVE 1107 (1251)
Q Consensus 1028 ~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~ 1107 (1251)
++|+|.+++++. +.+++....+++.|++.|++|||+.. +++||||||+||++++++.+||+|||+++....
T Consensus 105 ~~g~L~~~l~~~-------~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~ 175 (283)
T PHA02988 105 TRGYLREVLDKE-------KDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKILSS 175 (283)
T ss_pred CCCcHHHHHhhC-------CCCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhhcc
Confidence 999999999763 46889999999999999999999732 788999999999999999999999999876432
Q ss_pred ccCCCCcccceeecccceeccccccc--CCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccchhhh
Q 000859 1108 DYNSNTESNTWFAGSYGYIAPEYAYS--LKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSARE 1185 (1251)
Q Consensus 1108 ~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1185 (1251)
.. ....|+..|+|||.+.+ ..++.++|||||||++|||++|+.||.+....+ ....
T Consensus 176 ~~-------~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~-----~~~~---------- 233 (283)
T PHA02988 176 PP-------FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKE-----IYDL---------- 233 (283)
T ss_pred cc-------ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHH-----HHHH----------
Confidence 11 12367899999999876 679999999999999999999999997653211 1111
Q ss_pred hhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhc
Q 000859 1186 ELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNVF 1235 (1251)
Q Consensus 1186 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~ 1235 (1251)
......+... +..++.++.+++.+||+.||++|||++|+++.|+++.
T Consensus 234 -i~~~~~~~~~--~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 234 -IINKNNSLKL--PLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred -HHhcCCCCCC--CCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 1011111111 2235667999999999999999999999999998875
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=330.39 Aligned_cols=266 Identities=24% Similarity=0.321 Sum_probs=199.6
Q ss_pred cCCCcCceecccCCceEEEEEec-CCcEEEEEEeccCCchhhhHHHHHHHHHHHhccCCCccceeceeeecCCC---cee
Q 000859 946 NNLSDEFIIGSGGSGTVYKAELA-NGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAG---SNL 1021 (1251)
Q Consensus 946 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~---~~~ 1021 (1251)
-.|...+++|.|+||.||+|... +++.||||++..+... -.+|+++|+.++|||||++.-+|....+. ...
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~-----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ln 98 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY-----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLN 98 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc-----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHH
Confidence 34667789999999999999654 5789999998654432 24799999999999999999888766554 446
Q ss_pred EEEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCC-CCeEEcccc
Q 000859 1022 LIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSN-MEAHLGDFG 1100 (1251)
Q Consensus 1022 lv~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~-~~~kl~DfG 1100 (1251)
+|||||+. +|+++++... .....++.-.++-+.+||.+|++|||+. +|+||||||.|+|+|.+ |.+||||||
T Consensus 99 lVleymP~-tL~~~~r~~~---~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFG 171 (364)
T KOG0658|consen 99 LVLEYMPE-TLYRVIRHYT---RANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFG 171 (364)
T ss_pred HHHHhchH-HHHHHHHHHh---hcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCC
Confidence 89999986 9999998421 1235677778888999999999999998 99999999999999976 999999999
Q ss_pred cccccccccCCCCcccceeecccceecccccccC-CCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhc
Q 000859 1101 LAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSL-KATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEM 1179 (1251)
Q Consensus 1101 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 1179 (1251)
.|+.+.... +...+..|..|+|||.+.+. .|+.+.||||.|||+.||+-|++-|.+... ...+...++.....
T Consensus 172 SAK~L~~~e-----pniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~-~dQL~eIik~lG~P 245 (364)
T KOG0658|consen 172 SAKVLVKGE-----PNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSS-VDQLVEIIKVLGTP 245 (364)
T ss_pred cceeeccCC-----CceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCH-HHHHHHHHHHhCCC
Confidence 999875432 23446779999999988865 699999999999999999999999987533 22333333322221
Q ss_pred cchhhhhhhcc-------cCCCCCC---chHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 000859 1180 SGSAREELLDD-------QMKPLLP---GEECAAYQVLEIALQCTKTSPQERPSSRQVCD 1229 (1251)
Q Consensus 1180 ~~~~~~~~~~~-------~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1229 (1251)
..+....+-.. ..++..- .....+++..+++.++++.+|.+|.++.|++.
T Consensus 246 t~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 246 TREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred CHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 11111111111 0110000 11225577899999999999999999999874
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=357.15 Aligned_cols=366 Identities=28% Similarity=0.437 Sum_probs=331.2
Q ss_pred CCCccceEeccCCccc-CCCCCcccccCCCcEEeccCCccCCCcCccccccccCCeeecCCCcCcccCCcchhccchhhh
Q 000859 454 NCSSLKWIDFFGNSFT-GEIPTSIGRLKDLNFLHLRQNELVGQIPASLGNCHQLIILDLADNKLSGGVPASFGFLQALEQ 532 (1251)
Q Consensus 454 ~l~~L~~L~l~~N~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 532 (1251)
-++-.+-+|+++|.|+ +..|.....++++++|.|...++. .+|+.++.|.+|+.|.+++|++. .+-+.+..|+.|+.
T Consensus 5 VLpFVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRs 82 (1255)
T KOG0444|consen 5 VLPFVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRS 82 (1255)
T ss_pred ccceeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHH
Confidence 3556677899999998 578999999999999999999998 78999999999999999999998 56677889999999
Q ss_pred hhccCCcccc-CCchhhhhhcCCCeeecccccccccccccccCccceeeecccCccccCCCCCC-CCcccCceeecccCc
Q 000859 533 LMLYNNSLEG-NLPGSLINLRNLTRINFSKNRLNGRIATLCSSHSFLSFDVTNNEFDHEIPPQL-GNSPSLERLRLGNNK 610 (1251)
Q Consensus 533 L~L~~N~l~~-~~~~~l~~l~~L~~L~l~~N~l~~~~~~l~~~~~l~~l~l~~n~l~~~~p~~l-~~l~~L~~L~L~~N~ 610 (1251)
+.+.+|++.. -+|..+..+..|+.||||+|+++..|..+-..+++..|++|+|+|. .||..+ -++..|-.|+||+|+
T Consensus 83 v~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~EvP~~LE~AKn~iVLNLS~N~Ie-tIPn~lfinLtDLLfLDLS~Nr 161 (1255)
T KOG0444|consen 83 VIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLREVPTNLEYAKNSIVLNLSYNNIE-TIPNSLFINLTDLLFLDLSNNR 161 (1255)
T ss_pred HhhhccccccCCCCchhcccccceeeecchhhhhhcchhhhhhcCcEEEEcccCccc-cCCchHHHhhHhHhhhccccch
Confidence 9999999853 4677888999999999999999999999999999999999999997 566554 589999999999999
Q ss_pred cccccCcccccccccceEEccCCcccCCCCccccccCCccEEEcCCCccC-CCCccccCCCcccccccccCccccCCCcc
Q 000859 611 FIGKIPWTFGKIRELSLLDLSGNSLTGPIPTQLLMCKKLSHIDLNNNLLS-GAVPSWLGTLPQLGELKLSFNQFVGFLPR 689 (1251)
Q Consensus 611 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~-~~~~~~~~~l~~L~~L~l~~N~l~~~~p~ 689 (1251)
+. .+|..+.++..|++|+||+|.+....-.++..+++|++|.+++.+-+ .-+|..+..|.+|+.+|||.|.+.- .|.
T Consensus 162 Le-~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp~-vPe 239 (1255)
T KOG0444|consen 162 LE-MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLPI-VPE 239 (1255)
T ss_pred hh-hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCCc-chH
Confidence 98 57778899999999999999998666677888999999999986644 5689999999999999999999984 799
Q ss_pred ccccccccceeeccCcccccccCcccCCCCCCceeccCCCcCCCCCCcccccccccceeeccCccccc-ccchhhhchhh
Q 000859 690 ELFNCSKLLVLSLDGNMLNGSLPNEVGNLASLNVLTLSGNLLSGPIPPAIGRLSKLYELRLSNNSLNG-VIPLEIGQLQN 768 (1251)
Q Consensus 690 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~-~~p~~~~~l~~ 768 (1251)
++.++.+|+.|+|++|+|+ .+....+...+|++|++|.|+++ .+|+++++|++|+.|++.+|+|+- -+|..||+|.+
T Consensus 240 cly~l~~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~ 317 (1255)
T KOG0444|consen 240 CLYKLRNLRRLNLSGNKIT-ELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQ 317 (1255)
T ss_pred HHhhhhhhheeccCcCcee-eeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccccCCccchhhhhh
Confidence 9999999999999999999 77777888899999999999999 899999999999999999999962 38999999999
Q ss_pred HHHHHhccCCcccCCCCCCcCccccccEEEccCCccccCCchhhhhccCCCcEeeccccCc
Q 000859 769 LQSILDLSHNNFTGQIPPSMGTLAKLEVLNLSHNQLVGELPSQLGEMSSLGKLNLSYNDLQ 829 (1251)
Q Consensus 769 l~~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~ 829 (1251)
|+ ++..++|++. -+|+.+..+..|+.|.|++|+|. .+|+.+.-++.|+.||+..||=-
T Consensus 318 Le-vf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreNpnL 375 (1255)
T KOG0444|consen 318 LE-VFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRENPNL 375 (1255)
T ss_pred hH-HHHhhccccc-cCchhhhhhHHHHHhccccccee-echhhhhhcCCcceeeccCCcCc
Confidence 95 5899999998 89999999999999999999998 89999999999999999999854
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=326.21 Aligned_cols=250 Identities=25% Similarity=0.376 Sum_probs=205.4
Q ss_pred CCCcCceecccCCceEEEE-EecCCcEEEEEEeccCC--chhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEE
Q 000859 947 NLSDEFIIGSGGSGTVYKA-ELANGATVAVKKISCKD--DHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLI 1023 (1251)
Q Consensus 947 ~~~~~~~lG~G~fg~V~~~-~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv 1023 (1251)
+|++.+.||+|.||+|-+| ....|+.||||.+++.. ++...-.+.+|++||..++||||+.+|.+|.. ....++|
T Consensus 54 RyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFEN--kdKIviv 131 (668)
T KOG0611|consen 54 RYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFEN--KDKIVIV 131 (668)
T ss_pred HHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcC--CceEEEE
Confidence 4556668999999999999 55789999999997654 44455567899999999999999999999854 4557999
Q ss_pred EeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEccccccc
Q 000859 1024 YEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAK 1103 (1251)
Q Consensus 1024 ~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~ 1103 (1251)
|||..+|.|++|+.+ ++.+++.+++.+++||+.|+.|+|.+ ++||||+|.+|||+|+++.+||+|||++-
T Consensus 132 MEYaS~GeLYDYiSe-------r~~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSN 201 (668)
T KOG0611|consen 132 MEYASGGELYDYISE-------RGSLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSN 201 (668)
T ss_pred EEecCCccHHHHHHH-------hccccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhh
Confidence 999999999999987 57899999999999999999999999 99999999999999999999999999986
Q ss_pred ccccccCCCCcccceeecccceecccccccCCC-CCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccch
Q 000859 1104 ALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKA-TEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGS 1182 (1251)
Q Consensus 1104 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 1182 (1251)
.+. ....-+.++|++-|.+||++.+.+| +..+|.||+||++|-+..|..||++... ...+.....
T Consensus 202 ly~-----~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh-----k~lvrQIs~---- 267 (668)
T KOG0611|consen 202 LYA-----DKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH-----KRLVRQISR---- 267 (668)
T ss_pred hhc-----cccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH-----HHHHHHhhc----
Confidence 653 3334455899999999999999988 4689999999999999999999997622 222221110
Q ss_pred hhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 000859 1183 AREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNV 1234 (1251)
Q Consensus 1183 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 1234 (1251)
..+..|. .+.+..-+|++|+..+|++|.|+++|....+--
T Consensus 268 ------GaYrEP~------~PSdA~gLIRwmLmVNP~RRATieDiAsHWWvN 307 (668)
T KOG0611|consen 268 ------GAYREPE------TPSDASGLIRWMLMVNPERRATIEDIASHWWVN 307 (668)
T ss_pred ------ccccCCC------CCchHHHHHHHHHhcCcccchhHHHHhhhheee
Confidence 0011111 223355799999999999999999999988643
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=309.28 Aligned_cols=252 Identities=23% Similarity=0.328 Sum_probs=207.3
Q ss_pred hcCCCcCceecccCCceEEEEE-ecCCcEEEEEEeccCC--chhhhHHHHHHHHHHHhccCCCccceeceeeecCCCcee
Q 000859 945 TNNLSDEFIIGSGGSGTVYKAE-LANGATVAVKKISCKD--DHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNL 1021 (1251)
Q Consensus 945 ~~~~~~~~~lG~G~fg~V~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~ 1021 (1251)
.++|+..+.||+|.||.||.|+ .+++-.||+|++.+.. ......++.+|++|-..++||||+++||+|.+. ...|
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~--~riy 98 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDS--KRIY 98 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheecc--ceeE
Confidence 3458899999999999999995 4567889999996543 222446788999999999999999999999654 4579
Q ss_pred EEEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEccccc
Q 000859 1022 LIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGL 1101 (1251)
Q Consensus 1022 lv~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~ 1101 (1251)
+++||.++|.++..|++++ ...+++.....+..|+|.|+.|+|.+ +|+||||||+|+|++..+..||+|||.
T Consensus 99 LilEya~~gel~k~L~~~~-----~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGw 170 (281)
T KOG0580|consen 99 LILEYAPRGELYKDLQEGR-----MKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGW 170 (281)
T ss_pred EEEEecCCchHHHHHHhcc-----cccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCc
Confidence 9999999999999999654 56788889999999999999999999 999999999999999999999999999
Q ss_pred ccccccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccc
Q 000859 1102 AKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSG 1181 (1251)
Q Consensus 1102 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 1181 (1251)
+..- . .......+||..|.|||...+..++..+|+|++|++.||++.|.+||......+. +
T Consensus 171 sV~~-----p-~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~et-Y------------ 231 (281)
T KOG0580|consen 171 SVHA-----P-SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSET-Y------------ 231 (281)
T ss_pred eeec-----C-CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHH-H------------
Confidence 8542 1 2233447999999999999999999999999999999999999999976532111 0
Q ss_pred hhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 000859 1182 SAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLL 1232 (1251)
Q Consensus 1182 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 1232 (1251)
.++.. -....+...+....++|.+|+..+|.+|.+..|+++.-+
T Consensus 232 ---krI~k----~~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpw 275 (281)
T KOG0580|consen 232 ---KRIRK----VDLKFPSTISGGAADLISRLLVKNPIERLALTEVMDHPW 275 (281)
T ss_pred ---HHHHH----ccccCCcccChhHHHHHHHHhccCccccccHHHHhhhHH
Confidence 11111 111122445667889999999999999999999988654
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=317.85 Aligned_cols=266 Identities=20% Similarity=0.296 Sum_probs=206.9
Q ss_pred hcCCCcCceecccCCceEEEE-EecCCcEEEEEEeccCCchh-hhHHHHHHHHHHHhccCCCccceeceeeecCCCceeE
Q 000859 945 TNNLSDEFIIGSGGSGTVYKA-ELANGATVAVKKISCKDDHL-LNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLL 1022 (1251)
Q Consensus 945 ~~~~~~~~~lG~G~fg~V~~~-~~~~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~l 1022 (1251)
.++|+..+.|++|.||.||+| +.++++.||+|+++-..... -.-...+|+.++.+++|||||.+-.+.....-+..|+
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~ 154 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI 154 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence 345778889999999999999 56688999999997544221 1124579999999999999999999888777777899
Q ss_pred EEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcccccc
Q 000859 1023 IYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLA 1102 (1251)
Q Consensus 1023 v~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a 1102 (1251)
|||||+. ||...++.. ...+...++..+..|+++|++|||.. .|+|||+||+|+|+++.|.+||+|||+|
T Consensus 155 VMe~~Eh-DLksl~d~m------~q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLA 224 (419)
T KOG0663|consen 155 VMEYVEH-DLKSLMETM------KQPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLA 224 (419)
T ss_pred eHHHHHh-hHHHHHHhc------cCCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchh
Confidence 9999987 899999875 36789999999999999999999999 9999999999999999999999999999
Q ss_pred cccccccCCCCcccceeecccceecccccccC-CCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccc
Q 000859 1103 KALVEDYNSNTESNTWFAGSYGYIAPEYAYSL-KATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSG 1181 (1251)
Q Consensus 1103 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 1181 (1251)
+.+..+ ....+..+-|..|+|||.+.+. .|+++.|+||+|||+.|++++++-|.+... .+....+-. ..+
T Consensus 225 R~ygsp----~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE--~dQl~~If~---llG 295 (419)
T KOG0663|consen 225 REYGSP----LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSE--IDQLDKIFK---LLG 295 (419)
T ss_pred hhhcCC----cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCch--HHHHHHHHH---HhC
Confidence 988644 3344556789999999998865 599999999999999999999999987633 222221111 111
Q ss_pred hhhhhhhcc------------------cCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 000859 1182 SAREELLDD------------------QMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDL 1230 (1251)
Q Consensus 1182 ~~~~~~~~~------------------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 1230 (1251)
...+.++.. .+++.++... ....-.+++...+..||.+|.||+|.++.
T Consensus 296 tPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~-lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 296 TPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALS-LSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred CCccccCCCccccchhhccccCCCCchhhhhhccccc-cchhHHHHHHHHhccCccccccHHHhhcc
Confidence 111111110 0111121111 33567789999999999999999998753
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=346.44 Aligned_cols=269 Identities=24% Similarity=0.380 Sum_probs=203.4
Q ss_pred cCCCcCceecccCCceEEEEEecC-----------------CcEEEEEEeccCCchhhhHHHHHHHHHHHhccCCCccce
Q 000859 946 NNLSDEFIIGSGGSGTVYKAELAN-----------------GATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKL 1008 (1251)
Q Consensus 946 ~~~~~~~~lG~G~fg~V~~~~~~~-----------------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 1008 (1251)
.+|...+.||+|+||.||+|.+.+ +..||+|++.........+.+.+|++++++++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 468888899999999999996532 336999999765555556789999999999999999999
Q ss_pred eceeeecCCCceeEEEeecCCCChHHhhhcCCCC------------cccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 000859 1009 MGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVN------------IKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKI 1076 (1251)
Q Consensus 1009 ~g~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~------------~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i 1076 (1251)
+|++... ...++||||+++|+|.+++...... ......+++..+.+++.||+.|++|||+. +|
T Consensus 85 ~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i 159 (304)
T cd05096 85 LGVCVDE--DPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NF 159 (304)
T ss_pred EEEEecC--CceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Cc
Confidence 9988654 3469999999999999998654211 11124578899999999999999999999 99
Q ss_pred eecCCCCCCeeecCCCCeEEcccccccccccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhh--
Q 000859 1077 LHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS-- 1154 (1251)
Q Consensus 1077 vH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~t-- 1154 (1251)
+||||||+||+++.++.+||+|||+++.+...... .......++..|+|||++.+..++.++|||||||++|||++
T Consensus 160 vH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~ 237 (304)
T cd05096 160 VHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYY--RIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLC 237 (304)
T ss_pred cccCcchhheEEcCCccEEECCCccceecccCcee--EecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHcc
Confidence 99999999999999999999999999765322111 11122345789999999988899999999999999999987
Q ss_pred CCCCCCCccccchhHHHHHHHHHhccchhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 000859 1155 GKMPTDATFGVEMDMVRWVEMHMEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLN 1233 (1251)
Q Consensus 1155 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 1233 (1251)
+..||......+ .......... ..........+..++..+.+++.+||+.||++|||+++|.+.|++
T Consensus 238 ~~~p~~~~~~~~--~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 238 KEQPYGELTDEQ--VIENAGEFFR----------DQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCCCCCcCCHHH--HHHHHHHHhh----------hccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 567776543221 1111111000 000000000112245678999999999999999999999988863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=345.80 Aligned_cols=252 Identities=25% Similarity=0.409 Sum_probs=209.2
Q ss_pred CcCceecccCCceEEEEEecC--C--cEEEEEEeccCCchhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEEE
Q 000859 949 SDEFIIGSGGSGTVYKAELAN--G--ATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIY 1024 (1251)
Q Consensus 949 ~~~~~lG~G~fg~V~~~~~~~--~--~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv~ 1024 (1251)
...++||+|.||.|++|.|.. | ..||||.++.........+|.+|+.+|.+++|||++++||+..+. ...+||
T Consensus 113 ~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~q---p~mMV~ 189 (1039)
T KOG0199|consen 113 KLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLDQ---PAMMVF 189 (1039)
T ss_pred HHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeeccc---hhhHHh
Confidence 344579999999999998753 3 369999998666555778999999999999999999999988652 357999
Q ss_pred eecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcccccccc
Q 000859 1025 EYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKA 1104 (1251)
Q Consensus 1025 E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~ 1104 (1251)
|.++.|+|.+.|++.. ...+-......++.|||.||.||..+ ++||||+.++|+++-....|||+|||+.+.
T Consensus 190 ELaplGSLldrLrka~-----~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRa 261 (1039)
T KOG0199|consen 190 ELAPLGSLLDRLRKAK-----KAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRA 261 (1039)
T ss_pred hhcccchHHHHHhhcc-----ccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceec
Confidence 9999999999998732 56788899999999999999999999 999999999999999999999999999998
Q ss_pred cccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhh-CCCCCCCccccchhHHHHHHHHHhccchh
Q 000859 1105 LVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMVRWVEMHMEMSGSA 1183 (1251)
Q Consensus 1105 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1183 (1251)
+....... .......-...|+|||.++...++.++|||+|||++|||+| |..||.+..+..+
T Consensus 262 Lg~ned~Y-vm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qI---------------- 324 (1039)
T KOG0199|consen 262 LGENEDMY-VMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQI---------------- 324 (1039)
T ss_pred cCCCCcce-EecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHH----------------
Confidence 76543222 22222345678999999999999999999999999999999 9999976643221
Q ss_pred hhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 000859 1184 REELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLL 1231 (1251)
Q Consensus 1184 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L 1231 (1251)
-+.+| -+..++.++.|+.+++++|+.||...|++||||..|.+.+
T Consensus 325 -L~~iD--~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 325 -LKNID--AGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred -HHhcc--ccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 12222 2245666777999999999999999999999999997444
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=354.42 Aligned_cols=265 Identities=28% Similarity=0.425 Sum_probs=204.8
Q ss_pred hcCCCcCceecccCCceEEEEEe------cCCcEEEEEEeccCCchhhhHHHHHHHHHHHhc-cCCCccceeceeeecCC
Q 000859 945 TNNLSDEFIIGSGGSGTVYKAEL------ANGATVAVKKISCKDDHLLNKSFTREVKTLGRI-RHRHLVKLMGHCCNKGA 1017 (1251)
Q Consensus 945 ~~~~~~~~~lG~G~fg~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~ 1017 (1251)
.++|+..+.||+|+||.||+|.+ .++..||||+++........+.+.+|+++++.+ +|||||+++|+|...
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~-- 111 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVG-- 111 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccC--
Confidence 34588889999999999999953 245689999997555444567889999999999 899999999988654
Q ss_pred CceeEEEeecCCCChHHhhhcCCCCc------------------------------------------------------
Q 000859 1018 GSNLLIYEYMENGSVWDWLHKQPVNI------------------------------------------------------ 1043 (1251)
Q Consensus 1018 ~~~~lv~E~~~~gsL~~~l~~~~~~~------------------------------------------------------ 1043 (1251)
...++||||+++|+|.++++......
T Consensus 112 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (375)
T cd05104 112 GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRS 191 (375)
T ss_pred CcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccc
Confidence 34689999999999999997532100
Q ss_pred --------------ccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEccccccccccccc
Q 000859 1044 --------------KMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDY 1109 (1251)
Q Consensus 1044 --------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 1109 (1251)
.....+++.++.+++.||++|++|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 192 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 268 (375)
T cd05104 192 GSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDS 268 (375)
T ss_pred ceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCcc
Confidence 0123578999999999999999999999 99999999999999999999999999997654322
Q ss_pred CCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhh-CCCCCCCccccchhHHHHHHHHHhccchhhhhhh
Q 000859 1110 NSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMVRWVEMHMEMSGSAREELL 1188 (1251)
Q Consensus 1110 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1188 (1251)
.. .......++..|+|||.+.+..++.++|||||||++|||++ |..||........ ...+.
T Consensus 269 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~-~~~~~--------------- 330 (375)
T cd05104 269 NY--VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSK-FYKMI--------------- 330 (375)
T ss_pred cc--cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHH-HHHHH---------------
Confidence 11 11112345678999999999999999999999999999998 8999875432211 11111
Q ss_pred cccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 000859 1189 DDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNV 1234 (1251)
Q Consensus 1189 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 1234 (1251)
........ +...+.++.+++.+||+.||++|||++||++.|++.
T Consensus 331 ~~~~~~~~--~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 331 KEGYRMLS--PECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred HhCccCCC--CCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 11111111 112345789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=331.15 Aligned_cols=265 Identities=23% Similarity=0.332 Sum_probs=204.6
Q ss_pred HHhhcCCCcCceecccCCceEEEEE-ecCCcEEEEEEeccCCch-------------hhhHHHHHHHHHHHhccCCCccc
Q 000859 942 MGATNNLSDEFIIGSGGSGTVYKAE-LANGATVAVKKISCKDDH-------------LLNKSFTREVKTLGRIRHRHLVK 1007 (1251)
Q Consensus 942 ~~~~~~~~~~~~lG~G~fg~V~~~~-~~~~~~vavK~~~~~~~~-------------~~~~~~~~E~~~l~~l~h~niv~ 1007 (1251)
....++|+..+.||+|.||.|-+|+ ..+++.||||++.+..-. ...+...+|++||++++|||||+
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~ 172 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK 172 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence 3456889999999999999999995 457899999999643211 11257889999999999999999
Q ss_pred eeceeeecCCCceeEEEeecCCCChHHhhhcCCCCcccCCC-CCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCe
Q 000859 1008 LMGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKS-LDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNI 1086 (1251)
Q Consensus 1008 l~g~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~-l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Ni 1086 (1251)
++.+..+......|+|+|||..|.+...=. .+. ++..++++++.+++.||+|||.+ |||||||||+|+
T Consensus 173 LiEvLDDP~s~~~YlVley~s~G~v~w~p~--------d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNL 241 (576)
T KOG0585|consen 173 LIEVLDDPESDKLYLVLEYCSKGEVKWCPP--------DKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNL 241 (576)
T ss_pred EEEeecCcccCceEEEEEeccCCccccCCC--------CcccccHHHHHHHHHHHHHHHHHHHhc---Ceeccccchhhe
Confidence 999887777778999999999886543211 233 89999999999999999999999 999999999999
Q ss_pred eecCCCCeEEcccccccccccccCCC-CcccceeecccceecccccccCC----CCCccceeehhHHHHHHhhCCCCCCC
Q 000859 1087 LLDSNMEAHLGDFGLAKALVEDYNSN-TESNTWFAGSYGYIAPEYAYSLK----ATEKCDVYSMGIVLMELVSGKMPTDA 1161 (1251)
Q Consensus 1087 ll~~~~~~kl~DfG~a~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDiwSlGv~l~el~tg~~p~~~ 1161 (1251)
|++++|+|||+|||.+..+....... ...-...+||+.|+|||...++. .+.+.||||+||++|.++.|+.||-+
T Consensus 242 Ll~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~ 321 (576)
T KOG0585|consen 242 LLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFD 321 (576)
T ss_pred EEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCccc
Confidence 99999999999999997653321111 11112368999999999887632 35689999999999999999999976
Q ss_pred ccccchhHHHHHHHHHhccchhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhc
Q 000859 1162 TFGVEMDMVRWVEMHMEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNVF 1235 (1251)
Q Consensus 1162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~ 1235 (1251)
....+. ..+++.+.+ .+|........+.++|++++.+||++|.+..+|..+.+-.-
T Consensus 322 ~~~~~l----------------~~KIvn~pL--~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~ 377 (576)
T KOG0585|consen 322 DFELEL----------------FDKIVNDPL--EFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTR 377 (576)
T ss_pred chHHHH----------------HHHHhcCcc--cCCCcccccHHHHHHHHHHhhcChhheeehhhheecceecc
Confidence 532211 111222111 12222234567899999999999999999999987765443
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=313.07 Aligned_cols=254 Identities=20% Similarity=0.313 Sum_probs=203.4
Q ss_pred cCCCcCceecccCCceEEEE-EecCCcEEEEEEeccCC-chhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEE
Q 000859 946 NNLSDEFIIGSGGSGTVYKA-ELANGATVAVKKISCKD-DHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLI 1023 (1251)
Q Consensus 946 ~~~~~~~~lG~G~fg~V~~~-~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv 1023 (1251)
+.|+..+.||+|+|+.||++ ...+|+.+|+|++..+. .....+++.+|+.|-+.++|||||++...+.+ ....|+|
T Consensus 11 d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~--~~~~ylv 88 (355)
T KOG0033|consen 11 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE--ESFHYLV 88 (355)
T ss_pred hhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcc--cceeEEE
Confidence 35667778999999999999 56689999999885432 23356788999999999999999999987644 4557999
Q ss_pred EeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCC---CCeEEcccc
Q 000859 1024 YEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSN---MEAHLGDFG 1100 (1251)
Q Consensus 1024 ~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~---~~~kl~DfG 1100 (1251)
+|+|+||+|..-+-. +..+++..+-....||++|++|+|.+ +|||||+||+|+++.+. --+|++|||
T Consensus 89 Fe~m~G~dl~~eIV~-------R~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FG 158 (355)
T KOG0033|consen 89 FDLVTGGELFEDIVA-------REFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFG 158 (355)
T ss_pred EecccchHHHHHHHH-------HHHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccc
Confidence 999999998776644 24567888889999999999999999 99999999999999543 459999999
Q ss_pred cccccccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhcc
Q 000859 1101 LAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMS 1180 (1251)
Q Consensus 1101 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 1180 (1251)
+|..+. ....+.+++||++|||||++...+|+..+|||+.||++|-++.|++||.+..... +
T Consensus 159 vAi~l~-----~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~r--l----------- 220 (355)
T KOG0033|consen 159 LAIEVN-----DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR--L----------- 220 (355)
T ss_pred eEEEeC-----CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHH--H-----------
Confidence 998764 3344556899999999999999999999999999999999999999998642211 1
Q ss_pred chhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 000859 1181 GSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLL 1232 (1251)
Q Consensus 1181 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 1232 (1251)
.+.+......-..+.+....++..+++++|+..||.+|.|+.|.++.=+
T Consensus 221 ---ye~I~~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpW 269 (355)
T KOG0033|consen 221 ---YEQIKAGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPW 269 (355)
T ss_pred ---HHHHhccccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCCch
Confidence 1112222222223344556677889999999999999999999886544
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=322.00 Aligned_cols=269 Identities=25% Similarity=0.344 Sum_probs=206.9
Q ss_pred hhcCCCcCceecccCCceEEEE-EecCCcEEEEEEeccC-CchhhhHHHHHHHHHHHhccCCCccceeceeee---cCCC
Q 000859 944 ATNNLSDEFIIGSGGSGTVYKA-ELANGATVAVKKISCK-DDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCN---KGAG 1018 (1251)
Q Consensus 944 ~~~~~~~~~~lG~G~fg~V~~~-~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~---~~~~ 1018 (1251)
....|...+.||+|+||.|+.| ...+|+.||||++... ......+...+|+++++.++|+||+.+.+.+.. ..-.
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 3445666788999999999999 5668999999999632 344566788899999999999999999998765 2233
Q ss_pred ceeEEEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcc
Q 000859 1019 SNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGD 1098 (1251)
Q Consensus 1019 ~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D 1098 (1251)
..|+|+|+|+ -+|.+.++.+ ..++.+.+..+.+|+++|+.|+|+. +|+|||+||+|++++.+...||+|
T Consensus 100 DvYiV~elMe-tDL~~iik~~-------~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~D 168 (359)
T KOG0660|consen 100 DVYLVFELME-TDLHQIIKSQ-------QDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICD 168 (359)
T ss_pred eeEEehhHHh-hHHHHHHHcC-------ccccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEecc
Confidence 4699999994 5999999873 4599999999999999999999999 999999999999999999999999
Q ss_pred cccccccccccCCCCcccceeecccceecccccc-cCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHH
Q 000859 1099 FGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAY-SLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHM 1177 (1251)
Q Consensus 1099 fG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~ 1177 (1251)
||+|+..... ......+.++.|..|+|||.+. ...|+.+.||||.||++.||++|++-|.+....+ ......
T Consensus 169 FGLAR~~~~~--~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~-----Ql~lI~ 241 (359)
T KOG0660|consen 169 FGLARYLDKF--FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVH-----QLQLIL 241 (359)
T ss_pred ccceeecccc--CcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHH-----HHHHHH
Confidence 9999987544 3344556678899999999764 5679999999999999999999999998763321 111111
Q ss_pred hccch-------------hhhhhhcccCCCCCCch---HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 000859 1178 EMSGS-------------AREELLDDQMKPLLPGE---ECAAYQVLEIALQCTKTSPQERPSSRQVCDL 1230 (1251)
Q Consensus 1178 ~~~~~-------------~~~~~~~~~~~~~~~~~---~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 1230 (1251)
+..+. .+..+..-...+..+.. ....+...+++.+|+..||.+|+|++|+++.
T Consensus 242 ~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 242 ELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred HhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 11111 11111111111222211 1245677899999999999999999999764
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=354.68 Aligned_cols=266 Identities=27% Similarity=0.429 Sum_probs=205.5
Q ss_pred hcCCCcCceecccCCceEEEEEec------CCcEEEEEEeccCCchhhhHHHHHHHHHHHhc-cCCCccceeceeeecCC
Q 000859 945 TNNLSDEFIIGSGGSGTVYKAELA------NGATVAVKKISCKDDHLLNKSFTREVKTLGRI-RHRHLVKLMGHCCNKGA 1017 (1251)
Q Consensus 945 ~~~~~~~~~lG~G~fg~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~ 1017 (1251)
.++|+..+.||+|+||.||+|... ++..||||++.........+.+.+|+++++.+ +|||||+++|+|...
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~-- 114 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHG-- 114 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCC--
Confidence 346888899999999999998532 23579999997665555567788999999999 899999999988654
Q ss_pred CceeEEEeecCCCChHHhhhcCCCC-------------------------------------------------------
Q 000859 1018 GSNLLIYEYMENGSVWDWLHKQPVN------------------------------------------------------- 1042 (1251)
Q Consensus 1018 ~~~~lv~E~~~~gsL~~~l~~~~~~------------------------------------------------------- 1042 (1251)
...++||||+++|+|.++++.....
T Consensus 115 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (374)
T cd05106 115 GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQS 194 (374)
T ss_pred CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccc
Confidence 4569999999999999998653210
Q ss_pred --------cccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcccccccccccccCCCCc
Q 000859 1043 --------IKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTE 1114 (1251)
Q Consensus 1043 --------~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~ 1114 (1251)
......+++.++++++.||++|++|||++ +|+||||||+||++++++.+||+|||+++........ .
T Consensus 195 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~--~ 269 (374)
T cd05106 195 SDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNY--V 269 (374)
T ss_pred ccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcce--e
Confidence 01123578999999999999999999999 9999999999999999999999999999765332111 1
Q ss_pred ccceeecccceecccccccCCCCCccceeehhHHHHHHhh-CCCCCCCccccchhHHHHHHHHHhccchhhhhhhcccCC
Q 000859 1115 SNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMVRWVEMHMEMSGSAREELLDDQMK 1193 (1251)
Q Consensus 1115 ~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1193 (1251)
......++..|+|||++.+..++.++|||||||++|||++ |+.||........ .... ......
T Consensus 270 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~-~~~~---------------~~~~~~ 333 (374)
T cd05106 270 VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK-FYKM---------------VKRGYQ 333 (374)
T ss_pred eccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH-HHHH---------------HHcccC
Confidence 1112235678999999998899999999999999999997 9999975432211 0000 000011
Q ss_pred CCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhc
Q 000859 1194 PLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNVF 1235 (1251)
Q Consensus 1194 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~ 1235 (1251)
... +...+.++.+++.+||+.||++|||+.++++.|++++
T Consensus 334 ~~~--~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 334 MSR--PDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred ccC--CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 111 1123467899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=373.24 Aligned_cols=509 Identities=28% Similarity=0.322 Sum_probs=319.2
Q ss_pred eeccCccCCCCCCccccCCCccceeeccCccccCcCCcccccCCCccEEEeccccccCCCCCccccccceEEEEccCccc
Q 000859 244 LNLGNNSLSGEIPSELGELSQLGYLNLMGNRLEGAIPRSFAKMGNLQSLDLSMNRLTGGIPEEFGNMGQLVFLVLSNNNI 323 (1251)
Q Consensus 244 L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l 323 (1251)
+|+++.++. .+|..+-.-..++.|+++.|-+-...-+...+--+|++|||++|++. ..|..+..+.+|+.|+++.|.|
T Consensus 3 vd~s~~~l~-~ip~~i~~~~~~~~ln~~~N~~l~~pl~~~~~~v~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i 80 (1081)
T KOG0618|consen 3 VDASDEQLE-LIPEQILNNEALQILNLRRNSLLSRPLEFVEKRVKLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYI 80 (1081)
T ss_pred cccccccCc-ccchhhccHHHHHhhhccccccccCchHHhhheeeeEEeeccccccc-cCCchhhhHHHHhhcccchhhH
Confidence 445555554 44444444334666666666554322222333344667777766665 5566666666666666666666
Q ss_pred cCcccccccccccchhhhhccchhcccCCCcCccCCCCCceEEccCCcccCCccccccccccccEEEeeccccccccccc
Q 000859 324 SGSIPRRICTNATSLEHLILAEIQLSGEIPVELSQCQSLKQLDLSNNTLNGTIPVELFQLVALTHLYLHNNSLVGSISPF 403 (1251)
Q Consensus 324 ~~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~ 403 (1251)
. . .|....++.+|++|.|.+|.+. ..|..+..+++|+.|+++.|.+. ..|..
T Consensus 81 ~-~-------------------------vp~s~~~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS~N~f~-~~Pl~ 132 (1081)
T KOG0618|consen 81 R-S-------------------------VPSSCSNMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDLSFNHFG-PIPLV 132 (1081)
T ss_pred h-h-------------------------Cchhhhhhhcchhheeccchhh-cCchhHHhhhcccccccchhccC-CCchh
Confidence 5 2 2334445555555555555555 55555555555666666665555 34455
Q ss_pred ccccccccEEEecccccCCCCchhhhcccccchhhcccCcccccccCCcCCCCccceEeccCCcccCCCCCcccccCCCc
Q 000859 404 VANLSNLQELALYHNNFQGSLPREIGMLVKLELLYLYDNHLSGQIPSEVGNCSSLKWIDFFGNSFTGEIPTSIGRLKDLN 483 (1251)
Q Consensus 404 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~ 483 (1251)
+..++.+..+..++|.... .++... .+.+++..|.+.+.++..+.+++. .|+|.+|.+. . ..+..+.+|+
T Consensus 133 i~~lt~~~~~~~s~N~~~~----~lg~~~-ik~~~l~~n~l~~~~~~~i~~l~~--~ldLr~N~~~-~--~dls~~~~l~ 202 (1081)
T KOG0618|consen 133 IEVLTAEEELAASNNEKIQ----RLGQTS-IKKLDLRLNVLGGSFLIDIYNLTH--QLDLRYNEME-V--LDLSNLANLE 202 (1081)
T ss_pred HHhhhHHHHHhhhcchhhh----hhcccc-chhhhhhhhhcccchhcchhhhhe--eeecccchhh-h--hhhhhccchh
Confidence 5556666666666662111 122222 666677777776666666666655 6777777765 2 2355667777
Q ss_pred EEeccCCccCCCcCccccccccCCeeecCCCcCcccCCcchhccchhhhhhccCCccccCCchhhhhhcCCCeeeccccc
Q 000859 484 FLHLRQNELVGQIPASLGNCHQLIILDLADNKLSGGVPASFGFLQALEQLMLYNNSLEGNLPGSLINLRNLTRINFSKNR 563 (1251)
Q Consensus 484 ~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~l~~N~ 563 (1251)
.|+...|+++.. --..++|+.|+.++|.++...+ -..-.+|+++++++|+++ .+|.++..+.+|+.|+..+|+
T Consensus 203 ~l~c~rn~ls~l----~~~g~~l~~L~a~~n~l~~~~~--~p~p~nl~~~dis~n~l~-~lp~wi~~~~nle~l~~n~N~ 275 (1081)
T KOG0618|consen 203 VLHCERNQLSEL----EISGPSLTALYADHNPLTTLDV--HPVPLNLQYLDISHNNLS-NLPEWIGACANLEALNANHNR 275 (1081)
T ss_pred hhhhhhcccceE----EecCcchheeeeccCcceeecc--ccccccceeeecchhhhh-cchHHHHhcccceEecccchh
Confidence 777777777632 1234677788888887763322 223456778888888887 456888888888888888888
Q ss_pred ccccccccccCccceeeecccCccccCCCCCCCCcccCceeecccCccccccCcccccccc-cceEEccCCcccCCCCcc
Q 000859 564 LNGRIATLCSSHSFLSFDVTNNEFDHEIPPQLGNSPSLERLRLGNNKFIGKIPWTFGKIRE-LSLLDLSGNSLTGPIPTQ 642 (1251)
Q Consensus 564 l~~~~~~l~~~~~l~~l~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~-L~~L~Ls~N~l~~~~p~~ 642 (1251)
|...+..++...+++++.+..|.+. .+|+.+..+..|++|+|..|+|....+..+..... |..|+.+.|++....--.
T Consensus 276 l~~lp~ri~~~~~L~~l~~~~nel~-yip~~le~~~sL~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~ 354 (1081)
T KOG0618|consen 276 LVALPLRISRITSLVSLSAAYNELE-YIPPFLEGLKSLRTLDLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLSTLPSYE 354 (1081)
T ss_pred HHhhHHHHhhhhhHHHHHhhhhhhh-hCCCcccccceeeeeeehhccccccchHHHhhhhHHHHHHhhhhcccccccccc
Confidence 8777777777777777777777775 56777777888888888888876444434444443 677777777776432222
Q ss_pred ccccCCccEEEcCCCccCCCCccccCCCcccccccccCccccCCCccccccccccceeeccCcccccccCcccCCCCCCc
Q 000859 643 LLMCKKLSHIDLNNNLLSGAVPSWLGTLPQLGELKLSFNQFVGFLPRELFNCSKLLVLSLDGNMLNGSLPNEVGNLASLN 722 (1251)
Q Consensus 643 ~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 722 (1251)
-...+.|+.|++.+|.+++..-..+..+++|+.|+|++|++..+....+.++..|+.|+|+||+|+ .+|+.+..+..|+
T Consensus 355 e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~ 433 (1081)
T KOG0618|consen 355 ENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLH 433 (1081)
T ss_pred chhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhH
Confidence 234556777777777777666666666777777777777777654455666777777777777776 6666677777777
Q ss_pred eeccCCCcCCCCCCcccccccccceeeccCcccccccchhhhchhhHHHHHhccCCcccCCCCCCcCccccccEEEccCC
Q 000859 723 VLTLSGNLLSGPIPPAIGRLSKLYELRLSNNSLNGVIPLEIGQLQNLQSILDLSHNNFTGQIPPSMGTLAKLEVLNLSHN 802 (1251)
Q Consensus 723 ~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N 802 (1251)
+|...+|+|. ..| .+..+++|+.+|+|.|.|+.. .+|+..- .++|++|||++|
T Consensus 434 tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~------------------------~l~~~~p-~p~LkyLdlSGN 486 (1081)
T KOG0618|consen 434 TLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEV------------------------TLPEALP-SPNLKYLDLSGN 486 (1081)
T ss_pred HHhhcCCcee-ech-hhhhcCcceEEecccchhhhh------------------------hhhhhCC-CcccceeeccCC
Confidence 7777777766 455 566666677666666666411 2333322 278999999999
Q ss_pred ccccCCchhhhhccCCCcEeeccccC
Q 000859 803 QLVGELPSQLGEMSSLGKLNLSYNDL 828 (1251)
Q Consensus 803 ~l~~~~p~~l~~l~~L~~L~l~~N~l 828 (1251)
.=...--..|..+.++...+++-|+-
T Consensus 487 ~~l~~d~~~l~~l~~l~~~~i~~~~~ 512 (1081)
T KOG0618|consen 487 TRLVFDHKTLKVLKSLSQMDITLNNT 512 (1081)
T ss_pred cccccchhhhHHhhhhhheecccCCC
Confidence 84323345677888888888887733
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=335.64 Aligned_cols=256 Identities=23% Similarity=0.363 Sum_probs=204.2
Q ss_pred cCCCcCceecccCCceEEEEEec----CCcEEEEEEeccCCchhhhHHHHHHHHHHHhccCCCccceeceeeecCCCcee
Q 000859 946 NNLSDEFIIGSGGSGTVYKAELA----NGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNL 1021 (1251)
Q Consensus 946 ~~~~~~~~lG~G~fg~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~ 1021 (1251)
++|++.+.||+|+||.||+|.++ .+..||+|+++........+.+.+|+.++++++||||++++|++... ...+
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~ 82 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRG--NTMM 82 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecC--CCcE
Confidence 45788889999999999999643 35689999998665555567899999999999999999999988643 4579
Q ss_pred EEEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEccccc
Q 000859 1022 LIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGL 1101 (1251)
Q Consensus 1022 lv~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~ 1101 (1251)
+||||+++|+|.+++... ...+++.+++.++.|++.|++|||+. +++||||||+||+++.++.+|++|||.
T Consensus 83 lv~e~~~~~~L~~~l~~~------~~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~ 153 (266)
T cd05064 83 IVTEYMSNGALDSFLRKH------EGQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRR 153 (266)
T ss_pred EEEEeCCCCcHHHHHHhC------CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCcc
Confidence 999999999999999764 24689999999999999999999999 999999999999999999999999998
Q ss_pred ccccccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhh-CCCCCCCccccchhHHHHHHHHHhcc
Q 000859 1102 AKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMVRWVEMHMEMS 1180 (1251)
Q Consensus 1102 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~ 1180 (1251)
+........ .......++..|+|||.+.+..++.++|||||||++||+++ |+.||......+ . .+..
T Consensus 154 ~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~--~---~~~~---- 221 (266)
T cd05064 154 LQEDKSEAI---YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD--V---IKAV---- 221 (266)
T ss_pred cccccccch---hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH--H---HHHH----
Confidence 754321110 11111245678999999999999999999999999999875 999997653221 1 1110
Q ss_pred chhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 000859 1181 GSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNV 1234 (1251)
Q Consensus 1181 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 1234 (1251)
.+ .. ..+.+..++..+.+++.+||+.+|++||++++|.+.|.++
T Consensus 222 -------~~-~~--~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 222 -------ED-GF--RLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred -------HC-CC--CCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 01 10 1122333566789999999999999999999999998775
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=304.78 Aligned_cols=271 Identities=22% Similarity=0.317 Sum_probs=211.6
Q ss_pred hhcCCCcCceecccCCceEEEEE-ecCCcEEEEEEeccCCchhhhHHHHHHHHHHHhccCCCccceeceeeecC---CCc
Q 000859 944 ATNNLSDEFIIGSGGSGTVYKAE-LANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKG---AGS 1019 (1251)
Q Consensus 944 ~~~~~~~~~~lG~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~---~~~ 1019 (1251)
..++|++.+.+|+|||+.||.++ ..+++.||+|++.+.. .+..+...+|++..++++||||++++++...+. ...
T Consensus 19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~-~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~ 97 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS-QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE 97 (302)
T ss_pred cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc-hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence 45689999999999999999994 6678999999998776 446678899999999999999999999876432 234
Q ss_pred eeEEEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEccc
Q 000859 1020 NLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDF 1099 (1251)
Q Consensus 1020 ~~lv~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 1099 (1251)
.|++++|...|+|.+.+.... ..+..+++.++++++.+|++|+++||+. .++++||||||.||++++.+.+++.||
T Consensus 98 ~yll~Pyy~~Gsl~d~i~~~k---~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~ 173 (302)
T KOG2345|consen 98 AYLLLPYYKRGSLLDEIERLK---IKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDL 173 (302)
T ss_pred EEEEeehhccccHHHHHHHHh---hcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEec
Confidence 699999999999999998653 2245799999999999999999999997 346999999999999999999999999
Q ss_pred ccccccccccCCCC-----cccceeecccceecccccc---cCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHH
Q 000859 1100 GLAKALVEDYNSNT-----ESNTWFAGSYGYIAPEYAY---SLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVR 1171 (1251)
Q Consensus 1100 G~a~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~---~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~ 1171 (1251)
|.++...-...... ..+.....|..|+|||.+. +...++++||||+||++|+|+.|..||+.....
T Consensus 174 GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~------ 247 (302)
T KOG2345|consen 174 GSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQ------ 247 (302)
T ss_pred cCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhc------
Confidence 99876432111111 1122245689999999876 456789999999999999999999999743221
Q ss_pred HHHHHHhccchhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhc
Q 000859 1172 WVEMHMEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNVF 1235 (1251)
Q Consensus 1172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~ 1235 (1251)
+....-.+.. ..-..|.....+..+.+++++|++.||.+||++.+++..+.+..
T Consensus 248 ---------GgSlaLAv~n-~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 248 ---------GGSLALAVQN-AQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred ---------CCeEEEeeec-cccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 1111111111 01122233336778999999999999999999999999887653
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=339.58 Aligned_cols=252 Identities=23% Similarity=0.269 Sum_probs=197.0
Q ss_pred CCcCceecccCCceEEEEEe-cCCcEEEEEEeccCCc--hhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEEE
Q 000859 948 LSDEFIIGSGGSGTVYKAEL-ANGATVAVKKISCKDD--HLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIY 1024 (1251)
Q Consensus 948 ~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv~ 1024 (1251)
|+..+.||+|+||.||+|.. .+|+.||||++..... ....+.+.+|++++++++|++|+++++++... ...++||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~--~~~~lv~ 79 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETK--DALCLVL 79 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccC--CeEEEEE
Confidence 66778999999999999954 5789999999864432 22335678899999999999999999887543 4579999
Q ss_pred eecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcccccccc
Q 000859 1025 EYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKA 1104 (1251)
Q Consensus 1025 E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~ 1104 (1251)
||+++|+|.+++.... ...+++..+..++.|++.|++|||+. +|+||||||+||++++++.+||+|||+++.
T Consensus 80 e~~~~g~L~~~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~ 151 (285)
T cd05631 80 TIMNGGDLKFHIYNMG-----NPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQ 151 (285)
T ss_pred EecCCCcHHHHHHhhC-----CCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEE
Confidence 9999999998886532 34689999999999999999999999 999999999999999999999999999976
Q ss_pred cccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccchhh
Q 000859 1105 LVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSAR 1184 (1251)
Q Consensus 1105 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1184 (1251)
..... ......||..|+|||++.+..++.++||||+||++|||++|+.||......... .....
T Consensus 152 ~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~-~~~~~---------- 215 (285)
T cd05631 152 IPEGE-----TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKR-EEVDR---------- 215 (285)
T ss_pred cCCCC-----eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhH-HHHHH----------
Confidence 43211 112346899999999999999999999999999999999999999764322110 00000
Q ss_pred hhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 000859 1185 EELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPS-----SRQVCDL 1230 (1251)
Q Consensus 1185 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~eil~~ 1230 (1251)
.... .........+.++.+++.+||+.||++||+ ++++++.
T Consensus 216 -~~~~----~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 216 -RVKE----DQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred -Hhhc----ccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 0000 001111223457889999999999999997 7777763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=320.90 Aligned_cols=273 Identities=20% Similarity=0.284 Sum_probs=226.5
Q ss_pred HHHHHHhhcCCCcCceecccCCceEEEEEecC------CcEEEEEEeccCCchhhhHHHHHHHHHHHhccCCCccceece
Q 000859 938 WEDIMGATNNLSDEFIIGSGGSGTVYKAELAN------GATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGH 1011 (1251)
Q Consensus 938 ~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~ 1011 (1251)
..++.....+++....+-+|.||.||+|.|++ .+.|-||.++..+++.....+.+|.-.+..+.|||+.++.|+
T Consensus 276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V 355 (563)
T KOG1024|consen 276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV 355 (563)
T ss_pred HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence 44555566777777889999999999996653 456889999888888888889999999999999999999999
Q ss_pred eeecCCCceeEEEeecCCCChHHhhhcCCC-CcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecC
Q 000859 1012 CCNKGAGSNLLIYEYMENGSVWDWLHKQPV-NIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDS 1090 (1251)
Q Consensus 1012 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~-~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~ 1090 (1251)
+.++.. ..++++.++.-|+|..||.-.+. ..+..+.++..+...+|.|++.||+|||.+ +|||.||.++|+++|+
T Consensus 356 ~ie~~~-~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd 431 (563)
T KOG1024|consen 356 SIEDYA-TPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDD 431 (563)
T ss_pred EeeccC-cceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhcceehh
Confidence 887654 46899999999999999984332 223356678888999999999999999999 9999999999999999
Q ss_pred CCCeEEcccccccccccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhh-CCCCCCCccccchhH
Q 000859 1091 NMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDM 1169 (1251)
Q Consensus 1091 ~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~t-g~~p~~~~~~~~~~~ 1169 (1251)
..+||++|-.++|.+.+.++..-+... ..+.+||+||.+....|+.++|||||||++|||+| |+.||...++.|+..
T Consensus 432 ~LqVkltDsaLSRDLFP~DYhcLGDnE--nRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ 509 (563)
T KOG1024|consen 432 QLQVKLTDSALSRDLFPGDYHCLGDNE--NRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEH 509 (563)
T ss_pred heeEEeccchhccccCcccccccCCCC--CCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHH
Confidence 999999999999988776665444333 34689999999999999999999999999999999 999998765544311
Q ss_pred HHHHHHHHhccchhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhc
Q 000859 1170 VRWVEMHMEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNVF 1235 (1251)
Q Consensus 1170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~ 1235 (1251)
++.+. .++..+-.|++++..+|..||..+|++||+++|++.-|.++-
T Consensus 510 -----------------ylkdG--yRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~ 556 (563)
T KOG1024|consen 510 -----------------YLKDG--YRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFH 556 (563)
T ss_pred -----------------HHhcc--ceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHH
Confidence 11111 223345568899999999999999999999999999998874
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=346.78 Aligned_cols=243 Identities=21% Similarity=0.303 Sum_probs=194.0
Q ss_pred ceecccCCceEEEEEe-cCCcEEEEEEeccCC--chhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEEEeecC
Q 000859 952 FIIGSGGSGTVYKAEL-ANGATVAVKKISCKD--DHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIYEYME 1028 (1251)
Q Consensus 952 ~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv~E~~~ 1028 (1251)
+.||+|+||.||+|.. .+|+.||||++.... .....+.+.+|++++++++||||+++++++.. ....++||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~--~~~~~lv~e~~~ 78 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQT--HDRLCFVMEYAN 78 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEc--CCEEEEEEeCCC
Confidence 3699999999999954 578999999986432 22334567889999999999999999988754 446799999999
Q ss_pred CCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcccccccccccc
Q 000859 1029 NGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVED 1108 (1251)
Q Consensus 1029 ~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 1108 (1251)
+|+|.+++.. .+.+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 79 ~~~L~~~l~~-------~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~ 148 (323)
T cd05571 79 GGELFFHLSR-------ERVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISD 148 (323)
T ss_pred CCcHHHHHHH-------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccC
Confidence 9999999876 35689999999999999999999999 9999999999999999999999999998753211
Q ss_pred cCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccchhhhhhh
Q 000859 1109 YNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSAREELL 1188 (1251)
Q Consensus 1109 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1188 (1251)
........||+.|+|||++.+..++.++||||+||++|||++|+.||........ .... .
T Consensus 149 ----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~-----~~~~-----------~ 208 (323)
T cd05571 149 ----GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL-----FELI-----------L 208 (323)
T ss_pred ----CCcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHH-----HHHH-----------H
Confidence 1122335799999999999999999999999999999999999999965422110 0000 0
Q ss_pred cccCCCCCCchHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 000859 1189 DDQMKPLLPGEECAAYQVLEIALQCTKTSPQERP-----SSRQVCDL 1230 (1251)
Q Consensus 1189 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~~ 1230 (1251)
.. ....+...+.++.+++.+|++.||++|| +++++++.
T Consensus 209 ~~----~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 209 ME----EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred cC----CCCCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 00 0111122456788999999999999999 78888753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=317.72 Aligned_cols=248 Identities=25% Similarity=0.410 Sum_probs=210.7
Q ss_pred CCcCceecccCCceEEEE-EecCCcEEEEEEeccCCchhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEEEee
Q 000859 948 LSDEFIIGSGGSGTVYKA-ELANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIYEY 1026 (1251)
Q Consensus 948 ~~~~~~lG~G~fg~V~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv~E~ 1026 (1251)
|.++.+||+|+||.||+| +..+|+.||||.+.... ..+++.+|+.+|++++.|+||++||.|.... ..|+||||
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s---DLQEIIKEISIMQQC~S~yVVKYYGSYFK~s--DLWIVMEY 109 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT---DLQEIIKEISIMQQCKSKYVVKYYGSYFKHS--DLWIVMEY 109 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc---hHHHHHHHHHHHHHcCCchhhhhhhhhccCC--ceEeehhh
Confidence 555668999999999999 55679999999996544 3578899999999999999999999775543 36999999
Q ss_pred cCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcccccccccc
Q 000859 1027 MENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALV 1106 (1251)
Q Consensus 1027 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~ 1106 (1251)
|..|+..+.++.+ .+.++++++..+..+.++|++|||.. +-+|||||+.|||++.+|.+|++|||.|..+.
T Consensus 110 CGAGSiSDI~R~R------~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLT 180 (502)
T KOG0574|consen 110 CGAGSISDIMRAR------RKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLT 180 (502)
T ss_pred cCCCcHHHHHHHh------cCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhh
Confidence 9999999999875 57899999999999999999999998 88999999999999999999999999997664
Q ss_pred cccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccchhhhh
Q 000859 1107 EDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSAREE 1186 (1251)
Q Consensus 1107 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1186 (1251)
+.. .......||+.|||||++..-.|+.++||||+|++..||..|++||.+..+... .-
T Consensus 181 DTM----AKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRA-----------------IF 239 (502)
T KOG0574|consen 181 DTM----AKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRA-----------------IF 239 (502)
T ss_pred hhH----HhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccce-----------------eE
Confidence 332 223347899999999999999999999999999999999999999986643211 11
Q ss_pred hhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 000859 1187 LLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDL 1230 (1251)
Q Consensus 1187 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 1230 (1251)
++.....|.+..++..+.++.+++++|+-+.|++|-|+-++++.
T Consensus 240 MIPT~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 240 MIPTKPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred eccCCCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 22333445566788899999999999999999999999988764
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=342.29 Aligned_cols=260 Identities=25% Similarity=0.401 Sum_probs=206.6
Q ss_pred cCCCcCceecccCCceEEEEEec-CCc----EEEEEEeccCCchhhhHHHHHHHHHHHhccCCCccceeceeeecCCCce
Q 000859 946 NNLSDEFIIGSGGSGTVYKAELA-NGA----TVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSN 1020 (1251)
Q Consensus 946 ~~~~~~~~lG~G~fg~V~~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~ 1020 (1251)
.+|+..+.||+|+||.||+|.+. +++ .||||++.........+.+.+|+.+++.++||||++++|+|... ..
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~---~~ 83 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS---TV 83 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC---Cc
Confidence 45888999999999999999753 333 48999987555555667889999999999999999999988643 35
Q ss_pred eEEEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcccc
Q 000859 1021 LLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFG 1100 (1251)
Q Consensus 1021 ~lv~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG 1100 (1251)
++++||+++|+|.++++.. ...+++..+.+++.||+.||+|||+. +|+||||||+||++++++.+||+|||
T Consensus 84 ~~v~e~~~~g~l~~~l~~~------~~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG 154 (316)
T cd05108 84 QLITQLMPFGCLLDYVREH------KDNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFG 154 (316)
T ss_pred eeeeecCCCCCHHHHHHhc------cccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEcccc
Confidence 7999999999999999864 24588999999999999999999999 99999999999999999999999999
Q ss_pred cccccccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhh-CCCCCCCccccchhHHHHHHHHHhc
Q 000859 1101 LAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMVRWVEMHMEM 1179 (1251)
Q Consensus 1101 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~ 1179 (1251)
+++.+....... ......++..|+|||.+.+..++.++|||||||++||+++ |+.||++....+. ....
T Consensus 155 ~a~~~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~--~~~~------ 224 (316)
T cd05108 155 LAKLLGADEKEY--HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI--SSIL------ 224 (316)
T ss_pred ccccccCCCcce--eccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH--HHHH------
Confidence 998764322111 1111234678999999999999999999999999999998 9999975422111 1110
Q ss_pred cchhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhcCCC
Q 000859 1180 SGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNVFNNR 1238 (1251)
Q Consensus 1180 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~ 1238 (1251)
... ...+.+..++.++.+++.+||+.||++||++.+++..+.++....
T Consensus 225 ---------~~~--~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~ 272 (316)
T cd05108 225 ---------EKG--ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 272 (316)
T ss_pred ---------hCC--CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence 000 011112224457889999999999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=354.81 Aligned_cols=270 Identities=24% Similarity=0.355 Sum_probs=215.4
Q ss_pred hcCCCcCceecccCCceEEEEEecCC-cEEEEEEeccCCchhhhHHHHHHHHHHHhcc-CCCccceec-eeeec---C-C
Q 000859 945 TNNLSDEFIIGSGGSGTVYKAELANG-ATVAVKKISCKDDHLLNKSFTREVKTLGRIR-HRHLVKLMG-HCCNK---G-A 1017 (1251)
Q Consensus 945 ~~~~~~~~~lG~G~fg~V~~~~~~~~-~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g-~~~~~---~-~ 1017 (1251)
..++++.++|.+|||+.||.|+...+ ..||+|++... ++...+...+|+++|+++. |||||.+++ ..... . .
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~-de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~ 114 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN-DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV 114 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC-CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence 44567888999999999999976655 99999999877 6677889999999999996 999999999 33222 1 2
Q ss_pred CceeEEEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEc
Q 000859 1018 GSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLG 1097 (1251)
Q Consensus 1018 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~ 1097 (1251)
...++.||||+||.|-+++..+. ...|++.++++|+.|+++|+++||.. .++|||||||.+|||++.+|..|||
T Consensus 115 ~EvllLmEyC~gg~Lvd~mn~Rl-----q~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLC 188 (738)
T KOG1989|consen 115 WEVLLLMEYCKGGSLVDFMNTRL-----QTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLC 188 (738)
T ss_pred eEEEeehhhccCCcHHHHHHHHH-----hccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeC
Confidence 34689999999999999998643 34599999999999999999999996 5689999999999999999999999
Q ss_pred ccccccccccccCCCCc-----ccceeecccceeccccc---ccCCCCCccceeehhHHHHHHhhCCCCCCCccccchhH
Q 000859 1098 DFGLAKALVEDYNSNTE-----SNTWFAGSYGYIAPEYA---YSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDM 1169 (1251)
Q Consensus 1098 DfG~a~~~~~~~~~~~~-----~~~~~~gt~~y~aPE~~---~~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~ 1169 (1251)
|||.|............ .......|+-|+|||.+ .+...++|+||||+||+||-++....||+......
T Consensus 189 DFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~la--- 265 (738)
T KOG1989|consen 189 DFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLA--- 265 (738)
T ss_pred cccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCccee---
Confidence 99998643322211110 01113568999999976 46779999999999999999999999998552211
Q ss_pred HHHHHHHHhccchhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhcCCCccccc
Q 000859 1170 VRWVEMHMEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNVFNNRIVDFD 1243 (1251)
Q Consensus 1170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~~~~~ 1243 (1251)
++... ..+|....+...+.+||..||+.||++||++.+|+..+.++.....--.+
T Consensus 266 -----------------Ilng~--Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~~~~~ 320 (738)
T KOG1989|consen 266 -----------------ILNGN--YSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPCPIPD 320 (738)
T ss_pred -----------------EEecc--ccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCCCccc
Confidence 11111 22344456788899999999999999999999999999988876554433
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=341.64 Aligned_cols=245 Identities=22% Similarity=0.299 Sum_probs=197.7
Q ss_pred CCCcCceecccCCceEEEEEe-cCCcEEEEEEeccCC--chhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEE
Q 000859 947 NLSDEFIIGSGGSGTVYKAEL-ANGATVAVKKISCKD--DHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLI 1023 (1251)
Q Consensus 947 ~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv 1023 (1251)
+|+..+.||+|+||.||+|.. .+++.||+|++.... .....+.+.+|++++++++||||+++++++.+ ....++|
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~lv 79 (291)
T cd05612 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHD--QRFLYML 79 (291)
T ss_pred CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhcc--CCeEEEE
Confidence 678889999999999999965 468999999986432 22344668899999999999999999987754 4567999
Q ss_pred EeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEccccccc
Q 000859 1024 YEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAK 1103 (1251)
Q Consensus 1024 ~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~ 1103 (1251)
|||+++|+|.+++... +.+++..+..++.|++.|++|||++ +|+||||||+||++++++.+||+|||+++
T Consensus 80 ~e~~~~~~L~~~~~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~ 149 (291)
T cd05612 80 MEYVPGGELFSYLRNS-------GRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAK 149 (291)
T ss_pred EeCCCCCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcch
Confidence 9999999999999763 4688999999999999999999999 99999999999999999999999999997
Q ss_pred ccccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccchh
Q 000859 1104 ALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSA 1183 (1251)
Q Consensus 1104 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1183 (1251)
..... .....||+.|+|||++.+..++.++||||+||++|||++|+.||.+....+. .+..
T Consensus 150 ~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~-----~~~i------- 210 (291)
T cd05612 150 KLRDR-------TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGI-----YEKI------- 210 (291)
T ss_pred hccCC-------cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-----HHHH-------
Confidence 65321 1124689999999999988999999999999999999999999976432111 1110
Q ss_pred hhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 000859 1184 REELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPS-----SRQVCDL 1230 (1251)
Q Consensus 1184 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~eil~~ 1230 (1251)
... ....+...+..+.+++.+|++.||.+||+ ++|+++.
T Consensus 211 ----~~~----~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 211 ----LAG----KLEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred ----HhC----CcCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 000 01111123456889999999999999995 8887755
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=318.59 Aligned_cols=276 Identities=22% Similarity=0.305 Sum_probs=205.6
Q ss_pred CCCcCceecccCCceEEEE-EecCCcEEEEEEeccCCc-hhhhHHHHHHHHHHHhccCCC-ccceeceeeecCC----Cc
Q 000859 947 NLSDEFIIGSGGSGTVYKA-ELANGATVAVKKISCKDD-HLLNKSFTREVKTLGRIRHRH-LVKLMGHCCNKGA----GS 1019 (1251)
Q Consensus 947 ~~~~~~~lG~G~fg~V~~~-~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~n-iv~l~g~~~~~~~----~~ 1019 (1251)
.|...++||+|+||+||+| ...+|+.||+|+++...+ +-......+|+.++++++|+| ||++++++..... ..
T Consensus 12 ~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~ 91 (323)
T KOG0594|consen 12 DYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGK 91 (323)
T ss_pred HHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccce
Confidence 3556668999999999999 556789999999986654 334466789999999999999 9999998876542 35
Q ss_pred eeEEEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEccc
Q 000859 1020 NLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDF 1099 (1251)
Q Consensus 1020 ~~lv~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 1099 (1251)
.++|+||++. +|..|++..+... ..++...++.++.||++|++|||++ +|+||||||+||+++++|.+||+||
T Consensus 92 l~lvfe~~d~-DL~~ymd~~~~~~---~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDF 164 (323)
T KOG0594|consen 92 LYLVFEFLDR-DLKKYMDSLPKKP---QGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADF 164 (323)
T ss_pred EEEEEEeecc-cHHHHHHhccccc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeecc
Confidence 6899999965 9999998764211 4567788999999999999999999 9999999999999999999999999
Q ss_pred ccccccccccCCCCcccceeecccceecccccccC-CCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHh
Q 000859 1100 GLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSL-KATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHME 1178 (1251)
Q Consensus 1100 G~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 1178 (1251)
|+|+.+.- .....+..++|..|+|||++.+. .|+...||||+||+++||++++.-|.+....+ .+....+....
T Consensus 165 GlAra~~i----p~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~-ql~~If~~lGt 239 (323)
T KOG0594|consen 165 GLARAFSI----PMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEID-QLFRIFRLLGT 239 (323)
T ss_pred chHHHhcC----CcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHH-HHHHHHHHcCC
Confidence 99986532 22334456789999999998877 69999999999999999999999998764411 11111111111
Q ss_pred cc-chhhhhhhcccCCCCCCc-------h---HHHHHHHHHHHHHccccCCCCCCCHHHHHHH--HHhh
Q 000859 1179 MS-GSAREELLDDQMKPLLPG-------E---ECAAYQVLEIALQCTKTSPQERPSSRQVCDL--LLNV 1234 (1251)
Q Consensus 1179 ~~-~~~~~~~~~~~~~~~~~~-------~---~~~~~~l~~li~~cl~~dP~~RPs~~eil~~--L~~~ 1234 (1251)
.. ..|.....-...+..++. . .....+..+++.+|++.+|.+|.|++.++.+ +.+.
T Consensus 240 P~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~ 308 (323)
T KOG0594|consen 240 PNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSEL 308 (323)
T ss_pred CCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence 00 011111100111111111 0 1112468899999999999999999999876 4444
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=347.95 Aligned_cols=268 Identities=26% Similarity=0.392 Sum_probs=208.6
Q ss_pred hhcCCCcCceecccCCceEEEEEec------CCcEEEEEEeccCCchhhhHHHHHHHHHHHhcc-CCCccceeceeeecC
Q 000859 944 ATNNLSDEFIIGSGGSGTVYKAELA------NGATVAVKKISCKDDHLLNKSFTREVKTLGRIR-HRHLVKLMGHCCNKG 1016 (1251)
Q Consensus 944 ~~~~~~~~~~lG~G~fg~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~ 1016 (1251)
...+|.+.++||+|+||.||+|... .+..||||++.........+.+.+|+++++++. |||||+++|+|...
T Consensus 35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~- 113 (400)
T cd05105 35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKS- 113 (400)
T ss_pred cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccC-
Confidence 3567888899999999999999642 234699999976665556678999999999995 99999999988543
Q ss_pred CCceeEEEeecCCCChHHhhhcCCCCc-----------------------------------------------------
Q 000859 1017 AGSNLLIYEYMENGSVWDWLHKQPVNI----------------------------------------------------- 1043 (1251)
Q Consensus 1017 ~~~~~lv~E~~~~gsL~~~l~~~~~~~----------------------------------------------------- 1043 (1251)
...++||||+++|+|.++++......
T Consensus 114 -~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (400)
T cd05105 114 -GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPML 192 (400)
T ss_pred -CceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhh
Confidence 45799999999999999987532100
Q ss_pred ------------------------------------ccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCee
Q 000859 1044 ------------------------------------KMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNIL 1087 (1251)
Q Consensus 1044 ------------------------------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nil 1087 (1251)
.....+++.++.+++.|+++|++|||+. +|+||||||+||+
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nil 269 (400)
T cd05105 193 EIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVL 269 (400)
T ss_pred hhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEE
Confidence 0123578899999999999999999999 9999999999999
Q ss_pred ecCCCCeEEcccccccccccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhh-CCCCCCCccccc
Q 000859 1088 LDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVE 1166 (1251)
Q Consensus 1088 l~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~t-g~~p~~~~~~~~ 1166 (1251)
++.++.+||+|||+++.+...... .......++..|+|||.+.+..++.++|||||||++|||++ |..||.......
T Consensus 270 l~~~~~~kL~DfGla~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~ 347 (400)
T cd05105 270 LAQGKIVKICDFGLARDIMHDSNY--VSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS 347 (400)
T ss_pred EeCCCEEEEEeCCcceeccccccc--cccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH
Confidence 999999999999999765332111 11122356788999999998899999999999999999997 999987542211
Q ss_pred hhHHHHHHHHHhccchhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhcC
Q 000859 1167 MDMVRWVEMHMEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNVFN 1236 (1251)
Q Consensus 1167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~ 1236 (1251)
... . .+.... ..+.+...+.++.+++.+||+.||++||++.+|.++|++++.
T Consensus 348 ~~~-~---------------~~~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 348 TFY-N---------------KIKSGY--RMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred HHH-H---------------HHhcCC--CCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 100 0 000000 111122345678999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=342.69 Aligned_cols=267 Identities=24% Similarity=0.377 Sum_probs=205.2
Q ss_pred hcCCCcCceecccCCceEEEEEec-CCcEEEEEEeccCCchhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEE
Q 000859 945 TNNLSDEFIIGSGGSGTVYKAELA-NGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLI 1023 (1251)
Q Consensus 945 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv 1023 (1251)
.++|+..+.||+|+||.||+|+.. ++..||+|++.........+.+.+|++++++++||||+++++++... ...++|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv 81 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD--GEISIC 81 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEEC--CEEEEE
Confidence 357888999999999999999654 68899999997655555567899999999999999999999988654 457999
Q ss_pred EeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEccccccc
Q 000859 1024 YEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAK 1103 (1251)
Q Consensus 1024 ~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~ 1103 (1251)
|||+++|+|.+++... ..+++..+..++.|++.|++|||+.+ +|+||||||+||+++.++.+||+|||+++
T Consensus 82 ~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 152 (331)
T cd06649 82 MEHMDGGSLDQVLKEA-------KRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSG 152 (331)
T ss_pred eecCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcccc
Confidence 9999999999999763 46889999999999999999999852 69999999999999999999999999987
Q ss_pred ccccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHh-ccc-
Q 000859 1104 ALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHME-MSG- 1181 (1251)
Q Consensus 1104 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~-~~~- 1181 (1251)
..... ......||..|+|||++.+..++.++||||+||++|||++|+.||......+. ......... ...
T Consensus 153 ~~~~~------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~--~~~~~~~~~~~~~~ 224 (331)
T cd06649 153 QLIDS------MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKEL--EAIFGRPVVDGEEG 224 (331)
T ss_pred ccccc------ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHhcccccccccC
Confidence 65321 11234689999999999998999999999999999999999999975432221 110000000 000
Q ss_pred -----------------------------hhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 000859 1182 -----------------------------SAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLL 1231 (1251)
Q Consensus 1182 -----------------------------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L 1231 (1251)
......+.....+..+ ....+.++.+++.+||+.||++|||++|+++.-
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~ 302 (331)
T cd06649 225 EPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLP-NGVFTPDFQEFVNKCLIKNPAERADLKMLMNHT 302 (331)
T ss_pred CccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCC-CccccHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 0000000000111111 112456789999999999999999999998764
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=343.25 Aligned_cols=240 Identities=22% Similarity=0.294 Sum_probs=190.7
Q ss_pred ecccCCceEEEEEe-cCCcEEEEEEeccCC--chhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEEEeecCCC
Q 000859 954 IGSGGSGTVYKAEL-ANGATVAVKKISCKD--DHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIYEYMENG 1030 (1251)
Q Consensus 954 lG~G~fg~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv~E~~~~g 1030 (1251)
||+|+||.||+|.. .+++.||+|++.... .....+.+.+|++++++++||||+++++++.. +...++||||+++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~g 78 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQS--PEKLYLVLAFINGG 78 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEec--CCeEEEEEcCCCCC
Confidence 69999999999965 468899999986432 23344677889999999999999999988754 45679999999999
Q ss_pred ChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcccccccccccccC
Q 000859 1031 SVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYN 1110 (1251)
Q Consensus 1031 sL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 1110 (1251)
+|.+++... +.+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 79 ~L~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~-- 146 (312)
T cd05585 79 ELFHHLQRE-------GRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKD-- 146 (312)
T ss_pred cHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccC--
Confidence 999999763 4689999999999999999999999 9999999999999999999999999998753221
Q ss_pred CCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccchhhhhhhcc
Q 000859 1111 SNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSAREELLDD 1190 (1251)
Q Consensus 1111 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1190 (1251)
........||+.|+|||++.+..++.++||||+||++|||++|+.||.+.... ...... ..
T Consensus 147 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~-----~~~~~~-----------~~- 207 (312)
T cd05585 147 --DDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVN-----EMYRKI-----------LQ- 207 (312)
T ss_pred --CCccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHH-----HHHHHH-----------Hc-
Confidence 11223357899999999999999999999999999999999999999754221 111110 00
Q ss_pred cCCCCCCchHHHHHHHHHHHHHccccCCCCCCCH---HHHHH
Q 000859 1191 QMKPLLPGEECAAYQVLEIALQCTKTSPQERPSS---RQVCD 1229 (1251)
Q Consensus 1191 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~---~eil~ 1229 (1251)
.....+...+.++.+++.+||+.||++||++ +|+++
T Consensus 208 ---~~~~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~ 246 (312)
T cd05585 208 ---EPLRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKN 246 (312)
T ss_pred ---CCCCCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence 1111122345678899999999999999864 55543
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=345.51 Aligned_cols=246 Identities=22% Similarity=0.312 Sum_probs=197.7
Q ss_pred cCCCcCceecccCCceEEEEEec-CCcEEEEEEeccCC--chhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeE
Q 000859 946 NNLSDEFIIGSGGSGTVYKAELA-NGATVAVKKISCKD--DHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLL 1022 (1251)
Q Consensus 946 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~l 1022 (1251)
.+|+..+.||+|+||.||+|+.. +++.||||++.... .....+.+.+|++++++++||||+++++++.. ....++
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~l 95 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQD--ENRVYF 95 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEc--CCEEEE
Confidence 45888899999999999999654 68999999986432 22234678899999999999999999998865 445799
Q ss_pred EEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcccccc
Q 000859 1023 IYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLA 1102 (1251)
Q Consensus 1023 v~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a 1102 (1251)
||||+++|+|.+++.. .+.+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 96 v~e~~~~~~L~~~l~~-------~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~ 165 (329)
T PTZ00263 96 LLEFVVGGELFTHLRK-------AGRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFA 165 (329)
T ss_pred EEcCCCCChHHHHHHH-------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCc
Confidence 9999999999999976 34678999999999999999999999 9999999999999999999999999999
Q ss_pred cccccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccch
Q 000859 1103 KALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGS 1182 (1251)
Q Consensus 1103 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 1182 (1251)
+..... .....||+.|+|||++.+..++.++||||+||++|||++|+.||.+....+. .+.
T Consensus 166 ~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~-----~~~------- 226 (329)
T PTZ00263 166 KKVPDR-------TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRI-----YEK------- 226 (329)
T ss_pred eEcCCC-------cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHH-----HHH-------
Confidence 765321 1124789999999999999999999999999999999999999975422110 010
Q ss_pred hhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 000859 1183 AREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPS-----SRQVCDL 1230 (1251)
Q Consensus 1183 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~eil~~ 1230 (1251)
.... ..+.+...+..+.+++.+||+.||.+||+ ++++++.
T Consensus 227 ----i~~~----~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 227 ----ILAG----RLKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred ----HhcC----CcCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 0010 11111123456889999999999999997 6777644
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=344.22 Aligned_cols=268 Identities=27% Similarity=0.413 Sum_probs=207.6
Q ss_pred cCCCcCceecccCCceEEEEEec------CCcEEEEEEeccCCchhhhHHHHHHHHHHHhc-cCCCccceeceeeecCCC
Q 000859 946 NNLSDEFIIGSGGSGTVYKAELA------NGATVAVKKISCKDDHLLNKSFTREVKTLGRI-RHRHLVKLMGHCCNKGAG 1018 (1251)
Q Consensus 946 ~~~~~~~~lG~G~fg~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~ 1018 (1251)
.+|++.+.||+|+||.||+|... +++.||+|++.........+.+.+|+++++++ +|+||++++++|... ..
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~-~~ 85 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKP-GG 85 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecC-CC
Confidence 46888899999999999999532 35789999997554444556788999999999 899999999987654 34
Q ss_pred ceeEEEeecCCCChHHhhhcCCCCc------------------------------------------------------c
Q 000859 1019 SNLLIYEYMENGSVWDWLHKQPVNI------------------------------------------------------K 1044 (1251)
Q Consensus 1019 ~~~lv~E~~~~gsL~~~l~~~~~~~------------------------------------------------------~ 1044 (1251)
..++++||+++|+|.+++....... .
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 5689999999999999986432100 0
Q ss_pred cCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcccccccccccccCCCCcccceeecccc
Q 000859 1045 MRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYG 1124 (1251)
Q Consensus 1045 ~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~gt~~ 1124 (1251)
....+++..+.+++.||+.|++|||+. +|+||||||+||+++.++.+||+|||+++.+...... .......++..
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~--~~~~~~~~~~~ 240 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY--VRKGDARLPLK 240 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcch--hhccCCCCCcc
Confidence 123689999999999999999999999 9999999999999999999999999999875332111 11122345778
Q ss_pred eecccccccCCCCCccceeehhHHHHHHhh-CCCCCCCccccchhHHHHHHHHHhccchhhhhhhcccCCCCCCchHHHH
Q 000859 1125 YIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMVRWVEMHMEMSGSAREELLDDQMKPLLPGEECAA 1203 (1251)
Q Consensus 1125 y~aPE~~~~~~~~~~sDiwSlGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1203 (1251)
|+|||++.+..++.++||||+||++|||++ |+.||.+....+. .... . ........ +....
T Consensus 241 y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~-~~~~---~------------~~~~~~~~--~~~~~ 302 (337)
T cd05054 241 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE-FCRR---L------------KEGTRMRA--PEYAT 302 (337)
T ss_pred ccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH-HHHH---H------------hccCCCCC--CccCC
Confidence 999999999999999999999999999998 9999975432211 1110 0 00001111 12234
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHHHHHhhcCC
Q 000859 1204 YQVLEIALQCTKTSPQERPSSRQVCDLLLNVFNN 1237 (1251)
Q Consensus 1204 ~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~ 1237 (1251)
.++.+++.+||+.+|++||++.|++++|+++++.
T Consensus 303 ~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~~ 336 (337)
T cd05054 303 PEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQE 336 (337)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 5789999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=335.06 Aligned_cols=250 Identities=33% Similarity=0.534 Sum_probs=194.0
Q ss_pred CceecccCCceEEEEEec-----CCcEEEEEEeccCCchhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEEEe
Q 000859 951 EFIIGSGGSGTVYKAELA-----NGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIYE 1025 (1251)
Q Consensus 951 ~~~lG~G~fg~V~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv~E 1025 (1251)
.+.||.|+||.||+|.+. .+..||||++.........+.|.+|++.+++++||||++++|++... ...++|+|
T Consensus 4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~--~~~~lv~e 81 (259)
T PF07714_consen 4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIEN--EPLFLVME 81 (259)
T ss_dssp EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESS--SSEEEEEE
T ss_pred eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccc--cccccccc
Confidence 457999999999999776 35789999997655655678999999999999999999999999743 33799999
Q ss_pred ecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEccccccccc
Q 000859 1026 YMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKAL 1105 (1251)
Q Consensus 1026 ~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~ 1105 (1251)
|+++|+|.++++... ...+++..+.+|+.||++||+|||++ +++|+||+++||++++++.+||+|||+++..
T Consensus 82 ~~~~g~L~~~L~~~~-----~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~ 153 (259)
T PF07714_consen 82 YCPGGSLDDYLKSKN-----KEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPI 153 (259)
T ss_dssp --TTEBHHHHHHHTC-----TTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEET
T ss_pred ccccccccccccccc-----cccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccc
Confidence 999999999998752 35789999999999999999999999 9999999999999999999999999999765
Q ss_pred ccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhh-CCCCCCCccccchhHHHHHHHHHhccchhh
Q 000859 1106 VEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMVRWVEMHMEMSGSAR 1184 (1251)
Q Consensus 1106 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1184 (1251)
..... ........+...|+|||.+....++.++||||||+++||+++ |+.||......+ ..+...
T Consensus 154 ~~~~~--~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~-----~~~~~~------- 219 (259)
T PF07714_consen 154 SEKSK--YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEE-----IIEKLK------- 219 (259)
T ss_dssp TTSSS--EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHH-----HHHHHH-------
T ss_pred ccccc--ccccccccccccccccccccccccccccccccccccccccccccccccccccccc-----cccccc-------
Confidence 22111 112222456789999999998889999999999999999999 789986552211 111111
Q ss_pred hhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 000859 1185 EELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLL 1231 (1251)
Q Consensus 1185 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L 1231 (1251)
+.. ..+.+..++..+.+++.+||+.||++|||++++++.|
T Consensus 220 ----~~~---~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 220 ----QGQ---RLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp ----TTE---ETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ----ccc---cceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 100 0112223456788999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=337.16 Aligned_cols=268 Identities=20% Similarity=0.260 Sum_probs=198.4
Q ss_pred hcCCCcCceecccCCceEEEEEe-cCCcEEEEEEeccCCchhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEE
Q 000859 945 TNNLSDEFIIGSGGSGTVYKAEL-ANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLI 1023 (1251)
Q Consensus 945 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv 1023 (1251)
..+|...+.||+|+||.||+|.. .+++.||+|++...........+.+|++++++++||||+++++++.. ....++|
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv 81 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHT--ERCLTLV 81 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcC--CCeEEEE
Confidence 35688889999999999999954 47899999999755444344677899999999999999999998754 3457899
Q ss_pred EeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEccccccc
Q 000859 1024 YEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAK 1103 (1251)
Q Consensus 1024 ~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~ 1103 (1251)
|||++ |+|.+++... ...+++..+..++.||+.||+|||++ +|+||||||+||++++++.+||+|||+++
T Consensus 82 ~e~~~-~~l~~~l~~~------~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~ 151 (288)
T cd07871 82 FEYLD-SDLKQYLDNC------GNLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLAR 151 (288)
T ss_pred EeCCC-cCHHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCccee
Confidence 99997 4999998754 24578999999999999999999999 99999999999999999999999999987
Q ss_pred ccccccCCCCcccceeecccceeccccccc-CCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccch
Q 000859 1104 ALVEDYNSNTESNTWFAGSYGYIAPEYAYS-LKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGS 1182 (1251)
Q Consensus 1104 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 1182 (1251)
..... ........|++.|+|||.+.+ ..++.++||||+||++|||++|+.||.+....+. ..............
T Consensus 152 ~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~ 226 (288)
T cd07871 152 AKSVP----TKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEE-LHLIFRLLGTPTEE 226 (288)
T ss_pred eccCC----CccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCChH
Confidence 54321 111223467999999998865 5689999999999999999999999976533221 11111100000000
Q ss_pred hhhhh-----hcccCCCCC------CchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 000859 1183 AREEL-----LDDQMKPLL------PGEECAAYQVLEIALQCTKTSPQERPSSRQVCD 1229 (1251)
Q Consensus 1183 ~~~~~-----~~~~~~~~~------~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1229 (1251)
..... +.....+.. ......+.+..+++.+|++.||.+|||++|+++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 227 TWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred HhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 00000 000000000 001113456789999999999999999999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=340.20 Aligned_cols=243 Identities=23% Similarity=0.360 Sum_probs=197.7
Q ss_pred hcCCCcCceecccCCceEEEEEe-cCCcEEEEEEeccCC--chhhhHHHHHHHHHHHhc-cCCCccceeceeeecCCCce
Q 000859 945 TNNLSDEFIIGSGGSGTVYKAEL-ANGATVAVKKISCKD--DHLLNKSFTREVKTLGRI-RHRHLVKLMGHCCNKGAGSN 1020 (1251)
Q Consensus 945 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~~ 1020 (1251)
..+|...++||+|.||+|+.+.. .+++.+|||++++.. ...+.+..+.|..|+... +||.++.++..|. .....
T Consensus 367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQ--T~~~l 444 (694)
T KOG0694|consen 367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQ--TKEHL 444 (694)
T ss_pred ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccc--cCCeE
Confidence 34688889999999999999965 467899999998664 333557778898888877 5999999988664 45668
Q ss_pred eEEEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcccc
Q 000859 1021 LLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFG 1100 (1251)
Q Consensus 1021 ~lv~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG 1100 (1251)
++||||+.||++..+.+ .+.+++..++-+|..|+.||+|||++ +||+||+|.+|||+|.+|.+||+|||
T Consensus 445 ~fvmey~~Ggdm~~~~~--------~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFG 513 (694)
T KOG0694|consen 445 FFVMEYVAGGDLMHHIH--------TDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFG 513 (694)
T ss_pred EEEEEecCCCcEEEEEe--------cccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEecccc
Confidence 99999999999555444 36799999999999999999999999 99999999999999999999999999
Q ss_pred cccccccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhcc
Q 000859 1101 LAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMS 1180 (1251)
Q Consensus 1101 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 1180 (1251)
+++... . .....+.++||+.|||||++.+..|+.++|+|||||++|||+.|+.||.+....+.
T Consensus 514 lcKe~m---~-~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~------------- 576 (694)
T KOG0694|consen 514 LCKEGM---G-QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEV------------- 576 (694)
T ss_pred cccccC---C-CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHH-------------
Confidence 997532 1 22244558999999999999999999999999999999999999999987644322
Q ss_pred chhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCH
Q 000859 1181 GSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSS 1224 (1251)
Q Consensus 1181 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 1224 (1251)
++.........+...+.+...||++++.++|++|--+
T Consensus 577 -------FdsI~~d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 577 -------FDSIVNDEVRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred -------HHHHhcCCCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 1111111222233356678899999999999999766
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=332.89 Aligned_cols=263 Identities=25% Similarity=0.462 Sum_probs=207.3
Q ss_pred cCCCcCceecccCCceEEEEEecC------CcEEEEEEeccCCchhhhHHHHHHHHHHHhccCCCccceeceeeecCCCc
Q 000859 946 NNLSDEFIIGSGGSGTVYKAELAN------GATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGS 1019 (1251)
Q Consensus 946 ~~~~~~~~lG~G~fg~V~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 1019 (1251)
.+|+..+.||+|+||.||+|.... ...||+|.+.........+.+.+|++++++++||||+++++++... ..
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~--~~ 82 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKE--QP 82 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCC--Cc
Confidence 357888899999999999996532 2579999997665555667899999999999999999999988644 44
Q ss_pred eeEEEeecCCCChHHhhhcCCCCc---------ccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecC
Q 000859 1020 NLLIYEYMENGSVWDWLHKQPVNI---------KMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDS 1090 (1251)
Q Consensus 1020 ~~lv~E~~~~gsL~~~l~~~~~~~---------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~ 1090 (1251)
.+++|||+++|+|.+++....... .....+++.++..++.|++.|++|||+. +++||||||+||++++
T Consensus 83 ~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~ 159 (283)
T cd05048 83 TCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGE 159 (283)
T ss_pred eEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcC
Confidence 689999999999999997642211 1125688999999999999999999999 9999999999999999
Q ss_pred CCCeEEcccccccccccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhh-CCCCCCCccccchhH
Q 000859 1091 NMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDM 1169 (1251)
Q Consensus 1091 ~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~t-g~~p~~~~~~~~~~~ 1169 (1251)
++.+||+|||+++........ .......++..|+|||.+.+..++.++|||||||++|||++ |..||.+....+.
T Consensus 160 ~~~~~L~dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~-- 235 (283)
T cd05048 160 GLTVKISDFGLSRDIYSADYY--RVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEV-- 235 (283)
T ss_pred CCcEEECCCcceeeccccccc--cccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHH--
Confidence 999999999999765322111 11222356789999999988899999999999999999998 9999976533211
Q ss_pred HHHHHHHHhccchhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 000859 1170 VRWVEMHMEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNV 1234 (1251)
Q Consensus 1170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 1234 (1251)
... +.... ..+.+..++.++.+++.+||+.||.+||+++||.+.|+.+
T Consensus 236 ~~~--------------i~~~~---~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05048 236 IEM--------------IRSRQ---LLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283 (283)
T ss_pred HHH--------------HHcCC---cCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence 110 00111 1112334567899999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=322.49 Aligned_cols=249 Identities=23% Similarity=0.335 Sum_probs=209.3
Q ss_pred cCCCcCceecccCCceEEEEE-ecCCcEEEEEEeccCC-chhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEE
Q 000859 946 NNLSDEFIIGSGGSGTVYKAE-LANGATVAVKKISCKD-DHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLI 1023 (1251)
Q Consensus 946 ~~~~~~~~lG~G~fg~V~~~~-~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv 1023 (1251)
.-|...+.||+|.|+.|-.|+ .-+|+.||||++.+.. +......+.+|+.-|+-++|||||++|.+. +.....|+|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEVi--DTQTKlyLi 95 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVI--DTQTKLYLI 95 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehh--cccceEEEE
Confidence 346777789999999999994 4589999999996543 455667889999999999999999999876 445668999
Q ss_pred EeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeee-cCCCCeEEcccccc
Q 000859 1024 YEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILL-DSNMEAHLGDFGLA 1102 (1251)
Q Consensus 1024 ~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill-~~~~~~kl~DfG~a 1102 (1251)
+|.-++|+|++|+-++ ...+.++.+.+++.||+.|+.|+|+. .+||||+||+||.+ ..-|-||++|||++
T Consensus 96 LELGD~GDl~DyImKH------e~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFS 166 (864)
T KOG4717|consen 96 LELGDGGDLFDYIMKH------EEGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFS 166 (864)
T ss_pred EEecCCchHHHHHHhh------hccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeecccc
Confidence 9999999999999876 46789999999999999999999999 89999999999987 56789999999999
Q ss_pred cccccccCCCCcccceeecccceecccccccCCCC-CccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccc
Q 000859 1103 KALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKAT-EKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSG 1181 (1251)
Q Consensus 1103 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 1181 (1251)
-.+.+ ...-...+|+..|.|||++.+..|+ +++||||+||++|.+.+|++||......+
T Consensus 167 Nkf~P-----G~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSE--------------- 226 (864)
T KOG4717|consen 167 NKFQP-----GKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSE--------------- 226 (864)
T ss_pred ccCCC-----cchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchh---------------
Confidence 76643 2333447899999999999999987 57899999999999999999997553322
Q ss_pred hhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 000859 1182 SAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDL 1230 (1251)
Q Consensus 1182 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 1230 (1251)
.+...+..++..+.....++.++|..|+..||.+|.+.++|+..
T Consensus 227 -----TLTmImDCKYtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 227 -----TLTMIMDCKYTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVST 270 (864)
T ss_pred -----hhhhhhcccccCchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence 22223335566677788899999999999999999999999754
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=340.26 Aligned_cols=243 Identities=21% Similarity=0.304 Sum_probs=193.8
Q ss_pred ceecccCCceEEEEEe-cCCcEEEEEEeccCC--chhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEEEeecC
Q 000859 952 FIIGSGGSGTVYKAEL-ANGATVAVKKISCKD--DHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIYEYME 1028 (1251)
Q Consensus 952 ~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv~E~~~ 1028 (1251)
+.||+|+||.||+|+. .+++.||||++.... .....+.+.+|+++++.++||||+++++++.. ....++||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~lv~Ey~~ 78 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQT--KDRLCFVMEYVN 78 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEc--CCEEEEEEeCCC
Confidence 3699999999999954 568999999996432 22345677889999999999999999987754 445799999999
Q ss_pred CCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcccccccccccc
Q 000859 1029 NGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVED 1108 (1251)
Q Consensus 1029 ~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 1108 (1251)
+|+|.+++.. .+.+++.++..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 79 ~g~L~~~l~~-------~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~ 148 (328)
T cd05593 79 GGELFFHLSR-------ERVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITD 148 (328)
T ss_pred CCCHHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCc
Confidence 9999999876 34689999999999999999999999 9999999999999999999999999998753221
Q ss_pred cCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccchhhhhhh
Q 000859 1109 YNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSAREELL 1188 (1251)
Q Consensus 1109 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1188 (1251)
........||+.|+|||++.+..++.++||||+||++|||++|+.||......+. .... .
T Consensus 149 ----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~-----~~~~-----------~ 208 (328)
T cd05593 149 ----AATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL-----FELI-----------L 208 (328)
T ss_pred ----ccccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHH-----HHHh-----------c
Confidence 1112235789999999999998999999999999999999999999975422111 1000 0
Q ss_pred cccCCCCCCchHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 000859 1189 DDQMKPLLPGEECAAYQVLEIALQCTKTSPQERP-----SSRQVCDL 1230 (1251)
Q Consensus 1189 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~~ 1230 (1251)
. .....+...+.++.+++.+|++.||++|| +++|+++.
T Consensus 209 ~----~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 209 M----EDIKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred c----CCccCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 0 00111122455688999999999999997 89998864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=301.48 Aligned_cols=258 Identities=24% Similarity=0.382 Sum_probs=206.2
Q ss_pred HHHHhhcCCCcCceecccCCceEEEE-EecCCcEEEEEEeccCC-------chhhhHHHHHHHHHHHhc-cCCCccceec
Q 000859 940 DIMGATNNLSDEFIIGSGGSGTVYKA-ELANGATVAVKKISCKD-------DHLLNKSFTREVKTLGRI-RHRHLVKLMG 1010 (1251)
Q Consensus 940 ~~~~~~~~~~~~~~lG~G~fg~V~~~-~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l-~h~niv~l~g 1010 (1251)
+-.+..+.|...+.+|.|..++|.++ ...+|.++|+|++.... .....++-.+|+.|++++ .||+|+++.+
T Consensus 11 aa~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D 90 (411)
T KOG0599|consen 11 AAKGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQD 90 (411)
T ss_pred hHhhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeee
Confidence 33444556778889999999999999 56688999999985332 122345667899999999 6999999999
Q ss_pred eeeecCCCceeEEEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecC
Q 000859 1011 HCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDS 1090 (1251)
Q Consensus 1011 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~ 1090 (1251)
+|.. +...++|+|.|+.|.|.|||.. .-.+++.+.++|+.|+.+|++|||.+ .|||||+||+|||+++
T Consensus 91 ~yes--~sF~FlVFdl~prGELFDyLts-------~VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILldd 158 (411)
T KOG0599|consen 91 VYES--DAFVFLVFDLMPRGELFDYLTS-------KVTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDD 158 (411)
T ss_pred eccC--cchhhhhhhhcccchHHHHhhh-------heeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeecc
Confidence 8844 4556899999999999999987 45789999999999999999999999 9999999999999999
Q ss_pred CCCeEEcccccccccccccCCCCcccceeecccceecccccc------cCCCCCccceeehhHHHHHHhhCCCCCCCccc
Q 000859 1091 NMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAY------SLKATEKCDVYSMGIVLMELVSGKMPTDATFG 1164 (1251)
Q Consensus 1091 ~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~ 1164 (1251)
+.++||+|||+|..+.+ ...-...+||++|.|||.+. ...|+..+|+||.||++|.++.|++||.-.
T Consensus 159 n~~i~isDFGFa~~l~~-----GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHR-- 231 (411)
T KOG0599|consen 159 NMNIKISDFGFACQLEP-----GEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHR-- 231 (411)
T ss_pred ccceEEeccceeeccCC-----chhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHH--
Confidence 99999999999987643 23334479999999999875 346888999999999999999999998522
Q ss_pred cchhHHHHHHHHHhccchhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 000859 1165 VEMDMVRWVEMHMEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDL 1230 (1251)
Q Consensus 1165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 1230 (1251)
.+.+.. ..+....+.-..|.+...+..+.++|.+|++.||.+|.|++|+++.
T Consensus 232 -----kQmlML---------R~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 232 -----KQMLML---------RMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred -----HHHHHH---------HHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 111111 1111122223334556677789999999999999999999998764
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=342.27 Aligned_cols=358 Identities=30% Similarity=0.413 Sum_probs=231.8
Q ss_pred EEeecccccc-cccccccccccccEEEecccccCCCCchhhhcccccchhhcccCcccccccCCcCCCCccceEeccCCc
Q 000859 389 LYLHNNSLVG-SISPFVANLSNLQELALYHNNFQGSLPREIGMLVKLELLYLYDNHLSGQIPSEVGNCSSLKWIDFFGNS 467 (1251)
Q Consensus 389 L~L~~n~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~ 467 (1251)
.|+++|.++| ..|.....++.++.|.|...++. .+|+.++.+.+|++|.+++|++. .+-..+..++.|+.+++..|+
T Consensus 12 vDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRsv~~R~N~ 89 (1255)
T KOG0444|consen 12 VDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRSVIVRDNN 89 (1255)
T ss_pred ccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHHHhhhccc
Confidence 3344444432 23444455555666666666665 67777888888888888888877 566677778888888888887
Q ss_pred cc-CCCCCcccccCCCcEEeccCCccCCCcCccccccccCCeeecCCCcCcccCCcchhccchhhhhhccCCccccCCch
Q 000859 468 FT-GEIPTSIGRLKDLNFLHLRQNELVGQIPASLGNCHQLIILDLADNKLSGGVPASFGFLQALEQLMLYNNSLEGNLPG 546 (1251)
Q Consensus 468 l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~ 546 (1251)
+. .-+|..+.++..|+.|+||+|+++ +.|..+...+++..|+||+|+|..++-..|-+|+.|-.||||+|+++ .+|.
T Consensus 90 LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrLe-~LPP 167 (1255)
T KOG0444|consen 90 LKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRLE-MLPP 167 (1255)
T ss_pred cccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhccccchhh-hcCH
Confidence 75 356778888888888888888888 78888888888888999999888666666788888888999999988 5677
Q ss_pred hhhhhcCCCeeecccccccccc-cccccCccceeeecccCccccCCCCCCCCcccCceeecccCccc-cccCcccccccc
Q 000859 547 SLINLRNLTRINFSKNRLNGRI-ATLCSSHSFLSFDVTNNEFDHEIPPQLGNSPSLERLRLGNNKFI-GKIPWTFGKIRE 624 (1251)
Q Consensus 547 ~l~~l~~L~~L~l~~N~l~~~~-~~l~~~~~l~~l~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~-~~~p~~~~~l~~ 624 (1251)
.+..|..|++|.|++|++...- ..+++ +++|+.|.+++.+-+ ..+|.++..+.+
T Consensus 168 Q~RRL~~LqtL~Ls~NPL~hfQLrQLPs------------------------mtsL~vLhms~TqRTl~N~Ptsld~l~N 223 (1255)
T KOG0444|consen 168 QIRRLSMLQTLKLSNNPLNHFQLRQLPS------------------------MTSLSVLHMSNTQRTLDNIPTSLDDLHN 223 (1255)
T ss_pred HHHHHhhhhhhhcCCChhhHHHHhcCcc------------------------chhhhhhhcccccchhhcCCCchhhhhh
Confidence 7888888999999999886431 22333 344444444443322 234555555555
Q ss_pred cceEEccCCcccCCCCccccccCCccEEEcCCCccCCCCccccCCCcccccccccCccccCCCccccccccccceeeccC
Q 000859 625 LSLLDLSGNSLTGPIPTQLLMCKKLSHIDLNNNLLSGAVPSWLGTLPQLGELKLSFNQFVGFLPRELFNCSKLLVLSLDG 704 (1251)
Q Consensus 625 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~ 704 (1251)
|..+|+|+|.+. .+|+.+..+.+|+.|+||+|.|+ .+....+...+|+.|+||+|+++. +|.+++++++|+.|++.+
T Consensus 224 L~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt~-LP~avcKL~kL~kLy~n~ 300 (1255)
T KOG0444|consen 224 LRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKIT-ELNMTEGEWENLETLNLSRNQLTV-LPDAVCKLTKLTKLYANN 300 (1255)
T ss_pred hhhccccccCCC-cchHHHhhhhhhheeccCcCcee-eeeccHHHHhhhhhhccccchhcc-chHHHhhhHHHHHHHhcc
Confidence 555555555555 45555555555555555555555 334444555556666666666653 566666666666666666
Q ss_pred cccccc-cCcccCCCCCCceeccCCCcCCCCCCcccccccccceeeccCcccccccchhhhchhhHHHHHhccCCcc
Q 000859 705 NMLNGS-LPNEVGNLASLNVLTLSGNLLSGPIPPAIGRLSKLYELRLSNNSLNGVIPLEIGQLQNLQSILDLSHNNF 780 (1251)
Q Consensus 705 N~l~~~-~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~l~~N~l 780 (1251)
|+++-+ +|..++.|..|+++..++|.+. .+|+.+++|.+|+.|.|+.|+|. .+|++|.-|+.|. +||+..|.=
T Consensus 301 NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~-vLDlreNpn 374 (1255)
T KOG0444|consen 301 NKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLK-VLDLRENPN 374 (1255)
T ss_pred CcccccCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhccccccee-echhhhhhcCCcc-eeeccCCcC
Confidence 665422 5555666666666666666665 55666666666666666666665 4566666666653 356665543
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=342.67 Aligned_cols=246 Identities=22% Similarity=0.296 Sum_probs=197.2
Q ss_pred cCCCcCceecccCCceEEEEEecC--CcEEEEEEeccCC--chhhhHHHHHHHHHHHhccCCCccceeceeeecCCCcee
Q 000859 946 NNLSDEFIIGSGGSGTVYKAELAN--GATVAVKKISCKD--DHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNL 1021 (1251)
Q Consensus 946 ~~~~~~~~lG~G~fg~V~~~~~~~--~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~ 1021 (1251)
++|...+.||+|+||.||+|..+. +..||+|++.... .....+.+.+|+++++.++||||+++++++... ...+
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~--~~~~ 107 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDE--SYLY 107 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeC--CEEE
Confidence 358888999999999999996543 3689999986432 223446788999999999999999999988654 4579
Q ss_pred EEEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEccccc
Q 000859 1022 LIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGL 1101 (1251)
Q Consensus 1022 lv~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~ 1101 (1251)
+||||+++|+|.+++... +.+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 108 lv~Ey~~~g~L~~~i~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~ 177 (340)
T PTZ00426 108 LVLEFVIGGEFFTFLRRN-------KRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGF 177 (340)
T ss_pred EEEeCCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCC
Confidence 999999999999999763 4689999999999999999999999 999999999999999999999999999
Q ss_pred ccccccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccc
Q 000859 1102 AKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSG 1181 (1251)
Q Consensus 1102 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 1181 (1251)
++..... .....||+.|+|||++.+..++.++||||+||++|||++|+.||.+...... ...
T Consensus 178 a~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~-----~~~------ 239 (340)
T PTZ00426 178 AKVVDTR-------TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLI-----YQK------ 239 (340)
T ss_pred CeecCCC-------cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHH-----HHH------
Confidence 9764221 1235789999999999988899999999999999999999999975432111 000
Q ss_pred hhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 000859 1182 SAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERP-----SSRQVCDL 1230 (1251)
Q Consensus 1182 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~~ 1230 (1251)
..... ...+...+..+.+++.+|++.||++|+ +++++++.
T Consensus 240 -----i~~~~----~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 240 -----ILEGI----IYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred -----HhcCC----CCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 00100 001122345678999999999999995 88888764
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=327.29 Aligned_cols=251 Identities=26% Similarity=0.451 Sum_probs=200.1
Q ss_pred cCCCcCceecccCCceEEEEEecCCcEEEEEEeccCCchhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEEEe
Q 000859 946 NNLSDEFIIGSGGSGTVYKAELANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIYE 1025 (1251)
Q Consensus 946 ~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv~E 1025 (1251)
++|+..+.||+|+||.||+|+++++..||+|.+.... ...+.+.+|++++++++||||+++++++... ...++|||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~iv~e 79 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA--MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQ--KPLYIVTE 79 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC--ccHHHHHHHHHHHHHCCCCCceeEEEEEccC--CCEEEEEE
Confidence 4577788999999999999998888899999985332 2346788999999999999999999988553 45799999
Q ss_pred ecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEccccccccc
Q 000859 1026 YMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKAL 1105 (1251)
Q Consensus 1026 ~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~ 1105 (1251)
|+++|+|.++++.. ...+++..+..++.|++.|++|||+. +|+||||||+||++++++.+|++|||.++..
T Consensus 80 ~~~~~~L~~~~~~~------~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~ 150 (256)
T cd05114 80 FMENGCLLNYLRQR------QGKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYV 150 (256)
T ss_pred cCCCCcHHHHHHhC------ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCcccc
Confidence 99999999999753 23588999999999999999999999 9999999999999999999999999998765
Q ss_pred ccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhh-CCCCCCCccccchhHHHHHHHHHhccchhh
Q 000859 1106 VEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMVRWVEMHMEMSGSAR 1184 (1251)
Q Consensus 1106 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1184 (1251)
...... ......++..|+|||.+.+..++.++||||||+++||+++ |+.||......+. ......
T Consensus 151 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~-----~~~i~~------ 216 (256)
T cd05114 151 LDDEYT---SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEV-----VEMISR------ 216 (256)
T ss_pred CCCcee---ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHH-----HHHHHC------
Confidence 322111 1122345678999999988889999999999999999999 9999975532111 111100
Q ss_pred hhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 000859 1185 EELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLL 1231 (1251)
Q Consensus 1185 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L 1231 (1251)
. .... .+...+.++.+++.+||+.+|++||+++++++.|
T Consensus 217 -----~-~~~~--~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 217 -----G-FRLY--RPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred -----C-CCCC--CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 0 0001 1112345689999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=341.86 Aligned_cols=252 Identities=23% Similarity=0.282 Sum_probs=200.6
Q ss_pred CCCcCceecccCCceEEEEEec-CCcEEEEEEeccCC--chhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEE
Q 000859 947 NLSDEFIIGSGGSGTVYKAELA-NGATVAVKKISCKD--DHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLI 1023 (1251)
Q Consensus 947 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv 1023 (1251)
+|++.+.||+|+||.||+|+.. +++.||||++.... .....+.+.+|+++++.++||||+++++++.. ....++|
T Consensus 2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~--~~~~~lv 79 (333)
T cd05600 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQD--DEYLYLA 79 (333)
T ss_pred CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEc--CCEEEEE
Confidence 6888899999999999999664 58999999996442 12234578889999999999999999988754 4567999
Q ss_pred EeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEccccccc
Q 000859 1024 YEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAK 1103 (1251)
Q Consensus 1024 ~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~ 1103 (1251)
|||+++|+|.+++.. ...+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 80 ~e~~~g~~L~~~l~~-------~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~ 149 (333)
T cd05600 80 MEYVPGGDFRTLLNN-------LGVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSK 149 (333)
T ss_pred EeCCCCCCHHHHHHH-------cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCc
Confidence 999999999999976 34688999999999999999999999 99999999999999999999999999997
Q ss_pred ccccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccchh
Q 000859 1104 ALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSA 1183 (1251)
Q Consensus 1104 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1183 (1251)
.... ......||+.|+|||++.+..++.++||||+||++|||++|+.||......+. ...+...
T Consensus 150 ~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~--~~~i~~~------- 213 (333)
T cd05600 150 GIVT-------YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNET--WENLKYW------- 213 (333)
T ss_pred cccc-------ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHH--HHHHHhc-------
Confidence 6432 12235789999999999999999999999999999999999999976533221 0000000
Q ss_pred hhhhhcccCCCCCC-chHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 000859 1184 REELLDDQMKPLLP-GEECAAYQVLEIALQCTKTSPQERPSSRQVCDL 1230 (1251)
Q Consensus 1184 ~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 1230 (1251)
... . ..+... .....+.++.+++.+|++.+|.+||+++++++.
T Consensus 214 ~~~-~---~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 214 KET-L---QRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred ccc-c---cCCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 000 0 001110 011245678899999999999999999999865
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=340.94 Aligned_cols=242 Identities=22% Similarity=0.325 Sum_probs=192.7
Q ss_pred ceecccCCceEEEEEe-cCCcEEEEEEeccCC--chhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEEEeecC
Q 000859 952 FIIGSGGSGTVYKAEL-ANGATVAVKKISCKD--DHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIYEYME 1028 (1251)
Q Consensus 952 ~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv~E~~~ 1028 (1251)
+.||+|+||.||+++. .+|+.||+|++.... .......+.+|+++++.++||||+++++++.. ....++||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~--~~~~~lv~E~~~ 78 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT--HDRLCFVMEYAN 78 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEec--CCEEEEEEeCCC
Confidence 3699999999999954 578999999986432 22344567789999999999999999998754 346799999999
Q ss_pred CCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcccccccccccc
Q 000859 1029 NGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVED 1108 (1251)
Q Consensus 1029 ~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 1108 (1251)
+|+|..++.. .+.+++..++.++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 79 ~~~L~~~l~~-------~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 148 (323)
T cd05595 79 GGELFFHLSR-------ERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 148 (323)
T ss_pred CCcHHHHHHH-------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCC
Confidence 9999998876 34689999999999999999999999 9999999999999999999999999998653221
Q ss_pred cCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccchhhhhhh
Q 000859 1109 YNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSAREELL 1188 (1251)
Q Consensus 1109 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1188 (1251)
........||+.|+|||++.+..++.++||||+||++|||++|+.||........ ... ..
T Consensus 149 ----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~-----~~~-----------~~ 208 (323)
T cd05595 149 ----GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL-----FEL-----------IL 208 (323)
T ss_pred ----CCccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHH-----HHH-----------Hh
Confidence 1112235689999999999999999999999999999999999999965422111 000 00
Q ss_pred cccCCCCCCchHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 000859 1189 DDQMKPLLPGEECAAYQVLEIALQCTKTSPQERP-----SSRQVCD 1229 (1251)
Q Consensus 1189 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~ 1229 (1251)
.. ....+...++++.+++.+||+.||++|| +++++++
T Consensus 209 ~~----~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 209 ME----EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred cC----CCCCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 00 0011122456788999999999999998 8888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=336.87 Aligned_cols=269 Identities=21% Similarity=0.306 Sum_probs=198.5
Q ss_pred hcCCCcCceecccCCceEEEEEec-CCcEEEEEEeccCCchhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEE
Q 000859 945 TNNLSDEFIIGSGGSGTVYKAELA-NGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLI 1023 (1251)
Q Consensus 945 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv 1023 (1251)
.++|+..+.||+|+||.||+|+.. +++.||||++...........+.+|+.+++.++||||+++++++.. +...++|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv 81 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHT--KETLTLV 81 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEec--CCeEEEE
Confidence 467899999999999999999654 6899999999755444344567889999999999999999998864 3457999
Q ss_pred EeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEccccccc
Q 000859 1024 YEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAK 1103 (1251)
Q Consensus 1024 ~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~ 1103 (1251)
|||++ +++.+++... ...++++.+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++
T Consensus 82 ~e~~~-~~l~~~~~~~------~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 151 (303)
T cd07869 82 FEYVH-TDLCQYMDKH------PGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLAR 151 (303)
T ss_pred EECCC-cCHHHHHHhC------CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcce
Confidence 99995 6888888754 35688999999999999999999999 99999999999999999999999999986
Q ss_pred ccccccCCCCcccceeecccceeccccccc-CCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccch
Q 000859 1104 ALVEDYNSNTESNTWFAGSYGYIAPEYAYS-LKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGS 1182 (1251)
Q Consensus 1104 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 1182 (1251)
..... ........||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+.....................
T Consensus 152 ~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 227 (303)
T cd07869 152 AKSVP----SHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNED 227 (303)
T ss_pred eccCC----CccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChh
Confidence 53221 111223467899999998865 4588999999999999999999999986543222221111110000000
Q ss_pred -hh-----hhhhcccCCCCCCch--H-----HHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 000859 1183 -AR-----EELLDDQMKPLLPGE--E-----CAAYQVLEIALQCTKTSPQERPSSRQVCD 1229 (1251)
Q Consensus 1183 -~~-----~~~~~~~~~~~~~~~--~-----~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1229 (1251)
+. ............+.. . .....+.+++.+|++.||++|||++|+++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 228 TWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred hccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 00 000000000000000 0 01246789999999999999999999985
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=332.09 Aligned_cols=272 Identities=28% Similarity=0.383 Sum_probs=206.7
Q ss_pred CCcCceecccCCceEEEEEe-----cCCcEEEEEEeccCCchhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeE
Q 000859 948 LSDEFIIGSGGSGTVYKAEL-----ANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLL 1022 (1251)
Q Consensus 948 ~~~~~~lG~G~fg~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~l 1022 (1251)
|...+.||+|+||+||++.+ .+++.||+|++.........+.+.+|++++++++||||+++++++........++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 37788999999999988643 3578999999976544445678889999999999999999999887665566799
Q ss_pred EEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcccccc
Q 000859 1023 IYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLA 1102 (1251)
Q Consensus 1023 v~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a 1102 (1251)
||||+++|+|.+++.. ..+++..+..++.|++.|++|||+. +|+||||||+||++++++.+||+|||++
T Consensus 86 v~e~~~~~~l~~~~~~--------~~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~ 154 (283)
T cd05080 86 IMEYVPLGSLRDYLPK--------HKLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLA 154 (283)
T ss_pred EecCCCCCCHHHHHHH--------cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeecccc
Confidence 9999999999999975 2489999999999999999999999 9999999999999999999999999999
Q ss_pred cccccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccch
Q 000859 1103 KALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGS 1182 (1251)
Q Consensus 1103 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 1182 (1251)
+........ ........++..|+|||.+.+..++.++||||||+++|||+||+.||............+... .....
T Consensus 155 ~~~~~~~~~-~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~--~~~~~ 231 (283)
T cd05080 155 KAVPEGHEY-YRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQG--QMTVV 231 (283)
T ss_pred cccCCcchh-hccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhccccc--ccchh
Confidence 765432111 111122345677999999988889999999999999999999999986442211111100000 00000
Q ss_pred hhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhc
Q 000859 1183 AREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNVF 1235 (1251)
Q Consensus 1183 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~ 1235 (1251)
......+.... .+.+...+.++.+++.+||+.||++|||++++++.|+++-
T Consensus 232 ~~~~~~~~~~~--~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 232 RLIELLERGMR--LPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hhhhhhhcCCC--CCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 11111111111 1122335678999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=333.18 Aligned_cols=253 Identities=25% Similarity=0.345 Sum_probs=211.3
Q ss_pred cCCCcCceecccCCceEEEEEe-cCCcEEEEEEeccCC-chhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEE
Q 000859 946 NNLSDEFIIGSGGSGTVYKAEL-ANGATVAVKKISCKD-DHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLI 1023 (1251)
Q Consensus 946 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv 1023 (1251)
.+|...+++|+|+||.++.++. .++..||+|++.-.. .+..++...+|+.++++++|||||.+.+.|.+++ ...+||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~-~~l~Iv 82 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDG-QLLCIV 82 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCC-ceEEEE
Confidence 4688889999999999999944 467889999997554 3344557889999999999999999999886543 337999
Q ss_pred EeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEccccccc
Q 000859 1024 YEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAK 1103 (1251)
Q Consensus 1024 ~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~ 1103 (1251)
|+|++||++.+.+.++. +..++++.+.+++.|++.|+.|||+. .|+|||||+.||+++.++.|||+|||+|+
T Consensus 83 m~Y~eGg~l~~~i~~~k-----~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK 154 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQK-----GVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAK 154 (426)
T ss_pred EeecCCCCHHHHHHHHh-----hccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhh
Confidence 99999999999998864 57789999999999999999999998 99999999999999999999999999999
Q ss_pred ccccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccchh
Q 000859 1104 ALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSA 1183 (1251)
Q Consensus 1104 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1183 (1251)
.+..+. ......+||+.||.||.+.+.+|..|+||||+||++|||++-+++|.+..-.. .
T Consensus 155 ~l~~~~----~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~-----L----------- 214 (426)
T KOG0589|consen 155 ILNPED----SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSE-----L----------- 214 (426)
T ss_pred hcCCch----hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHH-----H-----------
Confidence 875443 23344789999999999999999999999999999999999999998652211 1
Q ss_pred hhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 000859 1184 REELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDL 1230 (1251)
Q Consensus 1184 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 1230 (1251)
..++.... ..|.+.....++..+++.|++.+|+.||++.+++..
T Consensus 215 i~ki~~~~---~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 215 ILKINRGL---YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred HHHHhhcc---CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 11111111 123445567789999999999999999999999987
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=338.30 Aligned_cols=243 Identities=23% Similarity=0.357 Sum_probs=192.8
Q ss_pred ceecccCCceEEEEEe----cCCcEEEEEEeccCC---chhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEEE
Q 000859 952 FIIGSGGSGTVYKAEL----ANGATVAVKKISCKD---DHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIY 1024 (1251)
Q Consensus 952 ~~lG~G~fg~V~~~~~----~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv~ 1024 (1251)
+.||+|+||.||+++. .+++.||||++.... .....+.+.+|+++++.++||||+++++++... ...++||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~--~~~~lv~ 79 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTG--GKLYLIL 79 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecC--CeEEEEE
Confidence 5799999999999964 357899999986432 222345677899999999999999999988654 4579999
Q ss_pred eecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcccccccc
Q 000859 1025 EYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKA 1104 (1251)
Q Consensus 1025 E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~ 1104 (1251)
||+++|+|.+++.. .+.+.+..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 80 e~~~~~~L~~~~~~-------~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 149 (323)
T cd05584 80 EYLSGGELFMHLER-------EGIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKE 149 (323)
T ss_pred eCCCCchHHHHHHH-------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCee
Confidence 99999999999976 34678889999999999999999999 999999999999999999999999999865
Q ss_pred cccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccchhh
Q 000859 1105 LVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSAR 1184 (1251)
Q Consensus 1105 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1184 (1251)
.... ........||+.|+|||++.+..++.++||||+||++|||++|+.||...... .....
T Consensus 150 ~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~-----~~~~~--------- 211 (323)
T cd05584 150 SIHE----GTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK-----KTIDK--------- 211 (323)
T ss_pred cccC----CCcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH-----HHHHH---------
Confidence 3221 11122356899999999999888999999999999999999999999754221 11111
Q ss_pred hhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 000859 1185 EELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERP-----SSRQVCDL 1230 (1251)
Q Consensus 1185 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~~ 1230 (1251)
... .....+...++++.+++.+|++.||++|| +++++++.
T Consensus 212 --~~~----~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 212 --ILK----GKLNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred --HHc----CCCCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 001 11111222345688999999999999999 78888763
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=326.81 Aligned_cols=256 Identities=24% Similarity=0.396 Sum_probs=204.9
Q ss_pred hcCCCcCceecccCCceEEEEEecCCcEEEEEEeccCCchhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEEE
Q 000859 945 TNNLSDEFIIGSGGSGTVYKAELANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIY 1024 (1251)
Q Consensus 945 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv~ 1024 (1251)
.++|+..++||+|+||.||+|...++..||+|.+.... ...+.+.+|+.++++++|+||+++++++.. ....+++|
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~ 80 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT--MSVQAFLEEANLMKTLQHDKLVRLYAVVTK--EEPIYIIT 80 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc--hhHHHHHHHHHHHHhCCCCCeeeEEEEEcC--CCCcEEEE
Confidence 34688889999999999999988888899999986432 235788999999999999999999987754 34569999
Q ss_pred eecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcccccccc
Q 000859 1025 EYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKA 1104 (1251)
Q Consensus 1025 E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~ 1104 (1251)
||+++|+|.++++... ...+++..+..++.|+++|++|||+. +++||||||+||+++.++.+||+|||.++.
T Consensus 81 e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~ 152 (261)
T cd05072 81 EYMAKGSLLDFLKSDE-----GGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARV 152 (261)
T ss_pred ecCCCCcHHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCcccee
Confidence 9999999999997642 45688999999999999999999999 999999999999999999999999999976
Q ss_pred cccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhh-CCCCCCCccccchhHHHHHHHHHhccchh
Q 000859 1105 LVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMVRWVEMHMEMSGSA 1183 (1251)
Q Consensus 1105 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1183 (1251)
...... .......++..|+|||++.+..++.++|||||||++|||+| |+.||......+ ..... .
T Consensus 153 ~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~--~~~~~---~------ 218 (261)
T cd05072 153 IEDNEY---TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD--VMSAL---Q------ 218 (261)
T ss_pred cCCCce---eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH--HHHHH---H------
Confidence 533211 11122345778999999988889999999999999999998 999997542211 11110 0
Q ss_pred hhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 000859 1184 REELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNV 1234 (1251)
Q Consensus 1184 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 1234 (1251)
. .. ..+.....+.++.+++.+|++.+|++||+++++.+.|+++
T Consensus 219 -----~-~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 219 -----R-GY--RMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred -----c-CC--CCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 0 00 0111122456788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=345.08 Aligned_cols=256 Identities=22% Similarity=0.297 Sum_probs=196.4
Q ss_pred CCCcCceecccCCceEEEEE-ecCCcEEEEEEeccCC--chhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEE
Q 000859 947 NLSDEFIIGSGGSGTVYKAE-LANGATVAVKKISCKD--DHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLI 1023 (1251)
Q Consensus 947 ~~~~~~~lG~G~fg~V~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv 1023 (1251)
.|...+.||+|+||+||+|. ..+++.||||++.... .....+.+.+|++++++++||||+++++++.+ ....++|
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~--~~~~~lv 79 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQD--KDNLYFV 79 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEec--CCEEEEE
Confidence 57788899999999999995 4568899999996543 23345678899999999999999999998864 4567999
Q ss_pred EeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEccccccc
Q 000859 1024 YEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAK 1103 (1251)
Q Consensus 1024 ~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~ 1103 (1251)
|||+++|+|.+++.+. +.+++..++.++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 80 ~E~~~gg~L~~~l~~~-------~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~ 149 (381)
T cd05626 80 MDYIPGGDMMSLLIRM-------EVFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCT 149 (381)
T ss_pred EecCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCc
Confidence 9999999999999763 4688999999999999999999999 99999999999999999999999999986
Q ss_pred ccccccCCC-------------------------------------------CcccceeecccceecccccccCCCCCcc
Q 000859 1104 ALVEDYNSN-------------------------------------------TESNTWFAGSYGYIAPEYAYSLKATEKC 1140 (1251)
Q Consensus 1104 ~~~~~~~~~-------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~s 1140 (1251)
.+....... ........||+.|+|||++.+..++.++
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~ 229 (381)
T cd05626 150 GFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLC 229 (381)
T ss_pred ccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCcc
Confidence 432110000 0001124699999999999988999999
Q ss_pred ceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccchhhhhhhcccCCCCCCchHHHHHHHHHHHHH--ccccCC
Q 000859 1141 DVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQ--CTKTSP 1218 (1251)
Q Consensus 1141 DiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~--cl~~dP 1218 (1251)
||||+||++|||++|+.||......+.... ..........+.....++++.+++.+ |+..+|
T Consensus 230 DiwSlG~il~elltG~~Pf~~~~~~~~~~~----------------i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~ 293 (381)
T cd05626 230 DWWSVGVILFEMLVGQPPFLAPTPTETQLK----------------VINWENTLHIPPQVKLSPEAVDLITKLCCSAEER 293 (381)
T ss_pred ceeehhhHHHHHHhCCCCCcCCCHHHHHHH----------------HHccccccCCCCCCCCCHHHHHHHHHHccCcccc
Confidence 999999999999999999976532211100 00000001112222234567788877 556677
Q ss_pred CCCCCHHHHHHH
Q 000859 1219 QERPSSRQVCDL 1230 (1251)
Q Consensus 1219 ~~RPs~~eil~~ 1230 (1251)
..||+++|+++.
T Consensus 294 ~~R~~~~~~l~h 305 (381)
T cd05626 294 LGRNGADDIKAH 305 (381)
T ss_pred cCCCCHHHHhcC
Confidence 779999999874
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=331.90 Aligned_cols=268 Identities=22% Similarity=0.300 Sum_probs=198.4
Q ss_pred cCCCcCceecccCCceEEEEEec-CCcEEEEEEeccCC-chhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEE
Q 000859 946 NNLSDEFIIGSGGSGTVYKAELA-NGATVAVKKISCKD-DHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLI 1023 (1251)
Q Consensus 946 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv 1023 (1251)
++|++.+.||+|+||+||+|+.+ +++.||||++.... .....+.+.+|+++++.++||||+++++++.. ....++|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 78 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRR--RGKLYLV 78 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEec--CCEEEEE
Confidence 36888899999999999999664 68899999987543 22345678899999999999999999998854 3457999
Q ss_pred EeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEccccccc
Q 000859 1024 YEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAK 1103 (1251)
Q Consensus 1024 ~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~ 1103 (1251)
|||++++.+..+.+. ...+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 79 ~e~~~~~~l~~~~~~-------~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~ 148 (287)
T cd07848 79 FEYVEKNMLELLEEM-------PNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFAR 148 (287)
T ss_pred EecCCCCHHHHHHhc-------CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCcc
Confidence 999998766554332 34689999999999999999999999 99999999999999999999999999997
Q ss_pred ccccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccchh
Q 000859 1104 ALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSA 1183 (1251)
Q Consensus 1104 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1183 (1251)
....... .......||..|+|||++.+..++.++||||+||++|||++|+.||.+....+. ...............
T Consensus 149 ~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~ 224 (287)
T cd07848 149 NLSEGSN---ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQ-LFTIQKVLGPLPAEQ 224 (287)
T ss_pred ccccccc---ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhhCCCCHHH
Confidence 6532211 112235689999999999988899999999999999999999999976533221 111000000000000
Q ss_pred hhhhh-c----ccCCCCCCc--------hHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 000859 1184 REELL-D----DQMKPLLPG--------EECAAYQVLEIALQCTKTSPQERPSSRQVCD 1229 (1251)
Q Consensus 1184 ~~~~~-~----~~~~~~~~~--------~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1229 (1251)
..... + ....+.... ....+.++.+++.+|++.||++|||++|+++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 225 MKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred HHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00000 0 000000000 0113567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=325.98 Aligned_cols=257 Identities=27% Similarity=0.415 Sum_probs=205.6
Q ss_pred cCCCcCceecccCCceEEEEEecC----CcEEEEEEeccCCchhhhHHHHHHHHHHHhccCCCccceeceeeecCCCcee
Q 000859 946 NNLSDEFIIGSGGSGTVYKAELAN----GATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNL 1021 (1251)
Q Consensus 946 ~~~~~~~~lG~G~fg~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~ 1021 (1251)
++|+..+.||+|+||+||+|.+.. ...||||++.........+.|.+|+.++++++||||+++++++... ...+
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~ 81 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKS--RPVM 81 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecC--CceE
Confidence 468888999999999999997642 4579999987666665667899999999999999999999987543 4468
Q ss_pred EEEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEccccc
Q 000859 1022 LIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGL 1101 (1251)
Q Consensus 1022 lv~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~ 1101 (1251)
+||||+++|+|.+++... ...+++..+.+++.|++.|++|||+. +|+||||||+||++++++.+|++|||+
T Consensus 82 iv~e~~~~~~L~~~~~~~------~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~ 152 (266)
T cd05033 82 IITEYMENGSLDKFLREN------DGKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGL 152 (266)
T ss_pred EEEEcCCCCCHHHHHHhc------cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccch
Confidence 999999999999999764 24689999999999999999999999 999999999999999999999999999
Q ss_pred ccccccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhh-CCCCCCCccccchhHHHHHHHHHhcc
Q 000859 1102 AKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMVRWVEMHMEMS 1180 (1251)
Q Consensus 1102 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~ 1180 (1251)
++........ .......++..|+|||.+.+..++.++||||||+++||+++ |..||......+ .....
T Consensus 153 ~~~~~~~~~~--~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~--~~~~~------- 221 (266)
T cd05033 153 SRRLEDSEAT--YTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD--VIKAV------- 221 (266)
T ss_pred hhcccccccc--eeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHH--HHHHH-------
Confidence 9876421111 11112234678999999998899999999999999999998 999986542211 11100
Q ss_pred chhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 000859 1181 GSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNV 1234 (1251)
Q Consensus 1181 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 1234 (1251)
... . ..+.+..++..+.+++.+||+.+|++||+++++++.|+++
T Consensus 222 -------~~~-~--~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 222 -------EDG-Y--RLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred -------HcC-C--CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 000 0 0111223456789999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=324.37 Aligned_cols=251 Identities=22% Similarity=0.370 Sum_probs=199.0
Q ss_pred eecccCCceEEEEEec---CCcEEEEEEeccCCchhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEEEeecCC
Q 000859 953 IIGSGGSGTVYKAELA---NGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIYEYMEN 1029 (1251)
Q Consensus 953 ~lG~G~fg~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv~E~~~~ 1029 (1251)
.||+|+||.||+|.+. ++..||+|++.........+.+.+|+.++++++||||+++++++.. ...++||||+++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~---~~~~lv~e~~~~ 78 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA---EALMLVMEMASG 78 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC---CCeEEEEEeCCC
Confidence 4899999999999653 3557999999766555556789999999999999999999998732 346899999999
Q ss_pred CChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEccccccccccccc
Q 000859 1030 GSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDY 1109 (1251)
Q Consensus 1030 gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 1109 (1251)
|+|.+++... ...+++..+.+++.|++.|++|||++ +++||||||+||+++.++.+|++|||.++.+..+.
T Consensus 79 ~~L~~~l~~~------~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~ 149 (257)
T cd05115 79 GPLNKFLSGK------KDEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADD 149 (257)
T ss_pred CCHHHHHHhC------CCCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCc
Confidence 9999999753 34689999999999999999999999 99999999999999999999999999997653322
Q ss_pred CCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhh-CCCCCCCccccchhHHHHHHHHHhccchhhhhhh
Q 000859 1110 NSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMVRWVEMHMEMSGSAREELL 1188 (1251)
Q Consensus 1110 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1188 (1251)
... .......++..|+|||.+....++.++|||||||++||+++ |+.||......+. ....
T Consensus 150 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~-----~~~~------------ 211 (257)
T cd05115 150 SYY-KARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEV-----MSFI------------ 211 (257)
T ss_pred cce-eccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHH-----HHHH------------
Confidence 111 11111234678999999988889999999999999999997 9999976532211 1000
Q ss_pred cccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhc
Q 000859 1189 DDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNVF 1235 (1251)
Q Consensus 1189 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~ 1235 (1251)
..... .+.+..++.++.+++.+||+.||++||++.+|.+.|+.++
T Consensus 212 ~~~~~--~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~~ 256 (257)
T cd05115 212 EQGKR--LDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTYY 256 (257)
T ss_pred HCCCC--CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhhc
Confidence 00011 1122234567889999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=342.33 Aligned_cols=269 Identities=23% Similarity=0.303 Sum_probs=197.8
Q ss_pred CCCcCceecccCCceEEEEE-ecCCcEEEEEEeccCC-chhhhHHHHHHHHHHHhccCCCccceeceeeecCC---Ccee
Q 000859 947 NLSDEFIIGSGGSGTVYKAE-LANGATVAVKKISCKD-DHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGA---GSNL 1021 (1251)
Q Consensus 947 ~~~~~~~lG~G~fg~V~~~~-~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~---~~~~ 1021 (1251)
+|+..+.||+|+||.||+|. ..+++.||||++.... .......+.+|++++++++||||+++++++..... ...+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 47788899999999999995 4578999999986432 22234568899999999999999999998764332 2468
Q ss_pred EEEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEccccc
Q 000859 1022 LIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGL 1101 (1251)
Q Consensus 1022 lv~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~ 1101 (1251)
+||||++ ++|.+++... ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 81 lv~e~~~-~~L~~~l~~~-------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~ 149 (338)
T cd07859 81 VVFELME-SDLHQVIKAN-------DDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGL 149 (338)
T ss_pred EEEecCC-CCHHHHHHhc-------ccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCcc
Confidence 9999995 6899998763 4689999999999999999999999 999999999999999999999999999
Q ss_pred ccccccccCCCCcccceeecccceeccccccc--CCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhc
Q 000859 1102 AKALVEDYNSNTESNTWFAGSYGYIAPEYAYS--LKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEM 1179 (1251)
Q Consensus 1102 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 1179 (1251)
++........ ........||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+..... ....+......
T Consensus 150 ~~~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~--~~~~~~~~~~~ 226 (338)
T cd07859 150 ARVAFNDTPT-AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVH--QLDLITDLLGT 226 (338)
T ss_pred ccccccccCc-cccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHH--HHHHHHHHhCC
Confidence 9764322111 112233578999999999865 678999999999999999999999997643211 11111000000
Q ss_pred c---------chhhhhhhcccCCCCCCc--h---HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 000859 1180 S---------GSAREELLDDQMKPLLPG--E---ECAAYQVLEIALQCTKTSPQERPSSRQVCDL 1230 (1251)
Q Consensus 1180 ~---------~~~~~~~~~~~~~~~~~~--~---~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 1230 (1251)
. ........... .+..+. . ...+.++.+++.+||+.||++|||++|+++.
T Consensus 227 ~~~~~~~~i~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 227 PSPETISRVRNEKARRYLSSM-RKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred CCHHHHHHhhhhhHHHHHHhh-cccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 0 00000001100 000000 0 1134567899999999999999999999864
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=342.97 Aligned_cols=247 Identities=26% Similarity=0.417 Sum_probs=191.8
Q ss_pred CCcCceecccCCceEEEEEe-cCCcEEEEEEeccCCchhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEEEee
Q 000859 948 LSDEFIIGSGGSGTVYKAEL-ANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIYEY 1026 (1251)
Q Consensus 948 ~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv~E~ 1026 (1251)
|+..+.||+|+||.||+|.. .+++.||||++.........+.+.+|+++++.++|+||+++++++.. ....++||||
T Consensus 76 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~ 153 (353)
T PLN00034 76 LERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDH--NGEIQVLLEF 153 (353)
T ss_pred HhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEecc--CCeEEEEEec
Confidence 55667899999999999965 46899999999766555566789999999999999999999998754 4457899999
Q ss_pred cCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcccccccccc
Q 000859 1027 MENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALV 1106 (1251)
Q Consensus 1027 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~ 1106 (1251)
+++|+|.+. ....+..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++.+.
T Consensus 154 ~~~~~L~~~-----------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~ 219 (353)
T PLN00034 154 MDGGSLEGT-----------HIADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILA 219 (353)
T ss_pred CCCCccccc-----------ccCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceecc
Confidence 999988643 2345677889999999999999999 99999999999999999999999999997653
Q ss_pred cccCCCCcccceeecccceeccccccc-----CCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccc
Q 000859 1107 EDYNSNTESNTWFAGSYGYIAPEYAYS-----LKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSG 1181 (1251)
Q Consensus 1107 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 1181 (1251)
... .......||..|+|||++.. ...+.++|||||||++|||++|+.||......+ |.......
T Consensus 220 ~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~-----~~~~~~~~-- 288 (353)
T PLN00034 220 QTM----DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD-----WASLMCAI-- 288 (353)
T ss_pred ccc----ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc-----HHHHHHHH--
Confidence 221 11223578999999998743 234568999999999999999999997332211 11111000
Q ss_pred hhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 000859 1182 SAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDL 1230 (1251)
Q Consensus 1182 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 1230 (1251)
. ...........+.++.+++.+||+.||++|||++|+++.
T Consensus 289 ------~---~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 289 ------C---MSQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred ------h---ccCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 000111122345678999999999999999999999875
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=329.75 Aligned_cols=262 Identities=26% Similarity=0.423 Sum_probs=206.5
Q ss_pred cCCCcCceecccCCceEEEEEec------CCcEEEEEEeccCCchhhhHHHHHHHHHHHhccCCCccceeceeeecCCCc
Q 000859 946 NNLSDEFIIGSGGSGTVYKAELA------NGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGS 1019 (1251)
Q Consensus 946 ~~~~~~~~lG~G~fg~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 1019 (1251)
.+|.+.+.||+|+||.||+|... +++.||||++.........+.+.+|++++++++||||+++++++... ..
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~ 82 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEG--DP 82 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecC--CC
Confidence 35777789999999999999653 34789999997665555668899999999999999999999988654 45
Q ss_pred eeEEEeecCCCChHHhhhcCCCC-------cccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCC
Q 000859 1020 NLLIYEYMENGSVWDWLHKQPVN-------IKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNM 1092 (1251)
Q Consensus 1020 ~~lv~E~~~~gsL~~~l~~~~~~-------~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~ 1092 (1251)
.++||||+++|+|.++++..... ......+++.++..++.|++.|++|||+. +++||||||+||+++.++
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~ 159 (280)
T cd05049 83 PIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDL 159 (280)
T ss_pred eEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCC
Confidence 79999999999999999764321 12235688999999999999999999999 999999999999999999
Q ss_pred CeEEcccccccccccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhh-CCCCCCCccccchhHHH
Q 000859 1093 EAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMVR 1171 (1251)
Q Consensus 1093 ~~kl~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~t-g~~p~~~~~~~~~~~~~ 1171 (1251)
.+||+|||.++........ .......+++.|+|||++.+..++.++||||+||++|||++ |+.||......+
T Consensus 160 ~~kl~d~g~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~----- 232 (280)
T cd05049 160 VVKIGDFGMSRDVYTTDYY--RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE----- 232 (280)
T ss_pred eEEECCcccceecccCcce--ecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH-----
Confidence 9999999999764322111 11122346788999999999999999999999999999999 999986543221
Q ss_pred HHHHHHhccchhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 000859 1172 WVEMHMEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLN 1233 (1251)
Q Consensus 1172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 1233 (1251)
..+.. ..... . ..+...+..+.+++.+||+.||++||+++||++.|++
T Consensus 233 ~~~~~-----------~~~~~-~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 233 VIECI-----------TQGRL-L--QRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred HHHHH-----------HcCCc-C--CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 11110 00000 1 1112345678999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-35 Score=327.89 Aligned_cols=260 Identities=25% Similarity=0.375 Sum_probs=203.8
Q ss_pred cCCCcCceecccCCceEEEEEec-CCc----EEEEEEeccCCchhhhHHHHHHHHHHHhccCCCccceeceeeecCCCce
Q 000859 946 NNLSDEFIIGSGGSGTVYKAELA-NGA----TVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSN 1020 (1251)
Q Consensus 946 ~~~~~~~~lG~G~fg~V~~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~ 1020 (1251)
.+|+..+.||+|+||+||+|.+. +++ .||+|++..........++..|+.++++++||||++++|++.. ...
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~---~~~ 83 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG---ASL 83 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC---Ccc
Confidence 35778889999999999999764 344 4788887644444445678888999999999999999998742 335
Q ss_pred eEEEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcccc
Q 000859 1021 LLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFG 1100 (1251)
Q Consensus 1021 ~lv~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG 1100 (1251)
++++||+++|+|.+++... ...+++..+..++.||+.|++|||+. +++||||||+||++++++.+||+|||
T Consensus 84 ~~i~e~~~~gsL~~~l~~~------~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg 154 (279)
T cd05111 84 QLVTQLSPLGSLLDHVRQH------RDSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFG 154 (279)
T ss_pred EEEEEeCCCCcHHHHHHhc------ccCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCc
Confidence 7899999999999999764 34689999999999999999999999 99999999999999999999999999
Q ss_pred cccccccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhh-CCCCCCCccccchhHHHHHHHHHhc
Q 000859 1101 LAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMVRWVEMHMEM 1179 (1251)
Q Consensus 1101 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~ 1179 (1251)
.++........ .......++..|+|||.+.+..++.++|||||||++||+++ |+.||.+...... .+..
T Consensus 155 ~~~~~~~~~~~--~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~--~~~~------ 224 (279)
T cd05111 155 VADLLYPDDKK--YFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEV--PDLL------ 224 (279)
T ss_pred cceeccCCCcc--cccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH--HHHH------
Confidence 99765432111 11223456788999999998899999999999999999998 9999976532211 1111
Q ss_pred cchhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhcCCC
Q 000859 1180 SGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNVFNNR 1238 (1251)
Q Consensus 1180 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~ 1238 (1251)
.... ..+.+..++.++.+++.+||..||++|||++|+++.+..+.+..
T Consensus 225 ---------~~~~--~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~~ 272 (279)
T cd05111 225 ---------EKGE--RLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARDP 272 (279)
T ss_pred ---------HCCC--cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhCC
Confidence 0000 01111123456788999999999999999999999998877644
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=324.90 Aligned_cols=256 Identities=25% Similarity=0.410 Sum_probs=203.2
Q ss_pred cCCCcCceecccCCceEEEEEe-cCCcEEEEEEeccCCchhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEEE
Q 000859 946 NNLSDEFIIGSGGSGTVYKAEL-ANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIY 1024 (1251)
Q Consensus 946 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv~ 1024 (1251)
.+|+..+.||+|+||.||+|.. ++++.||+|++... ....+.+.+|++++++++||||+++++++... ...+++|
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~ 81 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED--TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE--PPFYIIT 81 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC--chHHHHHHHHHHHHHhCCCCChhheEEEEcCC--CCcEEEE
Confidence 3477788999999999999954 45889999998643 23356788999999999999999999988654 4468999
Q ss_pred eecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcccccccc
Q 000859 1025 EYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKA 1104 (1251)
Q Consensus 1025 E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~ 1104 (1251)
||+++|+|.+++.... ...+++..++.++.|+++|++|||+. +++||||||+||++++++.+||+|||.++.
T Consensus 82 e~~~~~~L~~~~~~~~-----~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~ 153 (263)
T cd05052 82 EFMTYGNLLDYLRECN-----RQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRL 153 (263)
T ss_pred EeCCCCcHHHHHHhCC-----CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCccccc
Confidence 9999999999997642 35689999999999999999999999 999999999999999999999999999976
Q ss_pred cccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhh-CCCCCCCccccchhHHHHHHHHHhccchh
Q 000859 1105 LVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMVRWVEMHMEMSGSA 1183 (1251)
Q Consensus 1105 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1183 (1251)
....... ......++..|+|||.+.+..++.++|||||||++|||++ |..||.+....+ ......
T Consensus 154 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~-----~~~~~~------ 219 (263)
T cd05052 154 MTGDTYT---AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-----VYELLE------ 219 (263)
T ss_pred cccceee---ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH-----HHHHHH------
Confidence 5432111 1111234678999999998899999999999999999998 999987542211 111110
Q ss_pred hhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhc
Q 000859 1184 REELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNVF 1235 (1251)
Q Consensus 1184 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~ 1235 (1251)
..... +.+...+.++.+++.+||+.||++||+++++.+.|++++
T Consensus 220 ------~~~~~--~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 263 (263)
T cd05052 220 ------KGYRM--ERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETMF 263 (263)
T ss_pred ------CCCCC--CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhhC
Confidence 00111 112234567899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=324.54 Aligned_cols=256 Identities=27% Similarity=0.441 Sum_probs=204.3
Q ss_pred hcCCCcCceecccCCceEEEEEecCCcEEEEEEeccCCchhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEEE
Q 000859 945 TNNLSDEFIIGSGGSGTVYKAELANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIY 1024 (1251)
Q Consensus 945 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv~ 1024 (1251)
.++|+..+.||+|+||.||+|...+++.||+|.++... ...+.+.+|++++++++||||+++++++... ...++||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~ 80 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT--MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLE--EPIYIVT 80 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc--ccHHHHHHHHHHHHHCCCCCccceeEEEecC--CCeeeee
Confidence 45688889999999999999987778899999986433 2346788999999999999999999987544 4469999
Q ss_pred eecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcccccccc
Q 000859 1025 EYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKA 1104 (1251)
Q Consensus 1025 E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~ 1104 (1251)
||+++++|.+++.... ...+++..+..++.|++.|++|||+. +|+||||||+||++++++.+||+|||+++.
T Consensus 81 e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~ 152 (261)
T cd05068 81 ELMKYGSLLEYLQGGA-----GRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARV 152 (261)
T ss_pred ecccCCcHHHHHhccC-----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEE
Confidence 9999999999997642 35689999999999999999999999 999999999999999999999999999987
Q ss_pred cccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhh-CCCCCCCccccchhHHHHHHHHHhccchh
Q 000859 1105 LVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMVRWVEMHMEMSGSA 1183 (1251)
Q Consensus 1105 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1183 (1251)
....... .......+..|+|||++.+..++.++||||||+++|||++ |+.||.+...... ...
T Consensus 153 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~--~~~----------- 216 (261)
T cd05068 153 IKEDIYE---AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEV--LQQ----------- 216 (261)
T ss_pred ccCCccc---ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHH--HHH-----------
Confidence 6422111 1111223468999999998899999999999999999999 9999975422110 000
Q ss_pred hhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 000859 1184 REELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNV 1234 (1251)
Q Consensus 1184 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 1234 (1251)
+.... ..+.+...+..+.+++.+|++.+|++||+++++++.|+++
T Consensus 217 ----~~~~~--~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 217 ----VDQGY--RMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred ----HHcCC--CCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 00000 0112223456789999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=328.00 Aligned_cols=246 Identities=30% Similarity=0.419 Sum_probs=199.6
Q ss_pred CCcCceecccCCceEEEE-EecCCcEEEEEEeccCC--chhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEEE
Q 000859 948 LSDEFIIGSGGSGTVYKA-ELANGATVAVKKISCKD--DHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIY 1024 (1251)
Q Consensus 948 ~~~~~~lG~G~fg~V~~~-~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv~ 1024 (1251)
|...+.||.|+||.||-| +.++.+.||||++.-.. ......++.+|+.++++++|||+|.+-|+|..+ ...|+||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre--~TaWLVM 105 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLRE--HTAWLVM 105 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeecc--chHHHHH
Confidence 556678999999999999 56678999999996443 444557899999999999999999999987654 4469999
Q ss_pred eecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcccccccc
Q 000859 1025 EYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKA 1104 (1251)
Q Consensus 1025 E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~ 1104 (1251)
|||- |+-.|.+.-+ .+++.+.++..|+.+.+.|++|||+. +.||||||+.|||+++.|.||++|||.|..
T Consensus 106 EYCl-GSAsDlleVh------kKplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi 175 (948)
T KOG0577|consen 106 EYCL-GSASDLLEVH------KKPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASI 175 (948)
T ss_pred HHHh-ccHHHHHHHH------hccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhh
Confidence 9995 5788877654 46788999999999999999999999 999999999999999999999999999865
Q ss_pred cccccCCCCcccceeecccceecccccc---cCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccc
Q 000859 1105 LVEDYNSNTESNTWFAGSYGYIAPEYAY---SLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSG 1181 (1251)
Q Consensus 1105 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 1181 (1251)
.. +...++|||.|||||++. .+.|+.++||||+|++..|+...++|+..+.... ..
T Consensus 176 ~~--------PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMS--AL----------- 234 (948)
T KOG0577|consen 176 MA--------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--AL----------- 234 (948)
T ss_pred cC--------chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHH--HH-----------
Confidence 42 234479999999999875 5679999999999999999999999986552211 00
Q ss_pred hhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 000859 1182 SAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLL 1231 (1251)
Q Consensus 1182 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L 1231 (1251)
..+. ..-.|.++ ...++..+.+++..|+++-|.+|||.+++++.-
T Consensus 235 ---YHIA-QNesPtLq-s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~ 279 (948)
T KOG0577|consen 235 ---YHIA-QNESPTLQ-SNEWSDYFRNFVDSCLQKIPQERPTSEELLKHR 279 (948)
T ss_pred ---HHHH-hcCCCCCC-CchhHHHHHHHHHHHHhhCcccCCcHHHHhhcc
Confidence 0111 11112232 334677899999999999999999999988753
|
|
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=338.19 Aligned_cols=269 Identities=26% Similarity=0.403 Sum_probs=206.6
Q ss_pred hcCCCcCceecccCCceEEEEEe------cCCcEEEEEEeccCCchhhhHHHHHHHHHHHhc-cCCCccceeceeeecCC
Q 000859 945 TNNLSDEFIIGSGGSGTVYKAEL------ANGATVAVKKISCKDDHLLNKSFTREVKTLGRI-RHRHLVKLMGHCCNKGA 1017 (1251)
Q Consensus 945 ~~~~~~~~~lG~G~fg~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~ 1017 (1251)
.++|+..+.||+|+||.||+|.. .+++.||||+++..........+.+|+++++++ +||||+++++++...+
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~- 84 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG- 84 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCC-
Confidence 34688999999999999999953 356889999997655444556788999999999 6899999999876543
Q ss_pred CceeEEEeecCCCChHHhhhcCCCCc------------------------------------------------------
Q 000859 1018 GSNLLIYEYMENGSVWDWLHKQPVNI------------------------------------------------------ 1043 (1251)
Q Consensus 1018 ~~~~lv~E~~~~gsL~~~l~~~~~~~------------------------------------------------------ 1043 (1251)
...++||||+++|+|.+++.......
T Consensus 85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (343)
T cd05103 85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 164 (343)
T ss_pred CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence 35689999999999999987532100
Q ss_pred ------ccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcccccccccccccCCCCcccc
Q 000859 1044 ------KMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNT 1117 (1251)
Q Consensus 1044 ------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~ 1117 (1251)
.....+++..+.+++.|+++|++|||++ +|+||||||+||+++.++.+||+|||+++........ ....
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~--~~~~ 239 (343)
T cd05103 165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY--VRKG 239 (343)
T ss_pred hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcch--hhcC
Confidence 0113478899999999999999999999 9999999999999999999999999999765322111 1111
Q ss_pred eeecccceecccccccCCCCCccceeehhHHHHHHhh-CCCCCCCccccchhHHHHHHHHHhccchhhhhhhcccCCCCC
Q 000859 1118 WFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMVRWVEMHMEMSGSAREELLDDQMKPLL 1196 (1251)
Q Consensus 1118 ~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1196 (1251)
...++..|+|||.+.+..++.++||||||+++|||++ |..||......+. .. ... ........
T Consensus 240 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~-~~---~~~------------~~~~~~~~ 303 (343)
T cd05103 240 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-FC---RRL------------KEGTRMRA 303 (343)
T ss_pred CCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH-HH---HHH------------hccCCCCC
Confidence 1245678999999988899999999999999999997 9999875432211 00 000 00000111
Q ss_pred CchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhcCC
Q 000859 1197 PGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNVFNN 1237 (1251)
Q Consensus 1197 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~ 1237 (1251)
+...++++.+++.+||+.||++|||+.||++.|+.+++.
T Consensus 304 --~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~ 342 (343)
T cd05103 304 --PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 342 (343)
T ss_pred --CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 112345688999999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=343.68 Aligned_cols=256 Identities=21% Similarity=0.287 Sum_probs=197.9
Q ss_pred cCCCcCceecccCCceEEEEEe-cCCcEEEEEEeccCC--chhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeE
Q 000859 946 NNLSDEFIIGSGGSGTVYKAEL-ANGATVAVKKISCKD--DHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLL 1022 (1251)
Q Consensus 946 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~l 1022 (1251)
++|+..+.||+|+||+||+|+. .+++.||||++.... .....+.+.+|+++++.++||||+++++++.. +...++
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~--~~~~~l 78 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQD--ENYLYL 78 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEc--CCeEEE
Confidence 3688899999999999999965 468999999996432 22334567889999999999999999998854 456799
Q ss_pred EEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcccccc
Q 000859 1023 IYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLA 1102 (1251)
Q Consensus 1023 v~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a 1102 (1251)
||||+++|+|.+++... +.+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 79 v~E~~~~g~L~~~l~~~-------~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~ 148 (364)
T cd05599 79 IMEYLPGGDMMTLLMKK-------DTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLC 148 (364)
T ss_pred EECCCCCcHHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccc
Confidence 99999999999999763 4689999999999999999999999 9999999999999999999999999998
Q ss_pred cccccccCCCC----------------------------------cccceeecccceecccccccCCCCCccceeehhHH
Q 000859 1103 KALVEDYNSNT----------------------------------ESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIV 1148 (1251)
Q Consensus 1103 ~~~~~~~~~~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~ 1148 (1251)
+.+........ .......||+.|+|||++.+..++.++||||+||+
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~i 228 (364)
T cd05599 149 TGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVI 228 (364)
T ss_pred eeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhH
Confidence 76432111000 00011368999999999999999999999999999
Q ss_pred HHHHhhCCCCCCCccccchhHHHHHHHHHhccchhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCC---HH
Q 000859 1149 LMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPS---SR 1225 (1251)
Q Consensus 1149 l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~ 1225 (1251)
+|||++|+.||.+....+. .... .........+.....++++.+++.+|+. +|.+|++ ++
T Consensus 229 l~el~~G~~Pf~~~~~~~~-----~~~i-----------~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~ 291 (364)
T cd05599 229 MYEMLVGYPPFCSDNPQET-----YRKI-----------INWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVN 291 (364)
T ss_pred HHHhhcCCCCCCCCCHHHH-----HHHH-----------HcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHH
Confidence 9999999999976532211 0000 0000001111111234567899999996 9999998 88
Q ss_pred HHHHH
Q 000859 1226 QVCDL 1230 (1251)
Q Consensus 1226 eil~~ 1230 (1251)
|+++.
T Consensus 292 ~ll~h 296 (364)
T cd05599 292 EIKSH 296 (364)
T ss_pred HHhcC
Confidence 87663
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-35 Score=330.45 Aligned_cols=267 Identities=24% Similarity=0.333 Sum_probs=196.2
Q ss_pred CCCcCceecccCCceEEEEEe--cCCcEEEEEEeccCCc-hhhhHHHHHHHHHHHhc---cCCCccceeceeeec---CC
Q 000859 947 NLSDEFIIGSGGSGTVYKAEL--ANGATVAVKKISCKDD-HLLNKSFTREVKTLGRI---RHRHLVKLMGHCCNK---GA 1017 (1251)
Q Consensus 947 ~~~~~~~lG~G~fg~V~~~~~--~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l---~h~niv~l~g~~~~~---~~ 1017 (1251)
+|+..+.||+|+||+||+|+. .+++.||||++..... ......+.+|+++++.+ +||||++++++|... ..
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~ 81 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 81 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence 688889999999999999965 3468899999865432 22234566788877766 699999999987532 23
Q ss_pred CceeEEEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEc
Q 000859 1018 GSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLG 1097 (1251)
Q Consensus 1018 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~ 1097 (1251)
...++||||++ ++|.+++.... ...+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+
T Consensus 82 ~~~~lv~e~~~-~~l~~~~~~~~-----~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~ 152 (290)
T cd07862 82 TKLTLVFEHVD-QDLTTYLDKVP-----EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLA 152 (290)
T ss_pred CcEEEEEccCC-CCHHHHHHhCC-----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEc
Confidence 45789999996 69999997643 34589999999999999999999999 99999999999999999999999
Q ss_pred ccccccccccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHH
Q 000859 1098 DFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHM 1177 (1251)
Q Consensus 1098 DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~ 1177 (1251)
|||+++..... .......||..|+|||.+.+..++.++||||+||++|||++|++||.+....+. ...+....
T Consensus 153 Dfg~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~--~~~i~~~~ 225 (290)
T cd07862 153 DFGLARIYSFQ-----MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ--LGKILDVI 225 (290)
T ss_pred cccceEeccCC-----cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHH--HHHHHHHh
Confidence 99999765322 122235689999999999888999999999999999999999999986533221 11111111
Q ss_pred hccc--hhhhh--hhcccCCCCCC--ch---HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 000859 1178 EMSG--SAREE--LLDDQMKPLLP--GE---ECAAYQVLEIALQCTKTSPQERPSSRQVCD 1229 (1251)
Q Consensus 1178 ~~~~--~~~~~--~~~~~~~~~~~--~~---~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1229 (1251)
.... .+... .......+... .. ...+..+.+++.+|++.||++|||+.|+++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 226 GLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred CCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 0000 00000 00000000000 00 113456789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=338.02 Aligned_cols=253 Identities=23% Similarity=0.316 Sum_probs=195.2
Q ss_pred CCCcCceecccCCceEEEEEe----cCCcEEEEEEeccCC---chhhhHHHHHHHHHHHhc-cCCCccceeceeeecCCC
Q 000859 947 NLSDEFIIGSGGSGTVYKAEL----ANGATVAVKKISCKD---DHLLNKSFTREVKTLGRI-RHRHLVKLMGHCCNKGAG 1018 (1251)
Q Consensus 947 ~~~~~~~lG~G~fg~V~~~~~----~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~ 1018 (1251)
+|+..+.||+|+||.||+++. .+++.||+|++.... .....+.+.+|+++++++ +||+|+++++++.. ..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~--~~ 78 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQT--EA 78 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEec--CC
Confidence 477888999999999999864 357899999986432 222345678899999999 59999999987744 44
Q ss_pred ceeEEEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcc
Q 000859 1019 SNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGD 1098 (1251)
Q Consensus 1019 ~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D 1098 (1251)
..++||||+++|+|.+++.. ...+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+||+|
T Consensus 79 ~~~lv~e~~~~g~L~~~l~~-------~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~D 148 (332)
T cd05614 79 KLHLILDYVSGGEMFTHLYQ-------RDNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTD 148 (332)
T ss_pred EEEEEEeCCCCCcHHHHHHH-------cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEee
Confidence 57899999999999999976 35689999999999999999999999 999999999999999999999999
Q ss_pred cccccccccccCCCCcccceeecccceecccccccC-CCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHH
Q 000859 1099 FGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSL-KATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHM 1177 (1251)
Q Consensus 1099 fG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~ 1177 (1251)
||+++.+..... .......||..|+|||++.+. .++.++||||+||++|||++|+.||......... .....
T Consensus 149 fG~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~-~~~~~--- 221 (332)
T cd05614 149 FGLSKEFLSEEK---ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQ-SEVSR--- 221 (332)
T ss_pred CcCCccccccCC---CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCH-HHHHH---
Confidence 999976532211 112235789999999998765 4788999999999999999999999654222111 00000
Q ss_pred hccchhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 000859 1178 EMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERP-----SSRQVCDL 1230 (1251)
Q Consensus 1178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~~ 1230 (1251)
.... ..+. .+...+..+.+++.+|++.||++|| +++++++.
T Consensus 222 --------~~~~--~~~~--~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 222 --------RILK--CDPP--FPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred --------HHhc--CCCC--CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 0000 0011 1122456688999999999999999 67777654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=338.66 Aligned_cols=243 Identities=21% Similarity=0.305 Sum_probs=192.4
Q ss_pred ceecccCCceEEEEE-ecCCcEEEEEEeccCC--chhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEEEeecC
Q 000859 952 FIIGSGGSGTVYKAE-LANGATVAVKKISCKD--DHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIYEYME 1028 (1251)
Q Consensus 952 ~~lG~G~fg~V~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv~E~~~ 1028 (1251)
+.||+|+||.||+|. ..+|+.||+|++.... .......+..|+++++.++||||+++++++.. ....++||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~--~~~~~lv~E~~~ 78 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQT--HDRLCFVMEYAN 78 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEc--CCEEEEEEeCCC
Confidence 369999999999995 4578999999996432 22234567789999999999999999987754 345799999999
Q ss_pred CCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCCeeecCCCCCCeeecCCCCeEEccccccccccc
Q 000859 1029 NGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHH-DCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVE 1107 (1251)
Q Consensus 1029 ~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~ 1107 (1251)
+|+|.+++.. ...+++..+..++.||+.||+|||+ . +|+||||||+||+++.++.+||+|||+++....
T Consensus 79 ~~~L~~~l~~-------~~~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~ 148 (325)
T cd05594 79 GGELFFHLSR-------ERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK 148 (325)
T ss_pred CCcHHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCC
Confidence 9999998876 3468999999999999999999997 6 999999999999999999999999999865322
Q ss_pred ccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccchhhhhh
Q 000859 1108 DYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSAREEL 1187 (1251)
Q Consensus 1108 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1187 (1251)
. ........||+.|+|||++.+..++.++||||+||++|||++|+.||......+. ....
T Consensus 149 ~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~-----~~~i----------- 208 (325)
T cd05594 149 D----GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL-----FELI----------- 208 (325)
T ss_pred C----CcccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHH-----HHHH-----------
Confidence 1 1112235689999999999999999999999999999999999999965422111 0000
Q ss_pred hcccCCCCCCchHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 000859 1188 LDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERP-----SSRQVCDL 1230 (1251)
Q Consensus 1188 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~~ 1230 (1251)
.. .....+...++++.+++.+|++.||++|+ +++++++.
T Consensus 209 ~~----~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 209 LM----EEIRFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred hc----CCCCCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 00 00011122345688999999999999996 89998754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=341.44 Aligned_cols=206 Identities=25% Similarity=0.343 Sum_probs=172.6
Q ss_pred cCCCcCceecccCCceEEEEEe-cCCcEEEEEEeccCC--chhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeE
Q 000859 946 NNLSDEFIIGSGGSGTVYKAEL-ANGATVAVKKISCKD--DHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLL 1022 (1251)
Q Consensus 946 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~l 1022 (1251)
++|+..+.||+|+||+||+|.. .+++.||||++.... .....+.+.+|+.++++++||+|+++++.+.+ ....++
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~--~~~~~l 78 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQD--KLNLYL 78 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEec--CCeEEE
Confidence 3688889999999999999954 468999999996432 22234567889999999999999999998754 345799
Q ss_pred EEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcccccc
Q 000859 1023 IYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLA 1102 (1251)
Q Consensus 1023 v~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a 1102 (1251)
||||+++|+|.+++.+ .+.+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 79 v~E~~~gg~L~~~l~~-------~~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla 148 (363)
T cd05628 79 IMEFLPGGDMMTLLMK-------KDTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLC 148 (363)
T ss_pred EEcCCCCCcHHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCc
Confidence 9999999999999976 35689999999999999999999999 9999999999999999999999999998
Q ss_pred cccccccCCC-------------------------------CcccceeecccceecccccccCCCCCccceeehhHHHHH
Q 000859 1103 KALVEDYNSN-------------------------------TESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLME 1151 (1251)
Q Consensus 1103 ~~~~~~~~~~-------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~e 1151 (1251)
+.+....... ........||+.|+|||++.+..++.++||||+||++||
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~e 228 (363)
T cd05628 149 TGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYE 228 (363)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHH
Confidence 7643211000 000123579999999999999999999999999999999
Q ss_pred HhhCCCCCCCcc
Q 000859 1152 LVSGKMPTDATF 1163 (1251)
Q Consensus 1152 l~tg~~p~~~~~ 1163 (1251)
|++|+.||.+..
T Consensus 229 ll~G~~Pf~~~~ 240 (363)
T cd05628 229 MLIGYPPFCSET 240 (363)
T ss_pred HHhCCCCCCCCC
Confidence 999999997653
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=328.51 Aligned_cols=264 Identities=21% Similarity=0.357 Sum_probs=203.6
Q ss_pred hhcCCCcCceecccCCceEEEEEec------CCcEEEEEEeccCCchhhhHHHHHHHHHHHhccCCCccceeceeeecCC
Q 000859 944 ATNNLSDEFIIGSGGSGTVYKAELA------NGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGA 1017 (1251)
Q Consensus 944 ~~~~~~~~~~lG~G~fg~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~ 1017 (1251)
..++|+..+.||+|+||.||+|... ++..||||++...........+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~-- 81 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG-- 81 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC--
Confidence 4567899999999999999999643 34679999986544444556788999999999999999999987543
Q ss_pred CceeEEEeecCCCChHHhhhcCCCCcc---cCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCe
Q 000859 1018 GSNLLIYEYMENGSVWDWLHKQPVNIK---MRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEA 1094 (1251)
Q Consensus 1018 ~~~~lv~E~~~~gsL~~~l~~~~~~~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~ 1094 (1251)
...++||||+++|+|.++++....... ....+++..+..++.|++.|++|||+. +++||||||+||++++++.+
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~ 158 (277)
T cd05062 82 QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTV 158 (277)
T ss_pred CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCE
Confidence 456899999999999999975332111 123568889999999999999999998 99999999999999999999
Q ss_pred EEcccccccccccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhh-CCCCCCCccccchhHHHHH
Q 000859 1095 HLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMVRWV 1173 (1251)
Q Consensus 1095 kl~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~t-g~~p~~~~~~~~~~~~~~~ 1173 (1251)
|++|||+++.......... .....++..|+|||++.+..++.++|||||||++|||++ |+.||.+....+ ..
T Consensus 159 ~l~dfg~~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~-----~~ 231 (277)
T cd05062 159 KIGDFGMTRDIYETDYYRK--GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQ-----VL 231 (277)
T ss_pred EECCCCCccccCCcceeec--CCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH-----HH
Confidence 9999999876533221111 111245788999999998899999999999999999999 788986542211 11
Q ss_pred HHHHhccchhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 000859 1174 EMHMEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLN 1233 (1251)
Q Consensus 1174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 1233 (1251)
+... .... .+.+...+..+.+++.+|++.||++|||+.|+++.+++
T Consensus 232 ~~~~-----------~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 232 RFVM-----------EGGL---LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred HHHH-----------cCCc---CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 1100 0000 01112244578999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=323.67 Aligned_cols=256 Identities=25% Similarity=0.417 Sum_probs=196.9
Q ss_pred ceecccCCceEEEEEec----CCcEEEEEEeccCCchhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEEEeec
Q 000859 952 FIIGSGGSGTVYKAELA----NGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIYEYM 1027 (1251)
Q Consensus 952 ~~lG~G~fg~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv~E~~ 1027 (1251)
+.||+|+||.||+|... ++..||+|.+.........+.+.+|+.+++.++||||+++++++... +...++|+||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~~lv~e~~ 79 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPS-EGSPLVVLPYM 79 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecC-CCCcEEEEecC
Confidence 36899999999999653 24579999986544445567888999999999999999999977543 33468999999
Q ss_pred CCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEccccccccccc
Q 000859 1028 ENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVE 1107 (1251)
Q Consensus 1028 ~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~ 1107 (1251)
.+|+|.+++.+. ....++..+..++.|+++|++|||+. +++||||||+||++++++.+||+|||+++.+..
T Consensus 80 ~~~~L~~~~~~~------~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~ 150 (262)
T cd05058 80 KHGDLRNFIRSE------THNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYD 150 (262)
T ss_pred CCCCHHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccC
Confidence 999999999764 23467788899999999999999999 999999999999999999999999999976533
Q ss_pred ccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhhC-CCCCCCccccchhHHHHHHHHHhccchhhhh
Q 000859 1108 DYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSG-KMPTDATFGVEMDMVRWVEMHMEMSGSAREE 1186 (1251)
Q Consensus 1108 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1186 (1251)
.............++..|+|||.+.+..++.++|||||||++|||++| .+||......+ .....
T Consensus 151 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~-----~~~~~---------- 215 (262)
T cd05058 151 KEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFD-----ITVYL---------- 215 (262)
T ss_pred CcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHH-----HHHHH----------
Confidence 211111111223457789999999888999999999999999999995 56665432111 11100
Q ss_pred hhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhcC
Q 000859 1187 LLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNVFN 1236 (1251)
Q Consensus 1187 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~ 1236 (1251)
... ...+.+...+..+.+++.+||+.+|++||++.|+++.+++++.
T Consensus 216 -~~~---~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 216 -LQG---RRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred -hcC---CCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 000 0111122234578899999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=322.77 Aligned_cols=250 Identities=28% Similarity=0.399 Sum_probs=197.9
Q ss_pred eecccCCceEEEEEe---cCCcEEEEEEeccCC-chhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEEEeecC
Q 000859 953 IIGSGGSGTVYKAEL---ANGATVAVKKISCKD-DHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIYEYME 1028 (1251)
Q Consensus 953 ~lG~G~fg~V~~~~~---~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv~E~~~ 1028 (1251)
.||+|+||.||+|.+ .++..||+|++.... .....+.+.+|+.+++.++||||++++|++.. ...++||||++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~~lv~e~~~ 78 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA---ESWMLVMELAE 78 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC---CCcEEEEecCC
Confidence 589999999999964 357889999986443 23345788999999999999999999998742 34589999999
Q ss_pred CCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcccccccccccc
Q 000859 1029 NGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVED 1108 (1251)
Q Consensus 1029 ~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 1108 (1251)
+|+|.+++.. ...+++..+..++.|++.|++|||++ +|+||||||+||+++.++.+||+|||.++.....
T Consensus 79 ~~~L~~~l~~-------~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~ 148 (257)
T cd05116 79 LGPLNKFLQK-------NKHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGAD 148 (257)
T ss_pred CCcHHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCC
Confidence 9999999975 34688999999999999999999999 9999999999999999999999999999765432
Q ss_pred cCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhh-CCCCCCCccccchhHHHHHHHHHhccchhhhhh
Q 000859 1109 YNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMVRWVEMHMEMSGSAREEL 1187 (1251)
Q Consensus 1109 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1187 (1251)
.... .......++..|+|||.+....++.++|||||||++|||++ |+.||.+....+ .. ...
T Consensus 149 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--~~---~~i----------- 211 (257)
T cd05116 149 ENYY-KAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNE--VT---QMI----------- 211 (257)
T ss_pred CCee-eecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH--HH---HHH-----------
Confidence 2111 11112234678999999988889999999999999999998 999997653211 11 111
Q ss_pred hcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhc
Q 000859 1188 LDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNVF 1235 (1251)
Q Consensus 1188 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~ 1235 (1251)
.....+. .+...+.++.++|.+||+.||++||++++|.+.|++++
T Consensus 212 -~~~~~~~--~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~~ 256 (257)
T cd05116 212 -ESGERME--CPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNYY 256 (257)
T ss_pred -HCCCCCC--CCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhccc
Confidence 1111111 12234567899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=322.71 Aligned_cols=256 Identities=26% Similarity=0.431 Sum_probs=204.3
Q ss_pred hcCCCcCceecccCCceEEEEEecCCcEEEEEEeccCCchhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEEE
Q 000859 945 TNNLSDEFIIGSGGSGTVYKAELANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIY 1024 (1251)
Q Consensus 945 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv~ 1024 (1251)
..+|+..++||+|+||.||+|...++..||+|++..... ..+.+.+|++++++++||||+++++++.+ ...++||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~--~~~~~~~E~~~l~~l~~~~i~~~~~~~~~---~~~~lv~ 79 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAVVSE---EPIYIVT 79 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc--CHHHHHHHHHHHHhCCCCCcceEEEEECC---CCcEEEE
Confidence 345888899999999999999877777899999864332 34678999999999999999999987632 3468999
Q ss_pred eecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcccccccc
Q 000859 1025 EYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKA 1104 (1251)
Q Consensus 1025 E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~ 1104 (1251)
||+++|+|.+++.+.. ...++++.+..++.|+++|++|+|+. +|+||||||+||++++++.+||+|||.++.
T Consensus 80 e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~ 151 (262)
T cd05071 80 EYMSKGSLLDFLKGEM-----GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARL 151 (262)
T ss_pred EcCCCCcHHHHHhhcc-----ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceee
Confidence 9999999999997632 34678999999999999999999999 999999999999999999999999999976
Q ss_pred cccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhh-CCCCCCCccccchhHHHHHHHHHhccchh
Q 000859 1105 LVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMVRWVEMHMEMSGSA 1183 (1251)
Q Consensus 1105 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1183 (1251)
+...... ......++..|+|||+..+..++.++|||||||++||++| |+.||.+....+. ....
T Consensus 152 ~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~-----~~~~------- 216 (262)
T cd05071 152 IEDNEYT---ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV-----LDQV------- 216 (262)
T ss_pred ccccccc---cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHH-----HHHH-------
Confidence 5332111 1112346778999999988899999999999999999999 8889875532111 0000
Q ss_pred hhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhc
Q 000859 1184 REELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNVF 1235 (1251)
Q Consensus 1184 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~ 1235 (1251)
.. .. ..+.....+..+.+++.+|++.||++||+++++.+.|++++
T Consensus 217 ----~~-~~--~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 217 ----ER-GY--RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 261 (262)
T ss_pred ----hc-CC--CCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence 00 00 11112335567899999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=326.27 Aligned_cols=257 Identities=29% Similarity=0.480 Sum_probs=206.7
Q ss_pred hhcCCCcCceecccCCceEEEEEecCCcEEEEEEeccCCchhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEE
Q 000859 944 ATNNLSDEFIIGSGGSGTVYKAELANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLI 1023 (1251)
Q Consensus 944 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv 1023 (1251)
...+|+..+.||.|+||.||+|...+++.||+|++..... .....+.+|+.+++.++||||+++++++... ...++|
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~lv 80 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDL-LKQQDFQKEVQALKRLRHKHLISLFAVCSVG--EPVYII 80 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccch-hhHHHHHHHHHHHhcCCCcchhheeeeEecC--CCeEEE
Confidence 3456888889999999999999887799999999865433 2456788999999999999999999988554 446899
Q ss_pred EeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEccccccc
Q 000859 1024 YEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAK 1103 (1251)
Q Consensus 1024 ~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~ 1103 (1251)
|||+++|+|.++++... ...+++..+..++.|++.|++|||+. +|+||||||+||++++++.+||+|||.+.
T Consensus 81 ~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~ 152 (261)
T cd05148 81 TELMEKGSLLAFLRSPE-----GQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLAR 152 (261)
T ss_pred EeecccCCHHHHHhcCC-----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchh
Confidence 99999999999997643 45689999999999999999999999 99999999999999999999999999997
Q ss_pred ccccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhh-CCCCCCCccccchhHHHHHHHHHhccch
Q 000859 1104 ALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMVRWVEMHMEMSGS 1182 (1251)
Q Consensus 1104 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 1182 (1251)
......... ....++..|+|||...+..++.++||||||+++|+|++ |+.||......+. ....
T Consensus 153 ~~~~~~~~~----~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~--~~~~--------- 217 (261)
T cd05148 153 LIKEDVYLS----SDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEV--YDQI--------- 217 (261)
T ss_pred hcCCccccc----cCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHH--HHHH---------
Confidence 653321111 12345778999999988899999999999999999998 8999975532111 1110
Q ss_pred hhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 000859 1183 AREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNV 1234 (1251)
Q Consensus 1183 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 1234 (1251)
.. .. ..+.+...+.++.+++.+||+.||++|||++++.+.|+.+
T Consensus 218 -----~~-~~--~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 218 -----TA-GY--RMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred -----Hh-CC--cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 00 00 1112233456788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=341.97 Aligned_cols=256 Identities=22% Similarity=0.304 Sum_probs=201.6
Q ss_pred cCCCcCceecccCCceEEEEEec-CCcEEEEEEeccCC--chhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeE
Q 000859 946 NNLSDEFIIGSGGSGTVYKAELA-NGATVAVKKISCKD--DHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLL 1022 (1251)
Q Consensus 946 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~l 1022 (1251)
++|...+.||+|+||+||+|+.. +++.||||++.... .....+.+.+|+++++.++||||+++++++.+ ....++
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~l 78 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQD--EEHLYL 78 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheec--CCeEEE
Confidence 36888899999999999999654 78999999996432 12344678899999999999999999988754 445799
Q ss_pred EEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcccccc
Q 000859 1023 IYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLA 1102 (1251)
Q Consensus 1023 v~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a 1102 (1251)
||||+++|+|.+++.+. ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 79 v~e~~~~~~L~~~l~~~-------~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~ 148 (350)
T cd05573 79 VMEYMPGGDLMNLLIRK-------DVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLC 148 (350)
T ss_pred EEcCCCCCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCC
Confidence 99999999999999763 4689999999999999999999998 9999999999999999999999999999
Q ss_pred cccccccC-------------------------CCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhhCCC
Q 000859 1103 KALVEDYN-------------------------SNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKM 1157 (1251)
Q Consensus 1103 ~~~~~~~~-------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~ 1157 (1251)
+....... ..........||+.|+|||++.+..++.++||||+||++|||++|+.
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~ 228 (350)
T cd05573 149 KKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFP 228 (350)
T ss_pred ccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCC
Confidence 76543220 00011223578999999999999999999999999999999999999
Q ss_pred CCCCccccchhHHHHHHHHHhccchhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCC-HHHHHHH
Q 000859 1158 PTDATFGVEMDMVRWVEMHMEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPS-SRQVCDL 1230 (1251)
Q Consensus 1158 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~eil~~ 1230 (1251)
||......+. ..... .+... ...+.....++++.+++.+|++ ||.+||+ ++++++.
T Consensus 229 Pf~~~~~~~~-----~~~i~--------~~~~~---~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 229 PFYSDTLQET-----YNKII--------NWKES---LRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred CCCCCCHHHH-----HHHHh--------ccCCc---ccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 9976532111 00000 00000 0111111145678899999997 9999999 9999875
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=328.49 Aligned_cols=275 Identities=24% Similarity=0.400 Sum_probs=206.8
Q ss_pred CCCcCceecccCCceEEEEEe-----cCCcEEEEEEeccCCchhhhHHHHHHHHHHHhccCCCccceeceeeecCCCcee
Q 000859 947 NLSDEFIIGSGGSGTVYKAEL-----ANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNL 1021 (1251)
Q Consensus 947 ~~~~~~~lG~G~fg~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~ 1021 (1251)
.|.+.+.||+|+||.||+|++ .++..||+|.+.........+.+.+|+++++.++||||+++++++...+....+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 84 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence 467788999999999999964 357889999987655555567899999999999999999999988766556679
Q ss_pred EEEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEccccc
Q 000859 1022 LIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGL 1101 (1251)
Q Consensus 1022 lv~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~ 1101 (1251)
+||||+++++|.+++.+. ...+++.++..++.|++.|++|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 85 lv~e~~~g~~L~~~l~~~------~~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~ 155 (284)
T cd05079 85 LIMEFLPSGSLKEYLPRN------KNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGL 155 (284)
T ss_pred EEEEccCCCCHHHHHHhc------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCcc
Confidence 999999999999999753 23589999999999999999999999 999999999999999999999999999
Q ss_pred ccccccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccc
Q 000859 1102 AKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSG 1181 (1251)
Q Consensus 1102 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 1181 (1251)
++.+...... ........++..|+|||++.+..++.++|||||||++||+++++.|+............ ........
T Consensus 156 ~~~~~~~~~~-~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~--~~~~~~~~ 232 (284)
T cd05079 156 TKAIETDKEY-YTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIG--PTHGQMTV 232 (284)
T ss_pred ccccccCccc-eeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcc--cccccccH
Confidence 9865432211 11112245677899999998888999999999999999999987765322110000000 00000000
Q ss_pred hhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhc
Q 000859 1182 SAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNVF 1235 (1251)
Q Consensus 1182 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~ 1235 (1251)
.......... ...+.+...+.++.+++.+|++.+|++|||++++++.+++++
T Consensus 233 ~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~~ 284 (284)
T cd05079 233 TRLVRVLEEG--KRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAIL 284 (284)
T ss_pred HHHHHHHHcC--ccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhhC
Confidence 0000001110 011122235567999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=341.52 Aligned_cols=267 Identities=25% Similarity=0.389 Sum_probs=206.8
Q ss_pred hhcCCCcCceecccCCceEEEEEec------CCcEEEEEEeccCCchhhhHHHHHHHHHHHhcc-CCCccceeceeeecC
Q 000859 944 ATNNLSDEFIIGSGGSGTVYKAELA------NGATVAVKKISCKDDHLLNKSFTREVKTLGRIR-HRHLVKLMGHCCNKG 1016 (1251)
Q Consensus 944 ~~~~~~~~~~lG~G~fg~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~ 1016 (1251)
...+|...+.||+|+||.||+|.++ .+..||||++.........+.+.+|+++++++. |||||+++|+|...
T Consensus 35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~- 113 (401)
T cd05107 35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKG- 113 (401)
T ss_pred cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccC-
Confidence 3445777889999999999999753 346899999976554445567889999999997 99999999988654
Q ss_pred CCceeEEEeecCCCChHHhhhcCCCCc-----------------------------------------------------
Q 000859 1017 AGSNLLIYEYMENGSVWDWLHKQPVNI----------------------------------------------------- 1043 (1251)
Q Consensus 1017 ~~~~~lv~E~~~~gsL~~~l~~~~~~~----------------------------------------------------- 1043 (1251)
...++||||+++|+|.+++++.....
T Consensus 114 -~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (401)
T cd05107 114 -GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPM 192 (401)
T ss_pred -CCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccch
Confidence 35699999999999999997643100
Q ss_pred --------------------------------------ccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCC
Q 000859 1044 --------------------------------------KMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSN 1085 (1251)
Q Consensus 1044 --------------------------------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~N 1085 (1251)
.....+++..+.+++.|++.|++|||+. +|+||||||+|
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~N 269 (401)
T cd05107 193 QDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARN 269 (401)
T ss_pred hcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcce
Confidence 1123578888999999999999999998 99999999999
Q ss_pred eeecCCCCeEEcccccccccccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhh-CCCCCCCccc
Q 000859 1086 ILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFG 1164 (1251)
Q Consensus 1086 ill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~t-g~~p~~~~~~ 1164 (1251)
|++++++.+|++|||+++.+...... .......++..|+|||.+.+..++.++|||||||++|||++ |+.||.....
T Consensus 270 iLl~~~~~~kL~DfGla~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~ 347 (401)
T cd05107 270 VLICEGKLVKICDFGLARDIMRDSNY--ISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPM 347 (401)
T ss_pred EEEeCCCEEEEEecCcceeccccccc--ccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc
Confidence 99999999999999999765332111 11122356789999999988889999999999999999998 8999865422
Q ss_pred cchhHHHHHHHHHhccchhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhc
Q 000859 1165 VEMDMVRWVEMHMEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNVF 1235 (1251)
Q Consensus 1165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~ 1235 (1251)
.+. .. ..+....+. +.+...+.++.+++.+||+.+|.+||+++||++.|++++
T Consensus 348 ~~~-~~---------------~~~~~~~~~--~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 348 NEQ-FY---------------NAIKRGYRM--AKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred hHH-HH---------------HHHHcCCCC--CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 111 00 000001111 112224567999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=320.57 Aligned_cols=248 Identities=25% Similarity=0.397 Sum_probs=196.7
Q ss_pred eecccCCceEEEEEe-cCCcEEEEEEeccCCchhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEEEeecCCCC
Q 000859 953 IIGSGGSGTVYKAEL-ANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIYEYMENGS 1031 (1251)
Q Consensus 953 ~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv~E~~~~gs 1031 (1251)
.||+|+||.||+|.. .+++.||+|.+...........+.+|++++++++||||+++++++... ...++||||+++++
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~ 79 (252)
T cd05084 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQK--QPIYIVMELVQGGD 79 (252)
T ss_pred ccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCC--CCeEEEEeeccCCc
Confidence 699999999999965 478999999987555555667899999999999999999999988654 45699999999999
Q ss_pred hHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcccccccccccccCC
Q 000859 1032 VWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNS 1111 (1251)
Q Consensus 1032 L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 1111 (1251)
|.+++... ...+++.+++.++.|+++|++|||+. +|+||||||+||+++.++.+|++|||.++........
T Consensus 80 L~~~~~~~------~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~ 150 (252)
T cd05084 80 FLTFLRTE------GPRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYA 150 (252)
T ss_pred HHHHHHhC------CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCccccccccc
Confidence 99999753 24578999999999999999999999 9999999999999999999999999998754321111
Q ss_pred CCcccceeecccceecccccccCCCCCccceeehhHHHHHHhh-CCCCCCCccccchhHHHHHHHHHhccchhhhhhhcc
Q 000859 1112 NTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMVRWVEMHMEMSGSAREELLDD 1190 (1251)
Q Consensus 1112 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1190 (1251)
.......++..|+|||.+.+..++.++||||+||++|||++ |..||......+. .. .+..
T Consensus 151 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~--~~---------------~~~~ 211 (252)
T cd05084 151 --STGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQT--RE---------------AIEQ 211 (252)
T ss_pred --ccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHH--HH---------------HHHc
Confidence 01111233567999999998889999999999999999998 9999865422110 00 0001
Q ss_pred cCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 000859 1191 QMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLL 1232 (1251)
Q Consensus 1191 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 1232 (1251)
.... +.+...+..+.+++.+|++.+|++|||++++.+.|.
T Consensus 212 ~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 212 GVRL--PCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred CCCC--CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 1111 122234567899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=325.94 Aligned_cols=261 Identities=25% Similarity=0.391 Sum_probs=206.8
Q ss_pred hcCCCcCceecccCCceEEEEEec-CCc----EEEEEEeccCCchhhhHHHHHHHHHHHhccCCCccceeceeeecCCCc
Q 000859 945 TNNLSDEFIIGSGGSGTVYKAELA-NGA----TVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGS 1019 (1251)
Q Consensus 945 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 1019 (1251)
..+|+..++||+|+||+||+|.+. +++ .||+|++.........+.+.+|+.+++.++||||+++++++... .
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~---~ 82 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS---T 82 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC---C
Confidence 346888899999999999999653 444 48999997666665667889999999999999999999988532 3
Q ss_pred eeEEEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEccc
Q 000859 1020 NLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDF 1099 (1251)
Q Consensus 1020 ~~lv~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 1099 (1251)
.++++||+++|+|.++++.. ...+++.++..++.|++.|++|||+. +|+||||||+||++++++.+||+||
T Consensus 83 ~~l~~~~~~~g~l~~~l~~~------~~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~df 153 (279)
T cd05109 83 VQLVTQLMPYGCLLDYVREN------KDRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDF 153 (279)
T ss_pred cEEEEEcCCCCCHHHHHhhc------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCC
Confidence 57999999999999999764 34689999999999999999999999 9999999999999999999999999
Q ss_pred ccccccccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhh-CCCCCCCccccchhHHHHHHHHHh
Q 000859 1100 GLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMVRWVEMHME 1178 (1251)
Q Consensus 1100 G~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~ 1178 (1251)
|+++.+...... .......++..|+|||...+..++.++|||||||++||+++ |..||....... ...+..
T Consensus 154 G~~~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--~~~~~~---- 225 (279)
T cd05109 154 GLARLLDIDETE--YHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE--IPDLLE---- 225 (279)
T ss_pred Cceeecccccce--eecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH--HHHHHH----
Confidence 999765322111 11111234678999999998899999999999999999998 999987542211 111111
Q ss_pred ccchhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhcCCC
Q 000859 1179 MSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNVFNNR 1238 (1251)
Q Consensus 1179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~ 1238 (1251)
... ..+.+...+.++.+++.+||+.||++||++.++++.+.++...+
T Consensus 226 -----------~~~--~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05109 226 -----------KGE--RLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP 272 (279)
T ss_pred -----------CCC--cCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence 000 11112234567889999999999999999999999998886654
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=336.24 Aligned_cols=266 Identities=25% Similarity=0.407 Sum_probs=202.7
Q ss_pred hcCCCcCceecccCCceEEEEEec-CCcEEEEEEeccCCchhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEE
Q 000859 945 TNNLSDEFIIGSGGSGTVYKAELA-NGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLI 1023 (1251)
Q Consensus 945 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv 1023 (1251)
.++|+..+.||+|+||.||+|... ++..||+|++.........+.+.+|++++++++||||++++++|... ...++|
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv 81 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD--GEISIC 81 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEEC--CEEEEE
Confidence 357889999999999999999654 68899999987655555567899999999999999999999998764 457999
Q ss_pred EeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEccccccc
Q 000859 1024 YEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAK 1103 (1251)
Q Consensus 1024 ~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~ 1103 (1251)
|||+++|+|.++++.. +.+++..+..++.|++.|++|||+.+ +|+||||||+||++++++.+||+|||++.
T Consensus 82 ~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~ 152 (333)
T cd06650 82 MEHMDGGSLDQVLKKA-------GRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSG 152 (333)
T ss_pred EecCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcch
Confidence 9999999999999763 45788999999999999999999741 79999999999999999999999999987
Q ss_pred ccccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhcc---
Q 000859 1104 ALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMS--- 1180 (1251)
Q Consensus 1104 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~--- 1180 (1251)
.+... ......|+..|+|||++.+..++.++||||+||++|||++|+.||......+.. ..........
T Consensus 153 ~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~--~~~~~~~~~~~~~ 224 (333)
T cd06650 153 QLIDS------MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELE--LMFGCPVEGDPAE 224 (333)
T ss_pred hhhhh------ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHH--HHhcCcccCCccc
Confidence 55321 112346899999999999888999999999999999999999999754322111 0000000000
Q ss_pred ----------ch----------------hhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 000859 1181 ----------GS----------------AREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDL 1230 (1251)
Q Consensus 1181 ----------~~----------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 1230 (1251)
.. .....+.....+..+ ....+.++.+++.+||+.||++|||++|+++.
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h 299 (333)
T cd06650 225 SETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLP-SGVFGAEFQDFVNKCLIKNPAERADLKQLMVH 299 (333)
T ss_pred cccCcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCC-CCCcCHHHHHHHHHhccCCcccCcCHHHHhhC
Confidence 00 000000000001111 01134568899999999999999999999754
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=327.14 Aligned_cols=262 Identities=23% Similarity=0.401 Sum_probs=203.7
Q ss_pred cCCCcCceecccCCceEEEEEe-----cCCcEEEEEEeccCCchhhhHHHHHHHHHHHhccCCCccceeceeeecCCCce
Q 000859 946 NNLSDEFIIGSGGSGTVYKAEL-----ANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSN 1020 (1251)
Q Consensus 946 ~~~~~~~~lG~G~fg~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~ 1020 (1251)
.+|+..+.||+|+||.||+|.. .++..||+|.+.........+.+.+|++++++++||||+++++++... ...
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~ 82 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQE--QPV 82 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC--Cce
Confidence 3477788999999999999964 246789999997555554557888999999999999999999987554 446
Q ss_pred eEEEeecCCCChHHhhhcCCCCc----------ccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecC
Q 000859 1021 LLIYEYMENGSVWDWLHKQPVNI----------KMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDS 1090 (1251)
Q Consensus 1021 ~lv~E~~~~gsL~~~l~~~~~~~----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~ 1090 (1251)
++||||+++|+|.+++....... .....+++.++..++.|++.|++|||++ +|+||||||+||++++
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~ 159 (283)
T cd05090 83 CMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGE 159 (283)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcC
Confidence 99999999999999986432110 1123578999999999999999999999 9999999999999999
Q ss_pred CCCeEEcccccccccccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhh-CCCCCCCccccchhH
Q 000859 1091 NMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDM 1169 (1251)
Q Consensus 1091 ~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~t-g~~p~~~~~~~~~~~ 1169 (1251)
++.+|++|||+++........ .......++..|+|||++.+..++.++|||||||++|||++ |..||.+.... ..
T Consensus 160 ~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~--~~ 235 (283)
T cd05090 160 QLHVKISDLGLSREIYSADYY--RVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ--EV 235 (283)
T ss_pred CCcEEeccccccccccCCcce--ecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH--HH
Confidence 999999999999765332111 11122345778999999988889999999999999999999 99998654221 11
Q ss_pred HHHHHHHHhccchhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 000859 1170 VRWVEMHMEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLN 1233 (1251)
Q Consensus 1170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 1233 (1251)
...+. . ....+.+..++.++.+++.+||+.||++||++.+|.+.+..
T Consensus 236 ~~~~~--------------~---~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 236 IEMVR--------------K---RQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHH--------------c---CCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 11110 0 01112223345678999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=326.69 Aligned_cols=273 Identities=29% Similarity=0.415 Sum_probs=204.5
Q ss_pred cCCCcCceecccCCceEEEEEe-----cCCcEEEEEEeccCCchhhhHHHHHHHHHHHhccCCCccceeceeeecCCCce
Q 000859 946 NNLSDEFIIGSGGSGTVYKAEL-----ANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSN 1020 (1251)
Q Consensus 946 ~~~~~~~~lG~G~fg~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~ 1020 (1251)
.+|+..+.||+|+||.||+|.. .+++.||+|++.... ....+.+.+|++++++++||||+++++++...+....
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 82 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST-AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 82 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC-HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCce
Confidence 4678888999999999999964 357899999986443 3345678999999999999999999998766555567
Q ss_pred eEEEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcccc
Q 000859 1021 LLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFG 1100 (1251)
Q Consensus 1021 ~lv~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG 1100 (1251)
++||||+++|+|.+++.+. ...+++..+..++.|++.|++|||++ +|+||||||+||++++++.+||+|||
T Consensus 83 ~lv~e~~~~~~L~~~l~~~------~~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg 153 (284)
T cd05081 83 RLVMEYLPYGSLRDYLQKH------RERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFG 153 (284)
T ss_pred EEEEEecCCCCHHHHHHhc------CcCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCc
Confidence 9999999999999999753 24589999999999999999999999 99999999999999999999999999
Q ss_pred cccccccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHh--
Q 000859 1101 LAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHME-- 1178 (1251)
Q Consensus 1101 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~-- 1178 (1251)
+++......... .......++..|+|||...+..++.++|||||||++|||++|..|+...... ..........
T Consensus 154 ~~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~---~~~~~~~~~~~~ 229 (284)
T cd05081 154 LTKVLPQDKEYY-KVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE---FMRMMGNDKQGQ 229 (284)
T ss_pred ccccccCCCcce-eecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh---hhhhcccccccc
Confidence 998654322111 1111123445699999998888999999999999999999988775432110 0000000000
Q ss_pred ccchhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 000859 1179 MSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNV 1234 (1251)
Q Consensus 1179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 1234 (1251)
.......+..... ...+.....+.++.+++.+||+.+|++|||++||++.|+++
T Consensus 230 ~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 230 MIVYHLIELLKNN--GRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred cchHHHHHHHhcC--CcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 0000000111111 11122233456799999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=335.78 Aligned_cols=237 Identities=24% Similarity=0.338 Sum_probs=188.0
Q ss_pred ceecccCCceEEEEEe-cCCcEEEEEEeccCC--chhhhHHHHHHHHHHHhc-cCCCccceeceeeecCCCceeEEEeec
Q 000859 952 FIIGSGGSGTVYKAEL-ANGATVAVKKISCKD--DHLLNKSFTREVKTLGRI-RHRHLVKLMGHCCNKGAGSNLLIYEYM 1027 (1251)
Q Consensus 952 ~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~~~lv~E~~ 1027 (1251)
+.||+|+||+||+|.. .+++.||||++.... .....+.+..|..+++.. +||||+++++++.. ....++||||+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~--~~~~~iv~Ey~ 78 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQT--PDRLFFVMEFV 78 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEc--CCEEEEEEcCC
Confidence 3699999999999965 468899999986432 223345677888888877 69999999998754 45579999999
Q ss_pred CCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEccccccccccc
Q 000859 1028 ENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVE 1107 (1251)
Q Consensus 1028 ~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~ 1107 (1251)
++|+|.+++... +.+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++....
T Consensus 79 ~~g~L~~~i~~~-------~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~ 148 (320)
T cd05590 79 NGGDLMFHIQKS-------RRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIF 148 (320)
T ss_pred CCchHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCc
Confidence 999999998763 4689999999999999999999999 999999999999999999999999999865321
Q ss_pred ccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccchhhhhh
Q 000859 1108 DYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSAREEL 1187 (1251)
Q Consensus 1108 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1187 (1251)
. ........||+.|+|||++.+..++.++||||+||++|||++|+.||......+ ..+..
T Consensus 149 ~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~-----~~~~i----------- 208 (320)
T cd05590 149 N----GKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDD-----LFEAI----------- 208 (320)
T ss_pred C----CCcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH-----HHHHH-----------
Confidence 1 112223578999999999999899999999999999999999999997543211 11111
Q ss_pred hcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCH
Q 000859 1188 LDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSS 1224 (1251)
Q Consensus 1188 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 1224 (1251)
.. .....+...+.++.+++.+|++.||++||++
T Consensus 209 ~~----~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 209 LN----DEVVYPTWLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred hc----CCCCCCCCCCHHHHHHHHHHcccCHHHCCCC
Confidence 00 0011112245568899999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=342.89 Aligned_cols=256 Identities=20% Similarity=0.268 Sum_probs=195.9
Q ss_pred cCCCcCceecccCCceEEEEE-ecCCcEEEEEEeccCC--chhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeE
Q 000859 946 NNLSDEFIIGSGGSGTVYKAE-LANGATVAVKKISCKD--DHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLL 1022 (1251)
Q Consensus 946 ~~~~~~~~lG~G~fg~V~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~l 1022 (1251)
++|.+.+.||+|+||+||+|+ ..+++.||||++.... .....+.+.+|++++++++|||||++++++.+ +...++
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~--~~~~~l 78 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQD--AQYLYL 78 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEc--CCeeEE
Confidence 368888999999999999995 4578999999986432 22334677889999999999999999998854 446799
Q ss_pred EEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcccccc
Q 000859 1023 IYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLA 1102 (1251)
Q Consensus 1023 v~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a 1102 (1251)
||||+++|+|.+++.. .+.+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 79 v~E~~~gg~L~~~l~~-------~~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla 148 (377)
T cd05629 79 IMEFLPGGDLMTMLIK-------YDTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLS 148 (377)
T ss_pred EEeCCCCCcHHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeecccc
Confidence 9999999999999975 34688999999999999999999999 9999999999999999999999999999
Q ss_pred cccccccCCC-----------C--------------------------------cccceeecccceecccccccCCCCCc
Q 000859 1103 KALVEDYNSN-----------T--------------------------------ESNTWFAGSYGYIAPEYAYSLKATEK 1139 (1251)
Q Consensus 1103 ~~~~~~~~~~-----------~--------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~ 1139 (1251)
+.+....... . .......||+.|+|||++.+..++.+
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 228 (377)
T cd05629 149 TGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQE 228 (377)
T ss_pred cccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCc
Confidence 6432110000 0 00012469999999999999899999
Q ss_pred cceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccchhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCC
Q 000859 1140 CDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQ 1219 (1251)
Q Consensus 1140 sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~ 1219 (1251)
+||||+||++|||++|+.||.+....+. ...... +.. ...++.....+.++.+++.+|+. +|.
T Consensus 229 ~DiwSlGvil~elltG~~Pf~~~~~~~~-----~~~i~~--------~~~---~~~~p~~~~~s~~~~dli~~lL~-~~~ 291 (377)
T cd05629 229 CDWWSLGAIMFECLIGWPPFCSENSHET-----YRKIIN--------WRE---TLYFPDDIHLSVEAEDLIRRLIT-NAE 291 (377)
T ss_pred eeeEecchhhhhhhcCCCCCCCCCHHHH-----HHHHHc--------cCC---ccCCCCCCCCCHHHHHHHHHHhc-CHh
Confidence 9999999999999999999975533211 000000 000 01112222234568899999997 677
Q ss_pred CC---CCHHHHHHH
Q 000859 1220 ER---PSSRQVCDL 1230 (1251)
Q Consensus 1220 ~R---Ps~~eil~~ 1230 (1251)
+| ++++|++..
T Consensus 292 ~r~~r~~~~~~l~h 305 (377)
T cd05629 292 NRLGRGGAHEIKSH 305 (377)
T ss_pred hcCCCCCHHHHhcC
Confidence 65 599998775
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=334.74 Aligned_cols=248 Identities=21% Similarity=0.307 Sum_probs=192.2
Q ss_pred ceecccCCceEEEEEe-cCCcEEEEEEeccCC--chhhhHHHHHHHHHHHhc-cCCCccceeceeeecCCCceeEEEeec
Q 000859 952 FIIGSGGSGTVYKAEL-ANGATVAVKKISCKD--DHLLNKSFTREVKTLGRI-RHRHLVKLMGHCCNKGAGSNLLIYEYM 1027 (1251)
Q Consensus 952 ~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~~~lv~E~~ 1027 (1251)
+.||+|+||.||+|+. .+++.||||+++... .....+.+.+|..+++++ +||||+++++++.. ....++||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~--~~~~~lv~e~~ 78 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQT--ESRLFFVIEFV 78 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEc--CCEEEEEEeCC
Confidence 3699999999999955 468899999997532 223345678899999998 79999999998754 34579999999
Q ss_pred CCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEccccccccccc
Q 000859 1028 ENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVE 1107 (1251)
Q Consensus 1028 ~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~ 1107 (1251)
++|+|.+++.. .+.+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++....
T Consensus 79 ~~g~L~~~~~~-------~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~ 148 (329)
T cd05588 79 SGGDLMFHMQR-------QRKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIR 148 (329)
T ss_pred CCCCHHHHHHH-------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCcccccccc
Confidence 99999998865 35689999999999999999999999 999999999999999999999999999864321
Q ss_pred ccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhhCCCCCCCccccc---hhHHHHHHHHHhccchhh
Q 000859 1108 DYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVE---MDMVRWVEMHMEMSGSAR 1184 (1251)
Q Consensus 1108 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~ 1184 (1251)
. ........||+.|+|||++.+..++.++||||+||++|||++|+.||+.....+ ....++...
T Consensus 149 ~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~--------- 215 (329)
T cd05588 149 P----GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQ--------- 215 (329)
T ss_pred C----CCccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHH---------
Confidence 1 112223578999999999999999999999999999999999999997432211 111111111
Q ss_pred hhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCC------HHHHHH
Q 000859 1185 EELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPS------SRQVCD 1229 (1251)
Q Consensus 1185 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs------~~eil~ 1229 (1251)
..... ....+...+.++.+++.+|++.||.+||+ ++++++
T Consensus 216 -~~~~~----~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 216 -VILEK----QIRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred -HHHcC----CCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 01111 11111223456889999999999999998 566654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=335.26 Aligned_cols=243 Identities=23% Similarity=0.325 Sum_probs=191.6
Q ss_pred ceecccCCceEEEEEec-CCcEEEEEEeccCC--chhhhHHHHHHHHHHHhc-cCCCccceeceeeecCCCceeEEEeec
Q 000859 952 FIIGSGGSGTVYKAELA-NGATVAVKKISCKD--DHLLNKSFTREVKTLGRI-RHRHLVKLMGHCCNKGAGSNLLIYEYM 1027 (1251)
Q Consensus 952 ~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~~~lv~E~~ 1027 (1251)
+.||+|+||.||+|+.. +++.||||++.... .....+.+..|.++++.+ +||||+++++++.. ....++||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~--~~~~~lv~E~~ 78 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQT--KDRLFFVMEYV 78 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEc--CCeEEEEEeCC
Confidence 36999999999999654 57899999986432 223345677899998876 79999999998854 34579999999
Q ss_pred CCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEccccccccccc
Q 000859 1028 ENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVE 1107 (1251)
Q Consensus 1028 ~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~ 1107 (1251)
++|+|..++.. .+.+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 79 ~~~~L~~~l~~-------~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~ 148 (321)
T cd05591 79 NGGDLMFQIQR-------SRKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGIL 148 (321)
T ss_pred CCCcHHHHHHH-------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceeccc
Confidence 99999999876 34688999999999999999999999 999999999999999999999999999875322
Q ss_pred ccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccchhhhhh
Q 000859 1108 DYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSAREEL 1187 (1251)
Q Consensus 1108 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1187 (1251)
. ........||+.|+|||++.+..++.++||||+||++|||++|+.||......+. .+..
T Consensus 149 ~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~-----~~~i----------- 208 (321)
T cd05591 149 N----GVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDL-----FESI----------- 208 (321)
T ss_pred C----CccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHH-----HHHH-----------
Confidence 1 1122235689999999999998999999999999999999999999976532111 1110
Q ss_pred hcccCCCCCCchHHHHHHHHHHHHHccccCCCCCC-------CHHHHHHH
Q 000859 1188 LDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERP-------SSRQVCDL 1230 (1251)
Q Consensus 1188 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-------s~~eil~~ 1230 (1251)
... ....+...+.++.+++.+|++.||++|| +++++++.
T Consensus 209 ~~~----~~~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 209 LHD----DVLYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred HcC----CCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 000 0011112345688999999999999999 77777654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=327.47 Aligned_cols=265 Identities=25% Similarity=0.385 Sum_probs=206.5
Q ss_pred CCCcCceecccCCceEEEEEec------CCcEEEEEEeccCCchhhhHHHHHHHHHHHhccCCCccceeceeeecCCCce
Q 000859 947 NLSDEFIIGSGGSGTVYKAELA------NGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSN 1020 (1251)
Q Consensus 947 ~~~~~~~lG~G~fg~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~ 1020 (1251)
+|...+.||+|+||.||+|... ....||+|.+.........+.+.+|+.+++.++||||+++++.+... ...
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~ 78 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQD--GPL 78 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecC--CCc
Confidence 3677789999999999999643 23579999887655555567899999999999999999999988654 346
Q ss_pred eEEEeecCCCChHHhhhcCCCC-----------------cccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCC
Q 000859 1021 LLIYEYMENGSVWDWLHKQPVN-----------------IKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKS 1083 (1251)
Q Consensus 1021 ~lv~E~~~~gsL~~~l~~~~~~-----------------~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp 1083 (1251)
++++||+++|+|.+++...... ......+++.++..++.|++.|++|||+. +|+||||||
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp 155 (290)
T cd05045 79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAA 155 (290)
T ss_pred EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhhhhh
Confidence 8999999999999998753211 11234688999999999999999999999 999999999
Q ss_pred CCeeecCCCCeEEcccccccccccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhh-CCCCCCCc
Q 000859 1084 SNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDAT 1162 (1251)
Q Consensus 1084 ~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~t-g~~p~~~~ 1162 (1251)
+||++++++.+||+|||+++......... ......++..|+|||.+.+..++.++||||||+++|||++ |+.||.+.
T Consensus 156 ~nill~~~~~~kl~dfg~~~~~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~ 233 (290)
T cd05045 156 RNVLVAEGRKMKISDFGLSRDVYEEDSYV--KRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI 233 (290)
T ss_pred heEEEcCCCcEEeccccccccccCccchh--cccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCC
Confidence 99999999999999999997653321111 1122345678999999988889999999999999999999 99999754
Q ss_pred cccchhHHHHHHHHHhccchhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhcCC
Q 000859 1163 FGVEMDMVRWVEMHMEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNVFNN 1237 (1251)
Q Consensus 1163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~ 1237 (1251)
.+.+ ...+. ...... +.+...+.++.+++.+|++.+|++||+++++++.|++++.+
T Consensus 234 ~~~~--~~~~~---------------~~~~~~--~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~~ 289 (290)
T cd05045 234 APER--LFNLL---------------KTGYRM--ERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMVK 289 (290)
T ss_pred CHHH--HHHHH---------------hCCCCC--CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHhc
Confidence 3211 11111 011111 11223456788999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-35 Score=333.61 Aligned_cols=242 Identities=23% Similarity=0.337 Sum_probs=188.4
Q ss_pred ceecccCCceEEEEEe-cCCcEEEEEEeccCC--chhhhHHHHHHHHHHHhc-cCCCccceeceeeecCCCceeEEEeec
Q 000859 952 FIIGSGGSGTVYKAEL-ANGATVAVKKISCKD--DHLLNKSFTREVKTLGRI-RHRHLVKLMGHCCNKGAGSNLLIYEYM 1027 (1251)
Q Consensus 952 ~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~~~lv~E~~ 1027 (1251)
+.||+|+||.||+|+. .+++.||||+++... .....+.+..|..++... +||||+++++++.. ....++||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~--~~~~~lv~e~~ 78 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQT--KEHLFFVMEYL 78 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEc--CCEEEEEEcCC
Confidence 3699999999999965 457899999986432 122334556677777655 89999999988754 44679999999
Q ss_pred CCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEccccccccccc
Q 000859 1028 ENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVE 1107 (1251)
Q Consensus 1028 ~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~ 1107 (1251)
++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 79 ~gg~L~~~~~~~-------~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~ 148 (316)
T cd05592 79 NGGDLMFHIQSS-------GRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMN 148 (316)
T ss_pred CCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCC
Confidence 999999998763 4689999999999999999999999 999999999999999999999999999975422
Q ss_pred ccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccchhhhhh
Q 000859 1108 DYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSAREEL 1187 (1251)
Q Consensus 1108 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1187 (1251)
.. .......||+.|+|||++.+..++.++||||+||++|||++|+.||.+....+ .....
T Consensus 149 ~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~-----~~~~i----------- 208 (316)
T cd05592 149 GE----GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDE-----LFDSI----------- 208 (316)
T ss_pred CC----CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHH-----HHHHH-----------
Confidence 11 22233578999999999999899999999999999999999999997643211 11100
Q ss_pred hcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHH-HHHH
Q 000859 1188 LDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSR-QVCD 1229 (1251)
Q Consensus 1188 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-eil~ 1229 (1251)
.. ..+.. +...+.++.+++.+||+.||++||++. ++.+
T Consensus 209 ~~--~~~~~--~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 209 LN--DRPHF--PRWISKEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred Hc--CCCCC--CCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 00 00111 122445678999999999999999875 4543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-35 Score=350.83 Aligned_cols=260 Identities=25% Similarity=0.354 Sum_probs=205.2
Q ss_pred hhcCCCcCceecccCCceEEEEE-ecCCcEEEEEEeccCC-chhhhHHHHHHHHHHHhccCCCccceeceeeecCCC---
Q 000859 944 ATNNLSDEFIIGSGGSGTVYKAE-LANGATVAVKKISCKD-DHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAG--- 1018 (1251)
Q Consensus 944 ~~~~~~~~~~lG~G~fg~V~~~~-~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~--- 1018 (1251)
...+|.+.+.||+|+||+||+|+ ..+|+.||||++.... .......+.+|+.++..++|+||+++++.+......
T Consensus 30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~ 109 (496)
T PTZ00283 30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPE 109 (496)
T ss_pred cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcc
Confidence 45689999999999999999995 4578999999986543 344556788999999999999999998876543221
Q ss_pred ---ceeEEEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeE
Q 000859 1019 ---SNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAH 1095 (1251)
Q Consensus 1019 ---~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~k 1095 (1251)
..++||||+++|+|.++++... .....+++..+..++.|++.||+|+|+. +|+||||||+||+++.++.+|
T Consensus 110 ~~~~i~lV~Ey~~~gsL~~~l~~~~---~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vk 183 (496)
T PTZ00283 110 NVLMIALVLDYANAGDLRQEIKSRA---KTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVK 183 (496)
T ss_pred cceEEEEEEeCCCCCcHHHHHHHhh---ccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEE
Confidence 2579999999999999997542 1235689999999999999999999999 999999999999999999999
Q ss_pred EcccccccccccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHH
Q 000859 1096 LGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEM 1175 (1251)
Q Consensus 1096 l~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~ 1175 (1251)
|+|||+++.+...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.... .....
T Consensus 184 L~DFGls~~~~~~~~~--~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~-----~~~~~ 256 (496)
T PTZ00283 184 LGDFGFSKMYAATVSD--DVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENME-----EVMHK 256 (496)
T ss_pred EEecccCeeccccccc--cccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH-----HHHHH
Confidence 9999999765432111 1122357899999999999999999999999999999999999999754221 11111
Q ss_pred HHhccchhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 000859 1176 HMEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDL 1230 (1251)
Q Consensus 1176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 1230 (1251)
....... +.+...++++.+++.+||+.||++||+++++++.
T Consensus 257 -----------~~~~~~~---~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 257 -----------TLAGRYD---PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred -----------HhcCCCC---CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 1111111 1122345678999999999999999999999764
|
|
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=326.22 Aligned_cols=267 Identities=20% Similarity=0.342 Sum_probs=211.1
Q ss_pred hcCCCcCceecccCCceEEEEEecC-----CcEEEEEEeccCCchhhhHHHHHHHHHHHhccCCCccceeceeeecCCCc
Q 000859 945 TNNLSDEFIIGSGGSGTVYKAELAN-----GATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGS 1019 (1251)
Q Consensus 945 ~~~~~~~~~lG~G~fg~V~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 1019 (1251)
.++|...+.||+|+||.||+|.... +..||+|++.........+.+.+|+.++++++||||+++++++... +..
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~-~~~ 83 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIED-GEP 83 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC-CCC
Confidence 4568888999999999999997655 6889999987665666677889999999999999999999987654 345
Q ss_pred eeEEEeecCCCChHHhhhcCCCC-cccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcc
Q 000859 1020 NLLIYEYMENGSVWDWLHKQPVN-IKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGD 1098 (1251)
Q Consensus 1020 ~~lv~E~~~~gsL~~~l~~~~~~-~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D 1098 (1251)
.++++||+++|+|.+++...... ......+++..+..++.|++.|++|||+. +++||||||+||++++++.+||+|
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEECC
Confidence 68999999999999999764311 11125689999999999999999999999 999999999999999999999999
Q ss_pred cccccccccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhh-CCCCCCCccccchhHHHHHHHHH
Q 000859 1099 FGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMVRWVEMHM 1177 (1251)
Q Consensus 1099 fG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~ 1177 (1251)
||+++.+........ .....++..|+|||++.+..++.++|||||||++||+++ |+.||....+.+ ...+..
T Consensus 161 ~g~~~~~~~~~~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~~~~--- 233 (280)
T cd05043 161 NALSRDLFPMDYHCL--GDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE--MAAYLK--- 233 (280)
T ss_pred CCCcccccCCceEEe--CCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH--HHHHHH---
Confidence 999986543221111 111345678999999988889999999999999999999 999997542211 111111
Q ss_pred hccchhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhcC
Q 000859 1178 EMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNVFN 1236 (1251)
Q Consensus 1178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~ 1236 (1251)
. ... .+....++.++.+++.+||+.||++|||+.++++.|+++..
T Consensus 234 -----------~-~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 234 -----------D-GYR--LAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred -----------c-CCC--CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 0 000 11112245678999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=338.25 Aligned_cols=254 Identities=21% Similarity=0.275 Sum_probs=198.5
Q ss_pred cCCCcCceecccCCceEEEEEe-cCCcEEEEEEeccCC--chhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeE
Q 000859 946 NNLSDEFIIGSGGSGTVYKAEL-ANGATVAVKKISCKD--DHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLL 1022 (1251)
Q Consensus 946 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~l 1022 (1251)
++|...+.||+|+||+||+|.. .+++.||+|++.... .....+.+.+|+.+++.++||||+++++++.. ....++
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~--~~~~~l 78 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQD--KDNLYL 78 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEec--CCeEEE
Confidence 3688889999999999999954 478999999997543 22345678899999999999999999987754 345799
Q ss_pred EEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcccccc
Q 000859 1023 IYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLA 1102 (1251)
Q Consensus 1023 v~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a 1102 (1251)
||||+++|+|.+++.+. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 79 v~e~~~~~~L~~~l~~~------~~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a 149 (330)
T cd05601 79 VMEYQPGGDLLSLLNRY------EDQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSA 149 (330)
T ss_pred EECCCCCCCHHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCC
Confidence 99999999999999764 25689999999999999999999999 9999999999999999999999999999
Q ss_pred cccccccCCCCcccceeecccceecccccc------cCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHH
Q 000859 1103 KALVEDYNSNTESNTWFAGSYGYIAPEYAY------SLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMH 1176 (1251)
Q Consensus 1103 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~ 1176 (1251)
+.+...... ......||+.|+|||++. ...++.++||||+||++|||++|+.||......+ .....
T Consensus 150 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~-----~~~~i 221 (330)
T cd05601 150 ARLTANKMV---NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAK-----TYNNI 221 (330)
T ss_pred eECCCCCce---eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHH-----HHHHH
Confidence 765322111 112246899999999986 4567899999999999999999999997543211 11110
Q ss_pred HhccchhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 000859 1177 MEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDL 1230 (1251)
Q Consensus 1177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 1230 (1251)
. .......++.....+.++.+++.+|++ +|.+||+++++++.
T Consensus 222 ~-----------~~~~~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 222 M-----------NFQRFLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred H-----------cCCCccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 0 000001112222245668899999998 99999999998753
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=327.61 Aligned_cols=253 Identities=24% Similarity=0.272 Sum_probs=197.5
Q ss_pred CCCcCceecccCCceEEEEEe-cCCcEEEEEEeccCCc--hhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEE
Q 000859 947 NLSDEFIIGSGGSGTVYKAEL-ANGATVAVKKISCKDD--HLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLI 1023 (1251)
Q Consensus 947 ~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv 1023 (1251)
.|+..+.||+|+||+||++.. .+++.||||++..... ....+.+.+|+.++++++||||+++++++... ...++|
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv 78 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETK--DALCLV 78 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCC--CeEEEE
Confidence 367788999999999999964 4689999999864332 22335677899999999999999999987543 457999
Q ss_pred EeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEccccccc
Q 000859 1024 YEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAK 1103 (1251)
Q Consensus 1024 ~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~ 1103 (1251)
|||+++|+|.+++.... ...+++..+..++.|++.|++|||+. +|+||||||+||++++++.++|+|||+++
T Consensus 79 ~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~ 150 (285)
T cd05605 79 LTLMNGGDLKFHIYNMG-----NPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAV 150 (285)
T ss_pred EeccCCCcHHHHHHhcC-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCce
Confidence 99999999999886532 34689999999999999999999999 99999999999999999999999999987
Q ss_pred ccccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccchh
Q 000859 1104 ALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSA 1183 (1251)
Q Consensus 1104 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1183 (1251)
...... ......|+..|+|||++.+..++.++||||+||++|||++|+.||.+..... ....... .
T Consensus 151 ~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~-~~~~~~~-~------- 216 (285)
T cd05605 151 EIPEGE-----TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV-KREEVER-R------- 216 (285)
T ss_pred ecCCCC-----ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhh-HHHHHHH-H-------
Confidence 643211 1122468999999999998899999999999999999999999997542211 1111000 0
Q ss_pred hhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 000859 1184 REELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERP-----SSRQVCDL 1230 (1251)
Q Consensus 1184 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~~ 1230 (1251)
+.. .....+...+..+.+++.+||+.||++|| +++++++.
T Consensus 217 ----~~~---~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 217 ----VKE---DQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred ----hhh---cccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 000 00111222456788999999999999999 78888654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=325.46 Aligned_cols=262 Identities=23% Similarity=0.349 Sum_probs=203.6
Q ss_pred hcCCCcCceecccCCceEEEEEec------CCcEEEEEEeccCCchhhhHHHHHHHHHHHhccCCCccceeceeeecCCC
Q 000859 945 TNNLSDEFIIGSGGSGTVYKAELA------NGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAG 1018 (1251)
Q Consensus 945 ~~~~~~~~~lG~G~fg~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~ 1018 (1251)
+++|...+.||+|+||.||+|... .+..||+|.+...........|.+|+.++++++|+||+++++++.+..
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-- 82 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERL-- 82 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC--
Confidence 456888899999999999999664 357899999875555555677999999999999999999999876543
Q ss_pred ceeEEEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCC---CeE
Q 000859 1019 SNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNM---EAH 1095 (1251)
Q Consensus 1019 ~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~---~~k 1095 (1251)
..++||||+++|+|.++++...........+++..+.+++.||+.|++|||+. +++||||||+||+++.++ .+|
T Consensus 83 ~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~k 159 (277)
T cd05036 83 PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAK 159 (277)
T ss_pred CcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceE
Confidence 45899999999999999977543222334689999999999999999999999 999999999999998754 599
Q ss_pred EcccccccccccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhh-CCCCCCCccccchhHHHHHH
Q 000859 1096 LGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMVRWVE 1174 (1251)
Q Consensus 1096 l~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~t-g~~p~~~~~~~~~~~~~~~~ 1174 (1251)
++|||+++.+....... .......+..|+|||++.+..++.++|||||||++|||++ |+.||......+. ..
T Consensus 160 l~dfg~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~-----~~ 232 (277)
T cd05036 160 IADFGMARDIYRASYYR--KGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEV-----ME 232 (277)
T ss_pred eccCccccccCCcccee--cCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH-----HH
Confidence 99999998653221111 1111233578999999998899999999999999999997 9999976533211 11
Q ss_pred HHHhccchhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 000859 1175 MHMEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLL 1232 (1251)
Q Consensus 1175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 1232 (1251)
... ...+.. .+...+..+.+++.+|++.+|++|||+.+|++.|.
T Consensus 233 ~~~------------~~~~~~--~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 233 FVT------------GGGRLD--PPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred HHH------------cCCcCC--CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 100 000011 11223457889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=333.76 Aligned_cols=243 Identities=21% Similarity=0.318 Sum_probs=188.5
Q ss_pred ceecccCCceEEEEEe-cCCcEEEEEEeccCC--chhhhHHHHHHHHHHHhc-cCCCccceeceeeecCCCceeEEEeec
Q 000859 952 FIIGSGGSGTVYKAEL-ANGATVAVKKISCKD--DHLLNKSFTREVKTLGRI-RHRHLVKLMGHCCNKGAGSNLLIYEYM 1027 (1251)
Q Consensus 952 ~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~~~lv~E~~ 1027 (1251)
+.||+|+||.||+|.. .+++.||+|++.... .....+.+.+|+.++.++ +||||+++++++.. ....++||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~--~~~~~lv~E~~ 78 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT--ESRLFFVIEYV 78 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEe--CCEEEEEEeCC
Confidence 3699999999999964 467899999997542 233445677899988877 89999999998755 34679999999
Q ss_pred CCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEccccccccccc
Q 000859 1028 ENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVE 1107 (1251)
Q Consensus 1028 ~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~ 1107 (1251)
++|+|..++.. .+.+++..+..++.|++.|++|||++ +|+||||||+||+++.++.+||+|||+++....
T Consensus 79 ~~~~L~~~~~~-------~~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~ 148 (329)
T cd05618 79 NGGDLMFHMQR-------QRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 148 (329)
T ss_pred CCCCHHHHHHH-------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccC
Confidence 99999998875 34689999999999999999999999 999999999999999999999999999865321
Q ss_pred ccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhhCCCCCCCccccch---hHHHHHHHHHhccchhh
Q 000859 1108 DYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEM---DMVRWVEMHMEMSGSAR 1184 (1251)
Q Consensus 1108 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~ 1184 (1251)
. ........||..|+|||++.+..++.++||||+||++|||++|+.||........ ....+....
T Consensus 149 ~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~-------- 216 (329)
T cd05618 149 P----GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQV-------- 216 (329)
T ss_pred C----CCccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHH--------
Confidence 1 1112235789999999999999999999999999999999999999964322111 111111110
Q ss_pred hhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCH
Q 000859 1185 EELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSS 1224 (1251)
Q Consensus 1185 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 1224 (1251)
... .....+...+.++.+++.+|++.||++||++
T Consensus 217 --i~~----~~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 217 --ILE----KQIRIPRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred --Hhc----CCCCCCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 011 0111122234568899999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=327.65 Aligned_cols=266 Identities=23% Similarity=0.389 Sum_probs=206.8
Q ss_pred hhcCCCcCceecccCCceEEEEEec------CCcEEEEEEeccCCchhhhHHHHHHHHHHHhc-cCCCccceeceeeecC
Q 000859 944 ATNNLSDEFIIGSGGSGTVYKAELA------NGATVAVKKISCKDDHLLNKSFTREVKTLGRI-RHRHLVKLMGHCCNKG 1016 (1251)
Q Consensus 944 ~~~~~~~~~~lG~G~fg~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~ 1016 (1251)
..++|+..+.||+|+||.||+|... ....||+|.+...........+.+|+++++++ +||||+++++++...
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~- 88 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE- 88 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC-
Confidence 3456888889999999999999654 23689999987655544556788999999999 899999999988654
Q ss_pred CCceeEEEeecCCCChHHhhhcCCC---------CcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCee
Q 000859 1017 AGSNLLIYEYMENGSVWDWLHKQPV---------NIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNIL 1087 (1251)
Q Consensus 1017 ~~~~~lv~E~~~~gsL~~~l~~~~~---------~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nil 1087 (1251)
...+++|||+++|+|.++++.... .......+++..+++++.|++.|++|||+. +|+||||||+||+
T Consensus 89 -~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Nil 164 (293)
T cd05053 89 -GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVL 164 (293)
T ss_pred -CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeEE
Confidence 446999999999999999975321 112345789999999999999999999999 9999999999999
Q ss_pred ecCCCCeEEcccccccccccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhh-CCCCCCCccccc
Q 000859 1088 LDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVE 1166 (1251)
Q Consensus 1088 l~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~t-g~~p~~~~~~~~ 1166 (1251)
++.++.+|++|||.++.+....... ......++..|+|||.+.+..++.++|||||||++||+++ |..||......+
T Consensus 165 ~~~~~~~kL~Dfg~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~ 242 (293)
T cd05053 165 VTEDHVMKIADFGLARDIHHIDYYR--KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE 242 (293)
T ss_pred EcCCCeEEeCcccccccccccccee--ccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH
Confidence 9999999999999998654321111 1111234678999999988899999999999999999998 999986542211
Q ss_pred hhHHHHHHHHHhccchhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhc
Q 000859 1167 MDMVRWVEMHMEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNVF 1235 (1251)
Q Consensus 1167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~ 1235 (1251)
. .... ...... ..+...+.++.+++.+||+.||++|||++|+++.|+++.
T Consensus 243 ~-----~~~~------------~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 243 L-----FKLL------------KEGYRM--EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred H-----HHHH------------HcCCcC--CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 1 0000 000011 111223557889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=337.73 Aligned_cols=239 Identities=25% Similarity=0.338 Sum_probs=190.1
Q ss_pred ceecccCCceEEEEEe----cCCcEEEEEEeccCC-chhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEEEee
Q 000859 952 FIIGSGGSGTVYKAEL----ANGATVAVKKISCKD-DHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIYEY 1026 (1251)
Q Consensus 952 ~~lG~G~fg~V~~~~~----~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv~E~ 1026 (1251)
+.||+|+||.||+++. .+|+.||+|++.... .......+..|++++++++||||+++++++.. +...++||||
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~ 79 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQT--EGKLYLILDF 79 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEc--CCEEEEEEcC
Confidence 5799999999999854 368899999996433 22234567789999999999999999998854 4567999999
Q ss_pred cCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcccccccccc
Q 000859 1027 MENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALV 1106 (1251)
Q Consensus 1027 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~ 1106 (1251)
+++|+|.+++.+ ...+++.++..++.||++||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 80 ~~~~~L~~~l~~-------~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~ 149 (318)
T cd05582 80 LRGGDLFTRLSK-------EVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESI 149 (318)
T ss_pred CCCCcHHHHHHH-------cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccC
Confidence 999999999975 34689999999999999999999999 99999999999999999999999999987543
Q ss_pred cccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccchhhhh
Q 000859 1107 EDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSAREE 1186 (1251)
Q Consensus 1107 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1186 (1251)
... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||......+ .....
T Consensus 150 ~~~----~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~-----~~~~i---------- 210 (318)
T cd05582 150 DHE----KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKE-----TMTMI---------- 210 (318)
T ss_pred CCC----CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHH-----HHHHH----------
Confidence 221 11223578999999999998889999999999999999999999997542211 11100
Q ss_pred hhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHH
Q 000859 1187 LLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQ 1226 (1251)
Q Consensus 1187 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e 1226 (1251)
.. .....+...+..+.+++.+||+.||++||++.+
T Consensus 211 -~~----~~~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 211 -LK----AKLGMPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred -Hc----CCCCCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 00 011112224556889999999999999999655
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=342.13 Aligned_cols=254 Identities=23% Similarity=0.308 Sum_probs=193.8
Q ss_pred CCCcCceecccCCceEEEEEe-cCCcEEEEEEeccCC--chhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEE
Q 000859 947 NLSDEFIIGSGGSGTVYKAEL-ANGATVAVKKISCKD--DHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLI 1023 (1251)
Q Consensus 947 ~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv 1023 (1251)
.|+..+.||+|+||+||+|+. .+++.||+|++.... .....+.+.+|++++++++|||||++++++.+ ....++|
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~--~~~~~lv 79 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQD--KDNLYFV 79 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEe--CCEEEEE
Confidence 578889999999999999954 568899999986432 22344678899999999999999999998865 3457999
Q ss_pred EeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEccccccc
Q 000859 1024 YEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAK 1103 (1251)
Q Consensus 1024 ~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~ 1103 (1251)
|||+++|+|.+++.+. +.+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 80 ~E~~~gg~L~~~l~~~-------~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~ 149 (382)
T cd05625 80 MDYIPGGDMMSLLIRM-------GIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCT 149 (382)
T ss_pred EeCCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCc
Confidence 9999999999999763 4578899999999999999999999 99999999999999999999999999986
Q ss_pred ccccccCC-------------------------------------------CCcccceeecccceecccccccCCCCCcc
Q 000859 1104 ALVEDYNS-------------------------------------------NTESNTWFAGSYGYIAPEYAYSLKATEKC 1140 (1251)
Q Consensus 1104 ~~~~~~~~-------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~s 1140 (1251)
.+...... .........||+.|+|||++.+..++.++
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~ 229 (382)
T cd05625 150 GFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLC 229 (382)
T ss_pred cccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCee
Confidence 43210000 00001124689999999999999999999
Q ss_pred ceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccchhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCC
Q 000859 1141 DVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQE 1220 (1251)
Q Consensus 1141 DiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~ 1220 (1251)
||||+||++|||++|+.||.+..+.+... ...........+.....+++..+++.+++ .+|++
T Consensus 230 DiwSlGvil~elltG~~Pf~~~~~~~~~~----------------~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~ 292 (382)
T cd05625 230 DWWSVGVILYEMLVGQPPFLAQTPLETQM----------------KVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPED 292 (382)
T ss_pred eEEechHHHHHHHhCCCCCCCCCHHHHHH----------------HHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhH
Confidence 99999999999999999997653321100 00000001111222223455677777765 59999
Q ss_pred CCC---HHHHHH
Q 000859 1221 RPS---SRQVCD 1229 (1251)
Q Consensus 1221 RPs---~~eil~ 1229 (1251)
|++ ++++++
T Consensus 293 R~~~~~~~ei~~ 304 (382)
T cd05625 293 RLGKNGADEIKA 304 (382)
T ss_pred cCCCCCHHHHhc
Confidence 997 777764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-35 Score=335.06 Aligned_cols=245 Identities=23% Similarity=0.354 Sum_probs=190.3
Q ss_pred CCcCceecccCCceEEEEEe-cCCcEEEEEEeccCC--chhhhHHHHHHHHHH---HhccCCCccceeceeeecCCCcee
Q 000859 948 LSDEFIIGSGGSGTVYKAEL-ANGATVAVKKISCKD--DHLLNKSFTREVKTL---GRIRHRHLVKLMGHCCNKGAGSNL 1021 (1251)
Q Consensus 948 ~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l---~~l~h~niv~l~g~~~~~~~~~~~ 1021 (1251)
|++.+.||+|+||.||+|.. .+++.||||++.... .....+.+.+|++++ +.++||||+++++++.. ....+
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~--~~~~~ 78 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQT--EDHVC 78 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEc--CCEEE
Confidence 56678999999999999965 468999999996432 222345566676665 45679999999998754 34579
Q ss_pred EEEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEccccc
Q 000859 1022 LIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGL 1101 (1251)
Q Consensus 1022 lv~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~ 1101 (1251)
+||||+++|+|..++++ ..+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 79 lv~E~~~~~~L~~~~~~--------~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~ 147 (324)
T cd05589 79 FVMEYAAGGDLMMHIHT--------DVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGL 147 (324)
T ss_pred EEEcCCCCCcHHHHhhc--------CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccC
Confidence 99999999999988864 3589999999999999999999999 999999999999999999999999999
Q ss_pred ccccccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccc
Q 000859 1102 AKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSG 1181 (1251)
Q Consensus 1102 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 1181 (1251)
++..... ........|++.|+|||.+.+..++.++|||||||++|||++|+.||.+....+ ....
T Consensus 148 ~~~~~~~----~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~-----~~~~------ 212 (324)
T cd05589 148 CKEGMGF----GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEE-----VFDS------ 212 (324)
T ss_pred CccCCCC----CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHH-----HHHH------
Confidence 8643211 112233578999999999999999999999999999999999999997542211 1110
Q ss_pred hhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 000859 1182 SAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERP-----SSRQVCD 1229 (1251)
Q Consensus 1182 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~ 1229 (1251)
..... ... +...+..+.+++.+|++.||.+|| +++++++
T Consensus 213 -----i~~~~--~~~--p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 213 -----IVNDE--VRY--PRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred -----HHhCC--CCC--CCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 00000 011 112345688999999999999999 4666654
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=321.16 Aligned_cols=253 Identities=28% Similarity=0.436 Sum_probs=202.2
Q ss_pred cCCCcCceecccCCceEEEEEecCCcEEEEEEeccCCchhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEEEe
Q 000859 946 NNLSDEFIIGSGGSGTVYKAELANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIYE 1025 (1251)
Q Consensus 946 ~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv~E 1025 (1251)
++|++.+.||+|+||.||+|...++..||+|.+..... ..+.+.+|+.++++++|++++++++++.. ...+++||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~--~~~~~~~E~~~l~~l~~~~i~~~~~~~~~---~~~~lv~e 80 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM--SPESFLEEAQIMKKLRHDKLVQLYAVVSE---EPIYIVTE 80 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC--CHHHHHHHHHHHHhcCCCceEEEEeEECC---CCcEEEEE
Confidence 45788889999999999999888888999999864332 34678999999999999999999987632 34689999
Q ss_pred ecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEccccccccc
Q 000859 1026 YMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKAL 1105 (1251)
Q Consensus 1026 ~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~ 1105 (1251)
|+++++|.+++++.. ...+++.++..++.|++.|++|||+. +|+||||||+||++++++.++|+|||.+..+
T Consensus 81 ~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~ 152 (260)
T cd05070 81 YMSKGSLLDFLKDGE-----GRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLI 152 (260)
T ss_pred ecCCCcHHHHHHhcC-----CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeec
Confidence 999999999997642 34689999999999999999999999 9999999999999999999999999999765
Q ss_pred ccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhh-CCCCCCCccccchhHHHHHHHHHhccchhh
Q 000859 1106 VEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMVRWVEMHMEMSGSAR 1184 (1251)
Q Consensus 1106 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1184 (1251)
...... ......++..|+|||...+..++.++||||||+++|||++ |+.||.+....+ .....
T Consensus 153 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~-----~~~~~-------- 216 (260)
T cd05070 153 EDNEYT---ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNRE-----VLEQV-------- 216 (260)
T ss_pred cCcccc---cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHH-----HHHHH--------
Confidence 332111 1111235678999999988889999999999999999999 899997542211 11110
Q ss_pred hhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 000859 1185 EELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLN 1233 (1251)
Q Consensus 1185 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 1233 (1251)
.. .. ..+.+...+..+.+++.+|++.+|++|||++++.+.|++
T Consensus 217 ---~~-~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 217 ---ER-GY--RMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred ---Hc-CC--CCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 00 00 111223345679999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=310.26 Aligned_cols=255 Identities=23% Similarity=0.289 Sum_probs=203.7
Q ss_pred CCCcCceecccCCceEEEEEecC-CcEEEEEEeccCC--chhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEE
Q 000859 947 NLSDEFIIGSGGSGTVYKAELAN-GATVAVKKISCKD--DHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLI 1023 (1251)
Q Consensus 947 ~~~~~~~lG~G~fg~V~~~~~~~-~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv 1023 (1251)
.|+..+.||+|.-|+||.++.++ +..+|+|++.+.. ..........|-+||+.++||.++.+|+.+.. +...++|
T Consensus 78 ~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet--~~~~cl~ 155 (459)
T KOG0610|consen 78 HFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFET--DKYSCLV 155 (459)
T ss_pred HHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeec--cceeEEE
Confidence 35667789999999999997764 5899999996543 22334566789999999999999999998844 5667999
Q ss_pred EeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEccccccc
Q 000859 1024 YEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAK 1103 (1251)
Q Consensus 1024 ~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~ 1103 (1251)
||||+||+|...+++++ .+.+++..++-+|..++-||+|||-. |||.||+||+||||.++|.+.++||.++.
T Consensus 156 meyCpGGdL~~LrqkQp-----~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~ 227 (459)
T KOG0610|consen 156 MEYCPGGDLHSLRQKQP-----GKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSL 227 (459)
T ss_pred EecCCCccHHHHHhhCC-----CCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccc
Confidence 99999999999999876 78899999999999999999999999 99999999999999999999999999875
Q ss_pred ccccc-------c------------------------C-C--------------------CCcccceeecccceeccccc
Q 000859 1104 ALVED-------Y------------------------N-S--------------------NTESNTWFAGSYGYIAPEYA 1131 (1251)
Q Consensus 1104 ~~~~~-------~------------------------~-~--------------------~~~~~~~~~gt~~y~aPE~~ 1131 (1251)
..... . . . ...+...++||-.|.|||++
T Consensus 228 ~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI 307 (459)
T KOG0610|consen 228 RCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVI 307 (459)
T ss_pred cCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceee
Confidence 43110 0 0 0 00112236899999999999
Q ss_pred ccCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccchhhhhhhcccCCCCCCchHHHHHHHHHHHH
Q 000859 1132 YSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSAREELLDDQMKPLLPGEECAAYQVLEIAL 1211 (1251)
Q Consensus 1132 ~~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 1211 (1251)
.+...+.++|+|+|||++|||+.|+.||.+....+.- .. ++.+ ...++.....+....++|+
T Consensus 308 ~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl-~N---------------Iv~~--~l~Fp~~~~vs~~akDLIr 369 (459)
T KOG0610|consen 308 RGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETL-RN---------------IVGQ--PLKFPEEPEVSSAAKDLIR 369 (459)
T ss_pred ecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhH-HH---------------HhcC--CCcCCCCCcchhHHHHHHH
Confidence 9999999999999999999999999999876443321 11 1111 1233444456677899999
Q ss_pred HccccCCCCCCC----HHHHHH
Q 000859 1212 QCTKTSPQERPS----SRQVCD 1229 (1251)
Q Consensus 1212 ~cl~~dP~~RPs----~~eil~ 1229 (1251)
+.+.+||.+|.- ++||.+
T Consensus 370 ~LLvKdP~kRlg~~rGA~eIK~ 391 (459)
T KOG0610|consen 370 KLLVKDPSKRLGSKRGAAEIKR 391 (459)
T ss_pred HHhccChhhhhccccchHHhhc
Confidence 999999999988 555543
|
|
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=323.00 Aligned_cols=261 Identities=23% Similarity=0.329 Sum_probs=199.7
Q ss_pred CcCceecccCCceEEEEEecCC-c--EEEEEEeccCC-chhhhHHHHHHHHHHHhccCCCccceeceeeecC----CCce
Q 000859 949 SDEFIIGSGGSGTVYKAELANG-A--TVAVKKISCKD-DHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKG----AGSN 1020 (1251)
Q Consensus 949 ~~~~~lG~G~fg~V~~~~~~~~-~--~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~----~~~~ 1020 (1251)
.+.+.||+|+||.||+|...+. . .||+|.+.... .....+.+.+|+++++.++||||+++++++.... ....
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 4567899999999999976543 2 69999886542 3344678889999999999999999999875432 2235
Q ss_pred eEEEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcccc
Q 000859 1021 LLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFG 1100 (1251)
Q Consensus 1021 ~lv~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG 1100 (1251)
+++|||+++|+|.+++..... ......+++..+..++.|++.|++|||++ +|+||||||+||++++++.+||+|||
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRL-GDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcc-cCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCC
Confidence 899999999999998854321 11234589999999999999999999999 99999999999999999999999999
Q ss_pred cccccccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhh-CCCCCCCccccchhHHHHHHHHHhc
Q 000859 1101 LAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMVRWVEMHMEM 1179 (1251)
Q Consensus 1101 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~ 1179 (1251)
+++.+....... ......+++.|+|||...+..++.++|||||||++|||++ |+.||......+ ... ...
T Consensus 158 ~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--~~~---~~~-- 228 (272)
T cd05075 158 LSKKIYNGDYYR--QGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE--IYD---YLR-- 228 (272)
T ss_pred cccccCccccee--cCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHH--HHH---HHH--
Confidence 998654322111 1122345778999999999899999999999999999999 899987542211 111 000
Q ss_pred cchhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 000859 1180 SGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNV 1234 (1251)
Q Consensus 1180 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 1234 (1251)
.. ...+.....+..+.+++.+||+.||++|||++++++.|+++
T Consensus 229 ---------~~---~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 229 ---------QG---NRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred ---------cC---CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 00 00111122445688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=326.28 Aligned_cols=266 Identities=26% Similarity=0.430 Sum_probs=206.7
Q ss_pred cCCCcCceecccCCceEEEEEe------cCCcEEEEEEeccCCchhhhHHHHHHHHHHHhccCCCccceeceeeecCCCc
Q 000859 946 NNLSDEFIIGSGGSGTVYKAEL------ANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGS 1019 (1251)
Q Consensus 946 ~~~~~~~~lG~G~fg~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 1019 (1251)
.+|.+.+.||+|+||+||++.. .++..||+|.+.... ....+.+.+|++++++++||||+++++++... ..
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~ 81 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS-DNARKDFHREAELLTNLQHEHIVKFYGVCVEG--DP 81 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEecC--Cc
Confidence 4578888999999999999964 234569999986443 33456789999999999999999999988643 45
Q ss_pred eeEEEeecCCCChHHhhhcCCCC------cccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCC
Q 000859 1020 NLLIYEYMENGSVWDWLHKQPVN------IKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNME 1093 (1251)
Q Consensus 1020 ~~lv~E~~~~gsL~~~l~~~~~~------~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~ 1093 (1251)
.++||||+++|+|.+++...... ......+++..+..++.|++.|++|||++ +++||||||+||++++++.
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~ 158 (288)
T cd05093 82 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLL 158 (288)
T ss_pred cEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCc
Confidence 79999999999999999754310 01123589999999999999999999999 9999999999999999999
Q ss_pred eEEcccccccccccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhh-CCCCCCCccccchhHHHH
Q 000859 1094 AHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMVRW 1172 (1251)
Q Consensus 1094 ~kl~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~t-g~~p~~~~~~~~~~~~~~ 1172 (1251)
+||+|||.++........ .......++..|+|||++.+..++.++|||||||++|||++ |+.||......+. ..
T Consensus 159 ~kl~dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~--~~- 233 (288)
T cd05093 159 VKIGDFGMSRDVYSTDYY--RVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEV--IE- 233 (288)
T ss_pred EEeccCCccccccCCcee--ecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH--HH-
Confidence 999999999765322111 11122345788999999998899999999999999999998 9999875532211 00
Q ss_pred HHHHHhccchhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhcCCC
Q 000859 1173 VEMHMEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNVFNNR 1238 (1251)
Q Consensus 1173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~ 1238 (1251)
.. ..... .+.....+.++.+++.+||+.||.+|||++++.+.|+++.+..
T Consensus 234 --~i-----------~~~~~---~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~~ 283 (288)
T cd05093 234 --CI-----------TQGRV---LQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKAS 283 (288)
T ss_pred --HH-----------HcCCc---CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHhc
Confidence 00 00000 0111123456899999999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=321.29 Aligned_cols=252 Identities=25% Similarity=0.403 Sum_probs=200.0
Q ss_pred cCCCcCceecccCCceEEEEEecCCcEEEEEEeccCCchhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEEEe
Q 000859 946 NNLSDEFIIGSGGSGTVYKAELANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIYE 1025 (1251)
Q Consensus 946 ~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv~E 1025 (1251)
.+|...+.||+|+||.||+|++.++..||||.+.... ...+.+.+|+.++++++||||+++++++... ...++|||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e 79 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS--MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQ--RPIYIVTE 79 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc--ccHHHHHHHHHHHhcCCCCCeeeEEEEEccC--CCcEEEEE
Confidence 3477788999999999999988777789999986433 2346789999999999999999999988654 34699999
Q ss_pred ecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEccccccccc
Q 000859 1026 YMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKAL 1105 (1251)
Q Consensus 1026 ~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~ 1105 (1251)
|+++|+|.+++... ...+++..++.++.||+.|++|||+. +++|+||||+||+++.++.+||+|||.++..
T Consensus 80 ~~~~~~l~~~i~~~------~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~ 150 (256)
T cd05113 80 YMSNGCLLNYLREH------GKRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYV 150 (256)
T ss_pred cCCCCcHHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceec
Confidence 99999999999764 23689999999999999999999999 9999999999999999999999999998765
Q ss_pred ccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhh-CCCCCCCccccchhHHHHHHHHHhccchhh
Q 000859 1106 VEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMVRWVEMHMEMSGSAR 1184 (1251)
Q Consensus 1106 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1184 (1251)
..... .......++..|+|||...+..++.++|||||||++|||++ |+.||......+. ...
T Consensus 151 ~~~~~---~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~--~~~------------ 213 (256)
T cd05113 151 LDDEY---TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSET--VEK------------ 213 (256)
T ss_pred CCCce---eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHH--HHH------------
Confidence 33211 11112345678999999988889999999999999999999 9999865432111 110
Q ss_pred hhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 000859 1185 EELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLL 1232 (1251)
Q Consensus 1185 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 1232 (1251)
...... .. .+...+..+.+++.+||+.||++||++.++++.++
T Consensus 214 --~~~~~~-~~--~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 214 --VSQGLR-LY--RPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred --HhcCCC-CC--CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 001000 00 11123467899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=339.74 Aligned_cols=262 Identities=21% Similarity=0.274 Sum_probs=194.8
Q ss_pred hcCCCcCceecccCCceEEEEE-ecCCcEEEEEEeccCCchhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEE
Q 000859 945 TNNLSDEFIIGSGGSGTVYKAE-LANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLI 1023 (1251)
Q Consensus 945 ~~~~~~~~~lG~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv 1023 (1251)
..+|++.+.||+|+||.||+|. ..+++.||+|+.. .+.+.+|++++++++|||||++++++... ...++|
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~-------~~~~~~E~~il~~l~HpnIv~~~~~~~~~--~~~~lv 161 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ-------RGGTATEAHILRAINHPSIIQLKGTFTYN--KFTCLI 161 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh-------hhhhHHHHHHHHhCCCCCCCCEeEEEEEC--CeeEEE
Confidence 4579999999999999999994 5678999999753 23467899999999999999999988653 456899
Q ss_pred EeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEccccccc
Q 000859 1024 YEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAK 1103 (1251)
Q Consensus 1024 ~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~ 1103 (1251)
+|++. ++|.+++.. ...+++.+++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+|+
T Consensus 162 ~e~~~-~~L~~~l~~-------~~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~ 230 (391)
T PHA03212 162 LPRYK-TDLYCYLAA-------KRNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAAC 230 (391)
T ss_pred EecCC-CCHHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCccc
Confidence 99995 789998865 34688999999999999999999999 99999999999999999999999999996
Q ss_pred ccccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhhCCCCCCCccccc------hhHHHHHHHHH
Q 000859 1104 ALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVE------MDMVRWVEMHM 1177 (1251)
Q Consensus 1104 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~------~~~~~~~~~~~ 1177 (1251)
...... ........||+.|+|||++.+..++.++||||+||++|||++|+.||....... ...........
T Consensus 231 ~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g 307 (391)
T PHA03212 231 FPVDIN---ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSG 307 (391)
T ss_pred cccccc---ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhc
Confidence 532211 111223579999999999999899999999999999999999998875332211 11111111000
Q ss_pred hc----c---chhhhhhh----cc-cCCC-CCC---chHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 000859 1178 EM----S---GSAREELL----DD-QMKP-LLP---GEECAAYQVLEIALQCTKTSPQERPSSRQVCD 1229 (1251)
Q Consensus 1178 ~~----~---~~~~~~~~----~~-~~~~-~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1229 (1251)
.. . ........ .. ...+ ..+ .....+.++.+++.+|++.||++|||++|+++
T Consensus 308 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 308 THPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred CChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 00 0 00000000 00 0000 011 11124567899999999999999999999986
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=325.87 Aligned_cols=249 Identities=20% Similarity=0.275 Sum_probs=191.9
Q ss_pred ecccCCceEEEEEe-cCCcEEEEEEeccCCch--hhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEEEeecCCC
Q 000859 954 IGSGGSGTVYKAEL-ANGATVAVKKISCKDDH--LLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIYEYMENG 1030 (1251)
Q Consensus 954 lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv~E~~~~g 1030 (1251)
||+|+||+||+|.. .+++.||+|++...... ...+.+..|+++++.++||||+++.+++.. ....++||||+++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~--~~~~~lv~e~~~~g 78 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQT--KTDLCLVMTIMNGG 78 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcC--CCeEEEEEeCCCCC
Confidence 69999999999954 47899999998643321 223567789999999999999999987754 34579999999999
Q ss_pred ChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcccccccccccccC
Q 000859 1031 SVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYN 1110 (1251)
Q Consensus 1031 sL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 1110 (1251)
+|.+++.... .....+++..+..++.||+.|++|||+. +|+||||||+||+++.++.+||+|||.+..+....
T Consensus 79 ~L~~~~~~~~---~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~- 151 (280)
T cd05608 79 DLRYHIYNVD---EENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ- 151 (280)
T ss_pred CHHHHHHhcc---ccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCC-
Confidence 9998875421 1235689999999999999999999999 99999999999999999999999999987653221
Q ss_pred CCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccchhhhhhhcc
Q 000859 1111 SNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSAREELLDD 1190 (1251)
Q Consensus 1111 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1190 (1251)
.......||+.|+|||++.+..++.++||||+||++|||++|+.||........ ..... ....
T Consensus 152 ---~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~-~~~~~-----------~~~~-- 214 (280)
T cd05608 152 ---SKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE-NKELK-----------QRIL-- 214 (280)
T ss_pred ---ccccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchh-HHHHH-----------Hhhc--
Confidence 112235789999999999999999999999999999999999999975422111 00000 0000
Q ss_pred cCCCCCCchHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 000859 1191 QMKPLLPGEECAAYQVLEIALQCTKTSPQERP-----SSRQVCDL 1230 (1251)
Q Consensus 1191 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~~ 1230 (1251)
......+...+..+.+++.+|++.||++|| +++++++.
T Consensus 215 --~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 215 --NDSVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred --ccCCCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 111112223456788999999999999999 66777653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=327.23 Aligned_cols=243 Identities=26% Similarity=0.429 Sum_probs=198.5
Q ss_pred eecccCCceEEEEE-ecCCcEEEEEEeccCCchhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEEEeecCCCC
Q 000859 953 IIGSGGSGTVYKAE-LANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIYEYMENGS 1031 (1251)
Q Consensus 953 ~lG~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv~E~~~~gs 1031 (1251)
++|+|.||+||-|+ ..+...+|||.+..+.+. ..+....|++..++++|+|||+++|.|.+. +..-|.||-++||+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr-~~QPLhEEIaLH~~LrHkNIVrYLGs~sen--Gf~kIFMEqVPGGS 658 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSR-EVQPLHEEIALHSTLRHKNIVRYLGSVSEN--GFFKIFMEQVPGGS 658 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccch-hhccHHHHHHHHHHHhhHhHHHHhhccCCC--CeEEEEeecCCCCc
Confidence 79999999999995 455678999999765544 456788999999999999999999987543 35678999999999
Q ss_pred hHHhhhcCCCCcccCCCC--CHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeec-CCCCeEEcccccccccccc
Q 000859 1032 VWDWLHKQPVNIKMRKSL--DWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLD-SNMEAHLGDFGLAKALVED 1108 (1251)
Q Consensus 1032 L~~~l~~~~~~~~~~~~l--~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~-~~~~~kl~DfG~a~~~~~~ 1108 (1251)
|.+.|+... +++ .+.++-.+..||++|+.|||+. .|||||||-+||+|+ -.|.+||+|||-++.+..
T Consensus 659 LSsLLrskW------GPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg- 728 (1226)
T KOG4279|consen 659 LSSLLRSKW------GPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG- 728 (1226)
T ss_pred HHHHHHhcc------CCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhcc-
Confidence 999998764 344 5677778899999999999999 999999999999996 478999999999987632
Q ss_pred cCCCCcccceeecccceecccccccC--CCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccchhhhh
Q 000859 1109 YNSNTESNTWFAGSYGYIAPEYAYSL--KATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSAREE 1186 (1251)
Q Consensus 1109 ~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1186 (1251)
-......+.||..|||||++..+ .|+.++|||||||++.||.||++||-....... .
T Consensus 729 ---inP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA------------------A 787 (1226)
T KOG4279|consen 729 ---INPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA------------------A 787 (1226)
T ss_pred ---CCccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH------------------h
Confidence 22333447899999999999865 488999999999999999999999976533221 1
Q ss_pred hhcc-cCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 000859 1187 LLDD-QMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCD 1229 (1251)
Q Consensus 1187 ~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1229 (1251)
++.- .++...+.++..+.+...+|.+|+.+||.+||++++++.
T Consensus 788 MFkVGmyKvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 788 MFKVGMYKVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred hhhhcceecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 2222 223344566778888999999999999999999999874
|
|
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=321.20 Aligned_cols=255 Identities=25% Similarity=0.416 Sum_probs=204.1
Q ss_pred hcCCCcCceecccCCceEEEEEecCCcEEEEEEeccCCchhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEEE
Q 000859 945 TNNLSDEFIIGSGGSGTVYKAELANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIY 1024 (1251)
Q Consensus 945 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv~ 1024 (1251)
.++|+..++||+|+||.||+|..++++.||+|.+..... ..+.+.+|+.++++++||||+++++++.. ...+++|
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~~~v~ 79 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM--SPEAFLAEANLMKQLQHPRLVRLYAVVTQ---EPIYIIT 79 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC--cHHHHHHHHHHHHhcCCcCeeeEEEEEcc---CCcEEEE
Confidence 456888899999999999999888899999999864332 34678999999999999999999987632 3468999
Q ss_pred eecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcccccccc
Q 000859 1025 EYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKA 1104 (1251)
Q Consensus 1025 E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~ 1104 (1251)
||+++|+|.+++.... ...+++.++..++.|++.|++|||+. +++||||||+||++++++.++++|||.+..
T Consensus 80 e~~~~~~L~~~~~~~~-----~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~ 151 (260)
T cd05067 80 EYMENGSLVDFLKTPE-----GIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARL 151 (260)
T ss_pred EcCCCCCHHHHHHhcC-----CCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceee
Confidence 9999999999987543 45689999999999999999999998 999999999999999999999999999976
Q ss_pred cccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhh-CCCCCCCccccchhHHHHHHHHHhccchh
Q 000859 1105 LVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMVRWVEMHMEMSGSA 1183 (1251)
Q Consensus 1105 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1183 (1251)
....... ......++..|+|||++....++.++||||||+++||+++ |+.||.+....+. ....
T Consensus 152 ~~~~~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~-----~~~~------- 216 (260)
T cd05067 152 IEDNEYT---AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEV-----IQNL------- 216 (260)
T ss_pred cCCCCcc---cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHH-----HHHH-------
Confidence 5422111 1112345678999999988889999999999999999999 9999975532111 1110
Q ss_pred hhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 000859 1184 REELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNV 1234 (1251)
Q Consensus 1184 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 1234 (1251)
.... ..+.+...+.++.+++.+|++.+|++||+++++...|+++
T Consensus 217 -----~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 260 (260)
T cd05067 217 -----ERGY--RMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLEDF 260 (260)
T ss_pred -----HcCC--CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhcC
Confidence 0000 0111222445799999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=320.85 Aligned_cols=261 Identities=22% Similarity=0.324 Sum_probs=205.3
Q ss_pred cCCCcCceecccCCceEEEEEe-cCCcEEEEEEeccCC--chhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeE
Q 000859 946 NNLSDEFIIGSGGSGTVYKAEL-ANGATVAVKKISCKD--DHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLL 1022 (1251)
Q Consensus 946 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~l 1022 (1251)
.+|++.+.||+|+||.||+|.. .+++.||||.+.... .....+.+.+|+++++.++||||+++++++... ...++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~~ 79 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIED--NELNI 79 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEEC--CeEEE
Confidence 4688889999999999999964 478999999876422 344456788999999999999999999988654 45689
Q ss_pred EEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcccccc
Q 000859 1023 IYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLA 1102 (1251)
Q Consensus 1023 v~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a 1102 (1251)
|+||+++|+|.+++.... .....+++..+..++.|++.|++|||++ +++|+||||+||+++.++.++|+|||.+
T Consensus 80 v~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~ 153 (267)
T cd08228 80 VLELADAGDLSQMIKYFK---KQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLG 153 (267)
T ss_pred EEEecCCCcHHHHHHHhh---hccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccc
Confidence 999999999999886421 1134578999999999999999999999 9999999999999999999999999998
Q ss_pred cccccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccch
Q 000859 1103 KALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGS 1182 (1251)
Q Consensus 1103 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 1182 (1251)
....... .......|+..|+|||.+.+..++.++|+||+|+++|||++|+.||........ .+....
T Consensus 154 ~~~~~~~----~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~---~~~~~~------ 220 (267)
T cd08228 154 RFFSSKT----TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLF---SLCQKI------ 220 (267)
T ss_pred eeccchh----HHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHH---HHHHHH------
Confidence 7653221 111224678899999999888899999999999999999999999864422111 111110
Q ss_pred hhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 000859 1183 AREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNV 1234 (1251)
Q Consensus 1183 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 1234 (1251)
.....+.. .....+..+.+++.+||+.+|++||++++|++.+++.
T Consensus 221 ------~~~~~~~~-~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 221 ------EQCDYPPL-PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred ------hcCCCCCC-ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 00000111 1223556799999999999999999999999998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=353.82 Aligned_cols=271 Identities=24% Similarity=0.315 Sum_probs=206.7
Q ss_pred cCCCcCceecccCCceEEEEEe-cCCcEEEEEEeccCC--chhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeE
Q 000859 946 NNLSDEFIIGSGGSGTVYKAEL-ANGATVAVKKISCKD--DHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLL 1022 (1251)
Q Consensus 946 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~l 1022 (1251)
.+|++.++||+|+||.||+|.. .+|+.||||++.... .....+.+.+|++++++++||||+++++++... ...++
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~--~~lyL 79 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDG--DPVYY 79 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeC--CEEEE
Confidence 4688899999999999999965 468999999986432 233456789999999999999999999988553 45799
Q ss_pred EEeecCCCChHHhhhcCCC----CcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcc
Q 000859 1023 IYEYMENGSVWDWLHKQPV----NIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGD 1098 (1251)
Q Consensus 1023 v~E~~~~gsL~~~l~~~~~----~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D 1098 (1251)
||||+++|+|.+++..... ........++..+.+++.||++||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 80 VMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiD 156 (932)
T PRK13184 80 TMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILD 156 (932)
T ss_pred EEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEe
Confidence 9999999999999864211 011134567888899999999999999999 999999999999999999999999
Q ss_pred cccccccccccCC--------------CCcccceeecccceecccccccCCCCCccceeehhHHHHHHhhCCCCCCCccc
Q 000859 1099 FGLAKALVEDYNS--------------NTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFG 1164 (1251)
Q Consensus 1099 fG~a~~~~~~~~~--------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~ 1164 (1251)
||+++........ .........||+.|+|||++.+..++.++||||+||++|||+||+.||.....
T Consensus 157 FGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~ 236 (932)
T PRK13184 157 WGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKG 236 (932)
T ss_pred cCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcch
Confidence 9999765211100 00111224699999999999999999999999999999999999999975422
Q ss_pred cchhHHHHHHHHHhccchhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCC-CCHHHHHHHHHhhcCCC
Q 000859 1165 VEMDMVRWVEMHMEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQER-PSSRQVCDLLLNVFNNR 1238 (1251)
Q Consensus 1165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R-Ps~~eil~~L~~~~~~~ 1238 (1251)
.+..... ..... .........++.+.+++.+|++.||++| ++++++.+.|+.+....
T Consensus 237 ~ki~~~~--------------~i~~P---~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~~ 294 (932)
T PRK13184 237 RKISYRD--------------VILSP---IEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQGS 294 (932)
T ss_pred hhhhhhh--------------hccCh---hhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcC
Confidence 2111000 00000 0001112345668899999999999999 56788888888887643
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-35 Score=342.57 Aligned_cols=255 Identities=22% Similarity=0.287 Sum_probs=195.0
Q ss_pred CCCcCceecccCCceEEEEEe-cCCcEEEEEEeccCC--chhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEE
Q 000859 947 NLSDEFIIGSGGSGTVYKAEL-ANGATVAVKKISCKD--DHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLI 1023 (1251)
Q Consensus 947 ~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv 1023 (1251)
+|++.+.||+|+||.||+|+. .+++.||||++.... .....+.+.+|++++++++||||+++++.+.. ....++|
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~--~~~~~lv 79 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQD--KDNLYFV 79 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEc--CCEEEEE
Confidence 688899999999999999954 568999999986432 12234567899999999999999999998854 4567999
Q ss_pred EeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEccccccc
Q 000859 1024 YEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAK 1103 (1251)
Q Consensus 1024 ~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~ 1103 (1251)
|||+++|+|.+++.+ .+.+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+|.
T Consensus 80 ~E~~~~g~L~~~i~~-------~~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~ 149 (376)
T cd05598 80 MDYIPGGDMMSLLIR-------LGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCT 149 (376)
T ss_pred EeCCCCCcHHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCc
Confidence 999999999999976 34678899999999999999999999 99999999999999999999999999985
Q ss_pred ccccccCC---------------------------------------CCcccceeecccceecccccccCCCCCccceee
Q 000859 1104 ALVEDYNS---------------------------------------NTESNTWFAGSYGYIAPEYAYSLKATEKCDVYS 1144 (1251)
Q Consensus 1104 ~~~~~~~~---------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwS 1144 (1251)
.+...... .........||+.|+|||++.+..++.++||||
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS 229 (376)
T cd05598 150 GFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWS 229 (376)
T ss_pred cccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeee
Confidence 43110000 000011247999999999999999999999999
Q ss_pred hhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccchhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCC--
Q 000859 1145 MGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERP-- 1222 (1251)
Q Consensus 1145 lGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-- 1222 (1251)
+||++|||++|+.||.+....+... .... +. .....+.....+.++.+++.+|+ .+|.+|+
T Consensus 230 lGvilyell~G~~Pf~~~~~~~~~~-----~i~~----~~-------~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~ 292 (376)
T cd05598 230 VGVILYEMLVGQPPFLADTPAETQL-----KVIN----WE-------TTLHIPSQAKLSREASDLILRLC-CGAEDRLGK 292 (376)
T ss_pred ccceeeehhhCCCCCCCCCHHHHHH-----HHhc----cC-------ccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCC
Confidence 9999999999999997653322110 0000 00 00011111123455677888876 5999999
Q ss_pred -CHHHHHHH
Q 000859 1223 -SSRQVCDL 1230 (1251)
Q Consensus 1223 -s~~eil~~ 1230 (1251)
++.++++.
T Consensus 293 ~t~~ell~h 301 (376)
T cd05598 293 NGADEIKAH 301 (376)
T ss_pred CCHHHHhCC
Confidence 88888765
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=318.62 Aligned_cols=252 Identities=27% Similarity=0.401 Sum_probs=199.5
Q ss_pred ceecccCCceEEEEEecC----CcEEEEEEeccCCchhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEEEeec
Q 000859 952 FIIGSGGSGTVYKAELAN----GATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIYEYM 1027 (1251)
Q Consensus 952 ~~lG~G~fg~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv~E~~ 1027 (1251)
++||+|+||.||+|.+.. +..||+|.+.........+.+.+|+++++.++||||+++++++.. ...++||||+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~~~v~e~~ 77 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKG---EPLMLVMELA 77 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcC---CceEEEEEeC
Confidence 369999999999995432 268999999766554456788999999999999999999997642 2468999999
Q ss_pred CCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEccccccccccc
Q 000859 1028 ENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVE 1107 (1251)
Q Consensus 1028 ~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~ 1107 (1251)
++|+|.+++... ..+++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|||.++....
T Consensus 78 ~~~~L~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~ 147 (257)
T cd05060 78 PLGPLLKYLKKR-------REIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGA 147 (257)
T ss_pred CCCcHHHHHHhC-------CCCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeec
Confidence 999999999763 3689999999999999999999999 999999999999999999999999999986643
Q ss_pred ccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhh-CCCCCCCccccchhHHHHHHHHHhccchhhhh
Q 000859 1108 DYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMVRWVEMHMEMSGSAREE 1186 (1251)
Q Consensus 1108 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1186 (1251)
..... .......++..|+|||.+.+..++.++|||||||++||+++ |+.||....+.+ ...+....
T Consensus 148 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~--~~~~~~~~---------- 214 (257)
T cd05060 148 GSDYY-RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAE--VIAMLESG---------- 214 (257)
T ss_pred CCccc-ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHH--HHHHHHcC----------
Confidence 22111 11111234568999999998899999999999999999998 999997653321 11111100
Q ss_pred hhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhcC
Q 000859 1187 LLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNVFN 1236 (1251)
Q Consensus 1187 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~ 1236 (1251)
...+.+..++..+.+++.+||+.+|++||++.++++.|+++.+
T Consensus 215 -------~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~~ 257 (257)
T cd05060 215 -------ERLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDPE 257 (257)
T ss_pred -------CcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhccC
Confidence 0011122345678899999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=326.22 Aligned_cols=265 Identities=27% Similarity=0.409 Sum_probs=204.9
Q ss_pred cCCCcCceecccCCceEEEEEec-CCc--EEEEEEeccCCchhhhHHHHHHHHHHHhc-cCCCccceeceeeecCCCcee
Q 000859 946 NNLSDEFIIGSGGSGTVYKAELA-NGA--TVAVKKISCKDDHLLNKSFTREVKTLGRI-RHRHLVKLMGHCCNKGAGSNL 1021 (1251)
Q Consensus 946 ~~~~~~~~lG~G~fg~V~~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~~~ 1021 (1251)
++|++.+.||+|+||.||+|... ++. .+|+|.++........+.+.+|+++++++ +||||+++++++... ...+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~--~~~~ 79 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENR--GYLY 79 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccC--Ccce
Confidence 46888899999999999999654 333 47888887544444567789999999999 799999999987543 4569
Q ss_pred EEEeecCCCChHHhhhcCCCC---------cccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCC
Q 000859 1022 LIYEYMENGSVWDWLHKQPVN---------IKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNM 1092 (1251)
Q Consensus 1022 lv~E~~~~gsL~~~l~~~~~~---------~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~ 1092 (1251)
+|+||+++|+|.+++++.... ......+++..+..++.|++.|++|||++ +|+||||||+||++++++
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~ 156 (297)
T cd05089 80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENL 156 (297)
T ss_pred EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCC
Confidence 999999999999999764311 11224689999999999999999999999 999999999999999999
Q ss_pred CeEEcccccccccccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhh-CCCCCCCccccchhHHH
Q 000859 1093 EAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMVR 1171 (1251)
Q Consensus 1093 ~~kl~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~t-g~~p~~~~~~~~~~~~~ 1171 (1251)
.+||+|||++....... .......+..|+|||+..+..++.++|||||||++|||++ |..||......+
T Consensus 157 ~~kl~dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~----- 226 (297)
T cd05089 157 ASKIADFGLSRGEEVYV-----KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE----- 226 (297)
T ss_pred eEEECCcCCCcccccee-----ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH-----
Confidence 99999999986421110 1111123567999999988889999999999999999998 999997553211
Q ss_pred HHHHHHhccchhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhcCCCc
Q 000859 1172 WVEMHMEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNVFNNRI 1239 (1251)
Q Consensus 1172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~ 1239 (1251)
..... ...... +.+...+.++.+++.+||+.+|.+||+++++++.|+++.+...
T Consensus 227 ~~~~~------------~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~ 280 (297)
T cd05089 227 LYEKL------------PQGYRM--EKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARK 280 (297)
T ss_pred HHHHH------------hcCCCC--CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence 11110 001111 1122345678999999999999999999999999999887553
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=337.49 Aligned_cols=255 Identities=19% Similarity=0.247 Sum_probs=197.8
Q ss_pred hhcCCCcCceecccCCceEEEEEe-cCCcEEEEEEeccCC--chhhhHHHHHHHHHHHhccCCCccceeceeeecCCCce
Q 000859 944 ATNNLSDEFIIGSGGSGTVYKAEL-ANGATVAVKKISCKD--DHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSN 1020 (1251)
Q Consensus 944 ~~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~ 1020 (1251)
...+|+..+.||+|+||.||+|+. .+++.||+|++.... .....+.+.+|+.+++.++||||+++++++.. +...
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~--~~~~ 118 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQD--DKYL 118 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEec--CCEE
Confidence 345688999999999999999955 468899999986422 22234567889999999999999999987754 4567
Q ss_pred eEEEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcccc
Q 000859 1021 LLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFG 1100 (1251)
Q Consensus 1021 ~lv~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG 1100 (1251)
++||||+++|+|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 119 ~lv~Ey~~gg~L~~~l~~--------~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG 187 (370)
T cd05596 119 YMVMEYMPGGDLVNLMSN--------YDIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFG 187 (370)
T ss_pred EEEEcCCCCCcHHHHHHh--------cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEecc
Confidence 999999999999999875 2478888999999999999999999 99999999999999999999999999
Q ss_pred cccccccccCCCCcccceeecccceecccccccC----CCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHH
Q 000859 1101 LAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSL----KATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMH 1176 (1251)
Q Consensus 1101 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~ 1176 (1251)
.++...... ........||+.|+|||++.+. .++.++||||+||++|||++|+.||.+...... .
T Consensus 188 ~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~-----~--- 256 (370)
T cd05596 188 TCMKMDANG---MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT-----Y--- 256 (370)
T ss_pred ceeeccCCC---cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHH-----H---
Confidence 997653221 1112235789999999988653 478999999999999999999999976422110 0
Q ss_pred HhccchhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 000859 1177 MEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQE--RPSSRQVCDL 1230 (1251)
Q Consensus 1177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~eil~~ 1230 (1251)
..+.........+.....+.++.+++.+|++.+|++ ||+++|+++.
T Consensus 257 --------~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 257 --------SKIMDHKNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred --------HHHHcCCCcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 011111101112222224567889999999999998 9999999765
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=325.77 Aligned_cols=269 Identities=23% Similarity=0.366 Sum_probs=204.4
Q ss_pred cCCCcCceecccCCceEEEEEec-----------------CCcEEEEEEeccCCchhhhHHHHHHHHHHHhccCCCccce
Q 000859 946 NNLSDEFIIGSGGSGTVYKAELA-----------------NGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKL 1008 (1251)
Q Consensus 946 ~~~~~~~~lG~G~fg~V~~~~~~-----------------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 1008 (1251)
++|++.+.||+|+||.||+++.. ++..||+|++.........+.+.+|+++++.++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 45888899999999999998532 2346999999765555556789999999999999999999
Q ss_pred eceeeecCCCceeEEEeecCCCChHHhhhcCCCC----cccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCC
Q 000859 1009 MGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVN----IKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSS 1084 (1251)
Q Consensus 1009 ~g~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~----~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~ 1084 (1251)
++++... ...++||||+++|+|.+++...... ......+++.++..++.|++.|++|||+. +++||||||+
T Consensus 85 ~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~ 159 (296)
T cd05095 85 LAVCITS--DPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATR 159 (296)
T ss_pred EEEEecC--CccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChh
Confidence 9988654 3469999999999999999764321 12234578899999999999999999999 9999999999
Q ss_pred CeeecCCCCeEEcccccccccccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhh--CCCCCCCc
Q 000859 1085 NILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS--GKMPTDAT 1162 (1251)
Q Consensus 1085 Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~t--g~~p~~~~ 1162 (1251)
||+++.++.++++|||.++.+...... .......++..|+|||...+..++.++|||||||++|||++ |..||...
T Consensus 160 Nili~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~ 237 (296)
T cd05095 160 NCLVGKNYTIKIADFGMSRNLYSGDYY--RIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQL 237 (296)
T ss_pred eEEEcCCCCEEeccCcccccccCCcce--eccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCcccc
Confidence 999999999999999999765332111 11122344678999999888889999999999999999998 77888654
Q ss_pred cccchhHHHHHHHHHhccchhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 000859 1163 FGVEMDMVRWVEMHMEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLN 1233 (1251)
Q Consensus 1163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 1233 (1251)
...+. .+.... ... ........+.+..++..+.+++.+||+.||++||++++|.+.|++
T Consensus 238 ~~~~~-----~~~~~~----~~~---~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 238 SDEQV-----IENTGE----FFR---DQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred ChHHH-----HHHHHH----HHh---hccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 32221 110000 000 000001112222345678999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=326.41 Aligned_cols=261 Identities=22% Similarity=0.351 Sum_probs=202.6
Q ss_pred CCCcCceecccCCceEEEEEec------CCcEEEEEEeccCCchhhhHHHHHHHHHHHhccCCCccceeceeeecCCCce
Q 000859 947 NLSDEFIIGSGGSGTVYKAELA------NGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSN 1020 (1251)
Q Consensus 947 ~~~~~~~lG~G~fg~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~ 1020 (1251)
+|+..+.||+|+||.||+|... ++..||+|++.........+.+.+|+.+++.++||||+++++++... ...
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~--~~~ 83 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKE--QPL 83 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC--Cce
Confidence 3566678999999999999653 24789999997665555567789999999999999999999988654 346
Q ss_pred eEEEeecCCCChHHhhhcCCCC---------cccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCC
Q 000859 1021 LLIYEYMENGSVWDWLHKQPVN---------IKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSN 1091 (1251)
Q Consensus 1021 ~lv~E~~~~gsL~~~l~~~~~~---------~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~ 1091 (1251)
++++||+++++|.+++...... ......+++..+.+++.|++.|++|+|++ +|+||||||+||+++++
T Consensus 84 ~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~ 160 (283)
T cd05091 84 SMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDK 160 (283)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCC
Confidence 8999999999999998643211 11134588999999999999999999999 99999999999999999
Q ss_pred CCeEEcccccccccccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhh-CCCCCCCccccchhHH
Q 000859 1092 MEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMV 1170 (1251)
Q Consensus 1092 ~~~kl~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~t-g~~p~~~~~~~~~~~~ 1170 (1251)
+.+||+|||+++........ .......+++.|+|||.+.+..++.++||||+||++|||++ |..||.+....
T Consensus 161 ~~~kl~Dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~----- 233 (283)
T cd05091 161 LNVKISDLGLFREVYAADYY--KLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ----- 233 (283)
T ss_pred CceEecccccccccccchhe--eeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH-----
Confidence 99999999998765332111 11122345789999999988889999999999999999998 88888654221
Q ss_pred HHHHHHHhccchhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 000859 1171 RWVEMHMEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLN 1233 (1251)
Q Consensus 1171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 1233 (1251)
++.+... ... ..+.+..++..+.+++.+||+.+|++||++++|+..|+.
T Consensus 234 ~~~~~i~-----------~~~---~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 234 DVIEMIR-----------NRQ---VLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHHHHHH-----------cCC---cCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 1111111 111 011123356678999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=320.39 Aligned_cols=250 Identities=26% Similarity=0.414 Sum_probs=198.8
Q ss_pred CCCcCceecccCCceEEEEEecCCcEEEEEEeccCCchhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEEEee
Q 000859 947 NLSDEFIIGSGGSGTVYKAELANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIYEY 1026 (1251)
Q Consensus 947 ~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv~E~ 1026 (1251)
+|+..+.||+|+||.||+|.++++..+|+|++..... ....+.+|++++++++||||+++++++... ...++||||
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~lv~e~ 80 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM--SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQ--RPIFIVTEY 80 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC--CHHHHHHHHHHHHhCCCCCEEEEEEEEcCC--CceEEEEec
Confidence 4777889999999999999887778999999854332 335788999999999999999999987544 456899999
Q ss_pred cCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcccccccccc
Q 000859 1027 MENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALV 1106 (1251)
Q Consensus 1027 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~ 1106 (1251)
+++++|.+++.... ..+++..+..++.|++.|++|||+. +|+||||||+||++++++.+||+|||.++...
T Consensus 81 ~~~~~L~~~l~~~~------~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~ 151 (256)
T cd05059 81 MANGCLLNYLRERK------GKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVL 151 (256)
T ss_pred CCCCCHHHHHHhcc------cCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceecc
Confidence 99999999997642 3689999999999999999999999 99999999999999999999999999987653
Q ss_pred cccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhh-CCCCCCCccccchhHHHHHHHHHhccchhhh
Q 000859 1107 EDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMVRWVEMHMEMSGSARE 1185 (1251)
Q Consensus 1107 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1185 (1251)
..... ......++..|+|||.+.+..++.++||||||+++||+++ |+.||......+. ... .
T Consensus 152 ~~~~~---~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~--~~~---~--------- 214 (256)
T cd05059 152 DDQYT---SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEV--VES---V--------- 214 (256)
T ss_pred ccccc---ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHH--HHH---H---------
Confidence 22111 1111234568999999998899999999999999999999 8999975422111 110 0
Q ss_pred hhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 000859 1186 ELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLL 1231 (1251)
Q Consensus 1186 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L 1231 (1251)
...... +.+...+.++.+++.+||+.+|++|||++|+++.|
T Consensus 215 ---~~~~~~--~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 215 ---SAGYRL--YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred ---HcCCcC--CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 000001 11122466799999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=333.58 Aligned_cols=242 Identities=21% Similarity=0.295 Sum_probs=189.8
Q ss_pred CCCcCceecccCCceEEEEEec-CCcEEEEEEeccCC--chhhhHHHHHHHHHHHhccCC-CccceeceeeecCCCceeE
Q 000859 947 NLSDEFIIGSGGSGTVYKAELA-NGATVAVKKISCKD--DHLLNKSFTREVKTLGRIRHR-HLVKLMGHCCNKGAGSNLL 1022 (1251)
Q Consensus 947 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~-niv~l~g~~~~~~~~~~~l 1022 (1251)
+|+..+.||+|+||.||+|+.. +++.||||++.... .....+.+..|.++++.+.|+ +|+++++++.. ....++
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~--~~~~~l 78 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT--MDRLYF 78 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEc--CCEEEE
Confidence 4778889999999999999654 57899999986432 223446678899999999764 57788777644 345799
Q ss_pred EEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcccccc
Q 000859 1023 IYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLA 1102 (1251)
Q Consensus 1023 v~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a 1102 (1251)
||||+++|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 79 v~E~~~~g~L~~~~~~-------~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~ 148 (324)
T cd05587 79 VMEYVNGGDLMYHIQQ-------VGKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMC 148 (324)
T ss_pred EEcCCCCCcHHHHHHH-------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcc
Confidence 9999999999999876 34688999999999999999999999 9999999999999999999999999998
Q ss_pred cccccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccch
Q 000859 1103 KALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGS 1182 (1251)
Q Consensus 1103 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 1182 (1251)
+.... .........||+.|+|||++.+..++.++||||+||++|||+||+.||.+....+. .....
T Consensus 149 ~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~-----~~~i~----- 214 (324)
T cd05587 149 KENIF----GGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL-----FQSIM----- 214 (324)
T ss_pred eecCC----CCCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH-----HHHHH-----
Confidence 64321 11122335789999999999999999999999999999999999999975532111 00000
Q ss_pred hhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCH
Q 000859 1183 AREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSS 1224 (1251)
Q Consensus 1183 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 1224 (1251)
.. ....+...+.++.+++.+|++.||.+|++.
T Consensus 215 ------~~----~~~~~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 215 ------EH----NVSYPKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred ------cC----CCCCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 00 011112234568899999999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=333.94 Aligned_cols=238 Identities=26% Similarity=0.344 Sum_probs=185.4
Q ss_pred ceecccCCceEEEEEe-cCCcEEEEEEeccCC--chhhhHHHHHHHH-HHHhccCCCccceeceeeecCCCceeEEEeec
Q 000859 952 FIIGSGGSGTVYKAEL-ANGATVAVKKISCKD--DHLLNKSFTREVK-TLGRIRHRHLVKLMGHCCNKGAGSNLLIYEYM 1027 (1251)
Q Consensus 952 ~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~-~l~~l~h~niv~l~g~~~~~~~~~~~lv~E~~ 1027 (1251)
+.||+|+||+||+|.. .+|+.||||++.... .....+.+..|.. +++.++||||+++++++.. ....++||||+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~--~~~~~lv~e~~ 78 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQT--ADKLYFVLDYV 78 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEe--CCEEEEEEcCC
Confidence 3699999999999965 478999999986432 1122344555555 4677899999999988754 44679999999
Q ss_pred CCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEccccccccccc
Q 000859 1028 ENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVE 1107 (1251)
Q Consensus 1028 ~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~ 1107 (1251)
++|+|.+++.. ...+++..+..++.||++||+|||++ +|+||||||+||+++.++.+||+|||+++....
T Consensus 79 ~~g~L~~~l~~-------~~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~ 148 (323)
T cd05575 79 NGGELFFHLQR-------ERSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIE 148 (323)
T ss_pred CCCCHHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCccccc
Confidence 99999999876 34688999999999999999999999 999999999999999999999999999865322
Q ss_pred ccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccchhhhhh
Q 000859 1108 DYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSAREEL 1187 (1251)
Q Consensus 1108 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1187 (1251)
. ........||+.|+|||++.+..++.++||||+||++|||++|+.||......+ .....
T Consensus 149 ~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~-----~~~~i----------- 208 (323)
T cd05575 149 H----SKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAE-----MYDNI----------- 208 (323)
T ss_pred C----CCccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHH-----HHHHH-----------
Confidence 1 112233578999999999999999999999999999999999999997542211 11110
Q ss_pred hcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHH
Q 000859 1188 LDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSR 1225 (1251)
Q Consensus 1188 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 1225 (1251)
.... .......+.++.+++.+|++.||.+||+++
T Consensus 209 ~~~~----~~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 209 LNKP----LRLKPNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred HcCC----CCCCCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 0100 001111355688999999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-34 Score=320.10 Aligned_cols=263 Identities=24% Similarity=0.411 Sum_probs=203.3
Q ss_pred CCcCceecccCCceEEEEEec-C---CcEEEEEEeccCC-chhhhHHHHHHHHHHHhccCCCccceeceeeecCC----C
Q 000859 948 LSDEFIIGSGGSGTVYKAELA-N---GATVAVKKISCKD-DHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGA----G 1018 (1251)
Q Consensus 948 ~~~~~~lG~G~fg~V~~~~~~-~---~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~----~ 1018 (1251)
|...+.||+|+||.||+|... + +..||||++.... .....+.+.+|+++++.++||||+++++++..... .
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 456778999999999999653 2 3679999987543 23345678999999999999999999998765432 2
Q ss_pred ceeEEEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcc
Q 000859 1019 SNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGD 1098 (1251)
Q Consensus 1019 ~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D 1098 (1251)
..++++||+++|+|..++...... .....+++..+..++.|++.|++|||+. +|+||||||+||++++++.+||+|
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~-~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~d 156 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLG-GLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVAD 156 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhcc-CCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECC
Confidence 358999999999999998654311 1234689999999999999999999999 999999999999999999999999
Q ss_pred cccccccccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhh-CCCCCCCccccchhHHHHHHHHH
Q 000859 1099 FGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMVRWVEMHM 1177 (1251)
Q Consensus 1099 fG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~ 1177 (1251)
||.++.+....... ......++..|+|||++.+..++.++|||||||++|||++ |..||.+....+ ..++. .
T Consensus 157 fg~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~--~~~~~---~ 229 (273)
T cd05035 157 FGLSKKIYSGDYYR--QGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE--IYDYL---R 229 (273)
T ss_pred ccceeecccccccc--ccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHH---H
Confidence 99998654322111 1122345678999999988889999999999999999999 899986543211 11111 0
Q ss_pred hccchhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhc
Q 000859 1178 EMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNVF 1235 (1251)
Q Consensus 1178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~ 1235 (1251)
... ....+...+.++.+++.+||+.||++|||+.|+++.|++++
T Consensus 230 -----------~~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~~ 273 (273)
T cd05035 230 -----------HGN---RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENIL 273 (273)
T ss_pred -----------cCC---CCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhhC
Confidence 000 01112234567899999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=332.67 Aligned_cols=242 Identities=21% Similarity=0.297 Sum_probs=190.1
Q ss_pred CCCcCceecccCCceEEEEEec-CCcEEEEEEeccCC--chhhhHHHHHHHHHHHhc-cCCCccceeceeeecCCCceeE
Q 000859 947 NLSDEFIIGSGGSGTVYKAELA-NGATVAVKKISCKD--DHLLNKSFTREVKTLGRI-RHRHLVKLMGHCCNKGAGSNLL 1022 (1251)
Q Consensus 947 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~~~l 1022 (1251)
+|...+.||+|+||.||+|... +++.||||++.... .....+.+..|..++... +|++|+++++++.. ....++
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~--~~~~~l 78 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQT--MDRLYF 78 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEec--CCEEEE
Confidence 4778889999999999999654 67899999987432 122334567788888877 58999999887754 345799
Q ss_pred EEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcccccc
Q 000859 1023 IYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLA 1102 (1251)
Q Consensus 1023 v~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a 1102 (1251)
||||+++|+|.+++.. ...+++.++..++.|++.|++|||++ +|+||||||+||++++++.+||+|||++
T Consensus 79 v~E~~~~g~L~~~~~~-------~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~ 148 (323)
T cd05616 79 VMEYVNGGDLMYQIQQ-------VGRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMC 148 (323)
T ss_pred EEcCCCCCCHHHHHHH-------cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCc
Confidence 9999999999999876 34688999999999999999999999 9999999999999999999999999998
Q ss_pred cccccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccch
Q 000859 1103 KALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGS 1182 (1251)
Q Consensus 1103 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 1182 (1251)
+..... ........||+.|+|||++.+..++.++||||+||++|||++|+.||.+....+. . ....
T Consensus 149 ~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~--~---~~i~----- 214 (323)
T cd05616 149 KENMWD----GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL--F---QSIM----- 214 (323)
T ss_pred eecCCC----CCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHH--H---HHHH-----
Confidence 653211 1122235789999999999999999999999999999999999999976532111 1 1000
Q ss_pred hhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCH
Q 000859 1183 AREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSS 1224 (1251)
Q Consensus 1183 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 1224 (1251)
.. ....+...+.++.+++.+|++.||++|+++
T Consensus 215 ------~~----~~~~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 215 ------EH----NVAYPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred ------hC----CCCCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 00 011112244568899999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=326.19 Aligned_cols=266 Identities=27% Similarity=0.407 Sum_probs=205.0
Q ss_pred cCCCcCceecccCCceEEEEEec-CCc--EEEEEEeccCCchhhhHHHHHHHHHHHhc-cCCCccceeceeeecCCCcee
Q 000859 946 NNLSDEFIIGSGGSGTVYKAELA-NGA--TVAVKKISCKDDHLLNKSFTREVKTLGRI-RHRHLVKLMGHCCNKGAGSNL 1021 (1251)
Q Consensus 946 ~~~~~~~~lG~G~fg~V~~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~~~ 1021 (1251)
++|++.+.||+|+||.||+|..+ ++. .+|+|.+.........+.+.+|++++.++ +||||+++++++... ...+
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~--~~~~ 84 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR--GYLY 84 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCC--CCce
Confidence 45888889999999999999654 454 46888776444444567888999999999 899999999988543 4579
Q ss_pred EEEeecCCCChHHhhhcCCCCc---------ccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCC
Q 000859 1022 LIYEYMENGSVWDWLHKQPVNI---------KMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNM 1092 (1251)
Q Consensus 1022 lv~E~~~~gsL~~~l~~~~~~~---------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~ 1092 (1251)
+||||+++|+|.+++++..... .....+++.+++.++.|++.|++|||+. +|+||||||+||++++++
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~ 161 (303)
T cd05088 85 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENY 161 (303)
T ss_pred EEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCC
Confidence 9999999999999997643110 1124689999999999999999999999 999999999999999999
Q ss_pred CeEEcccccccccccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhh-CCCCCCCccccchhHHH
Q 000859 1093 EAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMVR 1171 (1251)
Q Consensus 1093 ~~kl~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~t-g~~p~~~~~~~~~~~~~ 1171 (1251)
.+||+|||+++..... .......++..|+|||++.+..++.++|||||||++|||+| |..||......+
T Consensus 162 ~~kl~dfg~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~----- 231 (303)
T cd05088 162 VAKIADFGLSRGQEVY-----VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE----- 231 (303)
T ss_pred cEEeCccccCcccchh-----hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHH-----
Confidence 9999999998642111 11111234678999999988889999999999999999998 999996542211
Q ss_pred HHHHHHhccchhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhcCCCcc
Q 000859 1172 WVEMHMEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNVFNNRIV 1240 (1251)
Q Consensus 1172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~~ 1240 (1251)
..+... ...... .+...+.++.+++.+||+.+|++||++++++..++++...+..
T Consensus 232 ~~~~~~------------~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~~ 286 (303)
T cd05088 232 LYEKLP------------QGYRLE--KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT 286 (303)
T ss_pred HHHHHh------------cCCcCC--CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhhh
Confidence 111100 000011 1112345688999999999999999999999999998876653
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=318.29 Aligned_cols=254 Identities=26% Similarity=0.443 Sum_probs=201.8
Q ss_pred cCCCcCceecccCCceEEEEEecCCcEEEEEEeccCCchhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEEEe
Q 000859 946 NNLSDEFIIGSGGSGTVYKAELANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIYE 1025 (1251)
Q Consensus 946 ~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv~E 1025 (1251)
.+|.....||+|+||.||+|....+..||+|.+.... ...+.+.+|++++++++|||++++++++.. ...+++||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~~~v~e 80 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT--MMPEAFLQEAQIMKKLRHDKLVPLYAVVSE---EPIYIVTE 80 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC--ccHHHHHHHHHHHHhCCCCCeeeEEEEEcC---CCcEEEEE
Confidence 4577888999999999999988777789999875432 234678899999999999999999987632 34689999
Q ss_pred ecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEccccccccc
Q 000859 1026 YMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKAL 1105 (1251)
Q Consensus 1026 ~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~ 1105 (1251)
|+++|+|.++++... ...+++..+..++.|++.|++|||+. +++||||||+||++++++.++|+|||.++..
T Consensus 81 ~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~ 152 (260)
T cd05069 81 FMGKGSLLDFLKEGD-----GKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLI 152 (260)
T ss_pred cCCCCCHHHHHhhCC-----CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEc
Confidence 999999999997642 34578999999999999999999999 9999999999999999999999999999765
Q ss_pred ccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhh-CCCCCCCccccchhHHHHHHHHHhccchhh
Q 000859 1106 VEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMVRWVEMHMEMSGSAR 1184 (1251)
Q Consensus 1106 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1184 (1251)
..... .......++..|+|||...+..++.++||||+||++|||++ |+.||.+....+ ...+.
T Consensus 153 ~~~~~---~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--~~~~~----------- 216 (260)
T cd05069 153 EDNEY---TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE--VLEQV----------- 216 (260)
T ss_pred cCCcc---cccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHH-----------
Confidence 32211 11112345778999999988899999999999999999999 999997643211 11110
Q ss_pred hhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 000859 1185 EELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNV 1234 (1251)
Q Consensus 1185 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 1234 (1251)
.. .. ..+.+...+..+.+++.+||+.||++||+++++.+.|+++
T Consensus 217 ---~~-~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 260 (260)
T cd05069 217 ---ER-GY--RMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLEDY 260 (260)
T ss_pred ---Hc-CC--CCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 00 00 0111223456789999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=353.39 Aligned_cols=268 Identities=27% Similarity=0.444 Sum_probs=214.3
Q ss_pred hcCCCcCceecccCCceEEEEEec--------CCcEEEEEEeccCCchhhhHHHHHHHHHHHhc-cCCCccceeceeeec
Q 000859 945 TNNLSDEFIIGSGGSGTVYKAELA--------NGATVAVKKISCKDDHLLNKSFTREVKTLGRI-RHRHLVKLMGHCCNK 1015 (1251)
Q Consensus 945 ~~~~~~~~~lG~G~fg~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~ 1015 (1251)
.++....+.+|+|+||.||+|... ....||||..+......+.+.+..|+++|+.+ +|+||+.++|+|..
T Consensus 295 ~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~- 373 (609)
T KOG0200|consen 295 RENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQ- 373 (609)
T ss_pred hhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeecc-
Confidence 334455568999999999999532 14579999998887777889999999999999 69999999999977
Q ss_pred CCCceeEEEeecCCCChHHhhhcCC--CCcc-------cCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCe
Q 000859 1016 GAGSNLLIYEYMENGSVWDWLHKQP--VNIK-------MRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNI 1086 (1251)
Q Consensus 1016 ~~~~~~lv~E~~~~gsL~~~l~~~~--~~~~-------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Ni 1086 (1251)
....++|+||+..|+|.+|++..+ .... ....++..+...++.|||.||+||++. ++||||+.++||
T Consensus 374 -~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaRNV 449 (609)
T KOG0200|consen 374 -DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAARNV 449 (609)
T ss_pred -CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---CccchhhhhhhE
Confidence 445699999999999999998876 1111 113489999999999999999999999 999999999999
Q ss_pred eecCCCCeEEcccccccccccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhh-CCCCCCCcccc
Q 000859 1087 LLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGV 1165 (1251)
Q Consensus 1087 ll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~t-g~~p~~~~~~~ 1165 (1251)
+++++..+||+|||+|+................ -+.+|||||.+....|+.++|||||||++||++| |..||.+....
T Consensus 450 Li~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~-LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~ 528 (609)
T KOG0200|consen 450 LITKNKVIKIADFGLARDHYNKDYYRTKSSAGT-LPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPT 528 (609)
T ss_pred EecCCCEEEEccccceeccCCCCceEecCCCCc-cceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcH
Confidence 999999999999999987554333322211111 3567999999999999999999999999999999 99999763211
Q ss_pred chhHHHHHHHHHhccchhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhcC
Q 000859 1166 EMDMVRWVEMHMEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNVFN 1236 (1251)
Q Consensus 1166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~ 1236 (1251)
+ +..++.+ +. .+...+..+..+++++|+.||+.+|++||++.++.+.++..+.
T Consensus 529 ~-~l~~~l~---------------~G--~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~ 581 (609)
T KOG0200|consen 529 E-ELLEFLK---------------EG--NRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ 581 (609)
T ss_pred H-HHHHHHh---------------cC--CCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence 1 1111111 11 1233455578899999999999999999999999999999654
|
|
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=324.16 Aligned_cols=268 Identities=21% Similarity=0.359 Sum_probs=206.1
Q ss_pred hhcCCCcCceecccCCceEEEEEec------CCcEEEEEEeccCCchhhhHHHHHHHHHHHhccCCCccceeceeeecCC
Q 000859 944 ATNNLSDEFIIGSGGSGTVYKAELA------NGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGA 1017 (1251)
Q Consensus 944 ~~~~~~~~~~lG~G~fg~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~ 1017 (1251)
...+|++.+.||+|+||.||+|..+ .+..||+|.+...........+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-- 81 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKG-- 81 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC--
Confidence 4567899999999999999999543 24589999986555444556788999999999999999999987554
Q ss_pred CceeEEEeecCCCChHHhhhcCCCCc---ccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCe
Q 000859 1018 GSNLLIYEYMENGSVWDWLHKQPVNI---KMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEA 1094 (1251)
Q Consensus 1018 ~~~~lv~E~~~~gsL~~~l~~~~~~~---~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~ 1094 (1251)
...++||||+++|+|.++++...... ......++..+.+++.|++.|++|||++ +|+||||||+||++++++.+
T Consensus 82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~ 158 (288)
T cd05061 82 QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTV 158 (288)
T ss_pred CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcE
Confidence 35699999999999999997532111 1124457788899999999999999999 99999999999999999999
Q ss_pred EEcccccccccccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhh-CCCCCCCccccchhHHHHH
Q 000859 1095 HLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMVRWV 1173 (1251)
Q Consensus 1095 kl~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~t-g~~p~~~~~~~~~~~~~~~ 1173 (1251)
|++|||+++.......... .....++..|+|||.+.+..++.++|||||||++|||++ |..||.+....+ ..
T Consensus 159 ~L~Dfg~~~~~~~~~~~~~--~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~-----~~ 231 (288)
T cd05061 159 KIGDFGMTRDIYETDYYRK--GGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ-----VL 231 (288)
T ss_pred EECcCCccccccccccccc--cCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHH-----HH
Confidence 9999999976533221111 111245678999999998899999999999999999999 788987542211 11
Q ss_pred HHHHhccchhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhcCC
Q 000859 1174 EMHMEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNVFNN 1237 (1251)
Q Consensus 1174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~ 1237 (1251)
.. ..+.. ..+.+...+..+.+++.+|++.||++|||+.++++.+.+.+..
T Consensus 232 ~~-----------~~~~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~ 281 (288)
T cd05061 232 KF-----------VMDGG---YLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHP 281 (288)
T ss_pred HH-----------HHcCC---CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCC
Confidence 10 00100 0011122346799999999999999999999999999886543
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=331.02 Aligned_cols=243 Identities=23% Similarity=0.327 Sum_probs=191.7
Q ss_pred ceecccCCceEEEEEec-CCcEEEEEEeccCC--chhhhHHHHHHHHHHHhc-cCCCccceeceeeecCCCceeEEEeec
Q 000859 952 FIIGSGGSGTVYKAELA-NGATVAVKKISCKD--DHLLNKSFTREVKTLGRI-RHRHLVKLMGHCCNKGAGSNLLIYEYM 1027 (1251)
Q Consensus 952 ~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~~~lv~E~~ 1027 (1251)
+.||+|+||+||+|... +++.||||++.... .....+.+..|.++++.+ +||||+++++++.. ....++||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~--~~~~~lv~e~~ 78 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQT--KDRLFFVMEYV 78 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEc--CCEEEEEEcCC
Confidence 36999999999999654 57899999986432 223345677899999888 79999999998754 34579999999
Q ss_pred CCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEccccccccccc
Q 000859 1028 ENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVE 1107 (1251)
Q Consensus 1028 ~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~ 1107 (1251)
++|+|.+++.+. ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++....
T Consensus 79 ~~~~L~~~~~~~-------~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 148 (318)
T cd05570 79 NGGDLMFHIQRS-------GRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGIL 148 (318)
T ss_pred CCCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCc
Confidence 999999998763 4689999999999999999999999 999999999999999999999999999864321
Q ss_pred ccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccchhhhhh
Q 000859 1108 DYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSAREEL 1187 (1251)
Q Consensus 1108 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1187 (1251)
. ........||+.|+|||++.+..++.++||||+||++|||++|+.||.+....+ .....
T Consensus 149 ~----~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~-----~~~~i----------- 208 (318)
T cd05570 149 G----GVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDE-----LFQSI----------- 208 (318)
T ss_pred C----CCcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHH-----HHHHH-----------
Confidence 1 111223468999999999999999999999999999999999999997543211 11100
Q ss_pred hcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCH-----HHHHHH
Q 000859 1188 LDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSS-----RQVCDL 1230 (1251)
Q Consensus 1188 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~eil~~ 1230 (1251)
.... ... +...+.++.+++.+||+.||.+||++ .++++.
T Consensus 209 ~~~~--~~~--~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 209 LEDE--VRY--PRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred HcCC--CCC--CCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 0000 011 12234568899999999999999999 777653
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=330.18 Aligned_cols=241 Identities=24% Similarity=0.349 Sum_probs=188.6
Q ss_pred ceecccCCceEEEEEec-CCcEEEEEEeccCC--chhhhHHHHHHHHHHHhc-cCCCccceeceeeecCCCceeEEEeec
Q 000859 952 FIIGSGGSGTVYKAELA-NGATVAVKKISCKD--DHLLNKSFTREVKTLGRI-RHRHLVKLMGHCCNKGAGSNLLIYEYM 1027 (1251)
Q Consensus 952 ~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~~~lv~E~~ 1027 (1251)
+.||+|+||+||+|+.. +++.||||+++... .....+.+..|..+++.. +||||+++++++... ...++||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~--~~~~lv~ey~ 78 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTK--ENLFFVMEYL 78 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeC--CEEEEEEeCC
Confidence 36999999999999654 57899999986542 122335566788888765 899999999988653 4579999999
Q ss_pred CCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEccccccccccc
Q 000859 1028 ENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVE 1107 (1251)
Q Consensus 1028 ~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~ 1107 (1251)
++|+|.+++.. ...+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 79 ~~g~L~~~l~~-------~~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~ 148 (316)
T cd05619 79 NGGDLMFHIQS-------CHKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENML 148 (316)
T ss_pred CCCcHHHHHHH-------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCC
Confidence 99999999976 34688999999999999999999999 999999999999999999999999999864321
Q ss_pred ccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccchhhhhh
Q 000859 1108 DYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSAREEL 1187 (1251)
Q Consensus 1108 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1187 (1251)
. ........||..|+|||++.+..++.++||||+||++|||++|+.||.+....+ . .+...
T Consensus 149 ~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~--~---~~~i~---------- 209 (316)
T cd05619 149 G----DAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEE--L---FQSIR---------- 209 (316)
T ss_pred C----CCceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHH--H---HHHHH----------
Confidence 1 111223578999999999999899999999999999999999999997543211 1 11000
Q ss_pred hcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHH-HHH
Q 000859 1188 LDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSR-QVC 1228 (1251)
Q Consensus 1188 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-eil 1228 (1251)
. ..+..+ ...+.++.+++.+||+.||++||+++ ++.
T Consensus 210 -~--~~~~~~--~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05619 210 -M--DNPCYP--RWLTREAKDILVKLFVREPERRLGVKGDIR 246 (316)
T ss_pred -h--CCCCCC--ccCCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence 0 001111 12345678999999999999999997 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=330.77 Aligned_cols=241 Identities=24% Similarity=0.325 Sum_probs=188.6
Q ss_pred ceecccCCceEEEEEec-CCcEEEEEEeccCCc--hhhhHHHHHHHHHHHhc-cCCCccceeceeeecCCCceeEEEeec
Q 000859 952 FIIGSGGSGTVYKAELA-NGATVAVKKISCKDD--HLLNKSFTREVKTLGRI-RHRHLVKLMGHCCNKGAGSNLLIYEYM 1027 (1251)
Q Consensus 952 ~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~~~lv~E~~ 1027 (1251)
+.||+|+||.||+|+.. +|+.||+|++..... ....+.+..|..++... +||+|+++++++.. ....++||||+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~--~~~~~lv~E~~ 78 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQT--KEHLFFVMEFL 78 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEe--CCEEEEEECCC
Confidence 36999999999999654 688999999964321 22345567788888765 89999999998854 34679999999
Q ss_pred CCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEccccccccccc
Q 000859 1028 ENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVE 1107 (1251)
Q Consensus 1028 ~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~ 1107 (1251)
++|+|.+++.. ...+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 79 ~~g~L~~~i~~-------~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 148 (316)
T cd05620 79 NGGDLMFHIQD-------KGRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVF 148 (316)
T ss_pred CCCcHHHHHHH-------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeeccc
Confidence 99999999876 34688999999999999999999999 999999999999999999999999999864321
Q ss_pred ccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccchhhhhh
Q 000859 1108 DYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSAREEL 1187 (1251)
Q Consensus 1108 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1187 (1251)
.........||+.|+|||++.+..++.++||||+||++|||++|+.||.+....+ ..+...
T Consensus 149 ----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~-----~~~~~~---------- 209 (316)
T cd05620 149 ----GDNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDE-----LFESIR---------- 209 (316)
T ss_pred ----CCCceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH-----HHHHHH----------
Confidence 1112233578999999999999999999999999999999999999997542211 111100
Q ss_pred hcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHH-HHH
Q 000859 1188 LDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSR-QVC 1228 (1251)
Q Consensus 1188 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-eil 1228 (1251)
. ..+..+ .....++.+++.+|++.||++||++. ++.
T Consensus 210 -~--~~~~~~--~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 210 -V--DTPHYP--RWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred -h--CCCCCC--CCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 0 001111 12345688999999999999999985 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=325.88 Aligned_cols=259 Identities=27% Similarity=0.411 Sum_probs=204.1
Q ss_pred cCCCcCceecccCCceEEEEEe------cCCcEEEEEEeccCCchhhhHHHHHHHHHHHhc-cCCCccceeceeeecCCC
Q 000859 946 NNLSDEFIIGSGGSGTVYKAEL------ANGATVAVKKISCKDDHLLNKSFTREVKTLGRI-RHRHLVKLMGHCCNKGAG 1018 (1251)
Q Consensus 946 ~~~~~~~~lG~G~fg~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~ 1018 (1251)
++|...+.||+|+||.||+|.. .++..||||+++........+.+.+|+++++++ +||||+++++++... .
T Consensus 35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~--~ 112 (302)
T cd05055 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIG--G 112 (302)
T ss_pred HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecC--C
Confidence 4588889999999999999953 234579999987655455567889999999999 799999999988654 3
Q ss_pred ceeEEEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcc
Q 000859 1019 SNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGD 1098 (1251)
Q Consensus 1019 ~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D 1098 (1251)
..++||||+++|+|.++++... ...+++.++..++.|++.|++|||+. +|+|+||||+||+++.++.+|++|
T Consensus 113 ~~~lv~e~~~~~~L~~~i~~~~-----~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~d 184 (302)
T cd05055 113 PILVITEYCCYGDLLNFLRRKR-----ESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICD 184 (302)
T ss_pred ceEEEEEcCCCCcHHHHHHhCC-----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECC
Confidence 4699999999999999997632 23489999999999999999999999 999999999999999999999999
Q ss_pred cccccccccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhh-CCCCCCCccccchhHHHHHHHHH
Q 000859 1099 FGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMVRWVEMHM 1177 (1251)
Q Consensus 1099 fG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~ 1177 (1251)
||.++........ .......++..|+|||.+.+..++.++||||+||++|||++ |+.||......+. ....
T Consensus 185 fg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~-~~~~----- 256 (302)
T cd05055 185 FGLARDIMNDSNY--VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK-FYKL----- 256 (302)
T ss_pred CcccccccCCCce--eecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH-HHHH-----
Confidence 9999765432111 11122345788999999999899999999999999999998 9999875532111 1010
Q ss_pred hccchhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 000859 1178 EMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNV 1234 (1251)
Q Consensus 1178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 1234 (1251)
........ .+...+.++.+++.+|++.+|++|||+.|+++.|.+.
T Consensus 257 ----------~~~~~~~~--~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 257 ----------IKEGYRMA--QPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred ----------HHcCCcCC--CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 11111111 1112345789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=315.09 Aligned_cols=247 Identities=25% Similarity=0.386 Sum_probs=197.3
Q ss_pred eecccCCceEEEEEecCCcEEEEEEeccCCchhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEEEeecCCCCh
Q 000859 953 IIGSGGSGTVYKAELANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIYEYMENGSV 1032 (1251)
Q Consensus 953 ~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv~E~~~~gsL 1032 (1251)
+||+|+||.||+|...+++.||+|++...........+.+|++++++++||||+++++++... ...++||||+++|+|
T Consensus 2 ~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L 79 (250)
T cd05085 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQR--QPIYIVMELVPGGDF 79 (250)
T ss_pred ccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecC--CccEEEEECCCCCcH
Confidence 689999999999988888999999987655555556789999999999999999999988654 346999999999999
Q ss_pred HHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcccccccccccccCCC
Q 000859 1033 WDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSN 1112 (1251)
Q Consensus 1033 ~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 1112 (1251)
.+++... ...+++..+..++.|++.|+.|+|+. +++||||||+||+++.++.+|++|||++.........
T Consensus 80 ~~~~~~~------~~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~- 149 (250)
T cd05085 80 LSFLRKK------KDELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS- 149 (250)
T ss_pred HHHHHhc------CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccccc-
Confidence 9998753 24578999999999999999999999 9999999999999999999999999998654322111
Q ss_pred CcccceeecccceecccccccCCCCCccceeehhHHHHHHhh-CCCCCCCccccchhHHHHHHHHHhccchhhhhhhccc
Q 000859 1113 TESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMVRWVEMHMEMSGSAREELLDDQ 1191 (1251)
Q Consensus 1113 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1191 (1251)
......++..|+|||++.+..++.++||||||+++||+++ |..||........ ... . ...
T Consensus 150 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~--~~~---~------------~~~ 210 (250)
T cd05085 150 --SSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQA--REQ---V------------EKG 210 (250)
T ss_pred --cCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHH--HHH---H------------HcC
Confidence 1111234678999999998899999999999999999998 9999975522111 000 0 000
Q ss_pred CCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 000859 1192 MKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLL 1232 (1251)
Q Consensus 1192 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 1232 (1251)
.... .+...+.++.+++.+|++.+|++||++.|+.++|.
T Consensus 211 ~~~~--~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 211 YRMS--CPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCCC--CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 0111 11124567899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=324.87 Aligned_cols=270 Identities=26% Similarity=0.385 Sum_probs=205.3
Q ss_pred hcCCCcCceecccCCceEEEEEecC-----------------CcEEEEEEeccCCchhhhHHHHHHHHHHHhccCCCccc
Q 000859 945 TNNLSDEFIIGSGGSGTVYKAELAN-----------------GATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVK 1007 (1251)
Q Consensus 945 ~~~~~~~~~lG~G~fg~V~~~~~~~-----------------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 1007 (1251)
..+|+..+.||+|+||.||+|.... +..||+|++.........+.+.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 3468889999999999999986432 24689999976665556778999999999999999999
Q ss_pred eeceeeecCCCceeEEEeecCCCChHHhhhcCCCC----cccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCC
Q 000859 1008 LMGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVN----IKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKS 1083 (1251)
Q Consensus 1008 l~g~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~----~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp 1083 (1251)
+++++... ...++++||+++++|.+++.+.... ......+++..++.++.|++.|++|||+. +|+||||||
T Consensus 84 ~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp 158 (296)
T cd05051 84 LLGVCTVD--PPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLAT 158 (296)
T ss_pred EEEEEecC--CCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccch
Confidence 99988654 4569999999999999999764311 01123689999999999999999999999 999999999
Q ss_pred CCeeecCCCCeEEcccccccccccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhh--CCCCCCC
Q 000859 1084 SNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS--GKMPTDA 1161 (1251)
Q Consensus 1084 ~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~t--g~~p~~~ 1161 (1251)
+||+++.++.++++|||.++........ .......++..|+|||.+.+..++.++|||||||++|||++ |..||..
T Consensus 159 ~Nili~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~ 236 (296)
T cd05051 159 RNCLVGKNYTIKIADFGMSRNLYSSDYY--RVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEH 236 (296)
T ss_pred hceeecCCCceEEccccceeecccCcce--eecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCC
Confidence 9999999999999999998765322111 11122356789999999988889999999999999999998 7788765
Q ss_pred ccccchhHHHHHHHHHhccchhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 000859 1162 TFGVEMDMVRWVEMHMEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLN 1233 (1251)
Q Consensus 1162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 1233 (1251)
....+. ....... ..........+.+...+.++.+++.+|++.||++|||++||++.|++
T Consensus 237 ~~~~~~--~~~~~~~----------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 237 LTDQQV--IENAGHF----------FRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred cChHHH--HHHHHhc----------cccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 422111 1111000 00000111111122244679999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=321.67 Aligned_cols=263 Identities=22% Similarity=0.363 Sum_probs=205.7
Q ss_pred hcCCCcCceecccCCceEEEEEec------CCcEEEEEEeccCCchhhhHHHHHHHHHHHhccCCCccceeceeeecCCC
Q 000859 945 TNNLSDEFIIGSGGSGTVYKAELA------NGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAG 1018 (1251)
Q Consensus 945 ~~~~~~~~~lG~G~fg~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~ 1018 (1251)
.++|.+.+.||+|+||.||+|... ++..||+|.+...........+.+|+.+++.++||||+++++++... .
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~ 82 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTG--Q 82 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCC--C
Confidence 356888899999999999999653 24689999987555555567888999999999999999999988654 4
Q ss_pred ceeEEEeecCCCChHHhhhcCCCCc---ccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeE
Q 000859 1019 SNLLIYEYMENGSVWDWLHKQPVNI---KMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAH 1095 (1251)
Q Consensus 1019 ~~~lv~E~~~~gsL~~~l~~~~~~~---~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~k 1095 (1251)
..++||||+++|+|.+++....... .....+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+|
T Consensus 83 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~k 159 (277)
T cd05032 83 PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVK 159 (277)
T ss_pred CcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEE
Confidence 5699999999999999997543211 1234578999999999999999999999 999999999999999999999
Q ss_pred EcccccccccccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhh-CCCCCCCccccchhHHHHHH
Q 000859 1096 LGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMVRWVE 1174 (1251)
Q Consensus 1096 l~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~t-g~~p~~~~~~~~~~~~~~~~ 1174 (1251)
|+|||+++.+...... .......++..|+|||.+.+..++.++|||||||++||+++ |+.||.+....+. ..+.
T Consensus 160 l~dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~--~~~~- 234 (277)
T cd05032 160 IGDFGMTRDIYETDYY--RKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEV--LKFV- 234 (277)
T ss_pred ECCcccchhhccCccc--ccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHH--HHHH-
Confidence 9999999765432211 11122356789999999988889999999999999999998 9999865422111 1111
Q ss_pred HHHhccchhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 000859 1175 MHMEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLN 1233 (1251)
Q Consensus 1175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 1233 (1251)
... ..... +...+.++.+++.+||+.+|++|||+.++++.|++
T Consensus 235 -------------~~~-~~~~~--~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 235 -------------IDG-GHLDL--PENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred -------------hcC-CCCCC--CCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 000 01111 12235678999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=335.11 Aligned_cols=256 Identities=19% Similarity=0.239 Sum_probs=196.9
Q ss_pred HhhcCCCcCceecccCCceEEEEEec-CCcEEEEEEeccCC--chhhhHHHHHHHHHHHhccCCCccceeceeeecCCCc
Q 000859 943 GATNNLSDEFIIGSGGSGTVYKAELA-NGATVAVKKISCKD--DHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGS 1019 (1251)
Q Consensus 943 ~~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 1019 (1251)
....+|+..+.||+|+||.||+|+.. +++.||+|++.... .....+.+.+|+.+++.++||||+++++++.. +..
T Consensus 40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~--~~~ 117 (370)
T cd05621 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQD--DKY 117 (370)
T ss_pred CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEc--CCE
Confidence 34567999999999999999999654 68899999986422 22234567889999999999999999998754 456
Q ss_pred eeEEEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEccc
Q 000859 1020 NLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDF 1099 (1251)
Q Consensus 1020 ~~lv~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 1099 (1251)
.++||||+++|+|.+++... .+++..+..++.||+.||+|||++ +|+||||||+||++++++.+||+||
T Consensus 118 ~~lv~Ey~~gg~L~~~l~~~--------~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DF 186 (370)
T cd05621 118 LYMVMEYMPGGDLVNLMSNY--------DVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADF 186 (370)
T ss_pred EEEEEcCCCCCcHHHHHHhc--------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEec
Confidence 79999999999999999652 478889999999999999999999 9999999999999999999999999
Q ss_pred ccccccccccCCCCcccceeecccceecccccccCC----CCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHH
Q 000859 1100 GLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLK----ATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEM 1175 (1251)
Q Consensus 1100 G~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~ 1175 (1251)
|+|+.+.... ........||+.|+|||++.+.. ++.++||||+||++|||++|+.||.+...... .
T Consensus 187 G~a~~~~~~~---~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~-----~-- 256 (370)
T cd05621 187 GTCMKMDETG---MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGT-----Y-- 256 (370)
T ss_pred ccceecccCC---ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHH-----H--
Confidence 9997653211 11122357999999999987543 78899999999999999999999975422110 0
Q ss_pred HHhccchhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 000859 1176 HMEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQE--RPSSRQVCDL 1230 (1251)
Q Consensus 1176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~eil~~ 1230 (1251)
..+.........+.....+..+.+++.+|+..++.+ ||+++|+++.
T Consensus 257 ---------~~i~~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 257 ---------SKIMDHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred ---------HHHHhCCcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 011111111112222234556788999999865544 8999999875
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=319.12 Aligned_cols=258 Identities=26% Similarity=0.420 Sum_probs=203.3
Q ss_pred cCCCcCceecccCCceEEEEEec-C---CcEEEEEEeccCCchhhhHHHHHHHHHHHhccCCCccceeceeeecCCCcee
Q 000859 946 NNLSDEFIIGSGGSGTVYKAELA-N---GATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNL 1021 (1251)
Q Consensus 946 ~~~~~~~~lG~G~fg~V~~~~~~-~---~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~ 1021 (1251)
.+|+..+.||+|+||.||+|... + +..||+|.+.........+.+..|+.++++++||||+++++++... ...+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~ 81 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKS--KPVM 81 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecC--CccE
Confidence 45778889999999999999653 2 3479999987655455567889999999999999999999988543 4579
Q ss_pred EEEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEccccc
Q 000859 1022 LIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGL 1101 (1251)
Q Consensus 1022 lv~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~ 1101 (1251)
+||||+++|+|.+++... ...+++.++..++.|++.|++|||+. +++||||||+||+++.++.++++|||.
T Consensus 82 lv~e~~~~~~L~~~~~~~------~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~ 152 (267)
T cd05066 82 IVTEYMENGSLDAFLRKH------DGQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGL 152 (267)
T ss_pred EEEEcCCCCCHHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCc
Confidence 999999999999999764 24689999999999999999999999 999999999999999999999999999
Q ss_pred ccccccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhh-CCCCCCCccccchhHHHHHHHHHhcc
Q 000859 1102 AKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMVRWVEMHMEMS 1180 (1251)
Q Consensus 1102 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~ 1180 (1251)
++.+....... .......++..|+|||.+.+..++.++|+|||||++||+++ |+.||......+ .....
T Consensus 153 ~~~~~~~~~~~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~--~~~~~------- 222 (267)
T cd05066 153 SRVLEDDPEAA-YTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD--VIKAI------- 222 (267)
T ss_pred cccccccccee-eecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH--HHHHH-------
Confidence 97654321111 11111233568999999998899999999999999999887 999987543221 11111
Q ss_pred chhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 000859 1181 GSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNV 1234 (1251)
Q Consensus 1181 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 1234 (1251)
.+. .. .+.....+..+.+++.+|++.+|.+||++.++++.|.++
T Consensus 223 -------~~~-~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 223 -------EEG-YR--LPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred -------hCC-Cc--CCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 000 00 111222456788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=355.58 Aligned_cols=260 Identities=24% Similarity=0.340 Sum_probs=201.1
Q ss_pred HhhcCCCcCceecccCCceEEEEEe-cCCcEEEEEEeccCC-chhhhHHHHHHHHHHHhccCCCccceeceeeecCCCce
Q 000859 943 GATNNLSDEFIIGSGGSGTVYKAEL-ANGATVAVKKISCKD-DHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSN 1020 (1251)
Q Consensus 943 ~~~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~ 1020 (1251)
....+|.+.+.||+|+||+||+|.. .++..||+|++.... .....+.+..|+.++++++|||||+++++|........
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l 89 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL 89 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence 3456799999999999999999954 467889999986443 33455778999999999999999999998877666678
Q ss_pred eEEEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCC----CCeeecCCCCCCeeecC------
Q 000859 1021 LLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCV----PKILHRDIKSSNILLDS------ 1090 (1251)
Q Consensus 1021 ~lv~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~----~~ivH~Dlkp~Nill~~------ 1090 (1251)
++||||+++|+|.+++.... .....+++..++.|+.||+.||+|||+... .+||||||||+|||++.
T Consensus 90 yIVMEY~~gGSL~~lL~k~~---~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg 166 (1021)
T PTZ00266 90 YILMEFCDAGDLSRNIQKCY---KMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIG 166 (1021)
T ss_pred EEEEeCCCCCcHHHHHHHHh---hccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccc
Confidence 99999999999999997532 113568999999999999999999998521 25999999999999964
Q ss_pred -----------CCCeEEcccccccccccccCCCCcccceeecccceeccccccc--CCCCCccceeehhHHHHHHhhCCC
Q 000859 1091 -----------NMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYS--LKATEKCDVYSMGIVLMELVSGKM 1157 (1251)
Q Consensus 1091 -----------~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDiwSlGv~l~el~tg~~ 1157 (1251)
.+.+||+|||+++.+.... ......||+.|+|||++.+ ..++.++|||||||++|||+||+.
T Consensus 167 ~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s-----~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~ 241 (1021)
T PTZ00266 167 KITAQANNLNGRPIAKIGDFGLSKNIGIES-----MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKT 241 (1021)
T ss_pred cccccccccCCCCceEEccCCccccccccc-----cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCC
Confidence 2458999999997653211 1123478999999999864 458899999999999999999999
Q ss_pred CCCCccccchhHHHHHHHHHhccchhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 000859 1158 PTDATFGVEMDMVRWVEMHMEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCD 1229 (1251)
Q Consensus 1158 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1229 (1251)
||....... ........ .+..+ ....+.++.++|..||+.+|.+||++.|++.
T Consensus 242 PF~~~~~~~----qli~~lk~--------------~p~lp-i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 242 PFHKANNFS----QLISELKR--------------GPDLP-IKGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred CCCcCCcHH----HHHHHHhc--------------CCCCC-cCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 997542211 11111000 01111 1123467889999999999999999999984
|
|
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=319.26 Aligned_cols=259 Identities=27% Similarity=0.429 Sum_probs=203.7
Q ss_pred hcCCCcCceecccCCceEEEEEec-CC---cEEEEEEeccCCchhhhHHHHHHHHHHHhccCCCccceeceeeecCCCce
Q 000859 945 TNNLSDEFIIGSGGSGTVYKAELA-NG---ATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSN 1020 (1251)
Q Consensus 945 ~~~~~~~~~lG~G~fg~V~~~~~~-~~---~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~ 1020 (1251)
.++|+..+.||+|+||.||+|... ++ ..||+|.+.........+.+..|++++++++||||+++.+++... ...
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~ 81 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKF--KPA 81 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccC--CCc
Confidence 346788889999999999999654 33 379999987554455567889999999999999999999988654 456
Q ss_pred eEEEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcccc
Q 000859 1021 LLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFG 1100 (1251)
Q Consensus 1021 ~lv~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG 1100 (1251)
++||||+++++|.+++... ...+++.++..++.|++.|++|||+. +++||||||+||++++++.+|++|||
T Consensus 82 ~lv~e~~~~~~L~~~~~~~------~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg 152 (268)
T cd05063 82 MIITEYMENGALDKYLRDH------DGEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFG 152 (268)
T ss_pred EEEEEcCCCCCHHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCc
Confidence 9999999999999999763 35689999999999999999999999 99999999999999999999999999
Q ss_pred cccccccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhh-CCCCCCCccccchhHHHHHHHHHhc
Q 000859 1101 LAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMVRWVEMHMEM 1179 (1251)
Q Consensus 1101 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~ 1179 (1251)
++.......... ........+..|+|||++.+..++.++|||||||++||+++ |+.||...... .......
T Consensus 153 ~~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~-----~~~~~i~-- 224 (268)
T cd05063 153 LSRVLEDDPEGT-YTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH-----EVMKAIN-- 224 (268)
T ss_pred cceecccccccc-eeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH-----HHHHHHh--
Confidence 987653321111 11111223567999999988889999999999999999998 99999654221 1111110
Q ss_pred cchhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 000859 1180 SGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNV 1234 (1251)
Q Consensus 1180 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 1234 (1251)
.. ...+.....+.++.+++.+||+.+|++||++++|++.|.++
T Consensus 225 ---------~~---~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 225 ---------DG---FRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred ---------cC---CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 00 01112223456789999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=347.33 Aligned_cols=252 Identities=21% Similarity=0.287 Sum_probs=198.5
Q ss_pred CCcCceecccCCceEEEEEe-cC-CcEEEEEEeccCCchhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEEEe
Q 000859 948 LSDEFIIGSGGSGTVYKAEL-AN-GATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIYE 1025 (1251)
Q Consensus 948 ~~~~~~lG~G~fg~V~~~~~-~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv~E 1025 (1251)
|...+.||+|+||.||+|.. .+ ++.||+|.+.... ....+.+.+|+.+++.++|||||++++++... ...++|||
T Consensus 69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~--~~~~lv~E 145 (478)
T PTZ00267 69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND-ERQAAYARSELHCLAACDHFGIVKHFDDFKSD--DKLLLIME 145 (478)
T ss_pred EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEEC--CEEEEEEE
Confidence 77888999999999999954 34 6788998775433 33446778899999999999999999988654 46799999
Q ss_pred ecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEccccccccc
Q 000859 1026 YMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKAL 1105 (1251)
Q Consensus 1026 ~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~ 1105 (1251)
|+++|+|.++++... .....+++.++..++.|++.||+|+|++ +|+||||||+||+++.++.+||+|||+++.+
T Consensus 146 ~~~gg~L~~~l~~~~---~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~ 219 (478)
T PTZ00267 146 YGSGGDLNKQIKQRL---KEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQY 219 (478)
T ss_pred CCCCCCHHHHHHHHH---hccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceec
Confidence 999999999886431 1235688999999999999999999999 9999999999999999999999999999865
Q ss_pred ccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccchhhh
Q 000859 1106 VEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSARE 1185 (1251)
Q Consensus 1106 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1185 (1251)
..... ........||+.|+|||++.+..++.++||||+||++|||++|+.||.+....+ ....
T Consensus 220 ~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~-----~~~~---------- 282 (478)
T PTZ00267 220 SDSVS--LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQRE-----IMQQ---------- 282 (478)
T ss_pred CCccc--cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHH----------
Confidence 33211 112233568999999999999999999999999999999999999997542211 1110
Q ss_pred hhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 000859 1186 ELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCD 1229 (1251)
Q Consensus 1186 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1229 (1251)
....... +.+...+.++.+++.+||+.||++||++++++.
T Consensus 283 -~~~~~~~---~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 283 -VLYGKYD---PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred -HHhCCCC---CCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 0111110 111224467899999999999999999999864
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=332.67 Aligned_cols=244 Identities=25% Similarity=0.300 Sum_probs=187.0
Q ss_pred ceecccCCceEEEEEec-CCcEEEEEEeccCCc--hhhhHHHHHHHH-HHHhccCCCccceeceeeecCCCceeEEEeec
Q 000859 952 FIIGSGGSGTVYKAELA-NGATVAVKKISCKDD--HLLNKSFTREVK-TLGRIRHRHLVKLMGHCCNKGAGSNLLIYEYM 1027 (1251)
Q Consensus 952 ~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~-~l~~l~h~niv~l~g~~~~~~~~~~~lv~E~~ 1027 (1251)
+.||+|+||+||+|+.. +++.||+|++..... ......+..|.. +++.++||||+++++++.. ....++||||+
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~--~~~~~lv~e~~ 78 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQT--ADKLYFVLDYI 78 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEc--CCeEEEEEeCC
Confidence 36999999999999654 678899999864321 112234444444 5677899999999988754 34579999999
Q ss_pred CCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEccccccccccc
Q 000859 1028 ENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVE 1107 (1251)
Q Consensus 1028 ~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~ 1107 (1251)
++|+|.+++.. ...+++..+..++.||++||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 79 ~~~~L~~~~~~-------~~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~ 148 (325)
T cd05602 79 NGGELFYHLQR-------ERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIE 148 (325)
T ss_pred CCCcHHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCccccc
Confidence 99999999976 34578888899999999999999999 999999999999999999999999999875422
Q ss_pred ccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccchhhhhh
Q 000859 1108 DYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSAREEL 1187 (1251)
Q Consensus 1108 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1187 (1251)
. ........||+.|+|||++.+..++.++||||+||++|||++|+.||.+....+. .....
T Consensus 149 ~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-----~~~i~---------- 209 (325)
T cd05602 149 H----NGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM-----YDNIL---------- 209 (325)
T ss_pred C----CCCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHH-----HHHHH----------
Confidence 1 1122335789999999999999999999999999999999999999975432111 11100
Q ss_pred hcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 000859 1188 LDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLL 1231 (1251)
Q Consensus 1188 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L 1231 (1251)
.. ........+..+.+++.+|++.||.+||++++.+..+
T Consensus 210 -~~----~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i 248 (325)
T cd05602 210 -NK----PLQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEI 248 (325)
T ss_pred -hC----CcCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHH
Confidence 00 0011112345688999999999999999987544433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-34 Score=323.01 Aligned_cols=264 Identities=25% Similarity=0.425 Sum_probs=205.5
Q ss_pred CCCcCceecccCCceEEEEEec------CCcEEEEEEeccCCchhhhHHHHHHHHHHHhccCCCccceeceeeecCCCce
Q 000859 947 NLSDEFIIGSGGSGTVYKAELA------NGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSN 1020 (1251)
Q Consensus 947 ~~~~~~~lG~G~fg~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~ 1020 (1251)
+|...+.||+|+||.||+|... ++..||+|.+.... ....+.+.+|++++++++||||+++++++.. ....
T Consensus 6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~ 82 (291)
T cd05094 6 DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT-LAARKDFQREAELLTNLQHEHIVKFYGVCGD--GDPL 82 (291)
T ss_pred HeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc-HHHHHHHHHHHHHHhcCCCCCcceEEEEEcc--CCce
Confidence 4777789999999999999642 34569999986433 3344678899999999999999999998864 3457
Q ss_pred eEEEeecCCCChHHhhhcCCCC---------cccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCC
Q 000859 1021 LLIYEYMENGSVWDWLHKQPVN---------IKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSN 1091 (1251)
Q Consensus 1021 ~lv~E~~~~gsL~~~l~~~~~~---------~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~ 1091 (1251)
++||||+++++|.+++...... ......+++..++.++.|++.|++|||++ +|+||||||+||+++.+
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~ 159 (291)
T cd05094 83 IMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGAN 159 (291)
T ss_pred EEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccC
Confidence 9999999999999999764321 11234589999999999999999999999 99999999999999999
Q ss_pred CCeEEcccccccccccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhh-CCCCCCCccccchhHH
Q 000859 1092 MEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMV 1170 (1251)
Q Consensus 1092 ~~~kl~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~t-g~~p~~~~~~~~~~~~ 1170 (1251)
+.+||+|||+++....... ........++..|+|||++.+..++.++|||||||++|||+| |+.||......+
T Consensus 160 ~~~~l~dfg~a~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~---- 233 (291)
T cd05094 160 LLVKIGDFGMSRDVYSTDY--YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE---- 233 (291)
T ss_pred CcEEECCCCcccccCCCce--eecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH----
Confidence 9999999999976533211 111222456789999999999999999999999999999999 999987553321
Q ss_pred HHHHHHHhccchhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhcCC
Q 000859 1171 RWVEMHMEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNVFNN 1237 (1251)
Q Consensus 1171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~ 1237 (1251)
..+.. ..... .. .....+..+.+++.+||+.||++|||+++|+++|.++...
T Consensus 234 -~~~~~-----------~~~~~-~~--~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 234 -VIECI-----------TQGRV-LE--RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred -HHHHH-----------hCCCC-CC--CCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 11100 00000 00 1122456788999999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=323.44 Aligned_cols=263 Identities=26% Similarity=0.398 Sum_probs=205.0
Q ss_pred hcCCCcCceecccCCceEEEEEec------CCcEEEEEEeccCCchhhhHHHHHHHHHHHhccCCCccceeceeeecCCC
Q 000859 945 TNNLSDEFIIGSGGSGTVYKAELA------NGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAG 1018 (1251)
Q Consensus 945 ~~~~~~~~~lG~G~fg~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~ 1018 (1251)
.++|+..+.||+|+||.||+|... ++..||+|++.........+.+.+|++++++++||||+++++++... .
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~--~ 81 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVG--K 81 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCC--C
Confidence 456888899999999999999653 46789999997665555667899999999999999999999987654 3
Q ss_pred ceeEEEeecCCCChHHhhhcCCCC---------------cccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCC
Q 000859 1019 SNLLIYEYMENGSVWDWLHKQPVN---------------IKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKS 1083 (1251)
Q Consensus 1019 ~~~lv~E~~~~gsL~~~l~~~~~~---------------~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp 1083 (1251)
..++||||+++|+|.+++...... ......+++.+++.++.|++.|++|||+. +++||||||
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p 158 (288)
T cd05050 82 PMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLAT 158 (288)
T ss_pred ccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccH
Confidence 469999999999999999753210 01123578999999999999999999999 999999999
Q ss_pred CCeeecCCCCeEEcccccccccccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhh-CCCCCCCc
Q 000859 1084 SNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDAT 1162 (1251)
Q Consensus 1084 ~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~t-g~~p~~~~ 1162 (1251)
+||++++++.+||+|||.++.+....... ......++..|+|||.+.+..++.++|||||||++|||++ |..||.+.
T Consensus 159 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~ 236 (288)
T cd05050 159 RNCLVGENMVVKIADFGLSRNIYSADYYK--ASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGM 236 (288)
T ss_pred hheEecCCCceEECccccceecccCcccc--ccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999987653321111 1112234678999999988899999999999999999998 88898654
Q ss_pred cccchhHHHHHHHHHhccchhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 000859 1163 FGVEMDMVRWVEMHMEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLN 1233 (1251)
Q Consensus 1163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 1233 (1251)
...+ ..... .+.. ..+.+...+.++.+++.+|++.||++|||++|+++.|++
T Consensus 237 ~~~~-----~~~~~-----------~~~~---~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 237 AHEE-----VIYYV-----------RDGN---VLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred CHHH-----HHHHH-----------hcCC---CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 2211 11110 0000 011122345678999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=325.53 Aligned_cols=267 Identities=22% Similarity=0.363 Sum_probs=207.0
Q ss_pred hcCCCcCceecccCCceEEEEEec--------CCcEEEEEEeccCCchhhhHHHHHHHHHHHhc-cCCCccceeceeeec
Q 000859 945 TNNLSDEFIIGSGGSGTVYKAELA--------NGATVAVKKISCKDDHLLNKSFTREVKTLGRI-RHRHLVKLMGHCCNK 1015 (1251)
Q Consensus 945 ~~~~~~~~~lG~G~fg~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~ 1015 (1251)
..+|.+.+.||+|+||.||+|+.. ++..||+|.+.........+.+.+|+.+++.+ +||||+++++++...
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 445778889999999999999641 24579999987554455567889999999999 899999999988654
Q ss_pred CCCceeEEEeecCCCChHHhhhcCCCCc---------ccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCe
Q 000859 1016 GAGSNLLIYEYMENGSVWDWLHKQPVNI---------KMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNI 1086 (1251)
Q Consensus 1016 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~---------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Ni 1086 (1251)
...++||||+++|+|.+++....... .....+++.++..++.||++|++|||+. +|+||||||+||
T Consensus 94 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Ni 168 (304)
T cd05101 94 --GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNV 168 (304)
T ss_pred --CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceE
Confidence 45689999999999999997643110 1134688999999999999999999999 999999999999
Q ss_pred eecCCCCeEEcccccccccccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhh-CCCCCCCcccc
Q 000859 1087 LLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGV 1165 (1251)
Q Consensus 1087 ll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~t-g~~p~~~~~~~ 1165 (1251)
++++++.+||+|||.++.+...... .......++..|+|||++.+..++.++||||||+++||+++ |..||.+....
T Consensus 169 li~~~~~~kl~D~g~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~ 246 (304)
T cd05101 169 LVTENNVMKIADFGLARDVNNIDYY--KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 246 (304)
T ss_pred EEcCCCcEEECCCccceeccccccc--ccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH
Confidence 9999999999999999765432211 11122345678999999988889999999999999999998 88888654211
Q ss_pred chhHHHHHHHHHhccchhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhcCC
Q 000859 1166 EMDMVRWVEMHMEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNVFNN 1237 (1251)
Q Consensus 1166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~ 1237 (1251)
.+...... ... ...+..++.++.+++.+||+.+|++|||+.|+++.|.+++.-
T Consensus 247 -----~~~~~~~~------------~~~--~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~ 299 (304)
T cd05101 247 -----ELFKLLKE------------GHR--MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL 299 (304)
T ss_pred -----HHHHHHHc------------CCc--CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence 11111100 000 011223456788999999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=292.85 Aligned_cols=254 Identities=26% Similarity=0.406 Sum_probs=204.1
Q ss_pred hcCCCcCceecccCCceEEEEEec-CCcEEEEEEeccCCchhhhHHHHHHHHHHHhc-cCCCccceeceeeecCCCceeE
Q 000859 945 TNNLSDEFIIGSGGSGTVYKAELA-NGATVAVKKISCKDDHLLNKSFTREVKTLGRI-RHRHLVKLMGHCCNKGAGSNLL 1022 (1251)
Q Consensus 945 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~~~l 1022 (1251)
.++.+....||.|..|.||+++.+ +|..+|||.+......++.+.+...+.++... +.|.||+.+|||....+ .++
T Consensus 91 indl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~d--V~I 168 (391)
T KOG0983|consen 91 INDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTD--VFI 168 (391)
T ss_pred hHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCch--HHH
Confidence 344555667999999999999665 58999999999888777888888899887776 48999999999976544 578
Q ss_pred EEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcccccc
Q 000859 1023 IYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLA 1102 (1251)
Q Consensus 1023 v~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a 1102 (1251)
.||.|.. .+...+++- .+++++..+-++...+++|+.||.++| +|+|||+||+|||+|+.|.+|+||||.+
T Consensus 169 cMelMs~-C~ekLlkri------k~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIs 239 (391)
T KOG0983|consen 169 CMELMST-CAEKLLKRI------KGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGIS 239 (391)
T ss_pred HHHHHHH-HHHHHHHHh------cCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeeccccc
Confidence 9999853 455555543 456888888899999999999999986 9999999999999999999999999999
Q ss_pred cccccccCCCCcccceeecccceecccccc---cCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhc
Q 000859 1103 KALVEDYNSNTESNTWFAGSYGYIAPEYAY---SLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEM 1179 (1251)
Q Consensus 1103 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 1179 (1251)
-.+.+ ...++..+|.+.|||||.+. ...|+.++||||||+.++|+.||+.||.+-... .
T Consensus 240 Grlvd-----SkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td-F------------ 301 (391)
T KOG0983|consen 240 GRLVD-----SKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD-F------------ 301 (391)
T ss_pred ceeec-----ccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc-H------------
Confidence 76643 33344468999999999876 446899999999999999999999999763221 1
Q ss_pred cchhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 000859 1180 SGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDL 1230 (1251)
Q Consensus 1180 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 1230 (1251)
.....+.+ ...|.++.....++.+.+++..|+.+|+.+||.+.+++++
T Consensus 302 --e~ltkvln-~ePP~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 302 --EVLTKVLN-EEPPLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred --HHHHHHHh-cCCCCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 11122233 2236666666678889999999999999999999988754
|
|
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=317.37 Aligned_cols=251 Identities=25% Similarity=0.370 Sum_probs=201.2
Q ss_pred CCCcCceecccCCceEEEEEe-cCCcEEEEEEeccCCchhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEEEe
Q 000859 947 NLSDEFIIGSGGSGTVYKAEL-ANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIYE 1025 (1251)
Q Consensus 947 ~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv~E 1025 (1251)
+|+..+.||+|+||.||+++. .+++.||+|.+.........+.+.+|+.+++.++||||+++++.+.. ....+++||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e 78 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEA--DGHLYIVME 78 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEE--CCEEEEEEe
Confidence 467788999999999999954 46899999998655545556788899999999999999999998754 346799999
Q ss_pred ecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEccccccccc
Q 000859 1026 YMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKAL 1105 (1251)
Q Consensus 1026 ~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~ 1105 (1251)
|+++|++.+++.... ...+++..+..++.|++.|++|||+. +|+|+||||+||++++++.++++|||.++..
T Consensus 79 ~~~~~~l~~~~~~~~-----~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~ 150 (255)
T cd08219 79 YCDGGDLMQKIKLQR-----GKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLL 150 (255)
T ss_pred eCCCCcHHHHHHhcc-----CCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceee
Confidence 999999999987532 34578999999999999999999999 9999999999999999999999999998765
Q ss_pred ccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccchhhh
Q 000859 1106 VEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSARE 1185 (1251)
Q Consensus 1106 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1185 (1251)
... ........|+..|+|||++.+..++.++|+||||+++|+|++|+.||........ ....
T Consensus 151 ~~~----~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~-----~~~~--------- 212 (255)
T cd08219 151 TSP----GAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNL-----ILKV--------- 212 (255)
T ss_pred ccc----ccccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHH-----HHHH---------
Confidence 322 1122235688999999999988899999999999999999999999975422111 0000
Q ss_pred hhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 000859 1186 ELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDL 1230 (1251)
Q Consensus 1186 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 1230 (1251)
...... +.+...+..+.+++.+||+.||++|||+++++..
T Consensus 213 --~~~~~~---~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 213 --CQGSYK---PLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred --hcCCCC---CCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 000010 1122244568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=328.82 Aligned_cols=204 Identities=23% Similarity=0.370 Sum_probs=164.5
Q ss_pred CceecccCCceEEEEEec---CCcEEEEEEeccCCchhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEEEeec
Q 000859 951 EFIIGSGGSGTVYKAELA---NGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIYEYM 1027 (1251)
Q Consensus 951 ~~~lG~G~fg~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv~E~~ 1027 (1251)
..+||+|+||+||+|+.. +++.||+|.+..... ...+.+|++++++++||||+++++++........+++|||+
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~ 82 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI---SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA 82 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC---cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEecc
Confidence 357999999999999754 467899999864332 34577899999999999999999988766666789999999
Q ss_pred CCCChHHhhhcCCCC--cccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeee----cCCCCeEEccccc
Q 000859 1028 ENGSVWDWLHKQPVN--IKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILL----DSNMEAHLGDFGL 1101 (1251)
Q Consensus 1028 ~~gsL~~~l~~~~~~--~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill----~~~~~~kl~DfG~ 1101 (1251)
+ ++|.+++...... ......+++..++.++.|++.||+|||+. +|+||||||+||++ +..+.+||+|||+
T Consensus 83 ~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07868 83 E-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred C-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCc
Confidence 6 5898888643211 11223589999999999999999999999 99999999999999 4568899999999
Q ss_pred ccccccccCCCCcccceeecccceeccccccc-CCCCCccceeehhHHHHHHhhCCCCCCCc
Q 000859 1102 AKALVEDYNSNTESNTWFAGSYGYIAPEYAYS-LKATEKCDVYSMGIVLMELVSGKMPTDAT 1162 (1251)
Q Consensus 1102 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlGv~l~el~tg~~p~~~~ 1162 (1251)
|+.+..... .........||+.|+|||++.+ ..++.++||||+||++|||++|++||...
T Consensus 159 a~~~~~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 159 ARLFNSPLK-PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eeccCCCCc-cccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 976543221 1112233578999999999876 45899999999999999999999999654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=329.96 Aligned_cols=244 Identities=21% Similarity=0.319 Sum_probs=189.2
Q ss_pred ceecccCCceEEEEEe-cCCcEEEEEEeccCC--chhhhHHHHHHHHHHHhc-cCCCccceeceeeecCCCceeEEEeec
Q 000859 952 FIIGSGGSGTVYKAEL-ANGATVAVKKISCKD--DHLLNKSFTREVKTLGRI-RHRHLVKLMGHCCNKGAGSNLLIYEYM 1027 (1251)
Q Consensus 952 ~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~~~lv~E~~ 1027 (1251)
+.||+|+||+||+|.. .+++.||+|++.... .....+.+.+|+.++.++ +||+|+++++++.. ....++||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--~~~~~lv~e~~ 78 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQT--TSRLFLVIEYV 78 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEe--CCEEEEEEeCC
Confidence 3699999999999965 467899999997543 223445678899999888 69999999997754 34579999999
Q ss_pred CCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEccccccccccc
Q 000859 1028 ENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVE 1107 (1251)
Q Consensus 1028 ~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~ 1107 (1251)
++|+|..++.. .+.+++..+..++.|++.|++|||++ +|+||||||+||+++.++.+||+|||+++....
T Consensus 79 ~~~~L~~~~~~-------~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~ 148 (327)
T cd05617 79 NGGDLMFHMQR-------QRKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLG 148 (327)
T ss_pred CCCcHHHHHHH-------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccC
Confidence 99999998875 34689999999999999999999999 999999999999999999999999999864321
Q ss_pred ccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhhCCCCCCCccccc-hhHHHHHHHHHhccchhhhh
Q 000859 1108 DYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVE-MDMVRWVEMHMEMSGSAREE 1186 (1251)
Q Consensus 1108 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 1186 (1251)
. ........||+.|+|||++.+..++.++||||+||++|||++|+.||....... .....+.....
T Consensus 149 ~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~--------- 215 (327)
T cd05617 149 P----GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVI--------- 215 (327)
T ss_pred C----CCceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHH---------
Confidence 1 112233578999999999999999999999999999999999999996432211 11111111110
Q ss_pred hhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHH
Q 000859 1187 LLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSR 1225 (1251)
Q Consensus 1187 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 1225 (1251)
.. .....+...+..+.+++.+|++.||++||+++
T Consensus 216 -~~----~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~ 249 (327)
T cd05617 216 -LE----KPIRIPRFLSVKASHVLKGFLNKDPKERLGCQ 249 (327)
T ss_pred -Hh----CCCCCCCCCCHHHHHHHHHHhccCHHHcCCCC
Confidence 00 01111222345678999999999999999853
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=323.92 Aligned_cols=269 Identities=22% Similarity=0.364 Sum_probs=201.5
Q ss_pred cCCCcCceecccCCceEEEEEecC---------------CcEEEEEEeccCCchhhhHHHHHHHHHHHhccCCCccceec
Q 000859 946 NNLSDEFIIGSGGSGTVYKAELAN---------------GATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMG 1010 (1251)
Q Consensus 946 ~~~~~~~~lG~G~fg~V~~~~~~~---------------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g 1010 (1251)
.+|++.+.||+|+||.||+|.... ...||+|++.........+.+.+|++++++++|||++++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 468888999999999999986532 23589999976555555678999999999999999999999
Q ss_pred eeeecCCCceeEEEeecCCCChHHhhhcCCCC-----cccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCC
Q 000859 1011 HCCNKGAGSNLLIYEYMENGSVWDWLHKQPVN-----IKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSN 1085 (1251)
Q Consensus 1011 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~-----~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~N 1085 (1251)
++... ...++||||+++++|.+++...... ......+++..+.+++.|++.|++|||+. +++||||||+|
T Consensus 85 ~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~N 159 (295)
T cd05097 85 VCVSD--DPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRN 159 (295)
T ss_pred EEcCC--CccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhh
Confidence 88654 4569999999999999999653210 01123478999999999999999999999 99999999999
Q ss_pred eeecCCCCeEEcccccccccccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhh--CCCCCCCcc
Q 000859 1086 ILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS--GKMPTDATF 1163 (1251)
Q Consensus 1086 ill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~t--g~~p~~~~~ 1163 (1251)
|++++++.+|++|||+++....... ........++..|+|||+..+..++.++|||||||++|||++ |..||....
T Consensus 160 ill~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~ 237 (295)
T cd05097 160 CLVGNHYTIKIADFGMSRNLYSGDY--YRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLS 237 (295)
T ss_pred EEEcCCCcEEecccccccccccCcc--eeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccC
Confidence 9999999999999999976532211 111122345778999999988889999999999999999998 667776543
Q ss_pred ccchhHHHHHHHHHhccchhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 000859 1164 GVEMDMVRWVEMHMEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLN 1233 (1251)
Q Consensus 1164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 1233 (1251)
..+. .....+.... . .... ........+..+.+++.+||+.||++|||+++|++.|.+
T Consensus 238 ~~~~-~~~~~~~~~~----~-----~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 238 DEQV-IENTGEFFRN----Q-----GRQI--YLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred hHHH-HHHHHHhhhh----c-----cccc--cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 2211 0010000000 0 0000 000111234579999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=326.56 Aligned_cols=269 Identities=22% Similarity=0.353 Sum_probs=207.4
Q ss_pred hcCCCcCceecccCCceEEEEEec--------CCcEEEEEEeccCCchhhhHHHHHHHHHHHhc-cCCCccceeceeeec
Q 000859 945 TNNLSDEFIIGSGGSGTVYKAELA--------NGATVAVKKISCKDDHLLNKSFTREVKTLGRI-RHRHLVKLMGHCCNK 1015 (1251)
Q Consensus 945 ~~~~~~~~~lG~G~fg~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~ 1015 (1251)
..+|.+.+.||+|+||.||+|... ++..||+|.+.........+.+.+|+++++++ +||||+++++++...
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 346888899999999999999642 23579999997654444556788999999999 799999999988654
Q ss_pred CCCceeEEEeecCCCChHHhhhcCCCCc---------ccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCe
Q 000859 1016 GAGSNLLIYEYMENGSVWDWLHKQPVNI---------KMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNI 1086 (1251)
Q Consensus 1016 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~---------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Ni 1086 (1251)
...++||||+++|+|.+++....... .....+++.++.+++.|++.|++|||+. +++||||||+||
T Consensus 97 --~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Ni 171 (307)
T cd05098 97 --GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNV 171 (307)
T ss_pred --CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHhe
Confidence 35699999999999999997643110 1234589999999999999999999999 999999999999
Q ss_pred eecCCCCeEEcccccccccccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhh-CCCCCCCcccc
Q 000859 1087 LLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGV 1165 (1251)
Q Consensus 1087 ll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~t-g~~p~~~~~~~ 1165 (1251)
+++.++.+||+|||.++........ .......++..|+|||.+.+..++.++||||+||++|||++ |+.||......
T Consensus 172 ll~~~~~~kL~dfg~a~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~ 249 (307)
T cd05098 172 LVTEDNVMKIADFGLARDIHHIDYY--KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE 249 (307)
T ss_pred EEcCCCcEEECCCcccccccccchh--hccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHH
Confidence 9999999999999998765321111 11111234578999999998889999999999999999998 88898643211
Q ss_pred chhHHHHHHHHHhccchhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhcCCCc
Q 000859 1166 EMDMVRWVEMHMEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNVFNNRI 1239 (1251)
Q Consensus 1166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~ 1239 (1251)
+..... .... ..+.+...+.++.+++.+||+.+|++|||+.++++.|.+++....
T Consensus 250 -----~~~~~~------------~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~~ 304 (307)
T cd05098 250 -----ELFKLL------------KEGH--RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALTS 304 (307)
T ss_pred -----HHHHHH------------HcCC--CCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHhh
Confidence 111100 0000 111122345678899999999999999999999999999886543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=321.32 Aligned_cols=249 Identities=24% Similarity=0.305 Sum_probs=191.5
Q ss_pred ecccCCceEEEEEe-cCCcEEEEEEeccCCc--hhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEEEeecCCC
Q 000859 954 IGSGGSGTVYKAEL-ANGATVAVKKISCKDD--HLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIYEYMENG 1030 (1251)
Q Consensus 954 lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv~E~~~~g 1030 (1251)
||+|+||.||+++. .+|+.||+|++..... ....+.+..|++++++++||||+++++++.. ....++||||+++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~--~~~~~lv~e~~~g~ 78 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFES--KTHLCLVMSLMNGG 78 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEec--CCeEEEEEecCCCC
Confidence 69999999999954 4689999999864321 1223456679999999999999999988754 44579999999999
Q ss_pred ChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcccccccccccccC
Q 000859 1031 SVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYN 1110 (1251)
Q Consensus 1031 sL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 1110 (1251)
+|.+++.... ...+++..+..++.|++.|++|||+. +|+||||||+||+++.++.++|+|||++......
T Consensus 79 ~L~~~~~~~~-----~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~-- 148 (277)
T cd05607 79 DLKYHIYNVG-----ERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG-- 148 (277)
T ss_pred CHHHHHHhcc-----ccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCC--
Confidence 9998886532 34588999999999999999999999 9999999999999999999999999998765321
Q ss_pred CCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccchhhhhhhcc
Q 000859 1111 SNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSAREELLDD 1190 (1251)
Q Consensus 1111 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1190 (1251)
.......|+..|+|||++.+..++.++||||+||++|||++|+.||........ ....... ....
T Consensus 149 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~-~~~~~~~-----------~~~~ 213 (277)
T cd05607 149 ---KTITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA-KEELKRR-----------TLED 213 (277)
T ss_pred ---ceeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh-HHHHHHH-----------hhcc
Confidence 111234688999999999988899999999999999999999999975422111 1111000 0010
Q ss_pred cCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 000859 1191 QMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLL 1232 (1251)
Q Consensus 1191 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 1232 (1251)
.... .....+.++.+++.+||+.||++||+++|+++...
T Consensus 214 ~~~~---~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~ 252 (277)
T cd05607 214 EVKF---EHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPR 252 (277)
T ss_pred cccc---ccccCCHHHHHHHHHHhccCHhhCCCCccchhhhh
Confidence 0000 01123556889999999999999999987765443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=317.94 Aligned_cols=259 Identities=27% Similarity=0.401 Sum_probs=202.8
Q ss_pred cCCCcCceecccCCceEEEEEec-CC---cEEEEEEeccCCchhhhHHHHHHHHHHHhccCCCccceeceeeecCCCcee
Q 000859 946 NNLSDEFIIGSGGSGTVYKAELA-NG---ATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNL 1021 (1251)
Q Consensus 946 ~~~~~~~~lG~G~fg~V~~~~~~-~~---~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~ 1021 (1251)
.+|+..+.||+|+||.||+|... ++ ..||||++.........+.|..|+.++++++||||+++++++... ...+
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~--~~~~ 81 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKS--RPVM 81 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCC--CceE
Confidence 34777889999999999999654 23 369999987655555667899999999999999999999987543 4568
Q ss_pred EEEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEccccc
Q 000859 1022 LIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGL 1101 (1251)
Q Consensus 1022 lv~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~ 1101 (1251)
+||||+++|+|.++++.. .+.+++.+++.++.|++.|++|||+. +++||||||+||+++.++.+|++|||.
T Consensus 82 lv~e~~~~~~L~~~l~~~------~~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~ 152 (269)
T cd05065 82 IITEFMENGALDSFLRQN------DGQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGL 152 (269)
T ss_pred EEEecCCCCcHHHHHhhC------CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCcc
Confidence 999999999999999764 34689999999999999999999999 999999999999999999999999999
Q ss_pred ccccccccCCCCc-ccceeecccceecccccccCCCCCccceeehhHHHHHHhh-CCCCCCCccccchhHHHHHHHHHhc
Q 000859 1102 AKALVEDYNSNTE-SNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMVRWVEMHMEM 1179 (1251)
Q Consensus 1102 a~~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~ 1179 (1251)
+............ .......+..|+|||.+.+..++.++||||+||++||+++ |..||......+ ...++.
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~--~~~~i~----- 225 (269)
T cd05065 153 SRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD--VINAIE----- 225 (269)
T ss_pred ccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHH--HHHHHH-----
Confidence 8765332211110 0011112457999999998899999999999999999887 999997543211 111110
Q ss_pred cchhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 000859 1180 SGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNV 1234 (1251)
Q Consensus 1180 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 1234 (1251)
. . ...+.+..++..+.+++.+||+.+|.+||++++++..|+++
T Consensus 226 ---------~-~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 226 ---------Q-D--YRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred ---------c-C--CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0 0 01112223456788999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=315.42 Aligned_cols=250 Identities=28% Similarity=0.401 Sum_probs=199.9
Q ss_pred cCCCcCceecccCCceEEEEEecCCcEEEEEEeccCCchhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEEEe
Q 000859 946 NNLSDEFIIGSGGSGTVYKAELANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIYE 1025 (1251)
Q Consensus 946 ~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv~E 1025 (1251)
.+|...+.||+|+||.||+|... |..||+|.+.... ..+.+.+|+.++++++|+|++++++++... ....++++|
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~~lv~e 80 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEE-KGGLYIVTE 80 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc---hHHHHHHHHHHHHhCCCCCeeeEEEEEEcC-CCceEEEEE
Confidence 46788889999999999999775 7889999985432 246788999999999999999999976544 344689999
Q ss_pred ecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEccccccccc
Q 000859 1026 YMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKAL 1105 (1251)
Q Consensus 1026 ~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~ 1105 (1251)
|+++|+|.++++... ...+++..+.+++.|++.|++|||++ +|+||||||+||++++++.+|++|||+++..
T Consensus 81 ~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~ 152 (256)
T cd05082 81 YMAKGSLVDYLRSRG-----RSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEA 152 (256)
T ss_pred CCCCCcHHHHHHhcC-----CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceec
Confidence 999999999997643 34588999999999999999999999 9999999999999999999999999998754
Q ss_pred ccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhh-CCCCCCCccccchhHHHHHHHHHhccchhh
Q 000859 1106 VEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMVRWVEMHMEMSGSAR 1184 (1251)
Q Consensus 1106 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1184 (1251)
.... ....++..|+|||++.+..++.++|||||||++|||++ |+.||..... ........
T Consensus 153 ~~~~-------~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~-----~~~~~~~~------- 213 (256)
T cd05082 153 SSTQ-------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-----KDVVPRVE------- 213 (256)
T ss_pred cccC-------CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH-----HHHHHHHh-------
Confidence 2211 11234568999999998889999999999999999998 9999864421 11111110
Q ss_pred hhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 000859 1185 EELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNV 1234 (1251)
Q Consensus 1185 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 1234 (1251)
....+. ....++..+.+++.+|++.+|++|||++++++.|+++
T Consensus 214 -----~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 214 -----KGYKMD--APDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred -----cCCCCC--CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 000111 1123456789999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=318.34 Aligned_cols=259 Identities=23% Similarity=0.371 Sum_probs=205.6
Q ss_pred cCCCcCceecccCCceEEEEEecC----CcEEEEEEeccCCchhhhHHHHHHHHHHHhccCCCccceeceeeecCCCcee
Q 000859 946 NNLSDEFIIGSGGSGTVYKAELAN----GATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNL 1021 (1251)
Q Consensus 946 ~~~~~~~~lG~G~fg~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~ 1021 (1251)
.+|...+.||+|+||.||+|...+ ...||||...........+.+.+|+.++++++||||+++++++.. ...+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~---~~~~ 82 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE---NPVW 82 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC---CCcE
Confidence 457778899999999999996543 347999998766555566789999999999999999999998753 2358
Q ss_pred EEEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEccccc
Q 000859 1022 LIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGL 1101 (1251)
Q Consensus 1022 lv~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~ 1101 (1251)
+||||+++|+|.+++... ...+++..+..++.|++.|++|||+. +++||||||+||+++.++.+|++|||+
T Consensus 83 lv~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~ 153 (270)
T cd05056 83 IVMELAPLGELRSYLQVN------KYSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGL 153 (270)
T ss_pred EEEEcCCCCcHHHHHHhC------CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCce
Confidence 999999999999999764 24589999999999999999999998 999999999999999999999999999
Q ss_pred ccccccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhh-CCCCCCCccccchhHHHHHHHHHhcc
Q 000859 1102 AKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMVRWVEMHMEMS 1180 (1251)
Q Consensus 1102 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~ 1180 (1251)
++........ ......++..|+|||.+....++.++|||||||++||+++ |+.||......+. ..+..
T Consensus 154 ~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~--~~~~~------ 222 (270)
T cd05056 154 SRYLEDESYY---KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDV--IGRIE------ 222 (270)
T ss_pred eeecccccce---ecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHH--HHHHH------
Confidence 8765332111 1112234568999999988889999999999999999986 9999976533211 11100
Q ss_pred chhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhcCCC
Q 000859 1181 GSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNVFNNR 1238 (1251)
Q Consensus 1181 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~ 1238 (1251)
.. ...+.+..++.++.+++.+|+..+|++|||+.++++.|.++....
T Consensus 223 --------~~---~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~~ 269 (270)
T cd05056 223 --------NG---ERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQEE 269 (270)
T ss_pred --------cC---CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 00 011112234567999999999999999999999999999877643
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-34 Score=315.94 Aligned_cols=251 Identities=25% Similarity=0.415 Sum_probs=199.6
Q ss_pred ceecccCCceEEEEEecC--C--cEEEEEEeccCCchhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEEEeec
Q 000859 952 FIIGSGGSGTVYKAELAN--G--ATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIYEYM 1027 (1251)
Q Consensus 952 ~~lG~G~fg~V~~~~~~~--~--~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv~E~~ 1027 (1251)
+.||+|++|.||+|.+.+ + ..||||.+.........+.+.+|++++++++||||+++++++.. ...++|+||+
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~~~v~e~~ 77 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT---HPLMMVTELA 77 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC---CeEEEEEEec
Confidence 368999999999997643 3 36999999765554566789999999999999999999998865 5579999999
Q ss_pred CCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEccccccccccc
Q 000859 1028 ENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVE 1107 (1251)
Q Consensus 1028 ~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~ 1107 (1251)
++|+|.+++.... ...+++..++.++.|++.|++|||+. +++||||||+||+++.++.+||+|||+++.+..
T Consensus 78 ~~~~L~~~l~~~~-----~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~ 149 (257)
T cd05040 78 PLGSLLDRLRKDA-----LGHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQ 149 (257)
T ss_pred CCCcHHHHHHhcc-----cccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccccc
Confidence 9999999998642 14689999999999999999999999 999999999999999999999999999987643
Q ss_pred ccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhh-CCCCCCCccccchhHHHHHHHHHhccchhhhh
Q 000859 1108 DYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMVRWVEMHMEMSGSAREE 1186 (1251)
Q Consensus 1108 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1186 (1251)
.... ........++..|+|||.+.+..++.++|||||||++|||++ |+.||......+. ... ...
T Consensus 150 ~~~~-~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~--~~~---~~~-------- 215 (257)
T cd05040 150 NEDH-YVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQI--LKK---IDK-------- 215 (257)
T ss_pred cccc-eecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHH--HHH---HHh--------
Confidence 2211 111112456789999999998899999999999999999999 9999965433211 110 000
Q ss_pred hhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 000859 1187 LLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLL 1232 (1251)
Q Consensus 1187 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 1232 (1251)
.....+.+...+..+.+++.+|++.+|++|||++++++.|.
T Consensus 216 -----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 216 -----EGERLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred -----cCCcCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 00111112234567899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=332.60 Aligned_cols=244 Identities=26% Similarity=0.328 Sum_probs=188.2
Q ss_pred ceecccCCceEEEEEe-cCCcEEEEEEeccCC--chhhhHHHHHHHH-HHHhccCCCccceeceeeecCCCceeEEEeec
Q 000859 952 FIIGSGGSGTVYKAEL-ANGATVAVKKISCKD--DHLLNKSFTREVK-TLGRIRHRHLVKLMGHCCNKGAGSNLLIYEYM 1027 (1251)
Q Consensus 952 ~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~-~l~~l~h~niv~l~g~~~~~~~~~~~lv~E~~ 1027 (1251)
+.||+|+||+||+|+. .+|+.||||++.... .....+.+..|.. +++.++||||+++++++.. ....++||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~--~~~~~lv~e~~ 78 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQT--TEKLYFVLDFV 78 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEec--CCEEEEEEcCC
Confidence 3699999999999954 578999999986432 2223345556655 4677899999999988754 44579999999
Q ss_pred CCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEccccccccccc
Q 000859 1028 ENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVE 1107 (1251)
Q Consensus 1028 ~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~ 1107 (1251)
++|+|..++.. ...+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 79 ~~~~L~~~l~~-------~~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~ 148 (325)
T cd05604 79 NGGELFFHLQR-------ERSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIA 148 (325)
T ss_pred CCCCHHHHHHH-------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCC
Confidence 99999998875 35689999999999999999999999 999999999999999999999999999865321
Q ss_pred ccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccchhhhhh
Q 000859 1108 DYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSAREEL 1187 (1251)
Q Consensus 1108 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1187 (1251)
. ........||+.|+|||++.+..++.++||||+||++|||++|+.||......+. ....
T Consensus 149 ~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~-----~~~~----------- 208 (325)
T cd05604 149 Q----SDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEM-----YDNI----------- 208 (325)
T ss_pred C----CCCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHH-----HHHH-----------
Confidence 1 1122335789999999999999999999999999999999999999975422111 1110
Q ss_pred hcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 000859 1188 LDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLL 1231 (1251)
Q Consensus 1188 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L 1231 (1251)
.... .......+..+.+++.+|++.||.+||++++.++.+
T Consensus 209 ~~~~----~~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i 248 (325)
T cd05604 209 LHKP----LVLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEI 248 (325)
T ss_pred HcCC----ccCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHH
Confidence 0000 000111345678999999999999999987544433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=341.53 Aligned_cols=268 Identities=22% Similarity=0.283 Sum_probs=193.1
Q ss_pred hcCCCcCceecccCCceEEEEEe-cCCcEEEEEEeccCCchhhhHHHHHHHHHHHhccCCCccceeceeeecC------C
Q 000859 945 TNNLSDEFIIGSGGSGTVYKAEL-ANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKG------A 1017 (1251)
Q Consensus 945 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~------~ 1017 (1251)
..+|...+.||+|+||.||+|.. .+++.||||++.... ....+|+.+++.++|||||++++++.... .
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 45789999999999999999965 568999999985332 23457999999999999999998764321 1
Q ss_pred CceeEEEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCC-CeEE
Q 000859 1018 GSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNM-EAHL 1096 (1251)
Q Consensus 1018 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~-~~kl 1096 (1251)
...++||||++ +++.+++.... .....+++..++.++.||+.||+|||++ +|+||||||+||+++.++ .+||
T Consensus 140 ~~l~lvmE~~~-~~l~~~~~~~~---~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL 212 (440)
T PTZ00036 140 IFLNVVMEFIP-QTVHKYMKHYA---RNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKL 212 (440)
T ss_pred eEEEEEEecCC-ccHHHHHHHHh---hcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceee
Confidence 23568999997 47877775321 1245689999999999999999999999 999999999999998664 7999
Q ss_pred cccccccccccccCCCCcccceeecccceecccccccC-CCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHH
Q 000859 1097 GDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSL-KATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEM 1175 (1251)
Q Consensus 1097 ~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~ 1175 (1251)
+|||+|+.+.... ......||+.|+|||++.+. .++.++||||+||++|||++|++||.+....+. .......
T Consensus 213 ~DFGla~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~-~~~i~~~ 286 (440)
T PTZ00036 213 CDFGSAKNLLAGQ-----RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQ-LVRIIQV 286 (440)
T ss_pred eccccchhccCCC-----CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHH
Confidence 9999998653221 12235689999999988654 689999999999999999999999976543221 1111111
Q ss_pred HHhccchhhhhh---hcccCCCCCC-------chHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 000859 1176 HMEMSGSAREEL---LDDQMKPLLP-------GEECAAYQVLEIALQCTKTSPQERPSSRQVCDL 1230 (1251)
Q Consensus 1176 ~~~~~~~~~~~~---~~~~~~~~~~-------~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 1230 (1251)
............ ......+... .+...+.++.+++.+||+.||.+|||+.|+++.
T Consensus 287 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 287 LGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred hCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 100000000000 0000000000 011134578899999999999999999999854
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=330.35 Aligned_cols=238 Identities=26% Similarity=0.333 Sum_probs=184.5
Q ss_pred ceecccCCceEEEEEe-cCCcEEEEEEeccCC--chhhhHHHHHHHH-HHHhccCCCccceeceeeecCCCceeEEEeec
Q 000859 952 FIIGSGGSGTVYKAEL-ANGATVAVKKISCKD--DHLLNKSFTREVK-TLGRIRHRHLVKLMGHCCNKGAGSNLLIYEYM 1027 (1251)
Q Consensus 952 ~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~-~l~~l~h~niv~l~g~~~~~~~~~~~lv~E~~ 1027 (1251)
++||+|+||.||+|+. .+++.||+|++.... .......+.+|.. +++.++||||+++++++.. ....++||||+
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~--~~~~~lv~e~~ 78 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQT--AEKLYFVLDYV 78 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEc--CCEEEEEEcCC
Confidence 3699999999999965 468899999986432 1222344555554 5788899999999988754 44679999999
Q ss_pred CCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEccccccccccc
Q 000859 1028 ENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVE 1107 (1251)
Q Consensus 1028 ~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~ 1107 (1251)
++|+|..++.. ...+++..+..++.||++||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 79 ~~~~L~~~l~~-------~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 148 (321)
T cd05603 79 NGGELFFHLQR-------ERCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVE 148 (321)
T ss_pred CCCCHHHHHHH-------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCC
Confidence 99999998865 34678899999999999999999999 999999999999999999999999999865322
Q ss_pred ccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccchhhhhh
Q 000859 1108 DYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSAREEL 1187 (1251)
Q Consensus 1108 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1187 (1251)
. ........||+.|+|||.+.+..++.++||||+||++|||++|+.||...... ...+. .
T Consensus 149 ~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-----~~~~~-----------i 208 (321)
T cd05603 149 P----EETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVS-----QMYDN-----------I 208 (321)
T ss_pred C----CCccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHH-----HHHHH-----------H
Confidence 1 11223357899999999999889999999999999999999999999754211 11111 0
Q ss_pred hcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHH
Q 000859 1188 LDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSR 1225 (1251)
Q Consensus 1188 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 1225 (1251)
... ....+.....++.+++.+|++.||.+||++.
T Consensus 209 ~~~----~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 209 LHK----PLQLPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred hcC----CCCCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 110 0111112345688999999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=325.50 Aligned_cols=198 Identities=24% Similarity=0.333 Sum_probs=169.1
Q ss_pred cCCCcCceecccCCceEEEE-EecCCcEEEEEEeccCCchhhhHHHHHHHHHHHhcc-C-----CCccceeceeeecCCC
Q 000859 946 NNLSDEFIIGSGGSGTVYKA-ELANGATVAVKKISCKDDHLLNKSFTREVKTLGRIR-H-----RHLVKLMGHCCNKGAG 1018 (1251)
Q Consensus 946 ~~~~~~~~lG~G~fg~V~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~l~g~~~~~~~~ 1018 (1251)
.+|.+.+.||+|+||.|.+| +..+++.||||+++.+.. -..+...|+.+|..++ | -|+|+++++|... .
T Consensus 186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~--f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr--~ 261 (586)
T KOG0667|consen 186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKR--FLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFR--N 261 (586)
T ss_pred EEEEEEEEecccccceeEEEEecCCCcEEEEEeeccChH--HHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccc--c
Confidence 37899999999999999999 677899999999964433 3455667999999996 4 4899999998654 4
Q ss_pred ceeEEEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCC--CCeEE
Q 000859 1019 SNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSN--MEAHL 1096 (1251)
Q Consensus 1019 ~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~--~~~kl 1096 (1251)
..|||+|.+. -+|+++++.+. -..++...++.|+.||+.||.+||+. +|||+||||+|||+.+. ..|||
T Consensus 262 HlciVfELL~-~NLYellK~n~-----f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKV 332 (586)
T KOG0667|consen 262 HLCIVFELLS-TNLYELLKNNK-----FRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKV 332 (586)
T ss_pred ceeeeehhhh-hhHHHHHHhcC-----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeE
Confidence 5699999996 49999999865 46699999999999999999999999 99999999999999654 36999
Q ss_pred cccccccccccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhhCCCCCCCcc
Q 000859 1097 GDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATF 1163 (1251)
Q Consensus 1097 ~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~ 1163 (1251)
+|||.|....... . .++.+..|+|||++.+.+|+.+.||||||||++||++|.+-|.+..
T Consensus 333 IDFGSSc~~~q~v------y-tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~n 392 (586)
T KOG0667|consen 333 IDFGSSCFESQRV------Y-TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDN 392 (586)
T ss_pred EecccccccCCcc------e-eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCC
Confidence 9999997643221 1 3567899999999999999999999999999999999988887663
|
|
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=317.50 Aligned_cols=256 Identities=24% Similarity=0.348 Sum_probs=191.0
Q ss_pred eecccCCceEEEEEecC---CcEEEEEEeccCCchhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEEEeecCC
Q 000859 953 IIGSGGSGTVYKAELAN---GATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIYEYMEN 1029 (1251)
Q Consensus 953 ~lG~G~fg~V~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv~E~~~~ 1029 (1251)
.||+|+||.||+|.+.+ +..+|+|.+...........+.+|+.++++++||||++++|++.+. ...++||||+++
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~ 79 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEV--TPYLLVMEFCPL 79 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC--CCcEEEEECCCC
Confidence 58999999999996543 4579999987665555556788999999999999999999988554 446899999999
Q ss_pred CChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEccccccccccccc
Q 000859 1030 GSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDY 1109 (1251)
Q Consensus 1030 gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 1109 (1251)
|+|.+++..... ......++..+.+++.|++.|++|||+. +++||||||+||+++.++.+|++|||.++......
T Consensus 80 g~L~~~l~~~~~--~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~ 154 (269)
T cd05087 80 GDLKGYLRSCRK--AELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKED 154 (269)
T ss_pred CcHHHHHHHhhh--cccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcc
Confidence 999999975421 1123467788889999999999999999 99999999999999999999999999986543221
Q ss_pred CCCCcccceeecccceecccccccC-------CCCCccceeehhHHHHHHhh-CCCCCCCccccchhHHHHHHHHHhccc
Q 000859 1110 NSNTESNTWFAGSYGYIAPEYAYSL-------KATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMVRWVEMHMEMSG 1181 (1251)
Q Consensus 1110 ~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~sDiwSlGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 1181 (1251)
. ........++..|+|||++.+. .++.++|||||||++|||++ |+.||......+.....+ ..
T Consensus 155 ~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~----~~--- 225 (269)
T cd05087 155 Y--YVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTV----RE--- 225 (269)
T ss_pred e--eecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHh----hc---
Confidence 1 1112234578899999987532 35789999999999999997 999997543322111000 00
Q ss_pred hhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 000859 1182 SAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLL 1232 (1251)
Q Consensus 1182 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 1232 (1251)
.. .....+.. ....+..+.+++..|| .+|++|||++||.+.|+
T Consensus 226 -~~----~~~~~~~~--~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 226 -QQ----LKLPKPRL--KLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred -cc----CCCCCCcc--CCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 00 00001111 1123445788999999 68999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=328.99 Aligned_cols=242 Identities=21% Similarity=0.304 Sum_probs=189.2
Q ss_pred CCCcCceecccCCceEEEEEe-cCCcEEEEEEeccCC--chhhhHHHHHHHHHHHhcc-CCCccceeceeeecCCCceeE
Q 000859 947 NLSDEFIIGSGGSGTVYKAEL-ANGATVAVKKISCKD--DHLLNKSFTREVKTLGRIR-HRHLVKLMGHCCNKGAGSNLL 1022 (1251)
Q Consensus 947 ~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~~~l 1022 (1251)
+|+..+.||+|+||+||+|.. .+|+.||+|++.... .....+.+..|..+++.+. |++|+++++++.. ....++
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~--~~~~~l 78 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQT--VDRLYF 78 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEec--CCEEEE
Confidence 367778999999999999964 468999999986432 2223456778999988885 5777788876644 345799
Q ss_pred EEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcccccc
Q 000859 1023 IYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLA 1102 (1251)
Q Consensus 1023 v~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a 1102 (1251)
||||+++|+|.+++.. ...+++.++..++.|++.||+|||++ +|+||||||+||++++++.+||+|||++
T Consensus 79 v~Ey~~~g~L~~~i~~-------~~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~ 148 (323)
T cd05615 79 VMEYVNGGDLMYHIQQ-------VGKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMC 148 (323)
T ss_pred EEcCCCCCcHHHHHHH-------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccc
Confidence 9999999999999876 34689999999999999999999999 9999999999999999999999999998
Q ss_pred cccccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccch
Q 000859 1103 KALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGS 1182 (1251)
Q Consensus 1103 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 1182 (1251)
+..... ........||+.|+|||++.+..++.++||||+||++|||++|+.||.+...... ....
T Consensus 149 ~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~-----~~~i------ 213 (323)
T cd05615 149 KEHMVD----GVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDEL-----FQSI------ 213 (323)
T ss_pred cccCCC----CccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHH-----HHHH------
Confidence 753221 1112235689999999999998999999999999999999999999976532111 1110
Q ss_pred hhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCH
Q 000859 1183 AREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSS 1224 (1251)
Q Consensus 1183 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 1224 (1251)
.... ...+...+.++.+++.+|++.+|.+|++.
T Consensus 214 -----~~~~----~~~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 214 -----MEHN----VSYPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred -----HhCC----CCCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 0000 01112234567899999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=326.76 Aligned_cols=267 Identities=19% Similarity=0.274 Sum_probs=197.7
Q ss_pred cCCCcCceecccCCceEEEEEe-cCCcEEEEEEeccCCchhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEEE
Q 000859 946 NNLSDEFIIGSGGSGTVYKAEL-ANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIY 1024 (1251)
Q Consensus 946 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv~ 1024 (1251)
++|...+.||+|+||.||+|+. .+++.||+|++...........+.+|++++++++||||+++++++... ...++||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~ 83 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTD--KSLTLVF 83 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeC--CeEEEEE
Confidence 5688889999999999999954 467899999987554444455678899999999999999999988653 4579999
Q ss_pred eecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcccccccc
Q 000859 1025 EYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKA 1104 (1251)
Q Consensus 1025 E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~ 1104 (1251)
||+++ ++.+++... ...+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||.++.
T Consensus 84 e~~~~-~l~~~~~~~------~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 153 (309)
T cd07872 84 EYLDK-DLKQYMDDC------GNIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARA 153 (309)
T ss_pred eCCCC-CHHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcccccee
Confidence 99975 898888654 34578999999999999999999999 999999999999999999999999999875
Q ss_pred cccccCCCCcccceeecccceeccccccc-CCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccchh
Q 000859 1105 LVEDYNSNTESNTWFAGSYGYIAPEYAYS-LKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSA 1183 (1251)
Q Consensus 1105 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1183 (1251)
..... .......+|..|+|||.+.+ ..++.++||||+||++|||+||+.||.+....+. ...............
T Consensus 154 ~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~-~~~~~~~~~~~~~~~ 228 (309)
T cd07872 154 KSVPT----KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDE-LHLIFRLLGTPTEET 228 (309)
T ss_pred cCCCc----cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCCHHH
Confidence 42211 11122467899999998765 4688999999999999999999999976533221 111111000000000
Q ss_pred h------hhhhcccCCCC-----CCchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 000859 1184 R------EELLDDQMKPL-----LPGEECAAYQVLEIALQCTKTSPQERPSSRQVCD 1229 (1251)
Q Consensus 1184 ~------~~~~~~~~~~~-----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1229 (1251)
. ....+....+. .......+.++.+++.+|++.||.+|||++|+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 229 WPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred HhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 0 00000000000 0001123456789999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-34 Score=319.92 Aligned_cols=254 Identities=25% Similarity=0.385 Sum_probs=197.9
Q ss_pred hhcCCCcCceecccCCceEEEEEe-cCCcEEEEEEeccCCchhhhHHHHHHHHHHHhc-cCCCccceeceeeecCC----
Q 000859 944 ATNNLSDEFIIGSGGSGTVYKAEL-ANGATVAVKKISCKDDHLLNKSFTREVKTLGRI-RHRHLVKLMGHCCNKGA---- 1017 (1251)
Q Consensus 944 ~~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~---- 1017 (1251)
+...|+..+.||+|+||.||+|.. .+++.||+|++..... ....+.+|+.+++++ +||||+++++++.....
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~--~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD--EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCc--cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 345677888999999999999965 4688999999864432 345778999999998 79999999998875432
Q ss_pred CceeEEEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEc
Q 000859 1018 GSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLG 1097 (1251)
Q Consensus 1018 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~ 1097 (1251)
...++||||+++|+|.+++.... ...+++..+..++.|++.|++|||++ +|+|||+||+||++++++.+||+
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~-----~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~ 153 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTK-----GNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLV 153 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhcc-----CCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEc
Confidence 34689999999999999997632 34688999999999999999999999 99999999999999999999999
Q ss_pred ccccccccccccCCCCcccceeecccceecccccc-----cCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHH
Q 000859 1098 DFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAY-----SLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRW 1172 (1251)
Q Consensus 1098 DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~ 1172 (1251)
|||+++...... .......|+..|+|||++. +..++.++||||+||++|||++|+.||........ +
T Consensus 154 Dfg~~~~~~~~~----~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~----~ 225 (272)
T cd06637 154 DFGVSAQLDRTV----GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA----L 225 (272)
T ss_pred cCCCceeccccc----ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHH----H
Confidence 999987643211 1223356889999999876 34578899999999999999999999965422111 0
Q ss_pred HHHHHhccchhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 000859 1173 VEMHMEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCD 1229 (1251)
Q Consensus 1173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1229 (1251)
.... .... ... .....+.++.+++.+||+.||.+|||++++++
T Consensus 226 ~~~~------------~~~~-~~~-~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 226 FLIP------------RNPA-PRL-KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred HHHh------------cCCC-CCC-CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 0000 0000 000 11123456889999999999999999999975
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-34 Score=332.10 Aligned_cols=267 Identities=24% Similarity=0.309 Sum_probs=197.0
Q ss_pred hcCCCcCceecccCCceEEEEEe-cCCcEEEEEEeccCC-chhhhHHHHHHHHHHHhccCCCccceeceeeecCC----C
Q 000859 945 TNNLSDEFIIGSGGSGTVYKAEL-ANGATVAVKKISCKD-DHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGA----G 1018 (1251)
Q Consensus 945 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~----~ 1018 (1251)
..+|+..+.||+|+||.||+|.. .+|+.||||++.... .....+.+.+|+.+++.++||||+++++++..... .
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 99 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ 99 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence 46789999999999999999954 568999999986442 33345677899999999999999999998764432 2
Q ss_pred ceeEEEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcc
Q 000859 1019 SNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGD 1098 (1251)
Q Consensus 1019 ~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D 1098 (1251)
..++||||+++ ++.+++.. .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|
T Consensus 100 ~~~lv~e~~~~-~l~~~~~~---------~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~D 166 (359)
T cd07876 100 DVYLVMELMDA-NLCQVIHM---------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILD 166 (359)
T ss_pred eeEEEEeCCCc-CHHHHHhc---------cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEec
Confidence 46899999975 66666542 378889999999999999999999 999999999999999999999999
Q ss_pred cccccccccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHh
Q 000859 1099 FGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHME 1178 (1251)
Q Consensus 1099 fG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 1178 (1251)
||+++..... .......||+.|+|||.+.+..++.++||||+||++|||++|+.||.+....+. .....+....
T Consensus 167 fg~a~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~-~~~~~~~~~~ 240 (359)
T cd07876 167 FGLARTACTN-----FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQ-WNKVIEQLGT 240 (359)
T ss_pred CCCccccccC-----ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhcCC
Confidence 9999754221 112235789999999999999999999999999999999999999976532211 1000000000
Q ss_pred ccc-------hhhhhhhccc---------------CCC-CCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 000859 1179 MSG-------SAREELLDDQ---------------MKP-LLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDL 1230 (1251)
Q Consensus 1179 ~~~-------~~~~~~~~~~---------------~~~-~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 1230 (1251)
... .......... ..+ ........+.++.+++.+|++.||++|||++|+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 241 PSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred CcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 000 0000000000 000 000011134568899999999999999999999875
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=314.52 Aligned_cols=251 Identities=27% Similarity=0.407 Sum_probs=201.8
Q ss_pred CCCcCceecccCCceEEEEEe-cCCcEEEEEEeccCC-chhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEEE
Q 000859 947 NLSDEFIIGSGGSGTVYKAEL-ANGATVAVKKISCKD-DHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIY 1024 (1251)
Q Consensus 947 ~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv~ 1024 (1251)
+|+..+.||+|+||.||+|.. .+++.||+|.+.... .....+.+.+|++++++++||||+++++++... ...++||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~ 78 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDK--GKLNIVM 78 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccC--CEEEEEE
Confidence 367778999999999999965 468999999986432 344567889999999999999999999988654 4579999
Q ss_pred eecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcccccccc
Q 000859 1025 EYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKA 1104 (1251)
Q Consensus 1025 E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~ 1104 (1251)
||+++++|.++++... ...+++..+..++.|++.|++|||+. +++||||||+||+++.++.+|++|||.++.
T Consensus 79 e~~~~~~L~~~l~~~~-----~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~ 150 (256)
T cd08529 79 EYAENGDLHKLLKMQR-----GRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKL 150 (256)
T ss_pred EeCCCCcHHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEccccccee
Confidence 9999999999998642 35689999999999999999999999 999999999999999999999999999876
Q ss_pred cccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccchhh
Q 000859 1105 LVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSAR 1184 (1251)
Q Consensus 1105 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1184 (1251)
+..... ......|+..|+|||+..+..++.++|+|||||++|||++|+.||......+ .. .
T Consensus 151 ~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~---~---------- 211 (256)
T cd08529 151 LSDNTN----FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGA--LI---L---------- 211 (256)
T ss_pred ccCccc----hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH--HH---H----------
Confidence 543211 1123467889999999999899999999999999999999999997553211 00 0
Q ss_pred hhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 000859 1185 EELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDL 1230 (1251)
Q Consensus 1185 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 1230 (1251)
...... .+. .....+.++.+++.+||+.+|++||++.++++.
T Consensus 212 -~~~~~~-~~~--~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 212 -KIIRGV-FPP--VSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred -HHHcCC-CCC--CccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 000111 111 112345678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=317.27 Aligned_cols=262 Identities=22% Similarity=0.325 Sum_probs=206.4
Q ss_pred cCCCcCceecccCCceEEEEEe-cCCcEEEEEEeccCC--chhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeE
Q 000859 946 NNLSDEFIIGSGGSGTVYKAEL-ANGATVAVKKISCKD--DHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLL 1022 (1251)
Q Consensus 946 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~l 1022 (1251)
.+|+..+.||+|+||.||+|.. .+++.||||.+.... .....+.+.+|+++++.++||||+++++++... ...++
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--~~~~~ 79 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIED--NELNI 79 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeC--CeEEE
Confidence 3577778999999999999964 578999999886432 233456888999999999999999999988654 45789
Q ss_pred EEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcccccc
Q 000859 1023 IYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLA 1102 (1251)
Q Consensus 1023 v~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a 1102 (1251)
+|||+++++|.++++... .....+++..++.++.|+++|++|||++ +++|+||||+||+++.++.++++|||.+
T Consensus 80 v~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~ 153 (267)
T cd08229 80 VLELADAGDLSRMIKHFK---KQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLG 153 (267)
T ss_pred EEEecCCCCHHHHHHHhh---ccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhh
Confidence 999999999999987421 1235689999999999999999999999 9999999999999999999999999998
Q ss_pred cccccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccch
Q 000859 1103 KALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGS 1182 (1251)
Q Consensus 1103 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 1182 (1251)
....... .......|+..|+|||.+.+..++.++|+||||+++|||++|+.||.+...... ......
T Consensus 154 ~~~~~~~----~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~---~~~~~~------ 220 (267)
T cd08229 154 RFFSSKT----TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY---SLCKKI------ 220 (267)
T ss_pred hccccCC----cccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHH---HHhhhh------
Confidence 7653221 111234678899999999888899999999999999999999999865422111 111100
Q ss_pred hhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhc
Q 000859 1183 AREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNVF 1235 (1251)
Q Consensus 1183 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~ 1235 (1251)
.. ...+.. .....+.++.+++.+||+.||++|||+.+|+++++++.
T Consensus 221 -----~~-~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 221 -----EQ-CDYPPL-PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred -----hc-CCCCCC-CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 00 001111 12235667999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=316.56 Aligned_cols=256 Identities=28% Similarity=0.459 Sum_probs=204.4
Q ss_pred hcCCCcCceecccCCceEEEEEecCCcEEEEEEeccCCchhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEEE
Q 000859 945 TNNLSDEFIIGSGGSGTVYKAELANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIY 1024 (1251)
Q Consensus 945 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv~ 1024 (1251)
.++|.+.+.||+|+||.||+|...+++.||||.+..... ..+++.+|+.++++++|+||+++++++... ...++||
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~~v~ 80 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM--SPEAFLQEAQIMKKLRHDKLVQLYAVCSEE--EPIYIVT 80 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc--CHHHHHHHHHHHhhCCCCCEeeeeeeeecC--CceEEEE
Confidence 457888899999999999999887788999999864332 346789999999999999999999987543 4469999
Q ss_pred eecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcccccccc
Q 000859 1025 EYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKA 1104 (1251)
Q Consensus 1025 E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~ 1104 (1251)
||+++++|.+++.... ...+++.++..++.|++.|++|||+. +++|+||||+||++++++.+|++|||.++.
T Consensus 81 e~~~~~~L~~~i~~~~-----~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~ 152 (261)
T cd05034 81 EYMSKGSLLDFLKSGE-----GKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARL 152 (261)
T ss_pred eccCCCCHHHHHhccc-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECcccccee
Confidence 9999999999997642 35689999999999999999999999 999999999999999999999999999876
Q ss_pred cccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhh-CCCCCCCccccchhHHHHHHHHHhccchh
Q 000859 1105 LVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMVRWVEMHMEMSGSA 1183 (1251)
Q Consensus 1105 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1183 (1251)
+...... ......++..|+|||.+.+..++.++||||+||++||+++ |+.||.+..... . ....
T Consensus 153 ~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~--~---~~~~------- 217 (261)
T cd05034 153 IEDDEYT---AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNRE--V---LEQV------- 217 (261)
T ss_pred ccchhhh---hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH--H---HHHH-------
Confidence 5432111 1112234578999999998889999999999999999999 999996542211 0 1100
Q ss_pred hhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 000859 1184 REELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNV 1234 (1251)
Q Consensus 1184 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 1234 (1251)
.. .. ..+.+...+.++.+++.+|++.+|++||+++++.+.|+++
T Consensus 218 ----~~-~~--~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~~ 261 (261)
T cd05034 218 ----ER-GY--RMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLEDY 261 (261)
T ss_pred ----Hc-CC--CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhcC
Confidence 00 00 0111122356789999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=316.03 Aligned_cols=254 Identities=26% Similarity=0.352 Sum_probs=200.1
Q ss_pred cCCCcCceecccCCceEEEEEe-cCCcEEEEEEeccCCc----hhhhHHHHHHHHHHHhccCCCccceeceeeecCCCce
Q 000859 946 NNLSDEFIIGSGGSGTVYKAEL-ANGATVAVKKISCKDD----HLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSN 1020 (1251)
Q Consensus 946 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~ 1020 (1251)
+.|...+.||+|++|.||+|.. .++++||+|.+..... ....+.+.+|++++++++||||+++++++... ...
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~ 79 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDD--ETL 79 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccC--CeE
Confidence 4688889999999999999954 5689999999864432 12335788999999999999999999988654 467
Q ss_pred eEEEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcccc
Q 000859 1021 LLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFG 1100 (1251)
Q Consensus 1021 ~lv~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG 1100 (1251)
++|+||+++++|.+++... ..+++..+.+++.|++.|++|||+. +|+||||+|+||++++++.++|+|||
T Consensus 80 ~~v~e~~~~~~l~~~~~~~-------~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg 149 (263)
T cd06625 80 SIFMEYMPGGSVKDQLKAY-------GALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFG 149 (263)
T ss_pred EEEEEECCCCcHHHHHHHh-------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecc
Confidence 9999999999999998763 4578899999999999999999999 99999999999999999999999999
Q ss_pred cccccccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhcc
Q 000859 1101 LAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMS 1180 (1251)
Q Consensus 1101 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 1180 (1251)
.++........ ........|+..|+|||.+.+..++.++||||+|+++||+++|+.||......+... .
T Consensus 150 ~~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~--~-------- 218 (263)
T cd06625 150 ASKRLQTICSS-GTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIF--K-------- 218 (263)
T ss_pred cceeccccccc-cccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHH--H--------
Confidence 98765332111 111122457889999999999889999999999999999999999997542211100 0
Q ss_pred chhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 000859 1181 GSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDL 1230 (1251)
Q Consensus 1181 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 1230 (1251)
.......+. .+...+..+.+++.+||+.+|++|||++|+++.
T Consensus 219 ------~~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 219 ------IATQPTNPQ--LPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred ------HhccCCCCC--CCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 000000111 122345678899999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=324.52 Aligned_cols=267 Identities=23% Similarity=0.382 Sum_probs=205.6
Q ss_pred hcCCCcCceecccCCceEEEEEec--------CCcEEEEEEeccCCchhhhHHHHHHHHHHHhc-cCCCccceeceeeec
Q 000859 945 TNNLSDEFIIGSGGSGTVYKAELA--------NGATVAVKKISCKDDHLLNKSFTREVKTLGRI-RHRHLVKLMGHCCNK 1015 (1251)
Q Consensus 945 ~~~~~~~~~lG~G~fg~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~ 1015 (1251)
..+|...+.||+|+||.||+|+.. ....||+|.+.........+.+.+|+++++++ +||||+++++++...
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 345788899999999999999642 24579999987555545567788999999999 699999999988543
Q ss_pred CCCceeEEEeecCCCChHHhhhcCCCC---------cccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCe
Q 000859 1016 GAGSNLLIYEYMENGSVWDWLHKQPVN---------IKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNI 1086 (1251)
Q Consensus 1016 ~~~~~~lv~E~~~~gsL~~~l~~~~~~---------~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Ni 1086 (1251)
...++||||+++|+|.+++...... ......+++.++.+++.|++.|++|||++ +|+||||||+||
T Consensus 91 --~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Ni 165 (314)
T cd05099 91 --GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNV 165 (314)
T ss_pred --CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeE
Confidence 4569999999999999999764311 11134689999999999999999999999 999999999999
Q ss_pred eecCCCCeEEcccccccccccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhh-CCCCCCCcccc
Q 000859 1087 LLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGV 1165 (1251)
Q Consensus 1087 ll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~t-g~~p~~~~~~~ 1165 (1251)
+++.++.+||+|||.++.......... .....++..|+|||.+.+..++.++|||||||++|||++ |..||......
T Consensus 166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~ 243 (314)
T cd05099 166 LVTEDNVMKIADFGLARGVHDIDYYKK--TSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE 243 (314)
T ss_pred EEcCCCcEEEccccccccccccccccc--cccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHH
Confidence 999999999999999976532211111 111234567999999988899999999999999999999 89998654221
Q ss_pred chhHHHHHHHHHhccchhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhcCC
Q 000859 1166 EMDMVRWVEMHMEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNVFNN 1237 (1251)
Q Consensus 1166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~ 1237 (1251)
+. ..... .... ...+..++.++.+++.+||+.||++|||+.|+++.|.++...
T Consensus 244 ~~-----~~~~~------------~~~~--~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~ 296 (314)
T cd05099 244 EL-----FKLLR------------EGHR--MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAA 296 (314)
T ss_pred HH-----HHHHH------------cCCC--CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHH
Confidence 11 11000 0000 111122445788999999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=314.19 Aligned_cols=262 Identities=23% Similarity=0.353 Sum_probs=207.2
Q ss_pred cCCCcCceecccCCceEEEEEec-CCcEEEEEEeccCC--chhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeE
Q 000859 946 NNLSDEFIIGSGGSGTVYKAELA-NGATVAVKKISCKD--DHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLL 1022 (1251)
Q Consensus 946 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~l 1022 (1251)
++|+..+.||+|+||.||+|... +|+.||+|.++... .....+.+.+|++++++++|++++++++++... ...++
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~--~~~~l 79 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIEN--NELNI 79 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecC--CeEEE
Confidence 46888899999999999999665 79999999886422 333457888999999999999999999988654 45699
Q ss_pred EEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcccccc
Q 000859 1023 IYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLA 1102 (1251)
Q Consensus 1023 v~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a 1102 (1251)
||||+++|+|.+++.... .....+++.++..++.|+++|++|||+. +|+||||+|+||+++.++.++++|||.+
T Consensus 80 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~ 153 (267)
T cd08224 80 VLELADAGDLSRMIKHFK---KQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLG 153 (267)
T ss_pred EEecCCCCCHHHHHHHhc---ccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEecccee
Confidence 999999999999986532 1235689999999999999999999999 9999999999999999999999999998
Q ss_pred cccccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccch
Q 000859 1103 KALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGS 1182 (1251)
Q Consensus 1103 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 1182 (1251)
...... ........++..|+|||.+.+..++.++|||||||++|||++|+.||..... ...+..+..
T Consensus 154 ~~~~~~----~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~------ 220 (267)
T cd08224 154 RFFSSK----TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM---NLYSLCKKI------ 220 (267)
T ss_pred eeccCC----CcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc---cHHHHHhhh------
Confidence 754321 1112234678899999999988899999999999999999999999864421 111111110
Q ss_pred hhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhc
Q 000859 1183 AREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNVF 1235 (1251)
Q Consensus 1183 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~ 1235 (1251)
... ..+..+ ....+..+.+++.+||+.+|++|||+.+|++.++++.
T Consensus 221 -----~~~-~~~~~~-~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 221 -----EKC-DYPPLP-ADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred -----hcC-CCCCCC-hhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 000 011111 1235567899999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-34 Score=331.92 Aligned_cols=261 Identities=19% Similarity=0.239 Sum_probs=198.3
Q ss_pred HHHHHhhcCCCcCceecccCCceEEEEEe-cCCcEEEEEEeccCC--chhhhHHHHHHHHHHHhccCCCccceeceeeec
Q 000859 939 EDIMGATNNLSDEFIIGSGGSGTVYKAEL-ANGATVAVKKISCKD--DHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNK 1015 (1251)
Q Consensus 939 ~~~~~~~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~ 1015 (1251)
.+.....++|+..+.||+|+||.||+|+. .+++.||+|++.... .....+.+.+|+.+++.++||||+++++++..
T Consensus 36 ~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~- 114 (371)
T cd05622 36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD- 114 (371)
T ss_pred hhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc-
Confidence 33444567899999999999999999965 468899999986422 22334567889999999999999999988754
Q ss_pred CCCceeEEEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeE
Q 000859 1016 GAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAH 1095 (1251)
Q Consensus 1016 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~k 1095 (1251)
+...++||||+++|+|.++++. ..++...+..++.||+.||+|||++ +|+||||||+||+++.++.+|
T Consensus 115 -~~~~~lv~Ey~~gg~L~~~~~~--------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ik 182 (371)
T cd05622 115 -DRYLYMVMEYMPGGDLVNLMSN--------YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLK 182 (371)
T ss_pred -CCEEEEEEcCCCCCcHHHHHHh--------cCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEE
Confidence 4567999999999999999875 2478888999999999999999999 999999999999999999999
Q ss_pred EcccccccccccccCCCCcccceeecccceecccccccC----CCCCccceeehhHHHHHHhhCCCCCCCccccchhHHH
Q 000859 1096 LGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSL----KATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVR 1171 (1251)
Q Consensus 1096 l~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~ 1171 (1251)
|+|||+++...... ........||+.|+|||++.+. .++.++||||+||++|||++|+.||.+.....
T Consensus 183 L~DfG~a~~~~~~~---~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~----- 254 (371)
T cd05622 183 LADFGTCMKMNKEG---MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG----- 254 (371)
T ss_pred EEeCCceeEcCcCC---cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHH-----
Confidence 99999997653211 1112235799999999998754 37899999999999999999999997542211
Q ss_pred HHHHHHhccchhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCC--CCCHHHHHHHH
Q 000859 1172 WVEMHMEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQE--RPSSRQVCDLL 1231 (1251)
Q Consensus 1172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~eil~~L 1231 (1251)
... .+........++.....+..+.+++.+|+..++.+ ||+++|+++..
T Consensus 255 ~~~-----------~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 255 TYS-----------KIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred HHH-----------HHHcCCCcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 000 11110001112222234556789999999844433 78899888754
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=314.62 Aligned_cols=255 Identities=26% Similarity=0.441 Sum_probs=203.7
Q ss_pred hhcCCCcCceecccCCceEEEEEecCCcEEEEEEeccCCchhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEE
Q 000859 944 ATNNLSDEFIIGSGGSGTVYKAELANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLI 1023 (1251)
Q Consensus 944 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv 1023 (1251)
...+|...+.||+|+||.||+|...++..||+|.+... ....+.+.+|++++++++|+||+++++++.. ...+++
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---~~~~~v 78 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG--SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK---EPIYII 78 (260)
T ss_pred cccceeEEeEecCccceEEEEEEecCCccEEEEecCCC--hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC---CCeEEE
Confidence 34578889999999999999998777888999988643 2245678899999999999999999988754 446899
Q ss_pred EeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEccccccc
Q 000859 1024 YEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAK 1103 (1251)
Q Consensus 1024 ~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~ 1103 (1251)
|||+++|+|.+++.+.. ...+++.+++.++.|++.|++|||+. +++||||||+||+++.++.+||+|||.++
T Consensus 79 ~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~ 150 (260)
T cd05073 79 TEFMAKGSLLDFLKSDE-----GSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLAR 150 (260)
T ss_pred EEeCCCCcHHHHHHhCC-----ccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCccee
Confidence 99999999999997642 35678899999999999999999998 99999999999999999999999999987
Q ss_pred ccccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhh-CCCCCCCccccchhHHHHHHHHHhccch
Q 000859 1104 ALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMVRWVEMHMEMSGS 1182 (1251)
Q Consensus 1104 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 1182 (1251)
....... .......++..|+|||++....++.++|+|||||++||++| |+.||....... ...+..
T Consensus 151 ~~~~~~~---~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~--~~~~~~-------- 217 (260)
T cd05073 151 VIEDNEY---TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE--VIRALE-------- 217 (260)
T ss_pred eccCCCc---ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHH--HHHHHh--------
Confidence 6532211 11122345678999999988889999999999999999999 999997542211 111110
Q ss_pred hhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 000859 1183 AREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLN 1233 (1251)
Q Consensus 1183 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 1233 (1251)
... ..+.....+.++.+++.+|++.+|++||++.++.+.|+.
T Consensus 218 -------~~~--~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 218 -------RGY--RMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred -------CCC--CCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 000 011112344578899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=314.51 Aligned_cols=254 Identities=26% Similarity=0.371 Sum_probs=197.7
Q ss_pred cCCCcCceecccCCceEEEEEe-cCCcEEEEEEeccCC----chhhhHHHHHHHHHHHhccCCCccceeceeeecCCCce
Q 000859 946 NNLSDEFIIGSGGSGTVYKAEL-ANGATVAVKKISCKD----DHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSN 1020 (1251)
Q Consensus 946 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~ 1020 (1251)
.+|...+.||+|+||.||+|.. .+++.||+|++.... .....+.+.+|+.++++++||||+++++++........
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 4688889999999999999954 568999999986432 12234578899999999999999999998876555667
Q ss_pred eEEEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcccc
Q 000859 1021 LLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFG 1100 (1251)
Q Consensus 1021 ~lv~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG 1100 (1251)
++++||+++++|.+++... ..+++.....++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 82 ~l~~e~~~~~~L~~~l~~~-------~~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg 151 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAY-------GALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFG 151 (266)
T ss_pred EEEEeCCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCC
Confidence 8999999999999999763 4578999999999999999999998 99999999999999999999999999
Q ss_pred cccccccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhcc
Q 000859 1101 LAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMS 1180 (1251)
Q Consensus 1101 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 1180 (1251)
+++.......... ......++..|+|||.+.+..++.++||||+||++||+++|+.||......+. ..
T Consensus 152 ~~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~-----~~------ 219 (266)
T cd06651 152 ASKRLQTICMSGT-GIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAA-----IF------ 219 (266)
T ss_pred CccccccccccCC-ccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHH-----HH------
Confidence 9876532211111 11224578999999999988899999999999999999999999975422111 00
Q ss_pred chhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 000859 1181 GSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCD 1229 (1251)
Q Consensus 1181 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1229 (1251)
........+.. +......+.+++ +||..+|++||+++||++
T Consensus 220 -----~~~~~~~~~~~--~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 220 -----KIATQPTNPQL--PSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred -----HHhcCCCCCCC--chhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 00000011111 222345567777 688899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=334.64 Aligned_cols=254 Identities=22% Similarity=0.306 Sum_probs=193.4
Q ss_pred CCCcCceecccCCceEEEEEe-cCCcEEEEEEeccCC--chhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEE
Q 000859 947 NLSDEFIIGSGGSGTVYKAEL-ANGATVAVKKISCKD--DHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLI 1023 (1251)
Q Consensus 947 ~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv 1023 (1251)
+|+..+.||+|+||.||+|.. .+++.||||++.... .....+.+.+|+.++..++||+|+++++.+.. ....++|
T Consensus 2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~--~~~~~lv 79 (360)
T cd05627 2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQD--KRNLYLI 79 (360)
T ss_pred CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEc--CCEEEEE
Confidence 578889999999999999955 468999999996432 22334677889999999999999999988754 4567999
Q ss_pred EeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEccccccc
Q 000859 1024 YEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAK 1103 (1251)
Q Consensus 1024 ~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~ 1103 (1251)
|||+++|+|.+++.+ .+.+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 80 ~E~~~gg~L~~~l~~-------~~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~ 149 (360)
T cd05627 80 MEFLPGGDMMTLLMK-------KDTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCT 149 (360)
T ss_pred EeCCCCccHHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCc
Confidence 999999999999976 34689999999999999999999999 99999999999999999999999999987
Q ss_pred ccccccCCC-------------------------------CcccceeecccceecccccccCCCCCccceeehhHHHHHH
Q 000859 1104 ALVEDYNSN-------------------------------TESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMEL 1152 (1251)
Q Consensus 1104 ~~~~~~~~~-------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el 1152 (1251)
.+....... ........||+.|+|||++.+..++.++||||+||++|||
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel 229 (360)
T cd05627 150 GLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEM 229 (360)
T ss_pred ccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeec
Confidence 543211000 0001124799999999999999999999999999999999
Q ss_pred hhCCCCCCCccccchhHHHHHHHHHhccchhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCC---HHHHHH
Q 000859 1153 VSGKMPTDATFGVEMDMVRWVEMHMEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPS---SRQVCD 1229 (1251)
Q Consensus 1153 ~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~eil~ 1229 (1251)
++|+.||.+....+.. ... ........++.....+.++.+++.+++ .||.+|++ ++|+++
T Consensus 230 ~tG~~Pf~~~~~~~~~-----~~i-----------~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~ 292 (360)
T cd05627 230 LIGYPPFCSETPQETY-----RKV-----------MNWKETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKS 292 (360)
T ss_pred ccCCCCCCCCCHHHHH-----HHH-----------HcCCCceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhc
Confidence 9999999765332110 000 000000011111123456778888876 49999986 555554
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=315.53 Aligned_cols=255 Identities=28% Similarity=0.423 Sum_probs=196.2
Q ss_pred eecccCCceEEEEEec-CCc--EEEEEEeccCCchhhhHHHHHHHHHHHhc-cCCCccceeceeeecCCCceeEEEeecC
Q 000859 953 IIGSGGSGTVYKAELA-NGA--TVAVKKISCKDDHLLNKSFTREVKTLGRI-RHRHLVKLMGHCCNKGAGSNLLIYEYME 1028 (1251)
Q Consensus 953 ~lG~G~fg~V~~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~~~lv~E~~~ 1028 (1251)
.||+|+||.||+|... ++. .+|+|.+.........+.+.+|+++++++ +||||+++++++... ...++||||++
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~--~~~~lv~e~~~ 79 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR--GYLYLAIEYAP 79 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecC--CCceEEEEeCC
Confidence 6899999999999764 343 57888886544444567888999999999 899999999988654 34699999999
Q ss_pred CCChHHhhhcCCCC---------cccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEccc
Q 000859 1029 NGSVWDWLHKQPVN---------IKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDF 1099 (1251)
Q Consensus 1029 ~gsL~~~l~~~~~~---------~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 1099 (1251)
+|+|.++++..... ......+++.++..++.|++.|++|||+. +++||||||+||++++++.+|++||
T Consensus 80 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~df 156 (270)
T cd05047 80 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADF 156 (270)
T ss_pred CCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCC
Confidence 99999999764311 01123588999999999999999999998 9999999999999999999999999
Q ss_pred ccccccccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhh-CCCCCCCccccchhHHHHHHHHHh
Q 000859 1100 GLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMVRWVEMHME 1178 (1251)
Q Consensus 1100 G~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~ 1178 (1251)
|++...... ........+..|+|||++....++.++|||||||++|||++ |..||......+ .....
T Consensus 157 gl~~~~~~~-----~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~-----~~~~~-- 224 (270)
T cd05047 157 GLSRGQEVY-----VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-----LYEKL-- 224 (270)
T ss_pred CCccccchh-----hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHH-----HHHHH--
Confidence 998532111 01111233567999999988889999999999999999997 999996542211 11100
Q ss_pred ccchhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhcC
Q 000859 1179 MSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNVFN 1236 (1251)
Q Consensus 1179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~ 1236 (1251)
...... +.+...+.++.+++.+||+.+|.+|||++++++.|.++++
T Consensus 225 ----------~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~~ 270 (270)
T cd05047 225 ----------PQGYRL--EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 270 (270)
T ss_pred ----------hCCCCC--CCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhhC
Confidence 000001 1112234568899999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=317.19 Aligned_cols=259 Identities=25% Similarity=0.420 Sum_probs=205.7
Q ss_pred cCCCcCceecccCCceEEEEEec-CCc----EEEEEEeccCCchhhhHHHHHHHHHHHhccCCCccceeceeeecCCCce
Q 000859 946 NNLSDEFIIGSGGSGTVYKAELA-NGA----TVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSN 1020 (1251)
Q Consensus 946 ~~~~~~~~lG~G~fg~V~~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~ 1020 (1251)
.+|+..+.||+|+||.||+|.+. +|+ .||+|...........+.+.+|+.++++++||||+++++++.. ...
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~ 83 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS---SQV 83 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec---Cce
Confidence 45788889999999999999654 333 6899988766555566788999999999999999999998864 456
Q ss_pred eEEEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcccc
Q 000859 1021 LLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFG 1100 (1251)
Q Consensus 1021 ~lv~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG 1100 (1251)
++||||+++|+|.+++... ...+++..+..++.|++.|++|||+. +|+||||||+||++++++.+||+|||
T Consensus 84 ~~v~e~~~~g~L~~~l~~~------~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg 154 (279)
T cd05057 84 QLITQLMPLGCLLDYVRNH------KDNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFG 154 (279)
T ss_pred EEEEecCCCCcHHHHHHhc------cCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCc
Confidence 8999999999999999764 24589999999999999999999998 99999999999999999999999999
Q ss_pred cccccccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhh-CCCCCCCccccchhHHHHHHHHHhc
Q 000859 1101 LAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMVRWVEMHMEM 1179 (1251)
Q Consensus 1101 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~ 1179 (1251)
.++......... ......++..|+|||.+....++.++|+|||||++||+++ |+.||.+....+. ...+ .
T Consensus 155 ~~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~--~~~~---~-- 225 (279)
T cd05057 155 LAKLLDVDEKEY--HAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEI--PDLL---E-- 225 (279)
T ss_pred ccccccCcccce--ecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHH--HHHH---h--
Confidence 998654221111 1111234678999999988889999999999999999999 9999976532111 1110 0
Q ss_pred cchhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhcCC
Q 000859 1180 SGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNVFNN 1237 (1251)
Q Consensus 1180 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~ 1237 (1251)
.. ...+.+..++.++.+++.+||..||.+||++.++++.+.++...
T Consensus 226 ---------~~---~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05057 226 ---------KG---ERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARD 271 (279)
T ss_pred ---------CC---CCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhC
Confidence 00 01111222445688999999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=318.64 Aligned_cols=274 Identities=27% Similarity=0.411 Sum_probs=207.8
Q ss_pred CCCcCceecccCCceEEEEEec-----CCcEEEEEEeccCCchhhhHHHHHHHHHHHhccCCCccceeceeeecCCCcee
Q 000859 947 NLSDEFIIGSGGSGTVYKAELA-----NGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNL 1021 (1251)
Q Consensus 947 ~~~~~~~lG~G~fg~V~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~ 1021 (1251)
+|...+.||+|+||.||+|.+. ++..||||++.........+.+.+|+++++.++||||+++++++...+....+
T Consensus 5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05038 5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLR 84 (284)
T ss_pred hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceE
Confidence 4667789999999999999753 36889999997555434567899999999999999999999988765566679
Q ss_pred EEEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEccccc
Q 000859 1022 LIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGL 1101 (1251)
Q Consensus 1022 lv~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~ 1101 (1251)
+||||+++++|.+++.... ..+++..+..++.|++.|++|||+. +++||||||+||+++.++.++++|||.
T Consensus 85 lv~e~~~~~~l~~~l~~~~------~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~ 155 (284)
T cd05038 85 LIMEYLPSGSLRDYLQRHR------DQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGL 155 (284)
T ss_pred EEEecCCCCCHHHHHHhCc------cccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEccccc
Confidence 9999999999999997642 3689999999999999999999999 999999999999999999999999999
Q ss_pred ccccccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccc
Q 000859 1102 AKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSG 1181 (1251)
Q Consensus 1102 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 1181 (1251)
+......... ........++..|+|||......++.++||||||+++|||++|+.|+............-. ......
T Consensus 156 ~~~~~~~~~~-~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~--~~~~~~ 232 (284)
T cd05038 156 AKVLPEDKDY-YYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIA--QGQMIV 232 (284)
T ss_pred ccccccCCcc-eeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccc--cccccH
Confidence 9876422111 1111122445679999999888999999999999999999999999864322111000000 000000
Q ss_pred hhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 000859 1182 SAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNV 1234 (1251)
Q Consensus 1182 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 1234 (1251)
.......... ...+.+..++.++.+++.+||+.+|++|||++||+++|+.+
T Consensus 233 ~~~~~~~~~~--~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 233 TRLLELLKEG--ERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHHHHHHcC--CcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 0001111111 11122233456799999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=326.66 Aligned_cols=269 Identities=23% Similarity=0.361 Sum_probs=208.0
Q ss_pred cCCCcCceecccCCceEEEEEec--------CCcEEEEEEeccCCchhhhHHHHHHHHHHHhc-cCCCccceeceeeecC
Q 000859 946 NNLSDEFIIGSGGSGTVYKAELA--------NGATVAVKKISCKDDHLLNKSFTREVKTLGRI-RHRHLVKLMGHCCNKG 1016 (1251)
Q Consensus 946 ~~~~~~~~lG~G~fg~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~ 1016 (1251)
.+|.+.+.||+|+||.||+|+.. .+..||+|.+.........+.+.+|+++++++ +||||++++++|...
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~- 90 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD- 90 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC-
Confidence 45788899999999999999642 12379999987655555567899999999999 899999999988654
Q ss_pred CCceeEEEeecCCCChHHhhhcCCCC---------cccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCee
Q 000859 1017 AGSNLLIYEYMENGSVWDWLHKQPVN---------IKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNIL 1087 (1251)
Q Consensus 1017 ~~~~~lv~E~~~~gsL~~~l~~~~~~---------~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nil 1087 (1251)
...++++||+++|+|.+++...... ......+++.++.+++.|++.|++|||+. +|+||||||+||+
T Consensus 91 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nil 166 (334)
T cd05100 91 -GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNVL 166 (334)
T ss_pred -CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEE
Confidence 4579999999999999999764211 01234688999999999999999999999 9999999999999
Q ss_pred ecCCCCeEEcccccccccccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhh-CCCCCCCccccc
Q 000859 1088 LDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVE 1166 (1251)
Q Consensus 1088 l~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~t-g~~p~~~~~~~~ 1166 (1251)
++.++.+||+|||+++........ .......++..|+|||++.+..++.++|||||||++|||++ |..||.+....+
T Consensus 167 l~~~~~~kL~Dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~ 244 (334)
T cd05100 167 VTEDNVMKIADFGLARDVHNIDYY--KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE 244 (334)
T ss_pred EcCCCcEEECCcccceeccccccc--ccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 999999999999999765322111 11112234578999999999999999999999999999998 889986542211
Q ss_pred hhHHHHHHHHHhccchhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhcCCCcc
Q 000859 1167 MDMVRWVEMHMEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNVFNNRIV 1240 (1251)
Q Consensus 1167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~~ 1240 (1251)
...... ..... +.+...+.++.+++.+||+.+|++|||+.|+++.|+++......
T Consensus 245 -----~~~~~~------------~~~~~--~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~~~ 299 (334)
T cd05100 245 -----LFKLLK------------EGHRM--DKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTST 299 (334)
T ss_pred -----HHHHHH------------cCCCC--CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhcCC
Confidence 111100 00011 11122345788999999999999999999999999999865443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=319.30 Aligned_cols=261 Identities=25% Similarity=0.404 Sum_probs=201.6
Q ss_pred cCCCcCceecccCCceEEEEEec------CCcEEEEEEeccCCchhhhHHHHHHHHHHHhccCCCccceeceeeecCCCc
Q 000859 946 NNLSDEFIIGSGGSGTVYKAELA------NGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGS 1019 (1251)
Q Consensus 946 ~~~~~~~~lG~G~fg~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 1019 (1251)
.+|...++||+|+||.||+|... ++..||+|.+... .....+.+.+|+++++.++|+||+++++++... ..
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~ 81 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA-SESARQDFQREAELLTVLQHQHIVRFYGVCTEG--RP 81 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC-CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecC--Cc
Confidence 35777889999999999999532 3568999988643 344567899999999999999999999987654 44
Q ss_pred eeEEEeecCCCChHHhhhcCCCC--------cccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCC
Q 000859 1020 NLLIYEYMENGSVWDWLHKQPVN--------IKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSN 1091 (1251)
Q Consensus 1020 ~~lv~E~~~~gsL~~~l~~~~~~--------~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~ 1091 (1251)
.+++|||+++|+|.+++...... ......+++..+..++.|++.|++|||+. +++||||||+||+++++
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~ 158 (280)
T cd05092 82 LLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQG 158 (280)
T ss_pred eEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCC
Confidence 69999999999999999764311 11124589999999999999999999999 99999999999999999
Q ss_pred CCeEEcccccccccccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhh-CCCCCCCccccchhHH
Q 000859 1092 MEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMV 1170 (1251)
Q Consensus 1092 ~~~kl~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~t-g~~p~~~~~~~~~~~~ 1170 (1251)
+.+||+|||+++........ .......+++.|+|||.+.+..++.++|||||||++|||++ |+.||......+.
T Consensus 159 ~~~kL~dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~--- 233 (280)
T cd05092 159 LVVKIGDFGMSRDIYSTDYY--RVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEA--- 233 (280)
T ss_pred CCEEECCCCceeEcCCCcee--ecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHH---
Confidence 99999999998754322111 11122345788999999999999999999999999999998 9999865432111
Q ss_pred HHHHHHHhccchhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 000859 1171 RWVEMHMEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLN 1233 (1251)
Q Consensus 1171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 1233 (1251)
.... .. ... ...+..++..+.+++.+||+.||.+||+++||.+.|+.
T Consensus 234 --~~~~-----------~~-~~~--~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 234 --IECI-----------TQ-GRE--LERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred --HHHH-----------Hc-Ccc--CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 0000 00 000 01112345678899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-34 Score=318.05 Aligned_cols=254 Identities=25% Similarity=0.339 Sum_probs=198.0
Q ss_pred cCCCcCceecccCCceEEEEEe-cCCcEEEEEEeccCCchhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEEE
Q 000859 946 NNLSDEFIIGSGGSGTVYKAEL-ANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIY 1024 (1251)
Q Consensus 946 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv~ 1024 (1251)
.+|++.+.||+|+||.||+|.. .+++.||+|++..... ...+.+.+|+.++++++||||+++++++... ...++||
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~-~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~--~~~~iv~ 85 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG-DDFSLIQQEIFMVKECKHCNIVAYFGSYLSR--EKLWICM 85 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc-chHHHHHHHHHHHHhcCCCCeeeeeEEEEeC--CEEEEEE
Confidence 4688899999999999999964 5788999999864432 2345678899999999999999999988654 4579999
Q ss_pred eecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcccccccc
Q 000859 1025 EYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKA 1104 (1251)
Q Consensus 1025 E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~ 1104 (1251)
||+++++|.++++. ...+++..+..++.|++.|++|||+. +|+|||+||+||+++.++.+||+|||+++.
T Consensus 86 e~~~~~~L~~~~~~-------~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~ 155 (267)
T cd06646 86 EYCGGGSLQDIYHV-------TGPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAK 155 (267)
T ss_pred eCCCCCcHHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCcccee
Confidence 99999999999875 34678999999999999999999999 999999999999999999999999999976
Q ss_pred cccccCCCCcccceeecccceecccccc---cCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccc
Q 000859 1105 LVEDYNSNTESNTWFAGSYGYIAPEYAY---SLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSG 1181 (1251)
Q Consensus 1105 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 1181 (1251)
+.... .......|+..|+|||.+. ...++.++||||+||++|||++|+.||....+.+... ..
T Consensus 156 ~~~~~----~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~--------~~-- 221 (267)
T cd06646 156 ITATI----AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF--------LM-- 221 (267)
T ss_pred ecccc----cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe--------ee--
Confidence 53221 1122346889999999874 3457889999999999999999999986442211100 00
Q ss_pred hhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 000859 1182 SAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLL 1231 (1251)
Q Consensus 1182 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L 1231 (1251)
.... ...+........+..+.+++.+||+.||++||+++++++.+
T Consensus 222 -~~~~----~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 222 -SKSN----FQPPKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred -ecCC----CCCCCCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 0000 00011111122456788999999999999999999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=322.59 Aligned_cols=254 Identities=25% Similarity=0.312 Sum_probs=208.6
Q ss_pred hcCCCcCceecccCCceEEEEEec-CCcEEEEEEeccCCch--hhhHHHHHHHHHHHhcc-CCCccceeceeeecCCCce
Q 000859 945 TNNLSDEFIIGSGGSGTVYKAELA-NGATVAVKKISCKDDH--LLNKSFTREVKTLGRIR-HRHLVKLMGHCCNKGAGSN 1020 (1251)
Q Consensus 945 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~~ 1020 (1251)
...|...+.||+|.||.||+++.+ +|+.+|+|++.+.... ...+.+.+|+++|+++. |||||.++++|... ...
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~--~~~ 111 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDP--DSV 111 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcC--CeE
Confidence 445777789999999999999554 5999999999765532 24478999999999998 99999999998654 467
Q ss_pred eEEEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCC----CCeEE
Q 000859 1021 LLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSN----MEAHL 1096 (1251)
Q Consensus 1021 ~lv~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~----~~~kl 1096 (1251)
++|||++.||.|.+.+... .+++.++..++.|++.|++|||+. ||+|||+||+|+++... +.+|+
T Consensus 112 ~lvmEL~~GGeLfd~i~~~--------~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~ 180 (382)
T KOG0032|consen 112 YLVMELCEGGELFDRIVKK--------HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKL 180 (382)
T ss_pred EEEEEecCCchHHHHHHHc--------cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEE
Confidence 9999999999999999763 389999999999999999999999 99999999999999643 57999
Q ss_pred cccccccccccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHH
Q 000859 1097 GDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMH 1176 (1251)
Q Consensus 1097 ~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~ 1176 (1251)
+|||+|..... .......+||+.|+|||++....|+..+||||+||++|.|++|..||.+........
T Consensus 181 ~DFGla~~~~~-----~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~------- 248 (382)
T KOG0032|consen 181 IDFGLAKFIKP-----GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL------- 248 (382)
T ss_pred eeCCCceEccC-----CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH-------
Confidence 99999987643 233445799999999999999999999999999999999999999998764322211
Q ss_pred HhccchhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 000859 1177 MEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLL 1232 (1251)
Q Consensus 1177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 1232 (1251)
.+....+.-..+..........+++..|+..||.+|+|++++++.-+
T Consensus 249 ---------~i~~~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpW 295 (382)
T KOG0032|consen 249 ---------AILRGDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPW 295 (382)
T ss_pred ---------HHHcCCCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCcc
Confidence 11111112222334455677889999999999999999999999643
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=320.97 Aligned_cols=268 Identities=25% Similarity=0.325 Sum_probs=194.7
Q ss_pred CCCcCceecccCCceEEEEEe-cCCcEEEEEEeccCCch-hhhHHHHHHHHHHHhc---cCCCccceeceeeecC---CC
Q 000859 947 NLSDEFIIGSGGSGTVYKAEL-ANGATVAVKKISCKDDH-LLNKSFTREVKTLGRI---RHRHLVKLMGHCCNKG---AG 1018 (1251)
Q Consensus 947 ~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l---~h~niv~l~g~~~~~~---~~ 1018 (1251)
+|+..+.||+|+||+||+|.. .+++.||+|.+...... .....+.+|+++++.+ +||||+++++++.... ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 477888999999999999954 47899999998654322 1234556777777766 6999999999876432 23
Q ss_pred ceeEEEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcc
Q 000859 1019 SNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGD 1098 (1251)
Q Consensus 1019 ~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D 1098 (1251)
..++||||++ ++|.+++.... ...+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~~-----~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~d 151 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKVP-----PPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLAD 151 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhcC-----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECc
Confidence 4689999997 58999987642 34589999999999999999999999 999999999999999999999999
Q ss_pred cccccccccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHh
Q 000859 1099 FGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHME 1178 (1251)
Q Consensus 1099 fG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 1178 (1251)
||+++...... ......||..|+|||++.+..++.++||||+||++|||++|++||.+....+. ..........
T Consensus 152 fg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~-~~~~~~~~~~ 225 (288)
T cd07863 152 FGLARIYSCQM-----ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ-LGKIFDLIGL 225 (288)
T ss_pred cCccccccCcc-----cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHH-HHHHHHHhCC
Confidence 99997653221 11224678999999999988999999999999999999999999975433211 1111111000
Q ss_pred ccc-hhhhh--hhcccCCCCCC-----chHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 000859 1179 MSG-SAREE--LLDDQMKPLLP-----GEECAAYQVLEIALQCTKTSPQERPSSRQVCD 1229 (1251)
Q Consensus 1179 ~~~-~~~~~--~~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1229 (1251)
... .+... .......+..+ .....+.++.+++.+|++.||++|||+.|+++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 226 PPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred CChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 000 00000 00000000000 01123456789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=321.36 Aligned_cols=264 Identities=27% Similarity=0.407 Sum_probs=202.2
Q ss_pred CCCcCceecccCCceEEEEEe-cCCcEEEEEEeccCCchhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEEEe
Q 000859 947 NLSDEFIIGSGGSGTVYKAEL-ANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIYE 1025 (1251)
Q Consensus 947 ~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv~E 1025 (1251)
+|+..+.||+|+||.||+|.. .++..||+|.+.........+.+.+|++++++++||||+++++++.. +...++|||
T Consensus 2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e 79 (308)
T cd06615 2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYS--DGEISICME 79 (308)
T ss_pred CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee--CCEEEEEee
Confidence 588889999999999999964 46888999998765455556778899999999999999999998865 445799999
Q ss_pred ecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCCeeecCCCCCCeeecCCCCeEEcccccccc
Q 000859 1026 YMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHH-DCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKA 1104 (1251)
Q Consensus 1026 ~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~ 1104 (1251)
|+++++|.++++.. +.+++..+..++.|+++||+|||+ . +++||||||+||+++.++.+||+|||++..
T Consensus 80 y~~~~~L~~~l~~~-------~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 149 (308)
T cd06615 80 HMDGGSLDQVLKKA-------GRIPENILGKISIAVLRGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQ 149 (308)
T ss_pred ccCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhhC---CEEECCCChHHEEEecCCcEEEccCCCccc
Confidence 99999999999763 468899999999999999999997 5 899999999999999999999999999865
Q ss_pred cccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccch--
Q 000859 1105 LVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGS-- 1182 (1251)
Q Consensus 1105 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~-- 1182 (1251)
.... ......|+..|+|||.+.+..++.++|+|||||++|||++|+.||....... ...+..........
T Consensus 150 ~~~~------~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~ 221 (308)
T cd06615 150 LIDS------MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKE--LEAMFGRPVSEGEAKE 221 (308)
T ss_pred cccc------ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhh--HHHhhcCccccccccC
Confidence 4221 1123468899999999988889999999999999999999999986543211 11111100000000
Q ss_pred ----------------hhhhhhc---ccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 000859 1183 ----------------AREELLD---DQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLL 1231 (1251)
Q Consensus 1183 ----------------~~~~~~~---~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L 1231 (1251)
...+..+ ....+..+. ...+.++.+++.+|++.||++|||++++++.-
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~ 288 (308)
T cd06615 222 SHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPS-GAFSDEFQDFVDKCLKKNPKERADLKELTKHP 288 (308)
T ss_pred CcccccCCCCCccchhhHHHHHHHHhcCCCccCcC-cccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 0000000 001111111 12456789999999999999999999998764
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=330.40 Aligned_cols=268 Identities=23% Similarity=0.295 Sum_probs=197.6
Q ss_pred CCCcCceecccCCceEEEEEe-cCCcEEEEEEeccCC-chhhhHHHHHHHHHHHhccCCCccceeceeeecCC---Ccee
Q 000859 947 NLSDEFIIGSGGSGTVYKAEL-ANGATVAVKKISCKD-DHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGA---GSNL 1021 (1251)
Q Consensus 947 ~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~---~~~~ 1021 (1251)
+|+..+.||+|+||.||+|.. .+++.||||++.... .....+.+.+|+++++.++||||+++++++..... ...+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 477888999999999999964 578999999986432 23345678899999999999999999998865431 1468
Q ss_pred EEEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEccccc
Q 000859 1022 LIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGL 1101 (1251)
Q Consensus 1022 lv~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~ 1101 (1251)
+|+||+. ++|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 81 lv~e~~~-~~l~~~~~~-------~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~ 149 (372)
T cd07853 81 VVTELMQ-SDLHKIIVS-------PQPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGL 149 (372)
T ss_pred EEeeccc-cCHHHHHhc-------CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccc
Confidence 9999996 588888765 35689999999999999999999999 999999999999999999999999999
Q ss_pred ccccccccCCCCcccceeecccceecccccccC-CCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHh--
Q 000859 1102 AKALVEDYNSNTESNTWFAGSYGYIAPEYAYSL-KATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHME-- 1178 (1251)
Q Consensus 1102 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~-- 1178 (1251)
++...... ........+|..|+|||.+.+. .++.++||||+||++|||++|+.||.+....+. ...+.....
T Consensus 150 a~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~i~~~~g~~ 224 (372)
T cd07853 150 ARVEEPDE---SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQ--LDLITDLLGTP 224 (372)
T ss_pred eeecccCc---cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHH--HHHHHHHcCCC
Confidence 97643221 1112234678999999998764 478999999999999999999999976543211 110000000
Q ss_pred -------ccchhhhhhhcccCCCC-----CCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 000859 1179 -------MSGSAREELLDDQMKPL-----LPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDL 1230 (1251)
Q Consensus 1179 -------~~~~~~~~~~~~~~~~~-----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 1230 (1251)
........+......+. .......+.++.+++.+|++.||++|||++|+++.
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 225 SLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred CHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 00000111111100000 00011134568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=316.45 Aligned_cols=256 Identities=23% Similarity=0.362 Sum_probs=189.1
Q ss_pred eecccCCceEEEEEecC---CcEEEEEEeccCCchhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEEEeecCC
Q 000859 953 IIGSGGSGTVYKAELAN---GATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIYEYMEN 1029 (1251)
Q Consensus 953 ~lG~G~fg~V~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv~E~~~~ 1029 (1251)
.||+|+||+||+|...+ ...||+|.+...........+.+|+++++.++||||++++|++... ...++||||+++
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~--~~~~lv~e~~~~ 79 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIES--IPYLLVLEFCPL 79 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCC--CceEEEEEeCCC
Confidence 58999999999996543 3578899876555555567788999999999999999999988643 457999999999
Q ss_pred CChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEccccccccccccc
Q 000859 1030 GSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDY 1109 (1251)
Q Consensus 1030 gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 1109 (1251)
|+|.+++..... ......++..+..++.|++.|++|||+. +|+||||||+||++++++.+||+|||+++......
T Consensus 80 g~L~~~l~~~~~--~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~ 154 (269)
T cd05042 80 GDLKNYLRSNRG--MVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPED 154 (269)
T ss_pred CcHHHHHHhccc--cccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccch
Confidence 999999976431 1123356788899999999999999999 99999999999999999999999999986542221
Q ss_pred CCCCcccceeecccceeccccccc-------CCCCCccceeehhHHHHHHhh-CCCCCCCccccchhHHHHHHHHHhccc
Q 000859 1110 NSNTESNTWFAGSYGYIAPEYAYS-------LKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMVRWVEMHMEMSG 1181 (1251)
Q Consensus 1110 ~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~sDiwSlGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 1181 (1251)
.. .......++..|+|||+... ..++.++||||+||++|||++ |..||....+.+. ......
T Consensus 155 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~-~~~~~~------- 224 (269)
T cd05042 155 YY--ITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQV-LKQVVR------- 224 (269)
T ss_pred he--eccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHH-HHHHhh-------
Confidence 11 11122345778999998643 356889999999999999999 7888865432211 000000
Q ss_pred hhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 000859 1182 SAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLL 1232 (1251)
Q Consensus 1182 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 1232 (1251)
....... .+ ......+..+.+++..|| .||++|||+++|++.+.
T Consensus 225 ~~~~~~~----~~--~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 225 EQDIKLP----KP--QLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred ccCccCC----CC--cccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 0000000 01 111224456778999999 59999999999998873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=321.84 Aligned_cols=249 Identities=22% Similarity=0.326 Sum_probs=199.1
Q ss_pred CcCceecccCCceEEEEEecC-CcEEEEEEeccCCchhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEEEeec
Q 000859 949 SDEFIIGSGGSGTVYKAELAN-GATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIYEYM 1027 (1251)
Q Consensus 949 ~~~~~lG~G~fg~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv~E~~ 1027 (1251)
.+...||.|+||.||+|..++ +--.|.|++..+ .+...++|.-|++|+..++||+||++++.|..+ ...|++.|||
T Consensus 35 eIiGELGDGAFGKVyKA~nket~~lAAaKvIetk-seEELEDylVEIeILa~CdHP~ivkLl~ayy~e--nkLwiliEFC 111 (1187)
T KOG0579|consen 35 EIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK-SEEELEDYLVEIEILAECDHPVIVKLLSAYYFE--NKLWILIEFC 111 (1187)
T ss_pred HHHhhhcCccchhhhhhhcccchhhhhhhhhccc-chhHHhhhhhhhhhhhcCCChHHHHHHHHHhcc--CceEEEEeec
Confidence 334469999999999996553 445677777544 445678999999999999999999999977543 4579999999
Q ss_pred CCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEccccccccccc
Q 000859 1028 ENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVE 1107 (1251)
Q Consensus 1028 ~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~ 1107 (1251)
.||-....+-+- ++.+++.++..+++|++.|+.|||+. .|||||+|+.|||++-+|.++++|||.+.....
T Consensus 112 ~GGAVDaimlEL------~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~ 182 (1187)
T KOG0579|consen 112 GGGAVDAIMLEL------GRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS 182 (1187)
T ss_pred CCchHhHHHHHh------ccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchh
Confidence 999888877654 57899999999999999999999999 999999999999999999999999998854322
Q ss_pred ccCCCCcccceeecccceecccccc-----cCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccch
Q 000859 1108 DYNSNTESNTWFAGSYGYIAPEYAY-----SLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGS 1182 (1251)
Q Consensus 1108 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 1182 (1251)
.......+.||+.|||||++. ..+|+.++||||||+++.||..+.+|.....+...-+.
T Consensus 183 ----t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllK------------ 246 (1187)
T KOG0579|consen 183 ----TRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLK------------ 246 (1187)
T ss_pred ----HHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHH------------
Confidence 222334579999999999865 56799999999999999999999999765433211110
Q ss_pred hhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 000859 1183 AREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDL 1230 (1251)
Q Consensus 1183 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 1230 (1251)
+...-.|.+-.+..+...+.+++..|+.++|..||+++++++.
T Consensus 247 -----iaKSePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 247 -----IAKSEPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred -----HhhcCCCcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 0111123344566678889999999999999999999998764
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=330.91 Aligned_cols=268 Identities=22% Similarity=0.287 Sum_probs=198.2
Q ss_pred hhcCCCcCceecccCCceEEEEEe-cCCcEEEEEEeccCC-chhhhHHHHHHHHHHHhccCCCccceeceeeecCC----
Q 000859 944 ATNNLSDEFIIGSGGSGTVYKAEL-ANGATVAVKKISCKD-DHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGA---- 1017 (1251)
Q Consensus 944 ~~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~---- 1017 (1251)
...+|+..+.||+|+||.||+|.. .+++.||||++.... .....+.+.+|+.+++.++||||+++++++.....
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 346799999999999999999954 468999999986543 33345677889999999999999999998764322
Q ss_pred CceeEEEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEc
Q 000859 1018 GSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLG 1097 (1251)
Q Consensus 1018 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~ 1097 (1251)
...++||||+++ ++.+++.. .+++..+..++.|+++||+|||++ +|+||||||+||+++.++.+||+
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~~---------~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~ 161 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQM---------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKIL 161 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHhh---------cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEe
Confidence 246899999975 67776643 478889999999999999999999 99999999999999999999999
Q ss_pred ccccccccccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHH
Q 000859 1098 DFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHM 1177 (1251)
Q Consensus 1098 DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~ 1177 (1251)
|||+++..... .......||..|+|||++.+..++.++||||+||++|||++|+.||.+....+. ....++...
T Consensus 162 Dfg~~~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~~~~~~~ 235 (355)
T cd07874 162 DFGLARTAGTS-----FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ-WNKVIEQLG 235 (355)
T ss_pred eCcccccCCCc-----cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhC
Confidence 99999754321 112235789999999999998999999999999999999999999976532211 111111000
Q ss_pred hcc-------chhhhhhhccc-----------C-CCCCC----chHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 000859 1178 EMS-------GSAREELLDDQ-----------M-KPLLP----GEECAAYQVLEIALQCTKTSPQERPSSRQVCDL 1230 (1251)
Q Consensus 1178 ~~~-------~~~~~~~~~~~-----------~-~~~~~----~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 1230 (1251)
... ......+.... . ....+ .......++.+++.+|++.||++|||++|+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 236 TPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred CCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 000 00000000000 0 00000 111134567899999999999999999999985
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=321.48 Aligned_cols=259 Identities=26% Similarity=0.430 Sum_probs=203.4
Q ss_pred cCCCcCceecccCCceEEEEEe-cCCc----EEEEEEeccCCchhhhHHHHHHHHHHHhccCCCccceeceeeecCCCce
Q 000859 946 NNLSDEFIIGSGGSGTVYKAEL-ANGA----TVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSN 1020 (1251)
Q Consensus 946 ~~~~~~~~lG~G~fg~V~~~~~-~~~~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~ 1020 (1251)
.+|+..+.||+|+||.||+|.+ .+|+ .||+|.+...........+.+|+.+++.++||||++++|+|... ..
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~---~~ 83 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP---TI 83 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC---Cc
Confidence 4577888999999999999965 3444 57999887655555556788999999999999999999988543 24
Q ss_pred eEEEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcccc
Q 000859 1021 LLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFG 1100 (1251)
Q Consensus 1021 ~lv~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG 1100 (1251)
++++||+++|+|.+++... ...+++..+..++.|++.|++|||++ +|+||||||+||+++.++.+||+|||
T Consensus 84 ~~v~e~~~~g~l~~~~~~~------~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg 154 (303)
T cd05110 84 QLVTQLMPHGCLLDYVHEH------KDNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFG 154 (303)
T ss_pred eeeehhcCCCCHHHHHHhc------ccCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEcccc
Confidence 7999999999999998764 24678999999999999999999999 99999999999999999999999999
Q ss_pred cccccccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhh-CCCCCCCccccchhHHHHHHHHHhc
Q 000859 1101 LAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMVRWVEMHMEM 1179 (1251)
Q Consensus 1101 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~ 1179 (1251)
+++.+...... .......++..|+|||.+.+..++.++|||||||++||+++ |+.||.+....+ ...+..
T Consensus 155 ~~~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~--~~~~~~----- 225 (303)
T cd05110 155 LARLLEGDEKE--YNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE--IPDLLE----- 225 (303)
T ss_pred ccccccCcccc--cccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHH-----
Confidence 99865322111 11112345778999999998899999999999999999998 999987542211 111110
Q ss_pred cchhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhcCC
Q 000859 1180 SGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNVFNN 1237 (1251)
Q Consensus 1180 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~ 1237 (1251)
.. ...+.+..++..+.+++..||..+|++||+++++++.+.++.+.
T Consensus 226 ----------~~--~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~ 271 (303)
T cd05110 226 ----------KG--ERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD 271 (303)
T ss_pred ----------CC--CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 00 01111222345688999999999999999999999999987644
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=312.38 Aligned_cols=255 Identities=29% Similarity=0.474 Sum_probs=202.6
Q ss_pred ceecccCCceEEEEEecC----CcEEEEEEeccCCchhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEEEeec
Q 000859 952 FIIGSGGSGTVYKAELAN----GATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIYEYM 1027 (1251)
Q Consensus 952 ~~lG~G~fg~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv~E~~ 1027 (1251)
+.||+|+||.||+|.... +..||+|++.........+.+.+|+++++.++|+||+++++++.. ....++||||+
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~lv~e~~ 78 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTE--EEPLYLVLEYM 78 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecC--CCceEEEEEec
Confidence 369999999999996653 789999999766554456788999999999999999999998865 45579999999
Q ss_pred CCCChHHhhhcCCCC--cccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEccccccccc
Q 000859 1028 ENGSVWDWLHKQPVN--IKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKAL 1105 (1251)
Q Consensus 1028 ~~gsL~~~l~~~~~~--~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~ 1105 (1251)
++++|.+++...... ......+++.++++++.|+++|++|||++ +|+||||||+||++++++.+|++|||.++..
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~ 155 (262)
T cd00192 79 EGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDV 155 (262)
T ss_pred cCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccccccc
Confidence 999999999864210 01125789999999999999999999999 9999999999999999999999999999876
Q ss_pred ccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhh-CCCCCCCccccchhHHHHHHHHHhccchhh
Q 000859 1106 VEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMVRWVEMHMEMSGSAR 1184 (1251)
Q Consensus 1106 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1184 (1251)
..... ........++..|+|||.+....++.++||||+||++|||++ |..||......+ ..+...
T Consensus 156 ~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-----~~~~~~------- 221 (262)
T cd00192 156 YDDDY--YRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE-----VLEYLR------- 221 (262)
T ss_pred ccccc--cccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHH-----HHHHHH-------
Confidence 43221 122233467889999999988889999999999999999999 699997652211 111110
Q ss_pred hhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 000859 1185 EELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLL 1232 (1251)
Q Consensus 1185 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 1232 (1251)
. . .....+...+.++.+++.+|++.+|++|||++|+++.|+
T Consensus 222 ----~-~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 222 ----K-G--YRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred ----c-C--CCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 0 0 111122234667999999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=321.42 Aligned_cols=203 Identities=23% Similarity=0.375 Sum_probs=163.9
Q ss_pred ceecccCCceEEEEEec---CCcEEEEEEeccCCchhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEEEeecC
Q 000859 952 FIIGSGGSGTVYKAELA---NGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIYEYME 1028 (1251)
Q Consensus 952 ~~lG~G~fg~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv~E~~~ 1028 (1251)
.+||+|+||+||+|+.. ++..||+|.+..... ...+.+|++++++++||||+++++++........++|+||++
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI---SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCCC---cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 47999999999999754 457899999864332 346778999999999999999999887666667899999986
Q ss_pred CCChHHhhhcCCCC--cccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeee----cCCCCeEEcccccc
Q 000859 1029 NGSVWDWLHKQPVN--IKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILL----DSNMEAHLGDFGLA 1102 (1251)
Q Consensus 1029 ~gsL~~~l~~~~~~--~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill----~~~~~~kl~DfG~a 1102 (1251)
++|.+++...... ......+++..+..++.|++.||+|||+. +|+||||||+||++ ++++.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 -HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 5888887643211 11234588999999999999999999999 99999999999999 56789999999999
Q ss_pred cccccccCCCCcccceeecccceeccccccc-CCCCCccceeehhHHHHHHhhCCCCCCCc
Q 000859 1103 KALVEDYNSNTESNTWFAGSYGYIAPEYAYS-LKATEKCDVYSMGIVLMELVSGKMPTDAT 1162 (1251)
Q Consensus 1103 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlGv~l~el~tg~~p~~~~ 1162 (1251)
+.+...... ........||..|+|||++.+ ..++.++||||+||++|||+||+.||...
T Consensus 160 ~~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 160 RLFNSPLKP-LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eccCCCccc-ccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 865432211 112233578999999999876 45899999999999999999999999643
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=342.19 Aligned_cols=266 Identities=20% Similarity=0.280 Sum_probs=192.7
Q ss_pred HHHhhcCCCcCceecccCCceEEEEEe-cCCcEEEEEEeccCCchhhhHHHHHHHHHHHhccC------CCccceeceee
Q 000859 941 IMGATNNLSDEFIIGSGGSGTVYKAEL-ANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRH------RHLVKLMGHCC 1013 (1251)
Q Consensus 941 ~~~~~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h------~niv~l~g~~~ 1013 (1251)
+.....+|++.++||+|+||+||+|.. .+++.||||+++... .....+..|+++++.++| .+++++++++.
T Consensus 124 ~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~ 201 (467)
T PTZ00284 124 IDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP--KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ 201 (467)
T ss_pred cccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch--hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence 344567899999999999999999954 568899999985322 223455678888777754 45888888776
Q ss_pred ecCCCceeEEEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCCeeecCCCCCCeeecCCC
Q 000859 1014 NKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHH-DCVPKILHRDIKSSNILLDSNM 1092 (1251)
Q Consensus 1014 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~Dlkp~Nill~~~~ 1092 (1251)
.. ....++|||++ +++|.+++.+ .+.+++..+..++.||+.||+|||+ . +||||||||+|||++.++
T Consensus 202 ~~-~~~~~iv~~~~-g~~l~~~l~~-------~~~l~~~~~~~i~~qi~~aL~yLH~~~---gIiHrDlKP~NILl~~~~ 269 (467)
T PTZ00284 202 NE-TGHMCIVMPKY-GPCLLDWIMK-------HGPFSHRHLAQIIFQTGVALDYFHTEL---HLMHTDLKPENILMETSD 269 (467)
T ss_pred cC-CceEEEEEecc-CCCHHHHHHH-------cCCCCHHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEecCC
Confidence 44 34578999988 7789998876 3468999999999999999999997 5 899999999999998765
Q ss_pred ----------------CeEEcccccccccccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhhCC
Q 000859 1093 ----------------EAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGK 1156 (1251)
Q Consensus 1093 ----------------~~kl~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~ 1156 (1251)
.+||+|||.+.... .......||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus 270 ~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~-------~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~ 342 (467)
T PTZ00284 270 TVVDPVTNRALPPDPCRVRICDLGGCCDER-------HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGK 342 (467)
T ss_pred cccccccccccCCCCceEEECCCCccccCc-------cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCC
Confidence 49999999875321 1123357899999999999999999999999999999999999
Q ss_pred CCCCCccccchhHHHHHHHHH-hccchhh--------hhhhccc--CCCCC-------------CchHHHHHHHHHHHHH
Q 000859 1157 MPTDATFGVEMDMVRWVEMHM-EMSGSAR--------EELLDDQ--MKPLL-------------PGEECAAYQVLEIALQ 1212 (1251)
Q Consensus 1157 ~p~~~~~~~~~~~~~~~~~~~-~~~~~~~--------~~~~~~~--~~~~~-------------~~~~~~~~~l~~li~~ 1212 (1251)
.||++....+. ...+.... .....+. ..+++.. ..+.. .........+.+|+.+
T Consensus 343 ~pf~~~~~~~~--~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~ 420 (467)
T PTZ00284 343 LLYDTHDNLEH--LHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYG 420 (467)
T ss_pred CCCCCCChHHH--HHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHH
Confidence 99976543211 11111000 0000000 0000000 00000 0011124567899999
Q ss_pred ccccCCCCCCCHHHHHH
Q 000859 1213 CTKTSPQERPSSRQVCD 1229 (1251)
Q Consensus 1213 cl~~dP~~RPs~~eil~ 1229 (1251)
||+.||++|||++|+++
T Consensus 421 mL~~dP~~R~ta~e~L~ 437 (467)
T PTZ00284 421 LLHYDRQKRLNARQMTT 437 (467)
T ss_pred hCCcChhhCCCHHHHhc
Confidence 99999999999999987
|
|
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=311.43 Aligned_cols=251 Identities=28% Similarity=0.450 Sum_probs=202.6
Q ss_pred hcCCCcCceecccCCceEEEEEecCCcEEEEEEeccCCchhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEEE
Q 000859 945 TNNLSDEFIIGSGGSGTVYKAELANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIY 1024 (1251)
Q Consensus 945 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv~ 1024 (1251)
.++|+..+.||+|+||.||+|... |+.||+|.+..... ..+.+.+|+.++++++|+||+++++++.. ....++||
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~v~ 79 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST--AAQAFLAEASVMTTLRHPNLVQLLGVVLQ--GNPLYIVT 79 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh--HHHHHHHHHHHHHhcCCcceeeeEEEEcC--CCCeEEEE
Confidence 346788889999999999999875 89999999965443 45788999999999999999999998765 44579999
Q ss_pred eecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcccccccc
Q 000859 1025 EYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKA 1104 (1251)
Q Consensus 1025 E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~ 1104 (1251)
||+++++|.++++... ...+++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|||.++.
T Consensus 80 e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~ 151 (256)
T cd05039 80 EYMAKGSLVDYLRSRG-----RAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKE 151 (256)
T ss_pred EecCCCcHHHHHHhcC-----CCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcccccccc
Confidence 9999999999997642 34689999999999999999999999 999999999999999999999999999976
Q ss_pred cccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhh-CCCCCCCccccchhHHHHHHHHHhccchh
Q 000859 1105 LVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMVRWVEMHMEMSGSA 1183 (1251)
Q Consensus 1105 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1183 (1251)
...... ...++..|+|||.+....++.++||||+|+++||+++ |+.||......+ .....
T Consensus 152 ~~~~~~-------~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--~~~~~---------- 212 (256)
T cd05039 152 ASQGQD-------SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--VVPHV---------- 212 (256)
T ss_pred cccccc-------cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH--HHHHH----------
Confidence 522111 1234568999999988889999999999999999998 999986542211 10000
Q ss_pred hhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 000859 1184 REELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNV 1234 (1251)
Q Consensus 1184 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 1234 (1251)
....... .+...+.++.+++.+|++.+|++|||++|++++|+++
T Consensus 213 -----~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 213 -----EKGYRME--APEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred -----hcCCCCC--CccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 0001111 1122456789999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=318.86 Aligned_cols=251 Identities=23% Similarity=0.362 Sum_probs=200.6
Q ss_pred hcCCCcCceecccCCceEEEEEe-cCCcEEEEEEeccCCchhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEE
Q 000859 945 TNNLSDEFIIGSGGSGTVYKAEL-ANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLI 1023 (1251)
Q Consensus 945 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv 1023 (1251)
..+|+..+.||+|+||.||+|.. .+++.||+|.+...... ..+.+.+|+.+++.++||||+++++.+.. ....++|
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~-~~~~~~~e~~~l~~~~h~~v~~~~~~~~~--~~~~~lv 95 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP-KKELIINEILVMRENKNPNIVNYLDSYLV--GDELWVV 95 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc-hHHHHHHHHHHHHhCCCCCEeeEEEEEEe--CCEEEEe
Confidence 35688888999999999999964 57899999998754433 34678899999999999999999998865 3467999
Q ss_pred EeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEccccccc
Q 000859 1024 YEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAK 1103 (1251)
Q Consensus 1024 ~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~ 1103 (1251)
|||+++++|.+++.+ ..+++.++..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||.+.
T Consensus 96 ~e~~~~~~L~~~~~~--------~~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~ 164 (296)
T cd06654 96 MEYLAGGSLTDVVTE--------TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCA 164 (296)
T ss_pred ecccCCCCHHHHHHh--------cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccch
Confidence 999999999999865 2478899999999999999999999 99999999999999999999999999987
Q ss_pred ccccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccchh
Q 000859 1104 ALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSA 1183 (1251)
Q Consensus 1104 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1183 (1251)
...... .......|++.|+|||.+.+..++.++|||||||++|||++|+.||....+... +....
T Consensus 165 ~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~----~~~~~------- 229 (296)
T cd06654 165 QITPEQ----SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA----LYLIA------- 229 (296)
T ss_pred hccccc----cccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHh----HHHHh-------
Confidence 643221 111224678999999999988899999999999999999999999975432111 10000
Q ss_pred hhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 000859 1184 REELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDL 1230 (1251)
Q Consensus 1184 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 1230 (1251)
.. ..+..+.+...+..+.+++.+||..||++||+++++++.
T Consensus 230 ----~~--~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 230 ----TN--GTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred ----cC--CCCCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 00 001111223345668899999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=315.34 Aligned_cols=255 Identities=27% Similarity=0.432 Sum_probs=198.0
Q ss_pred eecccCCceEEEEEecC-------CcEEEEEEeccCCchhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEEEe
Q 000859 953 IIGSGGSGTVYKAELAN-------GATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIYE 1025 (1251)
Q Consensus 953 ~lG~G~fg~V~~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv~E 1025 (1251)
.||+|+||.||+|+..+ ++.||||.+...........+.+|+++++.++||||+++++++... ...++|||
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~~v~e 79 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLN--EPQYIIME 79 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCC--CCeEEEEe
Confidence 68999999999996542 2579999986555444567889999999999999999999988543 45799999
Q ss_pred ecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCC-----CeEEcccc
Q 000859 1026 YMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNM-----EAHLGDFG 1100 (1251)
Q Consensus 1026 ~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~-----~~kl~DfG 1100 (1251)
|+++|+|.+++............+++.++..++.|++.|++|||+. +++|+||||+||+++.++ .+|++|||
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg 156 (269)
T cd05044 80 LMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFG 156 (269)
T ss_pred ccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCcc
Confidence 9999999999976432111234578999999999999999999998 999999999999999887 89999999
Q ss_pred cccccccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhh-CCCCCCCccccchhHHHHHHHHHhc
Q 000859 1101 LAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMVRWVEMHMEM 1179 (1251)
Q Consensus 1101 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~ 1179 (1251)
+++......... ......++..|+|||++.+..++.++|||||||++|||++ |+.||......+ ....+.
T Consensus 157 ~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~--~~~~~~----- 227 (269)
T cd05044 157 LARDIYKSDYYR--KEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE--VLQHVT----- 227 (269)
T ss_pred cccccccccccc--cCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHH--HHHHHh-----
Confidence 997653321111 1112345678999999999999999999999999999998 999986542211 111110
Q ss_pred cchhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 000859 1180 SGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLN 1233 (1251)
Q Consensus 1180 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 1233 (1251)
.. .....+...+..+.+++.+||+.+|.+||+++++++.|.+
T Consensus 228 ----------~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 228 ----------AG--GRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred ----------cC--CccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 00 0111122345678999999999999999999999998863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=317.59 Aligned_cols=252 Identities=23% Similarity=0.262 Sum_probs=194.9
Q ss_pred CCcCceecccCCceEEEEEe-cCCcEEEEEEeccCCc--hhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEEE
Q 000859 948 LSDEFIIGSGGSGTVYKAEL-ANGATVAVKKISCKDD--HLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIY 1024 (1251)
Q Consensus 948 ~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv~ 1024 (1251)
|+..+.||+|+||+||+|.. .+++.||+|.+..... ....+.+.+|++++++++|++|+++++++... ...++||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~--~~~~lv~ 79 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETK--DALCLVL 79 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecC--CEEEEEE
Confidence 56677899999999999955 5789999999864331 22335678899999999999999999877543 4579999
Q ss_pred eecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcccccccc
Q 000859 1025 EYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKA 1104 (1251)
Q Consensus 1025 E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~ 1104 (1251)
||+++|+|.+++.... ...+++..+..++.|++.|++|||+. +|+||||||+||++++++.+||+|||++..
T Consensus 80 e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~ 151 (285)
T cd05632 80 TIMNGGDLKFHIYNMG-----NPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVK 151 (285)
T ss_pred EeccCccHHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCccee
Confidence 9999999998886532 34689999999999999999999999 999999999999999999999999999865
Q ss_pred cccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccchhh
Q 000859 1105 LVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSAR 1184 (1251)
Q Consensus 1105 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1184 (1251)
.... .......|+..|+|||.+.+..++.++|+||+||++||+++|+.||.+...... ...+......
T Consensus 152 ~~~~-----~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~-~~~~~~~~~~------ 219 (285)
T cd05632 152 IPEG-----ESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK-REEVDRRVLE------ 219 (285)
T ss_pred cCCC-----CcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhhhc------
Confidence 4221 111234689999999999988999999999999999999999999975432111 1111100000
Q ss_pred hhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 000859 1185 EELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPS-----SRQVCDL 1230 (1251)
Q Consensus 1185 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~eil~~ 1230 (1251)
.........+.++.+++..|++.||++||+ ++++++.
T Consensus 220 ---------~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 220 ---------TEEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred ---------cccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 000011123456789999999999999999 6666654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=312.71 Aligned_cols=238 Identities=22% Similarity=0.368 Sum_probs=185.3
Q ss_pred eecccCCceEEEEEecC-------------CcEEEEEEeccCCchhhhHHHHHHHHHHHhccCCCccceeceeeecCCCc
Q 000859 953 IIGSGGSGTVYKAELAN-------------GATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGS 1019 (1251)
Q Consensus 953 ~lG~G~fg~V~~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 1019 (1251)
.||+|+||.||+|.+.+ ...||+|++.... ....+.+.+|+.+++.++||||+++++++... ..
T Consensus 2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~--~~ 78 (262)
T cd05077 2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH-RDISLAFFETASMMRQVSHKHIVLLYGVCVRD--VE 78 (262)
T ss_pred ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh-hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecC--CC
Confidence 58999999999997532 2358999875433 33456788899999999999999999988654 34
Q ss_pred eeEEEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCC------
Q 000859 1020 NLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNME------ 1093 (1251)
Q Consensus 1020 ~~lv~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~------ 1093 (1251)
.++||||+++|+|..++... ...+++..+.+++.||++||+|||++ +|+||||||+||+++.++.
T Consensus 79 ~~lv~e~~~~~~l~~~~~~~------~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~ 149 (262)
T cd05077 79 NIMVEEFVEFGPLDLFMHRK------SDVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGP 149 (262)
T ss_pred CEEEEecccCCCHHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCc
Confidence 58999999999999988753 34589999999999999999999999 9999999999999987664
Q ss_pred -eEEcccccccccccccCCCCcccceeecccceecccccc-cCCCCCccceeehhHHHHHHh-hCCCCCCCccccchhHH
Q 000859 1094 -AHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAY-SLKATEKCDVYSMGIVLMELV-SGKMPTDATFGVEMDMV 1170 (1251)
Q Consensus 1094 -~kl~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDiwSlGv~l~el~-tg~~p~~~~~~~~~~~~ 1170 (1251)
+|++|||.+...... ....++..|+|||.+. +..++.++|||||||++|||+ +|+.||......+..
T Consensus 150 ~~~l~d~g~~~~~~~~--------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~-- 219 (262)
T cd05077 150 FIKLSDPGIPITVLSR--------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE-- 219 (262)
T ss_pred eeEeCCCCCCccccCc--------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH--
Confidence 899999998654211 1235788899999886 567899999999999999998 588888654221110
Q ss_pred HHHHHHHhccchhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 000859 1171 RWVEMHMEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLL 1231 (1251)
Q Consensus 1171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L 1231 (1251)
.. ...... .......++.+++.+||+.||.+||++++|++.+
T Consensus 220 ----~~-----------~~~~~~----~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 220 ----RF-----------YEGQCM----LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred ----HH-----------HhcCcc----CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 00 000000 0111235688999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=315.58 Aligned_cols=251 Identities=28% Similarity=0.442 Sum_probs=196.7
Q ss_pred CCCcCceecccCCceEEEEE-ecCCcEEEEEEeccCCchhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEEEe
Q 000859 947 NLSDEFIIGSGGSGTVYKAE-LANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIYE 1025 (1251)
Q Consensus 947 ~~~~~~~lG~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv~E 1025 (1251)
+|+..++||+|+||.||+|. ..+++.||+|++.........+.+.+|++++++++||||+++++++... ...++|||
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e 79 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVE--NRISICTE 79 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEEC--CEEEEEEe
Confidence 57778899999999999995 4578999999987554444557789999999999999999999988664 45689999
Q ss_pred ecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEccccccccc
Q 000859 1026 YMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKAL 1105 (1251)
Q Consensus 1026 ~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~ 1105 (1251)
|+++|+|..+. .+++..+..++.|++.|++|||+. +|+|+||||+||+++.++.+||+|||++..+
T Consensus 80 ~~~~~~l~~~~-----------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~ 145 (279)
T cd06619 80 FMDGGSLDVYR-----------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQL 145 (279)
T ss_pred cCCCCChHHhh-----------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceec
Confidence 99999986542 357888899999999999999999 9999999999999999999999999999765
Q ss_pred ccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccchhhh
Q 000859 1106 VEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSARE 1185 (1251)
Q Consensus 1106 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1185 (1251)
... ......||..|+|||++.+..++.++||||+||++|||++|+.||........... +.+. ..
T Consensus 146 ~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~-~~~~--------~~ 210 (279)
T cd06619 146 VNS------IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLM-PLQL--------LQ 210 (279)
T ss_pred ccc------cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccc-hHHH--------HH
Confidence 321 12234789999999999988999999999999999999999999975432221110 0000 00
Q ss_pred hhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 000859 1186 ELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDL 1230 (1251)
Q Consensus 1186 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 1230 (1251)
...+. ..+..+ ....+.++.+++.+|++.+|++||+++|+++.
T Consensus 211 ~~~~~-~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 211 CIVDE-DPPVLP-VGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred HHhcc-CCCCCC-CCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 00010 011111 11234568899999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=329.41 Aligned_cols=267 Identities=22% Similarity=0.269 Sum_probs=197.5
Q ss_pred hcCCCcCceecccCCceEEEEE-ecCCcEEEEEEeccCC-chhhhHHHHHHHHHHHhccCCCccceeceeeecC----CC
Q 000859 945 TNNLSDEFIIGSGGSGTVYKAE-LANGATVAVKKISCKD-DHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKG----AG 1018 (1251)
Q Consensus 945 ~~~~~~~~~lG~G~fg~V~~~~-~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~----~~ 1018 (1251)
..+|...+.||+|+||.||+|. ..+++.||||++.... .....+.+.+|+.+++.++||||+++++++.... ..
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~ 102 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 102 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence 4678999999999999999995 4568899999986542 2334567789999999999999999999875432 23
Q ss_pred ceeEEEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcc
Q 000859 1019 SNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGD 1098 (1251)
Q Consensus 1019 ~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D 1098 (1251)
..++||||+++ ++.+++.. .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|
T Consensus 103 ~~~lv~e~~~~-~l~~~~~~---------~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~D 169 (364)
T cd07875 103 DVYIVMELMDA-NLCQVIQM---------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILD 169 (364)
T ss_pred eEEEEEeCCCC-CHHHHHHh---------cCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEe
Confidence 46899999975 77777643 378889999999999999999999 999999999999999999999999
Q ss_pred cccccccccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHh
Q 000859 1099 FGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHME 1178 (1251)
Q Consensus 1099 fG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 1178 (1251)
||+++..... .......||..|+|||++.+..++.++||||+||++|||++|+.||.+....+. .....+....
T Consensus 170 fG~a~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~-~~~~~~~~~~ 243 (364)
T cd07875 170 FGLARTAGTS-----FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQ-WNKVIEQLGT 243 (364)
T ss_pred CCCccccCCC-----CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhcCC
Confidence 9999764321 112234689999999999999999999999999999999999999976543221 1111110000
Q ss_pred cc-------chh---------------hhhhhcccCCCCC-CchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 000859 1179 MS-------GSA---------------REELLDDQMKPLL-PGEECAAYQVLEIALQCTKTSPQERPSSRQVCDL 1230 (1251)
Q Consensus 1179 ~~-------~~~---------------~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 1230 (1251)
.. ... ..........+.. ........++.+++.+|++.||++|||++|+++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 244 PCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred CCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00 000 0000000000000 0011123568899999999999999999999875
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=321.63 Aligned_cols=246 Identities=24% Similarity=0.402 Sum_probs=194.6
Q ss_pred CceecccCCceEEEE-EecCCcEEE---EEEeccCCchhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEEEee
Q 000859 951 EFIIGSGGSGTVYKA-ELANGATVA---VKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIYEY 1026 (1251)
Q Consensus 951 ~~~lG~G~fg~V~~~-~~~~~~~va---vK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv~E~ 1026 (1251)
..+||+|+|-+||+| +-.+|-+|| ||.-....++...+.|..|+.+|+.++|||||++|.++.+.......+|+|.
T Consensus 45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL 124 (632)
T KOG0584|consen 45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL 124 (632)
T ss_pred hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence 347999999999999 555677777 3332223355566899999999999999999999999888777778899999
Q ss_pred cCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecC-CCCeEEccccccccc
Q 000859 1027 MENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDS-NMEAHLGDFGLAKAL 1105 (1251)
Q Consensus 1027 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~-~~~~kl~DfG~a~~~ 1105 (1251)
+..|+|..|+++. +.+....++.+++||++||.|||++ .|+|+|||||.+||+|+. .|.|||+|+|+|+..
T Consensus 125 ~TSGtLr~Y~kk~-------~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~ 196 (632)
T KOG0584|consen 125 FTSGTLREYRKKH-------RRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLL 196 (632)
T ss_pred ccCCcHHHHHHHh-------ccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHh
Confidence 9999999999984 5788899999999999999999997 679999999999999975 599999999999875
Q ss_pred ccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccchhhh
Q 000859 1106 VEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSARE 1185 (1251)
Q Consensus 1106 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1185 (1251)
... .....+|||.|||||... ..|++.+||||||+.++||.|+..||..=.+..--+++ .......
T Consensus 197 r~s------~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKK-------V~SGiKP 262 (632)
T KOG0584|consen 197 RKS------HAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKK-------VTSGIKP 262 (632)
T ss_pred hcc------ccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHH-------HHcCCCH
Confidence 322 122368999999999765 78999999999999999999999999632221110100 0011111
Q ss_pred hhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 000859 1186 ELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCD 1229 (1251)
Q Consensus 1186 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1229 (1251)
..+. ....+++.+||.+|+.. ..+|||+.|+++
T Consensus 263 ~sl~----------kV~dPevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 263 AALS----------KVKDPEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred HHhh----------ccCCHHHHHHHHHHhcC-chhccCHHHHhh
Confidence 1111 11246799999999999 999999999875
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=324.23 Aligned_cols=282 Identities=24% Similarity=0.333 Sum_probs=214.5
Q ss_pred cCceecccCCceEEEEE-ecCCcEEEEEEeccCCchhhhHHHHHHHHHHHhccCCCccceeceeeecC----CCceeEEE
Q 000859 950 DEFIIGSGGSGTVYKAE-LANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKG----AGSNLLIY 1024 (1251)
Q Consensus 950 ~~~~lG~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~----~~~~~lv~ 1024 (1251)
..+.||+||||.||+|+ ..+|+.||||.++........+...+|++++++++|||||++.+.-.... .....+||
T Consensus 17 ~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvm 96 (732)
T KOG4250|consen 17 MDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVM 96 (732)
T ss_pred ehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEE
Confidence 34579999999999997 66899999999987666667788999999999999999999998654443 34468999
Q ss_pred eecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeec--CCC--CeEEcccc
Q 000859 1025 EYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLD--SNM--EAHLGDFG 1100 (1251)
Q Consensus 1025 E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~--~~~--~~kl~DfG 1100 (1251)
|||.+|||...|.+.. ....+++.+.+.+..+++.||.|||++ +||||||||.||++- .+| .-||+|||
T Consensus 97 EyC~gGsL~~~L~~PE----N~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG 169 (732)
T KOG4250|consen 97 EYCSGGSLRKVLNSPE----NAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFG 169 (732)
T ss_pred eecCCCcHHHHhcCcc----cccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeeccc
Confidence 9999999999998753 367899999999999999999999999 999999999999983 334 47999999
Q ss_pred cccccccccCCCCcccceeecccceeccccccc-CCCCCccceeehhHHHHHHhhCCCCCCCccccchhH-HHHHHHHHh
Q 000859 1101 LAKALVEDYNSNTESNTWFAGSYGYIAPEYAYS-LKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDM-VRWVEMHME 1178 (1251)
Q Consensus 1101 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~-~~~~~~~~~ 1178 (1251)
.|+.+.++. .....+||..|.+||.... ..|+..+|.|||||++||++||..||....+..... ..|......
T Consensus 170 ~Arel~d~s-----~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkk 244 (732)
T KOG4250|consen 170 AARELDDNS-----LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKK 244 (732)
T ss_pred ccccCCCCC-----eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccC
Confidence 999875432 3345799999999999884 889999999999999999999999998766553211 122222221
Q ss_pred ccchhhhhhhcc----cCCCCCCc----hHHHHHHHHHHHHHccccCCCCCC--CHHHHHHHHHhhcCCCccccc
Q 000859 1179 MSGSAREELLDD----QMKPLLPG----EECAAYQVLEIALQCTKTSPQERP--SSRQVCDLLLNVFNNRIVDFD 1243 (1251)
Q Consensus 1179 ~~~~~~~~~~~~----~~~~~~~~----~~~~~~~l~~li~~cl~~dP~~RP--s~~eil~~L~~~~~~~~~~~~ 1243 (1251)
..+......... .+...+|. .......+..++..++..+|.+|. .+.+....+.++++...+-..
T Consensus 245 p~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~~vvhiF 319 (732)
T KOG4250|consen 245 PSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNLKVVHIF 319 (732)
T ss_pred CCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhhheeEEE
Confidence 111110000000 01111222 122445567788889999999999 888888888888877666544
|
|
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-33 Score=311.20 Aligned_cols=254 Identities=24% Similarity=0.325 Sum_probs=198.2
Q ss_pred cCCCcCceecccCCceEEEEEe-cCCcEEEEEEeccCC----chhhhHHHHHHHHHHHhccCCCccceeceeeecCCCce
Q 000859 946 NNLSDEFIIGSGGSGTVYKAEL-ANGATVAVKKISCKD----DHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSN 1020 (1251)
Q Consensus 946 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~ 1020 (1251)
.+|+..+.||+|+||.||+|.. .+++.||||.+.... .....+.+.+|++++++++||||+++++++.+......
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 4688889999999999999954 568999999985432 12334678889999999999999999998766545567
Q ss_pred eEEEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcccc
Q 000859 1021 LLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFG 1100 (1251)
Q Consensus 1021 ~lv~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG 1100 (1251)
+++|||+++|+|.+++... ..+++..+.+++.|++.||+|||+. +|+|+||||+||+++.++.+||+|||
T Consensus 82 ~~v~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg 151 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSY-------GALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFG 151 (265)
T ss_pred EEEEEecCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCc
Confidence 8999999999999998753 4578889999999999999999999 99999999999999999999999999
Q ss_pred cccccccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhcc
Q 000859 1101 LAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMS 1180 (1251)
Q Consensus 1101 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 1180 (1251)
.++......... .......|+..|+|||.+.+..++.++|||||||++||+++|+.||........ ..
T Consensus 152 ~~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~----~~------- 219 (265)
T cd06652 152 ASKRLQTICLSG-TGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAA----IF------- 219 (265)
T ss_pred cccccccccccc-cccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHH----HH-------
Confidence 987653221111 111224588899999999888899999999999999999999999964421110 00
Q ss_pred chhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 000859 1181 GSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCD 1229 (1251)
Q Consensus 1181 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1229 (1251)
........+.. +......+.+++.+|+. +|++||+++|+++
T Consensus 220 -----~~~~~~~~~~~--~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 220 -----KIATQPTNPVL--PPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred -----HHhcCCCCCCC--chhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 00000011111 22345568889999995 9999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=317.21 Aligned_cols=252 Identities=24% Similarity=0.288 Sum_probs=196.1
Q ss_pred CCcCceecccCCceEEEEEe-cCCcEEEEEEeccCCc--hhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEEE
Q 000859 948 LSDEFIIGSGGSGTVYKAEL-ANGATVAVKKISCKDD--HLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIY 1024 (1251)
Q Consensus 948 ~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv~ 1024 (1251)
|+..+.||+|+||.||+|.. .+++.||||.+..... ....+.+.+|+.++++++|++|+++++.+... ...++||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~--~~~~lv~ 79 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETK--DALCLVL 79 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecC--CEEEEEE
Confidence 66778899999999999954 4789999999864432 22235577899999999999999999987553 4579999
Q ss_pred eecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcccccccc
Q 000859 1025 EYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKA 1104 (1251)
Q Consensus 1025 E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~ 1104 (1251)
||+++|+|.+++.... ...+++.++..++.|++.|++|||+. +|+||||||+||+++.++.++|+|||++..
T Consensus 80 e~~~g~~L~~~l~~~~-----~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~ 151 (285)
T cd05630 80 TLMNGGDLKFHIYHMG-----EAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVH 151 (285)
T ss_pred EecCCCcHHHHHHHhc-----ccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceee
Confidence 9999999999986532 34589999999999999999999998 999999999999999999999999999865
Q ss_pred cccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccchhh
Q 000859 1105 LVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSAR 1184 (1251)
Q Consensus 1105 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1184 (1251)
..... ......|+..|+|||++.+..++.++||||+||++|||++|+.||........ .... .... ....
T Consensus 152 ~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~-~~~~-~~~~---~~~~ 221 (285)
T cd05630 152 VPEGQ-----TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK-REEV-ERLV---KEVQ 221 (285)
T ss_pred cCCCc-----cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccch-HHHH-Hhhh---hhhh
Confidence 43211 11224689999999999999999999999999999999999999975432111 0000 0000 0000
Q ss_pred hhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 000859 1185 EELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPS-----SRQVCDL 1230 (1251)
Q Consensus 1185 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~eil~~ 1230 (1251)
. . .....++++.+++.+||+.||++||| ++|+++.
T Consensus 222 ~---------~--~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h 261 (285)
T cd05630 222 E---------E--YSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH 261 (285)
T ss_pred h---------h--cCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence 0 0 01123456889999999999999999 8888873
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=310.33 Aligned_cols=249 Identities=29% Similarity=0.444 Sum_probs=201.7
Q ss_pred cCCCcCceecccCCceEEEEEecC-CcEEEEEEeccCCchhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEEE
Q 000859 946 NNLSDEFIIGSGGSGTVYKAELAN-GATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIY 1024 (1251)
Q Consensus 946 ~~~~~~~~lG~G~fg~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv~ 1024 (1251)
++|+..+.||+|+||.||+|...+ ++.||+|.+..... .+.+.+|++++++++||||+++++++... ...++++
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~e~~~~~~l~~~~i~~~~~~~~~~--~~~~l~~ 77 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED---LQEIIKEISILKQCDSPYIVKYYGSYFKN--TDLWIVM 77 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH---HHHHHHHHHHHHhCCCCcEeeeeeeeecC--CcEEEEE
Confidence 568888899999999999997654 78999999864322 57899999999999999999999988654 5579999
Q ss_pred eecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcccccccc
Q 000859 1025 EYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKA 1104 (1251)
Q Consensus 1025 E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~ 1104 (1251)
||+++++|.+++... ...+++..+..++.|++.|++|||+. +++||||+|+||+++.++.+||+|||.+..
T Consensus 78 e~~~~~~L~~~l~~~------~~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~ 148 (256)
T cd06612 78 EYCGAGSVSDIMKIT------NKTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQ 148 (256)
T ss_pred ecCCCCcHHHHHHhC------ccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchh
Confidence 999999999998753 35689999999999999999999999 999999999999999999999999999876
Q ss_pred cccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccchhh
Q 000859 1105 LVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSAR 1184 (1251)
Q Consensus 1105 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1184 (1251)
..... .......|+..|+|||++.+..++.++|||||||++|||++|+.||..........
T Consensus 149 ~~~~~----~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~--------------- 209 (256)
T cd06612 149 LTDTM----AKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIF--------------- 209 (256)
T ss_pred cccCc----cccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhh---------------
Confidence 53321 11223457889999999998899999999999999999999999997542221100
Q ss_pred hhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 000859 1185 EELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCD 1229 (1251)
Q Consensus 1185 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1229 (1251)
.......+....+...+..+.+++.+||+.||++|||++|+++
T Consensus 210 --~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 210 --MIPNKPPPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred --hhccCCCCCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 0000111122223334567899999999999999999999985
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=323.37 Aligned_cols=256 Identities=22% Similarity=0.281 Sum_probs=193.7
Q ss_pred cCCCcCceecccCCceEEEEEe-cCCcEEEEEEeccCC--chhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeE
Q 000859 946 NNLSDEFIIGSGGSGTVYKAEL-ANGATVAVKKISCKD--DHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLL 1022 (1251)
Q Consensus 946 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~l 1022 (1251)
++|++.+.||+|+||+||+++. .+++.||+|++.... .....+.+.+|+.+++.++|+||+++++++.. +...++
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~l 78 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQD--ENNLYL 78 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEec--CCeEEE
Confidence 3688889999999999999964 468999999986422 22334568889999999999999999998754 456799
Q ss_pred EEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcccccc
Q 000859 1023 IYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLA 1102 (1251)
Q Consensus 1023 v~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a 1102 (1251)
||||+++|+|.+++.+. ...+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 79 v~e~~~g~~L~~~l~~~------~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~ 149 (331)
T cd05597 79 VMDYYVGGDLLTLLSKF------EDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSC 149 (331)
T ss_pred EEecCCCCcHHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCce
Confidence 99999999999999753 34688999999999999999999999 9999999999999999999999999998
Q ss_pred cccccccCCCCcccceeecccceeccccccc-----CCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHH
Q 000859 1103 KALVEDYNSNTESNTWFAGSYGYIAPEYAYS-----LKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHM 1177 (1251)
Q Consensus 1103 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~ 1177 (1251)
..+.... ........||+.|+|||++.. ..++.++||||+||++|||++|+.||.+....+. .....
T Consensus 150 ~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~-----~~~i~ 221 (331)
T cd05597 150 LRLLADG---TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET-----YGKIM 221 (331)
T ss_pred eecCCCC---CccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHH-----HHHHH
Confidence 7653221 111223468999999999863 4578899999999999999999999975422111 11000
Q ss_pred hccchhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCC--CCCCHHHHHHH
Q 000859 1178 EMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQ--ERPSSRQVCDL 1230 (1251)
Q Consensus 1178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~--~RPs~~eil~~ 1230 (1251)
. . .......+.....+.++.+++.+|+..+++ .||+++++++.
T Consensus 222 ~--~--------~~~~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 222 N--H--------KEHFQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred c--C--------CCcccCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 0 0 000011111112455678889887765443 37899988876
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=319.33 Aligned_cols=268 Identities=21% Similarity=0.270 Sum_probs=197.5
Q ss_pred hcCCCcCceecccCCceEEEEEe-cCCcEEEEEEeccCCchhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEE
Q 000859 945 TNNLSDEFIIGSGGSGTVYKAEL-ANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLI 1023 (1251)
Q Consensus 945 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv 1023 (1251)
.++|...+.||+|+||.||+|.. .+++.||+|.+...........+.+|++++++++||||+++++++.. +...++|
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~--~~~~~lv 82 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHT--EKSLTLV 82 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEec--CCeEEEE
Confidence 35688889999999999999965 46889999998755444444567889999999999999999998854 4457999
Q ss_pred EeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEccccccc
Q 000859 1024 YEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAK 1103 (1251)
Q Consensus 1024 ~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~ 1103 (1251)
|||++ ++|.+++... ...+++..+..++.|+++||+|||+. +|+||||||+||++++++.+||+|||++.
T Consensus 83 ~e~~~-~~l~~~l~~~------~~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~ 152 (301)
T cd07873 83 FEYLD-KDLKQYLDDC------GNSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLAR 152 (301)
T ss_pred Eeccc-cCHHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchh
Confidence 99997 5999988754 34678999999999999999999999 99999999999999999999999999987
Q ss_pred ccccccCCCCcccceeecccceeccccccc-CCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccch
Q 000859 1104 ALVEDYNSNTESNTWFAGSYGYIAPEYAYS-LKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGS 1182 (1251)
Q Consensus 1104 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 1182 (1251)
...... .......++..|+|||.+.+ ..++.++||||+||++|||++|+.||......+. ..............
T Consensus 153 ~~~~~~----~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~-~~~~~~~~~~~~~~ 227 (301)
T cd07873 153 AKSIPT----KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQ-LHFIFRILGTPTEE 227 (301)
T ss_pred ccCCCC----CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHcCCCChh
Confidence 542211 11122356889999998765 4578899999999999999999999976533211 00000000000000
Q ss_pred hhhhhhccc-----CCCCCC------chHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 000859 1183 AREELLDDQ-----MKPLLP------GEECAAYQVLEIALQCTKTSPQERPSSRQVCD 1229 (1251)
Q Consensus 1183 ~~~~~~~~~-----~~~~~~------~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1229 (1251)
....+.... ..+... .....++.+.+++.+|++.||.+|||++|+++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 228 TWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred hchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 000000000 000000 01123456889999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=324.85 Aligned_cols=265 Identities=22% Similarity=0.328 Sum_probs=196.5
Q ss_pred hhcCCCcCceecccCCceEEEEE-ecCCcEEEEEEeccCC-chhhhHHHHHHHHHHHhccCCCccceeceeeecCC----
Q 000859 944 ATNNLSDEFIIGSGGSGTVYKAE-LANGATVAVKKISCKD-DHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGA---- 1017 (1251)
Q Consensus 944 ~~~~~~~~~~lG~G~fg~V~~~~-~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~---- 1017 (1251)
..++|...+.||+|+||+||+|. ..+++.||||++.... .....+.+.+|++++++++||||+++++++.....
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 45678999999999999999995 4578899999986443 22234567789999999999999999997753321
Q ss_pred CceeEEEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEc
Q 000859 1018 GSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLG 1097 (1251)
Q Consensus 1018 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~ 1097 (1251)
...++++|++ +++|.++++. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~~--------~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~ 160 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVKC--------QKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRIL 160 (343)
T ss_pred CcEEEEeecC-CCCHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEc
Confidence 3358899988 7899888764 3589999999999999999999999 99999999999999999999999
Q ss_pred ccccccccccccCCCCcccceeecccceeccccccc-CCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHH
Q 000859 1098 DFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYS-LKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMH 1176 (1251)
Q Consensus 1098 DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~ 1176 (1251)
|||+++..... .....||..|+|||++.+ ..++.++||||+||++|||++|+.||.+....+ ....+....
T Consensus 161 Dfg~~~~~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~~~~~~ 232 (343)
T cd07878 161 DFGLARQADDE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYID-QLKRIMEVV 232 (343)
T ss_pred CCccceecCCC-------cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH-HHHHHHHHh
Confidence 99999764321 123468999999999876 568999999999999999999999997543211 111111110
Q ss_pred Hhc--------cchhhhhhhcccCCCCCCch------HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 000859 1177 MEM--------SGSAREELLDDQMKPLLPGE------ECAAYQVLEIALQCTKTSPQERPSSRQVCDL 1230 (1251)
Q Consensus 1177 ~~~--------~~~~~~~~~~~~~~~~~~~~------~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 1230 (1251)
... ........... + +..+.. ....+.+.+++.+|++.||++|||++|+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~-~-~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 233 GTPSPEVLKKISSEHARKYIQS-L-PHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred CCCCHHHHHhcchhhHHHHhhc-c-ccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000 00000000000 0 001100 0123457899999999999999999999864
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-33 Score=314.49 Aligned_cols=263 Identities=27% Similarity=0.383 Sum_probs=204.8
Q ss_pred CCCcCceecccCCceEEEEEe-cCCcEEEEEEeccCCchhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEEEe
Q 000859 947 NLSDEFIIGSGGSGTVYKAEL-ANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIYE 1025 (1251)
Q Consensus 947 ~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv~E 1025 (1251)
+|+..+.||.|++|.||+|.. .+++.||+|.+...........+.+|++++++++||||++++++|........++|||
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e 81 (287)
T cd06621 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAME 81 (287)
T ss_pred ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEE
Confidence 577788999999999999965 4689999999876555455678899999999999999999999987766667899999
Q ss_pred ecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEccccccccc
Q 000859 1026 YMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKAL 1105 (1251)
Q Consensus 1026 ~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~ 1105 (1251)
|+++++|.+++.... .....++...+..++.|++.|++|||+. +++|+||+|+||+++.++.++|+|||++...
T Consensus 82 ~~~~~~L~~~l~~~~---~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~ 155 (287)
T cd06621 82 YCEGGSLDSIYKKVK---KRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGEL 155 (287)
T ss_pred ecCCCCHHHHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeeccccccc
Confidence 999999999876421 1235578899999999999999999999 9999999999999999999999999998654
Q ss_pred ccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccchhhh
Q 000859 1106 VEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSARE 1185 (1251)
Q Consensus 1106 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1185 (1251)
.... .....++..|+|||.+.+..++.++||||+||++|||++|+.||+..........+......... .
T Consensus 156 ~~~~------~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~- 225 (287)
T cd06621 156 VNSL------AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMP---N- 225 (287)
T ss_pred cccc------cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCC---c-
Confidence 3211 11245788999999999889999999999999999999999999765321111111111111000 0
Q ss_pred hhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 000859 1186 ELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCD 1229 (1251)
Q Consensus 1186 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1229 (1251)
.............+..+.+++.+||+.+|++|||+.|+++
T Consensus 226 ----~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 226 ----PELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred ----hhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 0000111111224567899999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=311.72 Aligned_cols=254 Identities=24% Similarity=0.395 Sum_probs=199.8
Q ss_pred CCCcCceecccCCceEEEEEecCCcEEEEEEeccCCc-----hhhhHHHHHHHHHHHhccCCCccceeceeeecCCCcee
Q 000859 947 NLSDEFIIGSGGSGTVYKAELANGATVAVKKISCKDD-----HLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNL 1021 (1251)
Q Consensus 947 ~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~ 1021 (1251)
+|...+.||+|+||+||+|...+++.||||.+..... ....+.+.+|++++++++|+||+++++++.+. ...+
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~ 78 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDD--NTIS 78 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecC--CeEE
Confidence 4677889999999999999888899999999864431 22345688999999999999999999988654 5679
Q ss_pred EEEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEccccc
Q 000859 1022 LIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGL 1101 (1251)
Q Consensus 1022 lv~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~ 1101 (1251)
+|+||+++++|.+++.+. ..+++..+..++.|++.|++|||+. +|+|+||+|+||++++++.+||+|||.
T Consensus 79 lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~ 148 (265)
T cd06631 79 IFMEFVPGGSISSILNRF-------GPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGC 148 (265)
T ss_pred EEEecCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchh
Confidence 999999999999999763 4578999999999999999999999 999999999999999999999999999
Q ss_pred ccccccccC--CCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhc
Q 000859 1102 AKALVEDYN--SNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEM 1179 (1251)
Q Consensus 1102 a~~~~~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 1179 (1251)
+........ ..........|+..|+|||++.+..++.++||||+||++||+++|+.||......+... ....
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~--~~~~---- 222 (265)
T cd06631 149 ARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMF--YIGA---- 222 (265)
T ss_pred hHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHH--Hhhh----
Confidence 876432111 11111223468899999999998889999999999999999999999997542211100 0000
Q ss_pred cchhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 000859 1180 SGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCD 1229 (1251)
Q Consensus 1180 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1229 (1251)
.....+.. +...+.++.+++.+||+.+|++||++.++++
T Consensus 223 ---------~~~~~~~~--~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 223 ---------HRGLMPRL--PDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred ---------ccCCCCCC--CCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00000111 1224566889999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=313.65 Aligned_cols=253 Identities=34% Similarity=0.498 Sum_probs=196.9
Q ss_pred CCcCceecccCCceEEEEEec-CCcEEEEEEeccCCchhhh-HHHHHHHHHHHhccCCCccceeceeeecCCCceeEEEe
Q 000859 948 LSDEFIIGSGGSGTVYKAELA-NGATVAVKKISCKDDHLLN-KSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIYE 1025 (1251)
Q Consensus 948 ~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~-~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv~E 1025 (1251)
|+..+.||+|+||+||+|+.. +++.||+|++......... ....+|+.++++++||||+++++++.. ....++|||
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~--~~~~~~v~~ 78 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQD--DNYLYIVME 78 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEE--SSEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccc--ccccccccc
Confidence 456779999999999999654 5678999999876544332 244569999999999999999998866 455689999
Q ss_pred ecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEccccccccc
Q 000859 1026 YMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKAL 1105 (1251)
Q Consensus 1026 ~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~ 1105 (1251)
|+++++|.+++.. ...+++.++..++.|+++|++|||+. +|+|+||||+||++++++.++|+|||.+...
T Consensus 79 ~~~~~~L~~~l~~-------~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~ 148 (260)
T PF00069_consen 79 YCPGGSLQDYLQK-------NKPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKL 148 (260)
T ss_dssp EETTEBHHHHHHH-------HSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEES
T ss_pred ccccccccccccc-------cccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccc
Confidence 9999999999983 35689999999999999999999999 9999999999999999999999999998754
Q ss_pred ccccCCCCcccceeecccceecccccc-cCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccchhh
Q 000859 1106 VEDYNSNTESNTWFAGSYGYIAPEYAY-SLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSAR 1184 (1251)
Q Consensus 1106 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1184 (1251)
. ..........++..|+|||++. +..++.++||||+|+++|+|++|..||...... +.......... ....
T Consensus 149 ~----~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~--~~~~~~~~~~~--~~~~ 220 (260)
T PF00069_consen 149 S----ENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSD--DQLEIIEKILK--RPLP 220 (260)
T ss_dssp T----STTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHH--HHHHHHHHHHH--THHH
T ss_pred c----ccccccccccccccccccccccccccccccccccccccccccccccccccccccch--hhhhhhhhccc--cccc
Confidence 1 1122223357899999999998 888999999999999999999999999865111 11111111110 0000
Q ss_pred hhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 000859 1185 EELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCD 1229 (1251)
Q Consensus 1185 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1229 (1251)
... .........+.+++.+|++.||++||++.++++
T Consensus 221 ~~~---------~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 221 SSS---------QQSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp HHT---------TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred ccc---------cccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000 000011267999999999999999999999875
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=310.10 Aligned_cols=252 Identities=28% Similarity=0.441 Sum_probs=199.5
Q ss_pred cCCCcCceecccCCceEEEEEecCCcEEEEEEeccCCchhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEEEe
Q 000859 946 NNLSDEFIIGSGGSGTVYKAELANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIYE 1025 (1251)
Q Consensus 946 ~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv~E 1025 (1251)
.+|+..+.||+|+||.||+|.+.+++.+|+|++..... ..+.+.+|++++++++||+++++++++... ...++|||
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~~v~e 79 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM--SEEDFIEEAQVMMKLSHPKLVQLYGVCTER--SPICLVFE 79 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC--CHHHHHHHHHHHHhCCCCCeeeEEEEEccC--CceEEEEE
Confidence 45777889999999999999877788999999864332 346788999999999999999999987544 45689999
Q ss_pred ecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEccccccccc
Q 000859 1026 YMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKAL 1105 (1251)
Q Consensus 1026 ~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~ 1105 (1251)
|+++|+|.+++... ...++++.+..++.|++.|++|||+. +++||||||+||+++.++.+||+|||.++..
T Consensus 80 ~~~~~~L~~~~~~~------~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~ 150 (256)
T cd05112 80 FMEHGCLSDYLRAQ------RGKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFV 150 (256)
T ss_pred cCCCCcHHHHHHhC------ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeec
Confidence 99999999998754 24578999999999999999999999 9999999999999999999999999998765
Q ss_pred ccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhh-CCCCCCCccccchhHHHHHHHHHhccchhh
Q 000859 1106 VEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMVRWVEMHMEMSGSAR 1184 (1251)
Q Consensus 1106 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1184 (1251)
..... .......++.+|+|||.+.+..++.++||||+|+++||+++ |+.||......+ ..+....
T Consensus 151 ~~~~~---~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~-----~~~~~~~------ 216 (256)
T cd05112 151 LDDQY---TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE-----VVETINA------ 216 (256)
T ss_pred ccCcc---cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHH-----HHHHHhC------
Confidence 32211 11122345678999999998889999999999999999998 999987542211 1111100
Q ss_pred hhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 000859 1185 EELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLL 1232 (1251)
Q Consensus 1185 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 1232 (1251)
...... +...+..+.+++.+||+.+|++|||++++++.|.
T Consensus 217 ------~~~~~~--~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 217 ------GFRLYK--PRLASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred ------CCCCCC--CCCCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 000000 1113467899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-33 Score=312.59 Aligned_cols=261 Identities=23% Similarity=0.379 Sum_probs=202.4
Q ss_pred cCCCcCceecccCCceEEEEEec------CCcEEEEEEeccCCchhhhHHHHHHHHHHHhccCCCccceeceeeecCCCc
Q 000859 946 NNLSDEFIIGSGGSGTVYKAELA------NGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGS 1019 (1251)
Q Consensus 946 ~~~~~~~~lG~G~fg~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 1019 (1251)
.+|+....||+|+||.||+|+.+ +.+.||+|.+.........+.+.+|++++++++||||+++++++... ..
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~ 82 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREA--EP 82 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCC--Cc
Confidence 46788889999999999999754 34679999986555444567899999999999999999999987543 44
Q ss_pred eeEEEeecCCCChHHhhhcCCCCc--ccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEc
Q 000859 1020 NLLIYEYMENGSVWDWLHKQPVNI--KMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLG 1097 (1251)
Q Consensus 1020 ~~lv~E~~~~gsL~~~l~~~~~~~--~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~ 1097 (1251)
.++||||+++|+|.+++....... .....+++..+..++.|++.|++|||+. +|+||||||+||+++.++.++++
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~ 159 (275)
T cd05046 83 HYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVS 159 (275)
T ss_pred ceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEc
Confidence 699999999999999997643111 1122689999999999999999999999 99999999999999999999999
Q ss_pred ccccccccccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhh-CCCCCCCccccchhHHHHHHHH
Q 000859 1098 DFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMVRWVEMH 1176 (1251)
Q Consensus 1098 DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~ 1176 (1251)
|||+++...... ........++..|+|||.+.+..++.++||||+|+++||+++ |..||....... .+...
T Consensus 160 ~~~~~~~~~~~~---~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~-----~~~~~ 231 (275)
T cd05046 160 LLSLSKDVYNSE---YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE-----VLNRL 231 (275)
T ss_pred ccccccccCccc---ccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH-----HHHHH
Confidence 999986543221 111222356788999999988889999999999999999999 888986432211 11111
Q ss_pred HhccchhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 000859 1177 MEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLL 1232 (1251)
Q Consensus 1177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 1232 (1251)
.. ... ..+.....+..+.+++.+||+.+|++|||+.|+++.|.
T Consensus 232 ~~-----------~~~--~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 232 QA-----------GKL--ELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred Hc-----------CCc--CCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 00 000 01112234567899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=316.73 Aligned_cols=265 Identities=24% Similarity=0.345 Sum_probs=202.3
Q ss_pred HHHHHHhhcCCCcCceecccCCceEEEEEe-cCCcEEEEEEeccCCchhhhHHHHHHHHHHHhc-cCCCccceeceeeec
Q 000859 938 WEDIMGATNNLSDEFIIGSGGSGTVYKAEL-ANGATVAVKKISCKDDHLLNKSFTREVKTLGRI-RHRHLVKLMGHCCNK 1015 (1251)
Q Consensus 938 ~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~ 1015 (1251)
+++.....++|++.+.||+|+||.||+|.. .+++.||+|++..... ..+.+..|+.+++++ +||||+++++++...
T Consensus 10 ~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~--~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 87 (286)
T cd06638 10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD--IDEEIEAEYNILKALSDHPNVVKFYGMYYKK 87 (286)
T ss_pred eecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccc--hHHHHHHHHHHHHHHhcCCCeeeeeeeeeec
Confidence 344455678899999999999999999954 4688999998754322 235678899999999 699999999987542
Q ss_pred ---CCCceeEEEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCC
Q 000859 1016 ---GAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNM 1092 (1251)
Q Consensus 1016 ---~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~ 1092 (1251)
.....++||||+++|+|.++++... .....+++..+..++.|+++|+.|||+. +|+||||||+||++++++
T Consensus 88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~ 161 (286)
T cd06638 88 DVKNGDQLWLVLELCNGGSVTDLVKGFL---KRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEG 161 (286)
T ss_pred ccCCCCeEEEEEeecCCCCHHHHHHHhh---ccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCC
Confidence 2345799999999999999886421 1135688999999999999999999999 999999999999999999
Q ss_pred CeEEcccccccccccccCCCCcccceeecccceeccccccc-----CCCCCccceeehhHHHHHHhhCCCCCCCccccch
Q 000859 1093 EAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYS-----LKATEKCDVYSMGIVLMELVSGKMPTDATFGVEM 1167 (1251)
Q Consensus 1093 ~~kl~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~ 1167 (1251)
.+|++|||.++...... .......|+..|+|||++.. ..++.++||||+||++|||++|+.||........
T Consensus 162 ~~kl~dfg~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~ 237 (286)
T cd06638 162 GVKLVDFGVSAQLTSTR----LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA 237 (286)
T ss_pred CEEEccCCceeecccCC----CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHH
Confidence 99999999987653211 11223468999999998753 4578899999999999999999999975422110
Q ss_pred hHHHHHHHHHhccchhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 000859 1168 DMVRWVEMHMEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLL 1231 (1251)
Q Consensus 1168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L 1231 (1251)
.. .. .....+....+...+.++.+++.+||+.||++|||++|+++..
T Consensus 238 ----~~----~~---------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 238 ----LF----KI---------PRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred ----Hh----hc---------cccCCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 00 00 0000011111222345688999999999999999999998753
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-33 Score=307.48 Aligned_cols=249 Identities=27% Similarity=0.432 Sum_probs=197.8
Q ss_pred ceecccCCceEEEEEecCCcEEEEEEeccCCchhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEEEeecCCCC
Q 000859 952 FIIGSGGSGTVYKAELANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIYEYMENGS 1031 (1251)
Q Consensus 952 ~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv~E~~~~gs 1031 (1251)
++||+|+||.||+|...+++.||+|++.........+.+.+|++++++++||||+++++++... ...++||||+++++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~~v~e~~~~~~ 78 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQK--QPIYIVMELVPGGS 78 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecC--CCeEEEEEcCCCCc
Confidence 3699999999999977669999999987655544567899999999999999999999987654 45699999999999
Q ss_pred hHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcccccccccccccCC
Q 000859 1032 VWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNS 1111 (1251)
Q Consensus 1032 L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 1111 (1251)
|.+++... ...+++..+..++.+++.|++|||+. +++||||||+||+++.++.+||+|||.+.........
T Consensus 79 l~~~l~~~------~~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~ 149 (251)
T cd05041 79 LLTFLRKK------KNRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYT 149 (251)
T ss_pred HHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcce
Confidence 99999753 24578999999999999999999999 9999999999999999999999999998754321111
Q ss_pred CCcccceeecccceecccccccCCCCCccceeehhHHHHHHhh-CCCCCCCccccchhHHHHHHHHHhccchhhhhhhcc
Q 000859 1112 NTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMVRWVEMHMEMSGSAREELLDD 1190 (1251)
Q Consensus 1112 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1190 (1251)
.......++..|+|||.+.+..++.++|+||+||++|||+| |..||........ .... ..
T Consensus 150 --~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~--~~~~---------------~~ 210 (251)
T cd05041 150 --VSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQT--RERI---------------ES 210 (251)
T ss_pred --eccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHH--HHHH---------------hc
Confidence 11111234667999999988899999999999999999999 8889865432111 1100 00
Q ss_pred cCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 000859 1191 QMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLL 1232 (1251)
Q Consensus 1191 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 1232 (1251)
.. ..+.+...+.++.+++.+|++.+|++|||++|+++.|.
T Consensus 211 ~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 211 GY--RMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred CC--CCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 00 11112234567999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-33 Score=310.36 Aligned_cols=253 Identities=26% Similarity=0.384 Sum_probs=201.3
Q ss_pred cCCCcCceecccCCceEEEEEe-cCCcEEEEEEeccCCchhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEEE
Q 000859 946 NNLSDEFIIGSGGSGTVYKAEL-ANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIY 1024 (1251)
Q Consensus 946 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv~ 1024 (1251)
++|+..+.||+|+||.||+|.. .+++.+|+|++...... ..+.+.+|++++++++||||+++++++.. ....+++|
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~l~~ 79 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD-DFEIIQQEISMLKECRHPNIVAYFGSYLR--RDKLWIVM 79 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh-hHHHHHHHHHHHHhCCCCChhceEEEEEe--CCEEEEEE
Confidence 5688889999999999999965 46789999999755433 55788999999999999999999998755 34579999
Q ss_pred eecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcccccccc
Q 000859 1025 EYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKA 1104 (1251)
Q Consensus 1025 E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~ 1104 (1251)
||+++++|.+++... ...+++..+..++.|++.|++|||+. +|+|+||+|+||++++++.+||+|||.+..
T Consensus 80 e~~~~~~l~~~~~~~------~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~ 150 (262)
T cd06613 80 EYCGGGSLQDIYQVT------RGPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQ 150 (262)
T ss_pred eCCCCCcHHHHHHhh------ccCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchh
Confidence 999999999998763 25688999999999999999999999 999999999999999999999999999876
Q ss_pred cccccCCCCcccceeecccceecccccccC---CCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccc
Q 000859 1105 LVEDYNSNTESNTWFAGSYGYIAPEYAYSL---KATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSG 1181 (1251)
Q Consensus 1105 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 1181 (1251)
..... .......++..|+|||.+.+. .++.++|+||+||++|||++|+.||......+.... ..
T Consensus 151 ~~~~~----~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~-----~~---- 217 (262)
T cd06613 151 LTATI----AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFL-----IS---- 217 (262)
T ss_pred hhhhh----hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH-----HH----
Confidence 53221 112234678899999998776 789999999999999999999999975432211000 00
Q ss_pred hhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 000859 1182 SAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCD 1229 (1251)
Q Consensus 1182 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1229 (1251)
. ..............+.++.+++.+||+.+|.+|||+++|+.
T Consensus 218 --~----~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 218 --K----SNFPPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred --h----ccCCCccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0 00000111123335667899999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=315.69 Aligned_cols=262 Identities=28% Similarity=0.422 Sum_probs=203.5
Q ss_pred cCCCcCceecccCCceEEEEEe-cCCcEEEEEEeccCCchhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEEE
Q 000859 946 NNLSDEFIIGSGGSGTVYKAEL-ANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIY 1024 (1251)
Q Consensus 946 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv~ 1024 (1251)
++|+..+.||+|+||+||+|.. .+++.||+|++.........+.+.+|+++++.++||||+++++++... ...++||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~ 82 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNE--NNICMCM 82 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecC--CEEEEEE
Confidence 3567778999999999999965 468899999987665555667899999999999999999999988654 5679999
Q ss_pred eecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcccccccc
Q 000859 1025 EYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKA 1104 (1251)
Q Consensus 1025 E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~ 1104 (1251)
||+++|+|.+++.+ .+.+++..+..++.+++.|+.|||+.+ +++||||||+||+++.++.++|+|||++..
T Consensus 83 e~~~~~~L~~~~~~-------~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~ 153 (284)
T cd06620 83 EFMDCGSLDRIYKK-------GGPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGE 153 (284)
T ss_pred ecCCCCCHHHHHHh-------ccCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccc
Confidence 99999999999876 346899999999999999999999731 899999999999999999999999999865
Q ss_pred cccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccchhh
Q 000859 1105 LVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSAR 1184 (1251)
Q Consensus 1105 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1184 (1251)
.... ......|+..|+|||++.+..++.++|||||||++||+++|+.||......+........ .. ...
T Consensus 154 ~~~~------~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~-~~----~~~ 222 (284)
T cd06620 154 LINS------IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMG-IL----DLL 222 (284)
T ss_pred hhhh------ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhH-HH----HHH
Confidence 4221 112346899999999998889999999999999999999999999865432110000000 00 000
Q ss_pred hhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 000859 1185 EELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLL 1231 (1251)
Q Consensus 1185 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L 1231 (1251)
....... .+.++ ....+.++.+++.+|++.||++|||++|++++.
T Consensus 223 ~~~~~~~-~~~~~-~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 223 QQIVQEP-PPRLP-SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred HHHhhcc-CCCCC-chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 1111110 11111 122456789999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=314.78 Aligned_cols=260 Identities=23% Similarity=0.351 Sum_probs=200.2
Q ss_pred HHHHHHhhcCCCcCceecccCCceEEEEEe-cCCcEEEEEEeccCCchhhhHHHHHHHHHHHhc-cCCCccceeceeeec
Q 000859 938 WEDIMGATNNLSDEFIIGSGGSGTVYKAEL-ANGATVAVKKISCKDDHLLNKSFTREVKTLGRI-RHRHLVKLMGHCCNK 1015 (1251)
Q Consensus 938 ~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~ 1015 (1251)
..+.......|+..+.||+|+||.||+|.. .+++.||+|++.... .....+..|+.+++++ +||||+++++++...
T Consensus 8 ~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 8 LSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE--DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh--HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 334444566788889999999999999965 568899999985432 2345688899999999 799999999987643
Q ss_pred ----CCCceeEEEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCC
Q 000859 1016 ----GAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSN 1091 (1251)
Q Consensus 1016 ----~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~ 1091 (1251)
.....+++|||+++|+|.+++.... ...+++..+..++.|++.|++|||+. +|+|||+||+||+++++
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~ 157 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTK-----GNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTEN 157 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHcc-----CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCC
Confidence 2345789999999999999997643 34578888999999999999999999 99999999999999999
Q ss_pred CCeEEcccccccccccccCCCCcccceeecccceecccccc-----cCCCCCccceeehhHHHHHHhhCCCCCCCccccc
Q 000859 1092 MEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAY-----SLKATEKCDVYSMGIVLMELVSGKMPTDATFGVE 1166 (1251)
Q Consensus 1092 ~~~kl~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~ 1166 (1251)
+.++|+|||.+....... .......|+..|+|||.+. ...++.++||||+||++|||++|+.||......+
T Consensus 158 ~~~~l~dfg~~~~~~~~~----~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~ 233 (282)
T cd06636 158 AEVKLVDFGVSAQLDRTV----GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMR 233 (282)
T ss_pred CCEEEeeCcchhhhhccc----cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHh
Confidence 999999999987543211 1122356889999999875 3467889999999999999999999996542211
Q ss_pred hhHHHHHHHHHhccchhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 000859 1167 MDMVRWVEMHMEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCD 1229 (1251)
Q Consensus 1167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1229 (1251)
.. .. ......+.. .....+.++.+++.+||+.||.+||++.|+++
T Consensus 234 ~~----~~-------------~~~~~~~~~-~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 234 AL----FL-------------IPRNPPPKL-KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred hh----hh-------------HhhCCCCCC-cccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 10 00 000000111 11234567899999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=322.15 Aligned_cols=270 Identities=20% Similarity=0.272 Sum_probs=193.7
Q ss_pred Cceeccc--CCceEEEEE-ecCCcEEEEEEeccCC-chhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEEEee
Q 000859 951 EFIIGSG--GSGTVYKAE-LANGATVAVKKISCKD-DHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIYEY 1026 (1251)
Q Consensus 951 ~~~lG~G--~fg~V~~~~-~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv~E~ 1026 (1251)
..+||+| +||+||++. ..+|+.||||++.... .....+.+.+|+++++.++||||+++++++..+ ...++||||
T Consensus 3 ~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~--~~~~lv~e~ 80 (327)
T cd08227 3 LTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIAD--NELWVVTSF 80 (327)
T ss_pred hhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEEC--CEEEEEEec
Confidence 4579999 788999995 4678999999997543 233445677899999999999999999988654 457999999
Q ss_pred cCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcccccccccc
Q 000859 1027 MENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALV 1106 (1251)
Q Consensus 1027 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~ 1106 (1251)
+++|+|.+++.... ...+++..+++++.|++.||+|||++ +|+||||||+||+++.++.++++|||.+....
T Consensus 81 ~~~~~l~~~~~~~~-----~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~ 152 (327)
T cd08227 81 MAYGSAKDLICTHF-----MDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMI 152 (327)
T ss_pred cCCCcHHHHHHhhc-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhccc
Confidence 99999999997542 34589999999999999999999999 99999999999999999999999998764432
Q ss_pred cccCC---CCcccceeecccceeccccccc--CCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccc
Q 000859 1107 EDYNS---NTESNTWFAGSYGYIAPEYAYS--LKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSG 1181 (1251)
Q Consensus 1107 ~~~~~---~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 1181 (1251)
..... .........++..|+|||++.+ ..++.++|||||||++|||++|+.||......................
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 232 (327)
T cd08227 153 NHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLD 232 (327)
T ss_pred cccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCcccccc
Confidence 11110 0111122356788999999876 458999999999999999999999997543221111100000000000
Q ss_pred ---hhhhhh--------hc----c-c----CC------CCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 000859 1182 ---SAREEL--------LD----D-Q----MK------PLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDL 1230 (1251)
Q Consensus 1182 ---~~~~~~--------~~----~-~----~~------~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 1230 (1251)
...++. .+ . . .. ...+.....++.+.+++.+||+.||++|||++|+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~ 307 (327)
T cd08227 233 TTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 307 (327)
T ss_pred ccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence 000000 00 0 0 00 0001122345678999999999999999999999863
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-33 Score=308.83 Aligned_cols=252 Identities=22% Similarity=0.354 Sum_probs=199.9
Q ss_pred CCCcCceecccCCceEEEEEe-cCCcEEEEEEeccCC-chhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEEE
Q 000859 947 NLSDEFIIGSGGSGTVYKAEL-ANGATVAVKKISCKD-DHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIY 1024 (1251)
Q Consensus 947 ~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv~ 1024 (1251)
+|+..+.||+|++|.||++.. .+++.||+|++.... .....+.+.+|++++++++|+|++++++.+... ....+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~~lv~ 79 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGE-DGLLYIVM 79 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCC-CCEEEEEe
Confidence 477888999999999999954 467899999986543 233456788999999999999999999876432 33468999
Q ss_pred eecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcccccccc
Q 000859 1025 EYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKA 1104 (1251)
Q Consensus 1025 E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~ 1104 (1251)
||+++++|.+++.... ...+++.++..++.|++.|++|||+. +|+||||||+||+++.++.++|+|||++..
T Consensus 80 e~~~~~~l~~~l~~~~-----~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~ 151 (257)
T cd08223 80 GFCEGGDLYHKLKEQK-----GKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARV 151 (257)
T ss_pred cccCCCcHHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEE
Confidence 9999999999997632 34689999999999999999999999 999999999999999999999999999876
Q ss_pred cccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccchhh
Q 000859 1105 LVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSAR 1184 (1251)
Q Consensus 1105 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1184 (1251)
..... .......+++.|+|||+..+..++.++||||+|+++||+++|+.||...... .+.....
T Consensus 152 ~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~-----~~~~~~~------- 215 (257)
T cd08223 152 LENQC----DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMN-----SLVYRII------- 215 (257)
T ss_pred ecccC----CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH-----HHHHHHH-------
Confidence 53221 1222346789999999999989999999999999999999999998754211 1111110
Q ss_pred hhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 000859 1185 EELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDL 1230 (1251)
Q Consensus 1185 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 1230 (1251)
.... + +.+...+.++.+++.+|++.||++|||+.++++.
T Consensus 216 ----~~~~-~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 216 ----EGKL-P--PMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred ----hcCC-C--CCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0000 1 1122355678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-33 Score=313.79 Aligned_cols=254 Identities=24% Similarity=0.385 Sum_probs=198.7
Q ss_pred CCCcCceecccCCceEEEEEec-CCcEEEEEEeccCCchhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEEEe
Q 000859 947 NLSDEFIIGSGGSGTVYKAELA-NGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIYE 1025 (1251)
Q Consensus 947 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv~E 1025 (1251)
+|+..+.||+|+||.||+|... +++.||+|.+.........+.+.+|++++++++||||+++++.+.. +...++|||
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~lv~e 79 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFI--EGAVYMCME 79 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheec--CCeEEEEEe
Confidence 5778889999999999999664 7899999998755444455788999999999999999999998765 456799999
Q ss_pred ecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEccccccccc
Q 000859 1026 YMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKAL 1105 (1251)
Q Consensus 1026 ~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~ 1105 (1251)
|+++++|.++++... ....+++..+.+++.|++.|+.|||+.+ +|+||||||+||+++.++.+||+|||.+..+
T Consensus 80 ~~~~~~l~~~~~~~~----~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 153 (286)
T cd06622 80 YMDAGSLDKLYAGGV----ATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNL 153 (286)
T ss_pred ecCCCCHHHHHHhcc----ccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 999999999987531 1346899999999999999999999631 8999999999999999999999999998765
Q ss_pred ccccCCCCcccceeecccceecccccccC------CCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhc
Q 000859 1106 VEDYNSNTESNTWFAGSYGYIAPEYAYSL------KATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEM 1179 (1251)
Q Consensus 1106 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 1179 (1251)
.... .....++..|+|||.+.+. .++.++||||+||++|||++|+.||........ ....
T Consensus 154 ~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~-----~~~~--- 219 (286)
T cd06622 154 VASL------AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANI-----FAQL--- 219 (286)
T ss_pred cCCc------cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhH-----HHHH---
Confidence 3211 1223578899999988544 357899999999999999999999965422111 0000
Q ss_pred cchhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 000859 1180 SGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDL 1230 (1251)
Q Consensus 1180 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 1230 (1251)
...... ..+.. +...+.++.+++.+||+.+|++||+++++++.
T Consensus 220 -----~~~~~~-~~~~~--~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 220 -----SAIVDG-DPPTL--PSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred -----HHHhhc-CCCCC--CcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 011110 01111 22256778999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-33 Score=307.86 Aligned_cols=251 Identities=24% Similarity=0.389 Sum_probs=201.8
Q ss_pred CCCcCceecccCCceEEEEE-ecCCcEEEEEEeccCC-chhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEEE
Q 000859 947 NLSDEFIIGSGGSGTVYKAE-LANGATVAVKKISCKD-DHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIY 1024 (1251)
Q Consensus 947 ~~~~~~~lG~G~fg~V~~~~-~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv~ 1024 (1251)
+|+..+.||+|+||.||.++ ..+++.||+|++.... .....+.+.+|++++++++|+||+++++++.+. ...+++|
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--~~~~~~~ 78 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDD--NTLLIEM 78 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecC--CeEEEEE
Confidence 47888999999999999984 4568999999986543 344556788999999999999999999988653 4579999
Q ss_pred eecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcccccccc
Q 000859 1025 EYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKA 1104 (1251)
Q Consensus 1025 E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~ 1104 (1251)
||+++|+|.+++.... ...+++..+..++.|+++|++|||+. +++||||+|+||++++++.+||+|||.+..
T Consensus 79 e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~ 150 (256)
T cd08221 79 EYANGGTLYDKIVRQK-----GQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKI 150 (256)
T ss_pred EecCCCcHHHHHHhcc-----ccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEE
Confidence 9999999999997642 34689999999999999999999999 999999999999999999999999999976
Q ss_pred cccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccchhh
Q 000859 1105 LVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSAR 1184 (1251)
Q Consensus 1105 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1184 (1251)
...... ......|+..|+|||...+..++.++||||+|+++|||++|+.||......+ ....
T Consensus 151 ~~~~~~----~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~-----~~~~--------- 212 (256)
T cd08221 151 LGSEYS----MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLN-----LVVK--------- 212 (256)
T ss_pred cccccc----cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHH-----HHHH---------
Confidence 533221 1223468899999999988889999999999999999999999997542211 1110
Q ss_pred hhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 000859 1185 EELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDL 1230 (1251)
Q Consensus 1185 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 1230 (1251)
....... +.....+.++.+++.+||+.+|++||+++++++.
T Consensus 213 --~~~~~~~---~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 213 --IVQGNYT---PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred --HHcCCCC---CCccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 0011111 1112345678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=347.67 Aligned_cols=256 Identities=29% Similarity=0.387 Sum_probs=202.9
Q ss_pred hcCCCcCceecccCCceEEEE-EecCCcEEEEEEeccCCc-hhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeE
Q 000859 945 TNNLSDEFIIGSGGSGTVYKA-ELANGATVAVKKISCKDD-HLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLL 1022 (1251)
Q Consensus 945 ~~~~~~~~~lG~G~fg~V~~~-~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~l 1022 (1251)
+-++....+||.|.||.||.| ...+|+-.|+|-++.... ....+.+.+|+.++..+.|||+|++||+-... ...+|
T Consensus 1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHR--ekv~I 1311 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHR--EKVYI 1311 (1509)
T ss_pred eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecH--HHHHH
Confidence 345666778999999999999 567799999999876543 33456678999999999999999999966543 44689
Q ss_pred EEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcccccc
Q 000859 1023 IYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLA 1102 (1251)
Q Consensus 1023 v~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a 1102 (1251)
.||||++|+|.+.++.. +..++.....+..|++.|++|||++ |||||||||+||+++.+|.+|.+|||.|
T Consensus 1312 FMEyC~~GsLa~ll~~g-------ri~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa 1381 (1509)
T KOG4645|consen 1312 FMEYCEGGSLASLLEHG-------RIEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSA 1381 (1509)
T ss_pred HHHHhccCcHHHHHHhc-------chhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccce
Confidence 99999999999998763 3455666667888999999999999 9999999999999999999999999999
Q ss_pred cccccccCCCCcccceeecccceecccccccCC---CCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhc
Q 000859 1103 KALVEDYNSNTESNTWFAGSYGYIAPEYAYSLK---ATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEM 1179 (1251)
Q Consensus 1103 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 1179 (1251)
..+........+.-....||+.|||||++.+.. ...++||||+|||+.||+||+.||...+. +|..++.-
T Consensus 1382 ~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn------e~aIMy~V- 1454 (1509)
T KOG4645|consen 1382 VKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN------EWAIMYHV- 1454 (1509)
T ss_pred eEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc------hhHHHhHH-
Confidence 988766433334445678999999999997654 56789999999999999999999975533 12222211
Q ss_pred cchhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 000859 1180 SGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDL 1230 (1251)
Q Consensus 1180 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 1230 (1251)
.+....+.++..+.+-.+++..|+..||++|.++.|+++.
T Consensus 1455 -----------~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1455 -----------AAGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred -----------hccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 1112223334467778899999999999999888866543
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=313.82 Aligned_cols=251 Identities=24% Similarity=0.333 Sum_probs=195.3
Q ss_pred CCCcCceecccCCceEEEEEe-cCCcEEEEEEeccCCchhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEEEe
Q 000859 947 NLSDEFIIGSGGSGTVYKAEL-ANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIYE 1025 (1251)
Q Consensus 947 ~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv~E 1025 (1251)
+|...+.||+|+||.||+|.. .+++.||+|+++.... .....+.+|+.+++.++||||+++++++.. ....++|+|
T Consensus 10 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~--~~~~~lv~e 86 (267)
T cd06645 10 DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPG-EDFAVVQQEIIMMKDCKHSNIVAYFGSYLR--RDKLWICME 86 (267)
T ss_pred HHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhCCCCCeeeEEEEEEe--CCEEEEEEe
Confidence 466677899999999999954 5689999999865433 234567889999999999999999998755 345799999
Q ss_pred ecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEccccccccc
Q 000859 1026 YMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKAL 1105 (1251)
Q Consensus 1026 ~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~ 1105 (1251)
|+++++|.++++. .+.+++.++..++.|++.|++|||+. +++|+||||+||+++.++.+||+|||.+...
T Consensus 87 ~~~~~~L~~~~~~-------~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 156 (267)
T cd06645 87 FCGGGSLQDIYHV-------TGPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQI 156 (267)
T ss_pred ccCCCcHHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEc
Confidence 9999999999875 34689999999999999999999999 9999999999999999999999999998765
Q ss_pred ccccCCCCcccceeecccceecccccc---cCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccch
Q 000859 1106 VEDYNSNTESNTWFAGSYGYIAPEYAY---SLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGS 1182 (1251)
Q Consensus 1106 ~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 1182 (1251)
... ........|+..|+|||++. ...++.++|+||+||++|||++|+.||....+...... ...
T Consensus 157 ~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~---~~~------ 223 (267)
T cd06645 157 TAT----IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFL---MTK------ 223 (267)
T ss_pred cCc----ccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHh---hhc------
Confidence 322 11223357899999999874 45588999999999999999999999865432111000 000
Q ss_pred hhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 000859 1183 AREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCD 1229 (1251)
Q Consensus 1183 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1229 (1251)
.....+........+..+.+++.+|++.+|++||+++++++
T Consensus 224 ------~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 224 ------SNFQPPKLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred ------cCCCCCcccccCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 00000111111123456889999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=312.19 Aligned_cols=250 Identities=23% Similarity=0.324 Sum_probs=194.8
Q ss_pred CCcCceecccCCceEEEEEec-CCcEEEEEEeccCCchhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEEEee
Q 000859 948 LSDEFIIGSGGSGTVYKAELA-NGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIYEY 1026 (1251)
Q Consensus 948 ~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv~E~ 1026 (1251)
|+..+.||+|+||.||+|... ++..||+|.+.... ....+.+.+|+++++.++||||+++++++... ...++|+||
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~--~~~~~v~e~ 83 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS-EEELEDYMVEIDILASCDHPNIVKLLDAFYYE--NNLWILIEF 83 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC-HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeC--CEEEEEEEe
Confidence 455678999999999999654 57888999986443 33456788999999999999999999988654 457999999
Q ss_pred cCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcccccccccc
Q 000859 1027 MENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALV 1106 (1251)
Q Consensus 1027 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~ 1106 (1251)
+++|+|..++.+. ...+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+|++|||++....
T Consensus 84 ~~~~~l~~~~~~~------~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~ 154 (282)
T cd06643 84 CAGGAVDAVMLEL------ERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNT 154 (282)
T ss_pred cCCCcHHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEcccccccccc
Confidence 9999999987653 34689999999999999999999999 99999999999999999999999999987543
Q ss_pred cccCCCCcccceeecccceecccccc-----cCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccc
Q 000859 1107 EDYNSNTESNTWFAGSYGYIAPEYAY-----SLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSG 1181 (1251)
Q Consensus 1107 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 1181 (1251)
... .......++..|+|||++. +..++.++||||+||++|||++|+.||......+. ......
T Consensus 155 ~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~-----~~~~~~--- 222 (282)
T cd06643 155 RTI----QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRV-----LLKIAK--- 222 (282)
T ss_pred ccc----cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHH-----HHHHhh---
Confidence 221 1122346889999999874 34578899999999999999999999875422111 000000
Q ss_pred hhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 000859 1182 SAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDL 1230 (1251)
Q Consensus 1182 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 1230 (1251)
...+....+...+.++.+++.+||+.||.+||+++++++.
T Consensus 223 ---------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 223 ---------SEPPTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred ---------cCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0001111122245678999999999999999999998754
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=308.66 Aligned_cols=255 Identities=24% Similarity=0.388 Sum_probs=187.4
Q ss_pred eecccCCceEEEEEecCC---cEEEEEEeccCCchhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEEEeecCC
Q 000859 953 IIGSGGSGTVYKAELANG---ATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIYEYMEN 1029 (1251)
Q Consensus 953 ~lG~G~fg~V~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv~E~~~~ 1029 (1251)
.||+|+||+||+|+..++ ..+++|.+.........+.+.+|+.+++.++||||++++++|... ...++||||+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~ 79 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEA--IPYLLVFEYCEL 79 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCC--CccEEEEecCCC
Confidence 599999999999965433 356677766555445567899999999999999999999988654 446999999999
Q ss_pred CChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEccccccccccccc
Q 000859 1030 GSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDY 1109 (1251)
Q Consensus 1030 gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 1109 (1251)
|+|.+++++... .....++..+..++.||+.|++|||+. +++||||||+||+++.++.+||+|||++.......
T Consensus 80 ~~L~~~l~~~~~---~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~ 153 (268)
T cd05086 80 GDLKSYLSQEQW---HRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKED 153 (268)
T ss_pred CcHHHHHHhhhc---ccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcch
Confidence 999999976421 123467778889999999999999999 99999999999999999999999999985432111
Q ss_pred CCCCcccceeecccceeccccccc-------CCCCCccceeehhHHHHHHhh-CCCCCCCccccchhHHHHHHHHHhccc
Q 000859 1110 NSNTESNTWFAGSYGYIAPEYAYS-------LKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMVRWVEMHMEMSG 1181 (1251)
Q Consensus 1110 ~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~sDiwSlGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 1181 (1251)
. ........++..|+|||++.. ..++.++|||||||++|||++ |..||......+ .......
T Consensus 154 ~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~-----~~~~~~~--- 223 (268)
T cd05086 154 Y--IETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDRE-----VLNHVIK--- 223 (268)
T ss_pred h--hhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHH-----HHHHHHh---
Confidence 1 111123467889999998743 245789999999999999997 677886542211 1111000
Q ss_pred hhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 000859 1182 SAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLL 1232 (1251)
Q Consensus 1182 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 1232 (1251)
....... .+..+ ....+.+.+++..|| .+|++||++++|++.|.
T Consensus 224 ~~~~~~~----~~~~~--~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 224 DQQVKLF----KPQLE--LPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred hcccccC----CCccC--CCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 0000111 11111 124456888999999 67999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=308.10 Aligned_cols=255 Identities=29% Similarity=0.423 Sum_probs=201.3
Q ss_pred CCCcCceecccCCceEEEEEe-cCCcEEEEEEeccCCch-hhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEEE
Q 000859 947 NLSDEFIIGSGGSGTVYKAEL-ANGATVAVKKISCKDDH-LLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIY 1024 (1251)
Q Consensus 947 ~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv~ 1024 (1251)
+|...+.||+|+||.||+|.. .+++.||+|.+...... ...+.+..|++++++++|+||+++++++.. ....++|+
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~--~~~~~lv~ 78 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVH--REKVYIFM 78 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEec--CCEEEEEE
Confidence 477788999999999999965 46899999998755432 356788999999999999999999997644 45579999
Q ss_pred eecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcccccccc
Q 000859 1025 EYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKA 1104 (1251)
Q Consensus 1025 E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~ 1104 (1251)
||+++++|.+++... ..+++..+..++.|+++|++|||+. +|+|+||+|+||++++++.+||+|||.+..
T Consensus 79 e~~~~~~L~~~~~~~-------~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~ 148 (264)
T cd06626 79 EYCSGGTLEELLEHG-------RILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVK 148 (264)
T ss_pred ecCCCCcHHHHHhhc-------CCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccc
Confidence 999999999999763 4578899999999999999999999 999999999999999999999999999977
Q ss_pred cccccCCCCcccceeecccceecccccccCC---CCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccc
Q 000859 1105 LVEDYNSNTESNTWFAGSYGYIAPEYAYSLK---ATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSG 1181 (1251)
Q Consensus 1105 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 1181 (1251)
................++..|+|||++.+.. ++.++||||||+++||+++|+.||........ .....
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~------~~~~~--- 219 (264)
T cd06626 149 LKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQ------IMFHV--- 219 (264)
T ss_pred cCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHH------HHHHH---
Confidence 6443322221112346788999999988766 88999999999999999999999975432110 00000
Q ss_pred hhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 000859 1182 SAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCD 1229 (1251)
Q Consensus 1182 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1229 (1251)
.....+..+.....+..+.+++.+||+.+|++||+++|++.
T Consensus 220 -------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 220 -------GAGHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred -------hcCCCCCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00111222223234667889999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-33 Score=311.90 Aligned_cols=249 Identities=28% Similarity=0.402 Sum_probs=201.3
Q ss_pred CCCcCceecccCCceEEEEEe-cCCcEEEEEEeccCCchhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEEEe
Q 000859 947 NLSDEFIIGSGGSGTVYKAEL-ANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIYE 1025 (1251)
Q Consensus 947 ~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv~E 1025 (1251)
+|+..+.||.|+||.||+|.. .+++.||+|++...........+.+|+++++.++|+||+++++++.+. ...++|+|
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~~v~e 79 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKG--SKLWIIME 79 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEEC--CeEEEEEE
Confidence 577788999999999999965 468999999997655444557788999999999999999999988654 56799999
Q ss_pred ecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEccccccccc
Q 000859 1026 YMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKAL 1105 (1251)
Q Consensus 1026 ~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~ 1105 (1251)
|+++++|.+++... .+++..+..++.|++.|++|||+. +++||||+|+||++++++.++++|||.++..
T Consensus 80 ~~~~~~L~~~~~~~--------~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~ 148 (274)
T cd06609 80 YCGGGSCLDLLKPG--------KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQL 148 (274)
T ss_pred eeCCCcHHHHHhhc--------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceee
Confidence 99999999998752 688999999999999999999999 9999999999999999999999999999776
Q ss_pred ccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccchhhh
Q 000859 1106 VEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSARE 1185 (1251)
Q Consensus 1106 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1185 (1251)
.... .......++..|+|||.+.+..++.++|||||||++|||+||+.||....+.+. ....
T Consensus 149 ~~~~----~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~-----~~~~--------- 210 (274)
T cd06609 149 TSTM----SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRV-----LFLI--------- 210 (274)
T ss_pred cccc----cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHH-----HHHh---------
Confidence 4321 112234678899999999988899999999999999999999999975432111 0000
Q ss_pred hhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 000859 1186 ELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDL 1230 (1251)
Q Consensus 1186 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 1230 (1251)
.....+..+.. ..+.++.+++.+||..||++|||++++++.
T Consensus 211 ---~~~~~~~~~~~-~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 211 ---PKNNPPSLEGN-KFSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred ---hhcCCCCCccc-ccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 00011111111 145578899999999999999999999763
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-33 Score=315.32 Aligned_cols=250 Identities=23% Similarity=0.373 Sum_probs=200.2
Q ss_pred cCCCcCceecccCCceEEEEE-ecCCcEEEEEEeccCCchhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEEE
Q 000859 946 NNLSDEFIIGSGGSGTVYKAE-LANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIY 1024 (1251)
Q Consensus 946 ~~~~~~~~lG~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv~ 1024 (1251)
.+|+..+.||.|+||.||+|. ..+++.||+|.+..... ...+.+.+|+++++.++||||+++++++.. ....++|+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~ 95 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ-PKKELIINEILVMKELKNPNIVNFLDSFLV--GDELFVVM 95 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC-chHHHHHHHHHHHHhcCCCceeeeeeeEec--CceEEEEE
Confidence 458888899999999999995 46789999999865433 235678899999999999999999998864 34579999
Q ss_pred eecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcccccccc
Q 000859 1025 EYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKA 1104 (1251)
Q Consensus 1025 E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~ 1104 (1251)
||+++++|.+++.. ..+++.++..++.|++.|++|||+. +++||||||+||+++.++.+||+|||++..
T Consensus 96 e~~~~~~L~~~~~~--------~~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~ 164 (296)
T cd06655 96 EYLAGGSLTDVVTE--------TCMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQ 164 (296)
T ss_pred EecCCCcHHHHHHh--------cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchh
Confidence 99999999999864 3478999999999999999999999 999999999999999999999999999876
Q ss_pred cccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccchhh
Q 000859 1105 LVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSAR 1184 (1251)
Q Consensus 1105 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1184 (1251)
...... ......|+..|+|||.+.+..++.++|||||||++||+++|+.||......... .. .
T Consensus 165 ~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~--~~---~-------- 227 (296)
T cd06655 165 ITPEQS----KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL--YL---I-------- 227 (296)
T ss_pred cccccc----cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH--HH---H--------
Confidence 533211 112246788999999999888999999999999999999999999765321110 00 0
Q ss_pred hhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 000859 1185 EELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDL 1230 (1251)
Q Consensus 1185 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 1230 (1251)
.....+....+...+..+.+++.+||..||++||+++++++.
T Consensus 228 ----~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 228 ----ATNGTPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred ----HhcCCcccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 000011122223345678899999999999999999999753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=313.68 Aligned_cols=239 Identities=23% Similarity=0.373 Sum_probs=184.7
Q ss_pred eecccCCceEEEEEecC-------------------------CcEEEEEEeccCCchhhhHHHHHHHHHHHhccCCCccc
Q 000859 953 IIGSGGSGTVYKAELAN-------------------------GATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVK 1007 (1251)
Q Consensus 953 ~lG~G~fg~V~~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 1007 (1251)
.||+|+||.||+|.+.. ...||+|++.... ....+.+.+|+.+++.++||||++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~~~~~~~~l~h~niv~ 80 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH-RDIALAFFETASLMSQVSHIHLAF 80 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH-HHHHHHHHHHHHHHhcCCCCCeee
Confidence 59999999999996421 1358999885433 234467888999999999999999
Q ss_pred eeceeeecCCCceeEEEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCee
Q 000859 1008 LMGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNIL 1087 (1251)
Q Consensus 1008 l~g~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nil 1087 (1251)
++|+|... ...++||||+++|+|..++.+. .+.+++..+.+++.|+++||+|||++ +|+||||||+||+
T Consensus 81 ~~~~~~~~--~~~~lv~ey~~~g~L~~~l~~~------~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nil 149 (274)
T cd05076 81 VHGVCVRG--SENIMVEEFVEHGPLDVCLRKE------KGRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNIL 149 (274)
T ss_pred EEEEEEeC--CceEEEEecCCCCcHHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEE
Confidence 99998654 3468999999999999998753 35688999999999999999999999 9999999999999
Q ss_pred ecCCC-------CeEEcccccccccccccCCCCcccceeecccceeccccccc-CCCCCccceeehhHHHHHHh-hCCCC
Q 000859 1088 LDSNM-------EAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYS-LKATEKCDVYSMGIVLMELV-SGKMP 1158 (1251)
Q Consensus 1088 l~~~~-------~~kl~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlGv~l~el~-tg~~p 1158 (1251)
++..+ .+|++|||.+...... ....++..|+|||.+.+ ..++.++|||||||++||++ +|+.|
T Consensus 150 l~~~~~~~~~~~~~kl~d~g~~~~~~~~--------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p 221 (274)
T cd05076 150 LARLGLAEGTSPFIKLSDPGVSFTALSR--------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVP 221 (274)
T ss_pred EeccCcccCccceeeecCCccccccccc--------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence 97644 3899999987543211 11356788999998865 56899999999999999995 69999
Q ss_pred CCCccccchhHHHHHHHHHhccchhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 000859 1159 TDATFGVEMDMVRWVEMHMEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLL 1232 (1251)
Q Consensus 1159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 1232 (1251)
|......+. ..+. ... ...+ ......+.+++.+||+.+|++|||+++|++.|.
T Consensus 222 ~~~~~~~~~--~~~~---------------~~~--~~~~--~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 222 LKERTPSEK--ERFY---------------EKK--HRLP--EPSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred ccccChHHH--HHHH---------------Hhc--cCCC--CCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 875533221 1110 000 0111 112346889999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=308.66 Aligned_cols=258 Identities=24% Similarity=0.393 Sum_probs=204.2
Q ss_pred cCCCcCceecccCCceEEEEEe-cCCcEEEEEEeccCCchhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEEE
Q 000859 946 NNLSDEFIIGSGGSGTVYKAEL-ANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIY 1024 (1251)
Q Consensus 946 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv~ 1024 (1251)
++|+..+.||.|+||+||+|.. .++..||+|++.........+.+.+|+++++.++|+||+++++.+.. ....++|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~iv~ 78 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVV--GDELWLVM 78 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEee--CCEEEEEE
Confidence 3688889999999999999964 46789999998755544466789999999999999999999997754 45579999
Q ss_pred eecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcccccccc
Q 000859 1025 EYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKA 1104 (1251)
Q Consensus 1025 E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~ 1104 (1251)
|++++++|.++++... ....+++..+..++.|++.|++|||+. +|+||||+|+||++++++.++++|||++..
T Consensus 79 e~~~~~~l~~~~~~~~----~~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~ 151 (267)
T cd06610 79 PYLSGGSLLDIMKSSY----PRGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSAS 151 (267)
T ss_pred eccCCCcHHHHHHHhc----ccCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHH
Confidence 9999999999997632 124689999999999999999999999 999999999999999999999999999877
Q ss_pred cccccCCCCcccceeecccceecccccccC-CCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccchh
Q 000859 1105 LVEDYNSNTESNTWFAGSYGYIAPEYAYSL-KATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSA 1183 (1251)
Q Consensus 1105 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1183 (1251)
+...............|+..|+|||++... .++.++|+|||||++|||++|+.||......+. ..... ..
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~-~~~~~---~~----- 222 (267)
T cd06610 152 LADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV-LMLTL---QN----- 222 (267)
T ss_pred hccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhh-HHHHh---cC-----
Confidence 654332221222335689999999998776 789999999999999999999999975533211 11100 00
Q ss_pred hhhhhcccCCCCCCc---hHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 000859 1184 REELLDDQMKPLLPG---EECAAYQVLEIALQCTKTSPQERPSSRQVCD 1229 (1251)
Q Consensus 1184 ~~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1229 (1251)
..+..+. ....+..+.+++.+|++.||++||+++++++
T Consensus 223 --------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 223 --------DPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred --------CCCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 0011111 1234567889999999999999999999986
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=324.35 Aligned_cols=241 Identities=25% Similarity=0.311 Sum_probs=183.2
Q ss_pred ecccCCceEEEEEe-cCCcEEEEEEeccCCc--hhhhHHHHHHHHHHHhc---cCCCccceeceeeecCCCceeEEEeec
Q 000859 954 IGSGGSGTVYKAEL-ANGATVAVKKISCKDD--HLLNKSFTREVKTLGRI---RHRHLVKLMGHCCNKGAGSNLLIYEYM 1027 (1251)
Q Consensus 954 lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~g~~~~~~~~~~~lv~E~~ 1027 (1251)
||+|+||+||+|+. .+++.||||++..... ......+..|..++... +||+|+++++++.. +...++||||+
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~--~~~~~lv~e~~ 78 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQT--DSDLYLVTDYM 78 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEec--CCeEEEEEcCC
Confidence 69999999999954 4689999999864321 12233455677777665 69999999987754 34579999999
Q ss_pred CCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEccccccccccc
Q 000859 1028 ENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVE 1107 (1251)
Q Consensus 1028 ~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~ 1107 (1251)
++|+|.+++.. .+.+++..+..++.||++||+|||++ +|+||||||+||+++.++.+||+|||+++....
T Consensus 79 ~~g~L~~~l~~-------~~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~ 148 (330)
T cd05586 79 SGGELFWHLQK-------EGRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLT 148 (330)
T ss_pred CCChHHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCC
Confidence 99999999875 35689999999999999999999999 999999999999999999999999999865322
Q ss_pred ccCCCCcccceeecccceecccccccC-CCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccchhhhh
Q 000859 1108 DYNSNTESNTWFAGSYGYIAPEYAYSL-KATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSAREE 1186 (1251)
Q Consensus 1108 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1186 (1251)
. ........||..|+|||++.+. .++.++||||+||++|||++|+.||......+. ....
T Consensus 149 ~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~-----~~~i---------- 209 (330)
T cd05586 149 D----NKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQM-----YRNI---------- 209 (330)
T ss_pred C----CCCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHH-----HHHH----------
Confidence 1 1112235789999999998754 489999999999999999999999975422111 0000
Q ss_pred hhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCC----HHHHHH
Q 000859 1187 LLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPS----SRQVCD 1229 (1251)
Q Consensus 1187 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs----~~eil~ 1229 (1251)
.... ..++ ....+.++.+++.+||+.||.+||+ ++++++
T Consensus 210 -~~~~--~~~~-~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 210 -AFGK--VRFP-KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred -HcCC--CCCC-CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 0000 0111 1123456789999999999999984 555554
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=308.97 Aligned_cols=251 Identities=24% Similarity=0.409 Sum_probs=197.6
Q ss_pred CCcCceecccCCceEEEEEe-cCCcEEEEEEeccCCch--------hhhHHHHHHHHHHHhccCCCccceeceeeecCCC
Q 000859 948 LSDEFIIGSGGSGTVYKAEL-ANGATVAVKKISCKDDH--------LLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAG 1018 (1251)
Q Consensus 948 ~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~ 1018 (1251)
|.....||+|+||.||+|.. .+++.||+|.+...... ...+.+.+|++++++++||||+++++++... .
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~ 79 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDA--D 79 (267)
T ss_pred ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC--C
Confidence 66778999999999999954 46889999988644321 2235788999999999999999999987654 4
Q ss_pred ceeEEEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcc
Q 000859 1019 SNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGD 1098 (1251)
Q Consensus 1019 ~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D 1098 (1251)
..++|+||+++++|.+++... +.+++..+..++.|++.|++|||+. +++||||+|+||++++++.+||+|
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~-------~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~d 149 (267)
T cd06628 80 HLNIFLEYVPGGSVAALLNNY-------GAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISD 149 (267)
T ss_pred ccEEEEEecCCCCHHHHHHhc-------cCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecc
Confidence 568999999999999999763 4678899999999999999999999 999999999999999999999999
Q ss_pred cccccccccccCCC--CcccceeecccceecccccccCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHH
Q 000859 1099 FGLAKALVEDYNSN--TESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMH 1176 (1251)
Q Consensus 1099 fG~a~~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~ 1176 (1251)
||.++......... ........|+..|+|||.+.+..++.++|+||+||++|||++|+.||........ . .
T Consensus 150 fg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~----~-~-- 222 (267)
T cd06628 150 FGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQA----I-F-- 222 (267)
T ss_pred cCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHH----H-H--
Confidence 99998764321111 1111234578999999999988899999999999999999999999975422110 0 0
Q ss_pred HhccchhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 000859 1177 MEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCD 1229 (1251)
Q Consensus 1177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1229 (1251)
... ....+.. +...+..+.+++.+||+.||.+||++.|+++
T Consensus 223 ---------~~~-~~~~~~~--~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 223 ---------KIG-ENASPEI--PSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred ---------HHh-ccCCCcC--CcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 000 0111111 1224567889999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=313.70 Aligned_cols=247 Identities=26% Similarity=0.407 Sum_probs=198.4
Q ss_pred CCcCceecccCCceEEEEEe-cCCcEEEEEEeccCCchhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEEEee
Q 000859 948 LSDEFIIGSGGSGTVYKAEL-ANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIYEY 1026 (1251)
Q Consensus 948 ~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv~E~ 1026 (1251)
|+..+.||+|+||.||+|.. .+++.||+|.+.........+.+.+|++++++++||||+++++++.. ....++||||
T Consensus 6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~ 83 (277)
T cd06642 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLK--GTKLWIIMEY 83 (277)
T ss_pred HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhccccc--CCceEEEEEc
Confidence 45556799999999999954 56789999998755555556788999999999999999999998854 3457999999
Q ss_pred cCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcccccccccc
Q 000859 1027 MENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALV 1106 (1251)
Q Consensus 1027 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~ 1106 (1251)
+++++|.+++.. ..+++..+..++.|+++|++|||+. +++|+||+|+||++++++.++++|||++..+.
T Consensus 84 ~~~~~L~~~~~~--------~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 152 (277)
T cd06642 84 LGGGSALDLLKP--------GPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLT 152 (277)
T ss_pred cCCCcHHHHhhc--------CCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEcccccccccc
Confidence 999999999864 3578999999999999999999999 99999999999999999999999999987653
Q ss_pred cccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccchhhhh
Q 000859 1107 EDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSAREE 1186 (1251)
Q Consensus 1107 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1186 (1251)
... .......|+..|+|||++.+..++.++|||||||++|||++|+.||....+... ..
T Consensus 153 ~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~-----~~------------ 211 (277)
T cd06642 153 DTQ----IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV-----LF------------ 211 (277)
T ss_pred Ccc----hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhH-----Hh------------
Confidence 221 112224678899999999988899999999999999999999999865432111 00
Q ss_pred hhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 000859 1187 LLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDL 1230 (1251)
Q Consensus 1187 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 1230 (1251)
.......+.. ....+.++.+++.+||+.+|++||++.++++.
T Consensus 212 ~~~~~~~~~~--~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 212 LIPKNSPPTL--EGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred hhhcCCCCCC--CcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 0011111111 12345668899999999999999999999974
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-33 Score=309.66 Aligned_cols=255 Identities=26% Similarity=0.372 Sum_probs=203.7
Q ss_pred CCCcCceecccCCceEEEEE-ecCCcEEEEEEeccCC-chhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEEE
Q 000859 947 NLSDEFIIGSGGSGTVYKAE-LANGATVAVKKISCKD-DHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIY 1024 (1251)
Q Consensus 947 ~~~~~~~lG~G~fg~V~~~~-~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv~ 1024 (1251)
+|+..+.||.|+||.||+|. ..+++.||+|++.... .....+.+..|++++++++||||+++++++........+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 47778899999999999995 4578899999986443 344456788999999999999999999988766666679999
Q ss_pred eecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhh-----hcCCCCeeecCCCCCCeeecCCCCeEEccc
Q 000859 1025 EYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLH-----HDCVPKILHRDIKSSNILLDSNMEAHLGDF 1099 (1251)
Q Consensus 1025 E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH-----~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 1099 (1251)
||+++++|.+++.... .....+++..++.++.|++.|++||| +. +++|+||||+||+++.++.+|++||
T Consensus 81 e~~~~~~L~~~l~~~~---~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~~~~~~kl~d~ 154 (265)
T cd08217 81 EYCEGGDLAQLIQKCK---KERKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLDANNNVKLGDF 154 (265)
T ss_pred hhccCCCHHHHHHHHh---hcccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEecCCCEEEecc
Confidence 9999999999997532 12456899999999999999999999 66 9999999999999999999999999
Q ss_pred ccccccccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhc
Q 000859 1100 GLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEM 1179 (1251)
Q Consensus 1100 G~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 1179 (1251)
|++........ ......++..|+|||.+.+..++.++|+||||+++|+|++|+.||...... ...+..
T Consensus 155 g~~~~~~~~~~----~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-----~~~~~~--- 222 (265)
T cd08217 155 GLAKILGHDSS----FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQL-----QLASKI--- 222 (265)
T ss_pred cccccccCCcc----cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHH-----HHHHHH---
Confidence 99976533211 112346889999999999888999999999999999999999999765311 111110
Q ss_pred cchhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 000859 1180 SGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDL 1230 (1251)
Q Consensus 1180 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 1230 (1251)
.....+. .+...+..+.+++.+|++.+|++||++++|++.
T Consensus 223 ---------~~~~~~~--~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 223 ---------KEGKFRR--IPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred ---------hcCCCCC--CccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 0011111 122345678999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-33 Score=320.30 Aligned_cols=255 Identities=21% Similarity=0.268 Sum_probs=193.8
Q ss_pred cCCCcCceecccCCceEEEEEec-CCcEEEEEEeccCC--chhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeE
Q 000859 946 NNLSDEFIIGSGGSGTVYKAELA-NGATVAVKKISCKD--DHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLL 1022 (1251)
Q Consensus 946 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~l 1022 (1251)
++|+..++||+|+||+||++..+ +++.||+|++.... .....+.+..|+.++..++|++|+++++++.. +...++
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~l 78 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQD--ENNLYL 78 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEec--CCEEEE
Confidence 36888899999999999999654 57889999985322 22234557889999999999999999987754 455799
Q ss_pred EEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcccccc
Q 000859 1023 IYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLA 1102 (1251)
Q Consensus 1023 v~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a 1102 (1251)
||||+++|+|.+++++. ...+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 79 v~ey~~~g~L~~~l~~~------~~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a 149 (332)
T cd05623 79 VMDYYVGGDLLTLLSKF------EDRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSC 149 (332)
T ss_pred EEeccCCCcHHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchh
Confidence 99999999999999763 24688999999999999999999999 9999999999999999999999999998
Q ss_pred cccccccCCCCcccceeecccceecccccc-----cCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHH
Q 000859 1103 KALVEDYNSNTESNTWFAGSYGYIAPEYAY-----SLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHM 1177 (1251)
Q Consensus 1103 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~ 1177 (1251)
..+.... ........||+.|+|||++. ...++.++|||||||++|||++|+.||......+. ....
T Consensus 150 ~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~-----~~~i- 220 (332)
T cd05623 150 LKLMEDG---TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVET-----YGKI- 220 (332)
T ss_pred eecccCC---cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHH-----HHHH-
Confidence 7543221 11122357899999999886 34578999999999999999999999975422111 1110
Q ss_pred hccchhhhhhhcccCCCCCC-chHHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 000859 1178 EMSGSAREELLDDQMKPLLP-GEECAAYQVLEIALQCTKTSPQE--RPSSRQVCDL 1230 (1251)
Q Consensus 1178 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~--RPs~~eil~~ 1230 (1251)
.........+ .....+.++.+++.+|+..++++ |++++|+++.
T Consensus 221 ----------~~~~~~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 221 ----------MNHKERFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred ----------hCCCccccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 0000000111 11224567888999988665544 6899998766
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-33 Score=307.93 Aligned_cols=247 Identities=29% Similarity=0.438 Sum_probs=197.6
Q ss_pred cCCCcCceecccCCceEEEEEecCCcEEEEEEeccCCchhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEEEe
Q 000859 946 NNLSDEFIIGSGGSGTVYKAELANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIYE 1025 (1251)
Q Consensus 946 ~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv~E 1025 (1251)
.+|.+.+.||+|+||.||+|.. +++.||+|++.... ..+.+.+|+.++++++|||++++++++... ..++|||
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~---~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~---~~~~v~e 78 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV---TAQAFLEETAVMTKLHHKNLVRLLGVILHN---GLYIVME 78 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc---hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC---CcEEEEE
Confidence 3578888999999999999975 57899999986433 236788999999999999999999987543 3589999
Q ss_pred ecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEccccccccc
Q 000859 1026 YMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKAL 1105 (1251)
Q Consensus 1026 ~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~ 1105 (1251)
|+++|+|.+++.... ...+++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|||.+...
T Consensus 79 ~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~ 150 (254)
T cd05083 79 LMSKGNLVNFLRTRG-----RALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVG 150 (254)
T ss_pred CCCCCCHHHHHHhcC-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceec
Confidence 999999999997642 34678999999999999999999998 9999999999999999999999999998654
Q ss_pred ccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhh-CCCCCCCccccchhHHHHHHHHHhccchhh
Q 000859 1106 VEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMVRWVEMHMEMSGSAR 1184 (1251)
Q Consensus 1106 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1184 (1251)
.... .....+..|+|||.+.+..++.++|+||+||++|||++ |+.||......+ .....
T Consensus 151 ~~~~-------~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~-----~~~~~-------- 210 (254)
T cd05083 151 SMGV-------DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE-----VKECV-------- 210 (254)
T ss_pred cccC-------CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH-----HHHHH--------
Confidence 2211 11233568999999988899999999999999999998 999987553211 11110
Q ss_pred hhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 000859 1185 EELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLN 1233 (1251)
Q Consensus 1185 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 1233 (1251)
....... .....+..+.+++.+||+.+|++||+++++++.|++
T Consensus 211 ----~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 211 ----EKGYRME--PPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred ----hCCCCCC--CCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 0011111 122345678899999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-33 Score=309.88 Aligned_cols=254 Identities=30% Similarity=0.455 Sum_probs=203.3
Q ss_pred CCCcCceecccCCceEEEEEec-CCcEEEEEEeccCCchhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEEEe
Q 000859 947 NLSDEFIIGSGGSGTVYKAELA-NGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIYE 1025 (1251)
Q Consensus 947 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv~E 1025 (1251)
+|+..+.||+|+||.||+|... +++.||+|++.........+.+.+|++++++++||||+++++++... ...++++|
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~lv~e 79 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNN--GDISICME 79 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecC--CEEEEEEE
Confidence 5677788999999999999654 68999999997665555667889999999999999999999988654 56799999
Q ss_pred ecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCCeeecCCCCCCeeecCCCCeEEcccccccc
Q 000859 1026 YMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHH-DCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKA 1104 (1251)
Q Consensus 1026 ~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~ 1104 (1251)
|+++++|.+++.... ..+++..+.+++.|++.|++|+|+ . +++|+||||+||++++++.++|+|||.+..
T Consensus 80 ~~~~~~L~~~~~~~~------~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~ 150 (265)
T cd06605 80 YMDGGSLDKILKEVQ------GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQ 150 (265)
T ss_pred ecCCCcHHHHHHHcc------CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchh
Confidence 999999999997642 568899999999999999999999 8 999999999999999999999999999876
Q ss_pred cccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccchhh
Q 000859 1105 LVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSAR 1184 (1251)
Q Consensus 1105 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1184 (1251)
....... ...++..|+|||.+.+..++.++||||+|+++|++++|+.||...........+..+...
T Consensus 151 ~~~~~~~------~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~------- 217 (265)
T cd06605 151 LVNSLAK------TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIV------- 217 (265)
T ss_pred hHHHHhh------cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHh-------
Confidence 5322111 156788999999999889999999999999999999999999755322121111111111
Q ss_pred hhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 000859 1185 EELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDL 1230 (1251)
Q Consensus 1185 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 1230 (1251)
.. ..+..+.. ..+.++.++|.+||..||++|||+.+++..
T Consensus 218 ----~~-~~~~~~~~-~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 218 ----NE-PPPRLPSG-KFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred ----cC-CCCCCChh-hcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 10 11111111 155678999999999999999999999753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-33 Score=313.17 Aligned_cols=252 Identities=22% Similarity=0.330 Sum_probs=199.8
Q ss_pred cCCCcCceecccCCceEEEEEe-cCCcEEEEEEeccCCchhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEEE
Q 000859 946 NNLSDEFIIGSGGSGTVYKAEL-ANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIY 1024 (1251)
Q Consensus 946 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv~ 1024 (1251)
++|++.+.||+|+||.||+|.. .++..||+|++.... ....+.+.+|++++++++||||+++++++.. +...++||
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~ 81 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIES-EEELEDFMVEIDILSECKHPNIVGLYEAYFY--ENKLWILI 81 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCC-HHHHHHHHHHHHHHHhCCCCceeEEEEEEec--CCeEEEEe
Confidence 4577888999999999999965 468999999986443 3345678899999999999999999998865 44579999
Q ss_pred eecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcccccccc
Q 000859 1025 EYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKA 1104 (1251)
Q Consensus 1025 E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~ 1104 (1251)
||+++++|.+++... ...+++..+++++.|++.|++|||+. +|+|+||||+||+++.++.++|+|||.+..
T Consensus 82 e~~~~~~L~~~~~~~------~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~ 152 (280)
T cd06611 82 EFCDGGALDSIMLEL------ERGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAK 152 (280)
T ss_pred eccCCCcHHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchh
Confidence 999999999998763 34689999999999999999999999 999999999999999999999999998865
Q ss_pred cccccCCCCcccceeecccceecccccc-----cCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhc
Q 000859 1105 LVEDYNSNTESNTWFAGSYGYIAPEYAY-----SLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEM 1179 (1251)
Q Consensus 1105 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 1179 (1251)
.... ........|+..|+|||.+. ...++.++||||+||++|||++|+.||........ .....
T Consensus 153 ~~~~----~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~-----~~~~~-- 221 (280)
T cd06611 153 NKST----LQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRV-----LLKIL-- 221 (280)
T ss_pred hccc----ccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHH-----HHHHh--
Confidence 4221 11223356899999999874 34577899999999999999999999976532111 00000
Q ss_pred cchhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 000859 1180 SGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDL 1230 (1251)
Q Consensus 1180 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 1230 (1251)
....+....+...+.++.+++.+||+.+|++||+++++++.
T Consensus 222 ----------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 222 ----------KSEPPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred ----------cCCCCCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 00111222223345678899999999999999999999765
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-33 Score=314.40 Aligned_cols=264 Identities=26% Similarity=0.327 Sum_probs=202.4
Q ss_pred HHHHHHhhcCCCcCceecccCCceEEEEEe-cCCcEEEEEEeccCCchhhhHHHHHHHHHHHhc-cCCCccceeceeeec
Q 000859 938 WEDIMGATNNLSDEFIIGSGGSGTVYKAEL-ANGATVAVKKISCKDDHLLNKSFTREVKTLGRI-RHRHLVKLMGHCCNK 1015 (1251)
Q Consensus 938 ~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~ 1015 (1251)
.+++..+.++|...+.||+|+||.||+|.. .+++.||+|++.... ...+.+.+|+.+++++ +|||++++++++...
T Consensus 14 ~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~--~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~ 91 (291)
T cd06639 14 LESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS--DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKA 91 (291)
T ss_pred cccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc--cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEec
Confidence 344455678899999999999999999955 568899999985432 2346678899999999 899999999988754
Q ss_pred CC---CceeEEEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCC
Q 000859 1016 GA---GSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNM 1092 (1251)
Q Consensus 1016 ~~---~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~ 1092 (1251)
.. ...++||||+++|+|.++++... .....+++..++.++.|++.|++|||+. +++||||||+||+++.++
T Consensus 92 ~~~~~~~~~lv~ey~~~~sL~~~~~~~~---~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~ 165 (291)
T cd06639 92 DKLVGGQLWLVLELCNGGSVTELVKGLL---ICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEG 165 (291)
T ss_pred cccCCCeeEEEEEECCCCcHHHHHHHhh---hcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCC
Confidence 32 35799999999999999886421 1235689999999999999999999999 999999999999999999
Q ss_pred CeEEcccccccccccccCCCCcccceeecccceecccccccC-----CCCCccceeehhHHHHHHhhCCCCCCCccccch
Q 000859 1093 EAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSL-----KATEKCDVYSMGIVLMELVSGKMPTDATFGVEM 1167 (1251)
Q Consensus 1093 ~~kl~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~ 1167 (1251)
.+||+|||.++....... ......|+..|+|||.+... .++.++||||+||++|||++|+.||......+.
T Consensus 166 ~~kl~dfg~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~ 241 (291)
T cd06639 166 GVKLVDFGVSAQLTSTRL----RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKT 241 (291)
T ss_pred CEEEeecccchhcccccc----cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHH
Confidence 999999999876532211 11224678899999987543 368899999999999999999999975422111
Q ss_pred hHHHHHHHHHhccchhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 000859 1168 DMVRWVEMHMEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDL 1230 (1251)
Q Consensus 1168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 1230 (1251)
..... . ...+....++.....+.+++.+||+.+|++||+++|+++.
T Consensus 242 -----~~~~~-----------~-~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 242 -----LFKIP-----------R-NPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred -----HHHHh-----------c-CCCCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 00000 0 0001111122234568899999999999999999999863
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=309.91 Aligned_cols=248 Identities=25% Similarity=0.380 Sum_probs=201.1
Q ss_pred CCCcCceecccCCceEEEEEe-cCCcEEEEEEeccCCchhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEEEe
Q 000859 947 NLSDEFIIGSGGSGTVYKAEL-ANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIYE 1025 (1251)
Q Consensus 947 ~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv~E 1025 (1251)
.|+..+.||+|+||.||+|.. .+++.||+|++.........+.+.+|++++++++||||+++++++.. ....++|||
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e 82 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK--GTKLWIIME 82 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE--CCEEEEEEe
Confidence 466677899999999999965 46889999998765545556788999999999999999999998865 345799999
Q ss_pred ecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEccccccccc
Q 000859 1026 YMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKAL 1105 (1251)
Q Consensus 1026 ~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~ 1105 (1251)
|+++|+|.+++.. ..+++..+..++.|++.|++|+|+. +++|+||+|+||+++.++.++++|||.+...
T Consensus 83 ~~~~~~L~~~i~~--------~~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~ 151 (277)
T cd06640 83 YLGGGSALDLLRA--------GPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQL 151 (277)
T ss_pred cCCCCcHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceec
Confidence 9999999999865 3478889999999999999999999 9999999999999999999999999999765
Q ss_pred ccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccchhhh
Q 000859 1106 VEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSARE 1185 (1251)
Q Consensus 1106 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1185 (1251)
.... .......++..|+|||++.+..++.++|+|||||++|||++|+.||....+... ..
T Consensus 152 ~~~~----~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~-----~~----------- 211 (277)
T cd06640 152 TDTQ----IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRV-----LF----------- 211 (277)
T ss_pred cCCc----cccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhH-----hh-----------
Confidence 3221 112234678899999999888899999999999999999999999975432111 00
Q ss_pred hhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 000859 1186 ELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDL 1230 (1251)
Q Consensus 1186 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 1230 (1251)
.......+ ......+..+.+++.+||+.+|++||++++++..
T Consensus 212 -~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 212 -LIPKNNPP--TLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred -hhhcCCCC--CCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 00000111 1223456779999999999999999999999766
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-33 Score=314.79 Aligned_cols=250 Identities=23% Similarity=0.363 Sum_probs=200.2
Q ss_pred hcCCCcCceecccCCceEEEEEe-cCCcEEEEEEeccCCchhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEE
Q 000859 945 TNNLSDEFIIGSGGSGTVYKAEL-ANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLI 1023 (1251)
Q Consensus 945 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv 1023 (1251)
..+|+..+.||+|+||.||+|.. .+++.||+|.+...... ..+.+.+|+.+++.++||||+++++++.. ....++|
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~lv 94 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQP-KKELIINEILVMRENKNPNIVNYLDSYLV--GDELWVV 94 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccc-hHHHHHHHHHHHHhCCCCCEeeEEEEEec--CCEEEEe
Confidence 35688889999999999999964 57899999999754432 34678899999999999999999998854 4457999
Q ss_pred EeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEccccccc
Q 000859 1024 YEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAK 1103 (1251)
Q Consensus 1024 ~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~ 1103 (1251)
|||+++++|.+++.+ ..+++..+..++.|++.|++|||+. +|+||||||+||+++.++.++|+|||.+.
T Consensus 95 ~e~~~~~~L~~~~~~--------~~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~ 163 (297)
T cd06656 95 MEYLAGGSLTDVVTE--------TCMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCA 163 (297)
T ss_pred ecccCCCCHHHHHHh--------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccce
Confidence 999999999999865 3478899999999999999999999 99999999999999999999999999987
Q ss_pred ccccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccchh
Q 000859 1104 ALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSA 1183 (1251)
Q Consensus 1104 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1183 (1251)
...... .......+++.|+|||...+..++.++|+||+||++|++++|+.||..........
T Consensus 164 ~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~-------------- 225 (297)
T cd06656 164 QITPEQ----SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-------------- 225 (297)
T ss_pred EccCCc----cCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhee--------------
Confidence 643221 11123467889999999998889999999999999999999999996542211000
Q ss_pred hhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 000859 1184 REELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCD 1229 (1251)
Q Consensus 1184 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1229 (1251)
.. .....+....+...+..+.+++.+||+.+|++||+++++++
T Consensus 226 --~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 226 --LI-ATNGTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred --ee-ccCCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00 00001111122334566889999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-33 Score=319.85 Aligned_cols=255 Identities=20% Similarity=0.248 Sum_probs=193.4
Q ss_pred cCCCcCceecccCCceEEEEEe-cCCcEEEEEEeccCC--chhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeE
Q 000859 946 NNLSDEFIIGSGGSGTVYKAEL-ANGATVAVKKISCKD--DHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLL 1022 (1251)
Q Consensus 946 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~l 1022 (1251)
++|...+.||+|+||+||+++. .+++.||+|++.... .....+.+.+|..+++.++|++|+++++++.. ....++
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~--~~~~~l 78 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQD--ENYLYL 78 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc--CCEEEE
Confidence 3688889999999999999965 467899999986422 22234557889999999999999999988754 456799
Q ss_pred EEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcccccc
Q 000859 1023 IYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLA 1102 (1251)
Q Consensus 1023 v~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a 1102 (1251)
||||+++|+|.+++.+. ...+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 79 v~Ey~~gg~L~~~l~~~------~~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a 149 (331)
T cd05624 79 VMDYYVGGDLLTLLSKF------EDRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSC 149 (331)
T ss_pred EEeCCCCCcHHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccce
Confidence 99999999999999763 24688999999999999999999999 9999999999999999999999999999
Q ss_pred cccccccCCCCcccceeecccceeccccccc-----CCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHH
Q 000859 1103 KALVEDYNSNTESNTWFAGSYGYIAPEYAYS-----LKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHM 1177 (1251)
Q Consensus 1103 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~ 1177 (1251)
+.+..... .......||+.|+|||++.+ ..++.++||||+||++|||++|+.||......+. ....
T Consensus 150 ~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~-----~~~i- 220 (331)
T cd05624 150 LKMNQDGT---VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVET-----YGKI- 220 (331)
T ss_pred eeccCCCc---eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHH-----HHHH-
Confidence 76532211 11123468999999998875 4678899999999999999999999975422111 1100
Q ss_pred hccchhhhhhhcccCCCCCC-chHHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 000859 1178 EMSGSAREELLDDQMKPLLP-GEECAAYQVLEIALQCTKTSPQE--RPSSRQVCDL 1230 (1251)
Q Consensus 1178 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~--RPs~~eil~~ 1230 (1251)
.....+..++ .....+.++.+++.+|+..++.+ |++++++++.
T Consensus 221 ----------~~~~~~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 221 ----------MNHEERFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred ----------HcCCCcccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 0000000011 11123456889999999866544 4678887654
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=307.12 Aligned_cols=256 Identities=25% Similarity=0.461 Sum_probs=200.0
Q ss_pred CCCcCceecccCCceEEEEE-ecCCcEEEEEEeccCCc-----hhhhHHHHHHHHHHHhccCCCccceeceeeecCCCce
Q 000859 947 NLSDEFIIGSGGSGTVYKAE-LANGATVAVKKISCKDD-----HLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSN 1020 (1251)
Q Consensus 947 ~~~~~~~lG~G~fg~V~~~~-~~~~~~vavK~~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~ 1020 (1251)
+|+..+.||+|+||.||+|. ..+++.||+|++..... ....+.+.+|++++++++|+||+++++++.+ ....
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~ 78 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCE--DSHF 78 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceecc--CCeE
Confidence 36777899999999999995 46789999999864331 1235678899999999999999999998854 3457
Q ss_pred eEEEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCC-CeEEccc
Q 000859 1021 LLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNM-EAHLGDF 1099 (1251)
Q Consensus 1021 ~lv~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~-~~kl~Df 1099 (1251)
++|+||+++++|.+++.+. +.+++..+..++.|++.|++|||+. +++|+||+|+||+++.++ .+||+||
T Consensus 79 ~~v~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~df 148 (268)
T cd06630 79 NLFVEWMAGGSVSHLLSKY-------GAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADF 148 (268)
T ss_pred EEEEeccCCCcHHHHHHHh-------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccc
Confidence 8999999999999999763 4688999999999999999999999 999999999999998776 5999999
Q ss_pred ccccccccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhc
Q 000859 1100 GLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEM 1179 (1251)
Q Consensus 1100 G~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 1179 (1251)
|.+..................|+..|+|||.+.+..++.++||||+|+++||+++|+.||......... ....
T Consensus 149 g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~--~~~~----- 221 (268)
T cd06630 149 GAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHL--ALIF----- 221 (268)
T ss_pred ccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchH--HHHH-----
Confidence 999776443222222223356889999999998888999999999999999999999999643221110 0000
Q ss_pred cchhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 000859 1180 SGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCD 1229 (1251)
Q Consensus 1180 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1229 (1251)
...... .....+...+.++.+++.+|++.+|++||++.++++
T Consensus 222 ------~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 222 ------KIASAT--TAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred ------HHhccC--CCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 000000 111122345567889999999999999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=308.74 Aligned_cols=255 Identities=23% Similarity=0.378 Sum_probs=195.8
Q ss_pred HhhcCCCcCceecccCCceEEEEEe-cCCcEEEEEEeccCCchhhhHHHHHHHHHHHhccCCCccceeceeeecCCCcee
Q 000859 943 GATNNLSDEFIIGSGGSGTVYKAEL-ANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNL 1021 (1251)
Q Consensus 943 ~~~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~ 1021 (1251)
.+++.+.....||+|+||.||+|.. .+++.||+|.+..... ...+.+.+|++++++++|+||+++++++... ...+
T Consensus 5 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~ 81 (268)
T cd06624 5 YEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDS-RYVQPLHEEIALHSYLKHRNIVQYLGSDSEN--GFFK 81 (268)
T ss_pred cccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCH-HHHHHHHHHHHHHHhcCCCCeeeeeeeeccC--CEEE
Confidence 3455666667899999999999964 4678899999865443 3456889999999999999999999987553 4579
Q ss_pred EEEeecCCCChHHhhhcCCCCcccCCCC--CHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecC-CCCeEEcc
Q 000859 1022 LIYEYMENGSVWDWLHKQPVNIKMRKSL--DWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDS-NMEAHLGD 1098 (1251)
Q Consensus 1022 lv~E~~~~gsL~~~l~~~~~~~~~~~~l--~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~-~~~~kl~D 1098 (1251)
+|+||+++++|.+++.... ..+ ++..+..++.|++.|++|||+. +|+||||||+||+++. ++.+||+|
T Consensus 82 lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~d 152 (268)
T cd06624 82 IFMEQVPGGSLSALLRSKW------GPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISD 152 (268)
T ss_pred EEEecCCCCCHHHHHHHhc------ccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEec
Confidence 9999999999999997632 234 7888889999999999999999 9999999999999976 67999999
Q ss_pred cccccccccccCCCCcccceeecccceecccccccCC--CCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHH
Q 000859 1099 FGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLK--ATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMH 1176 (1251)
Q Consensus 1099 fG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~ 1176 (1251)
||.+....... .......|+..|+|||++.... ++.++||||+||++||+++|+.||.......... +....
T Consensus 153 fg~~~~~~~~~----~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~--~~~~~ 226 (268)
T cd06624 153 FGTSKRLAGIN----PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAM--FKVGM 226 (268)
T ss_pred chhheecccCC----CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhH--hhhhh
Confidence 99987543211 1112245789999999986543 7889999999999999999999986542211100 00000
Q ss_pred HhccchhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 000859 1177 MEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDL 1230 (1251)
Q Consensus 1177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 1230 (1251)
. ...+. .+.....++.+++.+||+.+|++|||++|+++.
T Consensus 227 ------------~-~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 227 ------------F-KIHPE--IPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred ------------h-ccCCC--CCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 0 00011 122345678899999999999999999998763
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=311.64 Aligned_cols=251 Identities=25% Similarity=0.350 Sum_probs=197.2
Q ss_pred cCCCcCceecccCCceEEEEEec-CCcEEEEEEeccCCchhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEEE
Q 000859 946 NNLSDEFIIGSGGSGTVYKAELA-NGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIY 1024 (1251)
Q Consensus 946 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv~ 1024 (1251)
..|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+++++.++||||+++++++..+ ...++||
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~ 88 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKS-EEELEDYMVEIEILATCNHPYIVKLLGAFYWD--GKLWIMI 88 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCC-HHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeC--CeEEEEE
Confidence 45788889999999999999654 58899999986543 34567788999999999999999999988654 4579999
Q ss_pred eecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcccccccc
Q 000859 1025 EYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKA 1104 (1251)
Q Consensus 1025 E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~ 1104 (1251)
||+++++|..++.+. ...+++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|||.+..
T Consensus 89 e~~~~~~l~~~~~~~------~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~ 159 (292)
T cd06644 89 EFCPGGAVDAIMLEL------DRGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAK 159 (292)
T ss_pred ecCCCCcHHHHHHhh------cCCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCcccee
Confidence 999999999887653 34689999999999999999999999 999999999999999999999999999865
Q ss_pred cccccCCCCcccceeecccceecccccc-----cCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhc
Q 000859 1105 LVEDYNSNTESNTWFAGSYGYIAPEYAY-----SLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEM 1179 (1251)
Q Consensus 1105 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 1179 (1251)
.... ........++..|+|||++. ...++.++|||||||++|||++|+.||....... .......
T Consensus 160 ~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-----~~~~~~~- 229 (292)
T cd06644 160 NVKT----LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR-----VLLKIAK- 229 (292)
T ss_pred cccc----ccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHH-----HHHHHhc-
Confidence 3221 11122346788999999874 3457889999999999999999999986542211 0000000
Q ss_pred cchhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 000859 1180 SGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCD 1229 (1251)
Q Consensus 1180 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1229 (1251)
...+....+...+.++.+++.+||+.||++||+++++++
T Consensus 230 -----------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 230 -----------SEPPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred -----------CCCccCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 001111122234456889999999999999999999976
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=308.59 Aligned_cols=255 Identities=22% Similarity=0.296 Sum_probs=194.9
Q ss_pred hcCCCcCceecccCCceEEEEEecCCcEEEEEEeccC-CchhhhHHHHHHHHHHHhc-cCCCccceeceeeecCCCceeE
Q 000859 945 TNNLSDEFIIGSGGSGTVYKAELANGATVAVKKISCK-DDHLLNKSFTREVKTLGRI-RHRHLVKLMGHCCNKGAGSNLL 1022 (1251)
Q Consensus 945 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~~~l 1022 (1251)
...|++.++||+||.+.||++...+.+.||+|++... .+......|..|++.|.++ .|.+||++|+|-.. ++..|+
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~--d~~lYm 437 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVT--DGYLYM 437 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeecc--CceEEE
Confidence 3458888899999999999998887888888887544 4666678899999999999 59999999997644 667899
Q ss_pred EEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcccccc
Q 000859 1023 IYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLA 1102 (1251)
Q Consensus 1023 v~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a 1102 (1251)
||||-+ -+|..+|+... ...+.-.++.+..|++.|+.+.|++ ||||.|+||.|+++- .|.+||+|||.|
T Consensus 438 vmE~Gd-~DL~kiL~k~~------~~~~~~~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlV-kG~LKLIDFGIA 506 (677)
T KOG0596|consen 438 VMECGD-IDLNKILKKKK------SIDPDWFLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLV-KGRLKLIDFGIA 506 (677)
T ss_pred Eeeccc-ccHHHHHHhcc------CCCchHHHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEE-eeeEEeeeechh
Confidence 999985 49999998753 2233227788999999999999999 999999999999985 579999999999
Q ss_pred cccccccCCCCcccceeecccceecccccccCC-----------CCCccceeehhHHHHHHhhCCCCCCCccccchhHHH
Q 000859 1103 KALVEDYNSNTESNTWFAGSYGYIAPEYAYSLK-----------ATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVR 1171 (1251)
Q Consensus 1103 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----------~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~ 1171 (1251)
..+..+...- .+...+||+.||+||.+.... .+.++||||+||++|+|+.|+.||+.-.+ .
T Consensus 507 ~aI~~DTTsI--~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n------~ 578 (677)
T KOG0596|consen 507 NAIQPDTTSI--VKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN------Q 578 (677)
T ss_pred cccCccccce--eeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH------H
Confidence 8876553332 223358999999999876433 45789999999999999999999964311 1
Q ss_pred HHHHHHhccchhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 000859 1172 WVEMHMEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDL 1230 (1251)
Q Consensus 1172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 1230 (1251)
|.. . ..+.+....-.++... ...++.++|+.|+++||++|||..++++.
T Consensus 579 ~aK-l--------~aI~~P~~~Iefp~~~-~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 579 IAK-L--------HAITDPNHEIEFPDIP-ENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred HHH-H--------HhhcCCCccccccCCC-CchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 111 1 1111111100111111 11238899999999999999999998763
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=288.31 Aligned_cols=272 Identities=22% Similarity=0.347 Sum_probs=205.2
Q ss_pred CHHHHHHhhcCCCcCceecccCCceEEEE-EecCCcEEEEEEeccCCchhhhHHHHHHHHHHHhc-cCCCccceeceeee
Q 000859 937 RWEDIMGATNNLSDEFIIGSGGSGTVYKA-ELANGATVAVKKISCKDDHLLNKSFTREVKTLGRI-RHRHLVKLMGHCCN 1014 (1251)
Q Consensus 937 ~~~~~~~~~~~~~~~~~lG~G~fg~V~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~ 1014 (1251)
+++|.+..+.+ .||+|+|+.|--+ ...+|.+||||++.+.. ...+....+|++++.++ .|+||++++.+|.+
T Consensus 74 ~F~d~YkLt~e-----~LGeGAyasVqtcv~i~t~~EYAVKiidKq~-gHsR~RvfREVe~f~~Cqgh~nilqLiefFEd 147 (463)
T KOG0607|consen 74 KFEDMYKLTSE-----LLGEGAYASVQTCVSIQTGKEYAVKIIDKQP-GHSRSRVFREVETFYQCQGHKNILQLIEFFED 147 (463)
T ss_pred hHHHHHHhHHH-----HhcCccceeeeeeeeeccchhhhhhhhhcCC-chHHHHHHHHHHHHHHhcCCccHHHHHHHhcc
Confidence 45666666654 7999999999999 56789999999997664 34667888999999999 59999999999955
Q ss_pred cCCCceeEEEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCC-
Q 000859 1015 KGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNME- 1093 (1251)
Q Consensus 1015 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~- 1093 (1251)
+...|+|||.|.||+|...+++ ++.+++.++.++..+|+.|+.|||.+ ||.|||+||+|||-.+...
T Consensus 148 --d~~FYLVfEKm~GGplLshI~~-------~~~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~v 215 (463)
T KOG0607|consen 148 --DTRFYLVFEKMRGGPLLSHIQK-------RKHFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKV 215 (463)
T ss_pred --cceEEEEEecccCchHHHHHHH-------hhhccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCc
Confidence 4557999999999999999987 56899999999999999999999999 9999999999999966543
Q ss_pred --eEEcccccccccccccCC---CCcccceeecccceecccccc-----cCCCCCccceeehhHHHHHHhhCCCCCCCcc
Q 000859 1094 --AHLGDFGLAKALVEDYNS---NTESNTWFAGSYGYIAPEYAY-----SLKATEKCDVYSMGIVLMELVSGKMPTDATF 1163 (1251)
Q Consensus 1094 --~kl~DfG~a~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~ 1163 (1251)
||||||.++..+.....- .+..-...+|+..|||||++. ...|+.++|.||+||++|-|++|.+||.+.-
T Consensus 216 sPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~C 295 (463)
T KOG0607|consen 216 SPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHC 295 (463)
T ss_pred CceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCcc
Confidence 899999987654322111 111122357999999999753 3358999999999999999999999998776
Q ss_pred ccchhHHHHHHHHHhccchhhhhhhcccCCCCCCc--hHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 000859 1164 GVEMDMVRWVEMHMEMSGSAREELLDDQMKPLLPG--EECAAYQVLEIALQCTKTSPQERPSSRQVCD 1229 (1251)
Q Consensus 1164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1229 (1251)
+.+..+.+- ...+..+...-+.+.+.. ..+|. +...+.+..+++...+..|+.+|-++.++++
T Consensus 296 g~dCGWdrG--e~Cr~CQ~~LFesIQEGk-YeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 296 GADCGWDRG--EVCRVCQNKLFESIQEGK-YEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred CCcCCccCC--CccHHHHHHHHHHHhccC-CcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 643322110 000000111111222211 12222 2336677888999999999999999999887
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=306.45 Aligned_cols=237 Identities=26% Similarity=0.417 Sum_probs=187.2
Q ss_pred ceecccCCceEEEEEecCCc-----------EEEEEEeccCCchhhhHHHHHHHHHHHhccCCCccceeceeeecCCCce
Q 000859 952 FIIGSGGSGTVYKAELANGA-----------TVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSN 1020 (1251)
Q Consensus 952 ~~lG~G~fg~V~~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~ 1020 (1251)
+.||+|+||.||+|...+.. .||+|.+...... ...+.+|+.++++++||||++++|++.. ...
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~ 75 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD--SLAFFETASLMSQLSHKHLVKLYGVCVR---DEN 75 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh--HHHHHHHHHHHHcCCCcchhheeeEEec---CCc
Confidence 36899999999999765322 5888887544332 5788999999999999999999998865 335
Q ss_pred eEEEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCC-------C
Q 000859 1021 LLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNM-------E 1093 (1251)
Q Consensus 1021 ~lv~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~-------~ 1093 (1251)
++||||+++|+|.+++...+ ..+++..+..++.|++.|++|||++ +|+||||||+||+++.++ .
T Consensus 76 ~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~ 146 (259)
T cd05037 76 IMVEEYVKFGPLDVFLHREK------NNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPF 146 (259)
T ss_pred EEEEEcCCCCcHHHHHHhhc------cCCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCcee
Confidence 89999999999999998642 3689999999999999999999999 999999999999999887 7
Q ss_pred eEEcccccccccccccCCCCcccceeecccceecccccccC--CCCCccceeehhHHHHHHhh-CCCCCCCccccchhHH
Q 000859 1094 AHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSL--KATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMV 1170 (1251)
Q Consensus 1094 ~kl~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDiwSlGv~l~el~t-g~~p~~~~~~~~~~~~ 1170 (1251)
+|++|||+++.... .....++..|+|||++.+. .++.++|||||||++||+++ |..||......+ ..
T Consensus 147 ~kl~Dfg~a~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~--~~ 216 (259)
T cd05037 147 IKLSDPGIPITVLS--------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE--KE 216 (259)
T ss_pred EEeCCCCccccccc--------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchh--HH
Confidence 99999999976432 1123566789999998876 78999999999999999999 577776543211 11
Q ss_pred HHHHHHHhccchhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 000859 1171 RWVEMHMEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLL 1231 (1251)
Q Consensus 1171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L 1231 (1251)
.+ .. ... ..+.+ ....+.+++.+||..+|.+|||+.++++.|
T Consensus 217 ~~---~~-----------~~~---~~~~~--~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 217 RF---YQ-----------DQH---RLPMP--DCAELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred HH---Hh-----------cCC---CCCCC--CchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 10 00 000 01111 115788999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=308.16 Aligned_cols=262 Identities=23% Similarity=0.363 Sum_probs=200.0
Q ss_pred CCcCceecccCCceEEEEEec----CCcEEEEEEeccCC-chhhhHHHHHHHHHHHhccCCCccceeceeeecCCC----
Q 000859 948 LSDEFIIGSGGSGTVYKAELA----NGATVAVKKISCKD-DHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAG---- 1018 (1251)
Q Consensus 948 ~~~~~~lG~G~fg~V~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~---- 1018 (1251)
|.+.+.||+|+||.||+|.+. +++.||||++.... .....+++.+|++++++++||||+++++++......
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 456678999999999999643 36889999986543 333456788999999999999999999987654322
Q ss_pred ceeEEEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcc
Q 000859 1019 SNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGD 1098 (1251)
Q Consensus 1019 ~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D 1098 (1251)
..++++||+++|+|.+++...... .....+++..+.+++.|++.|++|||+. +|+||||||+||+++.++.+|++|
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~-~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~d 156 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIG-EEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVAD 156 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhccc-CCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECc
Confidence 236889999999999987543211 1123578999999999999999999999 999999999999999999999999
Q ss_pred cccccccccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhh-CCCCCCCccccchhHHHHHHHHH
Q 000859 1099 FGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMVRWVEMHM 1177 (1251)
Q Consensus 1099 fG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~ 1177 (1251)
||.++........ .......++..|++||......++.++|||||||++|||++ |+.||......+ ...+..
T Consensus 157 fg~~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~--~~~~~~--- 229 (273)
T cd05074 157 FGLSKKIYSGDYY--RQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE--IYNYLI--- 229 (273)
T ss_pred ccccccccCCcce--ecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHH--HHHHHH---
Confidence 9999865322111 11112345678999999988889999999999999999999 899987553211 111110
Q ss_pred hccchhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 000859 1178 EMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNV 1234 (1251)
Q Consensus 1178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 1234 (1251)
. . .........+..+.+++.+||+.+|++|||++++++.|+++
T Consensus 230 ~-----------~---~~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 230 K-----------G---NRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred c-----------C---CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0 0 00011112345789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-33 Score=313.09 Aligned_cols=267 Identities=23% Similarity=0.322 Sum_probs=194.6
Q ss_pred CCCcCceecccCCceEEEEEe-cCCcEEEEEEeccCCc-hhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEEE
Q 000859 947 NLSDEFIIGSGGSGTVYKAEL-ANGATVAVKKISCKDD-HLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIY 1024 (1251)
Q Consensus 947 ~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv~ 1024 (1251)
+|+..+.||+|+||.||+|.. .+|+.||+|++..... ....+.+.+|++++++++||||+++++++.+. ...++|+
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~--~~~~lv~ 78 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSD--KKLTLVF 78 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccC--CceEEEE
Confidence 467788999999999999965 4689999999865432 22335678899999999999999999988643 4579999
Q ss_pred eecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcccccccc
Q 000859 1025 EYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKA 1104 (1251)
Q Consensus 1025 E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~ 1104 (1251)
||++ ++|.+++... ...+++..++.++.||++|++|||+. +|+||||||+||+++.++.+||+|||.++.
T Consensus 79 e~~~-~~l~~~~~~~------~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~ 148 (284)
T cd07839 79 EYCD-QDLKKYFDSC------NGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARA 148 (284)
T ss_pred ecCC-CCHHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhc
Confidence 9997 5888888653 34689999999999999999999999 999999999999999999999999999976
Q ss_pred cccccCCCCcccceeecccceecccccccC-CCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccch-
Q 000859 1105 LVEDYNSNTESNTWFAGSYGYIAPEYAYSL-KATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGS- 1182 (1251)
Q Consensus 1105 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~- 1182 (1251)
..... .......++..|+|||.+.+. .++.++||||+||++|||+||+.|+......+................
T Consensus 149 ~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (284)
T cd07839 149 FGIPV----RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEES 224 (284)
T ss_pred cCCCC----CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHH
Confidence 53221 111224568899999988764 478999999999999999999988654333221111111000000000
Q ss_pred --hhhhhhcccCCCCCCc-------hHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 000859 1183 --AREELLDDQMKPLLPG-------EECAAYQVLEIALQCTKTSPQERPSSRQVCD 1229 (1251)
Q Consensus 1183 --~~~~~~~~~~~~~~~~-------~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1229 (1251)
......+....+..+. ....+.++.+++.+|++.||.+|||++++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 225 WPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred hHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 0000000000011100 0113467889999999999999999999976
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-33 Score=313.71 Aligned_cols=268 Identities=23% Similarity=0.318 Sum_probs=195.8
Q ss_pred CCCcCceecccCCceEEEEEe-cCCcEEEEEEeccCCc-hhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEEE
Q 000859 947 NLSDEFIIGSGGSGTVYKAEL-ANGATVAVKKISCKDD-HLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIY 1024 (1251)
Q Consensus 947 ~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv~ 1024 (1251)
+|+..+.||+|+||.||+|.. .+++.||||++..... ....+.+.+|+.++++++||||+++++++.. +...++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~v~ 78 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQ--ESRLYLIF 78 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEee--CCeEEEEE
Confidence 477788999999999999965 4689999999865432 2234678899999999999999999998865 34579999
Q ss_pred eecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcccccccc
Q 000859 1025 EYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKA 1104 (1251)
Q Consensus 1025 E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~ 1104 (1251)
||++ ++|.+++.... ....+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||++..
T Consensus 79 e~~~-~~l~~~~~~~~----~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 150 (285)
T cd07861 79 EFLS-MDLKKYLDSLP----KGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARA 150 (285)
T ss_pred ecCC-CCHHHHHhcCC----CCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceee
Confidence 9997 68999886532 135689999999999999999999999 999999999999999999999999999875
Q ss_pred cccccCCCCcccceeecccceecccccccC-CCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccc--
Q 000859 1105 LVEDYNSNTESNTWFAGSYGYIAPEYAYSL-KATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSG-- 1181 (1251)
Q Consensus 1105 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~-- 1181 (1251)
.... ........++..|+|||.+.+. .++.++||||+||++|||+||+.||.+....+. .............
T Consensus 151 ~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 225 (285)
T cd07861 151 FGIP----VRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQ-LFRIFRILGTPTEDV 225 (285)
T ss_pred cCCC----cccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH-HHHHHHHhCCCChhh
Confidence 4321 1111223568899999987654 578899999999999999999999976533211 1111110000000
Q ss_pred -------hhhhhhhcccCCCCC-CchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 000859 1182 -------SAREELLDDQMKPLL-PGEECAAYQVLEIALQCTKTSPQERPSSRQVCD 1229 (1251)
Q Consensus 1182 -------~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1229 (1251)
............... ......+.++.+++.+||+.||++|||++++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 226 WPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred hhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 000000000000000 001113566789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=305.44 Aligned_cols=251 Identities=30% Similarity=0.514 Sum_probs=199.0
Q ss_pred CcCceecccCCceEEEEEecC-----CcEEEEEEeccCCchhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEE
Q 000859 949 SDEFIIGSGGSGTVYKAELAN-----GATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLI 1023 (1251)
Q Consensus 949 ~~~~~lG~G~fg~V~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv 1023 (1251)
++.+.||+|+||.||+|.... +..||+|++.........+.+.+|+++++.++|+||+++++++... ...+++
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~~i 79 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEE--EPLMIV 79 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCC--CeeEEE
Confidence 456789999999999996653 3889999997655544567899999999999999999999988654 457999
Q ss_pred EeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEccccccc
Q 000859 1024 YEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAK 1103 (1251)
Q Consensus 1024 ~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~ 1103 (1251)
|||+++++|.+++.... ...+++..+..++.|++.|++|||+. +++||||||+||++++++.++++|||.++
T Consensus 80 ~e~~~~~~l~~~~~~~~-----~~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~ 151 (258)
T smart00219 80 MEYMEGGDLLDYLRKNR-----PKELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSR 151 (258)
T ss_pred EeccCCCCHHHHHHhhh-----hccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCce
Confidence 99999999999997642 12289999999999999999999999 99999999999999999999999999997
Q ss_pred ccccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhh-CCCCCCCccccchhHHHHHHHHHhccch
Q 000859 1104 ALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMVRWVEMHMEMSGS 1182 (1251)
Q Consensus 1104 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 1182 (1251)
.......... ....++..|+|||.+.+..++.++||||+|+++|||++ |+.||......+ ......
T Consensus 152 ~~~~~~~~~~---~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~-----~~~~~~----- 218 (258)
T smart00219 152 DLYDDDYYKK---KGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEE-----VLEYLK----- 218 (258)
T ss_pred eccccccccc---ccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHH-----HHHHHh-----
Confidence 6643311111 11236789999999988889999999999999999998 888886532211 111100
Q ss_pred hhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 000859 1183 AREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLL 1231 (1251)
Q Consensus 1183 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L 1231 (1251)
... ..+.+...+.++.+++.+|++.||++|||++|+++.|
T Consensus 219 ------~~~---~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 219 ------KGY---RLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred ------cCC---CCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 000 0111222556789999999999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=305.51 Aligned_cols=251 Identities=24% Similarity=0.378 Sum_probs=199.6
Q ss_pred CCCcCceecccCCceEEEEE-ecCCcEEEEEEeccCC-chhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEEE
Q 000859 947 NLSDEFIIGSGGSGTVYKAE-LANGATVAVKKISCKD-DHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIY 1024 (1251)
Q Consensus 947 ~~~~~~~lG~G~fg~V~~~~-~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv~ 1024 (1251)
+|+..+.||+|+||.||++. ..+|+.||+|++.... .....+.+.+|+.++++++||||+++++++.. ....++|+
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv~ 78 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEE--NGNLYIVM 78 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecC--CCeEEEEE
Confidence 47788899999999999995 4578999999986432 33345678999999999999999999998754 34679999
Q ss_pred eecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcccccccc
Q 000859 1025 EYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKA 1104 (1251)
Q Consensus 1025 E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~ 1104 (1251)
||+++++|.+++.... ...+++.++.+++.|++.|++|||+. +++|+||+|+||+++.++.++++|||.+..
T Consensus 79 e~~~~~~l~~~~~~~~-----~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~ 150 (256)
T cd08218 79 DYCEGGDLYKKINAQR-----GVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARV 150 (256)
T ss_pred ecCCCCcHHHHHHhcc-----CCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceee
Confidence 9999999999997632 23578999999999999999999999 999999999999999999999999999976
Q ss_pred cccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccchhh
Q 000859 1105 LVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSAR 1184 (1251)
Q Consensus 1105 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1184 (1251)
...... ......|+..|+|||+..+..++.++|+|||||++||+++|+.||......+ .+.
T Consensus 151 ~~~~~~----~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~-----~~~---------- 211 (256)
T cd08218 151 LNSTVE----LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKN-----LVL---------- 211 (256)
T ss_pred cCcchh----hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHH-----HHH----------
Confidence 532211 1122457889999999988889999999999999999999999986542211 111
Q ss_pred hhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 000859 1185 EELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDL 1230 (1251)
Q Consensus 1185 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 1230 (1251)
....... + +.+...+.++.+++.+||+.+|++||++++|++.
T Consensus 212 -~~~~~~~-~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 212 -KIIRGSY-P--PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred -HHhcCCC-C--CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 1111110 1 1122345678999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-33 Score=328.82 Aligned_cols=265 Identities=20% Similarity=0.255 Sum_probs=193.7
Q ss_pred hcCCCcCceecccCCceEEEEEec-CCcEEEEEEeccCCchhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEE
Q 000859 945 TNNLSDEFIIGSGGSGTVYKAELA-NGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLI 1023 (1251)
Q Consensus 945 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv 1023 (1251)
...|.+.+.||+|+||.||+|... +++.||||.... ..+.+|++++++++|+|||++++++... ...++|
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~-------~~~~~E~~iL~~L~HpnIv~l~~~~~~~--~~~~lv 238 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY-------ASSVHEARLLRRLSHPAVLALLDVRVVG--GLTCLV 238 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc-------cCHHHHHHHHHHCCCCCCCcEEEEEEEC--CEEEEE
Confidence 446888999999999999999654 578999996421 3456899999999999999999987654 446899
Q ss_pred EeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEccccccc
Q 000859 1024 YEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAK 1103 (1251)
Q Consensus 1024 ~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~ 1103 (1251)
||++. ++|.+++... ...+++.+++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++
T Consensus 239 ~e~~~-~~L~~~l~~~------~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~ 308 (461)
T PHA03211 239 LPKYR-SDLYTYLGAR------LRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAAC 308 (461)
T ss_pred EEccC-CCHHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCce
Confidence 99995 7999998754 24689999999999999999999999 99999999999999999999999999997
Q ss_pred ccccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhhCCCCCCCcccc------chhHHHHHHHHH
Q 000859 1104 ALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGV------EMDMVRWVEMHM 1177 (1251)
Q Consensus 1104 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~------~~~~~~~~~~~~ 1177 (1251)
....... ........||..|+|||++.+..++.++|||||||++|||++|..|+...... .......+....
T Consensus 309 ~~~~~~~--~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~ 386 (461)
T PHA03211 309 FARGSWS--TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQ 386 (461)
T ss_pred ecccccc--cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhc
Confidence 6532211 11122357999999999999999999999999999999999987664322111 111111111110
Q ss_pred hccch--------hhhhhhc---ccCCCCCCc--h---HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 000859 1178 EMSGS--------AREELLD---DQMKPLLPG--E---ECAAYQVLEIALQCTKTSPQERPSSRQVCDL 1230 (1251)
Q Consensus 1178 ~~~~~--------~~~~~~~---~~~~~~~~~--~---~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 1230 (1251)
..... ....+.. ....+.... . .....++.+++.+||+.||.+|||++|+++.
T Consensus 387 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 387 VHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred cccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 00000 0000000 000111100 1 1123468899999999999999999999874
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=316.10 Aligned_cols=255 Identities=24% Similarity=0.340 Sum_probs=200.2
Q ss_pred CCCcCceecccCCceEEEEEec-CCcEEEEEEeccCCch--hhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEE
Q 000859 947 NLSDEFIIGSGGSGTVYKAELA-NGATVAVKKISCKDDH--LLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLI 1023 (1251)
Q Consensus 947 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv 1023 (1251)
+|+..+.||+|+||.||+|... +++.||+|.+...... ...+.+..|+++++.++||||+++++++.. ....++|
T Consensus 2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv 79 (316)
T cd05574 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQT--ETYLCLV 79 (316)
T ss_pred ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeec--CCEEEEE
Confidence 5788889999999999999654 5899999999755432 245678899999999999999999998754 4457999
Q ss_pred EeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEccccccc
Q 000859 1024 YEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAK 1103 (1251)
Q Consensus 1024 ~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~ 1103 (1251)
|||+.+++|.+++...+ ...+++..+..++.|+++|++|||+. +++||||||+||+++.++.++|+|||++.
T Consensus 80 ~e~~~~~~L~~~~~~~~-----~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~ 151 (316)
T cd05574 80 MDYCPGGELFRLLQRQP-----GKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSK 151 (316)
T ss_pred EEecCCCCHHHHHHhCC-----CCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhh
Confidence 99999999999997643 35689999999999999999999999 99999999999999999999999999987
Q ss_pred ccccccCCC-------------------------CcccceeecccceecccccccCCCCCccceeehhHHHHHHhhCCCC
Q 000859 1104 ALVEDYNSN-------------------------TESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMP 1158 (1251)
Q Consensus 1104 ~~~~~~~~~-------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~p 1158 (1251)
......... ........||..|+|||++.+..++.++||||||+++|+|++|+.|
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~p 231 (316)
T cd05574 152 QSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTP 231 (316)
T ss_pred cccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCC
Confidence 543221110 0011124688999999999988899999999999999999999999
Q ss_pred CCCccccchhHHHHHHHHHhccchhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCC----HHHHHH
Q 000859 1159 TDATFGVEMDMVRWVEMHMEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPS----SRQVCD 1229 (1251)
Q Consensus 1159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs----~~eil~ 1229 (1251)
|.+....+. +. ...... ...+.....+..+.+++.+|++.||++||| ++|+++
T Consensus 232 f~~~~~~~~----~~------------~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 232 FKGSNRDET----FS------------NILKKE--VTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred CCCCchHHH----HH------------HHhcCC--ccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 975532211 00 001100 111122225677999999999999999999 666655
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=320.22 Aligned_cols=192 Identities=23% Similarity=0.345 Sum_probs=161.1
Q ss_pred hhcCCCcCceecccCCceEEEEEec-CCcEEEEEEeccCCchhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeE
Q 000859 944 ATNNLSDEFIIGSGGSGTVYKAELA-NGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLL 1022 (1251)
Q Consensus 944 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~l 1022 (1251)
...+|.+.+.||+|+||.||+|... +++.||+|+.... ....|+.++++++||||+++++++... ...++
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~-------~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~l 134 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG-------TTLIEAMLLQNVNHPSVIRMKDTLVSG--AITCM 134 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc-------ccHHHHHHHHhCCCCCCcChhheEEeC--CeeEE
Confidence 3457999999999999999999654 5688999985322 234699999999999999999988654 34689
Q ss_pred EEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcccccc
Q 000859 1023 IYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLA 1102 (1251)
Q Consensus 1023 v~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a 1102 (1251)
|+||+. |+|.+++... ...+++..+.+++.||+.||+|||++ +|+||||||+||+++.++.+||+|||.+
T Consensus 135 v~e~~~-~~l~~~l~~~------~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a 204 (357)
T PHA03209 135 VLPHYS-SDLYTYLTKR------SRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAA 204 (357)
T ss_pred EEEccC-CcHHHHHHhc------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccc
Confidence 999995 6899998754 35689999999999999999999999 9999999999999999999999999998
Q ss_pred cccccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhhCCCCC
Q 000859 1103 KALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPT 1159 (1251)
Q Consensus 1103 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~p~ 1159 (1251)
+..... .......||..|+|||++.+..++.++|||||||++|||+++..|+
T Consensus 205 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 205 QFPVVA-----PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred cccccC-----cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 643211 1122356899999999999999999999999999999999854443
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-33 Score=326.96 Aligned_cols=265 Identities=21% Similarity=0.273 Sum_probs=196.7
Q ss_pred hcCCCcCceecccCCceEEEEEec---CCcEEEEEEeccCCchhhhHHHHHHHHHHHhccCCCccceeceeeecCCCcee
Q 000859 945 TNNLSDEFIIGSGGSGTVYKAELA---NGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNL 1021 (1251)
Q Consensus 945 ~~~~~~~~~lG~G~fg~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~ 1021 (1251)
..+|.+.+.||+|+||.||+|... .+..||||.+... +...+|++++++++|||||++++++... ...+
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~------~~~~~E~~il~~l~h~~iv~~~~~~~~~--~~~~ 162 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG------KTPGREIDILKTISHRAIINLIHAYRWK--STVC 162 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc------ccHHHHHHHHHhcCCCCccceeeeEeeC--CEEE
Confidence 346889999999999999999643 3578999988532 2346899999999999999999988543 4578
Q ss_pred EEEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEccccc
Q 000859 1022 LIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGL 1101 (1251)
Q Consensus 1022 lv~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~ 1101 (1251)
+|||++. ++|.+++.. ...+++.+++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 163 lv~e~~~-~~l~~~l~~-------~~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~ 231 (392)
T PHA03207 163 MVMPKYK-CDLFTYVDR-------SGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGA 231 (392)
T ss_pred EEehhcC-CCHHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCcc
Confidence 9999995 689998854 35689999999999999999999999 999999999999999999999999999
Q ss_pred ccccccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhhCCCCCCCccccch--hHHHHHHHHHh-
Q 000859 1102 AKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEM--DMVRWVEMHME- 1178 (1251)
Q Consensus 1102 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~--~~~~~~~~~~~- 1178 (1251)
++....... ........||+.|+|||++.+..++.++||||+||++|||++|+.||.+...... .+.........
T Consensus 232 a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~ 309 (392)
T PHA03207 232 ACKLDAHPD--TPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVH 309 (392)
T ss_pred ccccCcccc--cccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccC
Confidence 976543211 1122235789999999999999999999999999999999999999965433211 11111111000
Q ss_pred ---ccchh----hhhh--hcccCCCCCCch-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 000859 1179 ---MSGSA----REEL--LDDQMKPLLPGE-----ECAAYQVLEIALQCTKTSPQERPSSRQVCDL 1230 (1251)
Q Consensus 1179 ---~~~~~----~~~~--~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 1230 (1251)
..... .... .....++....+ ...+.++.+++.+|+..||++|||++|++..
T Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 310 PLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred ccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00000 0000 000111111111 1134568899999999999999999999875
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=312.02 Aligned_cols=270 Identities=22% Similarity=0.259 Sum_probs=197.6
Q ss_pred hhcCCCcCceecccCCceEEEEEe-cCCcEEEEEEeccCCchhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeE
Q 000859 944 ATNNLSDEFIIGSGGSGTVYKAEL-ANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLL 1022 (1251)
Q Consensus 944 ~~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~l 1022 (1251)
++.+|...+.||+|+||.||+|.. .+++.||+|++...........+.+|+++++.++|+||+++++++.. ....++
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~--~~~~~l 80 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHT--KETLTF 80 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEec--CCeEEE
Confidence 456789999999999999999954 56899999999765544444577899999999999999999998754 345799
Q ss_pred EEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcccccc
Q 000859 1023 IYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLA 1102 (1251)
Q Consensus 1023 v~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a 1102 (1251)
|+||++ +++.+++... ...+++..+..++.|++.||+|||+. +|+|+||||+||+++.++.+||+|||++
T Consensus 81 v~e~~~-~~l~~~~~~~------~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~ 150 (291)
T cd07870 81 VFEYMH-TDLAQYMIQH------PGGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLA 150 (291)
T ss_pred EEeccc-CCHHHHHHhC------CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccc
Confidence 999995 7888877543 24578888999999999999999999 9999999999999999999999999998
Q ss_pred cccccccCCCCcccceeecccceecccccccC-CCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhcc-
Q 000859 1103 KALVEDYNSNTESNTWFAGSYGYIAPEYAYSL-KATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMS- 1180 (1251)
Q Consensus 1103 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~- 1180 (1251)
+...... .......++..|+|||.+.+. .++.++||||+||++|||++|+.||++.........+.........
T Consensus 151 ~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~ 226 (291)
T cd07870 151 RAKSIPS----QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTE 226 (291)
T ss_pred cccCCCC----CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCCh
Confidence 7542211 111223568899999998754 5788999999999999999999999765432221111111000000
Q ss_pred ---------chhhhhhhcccCCCCCC---chHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 000859 1181 ---------GSAREELLDDQMKPLLP---GEECAAYQVLEIALQCTKTSPQERPSSRQVCD 1229 (1251)
Q Consensus 1181 ---------~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1229 (1251)
.....++.......... .....+.++.+++.+|++.||++|||++|++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 227 DTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred hhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 00000100000000000 00012456889999999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=312.86 Aligned_cols=245 Identities=22% Similarity=0.374 Sum_probs=194.7
Q ss_pred CceecccCCceEEEEEe-cCCcEEEEEEeccCCchhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEEEeecCC
Q 000859 951 EFIIGSGGSGTVYKAEL-ANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIYEYMEN 1029 (1251)
Q Consensus 951 ~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv~E~~~~ 1029 (1251)
...||+|+||.||++.. .++..||||++.... ....+.+.+|+.+++.++||||+++++.+.. ....++||||+++
T Consensus 27 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~--~~~~~lv~e~~~~ 103 (292)
T cd06658 27 FIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK-QQRRELLFNEVVIMRDYHHENVVDMYNSYLV--GDELWVVMEFLEG 103 (292)
T ss_pred hhcccCCCCeEEEEEEECCCCCEEEEEEEecch-HHHHHHHHHHHHHHHhCCCCcHHHHHHheec--CCeEEEEEeCCCC
Confidence 35699999999999954 468899999986433 3345678899999999999999999998754 3457999999999
Q ss_pred CChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEccccccccccccc
Q 000859 1030 GSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDY 1109 (1251)
Q Consensus 1030 gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 1109 (1251)
++|.+++.. ..+++.++..++.||+.|++|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 104 ~~L~~~~~~--------~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~ 172 (292)
T cd06658 104 GALTDIVTH--------TRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV 172 (292)
T ss_pred CcHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhccccc
Confidence 999998854 3478999999999999999999999 99999999999999999999999999987543221
Q ss_pred CCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccchhhhhhhc
Q 000859 1110 NSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSAREELLD 1189 (1251)
Q Consensus 1110 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1189 (1251)
.......|+..|+|||...+..++.++|||||||++||+++|+.||........ .... .
T Consensus 173 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~-----~~~~------------~ 231 (292)
T cd06658 173 ----PKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQA-----MRRI------------R 231 (292)
T ss_pred ----ccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-----HHHH------------H
Confidence 112235688999999999888899999999999999999999999975422111 0000 0
Q ss_pred ccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 000859 1190 DQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDL 1230 (1251)
Q Consensus 1190 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 1230 (1251)
....+..+.....+..+.+++.+|+..||.+|||++|+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 232 DNLPPRVKDSHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred hcCCCccccccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 00111111222244568899999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-32 Score=303.83 Aligned_cols=248 Identities=28% Similarity=0.421 Sum_probs=197.3
Q ss_pred CCCcCceecccCCceEEEEEec-CCcEEEEEEeccCCc----hhhhHHHHHHHHHHHhccCCCccceeceeeecCCCcee
Q 000859 947 NLSDEFIIGSGGSGTVYKAELA-NGATVAVKKISCKDD----HLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNL 1021 (1251)
Q Consensus 947 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~ 1021 (1251)
+|+..+.||+|+||.||+|... +++.||+|.+..... ....+.+.+|+++++.++|+||+++++++... ...+
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--~~~~ 78 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREE--DNLY 78 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecC--CeEE
Confidence 3677789999999999999665 789999999865431 23456788999999999999999999987543 4579
Q ss_pred EEEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEccccc
Q 000859 1022 LIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGL 1101 (1251)
Q Consensus 1022 lv~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~ 1101 (1251)
+++||+++++|.+++... ..+++..+..++.|+++|++|||+. +|+|+||+|+||+++.++.+||+|||.
T Consensus 79 lv~e~~~~~~L~~~~~~~-------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~ 148 (258)
T cd06632 79 IFLELVPGGSLAKLLKKY-------GSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGM 148 (258)
T ss_pred EEEEecCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCcc
Confidence 999999999999999763 4588999999999999999999999 999999999999999999999999999
Q ss_pred ccccccccCCCCcccceeecccceecccccccCC-CCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhcc
Q 000859 1102 AKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLK-ATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMS 1180 (1251)
Q Consensus 1102 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 1180 (1251)
+....... ......|+..|+|||.+.... ++.++|+|||||++|++++|+.||......+. .....
T Consensus 149 ~~~~~~~~-----~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~-----~~~~~--- 215 (258)
T cd06632 149 AKQVVEFS-----FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAA-----VFKIG--- 215 (258)
T ss_pred ceeccccc-----cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHH-----HHHHH---
Confidence 87653221 122356789999999987766 89999999999999999999999976532111 00000
Q ss_pred chhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 000859 1181 GSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCD 1229 (1251)
Q Consensus 1181 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1229 (1251)
.....+.. +.....++.+++.+||+.+|++||++++++.
T Consensus 216 --------~~~~~~~~--~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 216 --------RSKELPPI--PDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred --------hcccCCCc--CCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 00000111 1224566889999999999999999999875
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-33 Score=309.40 Aligned_cols=239 Identities=22% Similarity=0.368 Sum_probs=185.0
Q ss_pred eecccCCceEEEEEecC--------CcEEEEEEeccCCchhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEEE
Q 000859 953 IIGSGGSGTVYKAELAN--------GATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIY 1024 (1251)
Q Consensus 953 ~lG~G~fg~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv~ 1024 (1251)
.||+|+||.||+|.... ..+||+|.+... .....+.+.+|+.+++.++||||+++++++... ...++||
T Consensus 2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~--~~~~lv~ 78 (258)
T cd05078 2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS-HRNYSESFFEAASMMSQLSHKHLVLNYGVCVCG--DESIMVQ 78 (258)
T ss_pred CCCcccchhheeeeecccccccccccchhhHHhhcch-hHHHHHHHHHHHHHHHhCCCCChhheeeEEEeC--CCcEEEE
Confidence 69999999999996532 235888887533 233456788999999999999999999988654 3468999
Q ss_pred eecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCC--------eEE
Q 000859 1025 EYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNME--------AHL 1096 (1251)
Q Consensus 1025 E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~--------~kl 1096 (1251)
||+++|+|.++++.. ...+++..+..++.||+.|++|||+. +|+||||||+||+++.++. +++
T Consensus 79 e~~~~g~L~~~l~~~------~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l 149 (258)
T cd05078 79 EYVKFGSLDTYLKKN------KNLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKL 149 (258)
T ss_pred ecCCCCcHHHHHhcC------CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEe
Confidence 999999999999864 23688999999999999999999999 9999999999999987765 699
Q ss_pred cccccccccccccCCCCcccceeecccceeccccccc-CCCCCccceeehhHHHHHHhhCC-CCCCCccccchhHHHHHH
Q 000859 1097 GDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYS-LKATEKCDVYSMGIVLMELVSGK-MPTDATFGVEMDMVRWVE 1174 (1251)
Q Consensus 1097 ~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlGv~l~el~tg~-~p~~~~~~~~~~~~~~~~ 1174 (1251)
+|||.+..... .....++..|+|||++.+ ..++.++|||||||++||+++|. .||........ ..
T Consensus 150 ~d~g~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~-----~~ 216 (258)
T cd05078 150 SDPGISITVLP--------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKK-----LQ 216 (258)
T ss_pred cccccccccCC--------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHH-----HH
Confidence 99998865422 122457889999999876 45799999999999999999984 66543321110 00
Q ss_pred HHHhccchhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 000859 1175 MHMEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLL 1232 (1251)
Q Consensus 1175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 1232 (1251)
.. .. ....+. ....++.+++.+||+.||++|||++++++.|.
T Consensus 217 ~~------------~~--~~~~~~--~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 217 FY------------ED--RHQLPA--PKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred HH------------Hc--cccCCC--CCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 00 00 011111 12356889999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-32 Score=309.27 Aligned_cols=265 Identities=23% Similarity=0.322 Sum_probs=197.3
Q ss_pred CCCcCceecccCCceEEEEEec-CCcEEEEEEeccCC-chhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEEE
Q 000859 947 NLSDEFIIGSGGSGTVYKAELA-NGATVAVKKISCKD-DHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIY 1024 (1251)
Q Consensus 947 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv~ 1024 (1251)
+|+..+.||+|+||.||+|..+ +++.||+|++.... .....+.+.+|++++++++|||++++++++.. ....++||
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~~v~ 79 (286)
T cd07847 2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRR--KRKLHLVF 79 (286)
T ss_pred ceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEee--CCEEEEEE
Confidence 5788889999999999999664 68999999986443 22234667899999999999999999998865 34578999
Q ss_pred eecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcccccccc
Q 000859 1025 EYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKA 1104 (1251)
Q Consensus 1025 E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~ 1104 (1251)
||++++++..+... ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++..
T Consensus 80 e~~~~~~l~~~~~~-------~~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 149 (286)
T cd07847 80 EYCDHTVLNELEKN-------PRGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARI 149 (286)
T ss_pred eccCccHHHHHHhC-------CCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECcccccee
Confidence 99999888877654 34589999999999999999999998 999999999999999999999999999976
Q ss_pred cccccCCCCcccceeecccceeccccccc-CCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccchh
Q 000859 1105 LVEDYNSNTESNTWFAGSYGYIAPEYAYS-LKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSA 1183 (1251)
Q Consensus 1105 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1183 (1251)
...... ......++..|+|||.+.+ ..++.++||||+||++|||++|+.||.+....+... .. ..........
T Consensus 150 ~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~-~~-~~~~~~~~~~ 223 (286)
T cd07847 150 LTGPGD----DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLY-LI-RKTLGDLIPR 223 (286)
T ss_pred cCCCcc----cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHH-HH-HHHhCCCChH
Confidence 533211 1223457889999998875 557899999999999999999999997654322111 11 1100000000
Q ss_pred hhhhhc------ccCCCC----CCc---hHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 000859 1184 REELLD------DQMKPL----LPG---EECAAYQVLEIALQCTKTSPQERPSSRQVCD 1229 (1251)
Q Consensus 1184 ~~~~~~------~~~~~~----~~~---~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1229 (1251)
.....+ ....+. .+. ....+..+.+++.+||+.||++||++.|++.
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 224 HQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred HhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 000000 000000 000 0113466889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-32 Score=305.99 Aligned_cols=254 Identities=25% Similarity=0.432 Sum_probs=195.1
Q ss_pred CCCcCceecccCCceEEEEEe-cCCcEEEEEEeccCCc---------hhhhHHHHHHHHHHHhccCCCccceeceeeecC
Q 000859 947 NLSDEFIIGSGGSGTVYKAEL-ANGATVAVKKISCKDD---------HLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKG 1016 (1251)
Q Consensus 947 ~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~---------~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~ 1016 (1251)
+|...+.||+|+||.||+|.. .+++.||+|.+..... ....+.+.+|+.+++.++|||++++++++..
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-- 79 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETT-- 79 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEecc--
Confidence 366778999999999999954 4689999998853221 1123567889999999999999999998754
Q ss_pred CCceeEEEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEE
Q 000859 1017 AGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHL 1096 (1251)
Q Consensus 1017 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl 1096 (1251)
....++||||+++|+|.+++++. ..+++..+..++.|++.|+.|||+. +++||||+|+||+++.++.+++
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~~-------~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l 149 (272)
T cd06629 80 EEYLSIFLEYVPGGSIGSCLRTY-------GRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKI 149 (272)
T ss_pred CCceEEEEecCCCCcHHHHHhhc-------cCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEE
Confidence 45579999999999999999763 4688999999999999999999999 9999999999999999999999
Q ss_pred cccccccccccccCCCCcccceeecccceecccccccCC--CCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHH
Q 000859 1097 GDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLK--ATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVE 1174 (1251)
Q Consensus 1097 ~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~ 1174 (1251)
+|||.++....... ........|+..|+|||.+.... ++.++|+||+|+++||+++|+.||......+ ...+
T Consensus 150 ~d~~~~~~~~~~~~--~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~----~~~~ 223 (272)
T cd06629 150 SDFGISKKSDDIYD--NDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIA----AMFK 223 (272)
T ss_pred eecccccccccccc--ccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHH----HHHH
Confidence 99999875432211 11122346789999999987654 8899999999999999999999986432211 1110
Q ss_pred HHHhccchhhhhhhcccCCCCCCc--hHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 000859 1175 MHMEMSGSAREELLDDQMKPLLPG--EECAAYQVLEIALQCTKTSPQERPSSRQVCDL 1230 (1251)
Q Consensus 1175 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 1230 (1251)
.. .....+..+. ....+.++.+++.+|++.||++|||+++|++.
T Consensus 224 ~~------------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 224 LG------------NKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred hh------------ccccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 00 0000011111 11235678899999999999999999998863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-32 Score=306.64 Aligned_cols=257 Identities=28% Similarity=0.389 Sum_probs=201.0
Q ss_pred hhcCCCcCceecccCCceEEEEEec-CCcEEEEEEeccCCchhhhHHHHHHHHHHHhc-cCCCccceeceeeecC----C
Q 000859 944 ATNNLSDEFIIGSGGSGTVYKAELA-NGATVAVKKISCKDDHLLNKSFTREVKTLGRI-RHRHLVKLMGHCCNKG----A 1017 (1251)
Q Consensus 944 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~----~ 1017 (1251)
.+++|+..+.||+|+||.||+|... +++.||+|++..... ..+.+.+|+++++++ +|+||+++++++.... .
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED--EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch--hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 4578999999999999999999664 678999999865433 346789999999999 7999999999887644 3
Q ss_pred CceeEEEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEc
Q 000859 1018 GSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLG 1097 (1251)
Q Consensus 1018 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~ 1097 (1251)
...++||||+++++|.+++.... .....+++..+..++.|++.|++|||+. +++|+||+|+||++++++.+|++
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~ 155 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLR---KKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLV 155 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHh---hcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEEC
Confidence 45689999999999999986531 1135689999999999999999999999 99999999999999999999999
Q ss_pred ccccccccccccCCCCcccceeecccceeccccccc-----CCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHH
Q 000859 1098 DFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYS-----LKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRW 1172 (1251)
Q Consensus 1098 DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~ 1172 (1251)
|||.+....... .......|+..|+|||++.. ..++.++||||+||++|||++|+.||........ .
T Consensus 156 d~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~----~ 227 (275)
T cd06608 156 DFGVSAQLDSTL----GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRA----L 227 (275)
T ss_pred CCccceecccch----hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHH----H
Confidence 999987643221 11223468899999998753 3467899999999999999999999965422111 0
Q ss_pred HHHHHhccchhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 000859 1173 VEMHMEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCD 1229 (1251)
Q Consensus 1173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1229 (1251)
. .... ...+........+.++.+++.+||..||++|||++|+++
T Consensus 228 ~------------~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 228 F------------KIPR-NPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred H------------Hhhc-cCCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 0 0000 011122223335567899999999999999999999975
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-32 Score=303.57 Aligned_cols=250 Identities=24% Similarity=0.360 Sum_probs=198.1
Q ss_pred CCCcCceecccCCceEEEEEe-cCCcEEEEEEeccCC-chhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEEE
Q 000859 947 NLSDEFIIGSGGSGTVYKAEL-ANGATVAVKKISCKD-DHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIY 1024 (1251)
Q Consensus 947 ~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv~ 1024 (1251)
+|+..+.||+|+||.||+|.. .+++.||||++.... .....+.+.+|++++++++||||+++++.+.. ....++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~lv~ 78 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLE--DKALMIVM 78 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEec--CCEEEEEE
Confidence 477788999999999999954 578899999986543 33345788899999999999999999997754 44579999
Q ss_pred eecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCC-CCeEEccccccc
Q 000859 1025 EYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSN-MEAHLGDFGLAK 1103 (1251)
Q Consensus 1025 E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~-~~~kl~DfG~a~ 1103 (1251)
||+++++|.+++.... ...+++..+.+++.|+++|++|||++ +|+||||||+||+++++ +.+|++|||.+.
T Consensus 79 e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~ 150 (256)
T cd08220 79 EYAPGGTLAEYIQKRC-----NSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISK 150 (256)
T ss_pred ecCCCCCHHHHHHHhc-----ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCce
Confidence 9999999999997642 34589999999999999999999999 99999999999999865 468999999997
Q ss_pred ccccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccchh
Q 000859 1104 ALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSA 1183 (1251)
Q Consensus 1104 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1183 (1251)
...... ......|+..|+|||.+.+..++.++||||||+++|+|++|+.||....... ......
T Consensus 151 ~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~-----~~~~~~------ 214 (256)
T cd08220 151 ILSSKS-----KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPA-----LVLKIM------ 214 (256)
T ss_pred ecCCCc-----cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHH-----HHHHHH------
Confidence 653221 1122467889999999998889999999999999999999999997543211 111100
Q ss_pred hhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 000859 1184 REELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDL 1230 (1251)
Q Consensus 1184 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 1230 (1251)
... ..+.+...+.++.+++.+||+.+|++|||++|++..
T Consensus 215 -----~~~---~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 215 -----SGT---FAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred -----hcC---CCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 000 011112245678899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=310.29 Aligned_cols=269 Identities=20% Similarity=0.284 Sum_probs=195.6
Q ss_pred hcCCCcCceecccCCceEEEEEec-CCcEEEEEEeccCCchhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEE
Q 000859 945 TNNLSDEFIIGSGGSGTVYKAELA-NGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLI 1023 (1251)
Q Consensus 945 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv 1023 (1251)
.++|+..+.||+|+||.||+|..+ +++.||||.+...........+.+|++++++++||||+++++++.. ....++|
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 81 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHT--KKTLTLV 81 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEec--CCeEEEE
Confidence 356888899999999999999654 6899999998754433334557789999999999999999998854 3457999
Q ss_pred EeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEccccccc
Q 000859 1024 YEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAK 1103 (1251)
Q Consensus 1024 ~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~ 1103 (1251)
|||++ ++|.+++... ...+++..++.++.|+++|++|||+. +|+||||||+||++++++.+||+|||.++
T Consensus 82 ~e~~~-~~L~~~~~~~------~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~ 151 (291)
T cd07844 82 FEYLD-TDLKQYMDDC------GGGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLAR 151 (291)
T ss_pred EecCC-CCHHHHHHhC------CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECcccccc
Confidence 99997 4999998764 24678999999999999999999999 99999999999999999999999999986
Q ss_pred ccccccCCCCcccceeecccceeccccccc-CCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccch
Q 000859 1104 ALVEDYNSNTESNTWFAGSYGYIAPEYAYS-LKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGS 1182 (1251)
Q Consensus 1104 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 1182 (1251)
...... .......++..|+|||.+.+ ..++.++||||+||++|||++|+.||.......................
T Consensus 152 ~~~~~~----~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (291)
T cd07844 152 AKSVPS----KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEE 227 (291)
T ss_pred ccCCCC----ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChh
Confidence 532111 11112346789999998875 4588999999999999999999999975542221111111100000000
Q ss_pred hhhhh------hcccCCCCCCc-------hHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 000859 1183 AREEL------LDDQMKPLLPG-------EECAAYQVLEIALQCTKTSPQERPSSRQVCD 1229 (1251)
Q Consensus 1183 ~~~~~------~~~~~~~~~~~-------~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1229 (1251)
..... .........+. ......++.+++.+|++.+|++|||+.+++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 228 TWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred hhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 00000 00000000000 0001256789999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-32 Score=306.96 Aligned_cols=249 Identities=25% Similarity=0.378 Sum_probs=197.9
Q ss_pred CCCcCceecccCCceEEEEEe-cCCcEEEEEEeccCCchhhhHHHHHHHHHHHhcc---CCCccceeceeeecCCCceeE
Q 000859 947 NLSDEFIIGSGGSGTVYKAEL-ANGATVAVKKISCKDDHLLNKSFTREVKTLGRIR---HRHLVKLMGHCCNKGAGSNLL 1022 (1251)
Q Consensus 947 ~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~g~~~~~~~~~~~l 1022 (1251)
.|+..+.||+|+||.||+|.. .+++.||+|.+.........+.+.+|++++++++ |||++++++++.. ....++
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~--~~~~~l 79 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLK--GPRLWI 79 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeee--CCEEEE
Confidence 466778899999999999964 5789999999876555555677889999999996 9999999998754 345799
Q ss_pred EEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcccccc
Q 000859 1023 IYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLA 1102 (1251)
Q Consensus 1023 v~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a 1102 (1251)
||||+++++|.++++. ..+++..+..++.|++.|++|||+. +|+||||+|+||+++.++.++++|||.+
T Consensus 80 v~e~~~~~~L~~~~~~--------~~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~ 148 (277)
T cd06917 80 IMEYAEGGSVRTLMKA--------GPIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVA 148 (277)
T ss_pred EEecCCCCcHHHHHHc--------cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCce
Confidence 9999999999999864 2588999999999999999999999 9999999999999999999999999999
Q ss_pred cccccccCCCCcccceeecccceeccccccc-CCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccc
Q 000859 1103 KALVEDYNSNTESNTWFAGSYGYIAPEYAYS-LKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSG 1181 (1251)
Q Consensus 1103 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 1181 (1251)
..+.... .......|+..|+|||.+.+ ..++.++|+|||||++|+|++|+.||....... ....
T Consensus 149 ~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~-----~~~~------ 213 (277)
T cd06917 149 ALLNQNS----SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFR-----AMML------ 213 (277)
T ss_pred eecCCCc----cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhh-----hhhc------
Confidence 7654322 11223468899999998865 447899999999999999999999997542211 1000
Q ss_pred hhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 000859 1182 SAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDL 1230 (1251)
Q Consensus 1182 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 1230 (1251)
......+..+. ...+.++.+++.+||+.||++||++.|+++.
T Consensus 214 ------~~~~~~~~~~~-~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 214 ------IPKSKPPRLED-NGYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred ------cccCCCCCCCc-ccCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 00001111111 1145678999999999999999999999864
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=289.89 Aligned_cols=256 Identities=27% Similarity=0.365 Sum_probs=196.2
Q ss_pred CCCcCceecccCCceEEEE-EecCCcEEEEEEeccCCchhhhHHHHHHHHHHHhc-cCCCccceeceeeecCCCceeEEE
Q 000859 947 NLSDEFIIGSGGSGTVYKA-ELANGATVAVKKISCKDDHLLNKSFTREVKTLGRI-RHRHLVKLMGHCCNKGAGSNLLIY 1024 (1251)
Q Consensus 947 ~~~~~~~lG~G~fg~V~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~~~lv~ 1024 (1251)
+.+....||.|+||+|++- ....|+..|||+++....+.+.+++..|.+...+- +.||||++||++..+++ +|+.|
T Consensus 65 ~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGd--cWiCM 142 (361)
T KOG1006|consen 65 NLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGD--CWICM 142 (361)
T ss_pred hHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCc--eeeeH
Confidence 3445567999999999999 55679999999999888888888999999876555 79999999998876544 69999
Q ss_pred eecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcccccccc
Q 000859 1025 EYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKA 1104 (1251)
Q Consensus 1025 E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~ 1104 (1251)
|.|+- ++..+-+.- .......+++...-+|..-.+.|+.||.+.. +|||||+||+|||++..|.+|+||||.+-.
T Consensus 143 ELMd~-SlDklYk~v--y~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGq 217 (361)
T KOG1006|consen 143 ELMDI-SLDKLYKRV--YSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQ 217 (361)
T ss_pred HHHhh-hHHHHHHHH--HHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHh
Confidence 99974 555443321 0112456888888889999999999999874 899999999999999999999999999876
Q ss_pred cccccCCCCcccceeecccceeccccccc--CCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccch
Q 000859 1105 LVEDYNSNTESNTWFAGSYGYIAPEYAYS--LKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGS 1182 (1251)
Q Consensus 1105 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 1182 (1251)
+... ...+.-+|...|||||.+.. ..|+.+|||||+|+++||+.||..||......- +.+.
T Consensus 218 Lv~S-----iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svf----eql~-------- 280 (361)
T KOG1006|consen 218 LVDS-----IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVF----EQLC-------- 280 (361)
T ss_pred HHHH-----HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHH----HHHH--------
Confidence 5432 23334578899999998863 358999999999999999999999997542211 1111
Q ss_pred hhhhhhcccCCCCCCchH---HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 000859 1183 AREELLDDQMKPLLPGEE---CAAYQVLEIALQCTKTSPQERPSSRQVCDL 1230 (1251)
Q Consensus 1183 ~~~~~~~~~~~~~~~~~~---~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 1230 (1251)
.+... -.|.+..+. .....+..++.-|+.+|-..||++.++.+.
T Consensus 281 ---~Vv~g-dpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 281 ---QVVIG-DPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred ---HHHcC-CCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 11111 112222222 255678999999999999999999998753
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-33 Score=331.46 Aligned_cols=252 Identities=29% Similarity=0.445 Sum_probs=189.6
Q ss_pred cCCCcCceecccCCceEEEEEec-CCcEEEEEEeccCCchhhhHHHHHHHHHHHhccCCCccceeceeeecC--------
Q 000859 946 NNLSDEFIIGSGGSGTVYKAELA-NGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKG-------- 1016 (1251)
Q Consensus 946 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-------- 1016 (1251)
++|+....||+||||.||+++.+ ||+.||||++...........+.+|+..+++++|||||+++..+.+..
T Consensus 479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei 558 (1351)
T KOG1035|consen 479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEI 558 (1351)
T ss_pred hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccc
Confidence 45677779999999999999654 899999999988876777788899999999999999999875222110
Q ss_pred --------------------------------------------------------------------------------
Q 000859 1017 -------------------------------------------------------------------------------- 1016 (1251)
Q Consensus 1017 -------------------------------------------------------------------------------- 1016 (1251)
T Consensus 559 ~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~ 638 (1351)
T KOG1035|consen 559 VASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEG 638 (1351)
T ss_pred cccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCC
Confidence
Q ss_pred -----------------------------CCceeEEEeecCCCChHHhhhcCCCCcccCCCC-CHHHHHHHHHHHHHHHH
Q 000859 1017 -----------------------------AGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSL-DWEARLKIAVGLAQGVE 1066 (1251)
Q Consensus 1017 -----------------------------~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~l-~~~~~~~i~~~i~~~l~ 1066 (1251)
+...||=||||+.-++.++++++. .. .....++++++|++|++
T Consensus 639 ~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~-------~~~~~d~~wrLFreIlEGLa 711 (1351)
T KOG1035|consen 639 SVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNH-------FNSQRDEAWRLFREILEGLA 711 (1351)
T ss_pred ccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcc-------cchhhHHHHHHHHHHHHHHH
Confidence 022467888888877777776532 11 46788999999999999
Q ss_pred HhhhcCCCCeeecCCCCCCeeecCCCCeEEccccccccccc--------------ccCCCCcccceeecccceecccccc
Q 000859 1067 YLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVE--------------DYNSNTESNTWFAGSYGYIAPEYAY 1132 (1251)
Q Consensus 1067 ~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~--------------~~~~~~~~~~~~~gt~~y~aPE~~~ 1132 (1251)
|+|+. |||||||||.||+++++..|||+|||+|+.... .........+..+||.-|+|||++.
T Consensus 712 YIH~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~ 788 (1351)
T KOG1035|consen 712 YIHDQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLS 788 (1351)
T ss_pred HHHhC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhc
Confidence 99999 999999999999999999999999999987320 0111222445679999999999987
Q ss_pred cC---CCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccchhhhhhhcccCCCCCCch----HHHHHH
Q 000859 1133 SL---KATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSAREELLDDQMKPLLPGE----ECAAYQ 1205 (1251)
Q Consensus 1133 ~~---~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~ 1205 (1251)
+. .|+.|+|+||+|||++||+ .||... +..... +.....+.+|.+ ....+.
T Consensus 789 ~~~~~~Yn~KiDmYSLGIVlFEM~---yPF~Ts----MERa~i---------------L~~LR~g~iP~~~~f~~~~~~~ 846 (1351)
T KOG1035|consen 789 DTSSNKYNSKIDMYSLGIVLFEML---YPFGTS----MERASI---------------LTNLRKGSIPEPADFFDPEHPE 846 (1351)
T ss_pred ccccccccchhhhHHHHHHHHHHh---ccCCch----HHHHHH---------------HHhcccCCCCCCcccccccchH
Confidence 55 4999999999999999998 345432 111111 111112222222 122234
Q ss_pred HHHHHHHccccCCCCCCCHHHHHH
Q 000859 1206 VLEIALQCTKTSPQERPSSRQVCD 1229 (1251)
Q Consensus 1206 l~~li~~cl~~dP~~RPs~~eil~ 1229 (1251)
-.++|.++++.||.+||||.|+++
T Consensus 847 e~slI~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 847 EASLIRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred HHHHHHHHhcCCCccCCCHHHHhh
Confidence 468999999999999999999875
|
|
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.4e-32 Score=310.08 Aligned_cols=267 Identities=26% Similarity=0.395 Sum_probs=197.4
Q ss_pred cCCCcCceecccCCceEEEEEec-CCcEEEEEEeccCCch-hhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEE
Q 000859 946 NNLSDEFIIGSGGSGTVYKAELA-NGATVAVKKISCKDDH-LLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLI 1023 (1251)
Q Consensus 946 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv 1023 (1251)
++|+..+.||+|+||.||+|..+ +++.||+|++...... ...+.+.+|+++++.++||||+++++++.. +...++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 78 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRR--KKRLYLV 78 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhccc--CCeEEEE
Confidence 35788899999999999999764 5899999998644322 245678899999999999999999998854 4567999
Q ss_pred EeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEccccccc
Q 000859 1024 YEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAK 1103 (1251)
Q Consensus 1024 ~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~ 1103 (1251)
+||++++++.++... ...+++.++..++.|+++|++|||+. +++|||++|+||++++++.++++|||++.
T Consensus 79 ~e~~~~~~l~~~~~~-------~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~ 148 (286)
T cd07846 79 FEFVDHTVLDDLEKY-------PNGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFAR 148 (286)
T ss_pred EecCCccHHHHHHhc-------cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeee
Confidence 999999988887654 23589999999999999999999999 99999999999999999999999999987
Q ss_pred ccccccCCCCcccceeecccceeccccccc-CCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccch
Q 000859 1104 ALVEDYNSNTESNTWFAGSYGYIAPEYAYS-LKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGS 1182 (1251)
Q Consensus 1104 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 1182 (1251)
.+.... .......++..|+|||++.+ ..++.++|||||||++|||++|+.||......+. ..............
T Consensus 149 ~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~-~~~~~~~~~~~~~~ 223 (286)
T cd07846 149 TLAAPG----EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQ-LYHIIKCLGNLIPR 223 (286)
T ss_pred eccCCc----cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHH-HHHHHHHhCCCchh
Confidence 653321 11223467899999998875 4578899999999999999999999975432211 00100000000000
Q ss_pred hhh-----hhhcccCCCCCCc-------hHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 000859 1183 ARE-----ELLDDQMKPLLPG-------EECAAYQVLEIALQCTKTSPQERPSSRQVCD 1229 (1251)
Q Consensus 1183 ~~~-----~~~~~~~~~~~~~-------~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1229 (1251)
... ........+.... ....+..+.+++.+||+.+|++||+++++++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 224 HQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred hHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 000 0000000011000 1123567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.7e-32 Score=310.03 Aligned_cols=245 Identities=23% Similarity=0.323 Sum_probs=196.8
Q ss_pred cCCCcCceecccCCceEEEEEe-cCCcEEEEEEeccCC--chhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeE
Q 000859 946 NNLSDEFIIGSGGSGTVYKAEL-ANGATVAVKKISCKD--DHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLL 1022 (1251)
Q Consensus 946 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~l 1022 (1251)
++|+..+.||+|+||.||+|.. .+++.||+|++.... .....+.+.+|++++++++||||+++++++.. ....++
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~ 78 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQD--DSNLYL 78 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEc--CCeEEE
Confidence 3578888999999999999965 468999999986432 22344678899999999999999999998754 345799
Q ss_pred EEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcccccc
Q 000859 1023 IYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLA 1102 (1251)
Q Consensus 1023 v~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a 1102 (1251)
||||+++++|.+++... ..+++..+..++.|+++|++|||+. +|+||||+|+||+++.++.+||+|||++
T Consensus 79 v~e~~~~~~L~~~~~~~-------~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~ 148 (290)
T cd05580 79 VMEYVPGGELFSHLRKS-------GRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFA 148 (290)
T ss_pred EEecCCCCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCc
Confidence 99999999999999763 5689999999999999999999999 9999999999999999999999999998
Q ss_pred cccccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccch
Q 000859 1103 KALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGS 1182 (1251)
Q Consensus 1103 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 1182 (1251)
+..... .....|++.|+|||.+.+..++.++||||+|+++|||++|+.||......+ .. .
T Consensus 149 ~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~---~-------- 208 (290)
T cd05580 149 KRVKGR-------TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQ--IY---E-------- 208 (290)
T ss_pred cccCCC-------CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH--HH---H--------
Confidence 765322 223468899999999988889999999999999999999999997543110 00 0
Q ss_pred hhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 000859 1183 AREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERP-----SSRQVCD 1229 (1251)
Q Consensus 1183 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~ 1229 (1251)
.... ...+.+...+..+.+++.+||..||.+|| +++|+++
T Consensus 209 ---~~~~----~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 209 ---KILE----GKVRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred ---HHhc----CCccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 0000 01111122356788999999999999999 7777764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.4e-32 Score=301.96 Aligned_cols=254 Identities=25% Similarity=0.342 Sum_probs=199.5
Q ss_pred cCCCcCceecccCCceEEEEEe-cCCcEEEEEEeccCC----chhhhHHHHHHHHHHHhccCCCccceeceeeecCCCce
Q 000859 946 NNLSDEFIIGSGGSGTVYKAEL-ANGATVAVKKISCKD----DHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSN 1020 (1251)
Q Consensus 946 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~ 1020 (1251)
.+|+..+.||+|+||.||+|.. .++..||+|++.... .....+.+.+|++++++++||||+++++++........
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 4688889999999999999954 568999999875321 23345678899999999999999999998866555667
Q ss_pred eEEEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcccc
Q 000859 1021 LLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFG 1100 (1251)
Q Consensus 1021 ~lv~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG 1100 (1251)
++++||+++++|.+++... ..+++..+.+++.|++.|++|||+. +++|+||||+||+++.++.++|+|||
T Consensus 82 ~~v~e~~~~~~L~~~~~~~-------~~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg 151 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAY-------GALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFG 151 (264)
T ss_pred EEEEEeCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECccc
Confidence 8999999999999998753 4578899999999999999999999 99999999999999999999999999
Q ss_pred cccccccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhcc
Q 000859 1101 LAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMS 1180 (1251)
Q Consensus 1101 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 1180 (1251)
.++........ ........|+..|+|||.+.+..++.++|+|||||++||+++|+.||......+. +
T Consensus 152 ~~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-----~------- 218 (264)
T cd06653 152 ASKRIQTICMS-GTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAA-----I------- 218 (264)
T ss_pred ccccccccccc-CccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHH-----H-------
Confidence 99765322111 1111234688999999999888899999999999999999999999975422110 0
Q ss_pred chhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 000859 1181 GSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCD 1229 (1251)
Q Consensus 1181 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1229 (1251)
.........+.. +....+.+.+++.+|++ +|.+||++.+++.
T Consensus 219 ----~~~~~~~~~~~~--p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 219 ----FKIATQPTKPML--PDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred ----HHHHcCCCCCCC--CcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 000000011111 23345678999999999 5799999998875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.2e-32 Score=305.46 Aligned_cols=265 Identities=21% Similarity=0.274 Sum_probs=195.0
Q ss_pred CCcCceecccCCceEEEEEe-cCCcEEEEEEeccCCchhhhHHHHHHHHHHHhcc-CCCccceeceeeecCCCceeEEEe
Q 000859 948 LSDEFIIGSGGSGTVYKAEL-ANGATVAVKKISCKDDHLLNKSFTREVKTLGRIR-HRHLVKLMGHCCNKGAGSNLLIYE 1025 (1251)
Q Consensus 948 ~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~~~lv~E 1025 (1251)
|+..+.||+|+||.||+|.. .+++.||+|+++............+|+.+++++. |+|++++++++.+......++|+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 55677899999999999954 5689999999875433333345567999999985 999999999987664466899999
Q ss_pred ecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEccccccccc
Q 000859 1026 YMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKAL 1105 (1251)
Q Consensus 1026 ~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~ 1105 (1251)
|++ |++.+++... ...+++.++..++.|++.|++|||+. +++||||||+||+++. +.+||+|||.++..
T Consensus 81 ~~~-~~l~~~l~~~------~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~ 149 (282)
T cd07831 81 LMD-MNLYELIKGR------KRPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGI 149 (282)
T ss_pred cCC-ccHHHHHHhc------cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEeccccccc
Confidence 997 5888888753 24689999999999999999999999 9999999999999999 99999999999765
Q ss_pred ccccCCCCcccceeecccceeccccccc-CCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccchhh
Q 000859 1106 VEDYNSNTESNTWFAGSYGYIAPEYAYS-LKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSAR 1184 (1251)
Q Consensus 1106 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1184 (1251)
.... ......++..|+|||.+.. ..++.++||||+||++|||++|+.||.+....+ ...+............
T Consensus 150 ~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~--~~~~~~~~~~~~~~~~ 222 (282)
T cd07831 150 YSKP-----PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELD--QIAKIHDVLGTPDAEV 222 (282)
T ss_pred ccCC-----CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHH--HHHHHHHHcCCCCHHH
Confidence 3221 1122457889999997654 557889999999999999999999997653322 1111111110000000
Q ss_pred hhhhccc--CCCCCC---------chHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 000859 1185 EELLDDQ--MKPLLP---------GEECAAYQVLEIALQCTKTSPQERPSSRQVCDL 1230 (1251)
Q Consensus 1185 ~~~~~~~--~~~~~~---------~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 1230 (1251)
....... .....+ .....+.++.+++.+||+.+|++||+++++++.
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 223 LKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred HHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 0000000 000000 011245789999999999999999999999863
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5e-32 Score=306.96 Aligned_cols=254 Identities=27% Similarity=0.402 Sum_probs=192.5
Q ss_pred cCCCcCceecccCCceEEEEEe-cCCcEEEEEEeccCCchhhhHHHHHHHHH-HHhccCCCccceeceeeecCCCceeEE
Q 000859 946 NNLSDEFIIGSGGSGTVYKAEL-ANGATVAVKKISCKDDHLLNKSFTREVKT-LGRIRHRHLVKLMGHCCNKGAGSNLLI 1023 (1251)
Q Consensus 946 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~-l~~l~h~niv~l~g~~~~~~~~~~~lv 1023 (1251)
++|+..+.||+|+||.||+|.. .+|+.||+|++...........+..|+.+ ++..+||||+++++++... ...+++
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~--~~~~lv 78 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFRE--GDVWIC 78 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecC--CcEEEE
Confidence 3678888999999999999965 46999999998755433344556667765 5556899999999988653 457999
Q ss_pred EeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEccccccc
Q 000859 1024 YEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAK 1103 (1251)
Q Consensus 1024 ~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~ 1103 (1251)
|||++ |+|.+++.... .....+++..+..++.|++.|++|||++. +++||||||+||+++.++.+||+|||.++
T Consensus 79 ~e~~~-~~l~~~l~~~~---~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~ 152 (283)
T cd06617 79 MEVMD-TSLDKFYKKVY---DKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISG 152 (283)
T ss_pred hhhhc-ccHHHHHHHhc---cCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeeccccc
Confidence 99996 68988886532 11356899999999999999999999842 79999999999999999999999999987
Q ss_pred ccccccCCCCcccceeecccceeccccccc----CCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhc
Q 000859 1104 ALVEDYNSNTESNTWFAGSYGYIAPEYAYS----LKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEM 1179 (1251)
Q Consensus 1104 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 1179 (1251)
..... .......|+..|+|||.+.+ ..++.++|+||+||++|||++|+.||............
T Consensus 153 ~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~-------- 219 (283)
T cd06617 153 YLVDS-----VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQ-------- 219 (283)
T ss_pred ccccc-----cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHH--------
Confidence 65321 11222467889999998764 45688999999999999999999999643221111110
Q ss_pred cchhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 000859 1180 SGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCD 1229 (1251)
Q Consensus 1180 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1229 (1251)
... ...+..+ ....+.++.+++.+||+.+|++||+++++++
T Consensus 220 -------~~~-~~~~~~~-~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 220 -------VVE-EPSPQLP-AEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred -------HHh-cCCCCCC-ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000 0011111 1124567899999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.6e-32 Score=304.73 Aligned_cols=256 Identities=23% Similarity=0.359 Sum_probs=198.4
Q ss_pred CCCcCceecccCCceEEEEEecC--CcEEEEEEeccCC---------chhhhHHHHHHHHHHHh-ccCCCccceeceeee
Q 000859 947 NLSDEFIIGSGGSGTVYKAELAN--GATVAVKKISCKD---------DHLLNKSFTREVKTLGR-IRHRHLVKLMGHCCN 1014 (1251)
Q Consensus 947 ~~~~~~~lG~G~fg~V~~~~~~~--~~~vavK~~~~~~---------~~~~~~~~~~E~~~l~~-l~h~niv~l~g~~~~ 1014 (1251)
.|+..+.||+|+||.||+|.... ++.||+|.+.... .....+++.+|+.++.+ ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 36777889999999999997654 6889999885322 22334567788888875 699999999998865
Q ss_pred cCCCceeEEEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCCeeecCCCCCCeeecCCCC
Q 000859 1015 KGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHH-DCVPKILHRDIKSSNILLDSNME 1093 (1251)
Q Consensus 1015 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~Dlkp~Nill~~~~~ 1093 (1251)
....+++|||+++++|.+++.... .....+++..+++++.|++.|++|||+ . +++|+||+|+||++++++.
T Consensus 81 --~~~~~lv~e~~~~~~l~~~l~~~~---~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~i~H~dl~~~nil~~~~~~ 152 (269)
T cd08528 81 --NDRLYIVMDLIEGAPLGEHFNSLK---EKKQRFTEERIWNIFVQMVLALRYLHKEK---RIVHRDLTPNNIMLGEDDK 152 (269)
T ss_pred --CCeEEEEEecCCCCcHHHHHHHHH---hccCCCCHHHHHHHHHHHHHHHHHhccCC---ceeecCCCHHHEEECCCCc
Confidence 345799999999999999885421 113568999999999999999999996 5 8999999999999999999
Q ss_pred eEEcccccccccccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHH
Q 000859 1094 AHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWV 1173 (1251)
Q Consensus 1094 ~kl~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~ 1173 (1251)
+||+|||.+....... ......|+..|+|||.+.+..++.++||||||+++||+++|+.||...... ...
T Consensus 153 ~~l~dfg~~~~~~~~~-----~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~-----~~~ 222 (269)
T cd08528 153 VTITDFGLAKQKQPES-----KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNML-----SLA 222 (269)
T ss_pred EEEecccceeeccccc-----ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHH-----HHH
Confidence 9999999997643221 223356889999999999888999999999999999999999998644211 111
Q ss_pred HHHHhccchhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 000859 1174 EMHMEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLN 1233 (1251)
Q Consensus 1174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 1233 (1251)
.. .......+. .....+.++.+++.+||+.||++||++.|+..++++
T Consensus 223 ~~-----------~~~~~~~~~--~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~ 269 (269)
T cd08528 223 TK-----------IVEAVYEPL--PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMISD 269 (269)
T ss_pred HH-----------HhhccCCcC--CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence 11 111111111 111245678999999999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.9e-32 Score=310.95 Aligned_cols=259 Identities=22% Similarity=0.293 Sum_probs=198.3
Q ss_pred cCCCcCceecccCCceEEEEEe-cCCcEEEEEEeccCCc--hhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeE
Q 000859 946 NNLSDEFIIGSGGSGTVYKAEL-ANGATVAVKKISCKDD--HLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLL 1022 (1251)
Q Consensus 946 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~l 1022 (1251)
++|+..+.||+|+||.||++.. .+++.||+|.+..... ....+.+.+|+++++.++||||+++++.+.. +...++
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~l 78 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFET--KRHLCM 78 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEec--CCEEEE
Confidence 3678889999999999999965 4578999999865432 2334678899999999999999999998754 345799
Q ss_pred EEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcccccc
Q 000859 1023 IYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLA 1102 (1251)
Q Consensus 1023 v~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a 1102 (1251)
||||+++|+|.+++... +.+++..+..++.|++.|++|||+. +++||||||+||+++.++.+|++|||.+
T Consensus 79 v~e~~~g~~L~~~l~~~-------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~ 148 (305)
T cd05609 79 VMEYVEGGDCATLLKNI-------GALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLS 148 (305)
T ss_pred EEecCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCc
Confidence 99999999999999763 4689999999999999999999999 9999999999999999999999999998
Q ss_pred cccccccCCC-----------CcccceeecccceecccccccCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHH
Q 000859 1103 KALVEDYNSN-----------TESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVR 1171 (1251)
Q Consensus 1103 ~~~~~~~~~~-----------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~ 1171 (1251)
+......... ........|+..|+|||.+.+..++.++|+|||||++||+++|+.||.+....+
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~----- 223 (305)
T cd05609 149 KIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE----- 223 (305)
T ss_pred cccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-----
Confidence 6421110000 001112357889999999988889999999999999999999999997542211
Q ss_pred HHHHHHhccchhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 000859 1172 WVEMHMEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLN 1233 (1251)
Q Consensus 1172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 1233 (1251)
+..... .... .........+.++.+++.+||+.||++||++.++.+.++.
T Consensus 224 ~~~~~~-----------~~~~-~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 224 LFGQVI-----------SDDI-EWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred HHHHHH-----------hccc-CCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 111100 0000 0000111345668999999999999999997666666655
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.8e-32 Score=308.06 Aligned_cols=250 Identities=24% Similarity=0.371 Sum_probs=200.0
Q ss_pred cCCCcCceecccCCceEEEEEe-cCCcEEEEEEeccCCchhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEEE
Q 000859 946 NNLSDEFIIGSGGSGTVYKAEL-ANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIY 1024 (1251)
Q Consensus 946 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv~ 1024 (1251)
.+|...+.||+|+||.||+|.. .+++.||+|.+..... ...+.+.+|+.++++++||||+++++++... ...++|+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~--~~~~lv~ 95 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQ-PKKELIINEILVMRENKHPNIVNYLDSYLVG--DELWVVM 95 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccc-hHHHHHHHHHHHHhhcCCCCeeehhheeeeC--CcEEEEE
Confidence 5688889999999999999954 4688999999864332 3456788999999999999999999988653 4579999
Q ss_pred eecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcccccccc
Q 000859 1025 EYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKA 1104 (1251)
Q Consensus 1025 E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~ 1104 (1251)
||+++++|.+++.+ ..+++.++..++.|++.|++|||+. +++|||+||+||+++.++.+||+|||.+..
T Consensus 96 e~~~~~~L~~~~~~--------~~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~ 164 (293)
T cd06647 96 EYLAGGSLTDVVTE--------TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQ 164 (293)
T ss_pred ecCCCCcHHHHHhh--------cCCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceec
Confidence 99999999999875 3478899999999999999999999 999999999999999999999999998865
Q ss_pred cccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccchhh
Q 000859 1105 LVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSAR 1184 (1251)
Q Consensus 1105 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1184 (1251)
..... .......|++.|+|||.+.+..++.++|+|||||++||+++|+.||......+....
T Consensus 165 ~~~~~----~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~-------------- 226 (293)
T cd06647 165 ITPEQ----SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL-------------- 226 (293)
T ss_pred ccccc----cccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheee--------------
Confidence 43221 112234688899999999888899999999999999999999999975422111000
Q ss_pred hhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 000859 1185 EELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDL 1230 (1251)
Q Consensus 1185 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 1230 (1251)
......+..+.....+..+.+++.+||+.+|++||++++++.+
T Consensus 227 ---~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 227 ---IATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred ---hhcCCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000112222233345678899999999999999999999865
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.5e-32 Score=316.97 Aligned_cols=278 Identities=23% Similarity=0.326 Sum_probs=202.5
Q ss_pred hcCCCcCceecccCCceEEEEE-ecCCcEEEEEEeccCCchhhhHHHHHHHHHHHhccCCCccceeceeeecCC---Cce
Q 000859 945 TNNLSDEFIIGSGGSGTVYKAE-LANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGA---GSN 1020 (1251)
Q Consensus 945 ~~~~~~~~~lG~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~---~~~ 1020 (1251)
..+|.+.+.||+|+||.||+|. ..+|+.||||++...........+.+|+.++++++||||+++++++..... ...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 4578899999999999999995 457899999998654444455678899999999999999999997754322 246
Q ss_pred eEEEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcccc
Q 000859 1021 LLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFG 1100 (1251)
Q Consensus 1021 ~lv~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG 1100 (1251)
++|+||++ +++.+++.. ..+++..++.++.|+++|++|||+. +|+||||||+||+++.++.+||+|||
T Consensus 84 ~lv~e~~~-~~l~~~~~~--------~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg 151 (336)
T cd07849 84 YIVQELME-TDLYKLIKT--------QHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFG 151 (336)
T ss_pred EEEehhcc-cCHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECccc
Confidence 89999996 588887764 4589999999999999999999999 99999999999999999999999999
Q ss_pred cccccccccCCCCcccceeecccceeccccccc-CCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhc
Q 000859 1101 LAKALVEDYNSNTESNTWFAGSYGYIAPEYAYS-LKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEM 1179 (1251)
Q Consensus 1101 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 1179 (1251)
+++........ ........||..|+|||.+.+ ..++.++||||+||++|||++|+.||.+..... ....+.......
T Consensus 152 ~~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~-~~~~~~~~~~~~ 229 (336)
T cd07849 152 LARIADPEHDH-TGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLH-QLNLILGVLGTP 229 (336)
T ss_pred ceeeccccccc-cCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHcCCC
Confidence 98765332211 112223568899999998654 568899999999999999999999996542211 111111000000
Q ss_pred cchhhh--------hhhccc-CCCCCCch---HHHHHHHHHHHHHccccCCCCCCCHHHHHHH--HHhhcC
Q 000859 1180 SGSARE--------ELLDDQ-MKPLLPGE---ECAAYQVLEIALQCTKTSPQERPSSRQVCDL--LLNVFN 1236 (1251)
Q Consensus 1180 ~~~~~~--------~~~~~~-~~~~~~~~---~~~~~~l~~li~~cl~~dP~~RPs~~eil~~--L~~~~~ 1236 (1251)
...... ...... ..+..+.. ...+.++.+++.+||+.||++|||++|+++. +++..+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~ 300 (336)
T cd07849 230 SQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHD 300 (336)
T ss_pred CHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCC
Confidence 000000 000000 00011100 1134668899999999999999999999987 665554
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.3e-33 Score=287.74 Aligned_cols=277 Identities=22% Similarity=0.295 Sum_probs=201.3
Q ss_pred cCCCcCceecccCCceEEEEE-ecC----CcEEEEEEeccCCch-hhhHHHHHHHHHHHhccCCCccceeceeeecCCCc
Q 000859 946 NNLSDEFIIGSGGSGTVYKAE-LAN----GATVAVKKISCKDDH-LLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGS 1019 (1251)
Q Consensus 946 ~~~~~~~~lG~G~fg~V~~~~-~~~----~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 1019 (1251)
..|+....||+|.||.||+|. .++ ...+|||+++...+. .......+|+..++.++||||+.+..++... +..
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~-d~~ 102 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSH-DKK 102 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhcc-Cce
Confidence 457888899999999999993 322 237999999755322 2346778999999999999999999988765 677
Q ss_pred eeEEEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCC----CCeE
Q 000859 1020 NLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSN----MEAH 1095 (1251)
Q Consensus 1020 ~~lv~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~----~~~k 1095 (1251)
.++++||++. +|++.++-++.. ..+.++...+..|..||+.|+.|||+. =|+|||+||.||||..+ |.||
T Consensus 103 v~l~fdYAEh-DL~~II~fHr~~--~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VK 176 (438)
T KOG0666|consen 103 VWLLFDYAEH-DLWHIIKFHRAS--KAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVK 176 (438)
T ss_pred EEEEehhhhh-hHHHHHHHhccc--hhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeE
Confidence 8999999986 999999876532 236889999999999999999999999 78999999999999877 9999
Q ss_pred EcccccccccccccCCCCcccceeecccceecccccccC-CCCCccceeehhHHHHHHhhCCCCCCCccccch----hHH
Q 000859 1096 LGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSL-KATEKCDVYSMGIVLMELVSGKMPTDATFGVEM----DMV 1170 (1251)
Q Consensus 1096 l~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~----~~~ 1170 (1251)
|+|||+|+.+...-.. .......+-|..|+|||.+.+. .|+.+.||||+||++.||+|-++-|.+....-. ...
T Consensus 177 IaDlGlaR~~~~plkp-l~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~ 255 (438)
T KOG0666|consen 177 IADLGLARLFNNPLKP-LASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQH 255 (438)
T ss_pred eecccHHHHhhccccc-cccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchH
Confidence 9999999987544322 2223346789999999998875 589999999999999999999888865432110 011
Q ss_pred HHHHHHHhccchhhhh-hhc----------------ccCCCC-CC----chHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 000859 1171 RWVEMHMEMSGSAREE-LLD----------------DQMKPL-LP----GEECAAYQVLEIALQCTKTSPQERPSSRQVC 1228 (1251)
Q Consensus 1171 ~~~~~~~~~~~~~~~~-~~~----------------~~~~~~-~~----~~~~~~~~l~~li~~cl~~dP~~RPs~~eil 1228 (1251)
+.+....+..+...++ |-+ ...... +. ....-++...+++.+++..||.+|.|+++.+
T Consensus 256 dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAl 335 (438)
T KOG0666|consen 256 DQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQAL 335 (438)
T ss_pred HHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHh
Confidence 1111111111111100 000 000000 00 0000123367899999999999999999987
Q ss_pred HH
Q 000859 1229 DL 1230 (1251)
Q Consensus 1229 ~~ 1230 (1251)
+.
T Consensus 336 eh 337 (438)
T KOG0666|consen 336 EH 337 (438)
T ss_pred cc
Confidence 64
|
|
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.1e-32 Score=304.41 Aligned_cols=248 Identities=27% Similarity=0.396 Sum_probs=198.8
Q ss_pred CCCcCceecccCCceEEEEEe-cCCcEEEEEEeccCCchhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEEEe
Q 000859 947 NLSDEFIIGSGGSGTVYKAEL-ANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIYE 1025 (1251)
Q Consensus 947 ~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv~E 1025 (1251)
-|+..+.||+|+||.||+|.. .+++.||+|++.........+.+.+|++++++++||||+++++++... ...++|||
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e 82 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKD--TKLWIIME 82 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeC--CeEEEEEE
Confidence 366778899999999999964 468899999986554444557888999999999999999999988653 45799999
Q ss_pred ecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEccccccccc
Q 000859 1026 YMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKAL 1105 (1251)
Q Consensus 1026 ~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~ 1105 (1251)
|+++++|.+++.. ..+++..+..++.|++.|++|||+. +++|+||+|+||+++.++.++++|||++..+
T Consensus 83 ~~~~~~l~~~i~~--------~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~ 151 (277)
T cd06641 83 YLGGGSALDLLEP--------GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQL 151 (277)
T ss_pred eCCCCcHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceec
Confidence 9999999999864 3578999999999999999999999 9999999999999999999999999998765
Q ss_pred ccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccchhhh
Q 000859 1106 VEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSARE 1185 (1251)
Q Consensus 1106 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1185 (1251)
.... .......++..|+|||.+.+..++.++|+||+||++|||++|..||....... .....
T Consensus 152 ~~~~----~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-----~~~~~--------- 213 (277)
T cd06641 152 TDTQ----IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMK-----VLFLI--------- 213 (277)
T ss_pred ccch----hhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHH-----HHHHH---------
Confidence 3211 11222467889999999988889999999999999999999999996542211 11100
Q ss_pred hhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 000859 1186 ELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDL 1230 (1251)
Q Consensus 1186 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 1230 (1251)
.....+.. ....+.++.+++.+||+.+|++||++++++..
T Consensus 214 ---~~~~~~~~--~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 214 ---PKNNPPTL--EGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred ---hcCCCCCC--CcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 00001111 12245668899999999999999999999984
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.7e-32 Score=301.58 Aligned_cols=252 Identities=29% Similarity=0.472 Sum_probs=203.6
Q ss_pred CCCcCceecccCCceEEEEEec-CCcEEEEEEeccCCchhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEEEe
Q 000859 947 NLSDEFIIGSGGSGTVYKAELA-NGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIYE 1025 (1251)
Q Consensus 947 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv~E 1025 (1251)
+|+..+.||+|++|.||+|... +++.||||++.........+.+.+|++++++++|+|++++++++... ...++|||
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~lv~e 79 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKE--GEISIVLE 79 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccC--CeEEEEEE
Confidence 5788889999999999999655 58999999997665545567899999999999999999999988554 55799999
Q ss_pred ecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCCeeecCCCCCCeeecCCCCeEEcccccccc
Q 000859 1026 YMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHH-DCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKA 1104 (1251)
Q Consensus 1026 ~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~ 1104 (1251)
|+++++|.+++... ..+++..+..++.|+++|++|||+ . +++||||+|+||+++.++.++++|||.+..
T Consensus 80 ~~~~~~L~~~l~~~-------~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~ 149 (264)
T cd06623 80 YMDGGSLADLLKKV-------GKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKV 149 (264)
T ss_pred ecCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCcccee
Confidence 99999999999763 568999999999999999999999 8 999999999999999999999999999876
Q ss_pred cccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccchhh
Q 000859 1105 LVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSAR 1184 (1251)
Q Consensus 1105 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1184 (1251)
...... ......++..|+|||.+.+..++.++|+||||+++|||++|+.||....... ..+...
T Consensus 150 ~~~~~~----~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~--~~~~~~---------- 213 (264)
T cd06623 150 LENTLD----QCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPS--FFELMQ---------- 213 (264)
T ss_pred cccCCC----cccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccC--HHHHHH----------
Confidence 533221 1123467899999999998899999999999999999999999997654211 001000
Q ss_pred hhhhcccCCCCCCchHH-HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 000859 1185 EELLDDQMKPLLPGEEC-AAYQVLEIALQCTKTSPQERPSSRQVCDL 1230 (1251)
Q Consensus 1185 ~~~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~eil~~ 1230 (1251)
...... .+. .... .+..+.+++.+|++.+|++||++.++++.
T Consensus 214 -~~~~~~-~~~--~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 214 -AICDGP-PPS--LPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred -HHhcCC-CCC--CCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 000100 011 1112 45678999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.3e-32 Score=309.88 Aligned_cols=246 Identities=24% Similarity=0.386 Sum_probs=194.5
Q ss_pred cCceecccCCceEEEEEe-cCCcEEEEEEeccCCchhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEEEeecC
Q 000859 950 DEFIIGSGGSGTVYKAEL-ANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIYEYME 1028 (1251)
Q Consensus 950 ~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv~E~~~ 1028 (1251)
....||+|+||.||+|.. .+++.||+|++..... ...+.+.+|+.+++.++||||+++++++.. ....++|+||++
T Consensus 25 ~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~--~~~~~iv~e~~~ 101 (297)
T cd06659 25 NYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ-QRRELLFNEVVIMRDYQHQNVVEMYKSYLV--GEELWVLMEFLQ 101 (297)
T ss_pred hhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc-chHHHHHHHHHHHHhCCCCchhhhhhheee--CCeEEEEEecCC
Confidence 344799999999999954 4689999999865433 345678899999999999999999998865 345799999999
Q ss_pred CCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcccccccccccc
Q 000859 1029 NGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVED 1108 (1251)
Q Consensus 1029 ~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 1108 (1251)
+++|.+++.. ..+++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|||++..+...
T Consensus 102 ~~~L~~~~~~--------~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~ 170 (297)
T cd06659 102 GGALTDIVSQ--------TRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD 170 (297)
T ss_pred CCCHHHHHhh--------cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhcccc
Confidence 9999998754 3578999999999999999999999 9999999999999999999999999998754322
Q ss_pred cCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccchhhhhhh
Q 000859 1109 YNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSAREELL 1188 (1251)
Q Consensus 1109 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1188 (1251)
. .......|+..|+|||++.+..++.++|||||||++|||++|+.||......+. ..... . .
T Consensus 171 ~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~--~~~~~---~---~------ 232 (297)
T cd06659 171 V----PKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQA--MKRLR---D---S------ 232 (297)
T ss_pred c----ccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHh---c---c------
Confidence 1 112235688999999999988899999999999999999999999975422111 11000 0 0
Q ss_pred cccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 000859 1189 DDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDL 1230 (1251)
Q Consensus 1189 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 1230 (1251)
..+........+..+.+++.+|++.+|++||+++++++.
T Consensus 233 ---~~~~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 233 ---PPPKLKNAHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred ---CCCCccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 000011111234568899999999999999999999884
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.7e-32 Score=306.87 Aligned_cols=264 Identities=19% Similarity=0.213 Sum_probs=185.2
Q ss_pred hcCCCcCceecccCCceEEEEEecC----CcEEEEEEeccCCchhhh----------HHHHHHHHHHHhccCCCccceec
Q 000859 945 TNNLSDEFIIGSGGSGTVYKAELAN----GATVAVKKISCKDDHLLN----------KSFTREVKTLGRIRHRHLVKLMG 1010 (1251)
Q Consensus 945 ~~~~~~~~~lG~G~fg~V~~~~~~~----~~~vavK~~~~~~~~~~~----------~~~~~E~~~l~~l~h~niv~l~g 1010 (1251)
..+|.+.+.||+|+||+||+|...+ +..+|+|+.......... .....+...+..++|++++++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 3578899999999999999997654 345677654332221111 11223344455668999999998
Q ss_pred eeeecCCC--ceeEEEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeee
Q 000859 1011 HCCNKGAG--SNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILL 1088 (1251)
Q Consensus 1011 ~~~~~~~~--~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill 1088 (1251)
++...... ..++++|+.. .++.+.++.. ...++..+..++.|++.|++|||+. +|+||||||+||++
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~-------~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill 159 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLV-ENTKEIFKRI-------KCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMV 159 (294)
T ss_pred eeeEecCCceEEEEEEehhc-cCHHHHHHhh-------ccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEE
Confidence 65443222 2367777764 3666666542 2357888899999999999999999 99999999999999
Q ss_pred cCCCCeEEcccccccccccccCCC---CcccceeecccceecccccccCCCCCccceeehhHHHHHHhhCCCCCCCcccc
Q 000859 1089 DSNMEAHLGDFGLAKALVEDYNSN---TESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGV 1165 (1251)
Q Consensus 1089 ~~~~~~kl~DfG~a~~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~ 1165 (1251)
+.++.++|+|||+|+.+....... ........||+.|+|||+..+..++.++||||+||++|||++|+.||......
T Consensus 160 ~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~ 239 (294)
T PHA02882 160 DGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHN 239 (294)
T ss_pred cCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccc
Confidence 999999999999998764321111 11223357999999999999999999999999999999999999999766322
Q ss_pred chhHHHHHHHHHhccchhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 000859 1166 EMDMVRWVEMHMEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLL 1231 (1251)
Q Consensus 1166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L 1231 (1251)
........... ...... +... ...++..+.+++..|++.+|++||+++++.+.+
T Consensus 240 ~~~~~~~~~~~-------~~~~~~----~~~~-~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 240 GNLIHAAKCDF-------IKRLHE----GKIK-IKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred hHHHHHhHHHH-------HHHhhh----hhhc-cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 11111000000 000000 1000 112346788999999999999999999999876
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-32 Score=309.72 Aligned_cols=255 Identities=26% Similarity=0.331 Sum_probs=205.6
Q ss_pred hcCCCcCceecccCCceEEEEE-ecCCcEEEEEEeccCC-chhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeE
Q 000859 945 TNNLSDEFIIGSGGSGTVYKAE-LANGATVAVKKISCKD-DHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLL 1022 (1251)
Q Consensus 945 ~~~~~~~~~lG~G~fg~V~~~~-~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~l 1022 (1251)
...|.....||+|.|++|..|+ ..++..||||.+.+.. .....+.+.+|+++|+.++|||||+++.+... +...|+
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t--~~~lyl 132 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIET--EATLYL 132 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeee--cceeEE
Confidence 4567888899999999999994 4579999999997554 33344668899999999999999999997743 456799
Q ss_pred EEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcccccc
Q 000859 1023 IYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLA 1102 (1251)
Q Consensus 1023 v~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a 1102 (1251)
||||+.+|.+++|+.++ +...+.++..++.|+++|++|||++ .|||||+|++||+++.+..+||+|||++
T Consensus 133 V~eya~~ge~~~yl~~~-------gr~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS 202 (596)
T KOG0586|consen 133 VMEYASGGELFDYLVKH-------GRMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFS 202 (596)
T ss_pred EEEeccCchhHHHHHhc-------ccchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccc
Confidence 99999999999999885 4556688899999999999999999 9999999999999999999999999999
Q ss_pred cccccccCCCCcccceeecccceecccccccCCC-CCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccc
Q 000859 1103 KALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKA-TEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSG 1181 (1251)
Q Consensus 1103 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 1181 (1251)
..+.. ......++|++.|.|||++.+..| ++++|+||+|+++|-++.|..||++..-.
T Consensus 203 ~~~~~-----~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk---------------- 261 (596)
T KOG0586|consen 203 TFFDY-----GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLK---------------- 261 (596)
T ss_pred eeecc-----cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccc----------------
Confidence 87642 222334689999999999998876 57899999999999999999999864221
Q ss_pred hhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhcC
Q 000859 1182 SAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNVFN 1236 (1251)
Q Consensus 1182 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~ 1236 (1251)
+...+..+.++-.+.....++.+++++++-.+|.+|++.+++.+.-+....
T Consensus 262 ----~Lr~rvl~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~ 312 (596)
T KOG0586|consen 262 ----ELRPRVLRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDL 312 (596)
T ss_pred ----cccchheeeeecccceeechhHHHHHHhhccCccccCCHHHhhhhcccchh
Confidence 111111222222222234456689999999999999999999887655443
|
|
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.3e-32 Score=307.52 Aligned_cols=266 Identities=23% Similarity=0.307 Sum_probs=196.7
Q ss_pred CCCcCceecccCCceEEEEEe-cCCcEEEEEEeccCCch----hhhHHHHHHHHHHHhccCCCccceeceeeecCCCcee
Q 000859 947 NLSDEFIIGSGGSGTVYKAEL-ANGATVAVKKISCKDDH----LLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNL 1021 (1251)
Q Consensus 947 ~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~ 1021 (1251)
+|+..+.||+|+||.||+|.. .+++.||||++...... ...+.+..|++++++++|+||+++++++.. ....+
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~ 78 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGH--KSNIN 78 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeec--CCEEE
Confidence 367778999999999999965 46899999999754322 234567789999999999999999998865 45679
Q ss_pred EEEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEccccc
Q 000859 1022 LIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGL 1101 (1251)
Q Consensus 1022 lv~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~ 1101 (1251)
+||||+ +|+|.+++.... ..+++.++.+++.||++||+|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 79 lv~e~~-~~~L~~~i~~~~------~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~ 148 (298)
T cd07841 79 LVFEFM-ETDLEKVIKDKS------IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGL 148 (298)
T ss_pred EEEccc-CCCHHHHHhccC------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEcccee
Confidence 999999 899999997631 3689999999999999999999999 999999999999999999999999999
Q ss_pred ccccccccCCCCcccceeecccceeccccccc-CCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhcc
Q 000859 1102 AKALVEDYNSNTESNTWFAGSYGYIAPEYAYS-LKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMS 1180 (1251)
Q Consensus 1102 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 1180 (1251)
++...... .......++..|+|||.+.+ ..++.++|||||||++|||++|.+||.+....+. ............
T Consensus 149 ~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~-~~~~~~~~~~~~ 223 (298)
T cd07841 149 ARSFGSPN----RKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQ-LGKIFEALGTPT 223 (298)
T ss_pred eeeccCCC----ccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHH-HHHHHHHcCCCc
Confidence 97654321 11122356788999998864 4578999999999999999999888865433211 111111100000
Q ss_pred chhhh------hhhcccCCCCCC---chHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 000859 1181 GSARE------ELLDDQMKPLLP---GEECAAYQVLEIALQCTKTSPQERPSSRQVCD 1229 (1251)
Q Consensus 1181 ~~~~~------~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1229 (1251)
..... ........+..+ .....+.++.+++.+||+.||++|||++|+++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~ 281 (298)
T cd07841 224 EENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE 281 (298)
T ss_pred hhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 00000 000000000000 01123567889999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.9e-32 Score=307.16 Aligned_cols=267 Identities=22% Similarity=0.317 Sum_probs=195.2
Q ss_pred CCCcCceecccCCceEEEEEe-cCCcEEEEEEeccCCc-hhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEEE
Q 000859 947 NLSDEFIIGSGGSGTVYKAEL-ANGATVAVKKISCKDD-HLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIY 1024 (1251)
Q Consensus 947 ~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv~ 1024 (1251)
+|+..+.||.|+||.||+|+. .+++.||||++..... ....+.+.+|++++++++||||+++++++.. ....++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~~v~ 78 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT--ENKLYLVF 78 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhccc--CCcEEEEe
Confidence 377788999999999999965 4689999999865432 2234578899999999999999999998854 44579999
Q ss_pred eecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcccccccc
Q 000859 1025 EYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKA 1104 (1251)
Q Consensus 1025 E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~ 1104 (1251)
||+. ++|.+++...+ ...+++..+..++.|++.|++|||+. +++||||+|+||++++++.+|++|||.++.
T Consensus 79 e~~~-~~l~~~~~~~~-----~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~ 149 (284)
T cd07860 79 EFLH-QDLKKFMDASP-----LSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARA 149 (284)
T ss_pred eccc-cCHHHHHHhCC-----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhh
Confidence 9996 68999887643 45689999999999999999999999 999999999999999999999999999875
Q ss_pred cccccCCCCcccceeecccceecccccccCC-CCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccch-
Q 000859 1105 LVEDYNSNTESNTWFAGSYGYIAPEYAYSLK-ATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGS- 1182 (1251)
Q Consensus 1105 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~- 1182 (1251)
..... .......++..|+|||.+.+.. ++.++|||||||++|||+||+.||......+ ......+........
T Consensus 150 ~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~ 224 (284)
T cd07860 150 FGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID-QLFRIFRTLGTPDEVV 224 (284)
T ss_pred cccCc----cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHHHHhCCCChhh
Confidence 43211 1112235688999999887644 5889999999999999999999997543221 111111111000000
Q ss_pred -----hhhhhhcccC---CCCC-CchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 000859 1183 -----AREELLDDQM---KPLL-PGEECAAYQVLEIALQCTKTSPQERPSSRQVCD 1229 (1251)
Q Consensus 1183 -----~~~~~~~~~~---~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1229 (1251)
.......... .... ......+.++.+++.+|++.||++|||++++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 225 WPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred hhhhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 0000000000 0000 000113456789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.8e-32 Score=314.31 Aligned_cols=272 Identities=24% Similarity=0.332 Sum_probs=200.7
Q ss_pred cCCCcCceecccCCceEEEEE-ecCCcEEEEEEeccCCc-hhhhHHHHHHHHHHHhccCCCccceeceeeecC--CCcee
Q 000859 946 NNLSDEFIIGSGGSGTVYKAE-LANGATVAVKKISCKDD-HLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKG--AGSNL 1021 (1251)
Q Consensus 946 ~~~~~~~~lG~G~fg~V~~~~-~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~--~~~~~ 1021 (1251)
.+|+..+.||+|+||.||+|. ..+|+.||+|++..... ....+.+.+|+.++++++||||+++++++.... ....+
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 578888899999999999995 45699999999875432 234566778999999999999999999775432 34578
Q ss_pred EEEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEccccc
Q 000859 1022 LIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGL 1101 (1251)
Q Consensus 1022 lv~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~ 1101 (1251)
+||||+. |+|.+++.. ...+++..+.+++.|++.||+|||+. +|+||||||+||++++++.+||+|||.
T Consensus 85 lv~e~~~-~~l~~~~~~-------~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~ 153 (334)
T cd07855 85 VVMDLME-SDLHHIIHS-------DQPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGM 153 (334)
T ss_pred EEEehhh-hhHHHHhcc-------CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEeccccc
Confidence 9999995 689998865 34589999999999999999999999 999999999999999999999999999
Q ss_pred ccccccccCCCCcccceeecccceeccccccc-CCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhcc
Q 000859 1102 AKALVEDYNSNTESNTWFAGSYGYIAPEYAYS-LKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMS 1180 (1251)
Q Consensus 1102 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 1180 (1251)
++.................|+..|+|||.+.+ ..++.++||||+||++|||++|+.||.+...... ...........
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~--~~~~~~~~g~~ 231 (334)
T cd07855 154 ARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQ--LKLILSVLGSP 231 (334)
T ss_pred ceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHH--HHHHHHHhCCC
Confidence 97654332222222223478899999998765 4689999999999999999999999976533211 11111100000
Q ss_pred ---------chhhhhhhcccC-CCCCCc---hHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 000859 1181 ---------GSAREELLDDQM-KPLLPG---EECAAYQVLEIALQCTKTSPQERPSSRQVCDL 1230 (1251)
Q Consensus 1181 ---------~~~~~~~~~~~~-~~~~~~---~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 1230 (1251)
.....+..+... ....+. ....+.++.+++.+|++.||++||++++++..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 232 SEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred hhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 000001111000 001110 01235678999999999999999999998874
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-32 Score=280.82 Aligned_cols=249 Identities=25% Similarity=0.346 Sum_probs=199.6
Q ss_pred ceecccCCceEEEE-EecCCcEEEEEEeccCCchhhhHHHHHHHHHHHhc-cCCCccceeceeeecC--CCceeEEEeec
Q 000859 952 FIIGSGGSGTVYKA-ELANGATVAVKKISCKDDHLLNKSFTREVKTLGRI-RHRHLVKLMGHCCNKG--AGSNLLIYEYM 1027 (1251)
Q Consensus 952 ~~lG~G~fg~V~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~--~~~~~lv~E~~ 1027 (1251)
++||-|-.|.|-.+ +.++++.+|+|++... ....+|++.--.. .|||||.++++|.... .....+|||.|
T Consensus 68 qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~m 141 (400)
T KOG0604|consen 68 QVLGAGINGKVVQCVHKRTQEKFALKVLLDS------PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECM 141 (400)
T ss_pred hhhccccCCceEEEEeccchhhhHHHHHhcC------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeecc
Confidence 37999999999999 5668999999998522 3456788876655 6999999999887543 34557899999
Q ss_pred CCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecC---CCCeEEcccccccc
Q 000859 1028 ENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDS---NMEAHLGDFGLAKA 1104 (1251)
Q Consensus 1028 ~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~---~~~~kl~DfG~a~~ 1104 (1251)
+||.|.+.+.+++ ...+++.++..|..||+.|+.|||+. .|.||||||+|+|.+. +-.+|++|||+|+.
T Consensus 142 eGGeLfsriq~~g-----~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~ 213 (400)
T KOG0604|consen 142 EGGELFSRIQDRG-----DQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKE 213 (400)
T ss_pred cchHHHHHHHHcc-----cccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEecccccccc
Confidence 9999999998864 56799999999999999999999999 9999999999999964 55699999999976
Q ss_pred cccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccchhh
Q 000859 1105 LVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSAR 1184 (1251)
Q Consensus 1105 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1184 (1251)
..+. ......+-|+.|.|||++....|+..+|+||+||++|-|++|.+||-...+..+ +...+
T Consensus 214 t~~~-----~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~ai------------spgMk 276 (400)
T KOG0604|consen 214 TQEP-----GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI------------SPGMK 276 (400)
T ss_pred cCCC-----ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccC------------ChhHH
Confidence 4321 111224669999999999999999999999999999999999999976644322 11122
Q ss_pred hhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 000859 1185 EELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLL 1231 (1251)
Q Consensus 1185 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L 1231 (1251)
..+....+.-.-+.+.+.+.+..++|+.+++.+|.+|-|+.++++.=
T Consensus 277 ~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hp 323 (400)
T KOG0604|consen 277 RRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHP 323 (400)
T ss_pred hHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCc
Confidence 22333333333345677888999999999999999999999998653
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.1e-32 Score=308.68 Aligned_cols=267 Identities=24% Similarity=0.319 Sum_probs=198.7
Q ss_pred hcCCCcCceecccCCceEEEEEe-cCCcEEEEEEeccCCch-hhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeE
Q 000859 945 TNNLSDEFIIGSGGSGTVYKAEL-ANGATVAVKKISCKDDH-LLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLL 1022 (1251)
Q Consensus 945 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~l 1022 (1251)
..+|+..+.||+|+||.||+|.. .+|+.||+|++...... .....+.+|++++++++|+||+++++++........++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 45788999999999999999965 56899999998654322 22345668999999999999999999887655556799
Q ss_pred EEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcccccc
Q 000859 1023 IYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLA 1102 (1251)
Q Consensus 1023 v~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a 1102 (1251)
||||++ ++|.+++... ...+++.++..++.|+++|++|||+. +++||||||+||+++.++.+||+|||.+
T Consensus 86 v~e~~~-~~l~~~l~~~------~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~ 155 (309)
T cd07845 86 VMEYCE-QDLASLLDNM------PTPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLA 155 (309)
T ss_pred EEecCC-CCHHHHHHhc------ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcccee
Confidence 999996 5898888753 25689999999999999999999999 9999999999999999999999999999
Q ss_pred cccccccCCCCcccceeecccceeccccccc-CCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccc
Q 000859 1103 KALVEDYNSNTESNTWFAGSYGYIAPEYAYS-LKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSG 1181 (1251)
Q Consensus 1103 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 1181 (1251)
....... .......++..|+|||.+.+ ..++.++||||+||++|||++|+.||.+....+. ........+
T Consensus 156 ~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~-----~~~~~~~~~ 226 (309)
T cd07845 156 RTYGLPA----KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQ-----LDLIIQLLG 226 (309)
T ss_pred eecCCcc----CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH-----HHHHHHhcC
Confidence 7654321 11122345788999998865 4578999999999999999999999976533211 111111000
Q ss_pred hhhhhhhc---------cc-CC-CCCCc----hHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 000859 1182 SAREELLD---------DQ-MK-PLLPG----EECAAYQVLEIALQCTKTSPQERPSSRQVCDL 1230 (1251)
Q Consensus 1182 ~~~~~~~~---------~~-~~-~~~~~----~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 1230 (1251)
........ .. .. ..... ....++++.+++.+|++.||++|||++|++..
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 227 TPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred CCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00000000 00 00 00000 01135667899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.4e-32 Score=302.05 Aligned_cols=248 Identities=22% Similarity=0.287 Sum_probs=198.0
Q ss_pred CCCcCceecccCCceEEEEEec-CCcEEEEEEeccCC--chhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEE
Q 000859 947 NLSDEFIIGSGGSGTVYKAELA-NGATVAVKKISCKD--DHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLI 1023 (1251)
Q Consensus 947 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv 1023 (1251)
+|+..+.||.|+||.||+|... +++.||+|++.... .....+.+.+|++++++++||||+++++.+.. +...++|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 78 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQD--EENMYLV 78 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcC--CCeEEEE
Confidence 4778889999999999999654 68999999996433 22345788999999999999999999987743 4567999
Q ss_pred EeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEccccccc
Q 000859 1024 YEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAK 1103 (1251)
Q Consensus 1024 ~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~ 1103 (1251)
+||+++++|.+++... ..+++..+..++.|+++|++|||+. +++|+||+|+||++++++.++|+|||.+.
T Consensus 79 ~e~~~~~~L~~~l~~~-------~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~ 148 (258)
T cd05578 79 VDLLLGGDLRYHLSQK-------VKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIAT 148 (258)
T ss_pred EeCCCCCCHHHHHHhc-------CCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeeccccc
Confidence 9999999999999763 4688999999999999999999999 99999999999999999999999999987
Q ss_pred ccccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccchh
Q 000859 1104 ALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSA 1183 (1251)
Q Consensus 1104 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1183 (1251)
...... ......|+..|+|||.+.+..++.++|+||+|+++|+|++|+.||....... ..+......
T Consensus 149 ~~~~~~-----~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~~~~~~~~~----- 215 (258)
T cd05578 149 KVTPDT-----LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI---RDQIRAKQE----- 215 (258)
T ss_pred ccCCCc-----cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccH---HHHHHHHhc-----
Confidence 653221 1223467889999999988889999999999999999999999997654321 111110000
Q ss_pred hhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCH--HHHH
Q 000859 1184 REELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSS--RQVC 1228 (1251)
Q Consensus 1184 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~--~eil 1228 (1251)
. .....+...+..+.+++.+||+.||.+||++ +|++
T Consensus 216 ------~---~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 216 ------T---ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred ------c---ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 0 0111122245678899999999999999999 5554
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=303.00 Aligned_cols=248 Identities=22% Similarity=0.373 Sum_probs=196.2
Q ss_pred CCCcCceecccCCceEEEEEe-cCCcEEEEEEeccCCchhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEEEe
Q 000859 947 NLSDEFIIGSGGSGTVYKAEL-ANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIYE 1025 (1251)
Q Consensus 947 ~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv~E 1025 (1251)
.|...+.||+|++|.||+|.. .+++.||+|++.... ....+.+.+|+.+++.++||||+++++++.. ....++++|
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~--~~~~~~v~e 96 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK-QQRRELLFNEVVIMRDYQHPNIVEMYSSYLV--GDELWVVME 96 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc-hhHHHHHHHHHHHHHHcCCCChheEEEEEEc--CCeEEEEEe
Confidence 355567899999999999964 578999999986433 3345668899999999999999999998754 345799999
Q ss_pred ecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEccccccccc
Q 000859 1026 YMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKAL 1105 (1251)
Q Consensus 1026 ~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~ 1105 (1251)
|+++++|.+++.. ..+++.++..++.|++.|++|||+. +|+||||+|+||+++.++.++++|||.+...
T Consensus 97 ~~~~~~L~~~~~~--------~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~ 165 (285)
T cd06648 97 FLEGGALTDIVTH--------TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQV 165 (285)
T ss_pred ccCCCCHHHHHHh--------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhh
Confidence 9999999999875 3478999999999999999999999 9999999999999999999999999988654
Q ss_pred ccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccchhhh
Q 000859 1106 VEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSARE 1185 (1251)
Q Consensus 1106 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1185 (1251)
..... ......|+..|+|||...+..++.++||||+||++|||++|+.||....+.+ .......
T Consensus 166 ~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~-----~~~~~~~------- 229 (285)
T cd06648 166 SKEVP----RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQ-----AMKRIRD------- 229 (285)
T ss_pred ccCCc----ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHH-----HHHHHHh-------
Confidence 32211 1122468899999999988889999999999999999999999986542211 1111100
Q ss_pred hhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 000859 1186 ELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCD 1229 (1251)
Q Consensus 1186 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1229 (1251)
...+........+..+.+++.+||+.+|++||+++++++
T Consensus 230 -----~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 230 -----NLPPKLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred -----cCCCCCcccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 000111111124467899999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.5e-32 Score=306.02 Aligned_cols=268 Identities=24% Similarity=0.297 Sum_probs=198.8
Q ss_pred CCCcCceecccCCceEEEEEe-cCCcEEEEEEeccCCc-hhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEEE
Q 000859 947 NLSDEFIIGSGGSGTVYKAEL-ANGATVAVKKISCKDD-HLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIY 1024 (1251)
Q Consensus 947 ~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv~ 1024 (1251)
+|+..+.||+|+||.||+|.. .+|+.||||++..... ....+.+.+|+.++++++||||+++++++.. +...++|+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~~v~ 78 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPH--GSGFVLVM 78 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEec--CCeeEEEe
Confidence 477788999999999999965 4689999999875542 3345678999999999999999999998865 45579999
Q ss_pred eecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcccccccc
Q 000859 1025 EYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKA 1104 (1251)
Q Consensus 1025 E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~ 1104 (1251)
||+ +++|.+++... ...+++.+++.++.|+++|++|||+. +++|+||||+||+++.++.++++|||.+..
T Consensus 79 e~~-~~~L~~~~~~~------~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~ 148 (286)
T cd07832 79 EYM-PSDLSEVLRDE------ERPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARL 148 (286)
T ss_pred ccc-CCCHHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeeccc
Confidence 999 99999998764 25689999999999999999999999 999999999999999999999999999876
Q ss_pred cccccCCCCcccceeecccceecccccccC-CCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccchh
Q 000859 1105 LVEDYNSNTESNTWFAGSYGYIAPEYAYSL-KATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSA 1183 (1251)
Q Consensus 1105 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1183 (1251)
...... .......|+..|+|||.+.+. .++.++||||+||++|||++|++||.+....+. ...............
T Consensus 149 ~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 224 (286)
T cd07832 149 FSEEEP---RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQ-LAIVFRTLGTPNEET 224 (286)
T ss_pred ccCCCC---CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHH-HHHHHHHcCCCChHH
Confidence 543211 112234688999999988654 468999999999999999999888865433211 111111000000000
Q ss_pred hh------hhhcccCCCCCC-----chHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 000859 1184 RE------ELLDDQMKPLLP-----GEECAAYQVLEIALQCTKTSPQERPSSRQVCDL 1230 (1251)
Q Consensus 1184 ~~------~~~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 1230 (1251)
.. .+.......... .....+.++.+++.+|++.||++|||+++++..
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 225 WPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred HhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00 000000000000 001234678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-31 Score=302.89 Aligned_cols=252 Identities=26% Similarity=0.404 Sum_probs=202.0
Q ss_pred hhcCCCcCceecccCCceEEEEEec-CCcEEEEEEeccCCchhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeE
Q 000859 944 ATNNLSDEFIIGSGGSGTVYKAELA-NGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLL 1022 (1251)
Q Consensus 944 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~l 1022 (1251)
.++.|+..+.||+|+||.||+|... +++.||+|++..... ..+.+.+|+++++.++|+||+++++++... ...++
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~l 92 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ--NKELIINEILIMKDCKHPNIVDYYDSYLVG--DELWV 92 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch--hHHHHHHHHHHHHHCCCCCeeEEEEEEEEC--CEEEE
Confidence 4566778889999999999999665 689999999965443 456788999999999999999999988654 55799
Q ss_pred EEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcccccc
Q 000859 1023 IYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLA 1102 (1251)
Q Consensus 1023 v~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a 1102 (1251)
|+||+++++|.+++.... ..+++.++..++.|++.|++|||+. +|+|+|++|+||+++.++.++|+|||.+
T Consensus 93 v~e~~~~~~L~~~l~~~~------~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~ 163 (286)
T cd06614 93 VMEYMDGGSLTDIITQNF------VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFA 163 (286)
T ss_pred EEeccCCCcHHHHHHHhc------cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchh
Confidence 999999999999998742 3789999999999999999999998 9999999999999999999999999988
Q ss_pred cccccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccch
Q 000859 1103 KALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGS 1182 (1251)
Q Consensus 1103 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 1182 (1251)
....... .......++..|+|||.+.+..++.++|+|||||++|||++|+.||....+... .. .
T Consensus 164 ~~~~~~~----~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~-~~----~------- 227 (286)
T cd06614 164 AQLTKEK----SKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRA-LF----L------- 227 (286)
T ss_pred hhhccch----hhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHH-HH----H-------
Confidence 6543221 111224578899999999888899999999999999999999999865422111 00 0
Q ss_pred hhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 000859 1183 AREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCD 1229 (1251)
Q Consensus 1183 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1229 (1251)
.... ..+..+.....+..+.+++.+|++.+|.+||++.+++.
T Consensus 228 ----~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 228 ----ITTK-GIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred ----HHhc-CCCCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 0000 01112222234567899999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.5e-32 Score=306.56 Aligned_cols=268 Identities=21% Similarity=0.287 Sum_probs=198.3
Q ss_pred cCCCcCceecccCCceEEEEEec-CCcEEEEEEeccCCch-hhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEE
Q 000859 946 NNLSDEFIIGSGGSGTVYKAELA-NGATVAVKKISCKDDH-LLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLI 1023 (1251)
Q Consensus 946 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv 1023 (1251)
++|+..+.||+|+||.||+|... +++.||+|.++..... .....+.+|++++++++||||+++++++........++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 35788889999999999999664 6889999999654322 223456789999999999999999998876655678999
Q ss_pred EeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEccccccc
Q 000859 1024 YEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAK 1103 (1251)
Q Consensus 1024 ~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~ 1103 (1251)
|||++ ++|.+++.... ..+++.+++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||.++
T Consensus 85 ~e~~~-~~L~~~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~ 154 (293)
T cd07843 85 MEYVE-HDLKSLMETMK------QPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAR 154 (293)
T ss_pred ehhcC-cCHHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCcee
Confidence 99997 59999987642 3689999999999999999999999 99999999999999999999999999987
Q ss_pred ccccccCCCCcccceeecccceecccccccC-CCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccch
Q 000859 1104 ALVEDYNSNTESNTWFAGSYGYIAPEYAYSL-KATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGS 1182 (1251)
Q Consensus 1104 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 1182 (1251)
.+.... .......++..|+|||.+.+. .++.++|+||+|+++|||++|+.||......+. ..............
T Consensus 155 ~~~~~~----~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~-~~~~~~~~~~~~~~ 229 (293)
T cd07843 155 EYGSPL----KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQ-LNKIFKLLGTPTEK 229 (293)
T ss_pred eccCCc----cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCchH
Confidence 654321 112224578899999988754 468999999999999999999999975533211 11111000000000
Q ss_pred hhh----------h----hhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 000859 1183 ARE----------E----LLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCD 1229 (1251)
Q Consensus 1183 ~~~----------~----~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1229 (1251)
... . .........++.. ..+..+.+++.+|++.||++|||++|++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 230 IWPGFSELPGAKKKTFTKYPYNQLRKKFPAL-SLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred HHHHhhccchhcccccccccchhhhcccccc-CCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 000 0 0000000111110 02556889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=305.80 Aligned_cols=248 Identities=29% Similarity=0.392 Sum_probs=194.6
Q ss_pred cCCCcCceecccCCceEEEEEe-cCCcEEEEEEeccCC--chhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeE
Q 000859 946 NNLSDEFIIGSGGSGTVYKAEL-ANGATVAVKKISCKD--DHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLL 1022 (1251)
Q Consensus 946 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~l 1022 (1251)
..|...+.||+|+||+||+|.. .+++.||+|++.... .....+.+.+|+++++.++||||++++++|... ...++
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~--~~~~l 92 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLRE--HTAWL 92 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeC--CeEEE
Confidence 4477888999999999999965 468999999986432 233446788999999999999999999988654 44689
Q ss_pred EEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcccccc
Q 000859 1023 IYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLA 1102 (1251)
Q Consensus 1023 v~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a 1102 (1251)
|+||++ |++.+++... ...+++..+..++.|++.|+.|||+. +|+||||+|+||+++.++.+||+|||++
T Consensus 93 v~e~~~-g~l~~~~~~~------~~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~ 162 (307)
T cd06607 93 VMEYCL-GSASDILEVH------KKPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSA 162 (307)
T ss_pred EHHhhC-CCHHHHHHHc------ccCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcc
Confidence 999997 6787877543 24589999999999999999999999 9999999999999999999999999998
Q ss_pred cccccccCCCCcccceeecccceecccccc---cCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhc
Q 000859 1103 KALVEDYNSNTESNTWFAGSYGYIAPEYAY---SLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEM 1179 (1251)
Q Consensus 1103 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 1179 (1251)
...... ....++..|+|||++. ...++.++||||||+++|||++|+.||........ ...
T Consensus 163 ~~~~~~--------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~-----~~~---- 225 (307)
T cd06607 163 SLVSPA--------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-----LYH---- 225 (307)
T ss_pred eecCCC--------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHH-----HHH----
Confidence 653211 2246788999999874 45688999999999999999999999865422111 000
Q ss_pred cchhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 000859 1180 SGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLL 1231 (1251)
Q Consensus 1180 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L 1231 (1251)
... ...+.. .....+..+.+++.+||+.||++||++++++..-
T Consensus 226 -------~~~-~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 268 (307)
T cd06607 226 -------IAQ-NDSPTL-SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHR 268 (307)
T ss_pred -------Hhc-CCCCCC-CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence 000 000111 1223556789999999999999999999998753
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.5e-33 Score=284.44 Aligned_cols=264 Identities=20% Similarity=0.255 Sum_probs=204.0
Q ss_pred hhcCCCcCceecccCCceEEEE-EecCCcEEEEEEeccCC--chhhhHHHHHHHHHHHhccCCCccceeceeeecCCCce
Q 000859 944 ATNNLSDEFIIGSGGSGTVYKA-ELANGATVAVKKISCKD--DHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSN 1020 (1251)
Q Consensus 944 ~~~~~~~~~~lG~G~fg~V~~~-~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~ 1020 (1251)
..++|+..++||+|.||+|-.+ ...+++.+|+|++++.. ...+.+.-..|-++++..+||.+..+--.|. .....
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQ--t~drl 243 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQ--TQDRL 243 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhc--cCceE
Confidence 4566888999999999999999 46689999999997553 2233455567999999999999998875553 34567
Q ss_pred eEEEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcccc
Q 000859 1021 LLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFG 1100 (1251)
Q Consensus 1021 ~lv~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG 1100 (1251)
++||||+.||.|.-+|.+ .+.++++..+-+...|+.|+.|||++ +||.||+|.+|.|+|.+|.+||+|||
T Consensus 244 CFVMeyanGGeLf~HLsr-------er~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFG 313 (516)
T KOG0690|consen 244 CFVMEYANGGELFFHLSR-------ERVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFG 313 (516)
T ss_pred EEEEEEccCceEeeehhh-------hhcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecc
Confidence 999999999999988876 46788888888999999999999999 99999999999999999999999999
Q ss_pred cccccccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhcc
Q 000859 1101 LAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMS 1180 (1251)
Q Consensus 1101 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 1180 (1251)
+++.-. ........++||+.|.|||++....|+.++|.|.+||++|||++|+.||........--..
T Consensus 314 LCKE~I----~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLI--------- 380 (516)
T KOG0690|consen 314 LCKEEI----KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELI--------- 380 (516)
T ss_pred cchhcc----cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHH---------
Confidence 996532 2223334589999999999999999999999999999999999999999754332211100
Q ss_pred chhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCC--CHHHHHHHHHhhcCCCccccc
Q 000859 1181 GSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERP--SSRQVCDLLLNVFNNRIVDFD 1243 (1251)
Q Consensus 1181 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP--s~~eil~~L~~~~~~~~~~~~ 1243 (1251)
.. ..+..+....++...++...+.+||.+|. ..+++.++.+.-+...+.+++
T Consensus 381 -------l~----ed~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~ 434 (516)
T KOG0690|consen 381 -------LM----EDLKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEA 434 (516)
T ss_pred -------Hh----hhccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHHH
Confidence 00 01111222445677899999999999994 344555555444444454444
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=312.74 Aligned_cols=268 Identities=24% Similarity=0.303 Sum_probs=198.1
Q ss_pred hhcCCCcCceecccCCceEEEEEe-cCCcEEEEEEeccCC-chhhhHHHHHHHHHHHhccCCCccceeceeeecCC----
Q 000859 944 ATNNLSDEFIIGSGGSGTVYKAEL-ANGATVAVKKISCKD-DHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGA---- 1017 (1251)
Q Consensus 944 ~~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~---- 1017 (1251)
...+|+..+.||+|+||.||+|.. .+++.||||++.... .....+.+.+|++++++++||||+++++++.....
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 356799999999999999999954 578999999986432 33344567789999999999999999998764322
Q ss_pred CceeEEEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEc
Q 000859 1018 GSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLG 1097 (1251)
Q Consensus 1018 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~ 1097 (1251)
...++||||++ ++|.+++.. .++...+..++.|++.|++|||+. +|+||||||+||+++.++.+||+
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~---------~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~ 160 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQM---------DLDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKIL 160 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhh---------cCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEc
Confidence 24689999996 588888754 278889999999999999999999 99999999999999999999999
Q ss_pred ccccccccccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHH
Q 000859 1098 DFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHM 1177 (1251)
Q Consensus 1098 DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~ 1177 (1251)
|||.++...... ......++..|+|||.+.+..++.++||||+||++|+|++|+.||........ .........
T Consensus 161 Dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~-~~~~~~~~~ 234 (353)
T cd07850 161 DFGLARTAGTSF-----MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQ-WNKIIEQLG 234 (353)
T ss_pred cCccceeCCCCC-----CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHH-HHHHHHhcC
Confidence 999997653221 11224678899999999999999999999999999999999999975532111 101000000
Q ss_pred hc-------cchhhh---------------hhhcccCCCCCC--chHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 000859 1178 EM-------SGSARE---------------ELLDDQMKPLLP--GEECAAYQVLEIALQCTKTSPQERPSSRQVCDL 1230 (1251)
Q Consensus 1178 ~~-------~~~~~~---------------~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 1230 (1251)
.. ...... +.......+... .....+..+.+++.+|++.||++|||+.|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 235 TPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred CCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00 000000 000000000000 011245668899999999999999999999864
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.8e-32 Score=300.23 Aligned_cols=251 Identities=26% Similarity=0.388 Sum_probs=196.7
Q ss_pred CCCcCceecccCCceEEEEEe-cCCcEEEEEEeccCC-chhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEEE
Q 000859 947 NLSDEFIIGSGGSGTVYKAEL-ANGATVAVKKISCKD-DHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIY 1024 (1251)
Q Consensus 947 ~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv~ 1024 (1251)
+|+..+.||+|+||.||+|.. .+|..||+|.+.... .....+.+.+|++++++++|+||+++++.+.. ....++|+
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~--~~~~~lv~ 78 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQE--NGRLFIVM 78 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheecc--CCeEEEEE
Confidence 467788999999999999965 468899999986532 12344677899999999999999999998754 34579999
Q ss_pred eecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCC-eEEccccccc
Q 000859 1025 EYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNME-AHLGDFGLAK 1103 (1251)
Q Consensus 1025 E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~-~kl~DfG~a~ 1103 (1251)
||+++++|.+++.+.. ...+++..+..++.|+++|++|||+. +++|+||||+||++++++. +|++|||.+.
T Consensus 79 e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~ 150 (257)
T cd08225 79 EYCDGGDLMKRINRQR-----GVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIAR 150 (257)
T ss_pred ecCCCCcHHHHHHhcc-----CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccch
Confidence 9999999999997642 33579999999999999999999999 9999999999999998864 6999999987
Q ss_pred ccccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccchh
Q 000859 1104 ALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSA 1183 (1251)
Q Consensus 1104 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1183 (1251)
....... ......|++.|+|||+..+..++.++|+|||||++||+++|+.||..... .++....
T Consensus 151 ~~~~~~~----~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~~~------- 214 (257)
T cd08225 151 QLNDSME----LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNL-----HQLVLKI------- 214 (257)
T ss_pred hccCCcc----cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccH-----HHHHHHH-------
Confidence 6532211 11224578999999999888899999999999999999999999865421 1111111
Q ss_pred hhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 000859 1184 REELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDL 1230 (1251)
Q Consensus 1184 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 1230 (1251)
......+. ....+.++.+++.+|++.+|++|||+.|+++.
T Consensus 215 ----~~~~~~~~---~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 215 ----CQGYFAPI---SPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred ----hcccCCCC---CCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 11111111 11234568899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=304.85 Aligned_cols=266 Identities=25% Similarity=0.350 Sum_probs=198.2
Q ss_pred CCCcCceecccCCceEEEEEec-CCcEEEEEEeccCC-chhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEEE
Q 000859 947 NLSDEFIIGSGGSGTVYKAELA-NGATVAVKKISCKD-DHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIY 1024 (1251)
Q Consensus 947 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv~ 1024 (1251)
+|+..+.||+|+||.||+|... +++.||||++.... .....+.+.+|++++++++|+||+++++++.. ....++||
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~iv~ 79 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRR--KGRLYLVF 79 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEE--CCEEEEEE
Confidence 5788889999999999999654 68899999986543 23345788999999999999999999998865 44579999
Q ss_pred eecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcccccccc
Q 000859 1025 EYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKA 1104 (1251)
Q Consensus 1025 E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~ 1104 (1251)
||++++.+..+... ...+++.++..++.|++.|++|||+. +++|||++|+||++++++.+||+|||.+..
T Consensus 80 e~~~~~~l~~~~~~-------~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~ 149 (288)
T cd07833 80 EYVERTLLELLEAS-------PGGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARA 149 (288)
T ss_pred ecCCCCHHHHHHhc-------CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccc
Confidence 99998766665543 34589999999999999999999999 999999999999999999999999999876
Q ss_pred cccccCCCCcccceeecccceecccccccC-CCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccchh
Q 000859 1105 LVEDYNSNTESNTWFAGSYGYIAPEYAYSL-KATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSA 1183 (1251)
Q Consensus 1105 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1183 (1251)
...... .......++..|+|||++.+. .++.++||||+|+++|||++|+.||.+....+. ..............
T Consensus 150 ~~~~~~---~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~--~~~~~~~~~~~~~~ 224 (288)
T cd07833 150 LRARPA---SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQ--LYLIQKCLGPLPPS 224 (288)
T ss_pred cCCCcc---ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCCHH
Confidence 543321 122234678899999999887 889999999999999999999999975533211 11111100000000
Q ss_pred hhhhh--cccCC-----CCC-C------chHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 000859 1184 REELL--DDQMK-----PLL-P------GEECAAYQVLEIALQCTKTSPQERPSSRQVCD 1229 (1251)
Q Consensus 1184 ~~~~~--~~~~~-----~~~-~------~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1229 (1251)
..... +..+. ... + .+...+.++.+++.+||+.+|++||+++++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 225 HQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred HhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 00000 00000 000 0 01113577899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=311.83 Aligned_cols=273 Identities=25% Similarity=0.301 Sum_probs=200.4
Q ss_pred hcCCCcCceecccCCceEEEEEec-CCcEEEEEEeccC-CchhhhHHHHHHHHHHHhc-cCCCccceeceeeecCCCcee
Q 000859 945 TNNLSDEFIIGSGGSGTVYKAELA-NGATVAVKKISCK-DDHLLNKSFTREVKTLGRI-RHRHLVKLMGHCCNKGAGSNL 1021 (1251)
Q Consensus 945 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~~~ 1021 (1251)
..+|+..+.||+|+||.||+|... +++.||||++... ......+.+.+|+.+++++ +||||+++++++........+
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 85 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY 85 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence 346777889999999999999654 6889999988543 2223445677899999999 999999999988765555679
Q ss_pred EEEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEccccc
Q 000859 1022 LIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGL 1101 (1251)
Q Consensus 1022 lv~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~ 1101 (1251)
+||||++ ++|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||.
T Consensus 86 lv~e~~~-~~L~~~~~~--------~~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~ 153 (337)
T cd07852 86 LVFEYME-TDLHAVIRA--------NILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGL 153 (337)
T ss_pred EEecccc-cCHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccc
Confidence 9999997 599998865 2578889999999999999999999 999999999999999999999999999
Q ss_pred ccccccccCCC-Ccccceeecccceeccccccc-CCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhc
Q 000859 1102 AKALVEDYNSN-TESNTWFAGSYGYIAPEYAYS-LKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEM 1179 (1251)
Q Consensus 1102 a~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 1179 (1251)
++......... ........|+..|+|||.+.+ ..++.++||||||+++|||++|+.||.+....+. ...........
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~-~~~~~~~~~~~ 232 (337)
T cd07852 154 ARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQ-LEKIIEVIGPP 232 (337)
T ss_pred hhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCC
Confidence 98664332211 112233568999999998754 4578899999999999999999999975533221 11111110000
Q ss_pred cc--------hhhhhhhcccCCCC----CCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 000859 1180 SG--------SAREELLDDQMKPL----LPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDL 1230 (1251)
Q Consensus 1180 ~~--------~~~~~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 1230 (1251)
.. .......+...... .......+.++.+++.+||+.||++|||++++++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 233 SAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred CHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 00 00011111000000 00011145678999999999999999999999975
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.3e-32 Score=306.34 Aligned_cols=256 Identities=29% Similarity=0.385 Sum_probs=191.8
Q ss_pred CCCcCceecccCCceEEEEEe-cCCcEEEEEEeccCCchhhhHHHHHHHHHHHhcc-CCCccceeceeeecCCCceeEEE
Q 000859 947 NLSDEFIIGSGGSGTVYKAEL-ANGATVAVKKISCKDDHLLNKSFTREVKTLGRIR-HRHLVKLMGHCCNKGAGSNLLIY 1024 (1251)
Q Consensus 947 ~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~~~lv~ 1024 (1251)
+|...+.||+|+||.||++.. .+++.||+|++...........+.+|+.++.++. ||||+++++++.. +...+++|
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~--~~~~~~~~ 82 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFR--EGDCWICM 82 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEec--CCcEEEEE
Confidence 345566899999999999954 4689999999976554455678889999999996 9999999998765 34568999
Q ss_pred eecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcccccccc
Q 000859 1025 EYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKA 1104 (1251)
Q Consensus 1025 E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~ 1104 (1251)
||+.. ++.++..... ......+++..+.+++.|++.|++|||+.. +|+||||||+||+++.++.+||+|||+++.
T Consensus 83 e~~~~-~l~~l~~~~~--~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~ 157 (288)
T cd06616 83 ELMDI-SLDKFYKYVY--EVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQ 157 (288)
T ss_pred ecccC-CHHHHHHHHH--HhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHH
Confidence 99864 5555432110 011356899999999999999999999731 899999999999999999999999999976
Q ss_pred cccccCCCCcccceeecccceecccccccC---CCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccc
Q 000859 1105 LVEDYNSNTESNTWFAGSYGYIAPEYAYSL---KATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSG 1181 (1251)
Q Consensus 1105 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 1181 (1251)
+.... ......|+..|+|||.+.+. .++.++||||+||++|||++|+.||..... .. +....
T Consensus 158 ~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~----~~---~~~~~--- 222 (288)
T cd06616 158 LVDSI-----AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS----VF---DQLTQ--- 222 (288)
T ss_pred hccCC-----ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch----HH---HHHhh---
Confidence 53221 11223578899999998766 689999999999999999999999965421 00 00000
Q ss_pred hhhhhhhcccCCCCCC--chHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 000859 1182 SAREELLDDQMKPLLP--GEECAAYQVLEIALQCTKTSPQERPSSRQVCDL 1230 (1251)
Q Consensus 1182 ~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 1230 (1251)
.... ..+..+ .....+.++.+++.+||+.||++|||+++|++.
T Consensus 223 -----~~~~-~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 223 -----VVKG-DPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred -----hcCC-CCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000 001111 112355678999999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-32 Score=296.07 Aligned_cols=252 Identities=23% Similarity=0.284 Sum_probs=198.7
Q ss_pred HhhcCCCcCceecccCCceEEEEEe-cCCcEEEEEEeccCC--chhhhHHHHHHHHHHHhccCCCccceeceeeecCCCc
Q 000859 943 GATNNLSDEFIIGSGGSGTVYKAEL-ANGATVAVKKISCKD--DHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGS 1019 (1251)
Q Consensus 943 ~~~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 1019 (1251)
...+.|+.-++||+|+||.||-++. .+|+.+|.|++.++. ..........|-.|++++..+.||.+--+| +..+.
T Consensus 182 vt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAf--eTkd~ 259 (591)
T KOG0986|consen 182 VTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAF--ETKDA 259 (591)
T ss_pred ccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeee--cCCCc
Confidence 3457788889999999999999954 479999999986544 222335567899999999999999986555 44556
Q ss_pred eeEEEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEccc
Q 000859 1020 NLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDF 1099 (1251)
Q Consensus 1020 ~~lv~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 1099 (1251)
.++|+..|.||+|.-++-... ...+++..++-+|.+|+.||++||++ +||.||+||+|||+|+.|+|+|+|+
T Consensus 260 LClVLtlMNGGDLkfHiyn~g-----~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDL 331 (591)
T KOG0986|consen 260 LCLVLTLMNGGDLKFHIYNHG-----NPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDL 331 (591)
T ss_pred eEEEEEeecCCceeEEeeccC-----CCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeecc
Confidence 899999999999988886643 35799999999999999999999999 9999999999999999999999999
Q ss_pred ccccccccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhc
Q 000859 1100 GLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEM 1179 (1251)
Q Consensus 1100 G~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 1179 (1251)
|+|..+.+ ..+....+||.+|||||++....|+...|.||+||++|||+.|+.||...... .+|.+....
T Consensus 332 GLAvei~~-----g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeK----vk~eEvdrr- 401 (591)
T KOG0986|consen 332 GLAVEIPE-----GKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEK----VKREEVDRR- 401 (591)
T ss_pred ceEEecCC-----CCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhh----hhHHHHHHH-
Confidence 99987643 33344468999999999999999999999999999999999999999643111 111111100
Q ss_pred cchhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHH
Q 000859 1180 SGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSR 1225 (1251)
Q Consensus 1180 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 1225 (1251)
.. ......++..+++..++.+..+++||++|--.+
T Consensus 402 -------~~----~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcr 436 (591)
T KOG0986|consen 402 -------TL----EDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCR 436 (591)
T ss_pred -------Hh----cchhhcccccCHHHHHHHHHHHccCHHHhccCC
Confidence 00 011112244566788999999999999996544
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=306.19 Aligned_cols=270 Identities=24% Similarity=0.333 Sum_probs=196.0
Q ss_pred hcCCCcCceecccCCceEEEEEe-cCCcEEEEEEeccCCc-hhhhHHHHHHHHHHHhccCCCccceeceeeecCC-----
Q 000859 945 TNNLSDEFIIGSGGSGTVYKAEL-ANGATVAVKKISCKDD-HLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGA----- 1017 (1251)
Q Consensus 945 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~----- 1017 (1251)
.++|+..+.||+|+||.||+|.. .+++.||||++..... ......+.+|++++++++||||+++++++.....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 34688899999999999999965 4689999999864432 2223456789999999999999999998765432
Q ss_pred -CceeEEEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEE
Q 000859 1018 -GSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHL 1096 (1251)
Q Consensus 1018 -~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl 1096 (1251)
...++||||+. +++.+++... ...+++.++..++.|++.|++|||+. +++|+||||+||+++.++.+||
T Consensus 91 ~~~~~lv~e~~~-~~l~~~l~~~------~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl 160 (310)
T cd07865 91 KGSFYLVFEFCE-HDLAGLLSNK------NVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKL 160 (310)
T ss_pred CceEEEEEcCCC-cCHHHHHHhc------ccCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEE
Confidence 24589999996 5888888653 24689999999999999999999999 9999999999999999999999
Q ss_pred cccccccccccccCCCCcccceeecccceecccccccC-CCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHH
Q 000859 1097 GDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSL-KATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEM 1175 (1251)
Q Consensus 1097 ~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~ 1175 (1251)
+|||.+..+...............++..|+|||.+.+. .++.++||||||+++|||++|+.||....... .......
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~--~~~~~~~ 238 (310)
T cd07865 161 ADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQH--QLTLISQ 238 (310)
T ss_pred CcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHH
Confidence 99999976543322211222234678899999987654 47889999999999999999999997543221 1111111
Q ss_pred HHhccchhhhhh---------hcccCCCC-----CC---chHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 000859 1176 HMEMSGSAREEL---------LDDQMKPL-----LP---GEECAAYQVLEIALQCTKTSPQERPSSRQVCD 1229 (1251)
Q Consensus 1176 ~~~~~~~~~~~~---------~~~~~~~~-----~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1229 (1251)
.. +...... .+....+. .+ ........+.+++.+||+.||++|||++|+++
T Consensus 239 ~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 239 LC---GSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred Hh---CCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 10 0000000 00000000 00 00012345679999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=301.96 Aligned_cols=268 Identities=22% Similarity=0.362 Sum_probs=198.3
Q ss_pred CCCcCceecccCCceEEEEEec-CCcEEEEEEeccCCchhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEEEe
Q 000859 947 NLSDEFIIGSGGSGTVYKAELA-NGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIYE 1025 (1251)
Q Consensus 947 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv~E 1025 (1251)
+|+..+.||+|++|.||+|+.. +|+.||||++.........+.+.+|++++++++||||+++++++... ...++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e 78 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTE--NKLMLVFE 78 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeC--CcEEEEEe
Confidence 4778889999999999999664 68999999997665444456778899999999999999999988654 45699999
Q ss_pred ecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEccccccccc
Q 000859 1026 YMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKAL 1105 (1251)
Q Consensus 1026 ~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~ 1105 (1251)
|+++ +|.+++..... ...+++..+..++.|++.|++|||+. +++||||||+||++++++.++++|||.++..
T Consensus 79 ~~~~-~l~~~~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~ 150 (284)
T cd07836 79 YMDK-DLKKYMDTHGV----RGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAF 150 (284)
T ss_pred cCCc-cHHHHHHhcCC----CCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhh
Confidence 9984 89998865421 34689999999999999999999999 9999999999999999999999999999754
Q ss_pred ccccCCCCcccceeecccceecccccccC-CCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccchhh
Q 000859 1106 VEDYNSNTESNTWFAGSYGYIAPEYAYSL-KATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSAR 1184 (1251)
Q Consensus 1106 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1184 (1251)
.... .......++..|+|||.+.+. .++.++||||+||++||+++|+.||.+....+. .....+..........
T Consensus 151 ~~~~----~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 225 (284)
T cd07836 151 GIPV----NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQ-LLKIFRIMGTPTESTW 225 (284)
T ss_pred cCCc----cccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHH-HHHHHHHhCCCChhhH
Confidence 3221 111223568899999987654 578899999999999999999999976543221 1111111100000000
Q ss_pred hhhhc-ccCCCCCC---------chHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 000859 1185 EELLD-DQMKPLLP---------GEECAAYQVLEIALQCTKTSPQERPSSRQVCD 1229 (1251)
Q Consensus 1185 ~~~~~-~~~~~~~~---------~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1229 (1251)
+.+.. .......+ .....+..+.+++.+|++.||.+||+++|+++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 226 PGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred HHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00000 00000000 01123567889999999999999999999875
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=301.28 Aligned_cols=245 Identities=23% Similarity=0.290 Sum_probs=189.5
Q ss_pred ecccCCceEEEEE-ecCCcEEEEEEeccCC--chhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEEEeecCCC
Q 000859 954 IGSGGSGTVYKAE-LANGATVAVKKISCKD--DHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIYEYMENG 1030 (1251)
Q Consensus 954 lG~G~fg~V~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv~E~~~~g 1030 (1251)
||+|+||+||+|. ..+|+.||+|.+.... .....+.+..|+++++.++||||+++++++.. ....++||||++++
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv~e~~~~~ 78 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFET--KDDLCLVMTLMNGG 78 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEec--CCeEEEEEecCCCC
Confidence 6899999999995 4568999999986432 22234566789999999999999999988754 34579999999999
Q ss_pred ChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcccccccccccccC
Q 000859 1031 SVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYN 1110 (1251)
Q Consensus 1031 sL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 1110 (1251)
+|.+++.... ...+++.++..++.|++.|+.|||+. +++||||+|+||+++.++.+|++|||.++.....
T Consensus 79 ~L~~~l~~~~-----~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~-- 148 (277)
T cd05577 79 DLKYHIYNVG-----EPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG-- 148 (277)
T ss_pred cHHHHHHHcC-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccC--
Confidence 9999997642 24689999999999999999999999 9999999999999999999999999998764321
Q ss_pred CCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccchhhhhhhcc
Q 000859 1111 SNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSAREELLDD 1190 (1251)
Q Consensus 1111 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1190 (1251)
.......++..|+|||++.+..++.++||||+||++|+|++|+.||........ ...... ....
T Consensus 149 ---~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~-----------~~~~- 212 (277)
T cd05577 149 ---KKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVE-KEELKR-----------RTLE- 212 (277)
T ss_pred ---CccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccccc-HHHHHh-----------cccc-
Confidence 111224578899999999888899999999999999999999999975432111 000000 0000
Q ss_pred cCCCCCCchHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 000859 1191 QMKPLLPGEECAAYQVLEIALQCTKTSPQERP-----SSRQVCD 1229 (1251)
Q Consensus 1191 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~ 1229 (1251)
.....+...++.+.+++.+||+.||++|| ++++++.
T Consensus 213 ---~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 213 ---MAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred ---ccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 01111122356788999999999999999 5555654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=298.21 Aligned_cols=243 Identities=26% Similarity=0.362 Sum_probs=192.9
Q ss_pred ecccCCceEEEEEec-CCcEEEEEEeccCC--chhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEEEeecCCC
Q 000859 954 IGSGGSGTVYKAELA-NGATVAVKKISCKD--DHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIYEYMENG 1030 (1251)
Q Consensus 954 lG~G~fg~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv~E~~~~g 1030 (1251)
||.|+||.||+|... +++.||+|++.... .....+.+.+|+++++.++||||+++++++... ...++|+||++++
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~ 78 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDK--KYIYMLMEYCLGG 78 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcC--CccEEEEecCCCC
Confidence 699999999999654 58999999986543 223457789999999999999999999987543 4579999999999
Q ss_pred ChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcccccccccccccC
Q 000859 1031 SVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYN 1110 (1251)
Q Consensus 1031 sL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 1110 (1251)
+|.+++.+. ..+++..+..++.|+++|++|+|+. +++|+||+|+||+++.++.++|+|||.++......
T Consensus 79 ~L~~~l~~~-------~~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~- 147 (262)
T cd05572 79 ELWTILRDR-------GLFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ- 147 (262)
T ss_pred cHHHHHhhc-------CCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-
Confidence 999999763 3588999999999999999999998 99999999999999999999999999997653321
Q ss_pred CCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccchhhhhhhcc
Q 000859 1111 SNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSAREELLDD 1190 (1251)
Q Consensus 1111 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1190 (1251)
......|+..|+|||.+.+..++.++|+||+|+++|||++|+.||........ .... .....
T Consensus 148 ----~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~~~~-----------~~~~~ 209 (262)
T cd05572 148 ----KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPM---EIYN-----------DILKG 209 (262)
T ss_pred ----ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHH---HHHH-----------HHhcc
Confidence 11224678899999999888899999999999999999999999976542111 1111 11110
Q ss_pred cCCCCCCchHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 000859 1191 QMKPLLPGEECAAYQVLEIALQCTKTSPQERPS-----SRQVCD 1229 (1251)
Q Consensus 1191 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~eil~ 1229 (1251)
...... +...+.++.+++.+||+.+|++||+ ++|+++
T Consensus 210 ~~~~~~--~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 210 NGKLEF--PNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred CCCCCC--CcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 111111 1222567999999999999999999 777665
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-31 Score=304.07 Aligned_cols=253 Identities=29% Similarity=0.398 Sum_probs=197.0
Q ss_pred CCcCceecccCCceEEEEEe-cCCcEEEEEEeccCC--chhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEEE
Q 000859 948 LSDEFIIGSGGSGTVYKAEL-ANGATVAVKKISCKD--DHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIY 1024 (1251)
Q Consensus 948 ~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv~ 1024 (1251)
|...+.||+|+||.||+|.. .++..||+|++.... .....+.+.+|++++++++|||++++++++... ...++||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~ 104 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLRE--HTAWLVM 104 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeC--CeEEEEE
Confidence 56677899999999999965 468899999986432 223445788999999999999999999988654 4468999
Q ss_pred eecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcccccccc
Q 000859 1025 EYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKA 1104 (1251)
Q Consensus 1025 E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~ 1104 (1251)
||++ |++.+++... ...+++.++..++.|++.|+.|||+. +|+||||+|+||+++.++.+||+|||++..
T Consensus 105 e~~~-g~l~~~~~~~------~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~ 174 (317)
T cd06635 105 EYCL-GSASDLLEVH------KKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASI 174 (317)
T ss_pred eCCC-CCHHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccc
Confidence 9997 5888877543 34589999999999999999999999 999999999999999999999999998865
Q ss_pred cccccCCCCcccceeecccceecccccc---cCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccc
Q 000859 1105 LVEDYNSNTESNTWFAGSYGYIAPEYAY---SLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSG 1181 (1251)
Q Consensus 1105 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 1181 (1251)
... .....|+..|+|||++. ...++.++|||||||++|||++|+.||........ ..
T Consensus 175 ~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~-----~~------- 234 (317)
T cd06635 175 ASP--------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-----LY------- 234 (317)
T ss_pred cCC--------cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH-----HH-------
Confidence 321 11246788999999874 45688999999999999999999999865422111 00
Q ss_pred hhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhcCCC
Q 000859 1182 SAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNVFNNR 1238 (1251)
Q Consensus 1182 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~ 1238 (1251)
....... +. ......+..+.+++.+||+.+|.+||+++++++....+....
T Consensus 235 ----~~~~~~~-~~-~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~ 285 (317)
T cd06635 235 ----HIAQNES-PT-LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERP 285 (317)
T ss_pred ----HHHhccC-CC-CCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccCc
Confidence 0000000 11 112234567899999999999999999999998776655444
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=301.83 Aligned_cols=266 Identities=23% Similarity=0.320 Sum_probs=194.7
Q ss_pred CCcCceecccCCceEEEEEe-cCCcEEEEEEeccCCch-hhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEEEe
Q 000859 948 LSDEFIIGSGGSGTVYKAEL-ANGATVAVKKISCKDDH-LLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIYE 1025 (1251)
Q Consensus 948 ~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv~E 1025 (1251)
|+..+.||.|++|.||+|.. .+|+.||+|++...... ...+.+.+|++++++++|||++++++++... ...+++||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~--~~~~iv~e 78 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSE--NKLYLVFE 78 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccC--CeEEEEEe
Confidence 56678999999999999964 47999999998654322 2335688899999999999999999988643 56799999
Q ss_pred ecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEccccccccc
Q 000859 1026 YMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKAL 1105 (1251)
Q Consensus 1026 ~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~ 1105 (1251)
|++ ++|.+++...+ ...+++..+.+++.|+++|++|||+. +++||||+|+||+++.++.++|+|||.++..
T Consensus 79 ~~~-~~l~~~~~~~~-----~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~ 149 (283)
T cd07835 79 FLD-LDLKKYMDSSP-----LTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAF 149 (283)
T ss_pred ccC-cCHHHHHhhCC-----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeeccccccc
Confidence 995 69999987643 24689999999999999999999999 9999999999999999999999999998754
Q ss_pred ccccCCCCcccceeecccceecccccccC-CCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccchh-
Q 000859 1106 VEDYNSNTESNTWFAGSYGYIAPEYAYSL-KATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSA- 1183 (1251)
Q Consensus 1106 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~- 1183 (1251)
.... .......++..|+|||++.+. .++.++||||+|+++|||++|+.||......+. .....+.........
T Consensus 150 ~~~~----~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~ 224 (283)
T cd07835 150 GVPV----RTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQ-LFRIFRTLGTPDEDVW 224 (283)
T ss_pred CCCc----cccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCChHHh
Confidence 3211 111223568899999987654 578899999999999999999999975432211 111111100000000
Q ss_pred -----hhhhhcccCC----CCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 000859 1184 -----REELLDDQMK----PLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCD 1229 (1251)
Q Consensus 1184 -----~~~~~~~~~~----~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1229 (1251)
.......... .........+.++.+++.+|++.||++|||++|+++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 225 PGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0000000000 000001113356889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=300.38 Aligned_cols=243 Identities=21% Similarity=0.247 Sum_probs=184.4
Q ss_pred eecccCCceEEEEEe-cCCcEEEEEEeccCCc--hhhhHHHHHHHHHHHh---ccCCCccceeceeeecCCCceeEEEee
Q 000859 953 IIGSGGSGTVYKAEL-ANGATVAVKKISCKDD--HLLNKSFTREVKTLGR---IRHRHLVKLMGHCCNKGAGSNLLIYEY 1026 (1251)
Q Consensus 953 ~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~---l~h~niv~l~g~~~~~~~~~~~lv~E~ 1026 (1251)
.||+|+||.||++.. .+++.||+|.+..... ....+.+.+|..+++. .+||+|+.+++++... ...++||||
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~--~~~~lv~e~ 78 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTP--DKLCFILDL 78 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecC--CeEEEEEec
Confidence 489999999999965 4689999999864432 1222334455544443 3799999999887543 457899999
Q ss_pred cCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcccccccccc
Q 000859 1027 MENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALV 1106 (1251)
Q Consensus 1027 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~ 1106 (1251)
+++|+|.+++.. .+.+++..+..++.|++.|++|||+. +|+||||||+||++++++.++++|||++....
T Consensus 79 ~~~~~L~~~i~~-------~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~ 148 (279)
T cd05633 79 MNGGDLHYHLSQ-------HGVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFS 148 (279)
T ss_pred CCCCCHHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceecc
Confidence 999999999876 34689999999999999999999999 99999999999999999999999999986542
Q ss_pred cccCCCCcccceeecccceecccccc-cCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccchhhh
Q 000859 1107 EDYNSNTESNTWFAGSYGYIAPEYAY-SLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSARE 1185 (1251)
Q Consensus 1107 ~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1185 (1251)
.. ......|+..|+|||... +..++.++||||+||++|||++|..||.......... ......
T Consensus 149 ~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~---~~~~~~------- 212 (279)
T cd05633 149 KK------KPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE---IDRMTL------- 212 (279)
T ss_pred cc------CccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHH---HHHHhh-------
Confidence 21 112246899999999886 4568999999999999999999999997543321111 000000
Q ss_pred hhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 000859 1186 ELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERP-----SSRQVCDL 1230 (1251)
Q Consensus 1186 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~~ 1230 (1251)
.. ....+...+.++.+++.+|++.||++|| |++|+++.
T Consensus 213 -----~~--~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 213 -----TV--NVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred -----cC--CcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 00 0111223456788999999999999999 59888775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-31 Score=305.01 Aligned_cols=266 Identities=19% Similarity=0.219 Sum_probs=190.0
Q ss_pred ecccCCceEEEEEecCCcEEEEEEeccC-CchhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEEEeecCCCCh
Q 000859 954 IGSGGSGTVYKAELANGATVAVKKISCK-DDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIYEYMENGSV 1032 (1251)
Q Consensus 954 lG~G~fg~V~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv~E~~~~gsL 1032 (1251)
+|.|+++.||++.. +++.||||++... ......+.+.+|+++++.++||||+++++++... ...+++|||+++|++
T Consensus 10 ~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~--~~~~~~~e~~~~~~l 86 (314)
T cd08216 10 FEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVD--SELYVVSPLMAYGSC 86 (314)
T ss_pred hcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecC--CeEEEEEeccCCCCH
Confidence 44445555555544 6899999999765 3444567899999999999999999999988654 456999999999999
Q ss_pred HHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcccccccccccccCC-
Q 000859 1033 WDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNS- 1111 (1251)
Q Consensus 1033 ~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~- 1111 (1251)
.+++.... ...+++..+..++.|+++||+|||++ +|+||||||+||+++.++.+|++|||.+..+......
T Consensus 87 ~~~l~~~~-----~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~ 158 (314)
T cd08216 87 EDLLKTHF-----PEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQ 158 (314)
T ss_pred HHHHHHhc-----ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeeccccccc
Confidence 99998642 34578899999999999999999999 9999999999999999999999999998765432111
Q ss_pred --CCcccceeecccceeccccccc--CCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccchhhhhh
Q 000859 1112 --NTESNTWFAGSYGYIAPEYAYS--LKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSAREEL 1187 (1251)
Q Consensus 1112 --~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1187 (1251)
.........++..|+|||++.+ ..++.++|||||||++|||++|+.||............................
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (314)
T cd08216 159 RVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPL 238 (314)
T ss_pred cccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhh
Confidence 1111123457788999999875 358899999999999999999999997653322111100000000000000000
Q ss_pred h------------c--ccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 000859 1188 L------------D--DQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDL 1230 (1251)
Q Consensus 1188 ~------------~--~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 1230 (1251)
. + ...............++.+++.+||+.||++|||++++++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 239 YEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred hcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 0 0 00000111122345678899999999999999999999874
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-31 Score=293.00 Aligned_cols=249 Identities=29% Similarity=0.424 Sum_probs=200.7
Q ss_pred CCCcCceecccCCceEEEEEec-CCcEEEEEEeccCCchhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEEEe
Q 000859 947 NLSDEFIIGSGGSGTVYKAELA-NGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIYE 1025 (1251)
Q Consensus 947 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv~E 1025 (1251)
+|+..+.||+|++|.||+|... +++.||+|++..... ...+.+.+|++++++++||+++++++++... ...++++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~l~~e 77 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK-EKKEKIINEIQILKKCKHPNIVKYYGSYLKK--DELWIVME 77 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch-hHHHHHHHHHHHHHhCCCCCEeEEEEEEecC--CeEEEEEe
Confidence 3677889999999999999664 689999999965443 3557889999999999999999999987654 45799999
Q ss_pred ecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEccccccccc
Q 000859 1026 YMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKAL 1105 (1251)
Q Consensus 1026 ~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~ 1105 (1251)
|+++++|.+++.... ..+++..+..++.|++.|++|||+. +++||||+|+||++++++.++|+|||.+...
T Consensus 78 ~~~~~~L~~~~~~~~------~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~ 148 (253)
T cd05122 78 FCSGGSLKDLLKSTN------QTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQL 148 (253)
T ss_pred cCCCCcHHHHHhhcC------CCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeeccccccc
Confidence 999999999987642 5689999999999999999999998 9999999999999999999999999998765
Q ss_pred ccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccchhhh
Q 000859 1106 VEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSARE 1185 (1251)
Q Consensus 1106 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1185 (1251)
..... .....++..|+|||.+.+..++.++||||||+++|+|++|+.||....... ......
T Consensus 149 ~~~~~-----~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-----~~~~~~-------- 210 (253)
T cd05122 149 SDTKA-----RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMK-----ALFKIA-------- 210 (253)
T ss_pred ccccc-----ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHH-----HHHHHH--------
Confidence 43211 233568899999999988889999999999999999999999987542111 000000
Q ss_pred hhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 000859 1186 ELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCD 1229 (1251)
Q Consensus 1186 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1229 (1251)
....+..+.....+..+.+++.+|++.||++|||++|+++
T Consensus 211 ----~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 211 ----TNGPPGLRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred ----hcCCCCcCcccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0111111122223567899999999999999999999875
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-31 Score=303.05 Aligned_cols=276 Identities=22% Similarity=0.312 Sum_probs=198.7
Q ss_pred CCCcCceecccCCceEEEEEec---CCcEEEEEEeccCC--chhhhHHHHHHHHHHHhccCCCccceeceeeecCCCcee
Q 000859 947 NLSDEFIIGSGGSGTVYKAELA---NGATVAVKKISCKD--DHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNL 1021 (1251)
Q Consensus 947 ~~~~~~~lG~G~fg~V~~~~~~---~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~ 1021 (1251)
+|+..++||+|+||.||+|... +++.||+|.+.... .....+.+.+|++++++++||||+++++++........+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 3677889999999999999654 47899999997532 122346678899999999999999999999776556789
Q ss_pred EEEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecC----CCCeEEc
Q 000859 1022 LIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDS----NMEAHLG 1097 (1251)
Q Consensus 1022 lv~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~----~~~~kl~ 1097 (1251)
+||||+++ ++.+++..... .....+++..+..++.|++.|++|||+. +|+||||||+||+++. ++.+||+
T Consensus 81 lv~e~~~~-~l~~~~~~~~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~ 154 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQ--AKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIG 154 (316)
T ss_pred EEEeCCCc-CHHHHHHhhcc--CCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEEC
Confidence 99999974 78777754321 1124688999999999999999999999 9999999999999999 9999999
Q ss_pred ccccccccccccCCCCcccceeecccceecccccccC-CCCCccceeehhHHHHHHhhCCCCCCCccccc--------hh
Q 000859 1098 DFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSL-KATEKCDVYSMGIVLMELVSGKMPTDATFGVE--------MD 1168 (1251)
Q Consensus 1098 DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~--------~~ 1168 (1251)
|||+++........ ........++..|+|||.+.+. .++.++|||||||++|||++|+.||.+..... ..
T Consensus 155 Dfg~~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 233 (316)
T cd07842 155 DLGLARLFNAPLKP-LADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQ 233 (316)
T ss_pred CCccccccCCCccc-ccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHH
Confidence 99999765432211 1122235678999999987764 57899999999999999999999997554322 01
Q ss_pred HHHHHHHHHhccchh---------hhhhhcccCCCCCC---chH------HHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 000859 1169 MVRWVEMHMEMSGSA---------REELLDDQMKPLLP---GEE------CAAYQVLEIALQCTKTSPQERPSSRQVCD 1229 (1251)
Q Consensus 1169 ~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~---~~~------~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1229 (1251)
....++......... .....+.......+ ... ..+.++.+++.+|++.||++|||++|+++
T Consensus 234 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 234 LERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 111111100000000 00000000001111 000 23356889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=298.88 Aligned_cols=252 Identities=25% Similarity=0.354 Sum_probs=195.8
Q ss_pred ecccCCceEEEEEec-CCcEEEEEEeccCCc--hhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEEEeecCCC
Q 000859 954 IGSGGSGTVYKAELA-NGATVAVKKISCKDD--HLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIYEYMENG 1030 (1251)
Q Consensus 954 lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv~E~~~~g 1030 (1251)
||+|+||.||+|... +|+.||+|++..... ....+.+.+|++++++++||||+++++.+.. ....++++||++++
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~lv~e~~~~~ 78 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQG--KKNLYLVMEYLPGG 78 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheec--CcEEEEEEecCCCC
Confidence 689999999999765 589999999864432 2345678899999999999999999987754 45579999999999
Q ss_pred ChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcccccccccccccC
Q 000859 1031 SVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYN 1110 (1251)
Q Consensus 1031 sL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 1110 (1251)
+|.+++++. +.+++..+..++.|+++|++|||+. +++||||+|+||++++++.++|+|||++........
T Consensus 79 ~L~~~l~~~-------~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 148 (265)
T cd05579 79 DLASLLENV-------GSLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQ 148 (265)
T ss_pred cHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCcc
Confidence 999999763 3689999999999999999999999 999999999999999999999999999875432211
Q ss_pred CC----CcccceeecccceecccccccCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccchhhhh
Q 000859 1111 SN----TESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSAREE 1186 (1251)
Q Consensus 1111 ~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1186 (1251)
.. ........++..|+|||......++.++||||+|+++||+++|+.||......+ ......
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~-----~~~~~~--------- 214 (265)
T cd05579 149 INLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEE-----IFQNIL--------- 214 (265)
T ss_pred cccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHh---------
Confidence 00 112223467889999999988889999999999999999999999997553211 111000
Q ss_pred hhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhc
Q 000859 1187 LLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNVF 1235 (1251)
Q Consensus 1187 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~ 1235 (1251)
... ...+.....+..+.+++.+||+.+|++|||++++.+.++.-+
T Consensus 215 --~~~--~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~ 259 (265)
T cd05579 215 --NGK--IEWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPF 259 (265)
T ss_pred --cCC--cCCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCcc
Confidence 000 011111112567889999999999999999977776665443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-31 Score=301.51 Aligned_cols=268 Identities=21% Similarity=0.277 Sum_probs=194.9
Q ss_pred CCCcCceecccCCceEEEEEe-cCCcEEEEEEeccCCch-hhhHHHHHHHHHHHhc-cCCCccceeceeeecCC---Cce
Q 000859 947 NLSDEFIIGSGGSGTVYKAEL-ANGATVAVKKISCKDDH-LLNKSFTREVKTLGRI-RHRHLVKLMGHCCNKGA---GSN 1020 (1251)
Q Consensus 947 ~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~---~~~ 1020 (1251)
+|+..+.||+|+||.||+|.. .+++.||||++...... ...+.+.+|+++++++ +||||+++++++..... ...
T Consensus 2 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~ 81 (295)
T cd07837 2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSL 81 (295)
T ss_pred CceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceE
Confidence 588889999999999999965 46899999998654322 2335778899999999 46999999998765432 236
Q ss_pred eEEEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecC-CCCeEEccc
Q 000859 1021 LLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDS-NMEAHLGDF 1099 (1251)
Q Consensus 1021 ~lv~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~-~~~~kl~Df 1099 (1251)
++||||+++ ++.+++..... .....+++..++.++.||++|++|||+. +|+||||||+||+++. ++.+||+||
T Consensus 82 ~lv~e~~~~-~l~~~~~~~~~--~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~df 155 (295)
T cd07837 82 YLVFEYLDS-DLKKFMDSNGR--GPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADL 155 (295)
T ss_pred EEEeeccCc-CHHHHHHHhcc--cCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeec
Confidence 899999985 89998865421 1134689999999999999999999999 9999999999999998 899999999
Q ss_pred ccccccccccCCCCcccceeecccceeccccccc-CCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHh
Q 000859 1100 GLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYS-LKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHME 1178 (1251)
Q Consensus 1100 G~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 1178 (1251)
|.++.+..... ......+++.|+|||++.+ ..++.++|||||||++|||++|+.||.+....+. .......
T Consensus 156 g~~~~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~----~~~~~~~ 227 (295)
T cd07837 156 GLGRAFSIPVK----SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQ----LLHIFKL 227 (295)
T ss_pred ccceecCCCcc----ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHH----HHHHHHH
Confidence 99876532211 1122356788999998765 4578999999999999999999999976433221 1111000
Q ss_pred ccchhhhhhhcc-------cCCCCCC------chHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 000859 1179 MSGSAREELLDD-------QMKPLLP------GEECAAYQVLEIALQCTKTSPQERPSSRQVCD 1229 (1251)
Q Consensus 1179 ~~~~~~~~~~~~-------~~~~~~~------~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1229 (1251)
. .......... ...+... .....+.++.+++.+||+.||.+||+++|++.
T Consensus 228 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 228 L-GTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred h-CCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 0 0000000000 0000000 00124567889999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-32 Score=290.50 Aligned_cols=262 Identities=24% Similarity=0.354 Sum_probs=202.6
Q ss_pred hcCCCcCceecccCCceEEEE-EecCCcEEEEEEeccCCc------hhhhHHHHHHHHHHHhccCCCccceeceeeecCC
Q 000859 945 TNNLSDEFIIGSGGSGTVYKA-ELANGATVAVKKISCKDD------HLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGA 1017 (1251)
Q Consensus 945 ~~~~~~~~~lG~G~fg~V~~~-~~~~~~~vavK~~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~ 1017 (1251)
..+|-..++||+|+|+.||+| +....+.||||+-....+ +...+...+|..|-+.++||.||++|+|+..+.
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDt- 540 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDT- 540 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecc-
Confidence 445666778999999999999 677788999998643321 122345778999999999999999999998764
Q ss_pred CceeEEEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeec---CCCCe
Q 000859 1018 GSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLD---SNMEA 1094 (1251)
Q Consensus 1018 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~---~~~~~ 1094 (1251)
..++-|+||++|.+|.-||+. .+.+++.+++.|++||+.|+.||.+. .++|||-|+||.|||+- .-|.+
T Consensus 541 dsFCTVLEYceGNDLDFYLKQ-------hklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeI 612 (775)
T KOG1151|consen 541 DSFCTVLEYCEGNDLDFYLKQ-------HKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEI 612 (775)
T ss_pred ccceeeeeecCCCchhHHHHh-------hhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCccccee
Confidence 457899999999999999987 46789999999999999999999996 66999999999999994 56889
Q ss_pred EEcccccccccccccCCC---Ccccceeecccceeccccccc----CCCCCccceeehhHHHHHHhhCCCCCCCccccch
Q 000859 1095 HLGDFGLAKALVEDYNSN---TESNTWFAGSYGYIAPEYAYS----LKATEKCDVYSMGIVLMELVSGKMPTDATFGVEM 1167 (1251)
Q Consensus 1095 kl~DfG~a~~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~----~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~ 1167 (1251)
||+|||+++.+..+.+.. ..-....+||+.|.+||.+.- ...+.++||||+||++|+++.|+.||+.......
T Consensus 613 KITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQd 692 (775)
T KOG1151|consen 613 KITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQD 692 (775)
T ss_pred EeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHH
Confidence 999999999886654432 223345789999999998753 3468899999999999999999999975432221
Q ss_pred hHHHHHHHHHhccchhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 000859 1168 DMVRWVEMHMEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCD 1229 (1251)
Q Consensus 1168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1229 (1251)
-+ +... ++. ...-.+|.......+...+|++|+++.-++|.++.++..
T Consensus 693 IL----qeNT---------Ilk-AtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 693 IL----QENT---------ILK-ATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred HH----hhhc---------hhc-ceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 11 1110 000 111123333345567789999999999999999888753
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-31 Score=301.93 Aligned_cols=253 Identities=27% Similarity=0.403 Sum_probs=193.3
Q ss_pred cCCCcCceecccCCceEEEEEecC-CcEEEEEEeccCCchhhhHHHHHHHHHHHhc-cCCCccceeceeeecCCCceeEE
Q 000859 946 NNLSDEFIIGSGGSGTVYKAELAN-GATVAVKKISCKDDHLLNKSFTREVKTLGRI-RHRHLVKLMGHCCNKGAGSNLLI 1023 (1251)
Q Consensus 946 ~~~~~~~~lG~G~fg~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~~~lv 1023 (1251)
++|+..+.||+|+||.||+|...+ ++.||||.+.........+.+.+|+.++.+. .||||+++++++... ...++|
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~--~~~~~v 92 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITD--SDVFIC 92 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecC--CeEEEE
Confidence 457888899999999999997754 8999999997554444456677788877777 499999999988654 457999
Q ss_pred EeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCCeeecCCCCCCeeecCCCCeEEcccccc
Q 000859 1024 YEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHH-DCVPKILHRDIKSSNILLDSNMEAHLGDFGLA 1102 (1251)
Q Consensus 1024 ~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a 1102 (1251)
|||+. +++.++.... ...+++..+.+++.|++.||+|||+ . +|+||||+|+||++++++.+||+|||.+
T Consensus 93 ~e~~~-~~l~~l~~~~------~~~l~~~~~~~i~~~i~~~l~~lH~~~---~i~H~dl~p~nill~~~~~~kL~dfg~~ 162 (296)
T cd06618 93 MELMS-TCLDKLLKRI------QGPIPEDILGKMTVAIVKALHYLKEKH---GVIHRDVKPSNILLDASGNVKLCDFGIS 162 (296)
T ss_pred eeccC-cCHHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHhhC---CEecCCCcHHHEEEcCCCCEEECccccc
Confidence 99985 5777776553 2468999999999999999999997 5 8999999999999999999999999998
Q ss_pred cccccccCCCCcccceeecccceecccccccCC----CCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHh
Q 000859 1103 KALVEDYNSNTESNTWFAGSYGYIAPEYAYSLK----ATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHME 1178 (1251)
Q Consensus 1103 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 1178 (1251)
..+.... ......++..|+|||.+.+.. ++.++||||||+++|||++|+.||...........
T Consensus 163 ~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~-------- 229 (296)
T cd06618 163 GRLVDSK-----AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLT-------- 229 (296)
T ss_pred hhccCCC-----cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHH--------
Confidence 7653221 112235778999999987553 78899999999999999999999964321110000
Q ss_pred ccchhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 000859 1179 MSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLL 1231 (1251)
Q Consensus 1179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L 1231 (1251)
...... .+..+.....+.++.+++.+||+.||++||+++++++.-
T Consensus 230 -------~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~ 274 (296)
T cd06618 230 -------KILQEE-PPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHP 274 (296)
T ss_pred -------HHhcCC-CCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCh
Confidence 001110 011111122456789999999999999999999998764
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=308.47 Aligned_cols=278 Identities=22% Similarity=0.263 Sum_probs=202.3
Q ss_pred hcCCCcCceecccCCceEEEEE-ecCCcEEEEEEeccCC-chhhhHHHHHHHHHHHhccCCCccceeceeeecCC---Cc
Q 000859 945 TNNLSDEFIIGSGGSGTVYKAE-LANGATVAVKKISCKD-DHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGA---GS 1019 (1251)
Q Consensus 945 ~~~~~~~~~lG~G~fg~V~~~~-~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~---~~ 1019 (1251)
.++|...+.||+|+||+||+|. ..+++.||||.+.... .......+.+|+.+++.++||||+++++++..... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 4578889999999999999995 4578999999986432 22234567789999999999999999998764322 23
Q ss_pred eeEEEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEccc
Q 000859 1020 NLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDF 1099 (1251)
Q Consensus 1020 ~~lv~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 1099 (1251)
.++|+||+. ++|.+++.. .+.+++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+||
T Consensus 84 ~~lv~e~~~-~~L~~~~~~-------~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Df 152 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRS-------SQTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDF 152 (337)
T ss_pred EEEEEeCCC-CCHHHHHhc-------CCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcC
Confidence 689999996 689998875 35689999999999999999999999 9999999999999999999999999
Q ss_pred ccccccccccCCCCcccceeecccceeccccccc-CCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHH-
Q 000859 1100 GLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYS-LKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHM- 1177 (1251)
Q Consensus 1100 G~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~- 1177 (1251)
|+++...... .......++..|+|||.+.. ..++.++|||||||++|+|++|+.||.+....+. .........
T Consensus 153 g~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~-~~~~~~~~~~ 227 (337)
T cd07858 153 GLARTTSEKG----DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQ-LKLITELLGS 227 (337)
T ss_pred ccccccCCCc----ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHH-HHHHHHHhCC
Confidence 9997653221 11223467889999998764 4688999999999999999999999975432111 000000000
Q ss_pred -------hccchhhhhhhcccCCCC-C---CchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--HHhhcCCC
Q 000859 1178 -------EMSGSAREELLDDQMKPL-L---PGEECAAYQVLEIALQCTKTSPQERPSSRQVCDL--LLNVFNNR 1238 (1251)
Q Consensus 1178 -------~~~~~~~~~~~~~~~~~~-~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~--L~~~~~~~ 1238 (1251)
.................. . ......+.++.+++.+|++.||++|||++++++. +..+.+..
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~~ 301 (337)
T cd07858 228 PSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPS 301 (337)
T ss_pred CChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCcc
Confidence 000000000110000000 0 0011245678899999999999999999999987 65554433
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-31 Score=302.48 Aligned_cols=272 Identities=24% Similarity=0.321 Sum_probs=197.9
Q ss_pred hhcCCCcCceecccCCceEEEEEec-CCcEEEEEEeccCCc-hhhhHHHHHHHHHHHhccCCCccceeceeeecC-----
Q 000859 944 ATNNLSDEFIIGSGGSGTVYKAELA-NGATVAVKKISCKDD-HLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKG----- 1016 (1251)
Q Consensus 944 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~----- 1016 (1251)
...+|+..+.||+|+||.||+|... +|+.||||++..... ......+.+|++++++++||||+++++++....
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~ 84 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF 84 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence 4567888999999999999999654 689999999965432 223456778999999999999999999886543
Q ss_pred ---CCceeEEEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCC
Q 000859 1017 ---AGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNME 1093 (1251)
Q Consensus 1017 ---~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~ 1093 (1251)
....++|+||+++ ++.+++... ...+++..++.++.|++.||+|||+. +|+||||||+||++++++.
T Consensus 85 ~~~~~~~~lv~e~~~~-~l~~~l~~~------~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~ 154 (302)
T cd07864 85 KKDKGAFYLVFEYMDH-DLMGLLESG------LVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQ 154 (302)
T ss_pred cccCCcEEEEEcccCc-cHHHHHhcC------CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCc
Confidence 2357899999975 788877653 34689999999999999999999999 9999999999999999999
Q ss_pred eEEcccccccccccccCCCCcccceeecccceeccccccc-CCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHH
Q 000859 1094 AHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYS-LKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRW 1172 (1251)
Q Consensus 1094 ~kl~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~ 1172 (1251)
+||+|||.+........ .......++..|+|||.+.+ ..++.++||||+||++|||++|+.||......+ .....
T Consensus 155 ~kl~dfg~~~~~~~~~~---~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~-~~~~~ 230 (302)
T cd07864 155 IKLADFGLARLYNSEES---RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELA-QLELI 230 (302)
T ss_pred EEeCcccccccccCCcc---cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHH
Confidence 99999999976543221 11122356788999998764 457889999999999999999999997543211 11111
Q ss_pred HHHHHhccchhhhhhhccc----------C-CCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 000859 1173 VEMHMEMSGSAREELLDDQ----------M-KPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCD 1229 (1251)
Q Consensus 1173 ~~~~~~~~~~~~~~~~~~~----------~-~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1229 (1251)
..............+.... . +.........+..+.+++.+||+.||.+||+++++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 231 SRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred HHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1110000000000000000 0 0000011113567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=301.14 Aligned_cols=265 Identities=22% Similarity=0.279 Sum_probs=203.1
Q ss_pred CCCcCceecccCCceEEEEEe----cCCcEEEEEEeccCC---chhhhHHHHHHHHHHHhc-cCCCccceeceeeecCCC
Q 000859 947 NLSDEFIIGSGGSGTVYKAEL----ANGATVAVKKISCKD---DHLLNKSFTREVKTLGRI-RHRHLVKLMGHCCNKGAG 1018 (1251)
Q Consensus 947 ~~~~~~~lG~G~fg~V~~~~~----~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~ 1018 (1251)
+|+..+.||+|+||.||+|.. .+++.||||++.... .....+.+.+|+++++++ +||+|+++++.+.. ..
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~--~~ 78 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQT--DT 78 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeec--CC
Confidence 366778999999999999964 357889999986432 122345678999999999 69999999987744 34
Q ss_pred ceeEEEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcc
Q 000859 1019 SNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGD 1098 (1251)
Q Consensus 1019 ~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D 1098 (1251)
..++||||+++|+|.+++.. ...+++..+..++.|+++||+|||+. +++||||||+||+++.++.++++|
T Consensus 79 ~~~lv~e~~~~~~L~~~~~~-------~~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~d 148 (288)
T cd05583 79 KLHLILDYVNGGELFTHLYQ-------REHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTD 148 (288)
T ss_pred EEEEEEecCCCCcHHHHHhh-------cCCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEE
Confidence 57899999999999999875 34588999999999999999999998 999999999999999999999999
Q ss_pred cccccccccccCCCCcccceeecccceecccccccCC--CCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHH
Q 000859 1099 FGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLK--ATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMH 1176 (1251)
Q Consensus 1099 fG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~ 1176 (1251)
||+++....... .......|+..|+|||...+.. .+.++||||+|+++|||++|+.||........ .......
T Consensus 149 fg~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~-~~~~~~~- 223 (288)
T cd05583 149 FGLSKEFLAEEE---ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNS-QSEISRR- 223 (288)
T ss_pred Cccccccccccc---cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccch-HHHHHHH-
Confidence 999876533211 1112245789999999987655 78899999999999999999999964321110 1111110
Q ss_pred HhccchhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhcCCCcccc
Q 000859 1177 MEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNVFNNRIVDF 1242 (1251)
Q Consensus 1177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~~~~ 1242 (1251)
... ...+.+...+..+.+++.+||+.||++|||++++.+.+...+-+...+.
T Consensus 224 ----------~~~----~~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~~ 275 (288)
T cd05583 224 ----------ILK----SKPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDWD 275 (288)
T ss_pred ----------HHc----cCCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCCHH
Confidence 001 0111222245668899999999999999999999988887776665543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-31 Score=298.88 Aligned_cols=268 Identities=28% Similarity=0.384 Sum_probs=197.3
Q ss_pred CCcCceecccCCceEEEEEec-CCcEEEEEEeccCC-chhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEEEe
Q 000859 948 LSDEFIIGSGGSGTVYKAELA-NGATVAVKKISCKD-DHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIYE 1025 (1251)
Q Consensus 948 ~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv~E 1025 (1251)
|++.+.||+|+||.||+|... +++.||+|++.... .....+.+.+|++++++++|||++++++++........++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 566788999999999999665 58899999997653 2334467889999999999999999999887653456799999
Q ss_pred ecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEccccccccc
Q 000859 1026 YMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKAL 1105 (1251)
Q Consensus 1026 ~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~ 1105 (1251)
|+++ +|.+++... ...+++..+..++.|+++|++|||+. +++|+||||+||++++++.+||+|||.+...
T Consensus 81 ~~~~-~l~~~~~~~------~~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~ 150 (287)
T cd07840 81 YMDH-DLTGLLDSP------EVKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPY 150 (287)
T ss_pred cccc-cHHHHHhcc------CCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeec
Confidence 9974 899888653 24689999999999999999999999 9999999999999999999999999999765
Q ss_pred ccccCCCCcccceeecccceeccccccc-CCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccchhh
Q 000859 1106 VEDYNSNTESNTWFAGSYGYIAPEYAYS-LKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSAR 1184 (1251)
Q Consensus 1106 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1184 (1251)
..... .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||........ .....+..........
T Consensus 151 ~~~~~---~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~-~~~~~~~~~~~~~~~~ 226 (287)
T cd07840 151 TKRNS---ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQ-LEKIFELCGSPTDENW 226 (287)
T ss_pred cCCCc---ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCchhhc
Confidence 43221 11222456788999997764 4578999999999999999999999976543211 1111110000000000
Q ss_pred hhh----hcccCCCCCCch--------HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 000859 1185 EEL----LDDQMKPLLPGE--------ECAAYQVLEIALQCTKTSPQERPSSRQVCD 1229 (1251)
Q Consensus 1185 ~~~----~~~~~~~~~~~~--------~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1229 (1251)
... ......+..... ...+.++.+++.+|++.+|.+||+++++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 227 PGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred cccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 000 000000000000 002567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-32 Score=286.60 Aligned_cols=263 Identities=23% Similarity=0.333 Sum_probs=200.5
Q ss_pred HhhcCCCcCceecccCCceEEEE-EecCCcEEEEEEeccCCchhhhHHHHHHHHHHHhcc-C-CC----ccceeceeeec
Q 000859 943 GATNNLSDEFIIGSGGSGTVYKA-ELANGATVAVKKISCKDDHLLNKSFTREVKTLGRIR-H-RH----LVKLMGHCCNK 1015 (1251)
Q Consensus 943 ~~~~~~~~~~~lG~G~fg~V~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h-~n----iv~l~g~~~~~ 1015 (1251)
..+++|.+...+|+|.||.|-++ +...+..||||+++ .-....++..-|+++++++. + |+ +|.+.++|.-
T Consensus 86 ~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik--~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdy- 162 (415)
T KOG0671|consen 86 ILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIK--NVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDY- 162 (415)
T ss_pred ccccceehhhhhcCCcccceEEEeecCCCceehHHHHH--HHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhc-
Confidence 34788999999999999999999 55568999999995 44456677888999999993 3 32 6777777743
Q ss_pred CCCceeEEEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecC-----
Q 000859 1016 GAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDS----- 1090 (1251)
Q Consensus 1016 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~----- 1090 (1251)
.+..++|+|.+ |.++++|++++. -.+++.++++.|+.|++++++|||+. +++|.|+||+||++.+
T Consensus 163 -rghiCivfell-G~S~~dFlk~N~-----y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~ 232 (415)
T KOG0671|consen 163 -RGHICIVFELL-GLSTFDFLKENN-----YIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFK 232 (415)
T ss_pred -cCceEEEEecc-ChhHHHHhccCC-----ccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEE
Confidence 34568999999 569999998854 56789999999999999999999999 9999999999999932
Q ss_pred ---------------CCCeEEcccccccccccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhhC
Q 000859 1091 ---------------NMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSG 1155 (1251)
Q Consensus 1091 ---------------~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg 1155 (1251)
+..+|++|||.|+...+. ....+.|..|+|||++.+-.++.++||||+||+++|+.||
T Consensus 233 ~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~-------hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG 305 (415)
T KOG0671|consen 233 TYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEH-------HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTG 305 (415)
T ss_pred EeccCCccceeccCCCcceEEEecCCcceeccC-------cceeeeccccCCchheeccCcCCccCceeeeeEEEEeecc
Confidence 345899999999754222 2446889999999999999999999999999999999999
Q ss_pred CCCCCCccccchhHHHHHHHHHhccchhhhhhhccc----------------------------CCCC---CCchHHHHH
Q 000859 1156 KMPTDATFGVEMDMVRWVEMHMEMSGSAREELLDDQ----------------------------MKPL---LPGEECAAY 1204 (1251)
Q Consensus 1156 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------------------------~~~~---~~~~~~~~~ 1204 (1251)
..-|..-.+.+ ..+++....+.....++... .++. .........
T Consensus 306 ~~LFqtHen~E-----HLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~ 380 (415)
T KOG0671|consen 306 ETLFQTHENLE-----HLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHV 380 (415)
T ss_pred ceecccCCcHH-----HHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHh
Confidence 99987654322 12222222222211111111 0000 011223556
Q ss_pred HHHHHHHHccccCCCCCCCHHHHHHH
Q 000859 1205 QVLEIALQCTKTSPQERPSSRQVCDL 1230 (1251)
Q Consensus 1205 ~l~~li~~cl~~dP~~RPs~~eil~~ 1230 (1251)
++.+++++|+..||.+|+|++|+++.
T Consensus 381 ~LfDLl~~mL~fDP~~RiTl~EAL~H 406 (415)
T KOG0671|consen 381 QLFDLLRRMLEFDPARRITLREALSH 406 (415)
T ss_pred HHHHHHHHHHccCccccccHHHHhcC
Confidence 79999999999999999999999753
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=9e-31 Score=292.37 Aligned_cols=254 Identities=25% Similarity=0.373 Sum_probs=203.1
Q ss_pred CCCcCceecccCCceEEEEEec-CCcEEEEEEeccCCc-hhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEEE
Q 000859 947 NLSDEFIIGSGGSGTVYKAELA-NGATVAVKKISCKDD-HLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIY 1024 (1251)
Q Consensus 947 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv~ 1024 (1251)
+|...+.||+|++|.||+|... +++.|++|++..... ....+.+.+|++++++++||||+++++.+........++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 3677789999999999999665 789999999865442 34567889999999999999999999988655335679999
Q ss_pred eecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcccccccc
Q 000859 1025 EYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKA 1104 (1251)
Q Consensus 1025 E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~ 1104 (1251)
||+++++|.+++... ..+++..+..++.|++.|++|||+. +++|+|++|+||+++.++.++|+|||.+..
T Consensus 81 e~~~~~~L~~~~~~~-------~~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~ 150 (260)
T cd06606 81 EYVSGGSLSSLLKKF-------GKLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKR 150 (260)
T ss_pred EecCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEe
Confidence 999999999999763 3789999999999999999999998 999999999999999999999999999876
Q ss_pred cccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccchhh
Q 000859 1105 LVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSAR 1184 (1251)
Q Consensus 1105 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1184 (1251)
....... .......++..|+|||...+..++.++||||+|+++|++++|+.||........ ....
T Consensus 151 ~~~~~~~--~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-------~~~~------ 215 (260)
T cd06606 151 LGDIETG--EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMA-------ALYK------ 215 (260)
T ss_pred ccccccc--ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH-------HHHh------
Confidence 5433211 112234678999999999888899999999999999999999999976541110 0000
Q ss_pred hhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 000859 1185 EELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCD 1229 (1251)
Q Consensus 1185 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1229 (1251)
..... .....+...+..+.+++.+|++.+|++||++.|+++
T Consensus 216 --~~~~~--~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 216 --IGSSG--EPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred --ccccC--CCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 00000 111112233677999999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-31 Score=300.07 Aligned_cols=243 Identities=23% Similarity=0.385 Sum_probs=193.2
Q ss_pred ceecccCCceEEEEEe-cCCcEEEEEEeccCCchhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEEEeecCCC
Q 000859 952 FIIGSGGSGTVYKAEL-ANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIYEYMENG 1030 (1251)
Q Consensus 952 ~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv~E~~~~g 1030 (1251)
.+||+|+||.||+|.. .+++.||||++.... ....+.+.+|+.+++.++|+||+++++++.. ....++||||++++
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~ 102 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK-QQRRELLFNEVVIMRDYQHENVVEMYNSYLV--GDELWVVMEFLEGG 102 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccc-hhHHHHHHHHHHHHHhcCCcchhheeeEEEe--CCEEEEEEecCCCC
Confidence 4799999999999965 578999999985433 3345678899999999999999999998865 34579999999999
Q ss_pred ChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcccccccccccccC
Q 000859 1031 SVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYN 1110 (1251)
Q Consensus 1031 sL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 1110 (1251)
+|.+++.. ..+++..+..++.|++.|++|||+. +++||||+|+||+++.++.++|+|||.+.......
T Consensus 103 ~L~~~~~~--------~~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~- 170 (292)
T cd06657 103 ALTDIVTH--------TRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV- 170 (292)
T ss_pred cHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceeccccc-
Confidence 99998754 3478999999999999999999999 99999999999999999999999999987553221
Q ss_pred CCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccchhhhhhhcc
Q 000859 1111 SNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSAREELLDD 1190 (1251)
Q Consensus 1111 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1190 (1251)
.......|+..|+|||.+.+..++.++|+||+||++|||++|+.||.+....+. ..... .
T Consensus 171 ---~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~-----~~~~~------------~ 230 (292)
T cd06657 171 ---PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA-----MKMIR------------D 230 (292)
T ss_pred ---ccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-----HHHHH------------h
Confidence 112234678999999999888899999999999999999999999875422111 11000 0
Q ss_pred cCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 000859 1191 QMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCD 1229 (1251)
Q Consensus 1191 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1229 (1251)
...+........+..+.+++.+||+.||.+||++.++++
T Consensus 231 ~~~~~~~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 231 NLPPKLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred hCCcccCCcccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 011111111223456889999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=251.08 Aligned_cols=266 Identities=24% Similarity=0.353 Sum_probs=200.6
Q ss_pred CCCcCceecccCCceEEEEE-ecCCcEEEEEEeccCCc-hhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEEE
Q 000859 947 NLSDEFIIGSGGSGTVYKAE-LANGATVAVKKISCKDD-HLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIY 1024 (1251)
Q Consensus 947 ~~~~~~~lG~G~fg~V~~~~-~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv~ 1024 (1251)
+|...++||+|.||+||+|+ +.+++.||+|.++.+.+ +.......+|+.+++.+.|+|||+++++... +...-+|+
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhs--dkkltlvf 80 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS--DKKLTLVF 80 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhcc--CceeEEeH
Confidence 35566789999999999995 55688999999986653 3345677899999999999999999997643 45567999
Q ss_pred eecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcccccccc
Q 000859 1025 EYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKA 1104 (1251)
Q Consensus 1025 E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~ 1104 (1251)
||++. +|..|.... .+.++.+.++.++.|+++|+.|+|++ .+.|||+||.|.+++.+|+.|++|||+|+.
T Consensus 81 e~cdq-dlkkyfdsl------ng~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglara 150 (292)
T KOG0662|consen 81 EFCDQ-DLKKYFDSL------NGDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARA 150 (292)
T ss_pred HHhhH-HHHHHHHhc------CCcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhh
Confidence 99975 888888764 46789999999999999999999999 999999999999999999999999999987
Q ss_pred cccccCCCCcccceeecccceecccccccCC-CCCccceeehhHHHHHHhh-CCCCCCCccccchhHHHHHHHHHhccc-
Q 000859 1105 LVEDYNSNTESNTWFAGSYGYIAPEYAYSLK-ATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMVRWVEMHMEMSG- 1181 (1251)
Q Consensus 1105 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDiwSlGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~- 1181 (1251)
+.- .....+..+-|..|++|.++.+.. |+...|+||.||++.|+.. |++-|.+. ..++.+.+..........
T Consensus 151 fgi----pvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~-dvddqlkrif~~lg~p~ed 225 (292)
T KOG0662|consen 151 FGI----PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN-DVDDQLKRIFRLLGTPTED 225 (292)
T ss_pred cCC----ceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCC-cHHHHHHHHHHHhCCCccc
Confidence 643 223334456789999999998765 8899999999999999998 66666544 333333333222211111
Q ss_pred --hhhhhhhcccCCCCCCchHHHH-------HHHHHHHHHccccCCCCCCCHHHHHH
Q 000859 1182 --SAREELLDDQMKPLLPGEECAA-------YQVLEIALQCTKTSPQERPSSRQVCD 1229 (1251)
Q Consensus 1182 --~~~~~~~~~~~~~~~~~~~~~~-------~~l~~li~~cl~~dP~~RPs~~eil~ 1229 (1251)
..+...-+-...|.++...... ..-.+++.+.+.-+|.+|.++++.++
T Consensus 226 ~wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 226 QWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred cCCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 1122333333444444322211 22367888888889999999998775
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-31 Score=295.35 Aligned_cols=245 Identities=23% Similarity=0.287 Sum_probs=186.3
Q ss_pred ceecccCCceEEEEEe-cCCcEEEEEEeccCCc--hhhhHHHHHHHHHHH-hccCCCccceeceeeecCCCceeEEEeec
Q 000859 952 FIIGSGGSGTVYKAEL-ANGATVAVKKISCKDD--HLLNKSFTREVKTLG-RIRHRHLVKLMGHCCNKGAGSNLLIYEYM 1027 (1251)
Q Consensus 952 ~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~-~l~h~niv~l~g~~~~~~~~~~~lv~E~~ 1027 (1251)
+.||+|+||.||+|.. .+++.||||++..... ......+..|..++. ..+|+|++++++++.. ....++|+||+
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--~~~~~lv~e~~ 79 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQS--KDYLYLVMEYL 79 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEc--CCeEEEEEecc
Confidence 4699999999999955 4689999999864321 122234455555544 4489999999998854 34579999999
Q ss_pred CCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEccccccccccc
Q 000859 1028 ENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVE 1107 (1251)
Q Consensus 1028 ~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~ 1107 (1251)
++++|.++++.. ..+++..+..++.|++.||.|||+. +++||||+|+||++++++.+||+|||.++....
T Consensus 80 ~~~~L~~~l~~~-------~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 149 (260)
T cd05611 80 NGGDCASLIKTL-------GGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE 149 (260)
T ss_pred CCCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc
Confidence 999999999763 4688999999999999999999999 999999999999999999999999999865422
Q ss_pred ccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccchhhhhh
Q 000859 1108 DYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSAREEL 1187 (1251)
Q Consensus 1108 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1187 (1251)
.....|+..|+|||...+..++.++||||+|+++|||++|..||......+ .......
T Consensus 150 --------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-----~~~~~~~--------- 207 (260)
T cd05611 150 --------NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDA-----VFDNILS--------- 207 (260)
T ss_pred --------cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHH-----HHHHHHh---------
Confidence 122457889999999988889999999999999999999999997543211 1111100
Q ss_pred hcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 000859 1188 LDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLL 1232 (1251)
Q Consensus 1188 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 1232 (1251)
.............+..+.+++.+||+.+|++||++.++.+.+.
T Consensus 208 --~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~ 250 (260)
T cd05611 208 --RRINWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKS 250 (260)
T ss_pred --cccCCCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence 0000000111124567899999999999999998766655443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.4e-31 Score=293.47 Aligned_cols=244 Identities=22% Similarity=0.284 Sum_probs=187.7
Q ss_pred hhcCCCcCcee--cccCCceEEEEEe-cCCcEEEEEEeccCCchhhhHHHHHHHHHHHhc-cCCCccceeceeeecCCCc
Q 000859 944 ATNNLSDEFII--GSGGSGTVYKAEL-ANGATVAVKKISCKDDHLLNKSFTREVKTLGRI-RHRHLVKLMGHCCNKGAGS 1019 (1251)
Q Consensus 944 ~~~~~~~~~~l--G~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~ 1019 (1251)
..++|++.+.+ |+|+||.||++.. .+++.+|+|.+....... .|+.....+ +||||+++++.+... ..
T Consensus 12 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~------~e~~~~~~~~~h~~iv~~~~~~~~~--~~ 83 (267)
T PHA03390 12 FLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA------IEPMVHQLMKDNPNFIKLYYSVTTL--KG 83 (267)
T ss_pred HHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch------hhHHHHHHhhcCCCEEEEEEEEecC--Ce
Confidence 34556666665 9999999999954 568899999986432111 122222222 799999999988654 45
Q ss_pred eeEEEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCC-CeEEcc
Q 000859 1020 NLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNM-EAHLGD 1098 (1251)
Q Consensus 1020 ~~lv~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~-~~kl~D 1098 (1251)
.++||||+++|+|.+++... ..++++++..++.|+++|++|||+. +++||||||+||+++.++ .++|+|
T Consensus 84 ~~iv~e~~~~~~L~~~l~~~-------~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~d 153 (267)
T PHA03390 84 HVLIMDYIKDGDLFDLLKKE-------GKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCD 153 (267)
T ss_pred eEEEEEcCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEec
Confidence 79999999999999999763 3789999999999999999999999 999999999999999998 999999
Q ss_pred cccccccccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHh
Q 000859 1099 FGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHME 1178 (1251)
Q Consensus 1099 fG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 1178 (1251)
||.++..... ....|+..|+|||++.+..++.++||||+||++|||++|+.||......+.....+....
T Consensus 154 fg~~~~~~~~--------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-- 223 (267)
T PHA03390 154 YGLCKIIGTP--------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ-- 223 (267)
T ss_pred CccceecCCC--------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh--
Confidence 9998754221 123578999999999988999999999999999999999999985543332222221111
Q ss_pred ccchhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCC-HHHHHH
Q 000859 1179 MSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPS-SRQVCD 1229 (1251)
Q Consensus 1179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~eil~ 1229 (1251)
....+.....+..+.+++.+|++.+|.+||+ ++|+++
T Consensus 224 --------------~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 224 --------------QKKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred --------------cccCCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 0111122235567899999999999999996 688874
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=291.25 Aligned_cols=253 Identities=29% Similarity=0.393 Sum_probs=202.4
Q ss_pred CCCcCceecccCCceEEEEEec-CCcEEEEEEeccCCc-hhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEEE
Q 000859 947 NLSDEFIIGSGGSGTVYKAELA-NGATVAVKKISCKDD-HLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIY 1024 (1251)
Q Consensus 947 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv~ 1024 (1251)
+|+..+.||.|+||.||++... +++.||+|++..... ....+.+.+|+++++.++|||++++++.+... ...++|+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~--~~~~lv~ 78 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEK--GKLCIVM 78 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecC--CEEEEEE
Confidence 4777889999999999999654 689999999975442 34567788999999999999999999987654 5679999
Q ss_pred eecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcccccccc
Q 000859 1025 EYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKA 1104 (1251)
Q Consensus 1025 E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~ 1104 (1251)
||+++++|.++++.... ....+++.++..++.+++.|++|||+. +++|+||+|+||+++.++.++|+|||.+..
T Consensus 79 e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~ 152 (258)
T cd08215 79 EYADGGDLSQKIKKQKK---EGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKV 152 (258)
T ss_pred EecCCCcHHHHHHHhhc---cCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceee
Confidence 99999999999976421 236789999999999999999999999 999999999999999999999999999976
Q ss_pred cccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccchhh
Q 000859 1105 LVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSAR 1184 (1251)
Q Consensus 1105 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1184 (1251)
..... .......|++.|+|||...+..++.++|+||+|+++|+|++|+.||...... .....
T Consensus 153 ~~~~~----~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~-----~~~~~--------- 214 (258)
T cd08215 153 LSSTV----DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLL-----ELALK--------- 214 (258)
T ss_pred cccCc----ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHH-----HHHHH---------
Confidence 53321 1222346889999999998888999999999999999999999999654321 11111
Q ss_pred hhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 000859 1185 EELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDL 1230 (1251)
Q Consensus 1185 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 1230 (1251)
...... +.. +...+..+.+++.+||+.+|++|||++++++.
T Consensus 215 --~~~~~~-~~~--~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 215 --ILKGQY-PPI--PSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred --HhcCCC-CCC--CCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 111111 111 11345678899999999999999999999753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-31 Score=304.26 Aligned_cols=267 Identities=21% Similarity=0.301 Sum_probs=191.1
Q ss_pred eeccc--CCceEEEEEe-cCCcEEEEEEeccCC-chhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEEEeecC
Q 000859 953 IIGSG--GSGTVYKAEL-ANGATVAVKKISCKD-DHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIYEYME 1028 (1251)
Q Consensus 953 ~lG~G--~fg~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv~E~~~ 1028 (1251)
.||+| +||+||+|.. .+|+.||||++.... .....+.+.+|+.+++.++||||+++++++... ...++|+||++
T Consensus 5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~--~~~~~v~e~~~ 82 (328)
T cd08226 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTG--SWLWVISPFMA 82 (328)
T ss_pred HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecC--CceEEEEeccc
Confidence 46666 9999999965 579999999987543 233457788999999999999999999998653 45699999999
Q ss_pred CCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcccccccccccc
Q 000859 1029 NGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVED 1108 (1251)
Q Consensus 1029 ~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 1108 (1251)
+|++.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++++||+.+......
T Consensus 83 ~~~l~~~l~~~~-----~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~ 154 (328)
T cd08226 83 YGSANSLLKTYF-----PEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRN 154 (328)
T ss_pred CCCHHHHHHhhc-----ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhcc
Confidence 999999987642 24588999999999999999999999 9999999999999999999999999865433221
Q ss_pred cCCCC---cccceeecccceecccccccC--CCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHH-------
Q 000859 1109 YNSNT---ESNTWFAGSYGYIAPEYAYSL--KATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMH------- 1176 (1251)
Q Consensus 1109 ~~~~~---~~~~~~~gt~~y~aPE~~~~~--~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~------- 1176 (1251)
..... .......++..|+|||++.+. .++.++||||+||++|||++|+.||.......... ......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~ 233 (328)
T cd08226 155 GQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLL-QKLKGPPYSPLDI 233 (328)
T ss_pred CccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHH-HHhcCCCCCCccc
Confidence 11110 001112356679999998763 47899999999999999999999997653221110 000000
Q ss_pred ---------Hh-----ccchhhhhhhc-----cc--CCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 000859 1177 ---------ME-----MSGSAREELLD-----DQ--MKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDL 1230 (1251)
Q Consensus 1177 ---------~~-----~~~~~~~~~~~-----~~--~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 1230 (1251)
.. ......+.... .. .....+........+.+++.+||+.||++|||++|+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~ 308 (328)
T cd08226 234 TTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH 308 (328)
T ss_pred cccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 00 00000000000 00 000111233466789999999999999999999999743
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-31 Score=299.67 Aligned_cols=268 Identities=21% Similarity=0.302 Sum_probs=192.9
Q ss_pred cCCCcCceecccCCceEEEEEec-CCcEEEEEEeccCCc-hhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEE
Q 000859 946 NNLSDEFIIGSGGSGTVYKAELA-NGATVAVKKISCKDD-HLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLI 1023 (1251)
Q Consensus 946 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv 1023 (1251)
++|+..+.||+|++|+||+|... +++.||+|++..... ....+.+.+|++++++++||||+++++++.. ....++|
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 79 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHS--EKRLYLV 79 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEec--CCeEEEE
Confidence 46888889999999999999654 689999999864432 2234578899999999999999999998864 3467999
Q ss_pred EeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecC-CCCeEEcccccc
Q 000859 1024 YEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDS-NMEAHLGDFGLA 1102 (1251)
Q Consensus 1024 ~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~-~~~~kl~DfG~a 1102 (1251)
|||++ +++.+++.... ...+++..+..++.||+.|++|||++ +++||||+|+||+++. ++.+||+|||.+
T Consensus 80 ~e~~~-~~l~~~~~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~ 150 (294)
T PLN00009 80 FEYLD-LDLKKHMDSSP-----DFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLA 150 (294)
T ss_pred Eeccc-ccHHHHHHhCC-----CCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccc
Confidence 99996 58888876532 23467888899999999999999999 9999999999999985 567999999999
Q ss_pred cccccccCCCCcccceeecccceecccccccC-CCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccc
Q 000859 1103 KALVEDYNSNTESNTWFAGSYGYIAPEYAYSL-KATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSG 1181 (1251)
Q Consensus 1103 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 1181 (1251)
+...... .......++..|+|||.+.+. .++.++||||+||++|+|+||+.||......+. .............
T Consensus 151 ~~~~~~~----~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~-~~~~~~~~~~~~~ 225 (294)
T PLN00009 151 RAFGIPV----RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDE-LFKIFRILGTPNE 225 (294)
T ss_pred cccCCCc----cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCCh
Confidence 7543221 111223568899999988664 578999999999999999999999976533221 1111100000000
Q ss_pred hh------hhhhhcc--cCCCCCC--chHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 000859 1182 SA------REELLDD--QMKPLLP--GEECAAYQVLEIALQCTKTSPQERPSSRQVCD 1229 (1251)
Q Consensus 1182 ~~------~~~~~~~--~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1229 (1251)
.. ...+... ....... .....+.++.+++.+|++.+|++||+++++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 226 ETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred hhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00 0000000 0000000 00113456889999999999999999999986
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.6e-31 Score=292.47 Aligned_cols=250 Identities=24% Similarity=0.351 Sum_probs=200.8
Q ss_pred CCCcCceecccCCceEEEEE-ecCCcEEEEEEeccCC-chhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEEE
Q 000859 947 NLSDEFIIGSGGSGTVYKAE-LANGATVAVKKISCKD-DHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIY 1024 (1251)
Q Consensus 947 ~~~~~~~lG~G~fg~V~~~~-~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv~ 1024 (1251)
+|+..+.||+|+||.||++. ..+++.||+|++.... .......+.+|++++++++|+||+++++++... ...++|+
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~~v~ 78 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDG--NKLCIVM 78 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccC--CEEEEEe
Confidence 46778899999999999995 4578899999986533 334456778999999999999999999987654 5679999
Q ss_pred eecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcccccccc
Q 000859 1025 EYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKA 1104 (1251)
Q Consensus 1025 E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~ 1104 (1251)
||+++++|.+++.+.. .....+++..++.++.|++.|++|||+. +++|+||+|+||+++.++.+|++|||.++.
T Consensus 79 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~ 152 (256)
T cd08530 79 EYAPFGDLSKAISKRK---KKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKV 152 (256)
T ss_pred hhcCCCCHHHHHHHHH---hhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhh
Confidence 9999999999987632 1235689999999999999999999999 999999999999999999999999999976
Q ss_pred cccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccchhh
Q 000859 1105 LVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSAR 1184 (1251)
Q Consensus 1105 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1184 (1251)
.... ......++..|+|||.+.+..++.++|+||+|+++||+++|+.||......+. ..
T Consensus 153 ~~~~------~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~--~~------------- 211 (256)
T cd08530 153 LKKN------MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDL--RY------------- 211 (256)
T ss_pred hccC------CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HH-------------
Confidence 5432 11123578899999999998999999999999999999999999975532111 00
Q ss_pred hhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 000859 1185 EELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCD 1229 (1251)
Q Consensus 1185 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1229 (1251)
.. .....+. .+...+.++.+++.+|++.+|++||++.|+++
T Consensus 212 -~~-~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 212 -KV-QRGKYPP--IPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred -HH-hcCCCCC--CchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 00 0011111 12245677999999999999999999999975
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=294.27 Aligned_cols=267 Identities=24% Similarity=0.313 Sum_probs=195.1
Q ss_pred CCcCceecccCCceEEEEEec-CCcEEEEEEeccCCch-hhhHHHHHHHHHHHhc---cCCCccceeceeeecCC---Cc
Q 000859 948 LSDEFIIGSGGSGTVYKAELA-NGATVAVKKISCKDDH-LLNKSFTREVKTLGRI---RHRHLVKLMGHCCNKGA---GS 1019 (1251)
Q Consensus 948 ~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l---~h~niv~l~g~~~~~~~---~~ 1019 (1251)
|++.+.||+|+||.||+|..+ +++.||+|++...... .....+.+|+.+++++ +|||++++++++..... ..
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 566778999999999999765 4899999999754332 2234566788887766 59999999998876433 23
Q ss_pred eeEEEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEccc
Q 000859 1020 NLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDF 1099 (1251)
Q Consensus 1020 ~~lv~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 1099 (1251)
.+++|||++ ++|.+++.... ...+++..++.++.|+++||+|||+. +++|+||+|+||+++.++.+||+||
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~-----~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~df 151 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCP-----KPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADF 151 (287)
T ss_pred eEEEehhcc-cCHHHHHHHcc-----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEecc
Confidence 689999997 58999887643 23589999999999999999999999 9999999999999999999999999
Q ss_pred ccccccccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhc
Q 000859 1100 GLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEM 1179 (1251)
Q Consensus 1100 G~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 1179 (1251)
|.+..+.... ......++..|+|||.+.+..++.++|+|||||++|||++|+.||......+ ............
T Consensus 152 g~~~~~~~~~-----~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~-~~~~~~~~~~~~ 225 (287)
T cd07838 152 GLARIYSFEM-----ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEAD-QLDKIFDVIGLP 225 (287)
T ss_pred CcceeccCCc-----ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHH-HHHHHHHHcCCC
Confidence 9987653221 1122357889999999998899999999999999999999999987653322 111111111000
Q ss_pred cchh-h------hhhhcccCCCCC-CchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 000859 1180 SGSA-R------EELLDDQMKPLL-PGEECAAYQVLEIALQCTKTSPQERPSSRQVCD 1229 (1251)
Q Consensus 1180 ~~~~-~------~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1229 (1251)
.... . ............ ......+..+.+++.+||+.||++||+++|++.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 226 SEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred ChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 0000 0 000000000000 001123467789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=295.38 Aligned_cols=266 Identities=22% Similarity=0.321 Sum_probs=194.8
Q ss_pred CCcCceecccCCceEEEEEec-CCcEEEEEEeccCCchhhhHHHHHHHHHHHhcc-CCCccceeceeeecCCCceeEEEe
Q 000859 948 LSDEFIIGSGGSGTVYKAELA-NGATVAVKKISCKDDHLLNKSFTREVKTLGRIR-HRHLVKLMGHCCNKGAGSNLLIYE 1025 (1251)
Q Consensus 948 ~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~~~lv~E 1025 (1251)
|.+.+.||+|+||+||+|... +++.||||++.............+|+..+++++ ||||+++++++.. ....++|||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~--~~~~~lv~e 78 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRE--NDELYFVFE 78 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhc--CCcEEEEEe
Confidence 556778999999999999764 578999999865543333345567999999998 9999999998865 455799999
Q ss_pred ecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEccccccccc
Q 000859 1026 YMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKAL 1105 (1251)
Q Consensus 1026 ~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~ 1105 (1251)
|+ +|++.+++.... ...+++..+..++.|++.|++|||+. +++|+||+|+||++++++.++|+|||.++..
T Consensus 79 ~~-~~~l~~~~~~~~-----~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~ 149 (283)
T cd07830 79 YM-EGNLYQLMKDRK-----GKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREI 149 (283)
T ss_pred cC-CCCHHHHHHhcc-----cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceec
Confidence 99 789999987642 34689999999999999999999999 9999999999999999999999999998765
Q ss_pred ccccCCCCcccceeecccceecccccc-cCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhcc----
Q 000859 1106 VEDYNSNTESNTWFAGSYGYIAPEYAY-SLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMS---- 1180 (1251)
Q Consensus 1106 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~---- 1180 (1251)
.... ......++..|+|||.+. ...++.++|+||||+++|||++|+.||......+... ..........
T Consensus 150 ~~~~-----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 223 (283)
T cd07830 150 RSRP-----PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLY-KICSVLGTPTKQDW 223 (283)
T ss_pred cCCC-----CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHH-HHHHhcCCCChhhh
Confidence 3211 112246788999999875 4457899999999999999999999996553322110 0000000000
Q ss_pred --chhhhhhhcccCCCCCCc-----hHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 000859 1181 --GSAREELLDDQMKPLLPG-----EECAAYQVLEIALQCTKTSPQERPSSRQVCDL 1230 (1251)
Q Consensus 1181 --~~~~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 1230 (1251)
........+.......+. ....+..+.+++.+||+.||++|||++|++..
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 224 PEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred hhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 000000000000000000 00124678899999999999999999998753
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=290.87 Aligned_cols=248 Identities=29% Similarity=0.438 Sum_probs=199.1
Q ss_pred CCCcCceecccCCceEEEEEec-CCcEEEEEEeccCCc-hhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEEE
Q 000859 947 NLSDEFIIGSGGSGTVYKAELA-NGATVAVKKISCKDD-HLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIY 1024 (1251)
Q Consensus 947 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv~ 1024 (1251)
+|+..+.||+|++|.||+|... +++.||+|.+..... ....+.+.+|++++++++|||++++++++... ...+++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~~v~ 78 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETS--DSLYIIL 78 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeC--CEEEEEE
Confidence 4677889999999999999554 678999999975542 23557889999999999999999999987553 5579999
Q ss_pred eecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcccccccc
Q 000859 1025 EYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKA 1104 (1251)
Q Consensus 1025 E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~ 1104 (1251)
||+++++|.+++... ..+++..+..++.|++.|++|||+. +|+||||+|+||+++.++.++|+|||.+..
T Consensus 79 e~~~~~~L~~~~~~~-------~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~ 148 (254)
T cd06627 79 EYAENGSLRQIIKKF-------GPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATK 148 (254)
T ss_pred ecCCCCcHHHHHHhc-------cCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEecccccee
Confidence 999999999998763 5689999999999999999999999 999999999999999999999999999976
Q ss_pred cccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccchhh
Q 000859 1105 LVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSAR 1184 (1251)
Q Consensus 1105 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1184 (1251)
....... .....++..|+|||...+..++.++||||+|+++|+|++|+.||....... .....
T Consensus 149 ~~~~~~~----~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~----~~~~~--------- 211 (254)
T cd06627 149 LNDVSKD----DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMA----ALFRI--------- 211 (254)
T ss_pred cCCCccc----ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHH----HHHHH---------
Confidence 5432211 123467889999999888889999999999999999999999987543111 10000
Q ss_pred hhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 000859 1185 EELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCD 1229 (1251)
Q Consensus 1185 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1229 (1251)
..... + +.+...+..+.+++.+|++.+|++|||+.+++.
T Consensus 212 ---~~~~~-~--~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 212 ---VQDDH-P--PLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred ---hccCC-C--CCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 00000 1 112223567889999999999999999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8e-31 Score=298.04 Aligned_cols=252 Identities=24% Similarity=0.302 Sum_probs=191.8
Q ss_pred CCCcCceecccCCceEEEEEe----cCCcEEEEEEeccCCc---hhhhHHHHHHHHHHHhc-cCCCccceeceeeecCCC
Q 000859 947 NLSDEFIIGSGGSGTVYKAEL----ANGATVAVKKISCKDD---HLLNKSFTREVKTLGRI-RHRHLVKLMGHCCNKGAG 1018 (1251)
Q Consensus 947 ~~~~~~~lG~G~fg~V~~~~~----~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~ 1018 (1251)
+|++.+.||+|+||.||+|.. .+|+.||+|++..... ....+.+.+|+++++++ +|++|+++++.+.. ..
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~--~~ 78 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT--DT 78 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeec--CC
Confidence 367788999999999999965 3689999999864321 22346678899999999 69999999987754 34
Q ss_pred ceeEEEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcc
Q 000859 1019 SNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGD 1098 (1251)
Q Consensus 1019 ~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D 1098 (1251)
..++|+||+++++|.+++.. ...+++..+..++.|+++||+|||+. +++||||+|+||+++.++.+||+|
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~-------~~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~d 148 (290)
T cd05613 79 KLHLILDYINGGELFTHLSQ-------RERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTD 148 (290)
T ss_pred eEEEEEecCCCCcHHHHHHH-------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEee
Confidence 57899999999999999976 34678999999999999999999999 999999999999999999999999
Q ss_pred cccccccccccCCCCcccceeecccceecccccccC--CCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHH
Q 000859 1099 FGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSL--KATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMH 1176 (1251)
Q Consensus 1099 fG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~ 1176 (1251)
||+++....... .......|+..|+|||.+.+. .++.++||||||+++|+|++|+.||...... .....+....
T Consensus 149 fg~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~-~~~~~~~~~~ 224 (290)
T cd05613 149 FGLSKEFHEDEV---ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK-NSQAEISRRI 224 (290)
T ss_pred Cccceecccccc---cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcc-ccHHHHHHHh
Confidence 999876532211 111224688999999988753 4678999999999999999999998643211 1111111110
Q ss_pred HhccchhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 000859 1177 MEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERP-----SSRQVCD 1229 (1251)
Q Consensus 1177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~ 1229 (1251)
. . ...+.+...+..+.+++.+|++.||++|| +++++++
T Consensus 225 ~-----------~----~~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 225 L-----------K----SEPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred h-----------c----cCCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 0 0 01111222456788999999999999997 6666654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-32 Score=273.56 Aligned_cols=269 Identities=23% Similarity=0.365 Sum_probs=202.2
Q ss_pred hcCCCcCceecccCCceEEEEE-ecCCcEEEEEEeccCC-chhhhHHHHHHHHHHHhccCCCccceeceeeecC------
Q 000859 945 TNNLSDEFIIGSGGSGTVYKAE-LANGATVAVKKISCKD-DHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKG------ 1016 (1251)
Q Consensus 945 ~~~~~~~~~lG~G~fg~V~~~~-~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~------ 1016 (1251)
...|....+||+|.||+||+|+ .++|+.||+|++--.. .+.-.....+|++++..+.|+|++.++..|....
T Consensus 16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~ 95 (376)
T KOG0669|consen 16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRD 95 (376)
T ss_pred chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccc
Confidence 3456667789999999999995 4567889999875322 2223356679999999999999999998876432
Q ss_pred CCceeEEEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEE
Q 000859 1017 AGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHL 1096 (1251)
Q Consensus 1017 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl 1096 (1251)
....|+||++++. +|...|... ...++..++.+++.++..|+.|+|.. .|+|||+||+||+++.+|.+||
T Consensus 96 r~t~ylVf~~ceh-DLaGlLsn~------~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilkl 165 (376)
T KOG0669|consen 96 RATFYLVFDFCEH-DLAGLLSNR------KVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKL 165 (376)
T ss_pred cceeeeeHHHhhh-hHHHHhcCc------cccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEe
Confidence 2236899999986 888888664 35689999999999999999999999 9999999999999999999999
Q ss_pred cccccccccccccCCCCcccceeecccceecccccccC-CCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHH
Q 000859 1097 GDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSL-KATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEM 1175 (1251)
Q Consensus 1097 ~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~ 1175 (1251)
+|||+|+.+....+....+.+..+-|..|++||.+.+. .|+.+.|||..||++.||+||.+-+.+...... ...+..
T Consensus 166 ADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqq--l~~Is~ 243 (376)
T KOG0669|consen 166 ADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQ--LHLISQ 243 (376)
T ss_pred eccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHH--HHHHHH
Confidence 99999998876655555556667789999999988764 699999999999999999999999876533111 111100
Q ss_pred HH----------------------hccchhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 000859 1176 HM----------------------EMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDL 1230 (1251)
Q Consensus 1176 ~~----------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 1230 (1251)
.. +.........+....++.. -.++..+++..++..||.+|+++.++++.
T Consensus 244 LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~-----kd~~a~dLle~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 244 LCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYV-----KDDEALDLLEKLLKLDPTKRIDADQALNH 315 (376)
T ss_pred HhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhccccc-----CChhHHHHHHHHhccCcccCcchHhhhch
Confidence 00 0001111111222222211 12456789999999999999999998865
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-31 Score=320.31 Aligned_cols=276 Identities=17% Similarity=0.237 Sum_probs=187.2
Q ss_pred hhcCCCcCceecccCCceEEEEEecC--CcEEEEEEe--------------cc--CCchhhhHHHHHHHHHHHhccCCCc
Q 000859 944 ATNNLSDEFIIGSGGSGTVYKAELAN--GATVAVKKI--------------SC--KDDHLLNKSFTREVKTLGRIRHRHL 1005 (1251)
Q Consensus 944 ~~~~~~~~~~lG~G~fg~V~~~~~~~--~~~vavK~~--------------~~--~~~~~~~~~~~~E~~~l~~l~h~ni 1005 (1251)
...+|++.+.||+|+||+||+|..+. +..+++|.+ .. .........+.+|+.++++++||||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 34679999999999999999985432 222222211 00 1122234568899999999999999
Q ss_pred cceeceeeecCCCceeEEEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCC
Q 000859 1006 VKLMGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSN 1085 (1251)
Q Consensus 1006 v~l~g~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~N 1085 (1251)
|++++++... ...++|+|++. +++.+++...... ........++..++.|++.||+|||++ +||||||||+|
T Consensus 226 v~l~~~~~~~--~~~~lv~e~~~-~~l~~~l~~~~~~--~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~N 297 (501)
T PHA03210 226 LKIEEILRSE--ANTYMITQKYD-FDLYSFMYDEAFD--WKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLEN 297 (501)
T ss_pred CcEeEEEEEC--CeeEEEEeccc-cCHHHHHhhcccc--ccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHH
Confidence 9999988654 44689999985 5888887653221 122334667788999999999999999 99999999999
Q ss_pred eeecCCCCeEEcccccccccccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhhCCCC-CCCccc
Q 000859 1086 ILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMP-TDATFG 1164 (1251)
Q Consensus 1086 ill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~p-~~~~~~ 1164 (1251)
||++.++.+||+|||+++.+..... .......||..|+|||++.+..++.++|||||||++|||++|..+ +.....
T Consensus 298 ILl~~~~~vkL~DFGla~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~ 374 (501)
T PHA03210 298 IFLNCDGKIVLGDFGTAMPFEKERE---AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGG 374 (501)
T ss_pred EEECCCCCEEEEeCCCceecCcccc---cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCC
Confidence 9999999999999999986643211 112235789999999999999999999999999999999998754 443322
Q ss_pred cc-hhHHHHHHHHHh----ccch--hhhhhhcccCCCCCC-c------hHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 000859 1165 VE-MDMVRWVEMHME----MSGS--AREELLDDQMKPLLP-G------EECAAYQVLEIALQCTKTSPQERPSSRQVCDL 1230 (1251)
Q Consensus 1165 ~~-~~~~~~~~~~~~----~~~~--~~~~~~~~~~~~~~~-~------~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 1230 (1251)
.. ....+....... .... ....+++.......+ . ....+.++.+++.+|++.||++|||++|+++.
T Consensus 375 ~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 375 KPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred CHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 11 111111111000 0000 000000000000000 0 00123456788999999999999999999863
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=294.16 Aligned_cols=242 Identities=21% Similarity=0.251 Sum_probs=183.3
Q ss_pred eecccCCceEEEEEe-cCCcEEEEEEeccCCch--hhhHHHHHHHHH---HHhccCCCccceeceeeecCCCceeEEEee
Q 000859 953 IIGSGGSGTVYKAEL-ANGATVAVKKISCKDDH--LLNKSFTREVKT---LGRIRHRHLVKLMGHCCNKGAGSNLLIYEY 1026 (1251)
Q Consensus 953 ~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~--~~~~~~~~E~~~---l~~l~h~niv~l~g~~~~~~~~~~~lv~E~ 1026 (1251)
.||+|+||.||+|.. .+++.||+|.+...... .....+..|..+ ++...||+|+++++++.. ....++||||
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~--~~~~~~v~e~ 78 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT--PDKLSFILDL 78 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeec--CCEEEEEEec
Confidence 489999999999954 56899999998654311 112233444443 444579999999987754 3457899999
Q ss_pred cCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcccccccccc
Q 000859 1027 MENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALV 1106 (1251)
Q Consensus 1027 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~ 1106 (1251)
+++|+|.+++.. .+.+++.++..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||.++.+.
T Consensus 79 ~~g~~L~~~l~~-------~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~ 148 (278)
T cd05606 79 MNGGDLHYHLSQ-------HGVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFS 148 (278)
T ss_pred CCCCcHHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccC
Confidence 999999998865 34689999999999999999999999 99999999999999999999999999987543
Q ss_pred cccCCCCcccceeecccceecccccccC-CCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccchhhh
Q 000859 1107 EDYNSNTESNTWFAGSYGYIAPEYAYSL-KATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSARE 1185 (1251)
Q Consensus 1107 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1185 (1251)
.. ......|+..|+|||.+.+. .++.++||||+||++|||++|+.||.+............
T Consensus 149 ~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~------------ 210 (278)
T cd05606 149 KK------KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM------------ 210 (278)
T ss_pred cc------CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHH------------
Confidence 21 11224689999999998754 689999999999999999999999976532211110000
Q ss_pred hhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 000859 1186 ELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERP-----SSRQVCD 1229 (1251)
Q Consensus 1186 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~ 1229 (1251)
.. ...... +...+.++.+++.+|+..+|.+|| +++++++
T Consensus 211 --~~-~~~~~~--~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 211 --TL-TMAVEL--PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred --hh-ccCCCC--CCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 00 000111 112356788999999999999999 9999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-31 Score=306.49 Aligned_cols=269 Identities=24% Similarity=0.316 Sum_probs=194.3
Q ss_pred cCCCcCceecccCCceEEEEEe-cCCcEEEEEEeccCCchhhhHHHHHHHHHHHhccCCCccceeceeeecCC-------
Q 000859 946 NNLSDEFIIGSGGSGTVYKAEL-ANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGA------- 1017 (1251)
Q Consensus 946 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~------- 1017 (1251)
.+|...+.||+|+||.||+|.. .+|+.||+|++..... ...+.+.+|++++++++||||+++++++.....
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~-~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP-QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC-chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 5788899999999999999954 5689999999865543 345678899999999999999999987654332
Q ss_pred -----CceeEEEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeec-CC
Q 000859 1018 -----GSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLD-SN 1091 (1251)
Q Consensus 1018 -----~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~-~~ 1091 (1251)
...++|+||++ ++|.+++.. ..+++..++.++.||++|++|||+. +|+||||||+||+++ ++
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~~--------~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~ 151 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLEQ--------GPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTED 151 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCC
Confidence 23589999997 589888864 3588999999999999999999999 999999999999997 45
Q ss_pred CCeEEcccccccccccccCCCCcccceeecccceeccccccc-CCCCCccceeehhHHHHHHhhCCCCCCCccccchhHH
Q 000859 1092 MEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYS-LKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMV 1170 (1251)
Q Consensus 1092 ~~~kl~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~ 1170 (1251)
+.+|++|||.++........ ........++..|+|||.+.+ ..++.++||||+||++|||++|+.||.+....+.. .
T Consensus 152 ~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~-~ 229 (342)
T cd07854 152 LVLKIGDFGLARIVDPHYSH-KGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQM-Q 229 (342)
T ss_pred ceEEECCcccceecCCcccc-ccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-H
Confidence 67899999999765322111 111122357889999997654 56888999999999999999999999755332211 1
Q ss_pred HHHHHHHh--------ccchhhhhhhcccCCCCCCch---HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 000859 1171 RWVEMHME--------MSGSAREELLDDQMKPLLPGE---ECAAYQVLEIALQCTKTSPQERPSSRQVCD 1229 (1251)
Q Consensus 1171 ~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~---~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1229 (1251)
........ ..................+.. ...+.++.+++.+|++.||++|||++|++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 230 LILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred HHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 11000000 000000000000011111111 113456889999999999999999999985
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=296.30 Aligned_cols=265 Identities=25% Similarity=0.357 Sum_probs=197.5
Q ss_pred CCcCceecccCCceEEEEEe-cCCcEEEEEEeccCCch-hhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEEEe
Q 000859 948 LSDEFIIGSGGSGTVYKAEL-ANGATVAVKKISCKDDH-LLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIYE 1025 (1251)
Q Consensus 948 ~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv~E 1025 (1251)
|+..+.||+|++|.||+|.. .+++.||+|++...... .....+.+|++++++++|+||+++++++... ...++|+|
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~~v~e 78 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHK--GDLYLVFE 78 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccC--CCEEEEEe
Confidence 45677899999999999965 47899999998654322 3456788999999999999999999987543 55799999
Q ss_pred ecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEccccccccc
Q 000859 1026 YMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKAL 1105 (1251)
Q Consensus 1026 ~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~ 1105 (1251)
|+++ ++.+++... ...+++.++..++.|+++|++|||+. +|+|+||||+||+++.++.+||+|||.+...
T Consensus 79 ~~~~-~l~~~l~~~------~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~ 148 (283)
T cd05118 79 FMDT-DLYKLIKDR------QRGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSF 148 (283)
T ss_pred ccCC-CHHHHHHhh------cccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEec
Confidence 9975 898888763 24689999999999999999999999 9999999999999999999999999998766
Q ss_pred ccccCCCCcccceeecccceecccccccC-CCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccchhh
Q 000859 1106 VEDYNSNTESNTWFAGSYGYIAPEYAYSL-KATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSAR 1184 (1251)
Q Consensus 1106 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1184 (1251)
.... .......++..|+|||.+.+. .++.++|+||+|+++|+++||+.||......+. .....+..........
T Consensus 149 ~~~~----~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 223 (283)
T cd05118 149 GSPV----RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQ-LFKIFRTLGTPDPEVW 223 (283)
T ss_pred CCCc----ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHcCCCchHhc
Confidence 4332 111224578899999998776 789999999999999999999999975533211 1110000000000000
Q ss_pred hhhhc-------ccCC----CCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 000859 1185 EELLD-------DQMK----PLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCD 1229 (1251)
Q Consensus 1185 ~~~~~-------~~~~----~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1229 (1251)
..... .... .........+.++.+++.+||+.||.+||++++++.
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 224 PKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred ccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 00000 0000 000011235678999999999999999999999975
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-31 Score=297.60 Aligned_cols=252 Identities=24% Similarity=0.340 Sum_probs=199.3
Q ss_pred cCCCcCceecccCCceEEEEEe-cCCcEEEEEEeccCC--chhhhHHHHHHHHHHHhcc-CCCccceeceeeecCCCcee
Q 000859 946 NNLSDEFIIGSGGSGTVYKAEL-ANGATVAVKKISCKD--DHLLNKSFTREVKTLGRIR-HRHLVKLMGHCCNKGAGSNL 1021 (1251)
Q Consensus 946 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~~~ 1021 (1251)
++|...+.||+|+||.||+|.. .+++.||+|++.... .....+.+.+|++++++++ ||||+++++++.. ....+
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~--~~~~~ 78 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQD--EENLY 78 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcC--CceEE
Confidence 3678888999999999999965 478999999986432 2334567889999999998 9999999998754 44579
Q ss_pred EEEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEccccc
Q 000859 1022 LIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGL 1101 (1251)
Q Consensus 1022 lv~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~ 1101 (1251)
+||||+++++|.+++.+. +.+++..+..++.|++.|++|||+. +++|+||+|+||+++.++.++++|||+
T Consensus 79 lv~e~~~~~~L~~~l~~~-------~~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~ 148 (280)
T cd05581 79 FVLEYAPNGELLQYIRKY-------GSLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGT 148 (280)
T ss_pred EEEcCCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCcc
Confidence 999999999999999763 4689999999999999999999999 999999999999999999999999999
Q ss_pred ccccccccCCC----------------CcccceeecccceecccccccCCCCCccceeehhHHHHHHhhCCCCCCCcccc
Q 000859 1102 AKALVEDYNSN----------------TESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGV 1165 (1251)
Q Consensus 1102 a~~~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~ 1165 (1251)
+.......... ........++..|+|||......++.++|+||+|+++|++++|+.||......
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~ 228 (280)
T cd05581 149 AKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEY 228 (280)
T ss_pred ccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHH
Confidence 87654322110 11222346789999999998888999999999999999999999999755311
Q ss_pred chhHHHHHHHHHhccchhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCH----HHHHH
Q 000859 1166 EMDMVRWVEMHMEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSS----RQVCD 1229 (1251)
Q Consensus 1166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~----~eil~ 1229 (1251)
.. .... .. .....+...+..+.+++.+||+.+|++||++ +++++
T Consensus 229 ~~-----~~~~-----------~~----~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 229 LT-----FQKI-----------LK----LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred HH-----HHHH-----------Hh----cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 00 0000 00 0011112235568899999999999999999 77664
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=297.88 Aligned_cols=248 Identities=29% Similarity=0.412 Sum_probs=192.5
Q ss_pred CCcCceecccCCceEEEEEe-cCCcEEEEEEeccC--CchhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEEE
Q 000859 948 LSDEFIIGSGGSGTVYKAEL-ANGATVAVKKISCK--DDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIY 1024 (1251)
Q Consensus 948 ~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv~ 1024 (1251)
|+..+.||+|+||.||+|.. .+++.||+|.+... ......+.+.+|+++++.++|+|++++++++... ...++||
T Consensus 17 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~ 94 (308)
T cd06634 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE--HTAWLVM 94 (308)
T ss_pred HHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcC--CeeEEEE
Confidence 55567899999999999965 46789999998642 2233445788899999999999999999988654 4568999
Q ss_pred eecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcccccccc
Q 000859 1025 EYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKA 1104 (1251)
Q Consensus 1025 E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~ 1104 (1251)
||+. |++.+++... ...+++.++..++.|++.|++|||+. +++||||+|+||+++.++.+|++|||++..
T Consensus 95 e~~~-~~l~~~~~~~------~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 164 (308)
T cd06634 95 EYCL-GSASDLLEVH------KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASI 164 (308)
T ss_pred EccC-CCHHHHHHHc------CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCccccee
Confidence 9996 6888877543 24578999999999999999999999 999999999999999999999999999865
Q ss_pred cccccCCCCcccceeecccceecccccc---cCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccc
Q 000859 1105 LVEDYNSNTESNTWFAGSYGYIAPEYAY---SLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSG 1181 (1251)
Q Consensus 1105 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 1181 (1251)
.... ....|+..|+|||.+. ...++.++|||||||++|||++|+.||......+. ...
T Consensus 165 ~~~~--------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-----~~~------ 225 (308)
T cd06634 165 MAPA--------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-----LYH------ 225 (308)
T ss_pred ecCc--------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHH-----HHH------
Confidence 4221 1245788999999874 35678899999999999999999999865422110 000
Q ss_pred hhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 000859 1182 SAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLN 1233 (1251)
Q Consensus 1182 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 1233 (1251)
... ...+.. .....+..+.+++.+||+.+|++||+++++++.-..
T Consensus 226 -----~~~-~~~~~~-~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~ 270 (308)
T cd06634 226 -----IAQ-NESPAL-QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFV 270 (308)
T ss_pred -----Hhh-cCCCCc-CcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccc
Confidence 000 000111 122345678899999999999999999999876443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=301.89 Aligned_cols=275 Identities=25% Similarity=0.316 Sum_probs=203.0
Q ss_pred CCCcCceecccCCceEEEEEec-CCcEEEEEEeccCCc-hhhhHHHHHHHHHHHhccCCCccceeceeeecC---CCcee
Q 000859 947 NLSDEFIIGSGGSGTVYKAELA-NGATVAVKKISCKDD-HLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKG---AGSNL 1021 (1251)
Q Consensus 947 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~---~~~~~ 1021 (1251)
+|.+.+.||.|+||.||+|... +++.||||++..... ....+.+.+|+++++.++||||+++++++.... ....+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 4778889999999999999654 589999999875432 344577899999999999999999999876543 12468
Q ss_pred EEEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEccccc
Q 000859 1022 LIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGL 1101 (1251)
Q Consensus 1022 lv~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~ 1101 (1251)
++|||++ ++|.++++.. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||.
T Consensus 81 lv~e~~~-~~l~~~l~~~-------~~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~ 149 (330)
T cd07834 81 IVTELME-TDLHKVIKSP-------QPLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGL 149 (330)
T ss_pred EEecchh-hhHHHHHhCC-------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCc
Confidence 9999997 5899988753 4789999999999999999999999 999999999999999999999999999
Q ss_pred ccccccccCCCCcccceeecccceecccccccC-CCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhcc
Q 000859 1102 AKALVEDYNSNTESNTWFAGSYGYIAPEYAYSL-KATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMS 1180 (1251)
Q Consensus 1102 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 1180 (1251)
+......... ........++..|+|||.+.+. .++.++|+||+|+++|+|++|+.||.+....+. ...+.......
T Consensus 150 ~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~--~~~i~~~~~~~ 226 (330)
T cd07834 150 ARGVDPDEDE-KGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQ--LNLIVEVLGTP 226 (330)
T ss_pred eEeecccccc-cccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHH--HHHHHHhcCCC
Confidence 9865432211 1112234678899999999877 789999999999999999999999976643221 11110000000
Q ss_pred ---------chhhhhhhccc-CCCCCC---chHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--HHhhc
Q 000859 1181 ---------GSAREELLDDQ-MKPLLP---GEECAAYQVLEIALQCTKTSPQERPSSRQVCDL--LLNVF 1235 (1251)
Q Consensus 1181 ---------~~~~~~~~~~~-~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~--L~~~~ 1235 (1251)
.......+... .....+ .....+..+.+++.+||+.+|++||+++++++. ++.+.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~ 296 (330)
T cd07834 227 SEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLH 296 (330)
T ss_pred ChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhc
Confidence 00000000000 000000 001135678899999999999999999999874 44443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=301.51 Aligned_cols=272 Identities=24% Similarity=0.270 Sum_probs=194.2
Q ss_pred CCCcCceecccCCceEEEEEec-C--CcEEEEEEeccCC-chhhhHHHHHHHHHHHhc-cCCCccceeceeeec--CCCc
Q 000859 947 NLSDEFIIGSGGSGTVYKAELA-N--GATVAVKKISCKD-DHLLNKSFTREVKTLGRI-RHRHLVKLMGHCCNK--GAGS 1019 (1251)
Q Consensus 947 ~~~~~~~lG~G~fg~V~~~~~~-~--~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~--~~~~ 1019 (1251)
+|+..+.||+|+||.||+|+.. + +..||+|++.... .....+.+.+|+++++++ +||||+++++++... ....
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 3677789999999999999654 3 6789999986432 222346778899999999 599999999865432 2234
Q ss_pred eeEEEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEccc
Q 000859 1020 NLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDF 1099 (1251)
Q Consensus 1020 ~~lv~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 1099 (1251)
.++++||+. ++|.+++.. ...+++.+++.++.|++.||+|||+. +|+||||||+||++++++.+||+||
T Consensus 81 ~~~~~e~~~-~~L~~~l~~-------~~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Df 149 (332)
T cd07857 81 LYLYEELME-ADLHQIIRS-------GQPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDF 149 (332)
T ss_pred EEEEEeccc-CCHHHHHhc-------CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcC
Confidence 678889886 689998865 35689999999999999999999999 9999999999999999999999999
Q ss_pred ccccccccccCCCCcccceeecccceeccccccc-CCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHh
Q 000859 1100 GLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYS-LKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHME 1178 (1251)
Q Consensus 1100 G~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 1178 (1251)
|.++.+...............||..|+|||...+ ..++.++||||+||++|++++|+.||........ ..........
T Consensus 150 g~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~-~~~~~~~~~~ 228 (332)
T cd07857 150 GLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQ-LNQILQVLGT 228 (332)
T ss_pred CCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHH-HHHHHHHhCC
Confidence 9998654332222222233578999999998765 4689999999999999999999999976432110 0000000000
Q ss_pred ccc--------hhhhhh---hcccCCCCCC-chHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 000859 1179 MSG--------SAREEL---LDDQMKPLLP-GEECAAYQVLEIALQCTKTSPQERPSSRQVCDL 1230 (1251)
Q Consensus 1179 ~~~--------~~~~~~---~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 1230 (1251)
... ...... ........+. ........+.+++.+|++.||++|||++++++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 229 PDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred CCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 000 000000 0000000000 001124578899999999999999999998643
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=303.25 Aligned_cols=269 Identities=20% Similarity=0.327 Sum_probs=196.9
Q ss_pred hcCCCcCceecccCCceEEEEEe-cCCcEEEEEEeccCC-chhhhHHHHHHHHHHHhccCCCccceeceeeecCC----C
Q 000859 945 TNNLSDEFIIGSGGSGTVYKAEL-ANGATVAVKKISCKD-DHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGA----G 1018 (1251)
Q Consensus 945 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~----~ 1018 (1251)
..+|...+.||+|+||.||+|.. .+|+.||||++.... .......+.+|++++++++||||+++++++..... .
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 36788889999999999999964 578999999986543 22234567899999999999999999998764422 2
Q ss_pred ceeEEEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcc
Q 000859 1019 SNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGD 1098 (1251)
Q Consensus 1019 ~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D 1098 (1251)
..++|+||+.. ++.++.. ..++++.+..++.|++.||+|||+. +|+||||||+||+++.++.+|++|
T Consensus 94 ~~~lv~e~~~~-~l~~~~~---------~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~d 160 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIMG---------HPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILD 160 (342)
T ss_pred eEEEEeccccc-CHHHHHc---------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEee
Confidence 35899999964 6766542 3578999999999999999999999 999999999999999999999999
Q ss_pred cccccccccccCCCCcccceeecccceeccccccc-CCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHH
Q 000859 1099 FGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYS-LKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHM 1177 (1251)
Q Consensus 1099 fG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~ 1177 (1251)
||+++.... ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||.+...... ....... .
T Consensus 161 fg~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~-~~~~~~~-~ 231 (342)
T cd07879 161 FGLARHADA-------EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ-LTQILKV-T 231 (342)
T ss_pred CCCCcCCCC-------CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHh-c
Confidence 999875421 1122467889999998876 4688999999999999999999999976432111 1110000 0
Q ss_pred hccchhh---------hhhhcccCCCCCCch------HHHHHHHHHHHHHccccCCCCCCCHHHHHHH--HHhhcCC
Q 000859 1178 EMSGSAR---------EELLDDQMKPLLPGE------ECAAYQVLEIALQCTKTSPQERPSSRQVCDL--LLNVFNN 1237 (1251)
Q Consensus 1178 ~~~~~~~---------~~~~~~~~~~~~~~~------~~~~~~l~~li~~cl~~dP~~RPs~~eil~~--L~~~~~~ 1237 (1251)
....... ...... .+..+.. ...+.++.+++.+||+.||++||++++++.. ++.+.+.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~ 306 (342)
T cd07879 232 GVPGPEFVQKLEDKAAKSYIKS--LPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDA 306 (342)
T ss_pred CCCCHHHHHHhcccchHHHHhh--cCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccc
Confidence 0000000 000000 0000000 1134568899999999999999999999854 6666543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=302.20 Aligned_cols=273 Identities=19% Similarity=0.293 Sum_probs=198.5
Q ss_pred hhcCCCcCceecccCCceEEEEE-ecCCcEEEEEEeccCC-chhhhHHHHHHHHHHHhccCCCccceeceeeecCC----
Q 000859 944 ATNNLSDEFIIGSGGSGTVYKAE-LANGATVAVKKISCKD-DHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGA---- 1017 (1251)
Q Consensus 944 ~~~~~~~~~~lG~G~fg~V~~~~-~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~---- 1017 (1251)
..++|+..+.||+|+||.||+|. ..+++.||||++.... .....+.+.+|++++++++||||+++++++.....
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 45679999999999999999995 5578999999985432 23344568899999999999999999998764432
Q ss_pred CceeEEEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEc
Q 000859 1018 GSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLG 1097 (1251)
Q Consensus 1018 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~ 1097 (1251)
...++||||+ +++|.+++.. ..+++..+..++.|+++|++|||+. +|+||||||+||+++.++.+|++
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~~--------~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~ 160 (343)
T cd07880 93 HDFYLVMPFM-GTDLGKLMKH--------EKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKIL 160 (343)
T ss_pred ceEEEEEecC-CCCHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEe
Confidence 2358999999 6799888764 3588999999999999999999999 99999999999999999999999
Q ss_pred ccccccccccccCCCCcccceeecccceeccccccc-CCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHH
Q 000859 1098 DFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYS-LKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMH 1176 (1251)
Q Consensus 1098 DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~ 1176 (1251)
|||.+...... .....++..|+|||.+.+ ..++.++|+||+||++|++++|+.||.+...... ........
T Consensus 161 dfg~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~-~~~~~~~~ 232 (343)
T cd07880 161 DFGLARQTDSE-------MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQ-LMEIMKVT 232 (343)
T ss_pred ecccccccccC-------ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhc
Confidence 99998754221 122456889999998875 4588999999999999999999999975532111 11100000
Q ss_pred Hh--------ccchhhhhhhcccCCC---CC-CchHHHHHHHHHHHHHccccCCCCCCCHHHHH--HHHHhhcC
Q 000859 1177 ME--------MSGSAREELLDDQMKP---LL-PGEECAAYQVLEIALQCTKTSPQERPSSRQVC--DLLLNVFN 1236 (1251)
Q Consensus 1177 ~~--------~~~~~~~~~~~~~~~~---~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil--~~L~~~~~ 1236 (1251)
.. ................ .+ ......+.++.+++.+|++.||++|||+.+++ ..++.+.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~ 306 (343)
T cd07880 233 GTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHD 306 (343)
T ss_pred CCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcC
Confidence 00 0000000000000000 00 00012345688999999999999999999998 44444433
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.4e-31 Score=303.87 Aligned_cols=256 Identities=25% Similarity=0.367 Sum_probs=212.3
Q ss_pred HhhcCCCcCceecccCCceEEEE-EecCCcEEEEEEeccCCchhhhHHHHHHHHHHHhc-cCCCccceeceeeec---CC
Q 000859 943 GATNNLSDEFIIGSGGSGTVYKA-ELANGATVAVKKISCKDDHLLNKSFTREVKTLGRI-RHRHLVKLMGHCCNK---GA 1017 (1251)
Q Consensus 943 ~~~~~~~~~~~lG~G~fg~V~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~---~~ 1017 (1251)
..+..|++.+.||.|.+|.||++ ..++++.+|||++....+ ..++++.|.++++.. +|||++.+||+|... .+
T Consensus 16 dp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d--~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~ 93 (953)
T KOG0587|consen 16 DPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED--EEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNG 93 (953)
T ss_pred CCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc--ccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCC
Confidence 34556788889999999999999 456789999999865444 346778899999988 799999999988754 34
Q ss_pred CceeEEEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEc
Q 000859 1018 GSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLG 1097 (1251)
Q Consensus 1018 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~ 1097 (1251)
+..|+|||||.+|+.-|..++-. +..+.|+.+..|++.++.|+.|||.. .++|||||-.||+++.++.||++
T Consensus 94 DqLWLVMEfC~gGSVTDLVKn~~-----g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKLv 165 (953)
T KOG0587|consen 94 DQLWLVMEFCGGGSVTDLVKNTK-----GNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKLV 165 (953)
T ss_pred CeEEEEeeccCCccHHHHHhhhc-----ccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEEe
Confidence 56899999999999999998753 67899999999999999999999999 99999999999999999999999
Q ss_pred ccccccccccccCCCCcccceeecccceecccccccC-----CCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHH
Q 000859 1098 DFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSL-----KATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRW 1172 (1251)
Q Consensus 1098 DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~ 1172 (1251)
|||.+..+. ..........||+.|||||++... .|+.++|+||+|++..||.-|.+|+.++.+...
T Consensus 166 DFGvSaQld----sT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmra----- 236 (953)
T KOG0587|consen 166 DFGVSAQLD----STVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRA----- 236 (953)
T ss_pred eeeeeeeee----cccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhh-----
Confidence 999987653 333444557899999999998743 478899999999999999999999987744211
Q ss_pred HHHHHhccchhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 000859 1173 VEMHMEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCD 1229 (1251)
Q Consensus 1173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1229 (1251)
--.+.+...|.+..++....++.++|..|+.+|.++||++.++++
T Consensus 237 ------------LF~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 237 ------------LFLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred ------------hccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 011223344555567778899999999999999999999998764
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=299.26 Aligned_cols=274 Identities=22% Similarity=0.292 Sum_probs=196.1
Q ss_pred hcCCCcCceecccCCceEEEEEe-cCCcEEEEEEeccCCch-hhhHHHHHHHHHHHhccCCCccceeceeeecCC-----
Q 000859 945 TNNLSDEFIIGSGGSGTVYKAEL-ANGATVAVKKISCKDDH-LLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGA----- 1017 (1251)
Q Consensus 945 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~----- 1017 (1251)
..+|+..+.||+|+||.||+|.. .+++.||||++...... .....+.+|++++++++||||+++++++.....
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 46788999999999999999965 46899999998644322 223466789999999999999999997765432
Q ss_pred -CceeEEEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEE
Q 000859 1018 -GSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHL 1096 (1251)
Q Consensus 1018 -~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl 1096 (1251)
...++|+||+++ ++.+++... ...+++..+..++.|+++|++|||+. +|+||||||+||++++++.+||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~------~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l 156 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENP------SVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKI 156 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhcc------ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEE
Confidence 246899999964 777777643 34689999999999999999999999 9999999999999999999999
Q ss_pred cccccccccccccCCCC-------cccceeecccceecccccccC-CCCCccceeehhHHHHHHhhCCCCCCCccccchh
Q 000859 1097 GDFGLAKALVEDYNSNT-------ESNTWFAGSYGYIAPEYAYSL-KATEKCDVYSMGIVLMELVSGKMPTDATFGVEMD 1168 (1251)
Q Consensus 1097 ~DfG~a~~~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~ 1168 (1251)
+|||+++.......... .......+++.|+|||.+.+. .++.++|||||||++|||++|+.||.+.......
T Consensus 157 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~ 236 (311)
T cd07866 157 ADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQL 236 (311)
T ss_pred CcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 99999976543222111 112234678889999987654 5889999999999999999999999755332211
Q ss_pred HHHHHHHHHhccchhh------hhhhcccCCCCCCch-----HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 000859 1169 MVRWVEMHMEMSGSAR------EELLDDQMKPLLPGE-----ECAAYQVLEIALQCTKTSPQERPSSRQVCD 1229 (1251)
Q Consensus 1169 ~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1229 (1251)
. .............. ....+.......+.. ......+.+++.+|++.||++|||+.|++.
T Consensus 237 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 237 H-LIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred H-HHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 1 11100000000000 000000000000000 112256889999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-30 Score=296.24 Aligned_cols=245 Identities=30% Similarity=0.398 Sum_probs=190.4
Q ss_pred CCcCceecccCCceEEEEEe-cCCcEEEEEEeccCC--chhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEEE
Q 000859 948 LSDEFIIGSGGSGTVYKAEL-ANGATVAVKKISCKD--DHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIY 1024 (1251)
Q Consensus 948 ~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv~ 1024 (1251)
|...+.||+|+||+||+|.. .+++.||+|++.... .....+.+.+|+++++.++|||++++++++... ...++||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~ 100 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKE--HTAWLVM 100 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeC--CEEEEEE
Confidence 55566799999999999964 468899999986432 223345788899999999999999999988654 4579999
Q ss_pred eecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcccccccc
Q 000859 1025 EYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKA 1104 (1251)
Q Consensus 1025 E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~ 1104 (1251)
||+. |++.+++... ...+++.++..++.|++.|++|||+. +++||||+|+||+++.++.+||+|||.+..
T Consensus 101 e~~~-~~l~~~l~~~------~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~ 170 (313)
T cd06633 101 EYCL-GSASDLLEVH------KKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASK 170 (313)
T ss_pred ecCC-CCHHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcc
Confidence 9996 6888887653 34689999999999999999999999 999999999999999999999999998854
Q ss_pred cccccCCCCcccceeecccceecccccc---cCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccc
Q 000859 1105 LVEDYNSNTESNTWFAGSYGYIAPEYAY---SLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSG 1181 (1251)
Q Consensus 1105 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 1181 (1251)
.. ......|+..|+|||.+. ...++.++|||||||++|||++|+.||........ ......
T Consensus 171 ~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~-----~~~~~~--- 234 (313)
T cd06633 171 SS--------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-----LYHIAQ--- 234 (313)
T ss_pred cC--------CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH-----HHHHHh---
Confidence 21 112246788999999874 45688899999999999999999999865422111 000000
Q ss_pred hhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 000859 1182 SAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDL 1230 (1251)
Q Consensus 1182 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 1230 (1251)
.. .+.. .....+..+.+++.+||+.+|.+||++++++..
T Consensus 235 --------~~-~~~~-~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 235 --------ND-SPTL-QSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred --------cC-CCCC-CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 0111 111234568899999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.9e-31 Score=301.76 Aligned_cols=269 Identities=23% Similarity=0.306 Sum_probs=198.7
Q ss_pred HHHhhcCCCcCceecccCCceEEEEE-ecCCcEEEEEEeccCC-chhhhHHHHHHHHHHHhccCCCccceeceeeecCCC
Q 000859 941 IMGATNNLSDEFIIGSGGSGTVYKAE-LANGATVAVKKISCKD-DHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAG 1018 (1251)
Q Consensus 941 ~~~~~~~~~~~~~lG~G~fg~V~~~~-~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~ 1018 (1251)
+...+++|+..+.||+|+||.||+|. ..+++.||||++.... .....+.+.+|++++++++||||+++++++.... .
T Consensus 5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-~ 83 (328)
T cd07856 5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPL-E 83 (328)
T ss_pred eeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCC-C
Confidence 34567889999999999999999995 4578999999885432 2234567889999999999999999999876533 3
Q ss_pred ceeEEEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcc
Q 000859 1019 SNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGD 1098 (1251)
Q Consensus 1019 ~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D 1098 (1251)
..++++||+ +++|.++++. ..+++..+..++.|+++|++|||+. +|+||||+|+||++++++.+||+|
T Consensus 84 ~~~lv~e~~-~~~L~~~~~~--------~~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~d 151 (328)
T cd07856 84 DIYFVTELL-GTDLHRLLTS--------RPLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICD 151 (328)
T ss_pred cEEEEeehh-ccCHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCc
Confidence 468999998 5689888864 3478888889999999999999999 999999999999999999999999
Q ss_pred cccccccccccCCCCcccceeecccceeccccccc-CCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHH
Q 000859 1099 FGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYS-LKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHM 1177 (1251)
Q Consensus 1099 fG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~ 1177 (1251)
||.++.... ......++..|+|||.+.+ ..++.++||||+||++|||++|+.||........ ...+.+...
T Consensus 152 fg~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~-~~~~~~~~~ 223 (328)
T cd07856 152 FGLARIQDP-------QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQ-FSIITDLLG 223 (328)
T ss_pred cccccccCC-------CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhC
Confidence 999865321 1122356889999998765 5689999999999999999999999975533111 111111100
Q ss_pred hccchhhh--------hhhcccC-CCCCCch---HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 000859 1178 EMSGSARE--------ELLDDQM-KPLLPGE---ECAAYQVLEIALQCTKTSPQERPSSRQVCDL 1230 (1251)
Q Consensus 1178 ~~~~~~~~--------~~~~~~~-~~~~~~~---~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 1230 (1251)
........ ....... ....+.. ...+.++.+++.+|++.+|++||++++++..
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 224 TPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred CCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000000 0000000 0011111 1134678999999999999999999998765
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-30 Score=301.02 Aligned_cols=272 Identities=21% Similarity=0.290 Sum_probs=198.8
Q ss_pred HHHHHhhcCCCcCceecccCCceEEEEE-ecCCcEEEEEEeccCC-chhhhHHHHHHHHHHHhccCCCccceeceeeecC
Q 000859 939 EDIMGATNNLSDEFIIGSGGSGTVYKAE-LANGATVAVKKISCKD-DHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKG 1016 (1251)
Q Consensus 939 ~~~~~~~~~~~~~~~lG~G~fg~V~~~~-~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~ 1016 (1251)
.++...+++|...+.||+|+||.||+|. ..+++.||+|++.... .....+.+.+|++++++++||||+++++++....
T Consensus 10 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~ 89 (345)
T cd07877 10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR 89 (345)
T ss_pred HHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecc
Confidence 4455677889999999999999999995 4578999999986532 2233466788999999999999999999875432
Q ss_pred ----CCceeEEEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCC
Q 000859 1017 ----AGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNM 1092 (1251)
Q Consensus 1017 ----~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~ 1092 (1251)
....++++|++ +++|.++++. ..+++..+..++.|+++|++|||+. +|+||||||+||++++++
T Consensus 90 ~~~~~~~~~lv~~~~-~~~L~~~~~~--------~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~ 157 (345)
T cd07877 90 SLEEFNDVYLVTHLM-GADLNNIVKC--------QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDC 157 (345)
T ss_pred cccccccEEEEehhc-ccCHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCC
Confidence 12357788876 7899888764 3589999999999999999999999 999999999999999999
Q ss_pred CeEEcccccccccccccCCCCcccceeecccceeccccccc-CCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHH
Q 000859 1093 EAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYS-LKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVR 1171 (1251)
Q Consensus 1093 ~~kl~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~ 1171 (1251)
.+||+|||+++.... ......++..|+|||.+.+ ..++.++||||+||++|||++|+.||........ ...
T Consensus 158 ~~kl~dfg~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~-~~~ 229 (345)
T cd07877 158 ELKILDFGLARHTDD-------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ-LKL 229 (345)
T ss_pred CEEEecccccccccc-------cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHH
Confidence 999999999875421 1123467889999998766 5688899999999999999999999965432211 111
Q ss_pred HHHHHHh--------ccchhhhhhhccc-CCCCCCc---hHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 000859 1172 WVEMHME--------MSGSAREELLDDQ-MKPLLPG---EECAAYQVLEIALQCTKTSPQERPSSRQVCDL 1230 (1251)
Q Consensus 1172 ~~~~~~~--------~~~~~~~~~~~~~-~~~~~~~---~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 1230 (1251)
....... ............. ..+.... ....++++.+++.+|++.||.+||++.++++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 230 ILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred HHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 1110000 0000000000000 0000000 00134568899999999999999999998865
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=288.79 Aligned_cols=245 Identities=22% Similarity=0.306 Sum_probs=194.2
Q ss_pred ceecccCCceEEEE-EecCCcEEEEEEeccCC-chhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEEEeecCC
Q 000859 952 FIIGSGGSGTVYKA-ELANGATVAVKKISCKD-DHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIYEYMEN 1029 (1251)
Q Consensus 952 ~~lG~G~fg~V~~~-~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv~E~~~~ 1029 (1251)
++||.|.||+||-| +.++|+.||||++.+.. ......+...|++|+++++||.||.+.-.| +.++..++|||.+.
T Consensus 570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~--ET~ervFVVMEKl~- 646 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMF--ETPERVFVVMEKLH- 646 (888)
T ss_pred hhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEee--cCCceEEEEehhhc-
Confidence 47999999999999 45689999999997654 333446788899999999999999997555 55677899999995
Q ss_pred CChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCC---CCeEEcccccccccc
Q 000859 1030 GSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSN---MEAHLGDFGLAKALV 1106 (1251)
Q Consensus 1030 gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~---~~~kl~DfG~a~~~~ 1106 (1251)
|+..+++-.. +.+.+++....-+..||+.|+.|||.+ +|||+|+||+|||+.+. -.+||||||+|+.+.
T Consensus 647 GDMLEMILSs-----EkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIg 718 (888)
T KOG4236|consen 647 GDMLEMILSS-----EKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIG 718 (888)
T ss_pred chHHHHHHHh-----hcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecc
Confidence 5777766543 267888888888999999999999999 99999999999999654 469999999999886
Q ss_pred cccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccchhhhh
Q 000859 1107 EDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSAREE 1186 (1251)
Q Consensus 1107 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1186 (1251)
+.. .....+||+.|.|||+++...|...-|+||.||++|--++|..||.....-.+... ..
T Consensus 719 Eks-----FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQ----NA---------- 779 (888)
T KOG4236|consen 719 EKS-----FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQ----NA---------- 779 (888)
T ss_pred hhh-----hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHhh----cc----------
Confidence 532 23347899999999999999999999999999999999999999975422211111 00
Q ss_pred hhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 000859 1187 LLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDL 1230 (1251)
Q Consensus 1187 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 1230 (1251)
..+.| ..++........++|...++..-.+|-|+.+-+..
T Consensus 780 ---aFMyP-p~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh 819 (888)
T KOG4236|consen 780 ---AFMYP-PNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSH 819 (888)
T ss_pred ---ccccC-CCchhhcCHHHHHHHHHHHHHHHHHhcchHhhccc
Confidence 11111 22345566678899999999999999988876543
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-30 Score=288.09 Aligned_cols=251 Identities=24% Similarity=0.305 Sum_probs=191.7
Q ss_pred CCCcCceecccCCceEEEEEec-CCcEEEEEEeccCC----chhhhHHHHHHHHHHHhccCCCccceeceeeecCCCcee
Q 000859 947 NLSDEFIIGSGGSGTVYKAELA-NGATVAVKKISCKD----DHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNL 1021 (1251)
Q Consensus 947 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~ 1021 (1251)
+|...+.||+|+||.||++... .+..+++|+++... .......+.+|+.++++++||||+++++++.+. ...+
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~ 78 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLER--DAFC 78 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcC--CceE
Confidence 4777889999999999999654 34556666654211 222334577899999999999999999988544 4568
Q ss_pred EEEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEccccc
Q 000859 1022 LIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGL 1101 (1251)
Q Consensus 1022 lv~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~ 1101 (1251)
+|+||+++++|.+++.... .....+++.+++.++.|+++|++|||+. +++|+|+||+||++++ +.+|++|||.
T Consensus 79 lv~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~ 151 (260)
T cd08222 79 IITEYCEGRDLDCKLEELK---HTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGV 151 (260)
T ss_pred EEEEeCCCCCHHHHHHHHh---hcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCc
Confidence 9999999999999986532 1245689999999999999999999999 9999999999999975 5799999999
Q ss_pred ccccccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccc
Q 000859 1102 AKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSG 1181 (1251)
Q Consensus 1102 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 1181 (1251)
++....... ......|+..|+|||...+..++.++|+||+|+++|++++|..||.+... .......
T Consensus 152 ~~~~~~~~~----~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~-----~~~~~~~----- 217 (260)
T cd08222 152 SRLLMGSCD----LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF-----LSVVLRI----- 217 (260)
T ss_pred eeecCCCcc----cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH-----HHHHHHH-----
Confidence 876533211 12224578899999998888899999999999999999999999864321 1111100
Q ss_pred hhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 000859 1182 SAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCD 1229 (1251)
Q Consensus 1182 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1229 (1251)
.. . .....+...+.++.+++.+|++.+|++||++.|+++
T Consensus 218 ------~~-~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 218 ------VE-G--PTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred ------Hc-C--CCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 00 0 111112345667899999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=314.71 Aligned_cols=256 Identities=21% Similarity=0.238 Sum_probs=199.4
Q ss_pred HhhcCCCcCceecccCCceEEEEEe-cCCcEEEEEEeccCC--chhhhHHHHHHHHHHHhccCCCccceeceeeecCCCc
Q 000859 943 GATNNLSDEFIIGSGGSGTVYKAEL-ANGATVAVKKISCKD--DHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGS 1019 (1251)
Q Consensus 943 ~~~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 1019 (1251)
-...+|.+.++||+|+||.|..++. .+++.||+|++.+-. .......|..|-.+|...+.+-||.++-+|. ++.+
T Consensus 72 l~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQ--D~~~ 149 (1317)
T KOG0612|consen 72 LKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQ--DERY 149 (1317)
T ss_pred CCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhc--Cccc
Confidence 3456799999999999999999965 568899999986422 1223467888999999999999999987774 4667
Q ss_pred eeEEEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEccc
Q 000859 1020 NLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDF 1099 (1251)
Q Consensus 1020 ~~lv~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 1099 (1251)
.|+|||||+||+|...+.+. ..++++-++-+...|+-||+-+|+. |+|||||||+|||+|..|++|++||
T Consensus 150 LYlVMdY~pGGDlltLlSk~-------~~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADF 219 (1317)
T KOG0612|consen 150 LYLVMDYMPGGDLLTLLSKF-------DRLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADF 219 (1317)
T ss_pred eEEEEecccCchHHHHHhhc-------CCChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccc
Confidence 89999999999999999873 3788999999999999999999999 9999999999999999999999999
Q ss_pred ccccccccccCCCCcccceeecccceecccccc----c-CCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHH
Q 000859 1100 GLAKALVEDYNSNTESNTWFAGSYGYIAPEYAY----S-LKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVE 1174 (1251)
Q Consensus 1100 G~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~ 1174 (1251)
|.+..+..+ ........+|||.|.+||++. + +.|+..+|+||+||++|||+.|..||.+..- ++
T Consensus 220 GsClkm~~d---G~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadsl--------ve 288 (1317)
T KOG0612|consen 220 GSCLKMDAD---GTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSL--------VE 288 (1317)
T ss_pred hhHHhcCCC---CcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHH--------HH
Confidence 998776433 233344568999999999876 2 5689999999999999999999999964421 12
Q ss_pred HHHhccchhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCC---HHHHHHH
Q 000859 1175 MHMEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPS---SRQVCDL 1230 (1251)
Q Consensus 1175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~eil~~ 1230 (1251)
.+.. .+ +..-.-.+|.....+.+..++|.+.+. +|+.|-. ++++..+
T Consensus 289 TY~K----Im----~hk~~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~H 338 (1317)
T KOG0612|consen 289 TYGK----IM----NHKESLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNH 338 (1317)
T ss_pred HHHH----Hh----chhhhcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhC
Confidence 1111 11 111011233333366677888887665 6888887 7776543
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-30 Score=300.02 Aligned_cols=266 Identities=20% Similarity=0.306 Sum_probs=196.0
Q ss_pred hhcCCCcCceecccCCceEEEEEec-CCcEEEEEEeccCC-chhhhHHHHHHHHHHHhccCCCccceeceeeecCC----
Q 000859 944 ATNNLSDEFIIGSGGSGTVYKAELA-NGATVAVKKISCKD-DHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGA---- 1017 (1251)
Q Consensus 944 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~---- 1017 (1251)
..++|+..+.||+|+||.||+|... +++.||||++.... .....+.+.+|+.++++++||||+++++++.....
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 4567889999999999999999654 67899999986432 22234567789999999999999999987754332
Q ss_pred CceeEEEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEc
Q 000859 1018 GSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLG 1097 (1251)
Q Consensus 1018 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~ 1097 (1251)
...++|+||+ +++|.+++.. ..+++..+.+++.|+++|++|||+. +|+||||||+||++++++.+||+
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~--------~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~ 160 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC--------QKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKIL 160 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEc
Confidence 2368999999 6799998864 3589999999999999999999999 99999999999999999999999
Q ss_pred ccccccccccccCCCCcccceeecccceeccccccc-CCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHH
Q 000859 1098 DFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYS-LKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMH 1176 (1251)
Q Consensus 1098 DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~ 1176 (1251)
|||.+...... .....++..|+|||.+.+ ..++.++||||+||++||+++|+.||.+....+. ........
T Consensus 161 dfg~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~-~~~i~~~~ 232 (343)
T cd07851 161 DFGLARHTDDE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQ-LKRIMNLV 232 (343)
T ss_pred ccccccccccc-------ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHhc
Confidence 99999765321 122457889999998765 4678999999999999999999999975432211 11111100
Q ss_pred Hhcc--------chhhhhhhcccCC---CCCCc-hHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 000859 1177 MEMS--------GSAREELLDDQMK---PLLPG-EECAAYQVLEIALQCTKTSPQERPSSRQVCD 1229 (1251)
Q Consensus 1177 ~~~~--------~~~~~~~~~~~~~---~~~~~-~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1229 (1251)
.... ......+...... +.+.. ....+.++.+++.+|++.||++|||+++|+.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 233 GTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred CCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 0000 0000001110000 00000 0112567899999999999999999999975
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-30 Score=298.18 Aligned_cols=270 Identities=22% Similarity=0.257 Sum_probs=192.5
Q ss_pred cCCCc-CceecccCCceEEEEE-ecCCcEEEEEEeccCCchh-------------hhHHHHHHHHHHHhccCCCccceec
Q 000859 946 NNLSD-EFIIGSGGSGTVYKAE-LANGATVAVKKISCKDDHL-------------LNKSFTREVKTLGRIRHRHLVKLMG 1010 (1251)
Q Consensus 946 ~~~~~-~~~lG~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~-------------~~~~~~~E~~~l~~l~h~niv~l~g 1010 (1251)
++|.. .+.||+|+||+||+|. ..+++.||||++....... ....+.+|++++++++||||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 34543 4579999999999995 4478999999986443221 0124778999999999999999999
Q ss_pred eeeecCCCceeEEEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecC
Q 000859 1011 HCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDS 1090 (1251)
Q Consensus 1011 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~ 1090 (1251)
++... ...++||||++ |+|.+++.. ...+++.....++.|++.|++|||+. +|+||||+|+||+++.
T Consensus 88 ~~~~~--~~~~lv~e~~~-~~l~~~l~~-------~~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~ 154 (335)
T PTZ00024 88 VYVEG--DFINLVMDIMA-SDLKKVVDR-------KIRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINS 154 (335)
T ss_pred EEecC--CcEEEEEeccc-cCHHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECC
Confidence 88643 45789999997 699999875 34588999999999999999999999 9999999999999999
Q ss_pred CCCeEEcccccccccccccCC----------CCcccceeecccceecccccccC-CCCCccceeehhHHHHHHhhCCCCC
Q 000859 1091 NMEAHLGDFGLAKALVEDYNS----------NTESNTWFAGSYGYIAPEYAYSL-KATEKCDVYSMGIVLMELVSGKMPT 1159 (1251)
Q Consensus 1091 ~~~~kl~DfG~a~~~~~~~~~----------~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlGv~l~el~tg~~p~ 1159 (1251)
++.+|++|||.++........ .........++..|+|||.+.+. .++.++||||+||++|||++|+.||
T Consensus 155 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~ 234 (335)
T PTZ00024 155 KGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLF 234 (335)
T ss_pred CCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence 999999999999765411100 01111123467889999988764 4689999999999999999999999
Q ss_pred CCccccchhHHHHHHHHHhccch-hhhhhhccc---CCCCCCc-----hHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 000859 1160 DATFGVEMDMVRWVEMHMEMSGS-AREELLDDQ---MKPLLPG-----EECAAYQVLEIALQCTKTSPQERPSSRQVCD 1229 (1251)
Q Consensus 1160 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~---~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1229 (1251)
.+....+. .............. +........ .....+. ....+.++.+++.+|++.||++|||++|++.
T Consensus 235 ~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 235 PGENEIDQ-LGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred CCCCHHHH-HHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 76543221 11111100000000 000000000 0000000 0113456889999999999999999999986
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-30 Score=289.82 Aligned_cols=264 Identities=24% Similarity=0.353 Sum_probs=195.6
Q ss_pred CCcCceecccCCceEEEEEec-CCcEEEEEEeccCC-chhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEEEe
Q 000859 948 LSDEFIIGSGGSGTVYKAELA-NGATVAVKKISCKD-DHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIYE 1025 (1251)
Q Consensus 948 ~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv~E 1025 (1251)
|+..+.||+|+||.||+|... +++.||+|++.... .....+.+..|++++++++|+|++++++++... ...++|+|
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~~v~e 78 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTE--RKLYLVFE 78 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcC--CceEEEec
Confidence 455678999999999999654 58999999997553 233346778899999999999999999988654 56799999
Q ss_pred ecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEccccccccc
Q 000859 1026 YMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKAL 1105 (1251)
Q Consensus 1026 ~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~ 1105 (1251)
|++ ++|.+++.... ..+++..+.+++.|++.|++|||+. +|+||||+|+||++++++.+||+|||.++..
T Consensus 79 ~~~-~~l~~~i~~~~------~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~ 148 (282)
T cd07829 79 YCD-MDLKKYLDKRP------GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAF 148 (282)
T ss_pred CcC-cCHHHHHHhhc------cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCccccc
Confidence 997 59999998642 4689999999999999999999999 9999999999999999999999999998765
Q ss_pred ccccCCCCcccceeecccceecccccccC-CCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhcc-chh
Q 000859 1106 VEDYNSNTESNTWFAGSYGYIAPEYAYSL-KATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMS-GSA 1183 (1251)
Q Consensus 1106 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~ 1183 (1251)
..... ......++..|+|||.+.+. .++.++||||+||++||+++|+.||......+. ........... ...
T Consensus 149 ~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~ 222 (282)
T cd07829 149 GIPLR----TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQ--LFKIFQILGTPTEES 222 (282)
T ss_pred CCCcc----ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH--HHHHHHHhCCCcHHH
Confidence 32211 11223457789999998766 789999999999999999999999976532211 11110000000 000
Q ss_pred hhhh-----hcccCCCCCCc-----hHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 000859 1184 REEL-----LDDQMKPLLPG-----EECAAYQVLEIALQCTKTSPQERPSSRQVCD 1229 (1251)
Q Consensus 1184 ~~~~-----~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1229 (1251)
...+ .+......... ....+..+.+++.+||..||++||++++++.
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 223 WPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred HHhhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 0000 00000000000 0012467899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-30 Score=284.90 Aligned_cols=237 Identities=29% Similarity=0.355 Sum_probs=189.7
Q ss_pred ecccCCceEEEEEec-CCcEEEEEEeccCCc--hhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEEEeecCCC
Q 000859 954 IGSGGSGTVYKAELA-NGATVAVKKISCKDD--HLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIYEYMENG 1030 (1251)
Q Consensus 954 lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv~E~~~~g 1030 (1251)
||+|+||.||++... +++.||+|++..... ....+.+..|++++++++||||+++++.+.. ....++||||++++
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~v~e~~~~~ 78 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQT--EEKLYLVLEYAPGG 78 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeec--CCeeEEEEecCCCC
Confidence 699999999999654 589999999865432 2245678899999999999999999988754 45579999999999
Q ss_pred ChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcccccccccccccC
Q 000859 1031 SVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYN 1110 (1251)
Q Consensus 1031 sL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 1110 (1251)
+|.+++... ..+++..+..++.|+++|+.|+|+. +++|+||+|+||+++.++.++++|||.+.......
T Consensus 79 ~L~~~l~~~-------~~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~- 147 (250)
T cd05123 79 ELFSHLSKE-------GRFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG- 147 (250)
T ss_pred cHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCC-
Confidence 999999763 3689999999999999999999998 99999999999999999999999999987653221
Q ss_pred CCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccchhhhhhhcc
Q 000859 1111 SNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSAREELLDD 1190 (1251)
Q Consensus 1111 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1190 (1251)
.......++..|+|||...+...+.++|+||||+++||+++|+.||......+ .... ...
T Consensus 148 ---~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~-----~~~~-----------~~~- 207 (250)
T cd05123 148 ---SRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKE-----IYEK-----------ILK- 207 (250)
T ss_pred ---CcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH-----HHHH-----------Hhc-
Confidence 12233567889999999988889999999999999999999999996543211 0000 000
Q ss_pred cCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHH
Q 000859 1191 QMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQ 1226 (1251)
Q Consensus 1191 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e 1226 (1251)
...+.+...+..+.+++.+||..||++||++++
T Consensus 208 ---~~~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 208 ---DPLRFPEFLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred ---CCCCCCCCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 111122223567889999999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-30 Score=276.64 Aligned_cols=242 Identities=21% Similarity=0.289 Sum_probs=189.9
Q ss_pred hhcCCCcCceecccCCceEEEEEec-CCcEEEEEEeccCCc--hhhhHHHHHHHHHHHhc-cCCCccceeceeeecCCCc
Q 000859 944 ATNNLSDEFIIGSGGSGTVYKAELA-NGATVAVKKISCKDD--HLLNKSFTREVKTLGRI-RHRHLVKLMGHCCNKGAGS 1019 (1251)
Q Consensus 944 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~ 1019 (1251)
...+|....+||+|+||.|..|..+ +.+-+|||+++++.- ....+--+.|-++++-. +-|.++++...|.. .+.
T Consensus 347 ~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQT--mDR 424 (683)
T KOG0696|consen 347 KATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQT--MDR 424 (683)
T ss_pred eecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhh--hhh
Confidence 3456888899999999999999544 567799999875531 11223345677777766 57888898876643 456
Q ss_pred eeEEEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEccc
Q 000859 1020 NLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDF 1099 (1251)
Q Consensus 1020 ~~lv~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 1099 (1251)
.|+||||+.||+|.-.++. -+.+.+..+.-+|..||-|+-+||++ +|+.||+|.+|||+|.+|.+||+||
T Consensus 425 LyFVMEyvnGGDLMyhiQQ-------~GkFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DF 494 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHIQQ-------VGKFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADF 494 (683)
T ss_pred eeeEEEEecCchhhhHHHH-------hcccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeec
Confidence 7999999999999888876 46788888999999999999999999 9999999999999999999999999
Q ss_pred ccccccccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhc
Q 000859 1100 GLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEM 1179 (1251)
Q Consensus 1100 G~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 1179 (1251)
|+++.-. ........++||+.|+|||++...+|+.++|+|||||++|||+.|++||++....+.-.
T Consensus 495 GmcKEni----~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~---------- 560 (683)
T KOG0696|consen 495 GMCKENI----FDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQ---------- 560 (683)
T ss_pred ccccccc----cCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHH----------
Confidence 9996421 22233345899999999999999999999999999999999999999999774432211
Q ss_pred cchhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCC
Q 000859 1180 SGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQER 1221 (1251)
Q Consensus 1180 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R 1221 (1251)
..+......+...+.+...+++..+.+.|.+|
T Consensus 561 ----------aI~ehnvsyPKslSkEAv~ickg~ltK~P~kR 592 (683)
T KOG0696|consen 561 ----------AIMEHNVSYPKSLSKEAVAICKGLLTKHPGKR 592 (683)
T ss_pred ----------HHHHccCcCcccccHHHHHHHHHHhhcCCccc
Confidence 11111222334455667789999999999998
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-29 Score=317.63 Aligned_cols=146 Identities=29% Similarity=0.387 Sum_probs=127.7
Q ss_pred cCCCcCceecccCCceEEEEEec-CCcEEEEEEeccCC--chhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeE
Q 000859 946 NNLSDEFIIGSGGSGTVYKAELA-NGATVAVKKISCKD--DHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLL 1022 (1251)
Q Consensus 946 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~l 1022 (1251)
++|.+.++||+|+||+||+|... +++.||||++.... .....+.+.+|+.+++.++||||+++++++.. ....++
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~--~~~~~l 81 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQS--ANNVYL 81 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEE--CCEEEE
Confidence 56888899999999999999654 68999999996432 23344678899999999999999999987754 345799
Q ss_pred EEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcccccc
Q 000859 1023 IYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLA 1102 (1251)
Q Consensus 1023 v~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a 1102 (1251)
||||+++++|.+++... +.+++..+++++.||+.||+|||+. +||||||||+|||++.++.+||+|||++
T Consensus 82 VmEy~~g~~L~~li~~~-------~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls 151 (669)
T cd05610 82 VMEYLIGGDVKSLLHIY-------GYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLS 151 (669)
T ss_pred EEeCCCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCC
Confidence 99999999999999753 4578899999999999999999999 9999999999999999999999999998
Q ss_pred c
Q 000859 1103 K 1103 (1251)
Q Consensus 1103 ~ 1103 (1251)
+
T Consensus 152 ~ 152 (669)
T cd05610 152 K 152 (669)
T ss_pred c
Confidence 6
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-30 Score=252.38 Aligned_cols=207 Identities=27% Similarity=0.405 Sum_probs=170.2
Q ss_pred cCCCcCceecccCCceEEEEE-ecCCcEEEEEEeccCCchhhhHHHHHHHHHHHhc-cCCCccceeceeeecCCCceeEE
Q 000859 946 NNLSDEFIIGSGGSGTVYKAE-LANGATVAVKKISCKDDHLLNKSFTREVKTLGRI-RHRHLVKLMGHCCNKGAGSNLLI 1023 (1251)
Q Consensus 946 ~~~~~~~~lG~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~~~lv 1023 (1251)
+.......||+|++|.|-+-+ ..+|+..|+|.++..-..+..+...+|+.+..+. .+|.+|.|||.+..+ ...|+.
T Consensus 46 d~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~re--gdvwIc 123 (282)
T KOG0984|consen 46 DDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFRE--GDVWIC 123 (282)
T ss_pred hhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhcc--ccEEEe
Confidence 334455679999999998884 4579999999998776667778888999986665 799999999977554 346999
Q ss_pred EeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEccccccc
Q 000859 1024 YEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAK 1103 (1251)
Q Consensus 1024 ~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~ 1103 (1251)
||.|+. +|..|-++ ....+..+++...-+||..+++||.|||++. .++|||+||+|||++.+|+||+||||.+-
T Consensus 124 ME~M~t-Sldkfy~~---v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG 197 (282)
T KOG0984|consen 124 MELMDT-SLDKFYRK---VLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISG 197 (282)
T ss_pred HHHhhh-hHHHHHHH---HHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccce
Confidence 999975 77776554 2334678899999999999999999999984 89999999999999999999999999987
Q ss_pred ccccccCCCCcccceeecccceecccccc----cCCCCCccceeehhHHHHHHhhCCCCCCCcccc
Q 000859 1104 ALVEDYNSNTESNTWFAGSYGYIAPEYAY----SLKATEKCDVYSMGIVLMELVSGKMPTDATFGV 1165 (1251)
Q Consensus 1104 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~ 1165 (1251)
.+.+ ....+...|...|||||.+. ...|+.+|||||+|+++.||.+++.||+.....
T Consensus 198 ~L~d-----SiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tp 258 (282)
T KOG0984|consen 198 YLVD-----SIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTP 258 (282)
T ss_pred eehh-----hhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCH
Confidence 6533 23334457889999999875 347899999999999999999999999866443
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-30 Score=293.10 Aligned_cols=242 Identities=24% Similarity=0.318 Sum_probs=191.4
Q ss_pred hcCCCcCceecccCCceEEEE-EecCCcEEEEEEeccCCchhhhHHHHHHHHHHHhc-cCCCccceeceeeecCCCceeE
Q 000859 945 TNNLSDEFIIGSGGSGTVYKA-ELANGATVAVKKISCKDDHLLNKSFTREVKTLGRI-RHRHLVKLMGHCCNKGAGSNLL 1022 (1251)
Q Consensus 945 ~~~~~~~~~lG~G~fg~V~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~~~l 1022 (1251)
+..|.....+|.|+|+.|-++ ...+++..|||++.... .+..+|+.++... +||||+++.+.+.+ ....|+
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~-----~~~~~e~~~~~~~~~h~niv~~~~v~~~--~~~~~~ 393 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA-----DDNQDEIPISLLVRDHPNIVKSHDVYED--GKEIYL 393 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccc-----cccccccchhhhhcCCCcceeecceecC--Cceeee
Confidence 345666667999999999999 55678999999997552 2334677777666 79999999998844 556799
Q ss_pred EEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeee-cCCCCeEEccccc
Q 000859 1023 IYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILL-DSNMEAHLGDFGL 1101 (1251)
Q Consensus 1023 v~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill-~~~~~~kl~DfG~ 1101 (1251)
|||.+.+|-+.+.+...+ ... .++.+|+.+|+.|+.|||++ ||||||+||+|||+ ++.++++|+|||.
T Consensus 394 v~e~l~g~ell~ri~~~~-------~~~-~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~ 462 (612)
T KOG0603|consen 394 VMELLDGGELLRRIRSKP-------EFC-SEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGF 462 (612)
T ss_pred eehhccccHHHHHHHhcc-------hhH-HHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEech
Confidence 999999998888776642 233 67788999999999999999 99999999999999 6999999999999
Q ss_pred ccccccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccc
Q 000859 1102 AKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSG 1181 (1251)
Q Consensus 1102 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 1181 (1251)
++...+. ....+-|..|.|||+.....|++++||||+|+++|+|++|+.||...... ..
T Consensus 463 a~~~~~~-------~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-~e------------- 521 (612)
T KOG0603|consen 463 WSELERS-------CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-IE------------- 521 (612)
T ss_pred hhhCchh-------hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch-HH-------------
Confidence 9876443 11124588999999999999999999999999999999999999755332 11
Q ss_pred hhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 000859 1182 SAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLL 1232 (1251)
Q Consensus 1182 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 1232 (1251)
+......+.+ .+..+....+++.+|++.||.+||++.++...=+
T Consensus 522 -----i~~~i~~~~~--s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w 565 (612)
T KOG0603|consen 522 -----IHTRIQMPKF--SECVSDEAKDLLQQLLQVDPALRLGADEIGAHPW 565 (612)
T ss_pred -----HHHhhcCCcc--ccccCHHHHHHHHHhccCChhhCcChhhhccCcc
Confidence 1111111111 1456677889999999999999999999976543
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-30 Score=298.17 Aligned_cols=248 Identities=25% Similarity=0.384 Sum_probs=188.8
Q ss_pred CCcCceecccCCce-EEEEEecCCcEEEEEEeccCCchhhhHHHHHHHHHHHhc-cCCCccceeceeeecCCCceeEEEe
Q 000859 948 LSDEFIIGSGGSGT-VYKAELANGATVAVKKISCKDDHLLNKSFTREVKTLGRI-RHRHLVKLMGHCCNKGAGSNLLIYE 1025 (1251)
Q Consensus 948 ~~~~~~lG~G~fg~-V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~~~lv~E 1025 (1251)
|...+++|.|+.|+ ||+|.+. |++||||++... ......+|+..++.- +|||||+++ |.+.++...||+.|
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e----~~~~A~rEi~lL~eSD~H~NviRyy--c~E~d~qF~YIalE 583 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLEE----FFDFAQREIQLLQESDEHPNVIRYY--CSEQDRQFLYIALE 583 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeC-CceehHHHHhhH----hHHHHHHHHHHHHhccCCCceEEEE--eeccCCceEEEEeh
Confidence 34455789999997 8999885 899999998532 234567899999998 699999995 56677777899999
Q ss_pred ecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecC---C--CCeEEcccc
Q 000859 1026 YMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDS---N--MEAHLGDFG 1100 (1251)
Q Consensus 1026 ~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~---~--~~~kl~DfG 1100 (1251)
.|. .+|.++++...... ........+.+..|+++|++|||+. +|||||+||.||||+. + .+++|+|||
T Consensus 584 LC~-~sL~dlie~~~~d~---~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfg 656 (903)
T KOG1027|consen 584 LCA-CSLQDLIESSGLDV---EMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFG 656 (903)
T ss_pred Hhh-hhHHHHHhccccch---hhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecccc
Confidence 996 59999998741111 1111144567889999999999998 9999999999999975 3 569999999
Q ss_pred cccccccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhh-CCCCCCCccccchhHHHHHHHHHhc
Q 000859 1101 LAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMVRWVEMHMEM 1179 (1251)
Q Consensus 1101 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~ 1179 (1251)
+++.+..+...-.. .....||.+|+|||.+....-+.++||||+||++|+.++ |.+||++....+.....-.
T Consensus 657 lsKkl~~~~sS~~r-~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~~~------ 729 (903)
T KOG1027|consen 657 LSKKLAGGKSSFSR-LSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILTGN------ 729 (903)
T ss_pred cccccCCCcchhhc-ccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhcCc------
Confidence 99988655433332 455789999999999999999999999999999999999 6999986643332222100
Q ss_pred cchhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 000859 1180 SGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCD 1229 (1251)
Q Consensus 1180 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1229 (1251)
... ..+.....+ +..++|.+|++.||..||+|.+|+.
T Consensus 730 -----~~L------~~L~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 730 -----YTL------VHLEPLPDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred -----cce------eeeccCchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 000 001111111 6789999999999999999999964
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-30 Score=282.08 Aligned_cols=248 Identities=23% Similarity=0.321 Sum_probs=199.3
Q ss_pred CCcCceecccCCceEEEEEecCCc-EEEEEEeccCC--chhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEEE
Q 000859 948 LSDEFIIGSGGSGTVYKAELANGA-TVAVKKISCKD--DHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIY 1024 (1251)
Q Consensus 948 ~~~~~~lG~G~fg~V~~~~~~~~~-~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv~ 1024 (1251)
+.....||-|+||.|-.++..... .+|+|++++.. +....+.+..|-.||..++.|.||++|..|. +..+.|++|
T Consensus 422 l~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfr--d~kyvYmLm 499 (732)
T KOG0614|consen 422 LKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFR--DSKYVYMLM 499 (732)
T ss_pred hhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhc--cchhhhhhH
Confidence 445557999999999999765433 48999887554 4456677889999999999999999999774 456779999
Q ss_pred eecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcccccccc
Q 000859 1025 EYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKA 1104 (1251)
Q Consensus 1025 E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~ 1104 (1251)
|-|-||.+|..|++ ++.++..+++-++.-+++|++|||++ +||.||+||+|.+++.+|-+|+.|||+|+.
T Consensus 500 EaClGGElWTiLrd-------Rg~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKk 569 (732)
T KOG0614|consen 500 EACLGGELWTILRD-------RGSFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKK 569 (732)
T ss_pred HhhcCchhhhhhhh-------cCCcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHH
Confidence 99999999999987 56788889999999999999999999 999999999999999999999999999988
Q ss_pred cccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccchhh
Q 000859 1105 LVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSAR 1184 (1251)
Q Consensus 1105 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1184 (1251)
+... .+.++ ++||+.|.|||++.....+.++|.||+|+++||+++|.+||.+..+........ ...
T Consensus 570 i~~g----~KTwT-FcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~IL---------kGi 635 (732)
T KOG0614|consen 570 IGSG----RKTWT-FCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLIL---------KGI 635 (732)
T ss_pred hccC----Cceee-ecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHH---------hhh
Confidence 7422 22222 799999999999999999999999999999999999999998876544322211 011
Q ss_pred hhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 000859 1185 EELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPS-----SRQVCDL 1230 (1251)
Q Consensus 1185 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~eil~~ 1230 (1251)
+.+ ..+...+....++|++.+..+|.+|.- +.||.++
T Consensus 636 d~i---------~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH 677 (732)
T KOG0614|consen 636 DKI---------EFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKH 677 (732)
T ss_pred hhh---------hcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhh
Confidence 111 112224455678999999999999966 5555544
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.5e-29 Score=274.21 Aligned_cols=220 Identities=23% Similarity=0.269 Sum_probs=172.7
Q ss_pred cCCceEEEEE-ecCCcEEEEEEeccCCchhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEEEeecCCCChHHh
Q 000859 957 GGSGTVYKAE-LANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIYEYMENGSVWDW 1035 (1251)
Q Consensus 957 G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv~E~~~~gsL~~~ 1035 (1251)
|.||.||++. ..+++.||+|++.... .+.+|...+....||||+++++++... ...++||||+++|+|.++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~------~~~~~~~~~~~~~~~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~ 75 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS------EYSRERLTIIPHCVPNMVCLHKYIVSE--DSVFLVLQHAEGGKLWSH 75 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh------hhhhHHHHHHhcCCCceeehhhheecC--CeEEEEEecCCCCCHHHH
Confidence 8999999994 5678999999986432 233455555556799999999987643 457999999999999999
Q ss_pred hhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcccccccccccccCCCCcc
Q 000859 1036 LHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTES 1115 (1251)
Q Consensus 1036 l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~ 1115 (1251)
+.+. ..+++..+..++.|+++|++|||+. +|+||||||+||+++.++.++++|||.+.......
T Consensus 76 l~~~-------~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~------ 139 (237)
T cd05576 76 ISKF-------LNIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC------ 139 (237)
T ss_pred HHHh-------cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhcccccc------
Confidence 8763 3589999999999999999999999 99999999999999999999999999876543211
Q ss_pred cceeecccceecccccccCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccchhhhhhhcccCCCC
Q 000859 1116 NTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSAREELLDDQMKPL 1195 (1251)
Q Consensus 1116 ~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1195 (1251)
....++..|+|||...+..++.++|+||+|+++|||++|+.|+...... ... . ..
T Consensus 140 -~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~------------------~~~----~--~~ 194 (237)
T cd05576 140 -DGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG------------------INT----H--TT 194 (237)
T ss_pred -ccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh------------------ccc----c--cc
Confidence 1134567899999998888999999999999999999999887532100 000 0 00
Q ss_pred CCchHHHHHHHHHHHHHccccCCCCCCCHH
Q 000859 1196 LPGEECAAYQVLEIALQCTKTSPQERPSSR 1225 (1251)
Q Consensus 1196 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 1225 (1251)
...+...+..+.+++.+|++.||++||++.
T Consensus 195 ~~~~~~~~~~~~~li~~~l~~dp~~R~~~~ 224 (237)
T cd05576 195 LNIPEWVSEEARSLLQQLLQFNPTERLGAG 224 (237)
T ss_pred cCCcccCCHHHHHHHHHHccCCHHHhcCCC
Confidence 011122345688999999999999999973
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.1e-29 Score=269.62 Aligned_cols=134 Identities=24% Similarity=0.423 Sum_probs=115.6
Q ss_pred cCCCcCceecccCCceEEEE-EecCCcEEEEEEeccCCchhhhHHHHHHHHHHHhcc-----C---CCccceeceeeecC
Q 000859 946 NNLSDEFIIGSGGSGTVYKA-ELANGATVAVKKISCKDDHLLNKSFTREVKTLGRIR-----H---RHLVKLMGHCCNKG 1016 (1251)
Q Consensus 946 ~~~~~~~~lG~G~fg~V~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----h---~niv~l~g~~~~~~ 1016 (1251)
.+|.+.++||.|.|++||.| +..+.+.||+|+++. .+...+....|++++++++ | .+||+++++|...+
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKS--AqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG 155 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKS--AQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG 155 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEeh--hhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence 67889999999999999999 667789999999953 3445677889999999983 2 47999999998776
Q ss_pred CC--ceeEEEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeec
Q 000859 1017 AG--SNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLD 1089 (1251)
Q Consensus 1017 ~~--~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~ 1089 (1251)
+. ..++|+|+. |-+|..++.... .+.++...+++|++||+.||.|||.+| +|||.||||+|||+.
T Consensus 156 pNG~HVCMVfEvL-GdnLLklI~~s~-----YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 156 PNGQHVCMVFEVL-GDNLLKLIKYSN-----YRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLC 222 (590)
T ss_pred CCCcEEEEEehhh-hhHHHHHHHHhC-----CCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeee
Confidence 65 458899999 669999998754 567899999999999999999999997 999999999999993
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-29 Score=279.02 Aligned_cols=219 Identities=23% Similarity=0.291 Sum_probs=177.0
Q ss_pred CHHHHHHhhcCCCcCceecccCCceEEEEEe-cCCcEEEEEEeccCC--chhhhHHHHHHHHHHHhccCCCccceeceee
Q 000859 937 RWEDIMGATNNLSDEFIIGSGGSGTVYKAEL-ANGATVAVKKISCKD--DHLLNKSFTREVKTLGRIRHRHLVKLMGHCC 1013 (1251)
Q Consensus 937 ~~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~ 1013 (1251)
+.....-...-|...+.||-|+||+|..++. ++...||.|.+++.+ ..........|-.||+..+.+-||++|-.|.
T Consensus 620 RLkRaKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQ 699 (1034)
T KOG0608|consen 620 RLKRAKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQ 699 (1034)
T ss_pred HHHHhhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEec
Confidence 3333333455677788899999999999954 456679999997554 2223456778999999999999999986664
Q ss_pred ecCCCceeEEEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCC
Q 000859 1014 NKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNME 1093 (1251)
Q Consensus 1014 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~ 1093 (1251)
+ .+..|+||||++||++-..|-+ .+.+.++.++-++..+..|+++.|.. |+|||||||+|||||.+|.
T Consensus 700 D--kdnLYFVMdYIPGGDmMSLLIr-------mgIFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGH 767 (1034)
T KOG0608|consen 700 D--KDNLYFVMDYIPGGDMMSLLIR-------MGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGH 767 (1034)
T ss_pred c--CCceEEEEeccCCccHHHHHHH-------hccCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCc
Confidence 4 4568999999999999999876 35688888888999999999999999 9999999999999999999
Q ss_pred eEEccccccccccccc----CCCC-----c-----------------------------ccceeecccceecccccccCC
Q 000859 1094 AHLGDFGLAKALVEDY----NSNT-----E-----------------------------SNTWFAGSYGYIAPEYAYSLK 1135 (1251)
Q Consensus 1094 ~kl~DfG~a~~~~~~~----~~~~-----~-----------------------------~~~~~~gt~~y~aPE~~~~~~ 1135 (1251)
+||+|||+++-+.=.. +... . .....+||+.|+|||++....
T Consensus 768 IKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g 847 (1034)
T KOG0608|consen 768 IKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTG 847 (1034)
T ss_pred eeeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccC
Confidence 9999999987652110 0000 0 001257999999999999999
Q ss_pred CCCccceeehhHHHHHHhhCCCCCCCccccch
Q 000859 1136 ATEKCDVYSMGIVLMELVSGKMPTDATFGVEM 1167 (1251)
Q Consensus 1136 ~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~ 1167 (1251)
|+..+|+||.||++|||+.|++||-+..+.+.
T Consensus 848 ~~q~cdwws~gvil~em~~g~~pf~~~tp~~t 879 (1034)
T KOG0608|consen 848 YTQLCDWWSVGVILYEMLVGQPPFLADTPGET 879 (1034)
T ss_pred ccccchhhHhhHHHHHHhhCCCCccCCCCCcc
Confidence 99999999999999999999999987766654
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-29 Score=248.23 Aligned_cols=265 Identities=18% Similarity=0.246 Sum_probs=199.3
Q ss_pred hhcCCCcCceecccCCceEEEEE-ecCCcEEEEEEeccCCchhhhHHHHHHHHHHHhcc-CCCccceeceeeecCCCcee
Q 000859 944 ATNNLSDEFIIGSGGSGTVYKAE-LANGATVAVKKISCKDDHLLNKSFTREVKTLGRIR-HRHLVKLMGHCCNKGAGSNL 1021 (1251)
Q Consensus 944 ~~~~~~~~~~lG~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~~~ 1021 (1251)
...+|++.+++|+|.+++||.|. ..+.+.++||+++. ...+.+.+|++|++.+. ||||+++++...+.....+.
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP----VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktpa 111 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP----VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPS 111 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeech----HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCch
Confidence 45678889999999999999994 56788999999853 34578899999999996 99999999998887777789
Q ss_pred EEEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCC-CCeEEcccc
Q 000859 1022 LIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSN-MEAHLGDFG 1100 (1251)
Q Consensus 1022 lv~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~-~~~kl~DfG 1100 (1251)
+|+||+++-+..... ..++..+++..+.+++.|+.|+|+. ||+|||+||.|||+|.. -..+++|+|
T Consensus 112 LiFE~v~n~Dfk~ly----------~tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWG 178 (338)
T KOG0668|consen 112 LIFEYVNNTDFKQLY----------PTLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWG 178 (338)
T ss_pred hHhhhhccccHHHHh----------hhhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecc
Confidence 999999987766654 3477888999999999999999999 99999999999999865 469999999
Q ss_pred cccccccccCCCCcccceeecccceeccccccc-CCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHH----
Q 000859 1101 LAKALVEDYNSNTESNTWFAGSYGYIAPEYAYS-LKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEM---- 1175 (1251)
Q Consensus 1101 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~---- 1175 (1251)
+|..+.+.. .....+.+..|.-||.+.. ..|+..-|+|||||++..|+..+.||--.....+++...+..
T Consensus 179 LAEFYHp~~-----eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~ 253 (338)
T KOG0668|consen 179 LAEFYHPGK-----EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTD 253 (338)
T ss_pred hHhhcCCCc-----eeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChH
Confidence 998764432 2333566788999998765 458999999999999999999999985443333333322211
Q ss_pred --------HHhccchhhhhhhcccCCCCC----Cc--hHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 000859 1176 --------HMEMSGSAREELLDDQMKPLL----PG--EECAAYQVLEIALQCTKTSPQERPSSRQVCDL 1230 (1251)
Q Consensus 1176 --------~~~~~~~~~~~~~~~~~~~~~----~~--~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 1230 (1251)
..-........++.+..+... +. .....++..+++.+.+..|-.+|||++|.+..
T Consensus 254 el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 254 ELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred HHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 110011111111211111111 00 01134778899999999999999999998753
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.2e-29 Score=303.66 Aligned_cols=269 Identities=17% Similarity=0.207 Sum_probs=170.0
Q ss_pred hhcCCCcCceecccCCceEEEEEec-C----CcEEEEEEeccCCchhhhHHHHHHHHHHHhccCCCccceeceee----e
Q 000859 944 ATNNLSDEFIIGSGGSGTVYKAELA-N----GATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCC----N 1014 (1251)
Q Consensus 944 ~~~~~~~~~~lG~G~fg~V~~~~~~-~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~----~ 1014 (1251)
..++|...+.||+|+||.||+|... + +..||||++...... +.+..| .++...+.+++.++..+. .
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~---e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~ 204 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV---EIWMNE--RVRRACPNSCADFVYGFLEPVSS 204 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh---HHHHHH--HHHhhchhhHHHHHHhhhccccc
Confidence 3567899999999999999999664 4 689999997532211 111111 122222333333322211 1
Q ss_pred cCCCceeEEEeecCCCChHHhhhcCCCCcc-------------cCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCC
Q 000859 1015 KGAGSNLLIYEYMENGSVWDWLHKQPVNIK-------------MRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDI 1081 (1251)
Q Consensus 1015 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dl 1081 (1251)
......++|+||+++++|.+++........ .........+..++.|++.||+|||++ +|+||||
T Consensus 205 ~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDL 281 (566)
T PLN03225 205 KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDV 281 (566)
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcC
Confidence 234557999999999999999975431100 011122345668999999999999999 9999999
Q ss_pred CCCCeeecC-CCCeEEcccccccccccccCCCCcccceeecccceecccccccC----------------------CCCC
Q 000859 1082 KSSNILLDS-NMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSL----------------------KATE 1138 (1251)
Q Consensus 1082 kp~Nill~~-~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~ 1138 (1251)
||+|||++. ++.+||+|||+|+.+..... .......+|+.|+|||.+... .++.
T Consensus 282 KP~NILl~~~~~~~KL~DFGlA~~l~~~~~---~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~ 358 (566)
T PLN03225 282 KPQNIIFSEGSGSFKIIDLGAAADLRVGIN---YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPD 358 (566)
T ss_pred CHHHEEEeCCCCcEEEEeCCCccccccccc---cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCC
Confidence 999999986 68999999999976532211 122335789999999965322 2445
Q ss_pred ccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccchhhhhhh---cccCCC----CCCchHHHHHHHHHHHH
Q 000859 1139 KCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSAREELL---DDQMKP----LLPGEECAAYQVLEIAL 1211 (1251)
Q Consensus 1139 ~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~----~~~~~~~~~~~l~~li~ 1211 (1251)
++||||+||++|||+++..|++.. ........... +.....+. .....+ .+...........+++.
T Consensus 359 k~DVwSlGviL~el~~~~~~~~~~------~~~~~~~l~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~ 431 (566)
T PLN03225 359 RFDIYSAGLIFLQMAFPNLRSDSN------LIQFNRQLKRN-DYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLK 431 (566)
T ss_pred CcccHHHHHHHHHHHhCcCCCchH------HHHHHHHHHhc-CCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHH
Confidence 679999999999999987775432 11111111000 00001110 000000 00001112234568999
Q ss_pred HccccCCCCCCCHHHHHHH
Q 000859 1212 QCTKTSPQERPSSRQVCDL 1230 (1251)
Q Consensus 1212 ~cl~~dP~~RPs~~eil~~ 1230 (1251)
+|++.||++|||++|+++.
T Consensus 432 ~mL~~dP~kR~ta~e~L~H 450 (566)
T PLN03225 432 SMMRFKGRQRISAKAALAH 450 (566)
T ss_pred HHccCCcccCCCHHHHhCC
Confidence 9999999999999999874
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.6e-28 Score=286.05 Aligned_cols=274 Identities=16% Similarity=0.199 Sum_probs=184.6
Q ss_pred hhcCCCcCceecccCCceEEEEEe-----------------cCCcEEEEEEeccCCchh-------------hhHHHHHH
Q 000859 944 ATNNLSDEFIIGSGGSGTVYKAEL-----------------ANGATVAVKKISCKDDHL-------------LNKSFTRE 993 (1251)
Q Consensus 944 ~~~~~~~~~~lG~G~fg~V~~~~~-----------------~~~~~vavK~~~~~~~~~-------------~~~~~~~E 993 (1251)
..++|++.++||+|+||+||+|.. .+++.||||++....... ..+.+..|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 366899999999999999999953 235689999986433211 11233457
Q ss_pred HHHHHhccCCC-----ccceeceeeecC------CCceeEEEeecCCCChHHhhhcCCCCc-----------------cc
Q 000859 994 VKTLGRIRHRH-----LVKLMGHCCNKG------AGSNLLIYEYMENGSVWDWLHKQPVNI-----------------KM 1045 (1251)
Q Consensus 994 ~~~l~~l~h~n-----iv~l~g~~~~~~------~~~~~lv~E~~~~gsL~~~l~~~~~~~-----------------~~ 1045 (1251)
+.++.+++|.+ +++++++|.... ....++||||+++|+|.++++...... ..
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 77777776654 477888775421 234689999999999999997532110 01
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcccccccccccccCCCCcccceeecccce
Q 000859 1046 RKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGY 1125 (1251)
Q Consensus 1046 ~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~gt~~y 1125 (1251)
...+++..+..++.|++.|++|+|+. +|+||||||+||+++.++.+||+|||+++........ ......+|+.|
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~---~~~~g~~tp~Y 376 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF---NPLYGMLDPRY 376 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCcc---CccccCCCcce
Confidence 23457888999999999999999999 9999999999999999999999999999754322111 11112457899
Q ss_pred ecccccccCC--------------------C--CCccceeehhHHHHHHhhCCC-CCCCccccchhHHHHHHHHHhccch
Q 000859 1126 IAPEYAYSLK--------------------A--TEKCDVYSMGIVLMELVSGKM-PTDATFGVEMDMVRWVEMHMEMSGS 1182 (1251)
Q Consensus 1126 ~aPE~~~~~~--------------------~--~~~sDiwSlGv~l~el~tg~~-p~~~~~~~~~~~~~~~~~~~~~~~~ 1182 (1251)
+|||.+.... + ..+.||||+||++|||++|.. ||............+.... ..
T Consensus 377 ~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~----~~ 452 (507)
T PLN03224 377 SPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDL----NR 452 (507)
T ss_pred eChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchH----HH
Confidence 9999875322 1 234799999999999999875 6653321111111000000 00
Q ss_pred hhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCC---CCCCCHHHHHHH
Q 000859 1183 AREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSP---QERPSSRQVCDL 1230 (1251)
Q Consensus 1183 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP---~~RPs~~eil~~ 1230 (1251)
++. ... ....++..........+++.+++..+| .+|+|++|++++
T Consensus 453 ~r~-~~~--~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 453 WRM-YKG--QKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred HHh-hcc--cCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 000 000 011122223345678899999999876 689999999864
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.7e-28 Score=265.68 Aligned_cols=239 Identities=28% Similarity=0.411 Sum_probs=190.0
Q ss_pred CCceEEEEEec-CCcEEEEEEeccCCchhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEEEeecCCCChHHhh
Q 000859 958 GSGTVYKAELA-NGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIYEYMENGSVWDWL 1036 (1251)
Q Consensus 958 ~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv~E~~~~gsL~~~l 1036 (1251)
+||.||+|... +++.||+|++.........+.+.+|++.+++++|+||+++++++... ...++++||+++++|.+++
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~--~~~~l~~e~~~~~~L~~~~ 78 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDE--DKLYLVMEYCDGGDLFDLL 78 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeC--CEEEEEEeCCCCCCHHHHH
Confidence 58999999775 48999999997655443367899999999999999999999988654 4579999999999999999
Q ss_pred hcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcccccccccccccCCCCccc
Q 000859 1037 HKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESN 1116 (1251)
Q Consensus 1037 ~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 1116 (1251)
... ..+++..+..++.+++++++|||+. +++|+||+|+||+++.++.++++|||.+....... ..
T Consensus 79 ~~~-------~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-----~~ 143 (244)
T smart00220 79 KKR-------GRLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG-----LL 143 (244)
T ss_pred Hhc-------cCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc-----cc
Confidence 764 2388999999999999999999999 99999999999999999999999999997654321 22
Q ss_pred ceeecccceecccccccCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccchhhhhhhcccCCCCC
Q 000859 1117 TWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSAREELLDDQMKPLL 1196 (1251)
Q Consensus 1117 ~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1196 (1251)
....++..|+|||...+..++.++||||+|+++|++++|..||......+. ..++ .. .......
T Consensus 144 ~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~-~~~~---~~------------~~~~~~~ 207 (244)
T smart00220 144 TTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLE-LFKK---IG------------KPKPPFP 207 (244)
T ss_pred ccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHH-HHHH---Hh------------ccCCCCc
Confidence 234678899999999888899999999999999999999999975311111 1111 00 0000100
Q ss_pred CchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 000859 1197 PGEECAAYQVLEIALQCTKTSPQERPSSRQVCD 1229 (1251)
Q Consensus 1197 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1229 (1251)
......+.++.+++.+|+..+|++||++.++++
T Consensus 208 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 208 PPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred cccccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence 011114457889999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-29 Score=253.57 Aligned_cols=268 Identities=22% Similarity=0.304 Sum_probs=196.5
Q ss_pred CCcCceecccCCceEEEE-EecCCcEEEEEEeccCC-chhhhHHHHHHHHHHHhccCCCccceeceeeecCCC---ceeE
Q 000859 948 LSDEFIIGSGGSGTVYKA-ELANGATVAVKKISCKD-DHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAG---SNLL 1022 (1251)
Q Consensus 948 ~~~~~~lG~G~fg~V~~~-~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~---~~~l 1022 (1251)
.+..+.||.|+||.||.+ +-++|+.||.|++..-. .-...+.+.+|++++..++|.|++..++...-.... ..|+
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV 134 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV 134 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence 344568999999999998 55789999999985322 334567889999999999999999988865433222 2478
Q ss_pred EEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcccccc
Q 000859 1023 IYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLA 1102 (1251)
Q Consensus 1023 v~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a 1102 (1251)
++|.|. .+|...+-. ...++.+.+.-+.+||++|+.|||+. +|.||||||.|.+++++...||||||+|
T Consensus 135 ~TELmQ-SDLHKIIVS-------PQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLA 203 (449)
T KOG0664|consen 135 LTELMQ-SDLHKIIVS-------PQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLA 203 (449)
T ss_pred HHHHHH-hhhhheecc-------CCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccc
Confidence 889885 477777654 45788899999999999999999999 9999999999999999999999999999
Q ss_pred cccccccCCCCcccceeecccceecccccccC-CCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHH-------
Q 000859 1103 KALVEDYNSNTESNTWFAGSYGYIAPEYAYSL-KATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVE------- 1174 (1251)
Q Consensus 1103 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~------- 1174 (1251)
+.-..+. ....+..+-|..|+|||.+.+. .|+.+.||||.||++.|++.++.-|....+.+ ..+.+.
T Consensus 204 Rvee~d~---~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~Piq--QL~lItdLLGTPs 278 (449)
T KOG0664|consen 204 RTWDQRD---RLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIE--QLQMIIDLLGTPS 278 (449)
T ss_pred cccchhh---hhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHH--HHHHHHHHhCCCc
Confidence 8643322 2223345678999999999875 58999999999999999999999997664432 111111
Q ss_pred --HHHhccchhhhhhhcccCCC-CC------CchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 000859 1175 --MHMEMSGSAREELLDDQMKP-LL------PGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLL 1231 (1251)
Q Consensus 1175 --~~~~~~~~~~~~~~~~~~~~-~~------~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L 1231 (1251)
.+....+..+..++....++ .+ ........+...+...++..||++|.+.++.+...
T Consensus 279 ~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 279 QEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred HHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 11122222333333322221 11 11112334456788889999999999999887654
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.6e-28 Score=251.95 Aligned_cols=249 Identities=20% Similarity=0.313 Sum_probs=191.1
Q ss_pred hhcCCCcCceecccCCceEEEEEe-cCCcEEEEEEeccCC--chhhhHHHHHHHHHHHhc-cCCCccceeceeeecCCCc
Q 000859 944 ATNNLSDEFIIGSGGSGTVYKAEL-ANGATVAVKKISCKD--DHLLNKSFTREVKTLGRI-RHRHLVKLMGHCCNKGAGS 1019 (1251)
Q Consensus 944 ~~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~ 1019 (1251)
...+|+..++||+|+|++|..++. ++.+.+|+|++++.- +.+...=...|-.+..+. +||.+|.+...|.. +..
T Consensus 248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqt--esr 325 (593)
T KOG0695|consen 248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQT--ESR 325 (593)
T ss_pred ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcc--cce
Confidence 356788999999999999999954 467889999987542 222333345677777666 79999999987744 445
Q ss_pred eeEEEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEccc
Q 000859 1020 NLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDF 1099 (1251)
Q Consensus 1020 ~~lv~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 1099 (1251)
.++|.||++||+|.-.+++ .+.++++.++-+...|.-|+.|||++ ||+.||+|..||++|+.|.+|++|+
T Consensus 326 lffvieyv~ggdlmfhmqr-------qrklpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdy 395 (593)
T KOG0695|consen 326 LFFVIEYVNGGDLMFHMQR-------QRKLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDY 395 (593)
T ss_pred EEEEEEEecCcceeeehhh-------hhcCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeeccc
Confidence 7899999999999877766 46799999999999999999999999 9999999999999999999999999
Q ss_pred ccccccccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhhCCCCCCC--ccccchhHHHHHHHHH
Q 000859 1100 GLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDA--TFGVEMDMVRWVEMHM 1177 (1251)
Q Consensus 1100 G~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~p~~~--~~~~~~~~~~~~~~~~ 1177 (1251)
|+++.-.. .....+.++||+.|.|||++++..|...+|.|++||+++||+.|+.||+- +.+.+....++.-..
T Consensus 396 gmcke~l~----~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqv- 470 (593)
T KOG0695|consen 396 GMCKEGLG----PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQV- 470 (593)
T ss_pred chhhcCCC----CCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHH-
Confidence 99865322 22334458999999999999999999999999999999999999999973 333333332222111
Q ss_pred hccchhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCC
Q 000859 1178 EMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERP 1222 (1251)
Q Consensus 1178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP 1222 (1251)
++....+ .+...+.....+++.-+++||.+|.
T Consensus 471 ---------ilekqir----iprslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 471 ---------ILEKQIR----IPRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred ---------Hhhhccc----ccceeehhhHHHHHHhhcCCcHHhc
Confidence 1111111 1111223455788889999999984
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.3e-28 Score=267.48 Aligned_cols=207 Identities=25% Similarity=0.326 Sum_probs=171.0
Q ss_pred CCHHHHHHhhcCCCcCceecccCCceEEEEEe-cCCcEEEEEEeccCCc--hhh-----hHHHHHHHHHHHhcc---CCC
Q 000859 936 FRWEDIMGATNNLSDEFIIGSGGSGTVYKAEL-ANGATVAVKKISCKDD--HLL-----NKSFTREVKTLGRIR---HRH 1004 (1251)
Q Consensus 936 ~~~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~--~~~-----~~~~~~E~~~l~~l~---h~n 1004 (1251)
..|+-......+|...+.+|+|+||.|+.|.+ ++...|+||.+.+.+- ..+ .-....|++||..++ |+|
T Consensus 551 ~~~e~~~~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~N 630 (772)
T KOG1152|consen 551 IGCEKEYKKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHEN 630 (772)
T ss_pred ccceeeecccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccc
Confidence 34444445566789999999999999999954 4567899999865431 111 123457999999997 999
Q ss_pred ccceeceeeecCCCceeEEEeecCCC-ChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCC
Q 000859 1005 LVKLMGHCCNKGAGSNLLIYEYMENG-SVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKS 1083 (1251)
Q Consensus 1005 iv~l~g~~~~~~~~~~~lv~E~~~~g-sL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp 1083 (1251)
|++++++|.+ ++.+|++||....| +|.+|+..+ ..+++.++..|+.||+.|+++||+. +|||||||-
T Consensus 631 IlKlLdfFEd--dd~yyl~te~hg~gIDLFd~IE~k-------p~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikd 698 (772)
T KOG1152|consen 631 ILKLLDFFED--DDYYYLETEVHGEGIDLFDFIEFK-------PRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKD 698 (772)
T ss_pred hhhhhheeec--CCeeEEEecCCCCCcchhhhhhcc-------CccchHHHHHHHHHHHhcccccccc---Cceeccccc
Confidence 9999999854 56679999987654 999999874 5689999999999999999999999 999999999
Q ss_pred CCeeecCCCCeEEcccccccccccccCCCCcccceeecccceecccccccCCC-CCccceeehhHHHHHHhhCCCCCC
Q 000859 1084 SNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKA-TEKCDVYSMGIVLMELVSGKMPTD 1160 (1251)
Q Consensus 1084 ~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDiwSlGv~l~el~tg~~p~~ 1160 (1251)
+||.++.+|-+|++|||.|... ..++-..++||..|.|||++.+..| +..-|||++|+++|.++....||.
T Consensus 699 envivd~~g~~klidfgsaa~~------ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 699 ENVIVDSNGFVKLIDFGSAAYT------KSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred ccEEEecCCeEEEeeccchhhh------cCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 9999999999999999998543 2334445899999999999999887 456899999999999999998874
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.4e-27 Score=243.46 Aligned_cols=262 Identities=24% Similarity=0.334 Sum_probs=193.5
Q ss_pred hcCCCcCceecccCCceEEEE-EecCCcEEEEEEeccCC-chhhhHHHHHHHHHHHhccCCCccceeceeeecCC----C
Q 000859 945 TNNLSDEFIIGSGGSGTVYKA-ELANGATVAVKKISCKD-DHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGA----G 1018 (1251)
Q Consensus 945 ~~~~~~~~~lG~G~fg~V~~~-~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~----~ 1018 (1251)
..+|...+.+|.|+- .|..| +.-.+++||+|++.... .....+...+|...+..+.|+||++++.++.-... .
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 345777778999988 56666 55568999999986542 23345677899999999999999999998864321 2
Q ss_pred ceeEEEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcc
Q 000859 1019 SNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGD 1098 (1251)
Q Consensus 1019 ~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D 1098 (1251)
..|+|||+|+ .+|...+.. .++=+++..+..|++.|+.|||+. +|+|||+||+||++..+..+||.|
T Consensus 95 e~y~v~e~m~-~nl~~vi~~---------elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~d 161 (369)
T KOG0665|consen 95 EVYLVMELMD-ANLCQVILM---------ELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILD 161 (369)
T ss_pred hHHHHHHhhh-hHHHHHHHH---------hcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeecc
Confidence 3589999996 588887763 245577889999999999999999 999999999999999999999999
Q ss_pred cccccccccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHh
Q 000859 1099 FGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHME 1178 (1251)
Q Consensus 1099 fG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 1178 (1251)
||+|+.-..+ -..+.++.|..|.|||++.+..+.+.+||||.||++.||++|+.-|.+.. ...+|......
T Consensus 162 fg~ar~e~~~-----~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d----~idQ~~ki~~~ 232 (369)
T KOG0665|consen 162 FGLARTEDTD-----FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKD----HIDQWNKIIEQ 232 (369)
T ss_pred chhhcccCcc-----cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCch----HHHHHHHHHHH
Confidence 9999764222 23445788999999999999889999999999999999999999987432 22223221111
Q ss_pred ccch--------------------------hhhhhhc-ccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 000859 1179 MSGS--------------------------AREELLD-DQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDL 1230 (1251)
Q Consensus 1179 ~~~~--------------------------~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 1230 (1251)
.+. ...+.+. ..+......+........+++.+|+..||++|.|++++++.
T Consensus 233 -lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 233 -LGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred -hcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 000 0011111 11111111222234457899999999999999999999864
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3e-27 Score=266.06 Aligned_cols=253 Identities=25% Similarity=0.348 Sum_probs=199.7
Q ss_pred hcCCCcCceecccCCceEEEE-EecCCcEEEEEEeccCCchhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEE
Q 000859 945 TNNLSDEFIIGSGGSGTVYKA-ELANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLI 1023 (1251)
Q Consensus 945 ~~~~~~~~~lG~G~fg~V~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv 1023 (1251)
..+|+....+|.|.||.|||| +.++++..|||+++-.... ..+...+|+-+++.++|||||.++|.|... ...|++
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~d-d~~~iqqei~~~~dc~h~nivay~gsylr~--dklwic 90 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGD-DFSGIQQEIGMLRDCRHPNIVAYFGSYLRR--DKLWIC 90 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCc-cccccccceeeeecCCCcChHHHHhhhhhh--cCcEEE
Confidence 456888889999999999999 5668999999999765543 456678899999999999999999987543 446999
Q ss_pred EeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEccccccc
Q 000859 1024 YEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAK 1103 (1251)
Q Consensus 1024 ~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~ 1103 (1251)
|||+.+|+|++.-+. .+.+++.++..+++...+|++|||+. +-+|||||-.||++++.|.+|++|||.+.
T Consensus 91 MEycgggslQdiy~~-------TgplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsa 160 (829)
T KOG0576|consen 91 MEYCGGGSLQDIYHV-------TGPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSA 160 (829)
T ss_pred EEecCCCcccceeee-------cccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchh
Confidence 999999999998765 57899999999999999999999999 88999999999999999999999999986
Q ss_pred ccccccCCCCcccceeecccceeccccc---ccCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhcc
Q 000859 1104 ALVEDYNSNTESNTWFAGSYGYIAPEYA---YSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMS 1180 (1251)
Q Consensus 1104 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 1180 (1251)
.+... ......+.||+.|||||+. +.+.|...+|||+.|+...|+---++|..+..+... ..-+.
T Consensus 161 qitat----i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~----l~LmT---- 228 (829)
T KOG0576|consen 161 QITAT----IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRA----LFLMT---- 228 (829)
T ss_pred hhhhh----hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHH----HHHhh----
Confidence 65432 2223347899999999975 356799999999999999999887777443322110 00000
Q ss_pred chhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 000859 1181 GSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCD 1229 (1251)
Q Consensus 1181 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1229 (1251)
....-.+.+.........+.++++.|+.++|++||+++.++.
T Consensus 229 -------kS~~qpp~lkDk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 229 -------KSGFQPPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred -------ccCCCCCcccCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 000111223333446677899999999999999999987654
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.6e-26 Score=233.48 Aligned_cols=249 Identities=18% Similarity=0.296 Sum_probs=186.5
Q ss_pred cCCCcCceecccCCceEEEEEec-CCcEEEEEEeccCCchhhhHHHHHHHHHHHhc-cCCCccceeceeeecCCCceeEE
Q 000859 946 NNLSDEFIIGSGGSGTVYKAELA-NGATVAVKKISCKDDHLLNKSFTREVKTLGRI-RHRHLVKLMGHCCNKGAGSNLLI 1023 (1251)
Q Consensus 946 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~~~lv 1023 (1251)
+.|.+.+.+|+|.||.+-.++++ +.+.+|+|.+... ....++|.+|..---.+ .|.||+.-|++..+.. +.++++
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p--~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~-d~YvF~ 100 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP--QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTS-DAYVFV 100 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc--hhhHHHHHHHhccceeeccchhhhHHHHHHhhcC-ceEEEe
Confidence 45888889999999999999665 5788999998544 34568899998765555 6999999998655543 357889
Q ss_pred EeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeee-c-CCCCeEEccccc
Q 000859 1024 YEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILL-D-SNMEAHLGDFGL 1101 (1251)
Q Consensus 1024 ~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill-~-~~~~~kl~DfG~ 1101 (1251)
+||++.|+|.+-+.. ..+.+....+++.|+++|+.|+|++ .+||||||.+|||+ + +..+||+||||.
T Consensus 101 qE~aP~gdL~snv~~--------~GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~ 169 (378)
T KOG1345|consen 101 QEFAPRGDLRSNVEA--------AGIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGL 169 (378)
T ss_pred eccCccchhhhhcCc--------ccccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeeccc
Confidence 999999999887754 3467888899999999999999999 99999999999999 3 345799999999
Q ss_pred ccccccccCCCCcccceeecccceeccccccc-----CCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHH
Q 000859 1102 AKALVEDYNSNTESNTWFAGSYGYIAPEYAYS-----LKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMH 1176 (1251)
Q Consensus 1102 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~ 1176 (1251)
.+........ ..-+..|.|||.... ....+.+|||.||+++|.++||+.||......+..+.+|....
T Consensus 170 t~k~g~tV~~-------~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~ 242 (378)
T KOG1345|consen 170 TRKVGTTVKY-------LEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWL 242 (378)
T ss_pred ccccCceehh-------hhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHh
Confidence 8765332211 223557899996542 2356789999999999999999999987666565666665544
Q ss_pred HhccchhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHH
Q 000859 1177 MEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQV 1227 (1251)
Q Consensus 1177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei 1227 (1251)
.+... ...+. -....+...++.++-+..+|++|=-..++
T Consensus 243 ~rk~~-----~~P~~-------F~~fs~~a~r~Fkk~lt~~~~drcki~~~ 281 (378)
T KOG1345|consen 243 KRKNP-----ALPKK-------FNPFSEKALRLFKKSLTPRFKDRCKIWTA 281 (378)
T ss_pred cccCc-----cCchh-------hcccCHHHHHHHHHhcCCcccccchhHHH
Confidence 32111 11111 11234567789999999999999444333
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.3e-26 Score=248.33 Aligned_cols=264 Identities=27% Similarity=0.319 Sum_probs=198.1
Q ss_pred hhcCCCcCceecccCCceEEEEE-ecCCcEEEEEEeccCCchhhhHHHHHHHHHHHhcc------CCCccceeceeeecC
Q 000859 944 ATNNLSDEFIIGSGGSGTVYKAE-LANGATVAVKKISCKDDHLLNKSFTREVKTLGRIR------HRHLVKLMGHCCNKG 1016 (1251)
Q Consensus 944 ~~~~~~~~~~lG~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~------h~niv~l~g~~~~~~ 1016 (1251)
...+|.+....|+|-|++|.+|. ..-|..||||++... +...+.=.+|++||+++. --|+++++.+|...
T Consensus 430 LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN--E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hk- 506 (752)
T KOG0670|consen 430 LDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN--EVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHK- 506 (752)
T ss_pred hcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc--hHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhc-
Confidence 45678888889999999999994 445889999999643 344556678999999994 35899999887543
Q ss_pred CCceeEEEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCC-CCeE
Q 000859 1017 AGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSN-MEAH 1095 (1251)
Q Consensus 1017 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~-~~~k 1095 (1251)
...|+|||-+. -+|.+.|++... .-.+...++..++.|+.-||..|... +|+|.||||.||||++. ..+|
T Consensus 507 -nHLClVFE~Ls-lNLRevLKKyG~----nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~iLK 577 (752)
T KOG0670|consen 507 -NHLCLVFEPLS-LNLREVLKKYGR----NVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKNILK 577 (752)
T ss_pred -ceeEEEehhhh-chHHHHHHHhCc----ccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCcceee
Confidence 45799999985 589999987532 34577889999999999999999999 99999999999999865 5689
Q ss_pred EcccccccccccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHH
Q 000859 1096 LGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEM 1175 (1251)
Q Consensus 1096 l~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~ 1175 (1251)
|||||.|....+... +.+.-+..|.|||++.+.+|+...|+||.||.+||+.||+..|.+..+..+ . ..
T Consensus 578 LCDfGSA~~~~enei------tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~M--L---rl 646 (752)
T KOG0670|consen 578 LCDFGSASFASENEI------TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQM--L---RL 646 (752)
T ss_pred eccCccccccccccc------cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHH--H---HH
Confidence 999999976543211 223457889999999999999999999999999999999999987755332 2 22
Q ss_pred HHhccchhhhhhh------ccc--------------------------CCC------------CCCc-hHHHHHHHHHHH
Q 000859 1176 HMEMSGSAREELL------DDQ--------------------------MKP------------LLPG-EECAAYQVLEIA 1210 (1251)
Q Consensus 1176 ~~~~~~~~~~~~~------~~~--------------------------~~~------------~~~~-~~~~~~~l~~li 1210 (1251)
+++..+.....++ ++. .+| .++. .......+.+|+
T Consensus 647 ~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLL 726 (752)
T KOG0670|consen 647 FMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLL 726 (752)
T ss_pred HHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHH
Confidence 2222222111111 100 001 0111 112446688999
Q ss_pred HHccccCCCCCCCHHHHHHH
Q 000859 1211 LQCTKTSPQERPSSRQVCDL 1230 (1251)
Q Consensus 1211 ~~cl~~dP~~RPs~~eil~~ 1230 (1251)
..|+..||++|.|..+++..
T Consensus 727 dkml~LdP~KRit~nqAL~H 746 (752)
T KOG0670|consen 727 DKMLILDPEKRITVNQALKH 746 (752)
T ss_pred HHHhccChhhcCCHHHHhcC
Confidence 99999999999999998753
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=6e-25 Score=236.72 Aligned_cols=211 Identities=36% Similarity=0.594 Sum_probs=180.3
Q ss_pred ecccCCceEEEEEecC-CcEEEEEEeccCCchhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEEEeecCCCCh
Q 000859 954 IGSGGSGTVYKAELAN-GATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIYEYMENGSV 1032 (1251)
Q Consensus 954 lG~G~fg~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv~E~~~~gsL 1032 (1251)
||+|++|.||++...+ ++++++|++.........+.+.+|++.++.+.|++|+++++++... ...++++||+++++|
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~--~~~~~~~e~~~~~~l 78 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDE--NHLYLVMEYCEGGSL 78 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecC--CeEEEEEecCCCCcH
Confidence 6899999999997654 8999999997655433457889999999999999999999988654 457999999999999
Q ss_pred HHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecC-CCCeEEcccccccccccccCC
Q 000859 1033 WDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDS-NMEAHLGDFGLAKALVEDYNS 1111 (1251)
Q Consensus 1033 ~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~-~~~~kl~DfG~a~~~~~~~~~ 1111 (1251)
.+++.... ..+++..+..++.+++++++|||+. +++|+||+|.||+++. ++.++|+|||.+........
T Consensus 79 ~~~~~~~~------~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~- 148 (215)
T cd00180 79 KDLLKENE------GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS- 148 (215)
T ss_pred HHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-
Confidence 99987631 4688999999999999999999999 9999999999999999 89999999999976532211
Q ss_pred CCcccceeecccceecccccccC-CCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccchhhhhhhcc
Q 000859 1112 NTESNTWFAGSYGYIAPEYAYSL-KATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSAREELLDD 1190 (1251)
Q Consensus 1112 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1190 (1251)
......+...|++||..... .++.++|+|++|++++++
T Consensus 149 ---~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------------- 187 (215)
T cd00180 149 ---LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------------- 187 (215)
T ss_pred ---hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH--------------------------------------
Confidence 12224567899999998877 888999999999999998
Q ss_pred cCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 000859 1191 QMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDL 1230 (1251)
Q Consensus 1191 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 1230 (1251)
..+.+++..|++.+|++||+++++++.
T Consensus 188 -------------~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 -------------PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred -------------HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 347789999999999999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.3e-27 Score=250.71 Aligned_cols=401 Identities=23% Similarity=0.277 Sum_probs=238.6
Q ss_pred ccceeeccCccccCcCCcccccCCCccEEEeccccccCCCCCccccccceEEEEccC-ccccCcccccccccccchhhhh
Q 000859 264 QLGYLNLMGNRLEGAIPRSFAKMGNLQSLDLSMNRLTGGIPEEFGNMGQLVFLVLSN-NNISGSIPRRICTNATSLEHLI 342 (1251)
Q Consensus 264 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~-N~l~~~i~~~~~~~l~~L~~L~ 342 (1251)
.-.+++|..|+|+.+.+.+|..+++|+.||||+|.|+.+-|++|.++.+|.+|-+-+ |+|+ .+|+..|.++.+|+.|.
T Consensus 68 ~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~-~l~k~~F~gL~slqrLl 146 (498)
T KOG4237|consen 68 ETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKIT-DLPKGAFGGLSSLQRLL 146 (498)
T ss_pred cceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchh-hhhhhHhhhHHHHHHHh
Confidence 344555555556555555566666666666666666655556666665555554333 5555 56666666666666666
Q ss_pred ccchhcccCCCcCccCCCCCceEEccCCcccCCccc-cccccccccEEEeeccccc------------cccccccccccc
Q 000859 343 LAEIQLSGEIPVELSQCQSLKQLDLSNNTLNGTIPV-ELFQLVALTHLYLHNNSLV------------GSISPFVANLSN 409 (1251)
Q Consensus 343 L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~L~~n~l~------------~~~~~~~~~l~~ 409 (1251)
+.-|++.......|..+++|..|.+..|.+. .++. .+..+..++.+.+..|.+. ...+..++...-
T Consensus 147 lNan~i~Cir~~al~dL~~l~lLslyDn~~q-~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~ietsgarc 225 (498)
T KOG4237|consen 147 LNANHINCIRQDALRDLPSLSLLSLYDNKIQ-SICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPIETSGARC 225 (498)
T ss_pred cChhhhcchhHHHHHHhhhcchhcccchhhh-hhccccccchhccchHhhhcCccccccccchhhhHHhhchhhccccee
Confidence 6666666665666666666666666666666 4444 4555666666666666521 112233444444
Q ss_pred ccEEEecccccCCCCchhhhcc-cccchhhcccCccccccc-CCcCCCCccceEeccCCcccCCCCCcccccCCCcEEec
Q 000859 410 LQELALYHNNFQGSLPREIGML-VKLELLYLYDNHLSGQIP-SEVGNCSSLKWIDFFGNSFTGEIPTSIGRLKDLNFLHL 487 (1251)
Q Consensus 410 L~~L~L~~N~l~~~~~~~~~~l-~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L 487 (1251)
..-..+.++++..+.+..|... ..+..=..+.+...+..| ..|..+++|++|+|++|+|+.+-+.+|.++..+++|+|
T Consensus 226 ~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L 305 (498)
T KOG4237|consen 226 VSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYL 305 (498)
T ss_pred cchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcchhhhhhhhc
Confidence 5555666666665555554332 222221222332333333 46788888888888888888888888888888888888
Q ss_pred cCCccCCCcCccccccccCCeeecCCCcCcccCCcchhccchhhhhhccCCccccCC-chhhhhhcCCCeeecccccccc
Q 000859 488 RQNELVGQIPASLGNCHQLIILDLADNKLSGGVPASFGFLQALEQLMLYNNSLEGNL-PGSLINLRNLTRINFSKNRLNG 566 (1251)
Q Consensus 488 ~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~-~~~l~~l~~L~~L~l~~N~l~~ 566 (1251)
..|+|...-...|.++..|+.|+|++|+|+...|.+|..+.+|.+|+|-.|.+-..- -.++... |.++.-.+
T Consensus 306 ~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~CnC~l~wl~~W-------lr~~~~~~ 378 (498)
T KOG4237|consen 306 TRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCNCRLAWLGEW-------LRKKSVVG 378 (498)
T ss_pred CcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccCccchHHHHHH-------HhhCCCCC
Confidence 888888766777888888888888888888888888888888888888877765210 0111110 01111001
Q ss_pred cccccccCccceeeecccCccc---cCCCCCCC---------CcccCc-eeecccCccccccCcccccccccceEEccCC
Q 000859 567 RIATLCSSHSFLSFDVTNNEFD---HEIPPQLG---------NSPSLE-RLRLGNNKFIGKIPWTFGKIRELSLLDLSGN 633 (1251)
Q Consensus 567 ~~~~l~~~~~l~~l~l~~n~l~---~~~p~~l~---------~l~~L~-~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N 633 (1251)
.++ ......+..++++.+.+. ..-|++.+ ..+-+. ....+++.++ .+|..+- ..-+.|.+.+|
T Consensus 379 ~~~-Cq~p~~~~~~~~~dv~~~~~~c~~~ee~~~~~s~~cP~~c~c~~tVvRcSnk~lk-~lp~~iP--~d~telyl~gn 454 (498)
T KOG4237|consen 379 NPR-CQSPGFVRQIPISDVAFGDFRCGGPEELGCLTSSPCPPPCTCLDTVVRCSNKLLK-LLPRGIP--VDVTELYLDGN 454 (498)
T ss_pred CCC-CCCCchhccccchhccccccccCCccccCCCCCCCCCCCcchhhhhHhhcccchh-hcCCCCC--chhHHHhcccc
Confidence 000 011112333344333322 22222222 122333 2334444444 4444332 24567888899
Q ss_pred cccCCCCccccccCCccEEEcCCCccCCCCccccCCCcccccccccCc
Q 000859 634 SLTGPIPTQLLMCKKLSHIDLNNNLLSGAVPSWLGTLPQLGELKLSFN 681 (1251)
Q Consensus 634 ~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N 681 (1251)
.++ .+|.+ .+++| .+|+++|+++..-...|.++++|..|-||+|
T Consensus 455 ~~~-~vp~~--~~~~l-~~dls~n~i~~Lsn~tf~n~tql~tlilsyn 498 (498)
T KOG4237|consen 455 AIT-SVPDE--LLRSL-LLDLSNNRISSLSNYTFSNMTQLSTLILSYN 498 (498)
T ss_pred hhc-ccCHH--HHhhh-hcccccCceehhhcccccchhhhheeEEecC
Confidence 998 67777 66788 8999999998766777889999999999887
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.8e-25 Score=239.17 Aligned_cols=272 Identities=24% Similarity=0.312 Sum_probs=194.8
Q ss_pred HHHhhcCCCcCceecccCCceEEEEEec----CCcEEEEEEeccCCchhhhHHHHHHHHHHHhc-cCCCccceeceeeec
Q 000859 941 IMGATNNLSDEFIIGSGGSGTVYKAELA----NGATVAVKKISCKDDHLLNKSFTREVKTLGRI-RHRHLVKLMGHCCNK 1015 (1251)
Q Consensus 941 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~ 1015 (1251)
.....+.|..+++||+|.|++||+|... ..+.||+|.+...... ..+..|+++|..+ .+.||+++.+++.
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p---~ri~~El~~L~~~gG~~ni~~~~~~~r-- 105 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP---SRILNELEMLYRLGGSDNIIKLNGCFR-- 105 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc---hHHHHHHHHHHHhccchhhhcchhhhc--
Confidence 3345667888999999999999999432 4678999999755443 5688999999999 5999999998764
Q ss_pred CCCceeEEEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecC-CCCe
Q 000859 1016 GAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDS-NMEA 1094 (1251)
Q Consensus 1016 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~-~~~~ 1094 (1251)
..+...+|+||++..+..++... ++..++..+++.+..||+|+|.. |||||||||.|++.+. .+.-
T Consensus 106 nnd~v~ivlp~~~H~~f~~l~~~----------l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg 172 (418)
T KOG1167|consen 106 NNDQVAIVLPYFEHDRFRDLYRS----------LSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRG 172 (418)
T ss_pred cCCeeEEEecccCccCHHHHHhc----------CCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCc
Confidence 45567999999999988888754 67889999999999999999999 9999999999999974 5778
Q ss_pred EEccccccccccccc------------CCC-------------------------Cc---ccceeecccceecccccc-c
Q 000859 1095 HLGDFGLAKALVEDY------------NSN-------------------------TE---SNTWFAGSYGYIAPEYAY-S 1133 (1251)
Q Consensus 1095 kl~DfG~a~~~~~~~------------~~~-------------------------~~---~~~~~~gt~~y~aPE~~~-~ 1133 (1251)
.|+|||+|..+.... ... .. .....+||++|+|||++. .
T Consensus 173 ~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~ 252 (418)
T KOG1167|consen 173 VLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRC 252 (418)
T ss_pred eEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhc
Confidence 999999998321100 000 00 011257999999999876 4
Q ss_pred CCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHH--------hccch-------h---hhhh------hc
Q 000859 1134 LKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHM--------EMSGS-------A---REEL------LD 1189 (1251)
Q Consensus 1134 ~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~--------~~~~~-------~---~~~~------~~ 1189 (1251)
...+.++||||.||++.-+++++.||-.....-....+.+.... ...+. . ..+. ++
T Consensus 253 ~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~ 332 (418)
T KOG1167|consen 253 PRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLH 332 (418)
T ss_pred cCcCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccC
Confidence 56899999999999999999999998544332222222111100 00011 0 0000 00
Q ss_pred -ccCCC-------CCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 000859 1190 -DQMKP-------LLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDL 1230 (1251)
Q Consensus 1190 -~~~~~-------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 1230 (1251)
....+ .....+..+..+++++.+|+..||.+|.|+++.++.
T Consensus 333 ~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH 381 (418)
T KOG1167|consen 333 IESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH 381 (418)
T ss_pred hhhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence 00000 001112244578999999999999999999998764
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.9e-27 Score=249.40 Aligned_cols=277 Identities=21% Similarity=0.234 Sum_probs=197.5
Q ss_pred cccEEEccCCCCCCCcCccccccCcccEEecccccccCCCCcccCCCccccEEEecc-CCCCCCCCCccccccccccccc
Q 000859 96 SLIHLDLSSNSLTGPIPTALSNLSSLESLLLFSNQLAGTIPTQLGSLTSLRVMRIGD-NWLSGSIPTSFGNLVNLGTLGL 174 (1251)
Q Consensus 96 ~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~-n~l~~~~p~~~~~l~~L~~L~L 174 (1251)
.-+.++|..|+|+...|.+|+.+++|+.||||+|+|+..-|++|..|.+|..|-+.+ |+|+...-..|++|..|+.|.+
T Consensus 68 ~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLll 147 (498)
T KOG4237|consen 68 ETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLLL 147 (498)
T ss_pred cceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHhc
Confidence 446788888888877777888888888888888888888888888888877776665 8888666678888888888888
Q ss_pred ccCCCCCCCCCCcCcccccceeeeccccccCCCCcccCCCCCCceeecccccc------------CCCchhhhcccccCc
Q 000859 175 ASCSLSGPIPPQFGQLSQLEELILQQNQLQGPIPAELGNCSSLSIFTAAENNL------------NGSIPAALGRLQNLQ 242 (1251)
Q Consensus 175 ~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~l------------~~~~p~~~~~l~~L~ 242 (1251)
.-|++.-...+.|..|++|..|.+.+|.+...--..|..+.+++.+.+..|.+ ....|..++++.-..
T Consensus 148 Nan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~ietsgarc~~ 227 (498)
T KOG4237|consen 148 NANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPIETSGARCVS 227 (498)
T ss_pred ChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccccchhhhHHhhchhhcccceecc
Confidence 88888888888888888888888888888744445888888888888888873 234455556666666
Q ss_pred eeeccCccCCCCCCccccCC-CccceeeccCccccCcCC-cccccCCCccEEEeccccccCCCCCccccccceEEEEccC
Q 000859 243 LLNLGNNSLSGEIPSELGEL-SQLGYLNLMGNRLEGAIP-RSFAKMGNLQSLDLSMNRLTGGIPEEFGNMGQLVFLVLSN 320 (1251)
Q Consensus 243 ~L~L~~N~l~~~~~~~l~~l-~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 320 (1251)
-..+.++.+..+.+..|... ..+..=..+.+...++.| ..|.++++|+.|+|++|+++.+.+.+|.++..+++|.|..
T Consensus 228 p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~ 307 (498)
T KOG4237|consen 228 PYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTR 307 (498)
T ss_pred hHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcchhhhhhhhcCc
Confidence 66666666654444443322 122111122222333333 4577788888888888888877777788888888888888
Q ss_pred ccccCcccccccccccchhhhhccchhcccCCCcCccCCCCCceEEccCCccc
Q 000859 321 NNISGSIPRRICTNATSLEHLILAEIQLSGEIPVELSQCQSLKQLDLSNNTLN 373 (1251)
Q Consensus 321 N~l~~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~ 373 (1251)
|++. .+...+|.++..|+.|+|.+|+|+...|.+|..+..|.+|.|-.|.+.
T Consensus 308 N~l~-~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~ 359 (498)
T KOG4237|consen 308 NKLE-FVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFN 359 (498)
T ss_pred chHH-HHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCccc
Confidence 8776 666666666666666666666666666666666666666666666554
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.1e-24 Score=232.16 Aligned_cols=200 Identities=32% Similarity=0.465 Sum_probs=168.5
Q ss_pred CCcCceecccCCceEEEEEecC-CcEEEEEEeccCCchhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEEEee
Q 000859 948 LSDEFIIGSGGSGTVYKAELAN-GATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIYEY 1026 (1251)
Q Consensus 948 ~~~~~~lG~G~fg~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv~E~ 1026 (1251)
|+..+.||+|++|.||+|...+ ++.||+|.+.........+.+.+|++.+++++|+|++++++++... ...++++||
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~--~~~~~v~e~ 78 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDP--EPLYLVMEY 78 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecC--CceEEEEec
Confidence 4566789999999999997654 8999999997554332467889999999999999999999987543 457899999
Q ss_pred cCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcccccccccc
Q 000859 1027 MENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALV 1106 (1251)
Q Consensus 1027 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~ 1106 (1251)
+++++|.+++.... ..+++.....++.+++.+++|||+. +++|+|++|+||+++.++.++|+|||.+....
T Consensus 79 ~~~~~L~~~~~~~~------~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~ 149 (225)
T smart00221 79 CEGGDLFDYLRKKG------GKLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIH 149 (225)
T ss_pred cCCCCHHHHHHhcc------cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEec
Confidence 99999999998642 1178999999999999999999999 99999999999999999999999999987764
Q ss_pred cccCCCCcccceeecccceeccccc-ccCCCCCccceeehhHHHHHHhhCCCCCCC
Q 000859 1107 EDYNSNTESNTWFAGSYGYIAPEYA-YSLKATEKCDVYSMGIVLMELVSGKMPTDA 1161 (1251)
Q Consensus 1107 ~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~sDiwSlGv~l~el~tg~~p~~~ 1161 (1251)
... ........++..|++||.. ....++.++|+|++|++++||++|+.||..
T Consensus 150 ~~~---~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 150 RDL---AALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred Ccc---cccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 332 0122234678899999988 666778899999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.4e-25 Score=222.45 Aligned_cols=247 Identities=20% Similarity=0.362 Sum_probs=190.3
Q ss_pred CceecccCCceEEEEEecCCcEEEEEEeccCC-chhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEEEeecCC
Q 000859 951 EFIIGSGGSGTVYKAELANGATVAVKKISCKD-DHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIYEYMEN 1029 (1251)
Q Consensus 951 ~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv~E~~~~ 1029 (1251)
..+|.+...|+.|+|+|+ |..+++|++.... .....++|..|.-.++.+.||||++++|.|.. +....++..||+.
T Consensus 195 ~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacns--ppnlv~isq~mp~ 271 (448)
T KOG0195|consen 195 ITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNS--PPNLVIISQYMPF 271 (448)
T ss_pred hhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccC--CCCceEeeeeccc
Confidence 346889999999999997 5667777775433 33455789999999999999999999999954 4567899999999
Q ss_pred CChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEc--cccccccccc
Q 000859 1030 GSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLG--DFGLAKALVE 1107 (1251)
Q Consensus 1030 gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~--DfG~a~~~~~ 1107 (1251)
|+|+..+++.. .-.++-.+++++|.++|+||+|||+. .|-|.---+....|++|++.+++|+ |--++-.
T Consensus 272 gslynvlhe~t-----~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarismad~kfsfq--- 342 (448)
T KOG0195|consen 272 GSLYNVLHEQT-----SVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ--- 342 (448)
T ss_pred hHHHHHHhcCc-----cEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheecccceeeee---
Confidence 99999999864 33456678899999999999999996 3345555788999999999998875 3222210
Q ss_pred ccCCCCcccceeecccceecccccccCCCC---CccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccchhh
Q 000859 1108 DYNSNTESNTWFAGSYGYIAPEYAYSLKAT---EKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSAR 1184 (1251)
Q Consensus 1108 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~---~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1184 (1251)
. ....-.+.||+||.+...+.+ +++|+|||++++||+.|+..||.+..+.+...+...+.
T Consensus 343 ----e----~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeg--------- 405 (448)
T KOG0195|consen 343 ----E----VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEG--------- 405 (448)
T ss_pred ----c----cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhcc---------
Confidence 0 112336889999998866543 57999999999999999999999887766654432221
Q ss_pred hhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhc
Q 000859 1185 EELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNVF 1235 (1251)
Q Consensus 1185 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~ 1235 (1251)
++... +...+..+.++|.-|+++||.+||.+..|+-.|+++.
T Consensus 406 -------lrv~i--ppgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 406 -------LRVHI--PPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred -------ccccC--CCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 11222 2224556788999999999999999999999998764
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.2e-23 Score=270.69 Aligned_cols=346 Identities=21% Similarity=0.281 Sum_probs=207.2
Q ss_pred ccccccCcccEEeccccc------ccCCCCcccCCCc-cccEEEeccCCCCCCCCCcccccccccccccccCCCCCCCCC
Q 000859 113 TALSNLSSLESLLLFSNQ------LAGTIPTQLGSLT-SLRVMRIGDNWLSGSIPTSFGNLVNLGTLGLASCSLSGPIPP 185 (1251)
Q Consensus 113 ~~l~~l~~L~~L~L~~n~------l~~~~p~~l~~l~-~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~ 185 (1251)
.+|.++.+|+.|.+..+. +...+|..|..++ +|+.|++.++.+. .+|..| ...+|++|+|.+|.+. .+|.
T Consensus 552 ~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~L~~ 628 (1153)
T PLN03210 552 NAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-KLWD 628 (1153)
T ss_pred HHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-cccc
Confidence 345555666666554432 2223455555543 4666666666554 555555 3456666666666654 3455
Q ss_pred CcCcccccceeeeccccccCCCCcccCCCCCCceeeccccccCCCchhhhcccccCceeeccCccCCCCCCccccCCCcc
Q 000859 186 QFGQLSQLEELILQQNQLQGPIPAELGNCSSLSIFTAAENNLNGSIPAALGRLQNLQLLNLGNNSLSGEIPSELGELSQL 265 (1251)
Q Consensus 186 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L 265 (1251)
.+..+++|++|+|++|.....+|. ++.+++|+.|++++|.....+|..++++++|+.|++++|..-..+|..+ ++++|
T Consensus 629 ~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l~sL 706 (1153)
T PLN03210 629 GVHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NLKSL 706 (1153)
T ss_pred ccccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-CCCCC
Confidence 555666666666665544444443 5556666666666665555666666666666666666654333455444 56666
Q ss_pred ceeeccCccccCcCCcccccCCCccEEEeccccccCCCCCccccccceEEEEccCccccCcccccccccccchhhhhccc
Q 000859 266 GYLNLMGNRLEGAIPRSFAKMGNLQSLDLSMNRLTGGIPEEFGNMGQLVFLVLSNNNISGSIPRRICTNATSLEHLILAE 345 (1251)
Q Consensus 266 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~i~~~~~~~l~~L~~L~L~~ 345 (1251)
++|++++|.....+|.. ..+|+.|++++|.+. .+|..+ .+++|++|++.++... .+...
T Consensus 707 ~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~-~lP~~~-~l~~L~~L~l~~~~~~-~l~~~--------------- 765 (1153)
T PLN03210 707 YRLNLSGCSRLKSFPDI---STNISWLDLDETAIE-EFPSNL-RLENLDELILCEMKSE-KLWER--------------- 765 (1153)
T ss_pred CEEeCCCCCCccccccc---cCCcCeeecCCCccc-cccccc-cccccccccccccchh-hcccc---------------
Confidence 66666666544344432 345666666666665 344433 4556666666553321 11100
Q ss_pred hhcccCCCcCccCCCCCceEEccCCcccCCccccccccccccEEEeecccccccccccccccccccEEEecccccCCCCc
Q 000859 346 IQLSGEIPVELSQCQSLKQLDLSNNTLNGTIPVELFQLVALTHLYLHNNSLVGSISPFVANLSNLQELALYHNNFQGSLP 425 (1251)
Q Consensus 346 n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 425 (1251)
+....+..+...++|+.|+|++|...+.+|..+.++++|+.|++++|...+.+|..+ ++++|+.|++++|.....+|
T Consensus 766 --~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p 842 (1153)
T PLN03210 766 --VQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFP 842 (1153)
T ss_pred --ccccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCcccccc
Confidence 000111112234567777777776666677777777777777777765444445444 67788888888876544555
Q ss_pred hhhhcccccchhhcccCcccccccCCcCCCCccceEeccCCcccCCCCCcccccCCCcEEeccCCc
Q 000859 426 REIGMLVKLELLYLYDNHLSGQIPSEVGNCSSLKWIDFFGNSFTGEIPTSIGRLKDLNFLHLRQNE 491 (1251)
Q Consensus 426 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~ 491 (1251)
.. ..+|++|+|++|.++ .+|.++..+++|+.|++++|+--..+|..+..+++|+.|++++|.
T Consensus 843 ~~---~~nL~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L~~l~~~~~~L~~L~~L~l~~C~ 904 (1153)
T PLN03210 843 DI---STNISDLNLSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQRVSLNISKLKHLETVDFSDCG 904 (1153)
T ss_pred cc---ccccCEeECCCCCCc-cChHHHhcCCCCCEEECCCCCCcCccCcccccccCCCeeecCCCc
Confidence 42 357888888888887 678888889999999998854333677788888899988888763
|
syringae 6; Provisional |
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.89 E-value=4e-23 Score=273.09 Aligned_cols=306 Identities=23% Similarity=0.290 Sum_probs=204.7
Q ss_pred CCeeecCCCcCcccCCcchhccchhhhhhccCCccccCCchhhhhhcCCCeeecccccccccccccccCccceeeecccC
Q 000859 506 LIILDLADNKLSGGVPASFGFLQALEQLMLYNNSLEGNLPGSLINLRNLTRINFSKNRLNGRIATLCSSHSFLSFDVTNN 585 (1251)
Q Consensus 506 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~l~~~~~l~~l~l~~n 585 (1251)
|+.|++.+|.++ .+|..| ...+|++|+|++|.+. .++..+..+++|+.|+|++|..-...+.+....+|+.|++++|
T Consensus 591 Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip~ls~l~~Le~L~L~~c 667 (1153)
T PLN03210 591 LRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIPDLSMATNLETLKLSDC 667 (1153)
T ss_pred cEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCCccccCCcccEEEecCC
Confidence 444555444444 333333 2344455555555444 2344444455555555554432222233444445555555555
Q ss_pred ccccCCCCCCCCcccCceeecccCccccccCcccccccccceEEccCCcccCCCCccccccCCccEEEcCCCccCCCCcc
Q 000859 586 EFDHEIPPQLGNSPSLERLRLGNNKFIGKIPWTFGKIRELSLLDLSGNSLTGPIPTQLLMCKKLSHIDLNNNLLSGAVPS 665 (1251)
Q Consensus 586 ~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~ 665 (1251)
.....+|..+.++++|+.|++++|...+.+|..+ .+++|+.|++++|.....+|.. ..+|+.|++++|.++ .+|.
T Consensus 668 ~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l~sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~-~lP~ 742 (1153)
T PLN03210 668 SSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NLKSLYRLNLSGCSRLKSFPDI---STNISWLDLDETAIE-EFPS 742 (1153)
T ss_pred CCccccchhhhccCCCCEEeCCCCCCcCccCCcC-CCCCCCEEeCCCCCCccccccc---cCCcCeeecCCCccc-cccc
Confidence 4445677788888888888888865555666654 6788888888888665555543 467888888888887 5565
Q ss_pred ccCCCcccccccccCcccc-------CCCccccccccccceeeccCcccccccCcccCCCCCCceeccCCCcCCCCCCcc
Q 000859 666 WLGTLPQLGELKLSFNQFV-------GFLPRELFNCSKLLVLSLDGNMLNGSLPNEVGNLASLNVLTLSGNLLSGPIPPA 738 (1251)
Q Consensus 666 ~~~~l~~L~~L~l~~N~l~-------~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~ 738 (1251)
.+ .+++|++|++.++... ...|......++|+.|+|++|...+.+|..++.+++|+.|++++|...+.+|..
T Consensus 743 ~~-~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~ 821 (1153)
T PLN03210 743 NL-RLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTG 821 (1153)
T ss_pred cc-cccccccccccccchhhccccccccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCC
Confidence 55 5778888888764322 112222334568899999998877788988999999999999987544467777
Q ss_pred cccccccceeeccCcccccccchhhhchhhHHHHHhccCCcccCCCCCCcCccccccEEEccC-CccccCCchhhhhccC
Q 000859 739 IGRLSKLYELRLSNNSLNGVIPLEIGQLQNLQSILDLSHNNFTGQIPPSMGTLAKLEVLNLSH-NQLVGELPSQLGEMSS 817 (1251)
Q Consensus 739 ~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~-N~l~~~~p~~l~~l~~ 817 (1251)
+ .+++|+.|++++|..-..+|.... +++ .|+|++|+|+ .+|.++..+++|+.|+|++ |+|+ .+|..+..+++
T Consensus 822 ~-~L~sL~~L~Ls~c~~L~~~p~~~~---nL~-~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L~-~l~~~~~~L~~ 894 (1153)
T PLN03210 822 I-NLESLESLDLSGCSRLRTFPDIST---NIS-DLNLSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQ-RVSLNISKLKH 894 (1153)
T ss_pred C-CccccCEEECCCCCcccccccccc---ccC-EeECCCCCCc-cChHHHhcCCCCCEEECCCCCCcC-ccCcccccccC
Confidence 6 688899999998765555665433 443 3689999998 7898899999999999988 5566 68888888899
Q ss_pred CCcEeecccc
Q 000859 818 LGKLNLSYND 827 (1251)
Q Consensus 818 L~~L~l~~N~ 827 (1251)
|+.+++++++
T Consensus 895 L~~L~l~~C~ 904 (1153)
T PLN03210 895 LETVDFSDCG 904 (1153)
T ss_pred CCeeecCCCc
Confidence 9999988875
|
syringae 6; Provisional |
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.8e-23 Score=251.94 Aligned_cols=268 Identities=29% Similarity=0.395 Sum_probs=143.1
Q ss_pred CccceEeccCCcccCCCCCcccccCCCcEEeccCCccCCCcCccccccccCCeeecCCCcCcccCCcchhccchhhhhhc
Q 000859 456 SSLKWIDFFGNSFTGEIPTSIGRLKDLNFLHLRQNELVGQIPASLGNCHQLIILDLADNKLSGGVPASFGFLQALEQLML 535 (1251)
Q Consensus 456 ~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 535 (1251)
..-..|++++|.++ .+|..+. ++|+.|++++|+|+ .+|.. +++|++|++++|+|+. +|.. .++|+.|+|
T Consensus 201 ~~~~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt-~LP~l---p~~Lk~LdLs~N~Lts-LP~l---p~sL~~L~L 269 (788)
T PRK15387 201 NGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPAL---PPELRTLEVSGNQLTS-LPVL---PPGLLELSI 269 (788)
T ss_pred CCCcEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCC-CCCCC---CCCCcEEEecCCccCc-ccCc---ccccceeec
Confidence 34556788888887 6676665 36777788877777 34532 4667777777777763 3432 234555555
Q ss_pred cCCccccCCchhhhhhcCCCeeecccccccccccccccCccceeeecccCccccCCCCCCCCcccCceeecccCcccccc
Q 000859 536 YNNSLEGNLPGSLINLRNLTRINFSKNRLNGRIATLCSSHSFLSFDVTNNEFDHEIPPQLGNSPSLERLRLGNNKFIGKI 615 (1251)
Q Consensus 536 ~~N~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~l~~~~~l~~l~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~ 615 (1251)
++|.|+. +|..+ .+|+.|++++|+|+. +|. ..++|+.|++++|++++ +
T Consensus 270 s~N~L~~-Lp~lp---~~L~~L~Ls~N~Lt~------------------------LP~---~p~~L~~LdLS~N~L~~-L 317 (788)
T PRK15387 270 FSNPLTH-LPALP---SGLCKLWIFGNQLTS------------------------LPV---LPPGLQELSVSDNQLAS-L 317 (788)
T ss_pred cCCchhh-hhhch---hhcCEEECcCCcccc------------------------ccc---cccccceeECCCCcccc-C
Confidence 5555552 22211 334444444444431 221 12345555555555442 2
Q ss_pred CcccccccccceEEccCCcccCCCCccccccCCccEEEcCCCccCCCCccccCCCcccccccccCccccCCCcccccccc
Q 000859 616 PWTFGKIRELSLLDLSGNSLTGPIPTQLLMCKKLSHIDLNNNLLSGAVPSWLGTLPQLGELKLSFNQFVGFLPRELFNCS 695 (1251)
Q Consensus 616 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~ 695 (1251)
|... .+|+.|++ ++|.|++ +|.. ..+|++|+|++|+|++ +|.. .+
T Consensus 318 p~lp---~~L~~L~L------------------------s~N~L~~-LP~l---p~~Lq~LdLS~N~Ls~-LP~l---p~ 362 (788)
T PRK15387 318 PALP---SELCKLWA------------------------YNNQLTS-LPTL---PSGLQELSVSDNQLAS-LPTL---PS 362 (788)
T ss_pred CCCc---cccccccc------------------------ccCcccc-cccc---ccccceEecCCCccCC-CCCC---Cc
Confidence 2211 12334444 4444442 2221 1244555555555554 2321 13
Q ss_pred ccceeeccCcccccccCcccCCCCCCceeccCCCcCCCCCCcccccccccceeeccCcccccccchhhhchhhHHHHHhc
Q 000859 696 KLLVLSLDGNMLNGSLPNEVGNLASLNVLTLSGNLLSGPIPPAIGRLSKLYELRLSNNSLNGVIPLEIGQLQNLQSILDL 775 (1251)
Q Consensus 696 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~l 775 (1251)
+|+.|++++|+|+ .+|... .+|+.|++++|+|+ .+|... ++|+.|++++|+|++ +|..+. +|+ .|++
T Consensus 363 ~L~~L~Ls~N~L~-~LP~l~---~~L~~LdLs~N~Lt-~LP~l~---s~L~~LdLS~N~Lss-IP~l~~---~L~-~L~L 429 (788)
T PRK15387 363 ELYKLWAYNNRLT-SLPALP---SGLKELIVSGNRLT-SLPVLP---SELKELMVSGNRLTS-LPMLPS---GLL-SLSV 429 (788)
T ss_pred ccceehhhccccc-cCcccc---cccceEEecCCccc-CCCCcc---cCCCEEEccCCcCCC-CCcchh---hhh-hhhh
Confidence 4555566666665 344322 35666777777766 344432 456777777777763 454332 333 3667
Q ss_pred cCCcccCCCCCCcCccccccEEEccCCccccCCchhhhhc
Q 000859 776 SHNNFTGQIPPSMGTLAKLEVLNLSHNQLVGELPSQLGEM 815 (1251)
Q Consensus 776 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l 815 (1251)
++|+|+ .+|.++..+++|+.|+|++|+|++..|..+..+
T Consensus 430 s~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~~L~~l 468 (788)
T PRK15387 430 YRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREI 468 (788)
T ss_pred ccCccc-ccChHHhhccCCCeEECCCCCCCchHHHHHHHH
Confidence 777776 567767777777777777777776666555443
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.6e-23 Score=216.06 Aligned_cols=170 Identities=21% Similarity=0.202 Sum_probs=129.6
Q ss_pred CChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEccccccccccccc
Q 000859 1030 GSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDY 1109 (1251)
Q Consensus 1030 gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 1109 (1251)
|+|.++++.. ...+++.+++.++.|+++||+|||++ + ||+||+++.++.+|+ ||.++.....
T Consensus 1 GsL~~~l~~~------~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~- 62 (176)
T smart00750 1 VSLADILEVR------GRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPE- 62 (176)
T ss_pred CcHHHHHHHh------CCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeeccc-
Confidence 6899999763 35699999999999999999999998 5 999999999999999 9998764321
Q ss_pred CCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccchhhhhhhc
Q 000859 1110 NSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSAREELLD 1189 (1251)
Q Consensus 1110 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1189 (1251)
...||+.|||||++.+..++.++|||||||++|||+||+.||............+......
T Consensus 63 --------~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~----------- 123 (176)
T smart00750 63 --------QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPA----------- 123 (176)
T ss_pred --------cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhcc-----------
Confidence 1257899999999999999999999999999999999999997543322222222111100
Q ss_pred ccCCCCCCchHHHHH--HHHHHHHHccccCCCCCCCHHHHHHHHHhhcCC
Q 000859 1190 DQMKPLLPGEECAAY--QVLEIALQCTKTSPQERPSSRQVCDLLLNVFNN 1237 (1251)
Q Consensus 1190 ~~~~~~~~~~~~~~~--~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~ 1237 (1251)
. .....+....... ++.+++.+||+.||++||++.|+++.+..+..+
T Consensus 124 ~-~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~~ 172 (176)
T smart00750 124 D-DPRDRSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFAE 172 (176)
T ss_pred C-CccccccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHHH
Confidence 0 0000111222222 689999999999999999999999998877543
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.7e-23 Score=268.92 Aligned_cols=201 Identities=16% Similarity=0.186 Sum_probs=140.2
Q ss_pred hccC-CCccceeceeeecC-----CCceeEEEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcC
Q 000859 999 RIRH-RHLVKLMGHCCNKG-----AGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDC 1072 (1251)
Q Consensus 999 ~l~h-~niv~l~g~~~~~~-----~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ 1072 (1251)
.++| +||++++++|.... ....+.++||+ +++|.++++.. ...+++.+++.++.||++||+|||++
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~------~~~~~~~~~~~i~~qi~~al~~lH~~- 99 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP------DRSVDAFECFHVFRQIVEIVNAAHSQ- 99 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc------cccccHHHHHHHHHHHHHHHHHHHhC-
Confidence 3455 68888888762211 23457788988 56999999753 35689999999999999999999999
Q ss_pred CCCeeecCCCCCCeeecC-------------------CCCeEEcccccccccccccC----C--C------Ccccceeec
Q 000859 1073 VPKILHRDIKSSNILLDS-------------------NMEAHLGDFGLAKALVEDYN----S--N------TESNTWFAG 1121 (1251)
Q Consensus 1073 ~~~ivH~Dlkp~Nill~~-------------------~~~~kl~DfG~a~~~~~~~~----~--~------~~~~~~~~g 1121 (1251)
+|+||||||+|||++. ++.+|++|||+++....... . . ........|
T Consensus 100 --gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 177 (793)
T PLN00181 100 --GIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAME 177 (793)
T ss_pred --CeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCC
Confidence 9999999999999954 44566667776654211000 0 0 001112468
Q ss_pred ccceecccccccCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccchhhhhhhcccCCCCCCchHH
Q 000859 1122 SYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSAREELLDDQMKPLLPGEEC 1201 (1251)
Q Consensus 1122 t~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1201 (1251)
|+.|||||++.+..++.++|||||||++|||++|..|+..... ...... ..... + ....
T Consensus 178 t~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~-------~~~~~~-------~~~~~----~---~~~~ 236 (793)
T PLN00181 178 MSWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR-------TMSSLR-------HRVLP----P---QILL 236 (793)
T ss_pred CcceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH-------HHHHHH-------HhhcC----h---hhhh
Confidence 8999999999999999999999999999999999888643210 000000 00000 0 0011
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 000859 1202 AAYQVLEIALQCTKTSPQERPSSRQVCDL 1230 (1251)
Q Consensus 1202 ~~~~l~~li~~cl~~dP~~RPs~~eil~~ 1230 (1251)
.......++.+||+.+|.+||+++|+++.
T Consensus 237 ~~~~~~~~~~~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 237 NWPKEASFCLWLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred cCHHHHHHHHHhCCCChhhCcChHHHhhc
Confidence 12345688899999999999999999864
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=1e-22 Score=248.14 Aligned_cols=266 Identities=27% Similarity=0.339 Sum_probs=201.9
Q ss_pred ccchhhcccCcccccccCCcCCCCccceEeccCCcccCCCCCcccccCCCcEEeccCCccCCCcCccccccccCCeeecC
Q 000859 433 KLELLYLYDNHLSGQIPSEVGNCSSLKWIDFFGNSFTGEIPTSIGRLKDLNFLHLRQNELVGQIPASLGNCHQLIILDLA 512 (1251)
Q Consensus 433 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls 512 (1251)
+-..|++++|.++ .+|..+. ++|+.|++++|+++ .+|.. .++|++|+|++|+|+ .+|.. .++|+.|+++
T Consensus 202 ~~~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt-~LP~l---p~~Lk~LdLs~N~Lt-sLP~l---p~sL~~L~Ls 270 (788)
T PRK15387 202 GNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPAL---PPELRTLEVSGNQLT-SLPVL---PPGLLELSIF 270 (788)
T ss_pred CCcEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCC-CCCCC---CCCCcEEEecCCccC-cccCc---ccccceeecc
Confidence 4567899999999 7788776 48999999999999 56753 578999999999999 45643 4689999999
Q ss_pred CCcCcccCCcchhccchhhhhhccCCccccCCchhhhhhcCCCeeecccccccccccccccCccceeeecccCccccCCC
Q 000859 513 DNKLSGGVPASFGFLQALEQLMLYNNSLEGNLPGSLINLRNLTRINFSKNRLNGRIATLCSSHSFLSFDVTNNEFDHEIP 592 (1251)
Q Consensus 513 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~l~~~~~l~~l~l~~n~l~~~~p 592 (1251)
+|+|+. +|..+ ++|+.|+|++|+|+. +|.. +++|+.|++++|+|++++. +|
T Consensus 271 ~N~L~~-Lp~lp---~~L~~L~Ls~N~Lt~-LP~~---p~~L~~LdLS~N~L~~Lp~---------------------lp 321 (788)
T PRK15387 271 SNPLTH-LPALP---SGLCKLWIFGNQLTS-LPVL---PPGLQELSVSDNQLASLPA---------------------LP 321 (788)
T ss_pred CCchhh-hhhch---hhcCEEECcCCcccc-cccc---ccccceeECCCCccccCCC---------------------Cc
Confidence 999984 45433 568889999999994 4543 4789999999998875332 11
Q ss_pred CCCCCcccCceeecccCccccccCcccccccccceEEccCCcccCCCCccccccCCccEEEcCCCccCCCCccccCCCcc
Q 000859 593 PQLGNSPSLERLRLGNNKFIGKIPWTFGKIRELSLLDLSGNSLTGPIPTQLLMCKKLSHIDLNNNLLSGAVPSWLGTLPQ 672 (1251)
Q Consensus 593 ~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~ 672 (1251)
.+|+.|++++|++++ +|.. ..+|+.|+|++|+|++ +|.. ..+|+.|++++|.|+ .+|.. ..+
T Consensus 322 ------~~L~~L~Ls~N~L~~-LP~l---p~~Lq~LdLS~N~Ls~-LP~l---p~~L~~L~Ls~N~L~-~LP~l---~~~ 383 (788)
T PRK15387 322 ------SELCKLWAYNNQLTS-LPTL---PSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLT-SLPAL---PSG 383 (788)
T ss_pred ------ccccccccccCcccc-cccc---ccccceEecCCCccCC-CCCC---Ccccceehhhccccc-cCccc---ccc
Confidence 245667777777763 4431 1467888888888874 5543 356777888888888 45543 356
Q ss_pred cccccccCccccCCCccccccccccceeeccCcccccccCcccCCCCCCceeccCCCcCCCCCCcccccccccceeeccC
Q 000859 673 LGELKLSFNQFVGFLPRELFNCSKLLVLSLDGNMLNGSLPNEVGNLASLNVLTLSGNLLSGPIPPAIGRLSKLYELRLSN 752 (1251)
Q Consensus 673 L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~ 752 (1251)
|+.|+|++|+|++ +|.. .++|+.|++++|+|+ .+|... .+|+.|++++|+|+ .+|..++.+++|+.|+|++
T Consensus 384 L~~LdLs~N~Lt~-LP~l---~s~L~~LdLS~N~Ls-sIP~l~---~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~ 454 (788)
T PRK15387 384 LKELIVSGNRLTS-LPVL---PSELKELMVSGNRLT-SLPMLP---SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEG 454 (788)
T ss_pred cceEEecCCcccC-CCCc---ccCCCEEEccCCcCC-CCCcch---hhhhhhhhccCccc-ccChHHhhccCCCeEECCC
Confidence 8888888888886 4543 257888999999998 567543 46888999999998 7899999999999999999
Q ss_pred cccccccchhhhc
Q 000859 753 NSLNGVIPLEIGQ 765 (1251)
Q Consensus 753 N~l~~~~p~~~~~ 765 (1251)
|+|++..|..+..
T Consensus 455 N~Ls~~~~~~L~~ 467 (788)
T PRK15387 455 NPLSERTLQALRE 467 (788)
T ss_pred CCCCchHHHHHHH
Confidence 9998877765533
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.6e-21 Score=223.30 Aligned_cols=267 Identities=23% Similarity=0.321 Sum_probs=199.1
Q ss_pred CCCcCceecccCCceEEEEEecCC--cEEEEEEeccCCchhhhHHHHHHHHHHHhccC----CCccceeceeeecCCCce
Q 000859 947 NLSDEFIIGSGGSGTVYKAELANG--ATVAVKKISCKDDHLLNKSFTREVKTLGRIRH----RHLVKLMGHCCNKGAGSN 1020 (1251)
Q Consensus 947 ~~~~~~~lG~G~fg~V~~~~~~~~--~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h----~niv~l~g~~~~~~~~~~ 1020 (1251)
+|.+.+.||+|+||.||.|..... ..+|+|........... .+..|..++..+.. +++..+++... ..+...
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~-~l~~E~~vl~~l~~~~~~~~~~~~~~~G~-~~~~~~ 96 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPS-VLKIEIQVLKKLEKKNGPSHFPKLLDHGR-STEDFN 96 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCc-cchhHHHHHHHHhhhcCCCCCCEEEEecc-CCCcee
Confidence 789999999999999999965443 57899887654333222 67789999999863 68888887653 234456
Q ss_pred eEEEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCC-----CCeE
Q 000859 1021 LLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSN-----MEAH 1095 (1251)
Q Consensus 1021 ~lv~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~-----~~~k 1095 (1251)
++||+.. |.+|.+..+..+ .+.++..++.+|+.|++.+|+++|+. |++||||||.|+++... ..+.
T Consensus 97 ~iVM~l~-G~sL~dl~~~~~-----~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~ 167 (322)
T KOG1164|consen 97 FIVMSLL-GPSLEDLRKRNP-----PGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLY 167 (322)
T ss_pred EEEEecc-CccHHHHHHhCC-----CCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEE
Confidence 8999998 779999886653 57899999999999999999999999 99999999999999865 4699
Q ss_pred Eccccccc--ccccccCCC---Ccc-cceeecccceecccccccCCCCCccceeehhHHHHHHhhCCCCCCCccccchhH
Q 000859 1096 LGDFGLAK--ALVEDYNSN---TES-NTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDM 1169 (1251)
Q Consensus 1096 l~DfG~a~--~~~~~~~~~---~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~ 1169 (1251)
+.|||+|+ .+....... ... ...+.||.+|+++....+...+.+.|+||++.++.|+..|..||........ .
T Consensus 168 llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~-~ 246 (322)
T KOG1164|consen 168 LLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL-K 246 (322)
T ss_pred EEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch-H
Confidence 99999999 443333211 111 2346799999999999999999999999999999999999999965533211 0
Q ss_pred HHHHHHHHhccchhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhcCCCc
Q 000859 1170 VRWVEMHMEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNVFNNRI 1239 (1251)
Q Consensus 1170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~ 1239 (1251)
... .... ....... .....+.++.++...+-..+..++|....+...+.+.+....
T Consensus 247 ~~~-~~~~------~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~~ 302 (322)
T KOG1164|consen 247 SKF-EKDP------RKLLTDR-------FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSEG 302 (322)
T ss_pred HHH-HHHh------hhhcccc-------ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhcC
Confidence 000 0000 0000000 111233456677777777999999999999999988887653
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.2e-21 Score=203.98 Aligned_cols=265 Identities=18% Similarity=0.237 Sum_probs=203.2
Q ss_pred cCCCcCceecccCCceEEEE-EecCCcEEEEEEeccCCchhhhHHHHHHHHHHHhc-cCCCccceeceeeecCCCceeEE
Q 000859 946 NNLSDEFIIGSGGSGTVYKA-ELANGATVAVKKISCKDDHLLNKSFTREVKTLGRI-RHRHLVKLMGHCCNKGAGSNLLI 1023 (1251)
Q Consensus 946 ~~~~~~~~lG~G~fg~V~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~~~lv 1023 (1251)
-.|.+.++||+|.||.++.| .+-++++||||.-..+. ...++..|...++.+ ..+.|...|- .........+|
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS---~APQLrdEYr~YKlL~g~~GIP~vYY--FGqeG~~NiLV 102 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS---EAPQLRDEYRTYKLLGGTEGIPQVYY--FGQEGKYNILV 102 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccccC---CcchHHHHHHHHHHHcCCCCCCceee--eccccchhhhh
Confidence 35889999999999999999 45679999999864433 235677888888888 4688888763 33445566899
Q ss_pred EeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCC-----CeEEcc
Q 000859 1024 YEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNM-----EAHLGD 1098 (1251)
Q Consensus 1024 ~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~-----~~kl~D 1098 (1251)
+|.. |.+|.|..+-+ ++.++..++..+|.|++.-|+|+|++ .+|.|||||+|+||...+ .+.|+|
T Consensus 103 idLL-GPSLEDLFD~C------gR~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiD 172 (449)
T KOG1165|consen 103 IDLL-GPSLEDLFDLC------GRRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIID 172 (449)
T ss_pred hhhh-CcCHHHHHHHh------cCcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEe
Confidence 9999 77999988776 57899999999999999999999999 999999999999997544 489999
Q ss_pred cccccccccccCCCC---cccceeecccceecccccccCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHH
Q 000859 1099 FGLAKALVEDYNSNT---ESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEM 1175 (1251)
Q Consensus 1099 fG~a~~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~ 1175 (1251)
||+|+.+.++..... ..+....||.+||+--...+...+.+.|+-|+|-++++++-|..||.+...... ..++..-
T Consensus 173 FGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tn-K~kYeKI 251 (449)
T KOG1165|consen 173 FGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTN-KEKYEKI 251 (449)
T ss_pred ccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcch-HHHHHHh
Confidence 999998866544332 223346899999999999999999999999999999999999999987644321 1111110
Q ss_pred HHhccchhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhcCC
Q 000859 1176 HMEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNVFNN 1237 (1251)
Q Consensus 1176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~ 1237 (1251)
-........+++ -+..+.++...+.-.-..+-++-|+.+-+...+.++++.
T Consensus 252 Ge~Kr~T~i~~L-----------c~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr 302 (449)
T KOG1165|consen 252 GETKRSTPIEVL-----------CEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDR 302 (449)
T ss_pred ccccccCCHHHH-----------HhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHh
Confidence 000000111111 122456777888888889999999999999988888863
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=9.5e-22 Score=195.83 Aligned_cols=272 Identities=20% Similarity=0.258 Sum_probs=201.3
Q ss_pred hcCCCcCceecccCCceEEEE-EecCCcEEEEEEeccCCchhhhHHHHHHHHHHHhccC-CCccceeceeeecCCCceeE
Q 000859 945 TNNLSDEFIIGSGGSGTVYKA-ELANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRH-RHLVKLMGHCCNKGAGSNLL 1022 (1251)
Q Consensus 945 ~~~~~~~~~lG~G~fg~V~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~g~~~~~~~~~~~l 1022 (1251)
...|..+++||.|+||.+|.| ...+|++||||+-..++.. .+...|.++++.+++ ..|..+..|..+ .....+
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h---pqL~yEskvY~iL~~g~GiP~i~~y~~e--~~ynvl 88 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH---PQLLYESKVYRILQGGVGIPHIRHYGTE--KDYNVL 88 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC---cchhHHHHHHHHhccCCCCchhhhhccc--ccccee
Confidence 456889999999999999999 5678999999997655443 567789999999975 455555444433 344589
Q ss_pred EEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecC---CCCeEEccc
Q 000859 1023 IYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDS---NMEAHLGDF 1099 (1251)
Q Consensus 1023 v~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~---~~~~kl~Df 1099 (1251)
|||.. |.+|.+.+.-+ .+.++..+..-.|-|++.-++|+|.+ ++|||||||+|+|..- ...+.++||
T Consensus 89 VMdLL-GPsLEdLfnfC------~R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDF 158 (341)
T KOG1163|consen 89 VMDLL-GPSLEDLFNFC------SRRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDF 158 (341)
T ss_pred eeecc-CccHHHHHHHH------hhhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEec
Confidence 99999 77999988765 46789999999999999999999999 9999999999999963 456899999
Q ss_pred ccccccccccCCC---CcccceeecccceecccccccCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHH
Q 000859 1100 GLAKALVEDYNSN---TESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMH 1176 (1251)
Q Consensus 1100 G~a~~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~ 1176 (1251)
|+|+.+.+..... ........||.+|.+--...+...+.+.|+-|+|.++.++--|..||.+.....-.. ++..-.
T Consensus 159 GLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~Q-KyEkI~ 237 (341)
T KOG1163|consen 159 GLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQ-KYEKIS 237 (341)
T ss_pred cchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHH-HHHHHH
Confidence 9999876432221 222234689999999888888888999999999999999999999998764422111 111000
Q ss_pred HhccchhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhcCCCccccc
Q 000859 1177 MEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNVFNNRIVDFD 1243 (1251)
Q Consensus 1177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~~~~~ 1243 (1251)
+......+.. .-...+.++...+..|-..--++-|+..-+.+.+...+.+-.-.++
T Consensus 238 ----EkK~s~~ie~-------LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ln~~~d 293 (341)
T KOG1163|consen 238 ----EKKMSTPIEV-------LCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTLNHQYD 293 (341)
T ss_pred ----HhhcCCCHHH-------HhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhccccCC
Confidence 0000000000 0111456678889999999999999999888888777765544444
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=2e-21 Score=220.12 Aligned_cols=168 Identities=19% Similarity=0.176 Sum_probs=127.7
Q ss_pred hhcCCCcCceecccCCceEEEEEec--CCcEEEEEEeccCC----chhhhHHHHHHHHHHHhccCCCccceeceeeecCC
Q 000859 944 ATNNLSDEFIIGSGGSGTVYKAELA--NGATVAVKKISCKD----DHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGA 1017 (1251)
Q Consensus 944 ~~~~~~~~~~lG~G~fg~V~~~~~~--~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~ 1017 (1251)
...+|...+.||+|+||+||+|..+ +++.||||++.... .....+.|.+|++++++++|+|+++.+..+
T Consensus 16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----- 90 (365)
T PRK09188 16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----- 90 (365)
T ss_pred ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc-----
Confidence 4567999999999999999999654 57788999875331 223456789999999999999998633221
Q ss_pred CceeEEEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCC-CCCCeeecCCCCeEE
Q 000859 1018 GSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDI-KSSNILLDSNMEAHL 1096 (1251)
Q Consensus 1018 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dl-kp~Nill~~~~~~kl 1096 (1251)
...++||||+++++|... .. .. ...++.|+++|++|||+. +|+|||| ||+||+++.++.+||
T Consensus 91 ~~~~LVmE~~~G~~L~~~-~~-------~~------~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikL 153 (365)
T PRK09188 91 GKDGLVRGWTEGVPLHLA-RP-------HG------DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAV 153 (365)
T ss_pred CCcEEEEEccCCCCHHHh-Cc-------cc------hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEE
Confidence 235899999999999632 11 01 136788999999999999 9999999 999999999999999
Q ss_pred cccccccccccccCCCC----cccceeecccceeccccccc
Q 000859 1097 GDFGLAKALVEDYNSNT----ESNTWFAGSYGYIAPEYAYS 1133 (1251)
Q Consensus 1097 ~DfG~a~~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~ 1133 (1251)
+|||+|+.+........ ..-....+++.|+|||.+..
T Consensus 154 iDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 154 IDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred EECccceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 99999987654321111 11124567888999998753
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.7e-21 Score=237.91 Aligned_cols=287 Identities=26% Similarity=0.409 Sum_probs=170.0
Q ss_pred cceEeccCCcccCCCCCcccccCCCcEEeccCCccCCCcCccccccccCCeeecCCCcCcccCCcchhccchhhhhhccC
Q 000859 458 LKWIDFFGNSFTGEIPTSIGRLKDLNFLHLRQNELVGQIPASLGNCHQLIILDLADNKLSGGVPASFGFLQALEQLMLYN 537 (1251)
Q Consensus 458 L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 537 (1251)
.+.|+++++.++ .+|..+. ++|+.|+|++|+|+ .+|..+. ++|+.|++++|+|+ .+|..+. .+|+.|+|++
T Consensus 180 ~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls~ 250 (754)
T PRK15370 180 KTELRLKILGLT-TIPACIP--EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMELSI 250 (754)
T ss_pred ceEEEeCCCCcC-cCCcccc--cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEECcC
Confidence 345555555555 4444432 35566666666665 3444332 35666666666665 3343332 2456666666
Q ss_pred CccccCCchhhhhhcCCCeeecccccccccccccccCccceeeecccCccccCCCCCCCCcccCceeecccCccccccCc
Q 000859 538 NSLEGNLPGSLINLRNLTRINFSKNRLNGRIATLCSSHSFLSFDVTNNEFDHEIPPQLGNSPSLERLRLGNNKFIGKIPW 617 (1251)
Q Consensus 538 N~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~l~~~~~l~~l~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~ 617 (1251)
|.+. .+|..+. .+|+.|++++|+|+.+ |..+. ++|+.|++++|++++ +|.
T Consensus 251 N~L~-~LP~~l~--s~L~~L~Ls~N~L~~L------------------------P~~l~--~sL~~L~Ls~N~Lt~-LP~ 300 (754)
T PRK15370 251 NRIT-ELPERLP--SALQSLDLFHNKISCL------------------------PENLP--EELRYLSVYDNSIRT-LPA 300 (754)
T ss_pred CccC-cCChhHh--CCCCEEECcCCccCcc------------------------ccccC--CCCcEEECCCCcccc-Ccc
Confidence 6665 3444432 3566666666666533 22221 356666666666653 333
Q ss_pred ccccccccceEEccCCcccCCCCccccccCCccEEEcCCCccCCCCccccCCCcccccccccCccccCCCcccccccccc
Q 000859 618 TFGKIRELSLLDLSGNSLTGPIPTQLLMCKKLSHIDLNNNLLSGAVPSWLGTLPQLGELKLSFNQFVGFLPRELFNCSKL 697 (1251)
Q Consensus 618 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L 697 (1251)
.+. .+|+.|++++|+++. +|..+. ++|+.|++++|.+++ +|..+. ++|+.|+|++|+|+. +|..+. ++|
T Consensus 301 ~lp--~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~L~~-LP~~lp--~~L 369 (754)
T PRK15370 301 HLP--SGITHLNVQSNSLTA-LPETLP--PGLKTLEAGENALTS-LPASLP--PELQVLDVSKNQITV-LPETLP--PTI 369 (754)
T ss_pred cch--hhHHHHHhcCCcccc-CCcccc--ccceeccccCCcccc-CChhhc--CcccEEECCCCCCCc-CChhhc--CCc
Confidence 322 356677777777763 444332 567777777777773 555442 678888888888775 465443 578
Q ss_pred ceeeccCcccccccCcccCCCCCCceeccCCCcCCCCCCccc----ccccccceeeccCcccccccchhhhchhhHHHHH
Q 000859 698 LVLSLDGNMLNGSLPNEVGNLASLNVLTLSGNLLSGPIPPAI----GRLSKLYELRLSNNSLNGVIPLEIGQLQNLQSIL 773 (1251)
Q Consensus 698 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~----~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L 773 (1251)
+.|+|++|+|+ .+|..+. .+|+.|++++|+|+ .+|..+ +.++++..|+|.+|+++. ..+++|+. +
T Consensus 370 ~~LdLs~N~Lt-~LP~~l~--~sL~~LdLs~N~L~-~LP~sl~~~~~~~~~l~~L~L~~Npls~------~tl~~L~~-L 438 (754)
T PRK15370 370 TTLDVSRNALT-NLPENLP--AALQIMQASRNNLV-RLPESLPHFRGEGPQPTRIIVEYNPFSE------RTIQNMQR-L 438 (754)
T ss_pred CEEECCCCcCC-CCCHhHH--HHHHHHhhccCCcc-cCchhHHHHhhcCCCccEEEeeCCCccH------HHHHHHHH-h
Confidence 88888888888 5666554 46888999999988 566544 345788999999999862 45556654 3
Q ss_pred hccCCcccC-CCCCCcCccccccEEEccCCcccc
Q 000859 774 DLSHNNFTG-QIPPSMGTLAKLEVLNLSHNQLVG 806 (1251)
Q Consensus 774 ~l~~N~l~~-~~p~~~~~l~~L~~L~l~~N~l~~ 806 (1251)
++.+.+.| .++.+++.+.+++....-++.+++
T Consensus 439 -l~s~~~~gp~i~~~~~~~~~l~~~~~l~~a~~~ 471 (754)
T PRK15370 439 -MSSVGYQGPRVLFAMGDFSIVRVTRPLHQAVQG 471 (754)
T ss_pred -hhcccccCCcccccccccccccccchHHHHHhc
Confidence 45566654 345555555555544444444443
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.2e-21 Score=237.00 Aligned_cols=257 Identities=19% Similarity=0.225 Sum_probs=189.5
Q ss_pred cCceecccCCceEEEEE-ecCCcEEEEEEec----cCC-chhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEE
Q 000859 950 DEFIIGSGGSGTVYKAE-LANGATVAVKKIS----CKD-DHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLI 1023 (1251)
Q Consensus 950 ~~~~lG~G~fg~V~~~~-~~~~~~vavK~~~----~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv 1023 (1251)
...++|.|++|.|+.+. .......+.|.++ ... .......+..|+.+-..+.|||++..+..+.+.... .-.
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~--~~~ 399 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGI--LQS 399 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccc--hhh
Confidence 45579999999888874 3334444555443 111 222222366788888889999998888766544332 334
Q ss_pred EeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEccccccc
Q 000859 1024 YEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAK 1103 (1251)
Q Consensus 1024 ~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~ 1103 (1251)
|||+++ +|+.++... ..++..++..++.|+..|++|+|+. ||.|||+|++|++++.+|.+||+|||.+.
T Consensus 400 mE~~~~-Dlf~~~~~~-------~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~ 468 (601)
T KOG0590|consen 400 MEYCPY-DLFSLVMSN-------GKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAAS 468 (601)
T ss_pred hhcccH-HHHHHHhcc-------cccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcce
Confidence 999999 999999762 4688899999999999999999999 99999999999999999999999999998
Q ss_pred ccccccCCCCcccceeecccceecccccccCCCCCc-cceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccch
Q 000859 1104 ALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEK-CDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGS 1182 (1251)
Q Consensus 1104 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 1182 (1251)
.+.-+...........+|+..|+|||++.+..|+.+ .||||.|+++..|.+|+.||......+....... .
T Consensus 469 vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~-------~- 540 (601)
T KOG0590|consen 469 VFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNN-------Y- 540 (601)
T ss_pred eeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhc-------c-
Confidence 776555444455566899999999999999998765 8999999999999999999976654433220000 0
Q ss_pred hhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 000859 1183 AREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDL 1230 (1251)
Q Consensus 1183 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 1230 (1251)
...... ..+........+.....+|.++++.||.+|.|+++|++.
T Consensus 541 --~~~~~~-~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d 585 (601)
T KOG0590|consen 541 --SDQRNI-FEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILND 585 (601)
T ss_pred --cccccc-ccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence 000000 001111223355667889999999999999999999763
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=1e-20 Score=232.85 Aligned_cols=203 Identities=24% Similarity=0.394 Sum_probs=131.8
Q ss_pred cCceeecccCccccccCcccccccccceEEccCCcccCCCCccccccCCccEEEcCCCccCCCCccccCCCccccccccc
Q 000859 600 SLERLRLGNNKFIGKIPWTFGKIRELSLLDLSGNSLTGPIPTQLLMCKKLSHIDLNNNLLSGAVPSWLGTLPQLGELKLS 679 (1251)
Q Consensus 600 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~ 679 (1251)
+|+.|+|++|++. .+|..+. .+|+.|++++|+|+ .+|..+. ++|+.|++++|.|++ +|..+. ++|+.|+++
T Consensus 242 ~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt~-LP~~lp--~sL~~L~Ls 312 (754)
T PRK15370 242 TIQEMELSINRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIRT-LPAHLP--SGITHLNVQ 312 (754)
T ss_pred cccEEECcCCccC-cCChhHh--CCCCEEECcCCccC-ccccccC--CCCcEEECCCCcccc-Ccccch--hhHHHHHhc
Confidence 3444555555544 3333332 34666666666666 3454443 467777777777763 444332 467888888
Q ss_pred CccccCCCccccccccccceeeccCcccccccCcccCCCCCCceeccCCCcCCCCCCcccccccccceeeccCccccccc
Q 000859 680 FNQFVGFLPRELFNCSKLLVLSLDGNMLNGSLPNEVGNLASLNVLTLSGNLLSGPIPPAIGRLSKLYELRLSNNSLNGVI 759 (1251)
Q Consensus 680 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~ 759 (1251)
+|++++ +|..+. ++|+.|++++|.++ .+|..+. ++|+.|++++|+|+ .+|..+. ++|+.|+|++|+|+ .+
T Consensus 313 ~N~Lt~-LP~~l~--~sL~~L~Ls~N~Lt-~LP~~l~--~sL~~L~Ls~N~L~-~LP~~lp--~~L~~LdLs~N~Lt-~L 382 (754)
T PRK15370 313 SNSLTA-LPETLP--PGLKTLEAGENALT-SLPASLP--PELQVLDVSKNQIT-VLPETLP--PTITTLDVSRNALT-NL 382 (754)
T ss_pred CCcccc-CCcccc--ccceeccccCCccc-cCChhhc--CcccEEECCCCCCC-cCChhhc--CCcCEEECCCCcCC-CC
Confidence 888875 454432 57888888888888 4676554 68999999999988 5776653 68999999999998 46
Q ss_pred chhhhchhhHHHHHhccCCcccCCCCCCcC----ccccccEEEccCCccccCCchhhhhccCCCcEeeccccCcCcc
Q 000859 760 PLEIGQLQNLQSILDLSHNNFTGQIPPSMG----TLAKLEVLNLSHNQLVGELPSQLGEMSSLGKLNLSYNDLQGKL 832 (1251)
Q Consensus 760 p~~~~~l~~l~~~L~l~~N~l~~~~p~~~~----~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~ 832 (1251)
|..+.. .| +.|++++|+|+ .+|.++. .++++..|+|.+|+++. . .+++|+.| ++.+.+.|+.
T Consensus 383 P~~l~~--sL-~~LdLs~N~L~-~LP~sl~~~~~~~~~l~~L~L~~Npls~---~---tl~~L~~L-l~s~~~~gp~ 448 (754)
T PRK15370 383 PENLPA--AL-QIMQASRNNLV-RLPESLPHFRGEGPQPTRIIVEYNPFSE---R---TIQNMQRL-MSSVGYQGPR 448 (754)
T ss_pred CHhHHH--HH-HHHhhccCCcc-cCchhHHHHhhcCCCccEEEeeCCCccH---H---HHHHHHHh-hhcccccCCc
Confidence 665542 45 35899999998 6776543 34678888999998872 2 33344444 4455555543
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.2e-20 Score=224.12 Aligned_cols=251 Identities=22% Similarity=0.254 Sum_probs=181.3
Q ss_pred CCCcCceecccCCceEEEEEecCCcEEEEEEeccCCchhhhHHHHHHHHHH--HhccCCCccceeceeeecCCCceeEEE
Q 000859 947 NLSDEFIIGSGGSGTVYKAELANGATVAVKKISCKDDHLLNKSFTREVKTL--GRIRHRHLVKLMGHCCNKGAGSNLLIY 1024 (1251)
Q Consensus 947 ~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l--~~l~h~niv~l~g~~~~~~~~~~~lv~ 1024 (1251)
++...+.+|.+.|=+|.+|+.+.|. |+||++-++.+....+.|.++++-. ..++|||++++.-+- ......|+|=
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~--~t~kAAylvR 100 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVL--VTDKAAYLVR 100 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHH--HhhHHHHHHH
Confidence 4666778999999999999888776 9999998777666666666555444 444899999998754 3344457888
Q ss_pred eecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcccccccc
Q 000859 1025 EYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKA 1104 (1251)
Q Consensus 1025 E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~ 1104 (1251)
+|... +|+|.+.. +..+...+.+.|+.|++.|+.-+|.. ||+|||||.+|||+++-.-+.|+||..-+.
T Consensus 101 qyvkh-nLyDRlST-------RPFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKP 169 (1431)
T KOG1240|consen 101 QYVKH-NLYDRLST-------RPFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKP 169 (1431)
T ss_pred HHHhh-hhhhhhcc-------chHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCC
Confidence 88865 89998876 34678888999999999999999999 999999999999999999999999987654
Q ss_pred cccccCCCCcccceee----cccceecccccccC-----------CCCCccceeehhHHHHHHhh-CCCCCCCccccchh
Q 000859 1105 LVEDYNSNTESNTWFA----GSYGYIAPEYAYSL-----------KATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMD 1168 (1251)
Q Consensus 1105 ~~~~~~~~~~~~~~~~----gt~~y~aPE~~~~~-----------~~~~~sDiwSlGv~l~el~t-g~~p~~~~~~~~~~ 1168 (1251)
..-+...... .+.+. .--.|.|||.+... ..+++.||||.||+++|+++ |++||.-. +
T Consensus 170 tYLPeDNPad-f~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS-----Q 243 (1431)
T KOG1240|consen 170 TYLPEDNPAD-FTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS-----Q 243 (1431)
T ss_pred ccCCCCCccc-ceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH-----H
Confidence 3221111111 11111 12359999987541 15678999999999999999 89998522 1
Q ss_pred HHHHHHHHHhccchhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 000859 1169 MVRWVEMHMEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLL 1231 (1251)
Q Consensus 1169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L 1231 (1251)
+..|.... ....+..+. ......+++++..|++.||++|-|+++.++..
T Consensus 244 L~aYr~~~----~~~~e~~Le----------~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~y 292 (1431)
T KOG1240|consen 244 LLAYRSGN----ADDPEQLLE----------KIEDVSLRNLILSMIQRDPSKRLSAEDYLQKY 292 (1431)
T ss_pred HHhHhccC----ccCHHHHHH----------hCcCccHHHHHHHHHccCchhccCHHHHHHhh
Confidence 11111110 111111111 11223588999999999999999999999873
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.80 E-value=8.4e-19 Score=204.16 Aligned_cols=263 Identities=30% Similarity=0.391 Sum_probs=196.7
Q ss_pred CCcCceecccCCceEEEEEecCCcEEEEEEeccCCchh--hhHHHHHHHHHHHhccCC-CccceeceeeecCCCceeEEE
Q 000859 948 LSDEFIIGSGGSGTVYKAELANGATVAVKKISCKDDHL--LNKSFTREVKTLGRIRHR-HLVKLMGHCCNKGAGSNLLIY 1024 (1251)
Q Consensus 948 ~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~h~-niv~l~g~~~~~~~~~~~lv~ 1024 (1251)
|.....||.|+||.||++... ..+|+|.+....... ....+.+|+.+++.+.|+ +++++++++.. ....++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--~~~~~~~~ 77 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQD--EGSLYLVM 77 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEec--CCEEEEEE
Confidence 566778999999999999776 889999997665443 477899999999999888 79999998833 33368999
Q ss_pred eecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCC-CeEEccccccc
Q 000859 1025 EYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNM-EAHLGDFGLAK 1103 (1251)
Q Consensus 1025 E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~-~~kl~DfG~a~ 1103 (1251)
|++.++++.+++...... ..++......++.|++.+++|+|+. +++|||+||+||+++..+ .++++|||.++
T Consensus 78 ~~~~~~~l~~~~~~~~~~----~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~ 150 (384)
T COG0515 78 EYVDGGSLEDLLKKIGRK----GPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAK 150 (384)
T ss_pred ecCCCCcHHHHHHhcccc----cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcce
Confidence 999999999777654211 3688999999999999999999999 999999999999999998 79999999997
Q ss_pred ccccccCCCC--cccceeecccceeccccccc---CCCCCccceeehhHHHHHHhhCCCCCCCcccc--chhHHHHHHHH
Q 000859 1104 ALVEDYNSNT--ESNTWFAGSYGYIAPEYAYS---LKATEKCDVYSMGIVLMELVSGKMPTDATFGV--EMDMVRWVEMH 1176 (1251)
Q Consensus 1104 ~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~---~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~--~~~~~~~~~~~ 1176 (1251)
.+........ .......||..|+|||.+.+ ..+....|+||+|++++++++|..||...... ...........
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~ 230 (384)
T COG0515 151 LLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILEL 230 (384)
T ss_pred ecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhc
Confidence 5543322111 12345689999999999987 57889999999999999999999997655331 11111111100
Q ss_pred HhccchhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 000859 1177 MEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDL 1230 (1251)
Q Consensus 1177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 1230 (1251)
.. . ........... ......+.+++..|+..+|..|.+..+....
T Consensus 231 ~~----~---~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 231 PT----P---SLASPLSPSNP--ELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred CC----c---ccccccCcccc--chhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 00 0 00000000000 1223567899999999999999999987765
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.6e-19 Score=189.52 Aligned_cols=174 Identities=14% Similarity=0.161 Sum_probs=134.0
Q ss_pred hhcCCCcCceecccCCceEEEEEecCCcEEEEEEeccCCchh--hhHH------HHHHHHHHHhccCCCccceeceeeec
Q 000859 944 ATNNLSDEFIIGSGGSGTVYKAELANGATVAVKKISCKDDHL--LNKS------FTREVKTLGRIRHRHLVKLMGHCCNK 1015 (1251)
Q Consensus 944 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~--~~~~------~~~E~~~l~~l~h~niv~l~g~~~~~ 1015 (1251)
...+|+..+++|.|+||.||.++. ++..+|||+++...... ..+. +.+|+..+.+++||+|....+++...
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 468899999999999999999866 57789999997543222 1122 68999999999999999999876543
Q ss_pred C------CCceeEEEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeec
Q 000859 1016 G------AGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLD 1089 (1251)
Q Consensus 1016 ~------~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~ 1089 (1251)
. ....+++|||++|.+|.++.. ++. ....+++.++..+|+. |++|||+||+||+++
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~-----------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~ 169 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPE-----------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVS 169 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhh-----------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEe
Confidence 2 234689999999999988732 122 2456999999999999 999999999999999
Q ss_pred CCCCeEEcccccccccccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHh
Q 000859 1090 SNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELV 1153 (1251)
Q Consensus 1090 ~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~ 1153 (1251)
.+| ++++|||..+....+.. ...++....+..++|+||+||++....
T Consensus 170 ~~g-i~liDfg~~~~~~e~~a----------------~d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 170 KNG-LRIIDLSGKRCTAQRKA----------------KDRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CCC-EEEEECCCcccccchhh----------------HHHHHHHhHhcccccccceeEeehHHH
Confidence 988 99999998865421100 011344556778999999999987554
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=4.5e-21 Score=180.99 Aligned_cols=164 Identities=34% Similarity=0.572 Sum_probs=118.4
Q ss_pred CCCcccCceeecccCccccccCcccccccccceEEccCCcccCCCCccccccCCccEEEcCCCccCCCCccccCCCcccc
Q 000859 595 LGNSPSLERLRLGNNKFIGKIPWTFGKIRELSLLDLSGNSLTGPIPTQLLMCKKLSHIDLNNNLLSGAVPSWLGTLPQLG 674 (1251)
Q Consensus 595 l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~ 674 (1251)
+.++..++.|.|++|+++ .+|..++.+.+|+.|++++|+|+ .+|.+++.+++|+.|+++-|++. ..|.-||.+|.|+
T Consensus 29 Lf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~le 105 (264)
T KOG0617|consen 29 LFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALE 105 (264)
T ss_pred ccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhh
Confidence 445677788888888887 56667888888888888888887 68888888888888888888887 7788888888888
Q ss_pred cccccCccccCC-CccccccccccceeeccCcccccccCcccCCCCCCceeccCCCcCCCCCCcccccccccceeeccCc
Q 000859 675 ELKLSFNQFVGF-LPRELFNCSKLLVLSLDGNMLNGSLPNEVGNLASLNVLTLSGNLLSGPIPPAIGRLSKLYELRLSNN 753 (1251)
Q Consensus 675 ~L~l~~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N 753 (1251)
.|||.+|.+.+. +|..|+.++.|+.|+|++|.+. .+|..++.+++|+.|.+.+|.+- .+|..++.+.+|++|++.+|
T Consensus 106 vldltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgn 183 (264)
T KOG0617|consen 106 VLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGN 183 (264)
T ss_pred hhhccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccc
Confidence 888888887753 6777777777777777777776 56666666666666666666655 45555555555555555555
Q ss_pred ccccccchhhh
Q 000859 754 SLNGVIPLEIG 764 (1251)
Q Consensus 754 ~l~~~~p~~~~ 764 (1251)
+++ ++|.+++
T Consensus 184 rl~-vlppel~ 193 (264)
T KOG0617|consen 184 RLT-VLPPELA 193 (264)
T ss_pred eee-ecChhhh
Confidence 554 4444443
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.78 E-value=5.7e-19 Score=184.48 Aligned_cols=139 Identities=18% Similarity=0.141 Sum_probs=107.2
Q ss_pred ceecccCCceEEEEEecCCcEEEEEEeccCCch-hh------------------------hHHHHHHHHHHHhccCCCcc
Q 000859 952 FIIGSGGSGTVYKAELANGATVAVKKISCKDDH-LL------------------------NKSFTREVKTLGRIRHRHLV 1006 (1251)
Q Consensus 952 ~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~-~~------------------------~~~~~~E~~~l~~l~h~niv 1006 (1251)
..||+|+||.||+|...+|++||||+++..... .. ......|++.++++.++++.
T Consensus 3 ~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v~ 82 (190)
T cd05147 3 GCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGIP 82 (190)
T ss_pred CccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCCC
Confidence 479999999999998778999999999654211 00 11224599999999888774
Q ss_pred ceeceeeecCCCceeEEEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHh-hhcCCCCeeecCCCCCC
Q 000859 1007 KLMGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYL-HHDCVPKILHRDIKSSN 1085 (1251)
Q Consensus 1007 ~l~g~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~L-H~~~~~~ivH~Dlkp~N 1085 (1251)
....+.. . ..++||||++++++...... ...++..++.+++.|++.+++|+ |+. +|+||||||+|
T Consensus 83 ~p~~~~~--~--~~~iVmE~i~g~~l~~~~~~-------~~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~N 148 (190)
T cd05147 83 CPEPILL--K--SHVLVMEFIGDDGWAAPRLK-------DAPLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYN 148 (190)
T ss_pred CCcEEEe--c--CCEEEEEEeCCCCCcchhhh-------cCCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHH
Confidence 4332221 1 23899999998776554322 24578899999999999999999 688 99999999999
Q ss_pred eeecCCCCeEEccccccccc
Q 000859 1086 ILLDSNMEAHLGDFGLAKAL 1105 (1251)
Q Consensus 1086 ill~~~~~~kl~DfG~a~~~ 1105 (1251)
|+++ ++.++++|||+|...
T Consensus 149 Ili~-~~~v~LiDFG~a~~~ 167 (190)
T cd05147 149 LLYH-DGKLYIIDVSQSVEH 167 (190)
T ss_pred EEEE-CCcEEEEEccccccC
Confidence 9998 578999999999643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=3.1e-19 Score=190.00 Aligned_cols=204 Identities=22% Similarity=0.269 Sum_probs=144.2
Q ss_pred cCCCccceeceeeecC-------------------------CCceeEEEeecCCCChHHhhhcCCCCcccCCCCCHHHHH
Q 000859 1001 RHRHLVKLMGHCCNKG-------------------------AGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARL 1055 (1251)
Q Consensus 1001 ~h~niv~l~g~~~~~~-------------------------~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~ 1055 (1251)
+|||||++.++|++.- +...|+||...+. +|.+|+..+ ..+...+.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~--------~~s~r~~~ 344 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTR--------HRSYRTGR 344 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcC--------CCchHHHH
Confidence 5999999999876541 3345888887754 899998753 45666777
Q ss_pred HHHHHHHHHHHHhhhcCCCCeeecCCCCCCeee--cCCCC--eEEcccccccccccccCC-CCcc-cceeecccceeccc
Q 000859 1056 KIAVGLAQGVEYLHHDCVPKILHRDIKSSNILL--DSNME--AHLGDFGLAKALVEDYNS-NTES-NTWFAGSYGYIAPE 1129 (1251)
Q Consensus 1056 ~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill--~~~~~--~kl~DfG~a~~~~~~~~~-~~~~-~~~~~gt~~y~aPE 1129 (1251)
-|..|+++|+.|||.+ ||.|||+|.+||++ |+|+. ..|+|||++-.-....-. .... .....|...-||||
T Consensus 345 ~~laQlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPE 421 (598)
T KOG4158|consen 345 VILAQLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPE 421 (598)
T ss_pred HHHHHHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchh
Confidence 8899999999999999 99999999999999 44443 678999987432110000 0000 01134677899999
Q ss_pred ccccCC------CCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccchhhhhhhcccCCCCCCchHHHH
Q 000859 1130 YAYSLK------ATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSAREELLDDQMKPLLPGEECAA 1203 (1251)
Q Consensus 1130 ~~~~~~------~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1203 (1251)
+....+ --.++|.|+.|.+.||+++...||......-.+...|.+ . ...+.++.++
T Consensus 422 i~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe---------------~---qLPalp~~vp 483 (598)
T KOG4158|consen 422 IATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQE---------------S---QLPALPSRVP 483 (598)
T ss_pred hhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhh---------------h---hCCCCcccCC
Confidence 876433 235899999999999999999999763222222211111 0 1222345577
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 000859 1204 YQVLEIALQCTKTSPQERPSSRQVCDLLLNV 1234 (1251)
Q Consensus 1204 ~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 1234 (1251)
+.+.+++...++.||.+||+..-..+++.=.
T Consensus 484 p~~rqlV~~lL~r~pskRvsp~iAANvl~Ls 514 (598)
T KOG4158|consen 484 PVARQLVFDLLKRDPSKRVSPNIAANVLNLS 514 (598)
T ss_pred hHHHHHHHHHhcCCccccCCccHHHhHHHHH
Confidence 8899999999999999999998777776543
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=3.4e-21 Score=181.79 Aligned_cols=121 Identities=33% Similarity=0.579 Sum_probs=52.5
Q ss_pred ccccccccceeeccCcccccccCcccCCCCCCceeccCCCcCCC-CCCcccccccccceeeccCcccccccchhhhchhh
Q 000859 690 ELFNCSKLLVLSLDGNMLNGSLPNEVGNLASLNVLTLSGNLLSG-PIPPAIGRLSKLYELRLSNNSLNGVIPLEIGQLQN 768 (1251)
Q Consensus 690 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~-~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~ 768 (1251)
++..+++|+.|++.-|++. .+|..|+.++.|++|||+.|.+.. .+|..|..+..|+.|+|++|-+. .+|..+++|++
T Consensus 74 ~issl~klr~lnvgmnrl~-~lprgfgs~p~levldltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~ 151 (264)
T KOG0617|consen 74 SISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTN 151 (264)
T ss_pred hhhhchhhhheecchhhhh-cCccccCCCchhhhhhccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcc
Confidence 3333333333333333333 334444444444444444443332 23444444444444444444444 34444444444
Q ss_pred HHHHHhccCCcccCCCCCCcCccccccEEEccCCccccCCchhhhhc
Q 000859 769 LQSILDLSHNNFTGQIPPSMGTLAKLEVLNLSHNQLVGELPSQLGEM 815 (1251)
Q Consensus 769 l~~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l 815 (1251)
|| +|.++.|.+. ++|.+++.+++|++|.+.+|+++ .+|.+++.+
T Consensus 152 lq-il~lrdndll-~lpkeig~lt~lrelhiqgnrl~-vlppel~~l 195 (264)
T KOG0617|consen 152 LQ-ILSLRDNDLL-SLPKEIGDLTRLRELHIQGNRLT-VLPPELANL 195 (264)
T ss_pred ee-EEeeccCchh-hCcHHHHHHHHHHHHhcccceee-ecChhhhhh
Confidence 43 3444444444 34444455555555555555554 444444443
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=3.1e-18 Score=196.71 Aligned_cols=221 Identities=28% Similarity=0.386 Sum_probs=165.5
Q ss_pred HHhccCCCccceeceeeecCCCceeEEEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 000859 997 LGRIRHRHLVKLMGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKI 1076 (1251)
Q Consensus 997 l~~l~h~niv~l~g~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i 1076 (1251)
|+.+.|.|+.+|+|.+.+. ...++|.+|+..|+|.+.+... ...+++.-...+.++|+.||+|+|.. +|
T Consensus 1 l~~l~h~n~~~f~g~~~~~--~~~~~i~~~c~rGsl~D~i~~~------~~~~d~~F~~s~~rdi~~Gl~ylh~s---~i 69 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDG--PEMIVIWEYCSRGSLLDILSNE------DIKLDYFFILSFIRDISKGLAYLHNS---PI 69 (484)
T ss_pred CcccchhhhhhheeeEecC--CceEEEEeeecCccHHhHHhcc------ccCccHHHHHHHHHHHHHHHHHHhcC---cc
Confidence 4568999999999998776 4468999999999999999874 35688888999999999999999997 44
Q ss_pred -eecCCCCCCeeecCCCCeEEcccccccccccccCCCCcccceeecccceecccccccCC-------CCCccceeehhHH
Q 000859 1077 -LHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLK-------ATEKCDVYSMGIV 1148 (1251)
Q Consensus 1077 -vH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~sDiwSlGv~ 1148 (1251)
.|+.++++|+++|....+|++|||+.....+. ..........-..-|.|||.++... .+.++||||||++
T Consensus 70 ~~hg~l~s~nClvd~~w~lklt~~Gl~~~~~~~--~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii 147 (484)
T KOG1023|consen 70 GYHGALKSSNCLVDSRWVLKLTDFGLNSLLEET--AEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGII 147 (484)
T ss_pred eeeeeeccccceeeeeEEEEechhhhccccccc--ccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHH
Confidence 99999999999999999999999998765431 1111111123456799999887631 4677999999999
Q ss_pred HHHHhhCCCCCCCccccchhHHHHHHHHHhccchhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 000859 1149 LMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVC 1228 (1251)
Q Consensus 1149 l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil 1228 (1251)
++|+++.+.||+.....+.. .+.+.... ..-....+|.........+++..++..||..+|++||++++|.
T Consensus 148 ~~ei~~r~~~~~~~~~~~~~-~eii~~~~--------~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~ 218 (484)
T KOG1023|consen 148 MYEILFRSGPFDLRNLVEDP-DEIILRVK--------KGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIR 218 (484)
T ss_pred HHHHHhccCccccccccCCh-HHHHHHHH--------hcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHH
Confidence 99999999999864333322 11111100 0011112233322223445789999999999999999999999
Q ss_pred HHHHhhcCCCc
Q 000859 1229 DLLLNVFNNRI 1239 (1251)
Q Consensus 1229 ~~L~~~~~~~~ 1239 (1251)
..++.+.....
T Consensus 219 ~~~~~~~~~~~ 229 (484)
T KOG1023|consen 219 SKLLTINKGGS 229 (484)
T ss_pred hhhhhhccccc
Confidence 99998887654
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.76 E-value=5.7e-18 Score=178.06 Aligned_cols=139 Identities=20% Similarity=0.218 Sum_probs=109.4
Q ss_pred CceecccCCceEEEEEecCCcEEEEEEeccCCch-------------------------hhhHHHHHHHHHHHhccCCCc
Q 000859 951 EFIIGSGGSGTVYKAELANGATVAVKKISCKDDH-------------------------LLNKSFTREVKTLGRIRHRHL 1005 (1251)
Q Consensus 951 ~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~-------------------------~~~~~~~~E~~~l~~l~h~ni 1005 (1251)
...||+|+||.||+|...+|+.||||+++..... .....+.+|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 3579999999999997778999999998754211 001234578999999999987
Q ss_pred cceeceeeecCCCceeEEEeecCCCChHHh-hhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCCeeecCCCC
Q 000859 1006 VKLMGHCCNKGAGSNLLIYEYMENGSVWDW-LHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHH-DCVPKILHRDIKS 1083 (1251)
Q Consensus 1006 v~l~g~~~~~~~~~~~lv~E~~~~gsL~~~-l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~Dlkp 1083 (1251)
.....+... . .++||||++++++... +.. ..++..+..+++.|++.++.++|+ . ||+||||||
T Consensus 82 ~~p~~~~~~--~--~~lVmE~~~g~~~~~~~l~~--------~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP 146 (190)
T cd05145 82 PVPEPILLK--K--NVLVMEFIGDDGSPAPRLKD--------VPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSE 146 (190)
T ss_pred CCceEEEec--C--CEEEEEEecCCCchhhhhhh--------ccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCCh
Confidence 544433322 1 3899999998855433 332 346788899999999999999999 8 999999999
Q ss_pred CCeeecCCCCeEEccccccccc
Q 000859 1084 SNILLDSNMEAHLGDFGLAKAL 1105 (1251)
Q Consensus 1084 ~Nill~~~~~~kl~DfG~a~~~ 1105 (1251)
+||+++ ++.++|+|||+|+..
T Consensus 147 ~NIll~-~~~~~liDFG~a~~~ 167 (190)
T cd05145 147 YNILYH-DGKPYIIDVSQAVEL 167 (190)
T ss_pred hhEEEE-CCCEEEEEcccceec
Confidence 999999 899999999999765
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=3.9e-18 Score=174.50 Aligned_cols=190 Identities=14% Similarity=0.070 Sum_probs=137.5
Q ss_pred CcCceecccCCceEEEEEecCCcEEEEEEeccCCc---hhhhHHHHHHHHHHHhcc-CCCccceeceeeecCCCceeEEE
Q 000859 949 SDEFIIGSGGSGTVYKAELANGATVAVKKISCKDD---HLLNKSFTREVKTLGRIR-HRHLVKLMGHCCNKGAGSNLLIY 1024 (1251)
Q Consensus 949 ~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~~~lv~ 1024 (1251)
.+...|++|+||+||.+.- .+.+++.+.+....- ......+.+|+++|+++. |++|++++++. ..+++|
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~------~~~lvm 77 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHWD------GRHLDR 77 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEEc------CEEEEE
Confidence 3456899999999998865 578888887743322 112235789999999995 58899998751 248999
Q ss_pred eecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCC-CCCCeeecCCCCeEEccccccc
Q 000859 1025 EYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDI-KSSNILLDSNMEAHLGDFGLAK 1103 (1251)
Q Consensus 1025 E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dl-kp~Nill~~~~~~kl~DfG~a~ 1103 (1251)
||++|.+|.+.... . ...++.|++++++++|+. ||+|||| ||+||+++.++.++|+|||+|.
T Consensus 78 eyI~G~~L~~~~~~--------~------~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~ 140 (218)
T PRK12274 78 SYLAGAAMYQRPPR--------G------DLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAV 140 (218)
T ss_pred eeecCccHHhhhhh--------h------hHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCce
Confidence 99999888654321 1 134778999999999999 9999999 7999999999999999999997
Q ss_pred ccccccCC----CCc-----ccceeecccceecccccccC-CCC-CccceeehhHHHHHHhhCCCCCCCc
Q 000859 1104 ALVEDYNS----NTE-----SNTWFAGSYGYIAPEYAYSL-KAT-EKCDVYSMGIVLMELVSGKMPTDAT 1162 (1251)
Q Consensus 1104 ~~~~~~~~----~~~-----~~~~~~gt~~y~aPE~~~~~-~~~-~~sDiwSlGv~l~el~tg~~p~~~~ 1162 (1251)
.......- ... .+.....++.|++|+...-. ..+ .+.+.++-|.-+|.++||..|+.+.
T Consensus 141 ~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 141 RGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred ecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence 54321110 000 01122356777788753322 222 5678999999999999999887543
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=4.6e-19 Score=202.20 Aligned_cols=236 Identities=25% Similarity=0.311 Sum_probs=181.8
Q ss_pred ecccCCceEEEEEe----cCCcEEEEEEeccCCchh-hhHHHHHHHHHHHhcc-CCCccceeceeeecCCCceeEEEeec
Q 000859 954 IGSGGSGTVYKAEL----ANGATVAVKKISCKDDHL-LNKSFTREVKTLGRIR-HRHLVKLMGHCCNKGAGSNLLIYEYM 1027 (1251)
Q Consensus 954 lG~G~fg~V~~~~~----~~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~~~lv~E~~ 1027 (1251)
+|+|+||.|+.++. +.|.-+|.|+.+...... .......|..++..++ ||.+|++.-.+. .+...+++++|.
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafq--t~~kl~l~ld~~ 79 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQ--TDGKLYLILDFL 79 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeec--cccchhHhhhhc
Confidence 79999999998733 346778998886544211 1224556888899996 999999976554 345568999999
Q ss_pred CCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEccccccccccc
Q 000859 1028 ENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVE 1107 (1251)
Q Consensus 1028 ~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~ 1107 (1251)
.+|++...+.. ...++..........++-|++++|+. +|+|||+|++||+++.+|.+++.|||.++...+
T Consensus 80 rgg~lft~l~~-------~~~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~ 149 (612)
T KOG0603|consen 80 RGGDLFTRLSK-------EVMFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVK 149 (612)
T ss_pred ccchhhhcccc-------CCchHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHh
Confidence 99999888776 34567777777888899999999999 999999999999999999999999999976543
Q ss_pred ccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHHHhccchhhhhh
Q 000859 1108 DYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSAREEL 1187 (1251)
Q Consensus 1108 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1187 (1251)
... .+||..|||||++. ....++|.||||++.+||+||..||... .
T Consensus 150 ~~~--------~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~~------------------------~ 195 (612)
T KOG0603|consen 150 EKI--------ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGGD------------------------T 195 (612)
T ss_pred hhh--------cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCchH------------------------H
Confidence 211 18899999999988 6788999999999999999999999751 0
Q ss_pred hcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCH--HHHHHHHHhhc
Q 000859 1188 LDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSS--RQVCDLLLNVF 1235 (1251)
Q Consensus 1188 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~--~eil~~L~~~~ 1235 (1251)
....++..++.+........+++..+...+|..|--. ..+.+..+.-+
T Consensus 196 ~~~Il~~~~~~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f 245 (612)
T KOG0603|consen 196 MKRILKAELEMPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEF 245 (612)
T ss_pred HHHHhhhccCCchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccch
Confidence 1111223445556667778889999999999999665 34444444333
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.72 E-value=4.9e-18 Score=183.75 Aligned_cols=239 Identities=22% Similarity=0.262 Sum_probs=146.7
Q ss_pred CCcCceecccCCceEEEEEe-cCCcEEEEEEeccCCc--hhhhHHHHHHHHHHHhcc----------CCCccceeceeee
Q 000859 948 LSDEFIIGSGGSGTVYKAEL-ANGATVAVKKISCKDD--HLLNKSFTREVKTLGRIR----------HRHLVKLMGHCCN 1014 (1251)
Q Consensus 948 ~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~----------h~niv~l~g~~~~ 1014 (1251)
+.....||.|+|+.||.++. .+++++|||++....+ ....+.+.+|.-....+. |-.++.-++....
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i 93 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence 44566899999999999954 5689999999865542 223456666654444422 2122222221111
Q ss_pred --------cCC--C-----ceeEEEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeec
Q 000859 1015 --------KGA--G-----SNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHR 1079 (1251)
Q Consensus 1015 --------~~~--~-----~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~ 1079 (1251)
... . ..+++|+-+ .+||.+++..-.........+....+..+..|+++.+++||+. |+||+
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHg 169 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVHG 169 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEES
T ss_pred cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEec
Confidence 111 1 225677877 4688887643110001122344555667778999999999999 99999
Q ss_pred CCCCCCeeecCCCCeEEcccccccccccccCCCCcccceeecccceecccccccC--------CCCCccceeehhHHHHH
Q 000859 1080 DIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSL--------KATEKCDVYSMGIVLME 1151 (1251)
Q Consensus 1080 Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--------~~~~~sDiwSlGv~l~e 1151 (1251)
||+|+|++++.+|.++++||+........... ...+..|.+||..... .++.+.|.|++|+++|.
T Consensus 170 di~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~-------~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~ 242 (288)
T PF14531_consen 170 DIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC-------SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYS 242 (288)
T ss_dssp T-SGGGEEE-TTS-EEE--GGGEEETTEEEEG-------GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHH
T ss_pred ccceeeEEEcCCCCEEEcChHHHeecCceeec-------cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHH
Confidence 99999999999999999999987654332111 2345779999976442 47889999999999999
Q ss_pred HhhCCCCCCCccccchhHHHHHHHHHhccchhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCC
Q 000859 1152 LVSGKMPTDATFGVEMDMVRWVEMHMEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQER 1221 (1251)
Q Consensus 1152 l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R 1221 (1251)
|++|..||+...+...... .+. .+. ..+..+..+|..+++.+|.+|
T Consensus 243 lWC~~lPf~~~~~~~~~~~----------------~f~-------~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 243 LWCGRLPFGLSSPEADPEW----------------DFS-------RCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHSS-STCCCGGGSTSGG----------------GGT-------TSS----HHHHHHHHHHT-SSGGGS
T ss_pred HHHccCCCCCCCccccccc----------------cch-------hcC-CcCHHHHHHHHHHccCCcccC
Confidence 9999999985533211000 001 112 456779999999999999988
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.72 E-value=9.4e-20 Score=210.25 Aligned_cols=250 Identities=28% Similarity=0.344 Sum_probs=160.3
Q ss_pred EeccCCccCC-CCCCCCCCCCCcccEEEccCCCCCCC----cCccccccCcccEEecccccccC------CCCcccCCCc
Q 000859 75 SLNLSGLSLA-GSISPSLGRLQSLIHLDLSSNSLTGP----IPTALSNLSSLESLLLFSNQLAG------TIPTQLGSLT 143 (1251)
Q Consensus 75 ~l~l~~~~l~-g~~~~~l~~l~~L~~L~Ls~n~l~~~----~p~~l~~l~~L~~L~L~~n~l~~------~~p~~l~~l~ 143 (1251)
.|+|.++.+. +.....+..++.|+.|+++++.++.. ++..+...++|++|+++++.+.+ .++..++.++
T Consensus 2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~ 81 (319)
T cd00116 2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGC 81 (319)
T ss_pred ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcC
Confidence 3566666665 33444455667788888888877543 55566677778888888877662 2345566677
Q ss_pred cccEEEeccCCCCCCCCCccccccc---ccccccccCCCCC----CCCCCcCcc-cccceeeeccccccCC----CCccc
Q 000859 144 SLRVMRIGDNWLSGSIPTSFGNLVN---LGTLGLASCSLSG----PIPPQFGQL-SQLEELILQQNQLQGP----IPAEL 211 (1251)
Q Consensus 144 ~L~~L~L~~n~l~~~~p~~~~~l~~---L~~L~L~~n~l~~----~~p~~~~~l-~~L~~L~L~~N~l~~~----~p~~~ 211 (1251)
+|++|++++|.+.+..+..+..+.+ |++|++++|++++ .+...+..+ ++|++|+|++|.+++. ++..+
T Consensus 82 ~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~ 161 (319)
T cd00116 82 GLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKAL 161 (319)
T ss_pred ceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHH
Confidence 8888888888877666666655555 7888888777763 233344455 6778888887777642 23345
Q ss_pred CCCCCCceeeccccccCCC----chhhhcccccCceeeccCccCCCC----CCccccCCCccceeeccCccccCcCCccc
Q 000859 212 GNCSSLSIFTAAENNLNGS----IPAALGRLQNLQLLNLGNNSLSGE----IPSELGELSQLGYLNLMGNRLEGAIPRSF 283 (1251)
Q Consensus 212 ~~l~~L~~L~l~~n~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~----~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~ 283 (1251)
..+++|++|++++|.+++. ++..+..+++|++|+|++|.+++. ++..+..+++|++|++++|.+++.....+
T Consensus 162 ~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l 241 (319)
T cd00116 162 RANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAAL 241 (319)
T ss_pred HhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchHHHHHH
Confidence 6667777777777777742 334445556777777777777633 23345566777777777777765333322
Q ss_pred cc-----CCCccEEEeccccccC----CCCCccccccceEEEEccCcccc
Q 000859 284 AK-----MGNLQSLDLSMNRLTG----GIPEEFGNMGQLVFLVLSNNNIS 324 (1251)
Q Consensus 284 ~~-----l~~L~~L~Ls~N~l~~----~~~~~~~~l~~L~~L~Ls~N~l~ 324 (1251)
.. .+.|+.|++++|.++. .+...+..+++|+++++++|.++
T Consensus 242 ~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~ 291 (319)
T cd00116 242 ASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFG 291 (319)
T ss_pred HHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCc
Confidence 22 3677777777777752 22334455567777777777776
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.71 E-value=2.8e-19 Score=206.30 Aligned_cols=254 Identities=25% Similarity=0.318 Sum_probs=127.3
Q ss_pred EEEeccCCCC-CCCCCcccccccccccccccCCCCC----CCCCCcCcccccceeeeccccccC------CCCcccCCCC
Q 000859 147 VMRIGDNWLS-GSIPTSFGNLVNLGTLGLASCSLSG----PIPPQFGQLSQLEELILQQNQLQG------PIPAELGNCS 215 (1251)
Q Consensus 147 ~L~L~~n~l~-~~~p~~~~~l~~L~~L~L~~n~l~~----~~p~~~~~l~~L~~L~L~~N~l~~------~~p~~~~~l~ 215 (1251)
.|+|+.+.++ ...+.-|..+.+|+.|++++|.++. .++..+...++|++|+++++.+.+ .++..+.+++
T Consensus 2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~ 81 (319)
T cd00116 2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGC 81 (319)
T ss_pred ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcC
Confidence 4667777776 3445555666777777777777753 244445556667777777766552 2233445555
Q ss_pred CCceeeccccccCCCchhhhccccc---CceeeccCccCCC----CCCccccCC-CccceeeccCccccCc----CCccc
Q 000859 216 SLSIFTAAENNLNGSIPAALGRLQN---LQLLNLGNNSLSG----EIPSELGEL-SQLGYLNLMGNRLEGA----IPRSF 283 (1251)
Q Consensus 216 ~L~~L~l~~n~l~~~~p~~~~~l~~---L~~L~L~~N~l~~----~~~~~l~~l-~~L~~L~Ls~N~l~~~----~~~~~ 283 (1251)
+|+.|++++|.+.+..+..+..+.. |++|++++|.+++ .+...+..+ ++|++|++++|.+++. ++..+
T Consensus 82 ~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~ 161 (319)
T cd00116 82 GLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKAL 161 (319)
T ss_pred ceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHH
Confidence 6666666666665545555544444 6666666655542 112223334 5555555555555422 12233
Q ss_pred ccCCCccEEEeccccccCC----CCCccccccceEEEEccCccccCcccccccccccchhhhhccchhcccCCCcCccCC
Q 000859 284 AKMGNLQSLDLSMNRLTGG----IPEEFGNMGQLVFLVLSNNNISGSIPRRICTNATSLEHLILAEIQLSGEIPVELSQC 359 (1251)
Q Consensus 284 ~~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l 359 (1251)
..+.+|+.|++++|.+++. ++..+..+++|++|+|++|.+++.... .+...+..+
T Consensus 162 ~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~---------------------~l~~~~~~~ 220 (319)
T cd00116 162 RANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGAS---------------------ALAETLASL 220 (319)
T ss_pred HhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHH---------------------HHHHHhccc
Confidence 4444555555555555421 112222333455555555544311110 112234445
Q ss_pred CCCceEEccCCcccCCccccccc-----cccccEEEeeccccccc----ccccccccccccEEEecccccC
Q 000859 360 QSLKQLDLSNNTLNGTIPVELFQ-----LVALTHLYLHNNSLVGS----ISPFVANLSNLQELALYHNNFQ 421 (1251)
Q Consensus 360 ~~L~~L~Ls~N~l~~~~p~~~~~-----l~~L~~L~L~~n~l~~~----~~~~~~~l~~L~~L~L~~N~l~ 421 (1251)
++|++|++++|.+++.....+.. ...|++|++++|.++.. ....+..+++|+++++++|.+.
T Consensus 221 ~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~ 291 (319)
T cd00116 221 KSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFG 291 (319)
T ss_pred CCCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCc
Confidence 66666666666665322222221 14555555555555421 1223334445555555555555
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.4e-16 Score=167.68 Aligned_cols=140 Identities=16% Similarity=0.231 Sum_probs=105.9
Q ss_pred CCcCceecccCCceEEEEEecCCcEEEEEEeccCCchhhhHHHHHHHHHHHhc-----cCCCccceeceeeecCC-Cc-e
Q 000859 948 LSDEFIIGSGGSGTVYKAELANGATVAVKKISCKDDHLLNKSFTREVKTLGRI-----RHRHLVKLMGHCCNKGA-GS-N 1020 (1251)
Q Consensus 948 ~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~l~g~~~~~~~-~~-~ 1020 (1251)
+.....||+|+||.||. ...++. .+||++..... ...+.+.+|+++++.+ +||||++++|++..... +. .
T Consensus 4 L~~~~~LG~G~~~~Vy~-hp~~~~-k~IKv~~~~~~-~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~ 80 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA-HPEDAQ-RCIKIVYHRGD-GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY 80 (210)
T ss_pred cCCcceecCCCceEEEE-CCCCcC-eEEEEEecccc-chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence 44566899999999996 333444 47998865432 2446789999999999 57999999998876543 22 2
Q ss_pred eEEEee--cCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHH-HHhhhcCCCCeeecCCCCCCeeecC----CCC
Q 000859 1021 LLIYEY--MENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGV-EYLHHDCVPKILHRDIKSSNILLDS----NME 1093 (1251)
Q Consensus 1021 ~lv~E~--~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l-~~LH~~~~~~ivH~Dlkp~Nill~~----~~~ 1093 (1251)
.+|+|| +++|+|.+++++. .+++. ..++.|++.++ +|||+. +|+||||||+||+++. ++.
T Consensus 81 ~~I~e~~G~~~~tL~~~l~~~--------~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~ 147 (210)
T PRK10345 81 DVIADFDGKPSITLTEFAEQC--------RYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVI 147 (210)
T ss_pred EEEecCCCCcchhHHHHHHcc--------cccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCc
Confidence 378999 5579999999752 24444 35577778777 999999 9999999999999974 347
Q ss_pred eEEccccccc
Q 000859 1094 AHLGDFGLAK 1103 (1251)
Q Consensus 1094 ~kl~DfG~a~ 1103 (1251)
++|+||+.+.
T Consensus 148 ~~LiDg~G~~ 157 (210)
T PRK10345 148 PVVCDNIGES 157 (210)
T ss_pred EEEEECCCCc
Confidence 9999955443
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.67 E-value=2.5e-16 Score=193.24 Aligned_cols=250 Identities=18% Similarity=0.164 Sum_probs=177.7
Q ss_pred hhcCCCcCceecccCCceEEEEEecCCcEEEEEEeccCCchhhhHHHHHHHHHHHhcc---CCCccceeceeeecCCCce
Q 000859 944 ATNNLSDEFIIGSGGSGTVYKAELANGATVAVKKISCKDDHLLNKSFTREVKTLGRIR---HRHLVKLMGHCCNKGAGSN 1020 (1251)
Q Consensus 944 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~g~~~~~~~~~~ 1020 (1251)
....|.+.+.+|+|+||+||+|...+|+.||+|+=+.... -+|.-=.+++.+++ -+.|..+..++.- ....
T Consensus 696 ~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~----WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~--~~~S 769 (974)
T KOG1166|consen 696 GGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNP----WEFYICLQVMERLKPQMLPSIMHISSAHVF--QNAS 769 (974)
T ss_pred cceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCc----eeeeehHHHHHhhchhhhcchHHHHHHHcc--CCcc
Confidence 4456788889999999999999877799999998653332 12222333444444 2344444443322 3345
Q ss_pred eEEEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeec-------CCCC
Q 000859 1021 LLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLD-------SNME 1093 (1251)
Q Consensus 1021 ~lv~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~-------~~~~ 1093 (1251)
++|+||.+.|+|.+++.. .+.++|...+.++.|+++.+++||.. +|||+||||+|+|+. ....
T Consensus 770 ~lv~ey~~~Gtlld~~N~-------~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~ 839 (974)
T KOG1166|consen 770 VLVSEYSPYGTLLDLINT-------NKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKG 839 (974)
T ss_pred eeeeeccccccHHHhhcc-------CCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccc
Confidence 899999999999999984 46789999999999999999999999 999999999999994 2345
Q ss_pred eEEcccccccccccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHH
Q 000859 1094 AHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWV 1173 (1251)
Q Consensus 1094 ~kl~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~ 1173 (1251)
++|+|||.+..+.--. ....-....+|-.+-.+|...++.+++++|-|.++.+++-|+.|+.-- .
T Consensus 840 l~lIDfG~siDm~lfp--~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q--~----------- 904 (974)
T KOG1166|consen 840 LYLIDFGRSIDMKLFP--DGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME--V----------- 904 (974)
T ss_pred eEEEecccceeeeEcC--CCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH--h-----------
Confidence 8999999987653211 111223457788999999999999999999999999999999887431 0
Q ss_pred HHHHhccchhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhcC
Q 000859 1174 EMHMEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNVFN 1236 (1251)
Q Consensus 1174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~ 1236 (1251)
.......+...++ ++ ...+.+.+++..+|+.|-..=|...++...+++++.
T Consensus 905 -------~~g~~~~~~~~~~-Ry----~~~~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~ 955 (974)
T KOG1166|consen 905 -------KNGSSWMVKTNFP-RY----WKRDMWNKFFDLLLNPDCDTLPNLQELRTELEEVLA 955 (974)
T ss_pred -------cCCcceeccccch-hh----hhHHHHHHHHHHHhCcCcccchhHHHHHHHHHHHHH
Confidence 0000001111111 11 112235577777888666666888888888887764
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.66 E-value=6e-16 Score=167.37 Aligned_cols=142 Identities=19% Similarity=0.202 Sum_probs=109.8
Q ss_pred CCCcCceecccCCceEEEEE--ecCCcEEEEEEeccCCch-----------------------hhhHHHHHHHHHHHhcc
Q 000859 947 NLSDEFIIGSGGSGTVYKAE--LANGATVAVKKISCKDDH-----------------------LLNKSFTREVKTLGRIR 1001 (1251)
Q Consensus 947 ~~~~~~~lG~G~fg~V~~~~--~~~~~~vavK~~~~~~~~-----------------------~~~~~~~~E~~~l~~l~ 1001 (1251)
.|.+.+.||+|+||.||+|. ..+|+.||||+++..... .....+.+|++.++++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 46677899999999999997 568999999998743210 01234578999999997
Q ss_pred CC--CccceeceeeecCCCceeEEEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCC-eee
Q 000859 1002 HR--HLVKLMGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPK-ILH 1078 (1251)
Q Consensus 1002 h~--niv~l~g~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~-ivH 1078 (1251)
+. .+.+.+++ . ..++||||++++++..+... .......+...++.|++.+++|||+. + |+|
T Consensus 109 ~~~i~~p~~~~~---~---~~~lV~E~~~g~~L~~~~~~-------~~~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH 172 (237)
T smart00090 109 EAGVPVPKPIAW---R---RNVLVMEFIGGDGLPAPRLK-------DVEPEEEEEFELYDDILEEMRKLYKE---GELVH 172 (237)
T ss_pred hcCCCCCeeeEe---c---CceEEEEEecCCcccccccc-------cCCcchHHHHHHHHHHHHHHHHHHhc---CCEEe
Confidence 53 34444432 1 23799999999888766432 12345566789999999999999999 8 999
Q ss_pred cCCCCCCeeecCCCCeEEccccccccc
Q 000859 1079 RDIKSSNILLDSNMEAHLGDFGLAKAL 1105 (1251)
Q Consensus 1079 ~Dlkp~Nill~~~~~~kl~DfG~a~~~ 1105 (1251)
|||||+||+++ ++.++++|||.|...
T Consensus 173 ~Dikp~NIli~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 173 GDLSEYNILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred CCCChhhEEEE-CCCEEEEEChhhhcc
Confidence 99999999999 889999999998653
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.64 E-value=4.5e-16 Score=192.15 Aligned_cols=152 Identities=32% Similarity=0.520 Sum_probs=117.7
Q ss_pred cCCCHHhHHHHHHHHHHcCCCCCCCCCCCCCCCCCCC----ccccEEEcCC--C--CeEEEeccCCccCCCCCCCCCCCC
Q 000859 23 VLCKDEELSVLLEIKKSFTADPENVLHAWNQSNQNLC----TWRGITCGSS--S--ARVVSLNLSGLSLAGSISPSLGRL 94 (1251)
Q Consensus 23 ~~~~~~~~~all~~k~~~~~~~~~~l~sW~~~~~~~c----~w~gv~C~~~--~--~~v~~l~l~~~~l~g~~~~~l~~l 94 (1251)
..+.+.|..||++||+++. +|. ..+|+++ .|| .|.||.|+.. . .+|+.|+|+++++.|.+|+.++.+
T Consensus 367 ~~t~~~~~~aL~~~k~~~~-~~~--~~~W~g~--~C~p~~~~w~Gv~C~~~~~~~~~~v~~L~L~~n~L~g~ip~~i~~L 441 (623)
T PLN03150 367 SKTLLEEVSALQTLKSSLG-LPL--RFGWNGD--PCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKL 441 (623)
T ss_pred cccCchHHHHHHHHHHhcC-Ccc--cCCCCCC--CCCCcccccccceeeccCCCCceEEEEEECCCCCccccCCHHHhCC
Confidence 4567889999999999995 443 2489642 332 7999999532 2 368888888888888888888888
Q ss_pred CcccEEEccCCCCCCCcCccccccCcccEEecccccccCCCCcccCCCccccEEEeccCCCCCCCCCccccc-ccccccc
Q 000859 95 QSLIHLDLSSNSLTGPIPTALSNLSSLESLLLFSNQLAGTIPTQLGSLTSLRVMRIGDNWLSGSIPTSFGNL-VNLGTLG 173 (1251)
Q Consensus 95 ~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l-~~L~~L~ 173 (1251)
++|+.|+|++|.+.|.+|..++.+++|+.|+|++|+++|.+|..++++++|++|+|++|.++|.+|..++.+ .++..++
T Consensus 442 ~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~~~~~~~l~ 521 (623)
T PLN03150 442 RHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFN 521 (623)
T ss_pred CCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHhhccccCceEE
Confidence 888888888888888888888888888888888888888888888888888888888888888888777653 3455555
Q ss_pred cccCCC
Q 000859 174 LASCSL 179 (1251)
Q Consensus 174 L~~n~l 179 (1251)
+.+|..
T Consensus 522 ~~~N~~ 527 (623)
T PLN03150 522 FTDNAG 527 (623)
T ss_pred ecCCcc
Confidence 555543
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.63 E-value=2e-15 Score=160.24 Aligned_cols=138 Identities=19% Similarity=0.183 Sum_probs=108.2
Q ss_pred cCCCcCceecccCCceEEEEEecCCcEEEEEEeccCCch---------------------hhhHHHHHHHHHHHhccCCC
Q 000859 946 NNLSDEFIIGSGGSGTVYKAELANGATVAVKKISCKDDH---------------------LLNKSFTREVKTLGRIRHRH 1004 (1251)
Q Consensus 946 ~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~---------------------~~~~~~~~E~~~l~~l~h~n 1004 (1251)
..|...+.||+|+||.||+|...+|+.||||++...... .....+.+|..++..+.|++
T Consensus 15 ~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 94 (198)
T cd05144 15 VVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG 94 (198)
T ss_pred chhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence 346777899999999999998888999999987643210 01123677899999998874
Q ss_pred --ccceeceeeecCCCceeEEEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCC
Q 000859 1005 --LVKLMGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIK 1082 (1251)
Q Consensus 1005 --iv~l~g~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk 1082 (1251)
++..++. ...++||||+++++|.+.... ....+++.+++.++.++|+. +|+|||||
T Consensus 95 i~v~~~~~~------~~~~lv~e~~~g~~L~~~~~~-------------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~ 152 (198)
T cd05144 95 FPVPKPIDW------NRHAVVMEYIDGVELYRVRVL-------------EDPEEVLDEILEEIVKAYKH---GIIHGDLS 152 (198)
T ss_pred CCCCceeec------CCceEEEEEeCCcchhhcccc-------------ccHHHHHHHHHHHHHHHHHC---CCCcCCCC
Confidence 4444431 234899999999988765321 23457889999999999998 99999999
Q ss_pred CCCeeecCCCCeEEccccccccc
Q 000859 1083 SSNILLDSNMEAHLGDFGLAKAL 1105 (1251)
Q Consensus 1083 p~Nill~~~~~~kl~DfG~a~~~ 1105 (1251)
|+||++++++.++|+|||.+...
T Consensus 153 p~Nill~~~~~~~liDfg~~~~~ 175 (198)
T cd05144 153 EFNILVDDDEKIYIIDWPQMVST 175 (198)
T ss_pred cccEEEcCCCcEEEEECCccccC
Confidence 99999999999999999999654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.7e-16 Score=189.55 Aligned_cols=214 Identities=24% Similarity=0.334 Sum_probs=144.7
Q ss_pred hcCCCcCceecccCCceEEEEEec-CCcEEEEEEeccCCchhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEE
Q 000859 945 TNNLSDEFIIGSGGSGTVYKAELA-NGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLI 1023 (1251)
Q Consensus 945 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv 1023 (1251)
..+|..++.|-.|+||.||..+++ +.+++|+|+ .++.. |+ +||..+.| ..+.|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~l------------il-----Rnilt~a~--------npfvv 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQNL------------IL-----RNILTFAG--------NPFVV 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhcc-cccch------------hh-----hccccccC--------Cccee
Confidence 356888899999999999999654 567888843 22111 11 12333222 11222
Q ss_pred EeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEccccccc
Q 000859 1024 YEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAK 1103 (1251)
Q Consensus 1024 ~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~ 1103 (1251)
||-...++.. +.++. +++.+++|+|+. +|+|||+||+|.+|+.-|.+|++|||+++
T Consensus 136 ------gDc~tllk~~-------g~lPv--------dmvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk 191 (1205)
T KOG0606|consen 136 ------GDCATLLKNI-------GPLPV--------DMVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSK 191 (1205)
T ss_pred ------chhhhhcccC-------CCCcc--------hhhHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhh
Confidence 3434444431 23332 227899999999 99999999999999999999999999987
Q ss_pred ccccccCCC-----------CcccceeecccceecccccccCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHH
Q 000859 1104 ALVEDYNSN-----------TESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRW 1172 (1251)
Q Consensus 1104 ~~~~~~~~~-----------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~ 1172 (1251)
+........ .-.....+||+.|+|||++....|+..+|+|++|+++||.+.|+.||.+..+.+.-- ..
T Consensus 192 ~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg-~v 270 (1205)
T KOG0606|consen 192 KGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFG-QV 270 (1205)
T ss_pred hhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHh-hh
Confidence 643221110 011223689999999999999999999999999999999999999998875543211 11
Q ss_pred HHHHHhccchhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHH
Q 000859 1173 VEMHMEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSR 1225 (1251)
Q Consensus 1173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 1225 (1251)
+... ..+. ...+..+++.++++.+.++.+|.+|--..
T Consensus 271 isd~----i~wp------------E~dea~p~Ea~dli~~LL~qnp~~Rlgt~ 307 (1205)
T KOG0606|consen 271 ISDD----IEWP------------EEDEALPPEAQDLIEQLLRQNPLCRLGTG 307 (1205)
T ss_pred hhhh----cccc------------ccCcCCCHHHHHHHHHHHHhChHhhcccc
Confidence 1110 0111 11233456788999999999999994333
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.61 E-value=2.8e-16 Score=176.34 Aligned_cols=176 Identities=27% Similarity=0.433 Sum_probs=130.8
Q ss_pred ceeEEEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcc
Q 000859 1019 SNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGD 1098 (1251)
Q Consensus 1019 ~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D 1098 (1251)
+.++.|++++..+|.+|+.+.+. ...-++..+..++.|++.|++| + +.+|+|+||.||+...+..+||.|
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~----~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgD 399 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRT----GEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGD 399 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCc----ccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhh
Confidence 36899999999999999975432 4567888999999999999999 6 899999999999999999999999
Q ss_pred cccccccccccC--CCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhh-CCCCCCCccccchhHHHHHHH
Q 000859 1099 FGLAKALVEDYN--SNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMVRWVEM 1175 (1251)
Q Consensus 1099 fG~a~~~~~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~ 1175 (1251)
||+......... .....++...||..||+||.+.+..|+.++||||+|++++|+++ -..++.-.
T Consensus 400 Fgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~------------- 466 (516)
T KOG1033|consen 400 FGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERI------------- 466 (516)
T ss_pred hhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHH-------------
Confidence 999877644321 11223455789999999999999999999999999999999986 23222110
Q ss_pred HHhccchhhhhhhcccCCCCCCch-HHHHHHHHHHHHHccccCCCCCCCHHHH
Q 000859 1176 HMEMSGSAREELLDDQMKPLLPGE-ECAAYQVLEIALQCTKTSPQERPSSRQV 1227 (1251)
Q Consensus 1176 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~cl~~dP~~RPs~~ei 1227 (1251)
.....+.+ ..+|+. ....++=+.++.++++..|.+||++.+.
T Consensus 467 ------~t~~d~r~----g~ip~~~~~d~p~e~~ll~~lls~~p~~RP~~~~~ 509 (516)
T KOG1033|consen 467 ------ATLTDIRD----GIIPPEFLQDYPEEYTLLQQLLSPSPEERPSAIEV 509 (516)
T ss_pred ------Hhhhhhhc----CCCChHHhhcCcHHHHHHHHhcCCCcccCchHHHH
Confidence 00111111 112211 1111234579999999999999955443
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.60 E-value=6e-15 Score=158.82 Aligned_cols=135 Identities=22% Similarity=0.328 Sum_probs=110.8
Q ss_pred ceecccCCceEEEEEecCCcEEEEEEeccCCch-------hhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEEE
Q 000859 952 FIIGSGGSGTVYKAELANGATVAVKKISCKDDH-------LLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIY 1024 (1251)
Q Consensus 952 ~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv~ 1024 (1251)
+.||+|++|.||+|.+ +|..|+||+....... .....+.+|++++..+.|++++....++... ...+++|
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~--~~~~lv~ 78 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDP--ENFIIVM 78 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeC--CCCEEEE
Confidence 4799999999999987 5788999986543211 1234678899999999999987766665443 3458999
Q ss_pred eecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcccccccc
Q 000859 1025 EYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKA 1104 (1251)
Q Consensus 1025 E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~ 1104 (1251)
||++|++|.+++.... + ++..++.+++.+++++|+. +++|||++|+||+++ ++.++++|||.++.
T Consensus 79 e~~~G~~L~~~~~~~~----------~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 79 EYIEGEPLKDLINSNG----------M-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EEeCCcCHHHHHHhcc----------H-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999999986521 2 7789999999999999999 999999999999999 78999999998854
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.58 E-value=6.1e-15 Score=180.71 Aligned_cols=146 Identities=21% Similarity=0.292 Sum_probs=112.7
Q ss_pred CHHHHHHhhcCCCcCceecccCCceEEEEEecCCcEEEEEEeccCC-------chhhhHHHHHHHHHHHhccCCCcccee
Q 000859 937 RWEDIMGATNNLSDEFIIGSGGSGTVYKAELANGATVAVKKISCKD-------DHLLNKSFTREVKTLGRIRHRHLVKLM 1009 (1251)
Q Consensus 937 ~~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~h~niv~l~ 1009 (1251)
+|.........|...+.||+|+||+||+|.+... .+++|+...+. .....+.+.+|+++++.++|++++...
T Consensus 324 ~~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~ 402 (535)
T PRK09605 324 TWIKEEEVKRRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPV 402 (535)
T ss_pred eeccccccccccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeE
Confidence 3444444445556778999999999999987644 44444432111 112235688999999999999998877
Q ss_pred ceeeecCCCceeEEEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeec
Q 000859 1010 GHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLD 1089 (1251)
Q Consensus 1010 g~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~ 1089 (1251)
.++... ...++||||+++++|.+++. ....++.+++++++|||+. +++|||+||+||++
T Consensus 403 ~~~~~~--~~~~lv~E~~~g~~L~~~l~---------------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl- 461 (535)
T PRK09605 403 IYDVDP--EEKTIVMEYIGGKDLKDVLE---------------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV- 461 (535)
T ss_pred EEEEeC--CCCEEEEEecCCCcHHHHHH---------------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-
Confidence 666543 33589999999999999875 2457899999999999999 99999999999999
Q ss_pred CCCCeEEcccccccc
Q 000859 1090 SNMEAHLGDFGLAKA 1104 (1251)
Q Consensus 1090 ~~~~~kl~DfG~a~~ 1104 (1251)
+++.++|+|||+++.
T Consensus 462 ~~~~~~liDFGla~~ 476 (535)
T PRK09605 462 RDDRLYLIDFGLGKY 476 (535)
T ss_pred ECCcEEEEeCccccc
Confidence 678999999999865
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.58 E-value=9.9e-15 Score=155.50 Aligned_cols=131 Identities=22% Similarity=0.341 Sum_probs=104.3
Q ss_pred eecccCCceEEEEEecCCcEEEEEEeccCCc-------hhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEEEe
Q 000859 953 IIGSGGSGTVYKAELANGATVAVKKISCKDD-------HLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIYE 1025 (1251)
Q Consensus 953 ~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv~E 1025 (1251)
.||+|+||.||+|.+ +|..|++|+...... ....+.+.+|+++++.++|+++.....++... ...++|||
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~--~~~~lv~e 77 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDP--DNKTIVME 77 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEC--CCCEEEEE
Confidence 389999999999986 478999998653321 11235677899999999988755444444333 33589999
Q ss_pred ecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcccccccc
Q 000859 1026 YMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKA 1104 (1251)
Q Consensus 1026 ~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~ 1104 (1251)
|++|++|.+++.... . .++.+++.+++++|+. +++|||++|+||+++ ++.++++|||.++.
T Consensus 78 ~~~g~~l~~~~~~~~-------~-------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 78 YIEGKPLKDVIEEGN-------D-------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred EECCccHHHHHhhcH-------H-------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 999999999876421 0 7899999999999999 999999999999999 89999999998854
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.56 E-value=5.5e-16 Score=173.10 Aligned_cols=173 Identities=31% Similarity=0.481 Sum_probs=125.0
Q ss_pred cEEEcCCCccCCCCccccCCCcccccccccCccccCCCccccccccccceeeccCcccccccCcccCCCCCCceeccCCC
Q 000859 650 SHIDLNNNLLSGAVPSWLGTLPQLGELKLSFNQFVGFLPRELFNCSKLLVLSLDGNMLNGSLPNEVGNLASLNVLTLSGN 729 (1251)
Q Consensus 650 ~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N 729 (1251)
...||+.|++. .+|..+..+..|..+.|.+|.+.. +|..+.++..|..|||+.|+++ .+|..+..|+ |+.|-+++|
T Consensus 78 ~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r~-ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli~sNN 153 (722)
T KOG0532|consen 78 VFADLSRNRFS-ELPEEACAFVSLESLILYHNCIRT-IPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVLIVSNN 153 (722)
T ss_pred hhhhccccccc-cCchHHHHHHHHHHHHHHhcccee-cchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeEEEecC
Confidence 34566666666 566666666667777777777664 5667777777777777777776 5666666554 677777777
Q ss_pred cCCCCCCcccccccccceeeccCcccccccchhhhchhhHHHHHhccCCcccCCCCCCcCccccccEEEccCCccccCCc
Q 000859 730 LLSGPIPPAIGRLSKLYELRLSNNSLNGVIPLEIGQLQNLQSILDLSHNNFTGQIPPSMGTLAKLEVLNLSHNQLVGELP 809 (1251)
Q Consensus 730 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p 809 (1251)
+++ .+|+.++.+++|..||.+.|.+. .+|..++.|..|+. |+++.|++. .+|+++..|+ |..||+|.|+++ .||
T Consensus 154 kl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~-l~vrRn~l~-~lp~El~~Lp-Li~lDfScNkis-~iP 227 (722)
T KOG0532|consen 154 KLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRD-LNVRRNHLE-DLPEELCSLP-LIRLDFSCNKIS-YLP 227 (722)
T ss_pred ccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHH-HHHhhhhhh-hCCHHHhCCc-eeeeecccCcee-ecc
Confidence 776 67777777777777777777776 56777777777754 777778877 6777777654 778888888887 778
Q ss_pred hhhhhccCCCcEeeccccCcCcc
Q 000859 810 SQLGEMSSLGKLNLSYNDLQGKL 832 (1251)
Q Consensus 810 ~~l~~l~~L~~L~l~~N~l~~~~ 832 (1251)
-.|.+|..|+.|-|.+|||+.++
T Consensus 228 v~fr~m~~Lq~l~LenNPLqSPP 250 (722)
T KOG0532|consen 228 VDFRKMRHLQVLQLENNPLQSPP 250 (722)
T ss_pred hhhhhhhhheeeeeccCCCCCCh
Confidence 88888888888888888887544
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.49 E-value=1.7e-15 Score=169.35 Aligned_cols=196 Identities=30% Similarity=0.440 Sum_probs=173.2
Q ss_pred ccccccceEEccCCcccCCCCccccccCCccEEEcCCCccCCCCccccCCCcccccccccCccccCCCccccccccccce
Q 000859 620 GKIRELSLLDLSGNSLTGPIPTQLLMCKKLSHIDLNNNLLSGAVPSWLGTLPQLGELKLSFNQFVGFLPRELFNCSKLLV 699 (1251)
Q Consensus 620 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~ 699 (1251)
..+..-...||+.|++. ++|..+..+..|+.+.|..|.+- .+|..++.+..|+.|||+.|++.. +|..++.|+ |+.
T Consensus 72 ~~ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS~-lp~~lC~lp-Lkv 147 (722)
T KOG0532|consen 72 YDLTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLSH-LPDGLCDLP-LKV 147 (722)
T ss_pred ccccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhhc-CChhhhcCc-cee
Confidence 44556677899999998 89999999999999999999998 889999999999999999999985 788888877 999
Q ss_pred eeccCcccccccCcccCCCCCCceeccCCCcCCCCCCcccccccccceeeccCcccccccchhhhchhhHHHHHhccCCc
Q 000859 700 LSLDGNMLNGSLPNEVGNLASLNVLTLSGNLLSGPIPPAIGRLSKLYELRLSNNSLNGVIPLEIGQLQNLQSILDLSHNN 779 (1251)
Q Consensus 700 L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~l~~N~ 779 (1251)
|-+++|+++ .+|+.++.+..|..||.+.|.+. .+|..++.+.+|+.|.+..|++. .+|.+++.|+-. + ||+|+|+
T Consensus 148 li~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~LpLi-~-lDfScNk 222 (722)
T KOG0532|consen 148 LIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSLPLI-R-LDFSCNK 222 (722)
T ss_pred EEEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCCcee-e-eecccCc
Confidence 999999999 89999999999999999999998 79999999999999999999998 578888888755 4 8999999
Q ss_pred ccCCCCCCcCccccccEEEccCCccccCCchhhhhccC---CCcEeeccc
Q 000859 780 FTGQIPPSMGTLAKLEVLNLSHNQLVGELPSQLGEMSS---LGKLNLSYN 826 (1251)
Q Consensus 780 l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~---L~~L~l~~N 826 (1251)
++ .+|.+|.+|+.|++|-|.+|.|. .-|..+...=. .++|+..-.
T Consensus 223 is-~iPv~fr~m~~Lq~l~LenNPLq-SPPAqIC~kGkVHIFKyL~~qA~ 270 (722)
T KOG0532|consen 223 IS-YLPVDFRKMRHLQVLQLENNPLQ-SPPAQICEKGKVHIFKYLSTQAC 270 (722)
T ss_pred ee-ecchhhhhhhhheeeeeccCCCC-CChHHHHhccceeeeeeecchhc
Confidence 99 89999999999999999999998 67888765433 345555555
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.48 E-value=1.6e-13 Score=144.63 Aligned_cols=136 Identities=22% Similarity=0.247 Sum_probs=97.6
Q ss_pred CceecccCCceEEEEEecCCcEEEEEEeccCCchh-hhHH----------------------HHHHHHHHHhccCCC--c
Q 000859 951 EFIIGSGGSGTVYKAELANGATVAVKKISCKDDHL-LNKS----------------------FTREVKTLGRIRHRH--L 1005 (1251)
Q Consensus 951 ~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~-~~~~----------------------~~~E~~~l~~l~h~n--i 1005 (1251)
.+.||+|+||+||+|...++++||||++....... .... ...|.+.+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 35799999999999987789999999986432110 1111 135666666664433 4
Q ss_pred cceeceeeecCCCceeEEEeecCCCChHHh-hhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCCeeecCCCC
Q 000859 1006 VKLMGHCCNKGAGSNLLIYEYMENGSVWDW-LHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHH-DCVPKILHRDIKS 1083 (1251)
Q Consensus 1006 v~l~g~~~~~~~~~~~lv~E~~~~gsL~~~-l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~Dlkp 1083 (1251)
.+.++. ...++||||++++++... +... ... .++..++.+++.++.++|. . +|+|||+||
T Consensus 82 ~~~~~~------~~~~lv~e~~~g~~~~~~~l~~~--------~~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p 143 (187)
T cd05119 82 PKPIDL------NRHVLVMEFIGGDGIPAPRLKDV--------RLL-EDPEELYDQILELMRKLYREA---GLVHGDLSE 143 (187)
T ss_pred CceEec------CCCEEEEEEeCCCCccChhhhhh--------hhc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCCh
Confidence 444432 124899999998654321 1111 001 5678899999999999999 7 999999999
Q ss_pred CCeeecCCCCeEEccccccccc
Q 000859 1084 SNILLDSNMEAHLGDFGLAKAL 1105 (1251)
Q Consensus 1084 ~Nill~~~~~~kl~DfG~a~~~ 1105 (1251)
+||+++ ++.++++|||.+...
T Consensus 144 ~Nili~-~~~~~liDfg~a~~~ 164 (187)
T cd05119 144 YNILVD-DGKVYIIDVPQAVEI 164 (187)
T ss_pred hhEEEE-CCcEEEEECcccccc
Confidence 999999 999999999999654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.48 E-value=4.6e-15 Score=180.03 Aligned_cols=257 Identities=25% Similarity=0.292 Sum_probs=188.9
Q ss_pred cCCCcCceecccCCceEEEEEec--CCcEEEEEEeccCC-chhhhHHHHHHHHHHHhcc-CCCccceeceeeecCCCcee
Q 000859 946 NNLSDEFIIGSGGSGTVYKAELA--NGATVAVKKISCKD-DHLLNKSFTREVKTLGRIR-HRHLVKLMGHCCNKGAGSNL 1021 (1251)
Q Consensus 946 ~~~~~~~~lG~G~fg~V~~~~~~--~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~~~ 1021 (1251)
..|...+.||+|+|+.|-.+... ....+|+|.+.... .....+....|..+-+.+. |+|++.+++.. ..+...+
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~--~~~~~~~ 97 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPS--SSPRSYL 97 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCcc--CCCcccc
Confidence 34666777999999999988543 34567777765443 2333445556888777776 99999999865 3455678
Q ss_pred EEEeecCCCChHHhh-hcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhh-hcCCCCeeecCCCCCCeeecCCC-CeEEcc
Q 000859 1022 LIYEYMENGSVWDWL-HKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLH-HDCVPKILHRDIKSSNILLDSNM-EAHLGD 1098 (1251)
Q Consensus 1022 lv~E~~~~gsL~~~l-~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH-~~~~~~ivH~Dlkp~Nill~~~~-~~kl~D 1098 (1251)
++.||.++|++.+-+ +.. ....+...+..++.|+..++.|+| .. +++|||+||+|.+++..+ ..+++|
T Consensus 98 ~~~~~s~g~~~f~~i~~~~------~~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~d 168 (601)
T KOG0590|consen 98 LSLSYSDGGSLFSKISHPD------STGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIAD 168 (601)
T ss_pred cccCcccccccccccccCC------ccCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCC
Confidence 999999999998877 331 224556667789999999999999 77 999999999999999999 999999
Q ss_pred cccccccccccCCCCcccceeec-ccceecccccccC-CCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHHH
Q 000859 1099 FGLAKALVEDYNSNTESNTWFAG-SYGYIAPEYAYSL-KATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMH 1176 (1251)
Q Consensus 1099 fG~a~~~~~~~~~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~ 1176 (1251)
||+|..+... ...........| ++.|+|||...+. ......|+||.|+++.-+++|..|++...........|.+..
T Consensus 169 f~~At~~~~~-~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~ 247 (601)
T KOG0590|consen 169 FGLATAYRNK-NGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNK 247 (601)
T ss_pred chhhcccccc-CCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccc
Confidence 9999877542 122223334567 9999999998874 456789999999999999999999976654443333332211
Q ss_pred HhccchhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 000859 1177 MEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCD 1229 (1251)
Q Consensus 1177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1229 (1251)
................++..+++..+|+.|.+.+++..
T Consensus 248 ---------------~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 248 ---------------GRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred ---------------cccccCccccCChhhhhcccccccCCchhccccccccc
Confidence 00011122233445678889999999999999998754
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.48 E-value=3.6e-13 Score=146.17 Aligned_cols=138 Identities=19% Similarity=0.245 Sum_probs=106.4
Q ss_pred Cceec-ccCCceEEEEEecCCcEEEEEEeccCC------------chhhhHHHHHHHHHHHhccCCCc--cceeceeeec
Q 000859 951 EFIIG-SGGSGTVYKAELANGATVAVKKISCKD------------DHLLNKSFTREVKTLGRIRHRHL--VKLMGHCCNK 1015 (1251)
Q Consensus 951 ~~~lG-~G~fg~V~~~~~~~~~~vavK~~~~~~------------~~~~~~~~~~E~~~l~~l~h~ni--v~l~g~~~~~ 1015 (1251)
...|| .|+.|+||.+... +..+|||.+.... .......+.+|++++++++|++| ++.+++....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 34788 9999999999775 7889999885321 11233567889999999998775 6677654433
Q ss_pred CCC--ceeEEEeecCC-CChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCC
Q 000859 1016 GAG--SNLLIYEYMEN-GSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNM 1092 (1251)
Q Consensus 1016 ~~~--~~~lv~E~~~~-gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~ 1092 (1251)
... ..++|||++++ .+|.+++... .++.. .+.+++.+++++|+. ||+||||||+|||++.++
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~--------~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~ 179 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQEA--------PLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDG 179 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhcC--------CCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCC
Confidence 222 12599999997 6899888642 23433 356899999999999 999999999999999999
Q ss_pred CeEEcccccccc
Q 000859 1093 EAHLGDFGLAKA 1104 (1251)
Q Consensus 1093 ~~kl~DfG~a~~ 1104 (1251)
.++|+|||.++.
T Consensus 180 ~v~LIDfg~~~~ 191 (239)
T PRK01723 180 KFWLIDFDRGEL 191 (239)
T ss_pred CEEEEECCCccc
Confidence 999999998865
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.46 E-value=5.3e-13 Score=135.37 Aligned_cols=135 Identities=21% Similarity=0.226 Sum_probs=110.2
Q ss_pred cCceecccCCceEEEEEecCCcEEEEEEeccCCchhhhHHHHHHHHHHHhccC--CCccceeceeeecCCCceeEEEeec
Q 000859 950 DEFIIGSGGSGTVYKAELANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRH--RHLVKLMGHCCNKGAGSNLLIYEYM 1027 (1251)
Q Consensus 950 ~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~g~~~~~~~~~~~lv~E~~ 1027 (1251)
+.+.+|+|.++.||++... +..+++|....... ...+.+|+.+++.++| ..++++++++... ...++++||+
T Consensus 2 ~~~~i~~g~~~~v~~~~~~-~~~~~iK~~~~~~~---~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~--~~~~~v~e~~ 75 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTK-DEDYVLKINPSREK---GADREREVAILQLLARKGLPVPKVLASGESD--GWSYLLMEWI 75 (155)
T ss_pred cceecccccccceEEEEec-CCeEEEEecCCCCc---hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCC--CccEEEEEec
Confidence 3467999999999999875 47899999864433 4678899999999976 5888888766433 4579999999
Q ss_pred CCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcccccccc
Q 000859 1028 ENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKA 1104 (1251)
Q Consensus 1028 ~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~ 1104 (1251)
+++.+..+ +......++.+++++++++|.....+++|+|++|+||+++..+.++++|||.++.
T Consensus 76 ~g~~~~~~--------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 76 EGETLDEV--------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred CCeecccC--------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 88766443 4566678899999999999996444799999999999999989999999998854
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.42 E-value=1.6e-13 Score=169.74 Aligned_cols=107 Identities=39% Similarity=0.627 Sum_probs=75.6
Q ss_pred CCceeccCCCcCCCCCCcccccccccceeeccCcccccccchhhhchhhHHHHHhccCCcccCCCCCCcCccccccEEEc
Q 000859 720 SLNVLTLSGNLLSGPIPPAIGRLSKLYELRLSNNSLNGVIPLEIGQLQNLQSILDLSHNNFTGQIPPSMGTLAKLEVLNL 799 (1251)
Q Consensus 720 ~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~l~~N~l~~~~p~~~~~l~~L~~L~l 799 (1251)
.++.|+|++|.+++.+|..++.+++|+.|+|++|++.|.+|..++.+++|+. |+|++|+++|.+|+.++.|++|+.|+|
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~-LdLs~N~lsg~iP~~l~~L~~L~~L~L 497 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEV-LDLSYNSFNGSIPESLGQLTSLRILNL 497 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCE-EECCCCCCCCCCchHHhcCCCCCEEEC
Confidence 3667788888888777877877888888888888777777777777777753 777777777777777777777777777
Q ss_pred cCCccccCCchhhhhc-cCCCcEeecccc
Q 000859 800 SHNQLVGELPSQLGEM-SSLGKLNLSYND 827 (1251)
Q Consensus 800 ~~N~l~~~~p~~l~~l-~~L~~L~l~~N~ 827 (1251)
++|+++|.+|..+..+ .++..+++++|+
T Consensus 498 s~N~l~g~iP~~l~~~~~~~~~l~~~~N~ 526 (623)
T PLN03150 498 NGNSLSGRVPAALGGRLLHRASFNFTDNA 526 (623)
T ss_pred cCCcccccCChHHhhccccCceEEecCCc
Confidence 7777777777776553 234444444443
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.42 E-value=3.8e-13 Score=159.66 Aligned_cols=243 Identities=34% Similarity=0.418 Sum_probs=175.3
Q ss_pred ceeeecccCccccCCCCCCCCcc-cCceeecccCccccccCcccccccccceEEccCCcccCCCCccccccCCccEEEcC
Q 000859 577 FLSFDVTNNEFDHEIPPQLGNSP-SLERLRLGNNKFIGKIPWTFGKIRELSLLDLSGNSLTGPIPTQLLMCKKLSHIDLN 655 (1251)
Q Consensus 577 l~~l~l~~n~l~~~~p~~l~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~ 655 (1251)
+..+++.+|.+. .+|+...... +|+.|++++|++. .+|..++.+++|+.|++++|+++ .+|.....+++|+.|+++
T Consensus 118 l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L~ls 194 (394)
T COG4886 118 LTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLS 194 (394)
T ss_pred eeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCchhh-hhhhhhhhhhhhhheecc
Confidence 333444444443 4556566663 8888888888876 45556778888888888888888 566666677888888888
Q ss_pred CCccCCCCccccCCCcccccccccCccccCCCccccccccccceeeccCcccccccCcccCCCCCCceeccCCCcCCCCC
Q 000859 656 NNLLSGAVPSWLGTLPQLGELKLSFNQFVGFLPRELFNCSKLLVLSLDGNMLNGSLPNEVGNLASLNVLTLSGNLLSGPI 735 (1251)
Q Consensus 656 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~ 735 (1251)
+|+++ .+|...+.+..|++|.+++|.+.. .+..+.+++++..|.+++|++. .++..++.++++++|++++|+++ .+
T Consensus 195 ~N~i~-~l~~~~~~~~~L~~l~~~~N~~~~-~~~~~~~~~~l~~l~l~~n~~~-~~~~~~~~l~~l~~L~~s~n~i~-~i 270 (394)
T COG4886 195 GNKIS-DLPPEIELLSALEELDLSNNSIIE-LLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQIS-SI 270 (394)
T ss_pred CCccc-cCchhhhhhhhhhhhhhcCCccee-cchhhhhcccccccccCCceee-eccchhccccccceecccccccc-cc
Confidence 88888 667766667779999999995443 5777888899999999999987 55788899999999999999998 45
Q ss_pred CcccccccccceeeccCcccccccchhhhchhhHHHHHhccCCcccCCCCCCcCccccccEEEccCCccccCCchhhhhc
Q 000859 736 PPAIGRLSKLYELRLSNNSLNGVIPLEIGQLQNLQSILDLSHNNFTGQIPPSMGTLAKLEVLNLSHNQLVGELPSQLGEM 815 (1251)
Q Consensus 736 ~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l 815 (1251)
+. ++.+.+++.|++++|.+...+|.........+. ... +.++ ..+........+...++..|..+ ..|..+...
T Consensus 271 ~~-~~~~~~l~~L~~s~n~~~~~~~~~~~~~~~~~~--~~~-~~~~-~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 344 (394)
T COG4886 271 SS-LGSLTNLRELDLSGNSLSNALPLIALLLLLLEL--LLN-LLLT-LKALELKLNSILLNNNILSNGET-SSPEALSIL 344 (394)
T ss_pred cc-ccccCccCEEeccCccccccchhhhccchhHHh--hhh-hhhh-ccccccccccccccccccccccc-ccchhhccc
Confidence 55 888999999999999998777766555444332 222 4444 23344444555666777777776 667777777
Q ss_pred cCCCcEeeccccCcCcc
Q 000859 816 SSLGKLNLSYNDLQGKL 832 (1251)
Q Consensus 816 ~~L~~L~l~~N~l~~~~ 832 (1251)
..+..++...+......
T Consensus 345 ~~~~~~~~~~~~~~~~~ 361 (394)
T COG4886 345 ESLNNLWTLDNALDESN 361 (394)
T ss_pred ccccCceecccccccch
Confidence 77777777777665433
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.36 E-value=9.8e-13 Score=156.15 Aligned_cols=197 Identities=35% Similarity=0.514 Sum_probs=98.5
Q ss_pred eEeccCCcccCCCCCcccccCCCcEEeccCCccCCCcCccccccc-cCCeeecCCCcCcccCCcchhccchhhhhhccCC
Q 000859 460 WIDFFGNSFTGEIPTSIGRLKDLNFLHLRQNELVGQIPASLGNCH-QLIILDLADNKLSGGVPASFGFLQALEQLMLYNN 538 (1251)
Q Consensus 460 ~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 538 (1251)
.++++.|.+. ..+..+..++.++.|++.+|.++ .+|......+ +|+.|++++|++. .+|..++.++.|+.|++++|
T Consensus 97 ~l~~~~~~~~-~~~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N 173 (394)
T COG4886 97 SLDLNLNRLR-SNISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFN 173 (394)
T ss_pred eeeccccccc-cCchhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCc
Confidence 4555555553 22223344455555555555555 3444444442 5555555555554 33334455555555555555
Q ss_pred ccccCCchhhhhhcCCCeeecccccccccccccccCccceeeecccCccccCCCCCCCCcccCceeecccCccccccCcc
Q 000859 539 SLEGNLPGSLINLRNLTRINFSKNRLNGRIATLCSSHSFLSFDVTNNEFDHEIPPQLGNSPSLERLRLGNNKFIGKIPWT 618 (1251)
Q Consensus 539 ~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~l~~~~~l~~l~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~ 618 (1251)
+++ .+|.....+++|+.|++++|+++ .+|........|++|.+++|++. ..+..
T Consensus 174 ~l~-~l~~~~~~~~~L~~L~ls~N~i~------------------------~l~~~~~~~~~L~~l~~~~N~~~-~~~~~ 227 (394)
T COG4886 174 DLS-DLPKLLSNLSNLNNLDLSGNKIS------------------------DLPPEIELLSALEELDLSNNSII-ELLSS 227 (394)
T ss_pred hhh-hhhhhhhhhhhhhheeccCCccc------------------------cCchhhhhhhhhhhhhhcCCcce-ecchh
Confidence 555 23333334445555555555544 23333333344556666666432 34444
Q ss_pred cccccccceEEccCCcccCCCCccccccCCccEEEcCCCccCCCCccccCCCcccccccccCccccCCCc
Q 000859 619 FGKIRELSLLDLSGNSLTGPIPTQLLMCKKLSHIDLNNNLLSGAVPSWLGTLPQLGELKLSFNQFVGFLP 688 (1251)
Q Consensus 619 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p 688 (1251)
+..+.++..+.+++|++. ..+..+..+.+++.|++++|.++.. +. ++.+.+|+.|++++|.+....|
T Consensus 228 ~~~~~~l~~l~l~~n~~~-~~~~~~~~l~~l~~L~~s~n~i~~i-~~-~~~~~~l~~L~~s~n~~~~~~~ 294 (394)
T COG4886 228 LSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQISSI-SS-LGSLTNLRELDLSGNSLSNALP 294 (394)
T ss_pred hhhcccccccccCCceee-eccchhccccccceecccccccccc-cc-ccccCccCEEeccCccccccch
Confidence 555555666666666555 2345555555566666666666532 22 5555666666666666555433
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.31 E-value=7.9e-12 Score=147.61 Aligned_cols=142 Identities=20% Similarity=0.244 Sum_probs=100.5
Q ss_pred ceecccCCceEEEEEecCCcEEEEEEeccCCchhhh---------------------------------------HHHHH
Q 000859 952 FIIGSGGSGTVYKAELANGATVAVKKISCKDDHLLN---------------------------------------KSFTR 992 (1251)
Q Consensus 952 ~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~---------------------------------------~~~~~ 992 (1251)
+.||.|++|.||+|+.++|+.||||+.+........ -+|.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 579999999999999999999999998644211100 12445
Q ss_pred HHHHHHhcc----CCCccceeceeeecCCCceeEEEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHH-HHHH
Q 000859 993 EVKTLGRIR----HRHLVKLMGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQ-GVEY 1067 (1251)
Q Consensus 993 E~~~l~~l~----h~niv~l~g~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~-~l~~ 1067 (1251)
|++.+.++. |..-+.+-.++.+. ....++||||++|+++.++..... ... ...+++.+++. .+..
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~-~~~~vLvmE~i~G~~L~~~~~~~~------~~~---~~~~ia~~~~~~~l~q 272 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDR-TSERVLTMEWIDGIPLSDIAALDE------AGL---DRKALAENLARSFLNQ 272 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhh-cCCceEEEEeECCcccccHHHHHh------cCC---CHHHHHHHHHHHHHHH
Confidence 666555552 33333333333322 223589999999999988765321 111 23456666666 4678
Q ss_pred hhhcCCCCeeecCCCCCCeeecCCCCeEEcccccccccc
Q 000859 1068 LHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALV 1106 (1251)
Q Consensus 1068 LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~ 1106 (1251)
+|.. |++|+|++|.||+++.+++++++|||++..+.
T Consensus 273 l~~~---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 273 VLRD---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred HHhC---CceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 8988 99999999999999999999999999997664
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.25 E-value=8.4e-12 Score=131.11 Aligned_cols=207 Identities=23% Similarity=0.314 Sum_probs=140.7
Q ss_pred HHhccCCCccceeceeeecCC---CceeEEEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCC
Q 000859 997 LGRIRHRHLVKLMGHCCNKGA---GSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCV 1073 (1251)
Q Consensus 997 l~~l~h~niv~l~g~~~~~~~---~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~ 1073 (1251)
+-.+.|.|+|+++.|+.+... ....+++|||..|++..+|++.. .....+....-.+++.||..||.|||+. .
T Consensus 121 llqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~---~~~~a~~~~~wkkw~tqIlsal~yLhs~-~ 196 (458)
T KOG1266|consen 121 LLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTK---KNQKALFQKAWKKWCTQILSALSYLHSC-D 196 (458)
T ss_pred HHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHH---HhhhhhhHHHHHHHHHHHHhhhhhhhcc-C
Confidence 444579999999998875432 23578999999999999998753 2345677778889999999999999994 7
Q ss_pred CCeeecCCCCCCeeecCCCCeEEcccccccccccccCC-CCcccceeecccceecccccccCCCCCccceeehhHHHHHH
Q 000859 1074 PKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNS-NTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMEL 1152 (1251)
Q Consensus 1074 ~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el 1152 (1251)
|.|+|+++..+-|++..+|-+|++--.-. .+...... ....+....+-++|.|||+-.....+.++|||+||....||
T Consensus 197 PpiihgnlTc~tifiq~ngLIkig~~ap~-s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlem 275 (458)
T KOG1266|consen 197 PPIIHGNLTCDTIFIQHNGLIKIGSVAPD-STHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEM 275 (458)
T ss_pred CccccCCcchhheeecCCceEEecccCcc-ccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHH
Confidence 89999999999999999999998632111 00000000 01111123456889999987777788899999999999999
Q ss_pred hhCCCCCC-CccccchhHHHHHHHHHhccchhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 000859 1153 VSGKMPTD-ATFGVEMDMVRWVEMHMEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLL 1231 (1251)
Q Consensus 1153 ~tg~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L 1231 (1251)
..+..--. +....+. ++.+.......- ...=+.++.+|++..|..||+|++++...
T Consensus 276 ailEiq~tnseS~~~~-----------------ee~ia~~i~~le------n~lqr~~i~kcl~~eP~~rp~ar~llfHp 332 (458)
T KOG1266|consen 276 AILEIQSTNSESKVEV-----------------EENIANVIIGLE------NGLQRGSITKCLEGEPNGRPDARLLLFHP 332 (458)
T ss_pred HHheeccCCCcceeeh-----------------hhhhhhheeecc------CccccCcCcccccCCCCCCcchhhhhcCc
Confidence 88765421 1111100 000000000000 00112577889999999999999987543
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.22 E-value=1.7e-12 Score=141.53 Aligned_cols=208 Identities=26% Similarity=0.311 Sum_probs=141.4
Q ss_pred ccccccceEEccCCcccCCCC--ccccccCCccEEEcCCCccCC--CCccccCCCcccccccccCccccCCCcccc-ccc
Q 000859 620 GKIRELSLLDLSGNSLTGPIP--TQLLMCKKLSHIDLNNNLLSG--AVPSWLGTLPQLGELKLSFNQFVGFLPREL-FNC 694 (1251)
Q Consensus 620 ~~l~~L~~L~Ls~N~l~~~~p--~~~~~l~~L~~L~l~~N~l~~--~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~-~~l 694 (1251)
.++.+|+.+.|.+..+.. .+ .....|++++.||||.|.++. .+-....+||+|+.|+|+.|++..+..... ..+
T Consensus 118 sn~kkL~~IsLdn~~V~~-~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l 196 (505)
T KOG3207|consen 118 SNLKKLREISLDNYRVED-AGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLL 196 (505)
T ss_pred hhHHhhhheeecCccccc-cchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhh
Confidence 445667777777666652 22 345677888888888888873 334455789999999999999885433322 357
Q ss_pred cccceeeccCcccccc-cCcccCCCCCCceeccCCCcCCCCCCcccccccccceeeccCcccccccc-hhhhchhhHHHH
Q 000859 695 SKLLVLSLDGNMLNGS-LPNEVGNLASLNVLTLSGNLLSGPIPPAIGRLSKLYELRLSNNSLNGVIP-LEIGQLQNLQSI 772 (1251)
Q Consensus 695 ~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p-~~~~~l~~l~~~ 772 (1251)
++|+.|.|++|.|+-. +-.....+|+|+.|+|+.|.....-.....-+..|++|||++|++....- ...+.++.|. .
T Consensus 197 ~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~-~ 275 (505)
T KOG3207|consen 197 SHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLN-Q 275 (505)
T ss_pred hhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchh-h
Confidence 8899999999999721 22334568999999999995332333334556789999999998864321 3466777774 4
Q ss_pred HhccCCcccC-CCCCC-----cCccccccEEEccCCccccC-CchhhhhccCCCcEeeccccCc
Q 000859 773 LDLSHNNFTG-QIPPS-----MGTLAKLEVLNLSHNQLVGE-LPSQLGEMSSLGKLNLSYNDLQ 829 (1251)
Q Consensus 773 L~l~~N~l~~-~~p~~-----~~~l~~L~~L~l~~N~l~~~-~p~~l~~l~~L~~L~l~~N~l~ 829 (1251)
|+++.+.|++ .+|+. ...+++|++|++++|+|... .-..+..+++|+.|.+..|+|.
T Consensus 276 Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~~n~ln 339 (505)
T KOG3207|consen 276 LNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHLRITLNYLN 339 (505)
T ss_pred hhccccCcchhcCCCccchhhhcccccceeeecccCccccccccchhhccchhhhhhccccccc
Confidence 7888888874 33444 35677888888888888631 2234556666777776666664
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.21 E-value=2.8e-12 Score=132.46 Aligned_cols=133 Identities=27% Similarity=0.375 Sum_probs=73.0
Q ss_pred cCCccEEEcCCCccCCCCccccCCCcccccccccCccccCCCccccccccccceeeccCcccccccCcccCCCCCCceec
Q 000859 646 CKKLSHIDLNNNLLSGAVPSWLGTLPQLGELKLSFNQFVGFLPRELFNCSKLLVLSLDGNMLNGSLPNEVGNLASLNVLT 725 (1251)
Q Consensus 646 l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 725 (1251)
++.|+.+|||+|.|+ .+.+.+.-+|.++.|++|+|.++.+ ..+..+.+|+.|||++|.++ .+..+-..+-+.++|.
T Consensus 283 Wq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~ 358 (490)
T KOG1259|consen 283 WQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLK 358 (490)
T ss_pred Hhhhhhccccccchh-hhhhhhhhccceeEEeccccceeee--hhhhhcccceEeecccchhH-hhhhhHhhhcCEeeee
Confidence 344444444444444 3444444455555555555555532 23445555555555555555 3334444555566666
Q ss_pred cCCCcCCCCCCcccccccccceeeccCccccccc-chhhhchhhHHHHHhccCCcccCCCCC
Q 000859 726 LSGNLLSGPIPPAIGRLSKLYELRLSNNSLNGVI-PLEIGQLQNLQSILDLSHNNFTGQIPP 786 (1251)
Q Consensus 726 ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~-p~~~~~l~~l~~~L~l~~N~l~~~~p~ 786 (1251)
|++|.|.. -..++++.+|..||+++|++.... -..||+|+.|+ ++.|.+|.+.+ +|+
T Consensus 359 La~N~iE~--LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE-~l~L~~NPl~~-~vd 416 (490)
T KOG1259|consen 359 LAQNKIET--LSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLE-TLRLTGNPLAG-SVD 416 (490)
T ss_pred hhhhhHhh--hhhhHhhhhheeccccccchhhHHHhcccccccHHH-HHhhcCCCccc-cch
Confidence 66666542 134556666667777777665332 24577777774 47777777773 443
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.13 E-value=2.2e-10 Score=118.55 Aligned_cols=129 Identities=19% Similarity=0.149 Sum_probs=94.9
Q ss_pred ceecccCCceEEEEEecCCcEEEEEEeccCCchhhhHHHHHHHHHHHhccCCCcc-ceeceeeecCCCceeEEEeecCCC
Q 000859 952 FIIGSGGSGTVYKAELANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLV-KLMGHCCNKGAGSNLLIYEYMENG 1030 (1251)
Q Consensus 952 ~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~g~~~~~~~~~~~lv~E~~~~g 1030 (1251)
+.++.|.++.||+++.. +..|++|+...... ....+.+|+++++.+.+.+++ +++++. . ...++||||+++.
T Consensus 4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~--~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~--~~~~lv~e~i~G~ 76 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE--LLINRENEAENSKLAAEAGIGPKLYYFD--P--ETGVLITEFIEGS 76 (170)
T ss_pred eecCCcccCceEEEEEC-CeEEEEEeCCCCcc--cccCHHHHHHHHHHHHHhCCCCceEEEe--C--CCCeEEEEecCCC
Confidence 46899999999999875 78899999754332 224567899999998665544 444432 2 2247999999998
Q ss_pred ChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcC--CCCeeecCCCCCCeeecCCCCeEEccccccc
Q 000859 1031 SVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDC--VPKILHRDIKSSNILLDSNMEAHLGDFGLAK 1103 (1251)
Q Consensus 1031 sL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~ 1103 (1251)
++.+. . ......+.+++++++.||+.. ..+++|+|++|.||+++ ++.++++|||.+.
T Consensus 77 ~l~~~-~--------------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 77 ELLTE-D--------------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred ccccc-c--------------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 76542 0 011245678999999999982 12369999999999999 6789999999874
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.13 E-value=6.8e-11 Score=136.47 Aligned_cols=250 Identities=22% Similarity=0.241 Sum_probs=176.2
Q ss_pred CCcCceecc--cCCceEEEEEe---cCCcEEEEEEeccCCc-hhhhHHHHHHHHHHHhc-cCCCccceeceeeecCCCce
Q 000859 948 LSDEFIIGS--GGSGTVYKAEL---ANGATVAVKKISCKDD-HLLNKSFTREVKTLGRI-RHRHLVKLMGHCCNKGAGSN 1020 (1251)
Q Consensus 948 ~~~~~~lG~--G~fg~V~~~~~---~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~~ 1020 (1251)
+...+.+|. |.+|.||.+.. .++..+|+|+-+.... ......=.+|+...+++ .|++.++.+..+.. .+..
T Consensus 116 ~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~--~~~l 193 (524)
T KOG0601|consen 116 FPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEG--SGIL 193 (524)
T ss_pred cccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccccc--CCcc
Confidence 445567899 99999999955 5688899998433322 22223335677777777 59999997776643 4445
Q ss_pred eEEEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHH----HHHHhhhcCCCCeeecCCCCCCeeecCC-CCeE
Q 000859 1021 LLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQ----GVEYLHHDCVPKILHRDIKSSNILLDSN-MEAH 1095 (1251)
Q Consensus 1021 ~lv~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~----~l~~LH~~~~~~ivH~Dlkp~Nill~~~-~~~k 1095 (1251)
++-+|++. .++..+.+.. ...++....+....+..+ |+.++|.. .++|-|+||.||+...+ ..++
T Consensus 194 fiqtE~~~-~sl~~~~~~~------~~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~ 263 (524)
T KOG0601|consen 194 FIQTELCG-ESLQSYCHTP------CNFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCK 263 (524)
T ss_pred eeeecccc-chhHHhhhcc------cccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceee
Confidence 78888885 7898888764 345777788888888888 99999999 99999999999999999 8899
Q ss_pred EcccccccccccccCCCCcc-cceeecccceecccccccCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHH
Q 000859 1096 LGDFGLAKALVEDYNSNTES-NTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVE 1174 (1251)
Q Consensus 1096 l~DfG~a~~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~ 1174 (1251)
++|||+...+.+........ .....|...|++||... ..++..+|+|++|.++.+..+|..+...... ..|.+
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~-----~~W~~ 337 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKN-----SSWSQ 337 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCC-----CCccc
Confidence 99999998776543222211 12236788999999765 4688899999999999999998766532200 11111
Q ss_pred HHHhccchhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 000859 1175 MHMEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCD 1229 (1251)
Q Consensus 1175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1229 (1251)
.... ....+. .+....++...+..+++.+|-.|++++.+.+
T Consensus 338 ~r~~---~ip~e~-----------~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 338 LRQG---YIPLEF-----------CEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred cccc---cCchhh-----------hcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 1000 000000 1112344556888999999999999998764
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.13 E-value=2.1e-10 Score=136.64 Aligned_cols=147 Identities=18% Similarity=0.189 Sum_probs=93.1
Q ss_pred cCCCcCceecccCCceEEEEEecC-CcEEEEEEeccCCchh---------------------------------hhH---
Q 000859 946 NNLSDEFIIGSGGSGTVYKAELAN-GATVAVKKISCKDDHL---------------------------------LNK--- 988 (1251)
Q Consensus 946 ~~~~~~~~lG~G~fg~V~~~~~~~-~~~vavK~~~~~~~~~---------------------------------~~~--- 988 (1251)
..|+. +.||+|++|.||+|+.++ |+.||||+.+....+. ..+
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 44665 689999999999998877 9999999997442110 011
Q ss_pred ---HHHHHHHHHHhcc----CCCccceeceeeecCCCceeEEEeecCCCChHHhh--hcCCCCcccCCCCCHHHHHHHHH
Q 000859 989 ---SFTREVKTLGRIR----HRHLVKLMGHCCNKGAGSNLLIYEYMENGSVWDWL--HKQPVNIKMRKSLDWEARLKIAV 1059 (1251)
Q Consensus 989 ---~~~~E~~~l~~l~----h~niv~l~g~~~~~~~~~~~lv~E~~~~gsL~~~l--~~~~~~~~~~~~l~~~~~~~i~~ 1059 (1251)
++.+|+.-+.+++ +...+.+-.++.+- ....++||||++|+.+.++- .... .....+....+..++.
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~-st~~VLvmE~i~G~~l~d~~~l~~~g---~d~~~la~~~v~~~~~ 274 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDY-CSETVMVMERMYGIPVSDVAALRAAG---TDMKLLAERGVEVFFT 274 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeeccc-CCCceEEEeeecCccHHhHHHHHhcC---CCHHHHHHHHHHHHHH
Confidence 2334444444442 33333333333222 22358999999999998752 2211 0011122222333334
Q ss_pred HHHHHHHHhhhcCCCCeeecCCCCCCeeecCCC----CeEEccccccccccc
Q 000859 1060 GLAQGVEYLHHDCVPKILHRDIKSSNILLDSNM----EAHLGDFGLAKALVE 1107 (1251)
Q Consensus 1060 ~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~----~~kl~DfG~a~~~~~ 1107 (1251)
|+ ... |++|+|+||.||+++.++ +++++|||++..+.+
T Consensus 275 Qi-------f~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 275 QV-------FRD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HH-------HhC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 43 345 999999999999999888 999999999877643
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.12 E-value=2.8e-12 Score=136.57 Aligned_cols=241 Identities=23% Similarity=0.278 Sum_probs=129.5
Q ss_pred eEEEeccCCccCCC----CCCCCCCCCCcccEEEccCC---CCCCCcCccc-------cccCcccEEecccccccCCCCc
Q 000859 72 RVVSLNLSGLSLAG----SISPSLGRLQSLIHLDLSSN---SLTGPIPTAL-------SNLSSLESLLLFSNQLAGTIPT 137 (1251)
Q Consensus 72 ~v~~l~l~~~~l~g----~~~~~l~~l~~L~~L~Ls~n---~l~~~~p~~l-------~~l~~L~~L~L~~n~l~~~~p~ 137 (1251)
.++.|+|+||.+.- .+.+.|.+.+.|+..++|+- .....+|+++ -..++|++||||+|.|...-+.
T Consensus 31 s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA~G~~g~~ 110 (382)
T KOG1909|consen 31 SLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNAFGPKGIR 110 (382)
T ss_pred ceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCCceeEeeccccccCccchH
Confidence 46666666666542 23445556666666666652 2222344332 2233455555555554433222
Q ss_pred c----cCCCccccEEEeccCCCCCCCCCcccccccccccccccCCCCCCCCCCcCcccccceeeeccccccCCC----Cc
Q 000859 138 Q----LGSLTSLRVMRIGDNWLSGSIPTSFGNLVNLGTLGLASCSLSGPIPPQFGQLSQLEELILQQNQLQGPI----PA 209 (1251)
Q Consensus 138 ~----l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~----p~ 209 (1251)
. +.+++.|++|.|.+|.++-.....++. .|..|. .|. -...-++|+++..++|++..-. ..
T Consensus 111 ~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~--al~~l~--~~k-------k~~~~~~Lrv~i~~rNrlen~ga~~~A~ 179 (382)
T KOG1909|consen 111 GLEELLSSCTDLEELYLNNCGLGPEAGGRLGR--ALFELA--VNK-------KAASKPKLRVFICGRNRLENGGATALAE 179 (382)
T ss_pred HHHHHHHhccCHHHHhhhcCCCChhHHHHHHH--HHHHHH--HHh-------ccCCCcceEEEEeeccccccccHHHHHH
Confidence 2 223344444444444443111111111 122211 111 1223357888888888775322 23
Q ss_pred ccCCCCCCceeeccccccCC----CchhhhcccccCceeeccCccCCCC----CCccccCCCccceeeccCccccCcCCc
Q 000859 210 ELGNCSSLSIFTAAENNLNG----SIPAALGRLQNLQLLNLGNNSLSGE----IPSELGELSQLGYLNLMGNRLEGAIPR 281 (1251)
Q Consensus 210 ~~~~l~~L~~L~l~~n~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~----~~~~l~~l~~L~~L~Ls~N~l~~~~~~ 281 (1251)
.|...+.|+.+.++.|.|.. .+..+|..+++|+.|||.+|-++.. +...+..+++|++|++++|.+......
T Consensus 180 ~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dcll~~~Ga~ 259 (382)
T KOG1909|consen 180 AFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDCLLENEGAI 259 (382)
T ss_pred HHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeecccccccccccHH
Confidence 45666778888888887753 2345667778888888888877733 234556677778888887777655444
Q ss_pred ccc-----cCCCccEEEeccccccCC----CCCccccccceEEEEccCccc
Q 000859 282 SFA-----KMGNLQSLDLSMNRLTGG----IPEEFGNMGQLVFLVLSNNNI 323 (1251)
Q Consensus 282 ~~~-----~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l 323 (1251)
+|. ..++|++|.|.+|.++.. +...+...+.|+.|+|++|.+
T Consensus 260 a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l 310 (382)
T KOG1909|consen 260 AFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRL 310 (382)
T ss_pred HHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCcccc
Confidence 432 256777777777777621 222334456666666666666
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.11 E-value=6.5e-10 Score=129.12 Aligned_cols=170 Identities=18% Similarity=0.251 Sum_probs=127.1
Q ss_pred EecCCcEEEEEEeccCCchhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEEEeecCCCChHHhhhcCCCCccc
Q 000859 966 ELANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKM 1045 (1251)
Q Consensus 966 ~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~ 1045 (1251)
+..++.+|.|...+.... ...+...+-++.++.++||+|++++..+.. .+..|+|+|-+. .|..++++.
T Consensus 33 ~k~~~~~vsVF~~~~~~~-~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~--~~~~ylvTErV~--Pl~~~lk~l------ 101 (690)
T KOG1243|consen 33 RKADGGPVSVFVYKRSNG-EVTELAKRAVKRLKTLRHPNILSYLDTTEE--EGTLYLVTERVR--PLETVLKEL------ 101 (690)
T ss_pred eeccCCceEEEEEeCCCc-hhhHHHHHHHHHhhhccCchhhhhhhhhcc--cCceEEEeeccc--cHHHHHHHh------
Confidence 566789999999876555 455667788999999999999999986644 346799999996 577788763
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcccccccccccccCCCCcccceeecccce
Q 000859 1046 RKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGY 1125 (1251)
Q Consensus 1046 ~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~gt~~y 1125 (1251)
........++||+.||.|||+.+ +++|++|.-..|+|++.|..||++|-++...... ..+.....--..|
T Consensus 102 ----~~~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~----~~~~~~~~~~~s~ 171 (690)
T KOG1243|consen 102 ----GKEEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGF----NAPAKSLYLIESF 171 (690)
T ss_pred ----HHHHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccC----Ccccccchhhhcc
Confidence 35666778899999999999764 8999999999999999999999999987543211 1011111222345
Q ss_pred ecccccccCCCCCccceeehhHHHHHHhhCCCC
Q 000859 1126 IAPEYAYSLKATEKCDVYSMGIVLMELVSGKMP 1158 (1251)
Q Consensus 1126 ~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~p 1158 (1251)
..|+.+.... -..|.|-||+++||++.|..+
T Consensus 172 ~~P~~~~~s~--~s~D~~~Lg~li~el~ng~~~ 202 (690)
T KOG1243|consen 172 DDPEEIDPSE--WSIDSWGLGCLIEELFNGSLL 202 (690)
T ss_pred cChhhcCccc--cchhhhhHHHHHHHHhCcccC
Confidence 6666433222 346999999999999999433
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.09 E-value=1.8e-11 Score=126.50 Aligned_cols=140 Identities=33% Similarity=0.360 Sum_probs=112.6
Q ss_pred cccCcccccccccceEEccCCcccCCCCccccccCCccEEEcCCCccCCCCccccCCCcccccccccCccccCCCccccc
Q 000859 613 GKIPWTFGKIRELSLLDLSGNSLTGPIPTQLLMCKKLSHIDLNNNLLSGAVPSWLGTLPQLGELKLSFNQFVGFLPRELF 692 (1251)
Q Consensus 613 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~ 692 (1251)
|..-..+..+..|+++|||+|.|+ .+.+...-.++++.|++|+|.|. .+ +.+..+++|+.||||+|.++.. ...-.
T Consensus 274 G~~~~~~dTWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~-~v-~nLa~L~~L~~LDLS~N~Ls~~-~Gwh~ 349 (490)
T KOG1259|consen 274 GSALVSADTWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIR-TV-QNLAELPQLQLLDLSGNLLAEC-VGWHL 349 (490)
T ss_pred CceEEecchHhhhhhccccccchh-hhhhhhhhccceeEEecccccee-ee-hhhhhcccceEeecccchhHhh-hhhHh
Confidence 333344556678999999999998 67888888899999999999997 33 3388999999999999999863 34445
Q ss_pred cccccceeeccCcccccccCcccCCCCCCceeccCCCcCCCC-CCcccccccccceeeccCcccccc
Q 000859 693 NCSKLLVLSLDGNMLNGSLPNEVGNLASLNVLTLSGNLLSGP-IPPAIGRLSKLYELRLSNNSLNGV 758 (1251)
Q Consensus 693 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~-~~~~~~~l~~L~~L~l~~N~l~~~ 758 (1251)
++.+++.|.|++|.|. .+ ..++.+-+|..||+++|+|... --..|+++|-|+.+.|.+|++.+.
T Consensus 350 KLGNIKtL~La~N~iE-~L-SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~ 414 (490)
T KOG1259|consen 350 KLGNIKTLKLAQNKIE-TL-SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGS 414 (490)
T ss_pred hhcCEeeeehhhhhHh-hh-hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCcccc
Confidence 6788999999999996 22 3577888999999999999842 124689999999999999999853
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.08 E-value=2.6e-11 Score=143.94 Aligned_cols=150 Identities=27% Similarity=0.320 Sum_probs=81.1
Q ss_pred cccccEEEecccccCCCCchhhhcccccchhhcccCcccccccCCcCCCCccceEeccCCcccCCCCCcccccCCCcEEe
Q 000859 407 LSNLQELALYHNNFQGSLPREIGMLVKLELLYLYDNHLSGQIPSEVGNCSSLKWIDFFGNSFTGEIPTSIGRLKDLNFLH 486 (1251)
Q Consensus 407 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ 486 (1251)
+..++.+++..|.+.. .-..+..+.+|+.|++.+|+|. .+...+..+++|++|++++|.|+... .+..++.|+.|+
T Consensus 71 l~~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~-~i~~~l~~~~~L~~L~ls~N~I~~i~--~l~~l~~L~~L~ 146 (414)
T KOG0531|consen 71 LTSLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIE-KIENLLSSLVNLQVLDLSFNKITKLE--GLSTLTLLKELN 146 (414)
T ss_pred hHhHHhhccchhhhhh-hhcccccccceeeeeccccchh-hcccchhhhhcchheecccccccccc--chhhccchhhhe
Confidence 3444444455555542 2223445555666666666655 22222555666666666666665332 245555566666
Q ss_pred ccCCccCCCcCccccccccCCeeecCCCcCcccCC-cchhccchhhhhhccCCccccCCchhhhhhcCCCeeeccccccc
Q 000859 487 LRQNELVGQIPASLGNCHQLIILDLADNKLSGGVP-ASFGFLQALEQLMLYNNSLEGNLPGSLINLRNLTRINFSKNRLN 565 (1251)
Q Consensus 487 L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~l~~N~l~ 565 (1251)
+++|.|+.. ..+..++.|+.+++++|+++.+.+ . ...+.+++.+++.+|.+.. ...+..+..+..+++..|.++
T Consensus 147 l~~N~i~~~--~~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~~--i~~~~~~~~l~~~~l~~n~i~ 221 (414)
T KOG0531|consen 147 LSGNLISDI--SGLESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIRE--IEGLDLLKKLVLLSLLDNKIS 221 (414)
T ss_pred eccCcchhc--cCCccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchhc--ccchHHHHHHHHhhcccccce
Confidence 666666532 344556667777777776664333 2 4566666667777776652 233344444444455555553
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.06 E-value=3.7e-11 Score=142.55 Aligned_cols=268 Identities=24% Similarity=0.245 Sum_probs=127.9
Q ss_pred cccEEEecccccCCCCchhhhcccccchhhcccCcccccccCCcCCCCccceEeccCCcccCCCCCcccccCCCcEEecc
Q 000859 409 NLQELALYHNNFQGSLPREIGMLVKLELLYLYDNHLSGQIPSEVGNCSSLKWIDFFGNSFTGEIPTSIGRLKDLNFLHLR 488 (1251)
Q Consensus 409 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~ 488 (1251)
.++.++..++.+...--. ...+..++.+++..|.+. .+-..+..+++|+.|++.+|+|. .+...+..+++|++|+++
T Consensus 50 ~~~~~~~~~~~~~~~~~~-~~~l~~l~~l~l~~n~i~-~~~~~l~~~~~l~~l~l~~n~i~-~i~~~l~~~~~L~~L~ls 126 (414)
T KOG0531|consen 50 DLEEIDLIFNLDGSDEDL-VESLTSLKELNLRQNLIA-KILNHLSKLKSLEALDLYDNKIE-KIENLLSSLVNLQVLDLS 126 (414)
T ss_pred hhhhhcchhccccchhhh-HHHhHhHHhhccchhhhh-hhhcccccccceeeeeccccchh-hcccchhhhhcchheecc
Confidence 344445544444321111 145566777777777776 33344566666666666666666 222224455555555555
Q ss_pred CCccCCCcCccccccccCCeeecCCCcCcccCCcchhccchhhhhhccCCccccCCc-hhhhhhcCCCeeeccccccccc
Q 000859 489 QNELVGQIPASLGNCHQLIILDLADNKLSGGVPASFGFLQALEQLMLYNNSLEGNLP-GSLINLRNLTRINFSKNRLNGR 567 (1251)
Q Consensus 489 ~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~-~~l~~l~~L~~L~l~~N~l~~~ 567 (1251)
+|+|+.. ..+..++.|+.|++++|+|+.. ..+..+.+|+.+++++|.+....+ . ...+.+|+.+.+++|.+.
T Consensus 127 ~N~I~~i--~~l~~l~~L~~L~l~~N~i~~~--~~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~-- 199 (414)
T KOG0531|consen 127 FNKITKL--EGLSTLTLLKELNLSGNLISDI--SGLESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIR-- 199 (414)
T ss_pred ccccccc--cchhhccchhhheeccCcchhc--cCCccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchh--
Confidence 5555532 2344444455555555555421 223334445555555555443222 1 233444444444444432
Q ss_pred ccccccCccceeeecccCccccCCCCCCCCcccCceeecccCccccccCcccccccccceEEccCCcccCCCCccccccC
Q 000859 568 IATLCSSHSFLSFDVTNNEFDHEIPPQLGNSPSLERLRLGNNKFIGKIPWTFGKIRELSLLDLSGNSLTGPIPTQLLMCK 647 (1251)
Q Consensus 568 ~~~l~~~~~l~~l~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 647 (1251)
. ...+..+..+..+++..|.++..-+-....+.
T Consensus 200 ---------------------------------------------~--i~~~~~~~~l~~~~l~~n~i~~~~~l~~~~~~ 232 (414)
T KOG0531|consen 200 ---------------------------------------------E--IEGLDLLKKLVLLSLLDNKISKLEGLNELVML 232 (414)
T ss_pred ---------------------------------------------c--ccchHHHHHHHHhhcccccceeccCcccchhH
Confidence 1 11122222333334444444321111100000
Q ss_pred CccEEEcCCCccCCCCccccCCCcccccccccCccccCCCccccccccccceeeccCccccc---ccCcc-cCCCCCCce
Q 000859 648 KLSHIDLNNNLLSGAVPSWLGTLPQLGELKLSFNQFVGFLPRELFNCSKLLVLSLDGNMLNG---SLPNE-VGNLASLNV 723 (1251)
Q Consensus 648 ~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~---~~p~~-~~~l~~L~~ 723 (1251)
+|+.+++++|++. ..+..+..+.++..|+++.|++... ..+.....+..+.++.|++.. ..... .+..+.++.
T Consensus 233 ~L~~l~l~~n~i~-~~~~~~~~~~~l~~l~~~~n~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (414)
T KOG0531|consen 233 HLRELYLSGNRIS-RSPEGLENLKNLPVLDLSSNRISNL--EGLERLPKLSELWLNDNKLALSEAISQEYITSAAPTLVT 309 (414)
T ss_pred HHHHHhcccCccc-cccccccccccccccchhhcccccc--ccccccchHHHhccCcchhcchhhhhccccccccccccc
Confidence 2455555555555 3334445555666666666655542 233344455555566665541 11222 556677888
Q ss_pred eccCCCcCCCCCC
Q 000859 724 LTLSGNLLSGPIP 736 (1251)
Q Consensus 724 L~ls~N~l~~~~~ 736 (1251)
.++..|.+....+
T Consensus 310 ~~~~~~~~~~~~~ 322 (414)
T KOG0531|consen 310 LTLELNPIRKISS 322 (414)
T ss_pred cccccCccccccc
Confidence 8888888775443
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.05 E-value=1.5e-11 Score=131.07 Aligned_cols=201 Identities=26% Similarity=0.303 Sum_probs=115.5
Q ss_pred ccccccccCCeeecCCCcCcccCCcch----hccchhhhhhccCCccccCCchhhhhhcCCCeeeccccccccccccccc
Q 000859 498 ASLGNCHQLIILDLADNKLSGGVPASF----GFLQALEQLMLYNNSLEGNLPGSLINLRNLTRINFSKNRLNGRIATLCS 573 (1251)
Q Consensus 498 ~~l~~l~~L~~L~Ls~N~l~~~~p~~~----~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~l~~ 573 (1251)
..+..+++|++||||+|-+.-..+..| .....|++|+|.||.+.-..-..++. .|..|. .|..
T Consensus 86 ~aL~~~~~L~~ldLSDNA~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~--al~~l~--~~kk--------- 152 (382)
T KOG1909|consen 86 KALLGCPKLQKLDLSDNAFGPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGR--ALFELA--VNKK--------- 152 (382)
T ss_pred HHHhcCCceeEeeccccccCccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHH--HHHHHH--HHhc---------
Confidence 345567789999999998864444433 45677888999888876322222211 122222 1111
Q ss_pred CccceeeecccCccccCCCCCCCCcccCceeecccCcccccc----CcccccccccceEEccCCcccCC----CCccccc
Q 000859 574 SHSFLSFDVTNNEFDHEIPPQLGNSPSLERLRLGNNKFIGKI----PWTFGKIRELSLLDLSGNSLTGP----IPTQLLM 645 (1251)
Q Consensus 574 ~~~l~~l~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~----p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~ 645 (1251)
.+.-+.|+.+..++|.+-... ...|...+.|+.+.++.|.|... +-..+..
T Consensus 153 ---------------------~~~~~~Lrv~i~~rNrlen~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~ 211 (382)
T KOG1909|consen 153 ---------------------AASKPKLRVFICGRNRLENGGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEH 211 (382)
T ss_pred ---------------------cCCCcceEEEEeeccccccccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHh
Confidence 112244555555555543211 12244445566666666665421 2234556
Q ss_pred cCCccEEEcCCCccCC----CCccccCCCcccccccccCccccCCCcccc-----ccccccceeeccCcccccc----cC
Q 000859 646 CKKLSHIDLNNNLLSG----AVPSWLGTLPQLGELKLSFNQFVGFLPREL-----FNCSKLLVLSLDGNMLNGS----LP 712 (1251)
Q Consensus 646 l~~L~~L~l~~N~l~~----~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~-----~~l~~L~~L~L~~N~l~~~----~p 712 (1251)
|++|+.|||.+|-++. .+...+..+++|++|+++++.+...-...+ ...+.|++|.|.+|.++.. +-
T Consensus 212 ~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la 291 (382)
T KOG1909|consen 212 CPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDCLLENEGAIAFVDALKESAPSLEVLELAGNEITRDAALALA 291 (382)
T ss_pred CCcceeeecccchhhhHHHHHHHHHhcccchheeecccccccccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHH
Confidence 6677777777776662 234455667777777777777664322222 1356788888888888632 33
Q ss_pred cccCCCCCCceeccCCCcCC
Q 000859 713 NEVGNLASLNVLTLSGNLLS 732 (1251)
Q Consensus 713 ~~~~~l~~L~~L~ls~N~l~ 732 (1251)
..+...+.|+.|+|++|++.
T Consensus 292 ~~~~ek~dL~kLnLngN~l~ 311 (382)
T KOG1909|consen 292 ACMAEKPDLEKLNLNGNRLG 311 (382)
T ss_pred HHHhcchhhHHhcCCccccc
Confidence 34556788889999999883
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.03 E-value=2.7e-09 Score=110.14 Aligned_cols=136 Identities=16% Similarity=0.156 Sum_probs=97.4
Q ss_pred ceecccCCceEEEEEecC-------CcEEEEEEeccCC------------c---------hhhhHHHH----HHHHHHHh
Q 000859 952 FIIGSGGSGTVYKAELAN-------GATVAVKKISCKD------------D---------HLLNKSFT----REVKTLGR 999 (1251)
Q Consensus 952 ~~lG~G~fg~V~~~~~~~-------~~~vavK~~~~~~------------~---------~~~~~~~~----~E~~~l~~ 999 (1251)
..||.|--+.||.|...+ +..+|||+.+... + ....+.+. +|++.|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 368999999999996543 4799999985221 0 01122333 79999999
Q ss_pred cc--CCCccceeceeeecCCCceeEEEeecCCCChHH-hhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHh-hhcCCCC
Q 000859 1000 IR--HRHLVKLMGHCCNKGAGSNLLIYEYMENGSVWD-WLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYL-HHDCVPK 1075 (1251)
Q Consensus 1000 l~--h~niv~l~g~~~~~~~~~~~lv~E~~~~gsL~~-~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~L-H~~~~~~ 1075 (1251)
+. .-++.+.+++ ...++||||+.++.+.. .++. ..++.++...+..+++.+|.++ |+. +
T Consensus 83 l~~~Gv~vP~pi~~------~~~~lvME~Ig~~~~~~~~Lkd--------~~~~~~~~~~i~~~i~~~l~~l~H~~---g 145 (197)
T cd05146 83 MQKAGIPCPEVVVL------KKHVLVMSFIGDDQVPAPKLKD--------AKLNDEEMKNAYYQVLSMMKQLYKEC---N 145 (197)
T ss_pred HHHcCCCCCeEEEe------cCCEEEEEEcCCCCccchhhhc--------cccCHHHHHHHHHHHHHHHHHHHHhC---C
Confidence 95 3566666653 12489999997653322 1221 1244556677889999999999 787 9
Q ss_pred eeecCCCCCCeeecCCCCeEEccccccccc
Q 000859 1076 ILHRDIKSSNILLDSNMEAHLGDFGLAKAL 1105 (1251)
Q Consensus 1076 ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~ 1105 (1251)
+||||+++.||+++ ++.+.++|||.|...
T Consensus 146 lVHGDLs~~NIL~~-~~~v~iIDF~qav~~ 174 (197)
T cd05146 146 LVHADLSEYNMLWH-DGKVWFIDVSQSVEP 174 (197)
T ss_pred eecCCCCHHHEEEE-CCcEEEEECCCceeC
Confidence 99999999999997 578999999988653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.01 E-value=2e-10 Score=116.05 Aligned_cols=121 Identities=33% Similarity=0.432 Sum_probs=37.2
Q ss_pred ccccccccCccccCCCccccc-cccccceeeccCcccccccCcccCCCCCCceeccCCCcCCCCCCccc-ccccccceee
Q 000859 672 QLGELKLSFNQFVGFLPRELF-NCSKLLVLSLDGNMLNGSLPNEVGNLASLNVLTLSGNLLSGPIPPAI-GRLSKLYELR 749 (1251)
Q Consensus 672 ~L~~L~l~~N~l~~~~p~~~~-~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~-~~l~~L~~L~ 749 (1251)
++++|+|++|+|+.+ +.++ .+.+|+.|+|++|.|+ .++ .+..++.|++|++++|+|+ .+++.+ ..+++|++|+
T Consensus 20 ~~~~L~L~~n~I~~I--e~L~~~l~~L~~L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~L~~L~ 94 (175)
T PF14580_consen 20 KLRELNLRGNQISTI--ENLGATLDKLEVLDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRIS-SISEGLDKNLPNLQELY 94 (175)
T ss_dssp ------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS----S-CHHHHHH-TT--EEE
T ss_pred ccccccccccccccc--cchhhhhcCCCEEECCCCCCc-ccc-CccChhhhhhcccCCCCCC-ccccchHHhCCcCCEEE
Confidence 455555555555542 2233 3455555555555555 232 3444555555555555555 233222 2345555555
Q ss_pred ccCcccccccchhhhchhhHHHHHhccCCcccCCCCCCcCccccccEEEccCCccccCCch----hhhhccCCCcEe
Q 000859 750 LSNNSLNGVIPLEIGQLQNLQSILDLSHNNFTGQIPPSMGTLAKLEVLNLSHNQLVGELPS----QLGEMSSLGKLN 822 (1251)
Q Consensus 750 l~~N~l~~~~p~~~~~l~~l~~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~----~l~~l~~L~~L~ 822 (1251)
|++|+|... . .+ ..++.+++|+.|+|.+|+++. .+. .+..+|+|+.||
T Consensus 95 L~~N~I~~l-----~------------------~l-~~L~~l~~L~~L~L~~NPv~~-~~~YR~~vi~~lP~Lk~LD 146 (175)
T PF14580_consen 95 LSNNKISDL-----N------------------EL-EPLSSLPKLRVLSLEGNPVCE-KKNYRLFVIYKLPSLKVLD 146 (175)
T ss_dssp -TTS---SC-----C------------------CC-GGGGG-TT--EEE-TT-GGGG-STTHHHHHHHH-TT-SEET
T ss_pred CcCCcCCCh-----H------------------Hh-HHHHcCCCcceeeccCCcccc-hhhHHHHHHHHcChhheeC
Confidence 555554310 0 11 234567889999999999984 333 377888888886
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.98 E-value=5.7e-10 Score=140.59 Aligned_cols=282 Identities=24% Similarity=0.272 Sum_probs=163.0
Q ss_pred CCCCcccEEEccCCCCCCCcCccccccCcccEEeccccc--ccCCCCcccCCCccccEEEeccCCCCCCCCCcccccccc
Q 000859 92 GRLQSLIHLDLSSNSLTGPIPTALSNLSSLESLLLFSNQ--LAGTIPTQLGSLTSLRVMRIGDNWLSGSIPTSFGNLVNL 169 (1251)
Q Consensus 92 ~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~--l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L 169 (1251)
......++..+.+|.+. .++.... .++|++|-+..|. +.-..++.|..++.|++|||++|.=.+.+|.++++|-+|
T Consensus 520 ~~~~~~rr~s~~~~~~~-~~~~~~~-~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~L 597 (889)
T KOG4658|consen 520 KSWNSVRRMSLMNNKIE-HIAGSSE-NPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHL 597 (889)
T ss_pred cchhheeEEEEeccchh-hccCCCC-CCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhh
Confidence 34466777777777765 3444333 3478888888886 443334457788999999999888778899999999999
Q ss_pred cccccccCCCCCCCCCCcCcccccceeeeccccccCCCCcccCCCCCCceeecccccc--CCCchhhhcccccCceeecc
Q 000859 170 GTLGLASCSLSGPIPPQFGQLSQLEELILQQNQLQGPIPAELGNCSSLSIFTAAENNL--NGSIPAALGRLQNLQLLNLG 247 (1251)
Q Consensus 170 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~l--~~~~p~~~~~l~~L~~L~L~ 247 (1251)
++|+|++..+. .+|..+++|++|.+|++..+.-...+|.....+++|++|.+..-.. ++..-..+.++.+|+.+...
T Consensus 598 ryL~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~~~~~~~~l~el~~Le~L~~ls~~ 676 (889)
T KOG4658|consen 598 RYLDLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSALSNDKLLLKELENLEHLENLSIT 676 (889)
T ss_pred hcccccCCCcc-ccchHHHHHHhhheeccccccccccccchhhhcccccEEEeeccccccchhhHHhhhcccchhhheee
Confidence 99999998887 7888899999999999988876666677777788888888766542 22333344445555555443
Q ss_pred CccCCCCCCccccCCCccc----eeeccCccccCcCCcccccCCCccEEEeccccccCCCCCccccccceEEEEccCccc
Q 000859 248 NNSLSGEIPSELGELSQLG----YLNLMGNRLEGAIPRSFAKMGNLQSLDLSMNRLTGGIPEEFGNMGQLVFLVLSNNNI 323 (1251)
Q Consensus 248 ~N~l~~~~~~~l~~l~~L~----~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l 323 (1251)
.... .+-..+..+.+|. .+.+.++... ..+..+..+.+|+.|.+.++.+.......+.....+.
T Consensus 677 ~~s~--~~~e~l~~~~~L~~~~~~l~~~~~~~~-~~~~~~~~l~~L~~L~i~~~~~~e~~~~~~~~~~~~~--------- 744 (889)
T KOG4658|consen 677 ISSV--LLLEDLLGMTRLRSLLQSLSIEGCSKR-TLISSLGSLGNLEELSILDCGISEIVIEWEESLIVLL--------- 744 (889)
T ss_pred cchh--HhHhhhhhhHHHHHHhHhhhhcccccc-eeecccccccCcceEEEEcCCCchhhcccccccchhh---------
Confidence 3222 1111222333333 2222222222 3334455666666666666665532221111111000
Q ss_pred cCcccccccccccchhhhhccchhcccCCCcCccCCCCCceEEccCCcccCCccccccccccccEEEeeccccccc
Q 000859 324 SGSIPRRICTNATSLEHLILAEIQLSGEIPVELSQCQSLKQLDLSNNTLNGTIPVELFQLVALTHLYLHNNSLVGS 399 (1251)
Q Consensus 324 ~~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~ 399 (1251)
.++++..+...++... ..+.+.--.++|+.|.+..+.....+......+..+..+.+..+.+.+.
T Consensus 745 ----------~f~~l~~~~~~~~~~~-r~l~~~~f~~~L~~l~l~~~~~~e~~i~~~k~~~~l~~~i~~f~~~~~l 809 (889)
T KOG4658|consen 745 ----------CFPNLSKVSILNCHML-RDLTWLLFAPHLTSLSLVSCRLLEDIIPKLKALLELKELILPFNKLEGL 809 (889)
T ss_pred ----------hHHHHHHHHhhccccc-cccchhhccCcccEEEEecccccccCCCHHHHhhhcccEEecccccccc
Confidence 1122222222222211 1112222346777777777766655555555555555555555555443
|
|
| >PF08263 LRRNT_2: Leucine rich repeat N-terminal domain; InterPro: IPR013210 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape [] | Back alignment and domain information |
|---|
Probab=98.98 E-value=4.9e-10 Score=84.91 Aligned_cols=41 Identities=41% Similarity=0.955 Sum_probs=31.7
Q ss_pred HHhHHHHHHHHHHcCCCCCCCCCCCCCCC-CCCCccccEEEc
Q 000859 27 DEELSVLLEIKKSFTADPENVLHAWNQSN-QNLCTWRGITCG 67 (1251)
Q Consensus 27 ~~~~~all~~k~~~~~~~~~~l~sW~~~~-~~~c~w~gv~C~ 67 (1251)
++|++||++||+++..||.+.+.+|+.+. .+||+|.||+|+
T Consensus 2 ~~d~~aLl~~k~~l~~~~~~~l~~W~~~~~~~~C~W~GV~Cd 43 (43)
T PF08263_consen 2 NQDRQALLAFKKSLNNDPSGVLSSWNPSSDSDPCSWSGVTCD 43 (43)
T ss_dssp HHHHHHHHHHHHCTT-SC-CCCTT--TT--S-CCCSTTEEE-
T ss_pred cHHHHHHHHHHHhcccccCcccccCCCcCCCCCeeeccEEeC
Confidence 68999999999999878889999998763 799999999995
|
LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. This domain is often found at the N terminus of tandem leucine rich repeats.; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1OGQ_A. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.97 E-value=6.2e-10 Score=128.64 Aligned_cols=248 Identities=20% Similarity=0.215 Sum_probs=171.8
Q ss_pred HhhcCCCcCceecccCCceEEEEEe--cCCcEEEEEEeccCCchh-hhHHHHHHHHHHHhc-cCCCccceeceeeecCCC
Q 000859 943 GATNNLSDEFIIGSGGSGTVYKAEL--ANGATVAVKKISCKDDHL-LNKSFTREVKTLGRI-RHRHLVKLMGHCCNKGAG 1018 (1251)
Q Consensus 943 ~~~~~~~~~~~lG~G~fg~V~~~~~--~~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~ 1018 (1251)
....+|..+..||.|.|+.|++... .++..||+|......... ....-..|+.+...+ .|.++++.+..+.....
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~- 340 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQ- 340 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccc-
Confidence 3456788888999999999999854 467889999886443221 222234566666666 58888887765544333
Q ss_pred ceeEEEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCC-CCeEEc
Q 000859 1019 SNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSN-MEAHLG 1097 (1251)
Q Consensus 1019 ~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~-~~~kl~ 1097 (1251)
.++=-||+++++......- ...++...++++..|++.++.++|+. .++|+|+||+||++..+ +..+++
T Consensus 341 -~~ip~e~~~~~s~~l~~~~-------~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~ 409 (524)
T KOG0601|consen 341 -GYIPLEFCEGGSSSLRSVT-------SQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLG 409 (524)
T ss_pred -ccCchhhhcCcchhhhhHH-------HHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhcc
Confidence 3688899999987766522 34567788889999999999999998 99999999999999886 788999
Q ss_pred ccccccccccccCCCCcccceeeccccee--cccccccCCCCCccceeehhHHHHHHhhCCCCCCCccccchhHHHHHHH
Q 000859 1098 DFGLAKALVEDYNSNTESNTWFAGSYGYI--APEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEM 1175 (1251)
Q Consensus 1098 DfG~a~~~~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~ 1175 (1251)
|||.++.+.-. . ....+.-+++ +|+......+..+.|++|||..+.|.++|..--.... .|.
T Consensus 410 ~~~~~t~~~~~--~-----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~-------~~~-- 473 (524)
T KOG0601|consen 410 DFGCWTRLAFS--S-----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV-------QSL-- 473 (524)
T ss_pred cccccccccee--c-----ccccccccccccchhhccccccccccccccccccccccccCcccCcccc-------cce--
Confidence 99998642110 0 0012223333 5555667778899999999999999998865432110 010
Q ss_pred HHhccchhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 000859 1176 HMEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLL 1232 (1251)
Q Consensus 1176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 1232 (1251)
.+.....+..+. .......+.+.++..|+..||.+.+......
T Consensus 474 -----------~i~~~~~p~~~~---~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~ 516 (524)
T KOG0601|consen 474 -----------TIRSGDTPNLPG---LKLQLQVLLKVMINPDRKRRPSAVELSLHSE 516 (524)
T ss_pred -----------eeecccccCCCc---hHHhhhhhhhhhcCCccccchhhhhhcccch
Confidence 001111122222 2256778888899999999999998765443
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=98.96 E-value=1.3e-10 Score=127.18 Aligned_cols=161 Identities=25% Similarity=0.238 Sum_probs=93.9
Q ss_pred cccccCceeeccCccCCCCCC--ccccCCCccceeeccCccccCcC--CcccccCCCccEEEeccccccCCCCCc-cccc
Q 000859 236 GRLQNLQLLNLGNNSLSGEIP--SELGELSQLGYLNLMGNRLEGAI--PRSFAKMGNLQSLDLSMNRLTGGIPEE-FGNM 310 (1251)
Q Consensus 236 ~~l~~L~~L~L~~N~l~~~~~--~~l~~l~~L~~L~Ls~N~l~~~~--~~~~~~l~~L~~L~Ls~N~l~~~~~~~-~~~l 310 (1251)
.++++|+...|.+..+. ..+ .....+++++.||||+|-+.... ......+++|+.|+|+.|++....... -..+
T Consensus 118 sn~kkL~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l 196 (505)
T KOG3207|consen 118 SNLKKLREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLL 196 (505)
T ss_pred hhHHhhhheeecCcccc-ccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhh
Confidence 34556666666666554 222 24556677777777777665332 223455677777777777765322221 1245
Q ss_pred cceEEEEccCccccCcccccccccccchhhhhccchhcccCCCcCccCCCCCceEEccCCcccCCcc--ccccccccccE
Q 000859 311 GQLVFLVLSNNNISGSIPRRICTNATSLEHLILAEIQLSGEIPVELSQCQSLKQLDLSNNTLNGTIP--VELFQLVALTH 388 (1251)
Q Consensus 311 ~~L~~L~Ls~N~l~~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p--~~~~~l~~L~~ 388 (1251)
++|+.|.|+.|.++-.--.+....+++|+.|.|..|............++.|+.|||++|.+. ..+ .....++.|+.
T Consensus 197 ~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li-~~~~~~~~~~l~~L~~ 275 (505)
T KOG3207|consen 197 SHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLI-DFDQGYKVGTLPGLNQ 275 (505)
T ss_pred hhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCccc-ccccccccccccchhh
Confidence 667777777777764444455556677777777777432233334445667777777777775 333 33445666666
Q ss_pred EEeecccccc
Q 000859 389 LYLHNNSLVG 398 (1251)
Q Consensus 389 L~L~~n~l~~ 398 (1251)
|+++.+.+..
T Consensus 276 Lnls~tgi~s 285 (505)
T KOG3207|consen 276 LNLSSTGIAS 285 (505)
T ss_pred hhccccCcch
Confidence 6666666654
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=98.95 E-value=3.5e-10 Score=114.27 Aligned_cols=83 Identities=33% Similarity=0.408 Sum_probs=17.8
Q ss_pred cccccchhhcccCcccccccCCcC-CCCccceEeccCCcccCCCCCcccccCCCcEEeccCCccCCCcCccc-cccccCC
Q 000859 430 MLVKLELLYLYDNHLSGQIPSEVG-NCSSLKWIDFFGNSFTGEIPTSIGRLKDLNFLHLRQNELVGQIPASL-GNCHQLI 507 (1251)
Q Consensus 430 ~l~~L~~L~L~~N~l~~~~~~~~~-~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l-~~l~~L~ 507 (1251)
+..++++|+|++|.|+ .+ +.++ .+.+|+.|++++|.|+. ++ .+..+++|++|++++|+|+. +...+ ..+++|+
T Consensus 17 n~~~~~~L~L~~n~I~-~I-e~L~~~l~~L~~L~Ls~N~I~~-l~-~l~~L~~L~~L~L~~N~I~~-i~~~l~~~lp~L~ 91 (175)
T PF14580_consen 17 NPVKLRELNLRGNQIS-TI-ENLGATLDKLEVLDLSNNQITK-LE-GLPGLPRLKTLDLSNNRISS-ISEGLDKNLPNLQ 91 (175)
T ss_dssp ---------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS---S--CHHHHHH-TT--
T ss_pred cccccccccccccccc-cc-cchhhhhcCCCEEECCCCCCcc-cc-CccChhhhhhcccCCCCCCc-cccchHHhCCcCC
Confidence 4445666666666665 22 2343 35566666666666652 22 35555555555555555553 22223 2355555
Q ss_pred eeecCCCcCc
Q 000859 508 ILDLADNKLS 517 (1251)
Q Consensus 508 ~L~Ls~N~l~ 517 (1251)
.|++++|+|.
T Consensus 92 ~L~L~~N~I~ 101 (175)
T PF14580_consen 92 ELYLSNNKIS 101 (175)
T ss_dssp EEE-TTS---
T ss_pred EEECcCCcCC
Confidence 5555555554
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.95 E-value=5e-09 Score=113.81 Aligned_cols=145 Identities=20% Similarity=0.274 Sum_probs=107.6
Q ss_pred ceecccCCceEEEEEecCCcEEEEEEeccCCchhhhHHHHHHHHHHHhccC--CCccceeceeeecC-CCceeEEEeecC
Q 000859 952 FIIGSGGSGTVYKAELANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRH--RHLVKLMGHCCNKG-AGSNLLIYEYME 1028 (1251)
Q Consensus 952 ~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~g~~~~~~-~~~~~lv~E~~~ 1028 (1251)
+.++.|.++.||++...+|+.+++|.............+.+|+++++.+.+ ..+.+++++..... ....++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 468999999999998776789999997644332234678899999999965 34566776554322 124589999999
Q ss_pred CCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhc-------------------------------------
Q 000859 1029 NGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHD------------------------------------- 1071 (1251)
Q Consensus 1029 ~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~------------------------------------- 1071 (1251)
|.++.+.+.. ..++..+...++.++++++++||+.
T Consensus 84 G~~l~~~~~~--------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (223)
T cd05154 84 GRVLRDRLLR--------PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPP 155 (223)
T ss_pred CEecCCCCCC--------CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccH
Confidence 9887765431 2356677777888888888888752
Q ss_pred ----------------CCCCeeecCCCCCCeeecC--CCCeEEcccccccc
Q 000859 1072 ----------------CVPKILHRDIKSSNILLDS--NMEAHLGDFGLAKA 1104 (1251)
Q Consensus 1072 ----------------~~~~ivH~Dlkp~Nill~~--~~~~kl~DfG~a~~ 1104 (1251)
....++|+|++|.||+++. ++.+.|+||+.+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 156 AMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 0246899999999999998 66789999998753
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.90 E-value=4.2e-08 Score=107.22 Aligned_cols=270 Identities=14% Similarity=0.130 Sum_probs=162.6
Q ss_pred CcCceecccCCceEEEEEecCCcEEEEEEeccCCchhhhHHHHHHHHHHHhc-cCCCccceece----eeec-CCCceeE
Q 000859 949 SDEFIIGSGGSGTVYKAELANGATVAVKKISCKDDHLLNKSFTREVKTLGRI-RHRHLVKLMGH----CCNK-GAGSNLL 1022 (1251)
Q Consensus 949 ~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~----~~~~-~~~~~~l 1022 (1251)
...+.||+|+-+.+|-..-- +.. +.|+......... .+.++.|... .||-+-.-+.+ .... ......+
T Consensus 14 ~~gr~LgqGgea~ly~l~e~-~d~-VAKIYh~Pppa~~----aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGf 87 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEV-RDQ-VAKIYHAPPPAAQ----AQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGF 87 (637)
T ss_pred CCCccccCCccceeeecchh-hch-hheeecCCCchHH----HHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEE
Confidence 34557999999999976221 122 4566654433211 1233444444 56654331110 0011 1112456
Q ss_pred EEeecCCC-ChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEccccc
Q 000859 1023 IYEYMENG-SVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGL 1101 (1251)
Q Consensus 1023 v~E~~~~g-sL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~ 1101 (1251)
+|..+.+- ....++.- .-.........|+-.+++++.++.+.+.||+. |.+-+|+.++|+||++++.|.+.|-..
T Consensus 88 lmP~v~g~~pI~~~y~p-~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDs 163 (637)
T COG4248 88 LMPKVSGKEPIHMIYSP-ATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDS 163 (637)
T ss_pred ecccCCCccchhhhcCc-hhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEcccc
Confidence 77776653 22222211 11112234679999999999999999999999 999999999999999999999998664
Q ss_pred ccccccccCCCCcccceeecccceecccccc-----cCCCCCccceeehhHHHHHHhh-CCCCCCCccccch---hHHHH
Q 000859 1102 AKALVEDYNSNTESNTWFAGSYGYIAPEYAY-----SLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEM---DMVRW 1172 (1251)
Q Consensus 1102 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDiwSlGv~l~el~t-g~~p~~~~~~~~~---~~~~~ 1172 (1251)
-... .........+|...|.+||.-. +...+...|.|.+||++++++. |++||.+...... ....-
T Consensus 164 fqi~-----~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~ 238 (637)
T COG4248 164 FQIN-----ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETD 238 (637)
T ss_pred eeec-----cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhh
Confidence 4332 1222333457889999999644 4556788999999999999988 5999975432110 00000
Q ss_pred HHHHHhccchhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccC--CCCCCCHHHHHHHHHhhc
Q 000859 1173 VEMHMEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTS--PQERPSSRQVCDLLLNVF 1235 (1251)
Q Consensus 1173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d--P~~RPs~~eil~~L~~~~ 1235 (1251)
+ ....+ ....+.-......|...+.+..++++..+..+|+... +.-|||++.++..|.+..
T Consensus 239 I-a~g~f-~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~ 301 (637)
T COG4248 239 I-AHGRF-AYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALR 301 (637)
T ss_pred h-hccee-eechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHH
Confidence 0 00000 0001111111112233344556778999999999864 458999998887775544
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.88 E-value=6.7e-10 Score=134.13 Aligned_cols=251 Identities=21% Similarity=0.249 Sum_probs=167.2
Q ss_pred cCCCcCceecccCCceEEEEEec-CCcEEEEEEeccCCc--hhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeE
Q 000859 946 NNLSDEFIIGSGGSGTVYKAELA-NGATVAVKKISCKDD--HLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLL 1022 (1251)
Q Consensus 946 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~l 1022 (1251)
..+...+-+-.|+++.++.+.-. .|...++|+...... ....+...++-.+.-..++|.+++..--+.. ....++
T Consensus 804 d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~--rsP~~L 881 (1205)
T KOG0606|consen 804 DGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPC--RSPLPL 881 (1205)
T ss_pred ccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCC--CCCcch
Confidence 34556667889999999988433 344445554321110 0011222223333333345666665433222 233589
Q ss_pred EEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcccccc
Q 000859 1023 IYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLA 1102 (1251)
Q Consensus 1023 v~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a 1102 (1251)
+++|..+++|..-++..+ ..+.+..+.....+.++.+|||.. .+.|||++|.|.+...++..+++|||..
T Consensus 882 ~~~~~~~~~~~Skl~~~~-------~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~ 951 (1205)
T KOG0606|consen 882 VGHYLNGGDLPSKLHNSG-------CLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTL 951 (1205)
T ss_pred hhHHhccCCchhhhhcCC-------CcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCccccc
Confidence 999999999999988743 344444555667788999999998 7999999999999999999999999843
Q ss_pred cccccc---------------------cCC------CCcccceeecccceecccccccCCCCCccceeehhHHHHHHhhC
Q 000859 1103 KALVED---------------------YNS------NTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSG 1155 (1251)
Q Consensus 1103 ~~~~~~---------------------~~~------~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg 1155 (1251)
...... ... .........||+.|.|||...+......+|+|+.|++++|.++|
T Consensus 952 ~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g 1031 (1205)
T KOG0606|consen 952 SKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTG 1031 (1205)
T ss_pred cccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcC
Confidence 322110 000 00112335799999999999999999999999999999999999
Q ss_pred CCCCCCccccchhHHHHHHHHHhccchhhhhhhcccCCCCCCchHHHHHHHHHHHHHccccCCCCCCCHH
Q 000859 1156 KMPTDATFGVEMDMVRWVEMHMEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSR 1225 (1251)
Q Consensus 1156 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 1225 (1251)
..||.+..+... .+.+.... .+....++..+.+..+++...+..+|.+|-.+.
T Consensus 1032 ~pp~na~tpq~~----------------f~ni~~~~-~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1032 IPPFNAETPQQI----------------FENILNRD-IPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCCCCCcchhhh----------------hhccccCC-CCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 999987644322 11111111 122334455666788899999999999997766
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.85 E-value=3e-08 Score=97.97 Aligned_cols=131 Identities=25% Similarity=0.366 Sum_probs=94.0
Q ss_pred eecccCCceEEEEEecCCcEEEEEEeccCC--c-----hhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeEEEe
Q 000859 953 IIGSGGSGTVYKAELANGATVAVKKISCKD--D-----HLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIYE 1025 (1251)
Q Consensus 953 ~lG~G~fg~V~~~~~~~~~~vavK~~~~~~--~-----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv~E 1025 (1251)
.+++|+-+.+|.+.+. |.++++|.-..+. . ....+.-.+|+.++.+++--.|..-+=+..+ +....++||
T Consensus 3 ~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD--~~~~~I~me 79 (204)
T COG3642 3 LIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVD--PDNGLIVME 79 (204)
T ss_pred hhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEc--CCCCEEEEE
Confidence 5889999999999886 5556666543332 1 1123455679999999864333322222222 334479999
Q ss_pred ecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcccccccc
Q 000859 1026 YMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKA 1104 (1251)
Q Consensus 1026 ~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~ 1104 (1251)
|++|..|.+++... ...++..+=.-+.-||.. +|||+|+.++||++..+. +.++|||++..
T Consensus 80 ~I~G~~lkd~l~~~--------------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 80 YIEGELLKDALEEA--------------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred EeCChhHHHHHHhc--------------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 99999998888763 134566666778889999 999999999999998765 99999999863
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.82 E-value=4.5e-08 Score=95.88 Aligned_cols=144 Identities=22% Similarity=0.300 Sum_probs=101.2
Q ss_pred cCceecccCCceEEEEEecCCcEEEEEEeccCC-c------hhhhHHHHHHHHHHHhccCCCccceeceeeecCCCceeE
Q 000859 950 DEFIIGSGGSGTVYKAELANGATVAVKKISCKD-D------HLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLL 1022 (1251)
Q Consensus 950 ~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~------~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~l 1022 (1251)
....+-+|+-+.|+++.+. |+...||.-..+. . ....+...+|++.+.+++--.|..-.=++++... ..+
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~--~~i 87 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYG--GQI 87 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCC--CeE
Confidence 4557889999999999986 7777777543332 1 1234566789999999864343322223443333 369
Q ss_pred EEeecCC-CChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCC---CeEEcc
Q 000859 1023 IYEYMEN-GSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNM---EAHLGD 1098 (1251)
Q Consensus 1023 v~E~~~~-gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~---~~kl~D 1098 (1251)
+|||+++ .++.+|+...- ......+....++.+|-+.+.-||.. +|+|+|+..+||++.+++ .+.++|
T Consensus 88 ~ME~~~g~~~vk~~i~~~~-----~~~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lId 159 (229)
T KOG3087|consen 88 YMEFIDGASTVKDFILSTM-----EDESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILID 159 (229)
T ss_pred EEEeccchhHHHHHHHHHc-----cCcccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEe
Confidence 9999986 48888887642 12222223367888899999999999 999999999999996654 358999
Q ss_pred cccccc
Q 000859 1099 FGLAKA 1104 (1251)
Q Consensus 1099 fG~a~~ 1104 (1251)
||++..
T Consensus 160 fgls~~ 165 (229)
T KOG3087|consen 160 FGLSSV 165 (229)
T ss_pred ecchhc
Confidence 999843
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.76 E-value=1e-08 Score=129.44 Aligned_cols=129 Identities=23% Similarity=0.350 Sum_probs=82.4
Q ss_pred cccceeeeccccccCCCCcccCCCCCCceeeccccc--cCCCchhhhcccccCceeeccCccCCCCCCccccCCCcccee
Q 000859 191 SQLEELILQQNQLQGPIPAELGNCSSLSIFTAAENN--LNGSIPAALGRLQNLQLLNLGNNSLSGEIPSELGELSQLGYL 268 (1251)
Q Consensus 191 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~--l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L 268 (1251)
...+...+-+|.+. .++.... .+.|+.|-+..|. +.......|..++.|+.|||++|.=-+.+|..++++-+|++|
T Consensus 523 ~~~rr~s~~~~~~~-~~~~~~~-~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL 600 (889)
T KOG4658|consen 523 NSVRRMSLMNNKIE-HIAGSSE-NPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYL 600 (889)
T ss_pred hheeEEEEeccchh-hccCCCC-CCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcc
Confidence 45566666666554 2333322 2356667777765 443444456667777777777766555677777777777777
Q ss_pred eccCccccCcCCcccccCCCccEEEeccccccCCCCCccccccceEEEEccCcc
Q 000859 269 NLMGNRLEGAIPRSFAKMGNLQSLDLSMNRLTGGIPEEFGNMGQLVFLVLSNNN 322 (1251)
Q Consensus 269 ~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~ 322 (1251)
+|++..+. .+|..+.+++.|.+|++..+.-...+|.....+.+|++|.+..-.
T Consensus 601 ~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~ 653 (889)
T KOG4658|consen 601 DLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSA 653 (889)
T ss_pred cccCCCcc-ccchHHHHHHhhheeccccccccccccchhhhcccccEEEeeccc
Confidence 77777776 666677777777777777766554556666667777777765443
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.73 E-value=1.9e-07 Score=102.36 Aligned_cols=144 Identities=16% Similarity=0.105 Sum_probs=102.0
Q ss_pred ceecccCCceEEEEEecCCcEEEEEEeccCCchhhh----------HHHHHHHHHHHhccCCC--ccceeceeeecC---
Q 000859 952 FIIGSGGSGTVYKAELANGATVAVKKISCKDDHLLN----------KSFTREVKTLGRIRHRH--LVKLMGHCCNKG--- 1016 (1251)
Q Consensus 952 ~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~----------~~~~~E~~~l~~l~h~n--iv~l~g~~~~~~--- 1016 (1251)
+.+-+.....|+++.+ +|+.|.||........... ..+.+|...+.++...+ +++.+++.....
T Consensus 28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 3555566666888877 4789999977433311111 14778999998885333 334444443221
Q ss_pred CCceeEEEeecCCC-ChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecC-----
Q 000859 1017 AGSNLLIYEYMENG-SVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDS----- 1090 (1251)
Q Consensus 1017 ~~~~~lv~E~~~~g-sL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~----- 1090 (1251)
....++|||++++. +|.+++.... ....+......++.+++..++-||+. ||+|+|++++|||++.
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~-----~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~ 178 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWA-----TNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGR 178 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhc-----ccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCC
Confidence 22358999999886 8998885321 12345667778999999999999999 9999999999999975
Q ss_pred --CCCeEEcccccccc
Q 000859 1091 --NMEAHLGDFGLAKA 1104 (1251)
Q Consensus 1091 --~~~~kl~DfG~a~~ 1104 (1251)
++.+.++||+.++.
T Consensus 179 ~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 179 EEDLKLSVIDLHRAQI 194 (268)
T ss_pred CCCceEEEEECCcccc
Confidence 46799999998753
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.70 E-value=2.7e-10 Score=131.12 Aligned_cols=129 Identities=33% Similarity=0.288 Sum_probs=81.5
Q ss_pred cceeeccCcccccccCcccCCCCCCceeccCCCcCCCCCCcccccccccceeeccCcccccccchhhhchhhHHHHHhcc
Q 000859 697 LLVLSLDGNMLNGSLPNEVGNLASLNVLTLSGNLLSGPIPPAIGRLSKLYELRLSNNSLNGVIPLEIGQLQNLQSILDLS 776 (1251)
Q Consensus 697 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~l~ 776 (1251)
|...+.+.|.|+ .+...+.-++.|+.|+||+|+++.. +.+..|++|++|||+.|+|+.+.-.....++ |+ .|+|+
T Consensus 166 L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc~-L~-~L~lr 240 (1096)
T KOG1859|consen 166 LATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNCLRHVPQLSMVGCK-LQ-LLNLR 240 (1096)
T ss_pred HhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhh--HHHHhcccccccccccchhccccccchhhhh-he-eeeec
Confidence 444555566665 4555555566666666666666632 2566666677777777776644444445554 43 36777
Q ss_pred CCcccCCCCCCcCccccccEEEccCCccccCC-chhhhhccCCCcEeeccccCcCcc
Q 000859 777 HNNFTGQIPPSMGTLAKLEVLNLSHNQLVGEL-PSQLGEMSSLGKLNLSYNDLQGKL 832 (1251)
Q Consensus 777 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~-p~~l~~l~~L~~L~l~~N~l~~~~ 832 (1251)
+|.++ ++ ..+.+|++|+.|||+.|-|++.- -.-+..+..|..|+|.|||+....
T Consensus 241 nN~l~-tL-~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c~p 295 (1096)
T KOG1859|consen 241 NNALT-TL-RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCAP 295 (1096)
T ss_pred ccHHH-hh-hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccccCH
Confidence 77776 33 34677788888888888887521 123556677888888888887543
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.69 E-value=1.1e-07 Score=98.01 Aligned_cols=125 Identities=26% Similarity=0.323 Sum_probs=81.9
Q ss_pred eEEEEEecCCcEEEEEEeccCC-------------------------chhhhHHHHHHHHHHHhccCC--Cccceeceee
Q 000859 961 TVYKAELANGATVAVKKISCKD-------------------------DHLLNKSFTREVKTLGRIRHR--HLVKLMGHCC 1013 (1251)
Q Consensus 961 ~V~~~~~~~~~~vavK~~~~~~-------------------------~~~~~~~~~~E~~~l~~l~h~--niv~l~g~~~ 1013 (1251)
.||.|...+|..||||+.+... .........+|.+.|.++... ++.+.+++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 4899988889999999985321 011224567899999999655 566666432
Q ss_pred ecCCCceeEEEeecC--CCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHH-hhhcCCCCeeecCCCCCCeeecC
Q 000859 1014 NKGAGSNLLIYEYME--NGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEY-LHHDCVPKILHRDIKSSNILLDS 1090 (1251)
Q Consensus 1014 ~~~~~~~~lv~E~~~--~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~-LH~~~~~~ivH~Dlkp~Nill~~ 1090 (1251)
. .++||||++ |..+.. +... .++.++...++.+++..+.. +|.. ||+|+|+.+.||++++
T Consensus 80 ---~--~~ivME~I~~~G~~~~~-l~~~--------~~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~ 142 (188)
T PF01163_consen 80 ---R--NVIVMEYIGEDGVPLPR-LKDV--------DLSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDD 142 (188)
T ss_dssp ---T--TEEEEE--EETTEEGGC-HHHC--------GGGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEET
T ss_pred ---C--CEEEEEecCCCccchhh-HHhc--------cccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeec
Confidence 1 379999998 544443 3321 11134456778888886666 4677 9999999999999988
Q ss_pred CCCeEEcccccccc
Q 000859 1091 NMEAHLGDFGLAKA 1104 (1251)
Q Consensus 1091 ~~~~kl~DfG~a~~ 1104 (1251)
+ .+.++|||.|..
T Consensus 143 ~-~~~iIDf~qav~ 155 (188)
T PF01163_consen 143 G-KVYIIDFGQAVD 155 (188)
T ss_dssp T-CEEE--GTTEEE
T ss_pred c-eEEEEecCccee
Confidence 7 999999998854
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.64 E-value=6.7e-07 Score=100.93 Aligned_cols=176 Identities=20% Similarity=0.294 Sum_probs=129.9
Q ss_pred CCceEEEE-EecCCcEEEEEEeccCCchhhhHHHHHHHHHHHhccCCCccceeceeeec--CCCceeEEEeecCC-CChH
Q 000859 958 GSGTVYKA-ELANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNK--GAGSNLLIYEYMEN-GSVW 1033 (1251)
Q Consensus 958 ~fg~V~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~~~lv~E~~~~-gsL~ 1033 (1251)
-..+.|++ ...||..|+.|+++....... .....-+++++++.|+|||++..++... ++...++||+|.++ ++|+
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~-nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~ 366 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQST-NKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLY 366 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCc-ccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHH
Confidence 44578999 566899999999954433211 1223567889999999999999877622 34467899999986 5788
Q ss_pred HhhhcCC-CC-------cccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEccccccccc
Q 000859 1034 DWLHKQP-VN-------IKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKAL 1105 (1251)
Q Consensus 1034 ~~l~~~~-~~-------~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~ 1105 (1251)
++--... .. .......+++..|.++.|+..||.++|+. |+.-+-+.+++|+++.+.+++|+.-|....+
T Consensus 367 d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl 443 (655)
T KOG3741|consen 367 DLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVL 443 (655)
T ss_pred HHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeee
Confidence 7653322 22 22345678899999999999999999999 9999999999999999999999988877655
Q ss_pred ccccCCCCcccceeecccceecccccccCCCCCccceeehhHHHHHHhhCCCC
Q 000859 1106 VEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMP 1158 (1251)
Q Consensus 1106 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGv~l~el~tg~~p 1158 (1251)
..+.. |.+ .--.+-|.=.+|.+++.+.||..-
T Consensus 444 ~~d~~------------------~~l---e~~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 444 QEDPT------------------EPL---ESQQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred cCCCC------------------cch---hHHhhhhHHHHHHHHHHHhhcccc
Confidence 33220 111 112346778899999999998643
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.59 E-value=3.5e-08 Score=82.00 Aligned_cols=59 Identities=39% Similarity=0.566 Sum_probs=26.7
Q ss_pred cCceeeccCccCCCCCCccccCCCccceeeccCccccCcCCcccccCCCccEEEecccc
Q 000859 240 NLQLLNLGNNSLSGEIPSELGELSQLGYLNLMGNRLEGAIPRSFAKMGNLQSLDLSMNR 298 (1251)
Q Consensus 240 ~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~ 298 (1251)
+|++|++++|+++...+..|.++++|++|++++|+++.+.+..|.++++|++|++++|+
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~ 60 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN 60 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence 34444444444443333344444444444444444444444444444444444444443
|
... |
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.59 E-value=3.2e-08 Score=82.18 Aligned_cols=61 Identities=44% Similarity=0.640 Sum_probs=56.5
Q ss_pred CccceeeccCccccCcCCcccccCCCccEEEeccccccCCCCCccccccceEEEEccCccc
Q 000859 263 SQLGYLNLMGNRLEGAIPRSFAKMGNLQSLDLSMNRLTGGIPEEFGNMGQLVFLVLSNNNI 323 (1251)
Q Consensus 263 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l 323 (1251)
++|++|++++|+++.+.+..|.++++|++|++++|+++...+.+|.++++|++|++++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 5789999999999988888999999999999999999988889999999999999999975
|
... |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.58 E-value=3.5e-07 Score=96.03 Aligned_cols=134 Identities=24% Similarity=0.245 Sum_probs=97.4
Q ss_pred cCceecccCCceEEEEEecCCcEEEEEEeccCCc---------------------hhhhHHHHHHHHHHHhccCC--Ccc
Q 000859 950 DEFIIGSGGSGTVYKAELANGATVAVKKISCKDD---------------------HLLNKSFTREVKTLGRIRHR--HLV 1006 (1251)
Q Consensus 950 ~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~---------------------~~~~~~~~~E~~~l~~l~h~--niv 1006 (1251)
+...||.|.-+.||.|....|.++|||.=+.... ........+|.++|+++.-. .|.
T Consensus 95 iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~VP 174 (304)
T COG0478 95 IGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKVP 174 (304)
T ss_pred hccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCCC
Confidence 4468999999999999988899999997532210 12334567899999999654 677
Q ss_pred ceeceeeecCCCceeEEEeecCCCChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCe
Q 000859 1007 KLMGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNI 1086 (1251)
Q Consensus 1007 ~l~g~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Ni 1086 (1251)
+.+++ ...++||||++|-.|...- ++.+....++..|++-+.-.-.. ||||+|+.+-||
T Consensus 175 ~P~~~------nRHaVvMe~ieG~eL~~~r------------~~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNI 233 (304)
T COG0478 175 KPIAW------NRHAVVMEYIEGVELYRLR------------LDVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNI 233 (304)
T ss_pred Ccccc------ccceeeeehcccceeeccc------------CcccCHHHHHHHHHHHHHHHHHc---CccccCCchheE
Confidence 66653 2347999999986554421 12333444555666655555566 999999999999
Q ss_pred eecCCCCeEEcccccccc
Q 000859 1087 LLDSNMEAHLGDFGLAKA 1104 (1251)
Q Consensus 1087 ll~~~~~~kl~DfG~a~~ 1104 (1251)
+++++|.+.++||--+..
T Consensus 234 lV~~dg~~~vIDwPQ~v~ 251 (304)
T COG0478 234 LVTEDGDIVVIDWPQAVP 251 (304)
T ss_pred EEecCCCEEEEeCccccc
Confidence 999999999999987643
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.58 E-value=2.1e-09 Score=124.04 Aligned_cols=129 Identities=29% Similarity=0.208 Sum_probs=94.0
Q ss_pred CCCceeeccccccCCCchhhhcccccCceeeccCccCCCCCCccccCCCccceeeccCccccCcCCcccccCCCccEEEe
Q 000859 215 SSLSIFTAAENNLNGSIPAALGRLQNLQLLNLGNNSLSGEIPSELGELSQLGYLNLMGNRLEGAIPRSFAKMGNLQSLDL 294 (1251)
Q Consensus 215 ~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 294 (1251)
-.|...+.++|.+. ....++.-++.|+.|+|++|+++.. +.+..++.|++|||++|.++.+.--...++ +|+.|.+
T Consensus 164 n~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc-~L~~L~l 239 (1096)
T KOG1859|consen 164 NKLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNCLRHVPQLSMVGC-KLQLLNL 239 (1096)
T ss_pred hhHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhh--HHHHhcccccccccccchhccccccchhhh-hheeeee
Confidence 46677788888887 5667788888999999999999854 378888999999999999984432233334 4899999
Q ss_pred ccccccCCCCCccccccceEEEEccCccccCcccccccccccchhhhhccchhcc
Q 000859 295 SMNRLTGGIPEEFGNMGQLVFLVLSNNNISGSIPRRICTNATSLEHLILAEIQLS 349 (1251)
Q Consensus 295 s~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~i~~~~~~~l~~L~~L~L~~n~l~ 349 (1251)
++|.++.. ..+.++.+|+.||+++|-|.+--.-.....+..|+.|+|.+|.+-
T Consensus 240 rnN~l~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~ 292 (1096)
T KOG1859|consen 240 RNNALTTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC 292 (1096)
T ss_pred cccHHHhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence 99988743 356788888999999998875443344444556666666666553
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.49 E-value=4.1e-08 Score=114.99 Aligned_cols=153 Identities=18% Similarity=0.264 Sum_probs=104.8
Q ss_pred HHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCCeEEcccccccccccccCCCCcc-----cceeecccceeccccccc
Q 000859 1059 VGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTES-----NTWFAGSYGYIAPEYAYS 1133 (1251)
Q Consensus 1059 ~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~-----~~~~~gt~~y~aPE~~~~ 1133 (1251)
.+++.|+.|+|.. +++||+.|.|++|.++..+.+||+.|+.+..........-.. .....-...|.|||++.+
T Consensus 106 ~~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 3455999999987 599999999999999999999999999886544321111111 111234567999999999
Q ss_pred CCCCCccceeehhHHHHHHhh-CCCCCCCccccchhHHHHHHHHHhccchhhhhhhcccCCCCCCchHHHHHHHHHHHHH
Q 000859 1134 LKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMVRWVEMHMEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQ 1212 (1251)
Q Consensus 1134 ~~~~~~sDiwSlGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 1212 (1251)
...+.++|+||+||++|.+.. |+.-+.+.........+.. .++. +.+......+.++.+=+.+
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~--------------~~~~--~~~~~s~~~p~el~~~l~k 247 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRN--------------LLNA--GAFGYSNNLPSELRESLKK 247 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhc--------------cccc--ccccccccCcHHHHHHHHH
Confidence 889999999999999999995 6655544322221111100 0000 1111123456678888999
Q ss_pred ccccCCCCCCCHHHHHH
Q 000859 1213 CTKTSPQERPSSRQVCD 1229 (1251)
Q Consensus 1213 cl~~dP~~RPs~~eil~ 1229 (1251)
.+..++.-||++.++..
T Consensus 248 ~l~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 248 LLNGDSAVRPTLDLLLS 264 (700)
T ss_pred HhcCCcccCcchhhhhc
Confidence 99999999997776643
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.46 E-value=2.9e-06 Score=87.69 Aligned_cols=141 Identities=18% Similarity=0.163 Sum_probs=103.7
Q ss_pred ecccCCceEEEEEecCCcEEEEEEeccCCc-----hhhhHHHHHHHHHHHhccC--CCccceeceee-ecC--CCceeEE
Q 000859 954 IGSGGSGTVYKAELANGATVAVKKISCKDD-----HLLNKSFTREVKTLGRIRH--RHLVKLMGHCC-NKG--AGSNLLI 1023 (1251)
Q Consensus 954 lG~G~fg~V~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~~E~~~l~~l~h--~niv~l~g~~~-~~~--~~~~~lv 1023 (1251)
-|+||.+.|++.... |..+-+|.-...-. +-....|.+|...++++.. -.+.+.. ++. ... ....++|
T Consensus 26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 467999999998875 55788887641111 2245789999999999953 2244444 222 111 2234799
Q ss_pred EeecCC-CChHHhhhcCCCCcccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeecCCCC--eEEcccc
Q 000859 1024 YEYMEN-GSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNME--AHLGDFG 1100 (1251)
Q Consensus 1024 ~E~~~~-gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~--~kl~DfG 1100 (1251)
+|-+++ -+|.+++.+.. ....+......+..++++.++-||+. |+.|+|+.+.||+++.++. ++++||-
T Consensus 104 Te~L~g~~~L~~~l~~~~-----~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlE 175 (216)
T PRK09902 104 TEDMAGFISIADWYAQHA-----VSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLE 175 (216)
T ss_pred EEeCCCCccHHHHHhcCC-----cCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhh
Confidence 997764 48988886542 23456777889999999999999999 9999999999999987677 9999998
Q ss_pred cccc
Q 000859 1101 LAKA 1104 (1251)
Q Consensus 1101 ~a~~ 1104 (1251)
-++.
T Consensus 176 k~r~ 179 (216)
T PRK09902 176 KSRR 179 (216)
T ss_pred ccch
Confidence 6654
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.43 E-value=1.8e-08 Score=93.12 Aligned_cols=139 Identities=23% Similarity=0.305 Sum_probs=91.2
Q ss_pred ccceeeccCcccccccCcc---cCCCCCCceeccCCCcCCCCCCccccc-ccccceeeccCcccccccchhhhchhhHHH
Q 000859 696 KLLVLSLDGNMLNGSLPNE---VGNLASLNVLTLSGNLLSGPIPPAIGR-LSKLYELRLSNNSLNGVIPLEIGQLQNLQS 771 (1251)
Q Consensus 696 ~L~~L~L~~N~l~~~~p~~---~~~l~~L~~L~ls~N~l~~~~~~~~~~-l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~ 771 (1251)
.+..++|++++|- .+++. +.....|+..+|++|.+. ..|..|.. .+.++.|+|++|.|+ .+|.++..++.|+.
T Consensus 28 E~h~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~ 104 (177)
T KOG4579|consen 28 ELHFLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRS 104 (177)
T ss_pred Hhhhcccccchhh-HHHHHHHHHhCCceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhh
Confidence 3555666666664 34433 334445666677777776 45555543 346777777777776 56777777777754
Q ss_pred HHhccCCcccCCCCCCcCccccccEEEccCCccccCCchhhhhccCCCcEeeccccCcCccCcccCCCC
Q 000859 772 ILDLSHNNFTGQIPPSMGTLAKLEVLNLSHNQLVGELPSQLGEMSSLGKLNLSYNDLQGKLSKQFSHWP 840 (1251)
Q Consensus 772 ~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~ 840 (1251)
|+++.|.+. ..|..+..|.+|-.|+..+|.+. ++|-.+-.-+..-..++.++|+.+.-+..+..|.
T Consensus 105 -lNl~~N~l~-~~p~vi~~L~~l~~Lds~~na~~-eid~dl~~s~~~al~~lgnepl~~~~~~klqa~k 170 (177)
T KOG4579|consen 105 -LNLRFNPLN-AEPRVIAPLIKLDMLDSPENARA-EIDVDLFYSSLPALIKLGNEPLGDETKKKLQALK 170 (177)
T ss_pred -cccccCccc-cchHHHHHHHhHHHhcCCCCccc-cCcHHHhccccHHHHHhcCCcccccCcccccccC
Confidence 777777777 66777777777788888888776 6666644334445566688888888776666665
|
|
| >KOG2982 consensus Uncharacterized conserved protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.37 E-value=1.6e-07 Score=98.14 Aligned_cols=182 Identities=16% Similarity=0.157 Sum_probs=100.5
Q ss_pred cchhhhhhccCCcccc--CCchhhhhhcCCCeeecccccccccccccc-cCccceeeecccCcccc-CCCCCCCCcccCc
Q 000859 527 LQALEQLMLYNNSLEG--NLPGSLINLRNLTRINFSKNRLNGRIATLC-SSHSFLSFDVTNNEFDH-EIPPQLGNSPSLE 602 (1251)
Q Consensus 527 l~~L~~L~L~~N~l~~--~~~~~l~~l~~L~~L~l~~N~l~~~~~~l~-~~~~l~~l~l~~n~l~~-~~p~~l~~l~~L~ 602 (1251)
.+.+++|||.+|.|+. .+...+.+++.|++|+++.|+++..+..++ ...+++++-+.+..+.. .....+..+|.++
T Consensus 70 ~~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~I~~lp~p~~nl~~lVLNgT~L~w~~~~s~l~~lP~vt 149 (418)
T KOG2982|consen 70 VTDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSDIKSLPLPLKNLRVLVLNGTGLSWTQSTSSLDDLPKVT 149 (418)
T ss_pred hhhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCccccCcccccceEEEEEcCCCCChhhhhhhhhcchhhh
Confidence 3455566666666653 333455667777777777777777666664 55666666665554432 2334566788888
Q ss_pred eeecccCcccccc--Ccccccc-cccceEEccCCcccC--CCCccccccCCccEEEcCCCccCCC-CccccCCCcccccc
Q 000859 603 RLRLGNNKFIGKI--PWTFGKI-RELSLLDLSGNSLTG--PIPTQLLMCKKLSHIDLNNNLLSGA-VPSWLGTLPQLGEL 676 (1251)
Q Consensus 603 ~L~L~~N~l~~~~--p~~~~~l-~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~l~~N~l~~~-~~~~~~~l~~L~~L 676 (1251)
.|.++.|.+.... ....... +.+++|..-.|...- ..-.--...+++..+.+..|.|.+. -......+|.+..|
T Consensus 150 elHmS~N~~rq~n~Dd~c~e~~s~~v~tlh~~~c~~~~w~~~~~l~r~Fpnv~sv~v~e~PlK~~s~ek~se~~p~~~~L 229 (418)
T KOG2982|consen 150 ELHMSDNSLRQLNLDDNCIEDWSTEVLTLHQLPCLEQLWLNKNKLSRIFPNVNSVFVCEGPLKTESSEKGSEPFPSLSCL 229 (418)
T ss_pred hhhhccchhhhhccccccccccchhhhhhhcCCcHHHHHHHHHhHHhhcccchheeeecCcccchhhcccCCCCCcchhh
Confidence 8888888543221 1112222 133333333332210 0000012235677777777776632 22334556777777
Q ss_pred cccCccccCCCc-cccccccccceeeccCcccc
Q 000859 677 KLSFNQFVGFLP-RELFNCSKLLVLSLDGNMLN 708 (1251)
Q Consensus 677 ~l~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~ 708 (1251)
+|+.|+|.++.. .++..+++|..|.+++|.|.
T Consensus 230 nL~~~~idswasvD~Ln~f~~l~dlRv~~~Pl~ 262 (418)
T KOG2982|consen 230 NLGANNIDSWASVDALNGFPQLVDLRVSENPLS 262 (418)
T ss_pred hhcccccccHHHHHHHcCCchhheeeccCCccc
Confidence 777777765422 44555666666666666664
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.36 E-value=3.6e-08 Score=91.17 Aligned_cols=84 Identities=27% Similarity=0.322 Sum_probs=47.8
Q ss_pred cccccccccCccccCCCccccccccccceeeccCcccccccCcccCCCCCCceeccCCCcCCCCCCcccccccccceeec
Q 000859 671 PQLGELKLSFNQFVGFLPRELFNCSKLLVLSLDGNMLNGSLPNEVGNLASLNVLTLSGNLLSGPIPPAIGRLSKLYELRL 750 (1251)
Q Consensus 671 ~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l 750 (1251)
..|+..+|++|.|..+.++--..++.++.|+|++|+|+ .+|.++..++.|+.|+++.|.+. ..|..|..|.+|-.|+.
T Consensus 53 ~el~~i~ls~N~fk~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lNl~~N~l~-~~p~vi~~L~~l~~Lds 130 (177)
T KOG4579|consen 53 YELTKISLSDNGFKKFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLNLRFNPLN-AEPRVIAPLIKLDMLDS 130 (177)
T ss_pred ceEEEEecccchhhhCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhcccccCccc-cchHHHHHHHhHHHhcC
Confidence 34444555555555542222233445666666666665 56666666666666666666665 45555555666666666
Q ss_pred cCcccc
Q 000859 751 SNNSLN 756 (1251)
Q Consensus 751 ~~N~l~ 756 (1251)
.+|.+.
T Consensus 131 ~~na~~ 136 (177)
T KOG4579|consen 131 PENARA 136 (177)
T ss_pred CCCccc
Confidence 666654
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 1251 | ||||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 8e-58 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 7e-30 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 9e-58 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 8e-30 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-48 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 8e-48 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-34 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-34 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-30 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-30 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-29 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-27 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-25 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-25 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 4e-22 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 3e-21 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 3e-21 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 5e-20 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 8e-20 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 8e-20 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 8e-20 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 8e-20 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 9e-20 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-19 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-19 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-19 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-19 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-19 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-19 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-19 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 3e-19 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 5e-19 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 4e-18 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 5e-18 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 6e-18 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 6e-18 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 6e-18 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 7e-18 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 7e-18 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 8e-18 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 8e-18 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 8e-18 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 8e-18 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 8e-18 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 8e-18 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 9e-18 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-17 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-17 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-17 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-17 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 3e-17 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 3e-17 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 3e-17 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 3e-17 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 4e-17 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 4e-17 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 4e-17 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 5e-17 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 5e-17 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 6e-17 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 6e-17 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 6e-17 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 7e-17 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 9e-17 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-16 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-16 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-16 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-16 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-16 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-16 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-16 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-16 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-16 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-16 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-16 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-16 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-16 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-16 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-16 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-16 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-16 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-16 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-16 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-16 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-16 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 3e-16 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 4e-16 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 5e-16 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 6e-16 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 6e-16 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 7e-16 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 7e-16 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-16 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 8e-16 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 9e-16 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-15 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-15 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-15 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-15 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-15 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-15 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-15 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-15 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-15 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-15 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-15 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-15 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-15 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 3e-15 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-15 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 3e-15 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 4e-15 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 6e-15 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 6e-15 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 6e-15 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 6e-15 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 7e-15 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-15 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 7e-15 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-15 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 8e-15 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 8e-15 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 8e-15 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 8e-15 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 8e-15 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 9e-15 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 9e-15 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-14 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-14 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 1e-14 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-14 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-14 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-14 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-14 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-14 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-14 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-14 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-14 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-14 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-14 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 3e-14 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 3e-14 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 3e-14 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-14 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 3e-14 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 3e-14 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 3e-14 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 4e-14 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 4e-14 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 4e-14 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 4e-14 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-14 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-14 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-14 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 4e-14 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 4e-14 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 4e-14 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 4e-14 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-14 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 5e-14 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 5e-14 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 5e-14 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 5e-14 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 5e-14 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 6e-14 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 6e-14 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 6e-14 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 6e-14 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 7e-14 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 7e-14 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 8e-14 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 8e-14 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 8e-14 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 8e-14 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 8e-14 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 8e-14 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 8e-14 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 8e-14 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 8e-14 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 8e-14 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 8e-14 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 9e-14 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 9e-14 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 9e-14 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-13 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-13 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-13 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-13 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-13 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-13 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-13 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-13 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-13 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-13 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-13 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-13 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-13 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-13 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-13 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 1e-13 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 1e-13 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 1e-13 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-13 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-13 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-13 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-13 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-13 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-13 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-13 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-13 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-13 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-13 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-13 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 3e-13 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 3e-13 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 3e-13 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 3e-13 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-13 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-13 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 3e-13 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 3e-13 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 3e-13 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 3e-13 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 3e-13 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 3e-13 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 3e-13 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 3e-13 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 3e-13 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 3e-13 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-13 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 3e-13 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 3e-13 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 4e-13 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 4e-13 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 4e-13 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 4e-13 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 5e-13 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-13 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-13 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 5e-13 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 5e-13 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 5e-13 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 6e-13 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 6e-13 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 6e-13 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 6e-13 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 6e-13 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 6e-13 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 7e-13 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 7e-13 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-13 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 7e-13 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 7e-13 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 7e-13 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 7e-13 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 8e-13 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 8e-13 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 8e-13 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 8e-13 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-13 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 8e-13 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 8e-13 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 8e-13 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-13 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 9e-13 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 1e-12 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 1e-12 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-12 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 1e-12 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 1e-12 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 1e-12 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 1e-12 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-12 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-12 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 1e-12 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-12 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-12 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-12 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-12 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-12 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-12 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-12 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-12 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-12 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-12 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-12 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-12 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-12 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-12 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-12 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-12 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 3e-12 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 3e-12 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 3e-12 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 3e-12 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 3e-12 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 3e-12 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 3e-12 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 3e-12 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 3e-12 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 3e-12 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 3e-12 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 3e-12 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 3e-12 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-12 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 3e-12 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-12 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-12 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 3e-12 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 3e-12 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 3e-12 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-12 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 3e-12 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 3e-12 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 3e-12 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 3e-12 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 3e-12 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-12 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 4e-12 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-12 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 4e-12 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 4e-12 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-12 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 4e-12 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 4e-12 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 4e-12 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-12 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 4e-12 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 4e-12 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 5e-12 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 5e-12 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 5e-12 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 5e-12 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 5e-12 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 5e-12 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 5e-12 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 5e-12 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 5e-12 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 5e-12 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 5e-12 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 6e-12 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 6e-12 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 6e-12 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 6e-12 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 6e-12 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 6e-12 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 7e-12 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 8e-12 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 8e-12 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 8e-12 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 8e-12 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 8e-12 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 8e-12 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 9e-12 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 9e-12 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 9e-12 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 9e-12 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-11 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-11 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-11 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-11 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-11 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-11 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-11 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-11 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-11 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 1e-11 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-11 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-11 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-11 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-11 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-11 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-11 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-11 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-11 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-11 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-11 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-11 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-11 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-11 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-11 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-11 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-11 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-11 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-11 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-11 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-11 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-11 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-11 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-11 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-11 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-11 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 1e-11 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-11 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-11 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-11 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 2e-11 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-11 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-11 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-11 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-11 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-11 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-11 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-11 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-11 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-11 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-11 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-11 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-11 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-11 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 2e-11 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-11 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-11 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-11 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-11 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-11 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-11 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-11 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-11 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-11 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-11 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-11 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-11 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-11 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 3e-11 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-11 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 3e-11 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 3e-11 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 3e-11 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-11 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 3e-11 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 3e-11 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 3e-11 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 3e-11 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 3e-11 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 3e-11 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 3e-11 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 3e-11 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 3e-11 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 3e-11 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 3e-11 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 4e-11 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-11 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-11 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-11 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 5e-11 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-11 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 5e-11 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 5e-11 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 5e-11 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 5e-11 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 5e-11 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 5e-11 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 5e-11 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 5e-11 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 5e-11 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 5e-11 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 5e-11 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 5e-11 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-11 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-11 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 5e-11 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-11 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-11 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 5e-11 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 6e-11 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 6e-11 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 6e-11 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 7e-11 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 7e-11 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 7e-11 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 7e-11 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 7e-11 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 9e-11 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-10 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-10 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-10 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-10 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-10 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-10 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-10 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-10 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-10 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-10 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-10 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-10 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-10 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-10 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-10 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-10 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-10 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-10 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-10 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-10 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-10 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-10 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-10 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-10 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-10 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 3e-10 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-10 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 3e-10 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-10 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-10 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 3e-10 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 3e-10 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-10 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-10 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 4e-10 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-10 | ||
| 2omx_A | 462 | Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX | 4e-10 | ||
| 2omx_A | 462 | Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX | 1e-08 | ||
| 2omx_A | 462 | Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX | 2e-05 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 4e-10 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 4e-10 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 4e-10 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 4e-10 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 4e-10 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 4e-10 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 4e-10 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-10 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 4e-10 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-10 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 5e-10 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 5e-10 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 5e-10 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 5e-10 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 5e-10 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 5e-10 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 5e-10 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 5e-10 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 5e-10 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 5e-10 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-10 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 5e-10 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 6e-10 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 6e-10 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 6e-10 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 6e-10 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 6e-10 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-10 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 7e-10 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 7e-10 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 7e-10 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 7e-10 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-10 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 7e-10 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 8e-10 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 8e-10 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 8e-10 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 8e-10 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 8e-10 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 9e-10 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 9e-10 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-09 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-09 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 1e-09 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-09 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-09 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-09 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-09 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-09 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-09 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-09 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-09 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-09 | ||
| 2omy_A | 461 | Crystal Structure Of Inla S192n/hec1 Complex Length | 1e-09 | ||
| 2omy_A | 461 | Crystal Structure Of Inla S192n/hec1 Complex Length | 4e-08 | ||
| 2omy_A | 461 | Crystal Structure Of Inla S192n/hec1 Complex Length | 7e-05 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-09 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-09 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-09 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-09 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-09 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-09 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-09 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-09 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-09 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-09 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-09 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-09 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-09 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-09 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-09 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-09 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-09 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-09 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-09 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 1o6s_A | 466 | Internalin (Listeria Monocytogenes) E-Cadherin (Hum | 2e-09 | ||
| 1o6s_A | 466 | Internalin (Listeria Monocytogenes) E-Cadherin (Hum | 5e-08 | ||
| 1o6s_A | 466 | Internalin (Listeria Monocytogenes) E-Cadherin (Hum | 6e-05 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-09 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-09 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-09 | ||
| 2omt_A | 462 | Crystal Structure Of Inla G194s+sHEC1 COMPLEX Lengt | 2e-09 | ||
| 2omt_A | 462 | Crystal Structure Of Inla G194s+sHEC1 COMPLEX Lengt | 2e-08 | ||
| 2omt_A | 462 | Crystal Structure Of Inla G194s+sHEC1 COMPLEX Lengt | 4e-05 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-09 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-09 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-09 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-09 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-09 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 3e-09 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 3e-09 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 3e-09 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 3e-09 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 3e-09 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 3e-09 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-09 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 4e-09 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 4e-09 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 4e-09 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 4e-09 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 4e-09 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-09 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 5e-09 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 6e-09 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 6e-09 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-09 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 6e-09 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 6e-09 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 7e-09 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 7e-09 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 7e-09 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 7e-09 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 7e-09 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 8e-09 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 8e-09 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 8e-09 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 8e-09 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 8e-09 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 8e-09 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 9e-09 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 9e-09 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-08 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-08 | ||
| 2omu_A | 462 | Crystal Structure Of Inla G194s+s Y369s/hec1 Comple | 1e-08 | ||
| 2omu_A | 462 | Crystal Structure Of Inla G194s+s Y369s/hec1 Comple | 4e-05 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-08 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-08 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-08 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 1e-08 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 1e-08 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 1e-08 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 1e-08 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-08 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-08 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 1e-08 | ||
| 2omv_A | 461 | Crystal Structure Of Inla S192n Y369s/hec1 Complex | 2e-08 | ||
| 2omv_A | 461 | Crystal Structure Of Inla S192n Y369s/hec1 Complex | 2e-08 | ||
| 2omv_A | 461 | Crystal Structure Of Inla S192n Y369s/hec1 Complex | 6e-05 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-08 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-08 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-08 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-08 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-08 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-08 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-08 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-08 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-08 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-08 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-08 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-08 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-08 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-08 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-08 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-08 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-08 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-08 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-08 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-08 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-08 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-08 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-08 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-08 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-08 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-08 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-08 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-08 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-08 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-08 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-08 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-08 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-08 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-08 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 2e-08 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-08 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-08 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-08 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-08 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-08 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-08 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-08 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-08 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-08 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-08 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-08 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-08 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-08 | ||
| 2omz_A | 466 | Crystal Structure Of Inla Y369a/hec1 Complex Length | 2e-08 | ||
| 2omz_A | 466 | Crystal Structure Of Inla Y369a/hec1 Complex Length | 4e-08 | ||
| 2omz_A | 466 | Crystal Structure Of Inla Y369a/hec1 Complex Length | 7e-05 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-08 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-08 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-08 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-08 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-08 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-08 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 3e-08 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 3e-08 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 3e-08 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 3e-08 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 3e-08 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 3e-08 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 3e-08 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 3e-08 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 3e-08 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 4e-08 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 4e-08 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 4e-08 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 4e-08 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 4e-08 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 4e-08 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 4e-08 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-08 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-08 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 4e-08 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 5e-08 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 5e-08 | ||
| 3rfj_A | 279 | Design Of A Binding Scaffold Based On Variable Lymp | 5e-08 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 5e-08 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 5e-08 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 5e-08 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 5e-08 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-08 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 6e-08 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 7e-08 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 7e-08 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 7e-08 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 7e-08 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 8e-08 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 9e-08 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 9e-08 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 9e-08 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 9e-08 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 9e-08 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 9e-08 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-07 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-07 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-07 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-07 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-07 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-07 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-07 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-07 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 1e-07 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-07 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 1e-07 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-07 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-07 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-07 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-07 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-07 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-07 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-07 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-07 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-07 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-07 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-07 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-07 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-07 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-07 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-07 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-07 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-07 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-07 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-07 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 2e-07 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-07 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-07 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-07 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-07 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 3e-07 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 3e-07 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 3e-07 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-07 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-07 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-07 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-07 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-07 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-07 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-07 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-07 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 3e-07 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-07 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-07 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 4e-07 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-07 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 4e-07 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 4e-07 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 4e-07 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 4e-07 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 4e-07 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 4e-07 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-07 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 4e-07 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 4e-07 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 4e-07 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 4e-07 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 4e-07 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 4e-07 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 4e-07 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 5e-07 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 5e-07 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 5e-07 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 5e-07 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 5e-07 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 5e-07 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 6e-07 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 6e-07 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 6e-07 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 6e-07 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 6e-07 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 6e-07 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 6e-07 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 6e-07 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 6e-07 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 7e-07 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 7e-07 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 8e-07 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 8e-07 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 8e-07 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 8e-07 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 8e-07 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 9e-07 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 9e-07 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 9e-07 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 9e-07 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 9e-07 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 9e-07 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-06 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-06 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-06 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-06 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 1e-06 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 1e-06 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 1e-06 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 1e-06 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 1e-06 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 1e-06 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 1e-06 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 1e-06 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-06 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 1e-06 | ||
| 3rfs_A | 272 | Design Of A Binding Scaffold Based On Variable Lymp | 1e-06 | ||
| 3rfs_A | 272 | Design Of A Binding Scaffold Based On Variable Lymp | 1e-04 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-06 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 1e-06 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-06 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-06 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-06 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-06 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-06 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-06 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-06 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-06 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-06 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 1e-06 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 1e-06 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 1e-06 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-06 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 1e-06 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-06 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-06 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-06 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-06 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 2e-06 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-06 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-06 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-06 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-06 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-06 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-06 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-06 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-06 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-06 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-06 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-06 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-06 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 2e-06 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-06 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-06 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 3e-06 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-06 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 3e-06 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 3e-06 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 3e-06 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 3e-06 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 3e-06 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 3e-06 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 3e-06 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 3e-06 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 3e-06 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 3e-06 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-06 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 4e-06 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 4e-06 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 4e-06 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 4e-06 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 4e-06 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 4e-06 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-06 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 4e-06 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 4e-06 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 4e-06 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-06 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 5e-06 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 5e-06 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 6e-06 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 6e-06 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 6e-06 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 6e-06 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 6e-06 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 6e-06 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 6e-06 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 6e-06 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 6e-06 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 6e-06 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 6e-06 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 6e-06 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 6e-06 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 6e-06 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 6e-06 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 6e-06 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 7e-06 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 7e-06 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 7e-06 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 7e-06 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 7e-06 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 8e-06 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 8e-06 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 8e-06 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 8e-06 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 9e-06 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 9e-06 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 9e-06 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 9e-06 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 9e-06 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 9e-06 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 9e-06 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 9e-06 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 9e-06 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 9e-06 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 9e-06 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-05 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-05 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 1e-05 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 1e-05 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-05 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-05 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 1e-05 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-05 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 1e-05 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 1e-05 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 1e-05 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 1e-05 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-05 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-05 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 1e-05 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-05 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 1e-05 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-05 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-05 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 1e-05 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-05 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 1e-05 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 1e-05 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 1e-05 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 1e-05 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-05 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 1e-05 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 1e-05 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 1e-05 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 1e-05 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 1e-05 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-05 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 2e-05 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-05 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-05 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-05 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-05 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-05 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-05 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 2e-05 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-05 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-05 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-05 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-05 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 2e-05 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-05 | ||
| 2o6q_A | 270 | Structural Diversity Of The Hagfish Variable Lympho | 2e-05 | ||
| 2o6q_A | 270 | Structural Diversity Of The Hagfish Variable Lympho | 1e-04 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 2e-05 | ||
| 3b2d_A | 603 | Crystal Structure Of Human Rp105MD-1 Complex Length | 2e-05 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-05 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-05 | ||
| 4b8c_D | 727 | Nuclease Module Of The Yeast Ccr4-Not Complex Lengt | 3e-05 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 3e-05 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 3e-05 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 3e-05 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 4e-05 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 4e-05 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 5e-05 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 6e-05 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 6e-05 | ||
| 3kj4_A | 286 | Structure Of Rat Nogo Receptor Bound To 1d9 Antagon | 6e-05 | ||
| 3kj4_A | 286 | Structure Of Rat Nogo Receptor Bound To 1d9 Antagon | 3e-04 |
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2OMX|A Chain A, Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|2OMX|A Chain A, Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|2OMX|A Chain A, Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2OMY|A Chain A, Crystal Structure Of Inla S192n/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|2OMY|A Chain A, Crystal Structure Of Inla S192n/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|2OMY|A Chain A, Crystal Structure Of Inla S192n/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1O6S|A Chain A, Internalin (Listeria Monocytogenes) E-Cadherin (Human) Recognition Complex Length = 466 | Back alignment and structure |
|
| >pdb|1O6S|A Chain A, Internalin (Listeria Monocytogenes) E-Cadherin (Human) Recognition Complex Length = 466 | Back alignment and structure |
|
| >pdb|1O6S|A Chain A, Internalin (Listeria Monocytogenes) E-Cadherin (Human) Recognition Complex Length = 466 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2OMT|A Chain A, Crystal Structure Of Inla G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|2OMT|A Chain A, Crystal Structure Of Inla G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|2OMT|A Chain A, Crystal Structure Of Inla G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2OMU|A Chain A, Crystal Structure Of Inla G194s+s Y369s/hec1 Complex Length = 462 | Back alignment and structure |
|
| >pdb|2OMU|A Chain A, Crystal Structure Of Inla G194s+s Y369s/hec1 Complex Length = 462 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2OMV|A Chain A, Crystal Structure Of Inla S192n Y369s/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|2OMV|A Chain A, Crystal Structure Of Inla S192n Y369s/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|2OMV|A Chain A, Crystal Structure Of Inla S192n Y369s/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2OMZ|A Chain A, Crystal Structure Of Inla Y369a/hec1 Complex Length = 466 | Back alignment and structure |
|
| >pdb|2OMZ|A Chain A, Crystal Structure Of Inla Y369a/hec1 Complex Length = 466 | Back alignment and structure |
|
| >pdb|2OMZ|A Chain A, Crystal Structure Of Inla Y369a/hec1 Complex Length = 466 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3RFJ|A Chain A, Design Of A Binding Scaffold Based On Variable Lymphocyte Receptors Of Jawless Vertebrates By Module Engineering Length = 279 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3RFS|A Chain A, Design Of A Binding Scaffold Based On Variable Lymphocyte Receptors Of Jawless Vertebrates By Module Engineering Length = 272 | Back alignment and structure |
|
| >pdb|3RFS|A Chain A, Design Of A Binding Scaffold Based On Variable Lymphocyte Receptors Of Jawless Vertebrates By Module Engineering Length = 272 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2O6Q|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte Receptors A29 Length = 270 | Back alignment and structure |
|
| >pdb|2O6Q|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte Receptors A29 Length = 270 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3B2D|A Chain A, Crystal Structure Of Human Rp105MD-1 Complex Length = 603 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|4B8C|D Chain D, Nuclease Module Of The Yeast Ccr4-Not Complex Length = 727 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3KJ4|A Chain A, Structure Of Rat Nogo Receptor Bound To 1d9 Antagonist Antibody Length = 286 | Back alignment and structure |
|
| >pdb|3KJ4|A Chain A, Structure Of Rat Nogo Receptor Bound To 1d9 Antagonist Antibody Length = 286 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 664 bits (1715), Expect = 0.0
Identities = 236/866 (27%), Positives = 359/866 (41%), Gaps = 124/866 (14%)
Query: 18 FSPGFVLCKDEELSVLLEIKKSFTADPENVLHAWNQSNQNLCTWRGITCGSSSARVVSLN 77
F E+ L+ K +N+L W+ SN+N CT+ G+TC +V S++
Sbjct: 2 FQASPSQSLYREIHQLISFKDVL--PDKNLLPDWS-SNKNPCTFDGVTC--RDDKVTSID 56
Query: 78 LSGLSLA---GSISPSLGRLQSLIHLDLSSNSLTGPIPTALSNLSSLESLLLFSNQLAGT 134
LS L ++S SL L L L LS++ + G + +SL SL L N L+G
Sbjct: 57 LSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASLTSLDLSRNSLSGP 115
Query: 135 IPT--QLGSLTSLRVMRIGDNWLSGSIPTS-FGNLVNLGTLGLASCSLSGPIPPQF---G 188
+ T LGS + L+ + + N L S L +L L L++ S+SG +
Sbjct: 116 VTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSD 175
Query: 189 QLSQLEELILQQNQLQGPIPAELGNCSSLSIFTAAENNLNGSIPAALGRLQNLQLLNLGN 248
+L+ L + N++ G + + R NL+ L++ +
Sbjct: 176 GCGELKHLAISGNKISGDVD--------------------------VSRCVNLEFLDVSS 209
Query: 249 NSLSGEIPSELGELSQLGYLNLMGNRLEGAIPRSFAKMGNLQSLDLSMNRLTGGIPEEFG 308
N+ S IP LG+ S L +L++ GN+L G R+ + L+ L++S N+ G IP
Sbjct: 210 NNFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL-- 266
Query: 309 NMGQLVFLVLSNNNISGSIPRRICTNATSLEHLILAEIQLSGEIPVELSQCQSLKQLDLS 368
+ L +L L+ N +G IP + +L L L+ G +P C L+ L LS
Sbjct: 267 PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALS 326
Query: 369 NNTLNGTIPVE-LFQLVALTHLYLHNNSLVGSISPFVANLS-NLQELALYHNNFQGSLPR 426
+N +G +P++ L ++ L L L N G + + NLS +L L L NNF G +
Sbjct: 327 SNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILP 386
Query: 427 EIG--MLVKLELLYLYDNHLSGQIPSEVGNCSSLKWIDFFGNSFTGEIPTSIGRLKDLNF 484
+ L+ LYL +N +G+IP + NCS L + N +G IP+S+G L L
Sbjct: 387 NLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRD 446
Query: 485 LHLRQNELVGQIPASLGNCHQLIILDLADNKLSGGVPASFGFLQALEQLMLYNNSLEGNL 544
L L N L G+IP L L L L N L+G +P+ L + L NN L G +
Sbjct: 447 LKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEI 506
Query: 545 PGSLINLRNLTRINFSKNRLNGRIATLCSSHSFLSFDVTNNEFDHEIPPQLGNSPSLERL 604
P + L NL + S N +G IP +LG+ SL L
Sbjct: 507 PKWIGRLENLAILKLSNNSFSG-----------------------NIPAELGDCRSLIWL 543
Query: 605 RLGNNKFIGKIPWTFGKIRELSLLDLSGNSLTGPIPTQLLMCKKLSHIDLNNNL--LSGA 662
L N F G IP K ++ N + G + NL G
Sbjct: 544 DLNTNLFNGTIPAAMFKQS----GKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGI 599
Query: 663 VPSWLGTLPQLGELKLSFNQFVGFLPRELFNCSKLLVLSLDGNMLNGSLPNEVGNLASLN 722
L L ++ + G N ++ L + NML+G +P E+G++ L
Sbjct: 600 RSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLF 659
Query: 723 VLTLSGNLLSGPIPPAIGRLSKLYELRLSNNSLNGVIPLEIGQLQNLQSILDLSHNNFTG 782
+L L N +SG IP E+G L+ L LDLS N G
Sbjct: 660 ILNLGHNDISGSIPD------------------------EVGDLRGLNI-LDLSSNKLDG 694
Query: 783 QIPPSMGTLAKLEVLNLSHNQLVGELPSQLGEMSSLGKLNLSYNDLQGKLSKQFSHWPAE 842
+IP +M L L ++LS+N L G +P QF +P
Sbjct: 695 RIPQAMSALTMLTEIDLSNNNLSGPIPE----------------------MGQFETFPPA 732
Query: 843 AFEGNLHLCGSPLDHCNGLVSNQHQS 868
F N LCG PL C+ ++ +
Sbjct: 733 KFLNNPGLCGYPLPRCDPSNADGYAH 758
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 389 bits (1002), Expect = e-121
Identities = 148/722 (20%), Positives = 252/722 (34%), Gaps = 85/722 (11%)
Query: 167 VNLGTLGLASCSLSGPIPPQFGQLSQLEELILQQNQLQGPIPAELGNCSSLSIFTAAENN 226
V+ + L+ +P + + L L NQL+ A S L+ N
Sbjct: 4 VSHEVADCSHLKLTQ-VPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNT 60
Query: 227 LNGSIPAALGRLQNLQLLNLGNNSLSGEIPSELGELSQLGYLNLMGNRLEGAIPRSFAKM 286
++ P +L L++LNL +N LS + L L+LM N ++ F K
Sbjct: 61 ISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQ 120
Query: 287 GNLQSLDLSMNRLTGGIPEEFGNMGQLVFLVLSNNNISGSIPRRICTNATSLEHLILAEI 346
NL +LDLS N L+ + L L+LSNN I
Sbjct: 121 KNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSE----------------- 163
Query: 347 QLSGEIPVELSQCQSLKQLDLSNNTLNGTIPVELFQLVALTHLYLHNNSLVGSISP---F 403
+++ SLK+L+LS+N + P + L L+L+N L S++
Sbjct: 164 ------ELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCL 217
Query: 404 VANLSNLQELALYHNNFQGSLPREIGML--VKLELLYLYDNHLSGQIPSEVGNCSSLKWI 461
++++ L+L ++ + L L +L L N+L+ L++
Sbjct: 218 ELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYF 277
Query: 462 DFFGNSFTGEIPTSIGRLKDLNFLHLRQNELVGQIPASLGNCHQLIILDLADNKLSGGVP 521
N+ S+ L ++ +L+L+++ ++ L
Sbjct: 278 FLEYNNIQHLFSHSLHGLFNVRYLNLKRS---------------FTKQSISLASLPKIDD 322
Query: 522 ASFGFLQALEQLMLYNNSLEGNLPGSLINLRNLTRINFSKNRLNGRIATLCSSHSFLSFD 581
SF +L+ LE L + +N + G L NL ++ S + + R ++ +F+S
Sbjct: 323 FSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRT---LTNETFVSL- 378
Query: 582 VTNNEFDHEIPPQLGNSPSLERLRLGNNKFIGKIPWTFGKIRELSLLDLSGNSLTGPIPT 641
L L L NK F + L +LDL N + +
Sbjct: 379 ---------------AHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTG 423
Query: 642 QLLM-CKKLSHIDLNNNLLSGAVPSWLGTLPQLGELKLSFNQF--VGFLPRELFNCSKLL 698
Q + + I L+ N + +P L L L V P L
Sbjct: 424 QEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLT 483
Query: 699 VLSLDGNMLNGSLPNEVGNLASLNVLTLSGNLLS--------GPIPPAIGRLSKLYELRL 750
+L L N + + + L L +L L N L+ G + LS L+ L L
Sbjct: 484 ILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNL 543
Query: 751 SNNSLNGVIPLEIGQLQNLQSILDLSHNNFTGQIPPSMGTLAKLEVLNLSHNQLVGELPS 810
+N + + L L+ I+DL NN L+ LNL N +
Sbjct: 544 ESNGFDEIPVEVFKDLFELK-IIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKK 602
Query: 811 QLGE-MSSLGKLNLSYNDLQG--KLSKQFSHWPAEAFEGNLHL-----CGSPLDHCNGLV 862
G +L +L++ +N + F +W E L C +P + V
Sbjct: 603 VFGPAFRNLTELDMRFNPFDCTCESIAWFVNWINETHTNIPELSSHYLCNTPPHYHGFPV 662
Query: 863 SN 864
Sbjct: 663 RL 664
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 380 bits (977), Expect = e-117
Identities = 155/701 (22%), Positives = 251/701 (35%), Gaps = 75/701 (10%)
Query: 120 SLESLLLFSNQLAGTIPTQLGSLTSLRVMRIGDNWLSGSIPTSFGNLVNLGTLGLASCSL 179
S E +L +P L T++ V+ + N L +F L +L + ++
Sbjct: 5 SHEVADCSHLKLT-QVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTI 61
Query: 180 SGPIPPQFGQLSQLEELILQQNQLQGPIPAELGNCSSLSIFTAAENNLNGSIPAALGRLQ 239
S P +L L+ L LQ N+L C++L+ N++ + +
Sbjct: 62 SKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQK 121
Query: 240 NLQLLNLGNNSLSGEIPSELGELSQLGYLNLMGNRLEGAIPRSFAKMGN--LQSLDLSMN 297
NL L+L +N LS +L L L L N+++ N L+ L+LS N
Sbjct: 122 NLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSN 181
Query: 298 RLTGGIPEEFGNMGQLVFLVLSNNNISGSIPRRICT--NATSLEHLILAEIQLSGEIPVE 355
++ P F +G+L L L+N + S+ ++C TS+ +L L+ QLS
Sbjct: 182 QIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTT 241
Query: 356 LSQCQ--SLKQLDLSNNTLNGTIPVELFQLVALTHLYLHNNSLVGSISPFVANLSNLQEL 413
+ +L LDLS N LN L L + +L N++ S + L N++ L
Sbjct: 242 FLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYL 301
Query: 414 ALYHNNFQGSLPREIGMLVKLELLYLYDNHLSGQIPSEVGNCSSLKWIDFFGNSFTGEIP 473
L + + L L+ ++ N G
Sbjct: 302 NLKRS---------------FTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKS 346
Query: 474 TSIGRLKDLNFLHLRQN-----ELVGQIPASLGNCHQLIILDLADNKLSGGVPASFGFLQ 528
L +L +L L + L + SL + L IL+L NK+S +F +L
Sbjct: 347 NMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAH-SPLHILNLTKNKISKIESDAFSWLG 405
Query: 529 ALEQLMLYNNSLEGNLPGSLI-NLRNLTRINFSKNRLNGRIATLCSSHSFLSFDVTNNEF 587
LE L L N + L G L N+ I S N+
Sbjct: 406 HLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKY----------------------- 442
Query: 588 DHEIPPQLGNSPSLERLRLGNNKF--IGKIPWTFGKIRELSLLDLSGNSLTGPIPTQLLM 645
PSL+RL L + P F +R L++LDLS N++ L
Sbjct: 443 LQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEG 502
Query: 646 CKKLSHIDLNNNLLSGAVPSWLGTLPQLGELKLSFNQFVGFLPRELFNCSKLLVLSLDGN 705
+KL +DL +N L+ +L + G L S L +L+L+ N
Sbjct: 503 LEKLEILDLQHNNLA----------------RLWKHANPGGPIYFLKGLSHLHILNLESN 546
Query: 706 MLNGSLPNEVGNLASLNVLTLSGNLLSGPIPPAIGRLSKLYELRLSNNSLNGVIPLEIGQ 765
+ +L L ++ L N L+ L L L N + V G
Sbjct: 547 GFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGP 606
Query: 766 LQNLQSILDLSHNNFTGQIPPSMGTLAKLEVLNLSHNQLVG 806
+ LD+ N F S+ + +N +H +
Sbjct: 607 AFRNLTELDMRFNPFDC-TCESIAWF--VNWINETHTNIPE 644
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 371 bits (955), Expect = e-114
Identities = 144/661 (21%), Positives = 232/661 (35%), Gaps = 51/661 (7%)
Query: 73 VVSLNLSGLSLAGSISPSLGRLQSLIHLDLSSNSLTGPIPTALSNLSSLESLLLFSNQLA 132
+ LNL+ L + + R L LD+ N+++ P L L+ L L N+L+
Sbjct: 27 ITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELS 86
Query: 133 GTIPTQLGSLTSLRVMRIGDNWLSGSIPTSFGNLVNLGTLGLASCSLSGPIPPQFGQLSQ 192
T+L + + N + F NL TL L+ LS QL
Sbjct: 87 QLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLEN 146
Query: 193 LEELILQQNQLQGPIPAELG--NCSSLSIFTAAENNLNGSIPAALGRLQNLQLLNLGNNS 250
L+EL+L N++Q EL SSL + N + P + L L L N
Sbjct: 147 LQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQ 206
Query: 251 LSGEIPSELGE---LSQLGYLNLMGNRLEGAIPRSFAKMG--NLQSLDLSMNRLTGGIPE 305
L + +L + + L+L ++L +F + NL LDLS N L +
Sbjct: 207 LGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGND 266
Query: 306 EFGNMGQLVFLVLSNNNISGSIPRRICTNATSLEHLILAEIQLSGEIPVELSQCQSLKQL 365
F + QL + L NNI + ++ +L L +S +
Sbjct: 267 SFAWLPQLEYFFLEYNNIQHLFSHSLH-GLFNVRYLNLK---------------RSFTKQ 310
Query: 366 DLSNNTLNGTIPVELFQLVALTHLYLHNNSLVGSISPFVANLSNLQELALYHNNFQ-GSL 424
+S +L L L HL + +N + G S L NL+ L+L ++ +L
Sbjct: 311 SISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTL 370
Query: 425 PREIGM---LVKLELLYLYDNHLSGQIPSEVGNCSSLKWIDFFGNSFTGEIP-TSIGRLK 480
E + L +L L N +S L+ +D N E+ L+
Sbjct: 371 TNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLE 430
Query: 481 DLNFLHLRQNELVGQIPASLGNCHQLIILDLADNKLSG--GVPASFGFLQALEQLMLYNN 538
++ ++L N+ + S L L L L P+ F L+ L L L NN
Sbjct: 431 NIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNN 490
Query: 539 SLEGNLPGSLINLRNLTRINFSKNRLNGRIATLCSSHSFLSFDVTNNEFDHEIPPQLGNS 598
++ L L L ++ N L + + L
Sbjct: 491 NIANINDDMLEGLEKLEILDLQHNNLA---------------RLWKHANPGGPIYFLKGL 535
Query: 599 PSLERLRLGNNKFIGKIPWTFGKIRELSLLDLSGNSLTGPIPTQLLMCKKLSHIDLNNNL 658
L L L +N F F + EL ++DL N+L + L ++L NL
Sbjct: 536 SHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNL 595
Query: 659 LSGAVPSWLGT-LPQLGELKLSFNQFVGFLP-----RELFNCSKLLVLSLDGNMLNGSLP 712
++ G L EL + FN F N + + L + L + P
Sbjct: 596 ITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAWFVNWINETHTNIPELSSHYLCNTPP 655
Query: 713 N 713
+
Sbjct: 656 H 656
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 353 bits (909), Expect = e-108
Identities = 98/628 (15%), Positives = 201/628 (32%), Gaps = 83/628 (13%)
Query: 220 FTAAENNLNGSIPAALGRLQNLQLLNLGNNSLSGEIPSELGELSQLGYLNLMGNRLEG-- 277
F + +L + L+L SG +P +G+L++L L L + +
Sbjct: 62 FNKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNE 121
Query: 278 --AIPRSFAKMGNLQSLDLSMNRLTGGIPEEFG--NMGQLVFLVLSNNNISGSIPRRICT 333
P+ + + + + + L+ ++++ SI +
Sbjct: 122 RLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRI 181
Query: 334 NATSLEHLILAEIQLSGEIPVELSQCQSLKQLDLSNNTLNGTIPVELFQLVALTHLYLHN 393
+ ++ + + + L+Q + N+ E ++
Sbjct: 182 T-LKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSE-----Y 234
Query: 394 NSLVGSISPFVANLSNLQELALYHNNFQGSLPREIGMLVKLELLYLYDNHL--------S 445
+ NL +L ++ +Y+ LP + L +++L+ + N
Sbjct: 235 AQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDD 294
Query: 446 GQIPSEVGNCSSLKWIDFFGNSF-TGEIPTSIGRLKDLNFLHLRQNELVGQIPASLGNCH 504
Q ++ ++ I N+ T + TS+ ++K L L N+L G++P + G+
Sbjct: 295 WQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEI 353
Query: 505 QLIILDLADNKLSGGVPASFGFLQALEQLMLYNNSLEGNLPGSLI-NLRNLTRINFSKNR 563
+L L+LA N+++ GF + +E L +N L+ ++ ++ I+FS N
Sbjct: 354 KLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNE 413
Query: 564 LNGRIATLCSSHSFLSFDVTNNEFDHEIPPQLGNSPSLERLRLGNNKFIGKIPWTFGKIR 623
+ + P ++ + L NN+ F
Sbjct: 414 IGSVDGKNFDP----------------LDPTPFKGINVSSINLSNNQISKFPKELFSTGS 457
Query: 624 ELSLLDLSGNSLTGPIPTQLLMCKKLSHIDLNNNLLSGAVPSWLGTLPQLGELKLSFNQF 683
LS ++L GN LT IP L L + L FN+
Sbjct: 458 PLSSINLMGNMLTE-IPKNSL----------------KDENENFKNTYLLTSIDLRFNKL 500
Query: 684 VGFLPRELF--NCSKLLVLSLDGNMLNGSLPNEVGNLASLNVLTLSGNLLSGPIPPAIGR 741
L + L+ + L N + P + N ++L +
Sbjct: 501 TK-LSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRD---------- 548
Query: 742 LSKLYELRLSNNSLNGVIPLEIGQLQNLQSILDLSHNNFTGQIPPSMGTLAKLEVLNLSH 801
N P I +L L + N+ + + + VL++
Sbjct: 549 --------AQGNRTLREWPEGITLCPSLTQ-LQIGSNDIRK-VNEKI--TPNISVLDIKD 596
Query: 802 NQLVGELPSQLGEMSSLGKLNLSYNDLQ 829
N + S + G L Y+ Q
Sbjct: 597 NPNISIDLSYVCPYIEAGMYMLFYDKTQ 624
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 347 bits (891), Expect = e-106
Identities = 99/680 (14%), Positives = 207/680 (30%), Gaps = 140/680 (20%)
Query: 51 WNQSNQNLCTWR---GITCGSSSARVVSLNLSGLSLAGSISPSLGRLQSLIHLDLSSNSL 107
WN N+ L W G++ S+ RV L+L G +G + ++G+L L L L S+
Sbjct: 60 WNF-NKELDMWGAQPGVSLNSNG-RVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGE 117
Query: 108 TGP----IPTALSNLSSLESLLLFSNQLAGTIPTQLG--SLTSLRVMRIGDNWLSGSIPT 161
P +S S E T + L I + SI
Sbjct: 118 KVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKK 177
Query: 162 SFGNLVNLGTLGLASCSLSGPIPPQFGQLSQLEELILQQNQLQGPIPAELGNCSSLSIFT 221
S + +G S +++ + +L++L + + + E +
Sbjct: 178 SSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEY-- 234
Query: 222 AAENNLNGSIPAALGRLQNLQLLNLGNNSLSGEIPSELGELSQLGYLNLMGNRLEGAIPR 281
+ L++L + + N ++P+ L L
Sbjct: 235 ---AQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALP------------------ 273
Query: 282 SFAKMGNLQSLDLSMNRLTGG--------IPEEFGNMGQLVFLVLSNNNISGSIPRRICT 333
+Q ++++ NR G + ++ + + NN+
Sbjct: 274 ------EMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK--------- 318
Query: 334 NATSLEHLILAEIQLSGEIPVELSQCQSLKQLDLSNNTLNGTIPVELFQLVALTHLYLHN 393
+ + L + + L L+ N L G +P + L L L
Sbjct: 319 ---------------TFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAY 362
Query: 394 NSLVGSISPFVANLSNLQELALYHNNFQGSLPR--EIGMLVKLELLYLYDNHLSGQIPSE 451
N + + F ++ L+ HN + +P + + + + N +
Sbjct: 363 NQITEIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDG-- 419
Query: 452 VGNCSSLKWIDFFGNSFTGEIPTSIGRLKDLNFLHLRQNELVGQIPASLGNCHQLIILDL 511
+F + + + +++ ++L N++ L ++L
Sbjct: 420 --------------KNFDP-LDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINL 464
Query: 512 ADNKLSG-------GVPASFGFLQALEQLMLYNNSLEGNLPG-SLINLRNLTRINFSKNR 563
N L+ +F L + L N L L L I+ S N
Sbjct: 465 MGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNS 524
Query: 564 LNGRIATLCSSHSFLSFDVTNNEFDHEIPPQLGNSPSLERLRLGN------NKFIGKIPW 617
+ P Q NS +L+ + N N+ + + P
Sbjct: 525 FSK------------------------FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPE 560
Query: 618 TFGKIRELSLLDLSGNSLTGPIPTQLLMCKKLSHIDLNNNLLSGAVPSWLGTLPQLGELK 677
L+ L + N + + ++ +S +D+ +N S++ + G
Sbjct: 561 GITLCPSLTQLQIGSNDIRK-VNEKIT--PNISVLDIKDNPNISIDLSYVCPYIEAGMYM 617
Query: 678 LSFNQFVGFLPRELFNCSKL 697
L +++ +++ C L
Sbjct: 618 LFYDK-----TQDIRGCDAL 632
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 305 bits (784), Expect = 9e-91
Identities = 82/510 (16%), Positives = 167/510 (32%), Gaps = 45/510 (8%)
Query: 75 SLNLSGLSLAGSISPSLGRLQ--SLIHLDLSSNSLTGPIPTALSNLSSLESLLLFSNQLA 132
+ + R LI ++S+ I + + SN +
Sbjct: 137 QKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNI- 195
Query: 133 GTIPTQLGSLTSLRVMRIGDNWLSGSIPTSFGNLVNLGTLGLASCSLSGPIPPQFGQLSQ 192
+ + LT LR +G++ N ++ L
Sbjct: 196 TFVSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYA-----QQYKTEDLKWDNLKD 250
Query: 193 LEELILQQNQLQGPIPAELGNCSSLSIFTAAENNL--------NGSIPAALGRLQNLQLL 244
L ++ + +P L + + A N + A + +Q++
Sbjct: 251 LTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQII 310
Query: 245 NLGNNSL-SGEIPSELGELSQLGYLNLMGNRLEGAIPRSFAKMGNLQSLDLSMNRLTGGI 303
+G N+L + + + L ++ +LG L + N+LEG +P +F L SL+L+ N++T
Sbjct: 311 YIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQITEIP 369
Query: 304 PEEFGNMGQLVFLVLSNNNISGSIPRRICTNATSLEHLILAEIQLSG-------EIPVEL 356
G Q+ L ++N + + + + + + ++ +
Sbjct: 370 ANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTP 429
Query: 357 SQCQSLKQLDLSNNTLNGTIPVELFQLVALTHLYLHNNSLVG-------SISPFVANLSN 409
+ ++ ++LSNN ++ L+ + L N L + N
Sbjct: 430 FKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYL 489
Query: 410 LQELALYHNNFQGSLPREI--GMLVKLELLYLYDNHLSGQIPSEVGNCSSLKWI------ 461
L + L N L + L L + L N S P++ N S+LK
Sbjct: 490 LTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQR 547
Query: 462 DFFGNSFTGEIPTSIGRLKDLNFLHLRQNELVGQIPASLGNCHQLIILDLADNKLSGGVP 521
D GN E P I L L + N++ + + + +LD+ DN
Sbjct: 548 DAQGNRTLREWPEGITLCPSLTQLQIGSNDIRK-VNEKI--TPNISVLDIKDNPNISIDL 604
Query: 522 ASFGFLQALEQLMLYNNSLEGNLPGSLINL 551
+ ML+ + + +++
Sbjct: 605 SYVCPYIEAGMYMLFYDKTQDIRGCDALDI 634
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 254 bits (650), Expect = 1e-72
Identities = 76/453 (16%), Positives = 133/453 (29%), Gaps = 64/453 (14%)
Query: 406 NLSNLQELALYHNNFQGSLPREIGMLVKLELLYLYDNHLSGQ----IPSEVGNCSSLKWI 461
+ + L+L G +P IG L +LE+L L + P + S +
Sbjct: 79 SNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQK 138
Query: 462 DFFGNSFTGEIPTSIGRLK--DLNFLHLRQNELVGQIPASLGNCHQLIILDLADNKLSGG 519
+ R DL + + I S + + N ++
Sbjct: 139 QKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF- 197
Query: 520 VPASFGFLQALEQLMLYNNSLEGNLPGSLINLRNLTRINFSKNRLNGRIATLCSSHSFLS 579
V + L L Q + N+ N K
Sbjct: 198 VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKT----------------- 240
Query: 580 FDVTNNEFDHEIPPQLGNSPSLERLRLGNNKFIGKIPWTFGKIRELSLLDLSGNSLT--- 636
+ N L + + N + K+P + E+ L++++ N
Sbjct: 241 -----------EDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGE 289
Query: 637 -----GPIPTQLLMCKKLSHIDL-NNNLLSGAVPSWLGTLPQLGELKLSFNQFVGFLPRE 690
+ +K+ I + NNL + V + L + +LG L+ +NQ G LP
Sbjct: 290 QLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP-A 348
Query: 691 LFNCSKLLVLSLDGNMLNGSLPNEVGNLASLNVLTLSGNLLSG-PIPPAIGRLSKLYELR 749
+ KL L+L N + N G + L+ + N L P +S + +
Sbjct: 349 FGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAID 408
Query: 750 LSNNSLNGVIPLEIGQLQNLQSILDLSHNNFTGQIPPSMGTLAKLEVLNLSHNQLVGELP 809
S N + V + P+ + +NLS+NQ+
Sbjct: 409 FSYNEIGSVDG------------------KNFDPLDPTPFKGINVSSINLSNNQISKFPK 450
Query: 810 SQLGEMSSLGKLNLSYNDLQGKLSKQFSHWPAE 842
S L +NL N L
Sbjct: 451 ELFSTGSPLSSINLMGNMLTEIPKNSLKDENEN 483
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 329 bits (846), Expect = e-103
Identities = 113/301 (37%), Positives = 177/301 (58%), Gaps = 15/301 (4%)
Query: 934 RDFRWEDIMGATNNLSDEFIIGSGGSGTVYKAELANGATVAVKKISCKDDHLLNKSFTRE 993
+ F ++ A++N S++ I+G GG G VYK LA+G VAVK++ + F E
Sbjct: 18 KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTE 77
Query: 994 VKTLGRIRHRHLVKLMGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEA 1053
V+ + HR+L++L G C LL+Y YM NGSV L ++P + + LDW
Sbjct: 78 VEMISMAVHRNLLRLRG-FCMTPT-ERLLVYPYMANGSVASCLRERP---ESQPPLDWPK 132
Query: 1054 RLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNT 1113
R +IA+G A+G+ YLH C PKI+HRD+K++NILLD EA +GDFGLAK L++ +++
Sbjct: 133 RQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK-LMDYKDTHV 191
Query: 1114 ESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMD---MV 1170
T G+ G+IAPEY + K++EK DV+ G++L+EL++G+ D D ++
Sbjct: 192 T--TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLL 249
Query: 1171 RWVEMHMEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDL 1230
WV+ ++ E L+D ++ EE Q++++AL CT++SP ERP +V +
Sbjct: 250 DWVKGLLKEKKL--EALVDVDLQGNYKDEE--VEQLIQVALLCTQSSPMERPKMSEVVRM 305
Query: 1231 L 1231
L
Sbjct: 306 L 306
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 324 bits (832), Expect = 9e-98
Identities = 122/622 (19%), Positives = 211/622 (33%), Gaps = 62/622 (9%)
Query: 207 IPAELGNCSSLSIFTAAENNLNGSIPAALGRLQNLQLLNLGNNSLSGEIPSELGELSQLG 266
IP L S + N L + LQ+L+L + LS L
Sbjct: 22 IPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLS 79
Query: 267 YLNLMGNRLEGAIPRSFAKMGNLQSLDLSMNRLTGGIPEEFGNMGQLVFLVLSNNNISGS 326
L L GN ++ +F+ + +LQ L L G++ L L +++N I
Sbjct: 80 TLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSF 139
Query: 327 IPRRICTNATSLEHLILAEIQLSGEIPVELSQCQSLK----QLDLSNNTLNGTIPVELFQ 382
+N T+LEHL L+ ++ +L + LDLS N +N I F+
Sbjct: 140 KLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFK 198
Query: 383 LVALTHLYLHNNSLVGSISP-FVANLSNLQELALYHNNFQGSLPRE---IGMLVKLELLY 438
+ L L L NN ++ + L+ L+ L F+ E L L L
Sbjct: 199 EIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLT 258
Query: 439 LYDNHLSGQIPSEVGNCSSLKWIDFFGNSFTGEIPTSIGRLKDLNFLHLRQNELVGQIPA 498
+ + L+ + + + +I L +++ L +
Sbjct: 259 IEEFRLA------------------YLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD- 299
Query: 499 SLGNCHQLIILDLADNKLSGGVPASFGFLQALEQLMLYNNSLEGNLPGSLINLRNLTRIN 558
L+L + K F L+ L S +G S ++L +L ++
Sbjct: 300 -FSYNFGWQHLELVNCKFGQ-----FPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLD 353
Query: 559 FSKNRLNGRIATLCSSHSFLSFDVTNNEFDHEIPPQLGNSPSLERLRLGNNKFIGKIPWT 618
S+N L+ F + SL+ L L N I +
Sbjct: 354 LSRNGLS---------------------FKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSN 391
Query: 619 FGKIRELSLLDLSGNSLTGPIPTQLLM-CKKLSHIDLNNNLLSGAVPSWLGTLPQLGELK 677
F + +L LD ++L + + + L ++D+++ A L L LK
Sbjct: 392 FLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLK 451
Query: 678 LSFNQFVGFLPRELF-NCSKLLVLSLDGNMLNGSLPNEVGNLASLNVLTLSGNLLSGPIP 736
++ N F ++F L L L L P +L+SL VL +S N
Sbjct: 452 MAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDT 511
Query: 737 PAIGRLSKLYELRLSNNSLNGVIPLEIGQLQNLQSILDLSHNNFTGQIPPS--MGTLAKL 794
L+ L L S N + E+ + + L+L+ N+F + +
Sbjct: 512 FPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQ 571
Query: 795 EVLNLSHNQLVGELPSQLGEMS 816
L + ++ PS M
Sbjct: 572 RQLLVEVERMECATPSDKQGMP 593
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 312 bits (802), Expect = 1e-93
Identities = 133/675 (19%), Positives = 222/675 (32%), Gaps = 106/675 (15%)
Query: 74 VSLNLSGLSLAGSISPSLGRLQSLIHLDLSSNSLTGPIPTALSNLSSLESLLLFSNQLAG 133
++ L+ I +L S +LDLS N L + + L+ L L ++
Sbjct: 10 ITYQCMELNFY-KIPDNLPF--STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQT 66
Query: 134 TIPTQLGSLTSLRVMRIGDNWLSGSIPTSFGNLVNLGTLGLASCSLSGPIPPQFGQLSQL 193
SL+ L + + N + +F L +L L +L+ G L L
Sbjct: 67 IEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTL 126
Query: 194 EELILQQNQLQGPIPAELGNCSSLSIFTAAENNLNGSIPAALGRLQNLQLLNLGNNSLSG 253
+EL + N +Q +P L NL+ L+L +N +
Sbjct: 127 KELNVAHNLIQS-----------------------FKLPEYFSNLTNLEHLDLSSNKIQS 163
Query: 254 EIPSELGELSQLGYLNLMGNRLEGAIPRSFAKMGNLQSLDLSMNRLTGGIPEEFGNMGQL 313
++L L Q+ LNL SLDLS+N + P F + +L
Sbjct: 164 IYCTDLRVLHQMPLLNL--------------------SLDLSLNPMNFIQPGAFKEI-RL 202
Query: 314 VFLVLSNNNISGSIPRRICTNATSLEHLILAEIQLSGEIPVE---LSQCQSLKQLDLSNN 370
L L NN S ++ + LE L + E +E S + L L +
Sbjct: 203 HKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEF 262
Query: 371 TLNGTIPVELFQLVALTHLYLHNNSLVGSISPFVANLSNLQELALYHNNFQGSLPREIGM 430
L + + + I L+N+ +L +
Sbjct: 263 RLA------------------YLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD--FSY 302
Query: 431 LVKLELLYLYDNHLSGQIPSEVGNCSSLKWIDFFGNSFTGEIPTSIGRLKDLNFLHLRQN 490
+ L L + ++ + L + S G S L L FL L +N
Sbjct: 303 NFGWQHLELVNCKFGQFPTLKLKSLKRLTF-----TSNKGGNAFSEVDLPSLEFLDLSRN 357
Query: 491 EL--VGQIPASLGNCHQLIILDLADNKLSGGVPASFGFLQALEQLMLYNNSLEGNLPGSL 548
L G S L LDL+ N + + ++F L+ LE L +++L+ S+
Sbjct: 358 GLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSV 416
Query: 549 I-NLRNLTRINFSKNRLNGRIATLCSSHSFLSFDVTNNEFDHEIPPQLGNSPSLERLRLG 607
+LRNL ++ S SLE L++
Sbjct: 417 FLSLRNLIYLDISHTHTRV-----------------------AFNGIFNGLSSLEVLKMA 453
Query: 608 NNKFIGKIPW-TFGKIRELSLLDLSGNSLTGPIPTQLLMCKKLSHIDLNNNLLSGAVPSW 666
N F F ++R L+ LDLS L PT L +++++N
Sbjct: 454 GNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFP 513
Query: 667 LGTLPQLGELKLSFNQFVGFLPRELFNC-SKLLVLSLDGNMLNGSLPNE--VGNLASLNV 723
L L L S N + +EL + S L L+L N + ++ + +
Sbjct: 514 YKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQ 573
Query: 724 LTLSGNLLSGPIPPA 738
L + + P
Sbjct: 574 LLVEVERMECATPSD 588
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 310 bits (796), Expect = 8e-93
Identities = 123/563 (21%), Positives = 193/563 (34%), Gaps = 54/563 (9%)
Query: 288 NLQSLDLSMNRLTGGIPEEFGNMGQLVFLVLSNNNISGSIPRRICTNATSLEHLILAEIQ 347
+ ++LDLS N L F + +L L LS I + + L LIL
Sbjct: 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDG-AYQSLSHLSTLILTGNP 87
Query: 348 LSGEIPVELSQCQSLKQLDLSNNTLNGTIPVELFQLVALTHLYLHNNSLVG-SISPFVAN 406
+ S SL++L L + L L L + +N + + + +N
Sbjct: 88 IQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSN 147
Query: 407 LSNLQELALYHNNFQGSLPREIGMLVKLEL----LYLYDNHLSGQIPSEVGNCSSLKWID 462
L+NL+ L L N Q ++ +L ++ L L L N ++ I L +
Sbjct: 148 LTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLHKLT 206
Query: 463 FFGNSFTGEIP-TSIGRLKDLNFLHLRQNELVGQ------IPASLGNCHQLIILDLADNK 515
N + + T I L L L E + ++L L I +
Sbjct: 207 LRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAY 266
Query: 516 LS---GGVPASFGFLQALEQLMLYNNSLEGNLPGSLINLRNLTRINFSKNRLNGRIATLC 572
L + F L + L + ++E S + +
Sbjct: 267 LDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFS--YNFGWQHLELVNCKFGQ------ 318
Query: 573 SSHSFLSFDVTNNEFDHEIPPQLGNSPSLERLRLGNNKFIGKIPWTFGKIRELSLLDLSG 632
P SL+RL +NK G ++ + L LDLS
Sbjct: 319 ------------------FPTL--KLKSLKRLTFTSNK--GGNAFSEVDLPSLEFLDLSR 356
Query: 633 NSLT--GPIPTQLLMCKKLSHIDLNNNLLSGAVPSWLGTLPQLGELKLSFNQFVGFLPRE 690
N L+ G L ++DL+ N + + S L QL L +
Sbjct: 357 NGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFS 415
Query: 691 LF-NCSKLLVLSLDGNMLNGSLPNEVGNLASLNVLTLSGNLLSGPIPP-AIGRLSKLYEL 748
+F + L+ L + + L+SL VL ++GN P L L L
Sbjct: 416 VFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFL 475
Query: 749 RLSNNSLNGVIPLEIGQLQNLQSILDLSHNNFTGQIPPSMGTLAKLEVLNLSHNQLVGEL 808
LS L + P L +LQ L++SHNNF L L+VL+ S N ++
Sbjct: 476 DLSQCQLEQLSPTAFNSLSSLQV-LNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSK 534
Query: 809 PSQLGEM-SSLGKLNLSYNDLQG 830
+L SSL LNL+ ND
Sbjct: 535 KQELQHFPSSLAFLNLTQNDFAC 557
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 307 bits (788), Expect = 1e-91
Identities = 119/604 (19%), Positives = 201/604 (33%), Gaps = 56/604 (9%)
Query: 73 VVSLNLSGLSLAGSISPSLGRLQSLIHLDLSSNSLTGPIPTALSNLSSLESLLLFSNQLA 132
+L+LS L S S L LDLS + A +LS L +L+L N +
Sbjct: 30 TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ 89
Query: 133 GTIPTQLGSLTSLRVMRIGDNWLSGSIPTSFGNLVNLGTLGLASCSL-SGPIPPQFGQLS 191
L+SL+ + + L+ G+L L L +A + S +P F L+
Sbjct: 90 SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLT 149
Query: 192 QLEELILQQNQLQGPIPAELGNCSSLSIFTA----AENNLNGSIPAALGRLQNLQLLNLG 247
LE L L N++Q +L + + + N +N P A + L L L
Sbjct: 150 NLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLHKLTLR 208
Query: 248 NNSLSGEIPSE-LGELSQLGYLNLMGNRLEGAIPR---SFAKMGNLQSLDLSMNRLT--- 300
NN S + + L+ L L+ + + L +L + RL
Sbjct: 209 NNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLD 268
Query: 301 ---GGIPEEFGNMGQLVFLVLSNNNISGSIPRRICTNATSLEHLILAEIQLSGEIPVELS 357
I + F + + L + I + +HL L + ++L
Sbjct: 269 YYLDDIIDLFNCLTNVSSFSLVSVTIERVKDF---SYNFGWQHLELVNCKFGQFPTLKLK 325
Query: 358 QCQSLKQLDLSNNTLNGTIPVELFQLVALTHLYLHNNSL--VGSISPFVANLSNLQELAL 415
SLK+L ++N L +L L L N L G S ++L+ L L
Sbjct: 326 ---SLKRLTFTSNKGGNAFS--EVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDL 380
Query: 416 YHNNFQGSLPREIGMLVKLELLYLYDNHLSGQIPSEV-GNCSSLKWIDFFGNSFTGEIPT 474
N + L +LE L ++L V + +L ++D
Sbjct: 381 SFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNG 439
Query: 475 SIGRLKDLNFLHLRQNELVGQI-PASLGNCHQLIILDLADNKLSGGVPASFGFLQALEQL 533
L L L + N P L LDL+ +L P +F L +L+ L
Sbjct: 440 IFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVL 499
Query: 534 MLYNNSLEGNLPGSLINLRNLTRINFSKNRLNGRIATLCSSHSFLSFDVTNNEFDHEIPP 593
+ +N+ L +L +++S N +
Sbjct: 500 NMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMT-----------------------SKKQ 536
Query: 594 QLGNSP-SLERLRLGNNKFIGKIP--WTFGKIRELSLLDLSGNSLTGPIPTQLLMCKKLS 650
+L + P SL L L N F I++ L + + P+ +
Sbjct: 537 ELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQG-MPVL 595
Query: 651 HIDL 654
+++
Sbjct: 596 SLNI 599
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 2e-38
Identities = 57/346 (16%), Positives = 95/346 (27%), Gaps = 40/346 (11%)
Query: 530 LEQLMLYNNSLEGNLPGSLINLRNLTRINFSKNRLNGRIATLCSSHSFLSFDVTNNEFDH 589
+ L L N L S + L ++ S+ +
Sbjct: 30 TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQT----------------------- 66
Query: 590 EIPPQLGNSPSLERLRLGNNKFIGKIPWTFGKIRELSLLDLSGNSLTGPIPTQLLMCKKL 649
+ L L L N F + L L +L + K L
Sbjct: 67 IEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTL 126
Query: 650 SHIDL-NNNLLSGAVPSWLGTLPQLGELKLSFNQFVGFLPRELFNCSKL----LVLSLDG 704
+++ +N + S +P + L L L LS N+ +L ++ L L L
Sbjct: 127 KELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSL 186
Query: 705 NMLNGSLPNEVGNLASLNVLTLSGNLLSGPIPP-AIGRLSKLYELRLSNNSLNGVIPLE- 762
N +N P + L+ LTL N S + I L+ L RL LE
Sbjct: 187 NPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEK 245
Query: 763 --IGQLQNLQSI----LDLSHNN-FTGQIPPSMGTLAKLEVLNLSHNQLVGELPSQLGEM 815
L+ L ++ L++ + + I L + +L +
Sbjct: 246 FDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD--FSYN 303
Query: 816 SSLGKLNLSYNDLQGKLSKQFSHWPAEAFEGNLHLCGSPLDHCNGL 861
L L + + F N L
Sbjct: 304 FGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSL 349
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 304 bits (780), Expect = 4e-94
Identities = 108/323 (33%), Positives = 164/323 (50%), Gaps = 21/323 (6%)
Query: 908 SSQVNYTSSSSSSQAQRRLLFQAAAKRDFRWEDIMGATNNLSDEFIIGSGGSGTVYKAEL 967
S+ + ++S + L + R D+ ATNN +F+IG G G VYK L
Sbjct: 2 GSKYSKATNSINDALSSSYLVPFESYR-VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVL 60
Query: 968 ANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIYEYM 1027
+GA VA+K+ + + + F E++TL RH HLV L+G C + +LIY+YM
Sbjct: 61 RDGAKVALKRRT-PESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERN--EMILIYKYM 117
Query: 1028 ENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNIL 1087
ENG++ L+ S+ WE RL+I +G A+G+ YLH I+HRD+KS NIL
Sbjct: 118 ENGNLKRHLYGSD---LPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINIL 171
Query: 1088 LDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGI 1147
LD N + DFG++K E T +T G+ GYI PEY + TEK DVYS G+
Sbjct: 172 LDENFVPKITDFGISKKGTEL--DQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGV 229
Query: 1148 VLMELVSGKMPTDATFGVEMD-MVRWVEMHMEMSGSAREELLDDQMKPLLPGE--ECAAY 1204
VL E++ + + EM + W + +G E+++D P L + +
Sbjct: 230 VLFEVLCARSAIVQSLPREMVNLAEWA-VESHNNGQL-EQIVD----PNLADKIRPESLR 283
Query: 1205 QVLEIALQCTKTSPQERPSSRQV 1227
+ + A++C S ++RPS V
Sbjct: 284 KFGDTAVKCLALSSEDRPSMGDV 306
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 290 bits (745), Expect = 2e-89
Identities = 99/317 (31%), Positives = 154/317 (48%), Gaps = 12/317 (3%)
Query: 24 LCKDEELSVLLEIKKSFTADPENVLHAWNQSNQ-NLCTWRGITCGS--SSARVVSLNLSG 80
LC ++ LL+IKK L +W + TW G+ C + + RV +L+LSG
Sbjct: 2 LCNPQDKQALLQIKKDLGNPT--TLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSG 59
Query: 81 LSLAGS--ISPSLGRLQSLIHLDLSS-NSLTGPIPTALSNLSSLESLLLFSNQLAGTIPT 137
L+L I SL L L L + N+L GPIP A++ L+ L L + ++G IP
Sbjct: 60 LNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPD 119
Query: 138 QLGSLTSLRVMRIGDNWLSGSIPTSFGNLVNLGTLGLASCSLSGPIPPQFGQLSQL-EEL 196
L + +L + N LSG++P S +L NL + +SG IP +G S+L +
Sbjct: 120 FLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSM 179
Query: 197 ILQQNQLQGPIPAELGNCSSLSIFTAAENNLNGSIPAALGRLQNLQLLNLGNNSLSGEIP 256
+ +N+L G IP N + L+ + N L G G +N Q ++L NSL+ ++
Sbjct: 180 TISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG 238
Query: 257 SELGELSQLGYLNLMGNRLEGAIPRSFAKMGNLQSLDLSMNRLTGGIPEEFGNMGQLVFL 316
+G L L+L NR+ G +P+ ++ L SL++S N L G IP+ GN+ +
Sbjct: 239 K-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVS 296
Query: 317 VLSNNNISGSIPRRICT 333
+NN P CT
Sbjct: 297 AYANNKCLCGSPLPACT 313
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 266 bits (682), Expect = 1e-80
Identities = 86/324 (26%), Positives = 130/324 (40%), Gaps = 48/324 (14%)
Query: 537 NNSLEGNLPGSLINLRNLTRINFSKNRLNGRIATLCSSHSFLSFDVTNNEFDHEIPPQLG 596
N + G L + + ++ S L IP L
Sbjct: 35 NRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPY---------------------PIPSSLA 73
Query: 597 NSPSLERLRLGN-NKFIGKIPWTFGKIRELSLLDLSGNSLTGPIPTQLLMCKKLSHIDLN 655
N P L L +G N +G IP K+ +L L ++ +++G IP L K L +D +
Sbjct: 74 NLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFS 133
Query: 656 NNLLSGAVPSWLGTLPQLGELKLSFNQFVGFLPRELFNCSKLL-VLSLDGNMLNGSLPNE 714
N LSG +P + +LP L + N+ G +P + SKL +++ N L G +P
Sbjct: 134 YNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPT 193
Query: 715 VGNLASLNVLTLSGNLLSGPIPPAIGRLSKLYELRLSNNSLNGVIPLEIGQLQNLQSILD 774
NL +L + LS N+L G G ++ L+ NSL + ++G +NL LD
Sbjct: 194 FANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNG-LD 250
Query: 775 LSHNNFTGQIPPSMGTLAKLEVLNLSHNQLVGELPSQLGEMSSLGKLNLSYNDLQGKLSK 834
L +N G +P + L L LN+S N L GE+P
Sbjct: 251 LRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ----------------------GG 288
Query: 835 QFSHWPAEAFEGNLHLCGSPLDHC 858
+ A+ N LCGSPL C
Sbjct: 289 NLQRFDVSAYANNKCLCGSPLPAC 312
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 258 bits (661), Expect = 1e-77
Identities = 84/323 (26%), Positives = 128/323 (39%), Gaps = 34/323 (10%)
Query: 158 SIPTSFGNLVNL----GTLGLASCSLSGPIPPQFGQLSQLEELILQQNQLQG--PIPAEL 211
I GN L T + + G + Q ++ L L L PIP+ L
Sbjct: 13 QIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSL 72
Query: 212 GNCSSLSIFT-AAENNLNGSIPAALGRLQNLQLLNLGNNSLSGEIPSELGELSQLGYLNL 270
N L+ NNL G IP A+ +L L L + + ++SG IP L ++
Sbjct: 73 ANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIK------- 125
Query: 271 MGNRLEGAIPRSFAKMGNLQSLDLSMNRLTGGIPEEFGNMGQLVFLVLSNNNISGSIPRR 330
L +LD S N L+G +P ++ LV + N ISG+IP
Sbjct: 126 -----------------TLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDS 168
Query: 331 ICTNATSLEHLILAEIQLSGEIPVELSQCQSLKQLDLSNNTLNGTIPVELFQLVALTHLY 390
+ + + ++ +L+G+IP + +L +DLS N L G V ++
Sbjct: 169 YGSFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIH 227
Query: 391 LHNNSLVGSISPFVANLSNLQELALYHNNFQGSLPREIGMLVKLELLYLYDNHLSGQIPS 450
L NSL + V NL L L +N G+LP+ + L L L + N+L G+IP
Sbjct: 228 LAKNSLAFDL-GKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ 286
Query: 451 EVGNCSSLKWIDFFGNSFTGEIP 473
GN + N P
Sbjct: 287 G-GNLQRFDVSAYANNKCLCGSP 308
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 255 bits (655), Expect = 7e-77
Identities = 87/323 (26%), Positives = 133/323 (41%), Gaps = 36/323 (11%)
Query: 207 IPAELGNCSSLSIFTAA----ENNLNGSIPAALGRLQNLQLLNLGNNSLSGE--IPSELG 260
I +LGN ++LS + G + + + L+L +L IPS L
Sbjct: 14 IKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLA 73
Query: 261 ELSQLGYLNLMG-NRLEGAIPRSFAKMGNLQSLDLSMNRLTGGIPEEFGNMGQLVFLVLS 319
L L +L + G N L G IP + AK+ L L ++ ++G IP+ + LV L S
Sbjct: 74 NLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFS 133
Query: 320 NNNISGSIPRRICTNATSLEHLILAEIQLSGEIPVELSQCQSLKQLDLSNNTLNGTIPVE 379
N LSG +P +S +L + N ++G IP
Sbjct: 134 YNA-------------------------LSGTLPPSISSLPNLVGITFDGNRISGAIPDS 168
Query: 380 LFQLVAL-THLYLHNNSLVGSISPFVANLSNLQELALYHNNFQGSLPREIGMLVKLELLY 438
L T + + N L G I P ANL NL + L N +G G + ++
Sbjct: 169 YGSFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIH 227
Query: 439 LYDNHLSGQIPSEVGNCSSLKWIDFFGNSFTGEIPTSIGRLKDLNFLHLRQNELVGQIPA 498
L N L+ + VG +L +D N G +P + +LK L+ L++ N L G+IP
Sbjct: 228 LAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ 286
Query: 499 SLGNCHQLIILDLADNKLSGGVP 521
GN + + A+NK G P
Sbjct: 287 G-GNLQRFDVSAYANNKCLCGSP 308
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 234 bits (600), Expect = 2e-69
Identities = 68/293 (23%), Positives = 119/293 (40%), Gaps = 30/293 (10%)
Query: 393 NNSLVGSISPFVANLSNLQELALYHNNFQGS--LPREIGMLVKLELLYLYD-NHLSGQIP 449
N + +G + + L L N +P + L L LY+ N+L G IP
Sbjct: 35 NRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIP 94
Query: 450 SEVGNCSSLKWIDFFGNSFTGEIPTSIGRLKDLNFLHLRQNELVGQIPASLGNCHQLIIL 509
+ + L ++ + +G IP + ++K L L N L G +P S+ + L+ +
Sbjct: 95 PAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGI 154
Query: 510 DLADNKLSGGVPASFGFLQALEQ-LMLYNNSLEGNLPGSLINLRNLTRINFSKNRLNGRI 568
N++SG +P S+G L + + N L G +P + NL NL ++ S+N L G
Sbjct: 155 TFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDLSRNMLEG-- 211
Query: 569 ATLCSSHSFLSFDVTNNEFDHEIPPQLGNSPSLERLRLGNNKFIGKIPWTFGKIRELSLL 628
+ G+ + +++ L N + G + L+ L
Sbjct: 212 ---------------------DASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGL 249
Query: 629 DLSGNSLTGPIPTQLLMCKKLSHIDLNNNLLSGAVPSWLGTLPQLGELKLSFN 681
DL N + G +P L K L ++++ N L G +P G L + + N
Sbjct: 250 DLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANN 301
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 46.0 bits (110), Expect = 4e-05
Identities = 15/70 (21%), Positives = 27/70 (38%), Gaps = 3/70 (4%)
Query: 764 GQLQNLQSILDLSHNNFTGQIPPSMGTLAKLEVLNLSHNQLVGE--LPSQLGEMSSLGKL 821
L + D + + G + + ++ L+LS L +PS L + L L
Sbjct: 22 TTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFL 81
Query: 822 NLS-YNDLQG 830
+ N+L G
Sbjct: 82 YIGGINNLVG 91
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 307 bits (788), Expect = 4e-89
Identities = 91/614 (14%), Positives = 180/614 (29%), Gaps = 81/614 (13%)
Query: 244 LNLGNNSLSGEIPSELGELSQLGYLNLMGNRLEGAIPRSFAKMGNLQSLDLSMNRLTGGI 303
N + + +L ++ L+L G +G +P + ++ L+ L + T
Sbjct: 304 FNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSG 363
Query: 304 PEEFGNMGQLVFLVLSNNNISGSIPRRICTNATSLEHLILAEIQLSGE---IPVELSQCQ 360
+ I + L L + ++ P++
Sbjct: 364 RLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRI 423
Query: 361 SLKQLDLSNNTLN-GTIPVELFQLVALTHLYLHNNSLVGSISPFVANLSNLQELALYHNN 419
SLK + N T I + +L L +Y N+ + ++ +
Sbjct: 424 SLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIA-----VDWEDANSDYAK 478
Query: 420 FQGSLPREIGMLVKLELLYLYDNHLSGQIPSEVGNCSSLKWIDFFGNSFTGEIPTSIGRL 479
+ L L + LY+ Q+P + + L+ ++ N
Sbjct: 479 QYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGIS-AAQLKADW 537
Query: 480 KDLNFLHLRQNELVGQIPASLGNCHQLIILDLADNKLSG-GVPASFGFLQALEQLMLYNN 538
++ ++ I + N L AS + L L +N
Sbjct: 538 T--------------RLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHN 583
Query: 539 SLEGNLPGSLINLRNLTRINFSKNRLNGRIATLCSSHSFLSFDVTNNEFDHEIPPQLG-N 597
+ +L + LT + N++ EIP
Sbjct: 584 KVR-HLE-AFGTNVKLTDLKLDYNQIE------------------------EIPEDFCAF 617
Query: 598 SPSLERLRLGNNKFIGKIP--WTFGKIRELSLLDLSGNSLTG-----PIPTQLLMCKKLS 650
+ +E L +NK + IP + + + +D S N + S
Sbjct: 618 TDQVEGLGFSHNK-LKYIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINAS 676
Query: 651 HIDLNNNLLSGAVPSWLGTLPQLGELKLSFNQF-------VGFLPRELFNCSKLLVLSLD 703
+ L+ N + T + + LS N + N L + L
Sbjct: 677 TVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLR 736
Query: 704 GNMLNGSLPNE--VGNLASLNVLTLSGNLLSGPIPPAIGRLSKLYELRL------SNNSL 755
N L SL ++ L L+ + +S N S P S+L + N +
Sbjct: 737 FNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRI 794
Query: 756 NGVIPLEIGQLQNLQSILDLSHNNFTGQIPPSMGTLAKLEVLNLSHNQLVGELPSQLGEM 815
P I +L L + N+ + + +L +L+++ N + + +
Sbjct: 795 LRQWPTGITTCPSLIQ-LQIGSNDIRK-VDEKL--TPQLYILDIADNPNISIDVTSVCPY 850
Query: 816 SSLGKLNLSYNDLQ 829
G L Y+ Q
Sbjct: 851 IEAGMYVLLYDKTQ 864
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 300 bits (770), Expect = 1e-86
Identities = 98/637 (15%), Positives = 190/637 (29%), Gaps = 81/637 (12%)
Query: 38 KSFTADPENVLHAWNQSNQNLCTWRGITCGS--SSARVVSLNLSGLSLAGSISPSLGRLQ 95
S T + WN N+ L W ++ RV L+L+G G + ++G+L
Sbjct: 289 YSGTINNTIHSLNWN-FNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLT 347
Query: 96 SLIHLDLSSNSLTGPIPTALSNLSSLESLLLFSNQLAGTIP----TQLGSLTSLRVMRIG 151
L L ++S T + + +++ L +++
Sbjct: 348 ELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDA 407
Query: 152 DNWLSGSIPTSFGNLVNLGTLGLASCS-LSGPIPPQFGQLSQLEELILQQNQLQGPIPAE 210
N P + ++L + + + I +L++L+ + + A
Sbjct: 408 INRNPEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAV 467
Query: 211 LGNCSSLSIFTAAENNLNGSIPAALGRLQNLQLLNLGNNSLSGEIPSELGELSQLGYLNL 270
++ + + L++L + L N ++P L +L +L LN+
Sbjct: 468 DWEDANSD-----YAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNI 522
Query: 271 MGNRLEGAIPRSFAKMGNLQSLDLSMNRLTGGIPEEFGNMGQLVFLVLSNNNISGSIPRR 330
NR + A + ++ ++ + NN+
Sbjct: 523 ACNRGIS-AAQLKADWTR--------------LADDEDTGPKIQIFYMGYNNLEEFPASA 567
Query: 331 ICTNATSLEHLILAEIQLSGEIPVELSQCQSLKQLDLSNNTLNGTIPVELFQ-LVALTHL 389
L L ++ + L L L N + IP + + L
Sbjct: 568 SLQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGL 624
Query: 390 YLHNNSLVGSISPF-VANLSNLQELALYHNNFQGSLPREIGM------LVKLELLYLYDN 442
+N L + F ++ + + +N S R I + + L N
Sbjct: 625 GFSHNKLKYIPNIFNAKSVYVMGSVDFSYNKIG-SEGRNISCSMDDYKGINASTVTLSYN 683
Query: 443 HLSGQIPSEVGNCSSLKWIDFFGNSFTGEIPTSIGRLKDLNFLHLRQNELVGQIPASLGN 502
+ S + I N T IP + + N
Sbjct: 684 EIQKFPTELFATGSPISTIILSNNLMT-SIP----------------ENSLKPKDGNYKN 726
Query: 503 CHQLIILDLADNKLSGGVPASFGF--LQALEQLMLYNNSLEGNLPGSLINLRNLTRINFS 560
+ L +DL NKL+ + F L L + + N P +N L
Sbjct: 727 TYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIR 784
Query: 561 KNRLNGRIATLCSSHSFLSFDVTNNEFDHEIPPQLGNSPSLERLRLGNNKFIGKIPWTFG 620
R D N + P + PSL +L++G+N I K+
Sbjct: 785 HQR-----------------DAEGNRILRQWPTGITTCPSLIQLQIGSND-IRKVDEKLT 826
Query: 621 KIRELSLLDLSGNSLTGPIPTQLLMCKKLSHIDLNNN 657
+L +LD++ N T + + L +
Sbjct: 827 P--QLYILDIADNPNISIDVTSVCPYIEAGMYVLLYD 861
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 264 bits (676), Expect = 3e-74
Identities = 96/731 (13%), Positives = 194/731 (26%), Gaps = 126/731 (17%)
Query: 140 GSLTSLRVMRIGDNWLSGSIPTSFGNLVNLGTLGLASCSLSGPIPPQFGQLSQLEELILQ 199
T L+ M++ S +G+A+C + +P Q+
Sbjct: 168 RVTTELKGMKVTYKEDSKEHQNPDNANDKYMDIGVATCDSAVWLPAGTYQVV---AYTTY 224
Query: 200 QNQLQGPIPAELGNCSSLSIFTAAENNLN-------------GSIPAALGRLQNLQLLNL 246
E + S FT +N L I + L+
Sbjct: 225 SQSGIKRSELETQSVRGES-FTVIDNKLTKDANVPIQLKETAEYIKDYKALKAIWEALDG 283
Query: 247 GNNSLSGEIPSELGELSQLGYLNLMGNRLEGAIPRSFAKMGNLQSLDLSMNRLTGGIPEE 306
N + N + G + L L+ G +P+
Sbjct: 284 KNWRYYSGTINNTIHSLNWN-FNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDA 342
Query: 307 FGNMGQLVFLVLSNNNISGSIPRRICTNATSLEHLILAEIQLSGEIPVELSQCQSLKQLD 366
G + +L L ++ + S T + L Q L D
Sbjct: 343 IGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSD 402
Query: 367 LSNNTLNGTIPVELFQLVALTHLYLHNNSLVGSISPFVANLSNLQELALYHNNFQGSLPR 426
L + +N E+ + + + L + + N + +
Sbjct: 403 LLQDAINRNP--EMKPIKKDSRISLKDTQIGNL------------------TNRITFISK 442
Query: 427 EIGMLVKLELLYLYDNHLSGQIPSEVGNCSSLKWIDFFGNSFTGEIPTSIGRLKDLNFLH 486
I L KL+++Y ++ + + ++ S LKDL +
Sbjct: 443 AIQRLTKLQIIYFANSPFTYDNIAVDWEDANSD-----YAKQYENEELSWSNLKDLTDVE 497
Query: 487 LRQNELVGQIPASLGNCHQLIILDLADNKLSG---------GVPASFGFLQALEQLMLYN 537
L + Q+P L + +L L++A N+ + ++ +
Sbjct: 498 LYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGY 557
Query: 538 NSLEG-NLPGSLINLRNLTRINFSKNRLNGRIATLCSSHSFLSFDVTNNEFDHEIPPQLG 596
N+LE SL + L ++ N++ G
Sbjct: 558 NNLEEFPASASLQKMVKLGLLDCVHNKV-------------------------RHLEAFG 592
Query: 597 NSPSLERLRLGNNKFIGKIPWTFGKIRELSLLDLSGNSLTG-PIPTQLLMCKKLSHIDLN 655
+ L L+L N+ ++ L S N L P + +D +
Sbjct: 593 TNVKLTDLKLDYNQIEEIPEDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFS 652
Query: 656 NNLLSGAVPSWLGTLPQLGELKLSFNQFVGFLPRELFNCSKLLVLSLDGNMLNGSLPNEV 715
N + + + + ++L N +
Sbjct: 653 YNKIGSEGRNI-------------------SCSMDDYKGINASTVTLSYNEIQKFPTELF 693
Query: 716 GNLASLNVLTLSGNLLS-------GPIPPAIGRLSKLYELRLSNNSLNGVIP-LEIGQLQ 767
+ ++ + LS NL++ P L + L N L + L
Sbjct: 694 ATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLTSLSDDFRATTLP 753
Query: 768 NLQSILDLSHNNFTGQIPPSMGTLAKLEVLNLSHNQLVGELPSQLGEMSSLGKLNLSYND 827
L + +D+S+N F+ P ++L+ + H + N
Sbjct: 754 YLSN-MDVSYNCFSS-FPTQPLNSSQLKAFGIRHQ------------------RDAEGNR 793
Query: 828 LQGKLSKQFSH 838
+ + +
Sbjct: 794 ILRQWPTGITT 804
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 258 bits (660), Expect = 4e-72
Identities = 83/487 (17%), Positives = 161/487 (33%), Gaps = 52/487 (10%)
Query: 75 SLNLSGLSLAGSISPSLGRLQSLIHLDLSSNSLTGPIPTALSNLSSLESLLLFSNQLAGT 134
++ I + +N +T I A+ L+ L+ + ++
Sbjct: 405 QDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYD 463
Query: 135 IPTQLGSLTSLRVMRIGDNWLSGSIPTSFGNLVNLGTLGLASCSLSGPIPPQFGQLSQLE 194
+ + S+ NL +L + L +C +P L +L+
Sbjct: 464 NIAVDWEDANSD-----YAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQ 518
Query: 195 ELILQQNQLQGPIPAELGNCSSLSIFTAAENNLNGSIPAALGRLQNLQLLNLGNNSLSGE 254
L + N+ + +Q+ +G N+L E
Sbjct: 519 SLNIACNRGISAAQ---------------LKADWTRLADDEDTGPKIQIFYMGYNNLE-E 562
Query: 255 IPSE--LGELSQLGYLNLMGNRLEGAIPRSFAKMGNLQSLDLSMNRLTGGIPEEFGNMGQ 312
P+ L ++ +LG L+ + N++ +F L L L N++ + Q
Sbjct: 563 FPASASLQKMVKLGLLDCVHNKVR--HLEAFGTNVKLTDLKLDYNQIEEIPEDFCAFTDQ 620
Query: 313 LVFLVLSNNNISGSIPRRICTNATSLEHLILAEIQLSGEIP-----VELSQCQSLKQLDL 367
+ L S+N + + + + + ++ E ++ + + + L
Sbjct: 621 VEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTL 680
Query: 368 SNNTLNGTIPVELFQLVALTHLYLHNNSL-------VGSISPFVANLSNLQELALYHNNF 420
S N + ++ + L NN + + N L + L N
Sbjct: 681 SYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKL 740
Query: 421 QGSLPREI--GMLVKLELLYLYDNHLSGQIPSEVGNCSSLKWI------DFFGNSFTGEI 472
SL + L L + + N S P++ N S LK D GN +
Sbjct: 741 T-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQW 798
Query: 473 PTSIGRLKDLNFLHLRQNELVGQIPASLGNCHQLIILDLADNKL-SGGVPASFGFLQALE 531
PT I L L + N++ + L QL ILD+ADN S V + +++A
Sbjct: 799 PTGITTCPSLIQLQIGSNDIRK-VDEKL--TPQLYILDIADNPNISIDVTSVCPYIEAGM 855
Query: 532 QLMLYNN 538
++LY+
Sbjct: 856 YVLLYDK 862
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 131 bits (330), Expect = 5e-31
Identities = 41/292 (14%), Positives = 83/292 (28%), Gaps = 25/292 (8%)
Query: 557 INFSKNRLNGRIATLCSSHSFLSFDVTNNEFDHEIPPQLGNSPSLERLRLGNNKFIGKIP 616
++ R +F+ + + + L N+ + L L G++P
Sbjct: 281 LDGKNWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVP 340
Query: 617 WTFGKIRELSLLDLSGNSLTGPIPTQLLMCKKLSHIDLNNNLLSGAVPSWLGTLPQLGEL 676
G++ EL +L +S T + + + Q
Sbjct: 341 DAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQR--- 397
Query: 677 KLSFNQFVGFLPRELFNCSKLLVLSLDGNMLNGSLPNEVGNLASLNVLTLSGNLLSGPIP 736
N S LL +++ N + + + N ++ I
Sbjct: 398 ---------------LNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITF-IS 441
Query: 737 PAIGRLSKLYELRLSNNSLNGVIPLEIGQLQNLQSILDLSHNNFTGQIPPSMGTLAKLEV 796
AI RL+KL + +N+ + + + S L L
Sbjct: 442 KAIQRLTKLQIIYFANSPFTYDNIAVDWED------ANSDYAKQYENEELSWSNLKDLTD 495
Query: 797 LNLSHNQLVGELPSQLGEMSSLGKLNLSYNDLQGKLSKQFSHWPAEAFEGNL 848
+ L + + +LP L ++ L LN++ N + E
Sbjct: 496 VELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTG 547
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 279 bits (717), Expect = 1e-85
Identities = 95/309 (30%), Positives = 148/309 (47%), Gaps = 31/309 (10%)
Query: 934 RDFRWEDIMGATNNLSDEF------IIGSGGSGTVYKAELANGATVAVKKISCKDDHL-- 985
F + ++ TNN + +G GG G VYK + N TVAVKK++ D
Sbjct: 13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTE 71
Query: 986 -LNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSN-LLIYEYMENGSVWDWLHKQPVNI 1043
L + F +E+K + + +H +LV+L+G G + L+Y YM NGS+ D L +
Sbjct: 72 ELKQQFDQEIKVMAKCQHENLVELLGFSS---DGDDLCLVYVYMPNGSLLDRLS----CL 124
Query: 1044 KMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAK 1103
L W R KIA G A G+ +LH + +HRDIKS+NILLD A + DFGLA+
Sbjct: 125 DGTPPLSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLAR 181
Query: 1104 ALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATF 1163
A + + T + G+ Y+APE + T K D+YS G+VL+E+++G D
Sbjct: 182 ASEKF--AQTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDEHR 238
Query: 1164 GVEMDMVRWVEMHMEMSGSAREELLDDQMKPLLPG-EECAAYQVLEIALQCTKTSPQERP 1222
++ +E E+ +D + + + + +A QC +RP
Sbjct: 239 E-PQLLLDIK-EEIEDEEKTIEDYID----KKMNDADSTSVEAMYSVASQCLHEKKNKRP 292
Query: 1223 SSRQVCDLL 1231
++V LL
Sbjct: 293 DIKKVQQLL 301
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 288 bits (740), Expect = 4e-85
Identities = 113/550 (20%), Positives = 179/550 (32%), Gaps = 19/550 (3%)
Query: 75 SLNLSGLSLAGSISPSLGRLQSLIHLDLSSNSLTGPIPTALSNLSSLESLLLFSNQLAGT 134
+ N L L I +L S L+ S N L T S L +L L L Q+
Sbjct: 16 TYNCENLGLN-EIPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWI 72
Query: 135 IPTQLGSLTSLRVMRIGDNWLSGSIPTSFGNLVNLGTLGLASCSLSGPIPPQFGQLSQLE 194
S L + + N L T+ L L +S LE
Sbjct: 73 HEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLE 132
Query: 195 ELILQQNQLQGPIPAELGNCSSLSIFTAAENNLNGSIPAALGRLQNLQL--LNLGNNSLS 252
L L N + + L + N ++ + LQ LNL N ++
Sbjct: 133 SLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIA 192
Query: 253 GEIPSELGELSQLGYLNLMGNRLEGAIPR--SFAKMGNLQSLDLSMNRLTGGIPEEFGNM 310
I + + LN G + I + + + +L P F +
Sbjct: 193 -GIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGL 251
Query: 311 G--QLVFLVLSNNNISGSIPRRICTNATSLEHLILAEIQLSGEIPVELSQCQSLKQLDLS 368
+ + L + +I + L+ L L LS E+P L +LK+L LS
Sbjct: 252 CEMSVESINLQKHYFF-NISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLS 309
Query: 369 NNTLNGTIPVELFQLVALTHLYLHNNSLVGSISP-FVANLSNLQELALYHNNFQGS--LP 425
N + +LTHL + N+ + + NL NL+EL L H++ + S
Sbjct: 310 ANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCN 369
Query: 426 REIGMLVKLELLYLYDNHLSGQIPSEVGNCSSLKWIDFFGNSFTGEIPTSI-GRLKDLNF 484
++ L L+ L L N C L+ +D + S L L
Sbjct: 370 LQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKV 429
Query: 485 LHLRQNELVGQIPASLGNCHQLIILDLADNKLSGGV---PASFGFLQALEQLMLYNNSLE 541
L+L + L L L+L N G S L LE L+L L
Sbjct: 430 LNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLS 489
Query: 542 GNLPGSLINLRNLTRINFSKNRLNGRIATLCSSHSFLSFDVTNNEFDHEIPPQLGNSPSL 601
+ +L+ + ++ S NRL S + ++ +N +P L
Sbjct: 490 SIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIYLNLASNHISIILPSLLPILSQQ 549
Query: 602 ERLRLGNNKF 611
+ L N
Sbjct: 550 RTINLRQNPL 559
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 288 bits (738), Expect = 9e-85
Identities = 118/582 (20%), Positives = 188/582 (32%), Gaps = 60/582 (10%)
Query: 268 LNLMGNRLEGAIPRSFAKMGNLQSLDLSMNRLTGGIPEEFGNMGQLVFLVLSNNNISGSI 327
N L IP + + + L+ S N L F + L FL L+ I I
Sbjct: 17 YNCENLGLN-EIPGTLPN--STECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIY-WI 72
Query: 328 PRRICTNATSLEHLILAEIQLSGEIPVELSQCQSLKQLDLSNNTLNGTIPVELFQLVALT 387
+ L+ L+L L LS ++LK L ++ + L L
Sbjct: 73 HEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLE 132
Query: 388 HLYLHNNSLVGSISPFVANLSNLQELALYHNNFQGSLPREIGMLVKLELLYLYDNHLS-G 446
LYL +N + P L+ L +N ++ L + L L N
Sbjct: 133 SLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIA 192
Query: 447 QIPSEVGNCSSLKWIDFFGNSFTGEIPTSIGRLKDLNFLHLRQNELVGQIPASLGNCHQL 506
I + + + ++F G I K L + L
Sbjct: 193 GIEPGAFDSAVFQSLNFGGTQNLLVIF------KGLKNSTI----------------QSL 230
Query: 507 IILDLADNKLSGGVPASFGFLQA--LEQLMLYNNSLEGNLPGSLINLRNLTRINFSKNRL 564
+ D PA F L +E + L + + L ++ + L
Sbjct: 231 WLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHL 290
Query: 565 NGRIATLCSSHSFLSFDVTNNEFDHEIPPQLGNSPSLERLRLGNNKFIGKIPWTFGKIRE 624
+ E+P L +L++L L NKF +
Sbjct: 291 S------------------------ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPS 326
Query: 625 LSLLDLSGNSLTGPIPTQLLM-CKKLSHIDLNNNLL--SGAVPSWLGTLPQLGELKLSFN 681
L+ L + GN+ + T L + L +DL+++ + S L L L L LS+N
Sbjct: 327 LTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYN 386
Query: 682 QFVGFLPRELFNCSKLLVLSLDGNMLNGSLPNEV-GNLASLNVLTLSGNLLSGPIPPAIG 740
+ + C +L +L L L NL L VL LS +LL
Sbjct: 387 EPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFD 446
Query: 741 RLSKLYELRLSNNSLNGVIPLEIGQLQNLQS--ILDLSHNNFTGQIPPSMGTLAKLEVLN 798
L L L L N + LQ L IL LS + + + +L + ++
Sbjct: 447 GLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVD 506
Query: 799 LSHNQLVGELPSQLGEMSSLGKLNLSYNDLQGKLSKQFSHWP 840
LSHN+L L + + LNL+ N + L
Sbjct: 507 LSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILS 547
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 286 bits (734), Expect = 3e-84
Identities = 113/594 (19%), Positives = 191/594 (32%), Gaps = 59/594 (9%)
Query: 99 HLDLSSNSLTGPIPTALSNLSSLESLLLFSNQLAGTIPTQLGSLTSLRVMRIGDNWLSGS 158
+ + L IP L +S E L N L
Sbjct: 16 TYNCENLGLNE-IPGTLP--NSTECLEFSFNVL------------------------PTI 48
Query: 159 IPTSFGNLVNLGTLGLASCSLSGPIPPQFGQLSQLEELILQQNQLQGPIPAELGNCSSLS 218
T+F L+NL L L C + F +L+ L+L N L L +L
Sbjct: 49 QNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALK 108
Query: 219 IFTAAENNLNGSIPAALGRLQNLQLLNLGNNSLSGEIPSELGELSQLGYLNLMGNRLEGA 278
+ ++ L + L+ L LG+N +S + +L L+ N +
Sbjct: 109 HLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYL 168
Query: 279 IPRSFAKMGNLQ--SLDLSMNRLTGGIPEEFGNMGQLVFLVLSNNNISGSIPRRIC-TNA 335
+ + SL+L+ N + GI + L I + + +
Sbjct: 169 SKEDMSSLQQATNLSLNLNGNDIA-GIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTI 227
Query: 336 TSLEHLILAEIQLSGEIPVELSQCQ--SLKQLDLSNNTLNGTIPVELFQLVALTHLYLHN 393
SL ++ P S++ ++L + L L L
Sbjct: 228 QSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTA 287
Query: 394 NSLVGSISPFVANLSNLQELALYHNNFQGSLPREIGMLVKLELLYLYDNHLSGQIPSEV- 452
L + + LS L++L L N F+ L L + N ++ +
Sbjct: 288 THL-SELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCL 346
Query: 453 GNCSSLKWIDFFGNSFT--GEIPTSIGRLKDLNFLHLRQNELVGQIPASLGNCHQLIILD 510
N +L+ +D + + L L L+L NE + + C QL +LD
Sbjct: 347 ENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLD 406
Query: 511 LADNKLSG-GVPASFGFLQALEQLMLYNNSLEGNLPGSLINLRNLTRINFSKNRLNGRIA 569
LA +L + F L L+ L L ++ L+ + L L +N N
Sbjct: 407 LAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPK--- 463
Query: 570 TLCSSHSFLSFDVTNNEFDHEIPPQLGNSPSLERLRLGNNKFIGKIPWTFGKIRELSLLD 629
+ + L LE L L F ++ ++ +D
Sbjct: 464 -----------------GNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVD 506
Query: 630 LSGNSLTGPIPTQLLMCKKLSHIDLNNNLLSGAVPSWLGTLPQLGELKLSFNQF 683
LS N LT L K + +++L +N +S +PS L L Q + L N
Sbjct: 507 LSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPL 559
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 282 bits (723), Expect = 1e-82
Identities = 110/594 (18%), Positives = 183/594 (30%), Gaps = 47/594 (7%)
Query: 225 NNLNGSIPAALGRLQNLQLLNLGNNSLSGEIPSELGELSQLGYLNLMGNRLEGAIPRSFA 284
N L RL NL L+L + +L L L N L + +
Sbjct: 43 NVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALS 102
Query: 285 KMGNLQSLDLSMNRLTGGIPEEFGNMGQLVFLVLSNNNISGSIPRRICTNATSLEHLILA 344
L+ L ++ N L L L +N+IS SI L+ L
Sbjct: 103 GPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHIS-SIKLPKGFPTEKLKVLDFQ 161
Query: 345 EIQLSGEIPVELSQCQSLKQ--LDLSNNTLNGTIPVELFQLVALTHLYLHNNSLVGSISP 402
+ ++S Q L+L+ N + I F L + I
Sbjct: 162 NNAIHYLSKEDMSSLQQATNLSLNLNGNDI-AGIEPGAFDSAVFQSLNFGGTQNLLVIFK 220
Query: 403 FVAN--LSNLQELALYHNNFQGSLPREIGMLVKLEL--LYLYDNHLSGQIPSEVGNCSSL 458
+ N + +L + + P L ++ + + L ++ + S L
Sbjct: 221 GLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGL 280
Query: 459 KWIDFFGNSFTGEIPTSIGRLKDLNFLHLRQNELVGQIPASLGNCHQLIILDLADNKLSG 518
+ +D + E+P+ + L L L L N+ S N L L + N
Sbjct: 281 QELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRL 339
Query: 519 GV-PASFGFLQALEQLMLYNNSLE--GNLPGSLINLRNLTRINFSKNRLNGRIATLCSSH 575
+ L+ L +L L ++ +E L NL +L +N S N
Sbjct: 340 ELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLS--------- 390
Query: 576 SFLSFDVTNNEFDHEIPPQ-LGNSPSLERLRLGNNKFIGKIPWT-FGKIRELSLLDLSGN 633
+ + P LE L L + K + F + L +L+LS +
Sbjct: 391 ---------------LKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHS 435
Query: 634 SLTGPIPTQLLMCKKLSHIDLNNNLLSGAV---PSWLGTLPQLGELKLSFNQFVGFLPRE 690
L L H++L N + L TL +L L LSF
Sbjct: 436 LLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHA 495
Query: 691 LFNCSKLLVLSLDGNMLNGSLPNEVGNLASLNVLTLSGNLLSGPIPPAIGRLSKLYELRL 750
+ + + L N L S + +L + L L+ N +S +P + LS+ + L
Sbjct: 496 FTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINL 554
Query: 751 SNNSLNGVIPLEIGQLQNLQSILDLSHNNFTGQIPPSMGTLAKLEVLNLSHNQL 804
N L+ + L + LS L
Sbjct: 555 RQNPLDCTC-----SNIYFLEWYKENMQKLEDTEDTLCENPPLLRGVRLSDVTL 603
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 227 bits (582), Expect = 9e-64
Identities = 93/485 (19%), Positives = 156/485 (32%), Gaps = 27/485 (5%)
Query: 72 RVVSLNLSGLSLAGSISPSLGRLQSLIHLDLSSNSLTGPIPTALSNLSSLE--SLLLFSN 129
+ SL L ++ P + L LD +N++ +S+L SL L N
Sbjct: 130 TLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGN 189
Query: 130 QLAGTIPTQLGSLTSLRVMRIGDNWLSGSIPT--SFGNLVNLGTLGLASCSLSGPIPPQF 187
+ I + + G I + +L P F
Sbjct: 190 DI-AGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVF 248
Query: 188 GQLS--QLEELILQQNQLQGPIPAELGNCSSLSIFTAAENNLNGSIPAALGRLQNLQLLN 245
L +E + LQ++ S L +L+ +P+ L L L+ L
Sbjct: 249 EGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLV 307
Query: 246 LGNNSLSGEIPSELGELSQLGYLNLMGNRLEGAI-PRSFAKMGNLQSLDLSMNRLT--GG 302
L N L +L++ GN + + NL+ LDLS + +
Sbjct: 308 LSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDC 367
Query: 303 IPEEFGNMGQLVFLVLSNNNISGSIPRRICTNATSLEHLILAEIQLSG-EIPVELSQCQS 361
+ N+ L L LS N S+ LE L LA +L +
Sbjct: 368 CNLQLRNLSHLQSLNLSYNEPL-SLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHL 426
Query: 362 LKQLDLSNNTLNGTIPVELFQLVALTHLYLHNNSLVGSI---SPFVANLSNLQELALYHN 418
LK L+LS++ L+ + L AL HL L N + + L L+ L L
Sbjct: 427 LKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFC 486
Query: 419 NFQGSLPREIGMLVKLELLYLYDNHLSGQIPSEVGNCSSLKWIDFFGNSFTGEIPTSIGR 478
+ L + + L N L+ + + + +++ N + +P+ +
Sbjct: 487 DLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPI 545
Query: 479 LKDLNFLHLRQNELVGQIPASLGNCHQ---LIILDLADNKLSGGVPASFGFLQALEQLML 535
L ++LRQN L C L KL L + L
Sbjct: 546 LSQQRTINLRQNPL-------DCTCSNIYFLEWYKENMQKLEDTEDTLCENPPLLRGVRL 598
Query: 536 YNNSL 540
+ +L
Sbjct: 599 SDVTL 603
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 201 bits (512), Expect = 1e-54
Identities = 78/365 (21%), Positives = 131/365 (35%), Gaps = 12/365 (3%)
Query: 69 SSARVVSLNLSGLSLAGSISPSLG--RLQSLIHLDLSSNSLTGPIPTALSNLS--SLESL 124
SA SLN G I L +QSL P L S+ES+
Sbjct: 200 DSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESI 259
Query: 125 LLFSNQLAGTIPTQLGSLTSLRVMRIGDNWLSGSIPTSFGNLVNLGTLGLASCSLSGPIP 184
L + + L+ + + LS +P+ L L L L++
Sbjct: 260 NLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQ 318
Query: 185 PQFGQLSQLEELILQQNQLQGPIPAE-LGNCSSLSIFTAAENNLNGS--IPAALGRLQNL 241
L L ++ N + + L N +L + +++ S L L +L
Sbjct: 319 ISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHL 378
Query: 242 QLLNLGNNSLSGEIPSELGELSQLGYLNLMGNRLEGAIPRS-FAKMGNLQSLDLSMNRLT 300
Q LNL N E QL L+L RL+ +S F + L+ L+LS + L
Sbjct: 379 QSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLD 438
Query: 301 GGIPEEFGNMGQLVFLVLSNNNISGSIPRRICT--NATSLEHLILAEIQLSGEIPVELSQ 358
+ F + L L L N+ ++ + LE L+L+ LS +
Sbjct: 439 ISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTS 498
Query: 359 CQSLKQLDLSNNTLNGTIPVELFQLVALTHLYLHNNSLVGSISPFVANLSNLQELALYHN 418
+ + +DLS+N L + +E + +L L +N + + + LS + + L N
Sbjct: 499 LKMMNHVDLSHNRLT-SSSIEALSHLKGIYLNLASNHISIILPSLLPILSQQRTINLRQN 557
Query: 419 NFQGS 423
+
Sbjct: 558 PLDCT 562
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 184 bits (468), Expect = 5e-49
Identities = 83/366 (22%), Positives = 134/366 (36%), Gaps = 14/366 (3%)
Query: 62 RGITCGSSSARVVSLNLSGLSLAGSISPSLGRLQSLIHLDLSSNSLTGPIPTALSNLSSL 121
+ G V S+NL S + L LDL++ L+ +P+ L LS+L
Sbjct: 245 PAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSE-LPSGLVGLSTL 303
Query: 122 ESLLLFSNQLAGTIPTQLGSLTSLRVMRIGDNWLSGSIPT-SFGNLVNLGTLGLASCSL- 179
+ L+L +N+ + SL + I N + T NL NL L L+ +
Sbjct: 304 KKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIE 363
Query: 180 -SGPIPPQFGQLSQLEELILQQNQLQGPIPAELGNCSSLSIFTAAENNLNGSIP-AALGR 237
S Q LS L+ L L N+ C L + A L +
Sbjct: 364 TSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQN 423
Query: 238 LQNLQLLNLGNNSLSGEIPSELGELSQLGYLNLMGNRLEGAI---PRSFAKMGNLQSLDL 294
L L++LNL ++ L L L +LNL GN S +G L+ L L
Sbjct: 424 LHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVL 483
Query: 295 SMNRLTGGIPEEFGNMGQLVFLVLSNNNISGSIPRRICTNATSLEHLILAEIQLSGEIPV 354
S L+ F ++ + + LS+N ++ S ++ + +L LA +S +P
Sbjct: 484 SFCDLSSIDQHAFTSLKMMNHVDLSHNRLT-SSSIEALSHLKGI-YLNLASNHISIILPS 541
Query: 355 ELSQCQSLKQLDLSNNTLNGTIPVELFQLVALTHLYLHNNSLVGSISPFVANLSNLQELA 414
L + ++L N L+ T F L + L + N L+ +
Sbjct: 542 LLPILSQQRTINLRQNPLDCTCSNIYF----LEWYKENMQKLEDTEDTLCENPPLLRGVR 597
Query: 415 LYHNNF 420
L
Sbjct: 598 LSDVTL 603
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 4e-32
Identities = 50/268 (18%), Positives = 80/268 (29%), Gaps = 11/268 (4%)
Query: 579 SFDVTNNEFDHEIPPQLGNSPSLERLRLGNNKFIGKIPWTFGKIRELSLLDLSGNSLTGP 638
+++ N +EIP L S E L N TF ++ L+ LDL+ +
Sbjct: 16 TYNCENLGL-NEIPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWI 72
Query: 639 IPTQLLMCKKLSHIDLNNNLLSGAVPSWLGTLPQLGELKLSFNQFVGFLPRELFNCSKLL 698
+L + L N L + L L L L N L
Sbjct: 73 HEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLE 132
Query: 699 VLSLDGNMLNGSLPNEVGNLASLNVLTLSGNLLSGPIPPAIGRLSKL--YELRLSNNSLN 756
L L N ++ + L VL N + + L + L L+ N +
Sbjct: 133 SLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIA 192
Query: 757 GVIPLEIGQLQNLQSILDLSHNNFTGQIPPSMG--TLAKLEVLNLSHNQLVGELPSQLGE 814
G I QS L+ I + T+ L + P+
Sbjct: 193 G-IEPGAFDSAVFQS-LNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEG 250
Query: 815 MS--SLGKLNLSYNDLQGKLSKQFSHWP 840
+ S+ +NL + S F +
Sbjct: 251 LCEMSVESINLQKHYFFNISSNTFHCFS 278
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 2e-31
Identities = 54/280 (19%), Positives = 90/280 (32%), Gaps = 36/280 (12%)
Query: 76 LNLSG--LSLAGSISPSLGRLQSLIHLDLSSNSLTGPIPTALSNLSSLESLLLFSNQLAG 133
L+LS + + + L L L L+LS N A LE L L +L
Sbjct: 355 LDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKV 414
Query: 134 TIP-TQLGSLTSLRVMRIGDNWLSGSIPTSFGNLVNLGTLGLASCSLSGPI---PPQFGQ 189
+ +L L+V+ + + L S F L L L L
Sbjct: 415 KDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQT 474
Query: 190 LSQLEELILQQNQLQGPIPAELGNCSSLSIFTAAENNLNGSIPAALGRLQNLQLLNLGNN 249
L +LE L+L L + L+ + ++L +N
Sbjct: 475 LGRLEILVLSFCDLSSIDQHAFTS------------------------LKMMNHVDLSHN 510
Query: 250 SLSGEIPSELGELSQLGYLNLMGNRLEGAIPRSFAKMGNLQSLDLSMNRLTGGIPEEFGN 309
L+ L L + YLNL N + +P + ++++L N L +
Sbjct: 511 RLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCTC-----S 564
Query: 310 MGQLVFLVLSNNNISGSIPRRICTNATSLEHLILAEIQLS 349
+ N +C N L + L+++ LS
Sbjct: 565 NIYFLEWYKENMQKLEDTEDTLCENPPLLRGVRLSDVTLS 604
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 3e-04
Identities = 13/84 (15%), Positives = 27/84 (32%), Gaps = 11/84 (13%)
Query: 767 QNLQSILDLSHNNFTGQIPPSMGTLAKLEVLNLSHNQLVGELPSQLGEMSSLGKLNLSYN 826
+ + + + +IP ++ E L S N L + + +L L+L+
Sbjct: 11 KEVNKTYNCENLGLN-EIPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRC 67
Query: 827 DLQGKLSKQFSHWPAEAFEGNLHL 850
Q + F+ L
Sbjct: 68 --------QIYWIHEDTFQSQHRL 83
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 283 bits (726), Expect = 4e-83
Identities = 120/588 (20%), Positives = 199/588 (33%), Gaps = 44/588 (7%)
Query: 253 GEIPSELGELSQLGYLNLMGNRLEGAIPRSFAKMGNLQSLDLSMNRLTGGIPEEFGNMGQ 312
G + + + + M +L +P + +++DLS N L F N +
Sbjct: 2 GSLNPCIEVVPNI-TYQCMDQKLS-KVPDDIPS--STKNIDLSFNPLKILKSYSFSNFSE 57
Query: 313 LVFLVLSNNNISGSIPRRICTNATSLEHLILAEIQLSGEIPVELSQCQSLKQLDLSNNTL 372
L +L LS I +I + L +LIL + P S SL+ L L
Sbjct: 58 LQWLDLSRCEIE-TIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKL 116
Query: 373 NGTIPVELFQLVALTHLYLHNNSLVG-SISPFVANLSNLQELALYHNNFQGSLPREIGML 431
+ QL+ L L + +N + + + +NL+NL + L +N Q ++ L
Sbjct: 117 ASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFL 176
Query: 432 ----VKLELLYLYDNHLSGQIPSEVGNCSSLKWIDFFGNSFTGEIP-TSIGRLKDLNFLH 486
L + N + I + L + GN + I T + L L+
Sbjct: 177 RENPQVNLSLDMSLNPID-FIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHR 235
Query: 487 LRQNELVGQIPASLGNCHQLIILDLADNKLSGGVPASFGFLQALEQLMLY--NNSLEGNL 544
L E + L P+ L + + +
Sbjct: 236 LILGEFKD------------------ERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDD 277
Query: 545 PGSLINLRNLTRINFSKNRLNGRIATLCSSHSFLSFDVTNNEFDHEIPPQLGNSPSLERL 604
L N++ ++ + + + + + S + + + P + P L+ L
Sbjct: 278 IVKFHCLANVSAMSLAGVSIK-YLEDVPKHFKWQSLSIIRCQLK-QFPTL--DLPFLKSL 333
Query: 605 RLGNNKFIGKIPWTFGKIRELSLLDLSGNSLT--GPIPTQLLMCKKLSHIDLNNNLLSGA 662
L NK G I + + LS LDLS N+L+ G L L H+DL+ N
Sbjct: 334 TLTMNK--GSISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII- 390
Query: 663 VPSWLGTLPQLGELKLSFNQFVGFLPRELF-NCSKLLVLSLDGNMLNGSLPNEVGNLASL 721
+ + L +L L + F + KLL L + L SL
Sbjct: 391 MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSL 450
Query: 722 NVLTLSGNLLSGPIPP-AIGRLSKLYELRLSNNSLNGVIPLEIGQLQNLQSILDLSHNNF 780
N L ++GN + L L LS L + L LQ L++SHNN
Sbjct: 451 NTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQL-LNMSHNNL 509
Query: 781 TGQIPPSMGTLAKLEVLNLSHNQLVGELPSQLGEMSSLGKLNLSYNDL 828
L L L+ S N++ SL NL+ N +
Sbjct: 510 LFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSV 557
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 274 bits (703), Expect = 5e-80
Identities = 116/635 (18%), Positives = 200/635 (31%), Gaps = 90/635 (14%)
Query: 181 GPIPPQFGQLSQLEELILQQNQLQGPIPAELGNCSSLSIFTAAENNLNGSIPAALGRLQN 240
G + P + + +L +P ++ SS + N L +
Sbjct: 2 GSLNPCIEVVPNIT-YQCMDQKLSK-VPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSE 57
Query: 241 LQLLNLGNNSLSGEIPSELGELSQLGYLNLMGNRLEGAIPRSFAKMGNLQSLDLSMNRLT 300
LQ L+L + L L L L GN ++ P SF+ + +L++L +L
Sbjct: 58 LQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLA 117
Query: 301 GGIPEEFGNMGQLVFLVLSNNNISGSIPRRICTNATSLEHLILAEIQLSGEIPVELSQCQ 360
G + L L +++N I +N T+L H+ L+ + +L +
Sbjct: 118 SLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLR 177
Query: 361 SLKQ----LDLSNNTLNGTIPVELFQLVALTHLYLHNNSLVGSISP-FVANLSNLQELAL 415
Q LD+S N ++ I + FQ + L L L N +I + NL+ L L
Sbjct: 178 ENPQVNLSLDMSLNPID-FIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRL 236
Query: 416 YHNNFQGSLPREIGMLVKLELLYLYDNHLSGQIPSEVGNCSSLKWIDFFGNSFTGEIPTS 475
F+ + P+
Sbjct: 237 ILGEFKDE------------------------------------------RNLEIFEPSI 254
Query: 476 IGRLKDLNFLHLR--QNELVGQIPASLGNCHQLIILDLADNKLSGGVPASFGFLQALEQL 533
+ L D+ R + + LA + + L
Sbjct: 255 MEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKY--LEDVPKHFKWQSL 312
Query: 534 MLYNNSLEGNLPGSLINLRNLTRINFSKNRLNGRIATLCSSHSFLSFDVTNNEFDHEIPP 593
+ L+ ++L L + + N+ + I
Sbjct: 313 SIIRCQLKQF---PTLDLPFLKSLTLTMNKGS-------------------------ISF 344
Query: 594 QLGNSPSLERLRLGNNK--FIGKIPWTFGKIRELSLLDLSGNSLTGPIPTQLLMCKKLSH 651
+ PSL L L N F G ++ L LDLS N + + ++L H
Sbjct: 345 KKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQH 403
Query: 652 IDLNNNLLSGAVP-SWLGTLPQLGELKLSFNQFVGFLPRELFNCSKLLVLSLDGNMLNGS 710
+D ++ L S +L +L L +S+ + L L + GN +
Sbjct: 404 LDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDN 463
Query: 711 LPNEV-GNLASLNVLTLSGNLLSGPIPPAIGRLSKLYELRLSNNSLNGVIPLEIGQLQNL 769
+ V N +L L LS L L +L L +S+N+L + QL +L
Sbjct: 464 TLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSL 523
Query: 770 QSILDLSHNNFTGQIPPSMGTLAKLEVLNLSHNQL 804
+ LD S N L NL++N +
Sbjct: 524 ST-LDCSFNRIETSKGILQHFPKSLAFFNLTNNSV 557
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 262 bits (671), Expect = 1e-75
Identities = 112/621 (18%), Positives = 198/621 (31%), Gaps = 88/621 (14%)
Query: 74 VSLNLSGLSLAGSISPSLGRLQSLIHLDLSSNSLTGPIPTALSNLSSLESLLLFSNQLAG 133
++ L+ + + S ++DLS N L + SN S L+ L L ++
Sbjct: 14 ITYQCMDQKLS-KVPDDIPS--STKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIET 70
Query: 134 TIPTQLGSLTSLRVMRIGDNWLSGSIPTSFGNLVNLGTLGLASCSLSGPIPPQFGQLSQL 193
L L + + N + P SF L +L L L+ GQL L
Sbjct: 71 IEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITL 130
Query: 194 EELILQQNQLQGPIPAELGNCSSLSIFTAAENNLNGSIPAALGRLQNLQLLNLGNNSLSG 253
++L + N + +PA L NL ++L N +
Sbjct: 131 KKLNVAHNFIHS-----------------------CKLPAYFSNLTNLVHVDLSYNYIQT 167
Query: 254 EIPSELGELSQLGYLNLMGNRLEGAIPRSFAKMGNLQSLDLSMNRLTGGIPEEFGNMGQL 313
++L L + + SLD+S+N + + F + +L
Sbjct: 168 ITVNDLQFLRENPQV--------------------NLSLDMSLNPIDFIQDQAFQGI-KL 206
Query: 314 VFLVLSNNNISGSIPRRICTNATSLEHLILAEIQLSGEIPVELSQCQSLK--------QL 365
L L N S +I + N L L + E +E+ + ++ +
Sbjct: 207 HELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEF 266
Query: 366 DLSNNTLNGTIPVELFQLVALTHLYLHNNSLVGSISPFVANLSNLQELALYHNNFQGSLP 425
L+ V+ L ++ + L S+ V Q L++ +
Sbjct: 267 RLTYTNDFSDDIVKFHCLANVSAMSLAGVSI--KYLEDVPKHFKWQSLSIIRCQLKQF-- 322
Query: 426 REIGMLVKLELLYLYDNHLSGQIPSEVGNCSSLKWIDFFGNSFT--GEIPTSIGRLKDLN 483
L L+ L L N S I + SL ++D N+ + G S L
Sbjct: 323 -PTLDLPFLKSLTLTMNKGS--ISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLR 379
Query: 484 FLHLRQNELVGQIPASLGNCHQLIILDLADNKLSGGVPAS-FGFLQALEQLMLYNNSLEG 542
L L N + + A+ +L LD + L S F L+ L L + + +
Sbjct: 380 HLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKI 438
Query: 543 NLPGSLINLRNLTRINFSKNRLNGRIATLCSSHSFLSFDVTNNEFDHEIPPQLGNSPSLE 602
+ G + L +L + + N + N+ +L
Sbjct: 439 DFDGIFLGLTSLNTLKMAGNSFKDNT----------------------LSNVFANTTNLT 476
Query: 603 RLRLGNNKFIGKIPWTFGKIRELSLLDLSGNSLTGPIPTQLLMCKKLSHIDLNNNLLSGA 662
L L + F + L LL++S N+L + LS +D + N + +
Sbjct: 477 FLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETS 536
Query: 663 VPSWLGTLPQLGELKLSFNQF 683
L L+ N
Sbjct: 537 KGILQHFPKSLAFFNLTNNSV 557
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 259 bits (663), Expect = 1e-74
Identities = 113/635 (17%), Positives = 207/635 (32%), Gaps = 89/635 (14%)
Query: 85 GSISPSLGRLQSLIHLDLSSNSLTGPIPTALSNLSSLESLLLFSNQLAGTIPTQLGSLTS 144
GS++P + + ++ L+ +P + SS +++ L N L + +
Sbjct: 2 GSLNPCIEVVPNI-TYQCMDQKLSK-VPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSE 57
Query: 145 LRVMRIGDNWLSGSIPTSFGNLVNLGTLGLASCSLSGPIPPQFGQLSQLEELILQQNQLQ 204
L+ + + + ++ L +L L L + P F L+ LE L+ + +L
Sbjct: 58 LQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLA 117
Query: 205 GPIPAELGNCSSLSIFTAAENNLNG-SIPAALGRLQNLQLLNLGNNSLSGEIPSELGELS 263
+G +L A N ++ +PA L NL ++L N + ++L L
Sbjct: 118 SLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLR 177
Query: 264 QLGYLNLMGNRLEGAIPRSFAKMGNLQSLDLSMNRLTGGIPEEFGNMGQLVFLVLSNNNI 323
+ + SLD+S+N + + F + +L L L N
Sbjct: 178 ENPQV--------------------NLSLDMSLNPIDFIQDQAFQGI-KLHELTLRGNFN 216
Query: 324 SGSIPRRICTNATSLEHLILAEIQLSGEIPVELSQCQSLK--------QLDLSNNTLNGT 375
S +I + N L L + E +E+ + ++ + L+
Sbjct: 217 SSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSD 276
Query: 376 IPVELFQLVALTHLYLHNNSLVGSISPFVANLSNLQELALYHNNFQGSLPREIGMLVKLE 435
V+ L ++ + L S+ V Q L++ + L L+
Sbjct: 277 DIVKFHCLANVSAMSLAGVSI--KYLEDVPKHFKWQSLSIIRCQLKQF---PTLDLPFLK 331
Query: 436 LLYLYDNHLSGQIPSEVGNCSSLKWIDFFGNSFTGEIPTSIGRLKDLNFLHLRQNELVGQ 495
L L N S I + SL ++D N+ + S L
Sbjct: 332 SLTLTMNKGS--ISFKKVALPSLSYLDLSRNALSFSGCCSYSDL---------------- 373
Query: 496 IPASLGNCHQLIILDLADNKLSGGVPASFGFLQALEQLMLYNNSLEGNLPGSLI-NLRNL 554
+ L LDL+ N + A+F L+ L+ L +++L+ S +L L
Sbjct: 374 ------GTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKL 426
Query: 555 TRINFSKNRLNGRIATLCSSHSFLSFDVTNNEFDHEIPPQLGNSPSLERLRLGNNKFIGK 614
++ S + SL L++ N F
Sbjct: 427 LYLDIS-----------------------YTNTKIDFDGIFLGLTSLNTLKMAGNSFKDN 463
Query: 615 IPW-TFGKIRELSLLDLSGNSLTGPIPTQLLMCKKLSHIDLNNNLLSGAVPSWLGTLPQL 673
F L+ LDLS L +L +++++N L S L L
Sbjct: 464 TLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSL 523
Query: 674 GELKLSFNQFVGFLPRELFNCSKLLVLSLDGNMLN 708
L SFN+ L +L N +
Sbjct: 524 STLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVA 558
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 254 bits (652), Expect = 4e-73
Identities = 108/534 (20%), Positives = 179/534 (33%), Gaps = 27/534 (5%)
Query: 73 VVSLNLSGLSLAGSISPSLGRLQSLIHLDLSSNSLTGPIPTALSNLSSLESLLLFSNQLA 132
+++LS L S S L LDLS + A L L +L+L N +
Sbjct: 34 TKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQ 93
Query: 133 GTIPTQLGSLTSLRVMRIGDNWLSGSIPTSFGNLVNLGTLGLASCSLSG-PIPPQFGQLS 191
P LTSL + + L+ G L+ L L +A + +P F L+
Sbjct: 94 SFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLT 153
Query: 192 QLEELILQQNQLQGPIPAELGNCSSLSIFTAA---ENNLNGSIPAALGRLQNLQLLNLGN 248
L + L N +Q +L + N I + L L L
Sbjct: 154 NLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGIKLHELTLRG 213
Query: 249 NSLSGEIPSE-LGELSQLGYLNLMGNRLEGAI------PRSFAKMGNLQ--SLDLSMNRL 299
N S I L L+ L L+ + P + ++ L+
Sbjct: 214 NFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTND 273
Query: 300 TGGIPEEFGNMGQLVFLVLSNNNISGSIPRRICTNATSLEHLILAEIQLSGEIPVELSQC 359
+F + + + L+ +I + L + QL
Sbjct: 274 FSDDIVKFHCLANVSAMSLAGVSIKYLED---VPKHFKWQSLSIIRCQLKQ---FPTLDL 327
Query: 360 QSLKQLDLSNNTLNGTIPVELFQLVALTHLYLHNNSL--VGSISPFVANLSNLQELALYH 417
LK L L+ N G+I + L +L++L L N+L G S ++L+ L L
Sbjct: 328 PFLKSLTLTMN--KGSISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSF 385
Query: 418 NNFQGSLPREIGMLVKLELLYLYDNHLSGQIPSEV-GNCSSLKWIDFFGNSFTGEIPTSI 476
N + L +L+ L + L + L ++D + +
Sbjct: 386 NGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIF 444
Query: 477 GRLKDLNFLHLRQNELVGQIPAS-LGNCHQLIILDLADNKLSGGVPASFGFLQALEQLML 535
L LN L + N ++ N L LDL+ +L F L L+ L +
Sbjct: 445 LGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNM 504
Query: 536 YNNSLEGNLPGSLINLRNLTRINFSKNRLNGRIATLCSSHSFLS-FDVTNNEFD 588
+N+L L +L+ ++ S NR+ L L+ F++TNN
Sbjct: 505 SHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVA 558
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 3e-35
Identities = 55/265 (20%), Positives = 91/265 (34%), Gaps = 10/265 (3%)
Query: 64 ITCGSSSARVVSLNLSGLSLAGSISPSLGRLQSLIHLDLSSNSLTGPIPTALSNLSSLES 123
+ + SL++ L + L L+ L L+ N + I L SL
Sbjct: 300 LEDVPKHFKWQSLSIIRCQLKQFPTLDLPFLK---SLTLTMNKGS--ISFKKVALPSLSY 354
Query: 124 LLLFSNQLAGTIPT--QLGSLTSLRVMRIGDNWLSGSIPTSFGNLVNLGTLGLASCSLSG 181
L L N L+ + SLR + + N + +F L L L +L
Sbjct: 355 LDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKR 413
Query: 182 PIPPQ-FGQLSQLEELILQQNQLQGPIPAELGNCSSLSIFTAAENNLNGSIPA-ALGRLQ 239
F L +L L + + +SL+ A N+ + +
Sbjct: 414 VTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTT 473
Query: 240 NLQLLNLGNNSLSGEIPSELGELSQLGYLNLMGNRLEGAIPRSFAKMGNLQSLDLSMNRL 299
NL L+L L L +L LN+ N L + ++ +L +LD S NR+
Sbjct: 474 NLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRI 533
Query: 300 TGGIPEEFGNMGQLVFLVLSNNNIS 324
L F L+NN+++
Sbjct: 534 ETSKGILQHFPKSLAFFNLTNNSVA 558
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 4e-08
Identities = 22/106 (20%), Positives = 43/106 (40%), Gaps = 5/106 (4%)
Query: 733 GPIPPAIGRLSKLYELRLSNNSLNGVIPLEIGQLQNLQSILDLSHNNFTGQIPPSMGTLA 792
G + P I + + + + L+ +P +I + ++ +DLS N S +
Sbjct: 2 GSLNPCIEVVPNIT-YQCMDQKLSK-VPDDIPS--STKN-IDLSFNPLKILKSYSFSNFS 56
Query: 793 KLEVLNLSHNQLVGELPSQLGEMSSLGKLNLSYNDLQGKLSKQFSH 838
+L+ L+LS ++ + L L L+ N +Q FS
Sbjct: 57 ELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSG 102
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 249 bits (638), Expect = 1e-74
Identities = 79/314 (25%), Positives = 132/314 (42%), Gaps = 36/314 (11%)
Query: 934 RDFRWEDIMGATNNLSDEFIIGSGGSGTVYKAELANGATVAVKKISCKDDHLLNKSFTRE 993
D E++ + L + G G V+KA+L VAVK +D + E
Sbjct: 12 VDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQ--SWQNEYE 68
Query: 994 VKTLGRIRHRHLVKLMGHCCNKGAGSN---LLIYEYMENGSVWDWLHKQPVNIKMRKSLD 1050
V +L ++H ++++ +G +G + LI + E GS+ D+L +
Sbjct: 69 VYSLPGMKHENILQFIG-AEKRGTSVDVDLWLITAFHEKGSLSDFLKANV--------VS 119
Query: 1051 WEARLKIAVGLAQGVEYLHHDCV-------PKILHRDIKSSNILLDSNMEAHLGDFGLAK 1103
W IA +A+G+ YLH D P I HRDIKS N+LL +N+ A + DFGLA
Sbjct: 120 WNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLAL 179
Query: 1104 ALVEDYNSNTESNTWFAGSYGYIAPEYA-----YSLKATEKCDVYSMGIVLMELVSGKMP 1158
+ + G+ Y+APE + A + D+Y+MG+VL EL S
Sbjct: 180 --KFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTA 237
Query: 1159 TDATF-GVEMDMVRWVEMHMEMSGSAREELLDDQMKPLLPGEECAAYQVL----EIALQC 1213
D + + H + +E ++ + +P+L + + + E +C
Sbjct: 238 ADGPVDEYMLPFEEEIGQHPSLE-DMQEVVVHKKKRPVLR-DYWQKHAGMAMLCETIEEC 295
Query: 1214 TKTSPQERPSSRQV 1227
+ R S+ V
Sbjct: 296 WDHDAEARLSAGCV 309
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 214 bits (546), Expect = 3e-62
Identities = 88/280 (31%), Positives = 135/280 (48%), Gaps = 33/280 (11%)
Query: 954 IGSGGSGTVYKAELANGATVAVKKISCKDDH-LLNKSFTREVKTLGRIRHRHLVKLMGHC 1012
IG+G GTV++AE +G+ VAVK + +D H F REV + R+RH ++V MG
Sbjct: 45 IGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 1013 CNKGAGSNL-LIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHD 1071
NL ++ EY+ GS++ LHK R+ LD RL +A +A+G+ YLH+
Sbjct: 104 TQP---PNLSIVTEYLSRGSLYRLLHKS----GAREQLDERRRLSMAYDVAKGMNYLHN- 155
Query: 1072 CVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYA 1131
P I+HR++KS N+L+D + DFGL++ + S+ AG+ ++APE
Sbjct: 156 RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKS----AAGTPEWMAPEVL 211
Query: 1132 YSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSAREELLDDQ 1191
+ EK DVYS G++L EL + + P W ++ +
Sbjct: 212 RDEPSNEKSDVYSFGVILWELATLQQP-------------WGNLN---PAQVVAAVGFKC 255
Query: 1192 MKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLL 1231
+ +P QV I C P +RPS + DLL
Sbjct: 256 KRLEIP-RNLNP-QVAAIIEGCWTNEPWKRPSFATIMDLL 293
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 211 bits (538), Expect = 3e-61
Identities = 73/287 (25%), Positives = 125/287 (43%), Gaps = 37/287 (12%)
Query: 946 NNLSDEFIIGSGGSGTVYKAELANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHL 1005
+ E ++G G G V KA+ VA+K+I + + K+F E++ L R+ H ++
Sbjct: 8 KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESESE---RKAFIVELRQLSRVNHPNI 63
Query: 1006 VKLMGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGV 1065
VKL G C N L+ EY E GS+++ LH + + + +QGV
Sbjct: 64 VKLYGACLNPVC----LVMEYAEGGSLYNVLHGA----EPLPYYTAAHAMSWCLQCSQGV 115
Query: 1066 EYLHHDCVPKILHRDIKSSNILLDSNME-AHLGDFGLAKALVEDYNSNTESNTWFAGSYG 1124
YLH ++HRD+K N+LL + + DFG A + +N GS
Sbjct: 116 AYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNK-------GSAA 168
Query: 1125 YIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSAR 1184
++APE +EKCDV+S GI+L E+++ + P D +
Sbjct: 169 WMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFD---------------EIGGPAFRI 213
Query: 1185 EELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLL 1231
+ + +P L + + + +C P +RPS ++ ++
Sbjct: 214 MWAVHNGTRPPLI-KNLPK-PIESLMTRCWSKDPSQRPSMEEIVKIM 258
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 209 bits (533), Expect = 1e-60
Identities = 73/301 (24%), Positives = 129/301 (42%), Gaps = 40/301 (13%)
Query: 953 IIGSGGSGTVYKAELANGATVAVKKISCKDDHLLNKSFTREVK--TLGRIRHRHLVKLMG 1010
+G G G V++ G VAVK S +D+ KS+ RE + +RH +++ +
Sbjct: 15 CVGKGRYGEVWRGSW-QGENVAVKIFSSRDE----KSWFRETELYNTVMLRHENILGFIA 69
Query: 1011 HCCNKGAGSN---LLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEY 1067
S+ LI Y E GS++D+L LD + L+I + +A G+ +
Sbjct: 70 -SDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT--------LDTVSCLRIVLSIASGLAH 120
Query: 1068 LHHDCV-----PKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGS 1122
LH + P I HRD+KS NIL+ N + + D GLA + N N G+
Sbjct: 121 LHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGT 180
Query: 1123 YGYIAPE------YAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEM---DMVRWV 1173
Y+APE + ++ D+++ G+VL E+ + + D+V
Sbjct: 181 KRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPND 240
Query: 1174 EMHMEMSGSAREELLDDQMKPLLP---GEECAAYQVLEIALQCTKTSPQERPSSRQVCDL 1230
+M R+ + DQ +P +P + + ++ +C +P R ++ ++
Sbjct: 241 PSFEDM----RKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKT 296
Query: 1231 L 1231
L
Sbjct: 297 L 297
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 213 bits (544), Expect = 4e-60
Identities = 111/480 (23%), Positives = 185/480 (38%), Gaps = 37/480 (7%)
Query: 89 PSLGRLQSLIHLDLSSNSLTGPIPTALSNLSSLESLLLFSNQLAGTIPTQLGSLTSLRVM 148
+ L + L ++T + ++L + +L + + L +L +
Sbjct: 18 FTDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGI--KSIDGVEYLNNLTQI 73
Query: 149 RIGDNWLSGSIPTSFGNLVNLGTLGLASCSLSGPIPPQFGQLSQLEELILQQNQLQGPIP 208
+N L+ P NL L + + + ++ P L+ L L L NQ+ P
Sbjct: 74 NFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP 129
Query: 209 AELGNCSSLSIFTAAENNLNGSIPAALGRLQNLQLLNLGNNSLSGEIPSELGELSQLGYL 268
L N ++L+ + N ++ +AL L +LQ L+ GN L L+ L L
Sbjct: 130 --LKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSFGNQVTD---LKPLANLTTLERL 182
Query: 269 NLMGNRLEGAIPRSFAKMGNLQSLDLSMNRLTGGIPEEFGNMGQLVFLVLSNNNISGSIP 328
++ N++ AK+ NL+SL + N+++ P G + L L L+ N + I
Sbjct: 183 DISSNKVSD--ISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLK-DIG 237
Query: 329 RRICTNATSLEHLILAEIQLSGEIPVELSQCQSLKQLDLSNNTLNGTIPVELFQLVALTH 388
+ T+L L LA Q+S P LS L +L L N ++ P L L ALT+
Sbjct: 238 --TLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTN 291
Query: 389 LYLHNNSLVGSISPFVANLSNLQELALYHNNFQGSLPREIGMLVKLELLYLYDNHLSGQI 448
L L+ N L ISP +NL NL L LY NN P + L KL+ L+ Y+N +S
Sbjct: 292 LELNENQLE-DISPI-SNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSD-- 345
Query: 449 PSEVGNCSSLKWIDFFGNSFTGEIPTSIGRLKDLNFLHLRQNELVGQIPASLGNCHQLII 508
S + N +++ W+ N + P + L + L L N
Sbjct: 346 VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKANVSIPNT 403
Query: 509 LDLADNKLSGGVPASFGFLQALEQLMLYNNSLEGNLPGSLINLRNLTRINFSKNRLNGRI 568
+ L PA+ + + + N I +G +
Sbjct: 404 VKNVTGALI--APATISDGGSYTEPDITWNLPSY-TNEVSYTFSQPVTIGKGTTTFSGTV 460
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 203 bits (518), Expect = 1e-56
Identities = 97/482 (20%), Positives = 181/482 (37%), Gaps = 59/482 (12%)
Query: 356 LSQCQSLKQLDLSNNTLNGTIPVELFQLVALTHLYLHNNSLVGSISPFVANLSNLQELAL 415
+ + L + T+ L +T L + SI L+NL ++
Sbjct: 20 DTALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGI-KSIDGV-EYLNNLTQINF 75
Query: 416 YHNNFQGSLPREIGMLVKLELLYLYDNHLSGQIPSEVGNCSSLKWIDFFGNSFTGEIPTS 475
+N P + L KL + + +N ++ + + N ++L + F N T P
Sbjct: 76 SNNQLTDITP--LKNLTKLVDILMNNNQIAD--ITPLANLTNLTGLTLFNNQITDIDP-- 129
Query: 476 IGRLKDLNFLHLRQNELVGQIPASLGNCHQLIILDLADNKLSGGVPASFGFLQALEQLML 535
+ L +LN L L N + ++L L L N+++ L LE+L +
Sbjct: 130 LKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSF-GNQVTD--LKPLANLTTLERLDI 184
Query: 536 YNNSLEGNLPGSLINLRNLTRINFSKNRLNGRIATLCSSHSFLSFDVTNNEFDHEIPPQL 595
+N + L L NL + + N+++ I P L
Sbjct: 185 SSNKVSD--ISVLAKLTNLESLIATNNQISD------------------------ITP-L 217
Query: 596 GNSPSLERLRLGNNKFIGKIPWTFGKIRELSLLDLSGNSLTGPIPTQLLMCKKLSHIDLN 655
G +L+ L L N+ + I T + L+ LDL+ N ++ P L KL+ + L
Sbjct: 218 GILTNLDELSLNGNQ-LKDIG-TLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLG 273
Query: 656 NNLLSGAVPSWLGTLPQLGELKLSFNQFVGFLPRELFNCSKLLVLSLDGNMLNGSLPNEV 715
N +S P L L L L+L+ NQ P + N L L+L N ++ P V
Sbjct: 274 ANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--V 327
Query: 716 GNLASLNVLTLSGNLLSGPIPPAIGRLSKLYELRLSNNSLNGVIPLEIGQLQNLQSILDL 775
+L L L N +S ++ L+ + L +N ++ + P + L + L L
Sbjct: 328 SSLTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTP--LANLTRITQ-LGL 382
Query: 776 SHNNFTGQIPPSMGTLAKLEVLNLSHNQLVGELPSQLGEMSSLGKLNLSYNDLQGKLSKQ 835
+ +T P + + + + P+ + + S + ++++N
Sbjct: 383 NDQAWTN-APVNYKANVSIPNTVKNVTGAL-IAPATISDGGSYTEPDITWNLPSYTNEVS 440
Query: 836 FS 837
++
Sbjct: 441 YT 442
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 199 bits (509), Expect = 1e-55
Identities = 100/517 (19%), Positives = 186/517 (35%), Gaps = 65/517 (12%)
Query: 316 LVLSNNNISGSIPRRICTNATSLEHLILAEIQLSGEIPVELSQCQSLKQLDLSNNTLNGT 375
+ + I+ T +L + ++ + + + L +
Sbjct: 7 TITQDTPINQIFT---DTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGI--K 59
Query: 376 IPVELFQLVALTHLYLHNNSLVGSISPFVANLSNLQELALYHNNFQGSLPREIGMLVKLE 435
+ L LT + NN L I+P NL+ L ++ + +N P + L L
Sbjct: 60 SIDGVEYLNNLTQINFSNNQLT-DITPL-KNLTKLVDILMNNNQIADITP--LANLTNLT 115
Query: 436 LLYLYDNHLSGQIPSEVGNCSSLKWIDFFGNSFTGEIPTSIGRLKDLNFLHLRQNELVGQ 495
L L++N ++ P + N ++L ++ N+ + +++ L L L N++
Sbjct: 116 GLTLFNNQITDIDP--LKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSF-GNQVTDL 170
Query: 496 IPASLGNCHQLIILDLADNKLSGGVPASFGFLQALEQLMLYNNSLEGNLPGSLINLRNLT 555
P L N L LD++ NK+S + L LE L+ NN + P L L NL
Sbjct: 171 KP--LANLTTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQISDITP--LGILTNLD 224
Query: 556 RINFSKNRLNGRIATLCSSHSFLSFDVTNNEFDHEIPPQLGNSPSLERLRLGNNKFIGKI 615
++ + N+L L + +L L L NN+
Sbjct: 225 ELSLNGNQLKD-------------------------IGTLASLTNLTDLDLANNQISNLA 259
Query: 616 PWTFGKIRELSLLDLSGNSLTGPIPTQLLMCKKLSHIDLNNNLLSGAVPSWLGTLPQLGE 675
P + +L+ L L N ++ P L L++++LN N L P + L L
Sbjct: 260 P--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTY 313
Query: 676 LKLSFNQFVGFLPRELFNCSKLLVLSLDGNMLNGSLPNEVGNLASLNVLTLSGNLLSGPI 735
L L FN P + + +KL L N ++ + + NL ++N L+ N +S
Sbjct: 314 LTLYFNNISDISP--VSSLTKLQRLFFYNNKVSD--VSSLANLTNINWLSAGHNQISDLT 369
Query: 736 PPAIGRLSKLYELRLSNNSLNGVIPLEIGQLQNLQSILDLSHNNFTGQIPPS-MGTLAKL 794
P + L+++ +L L++ + + SI + N I P+ +
Sbjct: 370 P--LANLTRITQLGLNDQAWTNAPV----NYKANVSIPNTVKNVTGALIAPATISDGGSY 423
Query: 795 EVLNLSHNQLVGELPSQLGEMSSLGKLNLSYNDLQGK 831
+++ N S + G
Sbjct: 424 TEPDITWNLP-SYTNEVSYTFSQPVTIGKGTTTFSGT 459
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 195 bits (499), Expect = 3e-54
Identities = 102/524 (19%), Positives = 185/524 (35%), Gaps = 84/524 (16%)
Query: 189 QLSQLEELILQQNQLQGPIPAELGNCSSLSIFTAAENNLNGSIPAALGRLQNLQLLNLGN 248
L++ + +L + + + + ++ A + + L NL +N N
Sbjct: 22 ALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGI--KSIDGVEYLNNLTQINFSN 77
Query: 249 NSLSGEIPSELGELSQLGYLNLMGNRLEGAIPRSFAKMGNLQSLDLSMNRLTGGIPEEFG 308
N L+ P L L++L + + N++ P A + NL L L N++T +
Sbjct: 78 NQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITD--IDPLK 131
Query: 309 NMGQLVFLVLSNNNISGSIPRRICTNATSLEHLILAEIQLSGEIPVELSQCQSLKQLDLS 368
N+ L L LS+N IS LS SL+QL
Sbjct: 132 NLTNLNRLELSSNTISD---------------------------ISALSGLTSLQQLSFG 164
Query: 369 NNTLNGTIPVELFQLVALTHLYLHNNSLVGSISPFVANLSNLQELALYHNNFQGSLPREI 428
N + L L L L + +N + IS A L+NL+ L +N P +
Sbjct: 165 NQVTD---LKPLANLTTLERLDISSNKVS-DISVL-AKLTNLESLIATNNQISDITP--L 217
Query: 429 GMLVKLELLYLYDNHLSGQIPSEVGNCSSLKWIDFFGNSFTGEIPTSIGRLKDLNFLHLR 488
G+L L+ L L N L + + ++L +D N + P + L L L L
Sbjct: 218 GILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLG 273
Query: 489 QNELVGQIPASLGNCHQLIILDLADNKLSGGVPASFGFLQALEQLMLYNNSLEGNLPGSL 548
N++ P L L L+L +N+L + L+ L L LY N++ P +
Sbjct: 274 ANQISNISP--LAGLTALTNLELNENQLED--ISPISNLKNLTYLTLYFNNISDISP--V 327
Query: 549 INLRNLTRINFSKNRLNGRIATLCSSHSFLSFDVTNNEFDHEIPPQLGNSPSLERLRLGN 608
+L L R+ F N+++ L N ++ L G+
Sbjct: 328 SSLTKLQRLFFYNNKVSD-------------------------VSSLANLTNINWLSAGH 362
Query: 609 NKFIGKIPWTFGKIRELSLLDLSGNSLTGPIPTQLLMCKKLSHIDLNNNLLSGAVPSWLG 668
N+ P + ++ L L+ + T + + L P+ +
Sbjct: 363 NQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGALI--APATIS 418
Query: 669 TLPQLGELKLSFNQFVGFLPRELFNCSKLLVLSLDGNMLNGSLP 712
E +++N + + S+ + + +G++
Sbjct: 419 DGGSYTEPDITWNL-PSYTNEVSYTFSQPVTIGKGTTTFSGTVT 461
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 185 bits (471), Expect = 1e-50
Identities = 89/395 (22%), Positives = 158/395 (40%), Gaps = 32/395 (8%)
Query: 75 SLNLSGLSLAGSISPSLGRLQSLIHLDLSSNSLTGPIPTALSNLSSLESLLLFSNQLAGT 134
+N S L + L L L+ + +++N + P L+NL++L L LF+NQ+
Sbjct: 72 QINFSNNQL--TDITPLKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDI 127
Query: 135 IPTQLGSLTSLRVMRIGDNWLSGSIPTSFGNLVNLGTLGLASCSLSGPIPPQFGQLSQLE 194
P L +LT+L + + N +S ++ L +L L ++ P L+ LE
Sbjct: 128 DP--LKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSF-GNQVTDLKP--LANLTTLE 180
Query: 195 ELILQQNQLQGPIPAELGNCSSLSIFTAAENNLNGSIPAALGRLQNLQLLNLGNNSLSGE 254
L + N++ L ++L A N ++ P LG L NL L+L N L
Sbjct: 181 RLDISSNKVSDISV--LAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD- 235
Query: 255 IPSELGELSQLGYLNLMGNRLEGAIPRSFAKMGNLQSLDLSMNRLTGGIPEEFGNMGQLV 314
L L+ L L+L N++ P + + L L L N+++ + L
Sbjct: 236 -IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISN--ISPLAGLTALT 290
Query: 315 FLVLSNNNISGSIPRRICTNATSLEHLILAEIQLSGEIPVELSQCQSLKQLDLSNNTLNG 374
L L+ N + P +N +L +L L +S P +S L++L NN +
Sbjct: 291 NLELNENQLEDISP---ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKV-- 343
Query: 375 TIPVELFQLVALTHLYLHNNSLVGSISPFVANLSNLQELALYHNNFQGSLPREIGMLVKL 434
+ L L + L +N + ++P ANL+ + +L L + + +
Sbjct: 344 SDVSSLANLTNINWLSAGHNQIS-DLTPL-ANLTRITQLGLNDQAWTNAPVNYKANVSIP 401
Query: 435 ELLYLYDNHLSGQIPSEVGNCSSLKWIDFFGNSFT 469
+ L P+ + + S D N +
Sbjct: 402 NTVKNVTGALI--APATISDGGSYTEPDITWNLPS 434
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 1e-42
Identities = 94/376 (25%), Positives = 154/376 (40%), Gaps = 30/376 (7%)
Query: 77 NLSGLSLAG---SISPSLGRLQSLIHLDLSSNSLTGPIPTALSNLSSLESLLLFSNQLAG 133
NL+GL+L + L L +L L+LSSN+++ LS L+SL+ L NQ+
Sbjct: 113 NLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDISA--LSGLTSLQQLSF-GNQVTD 169
Query: 134 TIPTQLGSLTSLRVMRIGDNWLSGSIPTSFGNLVNLGTLGLASCSLSGPIPPQFGQLSQL 193
P L +LT+L + I N +S + L NL +L + +S P G L+ L
Sbjct: 170 LKP--LANLTTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQISDITP--LGILTNL 223
Query: 194 EELILQQNQLQGPIPAELGNCSSLSIFTAAENNLNGSIPAALGRLQNLQLLNLGNNSLSG 253
+EL L NQL+ L + ++L+ A N ++ P L L L L LG N +S
Sbjct: 224 DELSLNGNQLKDIGT--LASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISN 279
Query: 254 EIPSELGELSQLGYLNLMGNRLEGAIPRSFAKMGNLQSLDLSMNRLTGGIPEEFGNMGQL 313
P L L+ L L L N+LE P + + NL L L N ++ ++ +L
Sbjct: 280 ISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISD--ISPVSSLTKL 333
Query: 314 VFLVLSNNNISGSIPRRICTNATSLEHLILAEIQLSGEIPVELSQCQSLKQLDLSNNTLN 373
L NN +S N T++ L Q+S P L+ + QL L++
Sbjct: 334 QRLFFYNNKVSDVSS---LANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWT 388
Query: 374 GTIPVELFQLVALTHLYLHNNSLVGSISPFVANLSNLQELALYHNNFQGSLPREIGMLVK 433
PV V++ + + + + + ++ + E + N +
Sbjct: 389 -NAPVNYKANVSIPNTVKNVTGALIAPATI-SDGGSYTEPDITWNLPS-YTNEVSYTFSQ 445
Query: 434 LELLYLYDNHLSGQIP 449
+ SG +
Sbjct: 446 PVTIGKGTTTFSGTVT 461
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 8e-08
Identities = 18/115 (15%), Positives = 38/115 (33%), Gaps = 11/115 (9%)
Query: 716 GNLASLNVLTLSGNLLSGPIPPAIGRLSKLYELRLSNNSLNGVIPLEIGQLQNLQSILDL 775
G L S + ++ L++ + L ++ + L + + L
Sbjct: 1 GPLGSATIT--QDTPINQIFT--DTALAEKMKTVLGKTNVTDTVSQT--DLDQVTT-LQA 53
Query: 776 SHNNFTGQIPPSMGTLAKLEVLNLSHNQLVGELPSQLGEMSSLGKLNLSYNDLQG 830
+ L L +N S+NQL P L ++ L + ++ N +
Sbjct: 54 DRLGIK--SIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIAD 104
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 208 bits (530), Expect = 7e-60
Identities = 65/326 (19%), Positives = 121/326 (37%), Gaps = 51/326 (15%)
Query: 935 DFRWEDIMGATNNLSDEFIIGSGGSGTVYKAELANGATVAVKKISCKDDHLLNKSFTREV 994
+ + +NL +IG G G VYK L + VAVK S + ++F E
Sbjct: 2 EAAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANR----QNFINEK 56
Query: 995 K--TLGRIRHRHLVKLMGHCCNKGAGSN----LLIYEYMENGSVWDWLHKQPVNIKMRKS 1048
+ + H ++ + + + LL+ EY NGS+ +L +
Sbjct: 57 NIYRVPLMEHDNIARFIV-GDERVTADGRMEYLLVMEYYPNGSLXKYLSLH--------T 107
Query: 1049 LDWEARLKIAVGLAQGVEYLHHD------CVPKILHRDIKSSNILLDSNMEAHLGDFGLA 1102
DW + ++A + +G+ YLH + P I HRD+ S N+L+ ++ + DFGL+
Sbjct: 108 SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLS 167
Query: 1103 KALVEDY----NSNTESNTWFAGSYGYIAPEYAYSL-------KATEKCDVYSMGIVLME 1151
L + + G+ Y+APE A ++ D+Y++G++ E
Sbjct: 168 MRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWE 227
Query: 1152 LVSGKMPTDATFGVE------MDMVRWVEMHMEMSGSAREELLDDQMKPLLP----GEEC 1201
+ V V +M + + ++ +P P
Sbjct: 228 IFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDM----QVLVSREKQRPKFPEAWKENSL 283
Query: 1202 AAYQVLEIALQCTKTSPQERPSSRQV 1227
A + E C + R +++
Sbjct: 284 AVRSLKETIEDCWDQDAEARLTAQXA 309
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 214 bits (548), Expect = 1e-59
Identities = 118/554 (21%), Positives = 194/554 (35%), Gaps = 54/554 (9%)
Query: 245 NLGNNSLSGEIPSELGELSQLGYLNLMGNRLEGAIPRSFAKMGNLQSLDLSMNRLTGGIP 304
+ +IP L L+L N L SF LQ LDLS +
Sbjct: 13 QCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIED 69
Query: 305 EEFGNMGQLVFLVLSNNNISGSIPRRICTNATSLEHLILAEIQLSGEIPVELSQCQSLKQ 364
+ ++ L L+L+ N I S+ + +SL+ L+ E L+ + ++LK+
Sbjct: 70 GAYQSLSHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKE 128
Query: 365 LDLSNNTLNGTIPVELFQ-LVALTHLYLHNNSLVGSISPFVANLSNLQELALY---HNNF 420
L++++N + E F L L HL L +N + + L + L L N
Sbjct: 129 LNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNP 188
Query: 421 QGSLPREIGMLVKLELLYLYDNHLSGQIPSEV-GNCSSLKWIDFFGNSFTGEI------P 473
+ ++L L L +N S + + L+ F E
Sbjct: 189 MNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDK 248
Query: 474 TSIGRLKDLNFLHLRQNEL---VGQIPASLGNCHQLIILDLADNKLSGGVPASFGFLQAL 530
+++ L +L R L + I + L + S+
Sbjct: 249 SALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSY--NFGW 306
Query: 531 EQLMLYNNSLEGNLPGSLINLRNLTRINFSKNRLNGRIATLCSSHSFLSFDVTNNEFDHE 590
+ L L N P + L++L R+ F+ N+ ++ S +
Sbjct: 307 QHLELVNCKFG-QFPT--LKLKSLKRLTFTSNKGG-------NAFSEVDL---------- 346
Query: 591 IPPQLGNSPSLERLRLGNNK--FIGKIPWTFGKIRELSLLDLSGNSLTGPIPTQLLMCKK 648
PSLE L L N F G + L LDLS N + + + L ++
Sbjct: 347 --------PSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQ 397
Query: 649 LSHIDLNNNLLSGAVP-SWLGTLPQLGELKLSFNQFVGFLPRELFNCSKLLVLSLDGNML 707
L H+D ++ L S +L L L +S S L VL + GN
Sbjct: 398 LEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSF 457
Query: 708 NGSLPNEV-GNLASLNVLTLSGNLLSGPIPPAIGRLSKLYELRLSNNSLNGVIPLEIGQL 766
+ ++ L +L L LS L P A LS L L +++N L V +L
Sbjct: 458 QENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRL 517
Query: 767 QNLQSILDLSHNNF 780
+LQ + L N +
Sbjct: 518 TSLQ-KIWLHTNPW 530
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 211 bits (540), Expect = 1e-58
Identities = 99/535 (18%), Positives = 180/535 (33%), Gaps = 52/535 (9%)
Query: 96 SLIHLDLSSNSLTGPIPTALSNLSSLESLLLFSNQLAGTIPTQLGSLTSLRVMRIGDNWL 155
S +LDLS N L + + L+ L L ++ SL+ L + + N +
Sbjct: 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPI 88
Query: 156 SGSIPTSFGNLVNLGTLGLASCSLSGPIPPQFGQLSQLEELILQQNQLQ-GPIPAELGNC 214
+F L +L L +L+ G L L+EL + N +Q +P N
Sbjct: 89 QSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNL 148
Query: 215 SSLSIFTAAENNLNGSIPAALGRLQNLQL----LNLGNNSLSGEIPSELGELSQLGYLNL 270
++L + N + L L + L L+L N ++ I + +L L L
Sbjct: 149 TNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLHKLTL 207
Query: 271 MGNRLEGAIPR-SFAKMGNLQSLDL------SMNRLTGGIPEEFGNMGQLVF--LVLSNN 321
N + + + L+ L + L + L L+
Sbjct: 208 RNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYL 267
Query: 322 NISGSIPRRICTNATSLEHLILAEIQLSGEIPVELSQCQSLKQLDLSNNTLNGTIPVELF 381
+ + T++ L + + + + S + L+L N
Sbjct: 268 DYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVK-DFSYNFGWQHLELVNCKFGQ---FPTL 322
Query: 382 QLVALTHLYLHNNSLVGSISPFVANLSNLQELALYHN--NFQGSLPREIGMLVKLELLYL 439
+L +L L +N G+ V +L +L+ L L N +F+G + L+ L L
Sbjct: 323 KLKSLKRLTFTSNKG-GNAFSEV-DLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDL 380
Query: 440 YDNHLSGQIPSEVGNCSSLKWIDFFGNSFTGEIPTSI-GRLKDLNFLHLRQNELVGQIPA 498
N + + S L+ +DF ++ S+ L++L +L +
Sbjct: 381 SFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNG 439
Query: 499 SLGNCHQLIILDLADNKLSGGVPA-SFGFLQALEQLMLYNNSLEGNLPGSLINLRNLTRI 557
L +L +A N F L+ L L L LE P + +L +L +
Sbjct: 440 IFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVL 499
Query: 558 NFSKNRLNGRIATLCSSHSFLSFDVTNNEFDHEIPPQ-LGNSPSLERLRLGNNKF 611
N + N+L +P SL+++ L N +
Sbjct: 500 NMASNQL------------------------KSVPDGIFDRLTSLQKIWLHTNPW 530
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 211 bits (540), Expect = 1e-58
Identities = 108/543 (19%), Positives = 194/543 (35%), Gaps = 60/543 (11%)
Query: 225 NNLNGSIPAALGRLQNLQLLNLGNNSLSGEIPSELGELSQLGYLNLMGNRLEGAIPRSFA 284
N L + LQ+L+L + LS L L L GN ++ +F+
Sbjct: 38 NPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFS 97
Query: 285 KMGNLQSLDLSMNRLTGGIPEEFGNMGQLVFLVLSNNNISGSIPRRICTNATSLEHLILA 344
+ +LQ L L G++ L L +++N I +N T+LEHL L+
Sbjct: 98 GLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLS 157
Query: 345 EIQLSGEIPVELSQCQSLK----QLDLSNNTLNGTIPVELFQLVALTHLYLHNNSLVGSI 400
++ +L + LDLS N +N I F+ + L L L NN ++
Sbjct: 158 SNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLHKLTLRNNFDSLNV 216
Query: 401 SP-FVANLSNLQELALYHNNFQGS---LPREIGMLVKLELLYLYDNHLSGQIPSEVGNCS 456
+ L+ L+ L F+ + L L L + + L+
Sbjct: 217 MKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLA----------- 265
Query: 457 SLKWIDFFGNSFTGEIPTSIGRLKDLNFLHLRQNELVGQIPASLGNCHQLIILDLADNKL 516
+ + + +I L +++ L + ++ N L+L + K
Sbjct: 266 -------YLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYN-FGWQHLELVNCKF 316
Query: 517 SGGVPASFGFLQALEQLMLYNNSLEGNLPGSLINLRNLTRINFSKNRLNGRIATLCSSHS 576
L++L++L +N S ++L +L ++ S+N L+
Sbjct: 317 GQ---FPTLKLKSLKRLTFTSNKGGN--AFSEVDLPSLEFLDLSRNGLS----------- 360
Query: 577 FLSFDVTNNEFDHEIPPQLGNSPSLERLRLGNNKFIGKIPWTFGKIRELSLLDLSGNSLT 636
F + SL+ L L N + + F + +L LD ++L
Sbjct: 361 ----------FKGCCSQSDFGTTSLKYLDLSFNG-VITMSSNFLGLEQLEHLDFQHSNLK 409
Query: 637 G-PIPTQLLMCKKLSHIDLNNNLLSGAVPSWLGTLPQLGELKLSFNQFVGFLPRELF-NC 694
+ L + L ++D+++ A L L LK++ N F ++F
Sbjct: 410 QMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTEL 469
Query: 695 SKLLVLSLDGNMLNGSLPNEV-GNLASLNVLTLSGNLLSGPIPPAIGRLSKLYELRLSNN 753
L L L L L +L+SL VL ++ N L RL+ L ++ L N
Sbjct: 470 RNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTN 528
Query: 754 SLN 756
+
Sbjct: 529 PWD 531
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 211 bits (538), Expect = 2e-58
Identities = 110/526 (20%), Positives = 179/526 (34%), Gaps = 33/526 (6%)
Query: 73 VVSLNLSGLSLAGSISPSLGRLQSLIHLDLSSNSLTGPIPTALSNLSSLESLLLFSNQLA 132
+L+LS L S S L LDLS + A +LS L +L+L N +
Sbjct: 30 TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ 89
Query: 133 GTIPTQLGSLTSLRVMRIGDNWLSGSIPTSFGNLVNLGTLGLASCSL-SGPIPPQFGQLS 191
L+SL+ + + L+ G+L L L +A + S +P F L+
Sbjct: 90 SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLT 149
Query: 192 QLEELILQQNQLQGPIPAELGNCSSLSIFTA----AENNLNGSIPAALGRLQNLQLLNLG 247
LE L L N++Q +L + + + N +N I + L L L
Sbjct: 150 NLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLHKLTLR 208
Query: 248 NNSLSGEIPSE-LGELSQLGYLNLMGNRLEGA---IPRSFAKMGNLQSLDLSMNRLTG-- 301
NN S + + L+ L L+ + + L +L + RL
Sbjct: 209 NNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLD 268
Query: 302 ----GIPEEFGNMGQLVFLVLSNNNISGSIPRRICTNATSLEHLILAEIQLSGEIPVELS 357
I + F + + L + I LE + Q
Sbjct: 269 YYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPT------L 322
Query: 358 QCQSLKQLDLSNNTLNGTIPVELFQLVALTHLYLHNNSL--VGSISPFVANLSNLQELAL 415
+ +SLK+L ++N L +L L L N L G S ++L+ L L
Sbjct: 323 KLKSLKRLTFTSNKGGNAFS--EVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDL 380
Query: 416 YHNNFQGSLPREIGMLVKLELLYLYDNHLSGQIPSEV-GNCSSLKWIDFFGNSFTGEIPT 474
N ++ L +LE L ++L V + +L ++D
Sbjct: 381 SFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNG 439
Query: 475 SIGRLKDLNFLHLRQNELVGQIPA-SLGNCHQLIILDLADNKLSGGVPASFGFLQALEQL 533
L L L + N L LDL+ +L P +F L +L+ L
Sbjct: 440 IFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVL 499
Query: 534 MLYNNSLEGNLPGSLINLRNLTRINFSKNRLNGRIATLCSSHSFLS 579
+ +N L+ G L +L +I N + C +LS
Sbjct: 500 NMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDC----SCPRIDYLS 541
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 202 bits (516), Expect = 2e-55
Identities = 113/548 (20%), Positives = 178/548 (32%), Gaps = 56/548 (10%)
Query: 318 LSNNNISGSIPRRICTNATSLEHLILAEIQLSGEIPVELSQCQSLKQLDLSNNTLNGTIP 377
N IP + S ++L L+ L L+ LDLS + TI
Sbjct: 14 CMELNFY-KIPDNL---PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIE 68
Query: 378 VELFQ-LVALTHLYLHNNSLVGSISPFVANLSNLQELALYHNNFQGSLPREIGMLVKLEL 436
+Q L L+ L L N + + LS+LQ+L N IG L L+
Sbjct: 69 DGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKE 128
Query: 437 LYLYDNHL-SGQIPSEVGNCSSLKWIDFFGNSFTGEIPTSIGRLKDLNF----LHLRQNE 491
L + N + S ++P N ++L+ +D N T + L + L L N
Sbjct: 129 LNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNP 188
Query: 492 LVGQIPASLGNCHQLIILDLADNKLSGGVPA-SFGFLQALEQLMLYNNSLEGNLPGSLIN 550
+ I +L L L +N S V L LE L +
Sbjct: 189 M-NFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFD 247
Query: 551 ---LRNLTRINFSKNRLNGRIATLCSSHSFLSFDVTNNEFDHEIPPQLGNSPSLERLRLG 607
L L + + RL + + +I ++ L
Sbjct: 248 KSALEGLCNLTIEEFRLAY-----------------LDYYLDDIIDLFNCLTNVSSFSLV 290
Query: 608 NNKFIGKIPWTF-GKIRELSLLDLSGNSLTGPIPTQLLMCKKLSHIDLNNNLLSGAVPSW 666
+ +++ + L L++ L K L + +N A
Sbjct: 291 SVTIERVKDFSYNFGWQHLELVNCKFGQFPT------LKLKSLKRLTFTSNKGGNAFS-- 342
Query: 667 LGTLPQLGELKLSFNQ--FVGFLPRELFNCSKLLVLSLDGNMLNGSLPNEVGNLASLNVL 724
LP L L LS N F G + F + L L L N + ++ + L L L
Sbjct: 343 EVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHL 401
Query: 725 TLSGNLLSGPIPP-AIGRLSKLYELRLSNNSLNGVIPLEIGQLQNLQSILDLSHNNFTGQ 783
+ L L L L +S+ L +L+ +L ++ N+F
Sbjct: 402 DFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLE-VLKMAGNSFQEN 460
Query: 784 IPPSM-GTLAKLEVLNLSHNQLVGELPSQLGEMSSLGKLNLSYNDLQGKLSKQFSHWPAE 842
P + L L L+LS QL P+ +SSL LN++ N Q P
Sbjct: 461 FLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASN--------QLKSVPDG 512
Query: 843 AFEGNLHL 850
F+ L
Sbjct: 513 IFDRLTSL 520
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 5e-44
Identities = 99/497 (19%), Positives = 157/497 (31%), Gaps = 49/497 (9%)
Query: 366 DLSNNTLNGTIPVELFQLVALTHLYLHNNSLVGSISPFVANLSNLQELALYHNNFQGSLP 425
IP L + +L L N L S + LQ L L Q
Sbjct: 13 QCMELNFY-KIPDNLPF--STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIED 69
Query: 426 REIGMLVKLELLYLYDNHLSGQIPSEVGNCSSLKWIDFFGNSFTGEIPTSIGRLKDLNFL 485
L L L L N + SSL+ + + IG LK L L
Sbjct: 70 GAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKEL 129
Query: 486 HLRQNEL-VGQIPASLGNCHQLIILDLADNKLSGGVPASFGFLQALE----QLMLYNNSL 540
++ N + ++P N L LDL+ NK+ L + L L N +
Sbjct: 130 NVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPM 189
Query: 541 EGNLPGSLINLRNLTRINFSKNRLNGRIATLCSSHSFLSFDVTNNEFDHEIPPQLGNSPS 600
PG+ + L ++ N + + C + E + + N +
Sbjct: 190 NFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQ------GLAGLEVHRLVLGEFRNEGN 242
Query: 601 LERLRLGNNKFIGKIPWTFGKIRELSLLDLSGNSLTG---PIPTQLLMCKKLSHIDLNNN 657
LE+ + L++ + L I +S L +
Sbjct: 243 LEKFDKS----------ALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSV 292
Query: 658 LLSGAVP-SWLGTLPQLGELKLSFNQFVGFLPRELFNCSKLLVLSLDGNMLNGSLPNEVG 716
+ S+ L + F QF L L+ N + +EV
Sbjct: 293 TIERVKDFSYNFGWQHLELVNCKFGQF------PTLKLKSLKRLTFTSNKGG-NAFSEV- 344
Query: 717 NLASLNVLTLSGNLLS--GPIPPAIGRLSKLYELRLSNNSLNGVIPLEIGQLQNLQSILD 774
+L SL L LS N LS G + + L L LS N + + L+ L+ LD
Sbjct: 345 DLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLE-HLD 402
Query: 775 LSHNNFTGQIPPSM-GTLAKLEVLNLSHNQLVGELPSQLGEMSSLGKLNLSYNDLQGKLS 833
H+N S+ +L L L++SH +SSL L ++ N Q
Sbjct: 403 FQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQ---- 458
Query: 834 KQFSHWPAEAFEGNLHL 850
++ + F +L
Sbjct: 459 ---ENFLPDIFTELRNL 472
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-26
Identities = 61/262 (23%), Positives = 102/262 (38%), Gaps = 12/262 (4%)
Query: 72 RVVSLNLSGLSLAGSISPSLGRLQSLIHLDLSSNSLTGPIPTALSNLSSLESLLLFSNQL 131
V S +L +++ HL+L + PT L SL+ L SN+
Sbjct: 283 NVSSFSLVSVTI--ERVKDFSYNFGWQHLELVNCKFGQ-FPT--LKLKSLKRLTFTSNKG 337
Query: 132 AGTIPTQLGSLTSLRVMRIGDNWLS--GSIPTSFGNLVNLGTLGLASCSLSGPIPPQFGQ 189
G +++ L SL + + N LS G S +L L L+ + + F
Sbjct: 338 -GNAFSEVD-LPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLG 394
Query: 190 LSQLEELILQQNQLQGPIPAE-LGNCSSLSIFTAAENNLNGSIPAALGRLQNLQLLNLGN 248
L QLE L Q + L+ + +L + + + L +L++L +
Sbjct: 395 LEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAG 454
Query: 249 NSLSGEIPSE-LGELSQLGYLNLMGNRLEGAIPRSFAKMGNLQSLDLSMNRLTGGIPEEF 307
NS + EL L +L+L +LE P +F + +LQ L+++ N+L F
Sbjct: 455 NSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIF 514
Query: 308 GNMGQLVFLVLSNNNISGSIPR 329
+ L + L N S PR
Sbjct: 515 DRLTSLQKIWLHTNPWDCSCPR 536
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 204 bits (521), Expect = 3e-59
Identities = 55/292 (18%), Positives = 115/292 (39%), Gaps = 42/292 (14%)
Query: 946 NNLSDEFIIGSGGSGTVYKAELANGATVAVKKISCKDDH-LLNKSFTREVKTLGRIRHRH 1004
L+ + SG ++K G + VK + +D ++ F E L H +
Sbjct: 10 KQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPN 68
Query: 1005 LVKLMGHCCNKGAGSNL-LIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQ 1063
++ ++G C + LI +M GS+++ LH+ +D +K A+ +A+
Sbjct: 69 VLPVLG-ACQSPPAPHPTLITHWMPYGSLYNVLHEGT-----NFVVDQSQAVKFALDMAR 122
Query: 1064 GVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSY 1123
G+ +LH P I + S ++++D +M A + + + + +
Sbjct: 123 GMAFLHT-LEPLIPRHALNSRSVMIDEDMTARISMADVKF---------SFQSPGRMYAP 172
Query: 1124 GYIAPE---YAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMH-MEM 1179
++APE D++S ++L ELV+ ++P + ++ ME+
Sbjct: 173 AWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVP-------------FADLSNMEI 219
Query: 1180 SGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLL 1231
E ++P +P + V ++ C P +RP + +L
Sbjct: 220 GMKVALE----GLRPTIP-PGISP-HVSKLMKICMNEDPAKRPKFDMIVPIL 265
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 204 bits (520), Expect = 4e-59
Identities = 71/293 (24%), Positives = 133/293 (45%), Gaps = 48/293 (16%)
Query: 953 IIGSGGSGTVYKAE-LANGATVAVKKISCKDDH------LLNKSFTREVKTLGRIRHRHL 1005
IG GG G V+K + + + VA+K + D + F REV + + H ++
Sbjct: 26 QIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNI 85
Query: 1006 VKLMGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGV 1065
VKL G N ++ E++ G ++ L + + W +L++ + +A G+
Sbjct: 86 VKLYGLMHNP----PRMVMEFVPCGDLYHRLLDKA------HPIKWSVKLRLMLDIALGI 135
Query: 1066 EYLHHDCVPKILHRDIKSSNILLDS-----NMEAHLGDFGLAKALVEDYNSNTESNTWFA 1120
EY+ + P I+HRD++S NI L S + A + DFGL++ V +
Sbjct: 136 EYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVSGLL------- 187
Query: 1121 GSYGYIAPE--YAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHME 1178
G++ ++APE A TEK D YS ++L +++G+ P D ++++ M
Sbjct: 188 GNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD---EYSYGKIKFINM--- 241
Query: 1179 MSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLL 1231
+ ++ ++P +P E+C ++ + C P++RP + L
Sbjct: 242 --------IREEGLRPTIP-EDCPP-RLRNVIELCWSGDPKKRPHFSYIVKEL 284
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 205 bits (524), Expect = 6e-59
Identities = 76/299 (25%), Positives = 125/299 (41%), Gaps = 36/299 (12%)
Query: 953 IIGSGGSGTVYKAELANGATVAVKKISCKDDHLLNKSFTREVK--TLGRIRHRHLVKLMG 1010
IG G G V+ + G VAVK ++ S+ RE + +RH +++ +
Sbjct: 44 QIGKGRYGEVWMGKW-RGEKVAVKVFFTTEE----ASWFRETEIYQTVLMRHENILGFIA 98
Query: 1011 HCCNKGAGSN---LLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEY 1067
KG GS LI +Y ENGS++D+L +LD ++ LK+A G+ +
Sbjct: 99 -ADIKGTGSWTQLYLITDYHENGSLYDYLK--------STTLDAKSMLKLAYSSVSGLCH 149
Query: 1068 LH-----HDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGS 1122
LH P I HRD+KS NIL+ N + D GLA + D N G+
Sbjct: 150 LHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGT 209
Query: 1123 YGYIAPE------YAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMH 1176
Y+ PE ++ D+YS G++L E+ + ++ V
Sbjct: 210 KRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSD 269
Query: 1177 MEMSGSAREELLDDQMKPLLP----GEECAAYQVLEIALQCTKTSPQERPSSRQVCDLL 1231
RE + +++P P +EC Q+ ++ +C +P R ++ +V L
Sbjct: 270 PSY-EDMREIVCIKKLRPSFPNRWSSDECLR-QMGKLMTECWAHNPASRLTALRVKKTL 326
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 201 bits (514), Expect = 2e-58
Identities = 78/298 (26%), Positives = 133/298 (44%), Gaps = 48/298 (16%)
Query: 946 NNLSDEFIIGSGGSGTVYKAELANGATVAVKKISCKDDHLLN---KSFTREVKTLGRIRH 1002
L+ E IIG GG G VY+A G VAVK D ++ ++ +E K ++H
Sbjct: 7 AELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKH 65
Query: 1003 RHLVKLMGHCCNKGAGSNL-LIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGL 1061
+++ L G C + NL L+ E+ G + L K + + + AV +
Sbjct: 66 PNIIALRGVCLKE---PNLCLVMEFARGGPLNRVLSG--------KRIPPDILVNWAVQI 114
Query: 1062 AQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAH--------LGDFGLAKALVEDYNSNT 1113
A+G+ YLH + + I+HRD+KSSNIL+ +E + DFGLA+ T
Sbjct: 115 ARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREW-----HRT 169
Query: 1114 ESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWV 1173
+ AG+Y ++APE + ++ DV+S G++L EL++G++P +
Sbjct: 170 TKMS-AAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVP-------------FR 215
Query: 1174 EMHMEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLL 1231
+ + + +++ +P C ++ C P RPS + D L
Sbjct: 216 GID---GLAVAYGVAMNKLALPIP-STCPE-PFAKLMEDCWNPDPHSRPSFTNILDQL 268
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 200 bits (512), Expect = 6e-58
Identities = 77/285 (27%), Positives = 127/285 (44%), Gaps = 40/285 (14%)
Query: 954 IGSGGSGTVYKAELANGATVAVKKISCKDDH-LLNKSFTREVKTLGRIRHRHLVKLMGHC 1012
IGSG GTVYK + +G VAVK ++ ++F EV L + RH +++ MG
Sbjct: 32 IGSGSFGTVYKGKW-HG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG-Y 88
Query: 1013 CNKGAGSNL-LIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHD 1071
L ++ ++ E S++ LH + + + IA A+G++YLH
Sbjct: 89 STAP---QLAIVTQWCEGSSLYHHLHAS------ETKFEMKKLIDIARQTARGMDYLHA- 138
Query: 1072 CVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPE-- 1129
I+HRD+KS+NI L + +GDFGLA + S + +GS ++APE
Sbjct: 139 --KSIIHRDLKSNNIFLHEDNTVKIGDFGLAT--EKSRWSGSHQFEQLSGSILWMAPEVI 194
Query: 1130 -YAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSAREELL 1188
S + + DVY+ GIVL EL++G++P ++ E +
Sbjct: 195 RMQDSNPYSFQSDVYAFGIVLYELMTGQLPYS---------------NINNRDQIIEMVG 239
Query: 1189 DDQMKPLLPG--EECAAYQVLEIALQCTKTSPQERPSSRQVCDLL 1231
+ P L C ++ + +C K ERPS ++ +
Sbjct: 240 RGSLSPDLSKVRSNCPK-RMKRLMAECLKKKRDERPSFPRILAEI 283
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 201 bits (513), Expect = 1e-57
Identities = 70/291 (24%), Positives = 120/291 (41%), Gaps = 45/291 (15%)
Query: 953 IIGSGGSGTVYKAELANGATVAVKKISCKDDH-LLNKSFTREVKTLGRIRHRHLVKLMGH 1011
+IG G G VY +G VA++ I + D+ K+F REV + RH ++V MG
Sbjct: 40 LIGKGRFGQVYHGRW-HG-EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGA 97
Query: 1012 CCNKGAGSNL-LIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHH 1070
C + +L +I + +++ + + LD +IA + +G+ YLH
Sbjct: 98 CMSPP---HLAIITSLCKGRTLYSVVRDA------KIVLDVNKTRQIAQEIVKGMGYLHA 148
Query: 1071 DCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKAL-VEDYNSNTESNTWFAGSYGYIAPE 1129
ILH+D+KS N+ D N + + DFGL V + G ++APE
Sbjct: 149 ---KGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPE 204
Query: 1130 ---------YAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMS 1180
L ++ DV+++G + EL + + P + + W
Sbjct: 205 IIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFK---TQPAEAIIWQ------- 254
Query: 1181 GSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLL 1231
+ MKP L ++ +I L C +ERP+ ++ D+L
Sbjct: 255 -------MGTGMKPNLSQIGMGK-EISDILLFCWAFEQEERPTFTKLMDML 297
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 200 bits (509), Expect = 5e-57
Identities = 71/300 (23%), Positives = 134/300 (44%), Gaps = 38/300 (12%)
Query: 953 IIGSGGSGTVYKAELANGATVAVKKISCKDDHLLNKSFTRE--VKTLGRIRHRHLVKLMG 1010
IG G G V++ + G VAVK S +++ +S+ RE + +RH +++ +
Sbjct: 49 SIGKGRFGEVWRGKW-RGEEVAVKIFSSREE----RSWFREAEIYQTVMLRHENILGFIA 103
Query: 1011 HCCNKGAGSN--LLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYL 1068
L+ +Y E+GS++D+L+ R ++ E +K+A+ A G+ +L
Sbjct: 104 ADNKDNGTWTQLWLVSDYHEHGSLFDYLN--------RYTVTVEGMIKLALSTASGLAHL 155
Query: 1069 HHDCV-----PKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSY 1123
H + V P I HRD+KS NIL+ N + D GLA ++ + G+
Sbjct: 156 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 215
Query: 1124 GYIAPE------YAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEM---DMVRWVE 1174
Y+APE ++ ++ D+Y+MG+V E+ ++ D+V
Sbjct: 216 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 275
Query: 1175 MHMEMSGSAREELLDDQMKPLLPG--EECAAYQVL-EIALQCTKTSPQERPSSRQVCDLL 1231
EM + +++P +P + C A +V+ +I +C + R ++ ++ L
Sbjct: 276 SVEEMRKVV----CEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTL 331
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 197 bits (504), Expect = 1e-56
Identities = 69/313 (22%), Positives = 116/313 (37%), Gaps = 51/313 (16%)
Query: 932 AKRDFRWEDI-MGATNNLSDEFIIGSGGSGTVYKAEL-ANGATVAVKKISCKDDHLLNKS 989
R FR D+ G ++G G G K G + +K++ D+ ++
Sbjct: 3 PHRIFRPSDLIHGE--------VLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQ-RT 53
Query: 990 FTREVKTLGRIRHRHLVKLMGHCCNKGAGSNL-LIYEYMENGSVWDWLHKQPVNIKMRKS 1048
F +EVK + + H +++K +G L I EY++ G++ +
Sbjct: 54 FLKEVKVMRCLEHPNVLKFIGVLYKDK---RLNFITEYIKGGTLRGIIKSM------DSQ 104
Query: 1049 LDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVED 1108
W R+ A +A G+ YLH I+HRD+ S N L+ N + DFGLA+ +V++
Sbjct: 105 YPWSQRVSFAKDIASGMAYLHS---MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDE 161
Query: 1109 YNSNTESN----------TWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMP 1158
G+ ++APE EK DV+S GIVL E++
Sbjct: 162 KTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNA 221
Query: 1159 TDATFGVEMDMVRWVEMHMEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSP 1218
+ + P C I ++C P
Sbjct: 222 DP---------------DYLPRTMDFGLNVRGFLDRYCP-PNCPP-SFFPITVRCCDLDP 264
Query: 1219 QERPSSRQVCDLL 1231
++RPS ++ L
Sbjct: 265 EKRPSFVKLEHWL 277
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 204 bits (521), Expect = 2e-56
Identities = 99/547 (18%), Positives = 189/547 (34%), Gaps = 42/547 (7%)
Query: 213 NCSSLSIFTAAENNLNGSIPAALGRLQNLQLLNLGNNSLSGEIPSELGELSQLGYLNLMG 272
+C + + + SIP+ L ++ L+L N ++ +L + L L L
Sbjct: 3 SCDASGVCDGRSRSFT-SIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKS 59
Query: 273 NRLEGAIPRSFAKMGNLQSLDLSMNRLTGGIPEEFGNMGQLVFLVLSNNNISGSIPRRIC 332
+R+ +F +G+L+ LDLS N L+ FG + L +L L N +
Sbjct: 60 SRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLF 119
Query: 333 TNATSLEHLILAEIQLSGEIPVE-LSQCQSLKQLDLSNNTLNGTIPVELFQLVALTHLYL 391
N T+L+ L + ++ EI + SL +L++ +L L + + HL L
Sbjct: 120 PNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTL 179
Query: 392 HNNSLVGSISPFVANLSNLQELALYHNNFQGSLPREIGMLVKLELLYLYDNHLSGQIPSE 451
H + + F LS+++ L L N + + + S
Sbjct: 180 HLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDES 239
Query: 452 VGNCSSLKWIDFFGNSFTGEIPTSIGRLKDLNFLHLRQNELVGQIPASLGNCHQLIILDL 511
L + +E + L +
Sbjct: 240 FNELLKLLRYILELSEV------EFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHI 293
Query: 512 ADNKLSGGVPASFGFLQALEQLMLYNNSLEGNLPGSLINLRNLTRINFSKNRLNGRIATL 571
L + + L+ ++++ + N+ + +L++L ++ S+N +
Sbjct: 294 PQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKN 353
Query: 572 CSSHSFLSFDVTNNEFDHEIPPQLGNSPSLERLRLGNNKF--IGKIPWTFGKIRELSLLD 629
+ G PSL+ L L N + K ++ L+ LD
Sbjct: 354 SAC--------------------KGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLD 393
Query: 630 LSGNSLTGPIPTQLLMCKKLSHIDLNNNLLSGAVPSWLGTLPQLGELKLSFNQFVGFLPR 689
+S N+ P+P +K+ ++L++ + V + L L +S N
Sbjct: 394 ISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKT--CIPQTLEVLDVSNNNL-DSFSL 448
Query: 690 ELFNCSKLLVLSLDGNMLNGSLPNEVGNLASLNVLTLSGNLLSGPIPPAIGRLSKLYELR 749
L L L + N L +LP+ L V+ +S N L RL+ L ++
Sbjct: 449 FLPR---LQELYISRNKLK-TLPDAS-LFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIW 503
Query: 750 LSNNSLN 756
L N +
Sbjct: 504 LHTNPWD 510
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 193 bits (492), Expect = 2e-52
Identities = 96/550 (17%), Positives = 183/550 (33%), Gaps = 51/550 (9%)
Query: 263 SQLGYLNLMGNRLEGAIPRSFAKMGNLQSLDLSMNRLTGGIPEEFGNMGQLVFLVLSNNN 322
G + +IP ++SLDLS N++T + L L+L ++
Sbjct: 5 DASGVCDGRSRSFT-SIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSR 61
Query: 323 ISGSIPRRICTNATSLEHLILAEIQLSGEIPVELSQCQSLKQLDLSNNTLNGTIPVELFQ 382
I+ +I + SLEHL L++ LS SLK L+L N LF
Sbjct: 62 IN-TIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFP 120
Query: 383 -LVALTHLYLHNNSLVGSISPFV-ANLSNLQELALYHNNFQGSLPREIGMLVKLELLYLY 440
L L L + N I A L++L EL + + + + + + + L L+
Sbjct: 121 NLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLH 180
Query: 441 DNHLSGQIPSEVGNCSSLKWIDFFGNSFTGEIPTSIGRLKDLNFLHLRQNELVGQIPASL 500
+ + + SS+++++ + + + + + +
Sbjct: 181 LSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAF---------- 230
Query: 501 GNCHQLIILDLADNKLSGGVPASFGFLQALEQLMLYNNSLEGNLPGSLINLRNLTRINFS 560
++ D + N+L ++ L ++ + +L G + ++ +
Sbjct: 231 ---RGSVLTDESFNEL----LKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKV 283
Query: 561 KNRLNGRIATLCSSHSFLSFDVTNNEFDHEIPPQLGNSPSLERLRLGNNKFIGKIPWTFG 620
+ + + +++ ++R+ + N+K
Sbjct: 284 ETV------------TIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQ 331
Query: 621 KIRELSLLDLSGNSLTGPIPTQ---LLMCKKLSHIDLNNNLLS--GAVPSWLGTLPQLGE 675
++ L LDLS N + L + L+ N L L TL L
Sbjct: 332 HLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTS 391
Query: 676 LKLSFNQFVGFLPRELFNCSKLLVLSLDGNMLNGSLPNEVGNLASLNVLTLSGNLLSGPI 735
L +S N F +P K+ L+L + + +L VL +S N L
Sbjct: 392 LDISRNTF-HPMPDSCQWPEKMRFLNLSSTGIR-VVKT--CIPQTLEVLDVSNNNLDS-F 446
Query: 736 PPAIGRLSKLYELRLSNNSLNGVIPLEIGQLQNLQSILDLSHNNFTGQIPPSMGTLAKLE 795
L +L EL +S N L + L ++ +S N L L+
Sbjct: 447 SL---FLPRLQELYISRNKLKTLPD--ASLFPVLL-VMKISRNQLKSVPDGIFDRLTSLQ 500
Query: 796 VLNLSHNQLV 805
+ L N
Sbjct: 501 KIWLHTNPWD 510
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 192 bits (489), Expect = 4e-52
Identities = 102/531 (19%), Positives = 185/531 (34%), Gaps = 45/531 (8%)
Query: 75 SLNLSGLSLAGSISPSLGRLQSLIHLDLSSNSLTGPIPTALSNLSSLESLLLFSNQLAGT 134
+ S SI L ++ LDLS N +T L ++L+ L+L S+++
Sbjct: 9 VCDGRSRSFT-SIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTI 65
Query: 135 IPTQLGSLTSLRVMRIGDNWLSGSIPTSFGNLVNLGTLGLASCSLSG-PIPPQFGQLSQL 193
SL SL + + DN LS + FG L +L L L + F L+ L
Sbjct: 66 EGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNL 125
Query: 194 EELILQQNQLQGPIPAE-LGNCSSLSIFTAAENNLNGSIPAALGRLQNLQLLNLGNNSLS 252
+ L + + I +SL+ +L +L ++++ L L + +
Sbjct: 126 QTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESA 185
Query: 253 GEIPSELGELSQLGYLNLMGNRLEGAIPRSFAKMGNLQSLDLSMNRLTGGIPEEFGNMGQ 312
+ LS + YL L L + R + E F + +
Sbjct: 186 FLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLK 245
Query: 313 LVFLVLS-----------------NNNISGSIPRRICTNATSLEHLILAEIQLSGEIPVE 355
L+ +L N + S + ++ L + + L ++
Sbjct: 246 LLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTV 305
Query: 356 LSQCQSLKQLDLSNNTLNGTIPVELFQ-LVALTHLYLHNNSLVGSI---SPFVANLSNLQ 411
S + +K++ + N+ + +P Q L +L L L N +V S +LQ
Sbjct: 306 YSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQ 364
Query: 412 ELALYHNNFQGSLPREIGM---LVKLELLYLYDNHLSGQIPSEVGNCSSLKWIDFFGNSF 468
L L N+ + S+ + + L L L + N +P +++++
Sbjct: 365 TLVLSQNHLR-SMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGI 422
Query: 469 TGEIPTSIGRLKDLNFLHLRQNELVGQIPASLGNCHQLIILDLADNKLSGGVPASFGFLQ 528
+ T I + L L + N L L +L L ++ NKL +P
Sbjct: 423 R-VVKTCI--PQTLEVLDVSNNNL-DSFSLFL---PRLQELYISRNKLK-TLP-DASLFP 473
Query: 529 ALEQLMLYNNSLEGNLPGSLINLRNLTRINFSKNRLNGRIATLCSSHSFLS 579
L + + N L+ G L +L +I N + C +LS
Sbjct: 474 VLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDC----SCPRIDYLS 520
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 183 bits (465), Expect = 6e-49
Identities = 103/519 (19%), Positives = 195/519 (37%), Gaps = 51/519 (9%)
Query: 318 LSNNNISGSIPRRICTNATSLEHLILAEIQLSGEIPVELSQCQSLKQLDLSNNTLNGTIP 377
+ + + SIP + ++ L L+ +++ +L C +L+ L L ++ +N TI
Sbjct: 12 GRSRSFT-SIPSGLTAA---MKSLDLSFNKITYIGHGDLRACANLQVLILKSSRIN-TIE 66
Query: 378 VELFQ-LVALTHLYLHNNSLVGSISPFV-ANLSNLQELALYHNNFQG-SLPREIGMLVKL 434
+ F L +L HL L +N L S+S LS+L+ L L N +Q + L L
Sbjct: 67 GDAFYSLGSLEHLDLSDNHLS-SLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNL 125
Query: 435 ELLYLYDNHLSGQIPSEV-GNCSSLKWIDFFGNSFTGEIPTSIGRLKDLNFLHLRQNELV 493
+ L + + +I +SL ++ S S+ ++D++ L L +E
Sbjct: 126 QTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESA 185
Query: 494 GQIPASLGNCHQLIILDLADNKLSGGVPASFGFLQALEQLMLYNNSLEGNLPGSLINLRN 553
+ + L+L D L+ + + + S L
Sbjct: 186 FLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLK 245
Query: 554 LTRINFSKNRLNGRIATLCSSHSFLSFDVTNNEFDHEIPPQLGNSPSLERLRLGNNKFIG 613
L R + + C+ + F+ + ++ E+ + ++ RL +
Sbjct: 246 LLRYILELSEVE---FDDCTLNGLGDFNPSESDVVSELG--KVETVTIRRLHIPQFYLFY 300
Query: 614 KIPWTFGKIRELSLLDLSGNSLTGPIPTQLLMCKKLSHIDLNNNLLSGAV---PSWLGTL 670
+ + + ++ + + + + + K L +DL+ NL+ + G
Sbjct: 301 DLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAW 360
Query: 671 PQLGELKLSFNQFVGFLPRELFNCSKLLVLSLDGNMLNGSLPNEVGNLASLNVLTLSGNL 730
P L L LS N L + G +L L +L L +S N
Sbjct: 361 PSLQTLVLSQNH--------------LRSMQKTGEILL--------TLKNLTSLDISRNT 398
Query: 731 LSGPIPPAIGRLSKLYELRLSNNSLNGVIPLEIGQLQNLQSILDLSHNNFTGQIPPSMGT 790
P+P + K+ L LS+ + V+ I Q L+ +LD+S+NN
Sbjct: 399 FH-PMPDSCQWPEKMRFLNLSSTGIR-VVKTCI--PQTLE-VLDVSNNNLD-SFSLF--- 449
Query: 791 LAKLEVLNLSHNQLVGELPSQLGEMSSLGKLNLSYNDLQ 829
L +L+ L +S N+L LP L + +S N L+
Sbjct: 450 LPRLQELYISRNKLK-TLPDASL-FPVLLVMKISRNQLK 486
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 7e-40
Identities = 93/479 (19%), Positives = 152/479 (31%), Gaps = 67/479 (13%)
Query: 359 CQSLKQLDLSNNTLNGTIPVELFQLVALTHLYLHNNSLVGSISPFVANLSNLQELALYHN 418
C + D + + +IP L A+ L L N + + +NLQ L L +
Sbjct: 4 CDASGVCDGRSRSFT-SIPSGLTA--AMKSLDLSFNKITYIGHGDLRACANLQVLILKSS 60
Query: 419 NFQGSLPREIGMLVKLELLYLYDNHLSGQIPSEV-GNCSSLKWIDFFGNSFTG-EIPTSI 476
L LE L L DNHLS + S G SSLK+++ GN + + +
Sbjct: 61 RINTIEGDAFYSLGSLEHLDLSDNHLS-SLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLF 119
Query: 477 GRLKDLNFLHLRQNELVGQIPA-SLGNCHQLIILDLADNKLSGGVPASFGFLQALEQLML 535
L +L L + E +I L L++ L S ++ + L L
Sbjct: 120 PNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTL 179
Query: 536 YNNSLEGNLPGSLINLRNLTRINFSKNRLNGRIATLCSSHSFLSFDVTNNEFDHEIPPQL 595
+ + L L ++ + L F P
Sbjct: 180 HLSESAFLLEIFADILSSVRYLELRDTNLA--------------------RFQFSPLPVD 219
Query: 596 GNSPSLERLRLGNNKFIGKIPWTFGKIRELSLLDLSGNSLTGPIPTQLLMCKKLSHIDLN 655
S +++L R L D S N L + +L ++ D
Sbjct: 220 EVSSPMKKLAF----------------RGSVLTDESFNELL-KLLRYILELSEVEFDDCT 262
Query: 656 NNLLSGAVPSWLGTLPQLGELKLSFNQFVGFLPRELFNCSKLLVLSLDGNMLNGSLPNEV 715
N L PS + +LG+++ + L + L L
Sbjct: 263 LNGLGDFNPSESDVVSELGKVETV----------------TIRRLHIPQFYLFYDLSTVY 306
Query: 716 GNLASLNVLTLSGNLLSGPIPPAIGRLSKLYELRLSNNSLNGVI---PLEIGQLQNLQSI 772
L + +T+ + + L L L LS N + G +LQ
Sbjct: 307 SLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQ-T 365
Query: 773 LDLSHNNFT--GQIPPSMGTLAKLEVLNLSHNQLVGELPSQLGEMSSLGKLNLSYNDLQ 829
L LS N+ + + TL L L++S N +P + LNLS ++
Sbjct: 366 LVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTF-HPMPDSCQWPEKMRFLNLSSTGIR 423
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-24
Identities = 51/348 (14%), Positives = 104/348 (29%), Gaps = 47/348 (13%)
Query: 502 NCHQLIILDLADNKLSGGVPASFGFLQALEQLMLYNNSLEGNLPGSLINLRNLTRINFSK 561
+C + D + +P+ G A++ L L N + G L NL +
Sbjct: 3 SCDASGVCDGRSRSFTS-IPS--GLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKS 59
Query: 562 NRLNGRIATLCSSHSFLSFDVTNNEFDHEIPPQ-LGNSPSLERLRLGNNKFIGKIPWTFG 620
+R+ + I + SLE L L +N FG
Sbjct: 60 SRI------------------------NTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFG 95
Query: 621 KIRELSLLDLSGNSLTG-PIPTQLLMCKKLSHIDL-NNNLLSGAVPSWLGTLPQLGELKL 678
+ L L+L GN + + L + + N S L L EL++
Sbjct: 96 PLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEI 155
Query: 679 SFNQFVGFLPRELFNCSKLLVLSLDGNMLNGSLPNEVGNLASLNVLTLSGNLLSGPIPPA 738
+ + L + + L+L + L L+S+ L L L+
Sbjct: 156 KALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSP 215
Query: 739 IGRLSKLYELRLSNNSLNGVIPLEIGQLQNLQ---------SILDLSHNNFTGQIPPSMG 789
+ ++ + + +L L D + N P
Sbjct: 216 LPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESD 275
Query: 790 TLAK--------LEVLNLSHNQLVGELPSQLGEMSSLGKLNLSYNDLQ 829
+++ + L++ L +L + + + ++ + + +
Sbjct: 276 VVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF 323
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 210 bits (535), Expect = 3e-56
Identities = 140/716 (19%), Positives = 237/716 (33%), Gaps = 111/716 (15%)
Query: 225 NNLNGSIPAALGRLQNLQLLNLGNNSLSGEIPSELGELSQLGYLNLMGNRLEGAI-PRSF 283
NL +P L + L L N + S L QL L L I +F
Sbjct: 14 CNLT-QVPQ---VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAF 69
Query: 284 AKMGNLQSLDLSMNRLTGGIPEEFGNMGQLVFLVLSNNNIS-GSIPRRICTNATSLEHLI 342
+ NL+ LDL +++ P+ F + L L L +S + N +L L
Sbjct: 70 RNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLD 129
Query: 343 LAEIQLSG-EIPVELSQCQSLKQLDLSNNTLNGTIPVELF---QLVALTHLYLHNNSLVG 398
L++ Q+ + + SLK +D S+N + + Q L+ L NSL
Sbjct: 130 LSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIF-LVCEHELEPLQGKTLSFFSLAANSLYS 188
Query: 399 SISPFVANLSN------LQELALYHNNF------------QGSLPREIGMLVKLELLYLY 440
+S N L+ L + N + S + + +
Sbjct: 189 RVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFG 248
Query: 441 DNHLSGQIPSEV---GNCSSLKWIDFFGNSFTGEIPTSIGRLKDLNFLHLRQNELVGQIP 497
+++ SS++ +D LKDL L+L N++
Sbjct: 249 FHNIK-DPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIAD 307
Query: 498 ASLGNCHQLIILDLADNKLSGGVPASFGFLQALEQLMLYNNSLEGNLPGSLINLRNLTRI 557
+ L +L+L+ N L ++F L + + L N + + L L +
Sbjct: 308 EAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTL 367
Query: 558 NFSKNRLNGRIATLCSSHSFLSFDVTNNEFDHEIPPQLGNSPSLERLRLGNNKFIGKIPW 617
+ N L + PS+ + L N
Sbjct: 368 DLRDNALT----------------------------TIHFIPSIPDIFLSGN-------- 391
Query: 618 TFGKIRELSLLDLSGNSLTGPIPTQLLMCKKLSHIDLNNNLLSGAVPSWLGTLPQLGELK 677
K+ L ++L+ N + LS L N + +L +P L L
Sbjct: 392 ---KLVTLPKINLTANLI------------HLSENRLENLDIL----YFLLRVPHLQILI 432
Query: 678 LSFNQFVGFLPRELF-NCSKLLVLSLDGNMLNGSLPNEV-----GNLASLNVLTLSGNLL 731
L+ N+F + L L L NML + E+ L+ L VL L+ N L
Sbjct: 433 LNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYL 492
Query: 732 SGPIPPAIGRLSKLYELRLSNNSLNGVIPLEIGQLQNLQSILDLSHNNFTGQIPPSMGTL 791
+ P L+ L L L++N L L L ILD+S N P+
Sbjct: 493 NSLPPGVFSHLTALRGLSLNSNRLTV---LSHNDLPANLEILDISRNQLLA---PNPDVF 546
Query: 792 AKLEVLNLSHNQLVGELPSQLGEMSSLGKLNLSYNDLQGKLSKQFSHWPAEAFEGNLHLC 851
L VL+++HN+ + E + + LN + + G + + +P
Sbjct: 547 VSLSVLDITHNKFICECELS----TFINWLNHTNVTIAGPPADIYCVYP-------DSFS 595
Query: 852 GSPLDHCNGLVSNQHQSTISVSLVVAISVISTLSAIALLIAVVTLFVKRKREFLRK 907
G L + ++ + S+ + I TL+ + I VT F +
Sbjct: 596 GVSLFSLSTEGCDEEEVLKSLKFSLFIVCTVTLTLFLMTILTVTKFRGFCFICYKT 651
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 206 bits (527), Expect = 3e-55
Identities = 127/624 (20%), Positives = 212/624 (33%), Gaps = 65/624 (10%)
Query: 94 LQSLIHLDLSSNSLTGPIPTALSNLSSLESLLLFSNQLAGTI-PTQLGSLTSLRVMRIGD 152
L + L LS N + ++ L L+ L L S TI +L +LR++ +G
Sbjct: 23 LNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGS 82
Query: 153 NWLSGSIPTSFGNLVNLGTLGLASCSLSGPIPPQ--FGQLSQLEELILQQNQLQG-PIPA 209
+ + P +F L +L L L C LS + F L L L L +NQ++ +
Sbjct: 83 SKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHP 142
Query: 210 ELGNCSSLSIFTAAENNLNGSIPAALGRLQ--NLQLLNLGNNSLSGEIPSELGELSQ--- 264
G +SL + N + L LQ L +L NSL + + G+
Sbjct: 143 SFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFR 202
Query: 265 ---LGYLNLMGNRLEGAIPRSFAK------------MGNLQSLDLSMNRLTGGIPEEFGN 309
L L++ GN I +F+ ++ + + F
Sbjct: 203 NMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAG 262
Query: 310 MGQ--LVFLVLSNNNISGSIPRRICTNATSLEHLILAEIQLSGEIPVELSQCQSLKQLDL 367
+ + + L LS+ + S+ R+ L+ L LA +++ +L+ L+L
Sbjct: 263 LARSSVRHLDLSHGFVF-SLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNL 321
Query: 368 SNNTLNGTIPVELFQ-LVALTHLYLHNNSLVGSISPFVANLSNLQELALYHNNFQGSLPR 426
S N L + F L + ++ L N + L LQ L L N
Sbjct: 322 SYNLLG-ELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALT----- 375
Query: 427 EIGMLVKLELLYLYDNHLSGQIPSEVGNCSSLKWIDFFGNSFTG-EIPTSIGRLKDLNFL 485
I + + ++L N L +P + I N +I + R+ L L
Sbjct: 376 TIHFIPSIPDIFLSGNKLV-TLPK---INLTANLIHLSENRLENLDILYFLLRVPHLQIL 431
Query: 486 HLRQNELVG-QIPASLGNCHQLIILDLADNKLSGGVPAS-----FGFLQALEQLMLYNNS 539
L QN + L L L +N L F L L+ L L +N
Sbjct: 432 ILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNY 491
Query: 540 LEGNLPGSLINLRNLTRINFSKNRLNGRIATLCSSHSFLSFDVTNNEFDHEIPPQLGNSP 599
L PG +L L ++ + NRL ++ + D++ N+ P
Sbjct: 492 LNSLPPGVFSHLTALRGLSLNSNRLT-VLSHNDLPANLEILDISRNQLLAPNPDVF---V 547
Query: 600 SLERLRLGNNKFI----------------GKIPWTFGKIRELSLLDLSGNSLTGPIPTQL 643
SL L + +NKFI I I + SG SL
Sbjct: 548 SLSVLDITHNKFICECELSTFINWLNHTNVTIAGPPADIYCVYPDSFSGVSLFSLSTEGC 607
Query: 644 LMCKKLSHIDLNNNLLSGAVPSWL 667
+ L + + ++ +
Sbjct: 608 DEEEVLKSLKFSLFIVCTVTLTLF 631
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 193 bits (493), Expect = 1e-53
Identities = 109/574 (18%), Positives = 190/574 (33%), Gaps = 123/574 (21%)
Query: 183 IPPQFGQLSQLEELILQQNQLQGPIPAELGNCSSLSIFTAAENNLNGSIPAALGRLQNLQ 242
I P+ + L+E + + L +P E N S + + A + + P G + +
Sbjct: 3 INPRNVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMA 61
Query: 243 LLNLGNNSLSGEIPSELGELSQLGYLNLMGNRLEGAIPRSFAKMGNLQSLDLSMNRLTGG 302
+ L + Q L L L ++P +L+SL S N LT
Sbjct: 62 VSRLRDCLDR-----------QAHELELNNLGLS-SLPEL---PPHLESLVASCNSLTE- 105
Query: 303 IPEEFGNMGQLVFLVLSNNNISGSIPRRICTNATSLEHLILAEIQLSGEIPVELSQCQSL 362
+PE ++ L+ + +S P LE+L ++ QL ++P EL L
Sbjct: 106 LPELPQSLKSLLVDNNNLKALSDLPP--------LLEYLGVSNNQLE-KLP-ELQNSSFL 155
Query: 363 KQLDLSNNTLNGTIPVELFQLVALTHLYLHNNSLVGSISPFVANLSNLQELALYHNNFQG 422
K +D+ NN+L +P L + NN L P + NL L + +N+ +
Sbjct: 156 KIIDVDNNSLK-KLPDLPPSL---EFIAAGNNQL--EELPELQNLPFLTAIYADNNSLK- 208
Query: 423 SLPREIGMLVKLELLYLYDNHLSGQIPSEVGNCSSLKWIDFFGNSFTGEIPTSIGRLKDL 482
LP LE + +N L E+ N L I N +P L+ L
Sbjct: 209 KLPDLPL---SLESIVAGNNILE--ELPELQNLPFLTTIYADNNLLK-TLPDLPPSLEAL 262
Query: 483 NFLHLRQNELVGQIPASLGNCHQLIILDLADNKLSGGVPASFGFLQALEQLMLYNNSLEG 542
N +L P + L + + + LS L L +N +
Sbjct: 263 NVRDNYLTDL----PELPQSLTFLDVSENIFSGLSE-------LPPNLYYLNASSNEIR- 310
Query: 543 NLPGSLINLRNLTRINFSKNRLNGRIATLCSSHSFLSFDVTNNEFDHEIPPQLGNSPSLE 602
+L +L L N S N+L E+P LE
Sbjct: 311 SLCDLPPSLEEL---NVSNNKLI------------------------ELPALPPR---LE 340
Query: 603 RLRLGNNKFIGKIPWTFGKIRELSLLDLSGNSLTGPIPTQLLMCKKLSHIDLNNNLLSGA 662
RL N + ++P +++L + N L P + + + +N++L
Sbjct: 341 RLIASFNH-LAEVPELPQNLKQL---HVEYNPLRE-FPDIP---ESVEDLRMNSHLAE-- 390
Query: 663 VPSWLGTLPQLGELKLSFNQFVGFLPRELFNCSKLLVLSLDGNMLNGSLPNEVGNLASLN 722
+P L L ++ N L P+ ++ L
Sbjct: 391 ------------------------VPEL---PQNLKQLHVETNPLR-EFPDIPESVEDLR 422
Query: 723 VLTLSGNLLSGPIPPAIGRLSKLYELRLSNNSLN 756
++ + P A KL + ++ +
Sbjct: 423 ---MNSERVVDPYEFAHETTDKLEDDVFEHHHHH 453
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 189 bits (481), Expect = 5e-52
Identities = 109/544 (20%), Positives = 182/544 (33%), Gaps = 99/544 (18%)
Query: 117 NLSSLESLLLFSNQLAGTIPTQLGSLTSLRVMRIGDNWLSGSIPTSFGNLVNLGTLGLAS 176
+ + L+ L S+ L +P + ++ S + + P G + L
Sbjct: 9 SNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRD 67
Query: 177 CSLSGPIPPQFGQLSQLEELILQQNQLQGPIPAELGNCSSLSIFTAAENNLNGSIPAALG 236
C Q EL L L +P + SL + N+L +P
Sbjct: 68 CLDR-----------QAHELELNNLGLS-SLPELPPHLESLVA---SCNSLT-ELPELPQ 111
Query: 237 RLQNLQLLNLGNNSLSGEIPSELGELSQLGYLNLMGNRLEGAIPRSFAKMGNLQSLDLSM 296
L++L + N +LS P L YL + N+LE +P L+ +D+
Sbjct: 112 SLKSLLVDNNNLKALSDLPPL-------LEYLGVSNNQLE-KLP-ELQNSSFLKIIDVDN 162
Query: 297 NRLTGGIPEEFGNMGQLVFLVLSNNNISGSIPRRICTNATSLEHLILAEIQLSGEIPVEL 356
N L +P+ + L F+ NN + E+P EL
Sbjct: 163 NSLKK-LPDLPPS---LEFIAAGNNQLE--------------------------ELP-EL 191
Query: 357 SQCQSLKQLDLSNNTLNGTIPVELFQLVALTHLYLHNNSLVGSISPFVANLSNLQELALY 416
L + NN+L +P L + NN L P + NL L +
Sbjct: 192 QNLPFLTAIYADNNSLK-KLPDLPLSL---ESIVAGNNIL--EELPELQNLPFLTTIYAD 245
Query: 417 HNNFQGSLPREIGMLVKLELLYLYDNHLSGQIPSEVGNCSSLKWIDFFGNSFTGEIPTSI 476
+N + +LP LE L + DN+L+ +P + + L D N F+ +
Sbjct: 246 NNLLK-TLPDLPP---SLEALNVRDNYLT-DLPELPQSLTFL---DVSENIFS-GLSELP 296
Query: 477 GRLKDLNFLHLRQNELVGQIPASLGNCHQLIILDLADNKLSGGVPASFGFLQALEQLMLY 536
L LN L P L L++++NKL +PA LE+L+
Sbjct: 297 PNLYYLNASSNEIRSLCDLPP-------SLEELNVSNNKLIE-LPAL---PPRLERLIAS 345
Query: 537 NNSLEGNLPGSLINLRNLTRINFSKNRLNGRIATLCSSHSFLSFDVTNNEFDHEIPPQLG 596
N L +P NL+ L + N L + N+ E+P
Sbjct: 346 FNHLA-EVPELPQNLKQL---HVEYNPLR----EFPDIPESVEDLRMNSHL-AEVPELPQ 396
Query: 597 NSPSLERLRLGNNKFIGKIPWTFGKIRELSLLDLSGNSLTGPIPTQLLMCKKLSHIDLNN 656
N L++L + N + + P + L ++ + P KL +
Sbjct: 397 N---LKQLHVETNP-LREFP---DIPESVEDLRMNSERVVDPYEFAHETTDKLEDDVFEH 449
Query: 657 NLLS 660
+
Sbjct: 450 HHHH 453
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 6e-50
Identities = 108/539 (20%), Positives = 181/539 (33%), Gaps = 100/539 (18%)
Query: 288 NLQSLDLSMNRLTGGIPEEFGNMGQLVFLVLSNNNISGSIPRRICTNATSLEHLILAEIQ 347
LQ + LT +P E N+ + + + P + E +A +
Sbjct: 12 FLQEPLRHSSNLTE-MPVEAENVKSKTEYYNAWSEWERNAP------PGNGEQREMAVSR 64
Query: 348 LSGEIPVELSQCQSLKQLDLSNNTLNGTIPVELFQLVALTHLYLHNNSLVGSISPFVANL 407
L + +L+L+N L+ ++P L L NSL + +L
Sbjct: 65 LRD------CLDRQAHELELNNLGLS-SLPELPPHL---ESLVASCNSLT-ELPELPQSL 113
Query: 408 SNLQELALYHNNFQGSLPREIGMLVKLELLYLYDNHLSGQIPSEVGNCSSLKWIDFFGNS 467
+L P LE L + +N L ++P E+ N S LK ID NS
Sbjct: 114 KSLLVDNNNLKALSDLPP-------LLEYLGVSNNQLE-KLP-ELQNSSFLKIIDVDNNS 164
Query: 468 FTGEIPTSIGRLKDLNFLHLRQNELVGQIPASLGNCHQLIILDLADNKLSGGVPASFGFL 527
++P L+ + N+L ++P L N L + +N L
Sbjct: 165 LK-KLPDLPPSLEFIA---AGNNQLE-ELP-ELQNLPFLTAIYADNNSLK----KLPDLP 214
Query: 528 QALEQLMLYNNSLEGNLPGSLINLRNLTRINFSKNRLNGRIATLCSSHSFLSFDVTNNEF 587
+LE ++ NN LE LP L NL LT I N L
Sbjct: 215 LSLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLL----------------------- 249
Query: 588 DHEIPPQLGNSPSLERLRLGNNKFIGKIPWTFGKIRELSLLDLSGNSLTGPIPTQLLMCK 647
+P + LE L + +N + +P + L + + + L+ P
Sbjct: 250 -KTLPDLPPS---LEALNVRDNY-LTDLPELPQSLTFLDVSENIFSGLSELPP------- 297
Query: 648 KLSHIDLNNNLLSGAVPSWLGTLPQLGELKLSFNQFVGFLPRELFNCSKLLVLSLDGNML 707
L +++ ++N + S P L EL +S N+ + LP +L L N L
Sbjct: 298 NLYYLNASSNEIR----SLCDLPPSLEELNVSNNKLI-ELPALP---PRLERLIASFNHL 349
Query: 708 NGSLPNEVGNLASLNVLTLSGNLLSGPIPPAIGRLSKLYELRLSNNSLNGVIPLEIGQLQ 767
+P NL L+ + N L P + L N+ L +P L+
Sbjct: 350 A-EVPELPQNLKQLH---VEYNPLRE-FPDIPESVEDLR----MNSHLA-EVPELPQNLK 399
Query: 768 NLQSILDLSHNNFTGQIPPSMGTLAKLEVLNLSHNQLVGELPSQLGEMSSLGKLNLSYN 826
L + N + P +E L ++ ++V L ++
Sbjct: 400 ----QLHVETNPLR-EFPDIPE---SVEDLRMNSERVVDPYEFAHETTDKLEDDVFEHH 450
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 180 bits (460), Expect = 3e-49
Identities = 104/493 (21%), Positives = 171/493 (34%), Gaps = 77/493 (15%)
Query: 86 SISPSLGRLQSLIHLDLSSNSLTGPIPTALSNLS-------------SLESLLLFSNQLA 132
+ ++S + + P L L + L
Sbjct: 25 EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGL- 83
Query: 133 GTIPTQLGSLTSLRVMRIGDNWLSGSIPTSFGNLVNLGTLGLASCSLSGPIPPQFGQLSQ 192
++P L SL N L+ +P +L +L +LS P
Sbjct: 84 SSLPELPPHLESLVA---SCNSLT-ELPELPQSLKSLLVDNNNLKALSDLPP-------L 132
Query: 193 LEELILQQNQLQGPIPAELGNCSSLSIFTAAENNLNGSIPAALGRLQNLQLLNLGNNSLS 252
LE L + NQL+ +P EL N S L I N+L +P +L+ + GNN L
Sbjct: 133 LEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLK-KLPDLPP---SLEFIAAGNNQLE 186
Query: 253 GEIPSELGELSQLGYLNLMGNRLEGAIPRSFAKMGNLQSLDLSMNRLTGGIPEEFGNMGQ 312
E+P EL L L + N L+ +P +L+S+ N L E N+
Sbjct: 187 -ELP-ELQNLPFLTAIYADNNSLK-KLPDL---PLSLESIVAGNNILE--ELPELQNLPF 238
Query: 313 LVFLVLSNNNISGSIPRRICTNATSLEHLILAEIQLSGEIPVELSQCQSLKQLDLSNNTL 372
L + NN + ++P SLE L + + L+ ++P L + + L
Sbjct: 239 LTTIYADNNLLK-TLPDLPP----SLEALNVRDNYLT-DLPELPQSLTFLDVSENIFSGL 292
Query: 373 NGTIPVELFQLVALTHLYLHNNSLVGSISPFVANLSNLQELALYHNNFQGSLPREIGMLV 432
+ P L +L +N I +L+EL + +N LP
Sbjct: 293 SELPP-------NLYYLNASSN----EIRSLCDLPPSLEELNVSNNKLI-ELPALPP--- 337
Query: 433 KLELLYLYDNHLSGQIPSEVGNCSSLKWIDFFGNSFTGEIPTSIGRLKDLNFLHLRQNEL 492
+LE L NHL+ ++P N LK + N E P ++D LR N
Sbjct: 338 RLERLIASFNHLA-EVPELPQN---LKQLHVEYNPLR-EFPDIPESVED-----LRMNSH 387
Query: 493 VGQIPASLGNCHQLIILDLADNKLSGGVPASFGFLQALEQLMLYNNSLEGNLPGSLINLR 552
+ ++P N L L + N L P +++E L + + + +
Sbjct: 388 LAEVPELPQN---LKQLHVETNPLR-EFPDI---PESVEDLRMNSERVVDPYEFAHETTD 440
Query: 553 NLTRINFSKNRLN 565
L F + +
Sbjct: 441 KLEDDVFEHHHHH 453
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 1e-48
Identities = 102/567 (17%), Positives = 178/567 (31%), Gaps = 124/567 (21%)
Query: 238 LQNLQLLNLGNNSLSGEIPSELGELSQLGYLNLMGNRLEGAIPRSFAKMGNLQSLDLSMN 297
LQ +++L+ E+P E + + E P + + L
Sbjct: 10 NTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDC 68
Query: 298 RLTGGIPEEFGNMGQLVFLVLSNNNISGSIPRRICTNATSLEHLILAEIQLSGEIPVELS 357
Q L L+N +S S+P LE L+ + L+ E+P
Sbjct: 69 LDR-----------QAHELELNNLGLS-SLPELP----PHLESLVASCNSLT-ELPELPQ 111
Query: 358 QCQSLKQLDLSNNTLNGTIPVELFQLVALTHLYLHNNSLVGSISPFVANLSNLQELALYH 417
+SL + + L+ P L +L + NN L P + N S L+ + + +
Sbjct: 112 SLKSLLVDNNNLKALSDLPP-------LLEYLGVSNNQL--EKLPELQNSSFLKIIDVDN 162
Query: 418 NNFQGSLPREIGMLVKLELLYLYDNHLSGQIPSEVGNCSSLKWIDFFGNSFTGEIPTSIG 477
N+ + LP LE + +N L E+P +
Sbjct: 163 NSLK-KLPDLPP---SLEFIAAGNNQLE-------------------------ELP-ELQ 192
Query: 478 RLKDLNFLHLRQNELVGQIPASLGNCHQLIILDLADNKLSGGVPASFGFLQALEQLMLYN 537
L L ++ N L ++P + L + +N L L L + N
Sbjct: 193 NLPFLTAIYADNNSLK-KLPDLPLS---LESIVAGNNILE--ELPELQNLPFLTTIYADN 246
Query: 538 NSLEGNLPGSLINLRNLTRINFSKNRLNGRIATLCSSHSFLSFDVTNNEFDHEIPPQLGN 597
N L+ LP +L L N N L ++P +
Sbjct: 247 NLLK-TLPDLPPSLEAL---NVRDNYLT------------------------DLPELPQS 278
Query: 598 SPSLERLRLGNNKFIGKIPWTFGKIRELSLLDLSGNSLTGPIPTQLLMCKKLSHIDLNNN 657
L+ + P L L+ S N + + L ++++NN
Sbjct: 279 LTFLDVSENIFSGLSELPP-------NLYYLNASSNEIRS-LCDLP---PSLEELNVSNN 327
Query: 658 LLSGAVPSWLGTLPQLGELKLSFNQFVGFLPRELFNCSKLLVLSLDGNMLNGSLPNEVGN 717
L +P+ +L L SFN +P N L L ++ N L P+ +
Sbjct: 328 KLI-ELPALPP---RLERLIASFNHLA-EVPELPQN---LKQLHVEYNPLR-EFPDIPES 378
Query: 718 LASLNVLTLSGNLLSGPIPPAIGRLSKLYELRLSNNSLNGVIPLEIGQLQNLQSILDLSH 777
+ L + N +P L +L+ + N L P +++L ++
Sbjct: 379 VEDLRM-----NSHLAEVPELPQNLKQLH---VETNPLR-EFPDIPESVEDL----RMNS 425
Query: 778 NNFTGQIPPSMGTLAKLEVLNLSHNQL 804
+ T KLE H+
Sbjct: 426 ERVVDPYEFAHETTDKLEDDVFEHHHH 452
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 1e-13
Identities = 34/157 (21%), Positives = 57/157 (36%), Gaps = 27/157 (17%)
Query: 686 FLPRELFNCSKLLVLSLDGNMLNGSLPNEVGNLASLNVLTLSGNLLSGPIPPAIGRLS-- 743
F+ + + L + L +P E N+ S + + PP G
Sbjct: 2 FINPRNVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREM 60
Query: 744 -----------KLYELRLSNNSLNGVIPLEIGQLQNLQSILDLSHNNFTGQIPPSMGTLA 792
+ +EL L+N L+ +P L++ L S N+ T ++P +L
Sbjct: 61 AVSRLRDCLDRQAHELELNNLGLS-SLPELPPHLES----LVASCNSLT-ELPELPQSLK 114
Query: 793 KLEVLNLSHNQLVGELPSQLGEMSSLGKLNLSYNDLQ 829
L V N + L +LP L L +S N L+
Sbjct: 115 SLLVDNNNLKAL-SDLP------PLLEYLGVSNNQLE 144
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 188 bits (479), Expect = 9e-53
Identities = 79/371 (21%), Positives = 144/371 (38%), Gaps = 28/371 (7%)
Query: 75 SLNLSGLSLAGSISPSLGRLQSLIHLDLSSNSLTGPIPTALSNLSSLESLLLFSNQLAGT 134
+L + I P L I L S+T + L S+ L++ ++
Sbjct: 4 TLATLPAPI-NQIFP-DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKV--A 57
Query: 135 IPTQLGSLTSLRVMRIGDNWLSGSIPTSFGNLVNLGTLGLASCSLSGPIPPQFGQLSQLE 194
+ LT+L + + N ++ P NLV L L + + ++ L+ L
Sbjct: 58 SIQGIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKIT--DISALQNLTNLR 113
Query: 195 ELILQQNQLQGPIPAELGNCSSLSIFTAAENNLNGSIPAALGRLQNLQLLNLGNNSLSGE 254
EL L ++ + P L N + + N+ S + L + L L + + +
Sbjct: 114 ELYLNEDNISDISP--LANLTKMYSLNLGANHN-LSDLSPLSNMTGLNYLTVTESKVKD- 169
Query: 255 IPSELGELSQLGYLNLMGNRLEGAIPRSFAKMGNLQSLDLSMNRLTGGIPEEFGNMGQLV 314
+ + L+ L L+L N++E P A + +L +N++T P NM +L
Sbjct: 170 -VTPIANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLN 224
Query: 315 FLVLSNNNISGSIPRRICTNATSLEHLILAEIQLSGEIPVELSQCQSLKQLDLSNNTLNG 374
L + NN I+ P N + L L + Q+S + LK L++ +N ++
Sbjct: 225 SLKIGNNKITDLSP---LANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQISD 279
Query: 375 TIPVELFQLVALTHLYLHNNSLVGSISPFVANLSNLQELALYHNNFQGSLPREIGMLVKL 434
+ L L L+L+NN L + L+NL L L N+ P + L K+
Sbjct: 280 ISVLN--NLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKM 335
Query: 435 ELLYLYDNHLS 445
+ + +
Sbjct: 336 DSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 178 bits (454), Expect = 2e-49
Identities = 87/349 (24%), Positives = 141/349 (40%), Gaps = 26/349 (7%)
Query: 71 ARVVSLNLSGLSLAGSISPSLGRLQSLIHLDLSSNSLTGPIPTALSNLSSLESLLLFSNQ 130
A + L S+ ++ L+S+ L ++ + + L++LE L L NQ
Sbjct: 22 AEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVASI--QGIEYLTNLEYLNLNGNQ 77
Query: 131 LAGTIPTQLGSLTSLRVMRIGDNWLSGSIPTSFGNLVNLGTLGLASCSLSGPIPPQFGQL 190
+ P L +L L + IG N ++ ++ NL NL L L ++S P L
Sbjct: 78 ITDISP--LSNLVKLTNLYIGTNKIT--DISALQNLTNLRELYLNEDNISDISP--LANL 131
Query: 191 SQLEELILQQNQLQGPIPAELGNCSSLSIFTAAENNLNGSIPAALGRLQNLQLLNLGNNS 250
+++ L L N + L N + L+ T E+ + P + L +L L+L N
Sbjct: 132 TKMYSLNLGANHNLS-DLSPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQ 188
Query: 251 LSGEIPSELGELSQLGYLNLMGNRLEGAIPRSFAKMGNLQSLDLSMNRLTGGIPEEFGNM 310
+ P L L+ L Y N++ P A M L SL + N++T N+
Sbjct: 189 IEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITD--LSPLANL 242
Query: 311 GQLVFLVLSNNNISGSIPRRICTNATSLEHLILAEIQLSGEIPVELSQCQSLKQLDLSNN 370
QL +L + N IS + T L+ L + Q+S L+ L L L+NN
Sbjct: 243 SQLTWLEIGTNQISDINA---VKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNN 297
Query: 371 TLNGTIPVELFQLVALTHLYLHNNSLVGSISPFVANLSNLQELALYHNN 419
L + L LT L+L N + I P A+LS + +
Sbjct: 298 QLGNEDMEVIGGLTNLTTLFLSQNHI-TDIRPL-ASLSKMDSADFANQV 344
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 5e-48
Identities = 79/396 (19%), Positives = 147/396 (37%), Gaps = 51/396 (12%)
Query: 386 LTHLYLHNNSLVGSISPFVANLSNLQELALYHNNFQGSLPREIGMLVKLELLYLYDNHLS 445
L + I P A+L+ L + + L + L + ++
Sbjct: 2 AATLATLPAPI-NQIFPD-ADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA 57
Query: 446 GQIPSEVGNCSSLKWIDFFGNSFTGEIPTSIGRLKDLNFLHLRQNELVGQIPASLGNCHQ 505
+ ++L++++ GN T P + L L L++ N++ ++L N
Sbjct: 58 S--IQGIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKI--TDISALQNLTN 111
Query: 506 LIILDLADNKLSGGVPASFGFLQALEQLMLYNNSLEGNLPGSLINLRNLTRINFSKNRLN 565
L L L ++ +S + L + L L N +L L N+ L + +++++
Sbjct: 112 LRELYLNEDNISD--ISPLANLTKMYSLNLGANHNLSDLS-PLSNMTGLNYLTVTESKVK 168
Query: 566 GRIATLCSSHSFLSFDVTNNEFDHEIPPQLGNSPSLERLRLGNNKFIGKIPWTFGKIREL 625
+ P + N L L L N+ I I + L
Sbjct: 169 D------------------------VTP-IANLTDLYSLSLNYNQ-IEDIS-PLASLTSL 201
Query: 626 SLLDLSGNSLTGPIPTQLLMCKKLSHIDLNNNLLSGAVPSWLGTLPQLGELKLSFNQFVG 685
N +T P + +L+ + + NN ++ P L L QL L++ NQ
Sbjct: 202 HYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISD 257
Query: 686 FLPRELFNCSKLLVLSLDGNMLNGSLPNEVGNLASLNVLTLSGNLLSGPIPPAIGRLSKL 745
+ + +KL +L++ N ++ + + NL+ LN L L+ N L IG L+ L
Sbjct: 258 --INAVKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNL 313
Query: 746 YELRLSNNSLNGVIPLEIGQLQNLQSILDLSHNNFT 781
L LS N + + PL L + S D ++
Sbjct: 314 TTLFLSQNHITDIRPL--ASLSKMDS-ADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 170 bits (434), Expect = 1e-46
Identities = 75/393 (19%), Positives = 141/393 (35%), Gaps = 51/393 (12%)
Query: 437 LYLYDNHLSGQIPSEVGNCSSLKWIDFFGNSFTGEIPTSIGRLKDLNFLHLRQNELVGQI 496
L ++ P + + S T + L+ + L + ++ I
Sbjct: 5 LATLPAPINQIFP--DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKV-ASI 59
Query: 497 PASLGNCHQLIILDLADNKLSGGVPASFGFLQALEQLMLYNNSLEGNLPGSLINLRNLTR 556
+ L L+L N+++ + L L L + N + +L NL NL
Sbjct: 60 QG-IEYLTNLEYLNLNGNQITD--ISPLSNLVKLTNLYIGTNKITD--ISALQNLTNLRE 114
Query: 557 INFSKNRLNGRIATLCSSHSFLSFDVTNNEFDHEIPPQLGNSPSLERLRLGNNKFIGKIP 616
+ +++ ++ I P L N + L LG N + +
Sbjct: 115 LYLNEDNISD------------------------ISP-LANLTKMYSLNLGANHNLSDLS 149
Query: 617 WTFGKIRELSLLDLSGNSLTGPIPTQLLMCKKLSHIDLNNNLLSGAVPSWLGTLPQLGEL 676
+ L+ L ++ + + P + L + LN N + P L +L L
Sbjct: 150 -PLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYF 204
Query: 677 KLSFNQFVGFLPRELFNCSKLLVLSLDGNMLNGSLPNEVGNLASLNVLTLSGNLLSGPIP 736
NQ P + N ++L L + N + P + NL+ L L + N +S
Sbjct: 205 TAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISDI-- 258
Query: 737 PAIGRLSKLYELRLSNNSLNGVIPLEIGQLQNLQSILDLSHNNFTGQIPPSMGTLAKLEV 796
A+ L+KL L + +N ++ + + L L S L L++N + +G L L
Sbjct: 259 NAVKDLTKLKMLNVGSNQISDISV--LNNLSQLNS-LFLNNNQLGNEDMEVIGGLTNLTT 315
Query: 797 LNLSHNQLVGELPSQLGEMSSLGKLNLSYNDLQ 829
L LS N + P L +S + + + ++
Sbjct: 316 LFLSQNHITDIRP--LASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 2e-41
Identities = 70/352 (19%), Positives = 141/352 (40%), Gaps = 28/352 (7%)
Query: 479 LKDLNFLHLRQNELVGQIPASLGNCHQLIILDLADNKLSGGVPASFGFLQALEQLMLYNN 538
L L N++ + + I L ++ + L+++ +L++
Sbjct: 2 AATLATLPAPINQI-----FPDADLAEGIRAVLQKASVTD--VVTQEELESITKLVVAGE 54
Query: 539 SLEGNLPGSLINLRNLTRINFSKNRLNGRIATLCSSHSFLSFDVTNNEFDHEIPPQLGNS 598
+ ++ G + L NL +N + N++ I+ L + + + N+ L N
Sbjct: 55 KVA-SIQG-IEYLTNLEYLNLNGNQITD-ISPLSNLVKLTNLYIGTNKI--TDISALQNL 109
Query: 599 PSLERLRLGNNKFIGKIPWTFGKIRELSLLDLSGNSLTGPIPTQLLMCKKLSHIDLNNNL 658
+L L L + I I + ++ L+L N + L L+++ + +
Sbjct: 110 TNLRELYLNEDN-ISDIS-PLANLTKMYSLNLGANHNLS-DLSPLSNMTGLNYLTVTESK 166
Query: 659 LSGAVPSWLGTLPQLGELKLSFNQFVGFLPRELFNCSKLLVLSLDGNMLNGSLPNEVGNL 718
+ P + L L L L++NQ P L + + L + N + P V N+
Sbjct: 167 VKDVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANM 220
Query: 719 ASLNVLTLSGNLLSGPIPPAIGRLSKLYELRLSNNSLNGVIPLEIGQLQNLQSILDLSHN 778
LN L + N ++ P + LS+L L + N ++ + + L L+ L++ N
Sbjct: 221 TRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISDINAV--KDLTKLKM-LNVGSN 275
Query: 779 NFTGQIPPSMGTLAKLEVLNLSHNQLVGELPSQLGEMSSLGKLNLSYNDLQG 830
+ + L++L L L++NQL E +G +++L L LS N +
Sbjct: 276 QISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITD 325
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 4e-16
Identities = 32/161 (19%), Positives = 57/161 (35%), Gaps = 13/161 (8%)
Query: 673 LGELKLSFNQFVGFLPRELFNCSKLLVLSLDGNMLNGSLPNEVGNLASLNVLTLSGNLLS 732
L P + ++ + L + + L S+ L ++G ++
Sbjct: 2 AATLATLPAPINQIFP--DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA 57
Query: 733 GPIPPAIGRLSKLYELRLSNNSLNGVIPLEIGQLQNLQSILDLSHNNFTGQIPPSMGTLA 792
I L+ L L L+ N + + PL L L + L + N T ++ L
Sbjct: 58 SI--QGIEYLTNLEYLNLNGNQITDISPL--SNLVKLTN-LYIGTNKIT--DISALQNLT 110
Query: 793 KLEVLNLSHNQLVGELPSQLGEMSSLGKLNLSYNDLQGKLS 833
L L L+ + + S L ++ + LNL N LS
Sbjct: 111 NLRELYLNEDNISD--ISPLANLTKMYSLNLGANHNLSDLS 149
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 2e-49
Identities = 59/344 (17%), Positives = 106/344 (30%), Gaps = 31/344 (9%)
Query: 210 ELGNCSSLSIFTAAENNLNGSIPAALGRLQNLQLLNLGNNSLSGEIPSELGELSQLGYLN 269
+ S + L + Q + +
Sbjct: 7 HHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHS----AWRQANSNNPQIET 62
Query: 270 LMGNRLEGAIPRSF--AKMGNLQSLDLSMNRLTGGIPEEFGNMGQLVFLVLSNNNISGSI 327
G L+ A A +L+L L P++ + L + + + +
Sbjct: 63 RTGRALK-ATADLLEDATQPGRVALELRSVPLPQ-FPDQAFRLSHLQHMTIDAAGLM-EL 119
Query: 328 PRRICTNATSLEHLILAEIQLSGEIPVELSQCQSLKQLDLSNNTLNGTIPVELFQLVALT 387
P + LE L LA L +P ++ L++L + +P L
Sbjct: 120 PDTMQ-QFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLAST---- 173
Query: 388 HLYLHNNSLVGSISPFVANLSNLQELALYHNNFQGSLPREIGMLVKLELLYLYDNHLSGQ 447
S L NLQ L L + SLP I L L+ L + ++ LS
Sbjct: 174 -----------DASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-A 220
Query: 448 IPSEVGNCSSLKWIDFFGNSFTGEIPTSIGRLKDLNFLHLRQNELVGQIPASLGNCHQLI 507
+ + + L+ +D G + P G L L L+ + +P + QL
Sbjct: 221 LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLE 280
Query: 508 ILDLADNKLSGGVPASFGFLQALEQLMLYNNS---LEGNLPGSL 548
LDL +P+ L A +++ + L+ + P +
Sbjct: 281 KLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQHRPVAR 324
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 2e-48
Identities = 62/363 (17%), Positives = 110/363 (30%), Gaps = 52/363 (14%)
Query: 157 GSIPTSFGNLVNLGTLGLASCSLSGPIPPQFGQLSQLEELILQQNQLQGPIPAELGNCSS 216
GS + L + P Q + + N ++
Sbjct: 2 GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHS----AWRQANSNN 57
Query: 217 LSIFTAAENNLNGSIPAALGRLQ--NLQLLNLGNNSLSGEIPSELGELSQLGYLNLMGNR 274
I T L + L L L + L + P + LS L ++ +
Sbjct: 58 PQIETRTGRALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAG 115
Query: 275 LEGAIPRSFAKMGNLQSLDLSMNRLTGGIPEEFGNMGQLVFLVLSNNNISGSIPRRICTN 334
L +P + + L++L L+ N L +P ++ +L L + +P +
Sbjct: 116 LM-ELPDTMQQFAGLETLTLARNPLRA-LPASIASLNRLRELSIRACPELTELPEPLA-- 171
Query: 335 ATSLEHLILAEIQLSGEIPVELSQCQSLKQLDLSNNTLNGTIPVELFQLVALTHLYLHNN 394
S + E +L+ L L + ++P + L L L + N+
Sbjct: 172 --------------STDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNS 216
Query: 395 SLVGSISPFVANLSNLQELALYHNNFQGSLPREIGMLVKLELLYLYDNHLSGQIPSEVGN 454
L +L I L KLE L L P G
Sbjct: 217 PLS-------------------------ALGPAIHHLPKLEELDLRGCTALRNYPPIFGG 251
Query: 455 CSSLKWIDFFGNSFTGEIPTSIGRLKDLNFLHLRQNELVGQIPASLGNCHQLIILDLADN 514
+ LK + S +P I RL L L LR + ++P+ + I+ + +
Sbjct: 252 RAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPH 311
Query: 515 KLS 517
+
Sbjct: 312 LQA 314
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 9e-48
Identities = 61/367 (16%), Positives = 111/367 (30%), Gaps = 52/367 (14%)
Query: 85 GSISPSLGRLQSLIHLDLSSNSLTGPIPTALSNLSSLESLLLFSNQLAGTIPTQLGSLTS 144
GS +L ++ P LS + + + +
Sbjct: 2 GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHS----AWRQANSNN 57
Query: 145 LRVMRIGDNWLSGSIPTSFGNL--VNLGTLGLASCSLSGPIPPQFGQLSQLEELILQQNQ 202
++ L + + L L S L P Q +LS L+ + +
Sbjct: 58 PQIETRTGRALK-ATADLLEDATQPGRVALELRSVPLPQ-FPDQAFRLSHLQHMTIDAAG 115
Query: 203 LQGPIPAELGNCSSLSIFTAAENNLNGSIPAALGRLQNLQLLNLGNNSLSGEIPSELGEL 262
L +P + + L T A N L ++PA++ L L+ L++ E+P L
Sbjct: 116 LME-LPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLAST 173
Query: 263 SQLGYLNLMGNRLEGAIPRSFAKMGNLQSLDLSMNRLTGGIPEEFGNMGQLVFLVLSNNN 322
+ NLQSL L + +P N+ L L + N+
Sbjct: 174 D---------------ASGEHQGLVNLQSLRLEWTGIRS-LPASIANLQNLKSLKIRNSP 217
Query: 323 ISGSIPRRICTNATSLEHLILAEIQLSGEIPVELSQCQSLKQLDLSNNTLNGTIPVELFQ 382
+S + + L++LDL T P
Sbjct: 218 LS--------------------------ALGPAIHHLPKLEELDLRGCTALRNYPPIFGG 251
Query: 383 LVALTHLYLHNNSLVGSISPFVANLSNLQELALYHNNFQGSLPREIGMLVKLELLYLYDN 442
L L L + S + ++ + L+ L++L L LP I L ++ + +
Sbjct: 252 RAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPH 311
Query: 443 HLSGQIP 449
+
Sbjct: 312 LQAQLDQ 318
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 9e-46
Identities = 59/323 (18%), Positives = 106/323 (32%), Gaps = 22/323 (6%)
Query: 75 SLNLSGLSLAGSISPSLGRLQSLIHLDLSSNSLTGPIPTALSNLSSLESLLLFSNQLAGT 134
+L G + L + Q + D + +N ++ + L
Sbjct: 16 NLYFQGSTALRPYHDVLSQWQRHYNADRNRWHS----AWRQANSNNPQIETRTGRALK-A 70
Query: 135 IPTQLGSLTS--LRVMRIGDNWLSGSIPTSFGNLVNLGTLGLASCSLSGPIPPQFGQLSQ 192
L T + + L P L +L + + + L +P Q +
Sbjct: 71 TADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLME-LPDTMQQFAG 128
Query: 193 LEELILQQNQLQGPIPAELGNCSSLSIFTAAENNLNGSIPAALGR---------LQNLQL 243
LE L L +N L+ +PA + + + L + +P L L NLQ
Sbjct: 129 LETLTLARNPLRA-LPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQS 187
Query: 244 LNLGNNSLSGEIPSELGELSQLGYLNLMGNRLEGAIPRSFAKMGNLQSLDLSMNRLTGGI 303
L L + +P+ + L L L + + L A+ + + L+ LDL
Sbjct: 188 LRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNY 245
Query: 304 PEEFGNMGQLVFLVLSNNNISGSIPRRICTNATSLEHLILAEIQLSGEIPVELSQCQSLK 363
P FG L L+L + + ++P I T LE L L +P ++Q +
Sbjct: 246 PPIFGGRAPLKRLILKDCSNLLTLPLDIH-RLTQLEKLDLRGCVNLSRLPSLIAQLPANC 304
Query: 364 QLDLSNNTLNGTIPVELFQLVAL 386
+ + + A
Sbjct: 305 IILVPPHLQAQLDQHRPVARPAE 327
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 2e-44
Identities = 59/354 (16%), Positives = 103/354 (29%), Gaps = 46/354 (12%)
Query: 229 GSIPAALGRLQNLQLLNLGNNSLSGEIPSELGELSQLGYLNLMGNRLEGAIPRSFAKMGN 288
GS + L ++ L + + + A N
Sbjct: 2 GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHS----AWRQANSNN 57
Query: 289 LQSLDLSMNRLTGGIPEEFGN--MGQLVFLVLSNNNISGSIPRRICTNATSLEHLILAEI 346
Q + L + + V L L + +
Sbjct: 58 PQIETRTGRALKA-TADLLEDATQPGRVALELRSVPLP---------------------- 94
Query: 347 QLSGEIPVELSQCQSLKQLDLSNNTLNGTIPVELFQLVALTHLYLHNNSLVGSISPFVAN 406
+ P + + L+ + + L +P + Q L L L N L ++ +A+
Sbjct: 95 ----QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIAS 148
Query: 407 LSNLQELALYHNNFQGSLPREIG---------MLVKLELLYLYDNHLSGQIPSEVGNCSS 457
L+ L+EL++ LP + LV L+ L L + +P+ + N +
Sbjct: 149 LNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQN 207
Query: 458 LKWIDFFGNSFTGEIPTSIGRLKDLNFLHLRQNELVGQIPASLGNCHQLIILDLADNKLS 517
LK + + + + +I L L L LR + P G L L L D
Sbjct: 208 LKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNL 266
Query: 518 GGVPASFGFLQALEQLMLYNNSLEGNLPGSLINLRNLTRINFSKNRLNGRIATL 571
+P L LE+L L LP + L I +
Sbjct: 267 LTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQHR 320
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 5e-44
Identities = 60/364 (16%), Positives = 104/364 (28%), Gaps = 52/364 (14%)
Query: 451 EVGNCSSLKWIDFFGNSFTGEIPTSIGRLKDLNFLHLRQNELVGQIPASLGNCHQLIILD 510
+ S + + F G++ + + + + N + I
Sbjct: 7 HHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHS----AWRQANSNNPQIET 62
Query: 511 LADNKLSGGVPASFGFLQ--ALEQLMLYNNSLEGNLPGSLINLRNLTRINFSKNRLNGRI 568
L L L + L P L +L + L
Sbjct: 63 RTGRALKA-TADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGL---- 116
Query: 569 ATLCSSHSFLSFDVTNNEFDHEIPPQLGNSPSLERLRLGNNKFIGKIPWTFGKIRELSLL 628
E+P + LE L L N + +P + + L L
Sbjct: 117 --------------------MELPDTMQQFAGLETLTLARNP-LRALPASIASLNRLREL 155
Query: 629 DLSGNSLTGPIPTQLLMCKKLSHIDLNNNLLSGAVPSWLGTLPQLGELKLSFNQFVGFLP 688
+ +P L S L L L+L + LP
Sbjct: 156 SIRACPELTELP---------------EPLASTDASGEHQGLVNLQSLRLEWTGIR-SLP 199
Query: 689 RELFNCSKLLVLSLDGNMLNGSLPNEVGNLASLNVLTLSGNLLSGPIPPAIGRLSKLYEL 748
+ N L L + + L+ +L + +L L L L G PP G + L L
Sbjct: 200 ASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRL 258
Query: 749 RLSNNSLNGVIPLEIGQLQNLQSILDLSHNNFTGQIPPSMGTLAKLEVLNLSHNQLVGEL 808
L + S +PL+I +L L+ LDL ++P + L ++ + + +L
Sbjct: 259 ILKDCSNLLTLPLDIHRLTQLE-KLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQ-AQL 316
Query: 809 PSQL 812
Sbjct: 317 DQHR 320
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 3e-43
Identities = 64/327 (19%), Positives = 114/327 (34%), Gaps = 21/327 (6%)
Query: 527 LQALEQLMLYNNSLEGNLPGSLINLRNLTRINFSKNRLNGRIATLCSSHSFLSFDVTNNE 586
E L ++ L + + ++ R A + +
Sbjct: 11 SSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANS----NNPQIETRTGR 66
Query: 587 FDHEIPPQLGN--SPSLERLRLGNNKFIGKIPWTFGKIRELSLLDLSGNSLTGPIPTQLL 644
L + P L L + + + P ++ L + + L +P +
Sbjct: 67 ALKATADLLEDATQPGRVALELRSVP-LPQFPDQAFRLSHLQHMTIDAAGLME-LPDTMQ 124
Query: 645 MCKKLSHIDLNNNLLSGAVPSWLGTLPQLGELKLSFNQFVGFLPRELFNCS--------- 695
L + L N L A+P+ + +L +L EL + + LP L +
Sbjct: 125 QFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLV 183
Query: 696 KLLVLSLDGNMLNGSLPNEVGNLASLNVLTLSGNLLSGPIPPAIGRLSKLYELRLSNNSL 755
L L L+ + SLP + NL +L L + + LS + PAI L KL EL L +
Sbjct: 184 NLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTA 241
Query: 756 NGVIPLEIGQLQNLQSILDLSHNNFTGQIPPSMGTLAKLEVLNLSHNQLVGELPSQLGEM 815
P G L+ L L + +P + L +LE L+L + LPS + ++
Sbjct: 242 LRNYPPIFGGRAPLKR-LILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQL 300
Query: 816 SSLGKLNLSYNDLQGKLSKQFSHWPAE 842
+ + + + + PAE
Sbjct: 301 PANCIILVPPHLQAQLDQHRPVARPAE 327
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 7e-38
Identities = 61/363 (16%), Positives = 107/363 (29%), Gaps = 52/363 (14%)
Query: 397 VGSISPFVANLSNLQELALYHNNFQGSLPREIGMLVKLELLYLYDNHLSGQIPSEVGNCS 456
+GS + S + L + + + + Y D + N +
Sbjct: 1 MGSSHHHHHHSSGRENLYFQGSTALRPYHDVLS---QWQRHYNADRNRW-HSAWRQANSN 56
Query: 457 SLKWIDFFGNSFTGEIPTSIGRLKDLN--FLHLRQNELVGQIPASLGNCHQLIILDLADN 514
+ + G + + L LR L Q P L + +
Sbjct: 57 NPQIETRTGRALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAA 114
Query: 515 KLSGGVPASFGFLQALEQLMLYNNSLEGNLPGSLINLRNLTRINFSK-NRLNGRIATLCS 573
L +P + LE L L N L LP S+ +L L ++ L
Sbjct: 115 GLME-LPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPEL--------- 163
Query: 574 SHSFLSFDVTNNEFDHEIPPQLGNSPSLERLRLGNNKFIGKIPWTFGKIRELSLLDLSGN 633
E+P L ++ + L L L
Sbjct: 164 ---------------TELPEPLAST---------------DASGEHQGLVNLQSLRLEWT 193
Query: 634 SLTGPIPTQLLMCKKLSHIDLNNNLLSGAVPSWLGTLPQLGELKLSFNQFVGFLPRELFN 693
+ +P + + L + + N+ LS A+ + LP+L EL L + P
Sbjct: 194 GIRS-LPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGG 251
Query: 694 CSKLLVLSLDGNMLNGSLPNEVGNLASLNVLTLSGNLLSGPIPPAIGRLSKLYELRLSNN 753
+ L L L +LP ++ L L L L G + +P I +L + + +
Sbjct: 252 RAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPH 311
Query: 754 SLN 756
Sbjct: 312 LQA 314
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 5e-19
Identities = 29/178 (16%), Positives = 58/178 (32%), Gaps = 11/178 (6%)
Query: 673 LGELKLSFNQFVGFLPRELFNCSKLLVLSLDGNMLNGSLPNEVGNLASLNVLTLSGNLLS 732
L + + L + + N + + T +G L
Sbjct: 14 RENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQAN----SNNPQIETRTGRALK 69
Query: 733 GPIPPAIGRLS--KLYELRLSNNSLNGVIPLEIGQLQNLQSILDLSHNNFTGQIPPSMGT 790
+ + L L + L P + +L +LQ + + ++P +M
Sbjct: 70 A-TADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQH-MTIDAAGLM-ELPDTMQQ 125
Query: 791 LAKLEVLNLSHNQLVGELPSQLGEMSSLGKLNLSYNDLQGKLSKQFSHWPAEAFEGNL 848
A LE L L+ N L LP+ + ++ L +L++ +L + + A L
Sbjct: 126 FAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGL 182
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 2e-45
Identities = 69/433 (15%), Positives = 135/433 (31%), Gaps = 41/433 (9%)
Query: 230 SIPAALGRLQNLQLLNLGNNSLSGEIPSELGELSQLGYLNLMGNRLEGAIPRSFAKMGNL 289
+I ++ + ++SL + S + L+L GN L A L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 290 QSLDLSMNRLTGGIPEEFGNMGQLVFLVLSNNNISGSIPRRICTNATSLEHLILAEIQLS 349
+ L+LS N L + ++ L L L+NN + + S+E L A +S
Sbjct: 61 ELLNLSSNVLYE--TLDLESLSTLRTLDLNNNYVQ-ELL-----VGPSIETLHAANNNIS 112
Query: 350 GEIPVELSQCQSLKQLDLSNNTLNGTIPVELFQLVALTHLYLHNNSLVG-SISPFVANLS 408
V S+ Q K + L+NN + ++ + +L L N + + + A+
Sbjct: 113 R---VSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSD 169
Query: 409 NLQELALYHNNFQGSLPREIGMLVKLELLYLYDNHLSGQIPSEVGNCSSLKWIDFFGNSF 468
L+ L L +N + ++ KL+ L L N L+ + E + + + WI N
Sbjct: 170 TLEHLNLQYNFIY-DVKGQVV-FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKL 226
Query: 469 TGEIPTSIGRLKDLNFLHLRQNELVGQIPASLGNCHQLIILDLADNKLSGGVPASFGFLQ 528
I ++ ++L LR N + +A + +
Sbjct: 227 V-LIEKALRFSQNLEHFDLRGNGFHCGTLRDF-FSKNQRVQTVAKQTVKKLTGQNEEECT 284
Query: 529 ALEQLMLYNNSLEGNLPGSLINLRNLTRINFSKNRLNGRIATLCSSHSFLSFDVTNNEFD 588
E L L R + G
Sbjct: 285 VPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETE------------------ 326
Query: 589 HEIPPQLGNSPSLERLRLGNNKFIGKIPWTFGKIRELSLLDLSGNSLTGPIPTQLLMCKK 648
+ + N + ++ I + + L+ +L + + +
Sbjct: 327 -RLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKAL-----DEQVSNGR 380
Query: 649 LSHIDLNNNLLSG 661
+H +L+ L
Sbjct: 381 RAHAELDGTLQQA 393
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 8e-45
Identities = 73/531 (13%), Positives = 132/531 (24%), Gaps = 94/531 (17%)
Query: 86 SISPSLGRLQSLIHLDLSSNSLTGPIPTALSNLSSLESLLLFSNQLAGTIPTQLGSLTSL 145
+I ++ +SL + + + +++ L L N L+ L T L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 146 RVMRIGDNWLSGSIPTSFGNLVNLGTLGLASCSLSGPIPPQFGQLSQLEELILQQNQLQG 205
++ + N L LS L L L N +Q
Sbjct: 61 ELLNLSSNVLYE--------------------------TLDLESLSTLRTLDLNNNYVQ- 93
Query: 206 PIPAELGNCSSLSIFTAAENNLNGSIPAALGRLQNLQLLNLGNNSLSGEIPSELGELSQL 265
L +++ L+ NN++S +
Sbjct: 94 ----------------------------ELLVGPSIETLHAANNNIS-RVSCSR--GQGK 122
Query: 266 GYLNLMGNRLEGAIPRSFAKMGNLQSLDLSMNRLTG-GIPEEFGNMGQLVFLVLSNNNIS 324
+ L N++ +Q LDL +N + E + L L L N I
Sbjct: 123 KNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY 182
Query: 325 GSIPRRICTNATSLEHLILAEIQLSGEIPVELSQCQSLKQLDLSNNTLNGTIPVELFQLV 384
+ LK LDLS+N L + E
Sbjct: 183 -DVK--------------------------GQVVFAKLKTLDLSSNKLA-FMGPEFQSAA 214
Query: 385 ALTHLYLHNNSLVGSISPFVANLSNLQELALYHNNFQGSLPREIGMLVKLELLYLYDNHL 444
+T + L NN LV I + NL+ L N F R+ + + +
Sbjct: 215 GVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDF-FSKNQRVQTVAKQTV 272
Query: 445 SGQIPSEVGNCSSLKWIDFFGNSFTGEIPTSIGRLKDLNFLHLR----QNELVGQIPASL 500
C+ + RL L Q ++
Sbjct: 273 KKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECER 332
Query: 501 GNCHQLIILDLADNKLSGGVPASFGFLQALEQLMLYNNSLEGNLPGSLINLRNLTRINFS 560
N + +D + + QA L +L+ + L
Sbjct: 333 ENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQ 392
Query: 561 KNRLNGRIATLCSSHSFLSFDVTNNEFDHE-IPPQLGNSPSLERLRLGNNK 610
++ + Q + ++ + +K
Sbjct: 393 AVGQIELQHATEEQSPLQLLRAIVKRYEEMYVEQQSVQNNAIRDWDMYQHK 443
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 165 bits (418), Expect = 2e-43
Identities = 74/492 (15%), Positives = 156/492 (31%), Gaps = 25/492 (5%)
Query: 72 RVVSLNLSGLSLAGSISPSLGRLQSLIHLDLSSNSLTGPIPTALSNLSSLESLLLFSNQL 131
R ++ SL +++ ++ LDLS N L+ L+ + LE L L SN L
Sbjct: 11 RYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVL 70
Query: 132 AGTIPTQLGSLTSLRVMRIGDNWLSGSIPTSFGNLVNLGTLGLASCSLSGPIPPQFGQLS 191
L SL++LR + + +N++ ++ TL A+ ++S + +
Sbjct: 71 --YETLDLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNISR-VSC--SRGQ 120
Query: 192 QLEELILQQNQLQGPIPAELGNCSSLSIFTAAENNLNG-SIPAALGRLQNLQLLNLGNNS 250
+ + L N++ + G S + N ++ + L+ LNL N
Sbjct: 121 GKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNF 180
Query: 251 LSGEIPSELGELSQLGYLNLMGNRLEGAIPRSFAKMGNLQSLDLSMNRLTGGIPEEFGNM 310
+ ++ ++ ++L L+L N+L + F + + L N+L I +
Sbjct: 181 IY-DVKGQVV-FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFS 236
Query: 311 GQLVFLVLSNNNISGSIPRRICTNATSLEHLILAEIQLSGEIPVELSQCQSLKQLDLSNN 370
L L N R + ++ + + +C
Sbjct: 237 QNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQ--TVKKLTGQNEEECTVPTLGHYGAY 294
Query: 371 TLNGTIPVELFQLVALTHLYLHNNSL----VGSISPFVANLSNLQELALYHNNFQGSLPR 426
+L+AL S + N + +E+ ++ + +
Sbjct: 295 CCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQYRTVIDQ 354
Query: 427 EIGMLVKLELLYLYDNHLSGQIPSEVGNCSSLKWIDFFGNSFTG--EIPTSIGRLKDLNF 484
L L Q+ + + L L+ L
Sbjct: 355 VTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQIELQHATEEQSPLQLLRA 414
Query: 485 LHLRQNELVGQIPASLGNCHQLIILDLADNKLSGGVPASFGFLQALEQLMLYNNSLEGNL 544
+ R E+ + + N + D+ +K + + + + L S L
Sbjct: 415 IVKRYEEMYVEQQSVQNNAIR--DWDMYQHKETQLAEENARLKKLNGEADLALASANATL 472
Query: 545 PGSLINLRNLTR 556
++ +NL
Sbjct: 473 QELVVREQNLAS 484
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 6e-42
Identities = 65/476 (13%), Positives = 129/476 (27%), Gaps = 48/476 (10%)
Query: 360 QSLKQLDLSNNTLNGTIPVELFQ-LVALTHLYLHNNSLVGSISPFVANLSNLQELALYHN 418
K +++++L L Q + L L N L + +A + L+ L L N
Sbjct: 10 NRYKIEKVTDSSLK-QALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSN 68
Query: 419 NFQGSLPREIGMLVKLELLYLYDNHLSGQIPSEVGNCSSLKWIDFFGNSFTGEIPTSIGR 478
++ L L L L +N++ E+ S++ + N+ + + S
Sbjct: 69 VLYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RVSCSR-- 118
Query: 479 LKDLNFLHLRQNELVGQIPASLGNCHQLIILDLADNKLSG-GVPASFGFLQALEQLMLYN 537
+ ++L N++ G ++ LDL N++ LE L L
Sbjct: 119 GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQY 178
Query: 538 NSLEGNLPGSLINLRNLTRINFSKNRLNGRIATLCSSHSFLSFDVTNNEFDHEIPPQLGN 597
N + ++ + L ++ S N+L + P+ +
Sbjct: 179 NFIY-DVK-GQVVFAKLKTLDLSSNKLA------------------------FMGPEFQS 212
Query: 598 SPSLERLRLGNNKFIGKIPWTFGKIRELSLLDLSGNSLTGPIPTQLLMCKKLSHIDLNNN 657
+ + + L NNK + I + L DL GN K +
Sbjct: 213 AAGVTWISLRNNK-LVLIEKALRFSQNLEHFDLRGNGFHCGTLRDFFS-KNQRVQTVAKQ 270
Query: 658 LLSGAVPSWLGTLPQLGELKLSFNQFVGFLPRELFNCSKLLVLSLD----GNMLNGSLPN 713
+ L L
Sbjct: 271 TVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLEC 330
Query: 714 EVGNLASLNVLTLSGNLLSGPIPPAIGRLSKLYELRLSNNSLNGVIPLEIGQLQNLQSIL 773
E N A + I R L +L+ + L L
Sbjct: 331 ERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTL 390
Query: 774 DLSHNNFTGQIPPSMGTLAKLEVLNLSHNQLVGEL-PSQLGEMSSLGKLNLSYNDL 828
+ Q + L++L + Q + +++ ++ +
Sbjct: 391 QQAVGQIELQHATE--EQSPLQLLRAIVKRYEEMYVEQQSVQNNAIRDWDMYQHKE 444
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 1e-37
Identities = 58/395 (14%), Positives = 121/395 (30%), Gaps = 20/395 (5%)
Query: 448 IPSEVGNCSSLKWIDFFGNSFTGEIPTSIGRLKDLNFLHLRQNELVGQIPASLGNCHQLI 507
I N + K +S + + ++ L L N L A L +L
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 508 ILDLADNKLSGGVPASFGFLQALEQLMLYNNSLEGNLPGSLINLRNLTRINFSKNRLNGR 567
+L+L+ N L L L L L NN ++ L+ ++ ++ + N ++
Sbjct: 62 LLNLSSNVLYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNISRV 114
Query: 568 IATLCSSHSFLSFDVTNNEFDHEIPPQLGNSPSLERLRLGNNKFIG-KIPWTFGKIRELS 626
+ + + NN+ G ++ L L N+ L
Sbjct: 115 SCSRGQGKKNI--YLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLE 172
Query: 627 LLDLSGNSLTGPIPTQLLMCKKLSHIDLNNNLLSGAVPSWLGTLPQLGELKLSFNQFVGF 686
L+L N + + Q++ KL +DL++N L+ + + + + L N+ V
Sbjct: 173 HLNLQYNFIYD-VKGQVV-FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-L 228
Query: 687 LPRELFNCSKLLVLSLDGNMLNGSLPNEVGNLASLNVLTLSGNLLSGPIPPAIGRLSKLY 746
+ + L L L GN + + V T++ + +
Sbjct: 229 IEKALRFSQNLEHFDLRGNGFH-CGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPT 287
Query: 747 ELRLSNNSLNGVIPLEIGQLQNLQ----SILDLSHNNFTGQIPPSMGTLAKLEVLNLSHN 802
+ +L L+ ++L + + A+ ++
Sbjct: 288 LGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETER-LECERENQARQREIDALKE 346
Query: 803 QLVGELPSQLGEMSSLGKLNLSYNDLQGKLSKQFS 837
Q + + L L ++S
Sbjct: 347 QYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRR 381
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 1e-30
Identities = 48/246 (19%), Positives = 92/246 (37%), Gaps = 16/246 (6%)
Query: 596 GNSPSLERLRLGNNKFIGKIPWTFGKIRELSLLDLSGNSLTGPIPTQLLMCKKLSHIDLN 655
N + ++ ++ + + LDLSGN L+ L KL ++L+
Sbjct: 7 QNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLS 66
Query: 656 NNLLSGAVPSWLGTLPQLGELKLSFNQFVGFLPRELFNCSKLLVLSLDGNMLNGSLPNEV 715
+N+L + L +L L L L+ N +EL + L N ++ +
Sbjct: 67 SNVLYETLD--LESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS-RVS--C 116
Query: 716 GNLASLNVLTLSGNLLSGPIPPAIGRLSKLYELRLSNNSLNGV-IPLEIGQLQNLQSILD 774
+ L+ N ++ G S++ L L N ++ V L+ L+
Sbjct: 117 SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEH-LN 175
Query: 775 LSHNNFTGQIPPSMGTLAKLEVLNLSHNQLVGELPSQLGEMSSLGKLNLSYNDLQGKLSK 834
L +N + + AKL+ L+LS N+L + + + + ++L N L + K
Sbjct: 176 LQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEK 231
Query: 835 QFSHWP 840
Sbjct: 232 ALRFSQ 237
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 5e-45
Identities = 77/381 (20%), Positives = 138/381 (36%), Gaps = 25/381 (6%)
Query: 76 LNLSGLSLAGSISPSLGRLQSLIHLDLSSNSLTGPIPTALSNLSSLESLLLFSNQLAGTI 135
+++ + L + + ++++ L + +E L L Q+
Sbjct: 26 VHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEID 85
Query: 136 PTQLGSLTSLRVMRIGDNWLSGSIPTSFGNLVNLGTLGLASCSLSGPIPPQ-FGQLSQLE 194
+++ + +G N + P F N+ L L L LS +P F +L
Sbjct: 86 TYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSS-LPRGIFHNTPKLT 144
Query: 195 ELILQQNQLQGPIPAE-LGNCSSLSIFTAAENNLNGSIPAALGRLQNLQLLNLGNNSLSG 253
L + N L+ I + +SL + N L + L + +L N+ N LS
Sbjct: 145 TLSMSNNNLER-IEDDTFQATTSLQNLQLSSNRLT-HVD--LSLIPSLFHANVSYNLLS- 199
Query: 254 EIPSELGELSQLGYLNLMGNRLEGAIPRSFAKMGNLQSLDLSMNRLTGGIPEEFGNMGQL 313
L + L+ N + L L L N LT N L
Sbjct: 200 ----TLAIPIAVEELDASHNSINVVRGPVNV---ELTILKLQHNNLTD--TAWLLNYPGL 250
Query: 314 VFLVLSNNNISGSIPRRICTNATSLEHLILAEIQLSGEIPVELSQCQSLKQLDLSNNTLN 373
V + LS N + I LE L ++ +L + + +LK LDLS+N L
Sbjct: 251 VEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL 308
Query: 374 GTIPVELFQLVALTHLYLHNNSLVGSISPFVANLSNLQELALYHNNFQGSLPREIGMLVK 433
+ Q L +LYL +NS+V ++ + L+ L L HN++ + R +
Sbjct: 309 -HVERNQPQFDRLENLYLDHNSIV-TLKL--STHHTLKNLTLSHNDWDCNSLRAL--FRN 362
Query: 434 LELLYLYDNHLSGQIPSEVGN 454
+ + D +I ++ +
Sbjct: 363 VARPAVDDADQHCKIDYQLEH 383
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 5e-43
Identities = 69/361 (19%), Positives = 134/361 (37%), Gaps = 21/361 (5%)
Query: 158 SIPTSFGNLVNLGTLGLASCSLSGPIPPQFGQLSQLEELILQQNQLQGPIPAELGNCSSL 217
I ++ + + + + L+ + + + + ++ A L + +
Sbjct: 12 CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQV 71
Query: 218 SIFTAAENNLNGSIPAALGRLQNLQLLNLGNNSLSGEIPSELGELSQLGYLNLMGNRLEG 277
+ + + A +Q L +G N++ P + L L L N L
Sbjct: 72 ELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSS 131
Query: 278 AIPRSFAKMGNLQSLDLSMNRLTGGIPEEFGNMGQLVFLVLSNNNISGSIPRRICTNATS 337
F L +L +S N L + F L L LS+N ++ + + +
Sbjct: 132 LPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVDLSLIPS--- 187
Query: 338 LEHLILAEIQLSGEIPVELSQCQSLKQLDLSNNTLNGTIPVELFQLVALTHLYLHNNSLV 397
L H ++ LS L+ ++++LD S+N++N + + LT L L +N+L
Sbjct: 188 LFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRGPVNV--ELTILKLQHNNLT 239
Query: 398 GSISPFVANLSNLQELALYHNNFQGSLPREI-GMLVKLELLYLYDNHLSGQIPSEVGNCS 456
+ N L E+ L +N + + + +LE LY+ +N L +
Sbjct: 240 -DTAWL-LNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIP 295
Query: 457 SLKWIDFFGNSFTGEIPTSIGRLKDLNFLHLRQNELVGQIPASLGNCHQLIILDLADNKL 516
+LK +D N + + + L L+L N +V + L H L L L+ N
Sbjct: 296 TLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDW 351
Query: 517 S 517
Sbjct: 352 D 352
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 5e-42
Identities = 91/387 (23%), Positives = 151/387 (39%), Gaps = 47/387 (12%)
Query: 478 RLKDLNFLHLRQNELVGQIPASLGNCHQLIILDLADNKLSGGVPASFGFLQALEQLMLYN 537
L + + + + + A L + Q+ +L+L D ++ +F + +++L +
Sbjct: 43 TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGF 102
Query: 538 NSLEGNLPGSLINLRNLTRINFSKNRLNGRIATLCSSHSFLSFDVTNNEFDHEIPPQL-G 596
N++ P N+ LT + +N L+ +P +
Sbjct: 103 NAIRYLPPHVFQNVPLLTVLVLERNDLS------------------------SLPRGIFH 138
Query: 597 NSPSLERLRLGNNKFIGKIPW-TFGKIRELSLLDLSGNSLTGPIPTQLLMCKKLSHIDLN 655
N+P L L + NN + +I TF L L LS N LT + L+ L H +++
Sbjct: 139 NTPKLTTLSMSNNN-LERIEDDTFQATTSLQNLQLSSNRLTH-VDLSLI--PSLFHANVS 194
Query: 656 NNLLSGAVPSWLGTLPQLGELKLSFNQFVGFLPRELFNCSKLLVLSLDGNMLNGSLPNEV 715
NLLS L + EL S N + + +L +L L N L +
Sbjct: 195 YNLLST-----LAIPIAVEELDASHNSIN-VVRGPVN--VELTILKLQHNNLT-DTAW-L 244
Query: 716 GNLASLNVLTLSGNLLSGPIPPAIGRLSKLYELRLSNNSLNGVIPLEIGQLQNLQSILDL 775
N L + LS N L + ++ +L L +SNN L + L + L+ +LDL
Sbjct: 245 LNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLK-VLDL 302
Query: 776 SHNNFTGQIPPSMGTLAKLEVLNLSHNQLVGELPSQLGEMSSLGKLNLSYNDLQG-KLSK 834
SHN+ + + +LE L L HN +V L L +L L LS+ND L
Sbjct: 303 SHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDWDCNSLRA 358
Query: 835 QFSHWPAEAFEGNLHLCGSPLDHCNGL 861
F + A + C +GL
Sbjct: 359 LFRNVARPAVDDADQHCKIDYQLEHGL 385
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-28
Identities = 64/317 (20%), Positives = 129/317 (40%), Gaps = 28/317 (8%)
Query: 520 VPASFGFLQALEQLMLYNNSLEGNLPGSLINLRNLTRINFSKNRLNGRIATLCSSHSFL- 578
+ ++ + + + + + I L N + F + + A L S +
Sbjct: 13 IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVE 72
Query: 579 SFDVTNNEFDHEIPPQ-LGNSPSLERLRLGNNKFIGKIPW-TFGKIRELSLLDLSGNSLT 636
++ + + EI + ++++L +G N I +P F + L++L L N L+
Sbjct: 73 LLNLNDLQI-EEIDTYAFAYAHTIQKLYMGFNA-IRYLPPHVFQNVPLLTVLVLERNDLS 130
Query: 637 GPIPTQLLM-CKKLSHIDLNNNLLSGAVPSWLGTLPQLGELKLSFNQFVGFLPRELFNCS 695
+P + KL+ + ++NN L L L+LS N+ + L
Sbjct: 131 S-LPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTH-VDLSLI--P 186
Query: 696 KLLVLSLDGNMLNGSLPNEVGNLASLNVLTLSGNLLSGPIPPAIGRLSKLYELRLSNNSL 755
L ++ N+L + + ++ L S N ++ + + +L L+L +N+L
Sbjct: 187 SLFHANVSYNLL-----STLAIPIAVEELDASHNSINV-VRGPV--NVELTILKLQHNNL 238
Query: 756 NGVIPLEIGQLQNLQSI--LDLSHNNFTGQIPPSM-GTLAKLEVLNLSHNQLVGELPSQL 812
+ L N + +DLS+N +I + +LE L +S+N+LV L
Sbjct: 239 T-----DTAWLLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLV-ALNLYG 291
Query: 813 GEMSSLGKLNLSYNDLQ 829
+ +L L+LS+N L
Sbjct: 292 QPIPTLKVLDLSHNHLL 308
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 6e-24
Identities = 52/280 (18%), Positives = 94/280 (33%), Gaps = 38/280 (13%)
Query: 591 IPPQLGNSPSLERLRLGNNKFIGKIPWTFGKIRELSLLDLSGNSLTGPIPTQLLMCKKLS 650
I L + + + + ++ +++ L +++
Sbjct: 13 IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVE 72
Query: 651 HIDLNNNLLSGAVPSWLGTLPQLGELKLSFNQFVGFLPRELFNCSKLLVLSLDGNMLNGS 710
++LN+ + + +L + FN P N L VL L+ N L+ S
Sbjct: 73 LLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-S 131
Query: 711 LPNEV-GNLASLNVLTLSGNLLSGPIPPAIGR-LSKLYELRLSNNSLNGVIPLEIGQLQN 768
LP + N L L++S N L I + + L L+LS+N L +++ + +
Sbjct: 132 LPRGIFHNTPKLTTLSMSNNNLER-IEDDTFQATTSLQNLQLSSNRLTH---VDLSLIPS 187
Query: 769 LQSI------------------LDLSHNNFTGQIPPSMGTLAKLEVLNLSHNQLVGELPS 810
L LD SHN+ + +L +L L HN L +
Sbjct: 188 LFHANVSYNLLSTLAIPIAVEELDASHNSIN-VVRG--PVNVELTILKLQHNNLTD--TA 242
Query: 811 QLGEMSSLGKLNLSYNDLQGKLSKQFSHWPAEAFEGNLHL 850
L L +++LSYN + F L
Sbjct: 243 WLLNYPGLVEVDLSYN--------ELEKIMYHPFVKMQRL 274
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 2e-13
Identities = 27/172 (15%), Positives = 54/172 (31%), Gaps = 13/172 (7%)
Query: 681 NQFVGFLPRELFNCSKLLVLSLDGNMLNGSLPNEVGNLASLNVLTLSGNLLSGPIPPAIG 740
+ L + +D + E L + ++T + + +
Sbjct: 7 QPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLD 66
Query: 741 RLSKLYELRLSNNSLNGVIPLEIGQLQNLQSILDLSHNNFTGQIPPSM-GTLAKLEVLNL 799
++ L L++ + + +Q L + N +PP + + L VL L
Sbjct: 67 SFRQVELLNLNDLQIEEIDTYAFAYAHTIQK-LYMGFNAIR-YLPPHVFQNVPLLTVLVL 124
Query: 800 SHNQLVGELPSQL-GEMSSLGKLNLSYNDLQGKLSKQFSHWPAEAFEGNLHL 850
N L LP + L L++S N+L + F+ L
Sbjct: 125 ERNDLS-SLPRGIFHNTPKLTTLSMSNNNL--------ERIEDDTFQATTSL 167
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 4e-44
Identities = 93/473 (19%), Positives = 159/473 (33%), Gaps = 39/473 (8%)
Query: 76 LNLSGLSLAGSISPSLGRLQSLIHLDLSSNSLTGPIPTALSNLSSLESLLLFSNQLAGTI 135
+++ + L + + ++++ L + +E L L Q+
Sbjct: 32 VHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEID 91
Query: 136 PTQLGSLTSLRVMRIGDNWLSGSIPTSFGNLVNLGTLGLASCSLSGPIPPQ-FGQLSQLE 194
+++ + +G N + P F N+ L L L LS +P F +L
Sbjct: 92 TYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSS-LPRGIFHNTPKLT 150
Query: 195 ELILQQNQLQGPIPAE-LGNCSSLSIFTAAENNLNGSIPAALGRLQNLQLLNLGNNSLSG 253
L + N L+ I + +SL + N L + L + +L N+ N L
Sbjct: 151 TLSMSNNNLER-IEDDTFQATTSLQNLQLSSNRLT-HVD--LSLIPSLFHANVSYNLL-- 204
Query: 254 EIPSELGELSQLGYLNLMGNRLEGAIPRSFAKMGNLQSLDLSMNRLTGGIPEEFGNMGQL 313
S L + L+ N + L L L N LT N L
Sbjct: 205 ---STLAIPIAVEELDASHNSINVVRGPVNV---ELTILKLQHNNLTD--TAWLLNYPGL 256
Query: 314 VFLVLSNNNISGSIPRRICTNATSLEHLILAEIQLSGEIPVELSQCQSLKQLDLSNNTLN 373
V + LS N + I LE L ++ +L + + +LK LDLS+N L
Sbjct: 257 VEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL 314
Query: 374 GTIPVELFQLVALTHLYLHNNSLVGSISPFVANLSNLQELALYHNNFQGSLPREIGMLVK 433
+ Q L +LYL +NS+V ++ + L+ L L HN++ + R + V
Sbjct: 315 -HVERNQPQFDRLENLYLDHNSIV-TLKL--STHHTLKNLTLSHNDWDCNSLRALFRNVA 370
Query: 434 LELLYLYDNHLSGQIPSEVGNCSSLKWIDFFGNSFTGEIPTSIGRLKDLNFLHLRQNELV 493
+ D H E G C S D ++ +V
Sbjct: 371 RPAVDDADQHCKIDYQLEHGLCCK----------------ESDKPYLDRLLQYIALTSVV 414
Query: 494 GQIPASLGNCHQLIILDLADNKLSGGVPASFGFLQALEQLMLYNNSLEGNLPG 546
++ + G C ++ + LQ EQL N L +
Sbjct: 415 EKVQRAQGRCSATDTINSVQSLSHYITQQGGVPLQGNEQLEAEVNELRAEVQQ 467
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 155 bits (392), Expect = 2e-39
Identities = 69/361 (19%), Positives = 134/361 (37%), Gaps = 21/361 (5%)
Query: 158 SIPTSFGNLVNLGTLGLASCSLSGPIPPQFGQLSQLEELILQQNQLQGPIPAELGNCSSL 217
I ++ + + + + L+ + + + + ++ A L + +
Sbjct: 18 CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQV 77
Query: 218 SIFTAAENNLNGSIPAALGRLQNLQLLNLGNNSLSGEIPSELGELSQLGYLNLMGNRLEG 277
+ + + A +Q L +G N++ P + L L L N L
Sbjct: 78 ELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSS 137
Query: 278 AIPRSFAKMGNLQSLDLSMNRLTGGIPEEFGNMGQLVFLVLSNNNISGSIPRRICTNATS 337
F L +L +S N L + F L L LS+N ++ + + +
Sbjct: 138 LPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVDLSLIPS--- 193
Query: 338 LEHLILAEIQLSGEIPVELSQCQSLKQLDLSNNTLNGTIPVELFQLVALTHLYLHNNSLV 397
L H ++ LS L+ ++++LD S+N++N + + LT L L +N+L
Sbjct: 194 LFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRGPVNV--ELTILKLQHNNLT 245
Query: 398 GSISPFVANLSNLQELALYHNNFQGSLPREI-GMLVKLELLYLYDNHLSGQIPSEVGNCS 456
+ N L E+ L +N + + + +LE LY+ +N L +
Sbjct: 246 -DTAWL-LNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIP 301
Query: 457 SLKWIDFFGNSFTGEIPTSIGRLKDLNFLHLRQNELVGQIPASLGNCHQLIILDLADNKL 516
+LK +D N + + + L L+L N +V + L H L L L+ N
Sbjct: 302 TLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDW 357
Query: 517 S 517
Sbjct: 358 D 358
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 8e-29
Identities = 64/333 (19%), Positives = 129/333 (38%), Gaps = 50/333 (15%)
Query: 504 HQLIILDLADNKLSGGVPASFGF--LQALEQLMLYNNSLEGNLPGSLINLRNLTRINFSK 561
+ + D+ + + V F L + + N+++ L + R + +N +
Sbjct: 25 YDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLND 84
Query: 562 NRLNGRIATLCSSHSFLSFDVTNNEFDHEIPPQ-LGNSPSLERLRLGNNKFIGKIPW-TF 619
++ EI + ++++L +G N I +P F
Sbjct: 85 LQI------------------------EEIDTYAFAYAHTIQKLYMGFNA-IRYLPPHVF 119
Query: 620 GKIRELSLLDLSGNSLTGPIPTQLLM-CKKLSHIDLNNNLLSGAVPSWLGTLPQLGELKL 678
+ L++L L N L+ +P + KL+ + ++NN L L L+L
Sbjct: 120 QNVPLLTVLVLERNDLSS-LPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQL 178
Query: 679 SFNQFVGFLPRELFNCSKLLVLSLDGNMLNGSLPNEVGNLASLNVLTLSGNLLSGPIPPA 738
S N+ + L L ++ N+L+ + ++ L S N ++ +
Sbjct: 179 SSNRLT-HVDLSLI--PSLFHANVSYNLLS-----TLAIPIAVEELDASHNSINV-VRGP 229
Query: 739 IGRLSKLYELRLSNNSLNGVIPLEIGQLQNLQSI--LDLSHNNFTGQIPPSMGTLAKLEV 796
+ +L L+L +N+L + L N + +DLS+N + + +LE
Sbjct: 230 V--NVELTILKLQHNNLT-----DTAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLER 282
Query: 797 LNLSHNQLVGELPSQLGEMSSLGKLNLSYNDLQ 829
L +S+N+LV L + +L L+LS+N L
Sbjct: 283 LYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL 314
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 60.7 bits (147), Expect = 2e-09
Identities = 18/142 (12%), Positives = 41/142 (28%), Gaps = 11/142 (7%)
Query: 710 SLPNEVGNLASLNVLTLSGNLLSGPIPPAIGRLSKLYELRLSNNSLNGVIPLEIGQLQNL 769
+ + + + + L+ + N+++ + + + +
Sbjct: 18 CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQV 77
Query: 770 QSILDLSHNNFTGQIPPSM-GTLAKLEVLNLSHNQLVGELPSQLGEMSSLGKLNLSYNDL 828
+ L+L+ +I ++ L + N + P + L L L NDL
Sbjct: 78 EL-LNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDL 135
Query: 829 QGKLSKQFSHWPAEAFEGNLHL 850
S P F L
Sbjct: 136 --------SSLPRGIFHNTPKL 149
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 7e-43
Identities = 64/334 (19%), Positives = 118/334 (35%), Gaps = 21/334 (6%)
Query: 230 SIPAALGRLQNLQLLNLGNNSLSGEIPSELGELSQLGYLNLMGNRLEGAIPRSFAKMGNL 289
+I ++ + ++SL + S + L+L GN L A L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 290 QSLDLSMNRLTGGIPEEFGNMGQLVFLVLSNNNISGSIPRRICTNATSLEHLILAEIQLS 349
+ L+LS N L + ++ L L L+NN + + S+E L A +S
Sbjct: 61 ELLNLSSNVLYE--TLDLESLSTLRTLDLNNNYVQ-ELL-----VGPSIETLHAANNNIS 112
Query: 350 GEIPVELSQCQSLKQLDLSNNTLNGTIPVELFQLVALTHLYLHNNSLVG-SISPFVANLS 408
V S+ Q K + L+NN + ++ + +L L N + + + A+
Sbjct: 113 R---VSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSD 169
Query: 409 NLQELALYHNNFQGSLPREIGMLVKLELLYLYDNHLSGQIPSEVGNCSSLKWIDFFGNSF 468
L+ L L +N + ++ KL+ L L N L+ + E + + + WI N
Sbjct: 170 TLEHLNLQYNFIY-DVKGQVV-FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKL 226
Query: 469 TGEIPTSIGRLKDLNFLHLRQNELV-GQIPASLGNCHQLIILDLADNKLSGGVPASFGFL 527
I ++ ++L LR N G + ++ + K +
Sbjct: 227 V-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVK---KLTGQNEEE 282
Query: 528 QALEQLMLYNNSLEGNLPG-SLINLRNLTRINFS 560
+ L Y +LP L L +
Sbjct: 283 CTVPTLGHYGAYCCEDLPAPFADRLIALGHHHHH 316
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 8e-39
Identities = 56/358 (15%), Positives = 101/358 (28%), Gaps = 66/358 (18%)
Query: 86 SISPSLGRLQSLIHLDLSSNSLTGPIPTALSNLSSLESLLLFSNQLAGTIPTQLGSLTSL 145
+I ++ +SL + + + +++ L L N L+ L T L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 146 RVMRIGDNWLSGSIPTSFGNLVNLGTLGLASCSLSGPIPPQFGQLSQLEELILQQNQLQG 205
++ + N L LS L L L N +Q
Sbjct: 61 ELLNLSSNVLYE--------------------------TLDLESLSTLRTLDLNNNYVQ- 93
Query: 206 PIPAELGNCSSLSIFTAAENNLNGSIPAALGRLQNLQLLNLGNNSLSGEIPSELGELSQL 265
L +++ L+ NN++S +
Sbjct: 94 ----------------------------ELLVGPSIETLHAANNNIS-RVSCSR--GQGK 122
Query: 266 GYLNLMGNRLEGAIPRSFAKMGNLQSLDLSMNRLTG-GIPEEFGNMGQLVFLVLSNNNIS 324
+ L N++ +Q LDL +N + E + L L L N I
Sbjct: 123 KNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY 182
Query: 325 GSIPRRICTNATSLEHLILAEIQLSGEIPVELSQCQSLKQLDLSNNTLNGTIPVELFQLV 384
+ ++ L+ L L+ +L+ + E + + L NN L I L
Sbjct: 183 -DVKGQV--VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQ 237
Query: 385 ALTHLYLHNNSLVGSISPFVANLSNLQELALYHNNFQGSLPREIGMLVKLELLYLYDN 442
L H L N + N + + + L + + L Y
Sbjct: 238 NLEHFDLRGNGFH-CGTLRDFFSKNQRVQTVAKQTVK-KLTGQNEEECTVPTLGHYGA 293
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 4e-38
Identities = 57/318 (17%), Positives = 114/318 (35%), Gaps = 17/318 (5%)
Query: 76 LNLSGLSLAGSISPSLGRLQSLIHLDLSSNSLTGPIPTALSNLSSLESLLLFSNQLAGTI 135
++ SL +++ ++ LDLS N L+ L+ + LE L L SN L
Sbjct: 15 EKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVL--YE 72
Query: 136 PTQLGSLTSLRVMRIGDNWLSGSIPTSFGNLVNLGTLGLASCSLSGPIPPQFGQLSQLEE 195
L SL++LR + + +N++ ++ TL A+ ++S + + +
Sbjct: 73 TLDLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNISR-VSC--SRGQGKKN 124
Query: 196 LILQQNQLQGPIPAELGNCSSLSIFTAAENNLNG-SIPAALGRLQNLQLLNLGNNSLSGE 254
+ L N++ + G S + N ++ + L+ LNL N + +
Sbjct: 125 IYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-D 183
Query: 255 IPSELGELSQLGYLNLMGNRLEGAIPRSFAKMGNLQSLDLSMNRLTGGIPEEFGNMGQLV 314
+ ++ ++L L+L N+L + F + + L N+L I + L
Sbjct: 184 VKGQVV-FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLE 240
Query: 315 FLVLSNNNISGSIPRRICTNATSLEHLILAEIQLSGEIPVELSQCQSLKQLDLSNNTLNG 374
L N R + ++ + ++ E C
Sbjct: 241 HFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEE--CTVPTLGHYGAYCCED 298
Query: 375 TIPVELFQLVALTHLYLH 392
+L+AL H + H
Sbjct: 299 LPAPFADRLIALGHHHHH 316
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 2e-35
Identities = 49/250 (19%), Positives = 88/250 (35%), Gaps = 16/250 (6%)
Query: 581 DVTNNEFDHEIPPQLGNSPSLERLRLGNNKFIGKIPWTFGKIRELSLLDLSGNSLTGPIP 640
VT++ + ++ +++ L L N +L LL+LS N L +
Sbjct: 16 KVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD 75
Query: 641 TQLLMCKKLSHIDLNNNLLSGAVPSWLGTLPQLGELKLSFNQFVGFLPRELFNCSKLLVL 700
+ L L +DLNNN + L P + L + N + +
Sbjct: 76 LESL--STLRTLDLNNNYVQE-----LLVGPSIETLHAANNNI-SRVSCSRG--QGKKNI 125
Query: 701 SLDGNMLNGSLPNEVGNLASLNVLTLSGNLLSG-PIPPAIGRLSKLYELRLSNNSLNGVI 759
L N + + G + + L L N + L L L N + +
Sbjct: 126 YLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DV 184
Query: 760 PLEIGQLQNLQSILDLSHNNFTGQIPPSMGTLAKLEVLNLSHNQLVGELPSQLGEMSSLG 819
++ L++ LDLS N + P + A + ++L +N+LV + L +L
Sbjct: 185 KGQV-VFAKLKT-LDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLE 240
Query: 820 KLNLSYNDLQ 829
+L N
Sbjct: 241 HFDLRGNGFH 250
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 1e-34
Identities = 58/379 (15%), Positives = 120/379 (31%), Gaps = 64/379 (16%)
Query: 302 GIPEEFGNMGQLVFLVLSNNNISGSIPRRICTNATSLEHLILAEIQLSGEIPVELSQCQS 361
I E N + ++++++ + +A +++ L L+ LS +L+
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLK-QALASLRQSAWNVKELDLSGNPLSQISAADLAPFTK 59
Query: 362 LKQLDLSNNTLNGTIPVELFQLVALTHLYLHNNSLVGSISPFVANLSNLQELALYHNNFQ 421
L+ L+LS+N L +L L L L L+NN + + +++ L +NN
Sbjct: 60 LELLNLSSNVLY-ETL-DLESLSTLRTLDLNNNYV-QELLV----GPSIETLHAANNNIS 112
Query: 422 GSLPREIGMLVKLELLYLYDNHLSGQIPSEVGNCSSLKWIDFFGNSFTG-EIPTSIGRLK 480
+ + +YL +N ++ + G S ++++D N
Sbjct: 113 -RVSCSR--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSD 169
Query: 481 DLNFLHLRQNELVGQIPASLGNCHQLIILDLADNKLSGGVPASFGFLQALEQLMLYNNSL 540
L L+L+ N + + + +L LDL+ NKL+ + F + + L NN L
Sbjct: 170 TLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKL 226
Query: 541 EGNLPGSLINLRNLTRINFSKNRLNGRIATLCSSHSFLSFDVTNNEFDHEIPPQLGNSPS 600
+ +L +NL + N + +
Sbjct: 227 V-LIEKALRFSQNLEHFDLRGNGFH--------------------------------CGT 253
Query: 601 LERLRLGNNKFIGKIPWTFGKIRELSLLDLSGNSLTGPIPTQLLMCKKLSHIDLNNNLLS 660
L N + + ++ ++ C +
Sbjct: 254 LRDFFSKNQR----------------VQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCE 297
Query: 661 GAVPSWLGTLPQLGELKLS 679
+ L LG
Sbjct: 298 DLPAPFADRLIALGHHHHH 316
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 5e-34
Identities = 62/329 (18%), Positives = 114/329 (34%), Gaps = 40/329 (12%)
Query: 496 IPASLGNCHQLIILDLADNKLSGGVPASFGFLQALEQLMLYNNSLEGNLPGSLINLRNLT 555
I N ++ I + D+ L + + +++L L N L L L
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 556 RINFSKNRLNGRIATLCSSHSFLSFDVTNNEFDHEIPPQLGNSPSLERLRLGNNKFIGKI 615
+N S N L +E L + +L L L NN + ++
Sbjct: 62 LLNLSSNVL------------------------YETLD-LESLSTLRTLDLNNNY-VQEL 95
Query: 616 PWTFGKIRELSLLDLSGNSLTGPIPTQLLMCKKLSHIDLNNNLLSGAVPSWLGTLPQLGE 675
+ L + N+++ + + +I L NN ++ G ++
Sbjct: 96 L----VGPSIETLHAANNNISR-VSCSRG--QGKKNIYLANNKITMLRDLDEGCRSRVQY 148
Query: 676 LKLSFNQFVGFLPRELF-NCSKLLVLSLDGNMLNGSLPNEVGNLASLNVLTLSGNLLSGP 734
L L N+ EL + L L+L N + + +V A L L LS N L+
Sbjct: 149 LDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLAF- 205
Query: 735 IPPAIGRLSKLYELRLSNNSLNGVIPLEIGQLQNLQSILDLSHNNFT-GQIPPSMGTLAK 793
+ P + + + L NN L +I + QNL+ DL N F G + +
Sbjct: 206 MGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEH-FDLRGNGFHCGTLRDFFSKNQR 263
Query: 794 LEVLNLSHNQLVGELPSQLGEMSSLGKLN 822
++ + + + + + +LG
Sbjct: 264 VQTVAKQTVKKLTGQNEEECTVPTLGHYG 292
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 3e-17
Identities = 30/142 (21%), Positives = 60/142 (42%), Gaps = 12/142 (8%)
Query: 689 RELF-NCSKLLVLSLDGNMLNGSLPNEVGNLASLNVLTLSGNLLSGPIPPAIGRLSKLYE 747
E+ N ++ + + + L +L + + ++ L LSGN LS + +KL
Sbjct: 3 HEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLEL 62
Query: 748 LRLSNNSLNGVIPLEIGQLQNLQSILDLSHNNFTGQIPPSMGTLAKLEVLNLSHNQLVGE 807
L LS+N L + + L L++ LDL++N + +E L+ ++N +
Sbjct: 63 LNLSSNVLYETLD--LESLSTLRT-LDLNNNYVQ-----ELLVGPSIETLHAANNNI-SR 113
Query: 808 LPSQLGEMSSLGKLNLSYNDLQ 829
+ G + L+ N +
Sbjct: 114 VSCSRG--QGKKNIYLANNKIT 133
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 7e-17
Identities = 26/143 (18%), Positives = 54/143 (37%), Gaps = 18/143 (12%)
Query: 710 SLPNEVGNLASLNVLTLSGNLLSGPIPPAIGRLSKLYELRLSNNSLNGVIPLEIGQLQNL 769
++ N + ++ + L + + EL LS N L+ + ++ L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 770 QSILDLSHNNFTGQIPPSMGTLAKLEVLNLSHNQLVGELPSQLGEMSSLGKLNLSYNDLQ 829
+ L+LS N + +L+ L L+L++N + +L S+ L+ + N
Sbjct: 61 EL-LNLSSNVLYE--TLDLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANN--- 109
Query: 830 GKLSKQFSHWPAEAFEG--NLHL 850
S +G N++L
Sbjct: 110 -----NISRVSCSRGQGKKNIYL 127
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 2e-16
Identities = 30/197 (15%), Positives = 60/197 (30%), Gaps = 6/197 (3%)
Query: 75 SLNLSGLSLAGSISPSLGRLQSLIHLDLSSNSLTG-PIPTALSNLSSLESLLLFSNQLAG 133
++ L+ + G + +LDL N + ++ +LE L L N +
Sbjct: 124 NIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY- 182
Query: 134 TIPTQLGSLTSLRVMRIGDNWLSGSIPTSFGNLVNLGTLGLASCSLSGPIPPQFGQLSQL 193
+ Q+ L+ + + N L+ + F + + + L + L I L
Sbjct: 183 DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNL 239
Query: 194 EELILQQNQLQGPIPAELGNCSSLSIFTAAENNLNGSIPAALGRLQNLQLLNLGNNSLSG 253
E L+ N + + T A+ + L + G
Sbjct: 240 EHFDLRGNGFHC-GTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCED 298
Query: 254 EIPSELGELSQLGYLNL 270
L LG+ +
Sbjct: 299 LPAPFADRLIALGHHHH 315
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 5e-42
Identities = 76/361 (21%), Positives = 131/361 (36%), Gaps = 39/361 (10%)
Query: 65 TCGSSSARVVSLNLSGLSLAGSISPSLGRLQSLIHLDLSSNSLTGPIPTALSNLSSLESL 124
C S+ R V + ++ + LDL N + ++ LE L
Sbjct: 8 EC-SAQDRAVLCHRKRFV---AVPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEEL 61
Query: 125 LLFSNQLAGTIPTQLGSLTSLRVMRIGDNWLSGSIPT-SFGNLVNLGTLGLASCSLSGPI 183
L N ++ P +L +LR + + N L IP F L NL L ++ + +
Sbjct: 62 ELNENIVSAVEPGAFNNLFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIVILL 120
Query: 184 PPQFGQLSQLEELILQQNQLQGPIPAELGNCSSLSIFTAAENNLNGSIPAALGRLQNLQL 243
F L L+ L + N L +S A L +L+
Sbjct: 121 DYMFQDLYNLKSLEVGDNDL-----------VYIS-------------HRAFSGLNSLEQ 156
Query: 244 LNLGNNSLSGEIPSE-LGELSQLGYLNLMGNRLEGAIPRSFAKMGNLQSLDLSMNRLTGG 302
L L +L+ IP+E L L L L L + SF ++ L+ L++S
Sbjct: 157 LTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDT 215
Query: 303 IPEEFGNMGQLVFLVLSNNNISGSIPRRICTNATSLEHLILAEIQLSGEIPVELSQCQSL 362
+ L L +++ N++ ++P + L L L+ +S L + L
Sbjct: 216 MTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRL 274
Query: 363 KQLDLSNNTLNGTIPVELFQ-LVALTHLYLHNNSLVGSISPFV-ANLSNLQELALYHNNF 420
+++ L L + F+ L L L + N L ++ V ++ NL+ L L N
Sbjct: 275 QEIQLVGGQLA-VVEPYAFRGLNYLRVLNVSGNQLT-TLEESVFHSVGNLETLILDSNPL 332
Query: 421 Q 421
Sbjct: 333 A 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 2e-40
Identities = 71/327 (21%), Positives = 128/327 (39%), Gaps = 10/327 (3%)
Query: 242 QLLNLGNNSLSGEIPSELGELSQLGYLNLMGNRLEGAIPRSFAKMGNLQSLDLSMNRLTG 301
+ + +P + ++ L+L NR++ FA +L+ L+L+ N ++
Sbjct: 14 RAVLCHRKRFV-AVPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSA 70
Query: 302 GIPEEFGNMGQLVFLVLSNNNISGSIPRRICTNATSLEHLILAEIQLSGEIPVELSQCQS 361
P F N+ L L L +N + IP + T ++L L ++E ++ + +
Sbjct: 71 VEPGAFNNLFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYN 129
Query: 362 LKQLDLSNNTLNGTIPVELFQ-LVALTHLYLHNNSLVGSISPFV-ANLSNLQELALYHNN 419
LK L++ +N L I F L +L L L +L SI ++L L L L H N
Sbjct: 130 LKSLEVGDNDLV-YISHRAFSGLNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLN 187
Query: 420 FQGSLPREIGMLVKLELLYLYDNHLSGQIPSEVGNCSSLKWIDFFGNSFTGEIPT-SIGR 478
L +L++L + + +L + + T +P ++
Sbjct: 188 INAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRH 246
Query: 479 LKDLNFLHLRQNELVGQIPASLGNCHQLIILDLADNKLSGGVPASFGFLQALEQLMLYNN 538
L L FL+L N + + L +L + L +L+ P +F L L L + N
Sbjct: 247 LVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGN 306
Query: 539 SLEGNLPGSLINLRNLTRINFSKNRLN 565
L ++ NL + N L
Sbjct: 307 QLTTLEESVFHSVGNLETLILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 3e-39
Identities = 76/374 (20%), Positives = 130/374 (34%), Gaps = 60/374 (16%)
Query: 99 HLDLSSNSLTGPIPTALSNLSSLESLLLFSNQLAGTIPTQLGSLTSLRVMRIGDNWLSGS 158
+ +P + + L L N++ + S L + + +N +S
Sbjct: 15 AVLCHRKRFVA-VPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAV 71
Query: 159 IPTSFGNLVNLGTLGLASCSLSGPIPPQ-FGQLSQLEELILQQNQLQGPIPAELGNCSSL 217
P +F NL NL TLGL S L IP F LS L +L + +N++ +
Sbjct: 72 EPGAFNNLFNLRTLGLRSNRLKL-IPLGVFTGLSNLTKLDISENKIVI-LL--------- 120
Query: 218 SIFTAAENNLNGSIPAALGRLQNLQLLNLGNNSLSGEIPSELGELSQLGYLNLMGNRLEG 277
L NL+ L +G+N L I
Sbjct: 121 --------------DYMFQDLYNLKSLEVGDNDLV-YIS--------------------- 144
Query: 278 AIPRSFAKMGNLQSLDLSMNRLTGGIPEEFGNMGQLVFLVLSNNNISGSIPRRICTNATS 337
R+F+ + +L+ L L LT E ++ L+ L L + NI+ +I
Sbjct: 145 --HRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNIN-AIRDYSFKRLYR 201
Query: 338 LEHLILAEIQLSGEIPVELSQCQSLKQLDLSNNTLNGTIPVELFQ-LVALTHLYLHNNSL 396
L+ L ++ + +L L +++ L +P + LV L L L N +
Sbjct: 202 LKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPI 260
Query: 397 VGSISPFV-ANLSNLQELALYHNNFQGSLPREI-GMLVKLELLYLYDNHLSGQIPSEVGN 454
+I + L LQE+ L + L L +L + N L+ S +
Sbjct: 261 S-TIEGSMLHELLRLQEIQLVGGQLA-VVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHS 318
Query: 455 CSSLKWIDFFGNSF 468
+L+ + N
Sbjct: 319 VGNLETLILDSNPL 332
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 2e-32
Identities = 80/363 (22%), Positives = 122/363 (33%), Gaps = 70/363 (19%)
Query: 506 LIILDLADNKLSGGVPASFGFLQALEQLMLYNNSLEGNLPGSLINLRNLTRINFSKNRLN 565
+LDL N++ F LE+L L N + PG+ NL NL + NRL
Sbjct: 34 TRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRL- 92
Query: 566 GRIATLCSSHSFLSFDVTNNEFDHEIPPQ-LGNSPSLERLRLGNNKFIGKIPW-TFGKIR 623
IP +L +L + NK I + F +
Sbjct: 93 -----------------------KLIPLGVFTGLSNLTKLDISENK-IVILLDYMFQDLY 128
Query: 624 ELSLLDLSGNSLTGPIPTQLLMCKKLSHIDLNNNLLSGAVPSWLGTLPQLGELKLSFNQF 683
L L++ N L +++ SG L L +L L
Sbjct: 129 NLKSLEVGDNDLV----------------YISHRAFSG--------LNSLEQLTLEKCNL 164
Query: 684 VGFLPRELFNCSKLLVLSLDGNMLNGSLPNEVGNLASLNVLTLSGNLLSGPIPPAIGRLS 743
L + L+VL L +N L L VL +S + P
Sbjct: 165 TSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGL 224
Query: 744 KLYELRLSNNSLNGVIPLEIGQLQNLQSILDLSHNNFTGQIPPSM-GTLAKLEVLNLSHN 802
L L +++ +L V L + L L+ L+LS+N + I SM L +L+ + L
Sbjct: 225 NLTSLSITHCNLTAVPYLAVRHLVYLRF-LNLSYNPIS-TIEGSMLHELLRLQEIQLVGG 282
Query: 803 QLVGELPSQ-LGEMSSLGKLNLSYNDLQGKLSKQFSHWPAEAFEGN-----LHLCGSPLD 856
QL + ++ L LN+S N L + F L L +PL
Sbjct: 283 QL-AVVEPYAFRGLNYLRVLNVSGNQL--------TTLEESVFHSVGNLETLILDSNPL- 332
Query: 857 HCN 859
C+
Sbjct: 333 ACD 335
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 7e-32
Identities = 72/373 (19%), Positives = 120/373 (32%), Gaps = 59/373 (15%)
Query: 437 LYLYDNHLSGQIPSEVGNCSSLKWIDFFGNSFTGEIPTSIGRLKDLNFLHLRQNELVGQI 496
+ + +P + + + +D N L L L +N +
Sbjct: 16 VLCHRKRFV-AVPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVE 72
Query: 497 PASLGNCHQLIILDLADNKLSGGVPASFGFLQALEQLMLYNNSLEGNLPGSLINLRNLTR 556
P + N L L L N+L F L L +L + N + L +L NL
Sbjct: 73 PGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKS 132
Query: 557 INFSKNRLNGRIATLCSSHSFLSFDVTNNEFDHEIPPQ-LGNSPSLERLRLGNNKFIGKI 615
+ N L I + SLE+L L + I
Sbjct: 133 LEVGDNDL------------------------VYISHRAFSGLNSLEQLTLEKCN-LTSI 167
Query: 616 PW-TFGKIRELSLLDLSGNSLTGPIPTQLLMCKKLSHIDLNNNLLSGAVPSWLGTLPQLG 674
P + L +L L ++ + + L +L
Sbjct: 168 PTEALSHLHGLIVLRLRHLNIN----------------AIRDYSFKR--------LYRLK 203
Query: 675 ELKLSFNQFVGFLPRELFNCSKLLVLSLDGNMLNGSLPNEV-GNLASLNVLTLSGNLLSG 733
L++S ++ + L LS+ L ++P +L L L LS N +S
Sbjct: 204 VLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPIST 262
Query: 734 PIPPAIGRLSKLYELRLSNNSLNGVIPLEIGQLQNLQSILDLSHNNFTGQIPPSM-GTLA 792
+ L +L E++L L V P L L+ +L++S N T + S+ ++
Sbjct: 263 IEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLR-VLNVSGNQLT-TLEESVFHSVG 320
Query: 793 KLEVLNLSHNQLV 805
LE L L N L
Sbjct: 321 NLETLILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 3e-24
Identities = 53/229 (23%), Positives = 85/229 (37%), Gaps = 11/229 (4%)
Query: 623 RELSLLDLSGNSLTGPIPTQLLMCKKLSHIDLNNNLLSGAVPSWLGTLPQLGELKLSFNQ 682
E LLDL N + + L ++LN N++S P L L L L N+
Sbjct: 32 TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNR 91
Query: 683 FVGFLPRELF-NCSKLLVLSLDGNMLNGSLPNEVGNLASLNVLTLSGNLLSGPIPPAIGR 741
+P +F S L L + N + L +L +L L + N L A
Sbjct: 92 LKL-IPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSG 150
Query: 742 LSKLYELRLSNNSLNGVIPLEIGQLQNLQSILDLSHNNFTGQIPPSMGTLAKLEVLNLSH 801
L+ L +L L +L + + L L L L H N S L +L+VL +SH
Sbjct: 151 LNSLEQLTLEKCNLTSIPTEALSHLHGLIV-LRLRHLNINAIRDYSFKRLYRLKVLEISH 209
Query: 802 NQLVGELPSQLGEMSSLGKLNLSYNDLQGKLSKQFSHWPAEAFEGNLHL 850
+ + +L L++++ + P A ++L
Sbjct: 210 WPYLDTMTPNCLYGLNLTSLSITHC--------NLTAVPYLAVRHLVYL 250
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 4e-41
Identities = 68/294 (23%), Positives = 120/294 (40%), Gaps = 49/294 (16%)
Query: 954 IGSGGSGTVYKAE-LANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHC 1012
+G GG G V++A+ + A+K+I + L + REVK L ++ H +V+
Sbjct: 13 LGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAW 72
Query: 1013 CNKG-------AGSNLLIY---EYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLA 1062
K + + +Y + ++ DW++ + + + L I + +A
Sbjct: 73 LEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGR----CTIEERERSVCLHIFLQIA 128
Query: 1063 QGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNT--------E 1114
+ VE+LH ++HRD+K SNI + +GDFGL A+ +D T
Sbjct: 129 EAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYA 185
Query: 1115 SNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVE 1174
+T G+ Y++PE + + K D++S+G++L EL+ P F +M+
Sbjct: 186 RHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL---YP----FSTQME------ 232
Query: 1175 MHMEMSGSAREELLDDQMKPLLPGEECAAYQVL-EIALQCTKTSPQERPSSRQV 1227
R L D P Y + SP ERP + +
Sbjct: 233 ---------RVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINI 277
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 1e-39
Identities = 69/309 (22%), Positives = 131/309 (42%), Gaps = 59/309 (19%)
Query: 953 IIGSGGSGTVYKAE-LANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGH 1011
+IGSGG G V+KA+ +G T +K++ N+ REVK L ++ H ++V G
Sbjct: 18 LIGSGGFGQVFKAKHRIDGKTYVIKRVKYN-----NEKAEREVKALAKLDHVNIVHYNGC 72
Query: 1012 -------------CCNKGAGSNLLIY-EYMENGSVWDWLHKQPVNIKMRKSLDWEARLKI 1057
++ L I E+ + G++ W+ K+ + LD L++
Sbjct: 73 WDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR-----GEKLDKVLALEL 127
Query: 1058 AVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNT 1117
+ +GV+Y+H K+++RD+K SNI L + +GDFGL +L N T
Sbjct: 128 FEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSL-----KNDGKRT 179
Query: 1118 WFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHM 1177
G+ Y++PE S ++ D+Y++G++L EL+
Sbjct: 180 RSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT-----------------AF 222
Query: 1178 EMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNVFNN 1237
E S + D ++ + + + + P++RP++ ++ L
Sbjct: 223 ETS-----KFFTDLRDGIIS--DIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLT--VWK 273
Query: 1238 RIVDFDKLH 1246
+ + ++ H
Sbjct: 274 KSPEKNERH 282
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 4e-39
Identities = 91/517 (17%), Positives = 181/517 (35%), Gaps = 41/517 (7%)
Query: 75 SLNLSGLSLAGSISPSLGRLQSLIHLDLSSNSLTGPIPTALSNLSSLESLLLFSNQLAGT 134
++ S L + L + L++S N ++ + + +LS L L++ N++
Sbjct: 4 LVDRSKNGLI-HVPKDLSQ--KTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYL 60
Query: 135 IPTQLGSLTSLRVMRIGDNWLSGSIPTSFGNLVNLGTLGLASCSL-SGPIPPQFGQLSQL 193
+ L + + N L I VNL L L+ + + PI +FG +SQL
Sbjct: 61 DISVFKFNQELEYLDLSHNKLV-KIS--CHPTVNLKHLDLSFNAFDALPICKEFGNMSQL 117
Query: 194 EELILQQNQLQGPIPAELGNCSSLSIFTAAENNLNGSIPAALGRLQNLQLLNLGNNSLSG 253
+ L L L+ + + + + LQ+ +L +
Sbjct: 118 KFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKED--PEGLQDFNTESLHIVFPTN 175
Query: 254 EIPSELGELSQLGYLNLMGNRLEGAIPRSFAKMGNLQSLDLSMNRLTGGIPEEFGNMGQL 313
+ + ++S NL + ++ + + L N +L
Sbjct: 176 KEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNP-------------KL 222
Query: 314 VFLVLSNNNISGSIPRRI--CTNATSLEHLILAEIQLSGEIPVELSQC-----QSLKQLD 366
L L+N + + RI T++ + ++ ++L G++ ++L
Sbjct: 223 SNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQ 282
Query: 367 LSNNTLNGTIPVELFQLVALTHLYLHNNSLVGSISPFVANLSNLQELALYHNNFQGSLPR 426
+ ++ + + + +S L +N ++
Sbjct: 283 VVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFE 342
Query: 427 EIGMLVKLELLYLYDNHLSGQIPSEVG---NCSSLKWIDFFGNSFTGEIPTSI-GRLKDL 482
G L +LE L L N L ++ SL+ +D NS + + K L
Sbjct: 343 NCGHLTELETLILQMNQLK-ELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSL 401
Query: 483 NFLHLRQNELVGQIPASLGNCHQLIILDLADNKLSGGVPASFGFLQALEQLMLYNNSLEG 542
L++ N L I L ++ +LDL NK+ +P L+AL++L + +N L+
Sbjct: 402 LSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKS 458
Query: 543 NLPGSLINLRNLTRINFSKNRLNGRIATLCSSHSFLS 579
G L +L +I N + C +LS
Sbjct: 459 VPDGIFDRLTSLQKIWLHTNPWD----CSCPRIDYLS 491
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 3e-38
Identities = 90/483 (18%), Positives = 158/483 (32%), Gaps = 37/483 (7%)
Query: 361 SLKQLDLSNNTLNGTIPVELFQLVALTHLYLHNNSLVGSISPFV-ANLSNLQELALYHNN 419
L++S N ++ ++ L L L + +N + + V L+ L L HN
Sbjct: 22 KTTILNISQNYISELWTSDILSLSKLRILIISHNRI-QYLDISVFKFNQELEYLDLSHNK 80
Query: 420 FQGSLPREIGMLVKLELLYLYDNHL-SGQIPSEVGNCSSLKWIDFFGNSFTGEIPTSIGR 478
+ V L+ L L N + I E GN S LK++ I
Sbjct: 81 LV-KIS--CHPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAH 137
Query: 479 LKDLN-FLHLRQNELVGQIPASLGNCH--QLIILDLADNKLSGGVPASFGFLQALEQLML 535
L L L + + P L + + L I+ + + + S + LE +
Sbjct: 138 LNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNI 197
Query: 536 YNNSLEGNLPGSLINLRNLTRINFSKNRLNGRIATLCSSHSFLSFDVTNNEFDHEIPPQL 595
+ L L L N + + + T N F QL
Sbjct: 198 KCVLEDNKCSYFLSILAKLQTNPKLSN------------LTLNNIETTWNSFIR--ILQL 243
Query: 596 GNSPSLERLRLGNNKFIGKIPW-----TFGKIRELSLLDLSGNSLTGPIPTQLLMCKKLS 650
++ + N K G++ + + ++ LS+ + + P + ++
Sbjct: 244 VWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMN 303
Query: 651 HIDLNNNLLSGAVPSWLGTLPQLGELKLSFNQFVGFLPRELFNCSKLLVLSLDGNMLNGS 710
+ + + L S N + + ++L L L N L
Sbjct: 304 IKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK-E 362
Query: 711 LPNEVG---NLASLNVLTLSGNLLSGPIPPAI-GRLSKLYELRLSNNSLNGVIPLEIGQL 766
L + SL L +S N +S L L +S+N L I +
Sbjct: 363 LSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL--P 420
Query: 767 QNLQSILDLSHNNFTGQIPPSMGTLAKLEVLNLSHNQLVGELPSQLGEMSSLGKLNLSYN 826
++ +LDL N IP + L L+ LN++ NQL ++SL K+ L N
Sbjct: 421 PRIK-VLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTN 478
Query: 827 DLQ 829
Sbjct: 479 PWD 481
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 5e-37
Identities = 92/521 (17%), Positives = 164/521 (31%), Gaps = 52/521 (9%)
Query: 213 NCSSLSIFTAAENNLNGSIPAALGRLQNLQLLNLGNNSLSGEIPSELGELSQLGYLNLMG 272
+ S N L +P L + +LN+ N +S S++ LS+L L +
Sbjct: 6 DRSK--------NGLI-HVPKDLSQ--KTTILNISQNYISELWTSDILSLSKLRILIISH 54
Query: 273 NRLEGAIPRSFAKMGNLQSLDLSMNRLTGGIPEEFGNMGQLVFLVLSNNNISGSIPRRIC 332
NR++ F L+ LDLS N+L I L L LS N +
Sbjct: 55 NRIQYLDISVFKFNQELEYLDLSHNKLV-KIS--CHPTVNLKHLDLSFNAFDALPICKEF 111
Query: 333 TNATSLEHLILAEIQLSGEIPVELSQCQSLKQLDLSNNTLNGTIPVELFQLVALTHLYLH 392
N + L+ L L+ L + ++ K L + + L LH
Sbjct: 112 GNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGE--TYGEKEDPEGLQDFNTESLH 169
Query: 393 NNSLVGSISPFVANLSNLQELALYHNNFQGSLPREIGMLVKLELLYLYDNHLSGQIPSEV 452
F+ ++S L +N + L L L N +
Sbjct: 170 IVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNN 229
Query: 453 GNCSSLKWIDFFGNSFTGEIPTSIGRLKDLNFLHLRQNELVGQIPASLGNCHQLIILDLA 512
+ +I + ++ SL L I +
Sbjct: 230 IETTWNSFIRIL--QLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSL---KALSIHQVV 284
Query: 513 DNKLSGGVPASFGFLQALEQLMLYNNSLEGNLPGSLINLRNLTRINFSKNRLNGRIATLC 572
+ + + + + ++FS N L
Sbjct: 285 SDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLT------- 337
Query: 573 SSHSFLSFDVTNNEFDHEIPPQLGNSPSLERLRLGNNKF--IGKIPWTFGKIRELSLLDL 630
D + LE L L N+ + KI +++ L LD+
Sbjct: 338 --------DTVFENCG--------HLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDI 381
Query: 631 SGNSLTGPIPTQLLMC-KKLSHIDLNNNLLSGAVPSWLGTLPQLGELKLSFNQFVGFLPR 689
S NS++ K L +++++N+L+ + L P++ L L N+ +P+
Sbjct: 382 SQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL--PPRIKVLDLHSNKIK-SIPK 438
Query: 690 ELFNCSKLLVLSLDGNMLNGSLPNEV-GNLASLNVLTLSGN 729
++ L L++ N L S+P+ + L SL + L N
Sbjct: 439 QVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQKIWLHTN 478
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 6e-36
Identities = 87/536 (16%), Positives = 172/536 (32%), Gaps = 84/536 (15%)
Query: 100 LDLSSNSLTGPIPTALSNLSSLESLLLFSNQLAGTIPTQLGSLTSLRVMRIGDNWLSGSI 159
+D S N L +P LS L + N + + L
Sbjct: 5 VDRSKNGLIH-VPKDLS--QKTTILNISQNYI-----------SELW------------- 37
Query: 160 PTSFGNLVNLGTLGLASCSLSGPIPPQFGQLSQLEELILQQNQLQGPIPAELGNCSSLSI 219
+ +L L L ++ + F +LE L L N+L N L +
Sbjct: 38 TSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLVKISCHPTVNLKHLDL 97
Query: 220 FTAAENNLNGSIP--AALGRLQNLQLLNLGNNSLSGEIPSELGELSQLGYLNLMGNRLEG 277
+ N + ++P G + L+ L L L + L+ L ++G
Sbjct: 98 ---SFNAFD-ALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETY-- 151
Query: 278 AIPRSFAKMGNLQSLDLSMNRLTGGIPEEFGNMGQLVFLVLSNNNISGSIPRRICTNATS 337
+ + + L + T ++ L +NI + C+ S
Sbjct: 152 GEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLS 211
Query: 338 ----------LEHLILAEIQLSGEIPVELSQCQ---SLKQLDLSNNTLNGTIPVELF--- 381
L +L L I+ + + + Q ++ +SN L G + F
Sbjct: 212 ILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYS 271
Query: 382 --QLVALTHLYLHNNSLVGSISPFVANLSNLQELALYHNNFQGSLPREIGMLVKLELLYL 439
L AL+ + ++ S SN+ + + + L
Sbjct: 272 GTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDF 331
Query: 440 YDNHLSGQIPSEVGNCSSLKWIDFFGNSFTGEIPTSIG---RLKDLNFLHLRQNELVGQI 496
+N L+ + G+ + L+ + N E+ ++K L L + QN +
Sbjct: 332 SNNLLTDTVFENCGHLTELETLILQMNQLK-ELSKIAEMTTQMKSLQQLDISQNSVSYDE 390
Query: 497 PASL-GNCHQLIILDLADNKLSGGVPASFGFLQALEQLMLYNNSLEGNLPGSLINLRNLT 555
L+ L+++ N L+ + ++ L L++N ++ ++P ++ L L
Sbjct: 391 KKGDCSWTKSLLSLNMSSNILTDTIFRC--LPPRIKVLDLHSNKIK-SIPKQVVKLEALQ 447
Query: 556 RINFSKNRLNGRIATLCSSHSFLSFDVTNNEFDHEIPPQLGNSPSLERLRLGNNKF 611
+N + N+L V + FD SL+++ L N +
Sbjct: 448 ELNVASNQLK---------------SVPDGIFD--------RLTSLQKIWLHTNPW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 113 bits (283), Expect = 5e-26
Identities = 76/482 (15%), Positives = 144/482 (29%), Gaps = 73/482 (15%)
Query: 365 LDLSNNTLNGTIPVELFQLVALTHLYLHNNSLVGSISPFV-ANLSNLQELALYHNNFQGS 423
+D S N L +P +L T L + N + + +LS L+ L + HN Q
Sbjct: 5 VDRSKNGLI-HVPKDLS--QKTTILNISQNYIS-ELWTSDILSLSKLRILIISHNRIQ-Y 59
Query: 424 LPREI-GMLVKLELLYLYDNHLSGQIPSEVGNCSSLKWIDFFGNSFTGEIPTSIGRLKDL 482
L + +LE L L N L + S +L
Sbjct: 60 LDISVFKFNQELEYLDLSHNKLV-----------KI----------------SCHPTVNL 92
Query: 483 NFLHLRQNEL-VGQIPASLGNCHQLIILDLADNKLSGGVPASFGFLQALEQLMLYNNSLE 541
L L N I GN QL L L+ L L + L++ +
Sbjct: 93 KHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETY- 151
Query: 542 GNLPGSLINLRNLTRINFSKNRLNGRIATLCSSHSFLSF-DVTNNEFDHEIPPQLGNSPS 600
L++ + + S + ++ + + +
Sbjct: 152 -GEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFL 210
Query: 601 LERLRLGNNKFIGKIPWTFGKIRELSLLDLSGNSLTGPIPTQLLMCKKLSHIDLNNNLLS 660
+L N + + L+ ++ + NS + QL+ + + ++N L
Sbjct: 211 SILAKLQTNPKLSNL--------TLNNIETTWNSFIRIL--QLVWHTTVWYFSISNVKLQ 260
Query: 661 GAVPSWLGTLPQLGELKLSFNQFVGFLPRELFNCSKLLVLSLDGNMLNGSLPNEVGNLAS 720
G + S + L + + ++ ++
Sbjct: 261 G--------QLDFRDFDYSGT-----------SLKALSIHQVVSDVFGFPQSYIYEIFSN 301
Query: 721 LNVLTLSGNLLSGPIPPAIGRLSKLYELRLSNNSLNGVIPLEIGQLQNLQSILDLSHNNF 780
+N+ + + ++S L SNN L + G L L+ L L N
Sbjct: 302 MNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELE-TLILQMNQL 360
Query: 781 TGQIPPSMG---TLAKLEVLNLSHNQLVGELPSQL-GEMSSLGKLNLSYNDLQGKLSKQF 836
++ + L+ L++S N + + SL LN+S N L + +
Sbjct: 361 K-ELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL 419
Query: 837 SH 838
Sbjct: 420 PP 421
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 4e-25
Identities = 73/397 (18%), Positives = 137/397 (34%), Gaps = 31/397 (7%)
Query: 456 SSLKWIDFFGNSFTGEIPTSIGRLKDLNFLHLRQNELVGQIPASLGNCHQLIILDLADNK 515
++ N + + I L L L + N + + +L LDL+ NK
Sbjct: 21 QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNK 80
Query: 516 LSGGVPASFGFLQALEQLMLYNNSLEG-NLPGSLINLRNLTRINFSKNRL-NGRIATLCS 573
L S L+ L L N+ + + N+ L + S L + +
Sbjct: 81 LVK---ISCHPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAH 137
Query: 574 SHSFLSFDVTNNEFDHEIPP---QLGNSPSLERLRLGNNKFIGKIPWTFGKIRELSLLDL 630
+ V + + P Q N+ SL + N +F + + + L L ++
Sbjct: 138 LNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNI 197
Query: 631 SGNSLTGPIPTQLLMCKKLSHIDLNNNLLSGAVPSWLGTLPQLGELKLSFNQFVGFLPRE 690
L + KL +NL L ++ ++N F+ L +
Sbjct: 198 KCVLEDNKCSYFLSILAKLQTNPKLSNL-------------TLNNIETTWNSFIRIL--Q 242
Query: 691 LFNCSKLLVLSLDGNMLNGSLPNEVGNLA-----SLNVLTLSGNLLSGPIPPAIGRLSKL 745
L + + S+ L G L + + +L++ + ++ P S +
Sbjct: 243 LVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNM 302
Query: 746 YELRLSNNSLNGVIPLEIGQLQNLQSILDLSHNNFTGQIPPSMGTLAKLEVLNLSHNQL- 804
+ + V L ++ LD S+N T + + G L +LE L L NQL
Sbjct: 303 NIKNFTVSGTRMVHMLCPSKISPFLH-LDFSNNLLTDTVFENCGHLTELETLILQMNQLK 361
Query: 805 -VGELPSQLGEMSSLGKLNLSYNDLQGKLSKQFSHWP 840
+ ++ +M SL +L++S N + K W
Sbjct: 362 ELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWT 398
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 5e-39
Identities = 53/223 (23%), Positives = 98/223 (43%), Gaps = 22/223 (9%)
Query: 954 IGSGGSGTVYKAE-LANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHC 1012
+G GG V E L +G A+K+I C + ++ RE H ++++L+ +C
Sbjct: 37 LGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQ-READMHRLFNHPNILRLVAYC 95
Query: 1013 CNKGAGSN--LLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEAR-LKIAVGLAQGVEYLH 1069
+ + L+ + + G++W+ + + L E + L + +G+ +G+E +H
Sbjct: 96 LRERGAKHEAWLLLPFFKRGTLWNEIERLKDK---GNFLT-EDQILWLLLGICRGLEAIH 151
Query: 1070 HDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTW-----FAGSYG 1124
HRD+K +NILL + L D G + ++ T +
Sbjct: 152 A---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTIS 208
Query: 1125 YIAPE----YAYSLKATEKCDVYSMGIVLMELVSGKMPTDATF 1163
Y APE ++ E+ DV+S+G VL ++ G+ P D F
Sbjct: 209 YRAPELFSVQSHC-VIDERTDVWSLGCVLYAMMFGEGPYDMVF 250
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 153 bits (387), Expect = 1e-38
Identities = 71/342 (20%), Positives = 124/342 (36%), Gaps = 45/342 (13%)
Query: 168 NLGTLGLASCSLSGPIPPQFGQLSQLEELILQQNQLQGPIPAELGNCSSLSIFTAAENNL 227
L + L+ +P + L++ N L +PA +L + + N L
Sbjct: 41 GNAVLNVGESGLTT-LPDCLPA--HITTLVIPDNNLTS-LPALPPELRTLEV---SGNQL 93
Query: 228 NGSIPAALGRLQNLQLLNLGNNSLSGEIPSELGELSQLGYLNLMGNRLEGAIPRSFAKMG 287
S+P L L + + L L L + GN+L ++P
Sbjct: 94 T-SLPVLPPGLLELSIFSNPLTHLPALPSG-------LCKLWIFGNQLT-SLPVLP---P 141
Query: 288 NLQSLDLSMNRLTGGIPEEFGNMGQLVFLVLSNNNISGSIPRRICTNATSLEHLILAEIQ 347
LQ L +S N+L +P L L NN ++ S+P + L+ L +++ Q
Sbjct: 142 GLQELSVSDNQLA-SLPALPSE---LCKLWAYNNQLT-SLPMLP----SGLQELSVSDNQ 192
Query: 348 LSGEIPVELSQCQSLKQLDLSNNTLNGTIPVELFQLVALTHLYLHNNSLVGSISPFVANL 407
L+ +P S+ L +L NN L ++P L L + N L S+
Sbjct: 193 LA-SLPTLPSE---LYKLWAYNNRLT-SLPALPSG---LKELIVSGNRL-TSLPVL---P 240
Query: 408 SNLQELALYHNNFQGSLPREIGMLVKLELLYLYDNHLSGQIPSEVGNCSSLKWIDFFGNS 467
S L+EL + N SLP L L +Y N L+ ++P + + SS ++ GN
Sbjct: 241 SELKELMVSGNRLT-SLPMLPS---GLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNP 295
Query: 468 FTGEIPTSIGRLKDLNFLHLRQNELVGQIPASLGNCHQLIIL 509
+ ++ + ++ L +
Sbjct: 296 LSERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLA 337
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 3e-38
Identities = 79/362 (21%), Positives = 136/362 (37%), Gaps = 48/362 (13%)
Query: 93 RLQSLIHLDLSSNSLTGPIPTALSNLSSLESLLLFSNQLAGTIPTQLGSLTSLRVMRIGD 152
L++ + LT +P L + + +L++ N L ++P L +L V
Sbjct: 38 LNNGNAVLNVGESGLTT-LPDCL--PAHITTLVIPDNNLT-SLPALPPELRTLEV---SG 90
Query: 153 NWLSGSIPTSFGNLVNLGTLGLASCSLSGPIPPQFGQLSQLEELILQQNQLQGPIPAELG 212
N L+ S+P L+ L L S L +L + NQL +P
Sbjct: 91 NQLT-SLPVLPPGLLELSIFSNPLTHLP-------ALPSGLCKLWIFGNQLTS-LPVLPP 141
Query: 213 NCSSLSIFTAAENNLNGSIPAALGRLQNLQLLNLGNNSLSGEIPSELGELSQLGYLNLMG 272
LS+ +N S+PA L L NN L+ +P L L++
Sbjct: 142 GLQELSV----SDNQLASLPALPSELCKLWAY---NNQLT-SLPMLPS---GLQELSVSD 190
Query: 273 NRLEGAIPRSFAKMGNLQSLDLSMNRLTGGIPEEFGNMGQLVFLVLSNNNISGSIPRRIC 332
N+L ++P L L NRLT +P L L++S N ++ S+P
Sbjct: 191 NQLA-SLPTLP---SELYKLWAYNNRLT-SLPAL---PSGLKELIVSGNRLT-SLPVLP- 240
Query: 333 TNATSLEHLILAEIQLSGEIPVELSQCQSLKQLDLSNNTLNGTIPVELFQLVALTHLYLH 392
+ L+ L+++ +L+ +P+ S L L + N L +P L L + T + L
Sbjct: 241 ---SELKELMVSGNRLT-SLPMLPSG---LLSLSVYRNQLT-RLPESLIHLSSETTVNLE 292
Query: 393 NNSLVGSISPFVANLSNLQELA---LYHNNFQGSLPREIGMLVKLELLYLYDNHLSGQIP 449
N L + +++ + + + S PRE L +L P
Sbjct: 293 GNPLSERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAADWLVPAREGEPAP 352
Query: 450 SE 451
++
Sbjct: 353 AD 354
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 3e-37
Identities = 82/369 (22%), Positives = 141/369 (38%), Gaps = 52/369 (14%)
Query: 75 SLNLSGLSLAGSISPSLGRLQSLIHLDLSSNSLTGPIPTALSNLSSLESLLLFSNQLAGT 134
LN+ L ++ L + L + N+LT +P L +LE + NQL +
Sbjct: 44 VLNVGESGLT-TLPDCLP--AHITTLVIPDNNLTS-LPALPPELRTLE---VSGNQLT-S 95
Query: 135 IPTQLGSLTSLRVMRIGDNWLSGSIPTSFGNLVNLGTLGLASCSLSGPIPPQFGQLSQLE 194
+P L L + L L L + L+ +P L+
Sbjct: 96 LPVLPPGLLELSIFSNPLTHLPALPS-------GLCKLWIFGNQLTS-LPVLPP---GLQ 144
Query: 195 ELILQQNQLQGPIPAELGNCSSLSIFTAAENNLNGSIPAALGRLQNLQLLNLGNNSLSGE 254
EL + NQL +PA L + N L S+P LQ L++ +N L+
Sbjct: 145 ELSVSDNQLAS-LPALPSELCKLWAY---NNQLT-SLPMLPS---GLQELSVSDNQLA-S 195
Query: 255 IPSELGELSQLGYLNLMGNRLEGAIPRSFAKMGNLQSLDLSMNRLTGGIPEEFGNMGQLV 314
+P+ EL +L N NRL ++P L+ L +S NRLT +P +L
Sbjct: 196 LPTLPSELYKLWAYN---NRLT-SLPAL---PSGLKELIVSGNRLT-SLPVL---PSELK 244
Query: 315 FLVLSNNNISGSIPRRICTNATSLEHLILAEIQLSGEIPVELSQCQSLKQLDLSNNTLNG 374
L++S N ++ S+P + L L + QL+ +P L S ++L N L+
Sbjct: 245 ELMVSGNRLT-SLPMLP----SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLS- 297
Query: 375 TIPVELFQLVALTHLYLHNNSLVGSISPFVANLSNLQELALYHN-NFQGSLPREIGMLVK 433
++ + +T ++ + I +A S +E H +P G
Sbjct: 298 ERTLQALR--EITSAPGYSGPI---IRFDMAGASAPRETRALHLAAADWLVPAREGEPAP 352
Query: 434 LELLYLYDN 442
+ +++
Sbjct: 353 ADRWHMFGQ 361
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 1e-33
Identities = 72/322 (22%), Positives = 113/322 (35%), Gaps = 40/322 (12%)
Query: 74 VSLNLSGLSLAGSISPSLGRLQSLIHLDLSSNSLTGPIPTALSNLSSLESLLLFSNQLAG 133
+L +SG L S+ L L L + S L L +F NQL
Sbjct: 84 RTLEVSGNQLT-SLPVLPPGLLELSIFSNPLTHLP-------ALPSGLCKLWIFGNQLT- 134
Query: 134 TIPTQLGSLTSLRVMRIGDNWLSGSIPTSFGNLVNLGTLGLASCSLSGPIPPQFGQLSQL 193
++P L L V DN L+ S+P L L + L+ +P S L
Sbjct: 135 SLPVLPPGLQELSV---SDNQLA-SLPALPSELCK---LWAYNNQLTS-LPM---LPSGL 183
Query: 194 EELILQQNQLQGPIPAELGNCSSLSIFTAAENNLNGSIPAALGRLQNLQLLNLGNNSLSG 253
+EL + NQL +P L + NN S+PA L+ L + N L+
Sbjct: 184 QELSVSDNQLAS-LPTLPSELYKLWAY----NNRLTSLPALPS---GLKELIVSGNRLT- 234
Query: 254 EIPSELGELSQLGYLNLMGNRLEGAIPRSFAKMGNLQSLDLSMNRLTGGIPEEFGNMGQL 313
+P +L L + GNRL ++P L SL + N+LT +PE ++
Sbjct: 235 SLPVLPS---ELKELMVSGNRLT-SLPML---PSGLLSLSVYRNQLT-RLPESLIHLSSE 286
Query: 314 VFLVLSNNNISGSIPRRICTNATSLEHLILAEIQLSGEIPVELSQCQSLKQLDLSNNTLN 373
+ L N +S + TS I+ + ++L + + L
Sbjct: 287 TTVNLEGNPLS-ERTLQALREITSAPGYSGPIIRFDMAGASAPRETRAL--HLAAADWLV 343
Query: 374 GTIPVELFQLVALTHLYLHNNS 395
E +N+
Sbjct: 344 PAREGEPAPADRWHMFGQEDNA 365
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 2e-32
Identities = 74/399 (18%), Positives = 138/399 (34%), Gaps = 73/399 (18%)
Query: 405 ANLSNLQELALYHNNFQGSLPREIGMLVKLELLYLYDNHLSGQIPSEVGNCSSLKWIDFF 464
+ L + + +LP + + L + DN+L+ +P+ L+ ++
Sbjct: 37 CLNNGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPALPPE---LRTLEVS 89
Query: 465 GNSFTGEIPTSIGRLKDLNFLHLRQNELVGQIPASLGNCHQLIILDLADNKLSGGVPASF 524
GN T +P L +L+ L PA L L + N+L+ +P
Sbjct: 90 GNQLT-SLPVLPPGLLELSIFSNPLTHL----PALPSG---LCKLWIFGNQLTS-LPVLP 140
Query: 525 GFLQALEQLMLYNNSLEGNLPGSLINLRNLTRINFSKNRLNGRIATLCSSHSFLSFDVTN 584
L++L + +N L +LP L L N+L
Sbjct: 141 P---GLQELSVSDNQLA-SLPALPSELCKL---WAYNNQLT------------------- 174
Query: 585 NEFDHEIPPQLGNSPSLERLRLGNNKFIGKIPWTFGKIRELSLLDLSGNSLTGPIPTQLL 644
+P L+ L + +N+ + +P ++ +L + SL
Sbjct: 175 -----SLPMLPSG---LQELSVSDNQ-LASLPTLPSELYKLWAYNNRLTSLPALPS---- 221
Query: 645 MCKKLSHIDLNNNLLSGAVPSWLGTLPQLGELKLSFNQFVGFLPRELFNCSKLLVLSLDG 704
L + ++ N L+ ++P +L EL +S N+ LP S LL LS+
Sbjct: 222 ---GLKELIVSGNRLT-SLPVLPS---ELKELMVSGNRLTS-LPMLP---SGLLSLSVYR 270
Query: 705 NMLNGSLPNEVGNLASLNVLTLSGNLLSGPIPPAIGRLSKLYELRLSNNSLNGVIPLEIG 764
N L LP + +L+S + L GN LS A+ ++ +I ++
Sbjct: 271 NQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREITSAP------GYSGPIIRFDMA 323
Query: 765 QLQNLQSILDLSHNNFTGQIPPSMGTLAKLEVLNLSHNQ 803
+ L +P G A + ++ +
Sbjct: 324 GASAPRETRALHLAAADWLVPAREGEPAPADRWHMFGQE 362
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 9e-31
Identities = 82/387 (21%), Positives = 128/387 (33%), Gaps = 78/387 (20%)
Query: 478 RLKDLNFLHLRQNELVGQIPASLGNCHQLIILDLADNKLSGGVPASFGFLQALEQLMLYN 537
L++ ++ L +P L + L + DN L+ +PA L+ LE +
Sbjct: 38 LNNGNAVLNVGESGL-TTLPDCLPA--HITTLVIPDNNLTS-LPALPPELRTLE---VSG 90
Query: 538 NSLEGNLPGSLINLRNLTRINFSKNRLNGRIATLCSSHSFLSFDVTNNEFDHEIPPQLGN 597
N L +LP L L+ + L + LC + N+ +P
Sbjct: 91 NQLT-SLPVLPPGLLELSIFSNPLTHLPALPSGLCK------LWIFGNQL-TSLPVLPPG 142
Query: 598 SPSLERLRLGNNKFIGKIPWTFGKIRELSLLDLSGNSLTGPIPTQLLMCKKLSHIDLNNN 657
L+ L + +N+ + +P + L L N LT
Sbjct: 143 ---LQELSVSDNQ-LASLPALPSE---LCKLWAYNNQLT--------------------- 174
Query: 658 LLSGAVPSWLGTLPQLGELKLSFNQFVGFLPRELFNCSKLLVLSLDGNMLNGSLPNEVGN 717
++P L EL +S NQ LP S+L L N L SLP
Sbjct: 175 ----SLPMLPS---GLQELSVSDNQLA-SLPTLP---SELYKLWAYNNRLT-SLPALPSG 222
Query: 718 LASLNVLTLSGNLLSGPIPPAIGRLSKLYELRLSNNSLNGVIPLEIGQLQNLQSILDLSH 777
L L +SGN L+ +P L +L +S N L +P+ L +L +
Sbjct: 223 LKELI---VSGNRLTS-LPVLPSELKELM---VSGNRLTS-LPMLPSGLLSL----SVYR 270
Query: 778 NNFTGQIPPSMGTLAKLEVLNLSHNQL----------VGELPSQLGEMSSLGKLNLSYND 827
N T ++P S+ L+ +NL N L + P G + S
Sbjct: 271 NQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGASAPR 329
Query: 828 LQGKLSKQFSHWPAEAFEGNLHLCGSP 854
L + W A EG
Sbjct: 330 ETRALHLAAADWLVPAREGEPAPADRW 356
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 2e-38
Identities = 91/403 (22%), Positives = 152/403 (37%), Gaps = 62/403 (15%)
Query: 99 HLDLSSNSLTGPIPTALSNLSSLESLLLFSNQLAGTIPTQL-GSLTSLRVMRIGDNWLSG 157
++DLS NS+ T+ S L L+ L + I L+SL ++++ N
Sbjct: 34 YVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFL- 92
Query: 158 SIPTS-FGNLVNLGTLGLASCSLSGPIPPQ--FGQLSQLEELILQQNQLQGPIPAELGNC 214
+ T F L NL L L C+L G + F L+ LE L+L+ N ++ PA
Sbjct: 93 QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPA----- 147
Query: 215 SSLSIFTAAENNLNGSIPAALGRLQNLQLLNLGNNSLSGEIPSELGEL--SQLGYLNLMG 272
+ ++ +L+L N + +L L L
Sbjct: 148 ------------------SFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSS 189
Query: 273 NRL--------EGAIPRSFAKMGNLQSLDLSMNRLTGGIPEEF---GNMGQLVFLVLSNN 321
L + K ++ +LDLS N + + F ++ L+LSN+
Sbjct: 190 ITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNS 249
Query: 322 NISG---------SIPRRICTN--ATSLEHLILAEIQLSGEIPVEL-SQCQSLKQLDLSN 369
G A+ ++ L++ ++ + + S L+QL L+
Sbjct: 250 YNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQ 308
Query: 370 NTLNGTIPVELF-QLVALTHLYLHNNSLVGSISPFV-ANLSNLQELALYHNNFQGSLPRE 427
N +N I F L L L L N L GSI + NL L+ L L +N+ + +L +
Sbjct: 309 NEIN-KIDDNAFWGLTHLLKLNLSQNFL-GSIDSRMFENLDKLEVLDLSYNHIR-ALGDQ 365
Query: 428 I-GMLVKLELLYLYDNHLSGQIPSEV-GNCSSLKWIDFFGNSF 468
L L+ L L N L +P + +SL+ I N +
Sbjct: 366 SFLGLPNLKELALDTNQLKS-VPDGIFDRLTSLQKIWLHTNPW 407
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 5e-32
Identities = 83/386 (21%), Positives = 143/386 (37%), Gaps = 42/386 (10%)
Query: 71 ARVVSLNLSGLSLAGSISP-SLGRLQSLIHLDLSSNSLTGPIPT-ALSNLSSLESLLLFS 128
A V ++LS S+A ++ S RLQ L L + + I LSSL L L
Sbjct: 30 AHVNYVDLSLNSIA-ELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDY 88
Query: 129 NQLAGTIPTQ-LGSLTSLRVMRIGDNWLSGSI--PTSFGNLVNLGTLGLASCSLSGPIPP 185
NQ + T L +L V+ + L G++ F L +L L L ++ I P
Sbjct: 89 NQFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKK-IQP 146
Query: 186 Q--FGQLSQLEELILQQNQLQGPIPAELGNCSSLS----------IFTAAENNLNGSIPA 233
F + + L L N+++ +L N + E L
Sbjct: 147 ASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCG 206
Query: 234 ALGRLQNLQLLNLGNNSLSGEIPS---ELGELSQLGYLNLMGNRLEGAIPRSFA------ 284
+ ++ L+L N + + +++ L L + G+
Sbjct: 207 NPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDN 266
Query: 285 ------KMGNLQSLDLSMNRLTGGIPEEFGNMGQLVFLVLSNNNISGSIPRRICTNATSL 338
+ +++ DLS +++ + F + L L L+ N I+ I T L
Sbjct: 267 FTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEIN-KIDDNAFWGLTHL 325
Query: 339 EHLILAEIQLSGEIPVEL-SQCQSLKQLDLSNNTLNGTIPVELFQ-LVALTHLYLHNNSL 396
L L++ L I + L+ LDLS N + + + F L L L L N L
Sbjct: 326 LKLNLSQNFLG-SIDSRMFENLDKLEVLDLSYNHI-RALGDQSFLGLPNLKELALDTNQL 383
Query: 397 VGSISPFV-ANLSNLQELALYHNNFQ 421
S+ + L++LQ++ L+ N +
Sbjct: 384 K-SVPDGIFDRLTSLQKIWLHTNPWD 408
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 1e-31
Identities = 85/409 (20%), Positives = 135/409 (33%), Gaps = 63/409 (15%)
Query: 225 NNLNGSIPAALGRLQNLQLLNLGNNSLSGEIPSEL-GELSQLGYLNLMGNRLEGAIPRSF 283
N++ + RLQ+LQ L + + I + LS L L L N+ +F
Sbjct: 40 NSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAF 99
Query: 284 AKMGNLQSLDLSMNRLTGG-IPEE-FGNMGQLVFLVLSNNNISGSIPRRICTNATSLEHL 341
+ NL+ L L+ L G + F + L LVL +NNI P N L
Sbjct: 100 NGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVL 159
Query: 342 ILAEIQLSGEIPVEL---SQCQSLKQLDLSNNTLNGTIPVELFQLVALTHLYLHNNSLVG 398
L ++ I E Q + L LS+ TL ++ L
Sbjct: 160 DLTFNKVK-SICEEDLLNFQGKHFTLLRLSSITL----------------QDMNEYWLGW 202
Query: 399 SISPFVANLSNLQELALYHNNFQGSLPREI-GMLVKLELLYLYDNHLSGQIPSEVGNC-- 455
+++ L L N F+ S+ + + ++ L ++ S
Sbjct: 203 EKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFK 262
Query: 456 ------------SSLKWIDFFGNSFTGEIPTSI-GRLKDLNFLHLRQNELVGQIPASLGN 502
S +K D + + S+ DL L L QNE+ +
Sbjct: 263 DPDNFTFKGLEASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWG 321
Query: 503 CHQLIILDLADNKLSGGVPASFGFLQALEQLMLYNNSLEGNLPGSLINLRNLTRINFSKN 562
L+ L+L+ N L F L LE L L N + S + L NL + N
Sbjct: 322 LTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTN 381
Query: 563 RLNGRIATLCSSHSFLSFDVTNNEFDHEIPPQLGNSPSLERLRLGNNKF 611
+L V + FD SL+++ L N +
Sbjct: 382 QLK---------------SVPDGIFD--------RLTSLQKIWLHTNPW 407
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 9e-24
Identities = 80/382 (20%), Positives = 130/382 (34%), Gaps = 59/382 (15%)
Query: 456 SSLKWIDFFGNSFTGEIPTSIGRLKDLNFLHLRQNELVGQIPA-SLGNCHQLIILDLADN 514
+ + ++D NS TS RL+DL FL + Q I + LIIL L N
Sbjct: 30 AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYN 89
Query: 515 KLSGGVPASFGFLQALEQLMLYNNSLEGNL--PGSLINLRNLTRINFSKNRLNGRIATLC 572
+ +F L LE L L +L+G + L +L + N I +
Sbjct: 90 QFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNN----IKKIQ 145
Query: 573 SSHSFLSFDVTNNEFDHEIPPQLGNSPSLERLRLGNNKFIGKIP---WTFGKIRELSLLD 629
+ FL N L L NK + I + + +LL
Sbjct: 146 PASFFL------------------NMRRFHVLDLTFNK-VKSICEEDLLNFQGKHFTLLR 186
Query: 630 LSGNSLTGPIPTQLLMCKKLSHIDLNNNLLSGAVPSWLGTLPQLGELKLSFNQFVGFLPR 689
LS +L D+N L + L LS N F + +
Sbjct: 187 LSSITLQ----------------DMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAK 230
Query: 690 ELFNCSKLLVLSLDGNMLNGSLPNEVGNLASLNVLTLSGNLLSGPIPPAIGRLSKLYELR 749
F+ + + +++ + N + N G S +
Sbjct: 231 RFFD---AIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGL------EASGVKTCD 281
Query: 750 LSNNSLNGVIPLEIGQLQNLQSILDLSHNNFTGQIPPSM-GTLAKLEVLNLSHNQLVGEL 808
LS + + ++ +L+ L L+ N +I + L L LNLS N L G +
Sbjct: 282 LSKSKIFALLKSVFSHFTDLE-QLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQNFL-GSI 338
Query: 809 PSQL-GEMSSLGKLNLSYNDLQ 829
S++ + L L+LSYN ++
Sbjct: 339 DSRMFENLDKLEVLDLSYNHIR 360
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 5e-18
Identities = 55/340 (16%), Positives = 104/340 (30%), Gaps = 65/340 (19%)
Query: 530 LEQLMLYNNSLEGNLPGSLINLRNLTRINFSKNRLNGRIATLCSSHSFLSFDVTNNEFDH 589
+ + L NS+ S L++L + + + NN F
Sbjct: 32 VNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTP--------------GLVIRNNTFRG 77
Query: 590 EIPPQLGNSPSLERLRLGNNKFIGKIP-WTFGKIRELSLLDLSGNSLTG-PIPTQLLMC- 646
SL L+L N+ ++ F + L +L L+ +L G +
Sbjct: 78 --------LSSLIILKLDYNQ-FLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPL 128
Query: 647 KKLSHIDLNNNLLSGAVPSWL-GTLPQLGELKLSFNQFVGFLPRELFNCSKLLVLSLDGN 705
L + L +N + P+ + + L L+FN+ +L N L
Sbjct: 129 TSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLR-- 186
Query: 706 MLNGSLPNEVGNLASLNVLTLSGNLLSGPIPPAIGRLSKLYELRLSNNSLNGVIPLEIGQ 765
L+S+ + ++ L + + + L LS N +
Sbjct: 187 ------------LSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFD 234
Query: 766 LQNLQSILDLSHNNFTGQIP---------PSMGTL-----AKLEVLNLSHNQLVGELPSQ 811
I L +N P T + ++ +LS +++ L
Sbjct: 235 AIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKI-FALLKS 293
Query: 812 L-GEMSSLGKLNLSYNDLQGKLSKQFSHWPAEAFEGNLHL 850
+ + L +L L+ N + + AF G HL
Sbjct: 294 VFSHFTDLEQLTLAQN--------EINKIDDNAFWGLTHL 325
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 59.8 bits (145), Expect = 3e-09
Identities = 37/148 (25%), Positives = 58/148 (39%), Gaps = 18/148 (12%)
Query: 719 ASLNVLTLSGNLLSGPIPPAIGRLSKLYELRLSNNSLNGVIPLEI-GQLQNLQSILDLSH 777
A +N + LS N ++ + RL L L++ + VI L +L L L +
Sbjct: 30 AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLII-LKLDY 88
Query: 778 NNFTGQIPPSM-GTLAKLEVLNLSHNQLVGEL--PSQLGEMSSLGKLNLSYNDLQGKLSK 834
N F Q+ LA LEVL L+ L G + + ++SL L L N+++
Sbjct: 89 NQFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIK----- 142
Query: 835 QFSHWPAEAFEG-----NLHLCGSPLDH 857
PA F L L + +
Sbjct: 143 --KIQPASFFLNMRRFHVLDLTFNKVKS 168
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 3e-38
Identities = 63/288 (21%), Positives = 116/288 (40%), Gaps = 45/288 (15%)
Query: 953 IIGSGGSGTVYKA-ELANGATVAVKKISCKD---DHLLNKSFTREVKTLGRIRHRHLVKL 1008
IG G TVYK + VA ++ + + F E + L ++H ++V+
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSER--QRFKEEAEMLKGLQHPNIVRF 90
Query: 1009 MGHCCNKGAGSNLL--IYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVE 1066
+ G + + E M +G++ +L + K + + + +G++
Sbjct: 91 YDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF-------KVMKIKVLRSWCRQILKGLQ 143
Query: 1067 YLHHDCVPKILHRDIKSSNILLDSNM-EAHLGDFGLAKALVEDYNSNTESNTWFAGSYGY 1125
+LH P I+HRD+K NI + +GD GLA + + G+ +
Sbjct: 144 FLH-TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK-----RASFAKA-VIGTPEF 196
Query: 1126 IAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSARE 1185
+APE Y K E DVY+ G+ ++E+ + + P + E + +
Sbjct: 197 MAPEM-YEEKYDESVDVYAFGMCMLEMATSEYP-------------YSECQ---NAAQIY 239
Query: 1186 ELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLN 1233
+ +KP ++ A +V EI C + + ER S + LLN
Sbjct: 240 RRVTSGVKPASF-DKVAIPEVKEIIEGCIRQNKDERYSIKD----LLN 282
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 2e-37
Identities = 52/226 (23%), Positives = 95/226 (42%), Gaps = 34/226 (15%)
Query: 953 IIGSGGSGTVYKA-ELANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMG- 1010
++G G G V KA + A+KKI ++ L + EV L + H+++V+
Sbjct: 13 VLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKL--STILSEVMLLASLNHQYVVRYYAA 70
Query: 1011 -------HCCNKGAGSNLLIY---EYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVG 1060
++ EY ENG+++D +H + + + ++
Sbjct: 71 WLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSE------NLNQQRDEYWRLFRQ 124
Query: 1061 LAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTW-- 1118
+ + + Y+H I+HRD+K NI +D + +GDFGLAK + + +
Sbjct: 125 ILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLP 181
Query: 1119 --------FAGSYGYIAPE-YAYSLKATEKCDVYSMGIVLMELVSG 1155
G+ Y+A E + EK D+YS+GI+ E++
Sbjct: 182 GSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 1e-36
Identities = 64/312 (20%), Positives = 125/312 (40%), Gaps = 25/312 (8%)
Query: 264 QLGYLNLMGNRLEGAIPRSFAKMGNLQSLDLSMNRLTGGIPEEFGNMGQLVFLVLSNNNI 323
L + LE +P+ + LDL N++T +F N+ L L+L NN I
Sbjct: 32 HLRVVQCSDLGLE-KVPKDLPP--DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 88
Query: 324 SGSIPRRICTNATSLEHLILAEIQLSGEIPVELSQCQSLKQLDLSNNTLNGTIPVELFQ- 382
S I LE L L++ QL E+P ++ + +L++L + N + + +F
Sbjct: 89 S-KISPGAFAPLVKLERLYLSKNQLK-ELPEKMPK--TLQELRVHENEIT-KVRKSVFNG 143
Query: 383 LVALTHLYLHNNSL-VGSISPFV-ANLSNLQELALYHNNFQGSLPREIGMLVKLELLYLY 440
L + + L N L I + L + + N ++P+ G+ L L+L
Sbjct: 144 LNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQ--GLPPSLTELHLD 200
Query: 441 DNHLSGQIPSEV-GNCSSLKWIDFFGNSFTGEIPTSIGRLKDLNFLHLRQNELVGQIPAS 499
N ++ ++ + ++L + NS + S+ L LHL N+LV ++P
Sbjct: 201 GNKIT-KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGG 258
Query: 500 LGNCHQLIILDLADNKLSG------GVPASFGFLQALEQLMLYNNSLEGNL--PGSLINL 551
L + + ++ L +N +S P + + L++N ++ P + +
Sbjct: 259 LADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCV 318
Query: 552 RNLTRINFSKNR 563
+ +
Sbjct: 319 YVRAAVQLGNYK 330
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 3e-33
Identities = 65/305 (21%), Positives = 112/305 (36%), Gaps = 34/305 (11%)
Query: 96 SLIHLDLSSNSLTGPIPTALSNLSSLESLLLFSNQLAGTIPTQLGSLTSLRVMRIGDNWL 155
LDL +N +T NL +L +L+L +N+++ P L L + + N L
Sbjct: 53 DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQL 112
Query: 156 SGSIPTSFGNLVNLGTLGLASCSLSGPIPPQ-FGQLSQLEELILQQNQLQ-GPIPAE-LG 212
+P L L + ++ + F L+Q+ + L N L+ I
Sbjct: 113 K-ELPE--KMPKTLQELRVHENEITK-VRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQ 168
Query: 213 NCSSLSIFTAAENNLNGSIPAALGRLQNLQLLNLGNNSLSGEIPSE-LGELSQLGYLNLM 271
LS A+ N+ +IP L +L L+L N ++ ++ + L L+ L L L
Sbjct: 169 GMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKIT-KVDAASLKGLNNLAKLGLS 224
Query: 272 GNRLEGAIPRSFAKMGNLQSLDLSMNRLTGGIPEEFGNMGQLVFLVLSNNNISGSIPRRI 331
N + S A +L+ L L+ N+L +P + + + L NNNIS +I
Sbjct: 225 FNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS-AIGSND 282
Query: 332 CTNATSLEHLILAEIQLSGEIPVELSQCQSLKQLDLSNNTLNGT-IPVELFQ-LVALTHL 389
S + L +N + I F+ + +
Sbjct: 283 FCPPGYNTKK------------------ASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAV 324
Query: 390 YLHNN 394
L N
Sbjct: 325 QLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 4e-32
Identities = 62/315 (19%), Positives = 117/315 (37%), Gaps = 36/315 (11%)
Query: 230 SIPAALGRLQNLQLLNLGNNSLSGEIPSELGELSQLGYLNLMGNRLEGAIPRSFAKMGNL 289
+P L + LL+L NN ++ + L L L L+ N++ P +FA + L
Sbjct: 45 KVPKDLPP--DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 102
Query: 290 QSLDLSMNRLTGGIPEE-FGNMGQLVFLVLSNNNISGSIPRRICTNATSLEHLILAEIQL 348
+ L LS N+L +PE+ L L + N I+ + + + + + L L
Sbjct: 103 ERLYLSKNQLK-ELPEKMPKT---LQELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPL 157
Query: 349 -SGEIPVE-LSQCQSLKQLDLSNNTLNGTIPVELFQLVALTHLYLHNNSLVGSISPFV-A 405
S I + L + +++ + TIP L +LT L+L N + +
Sbjct: 158 KSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLPP--SLTELHLDGNKI-TKVDAASLK 213
Query: 406 NLSNLQELALYHNNFQGSLPREIGMLVKLELLYLYDNHLSGQIPSEVGNCSSLKWIDFFG 465
L+NL +L L N+ + L L+L +N L ++P + + ++ +
Sbjct: 214 GLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHN 272
Query: 466 NSFTGEIPTSIGRLKDLNFLHLRQNELVGQIPASLGNCHQLIILDLADNKLSGGV--PAS 523
N+ + + +F P + L N + P++
Sbjct: 273 NNIS--------AIGSNDFCP----------PGYNTKKASYSGVSLFSNPVQYWEIQPST 314
Query: 524 FGFLQALEQLMLYNN 538
F + + L N
Sbjct: 315 FRCVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 2e-30
Identities = 72/334 (21%), Positives = 127/334 (38%), Gaps = 48/334 (14%)
Query: 481 DLNFLHLRQNELVGQIPASLGNCHQLIILDLADNKLSGGVPASFGFLQALEQLMLYNNSL 540
L + L ++P L +LDL +NK++ F L+ L L+L NN +
Sbjct: 32 HLRVVQCSDLGLE-KVPKDLPP--DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 88
Query: 541 EGNLPGSLINLRNLTRINFSKNRLNGRIATLCSSHSFLSFDVTNNEFDHEIPPQLGNSPS 600
PG+ L L R+ SKN+L E+P ++ +
Sbjct: 89 SKISPGAFAPLVKLERLYLSKNQL------------------------KELPEKM--PKT 122
Query: 601 LERLRLGNNKFIGKIP-WTFGKIRELSLLDLSGNSLT-GPIPTQLLM-CKKLSHIDLNNN 657
L+ LR+ N+ I K+ F + ++ +++L N L I KKLS+I + +
Sbjct: 123 LQELRVHENE-ITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADT 181
Query: 658 LLSGAVPSWLGTLPQLGELKLSFNQFVGFLPRELF-NCSKLLVLSLDGNMLNGSLPNEVG 716
++ +P G P L EL L N+ + + L L L N ++ +
Sbjct: 182 NIT-TIPQ--GLPPSLTELHLDGNKI-TKVDAASLKGLNNLAKLGLSFNSISAVDNGSLA 237
Query: 717 NLASLNVLTLSGNLLSGPIPPAIGRLSKLYELRLSNNSLNGV------IPLEIGQLQNLQ 770
N L L L+ N L +P + + + L NN+++ + P + +
Sbjct: 238 NTPHLRELHLNNNKLVK-VPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYS 296
Query: 771 SILDLSHNNFT-GQIPPSM-GTLAKLEVLNLSHN 802
+ L N +I PS + + L +
Sbjct: 297 G-VSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-27
Identities = 64/259 (24%), Positives = 112/259 (43%), Gaps = 20/259 (7%)
Query: 581 DVTNNEFDHEIPP-QLGNSPSLERLRLGNNKFIGKI-PWTFGKIRELSLLDLSGNSLTGP 638
D+ NN+ EI N +L L L NNK I KI P F + +L L LS N L
Sbjct: 58 DLQNNKI-TEIKDGDFKNLKNLHTLILINNK-ISKISPGAFAPLVKLERLYLSKNQLKE- 114
Query: 639 IPTQLLMCKKLSHIDLNNNLLSGAVPSWLGTLPQLGELKLSFNQF-VGFLPRELF-NCSK 696
+P ++ K L + ++ N ++ S L Q+ ++L N + F K
Sbjct: 115 LPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKK 172
Query: 697 LLVLSLDGNMLNGSLPNEVGNLASLNVLTLSGNLLSGPIPPAIGRLSKLYELRLSNNSLN 756
L + + + ++P G SL L L GN ++ ++ L+ L +L LS NS++
Sbjct: 173 LSYIRIADTNIT-TIPQ--GLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSIS 229
Query: 757 GVIPLEIGQLQNLQSILDLSHNNFTGQIPPSMGTLAKLEVLNLSHNQL------VGELPS 810
V + +L+ L L++N ++P + ++V+ L +N + P
Sbjct: 230 AVDNGSLANTPHLRE-LHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPG 287
Query: 811 QLGEMSSLGKLNLSYNDLQ 829
+ +S ++L N +Q
Sbjct: 288 YNTKKASYSGVSLFSNPVQ 306
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 5e-22
Identities = 47/236 (19%), Positives = 90/236 (38%), Gaps = 21/236 (8%)
Query: 75 SLNLSGLSLAGSISPSLGRLQSLIHLDLSSNSLTGPIPTALSNLSSLESLLLFSNQL-AG 133
L LS L + + ++L L + N +T + + L+ + + L +N L +
Sbjct: 104 RLYLSKNQLK-ELPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSS 160
Query: 134 TIPTQ-LGSLTSLRVMRIGDNWLSGSIPTSFGNLVNLGTLGLASCSLSGPIPPQ-FGQLS 191
I + L +RI D ++ +IP G +L L L ++ + L+
Sbjct: 161 GIENGAFQGMKKLSYIRIADTNIT-TIPQ--GLPPSLTELHLDGNKITK-VDAASLKGLN 216
Query: 192 QLEELILQQNQLQGPIPAELGNCSSLSIFTAAENNLNGSIPAALGRLQNLQLLNLGNNSL 251
L +L L N + L N L N L +P L + +Q++ L NN++
Sbjct: 217 NLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNI 275
Query: 252 SGEIPSE-------LGELSQLGYLNLMGNRLEGAI--PRSFAKMGNLQSLDLSMNR 298
S I S + + ++L N ++ P +F + ++ L +
Sbjct: 276 S-AIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 5e-10
Identities = 24/111 (21%), Positives = 43/111 (38%), Gaps = 4/111 (3%)
Query: 719 ASLNVLTLSGNLLSGPIPPAIGRLSKLYELRLSNNSLNGVIPLEIGQLQNLQSILDLSHN 778
+L L N ++ L L+ L L NN ++ + P L L+ L LS N
Sbjct: 52 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLER-LYLSKN 110
Query: 779 NFTGQIPPSMGTLAKLEVLNLSHNQLVGELPSQLGEMSSLGKLNLSYNDLQ 829
++P L+ L + N++ S ++ + + L N L+
Sbjct: 111 QLK-ELPE--KMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLK 158
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 6e-36
Identities = 72/325 (22%), Positives = 136/325 (41%), Gaps = 58/325 (17%)
Query: 954 IGSGGSGTVYKAEL-ANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHC 1012
+G+G G V+K +G +A K I + + RE++ L ++V
Sbjct: 41 LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGF---- 96
Query: 1013 CNKGA---GSNLLIY-EYMENGSVWDWLHKQPVNIKMRKSLDWEARL-KIAVGLAQGVEY 1067
GA + I E+M+ GS+ D + K+ I E L K+++ + +G+ Y
Sbjct: 97 --YGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIP-------EQILGKVSIAVIKGLTY 146
Query: 1068 LHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIA 1127
L KI+HRD+K SNIL++S E L DFG++ L+ ++ +N+ F G+ Y++
Sbjct: 147 LREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI-----DSMANS-FVGTRSYMS 198
Query: 1128 PEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSAREEL 1187
PE + + D++SMG+ L+E+ G+ P E++++ ++ + + +
Sbjct: 199 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPR 258
Query: 1188 LDDQMKPLLPGEECAAYQVLEIALQ------------------------CTKTSPQERPS 1223
+ + + E+ C +P ER
Sbjct: 259 TPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERAD 318
Query: 1224 SRQVCDLLLNVFNNRIVDFDKLHID 1248
+Q L+++ F I D +D
Sbjct: 319 LKQ---LMVHAF---IKRSDAEEVD 337
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 9e-36
Identities = 71/411 (17%), Positives = 135/411 (32%), Gaps = 43/411 (10%)
Query: 75 SLNLSGLSLAGSISPSLGRLQSLIHLDLSSNSLTGPIPTALSNLSSLESLLLFSNQLAGT 134
S + + + + S +L +L LD ++S+T T + L+ L L+ SN + T
Sbjct: 22 SEVAAAFEMQATDTISEEQLATLTSLDCHNSSITD--MTGIEKLTGLTKLICTSNNIT-T 78
Query: 135 IPTQLGSLTSLRVMRIGDNWLSGSIPTSFGNLVNLGTLGLASCSLSGPIPPQFGQLSQLE 194
+ L T+L + N L+ ++ L L L + L+ + Q L
Sbjct: 79 LD--LSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKLT-KLD--VSQNPLLT 130
Query: 195 ELILQQNQLQGPIPAELGNCSSLSIFTAAENNLNGSIPAALGRLQNLQLLNLGNNSLSGE 254
L +N L ++ + + L+ N + + L L+ N ++
Sbjct: 131 YLNCARNTLT---EIDVSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKITE- 184
Query: 255 IPSELGELSQLGYLNLMGNRLEGAIPRSFAKMGNLQSLDLSMNRLTGGIPEEFGNMGQLV 314
++ + L LN N + + + L LD S N+LT I + QL
Sbjct: 185 --LDVSQNKLLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKLT-EID--VTPLTQLT 236
Query: 315 FLVLSNNNISGSIPRRICTNATSLEHLILAEIQLSGEIPVELSQCQSLKQLDLSNNTLNG 374
+ S N ++ + + L L + L ++L+ L
Sbjct: 237 YFDCSVNPLT-ELDVSTLSK---LTTLHCIQTDLLE---IDLTHNTQLIYFQAEGC--RK 287
Query: 375 TIPVELFQLVALTHLYLHNNSLVGSISPFVANLSNLQELALYHNNFQGSLPREIGMLVKL 434
+++ L L + + ++ L L L + L + KL
Sbjct: 288 IKELDVTHNTQLYLLDCQAAGIT-ELD--LSQNPKLVYLYLNNTELT-ELD--VSHNTKL 341
Query: 435 ELLYLYDNHLSGQIPSEVGNCSSLKWIDFFGNSFTGEIPTSIGRLKDLNFL 485
+ L + H+ S VG +L +P L
Sbjct: 342 KSLSCVNAHIQDF--SSVGKIPALNNNFEAEGQTI-TMPKETLTNNSLTIA 389
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 9e-35
Identities = 86/478 (17%), Positives = 157/478 (32%), Gaps = 72/478 (15%)
Query: 338 LEHLILAEIQLSGEIPVELSQCQSLKQLDLSNNTLNGTIPVELFQLVALTHLYLHNNSLV 397
+ A ++ + Q +L LD N+++ +E +L LT L +N++
Sbjct: 20 FASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITDMTGIE--KLTGLTKLICTSNNIT 77
Query: 398 GSISPFVANLSNLQELALYHNNFQGSLPREIGMLVKLELLYLYDNHLSGQIPSEVGNCSS 457
++ ++ +NL LA N +L + L KL L N L+ +V
Sbjct: 78 -TLD--LSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKLT---KLDVSQNPL 128
Query: 458 LKWIDFFGNSFTGEIPTSIGRLKDLNFLHLRQNELVGQIPASLGNCHQLIILDLADNKLS 517
L +++ N+ T EI + L L N+ + ++ + QL LD + NK++
Sbjct: 129 LTYLNCARNTLT-EID--VSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKIT 183
Query: 518 GGVPASFGFLQALEQLMLYNNSLEGNLPGSLINLRNLTRINFSKNRLNGRIATLCSSHSF 577
+ L +L N++ L L LT ++ S N+L
Sbjct: 184 E---LDVSQNKLLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKLT------------ 225
Query: 578 LSFDVTNNEFDHEIPPQLGNSPSLERLRLGNNKFIGKIPWTFGKIRELSLLDLSGNSLTG 637
DVT L N + ++ + +L+ L L
Sbjct: 226 -EIDVTPL-------------TQLTYFDCSVNP-LTELD--VSTLSKLTTLHCIQTDLLE 268
Query: 638 PIPTQLLMCKKLSHIDLNNNLLSGAVPSWLGTLPQLGELKLSFNQFVGFLPRELFNCSKL 697
I L +L + + + QL L +L KL
Sbjct: 269 -ID--LTHNTQLIYFQAEGCRKIKELD--VTHNTQLYLLDCQAAGITEL---DLSQNPKL 320
Query: 698 LVLSLDGNMLNGSLPNEVGNLASLNVLTLSGNLLSGPIPPAIGRLSKLYELRLSNNSLNG 757
+ L L+ L L V + L L+ + ++G++ L +
Sbjct: 321 VYLYLNNTELT-ELD--VSHNTKLKSLSCVNAHIQD--FSSVGKIPALNNNFEAEGQTI- 374
Query: 758 VIPLEIGQLQNLQ-----SILDLSHNNFTGQIPPSMGTLAKLEVLNLSHNQLVGELPS 810
+P E +L +LD N I P G + ++ L + P+
Sbjct: 375 TMPKETLTNNSLTIAVSPDLLDQFGNPMN--IEPGDGGVYDQATNTITWENLSTDNPA 430
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 1e-34
Identities = 77/421 (18%), Positives = 155/421 (36%), Gaps = 43/421 (10%)
Query: 168 NLGTLGLASCSLSGPIPPQFGQLSQLEELILQQNQLQGPIPAELGNCSSLSIFTAAENNL 227
N + A+ + QL+ L L + + + + + L+ NN+
Sbjct: 19 NFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITD-MT-GIEKLTGLTKLICTSNNI 76
Query: 228 NGSIPAALGRLQNLQLLNLGNNSLSGEIPSELGELSQLGYLNLMGNRLEGAIPRSFAKMG 287
++ L + NL L +N L+ + + L++L YLN N+L ++
Sbjct: 77 T-TLD--LSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKLTKL---DVSQNP 127
Query: 288 NLQSLDLSMNRLTGGIPEEFGNMGQLVFLVLSNNNISGSIPRRICTNATSLEHLILAEIQ 347
L L+ + N LT + + QL L N + T T L L + +
Sbjct: 128 LLTYLNCARNTLT---EIDVSHNTQLTELDCHLNKKITKLD---VTPQTQLTTLDCSFNK 181
Query: 348 LSGEIPVELSQCQSLKQLDLSNNTLNGTIPVELFQLVALTHLYLHNNSLVGSISPFVANL 407
++ +++SQ + L +L+ N + ++L Q + LT L +N L I V L
Sbjct: 182 ITE---LDVSQNKLLNRLNCDTNNITK---LDLNQNIQLTFLDCSSNKLT-EID--VTPL 232
Query: 408 SNLQELALYHNNFQGSLPREIGMLVKLELLYLYDNHLSGQIPSEVGNCSSLKWIDFFGNS 467
+ L N L + L KL L+ L +I + + + L + G
Sbjct: 233 TQLTYFDCSVNPLT-ELD--VSTLSKLTTLHCIQTDLL-EID--LTHNTQLIYFQAEGCR 286
Query: 468 FTGEIPTSIGRLKDLNFLHLRQNELVGQIPASLGNCHQLIILDLADNKLSGGVPASFGFL 527
E+ + L L + + ++ L +L+ L L + +L+
Sbjct: 287 KIKELD--VTHNTQLYLLDCQAAGIT-ELD--LSQNPKLVYLYLNNTELTEL---DVSHN 338
Query: 528 QALEQLMLYNNSLEGNLPGSLINLRNLTRINFSKNRLNGRIATLCSSHSFLSFDVTNNEF 587
L+ L N ++ + S+ + L ++ + + +++ L+ V+ +
Sbjct: 339 TKLKSLSCVNAHIQ-DFS-SVGKIPALNNNFEAEGQTI-TMPKETLTNNSLTIAVSPDLL 395
Query: 588 D 588
D
Sbjct: 396 D 396
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 5e-33
Identities = 80/405 (19%), Positives = 155/405 (38%), Gaps = 49/405 (12%)
Query: 71 ARVVSLNLSGLSLAGSISPSLGRLQSLIHLDLSSNSLTGPIPTALSNLSSLESLLLFSNQ 130
A + SL+ S+ + + +L L L +SN++T + LS ++L L SN+
Sbjct: 42 ATLTSLDCHNSSI--TDMTGIEKLTGLTKLICTSNNITT-LD--LSQNTNLTYLACDSNK 96
Query: 131 LAGTIPTQLGSLTSLRVMRIGDNWLSGSIPTSFGNLVNLGTLGLASCSLSGPIPPQFGQL 190
L + + LT L + N L+ + L L A +L+
Sbjct: 97 LT-NLD--VTPLTKLTYLNCDTNKLT-KLD--VSQNPLLTYLNCARNTLT---EIDVSHN 147
Query: 191 SQLEELILQQNQLQGPIPAELGNCSSLSIFTAAENNLNGSIPAALGRLQNLQLLNLGNNS 250
+QL EL N+ + + + L+ + N + + + + + L LN N+
Sbjct: 148 TQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKIT-ELD--VSQNKLLNRLNCDTNN 202
Query: 251 LSGEIPSELGELSQLGYLNLMGNRLEGAIPRSFAKMGNLQSLDLSMNRLTGGIPEEFGNM 310
++ ++ L + QL +L+ N+L I + L D S+N LT + +
Sbjct: 203 IT-KLD--LNQNIQLTFLDCSSNKLT-EID--VTPLTQLTYFDCSVNPLT-ELD--VSTL 253
Query: 311 GQLVFLVLSNNNISGSIPRRICTNATSLEHLILAEIQLSGEIPVELSQCQSLKQLDLSNN 370
+L L ++ I T + +I+ ++++ L LD
Sbjct: 254 SKLTTLHCIQTDLL-EIDLTHNTQLIYFQAEGCRKIK-----ELDVTHNTQLYLLDCQAA 307
Query: 371 TLNGTIPVELFQLVALTHLYLHNNSLVGSISPFVANLSNLQELALYHNNFQGSLPREIGM 430
+ ++L Q L +LYL+N L + V++ + L+ L+ + + Q +G
Sbjct: 308 GIT---ELDLSQNPKLVYLYLNNTELT-ELD--VSHNTKLKSLSCVNAHIQ-DFS-SVGK 359
Query: 431 LVKLELLYLYDNHLSGQIPSEVGNCSSL------KWIDFFGNSFT 469
+ L + + +P E +SL +D FGN
Sbjct: 360 IPALNNNFEAEGQTI-TMPKETLTNNSLTIAVSPDLLDQFGNPMN 403
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 3e-31
Identities = 79/452 (17%), Positives = 154/452 (34%), Gaps = 65/452 (14%)
Query: 379 ELFQLVALTHLYLHNNSLVGSISPFVANLSNLQELALYHNNFQGSLPREIGMLVKLELLY 438
+ F + + + L+ L L ++++ + I L L L
Sbjct: 13 DWFPDDNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSIT-DMT-GIEKLTGLTKLI 70
Query: 439 LYDNHLSGQIPSEVGNCSSLKWIDFFGNSFTGEIPTSIGRLKDLNFLHLRQNELVGQIPA 498
N+++ ++ ++L ++ N T + + L L +L+ N+L
Sbjct: 71 CTSNNITTL---DLSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKL---TKL 121
Query: 499 SLGNCHQLIILDLADNKLSGGVPASFGFLQALEQLMLYNNSLEGNLPGSLINLRNLTRIN 558
+ L L+ A N L+ L +L + N L + LT ++
Sbjct: 122 DVSQNPLLTYLNCARNTLT---EIDVSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLD 176
Query: 559 FSKNRLNGRIATLCSSHSFLSFDVTNNEFDHEIPPQLGNSPSLERLRLGNNKFIGKIPWT 618
S N++ DV+ N L RL N I K+
Sbjct: 177 CSFNKIT-------------ELDVSQN-------------KLLNRLNCDTNN-ITKLD-- 207
Query: 619 FGKIRELSLLDLSGNSLTGPIPTQLLMCKKLSHIDLNNNLLSGAVPSWLGTLPQLGELKL 678
+ +L+ LD S N LT I + +L++ D + N L+ + + TL +L L
Sbjct: 208 LNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSVNPLT-ELD--VSTLSKLTTLHC 261
Query: 679 SFNQFVGFLPRELFNCSKLLVLSLDGNMLNGSLPNEVGNLASLNVLTLSGNLLSGPIPPA 738
+ +L + ++L+ +G +V + L +L ++ +
Sbjct: 262 IQTDLLEI---DLTHNTQLIYFQAEGC--RKIKELDVTHNTQLYLLDCQAAGIT-ELD-- 313
Query: 739 IGRLSKLYELRLSNNSLNGVIPLEIGQLQNLQSILDLSHNNFTGQIPPSMGTLAKLEVLN 798
+ + KL L L+N L L++ L+S L + + S+G + L
Sbjct: 314 LSQNPKLVYLYLNNTELTE---LDVSHNTKLKS-LSCVNAHIQDF--SSVGKIPALNNNF 367
Query: 799 LSHNQLVGELPSQLGEMSSLGKLNLSYNDLQG 830
+ Q + L S ++ D G
Sbjct: 368 EAEGQTITMPKETLTNNSLTIAVSPDLLDQFG 399
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 8e-10
Identities = 35/211 (16%), Positives = 70/211 (33%), Gaps = 18/211 (8%)
Query: 90 SLGRLQSLIHLDLSSNSLTGPIPTALSNLSSLESLLLFSNQLAGTIPTQLGSLTSLRVMR 149
+ L L + D S N LT + +S LS L +L L I L T L +
Sbjct: 228 DVTPLTQLTYFDCSVNPLT-ELD--VSTLSKLTTLHCIQTDLL-EID--LTHNTQLIYFQ 281
Query: 150 IGDNWLSGSIPTSFGNLVNLGTLGLASCSLSGPIPPQFGQLSQLEELILQQNQLQGPIPA 209
+ + L L + ++ + Q +L L L +L +
Sbjct: 282 AEGCRKIKELD--VTHNTQLYLLDCQAAGIT-ELD--LSQNPKLVYLYLNNTELTE-LD- 334
Query: 210 ELGNCSSLSIFTAAENNLNGSIPAALGRLQNLQLLNLGNNSLSGEIPSELGELSQLGYLN 269
+ + + L + ++ ++G++ L +P E + L +
Sbjct: 335 -VSHNTKLKSLSCVNAHIQ-DFS-SVGKIPALNNNFEAEGQTI-TMPKETLTNNSL-TIA 389
Query: 270 LMGNRLEGAIPRSFAKMGNLQSLDLSMNRLT 300
+ + L+ + G+ D + N +T
Sbjct: 390 VSPDLLDQFGNPMNIEPGDGGVYDQATNTIT 420
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 1e-35
Identities = 77/302 (25%), Positives = 123/302 (40%), Gaps = 44/302 (14%)
Query: 953 IIGSGGSGTVYKAEL-----ANGATVAVKKISCKDDHL-LNKSFTREVKTLGRIRHRHLV 1006
+G G G+V GA VAVK+ + + F RE++ L + +V
Sbjct: 30 QLGKGNFGSVELCRYDPLGDNTGALVAVKQ--LQHSGPDQQRDFQREIQILKALHSDFIV 87
Query: 1007 KLMGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVE 1066
K G G S L+ EY+ +G + D+L + + + L + + + +G+E
Sbjct: 88 KYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLY------SSQICKGME 141
Query: 1067 YLH-HDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVED---YNSNTESNT---WF 1119
YL CV HRD+ + NIL++S + DFGLAK L D Y + W
Sbjct: 142 YLGSRRCV----HRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFW- 196
Query: 1120 AGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMVRWVEMHME 1178
APE + + DV+S G+VL EL + +
Sbjct: 197 ------YAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKS---CSPSAEFLRMMGCERDV 247
Query: 1179 MSGSAREELLDD--QM-KPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNVF 1235
+ S ELL++ ++ P C A +V E+ C SPQ+RPS + L ++
Sbjct: 248 PALSRLLELLEEGQRLPAP----PACPA-EVHELMKLCWAPSPQDRPSFSALGPQLDMLW 302
Query: 1236 NN 1237
+
Sbjct: 303 SG 304
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 2e-35
Identities = 72/297 (24%), Positives = 126/297 (42%), Gaps = 45/297 (15%)
Query: 953 IIGSGGSGTVYKAELA-----NGATVAVKKISCKDDHLLN--KSFTREVKTLGRIRHRHL 1005
+G G G V G VAVK S K + N +E++ L + H ++
Sbjct: 28 DLGEGHFGKVELCRYDPEGDNTGEQVAVK--SLKPESGGNHIADLKKEIEILRNLYHENI 85
Query: 1006 VKLMGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGV 1065
VK G C G LI E++ +GS+ ++L K I +++ L + AV + +G+
Sbjct: 86 VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKY------AVQICKGM 139
Query: 1066 EYLH-HDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVED---YNSNTESNT---W 1118
+YL V HRD+ + N+L++S + +GDFGL KA+ D Y + ++ W
Sbjct: 140 DYLGSRQYV----HRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFW 195
Query: 1119 FAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMVRWVEMHM 1177
+ APE K DV+S G+ L EL++ + + H
Sbjct: 196 Y-------APECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPT---HG 245
Query: 1178 EMSGSAREELLDD--QM-KPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLL 1231
+M+ + L + ++ P C +V ++ +C + P R S + + +
Sbjct: 246 QMTVTRLVNTLKEGKRLPCP----PNCPD-EVYQLMRKCWEFQPSNRTSFQNLIEGF 297
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 3e-35
Identities = 79/304 (25%), Positives = 128/304 (42%), Gaps = 47/304 (15%)
Query: 953 IIGSGGSGTVYKAEL-----ANGATVAVKKISCKDDHLLN-KSFTREVKTLGRIRHRHLV 1006
+G G G+V G VAVKK + + + F RE++ L ++H ++V
Sbjct: 17 QLGKGNFGSVEMCRYDPLQDNTGEVVAVKK--LQHSTEEHLRDFEREIEILKSLQHDNIV 74
Query: 1007 KLMGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVE 1066
K G C + G + LI EY+ GS+ D+L K I K L + + +G+E
Sbjct: 75 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQY------TSQICKGME 128
Query: 1067 YLH-HDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVED---YNSNTESNT---WF 1119
YL + HRD+ + NIL+++ +GDFGL K L +D + + W
Sbjct: 129 YLGTKRYI----HRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFW- 183
Query: 1120 AGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS---GKMPTDATFGVEMDMVRWVEMH 1176
APE K + DV+S G+VL EL + A F + + +M
Sbjct: 184 ------YAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQM- 236
Query: 1177 MEMSGSARE--ELLDDQMKPLLPG-EECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLN 1233
ELL + + LP + C ++ I +C + +RPS R + +
Sbjct: 237 -----IVFHLIELLKNNGR--LPRPDGCPD-EIYMIMTECWNNNVNQRPSFRDLALRVDQ 288
Query: 1234 VFNN 1237
+ +N
Sbjct: 289 IRDN 292
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 4e-35
Identities = 59/217 (27%), Positives = 99/217 (45%), Gaps = 17/217 (7%)
Query: 953 IIGSGGSGTVYKAE-LANGATVAVKKISCKDDHLLN----KSFTREVKTLGRIRHRHLVK 1007
IG+G G K ++G + K++ + + EV L ++H ++V+
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKELDYGS---MTEAEKQMLVSEVNLLRELKHPNIVR 69
Query: 1008 LMGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEY 1067
++ + ++ EY E G + + K K R+ LD E L++ L ++
Sbjct: 70 YYDRIIDRTNTTLYIVMEYCEGGDLASVITKG---TKERQYLDEEFVLRVMTQLTLALKE 126
Query: 1068 LH--HDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGY 1125
H D +LHRD+K +N+ LD LGDFGLA+ L N +T F G+ Y
Sbjct: 127 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL----NHDTSFAKTFVGTPYY 182
Query: 1126 IAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDAT 1162
++PE + EK D++S+G +L EL + P A
Sbjct: 183 MSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF 219
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 137 bits (345), Expect = 6e-35
Identities = 35/365 (9%), Positives = 91/365 (24%), Gaps = 52/365 (14%)
Query: 892 AVVTLFVKRKREFLRKSSQVNYTSSSSSSQAQRRLLFQAAAKRDFRWEDIMGATNNLSDE 951
+ + +KR+ E + + ++ +A ++ A+ + L
Sbjct: 9 SFMRDLLKREEELIGYCREEALKEPAAMVEAVTATVWPQNAETTVD-SLLSQGERKLKLV 67
Query: 952 FIIGSGGSGTVYKA-ELANGATVAVKKISCKDDHLLN--KSFTREVKTLGRIRHRHLVKL 1008
+ G V+ ++ A+K + ++ + + R+ +
Sbjct: 68 EPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEA 127
Query: 1009 MGHCC------------------------NKGAGSNLLIYEYMENGSVWDWLHKQPVNIK 1044
+ + LL+ +
Sbjct: 128 RDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYV 186
Query: 1045 MRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKA 1104
R A + L + L ++H N+ + + LGD
Sbjct: 187 FRGDEGILALHILTAQLIRLAANLQSK---GLVHGHFTPDNLFIMPDGRLMLGDVSALWK 243
Query: 1105 LVEDYNSNTESNTWFAGSYGYIAPEYAYSLKA--TEKCDVYSMGIVLMELVSGKMPTDAT 1162
+ + Y E+ + A T + + +G+ + + +P
Sbjct: 244 V-------GTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP---- 292
Query: 1163 FGVEMDMVRWVEMHMEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERP 1222
FG+ ++ + + L PL V + + + R
Sbjct: 293 FGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDF-------VKTLIGRFLNFDRRRRL 345
Query: 1223 SSRQV 1227
+
Sbjct: 346 LPLEA 350
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 9e-35
Identities = 95/516 (18%), Positives = 178/516 (34%), Gaps = 47/516 (9%)
Query: 63 GITCGSSSARVVSLNLSGLSLAGSISPSLGRLQSLIHLDLSSNSLTGPIPTALSNLSSLE 122
G S+ ++ S +L + P L LS NS++ +S LS L
Sbjct: 23 GSMTPFSNELESMVDYSNRNLT-HV-PK-DLPPRTKALSLSQNSISELRMPDISFLSELR 79
Query: 123 SLLLFSNQLAGTIPTQL-GSLTSLRVMRIGDNWLSGSIPTSFGNLVNLGTLGLASCSL-S 180
L L N++ ++ + L + + N L +I + +L L L+
Sbjct: 80 VLRLSHNRIR-SLDFHVFLFNQDLEYLDVSHNRLQ-NIS--CCPMASLRHLDLSFNDFDV 135
Query: 181 GPIPPQFGQLSQLEELILQQNQLQGPIPAELGNCSSLSIFTAAENNLNGSIPAALGRLQN 240
P+ +FG L++L L L + + + + I + ++ N
Sbjct: 136 LPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPN 195
Query: 241 LQLLNLGNNSLSGEIPSELGELSQLGYLNLMGNRLEGAIPRSFAKMGNLQSLDLSMNRLT 300
+L+L + S ++ LG+L L +L + + + ++ +T
Sbjct: 196 TTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVT 255
Query: 301 GGIPE----------EFGNMGQLVFLVLSNNNISGSIPRRICTNA-TSLEHLILAEI--- 346
E +F + +L + N I+ I R T + T+L+ L++ +
Sbjct: 256 LQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQ 315
Query: 347 QLSGEIPVELSQCQSLKQLDLSNNTLNGTIPVELFQLVALTHLYLHNNSLVGSISPFVAN 406
S + LS + V + T L N S+ +
Sbjct: 316 VFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCST 375
Query: 407 LSNLQELALYHNNFQGSLPREIGMLVKLELLYLYDNHLSGQIPSEVGNCSSLKWIDFFGN 466
L LQ L L N + + + M + L D L+ + S
Sbjct: 376 LKRLQTLILQRNGLK-NFFKVALMTKNMSSLETLDVSLN-SLNS---------------- 417
Query: 467 SFTGEIPTSIGRLKDLNFLHLRQNELVGQIPASLGNCHQLIILDLADNKLSGGVPASFGF 526
+ + + L+L N L G + L ++ +LDL +N++ +P
Sbjct: 418 ---HAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTH 471
Query: 527 LQALEQLMLYNNSLEGNLPGSLINLRNLTRINFSKN 562
LQAL++L + +N L+ G L +L I N
Sbjct: 472 LQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHDN 507
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 1e-33
Identities = 89/489 (18%), Positives = 152/489 (31%), Gaps = 57/489 (11%)
Query: 361 SLKQLDLSNNTLNGTIPVELFQLVALTHLYLHNNSLVGSISPFV-ANLSNLQELALYHNN 419
K L LS N+++ ++ L L L L +N + S+ V +L+ L + HN
Sbjct: 53 RTKALSLSQNSISELRMPDISFLSELRVLRLSHNRI-RSLDFHVFLFNQDLEYLDVSHNR 111
Query: 420 FQGSLPREIGMLVKLELLYLYDNHL-SGQIPSEVGNCSSLKWIDFFGNSFTGEIPTSIGR 478
Q ++ + L L L N + E GN + L ++ F +
Sbjct: 112 LQ-NISC--CPMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAH 168
Query: 479 LK-DLNFLHLRQNELVGQIPASLGNCHQLIILDLADNKLSGGVPASFGFLQALEQLMLYN 537
L L L + G SL +L L + S + AL L L N
Sbjct: 169 LHLSCILLDLVSYHIKGGETESL-QIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSN 227
Query: 538 NSLEGNLPGSLINL-----RNLTRINFSKNRLNGRIATLCSSHSFL------SFDVTNNE 586
L L+ R T +N + + F ++ N
Sbjct: 228 IKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLT 287
Query: 587 FDHEIPPQLGNS-----PSLERLRLGNNKFIGKIPWTFGKIRELSLLDLSGNSLTGPIPT 641
I + SL + N F+ + E+++ LS +
Sbjct: 288 ITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMV 347
Query: 642 QLLMCKKLSHIDLNNNLLSGAVPSWLGTLPQLGELKLSFNQFVGFLPRELFNCSKLLVLS 701
+ ++ N+ + +V TL +L L L N
Sbjct: 348 CPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK----------------- 390
Query: 702 LDGNMLNGSLPNEVGNLASLNVLTLSGN----LLSGPIPPAIGRLSKLYELRLSNNSLNG 757
+ +++ L L S + L LS+N L G
Sbjct: 391 --------NFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTG 442
Query: 758 VIPLEIGQLQNLQSILDLSHNNFTGQIPPSMGTLAKLEVLNLSHNQLVGELPSQLGEMSS 817
+ + ++ +LDL +N IP + L L+ LN++ NQL ++S
Sbjct: 443 SVFRCL--PPKVK-VLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKSVPDGVFDRLTS 498
Query: 818 LGKLNLSYN 826
L + L N
Sbjct: 499 LQYIWLHDN 507
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-30
Identities = 99/498 (19%), Positives = 168/498 (33%), Gaps = 57/498 (11%)
Query: 230 SIPAALGRLQNLQLLNLGNNSLSGEIPSELGELSQLGYLNLMGNRLEGAIPRS-FAKMGN 288
+P + L+L NS+S ++ LS+L L L NR+ ++ F +
Sbjct: 45 HVPK--DLPPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQD 101
Query: 289 LQSLDLSMNRLTGGIPEEFGNMGQLVFLVLSNNNISGSIPRRIC-TNATSLEHLILAEIQ 347
L+ LD+S NRL I M L L LS N+ +P N T L L L+ +
Sbjct: 102 LEYLDVSHNRLQ-NIS--CCPMASLRHLDLSFNDFD-VLPVCKEFGNLTKLTFLGLSAAK 157
Query: 348 L-SGEIPVELSQCQSLKQLDLSNNTLNGTIPVELFQL-VALTHLYLHNNSLVGSISP-FV 404
++ S LDL + + G L + HL H NSL V
Sbjct: 158 FRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSV 217
Query: 405 ANLSNLQ--ELALYHNNFQGSLPREIGMLVKLELLYLYDNHLSGQIPSEVG-----NCSS 457
L +LQ + L N Q + + LL + H+ V
Sbjct: 218 NALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRP 277
Query: 458 LKWIDFFGNSFTGEIPTSIGR-----LKDLNFLHLRQNELVGQIPASLGNCHQLIILDLA 512
+++++ + + T I LK L H++ + A ++ I L+
Sbjct: 278 VEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLS 337
Query: 513 DNKLSGGVPASFGFLQALEQLMLYNNSLEGNLPGSLINLRNLTRINFSKNRLNGRIATLC 572
+ + L N ++ L+ L + +N L
Sbjct: 338 ISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGL-------- 389
Query: 573 SSHSFLSFDVTNNEFDHEIPPQLGNSPSLERLRLGNNKF----IGKIPWTFGKIRELSLL 628
+ ++ L + T + +L
Sbjct: 390 ----------------KNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVL 433
Query: 629 DLSGNSLTGPIPTQLLMCKKLSHIDLNNNLLSGAVPSWLGTLPQLGELKLSFNQFVGFLP 688
+LS N LTG + L K+ +DL+NN + ++P + L L EL ++ NQ +P
Sbjct: 434 NLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVP 489
Query: 689 RELF-NCSKLLVLSLDGN 705
+F + L + L N
Sbjct: 490 DGVFDRLTSLQYIWLHDN 507
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 5e-30
Identities = 83/469 (17%), Positives = 161/469 (34%), Gaps = 45/469 (9%)
Query: 232 PAALGRLQNLQLLNLGNNSLSGEIPSEL-GELSQLGYLNLMGNRLEGAIPRSFAKMGNLQ 290
+ L L++L L +N + + + L YL++ NRL+ I M +L+
Sbjct: 69 MPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQDLEYLDVSHNRLQ-NIS--CCPMASLR 124
Query: 291 SLDLSMNRLTG-GIPEEFGNMGQLVFLVLSNNNISGSIPRRICTNATSLEHLILAEIQLS 349
LDLS N + +EFGN+ +L FL LS + S L L +
Sbjct: 125 HLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIK 184
Query: 350 GEIPVELSQCQSLK-QLDLSNNTLNGTIPVELFQLVA---LTHLYLHNNSLVGSISPFVA 405
G L + L N+L + L+++ L++ + ++
Sbjct: 185 GGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSE 244
Query: 406 NLSNLQELALYHNNFQGSLPREIGML-----VKLELLYLYDNHLSGQIPSEVGNCS---- 456
L + + + + + + +E L +Y+ ++ +I E S
Sbjct: 245 LTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETAL 304
Query: 457 -SLKWIDFFGNSFTGEIPTSIGRLKDLNFLHLRQNELVGQIPASLGNCHQLIILDLADNK 515
SL F ++N L ++ + L+ N
Sbjct: 305 KSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNV 364
Query: 516 LSGGVPASFGFLQALEQLMLYNNSLEGNLPGSLINLRNLTRINFSKNRLNGRIATLCSSH 575
+ V L+ L+ L+L N L+ N + +N++ + LN
Sbjct: 365 FTDSVFQGCSTLKRLQTLILQRNGLK-NFFKVALMTKNMSSLETLDVSLNS--------- 414
Query: 576 SFLSFDVTNNEFDHEIPPQLGNSPSLERLRLGNNKFIGKIPWTFGKI-RELSLLDLSGNS 634
+ ++ +D + S+ L L +N G + F + ++ +LDL N
Sbjct: 415 ------LNSHAYDRTC----AWAESILVLNLSSNMLTGSV---FRCLPPKVKVLDLHNNR 461
Query: 635 LTGPIPTQLLMCKKLSHIDLNNNLLSGAVPSWLGTLPQLGELKLSFNQF 683
+ IP + + L +++ +N L L L + L N +
Sbjct: 462 IMS-IPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHDNPW 509
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-25
Identities = 74/356 (20%), Positives = 131/356 (36%), Gaps = 27/356 (7%)
Query: 74 VSLNLSGLSLAGSISPSLGRLQSLI-HLDLSSNSLTGPIPTALSNLSSLESLLLFSNQLA 132
+ L+L + G + SL + + HL NSL ++++L L L + +L
Sbjct: 174 ILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQ--VNMSVNALGHLQLSNIKLN 231
Query: 133 GTIPTQLGSLTSLRVMRIGDNWLSGSIPTSFGNLVNLGTLGLASCSLSGPIPPQFGQLSQ 192
+L + + L+ L ++ T S L QF
Sbjct: 232 DENCQRLMTFL---------SELTRGPTLLNVTLQHIETTWKCSVKL-----FQFFWPRP 277
Query: 193 LEELILQQNQLQGPIPAELGNCSSLSIFTAAENNLNG-----SIPAALGRLQNLQLLNLG 247
+E L + + I E S ++ + ++ S A + + L
Sbjct: 278 VEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLS 337
Query: 248 NNSLSGEIPSELGELSQLGYLNLMGNRLEGAIPRSFAKMGNLQSLDLSMNRLT--GGIPE 305
+ S +LN N ++ + + + LQ+L L N L +
Sbjct: 338 ISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVAL 397
Query: 306 EFGNMGQLVFLVLSNNNISGSIPRRICTNATSLEHLILAEIQLSGEIPVELSQCQSLKQL 365
NM L L +S N+++ R C A S+ L L+ L+G + L +K L
Sbjct: 398 MTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLPP--KVKVL 455
Query: 366 DLSNNTLNGTIPVELFQLVALTHLYLHNNSLVGSISPFVANLSNLQELALYHNNFQ 421
DL NN + +IP ++ L AL L + +N L L++LQ + L+ N +
Sbjct: 456 DLHNNRIM-SIPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHDNPWD 510
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 95.7 bits (238), Expect = 2e-20
Identities = 83/498 (16%), Positives = 141/498 (28%), Gaps = 94/498 (18%)
Query: 357 SQCQSLKQLDLSNNTLNGTIPVELFQLVALTHLYLHNNSLVGSISPFV-ANLSNLQELAL 415
+ +D SN L +P +L L L NS+ + + LS L+ L L
Sbjct: 28 FSNELESMVDYSNRNLT-HVPKDL--PPRTKALSLSQNSIS-ELRMPDISFLSELRVLRL 83
Query: 416 YHNNFQGSLPREI-GMLVKLELLYLYDNHLSGQIPSEVGNCSSLKWIDFFGNSFTGEIPT 474
HN + SL + LE L + N L I +SL+ +D N F +P
Sbjct: 84 SHNRIR-SLDFHVFLFNQDLEYLDVSHNRLQN-ISC--CPMASLRHLDLSFNDFD-VLP- 137
Query: 475 SIGRLKDLNFLHLRQNELVGQIPASLGNCHQLIILDLADNKLSGGVPASFGFLQ-ALEQL 533
+ GN +L L L+ K L + L
Sbjct: 138 ---------------------VCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILL 176
Query: 534 MLYNNSLEGNLPGSLINLRNLTRINFSKNRLNGRIATLCSSHSFLSFDVTNNEFDHEIPP 593
L + ++G SL + S ++ ++N + + E
Sbjct: 177 DLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDE--- 233
Query: 594 QLGNSPSLERLRLGNNKFIGKIPWTFGKIRELSLLDLSGNSLTGPIPTQLLMCKKLSHID 653
N + + + L + L T +L
Sbjct: 234 --------------NCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRP-- 277
Query: 654 LNNNLLSGAVPSWLGTLPQLGELKLSFNQFVGFLPRELFNCSKLLVLSLDGNMLNGSLPN 713
+ L + + RE F S+
Sbjct: 278 -------------------VEYLNIYNLTITERIDREEFTYSET---------------- 302
Query: 714 EVGNLASLNVLTLSGNLLSGPIPPAIGRLSKLYELRLSNNSLNGVIPLEIGQLQNLQSIL 773
L SL + + + +++ LS + + + + L
Sbjct: 303 ---ALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFT-FL 358
Query: 774 DLSHNNFTGQIPPSMGTLAKLEVLNLSHNQL--VGELPSQLGEMSSLGKLNLSYNDLQGK 831
+ + N FT + TL +L+ L L N L ++ MSSL L++S N L
Sbjct: 359 NFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSH 418
Query: 832 LSKQFSHWPAEAFEGNLH 849
+ W NL
Sbjct: 419 AYDRTCAWAESILVLNLS 436
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 88.4 bits (219), Expect = 4e-18
Identities = 48/258 (18%), Positives = 89/258 (34%), Gaps = 33/258 (12%)
Query: 72 RVVSLNLSGLSLAGSISPSLGR-----LQSLIHLDLSSNSLTGPIPTALSNLSSLESLLL 126
V LN+ L++ I L+SL+ + + S + + +L
Sbjct: 277 PVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKML 336
Query: 127 FSNQLAGTIPTQLGSLTSLRVMRIGDNWLSGSIPTSFGNLVNLGTLGLASCSLSGPIPPQ 186
+ S +S + N + S+ L L TL L L
Sbjct: 337 SISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKN-FFKV 395
Query: 187 FGQLSQLEELILQQNQLQGPIPAELGNCSSLSIFTAAENNLNGSIPAAL-GRLQNLQLLN 245
+ L L N+LN +++ +LN
Sbjct: 396 ALMTKNMSSLETLDVSL---------------------NSLNSHAYDRTCAWAESILVLN 434
Query: 246 LGNNSLSGEIPSELGELSQLGYLNLMGNRLEGAIPRSFAKMGNLQSLDLSMNRLTGGIPE 305
L +N L+G + L ++ L+L NR+ +IP+ + LQ L+++ N+L +P+
Sbjct: 435 LSSNMLTGSVFRCL--PPKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVPD 490
Query: 306 E-FGNMGQLVFLVLSNNN 322
F + L ++ L +N
Sbjct: 491 GVFDRLTSLQYIWLHDNP 508
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 2e-34
Identities = 60/281 (21%), Positives = 113/281 (40%), Gaps = 33/281 (11%)
Query: 954 IGSGGSGTVYKAE-LANGATVAVKKISCKD--DHLLNKSFTREVKTLGRIRHRHLVKLMG 1010
IG G VY+A L +G VA+KK+ D D +E+ L ++ H +++K
Sbjct: 40 IGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYA 99
Query: 1011 HCCNKGAGSNLLIY-EYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLH 1069
L I E + G + + K ++ + K V L +E++H
Sbjct: 100 SFIEDN---ELNIVLELADAGDLSRMIKHF---KKQKRLIPERTVWKYFVQLCSALEHMH 153
Query: 1070 HDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPE 1129
+++HRDIK +N+ + + LGD GL + +S T + G+ Y++PE
Sbjct: 154 SR---RVMHRDIKPANVFITATGVVKLGDLGLGRFF----SSKTTAAHSLVGTPYYMSPE 206
Query: 1130 YAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSAREELLD 1189
+ K D++S+G +L E+ + + P + + +
Sbjct: 207 RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKI--------------EQ 252
Query: 1190 DQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDL 1230
PL + + ++ ++ C P++RP V D+
Sbjct: 253 CDYPPLPS--DHYSEELRQLVNMCINPDPEKRPDVTYVYDV 291
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 2e-34
Identities = 77/306 (25%), Positives = 125/306 (40%), Gaps = 51/306 (16%)
Query: 953 IIGSGGSGTVYKAEL-----ANGATVAVKKISCKDDHLLN-KSFTREVKTLGRIRHRHLV 1006
+G G G+V G VAVK + + + F RE++ L ++H ++V
Sbjct: 48 QLGKGNFGSVEMCRYDPLQDNTGEVVAVK--KLQHSTEEHLRDFEREIEILKSLQHDNIV 105
Query: 1007 KLMGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVE 1066
K G C + G + LI EY+ GS+ D+L K I K L + + +G+E
Sbjct: 106 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQY------TSQICKGME 159
Query: 1067 YLH-HDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVED---YNSNTESNT---WF 1119
YL + HRD+ + NIL+++ +GDFGL K L +D Y + W
Sbjct: 160 YLGTKRYI----HRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFW- 214
Query: 1120 AGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS---GKMPTDATFGVEMDMVRWVEMH 1176
APE K + DV+S G+VL EL + A F + + +M
Sbjct: 215 ------YAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQM- 267
Query: 1177 MEMSGSARE--ELLDDQM---KPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLL 1231
ELL + +P + C ++ I +C + +RPS R + +
Sbjct: 268 -----IVFHLIELLKNNGRLPRP----DGCPD-EIYMIMTECWNNNVNQRPSFRDLALRV 317
Query: 1232 LNVFNN 1237
+ +
Sbjct: 318 DQIRDQ 323
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 3e-34
Identities = 58/216 (26%), Positives = 96/216 (44%), Gaps = 24/216 (11%)
Query: 953 IIGSGGSGTVYKAE-LANGATVAVKKISCKDDHLLN----KSFTREVKTLGRIRHRHLVK 1007
IG G G + +G +K+I+ ++ + REV L ++H ++V+
Sbjct: 31 KIGEGSFGKAILVKSTEDGRQYVIKEINISR---MSSKEREESRREVAVLANMKHPNIVQ 87
Query: 1008 LMGHCCNKGAGSNLLIY-EYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVE 1066
G +L I +Y E G ++ ++ Q + L V + ++
Sbjct: 88 YRESFEENG---SLYIVMDYCEGGDLFKRINAQK-----GVLFQEDQILDWFVQICLALK 139
Query: 1067 YLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYI 1126
++H KILHRDIKS NI L + LGDFG+A+ L NS E G+ Y+
Sbjct: 140 HVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVL----NSTVELARACIGTPYYL 192
Query: 1127 APEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDAT 1162
+PE + K D++++G VL EL + K +A
Sbjct: 193 SPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAG 228
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 6e-34
Identities = 65/303 (21%), Positives = 114/303 (37%), Gaps = 63/303 (20%)
Query: 953 IIGSGGSGTVYKAELANGA-----TVAVKKISCKDDHLLN--KSFTREVKTLGRIRHRHL 1005
++GSG GTVYK VA+K ++ K E + + + H+
Sbjct: 22 VLGSGAFGTVYKGLWIPEGEKVKIPVAIK--ELREATSPKANKEILDEAYVMASVDNPHV 79
Query: 1006 VKLMGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGV 1065
+L+G C + LI + M G + D++ + NI + L+W V +A+G+
Sbjct: 80 CRLLGICLTS---TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGM 130
Query: 1066 EYL-HHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNT-----WF 1119
YL V HRD+ + N+L+ + + DFGLAK L + W
Sbjct: 131 NYLEDRRLV----HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW- 185
Query: 1120 AGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMVRWVEMHME 1178
+A E T + DV+S G+ + EL++ G P +
Sbjct: 186 ------MALESILHRIYTHQSDVWSYGVTVWELMTFGSKP-----------------YDG 222
Query: 1179 MSGSAREELLDD--QMKPLLPGEEC--AAYQVLEIALQCTKTSPQERPSSRQVCDLLLNV 1234
+ S +L+ ++ P C Y ++ +C RP R++ +
Sbjct: 223 IPASEISSILEKGERLPQ--P-PICTIDVYMIM---RKCWMIDADSRPKFRELIIEFSKM 276
Query: 1235 FNN 1237
+
Sbjct: 277 ARD 279
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 9e-34
Identities = 57/222 (25%), Positives = 96/222 (43%), Gaps = 36/222 (16%)
Query: 954 IGSGGSGTVYKAELANGATVAVKKISCKD-DHLLNKSFTREVKTLGRIRH--RHLVKLMG 1010
IGSGGS V++ A+K ++ ++ D+ S+ E+ L +++ +++L
Sbjct: 36 IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 95
Query: 1011 HCCNKGAGSNLLIYEYME--NGSVWDWLHKQPVNIKMRKSLD-WEARLKIAVGLAQGVEY 1067
+ IY ME N + WL K +KS+D WE + + + V
Sbjct: 96 YEITDQY-----IYMVMECGNIDLNSWLKK-------KKSIDPWERK-SYWKNMLEAVHT 142
Query: 1068 LHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIA 1127
+H I+H D+K +N L+ M L DFG+A + D S + + G+ Y+
Sbjct: 143 IHQH---GIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDS--QVGTVNYMP 196
Query: 1128 PE-----------YAYSLKATEKCDVYSMGIVLMELVSGKMP 1158
PE K + K DV+S+G +L + GK P
Sbjct: 197 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 238
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 1e-33
Identities = 75/293 (25%), Positives = 125/293 (42%), Gaps = 54/293 (18%)
Query: 953 IIGSGGSGTVYKAELANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHC 1012
IG G G V + G VAVK K+D ++F E + ++RH +LV+L+G
Sbjct: 28 TIGKGEFGDVMLGD-YRGNKVAVK--CIKNDAT-AQAFLAEASVMTQLRHSNLVQLLG-V 82
Query: 1013 CNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYL-HHD 1071
+ G ++ EYM GS+ D+L + R L + LK ++ + + +EYL ++
Sbjct: 83 IVEEKGGLYIVTEYMAKGSLVDYLRSRG-----RSVLGGDCLLKFSLDVCEAMEYLEGNN 137
Query: 1072 CVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNT---WFAGSYGYIAP 1128
V HRD+ + N+L+ + A + DFGL K E ++ W AP
Sbjct: 138 FV----HRDLAARNVLVSEDNVAKVSDFGLTK---EASSTQDTGKLPVKW-------TAP 183
Query: 1129 EYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMVRWVEMHMEMSGSAREEL 1187
E K + K DV+S GI+L E+ S G++P + +
Sbjct: 184 EALREKKFSTKSDVWSFGILLWEIYSFGRVP-----------------YPRIPLKDVVPR 226
Query: 1188 LDD--QM-KPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNVFNN 1237
++ +M P + C V E+ C RPS Q+ + L ++ +
Sbjct: 227 VEKGYKMDAP----DGCPP-AVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 1e-33
Identities = 79/308 (25%), Positives = 128/308 (41%), Gaps = 57/308 (18%)
Query: 953 IIGSGGSGTVYKAELAN-----GATVAVKKISCKDDHLLN--KSFTREVKTLGRIRHRHL 1005
+G G G V G VAVK + K D + +E+ L + H H+
Sbjct: 38 DLGEGHFGKVSLYCYDPTNDGTGEMVAVK--ALKADAGPQHRSGWKQEIDILRTLYHEHI 95
Query: 1006 VKLMGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGV 1065
+K G C + GA S L+ EY+ GS+ D+L + S+ L A + +G+
Sbjct: 96 IKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH--------SIGLAQLLLFAQQICEGM 147
Query: 1066 EYLH-HDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVED---YNSNTESNT---W 1118
YLH + HRD+ + N+LLD++ +GDFGLAKA+ E Y + ++ W
Sbjct: 148 AYLHAQHYI----HRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFW 203
Query: 1119 FAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHM- 1177
+ APE K DV+S G+ L EL+ T + +
Sbjct: 204 Y-------APECLKEYKFYYASDVWSFGVTLYELL--------THCDSSQSPPTKFLELI 248
Query: 1178 -----EMSGSAREELLDD--QM-KPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCD 1229
+M+ ELL+ ++ +P ++C A +V + C +T RP+ +
Sbjct: 249 GIAQGQMTVLRLTELLERGERLPRP----DKCPA-EVYHLMKNCWETEASFRPTFENLIP 303
Query: 1230 LLLNVFNN 1237
+L V
Sbjct: 304 ILKTVHEK 311
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 1e-33
Identities = 56/221 (25%), Positives = 94/221 (42%), Gaps = 34/221 (15%)
Query: 954 IGSGGSGTVYKAELANGATVAVKKISCKD-DHLLNKSFTREVKTLGRIRH--RHLVKLMG 1010
IGSGGS V++ A+K ++ ++ D+ S+ E+ L +++ +++L
Sbjct: 17 IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 76
Query: 1011 HCCNKGAGSNLLIYEYME--NGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYL 1068
+ IY ME N + WL K +KS+D R + + V +
Sbjct: 77 YEITDQY-----IYMVMECGNIDLNSWLKK-------KKSIDPWERKSYWKNMLEAVHTI 124
Query: 1069 HHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAP 1128
H I+H D+K +N L+ M L DFG+A + D S + + G+ Y+ P
Sbjct: 125 HQH---GIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDS--QVGTVNYMPP 178
Query: 1129 E-----------YAYSLKATEKCDVYSMGIVLMELVSGKMP 1158
E K + K DV+S+G +L + GK P
Sbjct: 179 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 219
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 2e-33
Identities = 56/221 (25%), Positives = 94/221 (42%), Gaps = 34/221 (15%)
Query: 954 IGSGGSGTVYKAELANGATVAVKKISCKD-DHLLNKSFTREVKTLGRIRH--RHLVKLMG 1010
IGSGGS V++ A+K ++ ++ D+ S+ E+ L +++ +++L
Sbjct: 64 IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 123
Query: 1011 HCCNKGAGSNLLIYEYME--NGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYL 1068
+ IY ME N + WL K +KS+D R + + V +
Sbjct: 124 YEITDQY-----IYMVMECGNIDLNSWLKK-------KKSIDPWERKSYWKNMLEAVHTI 171
Query: 1069 HHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAP 1128
H I+H D+K +N L+ M L DFG+A + D S + + G+ Y+ P
Sbjct: 172 HQH---GIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDS--QVGAVNYMPP 225
Query: 1129 E-----------YAYSLKATEKCDVYSMGIVLMELVSGKMP 1158
E K + K DV+S+G +L + GK P
Sbjct: 226 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 266
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 2e-33
Identities = 66/293 (22%), Positives = 104/293 (35%), Gaps = 57/293 (19%)
Query: 954 IGSGGSGTVYKA-ELANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHC 1012
+G G G V++ + G AVKK+ L E+ + +V L G
Sbjct: 66 VGRGSFGEVHRMKDKQTGFQCAVKKVR------LEVFRVEELVACAGLSSPRIVPLYGAV 119
Query: 1013 CNKGAGSNLLIY-EYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQ---GVEYL 1068
G + I+ E +E GS+ + K L E R L Q G+EYL
Sbjct: 120 RE---GPWVNIFMELLEGGSLGQLI-------KQMGCLP-EDR--ALYYLGQALEGLEYL 166
Query: 1069 HHDCVPKILHRDIKSSNILLDSN-MEAHLGDFGLAKALVEDYNSNTESNTW-FAGSYGYI 1126
H +ILH D+K+ N+LL S+ A L DFG A L D + G+ ++
Sbjct: 167 HTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHM 223
Query: 1127 APEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMH----MEMSGS 1182
APE K D++S +++ +++G P W + S
Sbjct: 224 APEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP-------------WTQYFRGPLCLKIAS 270
Query: 1183 AREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNVF 1235
P+ A + + + P R S+ + L V
Sbjct: 271 EP--------PPIREIPPSCAPLTAQAIQEGLRKEPVHRASAME---LRRKVG 312
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 3e-33
Identities = 77/296 (26%), Positives = 126/296 (42%), Gaps = 60/296 (20%)
Query: 953 IIGSGGSGTVYKAELANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHC 1012
IG G G V + G VAVK K+D ++F E + ++RH +LV+L+G
Sbjct: 200 TIGKGEFGDVMLGDY-RGNKVAVK--CIKNDAT-AQAFLAEASVMTQLRHSNLVQLLG-V 254
Query: 1013 CNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYL-HHD 1071
+ G ++ EYM GS+ D+L + R L + LK ++ + + +EYL ++
Sbjct: 255 IVEEKGGLYIVTEYMAKGSLVDYLRS-----RGRSVLGGDCLLKFSLDVCEAMEYLEGNN 309
Query: 1072 CVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNT---WFAGSYGYIAP 1128
V HRD+ + N+L+ + A + DFGL K E ++ W AP
Sbjct: 310 FV----HRDLAARNVLVSEDNVAKVSDFGLTK---EASSTQDTGKLPVKW-------TAP 355
Query: 1129 EYAYSLKATEKCDVYSMGIVLMELVS-GKMP----TDATFGVEMDMVRWVEM--HMEMSG 1181
E K + K DV+S GI+L E+ S G++P D+V VE M+
Sbjct: 356 EALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK------DVVPRVEKGYKMD--- 406
Query: 1182 SAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNVFNN 1237
P + C V ++ C RP+ Q+ + L ++ +
Sbjct: 407 -----------AP----DGCPP-AVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 4e-33
Identities = 49/224 (21%), Positives = 94/224 (41%), Gaps = 26/224 (11%)
Query: 954 IGSGGSGTVYKAE-LANGATVAVKKISCKDDHLLNKSFTREVKTLGRIR-HRHLVKLMGH 1011
+ GG VY+A+ + +G A+K++ ++ +EV + ++ H ++V+
Sbjct: 36 LAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAII-QEVCFMKKLSGHPNIVQFCSA 94
Query: 1012 CCNKGAGSNLLIYEY---ME--NGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVE 1066
S+ E+ E G + ++L ++ R L + LKI + V+
Sbjct: 95 ASIGKEESDTGQAEFLLLTELCKGQLVEFL----KKMESRGPLSCDTVLKIFYQTCRAVQ 150
Query: 1067 YLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFA------ 1120
++H P I+HRD+K N+LL + L DFG A + + + +
Sbjct: 151 HMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEIT 209
Query: 1121 --GSYGYIAPE----YAYSLKATEKCDVYSMGIVLMELVSGKMP 1158
+ Y PE Y+ EK D++++G +L L + P
Sbjct: 210 RNTTPMYRTPEIIDLYSN-FPIGEKQDIWALGCILYLLCFRQHP 252
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 2e-32
Identities = 67/291 (23%), Positives = 124/291 (42%), Gaps = 61/291 (20%)
Query: 953 IIGSGGSGTVYKA-ELANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGH 1011
++G G G VY +L+N +A+K+I +D + E+ ++H+++V+ +G
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYS-QPLHEEIALHKHLKHKNIVQYLGS 87
Query: 1012 CCNKGAGSNLLIY-EYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQ---GVEY 1067
+ I+ E + GS+ L + +K + I Q G++Y
Sbjct: 88 FSE---NGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQT-------IGFYTKQILEGLKY 137
Query: 1068 LHHDCVPKILHRDIKSSNILLDS-NMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYI 1126
LH + +I+HRDIK N+L+++ + + DFG +K L N TE+ F G+ Y+
Sbjct: 138 LHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRL-AGINPCTET---FTGTLQYM 190
Query: 1127 APE------YAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMS 1180
APE Y A D++S+G ++E+ +GK P + E+ +
Sbjct: 191 APEIIDKGPRGYGKAA----DIWSLGCTIIEMATGKPP-------------FYELGEPQA 233
Query: 1181 -----GSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQ 1226
G + P +P E + + L+C + P +R +
Sbjct: 234 AMFKVGMFKV-------HPEIP--ESMSAEAKAFILKCFEPDPDKRACAND 275
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 2e-32
Identities = 68/290 (23%), Positives = 126/290 (43%), Gaps = 42/290 (14%)
Query: 953 IIGSGGSGTVYKAELANGAT-VAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGH 1011
+G G G VY+ + VAVK + K+D + + F +E + I+H +LV+L+G
Sbjct: 227 KLGGGQYGEVYEGVWKKYSLTVAVK--TLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLG- 283
Query: 1012 CCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLH-H 1070
C + +I E+M G++ D+L + R+ + L +A ++ +EYL
Sbjct: 284 VCTRE-PPFYIITEFMTYGNLLDYLRECN-----RQEVSAVVLLYMATQISSAMEYLEKK 337
Query: 1071 DCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEY 1130
+ + HR++ + N L+ N + DFGL++ + D + + + APE
Sbjct: 338 NFI----HRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF---PIKWTAPES 390
Query: 1131 AYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMVRWVEM--HMEMSGSAREEL 1187
K + K DV++ G++L E+ + G P + + +E ME
Sbjct: 391 LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ--VYELLEKDYRME--------- 439
Query: 1188 LDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNVFNN 1237
+P E C +V E+ C + +P +RPS ++ +F
Sbjct: 440 -----RP----EGCPE-KVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 479
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-32
Identities = 71/295 (24%), Positives = 127/295 (43%), Gaps = 52/295 (17%)
Query: 953 IIGSGGSGTVYKAELANGAT-VAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGH 1011
+G G G VY+ + VAVK + K+D + + F +E + I+H +LV+L+G
Sbjct: 20 KLGGGQYGEVYEGVWKKYSLTVAVK--TLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLG- 76
Query: 1012 CCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYL-HH 1070
C + +I E+M G++ D+L + R+ + L +A ++ +EYL
Sbjct: 77 VCTRE-PPFYIITEFMTYGNLLDYLRECN-----RQEVSAVVLLYMATQISSAMEYLEKK 130
Query: 1071 DCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNT----WFAGSYGYI 1126
+ + HRD+ + N L+ N + DFGL++ + D + W
Sbjct: 131 NFI----HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKW-------T 179
Query: 1127 APEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVE-MDMVRWVEM--HMEMSGS 1182
APE K + K DV++ G++L E+ + G P G++ + +E ME
Sbjct: 180 APESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYP---GIDLSQVYELLEKDYRME---- 232
Query: 1183 AREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNVFNN 1237
+P E C +V E+ C + +P +RPS ++ +F
Sbjct: 233 ----------RP----EGCPE-KVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 272
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 4e-32
Identities = 69/297 (23%), Positives = 116/297 (39%), Gaps = 60/297 (20%)
Query: 953 IIGSGGSGTVYKAEL----ANGATVAVK--KISCKDDHLLNKSFTREVKTLGRIRHRHLV 1006
+G G G V + E +VAVK K F REV + + HR+L+
Sbjct: 25 KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84
Query: 1007 KLMGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVE 1066
+L G ++ E GS+ D L K + + + AV +A+G+
Sbjct: 85 RLYGVVLTP---PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRY------AVQVAEGMG 135
Query: 1067 YL-HHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVED---YNSNTESNT---WF 1119
YL + HRD+ + N+LL + +GDFGL +AL ++ Y W
Sbjct: 136 YLESKRFI----HRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW- 190
Query: 1120 AGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMVRWVEMHME 1178
APE + + D + G+ L E+ + G+ P W+ +
Sbjct: 191 ------CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP-------------WIGL--- 228
Query: 1179 MSGSARE--ELLDDQMKPLLPGEEC--AAYQVLEIALQCTKTSPQERPSSRQVCDLL 1231
+ + +D + + L E+C Y V+ +QC P++RP+ + D L
Sbjct: 229 ---NGSQILHKIDKEGERLPRPEDCPQDIYNVM---VQCWAHKPEDRPTFVALRDFL 279
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 4e-32
Identities = 67/294 (22%), Positives = 126/294 (42%), Gaps = 52/294 (17%)
Query: 953 IIGSGGSGTVYKAELANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHC 1012
IGSG G V+ N VA+K + ++ + + F E + + ++ H LV+L G C
Sbjct: 15 EIGSGQFGLVHLGYWLNKDKVAIK--TIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 72
Query: 1013 CNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYL-HHD 1071
+ L+ E+ME+G + D+L Q R E L + + + +G+ YL
Sbjct: 73 LEQA--PICLVTEFMEHGCLSDYLRTQ------RGLFAAETLLGMCLDVCEGMAYLEEAC 124
Query: 1072 CVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNT----WFAGSYGYIA 1127
+ HRD+ + N L+ N + DFG+ + +++D +++ W +
Sbjct: 125 VI----HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKW-------AS 173
Query: 1128 PEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMVRWVEMHMEMSGSAREE 1186
PE + + K DV+S G+++ E+ S GK+P + S S E
Sbjct: 174 PEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYE-----------------NRSNSEVVE 216
Query: 1187 LLDD--QM-KPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNVFNN 1237
+ ++ KP + V +I C + P++RP+ ++ L + +
Sbjct: 217 DISTGFRLYKP----RLAST-HVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 6e-32
Identities = 72/289 (24%), Positives = 129/289 (44%), Gaps = 42/289 (14%)
Query: 953 IIGSGGSGTVYKAELANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHC 1012
+G G G V+ VA+K + K + ++F +E + + ++RH LV+L
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIK--TLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 248
Query: 1013 CNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLH-HD 1071
+ ++ EYM GS+ D+L + K L + +A +A G+ Y+ +
Sbjct: 249 SEEP---IYIVTEYMSKGSLLDFLKG-----ETGKYLRLPQLVDMAAQIASGMAYVERMN 300
Query: 1072 CVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYA 1131
V HRD++++NIL+ N+ + DFGLA+ + ++ + + + + APE A
Sbjct: 301 YV----HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF---PIKWTAPEAA 353
Query: 1132 YSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMVRWVEM--HMEMSGSAREELL 1188
+ T K DV+S GI+L EL + G++P E ++ VE M
Sbjct: 354 LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE--VLDQVERGYRMP---------- 401
Query: 1189 DDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNVFNN 1237
P EC + ++ QC + P+ERP+ + L + F +
Sbjct: 402 ----CP----PECPE-SLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 441
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 7e-32
Identities = 76/303 (25%), Positives = 137/303 (45%), Gaps = 42/303 (13%)
Query: 954 IGSGGSGTVYKAE-LANGATVAVK--KISCKDDHLLNKSFTREVKTLGRIRHRHLVKL-- 1008
+G GG TVY AE VA+K I ++ K F REV ++ H+++V +
Sbjct: 19 LGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMID 78
Query: 1009 MGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYL 1068
+ L+ EY+E ++ +++ L + + + G+++
Sbjct: 79 VDE----EDDCYYLVMEYIEGPTLSEYIES-------HGPLSVDTAINFTNQILDGIKHA 127
Query: 1069 HHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAP 1128
H +I+HRDIK NIL+DSN + DFG+AKAL E S T++N G+ Y +P
Sbjct: 128 HDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSE--TSLTQTNH-VLGTVQYFSP 181
Query: 1129 EYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSAREEL- 1187
E A E D+YS+GIVL E++ G+ P + V + + H+ ++ +
Sbjct: 182 EQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAI-----KHI------QDSVP 230
Query: 1188 -LDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSS-RQVCDLLLNVFNNRIVDFDKL 1245
+ ++ +P + + L+ T+ R + +++ D L +V + + D
Sbjct: 231 NVTTDVRKDIP------QSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENRANEDVY 284
Query: 1246 HID 1248
+D
Sbjct: 285 ELD 287
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 7e-32
Identities = 53/210 (25%), Positives = 98/210 (46%), Gaps = 16/210 (7%)
Query: 954 IGSGGSGTVYKAE-LANGATVAVK--KISCKDDHLLNKSFTREVKTLGRIRHRHLVKL-- 1008
+G GG V+ A L + VAVK + D F RE + + H +V +
Sbjct: 20 LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 79
Query: 1009 MGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYL 1068
G ++ EY++ ++ D +H + + +++ Q + +
Sbjct: 80 TGEAETPAGPLPYIVMEYVDGVTLRDIVHT-------EGPMTPKRAIEVIADACQALNFS 132
Query: 1069 HHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAP 1128
H + I+HRD+K +NI++ + + DFG+A+A+ + NS T++ G+ Y++P
Sbjct: 133 HQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVI-GTAQYLSP 188
Query: 1129 EYAYSLKATEKCDVYSMGIVLMELVSGKMP 1158
E A + DVYS+G VL E+++G+ P
Sbjct: 189 EQARGDSVDARSDVYSLGCVLYEVLTGEPP 218
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 7e-32
Identities = 68/300 (22%), Positives = 124/300 (41%), Gaps = 54/300 (18%)
Query: 953 IIGSGGSGTVYKAELANGA----TVAVKKISCKDDHLLN--KSFTREVKTLGRIRHRHLV 1006
+IG G G VY L + AVK S + F E + H +++
Sbjct: 32 VIGRGHFGCVYHGTLLDNDGKKIHCAVK--SLNRITDIGEVSQFLTEGIIMKDFSHPNVL 89
Query: 1007 KLMGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVE 1066
L+G C + GS L++ YM++G + +++ + + + + + +A+G++
Sbjct: 90 SLLG-ICLRSEGSPLVVLPYMKHGDLRNFIRNE------THNPTVKDLIGFGLQVAKGMK 142
Query: 1067 YLH-HDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVED--YNSNTESNT-----W 1118
YL V HRD+ + N +LD + DFGLA+ + + Y+ + ++ W
Sbjct: 143 YLASKKFV----HRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKW 198
Query: 1119 FAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMVRWVEMHM 1177
+A E + K T K DV+S G++L EL++ G P V +
Sbjct: 199 -------MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP---YPDVNTFDI----TVY 244
Query: 1178 EMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNVFNN 1237
+ G L +P E C + E+ L+C + RPS ++ + +F+
Sbjct: 245 LLQG----RRLL---QP----EYCPD-PLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 292
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 1e-31
Identities = 60/246 (24%), Positives = 100/246 (40%), Gaps = 13/246 (5%)
Query: 230 SIPAALGRLQNLQLLNLGNNSLSGEIPSELGELSQLGYLNLMGNRLE--GAIPRSFAKMG 287
S+P + + L L +N L +L+QL L+L N L G +S
Sbjct: 21 SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTT 78
Query: 288 NLQSLDLSMNRLTGGIPEEFGNMGQLVFLVLSNNNISGSIPRRICTNATSLEHLILAEIQ 347
+L+ LDLS N + + F + QL L ++N+ + + +L +L ++
Sbjct: 79 SLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTH 137
Query: 348 LSGEIPVE-LSQCQSLKQLDLSNNTLNGTIPVELFQ-LVALTHLYLHNNSLVGSISPFV- 404
+ SL+ L ++ N+ ++F L LT L L L +SP
Sbjct: 138 TR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAF 195
Query: 405 ANLSNLQELALYHNNFQGSLPREIGMLVKLELLYLYDNHLSGQIPSEV--GNCSSLKWID 462
+LS+LQ L + HNNF L L++L NH+ + SSL +++
Sbjct: 196 NSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM-TSKKQELQHFPSSLAFLN 254
Query: 463 FFGNSF 468
N F
Sbjct: 255 LTQNDF 260
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 8e-29
Identities = 57/276 (20%), Positives = 97/276 (35%), Gaps = 38/276 (13%)
Query: 75 SLNLSGLSLAGSISPSLGRLQSLIHLDLSSNSLTGPIPTALSNLSSLESLLLFSNQLA-- 132
+ + L S+ + S L+L SN L L+ L L L SN L+
Sbjct: 11 EIRCNSKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFK 67
Query: 133 GTIPTQLGSLTSLRVMRIGDNWLSGSIPTSFGNLVNLGTLGLASCSLSGPIPPQ--FGQL 190
G TSL+ + + N + ++ ++F L L L +L + F L
Sbjct: 68 GCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQ-MSEFSVFLSL 125
Query: 191 SQLEELILQQNQLQGPIPAELGNCSSLSIFTAAENNLNGSIPA-ALGRLQNLQLLNLGNN 249
L L + + L +L++L + N
Sbjct: 126 RNLIYLDISHTHTR-------------------------VAFNGIFNGLSSLEVLKMAGN 160
Query: 250 SLSGEIPSE-LGELSQLGYLNLMGNRLEGAIPRSFAKMGNLQSLDLSMNRLTGGIPEEFG 308
S + EL L +L+L +LE P +F + +LQ L++S N +
Sbjct: 161 SFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYK 220
Query: 309 NMGQLVFLVLSNNNISGSIPRRICTN-ATSLEHLIL 343
+ L L S N+I + ++ + +SL L L
Sbjct: 221 CLNSLQVLDYSLNHIM-TSKKQELQHFPSSLAFLNL 255
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 9e-27
Identities = 54/303 (17%), Positives = 99/303 (32%), Gaps = 58/303 (19%)
Query: 268 LNLMGNRLEGAIPRSFAKMGNLQSLDLSMNRLTGGIPEEFGNMGQLVFLVLSNNNIS-GS 326
+ L ++P + L+L N+L F + QL L LS+N +S
Sbjct: 12 IRCNSKGLT-SVPTGIPS--SATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKG 68
Query: 327 IPRRICTNATSLEHLILAEIQLSGEIPVELSQCQSLKQLDLSNNTLNGTIPVELFQ-LVA 385
+ TSL++L L+ + + + L+ LD ++ L +F L
Sbjct: 69 CCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRN 127
Query: 386 LTHLYLHNNSLVGSISPFV-ANLSNLQELALYHNNFQGSLPREI-GMLVKLELLYLYDNH 443
L +L + + + LS+L+ L + N+FQ + +I L L L L
Sbjct: 128 LIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQ 186
Query: 444 LSGQIPSEVGNCSSLKWIDFFGNSFTGEIPTSIGRLKDLNFLHLRQNELVGQIPASLGNC 503
L Q+ F L
Sbjct: 187 LE-QLSPTA-------------------------------FNSL---------------- 198
Query: 504 HQLIILDLADNKLSGGVPASFGFLQALEQLMLYNNSLEGNLPGSLINL-RNLTRINFSKN 562
L +L+++ N + L +L+ L N + + L + +L +N ++N
Sbjct: 199 SSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQN 258
Query: 563 RLN 565
Sbjct: 259 DFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-26
Identities = 68/249 (27%), Positives = 99/249 (39%), Gaps = 15/249 (6%)
Query: 589 HEIPPQLGNSPSLERLRLGNNKFIGKIPWTFGKIRELSLLDLSGNSLT--GPIPTQLLMC 646
+P + S RL L +NK F K+ +L+ L LS N L+ G
Sbjct: 20 TSVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGT 77
Query: 647 KKLSHIDLNNNLLSGAVPSWLGTLPQLGELKLSFNQFVGFLPRELF-NCSKLLVLSLDGN 705
L ++DL+ N + + S L QL L + +F + L+ L +
Sbjct: 78 TSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHT 136
Query: 706 MLNGSLPNEV-GNLASLNVLTLSGNLLSGPIPP-AIGRLSKLYELRLSNNSLNGVIPLEI 763
N + L+SL VL ++GN P L L L LS L + P
Sbjct: 137 HTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAF 195
Query: 764 GQLQNLQSILDLSHNNFTGQIPPSM-GTLAKLEVLNLSHNQLVGELPSQL--GEMSSLGK 820
L +LQ L++SHNNF + L L+VL+ S N ++ Q SSL
Sbjct: 196 NSLSSLQV-LNMSHNNFF-SLDTFPYKCLNSLQVLDYSLNHIM-TSKKQELQHFPSSLAF 252
Query: 821 LNLSYNDLQ 829
LNL+ ND
Sbjct: 253 LNLTQNDFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 4e-26
Identities = 57/275 (20%), Positives = 99/275 (36%), Gaps = 29/275 (10%)
Query: 509 LDLADNKLSGGVPASFGFLQALEQLMLYNNSLEGNLPGSLINLRNLTRINFSKNRLNGRI 568
+ L+ VP G + +L L +N L+ G L LT+++ S N L+
Sbjct: 12 IRCNSKGLTS-VPT--GIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLS--- 65
Query: 569 ATLCSSHSFLSFDVTNNEFDHEIPPQLGNSPSLERLRLGNNKFIGKIPWTFGKIRELSLL 628
+ + SL+ L L N + + F + +L L
Sbjct: 66 ----------FKGCCSQSDF--------GTTSLKYLDLSFNG-VITMSSNFLGLEQLEHL 106
Query: 629 DLSGNSLTGPIPTQLLM-CKKLSHIDLNNNLLSGAVPSWLGTLPQLGELKLSFNQFVGFL 687
D ++L + + + L ++D+++ A L L LK++ N F
Sbjct: 107 DFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENF 166
Query: 688 PRELF-NCSKLLVLSLDGNMLNGSLPNEV-GNLASLNVLTLSGNLLSGPIPPAIGRLSKL 745
++F L L L L L +L+SL VL +S N L+ L
Sbjct: 167 LPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSL 225
Query: 746 YELRLSNNSLNGVIPLEIGQLQNLQSILDLSHNNF 780
L S N + E+ + + L+L+ N+F
Sbjct: 226 QVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDF 260
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 2e-22
Identities = 50/207 (24%), Positives = 81/207 (39%), Gaps = 11/207 (5%)
Query: 628 LDLSGNSLTGPIPTQLLMCKKLSHIDLNNNLLSGAVPSWLGTLPQLGELKLSFNQ--FVG 685
+ + LT +PT + + ++L +N L L QL +L LS N F G
Sbjct: 12 IRCNSKGLTS-VPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKG 68
Query: 686 FLPRELFNCSKLLVLSLDGNMLNGSLPNEVGNLASLNVLTLSGNLLSG-PIPPAIGRLSK 744
+ F + L L L N + ++ + L L L + L L
Sbjct: 69 CCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRN 127
Query: 745 LYELRLSNNSLNGVIPLEIGQLQNLQSILDLSHNNFTGQIPPSM-GTLAKLEVLNLSHNQ 803
L L +S+ L +L+ +L ++ N+F P + L L L+LS Q
Sbjct: 128 LIYLDISHTHTRVAFNGIFNGLSSLE-VLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQ 186
Query: 804 LVGELPSQ-LGEMSSLGKLNLSYNDLQ 829
L +L +SSL LN+S+N+
Sbjct: 187 LE-QLSPTAFNSLSSLQVLNMSHNNFF 212
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 3e-22
Identities = 58/254 (22%), Positives = 85/254 (33%), Gaps = 54/254 (21%)
Query: 76 LNLSG--LSLAGSISPSLGRLQSLIHLDLSSNSLTGPIPTALSNLSSLESLLLFSNQLAG 133
L+LS LS G S S SL +LDLS N + + + L LE L + L
Sbjct: 57 LSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNL-K 114
Query: 134 TIPTQLGSLTSLRVMRIGDNWLSGSIPTSFGNLVNLGTLGLASCSLSGPIPPQ-FGQLSQ 192
+ + F +L NL L ++ F LS
Sbjct: 115 QMSE----------------------FSVFLSLRNLIYLDISHTHTRV-AFNGIFNGLSS 151
Query: 193 LEELILQQNQLQGPIPAELGNCSSLSIFTAAENNLNGSIPAALGRLQNLQLLNLGNNSLS 252
LE L + N Q P L+NL L+L L
Sbjct: 152 LEVLKMAGNSFQENFL-----------------------PDIFTELRNLTFLDLSQCQLE 188
Query: 253 GEIPSE-LGELSQLGYLNLMGNRLEGAIPRSFAKMGNLQSLDLSMNRLTGGIPEEFGNM- 310
++ LS L LN+ N + + +LQ LD S+N + +E +
Sbjct: 189 -QLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFP 247
Query: 311 GQLVFLVLSNNNIS 324
L FL L+ N+ +
Sbjct: 248 SSLAFLNLTQNDFA 261
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 1e-31
Identities = 48/234 (20%), Positives = 94/234 (40%), Gaps = 29/234 (12%)
Query: 942 MGATNNLSDEFI----IGSGGSGTVYKA-ELANGATVAVKKISCKDDHLLNKSFTREVKT 996
MG+ + + ++ +G G + V++ G A+K + RE +
Sbjct: 1 MGSQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEV 60
Query: 997 LGRIRHRHLVKLMGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLK 1056
L ++ H+++VKL +LI E+ GS++ L + + +S E
Sbjct: 61 LKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPES---EFL-I 116
Query: 1057 IAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAH----LGDFGLAKALVEDYNSN 1112
+ + G+ +L + I+HR+IK NI+ + L DFG A+ L +D
Sbjct: 117 VLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFV 173
Query: 1113 TESNTWFAGSYGYIAPE--------YAYSLKATEKCDVYSMGIVLMELVSGKMP 1158
+ G+ Y+ P+ + K D++S+G+ +G +P
Sbjct: 174 S-----LYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 1e-31
Identities = 66/298 (22%), Positives = 113/298 (37%), Gaps = 58/298 (19%)
Query: 954 IGSGGSGTVYKAELANGAT-VAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHC 1012
IG G G V+ L T VAVK L F +E + L + H ++V+L+G C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 1013 CNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDC 1072
K ++ E ++ G +L + ++++ L++ A G+EYL
Sbjct: 182 TQKQ--PIYIVMELVQGGDFLTFLRTEGARLRVKT------LLQMVGDAAAGMEYLESK- 232
Query: 1073 VPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVED-YNSNTESNTWFAGSYGYI----- 1126
+HRD+ + N L+ + DFG+++ + Y + +G +
Sbjct: 233 --CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAA--------SGGLRQVPVKWT 282
Query: 1127 APEYAYSLKATEKCDVYSMGIVLMELVS-GKMP----TDATFGVEMDMVRWVEM--HMEM 1179
APE + + + DV+S GI+L E S G P ++ +VE +
Sbjct: 283 APEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQ------QTREFVEKGGRLP- 335
Query: 1180 SGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNVFNN 1237
P E C V + QC P +RPS + L ++
Sbjct: 336 -------------CP----ELCPD-AVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 2e-31
Identities = 69/297 (23%), Positives = 131/297 (44%), Gaps = 58/297 (19%)
Query: 953 IIGSGGSGTVYKAELANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHC 1012
+G+G G V+ A VAVK + K + ++F E + ++H LVKL
Sbjct: 195 KLGAGQFGEVWMATYNKHTKVAVK--TMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVV 252
Query: 1013 CNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYL-HHD 1071
+ +I E+M GS+ D+L + + +A+G+ ++ +
Sbjct: 253 TKE---PIYIITEFMAKGSLLDFLKS-----DEGSKQPLPKLIDFSAQIAEGMAFIEQRN 304
Query: 1072 CVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVED-YNSNTESN---TWFAGSYGYIA 1127
+ HRD++++NIL+ +++ + DFGLA+ + ++ Y + + W A
Sbjct: 305 YI----HRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKW-------TA 353
Query: 1128 PEYAYSLKATEKCDVYSMGIVLMELVS-GKMP----TDATFGVEMDMVRWVEM--HMEMS 1180
PE T K DV+S GI+LME+V+ G++P ++ +++R +E M
Sbjct: 354 PEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP------EVIRALERGYRMP-- 405
Query: 1181 GSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNVFNN 1237
+P E C ++ I ++C K P+ERP+ + +L + +
Sbjct: 406 ------------RP----ENCPE-ELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA 445
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 131 bits (330), Expect = 2e-31
Identities = 57/290 (19%), Positives = 112/290 (38%), Gaps = 30/290 (10%)
Query: 953 IIGSGGSGTVYKA-ELANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLM-- 1009
+G+GG G V + G VA+K+ + + + E++ + ++ H ++V
Sbjct: 21 RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREV 80
Query: 1010 --GHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEY 1067
G LL EY E G + +L++ +++ R + ++ + Y
Sbjct: 81 PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEG---PIR-TLLSDISSALRY 136
Query: 1068 LHHDCVPKILHRDIKSSNILLDSNMEAH---LGDFGLAKALVEDYNSNTESNTWFAGSYG 1124
LH + +I+HRD+K NI+L + + D G AK L + F G+
Sbjct: 137 LHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTE-----FVGTLQ 188
Query: 1125 YIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDM-------VRWVEMHM 1177
Y+APE K T D +S G + E ++G P + + ++
Sbjct: 189 YLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYD 248
Query: 1178 EMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQV 1227
+++G+ + + L + L+ L ++R + Q
Sbjct: 249 DLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLM---WHQRQRGTDPQN 295
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 2e-31
Identities = 59/212 (27%), Positives = 101/212 (47%), Gaps = 27/212 (12%)
Query: 953 IIGSGGSGTVYKAELANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHC 1012
+G+G G V+ VAVK S K + +F E + +++H+ LV+L
Sbjct: 20 RLGAGQFGEVWMGYYNGHTKVAVK--SLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 1013 CNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYL-HHD 1071
+ +I EYMENGS+ D+L L L +A +A+G+ ++ +
Sbjct: 78 TQEPI---YIITEYMENGSLVDFLKTPS-----GIKLTINKLLDMAAQIAEGMAFIEERN 129
Query: 1072 CVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVED-YNSNTESNT---WFAGSYGYIA 1127
+ HRD++++NIL+ + + DFGLA+ + ++ Y + + W A
Sbjct: 130 YI----HRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKW-------TA 178
Query: 1128 PEYAYSLKATEKCDVYSMGIVLMELVS-GKMP 1158
PE T K DV+S GI+L E+V+ G++P
Sbjct: 179 PEAINYGTFTIKSDVWSFGILLTEIVTHGRIP 210
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 3e-31
Identities = 63/301 (20%), Positives = 124/301 (41%), Gaps = 56/301 (18%)
Query: 951 EFIIGSGGSGTVYKAELANGA---TVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVK 1007
+ +G G G+V + VA+K + + + RE + + ++ + ++V+
Sbjct: 15 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 74
Query: 1008 LMGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEY 1067
L+G C + + +L+ E G + +L + R+ + ++ ++ G++Y
Sbjct: 75 LIGVCQAE---ALMLVMEMAGGGPLHKFLVGK------REEIPVSNVAELLHQVSMGMKY 125
Query: 1068 L-HHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYI 1126
L + V HRD+ + N+LL + A + DFGL+KAL D + + A S G
Sbjct: 126 LEEKNFV----HRDLAARNVLLVNRHYAKISDFGLSKALGAD------DSYYTARSAGKW 175
Query: 1127 -----APEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMVRWVEMHMEMS 1180
APE K + + DV+S G+ + E +S G+ P + +M
Sbjct: 176 PLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP-----------------YKKMK 218
Query: 1181 GSAREELLDD--QMKPLLPGEEC--AAYQVLEIALQCTKTSPQERPSSRQVCDLLLNVFN 1236
G ++ +M+ P EC Y ++ C ++RP V + +
Sbjct: 219 GPEVMAFIEQGKRMEC--P-PECPPELYALM---SDCWIYKWEDRPDFLTVEQRMRACYY 272
Query: 1237 N 1237
+
Sbjct: 273 S 273
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 3e-31
Identities = 63/309 (20%), Positives = 125/309 (40%), Gaps = 60/309 (19%)
Query: 946 NNLSDEFIIGSGGSGTVYKAELANGA----TVAVKKISCKDDHLLN--KSFTREVKTLGR 999
+ +IG G G VY E + A A+K S + ++F RE +
Sbjct: 21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIK--SLSRITEMQQVEAFLREGLLMRG 78
Query: 1000 IRHRHLVKLMGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAV 1059
+ H +++ L+G G ++ YM +G + ++ +++ + + +
Sbjct: 79 LNHPNVLALIG-IMLPPEGLPHVLLPYMCHGDLLQFIRSP------QRNPTVKDLISFGL 131
Query: 1060 GLAQGVEYL-HHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVED--YNSNTESN 1116
+A+G+EYL V HRD+ + N +LD + + DFGLA+ +++ Y+ +
Sbjct: 132 QVARGMEYLAEQKFV----HRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRH 187
Query: 1117 T-----WFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVE-MDM 1169
W A E + + T K DV+S G++L EL++ G P ++ D+
Sbjct: 188 ARLPVKW-------TALESLQTYRFTTKSDVWSFGVLLWELLTRGAPP---YRHIDPFDL 237
Query: 1170 VRWVE--MHMEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQV 1227
++ + +P E C + ++ QC + P RP+ R +
Sbjct: 238 THFLAQGRRLP--------------QP----EYCPD-SLYQVMQQCWEADPAVRPTFRVL 278
Query: 1228 CDLLLNVFN 1236
+ + +
Sbjct: 279 VGEVEQIVS 287
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 3e-31
Identities = 57/220 (25%), Positives = 93/220 (42%), Gaps = 36/220 (16%)
Query: 953 IIGSGGSGTVYKAELANGA-----TVAVKKISCKDDHLL--NKSFTREVKTLGRIRHRHL 1005
++GSG GTVYK VA+K ++ NK E + + + H+
Sbjct: 22 VLGSGAFGTVYKGLWIPEGEKVKIPVAIK--ELREATSPKANKEILDEAYVMASVDNPHV 79
Query: 1006 VKLMGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGV 1065
+L+G C + LI + M G + D++ + NI + L+W V +A+G+
Sbjct: 80 CRLLGICLTS---TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGM 130
Query: 1066 EYL-HHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNT-----WF 1119
YL V HRD+ + N+L+ + + DFGLAK L + W
Sbjct: 131 NYLEDRRLV----HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW- 185
Query: 1120 AGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMP 1158
+A E T + DV+S G+ + EL++ G P
Sbjct: 186 ------MALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 3e-31
Identities = 66/294 (22%), Positives = 121/294 (41%), Gaps = 52/294 (17%)
Query: 953 IIGSGGSGTVYKAELANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHC 1012
+G+G G V + VA+K K+ + F E K + + H LV+L G C
Sbjct: 31 ELGTGQFGVVKYGKWRGQYDVAIK--MIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 88
Query: 1013 CNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYL-HHD 1071
+ +I EYM NG + ++L + R + L++ + + +EYL
Sbjct: 89 TKQR--PIFIITEYMANGCLLNYLREM------RHRFQTQQLLEMCKDVCEAMEYLESKQ 140
Query: 1072 CVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVED-YNSNTESNT---WFAGSYGYIA 1127
+ HRD+ + N L++ + DFGL++ +++D Y S+ S W
Sbjct: 141 FL----HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRW-------SP 189
Query: 1128 PEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMVRWVEMHMEMSGSAREE 1186
PE K + K D+++ G+++ E+ S GKMP + + S E
Sbjct: 190 PEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMP-----------------YERFTNSETAE 232
Query: 1187 LLDD--QM-KPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNVFNN 1237
+ ++ +P + +V I C ERP+ + + +L+V +
Sbjct: 233 HIAQGLRLYRP----HLASE-KVYTIMYSCWHEKADERPTFKILLSNILDVMDE 281
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 3e-31
Identities = 58/304 (19%), Positives = 104/304 (34%), Gaps = 33/304 (10%)
Query: 96 SLIHLDLSSNSLTGPIPTALSNLSSLESLLLFSNQLAGTIPTQLGSLTSLRVMRIGDNWL 155
LDL +N ++ L L +L+L +N+++ L L+ + I N L
Sbjct: 55 DTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHL 114
Query: 156 SGSIPTSFGNLVNLGTLGLASCSLSGPIPPQ-FGQLSQLEELILQQNQLQ-GPIPAELGN 213
IP +L L + + +P F L + + + N L+ +
Sbjct: 115 V-EIPP--NLPSSLVELRIHDNRIRK-VPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFD 170
Query: 214 CSSLSIFTAAENNLNGSIPAALGRLQNLQLLNLGNNSLSGEIPSE-LGELSQLGYLNLMG 272
L+ +E L IP L + L L+L +N + I E L S+L L L
Sbjct: 171 GLKLNYLRISEAKLT-GIPKDL--PETLNELHLDHNKIQ-AIELEDLLRYSKLYRLGLGH 226
Query: 273 NRLEGAIPRSFAKMGNLQSLDLSMNRLTGGIPEEFGNMGQLVFLVLSNNNISGSIPRRIC 332
N++ S + + L+ L L N+L+ +P ++ L + L NNI+ +
Sbjct: 227 NQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNIT-KVGVNDF 284
Query: 333 TNATSLEHLILAEIQLSGEIPVELSQCQSLKQLDLSNNTL-NGTIPVELFQ-LVALTHLY 390
+ L NN + + F+ + +
Sbjct: 285 CPVGFGVKRA------------------YYNGISLFNNPVPYWEVQPATFRCVTDRLAIQ 326
Query: 391 LHNN 394
N
Sbjct: 327 FGNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 6e-30
Identities = 76/334 (22%), Positives = 126/334 (37%), Gaps = 47/334 (14%)
Query: 481 DLNFLHLRQNELVGQIPASLGNCHQLIILDLADNKLSGGVPASFGFLQALEQLMLYNNSL 540
L + L +P + +LDL +N +S F LQ L L+L NN +
Sbjct: 34 HLRVVQCSDLGLK-AVPKEISP--DTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKI 90
Query: 541 EGNLPGSLINLRNLTRINFSKNRLNGRIATLCSSHSFLSFDVTNNEFDHEIPPQLGNSPS 600
+ LR L ++ SKN L EIPP L S
Sbjct: 91 SKIHEKAFSPLRKLQKLYISKNHL------------------------VEIPPNL--PSS 124
Query: 601 LERLRLGNNKFIGKIP-WTFGKIRELSLLDLSGNSLT-GPIPTQLLMCKKLSHIDLNNNL 658
L LR+ +N+ I K+P F +R ++ +++ GN L KL+++ ++
Sbjct: 125 LVELRIHDNR-IRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAK 183
Query: 659 LSGAVPSWLGTLPQLGELKLSFNQFVGFLPRELF-NCSKLLVLSLDGNMLNGSLPNEV-G 716
L+ +P L EL L N+ + E SKL L L N + + N
Sbjct: 184 LT-GIPK--DLPETLNELHLDHNKIQ-AIELEDLLRYSKLYRLGLGHNQIR-MIENGSLS 238
Query: 717 NLASLNVLTLSGNLLSGPIPPAIGRLSKLYELRLSNNSLNGV-----IPLEIGQLQNLQS 771
L +L L L N LS +P + L L + L N++ V P+ G + +
Sbjct: 239 FLPTLRELHLDNNKLSR-VPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYN 297
Query: 772 ILDLSHNNFT-GQIPPSM-GTLAKLEVLNLSHNQ 803
+ L +N ++ P+ + + + +
Sbjct: 298 GISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 2e-29
Identities = 61/298 (20%), Positives = 118/298 (39%), Gaps = 25/298 (8%)
Query: 230 SIPAALGRLQNLQLLNLGNNSLSGEIPSELGELSQLGYLNLMGNRLEGAIPRSFAKMGNL 289
++P + + LL+L NN +S + L L L L+ N++ ++F+ + L
Sbjct: 47 AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKL 104
Query: 290 QSLDLSMNRLTGGIPEEFGNMGQLVFLVLSNNNISGSIPRRICTNATSLEHLILAEIQL- 348
Q L +S N L P + LV L + +N I +P+ + + ++ + + L
Sbjct: 105 QKLYISKNHLVEIPPNLPSS---LVELRIHDNRIR-KVPKGVFSGLRNMNCIEMGGNPLE 160
Query: 349 SGEIPVELSQCQSLKQLDLSNNTLNGTIPVELFQLVALTHLYLHNNSLVGSISPFV-ANL 407
+ L L +S L IP +L + L L+L +N + +I
Sbjct: 161 NSGFEPGAFDGLKLNYLRISEAKLT-GIPKDLPE--TLNELHLDHNKIQ-AIELEDLLRY 216
Query: 408 SNLQELALYHNNFQGSLPREI-GMLVKLELLYLYDNHLSGQIPSEVGNCSSLKWIDFFGN 466
S L L L HN + + L L L+L +N LS ++P+ + + L+ + N
Sbjct: 217 SKLYRLGLGHNQIR-MIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTN 274
Query: 467 SFTGEIP-------TSIGRLKDLNFLHLRQNEL-VGQIPASLGNC-HQLIILDLADNK 515
+ T ++ + N + L N + ++ + C + + + K
Sbjct: 275 NIT-KVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-27
Identities = 61/281 (21%), Positives = 103/281 (36%), Gaps = 29/281 (10%)
Query: 581 DVTNNEFDHEIPP-QLGNSPSLERLRLGNNKFIGKI-PWTFGKIRELSLLDLSGNSLTGP 638
D+ NN+ E+ L L L NNK I KI F +R+L L +S N L
Sbjct: 60 DLQNNDI-SELRKDDFKGLQHLYALVLVNNK-ISKIHEKAFSPLRKLQKLYISKNHLVE- 116
Query: 639 IPTQLLMCKKLSHIDLNNNLLSGAVPSWLGTLPQLGELKLSFNQF-VGFLPRELFNCSKL 697
IP L L + +++N + L + +++ N F+ KL
Sbjct: 117 IPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKL 174
Query: 698 LVLSLDGNMLNGSLPNEVGNLASLNVLTLSGNLLSGPIPP-AIGRLSKLYELRLSNNSLN 756
L + L +P +LN L L N + I + R SKLY L L +N +
Sbjct: 175 NYLRISEAKLT-GIPK--DLPETLNELHLDHNKIQA-IELEDLLRYSKLYRLGLGHNQIR 230
Query: 757 GVIPLEIGQLQNLQSILDLSHNNFTGQIPPSMGTLAKLEVLNLSHNQLVGELPSQ----- 811
+ + L L+ L L +N + ++P + L L+V+ L N + ++
Sbjct: 231 MIENGSLSFLPTLRE-LHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNIT-KVGVNDFCPV 287
Query: 812 --LGEMSSLGKLNLSYNDLQGKLSKQFSHWPAEAFEGNLHL 850
+ + ++L N + + F
Sbjct: 288 GFGVKRAYYNGISLFNNPV------PYWEVQPATFRCVTDR 322
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 6e-20
Identities = 46/238 (19%), Positives = 89/238 (37%), Gaps = 20/238 (8%)
Query: 72 RVVSLNLSGLSLAGSISPSLGRLQSLIHLDLSSNSLTGPIPTALSNLSSLESLLLFSNQL 131
++ L +S L I P+L SL+ L + N + S L ++ + + N L
Sbjct: 103 KLQKLYISKNHLV-EIPPNL--PSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPL 159
Query: 132 AGT-IPTQLGSLTSLRVMRIGDNWLSGSIPTSFGNLVNLGTLGLASCSLSGPIPPQ-FGQ 189
+ L +RI + L+ IP L L L + I + +
Sbjct: 160 ENSGFEPGAFDGLKLNYLRISEAKLT-GIPK--DLPETLNELHLDHNKIQA-IELEDLLR 215
Query: 190 LSQLEELILQQNQLQGPIPAELGNCSSLSIFTAAENNLNGSIPAALGRLQNLQLLNLGNN 249
S+L L L NQ++ L +L N L+ +PA L L+ LQ++ L N
Sbjct: 216 YSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTN 274
Query: 250 SLSGEIPSE-------LGELSQLGYLNLMGNRLEGAI--PRSFAKMGNLQSLDLSMNR 298
+++ ++ + + ++L N + P +F + + ++ +
Sbjct: 275 NIT-KVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 2e-10
Identities = 35/160 (21%), Positives = 62/160 (38%), Gaps = 12/160 (7%)
Query: 670 LPQLGELKLSFNQFVGFLPRELFNCSKLLVLSLDGNMLNGSLPNEVGNLASLNVLTLSGN 729
+P L L +++ P C L V+ L ++P E+ +L L N
Sbjct: 13 IPDLDSLPPTYSAM---CPFGCH-CH-LRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNN 64
Query: 730 LLSGPIPPAIGRLSKLYELRLSNNSLNGVIPLEIGQLQNLQSILDLSHNNFTGQIPPSMG 789
+S L LY L L NN ++ + L+ LQ L +S N+ +IPP
Sbjct: 65 DISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQK-LYISKNHLV-EIPP--N 120
Query: 790 TLAKLEVLNLSHNQLVGELPSQLGEMSSLGKLNLSYNDLQ 829
+ L L + N++ + ++ + + N L+
Sbjct: 121 LPSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLE 160
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 4e-31
Identities = 59/212 (27%), Positives = 103/212 (48%), Gaps = 27/212 (12%)
Query: 953 IIGSGGSGTVYKAELANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHC 1012
+GSG G V + VAVK K+ + F +E +T+ ++ H LVK G
Sbjct: 15 ELGSGQFGVVKLGKWKGQYDVAVK--MIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYG-V 71
Query: 1013 CNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYL-HHD 1071
C+K ++ EY+ NG + ++L K L+ L++ + +G+ +L H
Sbjct: 72 CSKE-YPIYIVTEYISNGCLLNYLRSH------GKGLEPSQLLEMCYDVCEGMAFLESHQ 124
Query: 1072 CVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVED-YNSNTESNT---WFAGSYGYIA 1127
+ HRD+ + N L+D ++ + DFG+ + +++D Y S+ + W A
Sbjct: 125 FI----HRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKW-------SA 173
Query: 1128 PEYAYSLKATEKCDVYSMGIVLMELVS-GKMP 1158
PE + K + K DV++ GI++ E+ S GKMP
Sbjct: 174 PEVFHYFKYSSKSDVWAFGILMWEVFSLGKMP 205
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 5e-31
Identities = 72/289 (24%), Positives = 129/289 (44%), Gaps = 42/289 (14%)
Query: 953 IIGSGGSGTVYKAELANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHC 1012
+G G G V+ VA+K + K + ++F +E + + ++RH LV+L
Sbjct: 274 KLGQGCFGEVWMGTWNGTTRVAIK--TLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 331
Query: 1013 CNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLH-HD 1071
+ ++ EYM GS+ D+L + K L + +A +A G+ Y+ +
Sbjct: 332 SEEP---IYIVTEYMSKGSLLDFLKG-----ETGKYLRLPQLVDMAAQIASGMAYVERMN 383
Query: 1072 CVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYA 1131
V HRD++++NIL+ N+ + DFGLA+ + ++ + + + + APE A
Sbjct: 384 YV----HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF---PIKWTAPEAA 436
Query: 1132 YSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMVRWVEM--HMEMSGSAREELL 1188
+ T K DV+S GI+L EL + G++P E ++ VE M
Sbjct: 437 LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE--VLDQVERGYRMP---------- 484
Query: 1189 DDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNVFNN 1237
P EC + ++ QC + P+ERP+ + L + F +
Sbjct: 485 ----CP----PECPE-SLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 524
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 5e-31
Identities = 63/348 (18%), Positives = 122/348 (35%), Gaps = 51/348 (14%)
Query: 78 LSGLSLAGSISPSLGRLQSLIHLDLSSNSLTGPIPTALSNLSSLESLLLFSNQLAGTIPT 137
+ LS S + + SS SL IP+ L+ +++SL L +N++ +
Sbjct: 14 IISLSKEESSNQASLSCDRNGICKGSSGSLNS-IPSGLT--EAVKSLDLSNNRITYISNS 70
Query: 138 QLGSLTSLRVMRIGDNWLSGSIPTSFGNLVNLGTLGLASCSLSGPIPPQ-FGQLSQLEEL 196
L +L+ + + N ++ SF +L +L L L+ LS + F LS L L
Sbjct: 71 DLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSN-LSSSWFKPLSSLTFL 129
Query: 197 ILQQNQLQG-PIPAELGNCSSLSIFTAAENNLNGSIPA-ALGRLQNLQLLNLGNNSLSGE 254
L N + + + + L I + I L L+ L + + L
Sbjct: 130 NLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQ-S 188
Query: 255 IPSELGELSQLGYLNLMGNRLEGAIPRSFAKMGNLQSLDLSMNRLTGGIPEEFGNMGQLV 314
P+S + N+ L L M + + +
Sbjct: 189 YE-----------------------PKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVE 225
Query: 315 FLVLSNNNISGSIPRRICTNATSLEHLILAEIQLSGEIPVELSQCQSLKQLDLSNNTLNG 374
L L + ++ + T T+ L + + + + +++ +L
Sbjct: 226 CLELRDTDLDTFHFSELSTGETNS-----------------LIKKFTFRNVKITDESLF- 267
Query: 375 TIPVELFQLVALTHLYLHNNSLVGSISPFV-ANLSNLQELALYHNNFQ 421
+ L Q+ L L N L S+ + L++LQ++ L+ N +
Sbjct: 268 QVMKLLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTNPWD 314
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 7e-26
Identities = 64/306 (20%), Positives = 109/306 (35%), Gaps = 29/306 (9%)
Query: 358 QCQSLKQLDLSNNTLNGTIPVELFQLVALTHLYLHNNSLVGSISPFV-ANLSNLQELALY 416
C S+ +LN +IP L A+ L L NN + IS NLQ L L
Sbjct: 29 SCDRNGICKGSSGSLN-SIPSGLT--EAVKSLDLSNNRI-TYISNSDLQRCVNLQALVLT 84
Query: 417 HNNFQGSLPREI-GMLVKLELLYLYDNHLSGQIPSEV-GNCSSLKWIDFFGNSFTGEIPT 474
N ++ + L LE L L N+LS + S SSL +++ GN + T
Sbjct: 85 SNGIN-TIEEDSFSSLGSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYKTLGET 142
Query: 475 SI-GRLKDLNFLHLRQNELVGQIPA-SLGNCHQLIILDLADNKLSGGVPASFGFLQALEQ 532
S+ L L L + + +I L L++ + L P S +Q +
Sbjct: 143 SLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSH 202
Query: 533 LMLYNNSLEGNLPGSLINLRNLTRINFSKNRLNGRIATLCSSHSFLSFDVTNNEFDHEIP 592
L+L+ L + ++ + L+ + S+ S
Sbjct: 203 LILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNS------------- 249
Query: 593 PQLGNSPSLERLRLGNNKFIGKIPWTFGKIRELSLLDLSGNSLTGPIPTQLL-MCKKLSH 651
L + +++ + + ++ +I L L+ S N L +P + L
Sbjct: 250 --LIKKFTFRNVKITDES-LFQVMKLLNQISGLLELEFSRNQLKS-VPDGIFDRLTSLQK 305
Query: 652 IDLNNN 657
I L+ N
Sbjct: 306 IWLHTN 311
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 98.7 bits (246), Expect = 4e-22
Identities = 67/362 (18%), Positives = 111/362 (30%), Gaps = 62/362 (17%)
Query: 430 MLVKLELLYLYDNHLSGQIPSEVGNCSSLKWIDFFGNSFTGEIPTSIGRLKDLNFLHLRQ 489
+ + L + +C S IP+ + + + L L
Sbjct: 5 LWMVWVLGVIISLSKEESSNQASLSCDRNGICKGSSGSLN-SIPSGL--TEAVKSLDLSN 61
Query: 490 NELVGQIPASLGNCHQLIILDLADNKLSGGVPASFGFLQALEQLMLYNNSLEGNLPGSLI 549
N + + L C L L L N ++ SF L +LE L L N L
Sbjct: 62 NRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFK 121
Query: 550 NLRNLTRINFSKNRLNGRIATLCSSHSFLSFDVTNNEFDHEIPPQLGNSPSLERLRLGNN 609
L +LT +N N TL + F + L+ LR+GN
Sbjct: 122 PLSSLTFLNLLGNP----YKTLGETSLF------------------SHLTKLQILRVGNM 159
Query: 610 KFIGKIPW-TFGKIRELSLLDLSGNSLTGPIPTQLLMCKKLSHIDLNNNLLSGAVPSWLG 668
KI F + L L++ + L P L
Sbjct: 160 DTFTKIQRKDFAGLTFLEELEIDASDLQS-YE-----------------------PKSLK 195
Query: 669 TLPQLGELKLSFNQFVGFLPRELFNC-SKLLVLSLDGNMLNGSLPNEV--------GNLA 719
++ + L L Q + L + S + L L L+ +E+
Sbjct: 196 SIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKF 254
Query: 720 SLNVLTLSGNLLSGPIPPAIGRLSKLYELRLSNNSLNGVIPLEIGQLQNLQSILDLSHNN 779
+ + ++ L + + ++S L EL S N L V +L +LQ + L N
Sbjct: 255 TFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQK-IWLHTNP 312
Query: 780 FT 781
+
Sbjct: 313 WD 314
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 2e-21
Identities = 49/247 (19%), Positives = 93/247 (37%), Gaps = 16/247 (6%)
Query: 596 GNSPSLERLRLGNNKFIGKIPW-TFGKIRELSLLDLSGNSLTGPIPTQLLMC-KKLSHID 653
G + +++ L L NN+ I I + L L L+ N + I L H+D
Sbjct: 49 GLTEAVKSLDLSNNR-ITYISNSDLQRCVNLQALVLTSNGINT-IEEDSFSSLGSLEHLD 106
Query: 654 LNNNLLSGAVPSWLGTLPQLGELKLSFNQFVGFLPRELF-NCSKLLVLSLDGNMLNGSLP 712
L+ N LS SW L L L L N + LF + +KL +L + +
Sbjct: 107 LSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQ 166
Query: 713 NEV-GNLASLNVLTLSGNLLSGPIPPAIGRLSKLYELRLSNNSLNGVIPLEIGQLQNLQS 771
+ L L L + + L P ++ + + L L ++ + + +++
Sbjct: 167 RKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVEC 226
Query: 772 ILDLSHNNFTG----QIPP----SMGTLAKLEVLNLSHNQLVGELPSQLGEMSSLGKLNL 823
L+L + ++ S+ + ++ L ++ L ++S L +L
Sbjct: 227 -LELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEF 284
Query: 824 SYNDLQG 830
S N L+
Sbjct: 285 SRNQLKS 291
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 96.0 bits (239), Expect = 3e-21
Identities = 50/253 (19%), Positives = 93/253 (36%), Gaps = 17/253 (6%)
Query: 590 EIPP-QLGNSPSLERLRLGNNKFIGKIPW-TFGKIRELSLLDLSGNSLTGPIPTQLLM-C 646
I L +L+ L L +N I I +F + L LDLS N L+ + +
Sbjct: 66 YISNSDLQRCVNLQALVLTSNG-INTIEEDSFSSLGSLEHLDLSYNYLSN-LSSSWFKPL 123
Query: 647 KKLSHIDLNNNLLSGAVP-SWLGTLPQLGELKLSFNQFVGFLPRELF-NCSKLLVLSLDG 704
L+ ++L N S L +L L++ + R+ F + L L +D
Sbjct: 124 SSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDA 183
Query: 705 NMLNGSLPNEV-GNLASLNVLTLSGNLLSGPIPPAIGRLSKLYELRLSNNSLNG-----V 758
+ L S + ++ +++ L L + + S + L L + L+ +
Sbjct: 184 SDLQ-SYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSEL 242
Query: 759 IPLEIGQLQNLQS--ILDLSHNNFTGQIPPSMGTLAKLEVLNLSHNQLVGELPSQLGEMS 816
E L + + ++ + Q+ + ++ L L S NQL ++
Sbjct: 243 STGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLT 301
Query: 817 SLGKLNLSYNDLQ 829
SL K+ L N
Sbjct: 302 SLQKIWLHTNPWD 314
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 82.5 bits (204), Expect = 9e-17
Identities = 53/227 (23%), Positives = 86/227 (37%), Gaps = 12/227 (5%)
Query: 629 DLSGNSLTGPIPTQLLMCKKLSHIDLNNNLLSGAVPSWLGTLPQLGELKLSFNQFVGFLP 688
S SL IP+ L + + +DL+NN ++ S L L L L+ N + +
Sbjct: 37 KGSSGSLNS-IPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNG-INTIE 92
Query: 689 RELFNC-SKLLVLSLDGNMLNGSLPNEV-GNLASLNVLTLSGNLLSGPIPPAI--GRLSK 744
+ F+ L L L N L +L + L+SL L L GN + L+K
Sbjct: 93 EDSFSSLGSLEHLDLSYNYL-SNLSSSWFKPLSSLTFLNLLGNPYKT-LGETSLFSHLTK 150
Query: 745 LYELRLSNNSLNGVIPLEI-GQLQNLQSILDLSHNNFTGQIPPSMGTLAKLEVLNLSHNQ 803
L LR+ N I + L L+ L++ ++ P S+ ++ + L L Q
Sbjct: 151 LQILRVGNMDTFTKIQRKDFAGLTFLEE-LEIDASDLQSYEPKSLKSIQNVSHLILHMKQ 209
Query: 804 LVGELPSQLGEMSSLGKLNLSYNDLQGKLSKQFSHWPAEAFEGNLHL 850
+ L + SS+ L L DL + S +
Sbjct: 210 HILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTF 256
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 5e-15
Identities = 49/247 (19%), Positives = 79/247 (31%), Gaps = 17/247 (6%)
Query: 625 LSLLDLSGNSLTGPIPTQLLMCKKLSHIDLNNNLLSGAVPSWLGTLPQLGELKLSFNQFV 684
L + S L C + ++ L+ ++PS G + L LS N+
Sbjct: 9 WVLGVIISLSKEESSNQASLSCDRNGICKGSSGSLN-SIPS--GLTEAVKSLDLSNNRIT 65
Query: 685 GFLPRELFNCSKLLVLSLDGNMLNGSLPNEV-GNLASLNVLTLSGNLLSGPIPP-AIGRL 742
+L C L L L N +N ++ + +L SL L LS N LS + L
Sbjct: 66 YISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYNYLSN-LSSSWFKPL 123
Query: 743 SKLYELRLSNNSLNGVIPLEIGQLQNLQSILDLSHNNFTGQIPPSM-GTLAKLEVLNLSH 801
S L L L N + + IL + + + +I L LE L +
Sbjct: 124 SSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDA 183
Query: 802 NQLVGELPSQLGEMSSLGKLNLSYNDLQGKLSKQFSHWPAEAFEGNLHLCGSPLDHCNGL 861
+ L P L + ++ L L Q + + L L
Sbjct: 184 SDLQSYEPKSLKSIQNVSHLILHMK--------QHILLLEIFVDVTSSVECLELRD-TDL 234
Query: 862 VSNQHQS 868
+
Sbjct: 235 DTFHFSE 241
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 6e-31
Identities = 71/251 (28%), Positives = 111/251 (44%), Gaps = 11/251 (4%)
Query: 96 SLIHLDLSSNSLTGPIPTALSNLSSLESLLLFSNQLAGTIPTQLGSLTSLRVMRIGDNWL 155
+ +L +P +S ++ L L NQ+ L L ++++ N +
Sbjct: 44 QFSKVICVRKNLRE-VPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHI 100
Query: 156 SGSIPTSFGNLVNLGTLGLASCSLSGPIPPQ-FGQLSQLEELILQQNQLQGPIPAEL-GN 213
+F L NL TL L L+ IP F LS+L+EL L+ N ++ IP+
Sbjct: 101 RTIEIGAFNGLANLNTLELFDNRLTT-IPNGAFVYLSKLKELWLRNNPIES-IPSYAFNR 158
Query: 214 CSSLSIFTAAENNLNGSIPA-ALGRLQNLQLLNLGNNSLSGEIPSELGELSQLGYLNLMG 272
SL E I A L NL+ LNL +L EIP+ L L +L L+L G
Sbjct: 159 IPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIPN-LTPLIKLDELDLSG 216
Query: 273 NRLEGAIPRSFAKMGNLQSLDLSMNRLTGGIPEEFGNMGQLVFLVLSNNNISGSIPRRIC 332
N L P SF + +LQ L + +++ F N+ LV + L++NN++ +P +
Sbjct: 217 NHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLT-LLPHDLF 275
Query: 333 TNATSLEHLIL 343
T LE + L
Sbjct: 276 TPLHHLERIHL 286
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 6e-28
Identities = 65/303 (21%), Positives = 104/303 (34%), Gaps = 59/303 (19%)
Query: 263 SQLGYLNLMGNRLEGAIPRSFAKMGNLQSLDLSMNRLTGGIPEEFGNMGQLVFLVLSNNN 322
+Q + + L +P + N + L+L N++ F ++ L L LS N+
Sbjct: 43 NQFSKVICVRKNLR-EVPDGIST--NTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNH 99
Query: 323 ISGSIPRRICTNATSLEHLILAEIQLSGEIPVELSQCQSLKQLDLSNNTLNGTIPVELFQ 382
I +I + +L L+L +N L TIP F
Sbjct: 100 IR-TIEIGA------------------------FNGLANLNTLELFDNRLT-TIPNGAFV 133
Query: 383 -LVALTHLYLHNNSLVGSISPFV-ANLSNLQELALYHNNFQGSLPREI-GMLVKLELLYL 439
L L L+L NN + SI + + +L+ L L + L L L L
Sbjct: 134 YLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNL 192
Query: 440 YDNHLSGQIPSEVGNCSSLKWIDFFGNSFTGEIPTSIGRLKDLNFLHLRQNELVGQIPAS 499
+L EIP + L L+ L L N L P S
Sbjct: 193 AMCNLR-------------------------EIPN-LTPLIKLDELDLSGNHLSAIRPGS 226
Query: 500 LGNCHQLIILDLADNKLSGGVPASFGFLQALEQLMLYNNSLEGNLPGSLINLRNLTRINF 559
L L + +++ +F LQ+L ++ L +N+L L +L RI+
Sbjct: 227 FQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHL 286
Query: 560 SKN 562
N
Sbjct: 287 HHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 4e-26
Identities = 62/255 (24%), Positives = 98/255 (38%), Gaps = 31/255 (12%)
Query: 70 SARVVSLNLSGLSLAGSISP-SLGRLQSLIHLDLSSNSLTGPIPTALSNLSSLESLLLFS 128
S LNL + I S L+ L L LS N + A + L++L +L LF
Sbjct: 63 STNTRLLNLHENQIQ-IIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFD 121
Query: 129 NQLAGTIPTQLGSLTSLRVMRIGDNWLSGSIPT-SFGNLVNLGTLGLASCSLSGPIPPQ- 186
N+L L+ L+ + + +N + SIP+ +F + +L L L I
Sbjct: 122 NRLTTIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLSYISEGA 180
Query: 187 FGQLSQLEELILQQNQLQGPIPAELGNCSSLSIFTAAENNLNGSIPAALGRLQNLQLLNL 246
F LS L L L L+ IP L L L L+L
Sbjct: 181 FEGLSNLRYLNLAMCNLR-------------------------EIP-NLTPLIKLDELDL 214
Query: 247 GNNSLSGEIPSELGELSQLGYLNLMGNRLEGAIPRSFAKMGNLQSLDLSMNRLTGGIPEE 306
N LS P L L L ++ ++++ +F + +L ++L+ N LT +
Sbjct: 215 SGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDL 274
Query: 307 FGNMGQLVFLVLSNN 321
F + L + L +N
Sbjct: 275 FTPLHHLERIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-25
Identities = 61/244 (25%), Positives = 94/244 (38%), Gaps = 12/244 (4%)
Query: 590 EIPPQLGNSPSLERLRLGNNKFIGKIPW-TFGKIRELSLLDLSGNSLTGPIPTQLLMCKK 648
E+P + S + L L N+ I I +F +R L +L LS N +
Sbjct: 57 EVPDGI--STNTRLLNLHENQ-IQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLAN 113
Query: 649 LSHIDLNNNLLSGAVPSWLGTLPQLGELKLSFNQFVGFLPRELF-NCSKLLVLSLDGNML 707
L+ ++L +N L+ L +L EL L N +P F L L L
Sbjct: 114 LNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKR 172
Query: 708 NGSLPNEV-GNLASLNVLTLSGNLLSGPIPPAIGRLSKLYELRLSNNSLNGVIPLEIGQL 766
+ L++L L L+ L P + L KL EL LS N L+ + P L
Sbjct: 173 LSYISEGAFEGLSNLRYLNLAMCNLREI--PNLTPLIKLDELDLSGNHLSAIRPGSFQGL 230
Query: 767 QNLQSILDLSHNNFTGQIPPSM-GTLAKLEVLNLSHNQLVGELPSQLGEMSSLGKLNLSY 825
+LQ L + + I + L L +NL+HN L + L +++L +
Sbjct: 231 MHLQK-LWMIQSQIQ-VIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHH 288
Query: 826 NDLQ 829
N
Sbjct: 289 NPWN 292
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-24
Identities = 65/277 (23%), Positives = 101/277 (36%), Gaps = 33/277 (11%)
Query: 456 SSLKWIDFFGNSFTGEIPTSIGRLKDLNFLHLRQNELVGQIPASLGNCHQLIILDLADNK 515
+ + + E+P I + L+L +N++ S + L IL L+ N
Sbjct: 43 NQFSKVICVRKNLR-EVPDGI--STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNH 99
Query: 516 LSGGVPASFGFLQALEQLMLYNNSLEGNLPGSLINLRNLTRINFSKNRLNGRIATLCSSH 575
+ +F L L L L++N L G+ + L L + N +
Sbjct: 100 IRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPI----------- 148
Query: 576 SFLSFDVTNNEFDHEIPPQL-GNSPSLERLRLGNNKFIGKIPW-TFGKIRELSLLDLSGN 633
IP PSL RL LG K + I F + L L+L+
Sbjct: 149 -------------ESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMC 195
Query: 634 SLTGPIPTQLLMCKKLSHIDLNNNLLSGAVPSWLGTLPQLGELKLSFNQFVGFLPRELFN 693
+L IP L KL +DL+ N LS P L L +L + +Q N
Sbjct: 196 NLRE-IPN-LTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDN 253
Query: 694 CSKLLVLSLDGNMLNGSLPNEV-GNLASLNVLTLSGN 729
L+ ++L N L LP+++ L L + L N
Sbjct: 254 LQSLVEINLAHNNLT-LLPHDLFTPLHHLERIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 3e-14
Identities = 48/182 (26%), Positives = 74/182 (40%), Gaps = 10/182 (5%)
Query: 77 NLSGLSLAG----SISP-SLGRLQSLIHLDLSSNSLTGPIPTALSNLSSLESLLLFS-NQ 130
NL+ L L +I + L L L L +N + A + + SL L L +
Sbjct: 113 NLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKR 172
Query: 131 LAGTIPTQLGSLTSLRVMRIGDNWLSGSIPTSFGNLVNLGTLGLASCSLSGPIPPQFGQL 190
L+ L++LR + + L IP L+ L L L+ LS P F L
Sbjct: 173 LSYISEGAFEGLSNLRYLNLAMCNLR-EIPN-LTPLIKLDELDLSGNHLSAIRPGSFQGL 230
Query: 191 SQLEELILQQNQLQGPIPAELGNCSSLSIFTAAENNLNGSIPA-ALGRLQNLQLLNLGNN 249
L++L + Q+Q+Q N SL A NNL +P L +L+ ++L +N
Sbjct: 231 MHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLT-LLPHDLFTPLHHLERIHLHHN 289
Query: 250 SL 251
Sbjct: 290 PW 291
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 8e-31
Identities = 68/251 (27%), Positives = 108/251 (43%), Gaps = 11/251 (4%)
Query: 96 SLIHLDLSSNSLTGPIPTALSNLSSLESLLLFSNQLAGTIPTQLGSLTSLRVMRIGDNWL 155
+ + L+ +P + S+ L L N + L L V+++G N +
Sbjct: 55 QFSKVVCTRRGLSE-VPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSI 111
Query: 156 SGSIPTSFGNLVNLGTLGLASCSLSGPIPPQ-FGQLSQLEELILQQNQLQGPIPAE-LGN 213
+F L +L TL L L+ IP F LS+L EL L+ N ++ IP+
Sbjct: 112 RQIEVGAFNGLASLNTLELFDNWLTV-IPSGAFEYLSKLRELWLRNNPIES-IPSYAFNR 169
Query: 214 CSSLSIFTAAENNLNGSIPA-ALGRLQNLQLLNLGNNSLSGEIPSELGELSQLGYLNLMG 272
SL E I A L NL+ LNLG ++ ++P+ L L L L + G
Sbjct: 170 VPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMPN-LTPLVGLEELEMSG 227
Query: 273 NRLEGAIPRSFAKMGNLQSLDLSMNRLTGGIPEEFGNMGQLVFLVLSNNNISGSIPRRIC 332
N P SF + +L+ L + ++++ F + LV L L++NN+S S+P +
Sbjct: 228 NHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLS-SLPHDLF 286
Query: 333 TNATSLEHLIL 343
T L L L
Sbjct: 287 TPLRYLVELHL 297
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 2e-28
Identities = 59/303 (19%), Positives = 99/303 (32%), Gaps = 59/303 (19%)
Query: 263 SQLGYLNLMGNRLEGAIPRSFAKMGNLQSLDLSMNRLTGGIPEEFGNMGQLVFLVLSNNN 322
+Q + L +P+ N + L+L N + + F ++ L L L N+
Sbjct: 54 NQFSKVVCTRRGLS-EVPQGIPS--NTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNS 110
Query: 323 ISGSIPRRICTNATSLEHLILAEIQLSGEIPVELSQCQSLKQLDLSNNTLNGTIPVELFQ 382
I I + SL L+L +N L IP F+
Sbjct: 111 IR-QIEVGA------------------------FNGLASLNTLELFDNWLT-VIPSGAFE 144
Query: 383 -LVALTHLYLHNNSLVGSISPFV-ANLSNLQELALYHNNFQGSLPREI-GMLVKLELLYL 439
L L L+L NN + SI + + +L L L + L L+ L L
Sbjct: 145 YLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNL 203
Query: 440 YDNHLSGQIPSEVGNCSSLKWIDFFGNSFTGEIPTSIGRLKDLNFLHLRQNELVGQIPAS 499
++ ++P + L L L + N P S
Sbjct: 204 GMCNIK-------------------------DMPN-LTPLVGLEELEMSGNHFPEIRPGS 237
Query: 500 LGNCHQLIILDLADNKLSGGVPASFGFLQALEQLMLYNNSLEGNLPGSLINLRNLTRINF 559
L L + ++++S +F L +L +L L +N+L LR L ++
Sbjct: 238 FHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHL 297
Query: 560 SKN 562
N
Sbjct: 298 HHN 300
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 6e-28
Identities = 58/231 (25%), Positives = 96/231 (41%), Gaps = 11/231 (4%)
Query: 96 SLIHLDLSSNSLTGPIPTALSNLSSLESLLLFSNQLAGTIPTQ-LGSLTSLRVMRIGDNW 154
+ +L+L N++ +L LE L L N + I L SL + + DNW
Sbjct: 76 NTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIR-QIEVGAFNGLASLNTLELFDNW 134
Query: 155 LSGSIPT-SFGNLVNLGTLGLASCSLSGPIPPQ-FGQLSQLEELILQQ-NQLQGPIPAEL 211
L+ IP+ +F L L L L + + IP F ++ L L L + +L+
Sbjct: 135 LT-VIPSGAFEYLSKLRELWLRNNPIES-IPSYAFNRVPSLMRLDLGELKKLEYISEGAF 192
Query: 212 GNCSSLSIFTAAENNLNGSIPAALGRLQNLQLLNLGNNSLSGEIPSELGELSQLGYLNLM 271
+L N+ +P L L L+ L + N P LS L L +M
Sbjct: 193 EGLFNLKYLNLGMCNIK-DMPN-LTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVM 250
Query: 272 GNRLEGAIPRSFAKMGNLQSLDLSMNRLTGGIPEE-FGNMGQLVFLVLSNN 321
+++ +F + +L L+L+ N L+ +P + F + LV L L +N
Sbjct: 251 NSQVSLIERNAFDGLASLVELNLAHNNLS-SLPHDLFTPLRYLVELHLHHN 300
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-24
Identities = 59/277 (21%), Positives = 99/277 (35%), Gaps = 33/277 (11%)
Query: 456 SSLKWIDFFGNSFTGEIPTSIGRLKDLNFLHLRQNELVGQIPASLGNCHQLIILDLADNK 515
+ + + E+P I + +L+L +N + + + H L +L L N
Sbjct: 54 NQFSKVVCTRRGLS-EVPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNS 110
Query: 516 LSGGVPASFGFLQALEQLMLYNNSLEGNLPGSLINLRNLTRINFSKNRLNGRIATLCSSH 575
+ +F L +L L L++N L G+ L L + N +
Sbjct: 111 IRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPI----------- 159
Query: 576 SFLSFDVTNNEFDHEIPPQ-LGNSPSLERLRLGNNKFIGKIPW-TFGKIRELSLLDLSGN 633
IP PSL RL LG K + I F + L L+L
Sbjct: 160 -------------ESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMC 206
Query: 634 SLTGPIPTQLLMCKKLSHIDLNNNLLSGAVPSWLGTLPQLGELKLSFNQFVGFLPRELFN 693
++ +P L L ++++ N P L L +L + +Q
Sbjct: 207 NIKD-MPN-LTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDG 264
Query: 694 CSKLLVLSLDGNMLNGSLPNEV-GNLASLNVLTLSGN 729
+ L+ L+L N L+ SLP+++ L L L L N
Sbjct: 265 LASLVELNLAHNNLS-SLPHDLFTPLRYLVELHLHHN 300
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-23
Identities = 59/230 (25%), Positives = 94/230 (40%), Gaps = 12/230 (5%)
Query: 581 DVTNNEFDHEIPP-QLGNSPSLERLRLGNNKFIGKI-PWTFGKIRELSLLDLSGNSLTGP 638
++ N I + LE L+LG N I +I F + L+ L+L N LT
Sbjct: 81 NLMENNI-QMIQADTFRHLHHLEVLQLGRNS-IRQIEVGAFNGLASLNTLELFDNWLTV- 137
Query: 639 IPTQLLMC-KKLSHIDLNNNLLSGAVPSWLGTLPQLGELKLSFNQFVGFLPRELF-NCSK 696
IP+ KL + L NN + +P L L L + + ++ F
Sbjct: 138 IPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFN 197
Query: 697 LLVLSLDGNMLNGSLPNEVGNLASLNVLTLSGNLLSGPIPPAIGRLSKLYELRLSNNSLN 756
L L+L + +P + L L L +SGN P + LS L +L + N+ ++
Sbjct: 198 LKYLNLGMCNIK-DMP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVS 255
Query: 757 GVIPLEIGQLQNLQSILDLSHNNFTGQIPPSM-GTLAKLEVLNLSHNQLV 805
+ L +L L+L+HNN + +P + L L L+L HN
Sbjct: 256 LIERNAFDGLASLVE-LNLAHNNLS-SLPHDLFTPLRYLVELHLHHNPWN 303
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 93.7 bits (233), Expect = 5e-20
Identities = 61/278 (21%), Positives = 100/278 (35%), Gaps = 48/278 (17%)
Query: 590 EIPPQLGNSPSLERLRLGNNKFIGKIPW-TFGKIRELSLLDLSGNSLTGPIPTQLLMCKK 648
E+P + + L L N I I TF + L +L L NS+
Sbjct: 68 EVPQGI--PSNTRYLNLMENN-IQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLAS 124
Query: 649 LSHIDLNNNLLSGAVPSWLGTLPQLGELKLSFNQFVGFLPRELF-NCSKLLVLSLDGNML 707
L+ ++L +N L+ L +L EL L N +P F L+ L L
Sbjct: 125 LNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELKK 183
Query: 708 NGSLPNEV-GNLASLNVLTLSGNLLSGPIPPAIGRLSKLYELRLSNNSLNGVIPLEIGQL 766
+ L +L L L + P + L L EL +S N
Sbjct: 184 LEYISEGAFEGLFNLKYLNLGMCNIKDM--PNLTPLVGLEELEMSGN-----------HF 230
Query: 767 QNLQSILDLSHNNFTGQIPPSMGTLAKLEVLNLSHNQLVGELPSQLGEMSSLGKLNLSYN 826
++ +F G L+ L+ L + ++Q+ + ++SL +LNL++N
Sbjct: 231 PEIRP------GSFHG--------LSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHN 276
Query: 827 DLQGKLSKQFSHWPAEAFEG-----NLHLCGSPLDHCN 859
+L S P + F LHL +P +C+
Sbjct: 277 NL--------SSLPHDLFTPLRYLVELHLHHNPW-NCD 305
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 2e-14
Identities = 43/182 (23%), Positives = 70/182 (38%), Gaps = 10/182 (5%)
Query: 77 NLSGLSLAG----SISP-SLGRLQSLIHLDLSSNSLTGPIPTALSNLSSLESLLLFS-NQ 130
+L+ L L I + L L L L +N + A + + SL L L +
Sbjct: 124 SLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKK 183
Query: 131 LAGTIPTQLGSLTSLRVMRIGDNWLSGSIPTSFGNLVNLGTLGLASCSLSGPIPPQFGQL 190
L L +L+ + +G + +P LV L L ++ P F L
Sbjct: 184 LEYISEGAFEGLFNLKYLNLGMCNIK-DMPN-LTPLVGLEELEMSGNHFPEIRPGSFHGL 241
Query: 191 SQLEELILQQNQLQGPIPAELGNCSSLSIFTAAENNLNGSIPA-ALGRLQNLQLLNLGNN 249
S L++L + +Q+ +SL A NNL+ S+P L+ L L+L +N
Sbjct: 242 SSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLS-SLPHDLFTPLRYLVELHLHHN 300
Query: 250 SL 251
Sbjct: 301 PW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 1e-08
Identities = 34/153 (22%), Positives = 56/153 (36%), Gaps = 13/153 (8%)
Query: 695 SKLLVLSLDGNMLNGSLPNEVGNLASLNVLTLSGNLLSGPIPPAIGRLSKLYELRLSNNS 754
++ + L+ +P + ++ L L N + L L L+L NS
Sbjct: 54 NQFSKVVCTRRGLS-EVPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNS 110
Query: 755 LNGVIPLEIGQLQNLQSILDLSHNNFTGQIPPSM-GTLAKLEVLNLSHNQLVGELPSQLG 813
+ + L +L L+L N T IP L+KL L L +N +
Sbjct: 111 IRQIEVGAFNGLASLN-TLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIESIPSYAFN 168
Query: 814 EMSSLGKLNLSYNDLQGKLSKQFSHWPAEAFEG 846
+ SL +L+L K+ + AFEG
Sbjct: 169 RVPSLMRLDLGEL-------KKLEYISEGAFEG 194
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-30
Identities = 56/221 (25%), Positives = 94/221 (42%), Gaps = 37/221 (16%)
Query: 954 IGSGGSGTVYKA-ELANGATVAVK---KISCKDDHLLNKSFTREVKTLGRIRHRHLVKLM 1009
+G GG ++ + A K K H K + E+ + H+H+V
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK-MSMEISIHRSLAHQHVVGFH 81
Query: 1010 GHCCNKGAGSNL-LIYEYMENGSVWDWLHKQPVNIKMRKSLD-WEARLKIAVGLAQGVEY 1067
G + + ++ E S+ + K RK+L EAR + G +Y
Sbjct: 82 GFFEDN---DFVFVVLELCRRRSLLEL-------HKRRKALTEPEAR-YYLRQIVLGCQY 130
Query: 1068 LHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNS--NTESNTWFAGSYGY 1125
LH + +++HRD+K N+ L+ ++E +GDFGLA VE G+ Y
Sbjct: 131 LHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLA-TKVEYDGERKKV-----LCGTPNY 181
Query: 1126 IAPE----YAYSLKATEKCDVYSMGIVLMELVSGKMPTDAT 1162
IAPE +S + DV+S+G ++ L+ GK P + +
Sbjct: 182 IAPEVLSKKGHSFEV----DVWSIGCIMYTLLVGKPPFETS 218
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 1e-30
Identities = 56/217 (25%), Positives = 92/217 (42%), Gaps = 37/217 (17%)
Query: 954 IGSGGSGTVYKA-ELANGATVAVK---KISCKDDHLLNKSFTREVKTLGRIRHRHLVKLM 1009
+G GG ++ + A K K H K + E+ + H+H+V
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK-MSMEISIHRSLAHQHVVGFH 107
Query: 1010 GHCCNKGAGSNL-LIYEYMENGSVWDWLHKQPVNIKMRKSLD-WEARLKIAVGLAQGVEY 1067
G + + ++ E S+ + K RK+L EAR + G +Y
Sbjct: 108 GFFEDN---DFVFVVLELCRRRSLLEL-------HKRRKALTEPEAR-YYLRQIVLGCQY 156
Query: 1068 LHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNS--NTESNTWFAGSYGY 1125
LH + +++HRD+K N+ L+ ++E +GDFGLA VE G+ Y
Sbjct: 157 LHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLA-TKVEYDGERKKV-----LCGTPNY 207
Query: 1126 IAPEY----AYSLKATEKCDVYSMGIVLMELVSGKMP 1158
IAPE +S + DV+S+G ++ L+ GK P
Sbjct: 208 IAPEVLSKKGHSFEV----DVWSIGCIMYTLLVGKPP 240
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 1e-30
Identities = 60/220 (27%), Positives = 102/220 (46%), Gaps = 36/220 (16%)
Query: 953 IIGSGGSGTVYKAELANGA-----TVAVKKISCKDDHLL--NKSFTREVKTLGRIRHRHL 1005
++GSG GTV+K V +K +D ++ T + +G + H H+
Sbjct: 20 VLGSGVFGTVHKGVWIPEGESIKIPVCIK--VIEDKSGRQSFQAVTDHMLAIGSLDHAHI 77
Query: 1006 VKLMGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGV 1065
V+L+G C S L+ +Y+ GS+ D + + + + L+W V +A+G+
Sbjct: 78 VRLLGLCPGS---SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNW------GVQIAKGM 128
Query: 1066 EYLH-HDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVED--YNSNTESNT---WF 1119
YL H V HR++ + N+LL S + + DFG+A L D +E+ T W
Sbjct: 129 YYLEEHGMV----HRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKW- 183
Query: 1120 AGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMP 1158
+A E + K T + DV+S G+ + EL++ G P
Sbjct: 184 ------MALESIHFGKYTHQSDVWSYGVTVWELMTFGAEP 217
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 2e-30
Identities = 60/211 (28%), Positives = 94/211 (44%), Gaps = 18/211 (8%)
Query: 954 IGSGGSGTVYKA-ELANGATVAVKKISCKDDHLLNKSFTREVKTLGR-IRHRHLVKLMGH 1011
IG G G+V K +G +AVK+I D K ++ + R ++V+ G
Sbjct: 30 IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGA 89
Query: 1012 CCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHD 1071
+G + E M + S + + + KI + + + +L +
Sbjct: 90 LFREGDCW--ICMELM-STSFDKFYKYVYSVLDDVIPEEILG--KITLATVKALNHLKEN 144
Query: 1072 CVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPE-- 1129
KI+HRDIK SNILLD + L DFG++ LV ++ + T AG Y+APE
Sbjct: 145 L--KIIHRDIKPSNILLDRSGNIKLCDFGISGQLV-----DSIAKTRDAGCRPYMAPERI 197
Query: 1130 --YAYSLKATEKCDVYSMGIVLMELVSGKMP 1158
A + DV+S+GI L EL +G+ P
Sbjct: 198 DPSASRQGYDVRSDVWSLGITLYELATGRFP 228
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 2e-30
Identities = 62/210 (29%), Positives = 101/210 (48%), Gaps = 26/210 (12%)
Query: 954 IGSGGSGTVYKA-ELANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHC 1012
IG G G V+K + VA+K I ++ + +E+ L + ++ K G
Sbjct: 30 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 89
Query: 1013 CNKGAGSNL-LIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAV---GLAQGVEYL 1068
+ L +I EY+ GS D L P++ E +IA + +G++YL
Sbjct: 90 LK---DTKLWIIMEYLGGGSALDLLEPGPLD---------ET--QIATILREILKGLDYL 135
Query: 1069 HHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAP 1128
H + K +HRDIK++N+LL + E L DFG+A L ++ + NT F G+ ++AP
Sbjct: 136 HSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLT---DTQIKRNT-FVGTPFWMAP 188
Query: 1129 EYAYSLKATEKCDVYSMGIVLMELVSGKMP 1158
E K D++S+GI +EL G+ P
Sbjct: 189 EVIKQSAYDSKADIWSLGITAIELARGEPP 218
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-30
Identities = 72/300 (24%), Positives = 127/300 (42%), Gaps = 58/300 (19%)
Query: 953 IIGSGGSGTVYKAELANGA---TVAVKKISCKDD---HLLNKSFTREVKTLGRIRHRHLV 1006
+GSG GTV K TVAVK K++ L E + ++ + ++V
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVK--ILKNEANDPALKDELLAEANVMQQLDNPYIV 81
Query: 1007 KLMGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVE 1066
+++G C + S +L+ E E G + +L + + + + +++ ++ G++
Sbjct: 82 RMIGICEAE---SWMLVMEMAELGPLNKYLQQ-------NRHVKDKNIIELVHQVSMGMK 131
Query: 1067 YL-HHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGY 1125
YL + V HRD+ + N+LL + A + DFGL+KAL D N + A ++G
Sbjct: 132 YLEESNFV----HRDLAARNVLLVTQHYAKISDFGLSKALRAD------ENYYKAQTHGK 181
Query: 1126 I-----APEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMVRWVEMHMEM 1179
APE K + K DV+S G+++ E S G+ P + M
Sbjct: 182 WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP-----------------YRGM 224
Query: 1180 SGSAREELLDD--QMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNVFNN 1237
GS +L+ +M P C ++ ++ C + RP V L N + +
Sbjct: 225 KGSEVTAMLEKGERMGC--P-AGCPR-EMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 280
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 3e-30
Identities = 72/305 (23%), Positives = 130/305 (42%), Gaps = 50/305 (16%)
Query: 954 IGSGGSGTVYKA-ELANGATVAVKKISCKDDHLLNKSFTREVKTLGR-IRHRHLVKLMGH 1011
+G G G V K + +G +AVK+I + K ++ R + V G
Sbjct: 15 LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74
Query: 1012 CCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHD 1071
+G + E M + S+ D +KQ ++ D KIAV + + +E+LH
Sbjct: 75 LFREGDVW--ICMELM-DTSL-DKFYKQVIDKGQTIPEDILG--KIAVSIVKALEHLHSK 128
Query: 1072 CVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPE-- 1129
++HRD+K SN+L+++ + + DFG++ LV + + AG Y+APE
Sbjct: 129 L--SVIHRDVKPSNVLINALGQVKMCDFGISGYLV-----DDVAKDIDAGCKPYMAPERI 181
Query: 1130 ------YAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSA 1183
YS+K+ D++S+GI ++EL + P ++G + + +
Sbjct: 182 NPELNQKGYSVKS----DIWSLGITMIELAILRFPY-DSWGTPFQQ-----LKQVVEEPS 231
Query: 1184 REELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNVFNNRIVDFD 1243
P LP ++ +A V + QC K + +ERP+ + L+ + F +
Sbjct: 232 ----------PQLPADKFSAEFVDFTS-QCLKKNSKERPTYPE---LMQHPF---FTLHE 274
Query: 1244 KLHID 1248
D
Sbjct: 275 SKGTD 279
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 4e-30
Identities = 54/215 (25%), Positives = 93/215 (43%), Gaps = 32/215 (14%)
Query: 954 IGSGGSGTVYKAE-LANGATVAVK--KISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMG 1010
+G GG G VY+AE VA+K + D + RE +T GR++ H+V
Sbjct: 42 VGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVP--- 98
Query: 1011 HCCNKGAGSNLLIYEYMENGSVWDWLHKQPVN-------IKMRKSLDWEARLKIAVGLAQ 1063
I+++ E ++ + +N ++ + L + I +
Sbjct: 99 ------------IHDFGEIDGQL-YVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGS 145
Query: 1064 GVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSY 1123
++ H HRD+K NIL+ ++ A+L DFG+A A + T+ G+
Sbjct: 146 ALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATTD--EKLTQLGN-TVGTL 199
Query: 1124 GYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMP 1158
Y+APE AT + D+Y++ VL E ++G P
Sbjct: 200 YYMAPERFSESHATYRADIYALTCVLYECLTGSPP 234
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 4e-30
Identities = 48/234 (20%), Positives = 94/234 (40%), Gaps = 29/234 (12%)
Query: 942 MGATNNLSDEFI----IGSGGSGTVYKA-ELANGATVAVKKISCKDDHLLNKSFTREVKT 996
MG+ + + ++ +G G + V++ G A+K + RE +
Sbjct: 1 MGSQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEV 60
Query: 997 LGRIRHRHLVKLMGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLK 1056
L ++ H+++VKL +LI E+ GS++ L + + +S E
Sbjct: 61 LKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPES---EFL-I 116
Query: 1057 IAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAH----LGDFGLAKALVEDYNSN 1112
+ + G+ +L + I+HR+IK NI+ + L DFG A+ L +D
Sbjct: 117 VLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFV 173
Query: 1113 TESNTWFAGSYGYIAPE--------YAYSLKATEKCDVYSMGIVLMELVSGKMP 1158
+ G+ Y+ P+ + K D++S+G+ +G +P
Sbjct: 174 S-----LYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 7e-30
Identities = 69/298 (23%), Positives = 122/298 (40%), Gaps = 55/298 (18%)
Query: 953 IIGSGGSGTVYKAELANGA----TVAVKKISCKDDHLLN--KSFTREVKTLGRIRHRHLV 1006
I+G G G VY+ N VAVK +CK D L+ + F E + + H H+V
Sbjct: 19 ILGEGFFGEVYEGVYTNHKGEKINVAVK--TCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 76
Query: 1007 KLMGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVE 1066
KL+G + +I E G + +L + ++K+ + + ++ + + +
Sbjct: 77 KLIGIIEEE---PTWIIMELYPYGELGHYLERNKNSLKVLTLVLY------SLQICKAMA 127
Query: 1067 YL-HHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGY 1125
YL +CV HRDI NIL+ S LGDFGL++ + E ++ S
Sbjct: 128 YLESINCV----HRDIAVRNILVASPECVKLGDFGLSRYI--------EDEDYYKASVTR 175
Query: 1126 I-----APEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMVRWVEMHMEM 1179
+ +PE + T DV+ + + E++S GK P ++ + +
Sbjct: 176 LPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDV-------IGVLE 228
Query: 1180 SGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNVFNN 1237
G + L KP + C + + +C P +RP ++ L +V+
Sbjct: 229 KG----DRLP---KP----DLCPP-VLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM 274
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 122 bits (306), Expect = 7e-30
Identities = 39/272 (14%), Positives = 83/272 (30%), Gaps = 54/272 (19%)
Query: 953 IIGSGGSGTVYKA-ELANGATVAVKKISCKDDHLLN--KSFTREVKTLGRIR-------- 1001
++G +A + G + V + N K EV L +R
Sbjct: 80 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139
Query: 1002 -----------------HRHLVKLMGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIK 1044
+ ++++ + S +Y M+ ++ + +
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQ-SNLQTFGEVLLSHSS 198
Query: 1045 MRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKA 1104
KSL ARL++ + + + + LHH ++H ++ +I+LD L F
Sbjct: 199 THKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVR 255
Query: 1105 LVEDYNSNTESNTWFAGSYGYIAPEY-----------AYSLKATEKCDVYSMGIVLMELV 1153
+ + S G+ PE T D +++G+V+ +
Sbjct: 256 D--------GARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIW 307
Query: 1154 SGKMPTDATFGVEMDMVRWV-EMHMEMSGSAR 1184
+P + W+ + R
Sbjct: 308 CADLPITKD--AALGGSEWIFRSCKNIPQPVR 337
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-29
Identities = 59/217 (27%), Positives = 100/217 (46%), Gaps = 36/217 (16%)
Query: 954 IGSGGSGTVYKA-ELANGATVAVK---KISCKDDHLLNKSFTREVKTLGRIRHRHLVKLM 1009
+G G VY+A + G VA+K K + ++ + EVK +++H +++L
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQR-VQNEVKIHCQLKHPSILELY 77
Query: 1010 GHCCNKGAGSNL-LIYEYMENGSVWDWLHKQPVNIKMRKSLD-WEARLKIAVGLAQGVEY 1067
+ + + + L+ E NG + +L + K EAR + + G+ Y
Sbjct: 78 NYFEDS---NYVYLVLEMCHNGEMNRYLKNR------VKPFSENEARHFMH-QIITGMLY 127
Query: 1068 LHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNS--NTESNTWFAGSYGY 1125
LH ILHRD+ SN+LL NM + DFGLA ++ + T G+ Y
Sbjct: 128 LHSH---GILHRDLTLSNLLLTRNMNIKIADFGLA-TQLKMPHEKHYT-----LCGTPNY 178
Query: 1126 IAPE----YAYSLKATEKCDVYSMGIVLMELVSGKMP 1158
I+PE A+ L++ DV+S+G + L+ G+ P
Sbjct: 179 ISPEIATRSAHGLES----DVWSLGCMFYTLLIGRPP 211
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 122 bits (306), Expect = 1e-29
Identities = 34/253 (13%), Positives = 67/253 (26%), Gaps = 40/253 (15%)
Query: 953 IIGSGGSGTVYKAE-LANGATVAVKKIS--CKDDHLLNKSFTREVKTLGRIRHRH----- 1004
++G +A G + V + K EV L +R
Sbjct: 85 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144
Query: 1005 -----------LVKLMGHCC--------NKGAGSNLLIYEYMENGSVWDWLHKQPVNIKM 1045
LVK + ++ + +
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204
Query: 1046 RKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKAL 1105
KSL ARL++ + + + + LHH ++H ++ +I+LD L F
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 261
Query: 1106 VEDYNSNTESNTWFAGSYGYIAPEYAYSLKA-----TEKCDVYSMGIVLMELVSGKMPTD 1160
S A + T D +++G+ + + +P
Sbjct: 262 GASAVSPI---GRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNT 318
Query: 1161 ATFGVEMDMVRWV 1173
+ W+
Sbjct: 319 DD--AALGGSEWI 329
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 1e-29
Identities = 66/298 (22%), Positives = 122/298 (40%), Gaps = 50/298 (16%)
Query: 953 IIGSGGSGTVYKAELANGA----TVAVKKISCKDDHLLN--KSFTREVKTLGRIRHRHLV 1006
+IG G G VY L + AVK S + F E + H +++
Sbjct: 96 VIGRGHFGCVYHGTLLDNDGKKIHCAVK--SLNRITDIGEVSQFLTEGIIMKDFSHPNVL 153
Query: 1007 KLMGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVE 1066
L+G C + GS L++ YM++G + +++ + + + + + +A+G++
Sbjct: 154 SLLG-ICLRSEGSPLVVLPYMKHGDLRNFIRNE------THNPTVKDLIGFGLQVAKGMK 206
Query: 1067 YL-HHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGY 1125
+L V HRD+ + N +LD + DFGLA+ + + E ++ +
Sbjct: 207 FLASKKFV----HRDLAARNCMLDEKFTVKVADFGLARDMYDK-----EFDSVHNKTGAK 257
Query: 1126 I-----APEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMVRWVEMHMEM 1179
+ A E + K T K DV+S G++L EL++ G P V + +
Sbjct: 258 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP---YPDVNTFDI----TVYLL 310
Query: 1180 SGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNVFNN 1237
G L +P E C + E+ L+C + RPS ++ + +F+
Sbjct: 311 QG----RRLL---QP----EYCPD-PLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 356
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 125 bits (314), Expect = 1e-29
Identities = 62/301 (20%), Positives = 124/301 (41%), Gaps = 56/301 (18%)
Query: 951 EFIIGSGGSGTVYKAELANGA---TVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVK 1007
+ +G G G+V + VA+K + + + RE + + ++ + ++V+
Sbjct: 341 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 400
Query: 1008 LMGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEY 1067
L+G C + + +L+ E G + +L + R+ + ++ ++ G++Y
Sbjct: 401 LIGVCQAE---ALMLVMEMAGGGPLHKFLVGK------REEIPVSNVAELLHQVSMGMKY 451
Query: 1068 L-HHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYI 1126
L + V HR++ + N+LL + A + DFGL+KAL D + + A S G
Sbjct: 452 LEEKNFV----HRNLAARNVLLVNRHYAKISDFGLSKALGAD------DSYYTARSAGKW 501
Query: 1127 -----APEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMVRWVEMHMEMS 1180
APE K + + DV+S G+ + E +S G+ P + +M
Sbjct: 502 PLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP-----------------YKKMK 544
Query: 1181 GSAREELLDD--QMKPLLPGEEC--AAYQVLEIALQCTKTSPQERPSSRQVCDLLLNVFN 1236
G ++ +M+ P EC Y ++ C ++RP V + +
Sbjct: 545 GPEVMAFIEQGKRMEC--P-PECPPELYALM---SDCWIYKWEDRPDFLTVEQRMRACYY 598
Query: 1237 N 1237
+
Sbjct: 599 S 599
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 2e-29
Identities = 47/214 (21%), Positives = 86/214 (40%), Gaps = 38/214 (17%)
Query: 1025 EYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSS 1084
+ ++ DW++++ + + L I + +A+ VE+LH ++HRD+K S
Sbjct: 141 QLCRKENLKDWMNRR----CSLEDREHGVCLHIFIQIAEAVEFLHSK---GLMHRDLKPS 193
Query: 1085 NILLDSNMEAHLGDFGLAKALVEDYNSNT--------ESNTWFAGSYGYIAPEYAYSLKA 1136
NI + +GDFGL A+ +D T ++T G+ Y++PE +
Sbjct: 194 NIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNY 253
Query: 1137 TEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSAREELLDDQMKPLL 1196
+ K D++S+G++L EL+ ME R ++ D
Sbjct: 254 SHKVDIFSLGLILFELLYSFST-----------------QME-----RVRIITDVRNLKF 291
Query: 1197 PGEECAAYQVL-EIALQCTKTSPQERPSSRQVCD 1229
P Y + SP ERP + + +
Sbjct: 292 PLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIE 325
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-29
Identities = 66/298 (22%), Positives = 116/298 (38%), Gaps = 55/298 (18%)
Query: 953 IIGSGGSGTVYKAELANGA----TVAVKKISCKDDHLLN--KSFTREVKTLGRIRHRHLV 1006
IG G G V++ + VA+K +CK+ + + F +E T+ + H H+V
Sbjct: 22 CIGEGQFGDVHQGIYMSPENPALAVAIK--TCKNCTSDSVREKFLQEALTMRQFDHPHIV 79
Query: 1007 KLMGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVE 1066
KL+G +I E G + +L + ++ + + + A L+ +
Sbjct: 80 KLIGVITEN---PVWIIMELCTLGELRSFLQVRKYSLDLASLILY------AYQLSTALA 130
Query: 1067 YL-HHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGY 1125
YL V HRDI + N+L+ SN LGDFGL++ + E +T++ S G
Sbjct: 131 YLESKRFV----HRDIAARNVLVSSNDCVKLGDFGLSRYM--------EDSTYYKASKGK 178
Query: 1126 I-----APEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMVRWVEMHMEM 1179
+ APE + T DV+ G+ + E++ G P ++ +
Sbjct: 179 LPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV-------IGRIE 231
Query: 1180 SGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNVFNN 1237
+G E L P C + + +C P RP ++ L +
Sbjct: 232 NG----ERLP---MP----PNCPP-TLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 277
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 2e-29
Identities = 80/346 (23%), Positives = 131/346 (37%), Gaps = 64/346 (18%)
Query: 916 SSSSSQAQRRLLFQAAAKRDFRWEDIMGATNNLSDEFI--IGSGGSGTVYKA-ELANGAT 972
SS SS Q L + D+ E + +GSG G V+K G
Sbjct: 2 SSGSSGKQTGYLTIGGQRYQAEINDL---------ENLGEMGSGTCGQVWKMRFRKTGHV 52
Query: 973 VAVKKISCKDDHLLNKSFTREVKTLGR-IRHRHLVKLMGHCCNKGAGSNLLIYEYMENGS 1031
+AVK++ + NK ++ + + ++V+ G + E M
Sbjct: 53 IAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVF--IAMELM-GTC 109
Query: 1032 VWDWLHKQPVNIKMRKSLDWEARL-KIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDS 1090
+ I E L K+ V + + + YL ++HRD+K SNILLD
Sbjct: 110 AEKLKKRMQGPIP-------ERILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDE 160
Query: 1091 NMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATE-----KCDVYSM 1145
+ L DFG++ LV + ++ AG Y+APE T+ + DV+S+
Sbjct: 161 RGQIKLCDFGISGRLV-----DDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSL 215
Query: 1146 GIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSAREELLD---DQMKPLLPGEECA 1202
GI L+EL +G+ P + + E+L + PLLPG
Sbjct: 216 GISLVELATGQFP-------------YKNCKTDF------EVLTKVLQEEPPLLPGHMGF 256
Query: 1203 AYQVLEIALQCTKTSPQERPSSRQVCDLLLNVFNNRIVDFDKLHID 1248
+ C ++RP + LL + F I ++ L +D
Sbjct: 257 SGDFQSFVKDCLTKDHRKRPKYNK---LLEHSF---IKRYETLEVD 296
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-29
Identities = 62/286 (21%), Positives = 110/286 (38%), Gaps = 46/286 (16%)
Query: 953 IIGSGGSGTVYKAELANGATVAVKKISCKDDHLLNKSFTREVKTLGRI-RHRHLVKLMGH 1011
++G G GT+ + + VAVK+I + REV+ L H ++++
Sbjct: 31 VLGHGAEGTIVYRGMFDNRDVAVKRIL-PECF---SFADREVQLLRESDEHPNVIRY--F 84
Query: 1012 CCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHD 1071
C K + E ++ +++ ++ E + G+ +LH
Sbjct: 85 CTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGL-----EPI-TLLQQTTSGLAHLHSL 137
Query: 1072 CVPKILHRDIKSSNILL-----DSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYI 1126
I+HRD+K NIL+ ++A + DFGL K L +S + + G+ G+I
Sbjct: 138 ---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSG-VPGTEGWI 193
Query: 1127 APEY---AYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDM-VRWVEMHMEMSG 1181
APE T D++S G V ++S G P FG + + +
Sbjct: 194 APEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHP----FGKSLQRQANILLGACSLDC 249
Query: 1182 SAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQV 1227
E+ D + L+ + PQ+RPS++ V
Sbjct: 250 LHPEKHEDVIARELI--------------EKMIAMDPQKRPSAKHV 281
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 3e-29
Identities = 65/210 (30%), Positives = 105/210 (50%), Gaps = 27/210 (12%)
Query: 954 IGSGGSGTVYKA-ELANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHC 1012
+G G G+VYKA G VA+K++ + D + +E+ + + H+VK G
Sbjct: 37 LGEGSYGSVYKAIHKETGQIVAIKQVPVESD---LQEIIKEISIMQQCDSPHVVKYYG-S 92
Query: 1013 CNKGAGSNL-LIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAV---GLAQGVEYL 1068
K ++L ++ EY GSV D + + K+L E +IA +G+EYL
Sbjct: 93 YFKN--TDLWIVMEYCGAGSVSDIIRLRN------KTLT-ED--EIATILQSTLKGLEYL 141
Query: 1069 HHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAP 1128
H + +HRDIK+ NILL++ A L DFG+A L ++ + NT G+ ++AP
Sbjct: 142 HFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLT---DTMAKRNT-VIGTPFWMAP 194
Query: 1129 EYAYSLKATEKCDVYSMGIVLMELVSGKMP 1158
E + D++S+GI +E+ GK P
Sbjct: 195 EVIQEIGYNCVADIWSLGITAIEMAEGKPP 224
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 5e-29
Identities = 58/214 (27%), Positives = 95/214 (44%), Gaps = 19/214 (8%)
Query: 954 IGSGGSGTVYKA-ELANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHC 1012
IGSG + V A VA+K+I+ + +E++ + + H ++V
Sbjct: 23 IGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSF 82
Query: 1013 CNKGAGSNL-LIYEYMENGSVWDWL-HKQPVNIKMRKSLDWEARLKIAVGLAQ---GVEY 1067
L L+ + + GSV D + H LD E+ IA L + G+EY
Sbjct: 83 VV---KDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLD-ES--TIATILREVLEGLEY 136
Query: 1068 LHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTES--NTWFAGSYGY 1125
LH + +HRD+K+ NILL + + DFG++ L + T F G+ +
Sbjct: 137 LHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKT-FVGTPCW 192
Query: 1126 IAPEYAYSLKA-TEKCDVYSMGIVLMELVSGKMP 1158
+APE ++ K D++S GI +EL +G P
Sbjct: 193 MAPEVMEQVRGYDFKADIWSFGITAIELATGAAP 226
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 6e-29
Identities = 61/219 (27%), Positives = 96/219 (43%), Gaps = 31/219 (14%)
Query: 954 IGSGGSGTVYKA-ELANGATVAVKKISCKDDHLLNKSFTREVKTLGRI-RHRHLVKLMG- 1010
+G+G G VYK + G A+K + D + +E+ L + HR++ G
Sbjct: 32 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE--EEIKQEINMLKKYSHHRNIATYYGA 89
Query: 1011 --HCCNKGAGSNL-LIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAV---GLAQG 1064
G L L+ E+ GSV D + +L E IA + +G
Sbjct: 90 FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTK-----GNTLK-EE--WIAYICREILRG 141
Query: 1065 VEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYG 1124
+ +LH K++HRDIK N+LL N E L DFG++ L + NT F G+
Sbjct: 142 LSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD---RTVGRRNT-FIGTPY 194
Query: 1125 YIAPEYAYSLKATE-----KCDVYSMGIVLMELVSGKMP 1158
++APE + + K D++S+GI +E+ G P
Sbjct: 195 WMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 233
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 8e-29
Identities = 66/240 (27%), Positives = 109/240 (45%), Gaps = 36/240 (15%)
Query: 932 AKRDFRWEDIMGATNNLSDEFIIGSGGSGTVYKAELANGA----TVAVKKISCKDDHLLN 987
A R F E I + + E IIGSG SG V L VA+K + K +
Sbjct: 38 AGRSFTRE-I--EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIK--ALKAGYTER 92
Query: 988 --KSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKM 1045
+ F E +G+ H ++++L G +G +++ EYMENGS+ +L +
Sbjct: 93 QRRDFLSEASIMGQFDHPNIIRLEG-VVTRGR-LAMIVTEYMENGSLDTFLRTHDGQFTI 150
Query: 1046 RKSLDWEARLKIAVGLAQGVEYL-HHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKA 1104
+ + G+ G+ YL V HRD+ + N+L+DSN+ + DFGL++
Sbjct: 151 MQLVGM------LRGVGAGMRYLSDLGYV----HRDLAARNVLVDSNLVCKVSDFGLSRV 200
Query: 1105 LVEDYNSNTESNTWFAGSYGYI-----APEYAYSLKATEKCDVYSMGIVLMELVS-GKMP 1158
L +D + + + G I APE + DV+S G+V+ E+++ G+ P
Sbjct: 201 LEDD------PDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERP 254
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 9e-29
Identities = 51/229 (22%), Positives = 86/229 (37%), Gaps = 40/229 (17%)
Query: 954 IGSGGSGTVYKAELANGATVAVKKIS----------------CKDDHLLNKSFTREVKTL 997
+ G + E + A+KK F E++ +
Sbjct: 39 LNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 998 GRIRHRHLVKLMGHCCNKGAGSNL-LIYEYMENGSVWDWLHKQPVNIKMRKSL--DWEAR 1054
I++ + + G N + +IYEYMEN S+ + V K +
Sbjct: 98 TDIKNEYCLTCEGIITNY---DEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIK 154
Query: 1055 LKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTE 1114
I + Y+H++ I HRD+K SNIL+D N L DFG ++ + D
Sbjct: 155 -CIIKSVLNSFSYIHNEK--NICHRDVKPSNILMDKNGRVKLSDFGESE-YMVDKKIKG- 209
Query: 1115 SNTWFAGSYGYIAPE-----YAYSLKATEKCDVYSMGIVLMELVSGKMP 1158
G+Y ++ PE +Y+ K D++S+GI L + +P
Sbjct: 210 ----SRGTYEFMPPEFFSNESSYN---GAKVDIWSLGICLYVMFYNVVP 251
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-28
Identities = 56/210 (26%), Positives = 90/210 (42%), Gaps = 25/210 (11%)
Query: 954 IGSGGSGTVYKA-ELANGATVAVKKISCKD---DHLLNKSFTREVKTLGRIRHRHLVKLM 1009
+G G G VY A E + +A+K + K + REV+ +RH ++++L
Sbjct: 17 LGKGKFGNVYLAREKQSKFILALKVLF-KAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 75
Query: 1010 GHCCNKGAGSNL-LIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYL 1068
G+ + + + LI EY G+V+ L K K + LA + Y
Sbjct: 76 GYFHDA---TRVYLILEYAPLGTVYRELQKL------SKFDEQRTA-TYITELANALSYC 125
Query: 1069 HHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAP 1128
H +++HRDIK N+LL S E + DFG + G+ Y+ P
Sbjct: 126 HSK---RVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTD-----LCGTLDYLPP 176
Query: 1129 EYAYSLKATEKCDVYSMGIVLMELVSGKMP 1158
E EK D++S+G++ E + GK P
Sbjct: 177 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 206
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 1e-28
Identities = 56/210 (26%), Positives = 102/210 (48%), Gaps = 27/210 (12%)
Query: 954 IGSGGSGTVYKA-ELANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHC 1012
IG G SGTVY A ++A G VA+++++ + E+ + ++ ++V +
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKE-LIINEILVMRENKNPNIVNYLD-S 85
Query: 1013 CNKGAGSNL-LIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAV---GLAQGVEYL 1068
G L ++ EY+ GS+ D + + ++ E +IA Q +E+L
Sbjct: 86 YLVG--DELWVVMEYLAGGSLTDVVTETCMD---------EG--QIAAVCRECLQALEFL 132
Query: 1069 HHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAP 1128
H + +++HRDIKS NILL + L DFG + ++ +T G+ ++AP
Sbjct: 133 HSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP---EQSKRST-MVGTPYWMAP 185
Query: 1129 EYAYSLKATEKCDVYSMGIVLMELVSGKMP 1158
E K D++S+GI+ +E++ G+ P
Sbjct: 186 EVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-28
Identities = 57/310 (18%), Positives = 102/310 (32%), Gaps = 73/310 (23%)
Query: 953 IIGSGGSGTVYKAEL--------ANGATVAVKKISCKDDHL-LNKSFTREVKTLGRIRHR 1003
+G G ++K + V +K H ++SF + ++ H+
Sbjct: 15 SLGQGTFTKIFKGVRREVGDYGQLHETEVLLK--VLDKAHRNYSESFFEAASMMSKLSHK 72
Query: 1004 HLVKLMGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQ 1063
HLV G C G N+L+ E+++ GS+ +L K I + L+ A LA
Sbjct: 73 HLVLNYG-VCVCGD-ENILVQEFVKFGSLDTYLKKNKNCINILWKLEV------AKQLAA 124
Query: 1064 GVEYL-HHDCVPKILHRDIKSSNILLDSNMEAH--------LGDFGLAKALVEDYNSNTE 1114
+ +L + + H ++ + NILL + L D G++ ++
Sbjct: 125 AMHFLEENTLI----HGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK------ 174
Query: 1115 SNTWFAGSYGYI-----APE-YAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEM 1167
PE D +S G L E+ S G P A
Sbjct: 175 -------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR- 226
Query: 1168 DMVRWVEMHMEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQV 1227
+++ E ++ P + ++ C P RPS R +
Sbjct: 227 -KLQFYEDRHQLP------------AP----KAAELANLI---NNCMDYEPDHRPSFRAI 266
Query: 1228 CDLLLNVFNN 1237
L ++F
Sbjct: 267 IRDLNSLFTP 276
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 1e-28
Identities = 66/314 (21%), Positives = 121/314 (38%), Gaps = 52/314 (16%)
Query: 953 IIGSGGSGTVYKAELANGA------TVAVKKISCKDDHLLN--KSFTREVKTLGRIRHRH 1004
+G G G VY+ VA+K + + + F E + H
Sbjct: 32 ELGQGSFGMVYEGVAKGVVKDEPETRVAIK--TVNEAASMRERIEFLNEASVMKEFNCHH 89
Query: 1005 LVKLMGHCCNKGAGSNLLIYEYMENGSVWDWLHK---QPVNIKMRKSLDWEARLKIAVGL 1061
+V+L+G ++G L+I E M G + +L N + +++A +
Sbjct: 90 VVRLLG-VVSQG-QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEI 147
Query: 1062 AQGVEYLH-HDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVED--YNSNTESNT- 1117
A G+ YL+ + V HRD+ + N ++ + +GDFG+ + + E Y +
Sbjct: 148 ADGMAYLNANKFV----HRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 203
Query: 1118 --WFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMVRWVE 1174
W ++PE T DV+S G+VL E+ + + P G+ + V
Sbjct: 204 VRW-------MSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP---YQGLSNEQV---- 249
Query: 1175 MHMEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNV 1234
+ M G LLD KP + C + E+ C + +P+ RPS ++ +
Sbjct: 250 LRFVMEG----GLLD---KP----DNCPD-MLFELMRMCWQYNPKMRPSFLEIISSIKEE 297
Query: 1235 FNNRIVDFDKLHID 1248
+ + +
Sbjct: 298 MEPGFREVSFYYSE 311
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 3e-28
Identities = 51/285 (17%), Positives = 93/285 (32%), Gaps = 56/285 (19%)
Query: 954 IGSGGSGTVYKA-ELANGATVAVKKISCKDDHLLNK-SFTREVKTLGRI-RHRHLVKLMG 1010
+G G G V+K +G AVK+ ++ EV + ++ +H V+L
Sbjct: 65 LGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQ 124
Query: 1011 HCCNKGAGSNLLIY-EYMENGSVWDWLHKQPVNIKMRKSLDWEARLK-IAVGLAQGVEYL 1068
G L + E S+ ++ EA++ + +L
Sbjct: 125 AWEEGG---ILYLQTELCG-PSLQQHCEAWGASLP-------EAQVWGYLRDTLLALAHL 173
Query: 1069 HHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAP 1128
H ++H D+K +NI L LGDFGL L G Y+AP
Sbjct: 174 HSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEV-----QEGDPRYMAP 225
Query: 1129 E-----YAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSA 1183
E Y DV+S+G+ ++E+ G
Sbjct: 226 ELLQGSY------GTAADVFSLGLTILEVACNMELPH-------------------GGEG 260
Query: 1184 REELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVC 1228
++L + P + + + + + P+ R ++ +
Sbjct: 261 WQQLRQGYLPPEFTAGLSSELR--SVLVMMLEPDPKLRATAEALL 303
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 4e-28
Identities = 67/304 (22%), Positives = 126/304 (41%), Gaps = 53/304 (17%)
Query: 953 IIGSGGSGTVYKAELANGA----TVAVKKISCKDDHLLN---KSFTREVKTLGRIRHRHL 1005
++G G G+V +A+L VAVK K D + + + F RE + H H+
Sbjct: 30 MLGKGEFGSVREAQLKQEDGSFVKVAVK--MLKADIIASSDIEEFLREAACMKEFDHPHV 87
Query: 1006 VKLMGHCCNKG----AGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGL 1061
KL+G ++I +M++G + +L + +L + ++ V +
Sbjct: 88 AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFL-LASRIGENPFNLPLQTLVRFMVDI 146
Query: 1062 AQGVEYL-HHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVED--YNSNTESNT- 1117
A G+EYL + + HRD+ + N +L +M + DFGL++ + Y S
Sbjct: 147 ACGMEYLSSRNFI----HRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLP 202
Query: 1118 --WFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVE-MDMVRWV 1173
W +A E T DV++ G+ + E+++ G+ P G+E ++ ++
Sbjct: 203 VKW-------LALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP---YAGIENAEIYNYL 252
Query: 1174 EMHMEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLN 1233
+ +P EC +V ++ QC P++RPS + L N
Sbjct: 253 IGGNRLK------------QP----PECME-EVYDLMYQCWSADPKQRPSFTCLRMELEN 295
Query: 1234 VFNN 1237
+ +
Sbjct: 296 ILGH 299
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 4e-28
Identities = 78/403 (19%), Positives = 143/403 (35%), Gaps = 74/403 (18%)
Query: 868 STISVSLVVAISVISTLSAIALLI--------AVVTLFVKRKREFLRKSSQVNYTSSSSS 919
+ L V ++ +A LI F+ R ++ ++ +++
Sbjct: 291 AGAPEPLTVTAPSLTIAENMADLIDGYCRLVNGATQSFIIRPQKEGERALPSIPKLANNE 350
Query: 920 SQAQRRLLFQAAAKRDFRWEDIMGATNNLSDEF-------------IIGSGGSGTVYKAE 966
Q R + D+ T + IG G G V++
Sbjct: 351 KQGVRSHTVSVSETDDYAEIIDEEDTYTMPSTRDYEIQRERIELGRCIGEGQFGDVHQGI 410
Query: 967 LANGA----TVAVKKISCKDDH--LLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSN 1020
+ VA+K +CK+ + + F +E T+ + H H+VKL+G
Sbjct: 411 YMSPENPAMAVAIK--TCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITEN---PV 465
Query: 1021 LLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLH-HDCVPKILHR 1079
+I E G + +L + ++ + + + A L+ + YL V HR
Sbjct: 466 WIIMELCTLGELRSFLQVRKFSLDLASLILY------AYQLSTALAYLESKRFV----HR 515
Query: 1080 DIKSSNILLDSNMEAHLGDFGLAKALVE-DYNSNTESNT---WFAGSYGYIAPEYAYSLK 1135
DI + N+L+ SN LGDFGL++ + + Y ++ W +APE +
Sbjct: 516 DIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKW-------MAPESINFRR 568
Query: 1136 ATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMVRWVEMHMEMSGSAREELLDDQMKP 1194
T DV+ G+ + E++ G P GV+ + V + +G E L P
Sbjct: 569 FTSASDVWMFGVCMWEILMHGVKPFQ---GVKNNDV----IGRIENG----ERLP---MP 614
Query: 1195 LLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNVFNN 1237
C + + +C P RP ++ L +
Sbjct: 615 ----PNCPP-TLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 652
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 5e-28
Identities = 86/375 (22%), Positives = 143/375 (38%), Gaps = 68/375 (18%)
Query: 894 VTLFVKRKREFLRKSSQVNYTSSSSSSQAQRRLLFQAAAKRDFRWEDIMGATNNLSDEFI 953
V K+K ++ + + +S + L + +WE NNL
Sbjct: 2 VDYKYKQKPKYQVRWKIIESYEGNSYTFIDPTQLPY-----NEKWE-F--PRNNLQFGKT 53
Query: 954 IGSGGSGTVYKAEL------ANGATVAVKKISCKDDHLLN--KSFTREVKTLGRI-RHRH 1004
+G+G G V +A VAVK K + ++ E+K + + +H +
Sbjct: 54 LGAGAFGKVVEATAFGLGKEDAVLKVAVK--MLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 1005 LVKLMGHCCNKGAGSNLLIYEYMENGSVWDWLHK-------QPVNIKMRKSLDWEARLKI 1057
+V L+G C G G L+I EY G + ++L + P + L
Sbjct: 112 IVNLLG-ACTHG-GPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHF 169
Query: 1058 AVGLAQGVEYL-HHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESN 1116
+ +AQG+ +L +C+ HRD+ + N+LL + A +GDFGLA+ ++ D N + N
Sbjct: 170 SSQVAQGMAFLASKNCI----HRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGN 225
Query: 1117 T-----WFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMV 1170
W +APE + T + DV+S GI+L E+ S G P V
Sbjct: 226 ARLPVKW-------MAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPY-PGILVNSKFY 277
Query: 1171 RWVEM--HMEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVC 1228
+ V+ M +P + I C P RP+ +Q+C
Sbjct: 278 KLVKDGYQMA--------------QP----AFAPK-NIYSIMQACWALEPTHRPTFQQIC 318
Query: 1229 DLLLNVFNNRIVDFD 1243
L + D
Sbjct: 319 SFLQEQAQEDRRERD 333
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 6e-28
Identities = 48/224 (21%), Positives = 87/224 (38%), Gaps = 39/224 (17%)
Query: 954 IGSGGS--GTVYKA-ELANGATVAVKKI---SCKDDHLLNKSFTREVKTLGRIRHRHLVK 1007
IG G TV A G V V++I +C ++ + E+ H ++V
Sbjct: 33 IGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMV--TFLQGELHVSKLFNHPNIVP 90
Query: 1008 LMGHCCNKGAGSNL-LIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAV---GLAQ 1063
A + L ++ +M GS D L M + IA G+ +
Sbjct: 91 Y--RATFI-ADNELWVVTSFMAYGSAKD-LICTHFMDGMNELA-------IAYILQGVLK 139
Query: 1064 GVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDY---NSNTESNTWFA 1120
++Y+HH +HR +K+S+IL+ + + +L +++ + +
Sbjct: 140 ALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSV 196
Query: 1121 GSYGYIAPE------YAYSLKATEKCDVYSMGIVLMELVSGKMP 1158
+++PE Y K D+YS+GI EL +G +P
Sbjct: 197 KVLPWLSPEVLQQNLQGY----DAKSDIYSVGITACELANGHVP 236
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 6e-28
Identities = 66/303 (21%), Positives = 113/303 (37%), Gaps = 52/303 (17%)
Query: 953 IIGSGGSGTVYKAELANGA------TVAVKKISCKDDHLLN--KSFTREVKTLGRIRHRH 1004
+G G G VY+ +++ VAVK + + F E + + H++
Sbjct: 37 GLGHGAFGEVYEGQVSGMPNDPSPLQVAVK--TLPEVCSEQDELDFLMEALIISKFNHQN 94
Query: 1005 LVKLMGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQG 1064
+V+ +G + ++ E M G + +L + SL L +A +A G
Sbjct: 95 IVRCIG-VSLQS-LPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 152
Query: 1065 VEYL-HHDCVPKILHRDIKSSNILLDSNMEAHL---GDFGLAKALVED--YNSNTESNT- 1117
+YL + + HRDI + N LL + GDFG+A+ + Y +
Sbjct: 153 CQYLEENHFI----HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLP 208
Query: 1118 --WFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMVRWVE 1174
W + PE T K D +S G++L E+ S G MP V
Sbjct: 209 VKW-------MPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP---YPSKSNQEV---- 254
Query: 1175 MHMEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNV 1234
+ SG +D P + C V I QC + P++RP+ + + +
Sbjct: 255 LEFVTSG----GRMD---PP----KNCPG-PVYRIMTQCWQHQPEDRPNFAIILERIEYC 302
Query: 1235 FNN 1237
+
Sbjct: 303 TQD 305
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 9e-28
Identities = 60/243 (24%), Positives = 100/243 (41%), Gaps = 36/243 (14%)
Query: 953 IIGSGGSGTVYKAELANGATVAVKKISCKDDHLLNKSFTREVKTLGRI-RHRHLVKLMGH 1011
I+G G SGTV G VAVK++ D E+K L H ++++
Sbjct: 22 ILGYGSSGTVVFQGSFQGRPVAVKRML-IDFC---DIALMEIKLLTESDDHPNVIRYYCS 77
Query: 1012 CCNKGAGSNL-LIYEYMENGSVWDWL-HKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLH 1069
L + E ++ D + K + ++ ++ + +A GV +LH
Sbjct: 78 ETTD---RFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPI-SLLRQIASGVAHLH 132
Query: 1070 HDCVPKILHRDIKSSNILLDS-------------NMEAHLGDFGLAKALVEDYNSNTESN 1116
KI+HRD+K NIL+ + N+ + DFGL K L +S +
Sbjct: 133 SL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNL 189
Query: 1117 TWFAGSYGYIAPE-------YAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMD 1168
+G+ G+ APE + T D++SMG V ++S GK P + E +
Sbjct: 190 NNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESN 249
Query: 1169 MVR 1171
++R
Sbjct: 250 IIR 252
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-27
Identities = 55/210 (26%), Positives = 98/210 (46%), Gaps = 27/210 (12%)
Query: 954 IGSGGSGTVYKA-ELANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHC 1012
IG G +G V A E +G VAVK + + EV + +H ++V++
Sbjct: 53 IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRE-LLFNEVVIMRDYQHFNVVEMYKSY 111
Query: 1013 CNKGAGSNL-LIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAV---GLAQGVEYL 1068
G L ++ E+++ G++ D + + +N E +IA + Q + YL
Sbjct: 112 LV---GEELWVLMEFLQGGALTDIVSQVRLN---------EE--QIATVCEAVLQALAYL 157
Query: 1069 HHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAP 1128
H ++HRDIKS +ILL + L DFG + +D + + G+ ++AP
Sbjct: 158 HAQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD---VPKRKS-LVGTPYWMAP 210
Query: 1129 EYAYSLKATEKCDVYSMGIVLMELVSGKMP 1158
E + D++S+GI+++E+V G+ P
Sbjct: 211 EVISRSLYATEVDIWSLGIMVIEMVDGEPP 240
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-27
Identities = 81/324 (25%), Positives = 130/324 (40%), Gaps = 63/324 (19%)
Query: 953 IIGSGGSGTVYKAELANGA---TVAVKKISCKDDHLLN--KSFTREVKTLGRI-RHRHLV 1006
+IG G G V KA + A+K K+ + + F E++ L ++ H +++
Sbjct: 32 VIGEGNFGQVLKARIKKDGLRMDAAIK--RMKEYASKDDHRDFAGELEVLCKLGHHPNII 89
Query: 1007 KLMGHCCNKGAGSNLLIYEYMENGSVWDWLHK---------QPVNIKMRKSLDWEARLKI 1057
L+G C G L EY +G++ D+L K + +L + L
Sbjct: 90 NLLG-ACEHR-GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 147
Query: 1058 AVGLAQGVEYL-HHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESN 1116
A +A+G++YL + HRD+ + NIL+ N A + DFGL++ E Y T
Sbjct: 148 AADVARGMDYLSQKQFI----HRDLAARNILVGENYVAKIADFGLSRG-QEVYVKKTMGR 202
Query: 1117 T---WFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMVRW 1172
W +A E T DV+S G++L E+VS G P
Sbjct: 203 LPVRW-------MAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP-------------- 241
Query: 1173 VEMHMEMSGSAREELLDD--QM-KPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCD 1229
+ M+ + E L ++ KP C +V ++ QC + P ERPS Q+
Sbjct: 242 ---YCGMTCAELYEKLPQGYRLEKP----LNCDD-EVYDLMRQCWREKPYERPSFAQILV 293
Query: 1230 LLLNVFNNRI--VDFDKLHIDPYA 1251
L + R V+ YA
Sbjct: 294 SLNRMLEERKTYVNTTLYEKFTYA 317
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-27
Identities = 55/215 (25%), Positives = 100/215 (46%), Gaps = 30/215 (13%)
Query: 954 IGSGGSGTVYKA-ELANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHC 1012
+G G G VYKA GA A K I K + L + E++ L H ++VKL+G
Sbjct: 27 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELE-DYIVEIEILATCDHPYIVKLLGAY 85
Query: 1013 CNKGAGSNL-LIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAV---GLAQGVEYL 1068
+ L ++ E+ G+V + + + L E +I V + + + +L
Sbjct: 86 YH---DGKLWIMIEFCPGGAVDAIMLELD------RGLT-EP--QIQVVCRQMLEALNFL 133
Query: 1069 HHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAP 1128
H +I+HRD+K+ N+L+ + L DFG++ + + + ++ F G+ ++AP
Sbjct: 134 HSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNL---KTLQKRDS-FIGTPYWMAP 186
Query: 1129 EYAYSLKATE-----KCDVYSMGIVLMELVSGKMP 1158
E + K D++S+GI L+E+ + P
Sbjct: 187 EVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP 221
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-27
Identities = 68/241 (28%), Positives = 114/241 (47%), Gaps = 37/241 (15%)
Query: 932 AKRDFRWEDIMGATNNLSDEFIIGSGGSGTVYKAELANGA-----TVAVKKISCKDD--H 984
A F E I + ++ + +IG+G G VYK L + VA+K + K
Sbjct: 33 AVLKFTTE-I--HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIK--TLKAGYTE 87
Query: 985 LLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIK 1044
F E +G+ H ++++L G +K ++I EYMENG++ +L ++
Sbjct: 88 KQRVDFLGEAGIMGQFSHHNIIRLEG-VISKYK-PMMIITEYMENGALDKFLREK----- 140
Query: 1045 MRKSLDWEARLKIAVGLAQGVEYL-HHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAK 1103
+ + G+A G++YL + + V HRD+ + NIL++SN+ + DFGL++
Sbjct: 141 -DGEFSVLQLVGMLRGIAAGMKYLANMNYV----HRDLAARNILVNSNLVCKVSDFGLSR 195
Query: 1104 ALVEDYNSNTESNTWFAGSYGYI-----APEYAYSLKATEKCDVYSMGIVLMELVS-GKM 1157
L +D + S G I APE K T DV+S GIV+ E+++ G+
Sbjct: 196 VLEDDP------EATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGER 249
Query: 1158 P 1158
P
Sbjct: 250 P 250
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 1e-27
Identities = 76/309 (24%), Positives = 132/309 (42%), Gaps = 61/309 (19%)
Query: 954 IGSGGSGTVYKAELANGA------TVAVKKISCKDDHLLNKS-FTREVKTLGRIRHRHLV 1006
+G G G V+ AE N + VAVK + KD L + F RE + L ++H H+V
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVK--ALKDPTLAARKDFQREAELLTNLQHEHIV 80
Query: 1007 KLMGHCCNKGAGSNLLIYEYMENGSVWDWL---------HKQPVNIKMRKSLDWEARLKI 1057
K G C G ++++EYM++G + +L + + L L I
Sbjct: 81 KFYG-VCGDG-DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 138
Query: 1058 AVGLAQGVEYL-HHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVED--YNSNTE 1114
A +A G+ YL V HRD+ + N L+ +N+ +GDFG+++ + Y
Sbjct: 139 ASQIASGMVYLASQHFV----HRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGH 194
Query: 1115 SNT---WFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMV 1170
+ W + PE K T + DV+S G++L E+ + GK P
Sbjct: 195 TMLPIRW-------MPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP------------ 235
Query: 1171 RWVEMHMEMSGSAREELLD--DQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVC 1228
++S E+++ Q + L C +V ++ L C + PQ+R + +++
Sbjct: 236 -----WFQLSN---TEVIECITQGRVLERPRVCPK-EVYDVMLGCWQREPQQRLNIKEIY 286
Query: 1229 DLLLNVFNN 1237
+L +
Sbjct: 287 KILHALGKA 295
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 1e-27
Identities = 67/311 (21%), Positives = 118/311 (37%), Gaps = 66/311 (21%)
Query: 954 IGSGGSGTVYKAELANGA------TVAVKKISCKDDHLLN--KSFTREVKTLGRIRHRHL 1005
+G G VYK L A VA+K + KD + F E R++H ++
Sbjct: 17 LGEDRFGKVYKGHLFGPAPGEQTQAVAIK--TLKDKAEGPLREEFRHEAMLRARLQHPNV 74
Query: 1006 VKLMGHCCNKGAGSNLLIYEYMENGSVWDWLHK---------QPVNIKMRKSLDWEARLK 1056
V L+G K +I+ Y +G + ++L + ++ +L+ +
Sbjct: 75 VCLLG-VVTKD-QPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVH 132
Query: 1057 IAVGLAQGVEYL-HHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVED--YNSNT 1113
+ +A G+EYL H V H+D+ + N+L+ + + D GL + + Y
Sbjct: 133 LVAQIAAGMEYLSSHHVV----HKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLG 188
Query: 1114 ESNT---WFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMP----TDATFGV 1165
S W +APE K + D++S G+VL E+ S G P ++
Sbjct: 189 NSLLPIRW-------MAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ---- 237
Query: 1166 EMDMVRWVEMHMEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSR 1225
D+V + + P ++C A V + ++C P RP +
Sbjct: 238 --DVVEMIRNRQVLP------------CP----DDCPA-WVYALMIECWNEFPSRRPRFK 278
Query: 1226 QVCDLLLNVFN 1236
+ L N
Sbjct: 279 DIHSRLRAWGN 289
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 2e-27
Identities = 66/240 (27%), Positives = 109/240 (45%), Gaps = 36/240 (15%)
Query: 932 AKRDFRWEDIMGATNNLSDEFIIGSGGSGTVYKAELANGA----TVAVKKISCKDDHLLN 987
+F E + N+S + ++G+G G V L + +VA+K + K +
Sbjct: 34 TVHEFAKE-L--DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIK--TLKVGYTEK 88
Query: 988 --KSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKM 1045
+ F E +G+ H ++++L G K +++ EYMENGS+ +L K
Sbjct: 89 QRRDFLGEASIMGQFDHPNIIRLEG-VVTKSK-PVMIVTEYMENGSLDSFLRKH------ 140
Query: 1046 RKSLDWEARLKIAVGLAQGVEYL-HHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKA 1104
+ + G+A G++YL V HRD+ + NIL++SN+ + DFGL +
Sbjct: 141 DAQFTVIQLVGMLRGIASGMKYLSDMGYV----HRDLAARNILINSNLVCKVSDFGLGRV 196
Query: 1105 LVEDYNSNTESNTWFAGSYGYI-----APEYAYSLKATEKCDVYSMGIVLMELVS-GKMP 1158
L +D + G I +PE K T DV+S GIVL E++S G+ P
Sbjct: 197 LEDDP------EAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 63/260 (24%), Positives = 92/260 (35%), Gaps = 34/260 (13%)
Query: 65 TCGSSSARVVSLNLSGLSLAGSISPSLGRLQSLIHLDLSSNSLTGPIPTALSNLSSLESL 124
C + S GL ++ + + + L N ++ + +L L
Sbjct: 7 VCYNEPKVTTSCPQQGLQ---AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTIL 61
Query: 125 LLFSNQLAGTIPTQLGSLTSLRVMRIGDNWLSGSIP-TSFGNLVNLGTLGLASCSLSGPI 183
L SN LA L L + + DN S+ +F L L TL L C L +
Sbjct: 62 WLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQE-L 120
Query: 184 PPQ-FGQLSQLEELILQQNQLQGPIPAELGNCSSLSIFTAAENNLNGSIPA-ALGRLQNL 241
P F L+ L+ L LQ N LQ ++P L NL
Sbjct: 121 GPGLFRGLAALQYLYLQDNALQ-------------------------ALPDDTFRDLGNL 155
Query: 242 QLLNLGNNSLSGEIPSELGELSQLGYLNLMGNRLEGAIPRSFAKMGNLQSLDLSMNRLTG 301
L L N +S L L L L NR+ P +F +G L +L L N L+
Sbjct: 156 THLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSA 215
Query: 302 GIPEEFGNMGQLVFLVLSNN 321
E + L +L L++N
Sbjct: 216 LPTEALAPLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 5e-26
Identities = 50/201 (24%), Positives = 84/201 (41%), Gaps = 8/201 (3%)
Query: 225 NNLNGSIPAALGRLQNLQLLNLGNNSLSGEIPSELGELSQLGYLNLMGNRLEGAIP-RSF 283
N ++ A+ +NL +L L +N L+ + L+ L L+L N ++ +F
Sbjct: 42 NRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATF 101
Query: 284 AKMGNLQSLDLSMNRLTGGIPEE-FGNMGQLVFLVLSNNNISGSIPRRICTNATSLEHLI 342
+G L +L L L + F + L +L L +N + ++P + +L HL
Sbjct: 102 HGLGRLHTLHLDRCGLQE-LGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLF 159
Query: 343 LAEIQLSGEIPVELSQCQSLKQLDLSNNTLNGTIPVELFQ-LVALTHLYLHNNSLVGSIS 401
L ++S SL +L L N + + F+ L L LYL N+L ++
Sbjct: 160 LHGNRISSVPERAFRGLHSLDRLLLHQNRVA-HVHPHAFRDLGRLMTLYLFANNLS-ALP 217
Query: 402 PFV-ANLSNLQELALYHNNFQ 421
A L LQ L L N +
Sbjct: 218 TEALAPLRALQYLRLNDNPWV 238
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 4e-25
Identities = 62/302 (20%), Positives = 94/302 (31%), Gaps = 81/302 (26%)
Query: 99 HLDLSSNSLTGPIPTALSNLSSLESLLLFSNQLAGTIPTQLGSLTSLRVMRIGDNWLSGS 158
L +P + ++ + + L N++ + +
Sbjct: 15 TTSCPQQGLQA-VPVGIP--AASQRIFLHGNRI-----------SHVP------------ 48
Query: 159 IPTSFGNLVNLGTLGLASCSLSGPIPPQ-FGQLSQLEELILQQNQLQGPIPAELGNCSSL 217
SF NL L L S L+ I F L+ LE+L L N +
Sbjct: 49 -AASFRACRNLTILWLHSNVLAR-IDAAAFTGLALLEQLDLSDNAQLRSVD--------- 97
Query: 218 SIFTAAENNLNGSIPAALGRLQNLQLLNLGNNSLSGEIPSE-LGELSQLGYLNLMGNRLE 276
PA L L L+L L E+ L+ L YL L N L+
Sbjct: 98 --------------PATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQ 142
Query: 277 GAIPRSFAKMGNLQSLDLSMNRLTGGIPEEFGNMGQLVFLVLSNNNISGSIPRRICTNAT 336
+F +GNL L L NR++ F + L L+L N ++ +
Sbjct: 143 ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVA-HVHPHA----- 196
Query: 337 SLEHLILAEIQLSGEIPVELSQCQSLKQLDLSNNTLNGTIPVELFQ-LVALTHLYLHNNS 395
L L L N L+ +P E L AL +L L++N
Sbjct: 197 -------------------FRDLGRLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDNP 236
Query: 396 LV 397
V
Sbjct: 237 WV 238
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 3e-22
Identities = 59/272 (21%), Positives = 102/272 (37%), Gaps = 64/272 (23%)
Query: 351 EIPVELSQCQSLKQLDLSNNTLNGTIPVELFQ-LVALTHLYLHNNSLVGSISPFV-ANLS 408
+PV + + +++ L N ++ +P F+ LT L+LH+N L I L+
Sbjct: 25 AVPVGIPA--ASQRIFLHGNRIS-HVPAASFRACRNLTILWLHSNVL-ARIDAAAFTGLA 80
Query: 409 NLQELALYHNNFQGSLPREI-GMLVKLELLYLYDNHLSGQIPSEVGNCSSLKWIDFFGNS 467
L++L L N S+ L +L L+L L ++
Sbjct: 81 LLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGP---------------GL 124
Query: 468 FTGEIPTSIGRLKDLNFLHLRQNELVGQIPA-SLGNCHQLIILDLADNKLSGGVPASFGF 526
F G L L +L+L+ N L +P + + L L L N++S +F
Sbjct: 125 FRG--------LAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRG 175
Query: 527 LQALEQLMLYNNSLEGNLPGSLINLRNLTRINFSKNRLNGRIATLCSSHSFLSFDVTNNE 586
L +L++L+L+ N + P + +L L + N L
Sbjct: 176 LHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNL---------------------- 213
Query: 587 FDHEIPPQ-LGNSPSLERLRLGNNKFIGKIPW 617
+P + L +L+ LRL +N PW
Sbjct: 214 --SALPTEALAPLRALQYLRLNDN------PW 237
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 1e-21
Identities = 59/238 (24%), Positives = 90/238 (37%), Gaps = 11/238 (4%)
Query: 572 CSSHSFLSFDVTNNEFDHEIPPQLGNSPSLERLRLGNNKFIGKIPWTFGKIRELSLLDLS 631
C + ++ +P + + +R+ L N+ +F R L++L L
Sbjct: 8 CYNEPKVTTSCPQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLH 64
Query: 632 GNSLTGPIPTQLLMCKKLSHIDLNNNLLSGAVPS-WLGTLPQLGELKLSFNQFVGFLPRE 690
N L L +DL++N +V L +L L L L
Sbjct: 65 SNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPG 123
Query: 691 LF-NCSKLLVLSLDGNMLNGSLPNEV-GNLASLNVLTLSGNLLSGPIPPAIGRLSKLYEL 748
LF + L L L N L +LP++ +L +L L L GN +S A L L L
Sbjct: 124 LFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRL 182
Query: 749 RLSNNSLNGVIPLEIGQLQNLQSILDLSHNNFTGQIPPS-MGTLAKLEVLNLSHNQLV 805
L N + V P L L + L L NN + +P + L L+ L L+ N V
Sbjct: 183 LLHQNRVAHVHPHAFRDLGRLMT-LYLFANNLS-ALPTEALAPLRALQYLRLNDNPWV 238
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 3e-27
Identities = 49/218 (22%), Positives = 89/218 (40%), Gaps = 23/218 (10%)
Query: 954 IGSGGSGTVYKA-ELANGATVAVKKISCKD--DHLLNKSFTREVKTLGRIRHRHLVKLMG 1010
+G G G VY A E N +A+K + + RE++ +RH +++++
Sbjct: 22 LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81
Query: 1011 HCCNKGAGSNL-LIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLH 1069
+ ++ + L+ E+ G ++ L K + + + + LA + Y H
Sbjct: 82 YFHDR---KRIYLMLEFAPRGELYKELQKH------GRFDEQRSATFME-ELADALHYCH 131
Query: 1070 HDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPE 1129
K++HRDIK N+L+ E + DFG + T G+ Y+ PE
Sbjct: 132 ER---KVIHRDIKPENLLMGYKGELKIADFGWS-VHAPSLRRRT-----MCGTLDYLPPE 182
Query: 1130 YAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEM 1167
EK D++ G++ E + G P D+ E
Sbjct: 183 MIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTET 220
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 4e-27
Identities = 76/308 (24%), Positives = 122/308 (39%), Gaps = 60/308 (19%)
Query: 954 IGSGGSGTVYKAELANGA------TVAVKKISCKDDHLLNKS-FTREVKTLGRIRHRHLV 1006
+G G G V+ AE N VAVK + K+ + F RE + L ++H+H+V
Sbjct: 49 LGEGAFGKVFLAECHNLLPEQDKMLVAVK--ALKEASESARQDFQREAELLTMLQHQHIV 106
Query: 1007 KLMGHCCNKGAGSNLLIYEYMENGSVWDWL--------HKQPVNIKMRKSLDWEARLKIA 1058
+ G C +G L+++EYM +G + +L L L +A
Sbjct: 107 RFFG-VCTEG-RPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 164
Query: 1059 VGLAQGVEYL-HHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVED--YNSNTES 1115
+A G+ YL V HRD+ + N L+ + +GDFG+++ + Y +
Sbjct: 165 SQVAAGMVYLAGLHFV----HRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRT 220
Query: 1116 NT---WFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMVR 1171
W + PE K T + DV+S G+VL E+ + GK P
Sbjct: 221 MLPIRW-------MPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP------------- 260
Query: 1172 WVEMHMEMSGSAREELLD--DQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCD 1229
++S E +D Q + L C +V I C + PQ+R S + V
Sbjct: 261 ----WYQLSN---TEAIDCITQGRELERPRACPP-EVYAIMRGCWQREPQQRHSIKDVHA 312
Query: 1230 LLLNVFNN 1237
L +
Sbjct: 313 RLQALAQA 320
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 4e-27
Identities = 69/303 (22%), Positives = 122/303 (40%), Gaps = 52/303 (17%)
Query: 953 IIGSGGSGTVYKAELANGA----TVAVK--KISCKDDHLLNKSFTREVKTLGRIRHRHLV 1006
I+G G G+V + L VAVK K+ + + F E + H +++
Sbjct: 41 ILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEE-FLSEAACMKDFSHPNVI 99
Query: 1007 KLMGHCCNKG---AGSNLLIYEYMENGSVWDWL--HKQPVNIKMRKSLDWEARLKIAVGL 1061
+L+G C ++I +M+ G + +L + K + + LK V +
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETG---PKHIPLQTLLKFMVDI 156
Query: 1062 AQGVEYL-HHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVED--YNSNTESNT- 1117
A G+EYL + + + HRD+ + N +L +M + DFGL+K + Y +
Sbjct: 157 ALGMEYLSNRNFL----HRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMP 212
Query: 1118 --WFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMVRWVE 1174
W IA E T K DV++ G+ + E+ + G P GV+ +
Sbjct: 213 VKW-------IAIESLADRVYTSKSDVWAFGVTMWEIATRGMTP---YPGVQNHEM---- 258
Query: 1175 MHMEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNV 1234
+ G L +P E+C ++ EI C +T P +RP+ + L +
Sbjct: 259 YDYLLHG----HRLK---QP----EDCLD-ELYEIMYSCWRTDPLDRPTFSVLRLQLEKL 306
Query: 1235 FNN 1237
+
Sbjct: 307 LES 309
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 5e-27
Identities = 71/309 (22%), Positives = 129/309 (41%), Gaps = 59/309 (19%)
Query: 953 IIGSGGSGTVYKAELANGA------TVAVKKISCKDDHLLN--KSFTREVKTLGRI-RHR 1003
+G G G V +A+ TVAVK K+ + ++ E+K L I H
Sbjct: 34 PLGRGAFGQVIEADAFGIDKTATCRTVAVK--MLKEGATHSEHRALMSELKILIHIGHHL 91
Query: 1004 HLVKLMGHCCNKGAGSNLLIYEYMENGSVWDWL---------HKQPVNIKMRKSLDWEAR 1054
++V L+G C K G ++I E+ + G++ +L +K + L E
Sbjct: 92 NVVNLLG-ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 150
Query: 1055 LKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTE 1114
+ + +A+G+E+L K +HRD+ + NILL + DFGLA+ + +D + +
Sbjct: 151 ICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 207
Query: 1115 SNT-----WFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMD 1168
+ W +APE + T + DV+S G++L E+ S G P ++ +
Sbjct: 208 GDARLPLKW-------MAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY-PGVKIDEE 259
Query: 1169 MVRWVEM--HMEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQ 1226
R ++ M P + ++ + L C P +RP+ +
Sbjct: 260 FCRRLKEGTRMR--------------AP----DYTTP-EMYQTMLDCWHGEPSQRPTFSE 300
Query: 1227 VCDLLLNVF 1235
+ + L N+
Sbjct: 301 LVEHLGNLL 309
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 6e-27
Identities = 66/303 (21%), Positives = 113/303 (37%), Gaps = 52/303 (17%)
Query: 953 IIGSGGSGTVYKAELANGA------TVAVKKISCKDDHLLN--KSFTREVKTLGRIRHRH 1004
+G G G VY+ +++ VAVK + + F E + + H++
Sbjct: 78 GLGHGAFGEVYEGQVSGMPNDPSPLQVAVK--TLPEVCSEQDELDFLMEALIISKFNHQN 135
Query: 1005 LVKLMGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQG 1064
+V+ +G + ++ E M G + +L + SL L +A +A G
Sbjct: 136 IVRCIG-VSLQS-LPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 193
Query: 1065 VEYL-HHDCVPKILHRDIKSSNILLDSNMEAHL---GDFGLAKALVED--YNSNTESNT- 1117
+YL + + HRDI + N LL + GDFG+A+ + Y +
Sbjct: 194 CQYLEENHFI----HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLP 249
Query: 1118 --WFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMVRWVE 1174
W + PE T K D +S G++L E+ S G MP V
Sbjct: 250 VKW-------MPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP---YPSKSNQEV---- 295
Query: 1175 MHMEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNV 1234
+ SG +D P + C V I QC + P++RP+ + + +
Sbjct: 296 LEFVTSGG----RMD---PP----KNCPG-PVYRIMTQCWQHQPEDRPNFAIILERIEYC 343
Query: 1235 FNN 1237
+
Sbjct: 344 TQD 346
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 9e-27
Identities = 50/287 (17%), Positives = 92/287 (32%), Gaps = 54/287 (18%)
Query: 954 IGSGGSGTVYKAE--LANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKL--M 1009
I GG G +Y A NG V +K + D E + L + H +V++
Sbjct: 88 IAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNF 147
Query: 1010 G-HCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYL 1068
H G ++ EY+ S+ + L + + + + YL
Sbjct: 148 VEHTDRHGDPVGYIVMEYVGGQSLKRSK---------GQKLPVAEAIAYLLEILPALSYL 198
Query: 1069 HHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAP 1128
H +++ D+K NI+L + L D G + + G+ G+ AP
Sbjct: 199 HSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVSRI-------NSFGYLY-GTPGFQAP 246
Query: 1129 EYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSAREELL 1188
E + T D+Y++G L L + G + L
Sbjct: 247 EIVRT-GPTVATDIYTVGRTLAALTLDLPTRN--------------------GRYVDGLP 285
Query: 1189 DDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSS-RQVCDLLLNV 1234
+D + + P++R ++ ++ L V
Sbjct: 286 EDDPVLKTYDS------YGRLLRRAIDPDPRQRFTTAEEMSAQLTGV 326
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 1e-26
Identities = 69/215 (32%), Positives = 102/215 (47%), Gaps = 34/215 (15%)
Query: 954 IGSGGSGTVYKA-ELANGATVAVKKI--SCKDDHLLNKSFTREVKTLGRIRHRHLVKLMG 1010
IG G G VY A ++ N VA+KK+ S K + + +EV+ L ++RH + ++ G
Sbjct: 62 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 121
Query: 1011 HCCNKGAGSNL-LIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAV---GLAQGVE 1066
C + L+ EY GS D L K L E +IA G QG+
Sbjct: 122 -CYLRE--HTAWLVMEYCL-GSASDLLEVHK------KPLQ-EV--EIAAVTHGALQGLA 168
Query: 1067 YLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYI 1126
YLH ++HRD+K+ NILL LGDFG A + +N+ F G+ ++
Sbjct: 169 YLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIM-------APANS-FVGTPYWM 217
Query: 1127 APEYAYSLKATE---KCDVYSMGIVLMELVSGKMP 1158
APE ++ + K DV+S+GI +EL K P
Sbjct: 218 APEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 252
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-26
Identities = 73/310 (23%), Positives = 135/310 (43%), Gaps = 64/310 (20%)
Query: 953 IIGSGGSGTVYKAELANGA------TVAVKKISCKDDHLLN--KSFTREVKTLGRIRHRH 1004
+G G G V KA + TVAVK K++ + + E L ++ H H
Sbjct: 30 TLGEGEFGKVVKATAFHLKGRAGYTTVAVK--MLKENASPSELRDLLSEFNVLKQVNHPH 87
Query: 1005 LVKLMGHCCNKGAGSNLLIYEYMENGSVWDWL-----------------HKQPVNIKMRK 1047
++KL G C++ G LLI EY + GS+ +L + ++ +
Sbjct: 88 VIKLYG-ACSQD-GPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDER 145
Query: 1048 SLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVE 1107
+L + A ++QG++YL K++HRD+ + NIL+ + + DFGL++ + E
Sbjct: 146 ALTMGDLISFAWQISQGMQYLAE---MKLVHRDLAARNILVAEGRKMKISDFGLSRDVYE 202
Query: 1108 D--YNSNTESNT---WFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDA 1161
+ Y ++ W +A E + T + DV+S G++L E+V+ G P
Sbjct: 203 EDSYVKRSQGRIPVKW-------MAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP--- 252
Query: 1162 TFGVEMDMVRWVEMHMEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQER 1221
G+ + + ++ +G ++ +P + C+ ++ + LQC K P +R
Sbjct: 253 YPGIPPERL----FNLLKTG----HRME---RP----DNCSE-EMYRLMLQCWKQEPDKR 296
Query: 1222 PSSRQVCDLL 1231
P + L
Sbjct: 297 PVFADISKDL 306
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 3e-26
Identities = 78/307 (25%), Positives = 123/307 (40%), Gaps = 62/307 (20%)
Query: 953 IIGSGGSGTVYKAELANGA------TVAVKKISCKDDHLLN--KSFTREVKTLGRI-RHR 1003
+G+G G V +A TVAVK K L ++ E+K L + H
Sbjct: 30 TLGAGAFGKVVEATAYGLIKSDAAMTVAVK--MLKPSAHLTEREALMSELKVLSYLGNHM 87
Query: 1004 HLVKLMGHCCNKGAGSNLLIYEYMENGSVWDWL-----------HKQPVNIKMRKSLDWE 1052
++V L+G C G G L+I EY G + ++L + +LD E
Sbjct: 88 NIVNLLG-ACTIG-GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 145
Query: 1053 ARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSN 1112
L + +A+G+ +L +HRD+ + NILL + DFGLA+ + D N
Sbjct: 146 DLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYV 202
Query: 1113 TESNT-----WFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVE 1166
+ N W +APE ++ T + DV+S GI L EL S G P V+
Sbjct: 203 VKGNARLPVKW-------MAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY-PGMPVD 254
Query: 1167 MDMVRWVEM--HMEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSS 1224
+ ++ M P E A ++ +I C P +RP+
Sbjct: 255 SKFYKMIKEGFRML--------------SP----EHAPA-EMYDIMKTCWDADPLKRPTF 295
Query: 1225 RQVCDLL 1231
+Q+ L+
Sbjct: 296 KQIVQLI 302
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 4e-26
Identities = 54/264 (20%), Positives = 94/264 (35%), Gaps = 59/264 (22%)
Query: 945 TNNLSDEFII----GSGGSGTVYKA-ELANGATVAVKKISCK----DDHLLNKSFTREVK 995
L ++ + G G G V A E A A+K ++ + + EV+
Sbjct: 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVR 80
Query: 996 TLGRIRHRHLVKLMGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARL 1055
+ ++ H ++ +L ++ L+ E G + D L+ + + ++D
Sbjct: 81 LMKKLHHPNIARLYEVYEDE--QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQ 138
Query: 1056 KIAVG---------------------------------LAQGVEYLHHDCVPKILHRDIK 1082
+ + YLH+ I HRDIK
Sbjct: 139 ICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIK 195
Query: 1083 SSNILLDSNMEAHL--GDFGLAKALVEDYNSNTESNTWFAGSYGYIAPE------YAYSL 1134
N L +N + DFGL+K + N T AG+ ++APE +Y
Sbjct: 196 PENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYG- 254
Query: 1135 KATEKCDVYSMGIVLMELVSGKMP 1158
KCD +S G++L L+ G +P
Sbjct: 255 ---PKCDAWSAGVLLHLLLMGAVP 275
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 5e-26
Identities = 64/315 (20%), Positives = 108/315 (34%), Gaps = 30/315 (9%)
Query: 101 DLSSNSLTGPIPTALSNLSSLESLLLFSNQLAGTIPTQLGSLTSLRVMRIGDNWLSGSIP 160
+ S + + P P S + L + + G + +++ D
Sbjct: 11 ESCSCNFSDPKPDWSSAFNCLGAA---------DVELYGGGRSLEYLLKRVDTEADLGQF 61
Query: 161 TSFGNLVNLGTLGLASCSLSGPIPPQ---FGQLSQLEELILQQNQLQGPIPAELGNCSSL 217
T ++L L + + + I +S L+EL L+ ++ G P L +
Sbjct: 62 TDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGP 121
Query: 218 SIFT-AAENNLNGSIPAALGRLQN-----LQLLNLGNNSLSGEIPSELGELSQLGYLNLM 271
+ N + A L LQ L++L++ ++ L L+L
Sbjct: 122 DLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLS 181
Query: 272 GNRLEGAIPRSFA----KMGNLQSLDLSMNRLT---GGIPEEFGNMGQLVFLVLSNNNIS 324
N G A K LQ L L + G QL L LS+N++
Sbjct: 182 DNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLR 241
Query: 325 GSIPRRICTNATSLEHLILAEIQLSGEIPVELSQCQSLKQLDLSNNTLNGTIPVELFQLV 384
+ C + L L L+ L ++P L L LDLS N L+ P +L
Sbjct: 242 DAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLD-RNPSPD-ELP 296
Query: 385 ALTHLYLHNNSLVGS 399
+ +L L N + S
Sbjct: 297 QVGNLSLKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 65/272 (23%), Positives = 98/272 (36%), Gaps = 25/272 (9%)
Query: 577 FLSFDVTNNEFDHEIPPQLGNSPSLERLRLGNNKFIGKIPWTFGKI---RELSLLDLSGN 633
+ E D + S SL+RL + + +I + ++ L L L
Sbjct: 46 EYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENL 105
Query: 634 SLTGPIPTQLLMC--KKLSHIDLNNNLLSGAVPSWLGTLPQ-----LGELKLSFNQFVGF 686
+TG P LL L+ ++L N + +WL L Q L L ++ + F
Sbjct: 106 EVTGTAPPPLLEATGPDLNILNLRNVSWAT-RDAWLAELQQWLKPGLKVLSIAQAHSLNF 164
Query: 687 LPRELFNCSKLLVLSLDGNMLNGSL-------PNEVGNLASLNVLTLSGNLLSGPIPPAI 739
++ L L L N G P + L L + SG
Sbjct: 165 SCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALA 224
Query: 740 GRLSKLYELRLSNNSLNGVIPLEIGQ-LQNLQSILDLSHNNFTGQIPPSMGTLAKLEVLN 798
+L L LS+NSL L S L+LS Q+P G AKL VL+
Sbjct: 225 AARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNS-LNLSFTGLK-QVPK--GLPAKLSVLD 280
Query: 799 LSHNQLVGELPSQLGEMSSLGKLNLSYNDLQG 830
LS+N+L + E+ +G L+L N
Sbjct: 281 LSYNRL--DRNPSPDELPQVGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 93.8 bits (233), Expect = 8e-21
Identities = 61/319 (19%), Positives = 97/319 (30%), Gaps = 55/319 (17%)
Query: 305 EEFGNMGQLVFLVLSNNNISGSIPRRICTNATSLEHLILAEIQLSGEIPVELSQCQS--- 361
E +G L +L+ + + + SL+ L + ++ I +
Sbjct: 37 ELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISG 96
Query: 362 LKQLDLSNNTLNGTIPVELFQLV--ALTHLYLHNNSLVGSISPFVA----NLSNLQELAL 415
L++L L N + GT P L + L L L N S + L+ L++
Sbjct: 97 LQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSI 156
Query: 416 YHNNFQGSLPREIGMLVKLELLYLYDNHLSGQIPSEVGNCSSLKWIDFFGNSFTGEIPTS 475
+ ++ + L L L DN G+ C P
Sbjct: 157 AQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALC-----------------PLK 199
Query: 476 IGRLKDLNFLHLRQNELVGQIPASLGNCHQLIILDLADNKLSGGVPA-SFGFLQALEQLM 534
L+ L + G A QL LDL+ N L A S + L L
Sbjct: 200 FPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLN 259
Query: 535 LYNNSLEGNLPGSLINLRNLTRINFSKNRLNGRIATLCSSHSFLSFDVTNNEFDHEIPPQ 594
L L+ +P L L+ ++ S NRL+ P
Sbjct: 260 LSFTGLKQ-VPKGL--PAKLSVLDLSYNRLDR-------------------------NPS 291
Query: 595 LGNSPSLERLRLGNNKFIG 613
P + L L N F+
Sbjct: 292 PDELPQVGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 84.9 bits (210), Expect = 7e-18
Identities = 54/265 (20%), Positives = 80/265 (30%), Gaps = 53/265 (20%)
Query: 69 SSARVVSLNLSGLSLAGSISPSLGRLQ--SLIHLDLSSNSLTG--PIPTALSNLS--SLE 122
+ + L L L + G+ P L L L+L + S L L+
Sbjct: 93 GISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLK 152
Query: 123 SLLLFSNQLAGTIPTQLGSLTSLRVMRIGDNWLSGSIPTSFGNLVNLGTLGLASCSLSGP 182
L + Q+ +L + + DN G L A C
Sbjct: 153 VLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERG-----------LISALC----- 196
Query: 183 IPPQFGQLSQLEELILQQNQLQGPIPAELGNCSSLSIFTAAENNLNGSIPAALGRLQNLQ 242
+ L+ L L+ + +G A LQ
Sbjct: 197 ----PLKFPTLQVLALRNAGM---------------------ETPSGVCSALAAARVQLQ 231
Query: 243 LLNLGNNSLSGEIPSELGE-LSQLGYLNLMGNRLEGAIPRSFAKMGNLQSLDLSMNRLTG 301
L+L +NSL + + SQL LNL L+ +P+ L LDLS NRL
Sbjct: 232 GLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLPA--KLSVLDLSYNRLDR 288
Query: 302 GIPEEFGNMGQLVFLVLSNNNISGS 326
+ Q+ L L N S
Sbjct: 289 N--PSPDELPQVGNLSLKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 76.9 bits (189), Expect = 4e-15
Identities = 37/206 (17%), Positives = 66/206 (32%), Gaps = 14/206 (6%)
Query: 649 LSHIDLNNNLLSGAVPSWLGTLPQLGELKLSFNQFVGFLPRELFNCSKLLVLSLDGNMLN 708
L +D +L +L +L + F + S L L+L+ +
Sbjct: 49 LKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVT 108
Query: 709 GSLPNEVGNLASLNVLTLS-GNLLSGPIPPAIGRLS-----KLYELRLSNNSLNGVIPLE 762
G+ P + ++ L+ N+ + L L L ++ +
Sbjct: 109 GTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQ 168
Query: 763 IGQLQNLQSILDLSHNNFTGQIPPS----MGTLAKLEVLNLSHNQ---LVGELPSQLGEM 815
+ L + LDLS N G+ L+VL L + G +
Sbjct: 169 VRVFPALST-LDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAAR 227
Query: 816 SSLGKLNLSYNDLQGKLSKQFSHWPA 841
L L+LS+N L+ WP+
Sbjct: 228 VQLQGLDLSHNSLRDAAGAPSCDWPS 253
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 68.8 bits (168), Expect = 2e-12
Identities = 34/190 (17%), Positives = 62/190 (32%), Gaps = 14/190 (7%)
Query: 653 DLNNNLLSGAVPSWLGTLPQLGELKLSFNQFVGFLPRELFNCSKLLVLSLDGNMLNGSLP 712
N L + V + G LK + ++ L L++ + +
Sbjct: 26 SAFNCLGAADVELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRIL 85
Query: 713 N---EVGNLASLNVLTLSGNLLSGPIPPAIGRLS--KLYELRLSNNSLNGVIPLEIGQLQ 767
V ++ L LTL ++G PP + + L L L N S + +LQ
Sbjct: 86 FGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWAT-RDAWLAELQ 144
Query: 768 NLQS----ILDLSHNNFTGQIPPSMGTLAKLEVLNLSHNQLVGELP----SQLGEMSSLG 819
+L ++ + + L L+LS N +GE + +L
Sbjct: 145 QWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQ 204
Query: 820 KLNLSYNDLQ 829
L L ++
Sbjct: 205 VLALRNAGME 214
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 67.6 bits (165), Expect = 4e-12
Identities = 49/234 (20%), Positives = 69/234 (29%), Gaps = 47/234 (20%)
Query: 46 NVLHAWNQSNQNLCTWRGITCGSSSARVVSLNLSGLSLAGSISPSLGRLQSLIHLDLSSN 105
N+L+ N S W + L+++ + +L LDLS N
Sbjct: 124 NILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDN 183
Query: 106 SLTGPIPTALSNLSSLESLLLFSNQLAGTIPTQLGSLTSLRVMRIGDNWLSGSIPTSFGN 165
G + P + +L L + G SG
Sbjct: 184 PELGERGLISA-----------------LCPLKFPTLQVLALRNAGMETPSGVCSALAAA 226
Query: 166 LVNLGTLGLASCSLSG-PIPPQFGQLSQLEELILQQNQLQGPIPAELGNCSSLSIFTAAE 224
V L L L+ SL P SQL L L L+
Sbjct: 227 RVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-------------------- 266
Query: 225 NNLNGSIPAALGRLQNLQLLNLGNNSLSGEIPSELGELSQLGYLNLMGNRLEGA 278
+P L L +L+L N L PS EL Q+G L+L GN +
Sbjct: 267 -----QVPKGL--PAKLSVLDLSYNRLD-RNPSPD-ELPQVGNLSLKGNPFLDS 311
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 5e-26
Identities = 70/310 (22%), Positives = 128/310 (41%), Gaps = 59/310 (19%)
Query: 954 IGSGGSGTVYKAEL--------ANGATVAVKKISCKDDHLLN--KSFTREVKTLGRI-RH 1002
+G G G V AE TVAVK KDD E++ + I +H
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVK--MLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 1003 RHLVKLMGHCCNKGAGSNLLIYEYMENGSVWDWL---------HKQPVNIKMRKSLDWEA 1053
++++ L+G C + G +I EY G++ ++L + +N + + ++
Sbjct: 101 KNIINLLG-ACTQD-GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 1054 RLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNT 1113
+ LA+G+EYL K +HRD+ + N+L+ N + DFGLA+ +
Sbjct: 159 LVSCTYQLARGMEYLAS---QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK 215
Query: 1114 ESNT-----WFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEM 1167
+N W +APE + T + DV+S G+++ E+ + G P G+ +
Sbjct: 216 TTNGRLPVKW-------MAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP---YPGIPV 265
Query: 1168 DMVRWVEMHMEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQV 1227
+ + + G +D KP C ++ + C P +RP+ +Q+
Sbjct: 266 EEL----FKLLKEG----HRMD---KP----ANCTN-ELYMMMRDCWHAVPSQRPTFKQL 309
Query: 1228 CDLLLNVFNN 1237
+ L +
Sbjct: 310 VEDLDRILTL 319
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 7e-26
Identities = 70/309 (22%), Positives = 128/309 (41%), Gaps = 59/309 (19%)
Query: 953 IIGSGGSGTVYKAELANGA--------TVAVKKISCKDDHLLN--KSFTREVKTLGRI-R 1001
+G G G V AE TVAVK KDD E++ + I +
Sbjct: 88 PLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVK--MLKDDATEKDLSDLVSEMEMMKMIGK 145
Query: 1002 HRHLVKLMGHCCNKGAGSNLLIYEYMENGSVWDWL---------HKQPVNIKMRKSLDWE 1052
H++++ L+G C + G +I EY G++ ++L + +N + + ++
Sbjct: 146 HKNIINLLG-ACTQD-GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 203
Query: 1053 ARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSN 1112
+ LA+G+EYL K +HRD+ + N+L+ N + DFGLA+ +
Sbjct: 204 DLVSCTYQLARGMEYLAS---QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK 260
Query: 1113 TESNT-----WFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVE 1166
+N W +APE + T + DV+S G+++ E+ + G P G+
Sbjct: 261 KTTNGRLPVKW-------MAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP---YPGIP 310
Query: 1167 MDMVRWVEMHMEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQ 1226
++ + + G +D KP C ++ + C P +RP+ +Q
Sbjct: 311 VEEL----FKLLKEG----HRMD---KP----ANCTN-ELYMMMRDCWHAVPSQRPTFKQ 354
Query: 1227 VCDLLLNVF 1235
+ + L +
Sbjct: 355 LVEDLDRIL 363
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 113 bits (283), Expect = 8e-26
Identities = 80/428 (18%), Positives = 142/428 (33%), Gaps = 55/428 (12%)
Query: 110 PIPTALSNLSSLESLLLFSNQLAGT---IPTQLGSLTSLRVMRIGDNWLSGSIPTSFGNL 166
I ++N SL S F N ++GT + + N + +
Sbjct: 2 SIMLPINNNFSL-SQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECL--I 58
Query: 167 VNLGTLGLASCSLSGPIPPQFGQLSQLEELILQQNQLQGPIPAELGNCSSLSIFTAAENN 226
L L +LS +P Q+ L + QN L +P + L +N
Sbjct: 59 NQFSELQLNRLNLSS-LPDNLPP--QITVLEITQNALI-SLPELPASLEYLDA---CDNR 111
Query: 227 LNGSIPAALGRLQNLQLLNLGNNSLSGEIPSELGELSQLGYLNLMGNRLEGAIPRSFAKM 286
L+ ++P L++L ++ NN L+ +P L Y+N N+L +P
Sbjct: 112 LS-TLPELPASLKHL---DVDNNQLT-MLPELPALLE---YINADNNQLT-MLP---ELP 159
Query: 287 GNLQSLDLSMNRLTGGIPEEFGNMGQLVFLVLSNNNISGSIPRRICTNA---TSLEHLIL 343
+L+ L + N+LT +PE L L +S N + S+P N +
Sbjct: 160 TSLEVLSVRNNQLTF-LPEL---PESLEALDVSTNLLE-SLPAVPVRNHHSEETEIFFRC 214
Query: 344 AEIQLSGEIPVELSQCQSLKQLDLSNNTLNGTIPVELFQLVALTHLYLHNNSLVGSISPF 403
E +++ IP + + L +N L+ I L Q A + S+S
Sbjct: 215 RENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYF--SMSDG 271
Query: 404 VANLSNLQELALYHNNFQGSLPREI-----------------GMLVKLELLYLYDNH--L 444
N + F + ++ L +L N
Sbjct: 272 QQNTLHRPLADAVTAWFPENKQSDVSQIWHAFEHEEHANTFSAFLDRLSDTVSARNTSGF 331
Query: 445 SGQIPSEVGNCSSLKWIDFFGNSFTGEIPTSIGRLKDLNFLHLRQNELVGQIPASLGNCH 504
Q+ + + S+ + + + S L + +LR+ LV Q L +
Sbjct: 332 REQVAAWLEKLSASAELRQQSFAVAADATESCEDRVALTWNNLRKTLLVHQASEGLFDND 391
Query: 505 QLIILDLA 512
+L L
Sbjct: 392 TGALLSLG 399
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 4e-24
Identities = 54/279 (19%), Positives = 96/279 (34%), Gaps = 39/279 (13%)
Query: 580 FDVTNNEFDHEIPPQLGNSPS----LERLRLGN---NKFIGKIPWTFGKIRELSLLDLSG 632
F ++ N F + I + S E+ L N+ + + I + S L L+
Sbjct: 11 FSLSQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLK--ECLINQFSELQLNR 68
Query: 633 NSLTGPIPTQLLMCKKLSHIDLNNNLLSGAVPSWLGTLPQLGELKLSFNQFVGFLPRELF 692
+L+ +P L +++ +++ N L ++P L L N+ LP
Sbjct: 69 LNLSS-LPDNL--PPQITVLEITQNALI-SLPELPA---SLEYLDACDNRLS-TLPELPA 120
Query: 693 NCSKLLVLSLDGNMLNGSLPNEVGNLASLNVLTLSGNLLSGPIPPAIGRLSKLYELRLSN 752
+ L +D N L LP L +N N L+ +P L L + N
Sbjct: 121 SLKHL---DVDNNQLT-MLPELPALLEYIN---ADNNQLTM-LPELPTSLEVLS---VRN 169
Query: 753 NSLNGVIPLEIGQLQNLQSILDLSHNNFTGQIPPSMGTLAKLE----VLNLSHNQLVGEL 808
N L +P L+ LD+S N +P E N++ +
Sbjct: 170 NQLT-FLPELPESLE----ALDVSTNLLE-SLPAVPVRNHHSEETEIFFRCRENRIT-HI 222
Query: 809 PSQLGEMSSLGKLNLSYNDLQGKLSKQFSHWPAEAFEGN 847
P + + + L N L ++ + S A+
Sbjct: 223 PENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHG 261
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 5e-24
Identities = 45/232 (19%), Positives = 84/232 (36%), Gaps = 28/232 (12%)
Query: 600 SLERLRLGNNKFIGKIPWTFGKIRELSLLDLSGNSLTGPIPTQLLMCKKLSHIDLNNNLL 659
L+L + +P ++++L+++ N+L +P L ++D +N L
Sbjct: 60 QFSELQLNRLN-LSSLPDNLPP--QITVLEITQNALI-SLPELP---ASLEYLDACDNRL 112
Query: 660 SGAVPSWLGTLPQLGELKLSFNQFVGFLPRELFNCSKLLVLSLDGNMLNGSLPNEVGNLA 719
S +P L L + NQ LP + L ++ D N L LP +L
Sbjct: 113 S-TLPE---LPASLKHLDVDNNQLT-MLPELP---ALLEYINADNNQLT-MLPELPTSLE 163
Query: 720 SLNVLTLSGNLLSGPIPPAIGRLSKLYELRLSNNSLNGVIPLEIGQLQNLQS---ILDLS 776
L+ + N L+ +P L L +S N L +P + + +
Sbjct: 164 VLS---VRNNQLTF-LPELPESLEALD---VSTNLLES-LPAVPVRNHHSEETEIFFRCR 215
Query: 777 HNNFTGQIPPSMGTLAKLEVLNLSHNQLVGELPSQLGEMSSLGKLNLSYNDL 828
N T IP ++ +L + L N L + L + ++ +
Sbjct: 216 ENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYF 266
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 3e-22
Identities = 53/325 (16%), Positives = 101/325 (31%), Gaps = 57/325 (17%)
Query: 471 EIPTSIGRLKDLNFLHLRQNELVGQIPASLGNCHQLIILDLADNKLSGGVPASFGFLQAL 530
+ ++ + + +NE V + L +Q L L LS +P + +
Sbjct: 28 DYFSAWDKWEKQALPGENRNEAVSLLKECL--INQFSELQLNRLNLSS-LPDNLP--PQI 82
Query: 531 EQLMLYNNSLEGNLPGSLINLRNLTRINFSKNRLNGRIATLCSSHSFLSFDVTNNEFDHE 590
L + N+L +LP +L L + NRL+
Sbjct: 83 TVLEITQNALI-SLPELPASLEYL---DACDNRLS------------------------T 114
Query: 591 IPPQLGNSPSLERLRLGNNKFIGKIPWTFGKIRELSLLDLSGNSLTGPIPTQLLMCKKLS 650
+P + L+ L + NN+ +P L ++ N LT +P L
Sbjct: 115 LPELPAS---LKHLDVDNNQLT-MLP---ELPALLEYINADNNQLTM-LPELP---TSLE 163
Query: 651 HIDLNNNLLSGAVPSWLGTLPQLGELKLSFNQFVGFLPRELFNCSKL----LVLSLDGNM 706
+ + NN L+ +P L L +S N LP + N
Sbjct: 164 VLSVRNNQLT-FLPELPE---SLEALDVSTNLLES-LPAVPVRNHHSEETEIFFRCRENR 218
Query: 707 LNGSLPNEVGNLASLNVLTLSGNLLSGPIPPAIGRLSKLYELRLSNNSLNGVIPLEIGQL 766
+ +P + +L + L N LS I ++ + + + + + Q
Sbjct: 219 IT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFS---MSDGQQN 274
Query: 767 QNLQSILDLSHNNFTGQIPPSMGTL 791
+ + D F + +
Sbjct: 275 TLHRPLADAVTAWFPENKQSDVSQI 299
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-25
Identities = 57/320 (17%), Positives = 114/320 (35%), Gaps = 75/320 (23%)
Query: 942 MGATNNLSDEF----IIGSGGSGTVYKA-ELANGATVAVKKISCKDDHLLNK-SFTREVK 995
MG + + EF IGSG G+V+K + +G A+K+ +++ + REV
Sbjct: 3 MGMKSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVY 62
Query: 996 TLGRI-RHRHLVKLMGHCCNKGAGSNLLIY-EYMENGSVWDWLHKQPVNIKMRKSLDWEA 1053
+ +H H+V+ ++LI EY GS+ D + + ++
Sbjct: 63 AHAVLGQHSHVVRYFSAWAEDD---HMLIQNEYCNGGSLADAISENY---RIMSYFKEAE 116
Query: 1054 RLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAH------------------ 1095
+ + + +G+ Y+H ++H DIK SNI + +
Sbjct: 117 LKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMF 173
Query: 1096 -LGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPE-----YAYSLKATEKCDVYSMGIVL 1149
+GD G + S+ + G ++A E Y + KA D++++ + +
Sbjct: 174 KIGDLGHVTRI-----SSPQV---EEGDSRFLANEVLQENYTHLPKA----DIFALALTV 221
Query: 1150 MELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSAREELLDDQMKPLLPGEECAAYQVLEI 1209
+ + + H G P +P + + + E+
Sbjct: 222 VCAAGAEPLPRNG----------DQWHEIRQGRL----------PRIP--QVLSQEFTEL 259
Query: 1210 ALQCTKTSPQERPSSRQVCD 1229
P+ RPS+ +
Sbjct: 260 LKVMIHPDPERRPSAMALVK 279
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-25
Identities = 61/244 (25%), Positives = 98/244 (40%), Gaps = 38/244 (15%)
Query: 934 RDFRWEDIMGATNNLSDEFII----GSGGSGTVYKA-ELANGATVAVKKIS-------CK 981
D +D L DE+I+ GSG G V A E VA++ IS
Sbjct: 119 FDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSA 178
Query: 982 DDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPV 1041
+ + E++ L ++ H ++K+ + ++ E ME G ++D
Sbjct: 179 READPALNVETEIEILKKLNHPCIIKIKNFFDAE---DYYIVLELMEGGELFDK------ 229
Query: 1042 NIKMRKSLD-WEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAH---LG 1097
+ K L + + V+YLH + I+HRD+K N+LL S E +
Sbjct: 230 -VVGNKRLKEATCK-LYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKIT 284
Query: 1098 DFGLAKALVEDYNSNTESNTWFAGSYGYIAPE---YAYSLKATEKCDVYSMGIVLMELVS 1154
DFG +K L E T G+ Y+APE + D +S+G++L +S
Sbjct: 285 DFGHSKILGETSLMRT-----LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLS 339
Query: 1155 GKMP 1158
G P
Sbjct: 340 GYPP 343
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-25
Identities = 69/310 (22%), Positives = 125/310 (40%), Gaps = 59/310 (19%)
Query: 954 IGSGGSGTVYKAELANGA--------TVAVKKISCKDDHLLN--KSFTREVKTLGRI-RH 1002
+G G G V AE VAVK K D E++ + I +H
Sbjct: 77 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVK--MLKSDATEKDLSDLISEMEMMKMIGKH 134
Query: 1003 RHLVKLMGHCCNKGAGSNLLIYEYMENGSVWDWL---------HKQPVNIKMRKSLDWEA 1053
++++ L+G C + G +I EY G++ ++L + + + L +
Sbjct: 135 KNIINLLG-ACTQD-GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 192
Query: 1054 RLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNT 1113
+ A +A+G+EYL K +HRD+ + N+L+ + + DFGLA+ +
Sbjct: 193 LVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 249
Query: 1114 ESNT-----WFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEM 1167
+N W +APE + T + DV+S G++L E+ + G P GV +
Sbjct: 250 TTNGRLPVKW-------MAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP---YPGVPV 299
Query: 1168 DMVRWVEMHMEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQV 1227
+ + + G +D KP C ++ + C P +RP+ +Q+
Sbjct: 300 EEL----FKLLKEG----HRMD---KP----SNCTN-ELYMMMRDCWHAVPSQRPTFKQL 343
Query: 1228 CDLLLNVFNN 1237
+ L +
Sbjct: 344 VEDLDRIVAL 353
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 4e-25
Identities = 74/316 (23%), Positives = 124/316 (39%), Gaps = 66/316 (20%)
Query: 954 IGSGGSGTVYKAELANGA------TVAVKKISCKDDHLLN--KSFTREVKTLGRIRHRHL 1005
IG G G V++A VAVK K++ + F RE + + ++
Sbjct: 55 IGEGAFGRVFQARAPGLLPYEPFTMVAVK--MLKEEASADMQADFQREAALMAEFDNPNI 112
Query: 1006 VKLMGHCCNKGAGSNLLIYEYMENGSVWDWL-----------------HKQPVNIKMRKS 1048
VKL+G C G L++EYM G + ++L + V+
Sbjct: 113 VKLLG-VCAVG-KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP 170
Query: 1049 LDWEARLKIAVGLAQGVEYLH-HDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVE 1107
L +L IA +A G+ YL V HRD+ + N L+ NM + DFGL++ +
Sbjct: 171 LSCAEQLCIARQVAAGMAYLSERKFV----HRDLATRNCLVGENMVVKIADFGLSRNIYS 226
Query: 1108 D--YNSNTESNT---WFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDA 1161
Y ++ W + PE + + T + DV++ G+VL E+ S G P
Sbjct: 227 ADYYKADGNDAIPIRW-------MPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP--- 276
Query: 1162 TFGVEMDMVRWVEMHMEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQER 1221
+G+ + V ++ G +L P E C ++ + C P +R
Sbjct: 277 YYGMAHEEV----IYYVRDG----NILA---CP----ENCPL-ELYNLMRLCWSKLPADR 320
Query: 1222 PSSRQVCDLLLNVFNN 1237
PS + +L +
Sbjct: 321 PSFCSIHRILQRMCER 336
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 4e-25
Identities = 55/237 (23%), Positives = 100/237 (42%), Gaps = 41/237 (17%)
Query: 944 ATNNLSDEF----IIGSGGSGTVYKA-ELANGATVAVKKIS--------CKDDHLLNKSF 990
+T+ + + I+G G S V + AVK I ++ L ++
Sbjct: 11 STHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREAT 70
Query: 991 TREVKTLGRI-RHRHLVKLMGHCCNKGAGSNL-LIYEYMENGSVWDWLHKQPVNIKMRKS 1048
+EV L ++ H ++++L + L+++ M+ G ++D+ + + +
Sbjct: 71 LKEVDILRKVSGHPNIIQLKDTYETN---TFFFLVFDLMKKGELFDY-------LTEKVT 120
Query: 1049 LD-WEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVE 1107
L E R KI L + + LH I+HRD+K NILLD +M L DFG + L
Sbjct: 121 LSEKETR-KIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP 176
Query: 1108 DYNSNTESNTWFAGSYGYIAPE------YAYSLKATEKCDVYSMGIVLMELVSGKMP 1158
G+ Y+APE ++ D++S G+++ L++G P
Sbjct: 177 GEKLRE-----VCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 5e-25
Identities = 82/366 (22%), Positives = 140/366 (38%), Gaps = 75/366 (20%)
Query: 899 KRKREFLRKSSQVNYTSSSSSSQAQRRLLFQAAAKRDFRWEDIMGATNNLSDEFIIGSGG 958
+ + E + QV +S + R + D +WE NL ++GSG
Sbjct: 6 QFRYESQLQMVQVTGSSDNEYFYVDFREY-----EYDLKWE-F--PRENLEFGKVLGSGA 57
Query: 959 SGTVYKAELANGA------TVAVKKISCKDDHLLN--KSFTREVKTLGRI-RHRHLVKLM 1009
G V A + VAVK K+ + ++ E+K + ++ H ++V L+
Sbjct: 58 FGKVMNATAYGISKTGVSIQVAVK--MLKEKADSSEREALMSELKMMTQLGSHENIVNLL 115
Query: 1010 GHCCNKGAGSNLLIYEYMENGSVWDWL----------------HKQPVNIKMRKSLDWEA 1053
G C G LI+EY G + ++L K+ + L +E
Sbjct: 116 G-ACTLS-GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFED 173
Query: 1054 RLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNT 1113
L A +A+G+E+L +HRD+ + N+L+ + DFGLA+ ++ D N
Sbjct: 174 LLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVV 230
Query: 1114 ESNT-----WFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEM 1167
N W +APE + T K DV+S GI+L E+ S G P V+
Sbjct: 231 RGNARLPVKW-------MAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY-PGIPVDA 282
Query: 1168 DMVRWVEM--HMEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSR 1225
+ + ++ M+ +P ++ I C ++RPS
Sbjct: 283 NFYKLIQNGFKMD--------------QP----FYATE-EIYIIMQSCWAFDSRKRPSFP 323
Query: 1226 QVCDLL 1231
+ L
Sbjct: 324 NLTSFL 329
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 7e-25
Identities = 64/217 (29%), Positives = 99/217 (45%), Gaps = 32/217 (14%)
Query: 954 IGSGGSGTVYKAE-LANGATVAVKKIS-CKDDHLLNKSFTREVKTLGRIRHRHLVKLMGH 1011
IG G V A + G VA+K I + + + REV+ + + H ++VKL
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 1012 CCNKGAGSNL-LIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHH 1070
+ L LI EY G V+D+L + +M++ EAR + V+Y H
Sbjct: 83 IETE---KTLYLIMEYASGGEVFDYLVA---HGRMKEK---EAR-SKFRQIVSAVQYCHQ 132
Query: 1071 DCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPE- 1129
I+HRD+K+ N+LLD++M + DFG + + F G+ Y APE
Sbjct: 133 KR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDA-----FCGAPPYAAPEL 184
Query: 1130 -----YAYSLKATEKCDVYSMGIVLMELVSGKMPTDA 1161
Y + DV+S+G++L LVSG +P D
Sbjct: 185 FQGKKYDGP-----EVDVWSLGVILYTLVSGSLPFDG 216
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-24
Identities = 64/266 (24%), Positives = 112/266 (42%), Gaps = 42/266 (15%)
Query: 914 TSSSSSSQAQRRLLFQAAAKRDFRWEDIMGATNNLSDEF----IIGSGGSGTVYKA-ELA 968
+ + + L FQ+ D + A ++ +IG G S V + A
Sbjct: 60 KLNDAQPKGTENLYFQSMGPEDELPD--WAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRA 117
Query: 969 NGATVAVKKI-------SCKDDHLLNKSFTREVKTLGRIR-HRHLVKLMGHCCNKGAGSN 1020
G AVK + S + + ++ RE L ++ H H++ L+ + S
Sbjct: 118 TGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESS---SF 174
Query: 1021 L-LIYEYMENGSVWDWLHKQPVNIKMRKSLD-WEARLKIAVGLAQGVEYLHHDCVPKILH 1078
+ L+++ M G ++D+ + + +L E R I L + V +LH + I+H
Sbjct: 175 MFLVFDLMRKGELFDY-------LTEKVALSEKETR-SIMRSLLEAVSFLHAN---NIVH 223
Query: 1079 RDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPE------YAY 1132
RD+K NILLD NM+ L DFG + L G+ GY+APE
Sbjct: 224 RDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRE-----LCGTPGYLAPEILKCSMDET 278
Query: 1133 SLKATEKCDVYSMGIVLMELVSGKMP 1158
++ D+++ G++L L++G P
Sbjct: 279 HPGYGKEVDLWACGVILFTLLAGSPP 304
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 4e-24
Identities = 59/231 (25%), Positives = 81/231 (35%), Gaps = 37/231 (16%)
Query: 94 LQSLIHLDLSSNSLTGPIPTALSNLSSLESLLLFSNQLAGTIPTQLGSLTSLRVMRIGDN 153
+ S + ++ +LT +P L L L N L L T L + +
Sbjct: 9 VASHLEVNCDKRNLTA-LPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRA 65
Query: 154 WLSGSIPTSFGNLVNLGTLGLASCSLSGPIPPQFGQLSQLEELILQQNQLQGPIPAELGN 213
L+ + G L LGTL L+ L +P L L L + N+L
Sbjct: 66 ELT-KLQV-DGTLPVLGTLDLSHNQLQS-LPLLGQTLPALTVLDVSFNRLT--------- 113
Query: 214 CSSLSIFTAAENNLNGSIPA-ALGRLQNLQLLNLGNNSLSGEIPSEL-GELSQLGYLNLM 271
S+P AL L LQ L L N L +P L +L L+L
Sbjct: 114 ----------------SLPLGALRGLGELQELYLKGNELK-TLPPGLLTPTPKLEKLSLA 156
Query: 272 GNRLEGAIPRS-FAKMGNLQSLDLSMNRLTGGIPEEFGNMGQLVFLVLSNN 321
N L +P + NL +L L N L IP+ F L F L N
Sbjct: 157 NNNLT-ELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 8e-22
Identities = 56/226 (24%), Positives = 86/226 (38%), Gaps = 37/226 (16%)
Query: 75 SLNLSGLSLAGSISPSLGRLQSLIHLDLSSNSLTGPIPTALSNLSSLESLLLFSNQLAGT 134
+N +L ++ P L + L LS N L L + L L L +L
Sbjct: 14 EVNCDKRNLT-ALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-K 69
Query: 135 IPTQLGSLTSLRVMRIGDNWLSGSIPTSFGNLVNLGTLGLASCSLSGPIPPQ-FGQLSQL 193
+ G+L L + + N L S+P L L L ++ L+ +P L +L
Sbjct: 70 LQV-DGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTS-LPLGALRGLGEL 126
Query: 194 EELILQQNQLQGPIPAELGNCSSLSIFTAAENNLNGSIPA-ALGRLQNLQLLNLGNNSLS 252
+EL L+ N+L+ ++P L L+ L+L NN+L+
Sbjct: 127 QELYLKGNELK-------------------------TLPPGLLTPTPKLEKLSLANNNLT 161
Query: 253 GEIPSEL-GELSQLGYLNLMGNRLEGAIPRSFAKMGNLQSLDLSMN 297
E+P+ L L L L L N L IP+ F L L N
Sbjct: 162 -ELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 95.6 bits (238), Expect = 1e-21
Identities = 55/280 (19%), Positives = 84/280 (30%), Gaps = 82/280 (29%)
Query: 116 SNLSSLESLLLFSNQLAGTIPTQLGSLTSLRVMRIGDNWLSGSIPTSFGNLVNLGTLGLA 175
S ++S + L +P ++ + +N L + L L L
Sbjct: 7 SKVASHLEVNCDKRNLT-ALPP--DLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLD 63
Query: 176 SCSLSGPIPPQFGQLSQLEELILQQNQLQGPIPAELGNCSSLSIFTAAENNLNGSIPAAL 235
L+ G L L L L NQLQ S+P
Sbjct: 64 RAELT--KLQVDGTLPVLGTLDLSHNQLQ-------------------------SLPLLG 96
Query: 236 GRLQNLQLLNLGNNSLSGEIPSELGELSQLGYLNLMGNRLEGAIPRSFAKMGNLQSLDLS 295
L L +L++ N L+ +P + +G LQ L L
Sbjct: 97 QTLPALTVLDVSFNRLT-SLP-----------------------LGALRGLGELQELYLK 132
Query: 296 MNRLTGGIPEE-FGNMGQLVFLVLSNNNISGSIPRRICTNATSLEHLILAEIQLSGEIPV 354
N L +P +L L L+NNN++ +P + +L+
Sbjct: 133 GNELK-TLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDT-------------- 176
Query: 355 ELSQCQSLKQLDLSNNTLNGTIPVELFQLVALTHLYLHNN 394
L L N+L TIP F L +LH N
Sbjct: 177 ----------LLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 6e-18
Identities = 53/214 (24%), Positives = 78/214 (36%), Gaps = 14/214 (6%)
Query: 353 PVELSQCQ-SLKQLDLSNNTLNGTIPVELFQLVALTHLYLHNNSLVGSISPFV-ANLSNL 410
P+ S +++ L +P +L T L+L N L + S + L
Sbjct: 2 PICEVSKVASHLEVNCDKRNL-TALPPDLP--KDTTILHLSENLL-YTFSLATLMPYTRL 57
Query: 411 QELALYHNNFQGSLPREIGMLVKLELLYLYDNHLSGQIPSEVGNCSSLKWIDFFGNSFTG 470
+L L L G L L L L N L +P +L +D N T
Sbjct: 58 TQLNLDRAELT-KLQ-VDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT- 113
Query: 471 EIPTSI-GRLKDLNFLHLRQNELVGQIPASL-GNCHQLIILDLADNKLSGGVPASFGFLQ 528
+P L +L L+L+ NEL +P L +L L LA+N L+ L+
Sbjct: 114 SLPLGALRGLGELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLE 172
Query: 529 ALEQLMLYNNSLEGNLPGSLINLRNLTRINFSKN 562
L+ L+L NSL +P L N
Sbjct: 173 NLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 9e-17
Identities = 52/184 (28%), Positives = 70/184 (38%), Gaps = 13/184 (7%)
Query: 599 PSLERLRLGNNKFIGKIPWTFGKIRELSLLDLSGNSLTG-PIPTQLLMCKKLSHIDLNNN 657
L L N T L+ L+L LT + L L +DL++N
Sbjct: 31 KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDGTL---PVLGTLDLSHN 87
Query: 658 LLSGAVPSWLGTLPQLGELKLSFNQFVGFLPRELF-NCSKLLVLSLDGNMLNGSLPNEV- 715
L ++P TLP L L +SFN+ LP +L L L GN L +LP +
Sbjct: 88 QLQ-SLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELK-TLPPGLL 144
Query: 716 GNLASLNVLTLSGNLLSGPIPPAI-GRLSKLYELRLSNNSLNGVIPLEIGQLQNLQSILD 774
L L+L+ N L+ +P + L L L L NSL IP L
Sbjct: 145 TPTPKLEKLSLANNNLTE-LPAGLLNGLENLDTLLLQENSLYT-IPKGFFGSHLLPFA-F 201
Query: 775 LSHN 778
L N
Sbjct: 202 LHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 9e-14
Identities = 56/186 (30%), Positives = 75/186 (40%), Gaps = 17/186 (9%)
Query: 649 LSHIDLNNNLLSGAVPSWLGTLPQLGELKLSFNQFVGFLPRELFNCSKLLVLSLDGNMLN 708
++ + L+ A+P L LS N F L ++L L+LD L
Sbjct: 12 HLEVNCDKRNLT-ALPP--DLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT 68
Query: 709 GSLPNEVGNLASLNVLTLSGNLLSGPIPPAIGRLSKLYELRLSNNSLNGVIPLEIG---Q 765
L G L L L LS N L +P L L L +S N L L +G
Sbjct: 69 -KLQ-VDGTLPVLGTLDLSHNQLQS-LPLLGQTLPALTVLDVSFNRLTS---LPLGALRG 122
Query: 766 LQNLQSILDLSHNNFTGQIPPSM-GTLAKLEVLNLSHNQLVGELPSQL-GEMSSLGKLNL 823
L LQ L L N +PP + KLE L+L++N L ELP+ L + +L L L
Sbjct: 123 LGELQE-LYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLL 179
Query: 824 SYNDLQ 829
N L
Sbjct: 180 QENSLY 185
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 2e-09
Identities = 39/139 (28%), Positives = 62/139 (44%), Gaps = 8/139 (5%)
Query: 692 FNCS-KLLVLSLDGNMLNGSLPNEVGNLASLNVLTLSGNLLSGPIPPAIGRLSKLYELRL 750
+ L ++ D L +LP ++ +L LS NLL + ++L +L L
Sbjct: 6 VSKVASHLEVNCDKRNL-TALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNL 62
Query: 751 SNNSLNGVIPLEIGQLQNLQSILDLSHNNFTGQIPPSMGTLAKLEVLNLSHNQLVGELPS 810
L + ++ G L L + LDLSHN +P TL L VL++S N+L
Sbjct: 63 DRAELT-KLQVD-GTLPVLGT-LDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLG 118
Query: 811 QLGEMSSLGKLNLSYNDLQ 829
L + L +L L N+L+
Sbjct: 119 ALRGLGELQELYLKGNELK 137
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 4e-24
Identities = 60/231 (25%), Positives = 95/231 (41%), Gaps = 38/231 (16%)
Query: 947 NLSDEFII----GSGGSGTVYKA-ELANGATVAVKKIS-------CKDDHLLNKSFTREV 994
L DE+I+ GSG G V A E VA+K IS + + E+
Sbjct: 7 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEI 66
Query: 995 KTLGRIRHRHLVKLMGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLD-WEA 1053
+ L ++ H ++K+ + ++ E ME G ++D + K L
Sbjct: 67 EILKKLNHPCIIKIKNFFDAE---DYYIVLELMEGGELFDK-------VVGNKRLKEATC 116
Query: 1054 RLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAH---LGDFGLAKALVEDYN 1110
+ + V+YLH + I+HRD+K N+LL S E + DFG +K L E
Sbjct: 117 K-LYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL 172
Query: 1111 SNTESNTWFAGSYGYIAPE---YAYSLKATEKCDVYSMGIVLMELVSGKMP 1158
T G+ Y+APE + D +S+G++L +SG P
Sbjct: 173 MRT-----LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 218
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 6e-24
Identities = 68/228 (29%), Positives = 101/228 (44%), Gaps = 36/228 (15%)
Query: 945 TNNLSDEF----IIGSGGSGTVYKA-ELANGATVAVKKIS-----CKDDHLLNKSFTREV 994
T SD + ++G G G V + G AVK IS K D +S REV
Sbjct: 21 TAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDK---ESLLREV 77
Query: 995 KTLGRIRHRHLVKLMGHCCNKGAGSNL-LIYEYMENGSVWDWLHKQPVNIKMRKSLDWEA 1053
+ L ++ H +++KL +K L+ E G ++D I RK
Sbjct: 78 QLLKQLDHPNIMKLYEFFEDK---GYFYLVGEVYTGGELFDE-------IISRKRFSEVD 127
Query: 1054 RLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNME-AHL--GDFGLAKALVEDYN 1110
+I + G+ Y+H + KI+HRD+K N+LL+S + A++ DFGL+
Sbjct: 128 AARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK 184
Query: 1111 SNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMP 1158
G+ YIAPE EKCDV+S G++L L+SG P
Sbjct: 185 MKD-----KIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGCPP 226
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 7e-24
Identities = 62/237 (26%), Positives = 99/237 (41%), Gaps = 41/237 (17%)
Query: 938 WEDIMGATNNLSDEFII----GSGGSGTVYKA-ELANGATVAVKKIS----CKDDHLLNK 988
+ + ++ + I G G G V K + AVK I+ D
Sbjct: 10 GRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDT---S 66
Query: 989 SFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNL-LIYEYMENGSVWDWLHKQPVNIKMRK 1047
+ REV+ L ++ H +++KL + S+ ++ E G ++D I RK
Sbjct: 67 TILREVELLKKLDHPNIMKLFEILEDS---SSFYIVGELYTGGELFDE-------IIKRK 116
Query: 1048 SLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAH---LGDFGLAKA 1104
+I + G+ Y+H I+HRD+K NILL+S + + DFGL+
Sbjct: 117 RFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173
Query: 1105 LVEDYNSNTESNTWFAGSYGYIAPE---YAYSLKATEKCDVYSMGIVLMELVSGKMP 1158
++ G+ YIAPE Y EKCDV+S G++L L+SG P
Sbjct: 174 FQQNTKMKD-----RIGTAYYIAPEVLRGTYD----EKCDVWSAGVILYILLSGTPP 221
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 8e-24
Identities = 61/235 (25%), Positives = 95/235 (40%), Gaps = 40/235 (17%)
Query: 945 TNNLSDEFII----GSGGSGTVYKA-ELANGATVAVKKIS------------CKDDHLLN 987
+ + + GSG G V E + A+K I K+ +
Sbjct: 31 EGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFH 90
Query: 988 KSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNL-LIYEYMENGSVWDWLHKQPVNIKMR 1046
+ E+ L + H +++KL +K L+ E+ E G +++ I R
Sbjct: 91 EEIYNEISLLKSLDHPNIIKLFDVFEDK---KYFYLVTEFYEGGELFEQ-------IINR 140
Query: 1047 KSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNME-AHL--GDFGLAK 1103
D I + G+ YLH I+HRDIK NILL++ ++ DFGL+
Sbjct: 141 HKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVDFGLSS 197
Query: 1104 ALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMP 1158
+DY G+ YIAPE K EKCDV+S G+++ L+ G P
Sbjct: 198 FFSKDYKLRD-----RLGTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCGYPP 246
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 8e-24
Identities = 53/228 (23%), Positives = 88/228 (38%), Gaps = 40/228 (17%)
Query: 953 IIGSGGSGTVYKA-ELANGATVAVKKIS----CKDDHLLNKSFTREVKTLGRIRHRHLVK 1007
+IG G V + G AVK + L + RE ++H H+V+
Sbjct: 31 VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 1008 LMGHCCNKGAGSNL-LIYEYMENGSVWDWLHKQPVNIKMRKSLDW-----EARLKIAVGL 1061
L+ + G L +++E+M+ + I R + A +
Sbjct: 91 LLETYSSDG---MLYMVFEFMDGADLCF-------EIVKRADAGFVYSEAVAS-HYMRQI 139
Query: 1062 AQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAH---LGDFGLAKALVEDYNSNTESNTW 1118
+ + Y H + I+HRD+K +LL S + LG FG+A L E
Sbjct: 140 LEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGG---- 192
Query: 1119 FAGSYGYIAPE----YAYSLKATEKCDVYSMGIVLMELVSGKMPTDAT 1162
G+ ++APE Y + DV+ G++L L+SG +P T
Sbjct: 193 RVGTPHFMAPEVVKREPYG----KPVDVWGCGVILFILLSGCLPFYGT 236
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-23
Identities = 59/218 (27%), Positives = 100/218 (45%), Gaps = 29/218 (13%)
Query: 954 IGSGGSGTVYKAE-LANGATVAVK-----KISCKDDHLLNKSFTREVKTLGRIRHR--HL 1005
+GSGG G+VY +++ VA+K +IS + EV L ++ +
Sbjct: 51 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 1006 VKLMGHCCNKGAGSNLLIYEYMEN-GSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQG 1064
++L+ S +LI E E ++D++ ++ +++ AR + +
Sbjct: 111 IRLLDWFERPD--SFVLILERPEPVQDLFDFITERG---ALQEE---LAR-SFFWQVLEA 161
Query: 1065 VEYLHHDCVPKILHRDIKSSNILLDSN-MEAHLGDFGLAKALVEDYNSNTESNTWFAGSY 1123
V + H+ +LHRDIK NIL+D N E L DFG AL++D F G+
Sbjct: 162 VRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTD-----FDGTR 212
Query: 1124 GYIAPEY-AYSLKATEKCDVYSMGIVLMELVSGKMPTD 1160
Y PE+ Y V+S+GI+L ++V G +P +
Sbjct: 213 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 250
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 1e-23
Identities = 52/259 (20%), Positives = 96/259 (37%), Gaps = 19/259 (7%)
Query: 235 LGRLQNLQLLNLGNNSLSGEIPSELGELSQLGYLNLMGNRLEGAIPRSFAKMGNLQSLDL 294
L N + G ++++ +L + L+ G + + NL L+L
Sbjct: 15 DPALANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVTTIEG--VQYLNNLIGLEL 70
Query: 295 SMNRLTGGIPEEFGNMGQLVFLVLSNNNISGSIPRRICTNATSLEHLILAEIQLSGEIPV 354
N++T N+ ++ L LS N + S++ L L Q++ P
Sbjct: 71 KDNQITD--LAPLKNLTKITELELSGNPLKNVSA---IAGLQSIKTLDLTSTQITDVTP- 124
Query: 355 ELSQCQSLKQLDLSNNTLNGTIPVELFQLVALTHLYLHNNSLVGSISPFVANLSNLQELA 414
L+ +L+ L L N + P+ L L +L + N + ++P ANLS L L
Sbjct: 125 -LAGLSNLQVLYLDLNQITNISPLA--GLTNLQYLSIGNAQVS-DLTPL-ANLSKLTTLK 179
Query: 415 LYHNNFQGSLPREIGMLVKLELLYLYDNHLSGQIPSEVGNCSSLKWIDFFGNSFTGEIPT 474
N + + L L ++L +N +S S + N S+L + + T +
Sbjct: 180 ADDNKIS-DIS-PLASLPNLIEVHLKNNQISDV--SPLANTSNLFIVTLTNQTITNQPVF 235
Query: 475 SIGRLKDLNFLHLRQNELV 493
L N + +
Sbjct: 236 YNNNLVVPNVVKGPSGAPI 254
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 1e-20
Identities = 58/266 (21%), Positives = 105/266 (39%), Gaps = 20/266 (7%)
Query: 71 ARVVSLNLSGLSLAGSISPSLGRLQSLIHLDLSSNSLTGPIPTALSNLSSLESLLLFSNQ 130
A + + ++ +++ L + L +T + L++L L L NQ
Sbjct: 19 ANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTT--IEGVQYLNNLIGLELKDNQ 74
Query: 131 LAGTIPTQLGSLTSLRVMRIGDNWLSGSIPTSFGNLVNLGTLGLASCSLSGPIPPQFGQL 190
+ T L +LT + + + N L ++ + L ++ TL L S ++ P L
Sbjct: 75 I--TDLAPLKNLTKITELELSGNPLK-NVS-AIAGLQSIKTLDLTSTQITDVTP--LAGL 128
Query: 191 SQLEELILQQNQLQGPIPAELGNCSSLSIFTAAENNLNGSIPAALGRLQNLQLLNLGNNS 250
S L+ L L NQ+ P L ++L + ++ + L L L L +N
Sbjct: 129 SNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVS-DLT-PLANLSKLTTLKADDNK 184
Query: 251 LSGEIPSELGELSQLGYLNLMGNRLEGAIPRSFAKMGNLQSLDLSMNRLTGGIPEEFGNM 310
+S +I S L L L ++L N++ P A NL + L+ +T N+
Sbjct: 185 IS-DI-SPLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITNQPVFYNNNL 240
Query: 311 GQLVFLVLSNNNISGSIPRRICTNAT 336
+V V+ + + P I N T
Sbjct: 241 --VVPNVVKGPSGAPIAPATISDNGT 264
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 5e-20
Identities = 55/259 (21%), Positives = 107/259 (41%), Gaps = 19/259 (7%)
Query: 139 LGSLTSLRVMRIGDNWLSGSIPTSFGNLVNLGTLGLASCSLSGPIPPQFGQLSQLEELIL 198
+L + + G + ++ ++ +L + TL ++ I L+ L L L
Sbjct: 15 DPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTT-IEG-VQYLNNLIGLEL 70
Query: 199 QQNQLQGPIPAELGNCSSLSIFTAAENNLNGSIPAALGRLQNLQLLNLGNNSLSGEIPSE 258
+ NQ+ P L N + ++ + N L ++ A + LQ+++ L+L + ++ P
Sbjct: 71 KDNQITDLAP--LKNLTKITELELSGNPLK-NVSA-IAGLQSIKTLDLTSTQITDVTP-- 124
Query: 259 LGELSQLGYLNLMGNRLEGAIPRSFAKMGNLQSLDLSMNRLTGGIPEEFGNMGQLVFLVL 318
L LS L L L N++ P A + NLQ L + +++ N+ +L L
Sbjct: 125 LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSD--LTPLANLSKLTTLKA 180
Query: 319 SNNNISGSIPRRICTNATSLEHLILAEIQLSGEIPVELSQCQSLKQLDLSNNTLNGTIPV 378
+N IS P + +L + L Q+S P L+ +L + L+N T+
Sbjct: 181 DDNKISDISP---LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITNQPVF 235
Query: 379 ELFQLVALTHLYLHNNSLV 397
LV + + + +
Sbjct: 236 YNNNLVVPNVVKGPSGAPI 254
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 3e-19
Identities = 52/290 (17%), Positives = 107/290 (36%), Gaps = 25/290 (8%)
Query: 527 LQALEQLMLYNNSLEGNLPGSLINLRNLTRINFSKNRLNGRIATLCSSHSFLSFDVTNNE 586
L ++ +++ + +L +T ++ + I + ++ + ++ +N+
Sbjct: 18 LANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVT-TIEGVQYLNNLIGLELKDNQ 74
Query: 587 FDHEIPPQLGNSPSLERLRLGNNKFIGKIPWTFGKIRELSLLDLSGNSLTGPIPTQLLMC 646
+ P L N + L L N + + ++ + LDL+ +T P L
Sbjct: 75 ITD-LAP-LKNLTKITELELSGNP-LKNVS-AIAGLQSIKTLDLTSTQITDVTP--LAGL 128
Query: 647 KKLSHIDLNNNLLSGAVPSWLGTLPQLGELKLSFNQFVGFLPRELFNCSKLLVLSLDGNM 706
L + L+ N ++ P L L L L + Q P L N SKL L D N
Sbjct: 129 SNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNK 184
Query: 707 LNGSLPNEVGNLASLNVLTLSGNLLSGPIPPAIGRLSKLYELRLSNNSLNGVIPLEIGQL 766
++ + + +L +L + L N +S P + S L+ + L+N ++
Sbjct: 185 IS-DISP-LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITNQPVFY---- 236
Query: 767 QNLQSILDLSHNNFTGQIPPSMGTLAKLEVLNLSHNQLVGELPSQLGEMS 816
N + ++ I P+ + + L L S + +S
Sbjct: 237 NNNLVVPNVVKGPSGAPIAPA----TISDNGTYASPNLTWNLTSFINNVS 282
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 5e-06
Identities = 35/148 (23%), Positives = 63/148 (42%), Gaps = 12/148 (8%)
Query: 77 NLSGLSLAG----SISPSLGRLQSLIHLDLSSNSLTGPIPTALSNLSSLESLLLFSNQLA 132
NL L L +ISP L L +L +L + + ++ P L+NLS L +L N+++
Sbjct: 130 NLQVLYLDLNQITNISP-LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKIS 186
Query: 133 GTIPTQLGSLTSLRVMRIGDNWLSGSIPTSFGNLVNLGTLGLASCSLSGPIPPQFGQLSQ 192
P L SL +L + + +N +S P N NL + L + +++ L
Sbjct: 187 DISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITNQPVFYNNNLVV 242
Query: 193 LEELILQQNQLQGPI-PAELGNCSSLSI 219
+ P ++ G +S ++
Sbjct: 243 PNVVKGPSGAPIAPATISDNGTYASPNL 270
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 51/232 (21%), Positives = 96/232 (41%), Gaps = 44/232 (18%)
Query: 945 TNNLSDEF----IIGSGGSGTVYKA-ELANGATVAVKKIS----CKDDHLLNKSFTREVK 995
+ SD + +G G V + G A K I+ D + RE +
Sbjct: 1 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDF---QKLEREAR 57
Query: 996 TLGRIRHRHLVKLMGHCCNKGAGSNL-LIYEYMENGSVWDWLHKQPVNIKMRKSLD-WEA 1053
+++H ++V+L + L+++ + G +++ I R+ +A
Sbjct: 58 ICRKLQHPNIVRLHDSIQEES---FHYLVFDLVTGGELFED-------IVAREFYSEADA 107
Query: 1054 RLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAH---LGDFGLAKALVEDYN 1110
+ + + Y H + I+HR++K N+LL S + L DFGLA + +
Sbjct: 108 S-HCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA 163
Query: 1111 SNTESNTWFAGSYGYIAPE----YAYSLKATEKCDVYSMGIVLMELVSGKMP 1158
+ FAG+ GY++PE YS + D+++ G++L L+ G P
Sbjct: 164 WHG-----FAGTPGYLSPEVLKKDPYS----KPVDIWACGVILYILLVGYPP 206
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-23
Identities = 61/239 (25%), Positives = 100/239 (41%), Gaps = 45/239 (18%)
Query: 938 WEDIMGATNNLSDEF----IIGSGGSGTVYKA-ELANGATVAVKKIS----CKDDHLLNK 988
+ + ++ + ++G G G V K + AVK I+ D
Sbjct: 10 GRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDT---S 66
Query: 989 SFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNL-LIYEYMENGSVWDWLHKQPVNIKMRK 1047
+ REV+ L ++ H +++KL + S+ ++ E G ++D I RK
Sbjct: 67 TILREVELLKKLDHPNIMKLFEILEDS---SSFYIVGELYTGGELFDE-------IIKRK 116
Query: 1048 SLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNME-AHL--GDFGLAKA 1104
+I + G+ Y+H I+HRD+K NILL+S + + DFGL+
Sbjct: 117 RFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173
Query: 1105 LVEDYNSNTESNTWFAGSYGYIAPE-----YAYSLKATEKCDVYSMGIVLMELVSGKMP 1158
++ G+ YIAPE Y EKCDV+S G++L L+SG P
Sbjct: 174 FQQNTKMKD-----RIGTAYYIAPEVLRGTY------DEKCDVWSAGVILYILLSGTPP 221
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 67/323 (20%), Positives = 102/323 (31%), Gaps = 104/323 (32%)
Query: 103 SSNSLTGPIPTALSNLSSLESLLLFSNQLAGTIPTQLGSLTSLRVMRIGDNWLSGSIPTS 162
+ IP L S ++L L N L L S
Sbjct: 15 MELNFYK-IPDNLP--FSTKNLDLSFNP-----------LRHLG-------------SYS 47
Query: 163 FGNLVNLGTLGLASCSLSGPIPPQ-FGQLSQLEELILQQNQLQGPIPAELGNCSSLSIFT 221
F + L L L+ C + I + LS L LIL N +Q
Sbjct: 48 FFSFPELQVLDLSRCEIQT-IEDGAYQSLSHLSTLILTGNPIQ----------------- 89
Query: 222 AAENNLNGSIPA-ALGRLQNLQLLNLGNNSLSGEIPSELGELSQLGYLNLMGNRLEGAIP 280
S+ A L +LQ L +L+ + +
Sbjct: 90 --------SLALGAFSGLSSLQKLVAVETNLA-SLEN----------------------- 117
Query: 281 RSFAKMGNLQSLDLSMNRLTG-GIPEEFGNMGQLVFLVLSNNNISGSIPRRICTNATSLE 339
+ L+ L+++ N + +PE F N+ L L LS+N I SI +
Sbjct: 118 FPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMP 176
Query: 340 HLILAEIQLSGEIPVELSQCQSLKQLDLSNNTLNGTIPVELFQLVALTHLYLHNNSLVGS 399
L L LDLS N +N I F+ + L L L N L S
Sbjct: 177 LLNL--------------------SLDLSLNPMN-FIQPGAFKEIRLKELALDTNQLK-S 214
Query: 400 ISPFV-ANLSNLQELALYHNNFQ 421
+ + L++LQ++ L+ N +
Sbjct: 215 VPDGIFDRLTSLQKIWLHTNPWD 237
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 4e-23
Identities = 54/233 (23%), Positives = 89/233 (38%), Gaps = 34/233 (14%)
Query: 96 SLIHLDLSSNSLTGPIPTALSNLSSLESLLLFSNQLAGTIPTQL-GSLTSLRVMRIGDNW 154
S +LDLS N L + + L+ L L ++ TI SL+ L + + N
Sbjct: 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNP 87
Query: 155 LSGSIPT-SFGNLVNLGTLGLASCSLSGPIPPQ-FGQLSQLEELILQQNQLQGPIPAELG 212
+ S+ +F L +L L +L+ + G L L+EL + N +Q
Sbjct: 88 IQ-SLALGAFSGLSSLQKLVAVETNLAS-LENFPIGHLKTLKELNVAHNLIQ-------- 137
Query: 213 NCSSLSIFTAAENNLNGSIPAALGRLQNLQLLNLGNN---SLSGEIPSELGELSQLGY-L 268
S +P L NL+ L+L +N S+ L ++ L L
Sbjct: 138 ---SF------------KLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSL 182
Query: 269 NLMGNRLEGAIPRSFAKMGNLQSLDLSMNRLTGGIPEEFGNMGQLVFLVLSNN 321
+L N + P +F ++ L+ L L N+L F + L + L N
Sbjct: 183 DLSLNPMNFIQPGAFKEI-RLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 2e-19
Identities = 58/212 (27%), Positives = 80/212 (37%), Gaps = 17/212 (8%)
Query: 628 LDLSGNSLTGPIPTQLLMCKKLSHIDLNNNLLSGAVPSWLGT---LPQLGELKLSFNQFV 684
LDLS N L +L +DL+ + + G L L L L+ N +
Sbjct: 33 LDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIED--GAYQSLSHLSTLILTGNP-I 88
Query: 685 GFLPRELF-NCSKLLVLSLDGNMLNGSLPNEV-GNLASLNVLTLSGN-LLSGPIPPAIGR 741
L F S L L L SL N G+L +L L ++ N + S +P
Sbjct: 89 QSLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSN 147
Query: 742 LSKLYELRLSNNSLNGVIPLEI----GQLQNLQSILDLSHNNFTGQIPPSMGTLAKLEVL 797
L+ L L LS+N + I Q+ L LDLS N I P +L+ L
Sbjct: 148 LTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLKEL 205
Query: 798 NLSHNQLVGELPSQLGEMSSLGKLNLSYNDLQ 829
L NQL ++SL K+ L N
Sbjct: 206 ALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWD 237
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 3e-15
Identities = 45/166 (27%), Positives = 63/166 (37%), Gaps = 14/166 (8%)
Query: 93 RLQSLIHLDLSSNSLTGPIPTALSNLSSLESLLLFSNQLAGTIPTQL-GSLTSLRVMRIG 151
L L L L+ N + A S LSSL+ L+ LA ++ G L +L+ + +
Sbjct: 74 SLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVA 132
Query: 152 DNWLSGSIPTS--FGNLVNLGTLGLASCSLSGPIPPQ-FGQLSQLE----ELILQQNQLQ 204
N + S F NL NL L L+S + I L Q+ L L N +
Sbjct: 133 HNLIQ-SFKLPEYFSNLTNLEHLDLSSNKIQS-IYCTDLRVLHQMPLLNLSLDLSLNPMN 190
Query: 205 GPIPAELGNCSSLSIFTAAENNLNGSIPA-ALGRLQNLQLLNLGNN 249
I L N L S+P RL +LQ + L N
Sbjct: 191 F-IQPGAFKEIRLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 7e-15
Identities = 52/252 (20%), Positives = 83/252 (32%), Gaps = 51/252 (20%)
Query: 386 LTHLYLHNNSLVGSISPFV-ANLSNLQELALYHNNFQGSLPREI-GMLVKLELLYLYDNH 443
+L L N L + + + LQ L L Q ++ L L L L N
Sbjct: 30 TKNLDLSFNPL-RHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNP 87
Query: 444 LSGQIPSEVGNCSSLKWIDFFGNSFTGEIPTSIGRLKDLNFLHLRQNELVGQIPASLGNC 503
+ + F+G L L L + L +G+
Sbjct: 88 IQ-SLALGA---------------FSG--------LSSLQKLVAVETNLASLENFPIGHL 123
Query: 504 HQLIILDLADNKL-SGGVPASFGFLQALEQLMLYNNSLEGNLPGSLINLRNLTRINFSKN 562
L L++A N + S +P F L LE L L +N ++ L L + +N
Sbjct: 124 KTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLN---- 179
Query: 563 RLNGRIATLCSSHSFLSFDVTNNEFDHEIPPQLGNSPSLERLRLGNNKFIGKIPW-TFGK 621
LS D++ N + I P L+ L L N+ + +P F +
Sbjct: 180 ---------------LSLDLSLNPM-NFIQPGAFKEIRLKELALDTNQ-LKSVPDGIFDR 222
Query: 622 IRELSLLDLSGN 633
+ L + L N
Sbjct: 223 LTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 4e-13
Identities = 45/181 (24%), Positives = 76/181 (41%), Gaps = 15/181 (8%)
Query: 675 ELKLSFNQFVGFLPRELF-NCSKLLVLSLDGNMLNGSLPNEV-GNLASLNVLTLSGNLLS 732
L LSFN L F + +L VL L + ++ + +L+ L+ L L+GN +
Sbjct: 32 NLDLSFNPL-RHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQ 89
Query: 733 GPIPPAI-GRLSKLYELRLSNNSLNGVIPLEIGQLQNLQSILDLSHNNFTGQIPPSM-GT 790
+ LS L +L +L + IG L+ L+ L+++HN P
Sbjct: 90 S-LALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLK-ELNVAHNLIQSFKLPEYFSN 147
Query: 791 LAKLEVLNLSHNQLVGELPSQLGEMSSLGKLNLSYNDLQGKLSK-QFSHWPAEAFEGNLH 849
L LE L+LS N++ + ++ L ++ L L LS + AF+ +
Sbjct: 148 LTNLEHLDLSSNKIQ-SIYC--TDLRVLHQMPLLNLSLD--LSLNPMNFIQPGAFK-EIR 201
Query: 850 L 850
L
Sbjct: 202 L 202
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 7e-12
Identities = 49/253 (19%), Positives = 88/253 (34%), Gaps = 57/253 (22%)
Query: 508 ILDLADNKLSGGVPASFGFLQALEQLMLYNNSLEGNLPGSLINLRNLTRINFSKNRLNGR 567
LDL+ N L SF L+ L L ++ G+ +L +L+ + + N +
Sbjct: 32 NLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPI--- 88
Query: 568 IATLCSSHSFLSFDVTNNEFDHEIPPQL-GNSPSLERLRLGNNKFIGKIP-WTFGKIREL 625
+ SL++L + + + G ++ L
Sbjct: 89 ---------------------QSLALGAFSGLSSLQKLVAVETN-LASLENFPIGHLKTL 126
Query: 626 SLLDLSGNSLTG-PIPTQLLMCKKLSHIDLNNNLLSGAVPSWLGTLPQL----GELKLSF 680
L+++ N + +P L H+DL++N + + L L Q+ L LS
Sbjct: 127 KELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSL 186
Query: 681 NQFVGFLPRELFNCSKLLVLSLDGNMLNGSLPNEVGNLASLNVLTLSGNLLSGPIPPAIG 740
N + F+ F +L L+LD N L S+P+
Sbjct: 187 NP-MNFIQPGAFKEIRLKELALDTNQLK-SVPDG-----------------------IFD 221
Query: 741 RLSKLYELRLSNN 753
RL+ L ++ L N
Sbjct: 222 RLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 5e-11
Identities = 50/232 (21%), Positives = 80/232 (34%), Gaps = 31/232 (13%)
Query: 456 SSLKWIDFFGNSFTGEIPTSIGRLKDLNFLHLRQNELVGQIPASL-GNCHQLIILDLADN 514
S K +D N S +L L L + E+ I + L L L N
Sbjct: 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEI-QTIEDGAYQSLSHLSTLILTGN 86
Query: 515 KLSGGVPASFGFLQALEQLMLYNNSLEGNLPGSLINLRNLTRINFSKNRLNGRIATLCSS 574
+ +F L +L++L+ +L + +L+ L +N + N +
Sbjct: 87 PIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLI---------- 136
Query: 575 HSFLSFDVTNNEFDHEIPPQLGNSPSLERLRLGNNKFIGKIP-WTFGKIRELSL----LD 629
SF + F N +LE L L +NK I I + ++ L LD
Sbjct: 137 QSFKLPEY----FS--------NLTNLEHLDLSSNK-IQSIYCTDLRVLHQMPLLNLSLD 183
Query: 630 LSGNSLTGPIPTQLLMCKKLSHIDLNNNLLSGAVPSWLGTLPQLGELKLSFN 681
LS N + I +L + L+ N L L L ++ L N
Sbjct: 184 LSLNPMNF-IQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 3e-07
Identities = 28/116 (24%), Positives = 45/116 (38%), Gaps = 11/116 (9%)
Query: 719 ASLNVLTLSGNLLSGPIPPAIGRLSKLYELRLSNNSLNGVIPLEIG---QLQNLQSILDL 775
S L LS N L + +L L LS + +E G L +L L L
Sbjct: 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQT---IEDGAYQSLSHLS-TLIL 83
Query: 776 SHNNFTGQIPPSM-GTLAKLEVLNLSHNQLVGELPSQL-GEMSSLGKLNLSYNDLQ 829
+ N + L+ L+ L L L + G + +L +LN+++N +Q
Sbjct: 84 TGNPIQ-SLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQ 137
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 1e-06
Identities = 31/117 (26%), Positives = 58/117 (49%), Gaps = 10/117 (8%)
Query: 92 GRLQSLIHLDLSSNSLTG-PIPTALSNLSSLESLLLFSNQLAGTIPTQ-LGSLTSLRVMR 149
G L++L L+++ N + +P SNL++LE L L SN++ +I L L + ++
Sbjct: 121 GHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLN 179
Query: 150 ----IGDNWLSGSIPTSFGNLVNLGTLGLASCSLSGPIPPQ-FGQLSQLEELILQQN 201
+ N ++ P +F + L L L + L +P F +L+ L+++ L N
Sbjct: 180 LSLDLSLNPMNFIQPGAFKEI-RLKELALDTNQLKS-VPDGIFDRLTSLQKIWLHTN 234
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-23
Identities = 62/228 (27%), Positives = 95/228 (41%), Gaps = 37/228 (16%)
Query: 945 TNNLSDEF----IIGSGGSGTVYKA-ELANGATVAVK-----KISCKDDHLLNKSFTREV 994
+LS+ + +GSG G V + A+K +S + L EV
Sbjct: 32 KGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKL----LEEV 87
Query: 995 KTLGRIRHRHLVKLMGHCCNKGAGSNL-LIYEYMENGSVWDWLHKQPVNIKMRKSLDWEA 1053
L + H +++KL +K N L+ E + G ++D I R +
Sbjct: 88 AVLKLLDHPNIMKLYDFFEDK---RNYYLVMECYKGGELFDE-------IIHRMKFNEVD 137
Query: 1054 RLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAH---LGDFGLAKALVEDYN 1110
I + GV YLH I+HRD+K N+LL+S + + DFGL+
Sbjct: 138 AAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKK 194
Query: 1111 SNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMP 1158
G+ YIAPE K EKCDV+S+G++L L++G P
Sbjct: 195 MKE-----RLGTAYYIAPE-VLRKKYDEKCDVWSIGVILFILLAGYPP 236
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 62/216 (28%), Positives = 93/216 (43%), Gaps = 30/216 (13%)
Query: 954 IGSGGSGTVYKAE-LANGATVAVKKISCKDDHL-LNKSFTREVKTLGRIRHRHLVKLMGH 1011
+G G G V A VAVK + + ++ +E+ + H ++VK GH
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVD-MKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 1012 CCNKGAGSNL-LIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHH 1070
+ L EY G ++D + +I M + +A+ + L GV YLH
Sbjct: 74 RREG---NIQYLFLEYCSGGELFDRIEP---DIGMP---EPDAQ-RFFHQLMAGVVYLHG 123
Query: 1071 DCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPE- 1129
I HRDIK N+LLD + DFGLA + N N G+ Y+APE
Sbjct: 124 I---GITHRDIKPENLLLDERDNLKISDFGLA-TVFRYNNRERLLNKM-CGTLPYVAPEL 178
Query: 1130 -----YAYSLKATEKCDVYSMGIVLMELVSGKMPTD 1160
+ E DV+S GIVL +++G++P D
Sbjct: 179 LKRREF-----HAEPVDVWSCGIVLTAMLAGELPWD 209
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 3e-23
Identities = 40/289 (13%), Positives = 91/289 (31%), Gaps = 33/289 (11%)
Query: 954 IGSGGSGTVYKAE------LANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVK 1007
+G G VY+A N +K + T+ ++ L +K
Sbjct: 73 LGEGAFAQVYEATQGDLNDAKNKQKFVLKVQK-PANPWEFYIGTQLMERLKPSMQHMFMK 131
Query: 1008 LMGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEY 1067
+ +L+ E G++ + ++ K + + A+ + +E
Sbjct: 132 FYSAHLFQNGS--VLVGELYSYGTLLNAINL--YKNTPEKVMPQGLVISFAMRMLYMIEQ 187
Query: 1068 LHHDCVPKILHRDIKSSNILLDSNMEAH-----------LGDFGLAKALVEDYNSNTESN 1116
+H +I+H DIK N +L + L D G + + + + T
Sbjct: 188 VHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDM-KLFPKGTIFT 243
Query: 1117 TWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMH 1176
+ G+ E + + D + + + ++ G G E
Sbjct: 244 A-KCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEG----- 297
Query: 1177 MEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSR 1225
++ ++ +L +C L++ Q K Q+ +++
Sbjct: 298 -LFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNK 345
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 4e-23
Identities = 50/213 (23%), Positives = 90/213 (42%), Gaps = 17/213 (7%)
Query: 954 IGSGGSGTVYKAE-LANGATVAVK---KISCKDDHLLNKSFTREVKTLGRIRHRHLVKLM 1009
+G G G V + AVK K + + +E++ L R+RH+++++L+
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 1010 GHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLH 1069
N+ ++ EY G + L + ++ +A L G+EYLH
Sbjct: 73 DVLYNEEKQKMYMVMEYCVCGM-QEMLDS----VPEKRFPVCQAH-GYFCQLIDGLEYLH 126
Query: 1070 HDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPE 1129
I+H+DIK N+LL + + G+A + + ++ T GS + PE
Sbjct: 127 SQ---GIVHKDIKPGNLLLTTGGTLKISALGVA-EALHPFAADDTCRTS-QGSPAFQPPE 181
Query: 1130 YAYSLKATE--KCDVYSMGIVLMELVSGKMPTD 1160
A L K D++S G+ L + +G P +
Sbjct: 182 IANGLDTFSGFKVDIWSAGVTLYNITTGLYPFE 214
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 4e-23
Identities = 57/243 (23%), Positives = 97/243 (39%), Gaps = 62/243 (25%)
Query: 954 IGSGGSGTVYKAE-LANGATVAVK-----KISCKDDHLLNKSFT---------------- 991
IG G G V A + A+K K+ +
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 992 ----REVKTLGRIRHRHLVKL---MGHCCNKGAGSNLLIY---EYMENGSVWDWLHKQPV 1041
+E+ L ++ H ++VKL + + +Y E + G V + +P+
Sbjct: 81 EQVYQEIAILKKLDHPNVVKLVEVLDD------PNEDHLYMVFELVNQGPVMEVPTLKPL 134
Query: 1042 NIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGL 1101
+ +AR L +G+EYLH+ KI+HRDIK SN+L+ + + DFG+
Sbjct: 135 SED-------QAR-FYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGV 183
Query: 1102 AKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEK------CDVYSMGIVLMELVSG 1155
+ + ++ + G+ ++APE SL T K DV++MG+ L V G
Sbjct: 184 S-NEFKGSDALLSN---TVGTPAFMAPE---SLSETRKIFSGKALDVWAMGVTLYCFVFG 236
Query: 1156 KMP 1158
+ P
Sbjct: 237 QCP 239
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 6e-23
Identities = 62/216 (28%), Positives = 93/216 (43%), Gaps = 30/216 (13%)
Query: 954 IGSGGSGTVYKAE-LANGATVAVKKISCKDDHL-LNKSFTREVKTLGRIRHRHLVKLMGH 1011
+G G G V A VAVK + + ++ +E+ + H ++VK GH
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVD-MKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 1012 CCNKGAGSNL-LIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHH 1070
+ L EY G ++D + +I M + +A+ + L GV YLH
Sbjct: 74 RREG---NIQYLFLEYCSGGELFDRIEP---DIGMP---EPDAQ-RFFHQLMAGVVYLHG 123
Query: 1071 DCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPE- 1129
I HRDIK N+LLD + DFGLA + N N G+ Y+APE
Sbjct: 124 I---GITHRDIKPENLLLDERDNLKISDFGLA-TVFRYNNRERLLNKM-CGTLPYVAPEL 178
Query: 1130 -----YAYSLKATEKCDVYSMGIVLMELVSGKMPTD 1160
+ E DV+S GIVL +++G++P D
Sbjct: 179 LKRREF-----HAEPVDVWSCGIVLTAMLAGELPWD 209
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 6e-23
Identities = 56/236 (23%), Positives = 86/236 (36%), Gaps = 65/236 (27%)
Query: 954 IGSGGSGTVYKAE-LANGATVAVKKI--------SCKDDHLLNKSFTREVKTLGRIRHRH 1004
+GSG G V+ A V VK I +D L K T E+ L R+ H +
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGK-VTLEIAILSRVEHAN 90
Query: 1005 LVKLMGHCCNKGAGSNLLIYEYMEN--------------GSVWDWLHKQPVNIKMRKSLD 1050
++K+ + EN ++ ++ + P ++ +
Sbjct: 91 IIKV---------------LDIFENQGFFQLVMEKHGSGLDLFAFIDRHP---RLDEP-- 130
Query: 1051 WEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYN 1110
A I L V YL I+HRDIK NI++ + L DFG A L
Sbjct: 131 -LAS-YIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKL 185
Query: 1111 SNTESNTWFAGSYGYIAPE------YAYSLKATEKCDVYSMGIVLMELVSGKMPTD 1160
T F G+ Y APE Y + +++S+G+ L LV + P
Sbjct: 186 FYT-----FCGTIEYCAPEVLMGNPYRGP-----ELEMWSLGVTLYTLVFEENPFC 231
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 8e-23
Identities = 54/252 (21%), Positives = 93/252 (36%), Gaps = 19/252 (7%)
Query: 193 LEELILQQNQLQGPIPAELGNCSSLSIFTAAENNLNGSIPAALGRLQNLQLLNLGNNSLS 252
+ E I ++ P + + ++ ++ L ++ + N+ +
Sbjct: 1 MGETITVSTPIKQIFP--DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK 56
Query: 253 GEIPSELGELSQLGYLNLMGNRLEGAIPRSFAKMGNLQSLDLSMNRLTGGIPEEFGNMGQ 312
+ + L + L L GN+L P + NL L L N++ ++ +
Sbjct: 57 -SV-QGIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIK--DLSSLKDLKK 110
Query: 313 LVFLVLSNNNISGSIPRRICTNATSLEHLILAEIQLSGEIPVELSQCQSLKQLDLSNNTL 372
L L L +N IS I + LE L L +++ +I V LS+ L L L +N +
Sbjct: 111 LKSLSLEHNGIS-DING--LVHLPQLESLYLGNNKIT-DITV-LSRLTKLDTLSLEDNQI 165
Query: 373 NGTIPVELFQLVALTHLYLHNNSLVGSISPFVANLSNLQELALYHNNFQGSLPREIGMLV 432
+ I L L L +LYL N + + A L NL L L+ LV
Sbjct: 166 S-DIV-PLAGLTKLQNLYLSKNHIS-DLRAL-AGLKNLDVLELFSQECLNKPINHQSNLV 221
Query: 433 KLELLYLYDNHL 444
+ D L
Sbjct: 222 VPNTVKNTDGSL 233
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 98.3 bits (244), Expect = 4e-21
Identities = 54/288 (18%), Positives = 105/288 (36%), Gaps = 44/288 (15%)
Query: 86 SISPSLGRLQSLIHLDLSSNSLTGPIPTALSNLSSLESLLLFSNQLAGTIPTQLGSLTSL 145
I P I +L S+T + + L+S++ ++ ++ + + L ++
Sbjct: 13 QIFP-DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDI--KSVQGIQYLPNV 67
Query: 146 RVMRIGDNWLSGSIPTSFGNLVNLGTLGLASCSLSGPIPPQFGQLSQLEELILQQNQLQG 205
+ + N L+ I NL NLG L L + + L +L+ L L+ N +
Sbjct: 68 TKLFLNGNKLT-DI-KPLTNLKNLGWLFLDENKIKD-LSS-LKDLKKLKSLSLEHNGI-- 121
Query: 206 PIPAELGNCSSLSIFTAAENNLNGSIPAALGRLQNLQLLNLGNNSLSGEIPSELGELSQL 265
S ++ L L L+ L LGNN ++ + L L++L
Sbjct: 122 ---------SDIN---------------GLVHLPQLESLYLGNNKIT--DITVLSRLTKL 155
Query: 266 GYLNLMGNRLEGAIPRSFAKMGNLQSLDLSMNRLTGGIPEEFGNMGQLVFLVLSNNNISG 325
L+L N++ +P A + LQ+L LS N ++ + L L L +
Sbjct: 156 DTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHIS--DLRALAGLKNLDVLELFSQECLN 211
Query: 326 SIPRRICTNATSLEHLILAEIQLSGEIPVELSQCQSLKQLDLSNNTLN 373
+N + + L P +S ++ ++ +
Sbjct: 212 KPINHQ-SNLVVPNTVKNTDGSL--VTPEIISDDGDYEKPNVKWHLPE 256
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 98.3 bits (244), Expect = 5e-21
Identities = 56/332 (16%), Positives = 117/332 (35%), Gaps = 41/332 (12%)
Query: 362 LKQLDLSNNTLNGTIPVELFQLVALTHLYLHNNSLVGSISPFVANLSNLQELALYHNNFQ 421
+ + + + P + L S+ L+++ ++ +++ +
Sbjct: 1 MGETITVSTPIKQIFPDD--AFAETIKDNLKKKSVT-DAVTQ-NELNSIDQIIANNSDIK 56
Query: 422 GSLPREIGMLVKLELLYLYDNHLSGQIPSEVGNCSSLKWIDFFGNSFTGEIPTSIGRLKD 481
S+ I L + L+L N L+ I + N +L W+ N ++ +S+ LK
Sbjct: 57 -SVQ-GIQYLPNVTKLFLNGNKLT-DI-KPLTNLKNLGWLFLDENKIK-DL-SSLKDLKK 110
Query: 482 LNFLHLRQNELVGQIPASLGNCHQLIILDLADNKLSGGVPASFGFLQALEQLMLYNNSLE 541
L L L N + I L + QL L L +NK++ L L+ L L +N +
Sbjct: 111 LKSLSLEHNGIS-DING-LVHLPQLESLYLGNNKIT--DITVLSRLTKLDTLSLEDNQIS 166
Query: 542 GNLPGSLINLRNLTRINFSKNRLNGRIATLCSSHSFLSFDVTNNEFDHEIPPQLGNSPSL 601
++ L L L + SKN ++ ++ L +L
Sbjct: 167 -DIVP-LAGLTKLQNLYLSKNHIS------------------------DLRA-LAGLKNL 199
Query: 602 ERLRLGNNKFIGKIPWTFGKIRELSLLDLSGNSLTGPIPTQLLMCKKLSHIDLNNNLLSG 661
+ L L + + + K + + + + SL P + ++ + +
Sbjct: 200 DVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIISDDGDYEKPNVKWHLPEFTN 259
Query: 662 AVPSWLGTLPQLGELKLSFNQFVGFLPRELFN 693
V +G+ K F+ V +E++
Sbjct: 260 EVSFIFYQPVTIGKAKARFHGRVTQPLKEVYT 291
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 97.9 bits (243), Expect = 6e-21
Identities = 52/259 (20%), Positives = 100/259 (38%), Gaps = 21/259 (8%)
Query: 165 NLVNLGTLGLASCSLSGPIPPQFGQLSQLEELILQQNQLQGPIPAELGNCSSLSIFTAAE 224
L S++ + +L+ ++++I + ++ + + +++
Sbjct: 19 AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKS-VQG-IQYLPNVTKLFLNG 74
Query: 225 NNLNGSIPAALGRLQNLQLLNLGNNSLSGEIPSELGELSQLGYLNLMGNRLEGAIPRSFA 284
N L I L L+NL L L N + ++ S L +L +L L+L N + I
Sbjct: 75 NKLT-DIKP-LTNLKNLGWLFLDENKIK-DL-SSLKDLKKLKSLSLEHNGIS-DIN-GLV 128
Query: 285 KMGNLQSLDLSMNRLTGGIPEEFGNMGQLVFLVLSNNNISGSIPRRICTNATSLEHLILA 344
+ L+SL L N++T + +L L L +N IS I T L++L L+
Sbjct: 129 HLPQLESLYLGNNKIT--DITVLSRLTKLDTLSLEDNQIS-DIV--PLAGLTKLQNLYLS 183
Query: 345 EIQLSGEIPVELSQCQSLKQLDLSNNTLNGTIPVELFQLVALTHLYLHNNSLVG----SI 400
+ +S ++ L+ ++L L+L + LV + + SLV S
Sbjct: 184 KNHIS-DLR-ALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIISD 241
Query: 401 SPFVANLSNLQELALYHNN 419
+ L + N
Sbjct: 242 DGDYEKPNVKWHLPEFTNE 260
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 91.7 bits (227), Expect = 5e-19
Identities = 50/250 (20%), Positives = 95/250 (38%), Gaps = 18/250 (7%)
Query: 590 EIPPQLGNSPSLERLRLGNNKFIGKIPWTFGKIRELSLLDLSGNSLTGPIPTQLLMCKKL 649
+I P + L + T ++ + + + + + + +
Sbjct: 13 QIFP-DDAFAETIKDNLKKKS-VTDAV-TQNELNSIDQIIANNSDIK--SVQGIQYLPNV 67
Query: 650 SHIDLNNNLLSGAVPSWLGTLPQLGELKLSFNQFVGFLPRELFNCSKLLVLSLDGNMLNG 709
+ + LN N L+ P L L LG L L N+ L + KL LSL+ N ++
Sbjct: 68 TKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIKDLSS--LKDLKKLKSLSLEHNGIS- 122
Query: 710 SLPNEVGNLASLNVLTLSGNLLSGPIPPAIGRLSKLYELRLSNNSLNGVIPLEIGQLQNL 769
+ + +L L L L N ++ + RL+KL L L +N ++ ++PL L L
Sbjct: 123 DING-LVHLPQLESLYLGNNKITDITV--LSRLTKLDTLSLEDNQISDIVPLA--GLTKL 177
Query: 770 QSILDLSHNNFTGQIPPSMGTLAKLEVLNLSHNQLVGELPSQLGEMSSLGKLNLSYNDLQ 829
Q+ L LS N+ + + + L L+VL L + + + + + + + L
Sbjct: 178 QN-LYLSKNHIS-DLRA-LAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLV 234
Query: 830 GKLSKQFSHW 839
Sbjct: 235 TPEIISDDGD 244
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 89.8 bits (222), Expect = 2e-18
Identities = 55/318 (17%), Positives = 105/318 (33%), Gaps = 44/318 (13%)
Query: 530 LEQLMLYNNSLEGNLPGSLINLRNLTRINFSKNRLNGRIATLCSSHSFLSFDVTNNEFDH 589
+ + + + ++ + + N K +
Sbjct: 1 MGETITVSTPIK-QIFP-DDAFAETIKDNLKKKSVT------------------------ 34
Query: 590 EIPPQLGNSPSLERLRLGNNKFIGKIPWTFGKIRELSLLDLSGNSLTGPIPTQLLMCKKL 649
+ S++++ N+ I + + ++ L L+GN LT P L K L
Sbjct: 35 DAVT-QNELNSIDQIIANNSD-IKSVQ-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNL 89
Query: 650 SHIDLNNNLLSGAVPSWLGTLPQLGELKLSFNQFVGFLPRELFNCSKLLVLSLDGNMLNG 709
+ L+ N + L L +L L L N L + +L L L N +
Sbjct: 90 GWLFLDENKIKDLSS--LKDLKKLKSLSLEHNGISDING--LVHLPQLESLYLGNNKIT- 144
Query: 710 SLPNEVGNLASLNVLTLSGNLLSGPIPPAIGRLSKLYELRLSNNSLNGVIPLEIGQLQNL 769
+ + L L+ L+L N +S I P + L+KL L LS N ++ + L L+NL
Sbjct: 145 DITV-LSRLTKLDTLSLEDNQISD-IVP-LAGLTKLQNLYLSKNHISDLRALA--GLKNL 199
Query: 770 QSILDLSHNNFTGQIPPSMGTLAKLEVLNLSHNQLVGELPSQLGEMSSLGKLNLSYNDLQ 829
+L+L + L + + L P + + K N+ ++ +
Sbjct: 200 D-VLELFSQECLNKPINHQSNLVVPNTVKNTDGSL--VTPEIISDDGDYEKPNVKWHLPE 256
Query: 830 GKLSKQFSHWPAEAFEGN 847
F +
Sbjct: 257 FTNEVSFIFYQPVTIGKA 274
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 77.1 bits (189), Expect = 2e-14
Identities = 46/226 (20%), Positives = 92/226 (40%), Gaps = 16/226 (7%)
Query: 75 SLNLSGLSLAGSISPSLGRLQSLIHLDLSSNSLTGPIPTALSNLSSLESLLLFSNQLAGT 134
+ + + S+ + L ++ L L+ N LT I L+NL +L L L N++
Sbjct: 47 QIIANNSDIK-SVQG-IQYLPNVTKLFLNGNKLTD-I-KPLTNLKNLGWLFLDENKIKDL 102
Query: 135 IPTQLGSLTSLRVMRIGDNWLSGSIPTSFGNLVNLGTLGLASCSLSGPIPPQFGQLSQLE 194
L L L+ + + N +S I +L L +L L + ++ +L++L+
Sbjct: 103 SS--LKDLKKLKSLSLEHNGIS-DI-NGLVHLPQLESLYLGNNKITDITV--LSRLTKLD 156
Query: 195 ELILQQNQLQGPIPAELGNCSSLSIFTAAENNLNGSIPAALGRLQNLQLLNLGNNSLSGE 254
L L+ NQ+ I L + L ++N+++ + A L L+NL +L L + +
Sbjct: 157 TLSLEDNQISD-IVP-LAGLTKLQNLYLSKNHIS-DLRA-LAGLKNLDVLELFSQECLNK 212
Query: 255 IPSELGELSQLGYLNLMGNRLEGAIPRSFAKMGNLQSLDLSMNRLT 300
+ L + L P + G+ + ++ +
Sbjct: 213 PINHQSNLVVPNTVKNTDGSLV--TPEIISDDGDYEKPNVKWHLPE 256
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 1e-22
Identities = 51/232 (21%), Positives = 96/232 (41%), Gaps = 36/232 (15%)
Query: 942 MGATNNLSDEFI----IGSGGSGTVYKA-ELANGATVAVKKIS---CKDDHLLNKSFTRE 993
+ + D FI +GSG G V+ E ++G +K I+ + + E
Sbjct: 14 LYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPM---EQIEAE 70
Query: 994 VKTLGRIRHRHLVKLMGHCCNKGAGSNL-LIYEYMENGSVWDWLHKQPVNIKMRKSLDWE 1052
++ L + H +++K+ + N+ ++ E E G + + + K
Sbjct: 71 IEVLKSLDHPNIIKIFEVFEDY---HNMYIVMETCEGGELLERIVSAQARGKALSEGY-- 125
Query: 1053 ARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAH---LGDFGLAKALVEDY 1109
++ + + Y H ++H+D+K NIL + DFGLA+ D
Sbjct: 126 VA-ELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE 181
Query: 1110 NSNTESNTWFAGSYGYIAPE---YAYSLKATEKCDVYSMGIVLMELVSGKMP 1158
+S AG+ Y+APE + KCD++S G+V+ L++G +P
Sbjct: 182 HSTN-----AAGTALYMAPEVFKRDVT----FKCDIWSAGVVMYFLLTGCLP 224
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 1e-22
Identities = 61/224 (27%), Positives = 99/224 (44%), Gaps = 47/224 (20%)
Query: 954 IGSGGSGTVYKAE-LANGATVAVK---KISCKDDHLLNKSFTREVKTLGRIRHRHLVKL- 1008
+G G G V E G VAVK + + ++ K RE++ L RH H++KL
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIK-REIQNLKLFRHPHIIKLY 77
Query: 1009 --MGHCCNKGAGSNLLIY---EYMENGSVWDWL-HKQPVNIKMRKSLDWEARLKIAVGLA 1062
+ + + EY+ G ++D++ V EAR ++ +
Sbjct: 78 QVIS--------TPTDFFMVMEYVSGGELFDYICKHGRVEEM-------EAR-RLFQQIL 121
Query: 1063 QGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGS 1122
V+Y H ++HRD+K N+LLD++M A + DFGL+ + + T GS
Sbjct: 122 SAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRT-----SCGS 173
Query: 1123 YGYIAPE------YAYSLKATEKCDVYSMGIVLMELVSGKMPTD 1160
Y APE YA + D++S G++L L+ G +P D
Sbjct: 174 PNYAAPEVISGRLYAGP-----EVDIWSCGVILYALLCGTLPFD 212
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 1e-22
Identities = 66/225 (29%), Positives = 97/225 (43%), Gaps = 35/225 (15%)
Query: 101 DLSSNSLTGPIPTALSNLSSLESLLLFSNQLAGTIPTQLGSLTSLRVMRIGDNWLSGSIP 160
D SS LT IP+ + + + L L SN+L+ LT LR++ + DN L ++P
Sbjct: 22 DCSSKKLTA-IPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLP 77
Query: 161 TS-FGNLVNLGTLGLASCSLSGPIPPQ-FGQLSQLEELILQQNQLQGPIPAELGNCSSLS 218
F L NL TL + L +P F QL L EL L +NQL+
Sbjct: 78 AGIFKELKNLETLWVTDNKLQA-LPIGVFDQLVNLAELRLDRNQLK-------------- 122
Query: 219 IFTAAENNLNGSIPA-ALGRLQNLQLLNLGNNSLSGEIPSEL-GELSQLGYLNLMGNRLE 276
S+P L L L+LG N L +P + +L+ L L L N+L+
Sbjct: 123 -----------SLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLK 170
Query: 277 GAIPRSFAKMGNLQSLDLSMNRLTGGIPEEFGNMGQLVFLVLSNN 321
+F K+ L++L L N+L F ++ +L L L N
Sbjct: 171 RVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 2e-20
Identities = 51/183 (27%), Positives = 88/183 (48%), Gaps = 9/183 (4%)
Query: 288 NLQSLDLSMNRLTGGIPEEFGNMGQLVFLVLSNNNISGSIPRRICTNATSLEHLILAEIQ 347
+ + LDL N+L+ + F + +L L L++N + ++P I +LE L + + +
Sbjct: 38 DTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNK 96
Query: 348 LSGEIPVEL-SQCQSLKQLDLSNNTLNGTIPVELF-QLVALTHLYLHNNSLVGSISPFV- 404
L +P+ + Q +L +L L N L ++P +F L LT+L L N L S+ V
Sbjct: 97 LQ-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVF 153
Query: 405 ANLSNLQELALYHNNFQGSLPREI-GMLVKLELLYLYDNHLSGQIPSEVGNCSSLKWIDF 463
L++L+EL LY+N + +P L +L+ L L +N L + LK +
Sbjct: 154 DKLTSLKELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQL 212
Query: 464 FGN 466
N
Sbjct: 213 QEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 2e-17
Identities = 59/209 (28%), Positives = 87/209 (41%), Gaps = 38/209 (18%)
Query: 361 SLKQLDLSNNTLNGTIPVELFQ-LVALTHLYLHNNSLVGSISPFV-ANLSNLQELALYHN 418
K+LDL +N L+ ++P + F L L LYL++N L ++ + L NL+ L + N
Sbjct: 38 DTKKLDLQSNKLS-SLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDN 95
Query: 419 NFQGSLPREI-GMLVKLELLYLYDNHLSGQIPSEVGNCSSLKWIDFFGNSFTGEIPTSIG 477
Q +LP + LV L L L N L +P V F
Sbjct: 96 KLQ-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRV---------------FDS------- 131
Query: 478 RLKDLNFLHLRQNELVGQIPA----SLGNCHQLIILDLADNKLSGGVPASFGFLQALEQL 533
L L +L L NEL +P L + L L L +N+L +F L L+ L
Sbjct: 132 -LTKLTYLSLGYNELQ-SLPKGVFDKLTS---LKELRLYNNQLKRVPEGAFDKLTELKTL 186
Query: 534 MLYNNSLEGNLPGSLINLRNLTRINFSKN 562
L NN L+ G+ +L L + +N
Sbjct: 187 KLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 2e-15
Identities = 51/185 (27%), Positives = 72/185 (38%), Gaps = 32/185 (17%)
Query: 93 RLQSLIHLDLSSNSLTGPIPTALSNLSSLESLLLFSNQLAGTIPTQL-GSLTSLRVMRIG 151
RL L L L+ N L L +LE+L + N+L +P + L +L +R+
Sbjct: 59 RLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLD 117
Query: 152 DNWLSGSIPTS-FGNLVNLGTLGLASCSLSGPIPPQ-FGQLSQLEELILQQNQLQGPIPA 209
N L S+P F +L L L L L +P F +L+ L+EL L NQL+
Sbjct: 118 RNQLK-SLPPRVFDSLTKLTYLSLGYNELQS-LPKGVFDKLTSLKELRLYNNQLK----- 170
Query: 210 ELGNCSSLSIFTAAENNLNGSIPA-ALGRLQNLQLLNLGNNSLSGEIPSELGELSQLGYL 268
+P A +L L+ L L NN L L +L L
Sbjct: 171 --------------------RVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKML 210
Query: 269 NLMGN 273
L N
Sbjct: 211 QLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 4e-13
Identities = 66/213 (30%), Positives = 91/213 (42%), Gaps = 26/213 (12%)
Query: 572 CSSHSFLSFDVTNNEFDHEIPPQLGNSPSLERLRLGNNKFIGKIPWTFGKIRELSLLDLS 631
CSS + IP ++L L +NK F ++ +L LL L+
Sbjct: 23 CSSKKLTA-----------IPS--NIPADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLN 69
Query: 632 GNSLTG-P--IPTQLLMCKKLSHIDLNNNLLSGAVPSWLGT-LPQLGELKLSFNQFVGFL 687
N L P I +L K L + + +N L A+P + L L EL+L NQ L
Sbjct: 70 DNKLQTLPAGIFKEL---KNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLK-SL 124
Query: 688 PRELF-NCSKLLVLSLDGNMLNGSLPNEV-GNLASLNVLTLSGNLLSGPIPPAIGRLSKL 745
P +F + +KL LSL N L SLP V L SL L L N L A +L++L
Sbjct: 125 PPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTEL 183
Query: 746 YELRLSNNSLNGVIPLEIGQLQNLQSILDLSHN 778
L+L NN L V L+ L+ + L N
Sbjct: 184 KTLKLDNNQLKRVPEGAFDSLEKLKML-QLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 1e-10
Identities = 57/217 (26%), Positives = 81/217 (37%), Gaps = 43/217 (19%)
Query: 496 IPASLGNCHQLIILDLADNKLSGGVPASFGFLQALEQLMLYNNSLEGNLPGSLINLRNLT 555
IPA LDL NKLS +F L L L L +N L+ G L+NL
Sbjct: 35 IPADTKK------LDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLE 88
Query: 556 RINFSKNRLNGRIATLCSSHSFLSFDVTNNEFDHEIPPQLGNSP-SLERLRLGNNKFIGK 614
+ + N+L +P + + +L LRL N+ +
Sbjct: 89 TLWVTDNKL------------------------QALPIGVFDQLVNLAELRLDRNQ-LKS 123
Query: 615 IP-WTFGKIRELSLLDLSGNSLTGPIP----TQLLMCKKLSHIDLNNNLLSGAVPSWLGT 669
+P F + +L+ L L N L +P +L L + L NN L
Sbjct: 124 LPPRVFDSLTKLTYLSLGYNELQS-LPKGVFDKL---TSLKELRLYNNQLKRVPEGAFDK 179
Query: 670 LPQLGELKLSFNQFVGFLPRELF-NCSKLLVLSLDGN 705
L +L LKL NQ +P F + KL +L L N
Sbjct: 180 LTELKTLKLDNNQLKR-VPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 1e-08
Identities = 45/152 (29%), Positives = 67/152 (44%), Gaps = 17/152 (11%)
Query: 699 VLSLDGNMLNGSLPNEVGNLASLNVLTLSGNLLSGPIPPAI-GRLSKLYELRLSNNSLNG 757
L L N L+ L L +L L+ N L +P I L L L +++N L
Sbjct: 41 KLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQT-LPAGIFKELKNLETLWVTDNKLQ- 98
Query: 758 VIPLEI-GQLQNLQSILDLSHNNFTGQIPPSM-GTLAKLEVLNLSHNQLVGELPSQL-GE 814
+P+ + QL NL L L N +PP + +L KL L+L +N+L LP + +
Sbjct: 99 ALPIGVFDQLVNLA-ELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDK 155
Query: 815 MSSLGKLNLSYNDLQGKLSKQFSHWPAEAFEG 846
++SL +L L N Q P AF+
Sbjct: 156 LTSLKELRLYNN--------QLKRVPEGAFDK 179
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 2e-22
Identities = 52/222 (23%), Positives = 91/222 (40%), Gaps = 35/222 (15%)
Query: 954 IGSGGSGTVYKAE-LANGATVAVK-----KISCKDDHLLNKSFTREVKTLGRIR----HR 1003
+G GG GTV+ L + VA+K ++ + + EV L ++ H
Sbjct: 39 LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 1004 HLVKLMGHCCNKGAGSNL-LIYEYMENGS-VWDWLHKQPVNIKMRKSLD-WEARLKIAVG 1060
+++L+ + L+ E ++D+ I + L +R
Sbjct: 99 GVIRLLDWFETQ---EGFMLVLERPLPAQDLFDY-------ITEKGPLGEGPSR-CFFGQ 147
Query: 1061 LAQGVEYLHHDCVPKILHRDIKSSNILLDSNM-EAHLGDFGLAKALVEDYNSNTESNTWF 1119
+ +++ H ++HRDIK NIL+D A L DFG AL+ D F
Sbjct: 148 VVAAIQHCHSR---GVVHRDIKDENILIDLRRGCAKLIDFGSG-ALLHDEPYTD-----F 198
Query: 1120 AGSYGYIAPEY-AYSLKATEKCDVYSMGIVLMELVSGKMPTD 1160
G+ Y PE+ + V+S+GI+L ++V G +P +
Sbjct: 199 DGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFE 240
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 97.6 bits (244), Expect = 4e-22
Identities = 59/221 (26%), Positives = 94/221 (42%), Gaps = 49/221 (22%)
Query: 954 IGSGGSGTVYKA-ELANGATVAVKKISC-KDDHLLNKSFTREVKTLGRIRHRHLVKLMGH 1011
IG G G V+K G VA+KK +DD ++ K RE++ L +++H +LV L+
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70
Query: 1012 CCNKGAGSNL-LIYEYMENGSVWDWLHKQPVNIKMR--KSLDWEARLKIAVGLAQGVEYL 1068
K L L++EY ++ +V L + + KS+ W+ Q V +
Sbjct: 71 FRRKR---RLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQ--------TLQAVNFC 118
Query: 1069 HHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNT------WFAGS 1122
H +HRD+K NIL+ + L DFG A+ ++ W
Sbjct: 119 HKH---NCIHRDVKPENILITKHSVIKLCDFGFARL----LTGPSDYYDDEVATRW---- 167
Query: 1123 YGYIAPE-------YAYSLKATEKCDVYSMGIVLMELVSGK 1156
Y +PE Y + DV+++G V EL+SG
Sbjct: 168 --YRSPELLVGDTQYGPPV------DVWAIGCVFAELLSGV 200
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 5e-22
Identities = 51/232 (21%), Positives = 89/232 (38%), Gaps = 60/232 (25%)
Query: 953 IIGSGGSGTVYKA-ELANGATVAVKKISCKDDHLLNKSFT----REVKTLGRIRHRHLVK 1007
+ G G GTV E + G +VA+KK+ + + F + ++ L + H ++V+
Sbjct: 30 MAGQGTFGTVQLGKEKSTGMSVAIKKV------IQDPRFRNRELQIMQDLAVLHHPNIVQ 83
Query: 1008 LMGHCCNKGAGSN-----LLIYEYME----NGSVWDWLHKQPVNIKMRKSLDWEARLKIA 1058
L + G ++ EY+ + + + K ++
Sbjct: 84 LQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQ------ 137
Query: 1059 VGLAQGVEYLHHDCVPKILHRDIKSSNILLD-SNMEAHLGDFGLAKALVEDYNSNTESNT 1117
L + + LH V + HRDIK N+L++ ++ L DFG AK L N
Sbjct: 138 --LIRSIGCLHLPSV-NVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPS-EPNVA--- 190
Query: 1118 WFAGSYGYI------APE-------YAYSLKATEKCDVYSMGIVLMELVSGK 1156
YI APE Y T D++S+G + E++ G+
Sbjct: 191 -------YICSRYYRAPELIFGNQHY------TTAVDIWSVGCIFAEMMLGE 229
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 99.1 bits (247), Expect = 5e-22
Identities = 48/233 (20%), Positives = 91/233 (39%), Gaps = 54/233 (23%)
Query: 952 FIIGSGGSGTVYKA---ELANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKL 1008
+G G G VYKA + + A+K+I + + + RE+ L ++H +++ L
Sbjct: 27 CKVGRGTYGHVYKAKRKDGKDDKDYALKQI--EGTGISMSAC-REIALLRELKHPNVISL 83
Query: 1009 MGHCCNKGAGSNLLIYEYME---------NGSVWDWLHKQPVNIKMRKSLDWEARLKIAV 1059
+ L+++Y E + + + M KSL ++
Sbjct: 84 QKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQ------- 136
Query: 1060 GLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAH----LGDFGLAKALVEDYNSNTES 1115
+ G+ YLH + +LHRD+K +NIL+ + D G A+ +
Sbjct: 137 -ILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADL 192
Query: 1116 NT-----WFAGSYGYIAPE-------YAYSLKATEKCDVYSMGIVLMELVSGK 1156
+ W Y APE Y T+ D++++G + EL++ +
Sbjct: 193 DPVVVTFW------YRAPELLLGARHY------TKAIDIWAIGCIFAELLTSE 233
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 5e-22
Identities = 66/228 (28%), Positives = 100/228 (43%), Gaps = 58/228 (25%)
Query: 953 IIGSGGSGTVYKAEL-ANGATVAVKKISCKDDHLLNKSFT-REVKTLGRIRHRHLVKLMG 1010
+IG+G G VY+A+L +G VA+KK+ L +K F RE++ + ++ H ++V+L
Sbjct: 61 VIGNGSFGVVYQAKLCDSGELVAIKKV------LQDKRFKNRELQIMRKLDHCNIVRLRY 114
Query: 1011 HCCNKGAGSNL----LIYEYME----NGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLA 1062
+ G + L+ +Y+ + KQ + + K ++ L
Sbjct: 115 FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ--------LF 166
Query: 1063 QGVEYLHHDCVPKILHRDIKSSNILLDSNMEA-HLGDFGLAKALVEDYNSNTESNTWFAG 1121
+ + Y+H I HRDIK N+LLD + L DFG AK LV E N
Sbjct: 167 RSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-----EPNV---- 214
Query: 1122 SYGYI------APE-------YAYSLKATEKCDVYSMGIVLMELVSGK 1156
YI APE Y T DV+S G VL EL+ G+
Sbjct: 215 --SYICSRYYRAPELIFGATDY------TSSIDVWSAGCVLAELLLGQ 254
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 6e-22
Identities = 62/221 (28%), Positives = 98/221 (44%), Gaps = 45/221 (20%)
Query: 953 IIGSGGSGTVYKAELANGATVAVKKISCKDDHLLNKSFT-REVKTLGRIRHRHLVKLMGH 1011
+IG+G G V++A+L VA+KK+ L +K F RE++ + ++H ++V L
Sbjct: 47 VIGNGSFGVVFQAKLVESDEVAIKKV------LQDKRFKNRELQIMRIVKHPNVVDLKAF 100
Query: 1012 CCNKGAGSNL----LIYEYME----NGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQ 1063
+ G + L+ EY+ S KQ + + + K ++ L +
Sbjct: 101 FYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQ--------LLR 152
Query: 1064 GVEYLHHDCVPKILHRDIKSSNILLDSNM-EAHLGDFGLAKALVEDYNSNTESNTWFAGS 1122
+ Y+H I HRDIK N+LLD L DFG AK L+ E N
Sbjct: 153 SLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAG-----EPNV----- 199
Query: 1123 YGYI------APEYAY-SLKATEKCDVYSMGIVLMELVSGK 1156
YI APE + + T D++S G V+ EL+ G+
Sbjct: 200 -SYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 8e-22
Identities = 54/238 (22%), Positives = 100/238 (42%), Gaps = 44/238 (18%)
Query: 939 EDIMGATNNLSDEF----IIGSGGSGTVYKA-ELANGATVAVKKIS----CKDDHLLNKS 989
E +M A+ SD + +G G V + G A K I+ D +
Sbjct: 18 EFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDF---QK 74
Query: 990 FTREVKTLGRIRHRHLVKLMGHCCNKGAGSNL-LIYEYMENGSVWDWLHKQPVNIKMRKS 1048
RE + +++H ++V+L + L+++ + G +++ I R+
Sbjct: 75 LEREARICRKLQHPNIVRLHDSIQEES---FHYLVFDLVTGGELFED-------IVAREF 124
Query: 1049 LD-WEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAH---LGDFGLAKA 1104
+A + + + Y H + I+HR++K N+LL S + L DFGLA
Sbjct: 125 YSEADAS-HCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIE 180
Query: 1105 LVEDYNSNTESNTWFAGSYGYIAPE----YAYSLKATEKCDVYSMGIVLMELVSGKMP 1158
+ + + FAG+ GY++PE YS + D+++ G++L L+ G P
Sbjct: 181 VNDSEAWHG-----FAGTPGYLSPEVLKKDPYS----KPVDIWACGVILYILLVGYPP 229
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 9e-22
Identities = 61/232 (26%), Positives = 96/232 (41%), Gaps = 59/232 (25%)
Query: 954 IGSGGSGTVYKA-ELANGATVAVKKISCKDDHLLNKS----FT--REVKTLGRIRHRHLV 1006
IG G G V+KA G VA+KK+ + N+ T RE+K L ++H ++V
Sbjct: 25 IGQGTFGEVFKARHRKTGQKVALKKV-----LMENEKEGFPITALREIKILQLLKHENVV 79
Query: 1007 KLMG------HCCNKGAGSNLLIYEYMENGSVWD---WLHKQPVNIKMR--KSLDWEARL 1055
L+ N+ GS L++++ E+ D L V + K +
Sbjct: 80 NLIEICRTKASPYNRCKGSIYLVFDFCEH----DLAGLLSNVLVKFTLSEIKRVMQM--- 132
Query: 1056 KIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTES 1115
L G+ Y+H + KILHRD+K++N+L+ + L DFGLA+A NS
Sbjct: 133 -----LLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNR 184
Query: 1116 NT------WFAGSYGYIAPEY-----AYSLKATEKCDVYSMGIVLMELVSGK 1156
T W Y PE Y D++ G ++ E+ +
Sbjct: 185 YTNRVVTLW------YRPPELLLGERDYG----PPIDLWGAGCIMAEMWTRS 226
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 1e-21
Identities = 45/229 (19%), Positives = 88/229 (38%), Gaps = 41/229 (17%)
Query: 945 TNNLSDEFII----GSGGSGTVYKA-ELANGATVAVKKIS---CKDDHLLNKSFTREVKT 996
+++ + + G G G V A + A KKI +D F +E++
Sbjct: 4 KGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDV----DRFKQEIEI 59
Query: 997 LGRIRHRHLVKLMGHCCNKGAGSNL-LIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARL 1055
+ + H ++++L + +++ L+ E G +++ + ++
Sbjct: 60 MKSLDHPNIIRLYETFEDN---TDIYLVMELCTGGELFER-------VVHKRVFRESDAA 109
Query: 1056 KIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAH---LGDFGLAKALVEDYNSN 1112
+I + V Y H + HRD+K N L ++ L DFGLA
Sbjct: 110 RIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMR 166
Query: 1113 TESNTWFAGSYGYIAPE---YAYSLKATEKCDVYSMGIVLMELVSGKMP 1158
T G+ Y++P+ Y +CD +S G+++ L+ G P
Sbjct: 167 T-----KVGTPYYVSPQVLEGLYG----PECDEWSAGVMMYVLLCGYPP 206
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 2e-21
Identities = 59/239 (24%), Positives = 104/239 (43%), Gaps = 37/239 (15%)
Query: 943 GATNNLSDEF---------IIGSGGSGTVYKA-ELANGATVAVKKISCKDDHLLNKSFTR 992
G+T++ S F ++G G V L AVK I K + R
Sbjct: 1 GSTDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIE-KQPGHIRSRVFR 59
Query: 993 EVKTLGRIR-HRHLVKLMGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLD- 1050
EV+ L + + HR++++L+ + L++E M GS+ +I R+ +
Sbjct: 60 EVEMLYQCQGHRNVLELIEFFEEED--RFYLVFEKMRGGSILS-------HIHKRRHFNE 110
Query: 1051 WEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAH---LGDFGLAKALVE 1107
EA + +A +++LH+ I HRD+K NIL + + + DF L +
Sbjct: 111 LEAS-VVVQDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKL 166
Query: 1108 DYNSNTESNTWF---AGSYGYIAPE-----YAYSLKATEKCDVYSMGIVLMELVSGKMP 1158
+ + + S GS Y+APE + ++CD++S+G++L L+SG P
Sbjct: 167 NGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP 225
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 2e-21
Identities = 65/228 (28%), Positives = 97/228 (42%), Gaps = 60/228 (26%)
Query: 954 IGSGGSGTVYKA-ELANGATVAVKKISCKDDHLLNKSF--T--REVKTLGRIRHRHLVKL 1008
+G G TVYKA + VA+KKI T RE+K L + H +++ L
Sbjct: 18 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77
Query: 1009 MGHCCNKGAGSNL-LIYEYMENGSVWDWL------HKQPVNIKMRKSLDWEARLKIAVGL 1061
+ +K SN+ L++++ME D L + + K+
Sbjct: 78 LDAFGHK---SNISLVFDFMET----D-LEVIIKDNSLVLTPSHIKAYMLM--------T 121
Query: 1062 AQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNT---- 1117
QG+EYLH ILHRD+K +N+LLD N L DFGLAK+ + S + T
Sbjct: 122 LQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKS----FGSPNRAYTHQVV 174
Query: 1118 --WFAGSYGYIAPE-------YAYSLKATEKCDVYSMGIVLMELVSGK 1156
W Y APE Y + D++++G +L EL+
Sbjct: 175 TRW------YRAPELLFGARMYGVGV------DMWAVGCILAELLLRV 210
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 94.9 bits (237), Expect = 3e-21
Identities = 55/224 (24%), Positives = 101/224 (45%), Gaps = 31/224 (13%)
Query: 945 TNNLSDEF----IIGSGGSGTVYKA-ELANGATVAVKKISCKDDHLLNKSFTREVKTLGR 999
T N+ F ++GSG V+ + G A+K I K + S E+ L +
Sbjct: 4 TTNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIK-KSPAFRDSSLENEIAVLKK 62
Query: 1000 IRHRHLVKLMGHCCNKGAGSNL-LIYEYMENGSVWDWLHKQPVNIKMRKSL-DWEARLKI 1057
I+H ++V L + ++ L+ + + G ++D I R + +A +
Sbjct: 63 IKHENIVTLEDIYEST---THYYLVMQLVSGGELFDR-------ILERGVYTEKDAS-LV 111
Query: 1058 AVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNME-AHL--GDFGLAKALVEDYNSNTE 1114
+ V+YLH + I+HRD+K N+L + E + + DFGL+K + ++ +T
Sbjct: 112 IQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSK-MEQNGIMST- 166
Query: 1115 SNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMP 1158
G+ GY+APE ++ D +S+G++ L+ G P
Sbjct: 167 ----ACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPP 206
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 94.5 bits (236), Expect = 3e-21
Identities = 55/223 (24%), Positives = 98/223 (43%), Gaps = 49/223 (21%)
Query: 954 IGSGGSGTVYKA-ELANGATVAVKKISC-KDDHLLNKSFTREVKTLGRIRHRHLVKLMGH 1011
IG G GTV+KA VA+K++ DD + S RE+ L ++H+++V+L
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 1012 CCNKGAGSNL-LIYEYMEN--GSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYL 1068
+ L L++E+ + +D ++ ++ KS ++ L +G+ +
Sbjct: 70 LHSD---KKLTLVFEFCDQDLKKYFD-SCNGDLDPEIVKSFLFQ--------LLKGLGFC 117
Query: 1069 HHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNT------WFAGS 1122
H +LHRD+K N+L++ N E L +FGLA+A + + W
Sbjct: 118 HSR---NVLHRDLKPQNLLINRNGELKLANFGLARA----FGIPVRCYSAEVVTLW---- 166
Query: 1123 YGYIAPE-------YAYSLKATEKCDVYSMGIVLMELVSGKMP 1158
Y P+ Y+ S+ D++S G + EL + P
Sbjct: 167 --YRPPDVLFGAKLYSTSI------DMWSAGCIFAELANAGRP 201
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 95.3 bits (238), Expect = 3e-21
Identities = 57/224 (25%), Positives = 103/224 (45%), Gaps = 51/224 (22%)
Query: 954 IGSGGSGTVYKA-ELANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHC 1012
+G+G TVYK G VA+K++ + + RE+ + ++H ++V+L
Sbjct: 13 LGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVI 72
Query: 1013 CNKGAGSNL-LIYEYMEN------GSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGV 1065
+ + L L++E+M+N S + + + + K W+ L QG+
Sbjct: 73 HTE---NKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQ--------LLQGL 121
Query: 1066 EYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNT------WF 1119
+ H + KILHRD+K N+L++ + LGDFGLA+A + + + W
Sbjct: 122 AFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARA----FGIPVNTFSSEVVTLW- 173
Query: 1120 AGSYGYIAPE-------YAYSLKATEKCDVYSMGIVLMELVSGK 1156
Y AP+ Y+ S+ D++S G +L E+++GK
Sbjct: 174 -----YRAPDVLMGSRTYSTSI------DIWSCGCILAEMITGK 206
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 3e-21
Identities = 50/232 (21%), Positives = 98/232 (42%), Gaps = 43/232 (18%)
Query: 945 TNNLSDEF----IIGSGGSGTVYKA-ELANGATVAVKKIS----CKDDHLLNKSFTREVK 995
++E+ +G G V + ++ G A I+ DH + RE +
Sbjct: 6 CTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDH---QKLEREAR 62
Query: 996 TLGRIRHRHLVKLMGHCCNKGAGSNL-LIYEYMENGSVWDWLHKQPVNIKMRKSLD-WEA 1053
++H ++V+L +G + LI++ + G +++ I R+ +A
Sbjct: 63 ICRLLKHPNIVRLHDSISEEG---HHYLIFDLVTGGELFED-------IVAREYYSEADA 112
Query: 1054 RLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAH---LGDFGLAKALVEDYN 1110
+ + V + H ++HR++K N+LL S ++ L DFGLA +
Sbjct: 113 S-HCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEV----E 164
Query: 1111 SNTESNTWFAGSYGYIAPE----YAYSLKATEKCDVYSMGIVLMELVSGKMP 1158
++ FAG+ GY++PE Y + D+++ G++L L+ G P
Sbjct: 165 GEQQAWFGFAGTPGYLSPEVLRKDPYG----KPVDLWACGVILYILLVGYPP 212
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 98.4 bits (245), Expect = 3e-21
Identities = 54/275 (19%), Positives = 111/275 (40%), Gaps = 28/275 (10%)
Query: 893 VVTLFVKRKREFLRKSSQVNYTSSSSSSQAQRRLLFQAAAKRDFRWEDIMGATNNLSDEF 952
V+ +RKR + + + + + + + + +++ D +
Sbjct: 100 VLIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHY 159
Query: 953 II----GSGGSGTVYKA-ELANGATVAVKKISCKDDHLLNK-SFTREVKTLGRIRHRHLV 1006
I G+G G V++ E A G A K + H +K + +E++T+ +RH LV
Sbjct: 160 DIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP--HESDKETVRKEIQTMSVLRHPTLV 217
Query: 1007 KLMGHCCNKGAGSNL-LIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGV 1065
L + + + +IYE+M G +++ + + + ++ + +G+
Sbjct: 218 NLHDAFEDD---NEMVMIYEFMSGGELFEKV------ADEHNKMSEDEAVEYMRQVCKGL 268
Query: 1066 EYLHHDCVPKILHRDIKSSNILLDSNMEAHL--GDFGLAKALVEDYNSNTESNTWFAGSY 1123
++H + +H D+K NI+ + L DFGL L + G+
Sbjct: 269 CHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV-----TTGTA 320
Query: 1124 GYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMP 1158
+ APE A D++S+G++ L+SG P
Sbjct: 321 EFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSP 355
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 4e-21
Identities = 57/221 (25%), Positives = 96/221 (43%), Gaps = 49/221 (22%)
Query: 954 IGSGGSGTVYKA-ELANGATVAVKKI-SCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGH 1011
+G G G V K G VA+KK DD ++ K RE+K L ++RH +LV L+
Sbjct: 33 VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEV 92
Query: 1012 CCNKGAGSNL-LIYEYMENGSVWDWLHKQPVNIKMR--KSLDWEARLKIAVGLAQGVEYL 1068
C K L++E++++ ++ D L P + + + ++ + G+ +
Sbjct: 93 CKKKK---RWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQ--------IINGIGFC 140
Query: 1069 HHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNT------WFAGS 1122
H I+HRDIK NIL+ + L DFG A+ + E W
Sbjct: 141 HSH---NIIHRDIKPENILVSQSGVVKLCDFGFART----LAAPGEVYDDEVATRW---- 189
Query: 1123 YGYIAPE-------YAYSLKATEKCDVYSMGIVLMELVSGK 1156
Y APE Y ++ DV+++G ++ E+ G+
Sbjct: 190 --YRAPELLVGDVKYGKAV------DVWAIGCLVTEMFMGE 222
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 6e-21
Identities = 62/220 (28%), Positives = 104/220 (47%), Gaps = 48/220 (21%)
Query: 954 IGSGGSGTVYKAELANGATVAVKKISC-KDDHLLNKSFTREVKTLGRIRHRHLVKLMGHC 1012
+G G G VYKA+ + G VA+K+I +D + + RE+ L + H ++V L+
Sbjct: 29 VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI 88
Query: 1013 CNKGAGSNL-LIYEYMEN--GSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLH 1069
++ L L++E+ME V D +K + K ++ L +GV + H
Sbjct: 89 HSE---RCLTLVFEFMEKDLKKVLD-ENKTGLQDSQIKIYLYQ--------LLRGVAHCH 136
Query: 1070 HDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNT------WFAGSY 1123
+ILHRD+K N+L++S+ L DFGLA+A + S T W
Sbjct: 137 QH---RILHRDLKPQNLLINSDGALKLADFGLARA----FGIPVRSYTHEVVTLW----- 184
Query: 1124 GYIAPE-------YAYSLKATEKCDVYSMGIVLMELVSGK 1156
Y AP+ Y+ S+ D++S+G + E+++GK
Sbjct: 185 -YRAPDVLMGSKKYSTSV------DIWSIGCIFAEMITGK 217
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 96.4 bits (240), Expect = 9e-21
Identities = 61/224 (27%), Positives = 103/224 (45%), Gaps = 47/224 (20%)
Query: 954 IGSGGSGTVYKAE-LANGATVAVK---KISCKDDHLLNKSFTREVKTLGRIRHRHLVKL- 1008
+G G G V + G VAVK + + ++ K RE++ L RH H++KL
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIR-REIQNLKLFRHPHIIKLY 82
Query: 1009 --MGHCCNKGAGSNLLIY---EYMENGSVWDWL-HKQPVNIKMRKSLDWEARLKIAVGLA 1062
+ + I+ EY+ G ++D++ ++ K E+R ++ +
Sbjct: 83 QVIS--------TPSDIFMVMEYVSGGELFDYICKNGRLDEK-------ESR-RLFQQIL 126
Query: 1063 QGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGS 1122
GV+Y H ++HRD+K N+LLD++M A + DFGL+ + + T GS
Sbjct: 127 SGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRT-----SCGS 178
Query: 1123 YGYIAPE------YAYSLKATEKCDVYSMGIVLMELVSGKMPTD 1160
Y APE YA + D++S G++L L+ G +P D
Sbjct: 179 PNYAAPEVISGRLYAGP-----EVDIWSSGVILYALLCGTLPFD 217
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 1e-20
Identities = 56/221 (25%), Positives = 95/221 (42%), Gaps = 50/221 (22%)
Query: 954 IGSGGSGTVYKA-ELANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHC 1012
+G G TVYK VA+K+I + + + REV L ++H ++V L
Sbjct: 10 LGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 69
Query: 1013 CNKGAGSNL-LIYEYMENGSVWD---WLHKQPVNIKMR--KSLDWEARLKIAVGLAQGVE 1066
+ +L L++EY++ D +L I M K ++ L +G+
Sbjct: 70 HTE---KSLTLVFEYLDK----DLKQYLDDCGNIINMHNVKLFLFQ--------LLRGLA 114
Query: 1067 YLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNT------WFA 1120
Y H K+LHRD+K N+L++ E L DFGLA+A + T++ W
Sbjct: 115 YCHR---QKVLHRDLKPQNLLINERGELKLADFGLARA----KSIPTKTYDNEVVTLW-- 165
Query: 1121 GSYGYIAPEY-----AYSLKATEKCDVYSMGIVLMELVSGK 1156
Y P+ YS + D++ +G + E+ +G+
Sbjct: 166 ----YRPPDILLGSTDYS----TQIDMWGVGCIFYEMATGR 198
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 1e-20
Identities = 61/223 (27%), Positives = 96/223 (43%), Gaps = 46/223 (20%)
Query: 954 IGSGGSGTVYKAE-LANGATVAVK---KISCKDDHLLNKSFTREVKTLGRIRHRHLVKL- 1008
+G G G V A VA+K + K + + RE+ L +RH H++KL
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVE-REISYLKLLRHPHIIKLY 75
Query: 1009 --MGHCCNKGAGSNLLIYEYME--NGSVWDWL-HKQPVNIKMRKSLDWEARLKIAVGLAQ 1063
+ + I +E G ++D++ K+ + E R + +
Sbjct: 76 DVIT--------TPTDIVMVIEYAGGELFDYIVEKKRMTED-------EGR-RFFQQIIC 119
Query: 1064 GVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSY 1123
+EY H KI+HRD+K N+LLD N+ + DFGL+ + + T GS
Sbjct: 120 AIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKT-----SCGSP 171
Query: 1124 GYIAPE------YAYSLKATEKCDVYSMGIVLMELVSGKMPTD 1160
Y APE YA + DV+S GIVL ++ G++P D
Sbjct: 172 NYAAPEVINGKLYAGP-----EVDVWSCGIVLYVMLVGRLPFD 209
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 1e-20
Identities = 57/223 (25%), Positives = 92/223 (41%), Gaps = 30/223 (13%)
Query: 945 TNNLSDEFII----GSGGSGTVYKA-ELANGATVAVKKISCKDDHLLNKSFTREVKTLGR 999
+ LSD F + G G + VY+ + A+K + D K E+ L R
Sbjct: 48 RDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDK---KIVRTEIGVLLR 104
Query: 1000 IRHRHLVKLMGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSL-DWEARLKIA 1058
+ H +++KL S L+ E + G ++D I + + +A
Sbjct: 105 LSHPNIIKLKEIFETPTEIS--LVLELVTGGELFDR-------IVEKGYYSERDAA-DAV 154
Query: 1059 VGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNME-AHL--GDFGLAKALVEDYNSNTES 1115
+ + V YLH + I+HRD+K N+L + A L DFGL+K + T
Sbjct: 155 KQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKT-- 209
Query: 1116 NTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMP 1158
G+ GY APE + D++S+GI+ L+ G P
Sbjct: 210 ---VCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEP 249
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 92.6 bits (231), Expect = 1e-20
Identities = 60/220 (27%), Positives = 100/220 (45%), Gaps = 48/220 (21%)
Query: 954 IGSGGSGTVYKAELANGATVAVKKISC-KDDHLLNKSFTREVKTLGRIRHRHLVKLMGHC 1012
IG G G VYKA+ G T A+KKI K+D + + RE+ L ++H ++VKL
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 1013 CNKGAGSNL-LIYEYMEN--GSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLH 1069
K L L++E+++ + D + + + KS + L G+ Y H
Sbjct: 70 HTK---KRLVLVFEHLDQDLKKLLD-VCEGGLESVTAKSFLLQ--------LLNGIAYCH 117
Query: 1070 HDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNT------WFAGSY 1123
++LHRD+K N+L++ E + DFGLA+A + T W
Sbjct: 118 DR---RVLHRDLKPQNLLINREGELKIADFGLARA----FGIPVRKYTHEIVTLW----- 165
Query: 1124 GYIAPE-------YAYSLKATEKCDVYSMGIVLMELVSGK 1156
Y AP+ Y+ ++ D++S+G + E+V+G
Sbjct: 166 -YRAPDVLMGSKKYSTTI------DIWSVGCIFAEMVNGT 198
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 2e-20
Identities = 57/233 (24%), Positives = 94/233 (40%), Gaps = 41/233 (17%)
Query: 945 TNNLSDEFII----GSGGSGTVYKA-ELANGATVAVKKISCK-----DDHLLNKSFTREV 994
+ D + I GSG V K E + G A K I + + + REV
Sbjct: 7 QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREV 66
Query: 995 KTLGRIRHRHLVKLMGHCCNKGAGSNL-LIYEYMENGSVWDWLHKQPVNIKMRKSLDWEA 1053
L ++ H +++ L N+ +++ LI E + G ++D+ + ++SL E
Sbjct: 67 SILRQVLHPNIITLHDVYENR---TDVVLILELVSGGELFDF-------LAQKESLSEEE 116
Query: 1054 RLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAH----LGDFGLAKALVEDY 1109
+ GV YLH KI H D+K NI+L L DFGLA + +
Sbjct: 117 ATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV 173
Query: 1110 NSNTESNTWFAGSYGYIAPE----YAYSLKATEKCDVYSMGIVLMELVSGKMP 1158
G+ ++APE + D++S+G++ L+SG P
Sbjct: 174 EFKN-----IFGTPEFVAPEIVNYEPLG----LEADMWSIGVITYILLSGASP 217
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 2e-20
Identities = 30/183 (16%), Positives = 69/183 (37%), Gaps = 7/183 (3%)
Query: 336 TSLEHLILAEIQLSGEIPVELSQCQSLKQLDLSNNTLNGTIPVELFQLVALTHLYLHNNS 395
++ + + + S + +Q SL + L+N + +E + L ++N
Sbjct: 20 STFKAYLNGLLGQSSTANITEAQMNSLTYITLANINVTDLTGIE--YAHNIKDLTINNIH 77
Query: 396 LVGSISPFVANLSNLQELALYHNNFQGSLPREIGMLVKLELLYLYDNHLSGQIPSEVGNC 455
+ +P + LSNL+ L + + + L L LL + + I +++
Sbjct: 78 A-TNYNPI-SGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTL 135
Query: 456 SSLKWIDFFGNSFTGEIPTSIGRLKDLNFLHLRQNELVGQIPASLGNCHQLIILDLADNK 515
+ ID N +I + L +L L+++ + + + + +L L
Sbjct: 136 PKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQT 192
Query: 516 LSG 518
+ G
Sbjct: 193 IGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 3e-20
Identities = 33/165 (20%), Positives = 66/165 (40%), Gaps = 8/165 (4%)
Query: 282 SFAKMGNLQSLDLSMNRLTGGIPEEFGNMGQLVFLVLSNNNISGSIPRRICTNATSLEHL 341
+ A+M +L + L+ +T + L ++N + + P + ++LE L
Sbjct: 39 TEAQMNSLTYITLANINVTD--LTGIEYAHNIKDLTINNIHATNYNP---ISGLSNLERL 93
Query: 342 ILAEIQLSGEIPVELSQCQSLKQLDLSNNTLNGTIPVELFQLVALTHLYLHNNSLVGSIS 401
+ ++ + LS SL LD+S++ + +I ++ L + + L N + I
Sbjct: 94 RIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIM 153
Query: 402 PFVANLSNLQELALYHNNFQGSLPREIGMLVKLELLYLYDNHLSG 446
P L L+ L + + I KL LY + + G
Sbjct: 154 PL-KTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 2e-17
Identities = 34/186 (18%), Positives = 66/186 (35%), Gaps = 10/186 (5%)
Query: 116 SNLSSLESLLLFSNQLAGTIPTQLGSLTSLRVMRIGDNWLSGSIPTSFGNLVNLGTLGLA 175
S + + LL + A Q+ SLT + + + ++ + T N+ L +
Sbjct: 20 STFKAYLNGLLGQSSTANITEAQMNSLTYI---TLANINVT-DL-TGIEYAHNIKDLTIN 74
Query: 176 SCSLSGPIPPQFGQLSQLEELILQQNQLQGPIPAELGNCSSLSIFTAAENNLNGSIPAAL 235
+ + P LS LE L + + L +SL++ + + + SI +
Sbjct: 75 NIHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKI 132
Query: 236 GRLQNLQLLNLGNNSLSGEIPSELGELSQLGYLNLMGNRLEGAIPRSFAKMGNLQSLDLS 295
L + ++L N +I L L +L LN+ + + L L
Sbjct: 133 NTLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAF 189
Query: 296 MNRLTG 301
+ G
Sbjct: 190 SQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 1e-16
Identities = 30/157 (19%), Positives = 64/157 (40%), Gaps = 8/157 (5%)
Query: 670 LPQLGELKLSFNQFVGFLPRELFNCSKLLVLSLDGNMLNGSLPNEVGNLASLNVLTLSGN 729
+ L + L+ + + L+++ P + L++L L + G
Sbjct: 43 MNSLTYITLANINVTDLTG--IEYAHNIKDLTINNIHATNYNP--ISGLSNLERLRIMGK 98
Query: 730 LLSGPIPPAIGRLSKLYELRLSNNSLNGVIPLEIGQLQNLQSILDLSHNNFTGQIPPSMG 789
++ P + L+ L L +S+++ + I +I L + S +DLS+N I P +
Sbjct: 99 DVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNS-IDLSYNGAITDIMP-LK 156
Query: 790 TLAKLEVLNLSHNQLVGELPSQLGEMSSLGKLNLSYN 826
TL +L+ LN+ + + + + L +L
Sbjct: 157 TLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQ 191
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 2e-16
Identities = 25/165 (15%), Positives = 56/165 (33%), Gaps = 8/165 (4%)
Query: 187 FGQLSQLEELILQQNQLQGPIPAELGNCSSLSIFTAAENNLNGSIPAALGRLQNLQLLNL 246
Q++ L + L + + ++ T + P + L NL+ L +
Sbjct: 40 EAQMNSLTYITLANINVTDLTG--IEYAHNIKDLTINNIHATNYNP--ISGLSNLERLRI 95
Query: 247 GNNSLSGEIPSELGELSQLGYLNLMGNRLEGAIPRSFAKMGNLQSLDLSMNRLTGGIPEE 306
++ + L L+ L L++ + + +I + + S+DLS N I
Sbjct: 96 MGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI-MP 154
Query: 307 FGNMGQLVFLVLSNNNISGSIPRRICTNATSLEHLILAEIQLSGE 351
+ +L L + + + + L L + G+
Sbjct: 155 LKTLPELKSLNIQFDGVHDYRG---IEDFPKLNQLYAFSQTIGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 3e-16
Identities = 33/182 (18%), Positives = 62/182 (34%), Gaps = 11/182 (6%)
Query: 623 RELSLLDLSGNSLTGPIPTQLLMCKKLSHIDLNNNLLSGAVPSWLGTLPQLGELKLSFNQ 682
+ L +S Q+ L++I L N ++ + + +L ++
Sbjct: 23 KAYLNGLLGQSSTANITEAQM---NSLTYITLANINVTDLTG--IEYAHNIKDLTINNIH 77
Query: 683 FVGFLPRELFNCSKLLVLSLDGNMLNGSLPNEVGNLASLNVLTLSGNLLSGPIPPAIGRL 742
+ P + S L L + G + + L SL +L +S + I I L
Sbjct: 78 ATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTL 135
Query: 743 SKLYELRLSNNSLNGVIPLEIGQLQNLQSILDLSHNNFTGQIPPSMGTLAKLEVLNLSHN 802
K+ + LS N I + L L+S L++ + + KL L
Sbjct: 136 PKVNSIDLSYNGAITDIM-PLKTLPELKS-LNIQFDGVHDYRG--IEDFPKLNQLYAFSQ 191
Query: 803 QL 804
+
Sbjct: 192 TI 193
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 5e-16
Identities = 24/165 (14%), Positives = 62/165 (37%), Gaps = 7/165 (4%)
Query: 90 SLGRLQSLIHLDLSSNSLTGPIPTALSNLSSLESLLLFSNQLAGTIPTQLGSLTSLRVMR 149
+ ++ SL ++ L++ ++T T + +++ L + + P + L++L +R
Sbjct: 39 TEAQMNSLTYITLANINVTD--LTGIEYAHNIKDLTINNIHATNYNP--ISGLSNLERLR 94
Query: 150 IGDNWLSGSIPTSFGNLVNLGTLGLASCSLSGPIPPQFGQLSQLEELILQQNQLQGPIPA 209
I ++ + L +L L ++ + I + L ++ + L N I
Sbjct: 95 IMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMP 154
Query: 210 ELGNCSSLSIFTAAENNLNGSIPAALGRLQNLQLLNLGNNSLSGE 254
L L + ++ + L L + ++ G+
Sbjct: 155 -LKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTIGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 2e-13
Identities = 29/134 (21%), Positives = 57/134 (42%), Gaps = 6/134 (4%)
Query: 693 NCSKLLVLSLDGNMLNGSLPNEVGNLASLNVLTLSGNLLSGPIPPAIGRLSKLYELRLSN 752
+ L ++L + L + ++ LT++ + P I LS L LR+
Sbjct: 42 QMNSLTYITLANINVT-DLTG-IEYAHNIKDLTINNIHATNYNP--ISGLSNLERLRIMG 97
Query: 753 NSLNGVIPLEIGQLQNLQSILDLSHNNFTGQIPPSMGTLAKLEVLNLSHNQLVGELPSQL 812
+ + L +L LD+SH+ I + TL K+ ++LS+N + ++ L
Sbjct: 98 KDVTSDKIPNLSGLTSLTL-LDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI-MPL 155
Query: 813 GEMSSLGKLNLSYN 826
+ L LN+ ++
Sbjct: 156 KTLPELKSLNIQFD 169
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 6e-13
Identities = 24/160 (15%), Positives = 51/160 (31%), Gaps = 7/160 (4%)
Query: 599 PSLERLRLGNNKFIGKIPWTFGKIRELSLLDLSGNSLTGPIPTQLLMCKKLSHIDLNNNL 658
SL + L N + + + L ++ T P + L + +
Sbjct: 44 NSLTYITLANIN-VTDLT-GIEYAHNIKDLTINNIHATNYNP--ISGLSNLERLRIMGKD 99
Query: 659 LSGAVPSWLGTLPQLGELKLSFNQFVGFLPRELFNCSKLLVLSLDGNMLNGSLPNEVGNL 718
++ L L L L +S + + ++ K+ + L N + + L
Sbjct: 100 VTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMP-LKTL 158
Query: 719 ASLNVLTLSGNLLSGPIPPAIGRLSKLYELRLSNNSLNGV 758
L L + + + I KL +L + ++ G
Sbjct: 159 PELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTIGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 7e-13
Identities = 24/133 (18%), Positives = 49/133 (36%), Gaps = 8/133 (6%)
Query: 77 NLSGLSLAG----SISPSLGRLQSLIHLDLSSNSLTGPIPTALSNLSSLESLLLFSNQLA 132
N+ L++ + +P + L +L L + +T LS L+SL L + +
Sbjct: 67 NIKDLTINNIHATNYNP-ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHD 125
Query: 133 GTIPTQLGSLTSLRVMRIGDNWLSGSIPTSFGNLVNLGTLGLASCSLSGPIPPQFGQLSQ 192
+I T++ +L + + + N I L L +L + + +
Sbjct: 126 DSILTKINTLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVHDYRG--IEDFPK 182
Query: 193 LEELILQQNQLQG 205
L +L + G
Sbjct: 183 LNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 8e-13
Identities = 23/118 (19%), Positives = 52/118 (44%), Gaps = 5/118 (4%)
Query: 716 GNLASLNVLTLSGNLLSGPIPPAIGRLSKLYELRLSNNSLNGVIPLEIGQLQNLQSILDL 775
+ SL +TL+ ++ + I + +L ++N P+ L NL+ L +
Sbjct: 41 AQMNSLTYITLANINVTD-LTG-IEYAHNIKDLTINNIHATNYNPIS--GLSNLER-LRI 95
Query: 776 SHNNFTGQIPPSMGTLAKLEVLNLSHNQLVGELPSQLGEMSSLGKLNLSYNDLQGKLS 833
+ T P++ L L +L++SH+ + +++ + + ++LSYN +
Sbjct: 96 MGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIM 153
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 2e-11
Identities = 27/205 (13%), Positives = 69/205 (33%), Gaps = 30/205 (14%)
Query: 529 ALEQLMLYNNSLEGNLPGSLINLRNLTRINFSKNRLNGRIATLCSSHSFLSFDVTNNEFD 588
+ + + + +LT I + + D+T
Sbjct: 21 TFKAYLNGLLGQSSTANITEAQMNSLTYITLANINVT---------------DLTG---- 61
Query: 589 HEIPPQLGNSPSLERLRLGNNKFIGKIPWTFGKIRELSLLDLSGNSLTGPIPTQLLMCKK 648
+ + +++ L + N + L L + G +T L
Sbjct: 62 ------IEYAHNIKDLTINNIH-ATNYN-PISGLSNLERLRIMGKDVTSDKIPNLSGLTS 113
Query: 649 LSHIDLNNNLLSGAVPSWLGTLPQLGELKLSFNQFVGFLPRELFNCSKLLVLSLDGNMLN 708
L+ +D++++ ++ + + TLP++ + LS+N + + L +L L++ + ++
Sbjct: 114 LTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIM-PLKTLPELKSLNIQFDGVH 172
Query: 709 GSLPNEVGNLASLNVLTLSGNLLSG 733
+ + LN L + G
Sbjct: 173 DYRG--IEDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 3e-10
Identities = 26/185 (14%), Positives = 61/185 (32%), Gaps = 10/185 (5%)
Query: 431 LVKLELLYLYDNHLSGQIPSEVGNCSSLKWIDFFGNSFTGEIPTSIGRLKDLNFLHLRQN 490
L + + +SL +I + T ++ T I ++ L +
Sbjct: 22 FKAYLNGLLGQSSTA---NITEAQMNSLTYITLANINVT-DL-TGIEYAHNIKDLTINNI 76
Query: 491 ELVGQIPASLGNCHQLIILDLADNKLSGGVPASFGFLQALEQLMLYNNSLEGNLPGSLIN 550
P + L L + ++ + L +L L + +++ + ++ +
Sbjct: 77 HATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINT 134
Query: 551 LRNLTRINFSKNRLNGRIATLCSSHSFLSFDVTNNEFDHEIPPQLGNSPSLERLRLGNNK 610
L + I+ S N I L + S ++ + + + + P L +L +
Sbjct: 135 LPKVNSIDLSYNGAITDIMPLKTLPELKSLNIQFDGVH-DYRG-IEDFPKLNQLYAFSQT 192
Query: 611 FIGKI 615
IG
Sbjct: 193 -IGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 55.7 bits (135), Expect = 1e-08
Identities = 20/122 (16%), Positives = 52/122 (42%), Gaps = 8/122 (6%)
Query: 717 NLASLNVLTLSGNLLSGPIPPAIGRLSKLYELRLSNNSLNGVIPLEIGQLQNLQSILDLS 776
+ L + + I A +++ L + L+N ++ + +E N++ L ++
Sbjct: 21 TFKAYLNGLLGQSSTA-NITEA--QMNSLTYITLANINVTDLTGIE--YAHNIKD-LTIN 74
Query: 777 HNNFTGQIPPSMGTLAKLEVLNLSHNQLVGELPSQLGEMSSLGKLNLSYNDLQGKLSKQF 836
+ + T P + L+ LE L + + + L ++SL L++S++ + +
Sbjct: 75 NIHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKI 132
Query: 837 SH 838
+
Sbjct: 133 NT 134
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 4e-08
Identities = 25/107 (23%), Positives = 43/107 (40%), Gaps = 3/107 (2%)
Query: 75 SLNLSGLSLAGSISPSLGRLQSLIHLDLSSNSLTGPIPTALSNLSSLESLLLFSNQLAGT 134
L + G + P+L L SL LD+S ++ I T ++ L + S+ L N
Sbjct: 92 RLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITD 151
Query: 135 IPTQLGSLTSLRVMRIGDNWLSGSIPTSFGNLVNLGTLGLASCSLSG 181
I L +L L+ + I + + + L L S ++ G
Sbjct: 152 I-MPLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTIGG 195
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 2e-20
Identities = 54/229 (23%), Positives = 93/229 (40%), Gaps = 38/229 (16%)
Query: 945 TNNLSDEF-----IIGSGGSGTVYKA-ELANGATVAVKKISCKDDHLLNKSFTREVKTLG 998
++D++ ++G G +G V + G A+K + +EV
Sbjct: 23 KYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPK------ARQEVDHHW 76
Query: 999 RI-RHRHLVKLMGHCCNKGAGSN--LLIYEYMENGSVWDWLHKQPVNIKMRKSLDW---E 1052
+ H+V ++ N G L+I E ME G ++ I+ R + E
Sbjct: 77 QASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFS-------RIQERGDQAFTERE 129
Query: 1053 ARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAH---LGDFGLAKALVEDY 1109
A +I + +++LH I HRD+K N+L S + L DFG AK
Sbjct: 130 AA-EIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK-----E 180
Query: 1110 NSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMP 1158
+ T + Y+APE K + CD++S+G+++ L+ G P
Sbjct: 181 TTQNALQT-PCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPP 228
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 3e-20
Identities = 55/232 (23%), Positives = 93/232 (40%), Gaps = 39/232 (16%)
Query: 941 IMGATNNLSDEF----IIGSGGSGTVYKA-ELANGATVAVKKISCKDDHLLNKSFTREVK 995
+ + +D + IG G + A AVK I + T E++
Sbjct: 13 LHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKS-----KRDPTEEIE 67
Query: 996 TLGR-IRHRHLVKLMGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLD-WEA 1053
L R +H +++ L + ++ E M+ G + D I +K EA
Sbjct: 68 ILLRYGQHPNIITLKDVYDDGKYV--YVVTELMKGGELLDK-------ILRQKFFSEREA 118
Query: 1054 RLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAH----LGDFGLAKALVEDY 1109
+ + + VEYLH ++HRD+K SNIL + DFG AK L +
Sbjct: 119 S-AVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE- 173
Query: 1110 NSNTESNTWFAGSYGYIAPEYAYSLKAT---EKCDVYSMGIVLMELVSGKMP 1158
N T + ++APE L+ CD++S+G++L +++G P
Sbjct: 174 --NGLLMT-PCYTANFVAPEV---LERQGYDAACDIWSLGVLLYTMLTGYTP 219
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 3e-20
Identities = 56/221 (25%), Positives = 89/221 (40%), Gaps = 43/221 (19%)
Query: 954 IGSGGSGTVYKAE-LANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHC 1012
IGSG G VAVK I + ++++ RE+ +RH ++V+
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIE-RG-AAIDENVQREIINHRSLRHPNIVRFKEVI 85
Query: 1013 CNKGAGSNL-LIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLK----IAVGLAQGVEY 1067
++L +I EY G +++ + + + EAR ++ GV Y
Sbjct: 86 LTP---THLAIIMEYASGGELYERICN---AGRFSED---EARFFFQQLLS-----GVSY 131
Query: 1068 LHHDCVPKILHRDIKSSNILLDSNMEAHL--GDFGLAKALVEDYNSNTESNTWFAGSYGY 1125
H +I HRD+K N LLD + L DFG +K+ V + G+ Y
Sbjct: 132 CHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS-----TVGTPAY 183
Query: 1126 IAPE------YAYSLKATEKCDVYSMGIVLMELVSGKMPTD 1160
IAPE Y DV+S G+ L ++ G P +
Sbjct: 184 IAPEVLLRQEYDGK-----IADVWSCGVTLYVMLVGAYPFE 219
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 3e-20
Identities = 53/216 (24%), Positives = 91/216 (42%), Gaps = 32/216 (14%)
Query: 953 IIGSGGSGTVYKA-ELANGATVAVKKISCKDDHLLNKSFTREVKTLGRI-RHRHLVKLMG 1010
++G G +G V + A+K + REV+ R + H+V+++
Sbjct: 69 VLGLGINGKVLQIFNKRTQEKFALKMLQDCPK------ARREVELHWRASQCPHIVRIVD 122
Query: 1011 HCCNKGAGSN--LLIYEYMENGSVWDWLHKQPVNIKMRKSLDW---EARLKIAVGLAQGV 1065
N AG L++ E ++ G ++ I+ R + EA +I + + +
Sbjct: 123 VYENLYAGRKCLLIVMECLDGGELFS-------RIQDRGDQAFTEREAS-EIMKSIGEAI 174
Query: 1066 EYLHHDCVPKILHRDIKSSNILLDSNMEAH---LGDFGLAKALVEDYNSNTESNTWFAGS 1122
+YLH I HRD+K N+L S L DFG AK + T +
Sbjct: 175 QYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT-----PCYT 226
Query: 1123 YGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMP 1158
Y+APE K + CD++S+G+++ L+ G P
Sbjct: 227 PYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 262
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 3e-20
Identities = 38/220 (17%), Positives = 81/220 (36%), Gaps = 14/220 (6%)
Query: 240 NLQLLNLGNNSLSGEIPSELGELSQLGYLNLMGNRLEGAIPRSFAKMGNLQSLDLSMNRL 299
+ + + IPS L L+ L +F+ + N+ + +S++
Sbjct: 12 QEEDFRVTCKDIQ-RIPSLPPSTQ---TLKLIETHLRTIPSHAFSNLPNISRIYVSIDVT 67
Query: 300 TGGIPEE-FGNMGQLVFLVLSNNNISGSIPRRICTNATSLEHLILAEIQLSGEIP--VEL 356
+ F N+ ++ + + N I L+ L + L P ++
Sbjct: 68 LQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKV 126
Query: 357 SQCQSLKQLDLSNNTLNGTIPVELFQLVA--LTHLYLHNNSLVGSISPFVANLSNLQELA 414
L++++N +IPV FQ + L L+NN S+ + N + L +
Sbjct: 127 YSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGF-TSVQGYAFNGTKLDAVY 185
Query: 415 LYHNNFQGSLPREI--GMLVKLELLYLYDNHLSGQIPSEV 452
L N + + ++ G+ LL + ++ +PS+
Sbjct: 186 LNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSKG 224
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 3e-17
Identities = 36/212 (16%), Positives = 70/212 (33%), Gaps = 11/212 (5%)
Query: 624 ELSLLDLSGNSLTGPIPTQLLMCKKLSHIDLNNNLLSGAVPSWLGTLPQLGELKLSFNQF 683
+ ++ + IP+ + L L LP + + +S +
Sbjct: 12 QEEDFRVTCKDIQR-IPSLP---PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVT 67
Query: 684 VGFLPRELF-NCSKLLVLSLDGNMLNGSLPNEV-GNLASLNVLTLSGNLLSG-PIPPAIG 740
+ L F N SK+ + + + + L L L + L P +
Sbjct: 68 LQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKMFPDLTKVY 127
Query: 741 RLSKLYELRLSNNSLNGVIPLEI-GQLQNLQSILDLSHNNFTGQIPPSMGTLAKLEVLNL 799
+ L +++N IP+ L N L L +N FT + KL+ + L
Sbjct: 128 STDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYL 186
Query: 800 SHNQLVGELPSQL--GEMSSLGKLNLSYNDLQ 829
+ N+ + + G S L++S +
Sbjct: 187 NKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT 218
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 4e-16
Identities = 41/227 (18%), Positives = 76/227 (33%), Gaps = 30/227 (13%)
Query: 96 SLIHLDLSSNSLTGPIPTALSNLSSLESLLLFSNQLAGTIPTQLGSLTSLRVMRIGDNWL 155
S L L L A SNL ++ + + + +
Sbjct: 32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLE------------------- 72
Query: 156 SGSIPTSFGNLVNLGTLGLASCSLSGPIPPQ-FGQLSQLEELILQQNQLQG-PIPAELGN 213
SF NL + + + + I P +L L+ L + L+ P ++ +
Sbjct: 73 ----SHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKMFPDLTKVYS 128
Query: 214 CSSLSIFTAAENNLNGSIPA-ALGRLQN-LQLLNLGNNSLSGEIPSELGELSQLGYLNLM 271
I +N SIP A L N L L NN + + ++L + L
Sbjct: 129 TDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLN 187
Query: 272 GNRLEGAIPR-SFAKMGN-LQSLDLSMNRLTGGIPEEFGNMGQLVFL 316
N+ I + +F + + LD+S +T + ++ +L+
Sbjct: 188 KNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSKGLEHLKELIAR 234
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 6e-16
Identities = 44/265 (16%), Positives = 89/265 (33%), Gaps = 42/265 (15%)
Query: 570 TLCSSHSFLSFDVTNNEFDHEIPPQLGNSPSLERLRLGNNKFIGKIPW-TFGKIRELSLL 628
C H F VT + IP PS + L+L + IP F + +S +
Sbjct: 6 PPCECHQEEDFRVTCKDI-QRIP---SLPPSTQTLKLIETH-LRTIPSHAFSNLPNISRI 60
Query: 629 DLSGNSLTGPIPTQLLMCKKLSHIDLNNNLLSGAVPSWLGTLPQLGELKLSFNQFVGFLP 688
+S + L ++ ++ L ++ +++ + + ++
Sbjct: 61 YVSIDV-------------TLQQLE--SHSFYN--------LSKVTHIEIRNTRNLTYID 97
Query: 689 RELF-NCSKLLVLSLDGNMLNGSLPNE--VGNLASLNVLTLSGNLLSGPIPPAI--GRLS 743
+ L L + L P+ V + +L ++ N IP G +
Sbjct: 98 PDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCN 156
Query: 744 KLYELRLSNNSLNGVIPLEIGQLQNLQSILDLSHNNFTGQIPPSM--GTLAKLEVLNLSH 801
+ L+L NN + L + + L+ N + I G + +L++S
Sbjct: 157 ETLTLKLYNNGFT-SVQGYAFNGTKLDA-VYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQ 214
Query: 802 NQLVGELPSQLGEMSSLGKLNLSYN 826
+ LPS+ + L +L
Sbjct: 215 TSVT-ALPSKG--LEHLKELIARNT 236
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 8e-16
Identities = 49/257 (19%), Positives = 89/257 (34%), Gaps = 36/257 (14%)
Query: 503 CHQLIILDLADNKLSGGVPASFGFLQALEQLMLYNNSLEGNLPGSLINLRNLTRINFSKN 562
CHQ + + +P + + L L L + NL N++RI S
Sbjct: 10 CHQEEDFRVTCKDIQR-IP---SLPPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSI- 64
Query: 563 RLNGRIATLCSSHSFLSFDVTNNEFDHEIPPQLGNSPSLERLRLGNNKFIGKIP-WTFGK 621
+ + L SHSF N + + + N + + I +
Sbjct: 65 --DVTLQQL-ESHSFY------------------NLSKVTHIEIRNTRNLTYIDPDALKE 103
Query: 622 IRELSLLDLSGNSLTG-PIPTQLLMCKKLSHIDLNNNLLSGAVPSWL--GTLPQLGELKL 678
+ L L + L P T++ +++ +N ++P G + LKL
Sbjct: 104 LPLLKFLGIFNTGLKMFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKL 163
Query: 679 SFNQFVGFLPRELFNCSKLLVLSLDGNMLNGSLPNEV--GNLASLNVLTLSGNLLSGPIP 736
N F + FN +KL + L+ N + + G + ++L +S ++ +P
Sbjct: 164 YNNGF-TSVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTA-LP 221
Query: 737 PAIGRLSKLYELRLSNN 753
L L EL N
Sbjct: 222 SKG--LEHLKELIARNT 236
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 1e-12
Identities = 36/205 (17%), Positives = 67/205 (32%), Gaps = 16/205 (7%)
Query: 646 CKKLSHIDLNNNLLSGAVPSWLGTLPQLGELKLSFNQFVGFLPRELFNCSKLLVLSLDGN 705
C + + + +PS P LKL N + + + +
Sbjct: 10 CHQEEDFRVTCKDIQ-RIPS---LPPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSID 65
Query: 706 MLNGSLPNEV-GNLASLNVLTLSGNLLSGPIPP-AIGRLSKLYELRLSNNSLNGVIPLEI 763
+ L + NL+ + + + I P A+ L L L + N L L
Sbjct: 66 VTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKMFPDLTK 125
Query: 764 GQLQNLQSILDLSHNNFTGQIPPSM--GTLAKLEVLNLSHNQLVGELPSQLGEMSSLGKL 821
++ IL+++ N + IP + G + L L +N + + L +
Sbjct: 126 VYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGF-TSVQGYAFNGTKLDAV 184
Query: 822 NLSYNDLQGKLSKQFSHWPAEAFEG 846
L+ N K + +AF G
Sbjct: 185 YLNKN-------KYLTVIDKDAFGG 202
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 2e-11
Identities = 42/237 (17%), Positives = 77/237 (32%), Gaps = 36/237 (15%)
Query: 429 GMLVKLELLYLYDNHLSGQIPSEV-GNCSSLKWIDFFGNSFTGEIPTSI-GRLKDLNFLH 486
+ + L L + HL IPS N ++ I + ++ + L + +
Sbjct: 28 SLPPSTQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIE 86
Query: 487 LRQNELVGQIPAS-LGNCHQLIILDLADNKLSGGVPASFGF-LQALEQLMLYNNSLEGNL 544
+R + I L L L + + L + + L + +N ++
Sbjct: 87 IRNTRNLTYIDPDALKELPLLKFLGIFNTGLKMFPDLTKVYSTDIFFILEITDNPYMTSI 146
Query: 545 P-GSLINLRNLTR-INFSKNRLNGRIATLCSSHSFLSFDVTNNEFDHEIPPQLGNSPSLE 602
P + L N T + N + N L+
Sbjct: 147 PVNAFQGLCNETLTLKLYNNGF------------------------TSVQGYAFNGTKLD 182
Query: 603 RLRLGNNKFIGKIP-WTF-GKIRELSLLDLSGNSLTGPIPTQLLMCKKLSHIDLNNN 657
+ L NK++ I F G SLLD+S S+T +P++ L + L + N
Sbjct: 183 AVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTA-LPSKGL--EHLKELIARNT 236
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 6e-10
Identities = 39/161 (24%), Positives = 72/161 (44%), Gaps = 11/161 (6%)
Query: 94 LQSLIHLDLSSN-SLTGPIPTALSNLSSLESLLLFSNQLAGTIP--TQLGSLTSLRVMRI 150
L + H+++ + +LT P AL L L+ L +F+ L P T++ S ++ I
Sbjct: 79 LSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEI 137
Query: 151 GDNWLSGSIPT-SFGNLVN-LGTLGLASCSLSGPIPPQFGQLSQLEELILQQNQLQGPIP 208
DN SIP +F L N TL L + + + ++L+ + L +N+ I
Sbjct: 138 TDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTS-VQGYAFNGTKLDAVYLNKNKYLTVID 196
Query: 209 AEL--GNCSSLSIFTAAENNLNGSIPA-ALGRLQNLQLLNL 246
+ G S S+ ++ ++ ++P+ L L+ L N
Sbjct: 197 KDAFGGVYSGPSLLDVSQTSVT-ALPSKGLEHLKELIARNT 236
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 4e-20
Identities = 82/392 (20%), Positives = 137/392 (34%), Gaps = 57/392 (14%)
Query: 230 SIPAALGRLQNLQLLNLGNNSLSGE----IPSELGELSQLGYLNLMGNRLEGAIPRSFAK 285
L LQ Q++ L + L+ I S L L LNL N L +
Sbjct: 19 RWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQ 78
Query: 286 M-----GNLQSLDLSMNRLT----GGIPEEFGNMGQLVFLVLSNNNISGSIPRRICT--- 333
+Q L L LT G + + L L LS+N + + + +C
Sbjct: 79 GLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLL 138
Query: 334 -NATSLEHLILAEIQLSGE----IPVELSQCQSLKQLDLSNNTLNGTIPVELFQLVA--- 385
LE L L LS + L K+L +SNN +N L Q +
Sbjct: 139 DPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSP 198
Query: 386 --LTHLYLHNNSL----VGSISPFVANLSNLQELALYHNNFQGSLPREIGMLVK-----L 434
L L L + + + VA+ ++L+ELAL N E+ + L
Sbjct: 199 CQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRL 258
Query: 435 ELLYLYDNHLSGQ----IPSEVGNCSSLKWIDFFGNSFTGEIPTSIGR-LKD----LNFL 485
L++++ ++ + + + SLK + GN E + L + L L
Sbjct: 259 RTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESL 318
Query: 486 HLRQNEL----VGQIPASLGNCHQLIILDLADNKLS-GGVPASFGFLQ----ALEQLMLY 536
++ + L L+ L +++N+L GV L L L L
Sbjct: 319 WVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLA 378
Query: 537 NNSL--EG--NLPGSLINLRNLTRINFSKNRL 564
+ + +L +L+ +L ++ S N L
Sbjct: 379 DCDVSDSSCSSLAATLLANHSLRELDLSNNCL 410
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 2e-18
Identities = 94/496 (18%), Positives = 156/496 (31%), Gaps = 109/496 (21%)
Query: 95 QSLIHLDLSSNSLTGP-IPTALSNLSSLESLLLFSNQL----AGTIPTQLGSLTSLRVMR 149
+ LD+ L+ L L + + L L I + L +L +
Sbjct: 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62
Query: 150 IGDNWLSGSIPTSFGNLVNLGTLGLASCSLSGPIPPQFGQLSQLEELILQQNQLQGPIPA 209
+ N L G + L P ++++L LQ L G
Sbjct: 63 LRSNELGDV-----------GVHCVLQG-LQTP-------SCKIQKLSLQNCCLTG---- 99
Query: 210 ELGNCSSLSIFTAAENNLNGSIPAALGRLQNLQLLNLGNNSLSGEIPSELGEL-----SQ 264
C LS + L L LQ L+L +N L L E +
Sbjct: 100 --AGCGVLS--------------STLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCR 143
Query: 265 LGYLNLMGNRLEGAIPRSFAKMGNLQSLDLSMNRLTGGIPEEFGNMGQLVFLVLSNNNIS 324
L L L L A A + L L +SNN+I+
Sbjct: 144 LEKLQLEYCSLSAASCEPLASV-------LRAKP-------------DFKELTVSNNDIN 183
Query: 325 GSIPRRIC----TNATSLEHLILAEIQLSGE----IPVELSQCQSLKQLDLSNNTLNGT- 375
+ R +C + LE L L ++ + + ++ SL++L L +N L
Sbjct: 184 EAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVG 243
Query: 376 ----IPVELFQLVALTHLYLHNNSL----VGSISPFVANLSNLQELALYHNNFQGSLPRE 427
P L L L++ + G + + +L+EL+L N R
Sbjct: 244 MAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARL 303
Query: 428 IGMLVK-----LELLYLYDNHLSGQ----IPSEVGNCSSLKWIDFFGNSFTGEIPTSIGR 478
+ + LE L++ + S + L + N + +
Sbjct: 304 LCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQ 363
Query: 479 -LKD----LNFLHLRQNEL----VGQIPASLGNCHQLIILDLADNKLS-GGVPASFGFLQ 528
L L L L ++ + A+L H L LDL++N L G+ ++
Sbjct: 364 GLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVR 423
Query: 529 ----ALEQLMLYNNSL 540
LEQL+LY+
Sbjct: 424 QPGCLLEQLVLYDIYW 439
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 6e-16
Identities = 79/407 (19%), Positives = 132/407 (32%), Gaps = 59/407 (14%)
Query: 313 LVFLVLSNNNISGSIPRRICTNATSLEHLILAEIQLSGE----IPVELSQCQSLKQLDLS 368
+ L + +S + + + + L + L+ I L +L +L+L
Sbjct: 5 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 64
Query: 369 NNTLNGTIPVELFQLVA-----LTHLYLHNNSL----VGSISPFVANLSNLQELALYHNN 419
+N L + Q + + L L N L G +S + L LQEL L N
Sbjct: 65 SNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNL 124
Query: 420 FQGSLPREIGMLV-----KLELLYLYDNHLSGQ----IPSEVGNCSSLKWIDFFGNSFTG 470
+ + + + +LE L L LS + S + K + N
Sbjct: 125 LGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINE 184
Query: 471 EIPTSIGR-LKD----LNFLHLRQNEL----VGQIPASLGNCHQLIILDLADNKL--SGG 519
+ + LKD L L L + + + + L L L NKL G
Sbjct: 185 AGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGM 244
Query: 520 VPASFGFLQ---ALEQLMLYNNSLE----GNLPGSLINLRNLTRINFSKNRL-----NGR 567
G L L L ++ + G+L L +L ++ + N L
Sbjct: 245 AELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLL 304
Query: 568 IATLCSSHSFL-SFDVTNNEFDHE----IPPQLGNSPSLERLRLGNNKFIGKIPWTFGKI 622
TL L S V + F L + L L++ NN+ +
Sbjct: 305 CETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQG 364
Query: 623 RE-----LSLLDLSGNSLT----GPIPTQLLMCKKLSHIDLNNNLLS 660
L +L L+ ++ + LL L +DL+NN L
Sbjct: 365 LGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLG 411
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 2e-15
Identities = 86/441 (19%), Positives = 154/441 (34%), Gaps = 70/441 (15%)
Query: 74 VSLNLSGLSLAGS------ISPSLGRLQSLIHLDLSSNSLT----GPIPTALSNLSSLES 123
+SL++ L + + L LQ + L LT I +AL +L
Sbjct: 1 MSLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAE 60
Query: 124 LLLFSNQL----AGTIPTQLGSL-TSLRVMRIGDNWLS----GSIPTSFGNLVNLGTLGL 174
L L SN+L + L + ++ + + + L+ G + ++ L L L L
Sbjct: 61 LNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHL 120
Query: 175 ASCSLSGPIPPQFGQL-----SQLEELILQQNQLQGPIPAE-----LGNCSSLSIFTAAE 224
+ L + +LE+L L+ L E L T +
Sbjct: 121 SDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSL-SAASCEPLASVLRAKPDFKELTVSN 179
Query: 225 NNLNGS----IPAALGRLQ-NLQLLNLGNNSLSGE----IPSELGELSQLGYLNLMGNRL 275
N++N + + L L+ L L + ++ + + + + L L L N+L
Sbjct: 180 NDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKL 239
Query: 276 EGAIPRSFAKMG-----NLQSLDLSMNRLT----GGIPEEFGNMGQLVFLVLSNNNISGS 326
L++L + +T G + L L L+ N +
Sbjct: 240 GDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDE 299
Query: 327 IPRRIC----TNATSLEHLILAEIQLSGE----IPVELSQCQSLKQLDLSNNTLNGTIPV 378
R +C LE L + + L+Q + L +L +SNN L
Sbjct: 300 GARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVR 359
Query: 379 ELFQLVA-----LTHLYLHNNSL----VGSISPFVANLSNLQELALYHNNFQGSLPREIG 429
EL Q + L L+L + + S++ + +L+EL L +N + ++
Sbjct: 360 ELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLV 419
Query: 430 MLVK-----LELLYLYDNHLS 445
V+ LE L LYD + S
Sbjct: 420 ESVRQPGCLLEQLVLYDIYWS 440
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 2e-14
Identities = 81/379 (21%), Positives = 128/379 (33%), Gaps = 71/379 (18%)
Query: 68 SSSARVVSLNLSGLSL----AGSISPSLGRLQSLIHLDLSSNSLTGP-----IPTALSNL 118
+ S ++ L+L L G +S +L L +L L LS N L L
Sbjct: 82 TPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQ 141
Query: 119 SSLESLLLFSNQL----AGTIPTQLGSLTSLRVMRIGDNWLSGSIPTSFG-----NLVNL 169
LE L L L + + L + + + + +N ++ + + L
Sbjct: 142 CRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQL 201
Query: 170 GTLGLASCSLS----GPIPPQFGQLSQLEELILQQNQL-----QGPIPAELGNCSSLSIF 220
L L SC ++ + + L EL L N+L P L S L
Sbjct: 202 EALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTL 261
Query: 221 TAAENNLN----GSIPAALGRLQNLQLLNLGNNSLSGEIPSELGEL-----SQLGYLNLM 271
E + G + L ++L+ L+L N L E L E QL L +
Sbjct: 262 WIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVK 321
Query: 272 GNRLEGAIPRSFAKM----GNLQSLDLSMNRLTGGIPEEFGNMG-QLVFLVLSNNNISGS 326
A F+ + L L +S NRL + G + + L
Sbjct: 322 SCSFTAACCSHFSSVLAQNRFLLELQISNNRL--------EDAGVRELCQGLGQPG---- 369
Query: 327 IPRRICTNATSLEHLILAEIQLSGE----IPVELSQCQSLKQLDLSNNTLNGTIPVELFQ 382
+ L L LA+ +S + L SL++LDLSNN L ++L +
Sbjct: 370 ---------SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVE 420
Query: 383 LVA-----LTHLYLHNNSL 396
V L L L++
Sbjct: 421 SVRQPGCLLEQLVLYDIYW 439
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 2e-13
Identities = 85/471 (18%), Positives = 147/471 (31%), Gaps = 86/471 (18%)
Query: 408 SNLQELALYHNNFQGSLPREIGMLVK-LELLYLYDNHLSGQ----IPSEVGNCSSLKWID 462
++Q L + + E+ L++ +++ L D L+ I S + +L ++
Sbjct: 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62
Query: 463 FFGNSFTGEIPTSIGR-LKDLNF----LHLRQNEL----VGQIPASLGNCHQLIILDLAD 513
N + + L+ + L L+ L G + ++L L L L+D
Sbjct: 63 LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSD 122
Query: 514 NKLS-GGVPASFGFLQ----ALEQLMLYNNSL--EG--NLPGSLINLRNLTRINFSKNRL 564
N L G+ L LE+L L SL L L + + S N +
Sbjct: 123 NLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDI 182
Query: 565 NGRIATLCSSHSFLSFDVTNNEFDHEIPPQLGNSP-SLERLRLGNNKF----IGKIPWTF 619
N + + L +SP LE L+L + +
Sbjct: 183 NEAGVRV-------------------LCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIV 223
Query: 620 GKIRELSLLDLSGNSLTGP-----IPTQLLMCKKLSHIDLNNNLLS----GAVPSWLGTL 670
L L L N L P L +L + + ++ G + L
Sbjct: 224 ASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAK 283
Query: 671 PQLGELKLSFNQF----VGFLPRELFNC-SKLLVLSLDGNMLNG----SLPNEVGNLASL 721
L EL L+ N+ L L +L L + + + L
Sbjct: 284 ESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFL 343
Query: 722 NVLTLSGNLLSGPIPPAIGRL-----SKLYELRLSNNSL--NGVIPL--EIGQLQNLQSI 772
L +S N L + + S L L L++ + + L + +L+
Sbjct: 344 LELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRE- 402
Query: 773 LDLSHNNFTGQIPPSMGTLA--------KLEVLNLSHNQLVGELPSQLGEM 815
LDLS+N + L LE L L E+ +L +
Sbjct: 403 LDLSNNCLG---DAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQAL 450
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 1e-10
Identities = 74/371 (19%), Positives = 118/371 (31%), Gaps = 68/371 (18%)
Query: 506 LIILDLADNKLS-GGVPASFGFLQALEQLMLYNNSL--EG--NLPGSLINLRNLTRINFS 560
+ LD+ +LS LQ + + L + L ++ +L L +N
Sbjct: 5 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 64
Query: 561 KNRLNGRIATLCSSHSFLSFDVTNNEFDHEIPPQLGNSPSLERLRLGNNKF----IGKIP 616
N L L S +++L L N G +
Sbjct: 65 SNELGDVGVHCVLQG--LQT----------------PSCKIQKLSLQNCCLTGAGCGVLS 106
Query: 617 WTFGKIRELSLLDLSGNSLTGP----IPTQLL-MCKKLSHIDLNNNLLS----GAVPSWL 667
T + L L LS N L + LL +L + L LS + S L
Sbjct: 107 STLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVL 166
Query: 668 GTLPQLGELKLSFNQF----VGFLPREL-FNCSKLLVLSLDGNMLN----GSLPNEVGNL 718
P EL +S N V L + L + +L L L+ + L V +
Sbjct: 167 RAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASK 226
Query: 719 ASLNVLTLSGNLLSGP-----IPPAIGRLSKLYELRLSNNSLNGVIPLEIGQ-LQNLQSI 772
ASL L L N L P + S+L L + + ++ + L+ +S+
Sbjct: 227 ASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESL 286
Query: 773 --LDLSHNNFTGQIPPSMGTLA--------KLEVLNLSHNQL----VGELPSQLGEMSSL 818
L L+ N + L +LE L + S L + L
Sbjct: 287 KELSLAGNELGDE---GARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFL 343
Query: 819 GKLNLSYNDLQ 829
+L +S N L+
Sbjct: 344 LELQISNNRLE 354
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 2e-08
Identities = 54/240 (22%), Positives = 90/240 (37%), Gaps = 37/240 (15%)
Query: 623 RELSLLDLSGNSLTGPIPTQLLMC-KKLSHIDLNNNLLS----GAVPSWLGTLPQLGELK 677
++ LD+ L+ +LL ++ + L++ L+ + S L P L EL
Sbjct: 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62
Query: 678 LSFNQF----VGFLPRELFNCS-KLLVLSLDGNMLN----GSLPNEVGNLASLNVLTLSG 728
L N+ V + + L S K+ LSL L G L + + L +L L LS
Sbjct: 63 LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSD 122
Query: 729 NLLSGPIPPAIGRL-----SKLYELRLSNNSLNGVIPLEIGQ-LQNLQSI--LDLSHNNF 780
NLL + +L +L+L SL+ + L+ L +S+N+
Sbjct: 123 NLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDI 182
Query: 781 TGQIPPSMGTLA--------KLEVLNLSHNQL----VGELPSQLGEMSSLGKLNLSYNDL 828
+ L +LE L L + +L + +SL +L L N L
Sbjct: 183 N---EAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKL 239
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 45.3 bits (108), Expect = 1e-04
Identities = 41/202 (20%), Positives = 62/202 (30%), Gaps = 40/202 (19%)
Query: 647 KKLSHIDLNNNLLS-GAVPSWLGTLPQLGELKLSFNQF----VGFLPRELFNCSKLLVLS 701
+ +D+ LS L L Q ++L + L L L+
Sbjct: 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62
Query: 702 LDGNMLNGSLPNEVGNL-----ASLNVLTLSGNLLS----GPIPPAIGRLSKLYELRLSN 752
L N L + V + L+L L+ G + + L L EL LS+
Sbjct: 63 LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSD 122
Query: 753 NSLNGVIPLEIGQLQNLQSILD-LSHNNFTGQIPPSMGTLAKLEVLNLSHNQL----VGE 807
N L LQ + + L +LE L L + L
Sbjct: 123 NLLGD---------AGLQLLCEGLLDPQC------------RLEKLQLEYCSLSAASCEP 161
Query: 808 LPSQLGEMSSLGKLNLSYNDLQ 829
L S L +L +S ND+
Sbjct: 162 LASVLRAKPDFKELTVSNNDIN 183
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 5e-20
Identities = 54/238 (22%), Positives = 104/238 (43%), Gaps = 28/238 (11%)
Query: 929 QAAAKRDFRWEDIMGATNNLSDEF----IIGSGGSGTVYKA-ELANGATVAVKKIS-CKD 982
++ +F +I +T + + IGSG G V A + VA+KK+S
Sbjct: 4 RSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ 63
Query: 983 DHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNL----LIYEYMENGSVWDWLHK 1038
+ K RE+ + + H++++ L+ + + ++ E M+ + L +
Sbjct: 64 NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA----N-LCQ 118
Query: 1039 QPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGD 1098
++ LD E + + G+++LH I+HRD+K SNI++ S+ + D
Sbjct: 119 V-----IQMELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILD 170
Query: 1099 FGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGK 1156
FGLA+ + T + Y APE + E D++S+G ++ E++ G
Sbjct: 171 FGLARTAGTSFMMTPYVVTRY-----YRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 5e-20
Identities = 56/233 (24%), Positives = 93/233 (39%), Gaps = 41/233 (17%)
Query: 945 TNNLSDEFII----GSGGSGTVYKA-ELANGATVAVK-----KISCKDDHLLNKSFTREV 994
+ D + I GSG V K E + G A K + + + REV
Sbjct: 7 QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREV 66
Query: 995 KTLGRIRHRHLVKLMGHCCNKGAGSNL-LIYEYMENGSVWDWLHKQPVNIKMRKSLDWEA 1053
L ++ H +++ L N+ +++ LI E + G ++D+ + ++SL E
Sbjct: 67 SILRQVLHHNVITLHDVYENR---TDVVLILELVSGGELFDF-------LAQKESLSEEE 116
Query: 1054 RLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAH----LGDFGLAKALVEDY 1109
+ GV YLH KI H D+K NI+L L DFGLA + +
Sbjct: 117 ATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV 173
Query: 1110 NSNTESNTWFAGSYGYIAPE----YAYSLKATEKCDVYSMGIVLMELVSGKMP 1158
G+ ++APE + D++S+G++ L+SG P
Sbjct: 174 EFKN-----IFGTPEFVAPEIVNYEPLG----LEADMWSIGVITYILLSGASP 217
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 7e-20
Identities = 50/235 (21%), Positives = 98/235 (41%), Gaps = 28/235 (11%)
Query: 933 KRDFRWEDIMGATNNLSDEFII----GSGGSGTVYKA-ELANGATVAVKKISCKDDHLLN 987
+ + + + ++ D + I GSG G V++ E A G K I+ + L+
Sbjct: 34 WKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP--YPLD 91
Query: 988 K-SFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNL-LIYEYMENGSVWDWLHKQPVNIKM 1045
K + E+ + ++ H L+ L +K + LI E++ G ++D + + +
Sbjct: 92 KYTVKNEISIMNQLHHPKLINLHDAFEDK---YEMVLILEFLSGGELFDRIAAEDYKMSE 148
Query: 1046 RKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHL--GDFGLAK 1103
E + +G++++H I+H DIK NI+ ++ + + DFGLA
Sbjct: 149 A-----EVINYMRQ-ACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLAT 199
Query: 1104 ALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMP 1158
L D + + APE D++++G++ L+SG P
Sbjct: 200 KLNPDEIVKV-----TTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSP 249
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 8e-20
Identities = 53/215 (24%), Positives = 90/215 (41%), Gaps = 33/215 (15%)
Query: 953 IIGSGGSGTVYKA-ELANGATVAVKKISCKDDHLLNKSFTREVKTLGRIR-HRHLVKLMG 1010
+G G K + AVK IS + + +E+ L H ++VKL
Sbjct: 18 PLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANT----QKEITALKLCEGHPNIVKLHE 73
Query: 1011 HCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLD-WEARLKIAVGLAQGVEYLH 1069
++ L+ E + G +++ IK +K EA I L V ++H
Sbjct: 74 VFHDQLH--TFLVMELLNGGELFE-------RIKKKKHFSETEAS-YIMRKLVSAVSHMH 123
Query: 1070 HDCVPKILHRDIKSSNILL---DSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYI 1126
++HRD+K N+L + N+E + DFG A+ D + + Y
Sbjct: 124 DV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD----NQPLKTPCFTLHYA 176
Query: 1127 APEYAYSLKAT---EKCDVYSMGIVLMELVSGKMP 1158
APE L E CD++S+G++L ++SG++P
Sbjct: 177 APEL---LNQNGYDESCDLWSLGVILYTMLSGQVP 208
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 8e-20
Identities = 59/226 (26%), Positives = 98/226 (43%), Gaps = 55/226 (24%)
Query: 954 IGSGGSGTVYKA-ELANGATVAVKKISC-KDDHLLNKSFTREVKTLGRIRHRHLVKLMGH 1011
+G G G VYKA + TVA+K+I ++ + + REV L ++HR++++L
Sbjct: 42 LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSV 101
Query: 1012 CCNKGAGSNL-LIYEYMEN--GSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYL 1068
+ L LI+EY EN D V++++ KS ++ L GV +
Sbjct: 102 IHHN---HRLHLIFEYAENDLKKYMD--KNPDVSMRVIKSFLYQ--------LINGVNFC 148
Query: 1069 HHDCVPKILHRDIKSSNILLDSNMEAH-----LGDFGLAKALVEDYNSNTESNT------ 1117
H + LHRD+K N+LL + + +GDFGLA+A + T
Sbjct: 149 HS---RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA----FGIPIRQFTHEIITL 201
Query: 1118 WFAGSYGYIAPE-------YAYSLKATEKCDVYSMGIVLMELVSGK 1156
W Y PE Y+ S+ D++S+ + E++
Sbjct: 202 W------YRPPEILLGSRHYSTSV------DIWSIACIWAEMLMKT 235
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 93.0 bits (231), Expect = 8e-20
Identities = 54/235 (22%), Positives = 100/235 (42%), Gaps = 28/235 (11%)
Query: 932 AKRDFRWEDIMGATNNLSDEF----IIGSGGSGTVYKA-ELANGATVAVKKIS-CKDDHL 985
F ++ +T + + IGSG G V A + VA+KK+S +
Sbjct: 44 VDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQT 103
Query: 986 LNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNL----LIYEYMENGSVWDWLHKQPV 1041
K RE+ + + H++++ L+ + L+ E M+ + L +
Sbjct: 104 HAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA----N-LCQV-- 156
Query: 1042 NIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGL 1101
++ LD E + + G+++LH + +HRD+K SNI++ S+ + DFGL
Sbjct: 157 ---IQMELDHERMSYLLYQMLCGIKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGL 210
Query: 1102 AKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGK 1156
A+ + T + Y APE + E D++S+G ++ E+V K
Sbjct: 211 ARTAGTSFMMTPYVVTRY-----YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 9e-20
Identities = 56/217 (25%), Positives = 90/217 (41%), Gaps = 31/217 (14%)
Query: 954 IGSGGSGTVYKA-ELANGATVAVKKISCKDDHLLNKSF--T--REVKTLGRIR---HRHL 1005
IG G GTVYKA + +G VA+K + + + REV L R+ H ++
Sbjct: 17 IGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNV 76
Query: 1006 VKLMG--HCCNKGAGSNL-LIYEYMEN--GSVWDWLHKQPVNIKMRKSLDWEARLKIAVG 1060
V+LM + L++E+++ + D + + K L +
Sbjct: 77 VRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQ-------- 128
Query: 1061 LAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNT-WF 1119
+G+++LH + I+HRD+K NIL+ S L DFGLA+ T W
Sbjct: 129 FLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTLW- 184
Query: 1120 AGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGK 1156
Y APE D++S+G + E+ K
Sbjct: 185 -----YRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 1e-19
Identities = 55/275 (20%), Positives = 113/275 (41%), Gaps = 38/275 (13%)
Query: 899 KRKREFLRKSSQVNYTSSSSSSQAQRRLLFQAAAKRDFRWEDIMGATNNLSDEFII---- 954
+ + + ++ + S + + A F + ++ + +
Sbjct: 36 HNEAKEVWSNADLTERMPVKSKRTSALAVDIPAPPAPFDHRIVTAKQGAVNSFYTVSKTE 95
Query: 955 --GSGGSGTVYKA-ELANGATVAVKKISCKDDHLLNK-SFTREVKTLGRIRHRHLVKLMG 1010
G G G V+K E A G +A K I + + +K E+ + ++ H +L++L
Sbjct: 96 ILGGGRFGQVHKCEETATGLKLAAKIIKTR--GMKDKEEVKNEISVMNQLDHANLIQLYD 153
Query: 1011 HCCNKGAGSNL-LIYEYMENGSVWDWLHKQPVNIKMRKSLD-WEARLKIAVGLAQGVEYL 1068
+K +++ L+ EY++ G ++D + I +L + L + + +G+ ++
Sbjct: 154 AFESK---NDIVLVMEYVDGGELFDRI------IDESYNLTELDTILFMKQ-ICEGIRHM 203
Query: 1069 HHDCVPKILHRDIKSSNILLDSNMEAHL--GDFGLAKALVEDYNSNTESNTWFAGSYGYI 1126
H ILH D+K NIL + + DFGLA+ G+ ++
Sbjct: 204 HQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKV-----NFGTPEFL 255
Query: 1127 APE---YAYSLKATEKCDVYSMGIVLMELVSGKMP 1158
APE Y + + D++S+G++ L+SG P
Sbjct: 256 APEVVNYDF---VSFPTDMWSVGVIAYMLLSGLSP 287
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 4e-19
Identities = 52/259 (20%), Positives = 89/259 (34%), Gaps = 41/259 (15%)
Query: 235 LGRLQNLQLLNLGNNSLSGEIPSELGELSQLGYLNLMGNRLEGAIPRSFAKMGNLQSLDL 294
NL S++ + EL+ + + + ++ + N+ L L
Sbjct: 20 DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFL 75
Query: 295 SMNRLTGGIPEEFGNMGQLVFLVLSNNNISGSIPRRICTNATSLEHLILAEIQLSGEIPV 354
+ N+LT + N+ L +L L N + LS
Sbjct: 76 NGNKLTDI--KPLANLKNLGWLFLDENKVK----------------------DLSS---- 107
Query: 355 ELSQCQSLKQLDLSNNTLNGTIPVELFQLVALTHLYLHNNSLVGSISPFVANLSNLQELA 414
L + LK L L +N ++ + L L LYL NN + I+ + L+ L L+
Sbjct: 108 -LKDLKKLKSLSLEHNGISDINGLV--HLPQLESLYLGNNKIT-DITVL-SRLTKLDTLS 162
Query: 415 LYHNNFQGSLPREIGMLVKLELLYLYDNHLSGQIPSEVGNCSSLKWIDFFGNSFTGEIPT 474
L N + + L KL+ LYL NH+S + +L ++ F +
Sbjct: 163 LEDNQIS-DIV-PLAGLTKLQNLYLSKNHISD--LRALAGLKNLDVLELFSQECLNKPIN 218
Query: 475 SIGRLKDLNFLHLRQNELV 493
L N + LV
Sbjct: 219 HQSNLVVPNTVKNTDGSLV 237
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 1e-17
Identities = 56/256 (21%), Positives = 92/256 (35%), Gaps = 41/256 (16%)
Query: 189 QLSQLEELILQQNQLQGPIPAELGNCSSLSIFTAAENNLNGSIPAALGRLQNLQLLNLGN 248
++ + L++ + + +S+ A +++ S+ + L N+ L L
Sbjct: 22 AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQG-IQYLPNVTKLFLNG 77
Query: 249 NSLSGEIPSELGELSQLGYLNLMGNRLEGAIPRSFAKMGNLQSLDLSMNRLTGGIPEEFG 308
N L+ +I L L LG+L L N+++ + L+SL L N ++
Sbjct: 78 NKLT-DI-KPLANLKNLGWLFLDENKVKDLSS--LKDLKKLKSLSLEHNGIS--DINGLV 131
Query: 309 NMGQLVFLVLSNNNISGSIPRRICTNATSLEHLILAEIQLSGEIPVELSQCQSLKQLDLS 368
++ QL L L NN I T+ T L L L L L
Sbjct: 132 HLPQLESLYLGNNKI---------TDITVLSRL------------------TKLDTLSLE 164
Query: 369 NNTLNGTIPVELFQLVALTHLYLHNNSLVGSISPFVANLSNLQELALYHNNFQGSLPREI 428
+N + + V L L L +LYL N + + A L NL L L+
Sbjct: 165 DNQI--SDIVPLAGLTKLQNLYLSKNHIS-DLRAL-AGLKNLDVLELFSQECLNKPINHQ 220
Query: 429 GMLVKLELLYLYDNHL 444
LV + D L
Sbjct: 221 SNLVVPNTVKNTDGSL 236
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 3e-17
Identities = 48/233 (20%), Positives = 94/233 (40%), Gaps = 17/233 (7%)
Query: 165 NLVNLGTLGLASCSLSGPIPPQFGQLSQLEELILQQNQLQGPIPAELGNCSSLSIFTAAE 224
L S++ + +L+ ++++I + ++ + + +++
Sbjct: 22 AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKS-VQG-IQYLPNVTKLFLNG 77
Query: 225 NNLNGSIPAALGRLQNLQLLNLGNNSLSGEIPSELGELSQLGYLNLMGNRLEGAIPRSFA 284
N L I L L+NL L L N + ++ S L +L +L L+L N +
Sbjct: 78 NKLT-DIKP-LANLKNLGWLFLDENKVK-DL-SSLKDLKKLKSLSLEHNGISDING--LV 131
Query: 285 KMGNLQSLDLSMNRLTGGIPEEFGNMGQLVFLVLSNNNISGSIPRRICTNATSLEHLILA 344
+ L+SL L N++T + +L L L +N IS I T L++L L+
Sbjct: 132 HLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQIS-DIV--PLAGLTKLQNLYLS 186
Query: 345 EIQLSGEIPVELSQCQSLKQLDLSNNTLNGTIPVELFQLVALTHLYLHNNSLV 397
+ +S ++ L+ ++L L+L + LV + + SLV
Sbjct: 187 KNHIS-DLR-ALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLV 237
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 1e-16
Identities = 55/289 (19%), Positives = 107/289 (37%), Gaps = 44/289 (15%)
Query: 87 ISPSLGRLQSLIHLDLSSNSLTGPIPTALSNLSSLESLLLFSNQLAGTIPTQLGSLTSLR 146
I I +L S+T + + L+S++ ++ ++ + + L ++
Sbjct: 17 IFS-DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDI--KSVQGIQYLPNVT 71
Query: 147 VMRIGDNWLSGSIPTSFGNLVNLGTLGLASCSLSGPIPPQFGQLSQLEELILQQNQLQGP 206
+ + N L+ I NL NLG L L + + L +L+ L L+ N +
Sbjct: 72 KLFLNGNKLT-DI-KPLANLKNLGWLFLDENKVKD-LSS-LKDLKKLKSLSLEHNGI--- 124
Query: 207 IPAELGNCSSLSIFTAAENNLNGSIPAALGRLQNLQLLNLGNNSLSGEIPSELGELSQLG 266
S ++ L L L+ L LGNN ++ + L L++L
Sbjct: 125 --------SDIN---------------GLVHLPQLESLYLGNNKIT--DITVLSRLTKLD 159
Query: 267 YLNLMGNRLEGAIPRSFAKMGNLQSLDLSMNRLTGGIPEEFGNMGQLVFLVLSNNNISGS 326
L+L N++ +P A + LQ+L LS N ++ + L L L + +
Sbjct: 160 TLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISD--LRALAGLKNLDVLELFSQECL-N 214
Query: 327 IPRRICTNATSLEHLILAEIQLSGEIPVELSQCQSLKQLDLSNNTLNGT 375
P +N + + L P +S ++ ++ + T
Sbjct: 215 KPINHQSNLVVPNTVKNTDGSLVT--PEIISDDGDYEKPNVKWHLPEFT 261
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 4e-15
Identities = 48/234 (20%), Positives = 92/234 (39%), Gaps = 17/234 (7%)
Query: 595 LGNSPSLERLRLGNNKFIGKIPWTFGKIRELSLLDLSGNSLTGPIPTQLLMCKKLSHIDL 654
+ L + T ++ + + + + + + ++ + L
Sbjct: 20 DDAFAETIKDNLKKKS-VTDAV-TQNELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFL 75
Query: 655 NNNLLSGAVPSWLGTLPQLGELKLSFNQFVGFLPRELFNCSKLLVLSLDGNMLNGSLPNE 714
N N L+ P L L LG L L N+ L + KL LSL+ N ++ +
Sbjct: 76 NGNKLTDIKP--LANLKNLGWLFLDENKVKDLSS--LKDLKKLKSLSLEHNGIS-DING- 129
Query: 715 VGNLASLNVLTLSGNLLSGPIPPAIGRLSKLYELRLSNNSLNGVIPLEIGQLQNLQSILD 774
+ +L L L L N ++ + RL+KL L L +N ++ ++PL L LQ+ L
Sbjct: 130 LVHLPQLESLYLGNNKITDITV--LSRLTKLDTLSLEDNQISDIVPLA--GLTKLQN-LY 184
Query: 775 LSHNNFTGQIPPSMGTLAKLEVLNLSHNQLVGELPSQLGEMSSLGKLNLSYNDL 828
LS N+ + + + L L+VL L + + + + + + + L
Sbjct: 185 LSKNHIS-DLRA-LAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL 236
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 3e-14
Identities = 52/258 (20%), Positives = 92/258 (35%), Gaps = 17/258 (6%)
Query: 581 DVTNNEFDHEIPPQLGNSPSLERLRLGNNKFIGKIPWTFGKIRELSLLDLSGNSLTGPIP 640
++ + S++++ N+ I + + ++ L L+GN LT P
Sbjct: 30 NLKKKSVTDAVT--QNELNSIDQIIANNSD-IKSVQ-GIQYLPNVTKLFLNGNKLTDIKP 85
Query: 641 TQLLMCKKLSHIDLNNNLLSGAVPSWLGTLPQLGELKLSFNQFVGFLPRELFNCSKLLVL 700
L K L + L+ N + L L +L L L N L + +L L
Sbjct: 86 --LANLKNLGWLFLDENKVKDLSS--LKDLKKLKSLSLEHNGISDING--LVHLPQLESL 139
Query: 701 SLDGNMLNGSLPNEVGNLASLNVLTLSGNLLSGPIPPAIGRLSKLYELRLSNNSLNGVIP 760
L N + + + L L+ L+L N +S I P + L+KL L LS N ++ +
Sbjct: 140 YLGNNKIT-DITV-LSRLTKLDTLSLEDNQISD-IVP-LAGLTKLQNLYLSKNHISDLRA 195
Query: 761 LEIGQLQNLQSILDLSHNNFTGQIPPSMGTLAKLEVLNLSHNQLVGELPSQLGEMSSLGK 820
L L+NL +L+L + L + + LV
Sbjct: 196 LA--GLKNLD-VLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIISDDGDYEKPN 252
Query: 821 LNLSYNDLQGKLSKQFSH 838
+ + ++S F
Sbjct: 253 VKWHLPEFTNEVSFIFYQ 270
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 3e-13
Identities = 54/235 (22%), Positives = 92/235 (39%), Gaps = 15/235 (6%)
Query: 500 LGNCHQLIILDLADNKLSGGVPASFGFLQALEQLMLYNNSLEGNLPGSLINLRNLTRINF 559
+ I +L ++ V L +++Q++ N+ ++ ++ G + L N+T++
Sbjct: 20 DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQG-IQYLPNVTKLFL 75
Query: 560 SKNRLNGRIATLCSSHSFLSFDVTNNEFDHEIPPQLGNSPSLERLRLGNNKFIGKIPWTF 619
+ N+L I L + + + N+ ++ L + L+ L L +N I I
Sbjct: 76 NGNKLT-DIKPLANLKNLGWLFLDENKV-KDLSS-LKDLKKLKSLSLEHNG-ISDIN-GL 130
Query: 620 GKIRELSLLDLSGNSLTGPIPTQLLMCKKLSHIDLNNNLLSGAVPSWLGTLPQLGELKLS 679
+ +L L L N +T L KL + L +N +S VP L L +L L LS
Sbjct: 131 VHLPQLESLYLGNNKITDITV--LSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLS 186
Query: 680 FNQFVGFLPRELFNCSKLLVLSLDGNMLNGSLPNEVGNLASLNVLTLSGNLLSGP 734
N R L L VL L N NL N + + L P
Sbjct: 187 KNHISDL--RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTP 239
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 1e-08
Identities = 46/192 (23%), Positives = 76/192 (39%), Gaps = 16/192 (8%)
Query: 77 NLSGLSLAG----SISPSLGRLQSLIHLDLSSNSLTGPIPTALSNLSSLESLLLFSNQLA 132
N++ L L G I P L L++L L L N + ++L +L L+SL L N +
Sbjct: 69 NVTKLFLNGNKLTDIKP-LANLKNLGWLFLDENKVK--DLSSLKDLKKLKSLSLEHNGI- 124
Query: 133 GTIPTQLGSLTSLRVMRIGDNWLSGSIPTSFGNLVNLGTLGLASCSLSGPIPPQFGQLSQ 192
+ L L L + +G+N + + T L L TL L +S I P L++
Sbjct: 125 -SDINGLVHLPQLESLYLGNNKI--TDITVLSRLTKLDTLSLEDNQISD-IVP-LAGLTK 179
Query: 193 LEELILQQNQLQGPIPAELGNCSSLSIFTAAENNLNGSIPAALGRLQNLQLL-NLGNNSL 251
L+ L L +N + L +L + L + N + +
Sbjct: 180 LQNLYLSKNHISDLRA--LAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLV 237
Query: 252 SGEIPSELGELS 263
+ EI S+ G+
Sbjct: 238 TPEIISDDGDYE 249
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 5e-19
Identities = 54/215 (25%), Positives = 96/215 (44%), Gaps = 29/215 (13%)
Query: 954 IGSGGSGTVYKA--ELANGATVAVKKISC-KDDHLLNKSFTREVKTLGRIR---HRHLVK 1007
IG G G V+KA G VA+K++ + + S REV L + H ++V+
Sbjct: 19 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 1008 L--MGHCCNKGAGSNL-LIYEYMEN--GSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLA 1062
L + + L L++E+++ + D + + V + K + ++ L
Sbjct: 79 LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ--------LL 130
Query: 1063 QGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNT-WFAG 1121
+G+++LH +++HRD+K NIL+ S+ + L DFGLA+ + T W
Sbjct: 131 RGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLW--- 184
Query: 1122 SYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGK 1156
Y APE D++S+G + E+ K
Sbjct: 185 ---YRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 5e-19
Identities = 48/246 (19%), Positives = 82/246 (33%), Gaps = 62/246 (25%)
Query: 953 IIGSGGSGTVYKA-ELANGATVAVKKISCKDDHLLNKSFT-REVKTLGRIRHRHLVKLMG 1010
+G+G G V + ++ +G A+KK+ L + + RE+ + + H +++KL+
Sbjct: 14 TLGTGSFGIVCEVFDIESGKRFALKKV------LQDPRYKNRELDIMKVLDHVNIIKLVD 67
Query: 1011 --HCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLD------------------ 1050
+ + + +
Sbjct: 68 YFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKV 127
Query: 1051 ----WEARLKIAVGLAQ--------GVEYLHHDCVPKILHRDIKSSNILLDSNM-EAHLG 1097
+ I + L V ++H I HRDIK N+L++S L
Sbjct: 128 LKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS---LGICHRDIKPQNLLVNSKDNTLKLC 184
Query: 1098 DFGLAKALVEDYNSNTESNTWFAGSYGYI------APEYAYSLKA-TEKCDVYSMGIVLM 1150
DFG AK L+ + YI APE T D++S+G V
Sbjct: 185 DFGSAKKLIPS-EPSVA----------YICSRFYRAPELMLGATEYTPSIDLWSIGCVFG 233
Query: 1151 ELVSGK 1156
EL+ GK
Sbjct: 234 ELILGK 239
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 87.6 bits (218), Expect = 6e-19
Identities = 54/220 (24%), Positives = 92/220 (41%), Gaps = 37/220 (16%)
Query: 954 IGSGGSGTVYKA-ELANGATVAVK-----KISCKDDHLLNKSFTREVKTLGRIRHRHLVK 1007
+GSG V K + G A K ++S + + REV L IRH +++
Sbjct: 13 LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 1008 LMGHCCNKGAGSNL-LIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVE 1066
L NK +++ LI E + G ++D+ + ++SL + + + GV
Sbjct: 73 LHDIFENK---TDVVLILELVSGGELFDF-------LAEKESLTEDEATQFLKQILDGVH 122
Query: 1067 YLHHDCVPKILHRDIKSSNILLDSNMEAH----LGDFGLAKALVEDYNSNTESNTWFAGS 1122
YLH +I H D+K NI+L + L DFG+A + G+
Sbjct: 123 YLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKN-----IFGT 174
Query: 1123 YGYIAPE----YAYSLKATEKCDVYSMGIVLMELVSGKMP 1158
++APE + D++S+G++ L+SG P
Sbjct: 175 PEFVAPEIVNYEPLG----LEADMWSIGVITYILLSGASP 210
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 7e-19
Identities = 57/212 (26%), Positives = 97/212 (45%), Gaps = 23/212 (10%)
Query: 953 IIGSGGSGTVYKA-ELANGATVAVKKISCKDDHLLNKSFTREVKT----LGRIRHRHLVK 1007
I+G G TV A ELA A+K + H++ ++ V + R+ H VK
Sbjct: 37 ILGEGSFSTVVLARELATSREYAIK--ILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 94
Query: 1008 LMGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIA-VGLAQGVE 1066
L + + Y +NG + ++ K + R A + A +E
Sbjct: 95 L--YFTFQDDEKLYFGLSYAKNGELLKYIRKI------GSFDETCTRFYTAEIVSA--LE 144
Query: 1067 YLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYI 1126
YLH I+HRD+K NILL+ +M + DFG AK ++ + +N+ F G+ Y+
Sbjct: 145 YLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAK-VLSPESKQARANS-FVGTAQYV 199
Query: 1127 APEYAYSLKATEKCDVYSMGIVLMELVSGKMP 1158
+PE A + D++++G ++ +LV+G P
Sbjct: 200 SPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 1e-18
Identities = 57/247 (23%), Positives = 98/247 (39%), Gaps = 39/247 (15%)
Query: 931 AAKRDFRWEDIMGATNNLSDEF----IIGSGGSGTVYKAELANGATVAVKKIS-CKDDHL 985
AK + D++ + + + I SG G V + G VA+K++ D
Sbjct: 3 QAKGEAAMRDLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGR 62
Query: 986 LNKSFT---------REVKTLGRIRHRHLVKL--MGHCCNKGAGSNL-LIYEYMENGSVW 1033
+ RE++ L H +++ L + + A L L+ E M
Sbjct: 63 TVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT---- 118
Query: 1034 DWLHKQPVNIKMRKSLDWEARLK-IAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNM 1092
D L + I ++ + ++ + G+ LH ++HRD+ NILL N
Sbjct: 119 D-LAQV---IHDQRIVISPQHIQYFMYHILLGLHVLHE---AGVVHRDLHPGNILLADNN 171
Query: 1093 EAHLGDFGLAKALVEDYNSNTE--SNTWFAGSYGYIAPEYAYSLKA-TEKCDVYSMGIVL 1149
+ + DF LA+ D N T ++ W Y APE K T+ D++S G V+
Sbjct: 172 DITICDFNLAREDTADANK-THYVTHRW------YRAPELVMQFKGFTKLVDMWSAGCVM 224
Query: 1150 MELVSGK 1156
E+ + K
Sbjct: 225 AEMFNRK 231
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 1e-18
Identities = 27/279 (9%), Positives = 68/279 (24%), Gaps = 71/279 (25%)
Query: 954 IGSGGSGTVYKAE-LANGATVAVKKI--SCKDDHLLNKSFTREVKTLGRIRHRHLVKLMG 1010
G ++A A VA+ + + + L RI + +
Sbjct: 39 HGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR--- 95
Query: 1011 HCCNKGAGSNLLIYEYMENGS----VWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVE 1066
+ + + + V +W+ + S ++ LA +
Sbjct: 96 ------------VLDVVHTRAGGLVVAEWIRGGSLQEVADTSPSPVGAIRAMQSLAAAAD 143
Query: 1067 YLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYI 1126
H + S + + + + L +
Sbjct: 144 AAHRA---GVALSIDHPSRVRVSIDGDVVLAYP------------------------ATM 176
Query: 1127 APEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSAREE 1186
A + D+ +G L L+ + P + E +
Sbjct: 177 PD-------ANPQDDIRGIGASLYALLVNRWPLPEAGV--RSGLAPAERD------TAGQ 221
Query: 1187 LLD-DQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSS 1224
++ + +P + + +A + + R +S
Sbjct: 222 PIEPADIDRDIPFQ------ISAVAARSVQGDGGIRSAS 254
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 1e-18
Identities = 46/218 (21%), Positives = 83/218 (38%), Gaps = 41/218 (18%)
Query: 954 IGSGGSGTVYKA-ELANGATVAVKKISCK-DDHLLNKSFTREVKTLGRIRHRHLVKLMGH 1011
+G G G V++ E ++ T K + K D +E+ L RHR+++ L
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ---VLVKKEISILNIARHRNILHLHES 69
Query: 1012 CCNKGAGSNL-LIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQ----GVE 1066
+ L +I+E++ +++ I E + V ++
Sbjct: 70 FESM---EELVMIFEFISGLDIFER-------INTSAFELNE---REIVSYVHQVCEALQ 116
Query: 1067 YLHHDCVPKILHRDIKSSNILLDSNMEAHL--GDFGLAKALVEDYNSNTESNTWFAGSYG 1124
+LH I H DI+ NI+ + + + +FG A+ L N +
Sbjct: 117 FLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL-----LFTAPE 168
Query: 1125 YIAPE----YAYSLKATEKCDVYSMGIVLMELVSGKMP 1158
Y APE S D++S+G ++ L+SG P
Sbjct: 169 YYAPEVHQHDVVS----TATDMWSLGTLVYVLLSGINP 202
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 2e-18
Identities = 63/243 (25%), Positives = 109/243 (44%), Gaps = 34/243 (13%)
Query: 929 QAAAKRDFRWEDIMGATNNLSDEF----IIGSGGSGTVYKA-ELANGATVAVKKISCKDD 983
AA E + G ++ + IG G G V A + N VA+KKIS +
Sbjct: 6 HMAAAAAAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEH 65
Query: 984 HLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNL----LIYEYMENGSVWDWLHKQ 1039
+ RE+K L R RH +++ + + ++ + ME D L+K
Sbjct: 66 QTYCQRTLREIKILLRFRHENIIGIN-DIIRAPTIEQMKDVYIVQDLMET----D-LYKL 119
Query: 1040 PVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDF 1099
+K + + + +G++Y+H +LHRD+K SN+LL++ + + DF
Sbjct: 120 ---LKTQHLSNDHICY-FLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDF 172
Query: 1100 GLAKALVEDYNSN---TE--SNTWFAGSYGYIAPEYAYSLKA-TEKCDVYSMGIVLMELV 1153
GLA+ D++ TE + W Y APE + K T+ D++S+G +L E++
Sbjct: 173 GLARVADPDHDHTGFLTEYVATRW------YRAPEIMLNSKGYTKSIDIWSVGCILAEML 226
Query: 1154 SGK 1156
S +
Sbjct: 227 SNR 229
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 3e-18
Identities = 58/237 (24%), Positives = 95/237 (40%), Gaps = 49/237 (20%)
Query: 945 TNNLSDEFII----GSGGSGTVYKA-ELANGATVAVKKISCK-----DDHLLNKSFTREV 994
N+ D + GSG V K E + G A K I + + + REV
Sbjct: 6 QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREV 65
Query: 995 KTLGRIRHRHLVKLMGHCCNKGAGSNL-LIYEYMENGSVWDWLHKQPVNIKMRKSLDWEA 1053
L I+H +++ L NK +++ LI E + G ++D+ + ++SL E
Sbjct: 66 SILKEIQHPNVITLHEVYENK---TDVILILELVAGGELFDF-------LAEKESLT-E- 113
Query: 1054 RLKIAVGLAQ----GVEYLHHDCVPKILHRDIKSSNILLDSNMEAH----LGDFGLAKAL 1105
+ A + GV YLH +I H D+K NI+L + DFGLA +
Sbjct: 114 --EEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 168
Query: 1106 VEDYNSNTESNTWFAGSYGYIAPE----YAYSLKATEKCDVYSMGIVLMELVSGKMP 1158
G+ ++APE + D++S+G++ L+SG P
Sbjct: 169 DFGNEFKN-----IFGTPEFVAPEIVNYEPLG----LEADMWSIGVITYILLSGASP 216
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 86.4 bits (214), Expect = 4e-18
Identities = 57/249 (22%), Positives = 86/249 (34%), Gaps = 25/249 (10%)
Query: 158 SIPTSFGNLVNLGTLGLASCSLSGPIPPQ-FGQLSQLEELILQQNQLQGPIPAE----LG 212
IP+ N L L I F LE++ + QN + I A+ L
Sbjct: 23 EIPSDL--PRNAIELRFVLTKLRV-IQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLP 79
Query: 213 NCSSLSIFTAAENNLNGSIPA-ALGRLQNLQLLNLGNNSLSGEIPSEL-GELSQLGYLNL 270
+ I A NNL I A L NLQ L + N + +P Q L++
Sbjct: 80 KLHEIRIEKA--NNLL-YINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDI 135
Query: 271 MGNRLEGAIP-RSFAKM-GNLQSLDLSMNRLTGGIPEE-FGNMGQLVFLVLSNNNISGSI 327
N I SF + L L+ N + I F + NNN+ +
Sbjct: 136 QDNINIHTIERNSFVGLSFESVILWLNKNGIQE-IHNSAFNGTQLDELNLSDNNNLE-EL 193
Query: 328 PRRICTNATSLEHLILAEIQLSGEIPVE-LSQCQSLKQLDLSNNTLNGTIPVELFQLVAL 386
P + A+ L ++ ++ +P L + L+ N +P L +LVAL
Sbjct: 194 PNDVFHGASGPVILDISRTRIH-SLPSYGLENLKKLRARSTYNLK---KLPT-LEKLVAL 248
Query: 387 THLYLHNNS 395
L S
Sbjct: 249 MEASLTYPS 257
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 86.4 bits (214), Expect = 4e-18
Identities = 45/280 (16%), Positives = 79/280 (28%), Gaps = 59/280 (21%)
Query: 96 SLIHLDLSSNSLTGPIPTALSNLSSLESLLLFSNQLAGTIPTQLGSLTSLRVMRIGDNWL 155
+ I L L A S LE + + N + I
Sbjct: 31 NAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIE------------------- 71
Query: 156 SGSIPTSFGNLVNLGTLGLASCSLSGPIPPQ-FGQLSQLEELILQQNQLQGPIPAELGNC 214
F NL L + + + I P+ F L L+ L++ ++
Sbjct: 72 ----ADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIK---------- 117
Query: 215 SSLSIFTAAENNLNGSIPA-ALGRLQNLQLLNLGNNSLSGEIPSEL--GELSQLGYLNLM 271
+P LL++ +N I G + L L
Sbjct: 118 ---------------HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLN 162
Query: 272 GNRLEGAIPRSFAKMGNLQSLDLSMNRLTGGIPEE-FGNMGQLVFLVLSNNNISGSIPRR 330
N ++ +F + N L +P + F V L +S I S+P
Sbjct: 163 KNGIQEIHNSAFNGTQLDELNLSDNNNLE-ELPNDVFHGASGPVILDISRTRIH-SLPSY 220
Query: 331 ICTNATSLEHLILAEIQLSGEIPVELSQCQSLKQLDLSNN 370
N L ++ ++P L + +L + L+
Sbjct: 221 GLENLKKLRARSTYNLK---KLPT-LEKLVALMEASLTYP 256
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 83.3 bits (206), Expect = 4e-17
Identities = 56/262 (21%), Positives = 99/262 (37%), Gaps = 21/262 (8%)
Query: 572 CSSHSFLSFDVTNNEFDHEIPPQLGNSPSLERLRLGNNKFIGKIP-WTFGKIRELSLLDL 630
CS+ F ++ EIP L + LR K + I F +L +++
Sbjct: 9 CSNRVF---LCQESKV-TEIPSDL--PRNAIELRFVLTK-LRVIQKGAFSGFGDLEKIEI 61
Query: 631 SGNSLTGPIPTQLLM-CKKLSHIDL-NNNLLSGAVPSWLGTLPQLGELKLSFNQFVGFLP 688
S N + I + KL I + N L P LP L L +S
Sbjct: 62 SQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPD 121
Query: 689 RELFNCSKLLVLSLDGNMLNGSLPNEV--GNLASLNVLTLSGNLLSGPIPPAIGRLSKLY 746
+ + ++L + N+ ++ G +L L+ N + I + ++L
Sbjct: 122 VHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQE-IHNSAFNGTQLD 180
Query: 747 ELRLS-NNSLNGVIPLEIGQLQNLQSILDLSHNNFTGQIPP-SMGTLAKLEVLNLSHNQL 804
EL LS NN+L + ILD+S +P + L KL + + +
Sbjct: 181 ELNLSDNNNLEELPNDVFHGASGPV-ILDISRTRIH-SLPSYGLENLKKLRARSTYNLK- 237
Query: 805 VGELPSQLGEMSSLGKLNLSYN 826
+LP+ L ++ +L + +L+Y
Sbjct: 238 --KLPT-LEKLVALMEASLTYP 256
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 80.3 bits (198), Expect = 5e-16
Identities = 42/242 (17%), Positives = 78/242 (32%), Gaps = 13/242 (5%)
Query: 328 PRRICTNATSLEHLILAEIQLSGEIPVELSQCQSLKQLDLSNNTLNGTIPVELFQ-LVAL 386
RIC S + E +++ EIP +L + + +L L I F L
Sbjct: 3 HHRICH--CSNRVFLCQESKVT-EIPSDLPR--NAIELRFVLTKLR-VIQKGAFSGFGDL 56
Query: 387 THLYLHNNSLVGSISPFV-ANLSNLQELALYHNNFQGSLPREI-GMLVKLELLYLYDNHL 444
+ + N ++ I V +NL L E+ + N + E L L+ L + + +
Sbjct: 57 EKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGI 116
Query: 445 SGQIPSEV-GNCSSLKWIDFFGNSFTGEIPTSI--GRLKDLNFLHLRQNELVGQIPASLG 501
+P + +D N I + G + L L +N + ++
Sbjct: 117 K-HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFN 175
Query: 502 NCHQLIILDLADNKLSGGVPASFGFLQALEQLMLYNNSLEGNLPGSLINLRNLTRINFSK 561
+ +N L F L + + L NL+ L +
Sbjct: 176 GTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYN 235
Query: 562 NR 563
+
Sbjct: 236 LK 237
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 76.4 bits (188), Expect = 8e-15
Identities = 58/257 (22%), Positives = 90/257 (35%), Gaps = 39/257 (15%)
Query: 506 LIILDLADNKLSGGVPASFGFLQALEQLMLYNNSLEGNLP-GSLINLRNLTRINFSK-NR 563
I L KL +F LE++ + N + + NL L I K N
Sbjct: 32 AIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANN 91
Query: 564 LNGRIATLCSSHSFLSFDVTNNEFDHEIPPQ-LGNSPSLERLRLGNNKFIGKIP-WTFGK 621
L I P+ N P+L+ L + N I +P
Sbjct: 92 L------------------------LYINPEAFQNLPNLQYLLISNTG-IKHLPDVHKIH 126
Query: 622 IRELSLLDLSGNSLTGPIPTQLL--MCKKLSHIDLNNNLLSGAVPSWLGTLPQLGELKLS 679
+ LLD+ N I + + + LN N + + + QL EL LS
Sbjct: 127 SLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLS 185
Query: 680 FNQFVGFLPRELF-NCSKLLVLSLDGNMLNGSLPNEV-GNLASLNVLTLSGNLLSGPIPP 737
N + LP ++F S ++L + ++ SLP+ NL L + NL P
Sbjct: 186 DNNNLEELPNDVFHGASGPVILDISRTRIH-SLPSYGLENLKKLRARSTY-NLKK---LP 240
Query: 738 AIGRLSKLYELRLSNNS 754
+ +L L E L+ S
Sbjct: 241 TLEKLVALMEASLTYPS 257
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 55.6 bits (134), Expect = 4e-08
Identities = 36/205 (17%), Positives = 60/205 (29%), Gaps = 36/205 (17%)
Query: 76 LNLSGLSLAGSISPS-LGRLQSLIHLDLS-SNSLTGPIPTALSNLSSLESLLLFSNQLAG 133
+ +S + I L L + + +N+L P A NL +L+ LL+ + +
Sbjct: 59 IEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIK- 117
Query: 134 TIPTQL-GSLTSLRVMRIGDNWLSGSIPT-SFGNL-VNLGTLGLASCSLSGPIPPQ---- 186
+P ++ I DN +I SF L L L + I
Sbjct: 118 HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQE-IHNSAFNG 176
Query: 187 ---------------------FGQLSQLEELILQQNQLQGPIPAELGNCSSLSIFTAAEN 225
F S L + + ++ L N L
Sbjct: 177 TQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRAR---ST 233
Query: 226 NLNGSIPAALGRLQNLQLLNLGNNS 250
+P L +L L +L S
Sbjct: 234 YNLKKLPT-LEKLVALMEASLTYPS 257
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 44.8 bits (106), Expect = 1e-04
Identities = 21/112 (18%), Positives = 41/112 (36%), Gaps = 6/112 (5%)
Query: 720 SLNVLTLSGNLLSGPIPPAIGRLSKLYELRLSNNSLNGVIPLEIGQLQNLQSILDLSHNN 779
S V + ++ IP + ELR L + +L+ +++S N+
Sbjct: 10 SNRVFLCQESKVTE-IPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLE-KIEISQND 65
Query: 780 FTGQIPPSM-GTLAKLEVLNLSH-NQLVGELPSQLGEMSSLGKLNLSYNDLQ 829
I + L KL + + N L+ P + +L L +S ++
Sbjct: 66 VLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIK 117
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 85.7 bits (212), Expect = 9e-18
Identities = 54/198 (27%), Positives = 80/198 (40%), Gaps = 38/198 (19%)
Query: 230 SIPAALGRLQNLQLLNLGNNSLSGEIPSE--LGELSQLGYLNLMGNRLEGAIPRSFAKMG 287
++P +L LL+L +N+LS + +E L+ L L L N L +F +
Sbjct: 32 NVPQSLPS--YTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVP 88
Query: 288 NLQSLDLSMNRLTGGIPEE-FGNMGQLVFLVLSNNNISGSIPRRICTNATSLEHLILAEI 346
NL+ LDLS N L + E F ++ L L+L NN+I + R
Sbjct: 89 NLRYLDLSSNHLHT-LDEFLFSDLQALEVLLLYNNHIV-VVDRNA--------------- 131
Query: 347 QLSGEIPVELSQCQSLKQLDLSNNTLNGTIPVELFQ----LVALTHLYLHNNSLVGSISP 402
L++L LS N ++ PVEL + L L L L +N L
Sbjct: 132 ---------FEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLT 181
Query: 403 FVANLSNLQELALY-HNN 419
+ L + LY HNN
Sbjct: 182 DLQKLPAWVKNGLYLHNN 199
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 84.5 bits (209), Expect = 2e-17
Identities = 41/166 (24%), Positives = 65/166 (39%), Gaps = 13/166 (7%)
Query: 288 NLQSLDLSMNRLTGGIPEE-FGNMGQLVFLVLSNNNISGSIPRRICTNATSLEHLILAEI 346
LDLS N L+ E + L L+LS+N+++ I +L +L L+
Sbjct: 40 YTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSN 98
Query: 347 QLSGEIPVE-LSQCQSLKQLDLSNNTLNGTIPVELFQ-LVALTHLYLHNNSLVGSISPFV 404
L + S Q+L+ L L NN + + F+ + L LYL N + +
Sbjct: 99 HLH-TLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQIS-RFPVEL 155
Query: 405 ----ANLSNLQELALYHNNFQGSLPREIGMLVKLEL--LYLYDNHL 444
L L L L N + ++ L LYL++N L
Sbjct: 156 IKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPL 201
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 76.0 bits (187), Expect = 1e-14
Identities = 50/200 (25%), Positives = 73/200 (36%), Gaps = 39/200 (19%)
Query: 351 EIPVELSQCQSLKQLDLSNNTLNGTIPVELFQ-LVALTHLYLHNNSLVGSISPFV-ANLS 408
+P L LDLS+N L+ L L L L +N L IS +
Sbjct: 32 NVPQSLPS--YTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHL-NFISSEAFVPVP 88
Query: 409 NLQELALYHNNFQGSLPREI-GMLVKLELLYLYDNHLSGQIPSEVGNCSSLKWIDFFGNS 467
NL+ L L N+ +L + L LE+L LY+NH+ +
Sbjct: 89 NLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIV-VVDRNA--------------- 131
Query: 468 FTGEIPTSIGRLKDLNFLHLRQNELVGQIPA----SLGNCHQLIILDLADNKLSGGVPAS 523
F + L L+L QN++ + P +L++LDL+ NKL
Sbjct: 132 FED--------MAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTD 182
Query: 524 FGFLQALEQLMLYNNSLEGN 543
L A + LY L N
Sbjct: 183 LQKLPAWVKNGLY---LHNN 199
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 75.7 bits (186), Expect = 2e-14
Identities = 40/189 (21%), Positives = 67/189 (35%), Gaps = 37/189 (19%)
Query: 143 TSLRVMRIGDNWLSGSIP--TSFGNLVNLGTLGLASCSLSGPIPPQ-FGQLSQLEELILQ 199
+ ++ + N LS + + L NL +L L+ L+ I + F + L L L
Sbjct: 39 SYTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLNF-ISSEAFVPVPNLRYLDLS 96
Query: 200 QNQLQGPIPAELGNCSSLSIFTAAENNLNGSIPA-ALGRLQNLQLLNLGNNSLSGEIPSE 258
N L ++ LQ L++L L NN + +
Sbjct: 97 SNHLH-------------------------TLDEFLFSDLQALEVLLLYNNHIV-VVDRN 130
Query: 259 -LGELSQLGYLNLMGNRLEGAIPRSFA---KMGNLQSLDLSMNRLTGGIPEEFGNMGQLV 314
+++QL L L N++ K+ L LDLS N+L + + V
Sbjct: 131 AFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWV 190
Query: 315 FLVLS-NNN 322
L +NN
Sbjct: 191 KNGLYLHNN 199
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 71.8 bits (176), Expect = 3e-13
Identities = 35/168 (20%), Positives = 59/168 (35%), Gaps = 34/168 (20%)
Query: 183 IPPQ--FGQLSQLEELILQQNQLQGPIPAELGNCSSLSIFTAAENNLNGSIPA-ALGRLQ 239
+ + +L+ L L+L N L I + A +
Sbjct: 54 LRAEWTPTRLTNLHSLLLSHNHLN-------------------------FISSEAFVPVP 88
Query: 240 NLQLLNLGNNSLSGEIPSE-LGELSQLGYLNLMGNRLEGAIPRSFAKMGNLQSLDLSMNR 298
NL+ L+L +N L + +L L L L N + +F M LQ L LS N+
Sbjct: 89 NLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQ 147
Query: 299 LTGGIPEEFGNMG---QLVFLVLSNNNISGSIPRRICTNATSLEHLIL 343
++ E + +L+ L LS+N + +P + L
Sbjct: 148 ISRFPVELIKDGNKLPKLMLLDLSSNKLK-KLPLTDLQKLPAWVKNGL 194
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 71.0 bits (174), Expect = 6e-13
Identities = 42/160 (26%), Positives = 62/160 (38%), Gaps = 11/160 (6%)
Query: 675 ELKLSFNQFVGFLPRELF-NCSKLLVLSLDGNMLNGSLPNEV-GNLASLNVLTLSGNLLS 732
L LS N + L L L N LN + +E + +L L LS N L
Sbjct: 43 LLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSNHLH 101
Query: 733 GPIPPAI-GRLSKLYELRLSNNSLNGVIPLEIGQLQNLQSILDLSHNNFTGQIPP----S 787
+ + L L L L NN + V + LQ L LS N + + P
Sbjct: 102 T-LDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQK-LYLSQNQIS-RFPVELIKD 158
Query: 788 MGTLAKLEVLNLSHNQLVGELPSQLGEMSSLGKLNLSYND 827
L KL +L+LS N+L + L ++ + K L ++
Sbjct: 159 GNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHN 198
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 70.6 bits (173), Expect = 7e-13
Identities = 47/201 (23%), Positives = 73/201 (36%), Gaps = 39/201 (19%)
Query: 590 EIPPQLGNSPSLERLRLGNNKFIGKIP--WTFGKIRELSLLDLSGNSLTGPIPTQLLMCK 647
+P L L L +N + ++ WT ++ L L LS N L
Sbjct: 32 NVPQSL--PSYTALLDLSHNN-LSRLRAEWTPTRLTNLHSLLLSHNHLN----------- 77
Query: 648 KLSHIDLNNNLLSGAVPSWLGTLPQLGELKLSFNQFVGFLPRELF-NCSKLLVLSLDGNM 706
+++ +P L L LS N + L LF + L VL L N
Sbjct: 78 -----FISSEAFVP--------VPNLRYLDLSSNH-LHTLDEFLFSDLQALEVLLLYNNH 123
Query: 707 LNGSLPNEV-GNLASLNVLTLSGNLLSGPIPP----AIGRLSKLYELRLSNNSLNGVIPL 761
+ + ++A L L LS N +S P +L KL L LS+N L +
Sbjct: 124 IV-VVDRNAFEDMAQLQKLYLSQNQISR-FPVELIKDGNKLPKLMLLDLSSNKLKKLPLT 181
Query: 762 EIGQLQNLQ-SILDLSHNNFT 781
++ +L + L L +N
Sbjct: 182 DLQKLPAWVKNGLYLHNNPLE 202
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 68.3 bits (167), Expect = 4e-12
Identities = 37/160 (23%), Positives = 65/160 (40%), Gaps = 12/160 (7%)
Query: 70 SARVVSLNLSGLSLAGSISP--SLGRLQSLIHLDLSSNSLTGPIPTALSNLSSLESLLLF 127
+ L+LS +L+ + + RL +L L LS N L A + +L L L
Sbjct: 38 PSYTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLS 96
Query: 128 SNQLAGTIPTQ-LGSLTSLRVMRIGDNWLSGSIPT-SFGNLVNLGTLGLASCSLSGPIPP 185
SN L T+ L +L V+ + +N + + +F ++ L L L+ +S P
Sbjct: 97 SNHLH-TLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQISR-FPV 153
Query: 186 Q----FGQLSQLEELILQQNQLQGPIPAELGNCSSLSIFT 221
+ +L +L L L N+L+ +L +
Sbjct: 154 ELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNG 193
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 67.9 bits (166), Expect = 5e-12
Identities = 49/169 (28%), Positives = 75/169 (44%), Gaps = 15/169 (8%)
Query: 699 VLSLDGNMLNGSLPNEV--GNLASLNVLTLSGNLLSGPIPP-AIGRLSKLYELRLSNNSL 755
+L L N L L E L +L+ L LS N L+ I A + L L LS+N L
Sbjct: 43 LLDLSHNNL-SRLRAEWTPTRLTNLHSLLLSHNHLNF-ISSEAFVPVPNLRYLDLSSNHL 100
Query: 756 NGVIPLEIGQLQNLQSILDLSHNNFTGQIPPSM-GTLAKLEVLNLSHNQLVGELP----S 810
+ + LQ L+ +L L +N+ + + +A+L+ L LS NQ+ P
Sbjct: 101 HTLDEFLFSDLQALE-VLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIK 157
Query: 811 QLGEMSSLGKLNLSYNDLQGKLSKQFSHWPAEAFEGNLHLCGSPLDHCN 859
++ L L+LS N L+ PA G L+L +PL+ C+
Sbjct: 158 DGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNG-LYLHNNPLE-CD 204
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 61.4 bits (149), Expect = 6e-10
Identities = 42/135 (31%), Positives = 61/135 (45%), Gaps = 14/135 (10%)
Query: 719 ASLNVLTLSGNLLSGPIPP--AIGRLSKLYELRLSNNSLNGVIPLEIGQLQNLQSILDLS 776
+ +L LS N LS + RL+ L+ L LS+N LN + + NL+ LDLS
Sbjct: 39 SYTALLDLSHNNLSR-LRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRY-LDLS 96
Query: 777 HNNFTGQIPPSM-GTLAKLEVLNLSHNQLVGELPSQLGEMSSLGKLNLSYNDLQGKLSKQ 835
N+ + + L LEVL L +N +V + +M+ L KL LS N Q
Sbjct: 97 SNHLH-TLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQN--------Q 147
Query: 836 FSHWPAEAFEGNLHL 850
S +P E + L
Sbjct: 148 ISRFPVELIKDGNKL 162
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 60.6 bits (147), Expect = 1e-09
Identities = 40/166 (24%), Positives = 58/166 (34%), Gaps = 32/166 (19%)
Query: 478 RLKDLNFLHLRQNELVGQIPA-SLGNCHQLIILDLADNKLSGGVPASFGFLQALEQLMLY 536
RL +L+ L L N L I + + L LDL+ N L F LQALE L+LY
Sbjct: 62 RLTNLHSLLLSHNHL-NFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLY 120
Query: 537 NNSLEGNLPGSLINLRNLTRINFSKNRLNGRIATLCSSHSFLSFDVTNNEFDHEIPPQ-- 594
NN + + ++ L ++ S+N++ P +
Sbjct: 121 NNHIVVVDRNAFEDMAQLQKLYLSQNQI------------------------SRFPVELI 156
Query: 595 --LGNSPSLERLRLGNNKFIGKIPWTFGKIRELSL--LDLSGNSLT 636
P L L L +NK K+ L L N L
Sbjct: 157 KDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLE 202
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 9e-18
Identities = 57/237 (24%), Positives = 104/237 (43%), Gaps = 35/237 (14%)
Query: 933 KRDFRWEDIMGATNNLSDEF----IIGSGGSGTVYKA-ELANGATVAVKKIS-CKDDHLL 986
K+ F +D+ L + +GSG G+V A + +G VA+KK+S +
Sbjct: 7 KKGFYKQDVNKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIF 66
Query: 987 NKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNL----LIYEYMENGSVWDWLHKQPVN 1042
K RE+ L ++H +++ L+ + N L+ +M+ D L K
Sbjct: 67 AKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQT----D-LQKI--- 118
Query: 1043 IKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLA 1102
M E + + +G++Y+H ++HRD+K N+ ++ + E + DFGLA
Sbjct: 119 --MGLKFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLA 173
Query: 1103 KALVEDYNSNTE--SNTWFAGSYGYIAPEYAYSLKA-TEKCDVYSMGIVLMELVSGK 1156
+ + T W Y APE S + D++S+G ++ E+++GK
Sbjct: 174 RHADAEM---TGYVVTRW------YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 86.0 bits (213), Expect = 2e-17
Identities = 65/303 (21%), Positives = 111/303 (36%), Gaps = 56/303 (18%)
Query: 900 RKREFLRKSSQVNYTSSSSSSQAQRRLLFQAAAKRDFRWEDIMGATNNLSDEF----IIG 955
+ + S SQ + + Q + + + + D + +IG
Sbjct: 3 SHEAAAAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLIG 62
Query: 956 SGGSGTVYKA-ELANGATVAVKKIS-CKDDHLLNKSFTREVKTLGRIRHRHLVKL--MGH 1011
+G G V +A + VA+KKI +D + K RE+ L R+ H H+VK+ +
Sbjct: 63 TGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVI 122
Query: 1012 CCNKGAGSNL-LIYEYMENGSVWDWLHK-----QPVNIKMRKSLDWEARLKIAVGLAQGV 1065
+ L ++ E + D K + K+L + L GV
Sbjct: 123 PKDVEKFDELYVVLEIAD----SD-FKKLFRTPVYLTELHIKTLLYN--------LLVGV 169
Query: 1066 EYLH-HDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYG 1124
+Y+H ILHRD+K +N L++ + + DFGLA+ + N N++
Sbjct: 170 KYVHSAG----ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDM 225
Query: 1125 -----------------------YIAPEYAYSLKA-TEKCDVYSMGIVLMELVSGKMPTD 1160
Y APE + TE DV+S+G + EL++
Sbjct: 226 NLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENV 285
Query: 1161 ATF 1163
A
Sbjct: 286 AYH 288
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 2e-17
Identities = 58/223 (26%), Positives = 96/223 (43%), Gaps = 39/223 (17%)
Query: 953 IIGSGGSGTVYKA-ELANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGH 1011
++G G G V A G VA+KKI D L RE+K L +H +++ + +
Sbjct: 18 LLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIF-N 76
Query: 1012 CCNKGAGSNL----LIYEYMENGSVWDWLHK----QPVNIKMRKSLDWEARLKIAVGLAQ 1063
+ N +I E M+ D LH+ Q ++ + + Q
Sbjct: 77 IQRPDSFENFNEVYIIQELMQT----D-LHRVISTQMLSDDHIQYF-----------IYQ 120
Query: 1064 ---GVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFA 1120
V+ LH ++HRD+K SN+L++SN + + DFGLA+ + E N+E +
Sbjct: 121 TLRAVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQS 177
Query: 1121 GSYGYI------APEYAYSLKA-TEKCDVYSMGIVLMELVSGK 1156
G ++ APE + + DV+S G +L EL +
Sbjct: 178 GMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 3e-17
Identities = 53/217 (24%), Positives = 94/217 (43%), Gaps = 42/217 (19%)
Query: 954 IGSGGSGTVYKA-ELANGATVAVKKISCKDDHLLNKSFTREVKTLGRIR-HRHLVKLMGH 1011
+G G V++A + N V VK + K RE+K L +R +++ L
Sbjct: 44 LGRGKYSEVFEAINITNNEKVVVKILKPVKK----KKIKREIKILENLRGGPNIITLADI 99
Query: 1012 CCNKGAGSNLLIYEYMENGSVWDWLHK--QPVNIKMRKSLDWEARLKIAVGLAQGVEYLH 1069
+ + + L++E++ N D + Q + + +E + + ++Y H
Sbjct: 100 VKDPVSRTPALVFEHVNNT---D-FKQLYQTLTDYDIRFYMYE--------ILKALDYCH 147
Query: 1070 HDCVPKILHRDIKSSNILLDS-NMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAP 1128
I+HRD+K N+++D + + L D+GLA E Y+ E N A Y + P
Sbjct: 148 SM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLA----EFYHPGQEYNVRVASRY-FKGP 199
Query: 1129 E-------YAYSLKATEKCDVYSMGIVLMELVSGKMP 1158
E Y YSL D++S+G +L ++ K P
Sbjct: 200 ELLVDYQMYDYSL------DMWSLGCMLASMIFRKEP 230
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 4e-17
Identities = 56/238 (23%), Positives = 103/238 (43%), Gaps = 34/238 (14%)
Query: 932 AKRDFRWEDIMGATNNLSDEF----IIGSGGSGTVYKA-ELANGATVAVKKIS-CKDDHL 985
A+ F +++ + + +GSG G V A + GA VA+KK+ L
Sbjct: 7 ARSGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSEL 66
Query: 986 LNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNL----LIYEYMENGSVWDWLHKQPV 1041
K RE++ L +RH +++ L+ + L+ +M D L K
Sbjct: 67 FAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGT----D-LGK--- 118
Query: 1042 NIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGL 1101
+ + L + + + +G+ Y+H I+HRD+K N+ ++ + E + DFGL
Sbjct: 119 -LMKHEKLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGL 174
Query: 1102 AKALVEDYNSNTE--SNTWFAGSYGYIAPEYAYSLKA-TEKCDVYSMGIVLMELVSGK 1156
A+ + T W Y APE + T+ D++S+G ++ E+++GK
Sbjct: 175 ARQADSEM---TGYVVTRW------YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 5e-17
Identities = 53/212 (25%), Positives = 94/212 (44%), Gaps = 24/212 (11%)
Query: 953 IIGSGGSGTVYKAEL-ANGATVAVKKISCKDDHLLNKSFTREVKT----LGRIRHRHLVK 1007
++G GG G V ++ A G A KK+ + + + L ++ R +V
Sbjct: 191 VLGKGGFGEVCACQVRATGKMYACKKL--EKKRIKKRKGEAMALNEKQILEKVNSRFVVS 248
Query: 1008 LMGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKI-AVGLAQGVE 1066
L + + L+ M G + ++ M ++ EAR A + G+E
Sbjct: 249 L--AYAYETKDALCLVLTLMNGGDLKFHIYH------MGQAGFPEARAVFYAAEICCGLE 300
Query: 1067 YLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYI 1126
LH + +I++RD+K NILLD + + D GLA + E G+ GY+
Sbjct: 301 DLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKG-----RVGTVGYM 352
Query: 1127 APEYAYSLKATEKCDVYSMGIVLMELVSGKMP 1158
APE + + T D +++G +L E+++G+ P
Sbjct: 353 APEVVKNERYTFSPDWWALGCLLYEMIAGQSP 384
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 7e-17
Identities = 47/233 (20%), Positives = 85/233 (36%), Gaps = 42/233 (18%)
Query: 945 TNNLSDEFII-----GSGGSGTVYKA-ELANGATVAVKKISCK----DDHLLNKSFTREV 994
N ++ +I+ G G V + + G A K + + D E+
Sbjct: 23 MENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCR---AEILHEI 79
Query: 995 KTLGRIRHR-HLVKLMGHCCNKGAGSNL-LIYEYMENGSVWDWLHKQPVNIKMRKSLDWE 1052
L + ++ L N S + LI EY G ++ + + +
Sbjct: 80 AVLELAKSCPRVINLHEVYENT---SEIILILEYAAGGEIFSLCLPELAEMVSEN----D 132
Query: 1053 ARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAH---LGDFGLAKALVEDY 1109
I + +GV YLH + I+H D+K NILL S + DFG+++ +
Sbjct: 133 VIRLIKQ-ILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHAC 188
Query: 1110 NSNTESNTWFAGSYGYIAPE----YAYSLKATEKCDVYSMGIVLMELVSGKMP 1158
G+ Y+APE + D++++GI+ L++ P
Sbjct: 189 ELRE-----IMGTPEYLAPEILNYDPIT----TATDMWNIGIIAYMLLTHTSP 232
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 9e-17
Identities = 68/264 (25%), Positives = 113/264 (42%), Gaps = 45/264 (17%)
Query: 912 NYTSSSSSSQAQRRLLFQAAAKRDF--RWEDIMGATNNLSD-EFI--IGSGGSGTVYKAE 966
N ++ S+ + F A AK DF +WE T L + I +G+G G V +
Sbjct: 2 NAAAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVK 61
Query: 967 L-ANGATVAVKKISCKD--------DHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGA 1017
+G A+K + K +H LN E + L + LVKL +
Sbjct: 62 HKESGNHYAMKILD-KQKVVKLKQIEHTLN-----EKRILQAVNFPFLVKLEFSFKDN-- 113
Query: 1018 GSNL-LIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIA-VGLAQGVEYLHHDCVPK 1075
SNL ++ EY+ G ++ L + + + AR A + L EYLH
Sbjct: 114 -SNLYMVMEYVAGGEMFSHLRRI------GRFSEPHARFYAAQIVLT--FEYLHSL---D 161
Query: 1076 ILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTW-FAGSYGYIAPEYAYSL 1134
+++RD+K N+L+D + DFG AK + + TW G+ +APE S
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRV--------KGRTWTLCGTPEALAPEIILSK 213
Query: 1135 KATEKCDVYSMGIVLMELVSGKMP 1158
+ D +++G+++ E+ +G P
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPP 237
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 1e-16
Identities = 60/224 (26%), Positives = 106/224 (47%), Gaps = 39/224 (17%)
Query: 953 IIGSGGSGTVYKA-ELANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLM-- 1009
+G GG+G V+ A + VA+KKI D K RE+K + R+ H ++VK+
Sbjct: 18 PLGCGGNGLVFSAVDNDCDKRVAIKKIVL-TDPQSVKHALREIKIIRRLDHDNIVKVFEI 76
Query: 1010 ------GHCCNKGAGSNL----LIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAV 1059
+ G+ + L ++ EYME D L ++ L+ ARL
Sbjct: 77 LGPSGSQLTDDVGSLTELNSVYIVQEYMET----D-LANV---LEQGPLLEEHARL-FMY 127
Query: 1060 GLAQGVEYLHHDCVPKILHRDIKSSNILLDS-NMEAHLGDFGLAKALVEDYNSN---TE- 1114
L +G++Y+H +LHRD+K +N+ +++ ++ +GDFGLA+ + Y+ +E
Sbjct: 128 QLLRGLKYIHS---ANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEG 184
Query: 1115 -SNTWFAGSYGYIAPEYAYSLKA-TEKCDVYSMGIVLMELVSGK 1156
W Y +P S T+ D+++ G + E+++GK
Sbjct: 185 LVTKW------YRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 2e-16
Identities = 50/188 (26%), Positives = 82/188 (43%), Gaps = 24/188 (12%)
Query: 213 NCSSLSIFTAAENNLNGSIPAALGRLQNLQLLNLGNNSLSGEIPSELGELSQLGYLNLMG 272
+C S + + IPA + + L+L + L+ + L++L +LNL
Sbjct: 20 DCQGKS-LDSVPSG----IPA------DTEKLDLQSTGLATLSDATFRGLTKLTWLNLDY 68
Query: 273 NRLEGAIPRS-FAKMGNLQSLDLSMNRLTGGIPEEFGNMGQLVFLVLSNNNISGSIPRRI 331
N+L+ + F + L +L L+ N+L F ++ QL L L N + S+P +
Sbjct: 69 NQLQ-TLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLK-SLPSGV 126
Query: 332 CTNATSLEHLILAEIQLSGEIPV----ELSQCQSLKQLDLSNNTLNGTIPVELF-QLVAL 386
T L+ L L QL IP +L+ L+ L LS N L ++P F +L L
Sbjct: 127 FDRLTKLKELRLNTNQLQ-SIPAGAFDKLTN---LQTLSLSTNQLQ-SVPHGAFDRLGKL 181
Query: 387 THLYLHNN 394
+ L N
Sbjct: 182 QTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 1e-12
Identities = 59/202 (29%), Positives = 91/202 (45%), Gaps = 37/202 (18%)
Query: 101 DLSSNSLTGPIPTALSNLSSLESLLLFSNQLAGTIPTQLGSLTSLRVMRIGDNWLSGSIP 160
D SL +P+ + + E L L S LA LT L + + N L ++
Sbjct: 20 DCQGKSLDS-VPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLS 75
Query: 161 TS-FGNLVNLGTLGLASCSLSGPIPPQ-FGQLSQLEELILQQNQLQGPIPAELGNCSSLS 218
F +L LGTLGLA+ L+ +P F L+QL++L L NQL+
Sbjct: 76 AGVFDDLTELGTLGLANNQLAS-LPLGVFDHLTQLDKLYLGGNQLK-------------- 120
Query: 219 IFTAAENNLNGSIPA-ALGRLQNLQLLNLGNNSLSGEIPSEL-GELSQLGYLNLMGNRLE 276
S+P+ RL L+ L L N L IP+ +L+ L L+L N+L+
Sbjct: 121 -----------SLPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFDKLTNLQTLSLSTNQLQ 168
Query: 277 GAIPR-SFAKMGNLQSLDLSMN 297
++P +F ++G LQ++ L N
Sbjct: 169 -SVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 2e-11
Identities = 53/182 (29%), Positives = 72/182 (39%), Gaps = 36/182 (19%)
Query: 363 KQLDLSNNTLNGTIPVELFQLVALTHLYLHNNSLVGSISPFV-ANLSNLQELALYHNNFQ 421
++LDL + L L LT L L N L ++S V +L+ L L L +N
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQLA 96
Query: 422 GSLPREI-GMLVKLELLYLYDNHLSGQIPSEVGNCSSLKWIDFFGNSFTGEIPTSIGRLK 480
SLP + L +L+ LYL N L +PS V F RL
Sbjct: 97 -SLPLGVFDHLTQLDKLYLGGNQLKS-LPSGV---------------FD--------RLT 131
Query: 481 DLNFLHLRQNELVGQIPA----SLGNCHQLIILDLADNKLSGGVPASFGFLQALEQLMLY 536
L L L N+L IPA L L L L+ N+L +F L L+ + L+
Sbjct: 132 KLKELRLNTNQL-QSIPAGAFDKLT---NLQTLSLSTNQLQSVPHGAFDRLGKLQTITLF 187
Query: 537 NN 538
N
Sbjct: 188 GN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 8e-10
Identities = 49/158 (31%), Positives = 70/158 (44%), Gaps = 12/158 (7%)
Query: 602 ERLRLGNNKFIGKIPWTFGKIRELSLLDLSGNSLTG-P--IPTQLLMCKKLSHIDLNNNL 658
E+L L + TF + +L+ L+L N L + L +L + L NN
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDL---TELGTLGLANNQ 94
Query: 659 LSGAVPSWL-GTLPQLGELKLSFNQFVGFLPRELF-NCSKLLVLSLDGNMLNGSLPNEV- 715
L+ ++P + L QL +L L NQ LP +F +KL L L+ N L S+P
Sbjct: 95 LA-SLPLGVFDHLTQLDKLYLGGNQLKS-LPSGVFDRLTKLKELRLNTNQLQ-SIPAGAF 151
Query: 716 GNLASLNVLTLSGNLLSGPIPPAIGRLSKLYELRLSNN 753
L +L L+LS N L A RL KL + L N
Sbjct: 152 DKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 2e-08
Identities = 53/179 (29%), Positives = 73/179 (40%), Gaps = 32/179 (17%)
Query: 75 SLNLSGLSLAGSISPSLGRLQSLIHLDLSSNSLTGPIPTALSNLSSLESLLLFSNQLAGT 134
L+L LA + L L L+L N L +L+ L +L L +NQLA +
Sbjct: 39 KLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLA-S 97
Query: 135 IPTQL-GSLTSLRVMRIGDNWLSGSIPTS-FGNLVNLGTLGLASCSLSGPIPP-QFGQLS 191
+P + LT L + +G N L S+P+ F L L L L + L IP F +L+
Sbjct: 98 LPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQS-IPAGAFDKLT 155
Query: 192 QLEELILQQNQLQGPIPAELGNCSSLSIFTAAENNLNGSIPA-ALGRLQNLQLLNLGNN 249
L+ L L NQLQ S+P A RL LQ + L N
Sbjct: 156 NLQTLSLSTNQLQ-------------------------SVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 3e-08
Identities = 50/148 (33%), Positives = 66/148 (44%), Gaps = 6/148 (4%)
Query: 628 LDLSGNSLTGPIPTQLLMCKKLSHIDLNNNLLSGAVPSWLGTLPQLGELKLSFNQFVGFL 687
LDL L KL+ ++L+ N L L +LG L L+ NQ L
Sbjct: 40 LDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLA-SL 98
Query: 688 PRELFNC-SKLLVLSLDGNMLNGSLPNEV-GNLASLNVLTLSGNLLSGPIPP-AIGRLSK 744
P +F+ ++L L L GN L SLP+ V L L L L+ N L IP A +L+
Sbjct: 99 PLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQS-IPAGAFDKLTN 156
Query: 745 LYELRLSNNSLNGVIPLEIGQLQNLQSI 772
L L LS N L V +L LQ+I
Sbjct: 157 LQTLSLSTNQLQSVPHGAFDRLGKLQTI 184
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 6e-07
Identities = 50/188 (26%), Positives = 66/188 (35%), Gaps = 33/188 (17%)
Query: 472 IPTSIGRLKDLNFLHLRQNELVGQIPASLGNCHQLIILDLADNKLSGGVPAS-FGFLQAL 530
IP +L L+ L A+ +L L+L N+L + A F L L
Sbjct: 33 IPADTEKL------DLQSTGLATLSDATFRGLTKLTWLNLDYNQLQT-LSAGVFDDLTEL 85
Query: 531 EQLMLYNNSLEGNLPGSLINLRNLTRINFSKNRLNGRIATLCSSHSFLSFDVTNNEFDHE 590
L L NN L G +L L ++ N+L L V FD
Sbjct: 86 GTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQL-----------KSLPSGV----FD-- 128
Query: 591 IPPQLGNSPSLERLRLGNNKFIGKIPW-TFGKIRELSLLDLSGNSLTGPIPTQLLMCKKL 649
+L L+ LRL N+ + IP F K+ L L LS N L KL
Sbjct: 129 ---RLTK---LKELRLNTNQ-LQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKL 181
Query: 650 SHIDLNNN 657
I L N
Sbjct: 182 QTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 7e-07
Identities = 44/158 (27%), Positives = 63/158 (39%), Gaps = 13/158 (8%)
Query: 675 ELKLSFNQFVGFLPRELFNCSKLLVLSLDGNMLNGSLPNEV-GNLASLNVLTLSGNLLSG 733
+L L +KL L+LD N L +L V +L L L L+ N L+
Sbjct: 39 KLDLQSTGLATLSDATFRGLTKLTWLNLDYNQL-QTLSAGVFDDLTELGTLGLANNQLAS 97
Query: 734 PIPPAI-GRLSKLYELRLSNNSLNGVIPLEIG---QLQNLQSILDLSHNNFTGQIPPSM- 788
+P + L++L +L L N L L G +L L+ L L+ N IP
Sbjct: 98 -LPLGVFDHLTQLDKLYLGGNQLKS---LPSGVFDRLTKLK-ELRLNTNQLQ-SIPAGAF 151
Query: 789 GTLAKLEVLNLSHNQLVGELPSQLGEMSSLGKLNLSYN 826
L L+ L+LS NQL + L + L N
Sbjct: 152 DKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 6e-05
Identities = 34/116 (29%), Positives = 47/116 (40%), Gaps = 11/116 (9%)
Query: 719 ASLNVLTLSGNLLSGPIPPAIGRLSKLYELRLSNNSLNGVIPLEIGQLQNLQSILDLSHN 778
A L L L+ L+KL L L N L + L L L L++N
Sbjct: 35 ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELG-TLGLANN 93
Query: 779 NFTGQIPPSM-GTLAKLEVLNLSHNQLVGELPS----QLGEMSSLGKLNLSYNDLQ 829
+P + L +L+ L L NQL LPS +L + L +L L+ N LQ
Sbjct: 94 QLA-SLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTK---LKELRLNTNQLQ 144
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 2e-16
Identities = 55/237 (23%), Positives = 95/237 (40%), Gaps = 39/237 (16%)
Query: 953 IIGSGGSGTVYKA-ELANGATVAVKKIS-CKDDHLLNKSFTREVKTLGRIRHRHLVKLMG 1010
+IG G G VY A + VA+KK++ +D + K RE+ L R++ ++++L
Sbjct: 33 LIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLY- 91
Query: 1011 HCCNKGAGSNL----LIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLK-IAVGLAQGV 1065
++ E + D L K K L E +K I L G
Sbjct: 92 DLIIPDDLLKFDELYIVLEIAD----SD-LKKL---FKTPIFLT-EEHIKTILYNLLLGE 142
Query: 1066 EYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYG- 1124
++H I+HRD+K +N LL+ + + DFGLA+ + + ++N ++ G
Sbjct: 143 NFIHE---SGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGP 199
Query: 1125 -----------------YIAPEYAYSLKA-TEKCDVYSMGIVLMELVSGKMPTDATF 1163
Y APE + T+ D++S G + EL++
Sbjct: 200 HNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDP 256
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 3e-16
Identities = 60/265 (22%), Positives = 98/265 (36%), Gaps = 41/265 (15%)
Query: 953 IIGSGGSGTVYKAEL-ANGATVAVKKISCKDDHLLNKS---FTREVKT-LGRIRHRHLVK 1007
+IG G V ++ G A+K + +L + RE + L R + +
Sbjct: 68 VIGRGAFSEVAVVKMKQTGQVYAMKIM--NKWDMLKRGEVSCFREERDVLVNGDRRWITQ 125
Query: 1008 LMGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIA-VGLAQGVE 1066
L H + L+ EY G + L K I + AR +A + +A ++
Sbjct: 126 L--HFAFQDENYLYLVMEYYVGGDLLTLLSKFGERI----PAEM-ARFYLAEIVMA--ID 176
Query: 1067 YLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYI 1126
+H +HRDIK NILLD L DFG L D S G+ Y+
Sbjct: 177 SVHRL---GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRAD--GTVRSLV-AVGTPDYL 230
Query: 1127 APE-------YAYSLKATEKCDVYSMGIVLMELVSGKMP-----TDATFG---VEMDMVR 1171
+PE + +CD +++G+ E+ G+ P T T+G + +
Sbjct: 231 SPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLS 290
Query: 1172 WVEMHMEMSGSAR---EELLDDQMK 1193
+ + AR + LL
Sbjct: 291 LPLVDEGVPEEARDFIQRLLCPPET 315
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 3e-16
Identities = 54/235 (22%), Positives = 97/235 (41%), Gaps = 54/235 (22%)
Query: 947 NLSD-EFI--IGSGGSGTVYKAEL-ANGATVAVKKISCKDDHLLNKSFT---REVKTLGR 999
N E + IG G G V + A+K ++ K + +E++ +
Sbjct: 13 NFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMN-KQKCVERNEVRNVFKELQIMQG 71
Query: 1000 IRHRHLVKLMGHCCNKGA---GSNL-LIYEYMENGSVWDWL--HKQPVNIKMRKSLDWEA 1053
+ H LV L + ++ ++ + + G L H Q + +
Sbjct: 72 LEHPFLVNL------WYSFQDEEDMFMVVDLLLGGD----LRYHLQ----QNVHFKEETV 117
Query: 1054 RLKIA-VGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSN 1112
+L I + +A ++YL + +I+HRD+K NILLD + H+ DF +A L +
Sbjct: 118 KLFICELVMA--LDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQIT 172
Query: 1113 TESNTWFAGSYGYIAPE---------YAYSLKATEKCDVYSMGIVLMELVSGKMP 1158
T AG+ Y+APE Y+++ D +S+G+ EL+ G+ P
Sbjct: 173 T-----MAGTKPYMAPEMFSSRKGAGYSFA------VDWWSLGVTAYELLRGRRP 216
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 4e-16
Identities = 54/217 (24%), Positives = 94/217 (43%), Gaps = 28/217 (12%)
Query: 953 IIGSGGSGTVYKAEL-ANGATVAVKKISCKDDHLLNKS---FTREVKT-LGRIRHRHLVK 1007
+IG G G V +L A+K + +L ++ RE + L + +
Sbjct: 81 VIGRGAFGEVAVVKLKNADKVFAMKIL--NKWEMLKRAETACFREERDVLVNGDSKWITT 138
Query: 1008 LMGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIA-VGLAQGVE 1066
L H + + L+ +Y G + L K + R + AR +A + +A ++
Sbjct: 139 L--HYAFQDDNNLYLVMDYYVGGDLLTLLSK----FEDRLPEEM-ARFYLAEMVIA--ID 189
Query: 1067 YLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYI 1126
+H +HRDIK NIL+D N L DFG L+ED + G+ YI
Sbjct: 190 SVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSV---AVGTPDYI 243
Query: 1127 APEYAYSLKATEK-----CDVYSMGIVLMELVSGKMP 1158
+PE +++ + CD +S+G+ + E++ G+ P
Sbjct: 244 SPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 4e-16
Identities = 51/211 (24%), Positives = 91/211 (43%), Gaps = 19/211 (9%)
Query: 953 IIGSGGSGTVYKAEL-ANGATVAVKKISCKDDHLLNKSFTREVKT----LGRIRHRHLVK 1007
++G GG G V+ ++ A G A KK+ L + + L ++ R +V
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKL--NKKRLKKRKGYQGAMVEKKILAKVHSRFIVS 249
Query: 1008 LMGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEY 1067
L + L+ M G + H V+ + A A + G+E+
Sbjct: 250 L--AYAFETKTDLCLVMTIMNGGDIR--YHIYNVDEDNPGFQEPRAIFYTA-QIVSGLEH 304
Query: 1068 LHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIA 1127
LH I++RD+K N+LLD + + D GLA L T++ +AG+ G++A
Sbjct: 305 LHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAG---QTKTKG-YAGTPGFMA 357
Query: 1128 PEYAYSLKATEKCDVYSMGIVLMELVSGKMP 1158
PE + D +++G+ L E+++ + P
Sbjct: 358 PELLLGEEYDFSVDYFALGVTLYEMIAARGP 388
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 6e-16
Identities = 48/216 (22%), Positives = 83/216 (38%), Gaps = 53/216 (24%)
Query: 953 IIGSGGSGTVYKA-ELANGATVAVKKISCKDDHLLNKSFTREVKTLGRI-RHRHLVKLMG 1010
++G G +G V + A+K + REV+ R + H+V+++
Sbjct: 25 VLGLGINGKVLQIFNKRTQEKFALKMLQDCPK------ARREVELHWRASQCPHIVRIVD 78
Query: 1011 HCCNKGAGSN--LLIYEYMENGSVWDWLHKQPVNIKMRKSLDW---EARLKIAVGLAQGV 1065
N AG L++ E ++ G ++ I+ R + EA +I + + +
Sbjct: 79 VYENLYAGRKCLLIVMECLDGGELFS-------RIQDRGDQAFTEREAS-EIMKSIGEAI 130
Query: 1066 EYLHHDCVPKILHRDIKSSNILLDSNMEAH---LGDFGLAKALVEDYNSNTESNTWFAGS 1122
+YLH I HRD+K N+L S L DFG AK
Sbjct: 131 QYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT-------------GEK 174
Query: 1123 YGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMP 1158
Y + CD++S+G+++ L+ G P
Sbjct: 175 YD-------------KSCDMWSLGVIMYILLCGYPP 197
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 8e-16
Identities = 54/241 (22%), Positives = 107/241 (44%), Gaps = 34/241 (14%)
Query: 929 QAAAKRDFRWEDIMGATNNLSDEF----IIGSGGSGTVYKA-ELANGATVAVKKISCK-D 982
+ + F +++ + + + +GSG G+V A + G VAVKK+S
Sbjct: 8 HSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ 67
Query: 983 DHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNL----LIYEYMENGSVWDWLHK 1038
+ K RE++ L ++H +++ L+ + L+ M D L+
Sbjct: 68 SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA----D-LNN 122
Query: 1039 QPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGD 1098
I + L + + + +G++Y+H I+HRD+K SN+ ++ + E + D
Sbjct: 123 ----IVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILD 175
Query: 1099 FGLAKALVEDYNSNTE--SNTWFAGSYGYIAPEYAYSLKA-TEKCDVYSMGIVLMELVSG 1155
FGLA+ ++ T + W Y APE + + D++S+G ++ EL++G
Sbjct: 176 FGLARHTADEM---TGYVATRW------YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 226
Query: 1156 K 1156
+
Sbjct: 227 R 227
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 79.6 bits (196), Expect = 9e-16
Identities = 65/350 (18%), Positives = 123/350 (35%), Gaps = 99/350 (28%)
Query: 953 IIGSGGSGTVYKAEL------ANGATVAVKKISCKDDHLLNKSFTREVKTLGRI-RHRHL 1005
+G G G V +A+ A TVAVK + H +++ E+K L I H ++
Sbjct: 29 PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 88
Query: 1006 VKLMGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLK------IAV 1059
V L+G C K G ++I E+ + G++ +L + K+ R I V
Sbjct: 89 VNLLG-ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPV 147
Query: 1060 GLAQGVEYL--------------------HHDCVPKILHRDIKSSNILL----------- 1088
L + ++ + + P+ L++D + L+
Sbjct: 148 DLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGME 207
Query: 1089 -------------------DSNMEAHLGDFGLAKALVEDYNSNTESNT-----WFAGSYG 1124
+ DFGLA+ + +D + + + W
Sbjct: 208 FLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKW------ 261
Query: 1125 YIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMVRWVE--MHMEMSG 1181
+APE + T + DV+S G++L E+ S G P ++ + R ++ M
Sbjct: 262 -MAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY-PGVKIDEEFCRRLKEGTRMR--- 316
Query: 1182 SAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLL 1231
P + ++ + L C P +RP+ ++ + L
Sbjct: 317 -----------AP-----DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 350
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 80.2 bits (197), Expect = 2e-15
Identities = 44/215 (20%), Positives = 78/215 (36%), Gaps = 11/215 (5%)
Query: 616 PWTFGKIRELSLLDLSGNSLTGPIPTQLLMCKKLSHIDLNNNLLSGAVPSWLGTLPQLGE 675
+L +LS T + ++L CK+L ++ N + + L L
Sbjct: 342 CRDSATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLY 400
Query: 676 LKLSFNQFVGFLPRELFNCSKLLVLSLDGNMLNGSLPNEVGNLASLNVLTLSGNLLSGPI 735
K + F + + + L + A + VL L+ L+ +
Sbjct: 401 EKETLQYFSTL---KAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT--V 455
Query: 736 PPAIGRLSKLYELRLSNNSLNGVIPLEIGQLQNLQSILDLSHNNFTGQIPPSMGTLAKLE 795
+ +L + L LS+N L +P + L+ L+ +L S N + + L +L+
Sbjct: 456 LCHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLE-VLQASDNALE-NVDG-VANLPRLQ 511
Query: 796 VLNLSHNQLVG-ELPSQLGEMSSLGKLNLSYNDLQ 829
L L +N+L L L LNL N L
Sbjct: 512 ELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC 546
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 74.4 bits (182), Expect = 1e-13
Identities = 55/350 (15%), Positives = 109/350 (31%), Gaps = 46/350 (13%)
Query: 95 QSLIHLDLSSNSLTGPIPTALSNLSSLESLLLFSNQLAGTI----PTQLGSLTSLRVMRI 150
+H+ L+ L+ S + +LLL ++ ++ P + + + +
Sbjct: 245 LCCVHVSREEACLSVCFSRPLTVGSRMGTLLLMVDEAPLSVEWRTPDGRNRPSHVWLCDL 304
Query: 151 GDNWLSGSIPTSFGNLVNLGTLGLASCSLSGPI----PPQFGQLSQLEELILQQNQLQGP 206
L+ +P ++ G+ C L QL L +
Sbjct: 305 PAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLFRCELSVEKST-V 363
Query: 207 IPAELGNCSSLSIFTAAENNLNGSIPAALGRLQNLQLLNLGNNSLSGEIPSELGELSQLG 266
+ +EL +C L +I + L L S + + +
Sbjct: 364 LQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFST---LKAVDPMRAA 420
Query: 267 YLNLMGNRLEGAIPRSFAKMGNLQSLDLSMNRLTGGIPEEFGNMGQLVFLVLSNNNISGS 326
YL+ + ++ + +++ L L+ LT + + + L LS+N +
Sbjct: 421 YLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLR-- 476
Query: 327 IPRRICTNATSLEHLILAEIQLSGEIPVELSQCQSLKQLDLSNNTLNGTIPVELFQLVAL 386
+P L+ + L+ L S+N L + + L L
Sbjct: 477 ------------------------ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRL 510
Query: 387 THLYLHNNSL--VGSISPFVANLSNLQELALYHNNFQGSLPREIGMLVKL 434
L L NN L +I P + L L L N+ L ++
Sbjct: 511 QELLLCNNRLQQSAAIQPL-VSCPRLVLLNLQGNSLC-QEEGIQERLAEM 558
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 72.9 bits (178), Expect = 3e-13
Identities = 54/311 (17%), Positives = 98/311 (31%), Gaps = 20/311 (6%)
Query: 505 QLIILDLADNKLSGGVPASFGFLQALEQLMLYNNSLEGNLPGSLINLRNLTRINFSKNRL 564
+ + + LS + L+L + ++ + RN + +
Sbjct: 246 CCVHVSREEACLSVCFSRPLTVGSRMGTLLLMVDEAPLSVEWRTPDGRNRPSHVWLCDLP 305
Query: 565 NGRIATLCSSHSFLSFDVTNNEFDHEI---------PPQLGNSPSLERLRLGNNKFIGKI 615
+ H+F ++ + L R L K +
Sbjct: 306 AASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLFRCELSVEK-STVL 364
Query: 616 PWTFGKIRELSLLDLSGNSLTGPIPTQLLMCKKLSHIDLNNNLLSGAVPSWLGTLPQLGE 675
+EL L+ + T +L+ + L + L +
Sbjct: 365 QSELESCKELQELEPENKW---CLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAY 421
Query: 676 LKLSFNQFVGFLPRELFNCSKLLVLSLDGNMLNGSLPNEVGNLASLNVLTLSGNLLSGPI 735
L ++F+ + + VL L L L + + L + L LS N L +
Sbjct: 422 LDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT-VLCH-LEQLLLVTHLDLSHNRLRA-L 478
Query: 736 PPAIGRLSKLYELRLSNNSLNGVIPLEIGQLQNLQSILDLSHNNFTG-QIPPSMGTLAKL 794
PPA+ L L L+ S+N+L V + L LQ L L +N + + +L
Sbjct: 479 PPALAALRCLEVLQASDNALENV--DGVANLPRLQ-ELLLCNNRLQQSAAIQPLVSCPRL 535
Query: 795 EVLNLSHNQLV 805
+LNL N L
Sbjct: 536 VLLNLQGNSLC 546
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 72.1 bits (176), Expect = 6e-13
Identities = 44/248 (17%), Positives = 85/248 (34%), Gaps = 13/248 (5%)
Query: 319 SNNNISGSIPRRICTNATSLEHLILAEIQLSGEIPVELSQCQSLKQLDLSNNTLNGTIPV 378
N+ + R I T + S + +L + + + + + L + +LS +
Sbjct: 309 LNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCR-DSATDEQLFRCELSVEKST-VLQS 366
Query: 379 ELFQLVALTHLYLHNNSLVGSISPFVANLSNLQELALYHNNFQGSLPREIGMLVKLELLY 438
EL L L N + +I + + L L Q + ++ L
Sbjct: 367 ELESCKELQELEPENKWCLLTI---ILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLD 423
Query: 439 LYDNHLSGQIPSEVGNCSSLKWIDFFGNSFTGEIPTSIGRLKDLNFLHLRQNELVGQIPA 498
+ + + ++ + T + + +L + L L N L +P
Sbjct: 424 DLRSKFLLENSVLKMEYADVRVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPP 480
Query: 499 SLGNCHQLIILDLADNKLSGGVPASFGFLQALEQLMLYNNSLEGNLPG--SLINLRNLTR 556
+L L +L +DN L L L++L+L NN L+ L++ L
Sbjct: 481 ALAALRCLEVLQASDNALE--NVDGVANLPRLQELLLCNNRLQ-QSAAIQPLVSCPRLVL 537
Query: 557 INFSKNRL 564
+N N L
Sbjct: 538 LNLQGNSL 545
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 71.3 bits (174), Expect = 1e-12
Identities = 54/281 (19%), Positives = 92/281 (32%), Gaps = 38/281 (13%)
Query: 239 QNLQLLNLGNNSLSGEIPSELGELSQLGYLNLMGNRLEGAIPRSFAKMGNLQSLDLSMNR 298
+L +L + L+ +R E R A L +LS+ +
Sbjct: 302 CDLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPE-CWCRDSATDEQLFRCELSVEK 360
Query: 299 LTGGIPEEFGNMGQLVFLVLSNNNISGSIPRRICTNATSLEHLILAEIQLSGEIPVELSQ 358
T + E + +L L N +I +L+ L+ + L ++
Sbjct: 361 STV-LQSELESCKELQELEPENKWCLLTI----ILLMRALDPLLYEKETLQYFSTLKAVD 415
Query: 359 CQSLKQLDLSNNTLNGTIPVELFQLVALTHLYLHNNSLVGSISPFVANLSNLQELALYHN 418
LD + V + + L+L + L + + L + L L HN
Sbjct: 416 PMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT-VL-CHLEQLLLVTHLDLSHN 473
Query: 419 NFQGSLPREIGMLVKLELLYLYDNHLSGQIPSEVGNCSSLKWIDFFGNSFTGEIPTSIGR 478
+ +LP + L LE+L DN L ++ +
Sbjct: 474 RLR-ALPPALAALRCLEVLQASDNALE-----------NVD---------------GVAN 506
Query: 479 LKDLNFLHLRQNELVGQIPA--SLGNCHQLIILDLADNKLS 517
L L L L N L Q A L +C +L++L+L N L
Sbjct: 507 LPRLQELLLCNNRL-QQSAAIQPLVSCPRLVLLNLQGNSLC 546
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 69.4 bits (169), Expect = 4e-12
Identities = 41/219 (18%), Positives = 75/219 (34%), Gaps = 20/219 (9%)
Query: 88 SPSLGRLQSLIHLDLSSNSLTGPIPTALSNLSSLESLLLFSNQLAGTIPTQLGSLTSLRV 147
+ L +LS T + + L + L+ L + TI + +L L
Sbjct: 342 CRDSATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPL-- 398
Query: 148 MRIGDNWLSGSIPTSFGNLVNLGTLGLA-----SCSLSGPIPPQFGQLSQLEELILQQNQ 202
+ ++ F L + + A + + + L L
Sbjct: 399 -----LYEKETL-QYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKD 452
Query: 203 LQGPIPAELGNCSSLSIFTAAENNLNGSIPAALGRLQNLQLLNLGNNSLSGEIPSELGEL 262
L + L ++ + N L ++P AL L+ L++L +N+L + + L
Sbjct: 453 LT--VLCHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANL 507
Query: 263 SQLGYLNLMGNRLEG-AIPRSFAKMGNLQSLDLSMNRLT 300
+L L L NRL+ A + L L+L N L
Sbjct: 508 PRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC 546
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 65.9 bits (160), Expect = 5e-11
Identities = 51/226 (22%), Positives = 74/226 (32%), Gaps = 32/226 (14%)
Query: 629 DLSGNSLTGPIPTQLLMCKKLSHIDLNNNLLSGAVPSWL----GTLPQLGELKLSFNQFV 684
DL SL +P +L P T QL +LS +
Sbjct: 303 DLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLFRCELSVEKST 362
Query: 685 GFLPRELFNCSKLLVLSLDGNMLN----------GSLPNEVGNLASLNVLTLSGNLLSGP 734
L EL +C +L L + L E L + L + +
Sbjct: 363 -VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAY 421
Query: 735 -----------IPPAIGRLSKLYELRLSNNSLNGVIPLEIGQLQNLQSILDLSHNNFTGQ 783
+ + L L++ L + LE QL + LDLSHN
Sbjct: 422 LDDLRSKFLLENSVLKMEYADVRVLHLAHKDLTVLCHLE--QLLLVTH-LDLSHNRLR-A 477
Query: 784 IPPSMGTLAKLEVLNLSHNQLVGELPSQLGEMSSLGKLNLSYNDLQ 829
+PP++ L LEVL S N L + + + L +L L N LQ
Sbjct: 478 LPPALAALRCLEVLQASDNALE-NVDG-VANLPRLQELLLCNNRLQ 521
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 45.9 bits (108), Expect = 7e-05
Identities = 25/84 (29%), Positives = 40/84 (47%), Gaps = 4/84 (4%)
Query: 71 ARVVSLNLSGLSLAGSISPSLGRLQSLIHLDLSSNSLTGPIPTALSNLSSLESLLLFSNQ 130
V L+LS L ++ P+L L+ L L S N+L + ++NL L+ LLL +N+
Sbjct: 463 LLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNR 519
Query: 131 LAG-TIPTQLGSLTSLRVMRIGDN 153
L L S L ++ + N
Sbjct: 520 LQQSAAIQPLVSCPRLVLLNLQGN 543
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 2e-15
Identities = 52/217 (23%), Positives = 88/217 (40%), Gaps = 31/217 (14%)
Query: 953 IIGSGGSGTVYKA-ELANGATVAVKKISCKDDHLLNKS---FTREVKT-LGRIRHRHLVK 1007
+IG G G V + A+K + ++ +S F E + + +V+
Sbjct: 76 VIGRGAFGEVQLVRHKSTRKVYAMKLL--SKFEMIKRSDSAFFWEERDIMAFANSPWVVQ 133
Query: 1008 LMGHCCNKGAGSNL-LIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIA-VGLAQGV 1065
L + L ++ EYM G + + + V K AR A V LA +
Sbjct: 134 L--FYAFQDD-RYLYMVMEYMPGGDLVNLMSNYDVPEKW-------ARFYTAEVVLA--L 181
Query: 1066 EYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGY 1125
+ +H +HRD+K N+LLD + L DFG + ++ +T G+ Y
Sbjct: 182 DAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE--GMVRCDT-AVGTPDY 235
Query: 1126 IAPE----YAYSLKATEKCDVYSMGIVLMELVSGKMP 1158
I+PE +CD +S+G+ L E++ G P
Sbjct: 236 ISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 79.9 bits (197), Expect = 2e-15
Identities = 61/331 (18%), Positives = 112/331 (33%), Gaps = 48/331 (14%)
Query: 841 AEAFEGNLHLCGSPLDHCNGLVSNQHQSTISVSLVVAISVISTLSAIALLIAVVTLFVKR 900
E E L D S S + V L + + +++
Sbjct: 95 LETEEERLVCSREIFDTYIMKELLACSHPFSKSAIE--HVQGHLVKKQVPPDLFQPYIEE 152
Query: 901 KREFLRKSSQVNYTSSSSSSQAQRRLLFQAAAKRDFRWEDIMGATNNLSDEF----IIGS 956
+ LR + S + R +W+++ + ++F IIG
Sbjct: 153 ICQNLRGDVFQKFIESDKFT-------------RFCQWKNVELNIHLTMNDFSVHRIIGR 199
Query: 957 GGSGTVYKAEL-ANGATVAVKKISCKDDHLLNKSFTREVKTLGRI-------RHRHLVKL 1008
GG G VY G A+K + + K + +V +
Sbjct: 200 GGFGEVYGCRKADTGKMYAMKCL--DKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCM 257
Query: 1009 MGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYL 1068
I + M G + L + + + R A + G+E++
Sbjct: 258 --SYAFHTPDKLSFILDLMNGGDLHYHLSQ------HGVFSEADMRFYAA-EIILGLEHM 308
Query: 1069 HHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAP 1128
H+ +++RD+K +NILLD + + D GLA + + + G++GY+AP
Sbjct: 309 HNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-----KPHA-SVGTHGYMAP 359
Query: 1129 E-YAYSLKATEKCDVYSMGIVLMELVSGKMP 1158
E + D +S+G +L +L+ G P
Sbjct: 360 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 4e-15
Identities = 61/245 (24%), Positives = 92/245 (37%), Gaps = 38/245 (15%)
Query: 101 DLSSNSLTGPIPTALSNLSSLESLLLFSNQLAGTIPTQLGSLTSLRVMRIGDNWLSGSIP 160
+S+ P + L + + L S+ + ++ + S+
Sbjct: 4 TVSTPIKQI-FPDDAF--AETIKANLKKKSVTDAVTQN--ELNSIDQIIANNSDIK-SVQ 57
Query: 161 TSFGNLVNLGTLGLASCSLSGPIPPQFGQLSQLEELILQQNQLQGPIPAELGNCSSLSIF 220
L N+ L L L +L+ L LIL NQLQ
Sbjct: 58 -GIQYLPNVRYLALGGNKLHDI--SALKELTNLTYLILTGNQLQ---------------- 98
Query: 221 TAAENNLNGSIPA-ALGRLQNLQLLNLGNNSLSGEIPSELGELSQLGYLNLMGNRLEGAI 279
S+P +L NL+ L L N L +L+ L YLNL N+L+
Sbjct: 99 ---------SLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLP 149
Query: 280 PRSFAKMGNLQSLDLSMNRLTGGIPEE-FGNMGQLVFLVLSNNNISGSIPRRICTNATSL 338
F K+ NL LDLS N+L +PE F + QL L L N + S+P + TSL
Sbjct: 150 KGVFDKLTNLTELDLSYNQLQ-SLPEGVFDKLTQLKDLRLYQNQLK-SVPDGVFDRLTSL 207
Query: 339 EHLIL 343
+++ L
Sbjct: 208 QYIWL 212
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 4e-13
Identities = 56/198 (28%), Positives = 88/198 (44%), Gaps = 24/198 (12%)
Query: 230 SIPAALGRLQNLQLLNLGNNSLSGE--IPSELGELSQLGYLNLMGNRLEGAIPRSFAKMG 287
L ++ + N+ + I L + YL L GN+L I + ++
Sbjct: 33 DAVTQNE-LNSIDQIIANNSDIKSVQGIQY----LPNVRYLALGGNKLH-DIS-ALKELT 85
Query: 288 NLQSLDLSMNRLTGGIPEEFGNMGQLVFLVLSNNNISGSIPRRICTNATSLEHLILAEIQ 347
NL L L+ N+L F + L LVL N + S+P + T+L +L LA Q
Sbjct: 86 NLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQ-SLPDGVFDKLTNLTYLNLAHNQ 144
Query: 348 LSGEIPV----ELSQCQSLKQLDLSNNTLNGTIPVELF-QLVALTHLYLHNNSLVGSISP 402
L +P +L+ L +LDLS N L ++P +F +L L L L+ N L S+ P
Sbjct: 145 LQ-SLPKGVFDKLTN---LTELDLSYNQLQ-SLPEGVFDKLTQLKDLRLYQNQL-KSV-P 197
Query: 403 FVA--NLSNLQELALYHN 418
L++LQ + L+ N
Sbjct: 198 DGVFDRLTSLQYIWLHDN 215
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 2e-12
Identities = 60/228 (26%), Positives = 101/228 (44%), Gaps = 41/228 (17%)
Query: 244 LNLGNNSLSGEIPSELGELSQLGYLNLMGNRLEGAIPRSFAKMGNLQSLDLSMNRLTG-G 302
NL S++ + ++ L+ + + + ++ ++ + N++ L L N+L
Sbjct: 24 ANLKKKSVT-DAVTQNE-LNSIDQIIANNSDIK-SVQ-GIQYLPNVRYLALGGNKLHDIS 79
Query: 303 IPEEFGNMGQLVFLVLSNNNISGSIPRRICTNATSLEHLILAEIQLSGEIPVELSQCQSL 362
+ L +L+L+ N + S+P + T+L+ L+L E QL QSL
Sbjct: 80 A---LKELTNLTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVENQL-----------QSL 124
Query: 363 KQLDLSNNTLNGTIPVELF-QLVALTHLYLHNNSLVGSISPFV-ANLSNLQELALYHNNF 420
P +F +L LT+L L +N L S+ V L+NL EL L +N
Sbjct: 125 --------------PDGVFDKLTNLTYLNLAHNQLQ-SLPKGVFDKLTNLTELDLSYNQL 169
Query: 421 QGSLPREI-GMLVKLELLYLYDNHLSGQIPSEV-GNCSSLKWIDFFGN 466
Q SLP + L +L+ L LY N L +P V +SL++I N
Sbjct: 170 Q-SLPEGVFDKLTQLKDLRLYQNQLKS-VPDGVFDRLTSLQYIWLHDN 215
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 2e-10
Identities = 43/162 (26%), Positives = 68/162 (41%), Gaps = 21/162 (12%)
Query: 290 QSLDLSMNRLTGGIPEEFGNMGQLVFLVLSNNNIS--GSIPRRICTNATSLEHLILAEIQ 347
+L +T + + + ++ +N++I I ++ +L L +
Sbjct: 22 IKANLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQGIQY-----LPNVRYLALGGNK 74
Query: 348 LSGEIPV--ELSQCQSLKQLDLSNNTLNGTIPVELFQ-LVALTHLYLHNNSLVGSISPFV 404
L +I EL+ L L L+ N L ++P +F L L L L N L S+ V
Sbjct: 75 LH-DISALKELTN---LTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVENQLQ-SLPDGV 128
Query: 405 AN-LSNLQELALYHNNFQGSLPREI-GMLVKLELLYLYDNHL 444
+ L+NL L L HN Q SLP+ + L L L L N L
Sbjct: 129 FDKLTNLTYLNLAHNQLQ-SLPKGVFDKLTNLTELDLSYNQL 169
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 5e-10
Identities = 57/199 (28%), Positives = 89/199 (44%), Gaps = 17/199 (8%)
Query: 59 CTWRGITCGSSSARVVSLNLSGLSLAGSIS-PSLGRLQSLIHLDLSSNSLTGPIPTALSN 117
+ +T + + S++ + + S + L ++ +L L N L I AL
Sbjct: 26 LKKKSVTDAVTQNELNSIDQIIANNSDIKSVQGIQYLPNVRYLALGGNKLH-DIS-ALKE 83
Query: 118 LSSLESLLLFSNQLAGTIPTQLGSLTSLRVMRIGDNWLSGSIPTS-FGNLVNLGTLGLAS 176
L++L L+L NQL LT+L+ + + +N L S+P F L NL L LA
Sbjct: 84 LTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQ-SLPDGVFDKLTNLTYLNLAH 142
Query: 177 CSLSGPIPPQ-FGQLSQLEELILQQNQLQGPIPA----ELGNCSSLSIFTAAENNLNGSI 231
L +P F +L+ L EL L NQLQ +P +L L ++ N L S+
Sbjct: 143 NQLQS-LPKGVFDKLTNLTELDLSYNQLQS-LPEGVFDKLTQLKDLRLYQ---NQLK-SV 196
Query: 232 P-AALGRLQNLQLLNLGNN 249
P RL +LQ + L +N
Sbjct: 197 PDGVFDRLTSLQYIWLHDN 215
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 4e-06
Identities = 53/229 (23%), Positives = 83/229 (36%), Gaps = 45/229 (19%)
Query: 437 LYLYDNHLSGQIPSEVGNCSSLKWIDFFGNSFTGEIPTSIGRLKDLNFLHLRQNELVGQI 496
L ++ ++ +S+ I + I L ++ +L L N+L
Sbjct: 24 ANLKKKSVT-DAVTQNE-LNSIDQIIANNSDIKSV--QGIQYLPNVRYLALGGNKL---- 75
Query: 497 PASLGNCHQLI---ILDLADNKLSGGVPASFGFLQALEQLMLYNNSLEGNLPGSLINLRN 553
+ +L L L N+L F L L++L+L N L+ G L N
Sbjct: 76 -HDISALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTN 134
Query: 554 LTRINFSKNRLNGRIATLCSSHSFLSFDVTNNEFDHEIPPQLGNSPSLERLRLGNNKFIG 613
LT +N + N+L L V FD L N L L L N+
Sbjct: 135 LTYLNLAHNQL-----------QSLPKGV----FDK-----LTN---LTELDLSYNQL-Q 170
Query: 614 KIPW-TFGKIRELSLLDLSGNSLTGPIPT----QLLMCKKLSHIDLNNN 657
+P F K+ +L L L N L +P +L L +I L++N
Sbjct: 171 SLPEGVFDKLTQLKDLRLYQNQLKS-VPDGVFDRL---TSLQYIWLHDN 215
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 2e-05
Identities = 48/170 (28%), Positives = 71/170 (41%), Gaps = 12/170 (7%)
Query: 593 PQLGNSPSLERLRLGNNKFIGKIPWTFGKIRELSLLDLSGNSLTG-PIPTQLLMCKKLSH 651
S++++ N+ I + + + L L GN L +L L++
Sbjct: 35 VTQNELNSIDQIIANNSD-IKSVQ-GIQYLPNVRYLALGGNKLHDISALKEL---TNLTY 89
Query: 652 IDLNNNLLSGAVPSWLGTLPQLGELKLSFNQFVGFLPRELFNC-SKLLVLSLDGNMLNGS 710
+ L N L L L EL L NQ LP +F+ + L L+L N L S
Sbjct: 90 LILTGNQLQSLPNGVFDKLTNLKELVLVENQLQ-SLPDGVFDKLTNLTYLNLAHNQLQ-S 147
Query: 711 LPNEV-GNLASLNVLTLSGNLLSGPIPPAI-GRLSKLYELRLSNNSLNGV 758
LP V L +L L LS N L +P + +L++L +LRL N L V
Sbjct: 148 LPKGVFDKLTNLTELDLSYNQLQS-LPEGVFDKLTQLKDLRLYQNQLKSV 196
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 2e-05
Identities = 52/205 (25%), Positives = 82/205 (40%), Gaps = 37/205 (18%)
Query: 628 LDLSGNSLTGPIPTQLLMCKKLSHIDLNNNLLSGAVPSWLGTLPQLGELKLSFNQFVGFL 687
+L S+T + L + I NN+ + +V + LP + L L N+
Sbjct: 24 ANLKKKSVTDAVTQNEL--NSIDQIIANNSDIK-SVQG-IQYLPNVRYLALGGNKL---- 75
Query: 688 PRELFNCSKLLVLSLDGNMLNGSLPNEVGNLASLNVLTLSGNLLSGPIPPAI-GRLSKLY 746
+ L L +L L L+GN L +P + +L+ L
Sbjct: 76 -------HDISALK---------------ELTNLTYLILTGNQLQS-LPNGVFDKLTNLK 112
Query: 747 ELRLSNNSLNGVIPLEIGQLQNLQSILDLSHNNFTGQIPPSM-GTLAKLEVLNLSHNQLV 805
EL L N L + +L NL L+L+HN +P + L L L+LS+NQL
Sbjct: 113 ELVLVENQLQSLPDGVFDKLTNLT-YLNLAHNQLQ-SLPKGVFDKLTNLTELDLSYNQL- 169
Query: 806 GELPSQL-GEMSSLGKLNLSYNDLQ 829
LP + +++ L L L N L+
Sbjct: 170 QSLPEGVFDKLTQLKDLRLYQNQLK 194
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 1e-14
Identities = 52/210 (24%), Positives = 88/210 (41%), Gaps = 22/210 (10%)
Query: 954 IGSGGSGTVYKAEL-ANGATVAVKKISCKDDHLLNKSFTREVKT----LGRIRHRHLVKL 1008
+G G G V + A G A+K + K + ++ K T L RH L L
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKIL--KKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 213
Query: 1009 MGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYL 1068
+ + EY G ++ L ++ R + AR A + ++YL
Sbjct: 214 --KYSFQTHDRLCFVMEYANGGELFFHLSRE------RVFSEDRARFYGA-EIVSALDYL 264
Query: 1069 HHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAP 1128
H + +++RD+K N++LD + + DFGL K E T F G+ Y+AP
Sbjct: 265 HSEK--NVVYRDLKLENLMLDKDGHIKITDFGLCK---EGIKDGATMKT-FCGTPEYLAP 318
Query: 1129 EYAYSLKATEKCDVYSMGIVLMELVSGKMP 1158
E D + +G+V+ E++ G++P
Sbjct: 319 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 348
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 2e-14
Identities = 39/208 (18%), Positives = 72/208 (34%), Gaps = 16/208 (7%)
Query: 235 LGRLQNLQLLNLGNNSLSGEIPSELGELSQLGYLNLMGNRLEGAIPRSFAKMGNLQSLDL 294
L N NLG S++ + ELS + N + ++ NL+ L L
Sbjct: 15 DPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQSLAG--MQFFTNLKELHL 70
Query: 295 SMNRLTGGIPEEFGNMGQLVFLVLSNNNISGSIPRRICTNATSLEHLILAEIQLSGEIPV 354
S N+++ ++ +L L ++ N + ++ + L L L +L
Sbjct: 71 SHNQISD--LSPLKDLTKLEELSVNRNRLK-NLN---GIPSACLSRLFLDNNELRDTDS- 123
Query: 355 ELSQCQSLKQLDLSNNTLNGTIPVELFQLVALTHLYLHNNSLVGSISPFVANLSNLQELA 414
L ++L+ L + NN L + + L L L LH N + + L + +
Sbjct: 124 -LIHLKNLEILSIRNNKLKSIVMLG--FLSKLEVLDLHGNEIT-NTGGL-TRLKKVNWID 178
Query: 415 LYHNNFQGSLPREIGMLVKLELLYLYDN 442
L + L + D
Sbjct: 179 LTGQKCVNEPVKYQPELYITNTVKDPDG 206
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 3e-13
Identities = 39/209 (18%), Positives = 82/209 (39%), Gaps = 16/209 (7%)
Query: 189 QLSQLEELILQQNQLQGPIPAELGNCSSLSIFTAAENNLNGSIPAALGRLQNLQLLNLGN 248
L+ + L + + + S + F +N+ S+ + NL+ L+L +
Sbjct: 17 GLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQ-SLAG-MQFFTNLKELHLSH 72
Query: 249 NSLSGEIPSELGELSQLGYLNLMGNRLEGAIPRSFAKMGNLQSLDLSMNRLTGGIPEEFG 308
N +S ++ S L +L++L L++ NRL+ + L L L N L +
Sbjct: 73 NQIS-DL-SPLKDLTKLEELSVNRNRLKNL---NGIPSACLSRLFLDNNELRD--TDSLI 125
Query: 309 NMGQLVFLVLSNNNISGSIPRRICTNATSLEHLILAEIQLSGEIPVELSQCQSLKQLDLS 368
++ L L + NN + SI + + LE L L +++ L++ + + +DL+
Sbjct: 126 HLKNLEILSIRNNKLK-SIV--MLGFLSKLEVLDLHGNEITNTGG--LTRLKKVNWIDLT 180
Query: 369 NNTLNGTIPVELFQLVALTHLYLHNNSLV 397
+L + + +
Sbjct: 181 GQKCVNEPVKYQPELYITNTVKDPDGRWI 209
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 6e-12
Identities = 43/240 (17%), Positives = 91/240 (37%), Gaps = 20/240 (8%)
Query: 86 SISPSLGRLQSLIHLDLSSNSLTGPIPTALSNLSSLESLLLFSNQLAGTIPTQLGSLTSL 145
+ P L + + +L S+T + LS +++ ++ + + T+L
Sbjct: 11 QVFP-DPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNI--QSLAGMQFFTNL 65
Query: 146 RVMRIGDNWLSGSIPTSFGNLVNLGTLGLASCSLSGPIPPQFGQLSQLEELILQQNQLQG 205
+ + + N +S + + +L L L + L + + L L L N+L+
Sbjct: 66 KELHLSHNQIS-DL-SPLKDLTKLEELSVNRNRLKN-LNG--IPSACLSRLFLDNNELRD 120
Query: 206 PIPAELGNCSSLSIFTAAENNLNGSIPAALGRLQNLQLLNLGNNSLSGEIPSELGELSQL 265
L + +L I + N L SI LG L L++L+L N ++ L L ++
Sbjct: 121 TDS--LIHLKNLEILSIRNNKLK-SIV-MLGFLSKLEVLDLHGNEIT-NT-GGLTRLKKV 174
Query: 266 GYLNLMGNRLEGAIPRSFAKMGNLQSL-DLSMNRLTGGIPEEFGNMGQLVFLVLSNNNIS 324
+++L G + + ++ ++ D ++ P N G V +
Sbjct: 175 NWIDLTGQKCVNEPVKYQPELYITNTVKDPDGRWIS---PYYISNGGSYVDGCVLWELPV 231
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 7e-12
Identities = 43/245 (17%), Positives = 89/245 (36%), Gaps = 20/245 (8%)
Query: 595 LGNSPSLERLRLGNNKFIGKIPWTFGKIRELSLLDLSGNSLTGPIPTQLLMCKKLSHIDL 654
+ + LG + + + ++ + + +++ + L + L
Sbjct: 15 DPGLANAVKQNLGKQS-VTDLV-SQKELSGVQNFNGDNSNIQSLAG--MQFFTNLKELHL 70
Query: 655 NNNLLSGAVPSWLGTLPQLGELKLSFNQFVGFLPRELFNCSKLLVLSLDGNMLNGSLPNE 714
++N +S P L L +L EL ++ N+ + L L LD N L +
Sbjct: 71 SHNQISDLSP--LKDLTKLEELSVNRNRLKNL---NGIPSACLSRLFLDNNELR-DTDS- 123
Query: 715 VGNLASLNVLTLSGNLLSGPIPPAIGRLSKLYELRLSNNSLNGVIPLEIGQLQNLQSILD 774
+ +L +L +L++ N L I +G LSKL L L N + L +L+ + +D
Sbjct: 124 LIHLKNLEILSIRNNKLKS-IVM-LGFLSKLEVLDLHGNEITNTGGLT--RLKKVN-WID 178
Query: 775 LSHNNFTGQIPPSMGTLAKLEVLNLSHNQLVGELPSQLGEMSSLGKLNLSYNDLQ--GKL 832
L+ + L + + + P + S + + ++
Sbjct: 179 LTGQKCVNEPVKYQPELYITNTVKDPDGRWIS--PYYISNGGSYVDGCVLWELPVYTDEV 236
Query: 833 SKQFS 837
S +FS
Sbjct: 237 SYKFS 241
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 1e-11
Identities = 34/202 (16%), Positives = 71/202 (35%), Gaps = 18/202 (8%)
Query: 316 LVLSNNNISGSIPRRICTNATSLEHLILAEIQLSGEIPVELSQCQSLKQLDLSNNTLNGT 375
+ I+ P + L + ++ + + ++ + N+ +
Sbjct: 2 SIQRPTPINQVFP---DPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQSL 56
Query: 376 IPVELFQLVALTHLYLHNNSLVGSISPFVANLSNLQELALYHNNFQGSLPREIGMLVKLE 435
++ L L+L +N + +SP +L+ L+EL++ N + L
Sbjct: 57 AGMQ--FFTNLKELHLSHNQIS-DLSPL-KDLTKLEELSVNRNRLKNLNGIP---SACLS 109
Query: 436 LLYLYDNHLSGQIPSEVGNCSSLKWIDFFGNSFTGEIPTSIGRLKDLNFLHLRQNELVGQ 495
L+L +N L + + +L+ + N I +G L L L L NE+
Sbjct: 110 RLFLDNNELRD--TDSLIHLKNLEILSIRNNKLK-SIV-MLGFLSKLEVLDLHGNEI--T 163
Query: 496 IPASLGNCHQLIILDLADNKLS 517
L ++ +DL K
Sbjct: 164 NTGGLTRLKKVNWIDLTGQKCV 185
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 3e-11
Identities = 48/200 (24%), Positives = 77/200 (38%), Gaps = 21/200 (10%)
Query: 367 LSNNTLNGTIPVELFQLVALTHLYLHNNSLVGSISPFVANLSNLQELALYHNNFQGSLPR 426
+N P L L S V + LS +Q ++N Q SL
Sbjct: 4 QRPTPINQVFPDP--GLANAVKQNLGKQS-VTDLVSQ-KELSGVQNFNGDNSNIQ-SLA- 57
Query: 427 EIGMLVKLELLYLYDNHLSGQIPSEVGNCSSLKWIDFFGNSFTGEIPTSIGRLKDLN--F 484
+ L+ L+L N +S + S + + + L+ + N ++ +
Sbjct: 58 GMQFFTNLKELHLSHNQIS-DL-SPLKDLTKLEELSVNRNRLK-----NLNGIPSACLSR 110
Query: 485 LHLRQNELVGQIPASLGNCHQLIILDLADNKLSGGVPASFGFLQALEQLMLYNNSLEGNL 544
L L NEL + SL + L IL + +NKL V GFL LE L L+ N + N
Sbjct: 111 LFLDNNEL--RDTDSLIHLKNLEILSIRNNKLKSIVM--LGFLSKLEVLDLHGNEIT-NT 165
Query: 545 PGSLINLRNLTRINFSKNRL 564
G L L+ + I+ + +
Sbjct: 166 GG-LTRLKKVNWIDLTGQKC 184
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 5e-11
Identities = 45/233 (19%), Positives = 87/233 (37%), Gaps = 40/233 (17%)
Query: 284 AKMGNLQSLDLSMNRLTGGIPEEFGNMGQLVFLVLSNNNISGSIPRRICTNATSLEHLIL 343
+ N +L +T + + N+NI S+ T+L+ L L
Sbjct: 16 PGLANAVKQNLGKQSVTD--LVSQKELSGVQNFNGDNSNIQ-SLA--GMQFFTNLKELHL 70
Query: 344 AEIQLSGEIPVELSQCQSLKQLDLSNNTLNGTIPVELFQLVALTHLYLHNNSLVGSISPF 403
+ Q+S ++ L L++L ++ N L + L+ L+L NN L
Sbjct: 71 SHNQIS-DLS-PLKDLTKLEELSVNRNRLKN---LNGIPSACLSRLFLDNNELR-DTDSL 124
Query: 404 VANLSNLQELALYHNNFQGSLPREIGMLVKLELLYLYDNHLSGQIPSEVGNCSSLKWIDF 463
+L NL+ L++ +N + S+ +G L KLE+L L+ N ++ +
Sbjct: 125 -IHLKNLEILSIRNNKLK-SIV-MLGFLSKLEVLDLHGNEIT----------------NT 165
Query: 464 FGNSFTGEIPTSIGRLKDLNFLHLRQNELVGQIPASLGNCHQLIILDLADNKL 516
+ RLK +N++ L + V + + + D +
Sbjct: 166 ----------GGLTRLKKVNWIDLTGQKCVNEPVKYQPELYITNTVKDPDGRW 208
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 1e-09
Identities = 45/236 (19%), Positives = 82/236 (34%), Gaps = 21/236 (8%)
Query: 548 LINLRNLTRINFSKNRLNGRIATLCSSHSFLSFDVTNNEFDHEIPPQLGNSPSLERLRLG 607
L N + N K + + + +F+ N+ + + +L+ L L
Sbjct: 15 DPGLANAVKQNLGKQSVT-DLVSQKELSGVQNFNGDNSNI-QSLAG-MQFFTNLKELHLS 71
Query: 608 NNKFIGKIPWTFGKIRELSLLDLSGNSLTGPIPTQLLMCKKLSHIDLNNNLLSGAVPSWL 667
+N+ I + + +L L ++ N L LS + L+NN L L
Sbjct: 72 HNQ-ISDLS-PLKDLTKLEELSVNRNRLKNLNGIPSA---CLSRLFLDNNELRD--TDSL 124
Query: 668 GTLPQLGELKLSFNQFVGFLPRELFNCSKLLVLSLDGNMLNGSLPNEVGNLASLNVLTLS 727
L L L + N+ + L SKL VL L GN + + + L +N + L+
Sbjct: 125 IHLKNLEILSIRNNKLKSIVM--LGFLSKLEVLDLHGNEI--TNTGGLTRLKKVNWIDLT 180
Query: 728 GNLLSGPIPPAIGRLSKLYEL-RLSNNSLNGVIPLEI---GQLQNLQSILDLSHNN 779
G + +LY + + + P I G + + +L
Sbjct: 181 GQKCV---NEPVKYQPELYITNTVKDPDGRWISPYYISNGGSYVDGCVLWELPVYT 233
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 4e-07
Identities = 38/194 (19%), Positives = 64/194 (32%), Gaps = 17/194 (8%)
Query: 77 NLSGLSLAG----SISPSLGRLQSLIHLDLSSNSLTGPIPTALSNLSSLESLLLFSNQLA 132
+ + S++ + +L L LS N ++ P L +L+ LE L + N+L
Sbjct: 42 GVQNFNGDNSNIQSLAG-MQFFTNLKELHLSHNQISDLSP--LKDLTKLEELSVNRNRLK 98
Query: 133 GTIPTQLGSLTSLRVMRIGDNWLSGSIPTSFGNLVNLGTLGLASCSLSGPIPPQFGQLSQ 192
L+ L + +N L S +L NL L + + L I G LS+
Sbjct: 99 NLNGIPSACLSRL---FLDNNELRD--TDSLIHLKNLEILSIRNNKLKS-IVM-LGFLSK 151
Query: 193 LEELILQQNQLQGPIPAELGNCSSLSIFTAAENNLNGSIPAALGRLQNLQLL-NLGNNSL 251
LE L L N++ L ++ L + + +
Sbjct: 152 LEVLDLHGNEITNTGG--LTRLKKVNWIDLTGQKCVNEPVKYQPELYITNTVKDPDGRWI 209
Query: 252 SGEIPSELGELSQL 265
S S G
Sbjct: 210 SPYYISNGGSYVDG 223
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 2e-14
Identities = 33/159 (20%), Positives = 57/159 (35%), Gaps = 32/159 (20%)
Query: 288 NLQSLDLSMNRLTGGIPE-EFGNMGQLVFLVLSNNNISGSIPRRICTNATSLEHLILAEI 346
L L+ N T F + QL + SNN I+ I + E
Sbjct: 33 YTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIE------EGAFEGA----- 80
Query: 347 QLSGEIPVELSQCQSLKQLDLSNNTLNGTIPVELFQ-LVALTHLYLHNNSLVGSISPFV- 404
+ ++ L++N L + ++F+ L +L L L +N + +
Sbjct: 81 -------------SGVNEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRIT-CVGNDSF 125
Query: 405 ANLSNLQELALYHNNFQGSLPREI-GMLVKLELLYLYDN 442
LS+++ L+LY N ++ L L L L N
Sbjct: 126 IGLSSVRLLSLYDNQIT-TVAPGAFDTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 2e-10
Identities = 31/133 (23%), Positives = 55/133 (41%), Gaps = 7/133 (5%)
Query: 628 LDLSGNSLTGPIPTQLLM-CKKLSHIDLNNNLLSGAVPSWLGTLPQLGELKLSFNQFVGF 686
L L+ N T T + +L I+ +NN ++ + E+ L+ N+
Sbjct: 37 LRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLEN- 95
Query: 687 LPRELF-NCSKLLVLSLDGNMLNGSLPNEV-GNLASLNVLTLSGNLLSGPIPP-AIGRLS 743
+ ++F L L L N + + N+ L+S+ +L+L N ++ + P A L
Sbjct: 96 VQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQIT-TVAPGAFDTLH 153
Query: 744 KLYELRLSNNSLN 756
L L L N N
Sbjct: 154 SLSTLNLLANPFN 166
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 7e-10
Identities = 28/137 (20%), Positives = 47/137 (34%), Gaps = 28/137 (20%)
Query: 187 FGQLSQLEELILQQNQLQGPIPAELGNCSSLSIFTAAENNLNGSIPA-ALGRLQNLQLLN 245
F +L QL ++ N++ I A + +
Sbjct: 53 FKKLPQLRKINFSNNKIT-------------------------DIEEGAFEGASGVNEIL 87
Query: 246 LGNNSLSGEIPSEL-GELSQLGYLNLMGNRLEGAIPRSFAKMGNLQSLDLSMNRLTGGIP 304
L +N L + ++ L L L L NR+ SF + +++ L L N++T P
Sbjct: 88 LTSNRLE-NVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAP 146
Query: 305 EEFGNMGQLVFLVLSNN 321
F + L L L N
Sbjct: 147 GAFDTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 1e-08
Identities = 33/159 (20%), Positives = 53/159 (33%), Gaps = 52/159 (32%)
Query: 93 RLQSLIHLDLSSNSLTGPIPTALSNLSSLESLLLFSNQLAGTIPTQLGSLTSLRVMRIGD 152
+L L ++ S+N +T A S + +LL SN+ L +++
Sbjct: 55 KLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNR-----------LENVQ------ 97
Query: 153 NWLSGSIPTSFGNLVNLGTLGLASCSLSGPIPP-QFGQLSQLEELILQQNQLQGPIPAEL 211
F L +L TL L S ++ + F LS + L L NQ+
Sbjct: 98 -------HKMFKGLESLKTLMLRSNRITC-VGNDSFIGLSSVRLLSLYDNQIT------- 142
Query: 212 GNCSSLSIFTAAENNLNGSIPA-ALGRLQNLQLLNLGNN 249
++ A L +L LNL N
Sbjct: 143 ------------------TVAPGAFDTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 2e-06
Identities = 30/151 (19%), Positives = 53/151 (35%), Gaps = 26/151 (17%)
Query: 485 LHLRQNELVGQIP-ASLGNCHQLIILDLADNKLSGGVPASFGFLQALEQLMLYNNSLEGN 543
L L NE QL ++ ++NK++ +F + +++L +N LE
Sbjct: 37 LRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENV 96
Query: 544 LPGSLINLRNLTRINFSKNRLNGRIATLCSSHSFLSFDVTNNEFDHEIPPQLGNSPSLER 603
L +L + NR+ + + D F S+
Sbjct: 97 QHKMFKGLESLKTLMLRSNRI-----------TCVGNDS----FI--------GLSSVRL 133
Query: 604 LRLGNNKFIGKIPW-TFGKIRELSLLDLSGN 633
L L +N+ I + F + LS L+L N
Sbjct: 134 LSLYDNQ-ITTVAPGAFDTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 5e-06
Identities = 29/134 (21%), Positives = 48/134 (35%), Gaps = 30/134 (22%)
Query: 599 PSLERLRLGNNKFIGKIP-WTFGKIRELSLLDLSGNSLTGPIPTQLLMCKKLSHIDLNNN 657
P L ++ NNK I I F ++ + L+ N L ++ +
Sbjct: 57 PQLRKINFSNNK-ITDIEEGAFEGASGVNEILLTSNRLE----------------NVQHK 99
Query: 658 LLSGAVPSWLGTLPQLGELKLSFNQFVGFLPRELF-NCSKLLVLSLDGNMLNGSLPNEV- 715
+ G L L L L N+ + + F S + +LSL N + ++
Sbjct: 100 MFKG--------LESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQIT-TVAPGAF 149
Query: 716 GNLASLNVLTLSGN 729
L SL+ L L N
Sbjct: 150 DTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 2e-04
Identities = 32/139 (23%), Positives = 54/139 (38%), Gaps = 32/139 (23%)
Query: 747 ELRLSNNSLNGVIPLEI-GQLQNLQSILDLSHNNFTGQIPPSMGT---LAKLEVLNLSHN 802
ELRL+NN + I +L L+ ++ S+N T I G + + + L+ N
Sbjct: 36 ELRLNNNEFTVLEATGIFKKLPQLRK-INFSNNKIT-DIEE--GAFEGASGVNEILLTSN 91
Query: 803 QLVGELPSQL-GEMSSLGKLNLSYNDLQ-------GKLSK---------QFSHWPAEAFE 845
+L + ++ + SL L L N + LS Q + AF+
Sbjct: 92 RLE-NVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFD 150
Query: 846 G-----NLHLCGSPLDHCN 859
L+L +P + CN
Sbjct: 151 TLHSLSTLNLLANPFN-CN 168
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 4e-14
Identities = 56/232 (24%), Positives = 93/232 (40%), Gaps = 47/232 (20%)
Query: 953 IIGSGGSGTVYKA-ELANGATVAVKKIS-CKDDHLLNKSFTREVKTLGRIR-HRHLVKLM 1009
+G G G V+K+ + G VAVKKI + + RE+ L + H ++V L+
Sbjct: 16 KLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLL 75
Query: 1010 GHCCNKGAGSNLLIYEYMENGSVWDWLHK----QPVNIKMRKSLDWEARLKIAVGLAQ-- 1063
L+++YME D LH + ++ + + Q
Sbjct: 76 NVLRADNDRDVYLVFDYMET----D-LHAVIRANILEPVHKQYV-----------VYQLI 119
Query: 1064 -GVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGS 1122
++YLH +LHRD+K SNILL++ + DFGL+++ V +
Sbjct: 120 KVIKYLHS---GGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINEN 176
Query: 1123 YG-----------------YIAPEYAYSLKA-TEKCDVYSMGIVLMELVSGK 1156
Y APE T+ D++S+G +L E++ GK
Sbjct: 177 TENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 5e-14
Identities = 36/166 (21%), Positives = 62/166 (37%), Gaps = 29/166 (17%)
Query: 230 SIPAALGRLQNLQLLNLGNNSLSGEIPSELGELSQLGYLNLMGNRLEGAIPRSFAKMGNL 289
IP L + + + L N++ P +L ++L N++ P +F + +L
Sbjct: 25 EIPTNL--PETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSL 82
Query: 290 QSLDLSMNRLTGGIPEEFGNMGQLVFLVLSNNNISGSIPRRICTNATSLEHLILAEIQLS 349
SL L N++T F + L L+L+ N I+ + + L
Sbjct: 83 NSLVLYGNKITELPKSLFEGLFSLQLLLLNANKIN-CLRVDA------FQDL-------- 127
Query: 350 GEIPVELSQCQSLKQLDLSNNTLNGTIPVELFQ-LVALTHLYLHNN 394
+L L L +N L TI F L A+ ++L N
Sbjct: 128 ----------HNLNLLSLYDNKLQ-TIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 4e-13
Identities = 36/146 (24%), Positives = 59/146 (40%), Gaps = 9/146 (6%)
Query: 326 SIPRRICTNATSLEHLILAEIQLSGEIPVELSQCQSLKQLDLSNNTLNGTIPVELF-QLV 384
IP + T + L + + P S + L+++DLSNN ++ + + F L
Sbjct: 25 EIPTNLPETITEIR---LEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLR 80
Query: 385 ALTHLYLHNNSLVGSISPFV-ANLSNLQELALYHNNFQGSLPREI-GMLVKLELLYLYDN 442
+L L L+ N + + + L +LQ L L N L + L L LL LYDN
Sbjct: 81 SLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDN 138
Query: 443 HLSGQIPSEVGNCSSLKWIDFFGNSF 468
L +++ + N F
Sbjct: 139 KLQTIAKGTFSPLRAIQTMHLAQNPF 164
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 1e-10
Identities = 38/128 (29%), Positives = 56/128 (43%), Gaps = 4/128 (3%)
Query: 628 LDLSGNSLTGPIPTQLLMCKKLSHIDLNNNLLSGAVPSWLGTLPQLGELKLSFNQFVGFL 687
+ L N++ P KKL IDL+NN +S P L L L L N+ L
Sbjct: 37 IRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKIT-EL 95
Query: 688 PRELF-NCSKLLVLSLDGNMLNGSLPNEV-GNLASLNVLTLSGNLLSGPIPPAIGRLSKL 745
P+ LF L +L L+ N +N L + +L +LN+L+L N L L +
Sbjct: 96 PKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAI 154
Query: 746 YELRLSNN 753
+ L+ N
Sbjct: 155 QTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 8e-10
Identities = 32/158 (20%), Positives = 63/158 (39%), Gaps = 30/158 (18%)
Query: 143 TSLRVMRIGDNWLSGSIPTSFGNLVNLGTLGLASCSLSGPIPPQ-FGQLSQLEELILQQN 201
++ +R+ N + P +F L + L++ +S + P F L L L+L N
Sbjct: 32 ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISE-LAPDAFQGLRSLNSLVLYGN 90
Query: 202 QLQGPIPAELGNCSSLSIFTAAENNLNGSIPA-ALGRLQNLQLLNLGNNSLSGEIPSEL- 259
++ +P L +LQLL L N ++ + +
Sbjct: 91 KIT-------------------------ELPKSLFEGLFSLQLLLLNANKIN-CLRVDAF 124
Query: 260 GELSQLGYLNLMGNRLEGAIPRSFAKMGNLQSLDLSMN 297
+L L L+L N+L+ +F+ + +Q++ L+ N
Sbjct: 125 QDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 1e-09
Identities = 32/151 (21%), Positives = 52/151 (34%), Gaps = 27/151 (17%)
Query: 509 LDLADNKLSGGVPASFGFLQALEQLMLYNNSLEGNLPGSLINLRNLTRINFSKNRLNGRI 568
+ L N + P +F + L ++ L NN + P + LR+L + N++
Sbjct: 37 IRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKI---- 92
Query: 569 ATLCSSHSFLSFDVTNNEFDHEIPPQL-GNSPSLERLRLGNNKFIGKIP-WTFGKIRELS 626
E+P L SL+ L L NK I + F + L+
Sbjct: 93 --------------------TELPKSLFEGLFSLQLLLLNANK-INCLRVDAFQDLHNLN 131
Query: 627 LLDLSGNSLTGPIPTQLLMCKKLSHIDLNNN 657
LL L N L + + + L N
Sbjct: 132 LLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 9e-09
Identities = 33/130 (25%), Positives = 53/130 (40%), Gaps = 5/130 (3%)
Query: 675 ELKLSFNQFVGFLPRELFNCSKLLVLSLDGNMLNGSLPNEV-GNLASLNVLTLSGNLLSG 733
E++L N P KL + L N ++ L + L SLN L L GN ++
Sbjct: 36 EIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKITE 94
Query: 734 PIPPAI-GRLSKLYELRLSNNSLNGVIPLEIGQLQNLQSILDLSHNNFTGQIPPSMGTLA 792
+P ++ L L L L+ N +N + L NL L L N + L
Sbjct: 95 -LPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNL-LSLYDNKLQTIAKGTFSPLR 152
Query: 793 KLEVLNLSHN 802
++ ++L+ N
Sbjct: 153 AIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 6e-08
Identities = 35/147 (23%), Positives = 58/147 (39%), Gaps = 22/147 (14%)
Query: 719 ASLNVLTLSGNLLSGPIPPAIGRLSKLYELRLSNNSLNGVIPLEIG---QLQNLQSILDL 775
++ + L N + P A KL + LSNN ++ L L++L S L L
Sbjct: 32 ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISE---LAPDAFQGLRSLNS-LVL 87
Query: 776 SHNNFTGQIPPSM-GTLAKLEVLNLSHNQLVGELPSQLGEMSSLGKLNLSYNDLQGKLSK 834
N T ++P S+ L L++L L+ N++ ++ +L L+L N LQ
Sbjct: 88 YGNKIT-ELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQ----- 141
Query: 835 QFSHWPAEAFEG-----NLHLCGSPLD 856
F +HL +P
Sbjct: 142 ---TIAKGTFSPLRAIQTMHLAQNPFI 165
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 2e-07
Identities = 30/110 (27%), Positives = 52/110 (47%), Gaps = 2/110 (1%)
Query: 93 RLQSLIHLDLSSNSLTGPIPTALSNLSSLESLLLFSNQLAGTIPTQLGSLTSLRVMRIGD 152
+ L +DLS+N ++ P A L SL SL+L+ N++ + L SL+++ +
Sbjct: 54 PYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNA 113
Query: 153 NWLSGSIPT-SFGNLVNLGTLGLASCSLSGPIPPQFGQLSQLEELILQQN 201
N ++ + +F +L NL L L L F L ++ + L QN
Sbjct: 114 NKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 2e-06
Identities = 35/155 (22%), Positives = 59/155 (38%), Gaps = 27/155 (17%)
Query: 531 EQLMLYNNSLEGNLPGSLINLRNLTRINFSKNRLNGRIATLCSSHSFLSFDVTNNEFDHE 590
++ L N+++ PG+ + L RI+ S N++ S L+ D F
Sbjct: 35 TEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQI-----------SELAPDA----FQG- 78
Query: 591 IPPQLGNSPSLERLRLGNNKFIGKIPW-TFGKIRELSLLDLSGNSLTGPIPTQLL-MCKK 648
L + L L L NK I ++P F + L LL L+ N + +
Sbjct: 79 ----LRS---LNSLVLYGNK-ITELPKSLFEGLFSLQLLLLNANKINC-LRVDAFQDLHN 129
Query: 649 LSHIDLNNNLLSGAVPSWLGTLPQLGELKLSFNQF 683
L+ + L +N L L + + L+ N F
Sbjct: 130 LNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPF 164
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 2e-06
Identities = 26/94 (27%), Positives = 41/94 (43%), Gaps = 8/94 (8%)
Query: 93 RLQSLIHLDLSSNSLTGPIPTALSNLSSLESLLLFSNQLAGTIPTQL-GSLTSLRVMRIG 151
L+SL L L N +T + L SL+ LLL +N++ + L +L ++ +
Sbjct: 78 GLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLY 136
Query: 152 DNWLSGSIPTSFGNLVNLGTLGLA------SCSL 179
DN L +F L + T+ LA C L
Sbjct: 137 DNKLQTIAKGTFSPLRAIQTMHLAQNPFICDCHL 170
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 3e-06
Identities = 27/152 (17%), Positives = 51/152 (33%), Gaps = 29/152 (19%)
Query: 466 NSFTGEIPTSIGRLKDLNFLHLRQNELVGQIPASLGNCHQLIILDLADNKLSGGVPASFG 525
N+ P + K L + L N++ P + L L L NK++ + F
Sbjct: 42 NTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITELPKSLFE 101
Query: 526 FLQALEQLMLYNNSLEGNLPGSLINLRNLTRINFSKNRLNGRIATLCSSHSFLSFDVTNN 585
L +L+ L+L N + + +L NL ++ N+L +
Sbjct: 102 GLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQT---------------IAKG 146
Query: 586 EFDHEIPPQLGNSPSLERLRLGNNKFIGKIPW 617
F +++ + L N P+
Sbjct: 147 TFS--------PLRAIQTMHLAQN------PF 164
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 9e-04
Identities = 22/82 (26%), Positives = 36/82 (43%), Gaps = 5/82 (6%)
Query: 77 NLSGLSLAG----SISPSL-GRLQSLIHLDLSSNSLTGPIPTALSNLSSLESLLLFSNQL 131
+L+ L L G + SL L SL L L++N + A +L +L L L+ N+L
Sbjct: 81 SLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKL 140
Query: 132 AGTIPTQLGSLTSLRVMRIGDN 153
L +++ M + N
Sbjct: 141 QTIAKGTFSPLRAIQTMHLAQN 162
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 5e-14
Identities = 52/272 (19%), Positives = 101/272 (37%), Gaps = 66/272 (24%)
Query: 953 IIGSGGSGTVYKAE-LANGATVAVKKISCKDDHLLNKSFTREVKTLGRIR---------- 1001
+G G TV+ A+ + N VA+K + + D + ++ E+K L R+
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIV--RGDKVYTEAAEDEIKLLQRVNDADNTKEDSM 83
Query: 1002 -HRHLVKLM----------GHCCNKGAGSNLLIYEYMENGSVWDWLHK---QPVNIKMRK 1047
H++KL+ H +++E + ++ + K + + + K
Sbjct: 84 GANHILKLLDHFNHKGPNGVHVV--------MVFEVL-GENLLALIKKYEHRGIPLIYVK 134
Query: 1048 SLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAH------LGDFGL 1101
+I+ L G++Y+H C I+H DIK N+L++ + D G
Sbjct: 135 --------QISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGN 184
Query: 1102 AKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKM---- 1157
A E T + Y +PE D++S ++ EL++G
Sbjct: 185 A-------CWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEP 237
Query: 1158 PTDATFGVEMDMVRWVEMHMEMSGSAREELLD 1189
++ + D + +E+ G LL
Sbjct: 238 DEGHSYTKDDDHIA---QIIELLGELPSYLLR 266
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 71.8 bits (177), Expect = 2e-13
Identities = 61/228 (26%), Positives = 108/228 (47%), Gaps = 40/228 (17%)
Query: 947 NLSD-EFI--IGSGGSGTVYKAELANGATV----AVKKISCKDDHLLNKSFTREVKT--- 996
+ S E + +G G G V+ + +G+ A+K + K L + V+T
Sbjct: 22 DPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVL--KKATLKVRD---RVRTKME 76
Query: 997 ---LGRIRHRHLVKLMGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEA 1053
L + H +VKL H + G LI +++ G ++ L K+ + +
Sbjct: 77 RDILVEVNHPFIVKL--HYAFQTEGKLYLILDFLRGGDLFTRLSKE------VMFTEEDV 128
Query: 1054 RLKIA-VGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAH--LGDFGLAKALVEDYN 1110
+ +A + LA +++LH I++RD+K NILLD E H L DFGL+K E +
Sbjct: 129 KFYLAELALA--LDHLHSL---GIIYRDLKPENILLDE--EGHIKLTDFGLSK---ESID 178
Query: 1111 SNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMP 1158
++ + F G+ Y+APE T+ D +S G+++ E+++G +P
Sbjct: 179 HEKKAYS-FCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 225
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 2e-13
Identities = 69/277 (24%), Positives = 120/277 (43%), Gaps = 48/277 (17%)
Query: 906 RKSSQVNYTSSSSSSQAQRRLLFQAAAKRDFRWEDIMGATNNLS-DEF----IIGSGGSG 960
+ + ++ +S+ K + R ++ G + + F ++G+G G
Sbjct: 9 EEEGGSSGGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIENFELLKVLGTGAYG 68
Query: 961 TVYKAELANGATV----AVKKISCKDDHLLNKSFTRE-VKT----LGRIRHRH-LVKLMG 1010
V+ +G A+K + K ++ K+ T E +T L IR LV L
Sbjct: 69 KVFLVRKISGHDTGKLYAMKVL--KKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTL-- 124
Query: 1011 HCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIA-VGLAQGVEYLH 1069
H + LI +Y+ G ++ L ++ + + E ++ + + LA +E+LH
Sbjct: 125 HYAFQTETKLHLILDYINGGELFTHLSQR------ERFTEHEVQIYVGEIVLA--LEHLH 176
Query: 1070 HDCVPKILHRDIKSSNILLDSNMEAH--LGDFGLAKALVEDYNSNTESNTWFAGSYGYIA 1127
I++RDIK NILLDS H L DFGL+K V D F G+ Y+A
Sbjct: 177 KL---GIIYRDIKLENILLDS--NGHVVLTDFGLSKEFVADETERAYD---FCGTIEYMA 228
Query: 1128 PE------YAYSLKATEKCDVYSMGIVLMELVSGKMP 1158
P+ + KA D +S+G+++ EL++G P
Sbjct: 229 PDIVRGGDSGHD-KA---VDWWSLGVLMYELLTGASP 261
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 70.6 bits (174), Expect = 6e-13
Identities = 56/227 (24%), Positives = 100/227 (44%), Gaps = 36/227 (15%)
Query: 947 NLSD-EFI--IGSGGSGTVYKAELANGATV----AVKKISCKDDHLLNKSFTRE-VKT-- 996
E + +G GG G V++ GA A+K + K ++ + K
Sbjct: 15 RPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVL--KKAMIVRNAKDTAHTKAER 72
Query: 997 --LGRIRHRHLVKLMGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEAR 1054
L ++H +V L + G LI EY+ G ++ L ++ ++ A
Sbjct: 73 NILEEVKHPFIVDL--IYAFQTGGKLYLILEYLSGGELFMQLERE------GIFMEDTAC 124
Query: 1055 LKIA-VGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAH--LGDFGLAKALVEDYNS 1111
+A + +A + +LH I++RD+K NI+L+ + H L DFGL K E +
Sbjct: 125 FYLAEISMA--LGHLHQK---GIIYRDLKPENIMLNH--QGHVKLTDFGLCK---ESIHD 174
Query: 1112 NTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMP 1158
T ++T F G+ Y+APE D +S+G ++ ++++G P
Sbjct: 175 GTVTHT-FCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPP 220
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 72.0 bits (176), Expect = 7e-13
Identities = 55/223 (24%), Positives = 95/223 (42%), Gaps = 31/223 (13%)
Query: 947 NLSD-EFI--IGSGGSGTVYKAEL-ANGATVAVKKISCKDDHLLNKSFTREVKTLGRI-- 1000
L+D F+ +G G G V +E AVK + K D ++ R+
Sbjct: 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKIL--KKDVVIQDDDVECTMVEKRVLA 396
Query: 1001 ---RHRHLVKLMGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKI 1057
+ L +L H C + + EY+ G + + + + + A
Sbjct: 397 LPGKPPFLTQL--HSCFQTMDRLYFVMEYVNGGDLMYHIQQV------GRFKEPHAVFYA 448
Query: 1058 AVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAH--LGDFGLAKALVEDYNSNTES 1115
A +A G+ +L I++RD+K N++LDS E H + DFG+ K E+ +
Sbjct: 449 A-EIAIGLFFLQSK---GIIYRDLKLDNVMLDS--EGHIKIADFGMCK---ENIWDGVTT 499
Query: 1116 NTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMP 1158
T F G+ YIAPE + D ++ G++L E+++G+ P
Sbjct: 500 KT-FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 541
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 3e-12
Identities = 49/325 (15%), Positives = 89/325 (27%), Gaps = 62/325 (19%)
Query: 96 SLIHLDLSSNSLTG----PIPTALSNLSSLESLLLFSNQL----AGTIPTQLGSLTSLRV 147
S+ L +++T + L S++ ++L N + A + + S L +
Sbjct: 5 SIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEI 64
Query: 148 MRIGDNWLSGSIPTSFGNLVNLGTLGLASCSLSGPIPPQFGQLSQLEELILQQNQLQG-- 205
D + L L L C +L + L N
Sbjct: 65 AEFSDIFTGRVKDEIPEALRLLLQ-ALLKC-------------PKLHTVRLSDNAFGPTA 110
Query: 206 --PIPAELGNCSSLSIFTAAENNL-------------NGSIPAALGRLQNLQLLNLGNNS 250
P+ L + L N L ++ L+ + G N
Sbjct: 111 QEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNR 170
Query: 251 LSGE----IPSELGELSQLGYLNLMGNRL-----EGAIPRSFAKMGNLQSLDLSMNRLTG 301
L L + ++ N + E + A L+ LDL N T
Sbjct: 171 LENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTH 230
Query: 302 ----GIPEEFGNMGQLVFLVLSNNNISGSIPRRIC-----TNATSLEHLILAEIQLSGEI 352
+ + L L L++ +S + L+ L L ++ +
Sbjct: 231 LGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDA 290
Query: 353 PVELSQ-----CQSLKQLDLSNNTL 372
L L L+L+ N
Sbjct: 291 VRTLKTVIDEKMPDLLFLELNGNRF 315
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 3e-11
Identities = 57/363 (15%), Positives = 104/363 (28%), Gaps = 79/363 (21%)
Query: 75 SLNLSGLSL----AGSISPSLGRLQSLIHLDLSSNSLTGP----IPTALSNLSSLESLLL 126
+L ++ S+ L S+ + LS N++ + +++ LE
Sbjct: 8 GKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEF 67
Query: 127 FSNQL----------AGTIPTQLGSLTSLRVMRIGDNWLSGSIPTSFGNLVNLGTLGLAS 176
+ L L +R+ DN L
Sbjct: 68 SDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFG-----------PTAQEPLID 116
Query: 177 CSLSGPIPPQFGQLSQLEELILQQNQL-------------QGPIPAELGNCSSLSIFTAA 223
+ + LE L L N L + + + N L
Sbjct: 117 F---------LSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICG 167
Query: 224 ENNL-NGSIPA---ALGRLQNLQLLNLGNNSLSGE-----IPSELGELSQLGYLNLMGNR 274
N L NGS+ + L + + N + E + L +L L+L N
Sbjct: 168 RNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNT 227
Query: 275 L--EGA--IPRSFAKMGNLQSLDLSMNRLT--GGIP-----EEFGNMGQLVFLVLSNNNI 323
G+ + + NL+ L L+ L+ G + N+ L L L N I
Sbjct: 228 FTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENI-GLQTLRLQYNEI 286
Query: 324 SG----SIPRRICTNATSLEHLILAEIQLS--GEIPVELSQC-QSLKQLDLSNNTLNGTI 376
++ I L L L + S ++ E+ + + + +L +
Sbjct: 287 ELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDDVVDEIREVFSTRGRGELDELDDMEEL 346
Query: 377 PVE 379
E
Sbjct: 347 TDE 349
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 6e-11
Identities = 51/332 (15%), Positives = 107/332 (32%), Gaps = 76/332 (22%)
Query: 241 LQLLNLGNNSLSGE----IPSELGELSQLGYLNLMGNRL--EGA--IPRSFAKMGNLQSL 292
++ +L ++++ E + + L E + + L GN + E A + + A +L+
Sbjct: 6 IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 65
Query: 293 DLS---MNRLTGGIPEEFGNMG-------QLVFLVLSNNNISGSIPRRICTNATSLEHLI 342
+ S R+ IPE + +L + LS+N + +
Sbjct: 66 EFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLID--------- 116
Query: 343 LAEIQLSGEIPVELSQCQSLKQLDLSNNTL-------------NGTIPVELFQLVALTHL 389
LS+ L+ L L NN L + + L +
Sbjct: 117 ------------FLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSI 164
Query: 390 YLHNNSL----VGSISPFVANLSNLQELALYHNNF-----QGSLPREIGMLVKLELLYLY 440
N L + + + L + + N + L + +L++L L
Sbjct: 165 ICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQ 224
Query: 441 DNHLSGQ----IPSEVGNCSSLKWIDFFGNSFTGEIPTSIGR-LKD-----LNFLHLRQN 490
DN + + + + +L+ + + ++ L L L+ N
Sbjct: 225 DNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYN 284
Query: 491 EL----VGQIPASLG-NCHQLIILDLADNKLS 517
E+ V + + L+ L+L N+ S
Sbjct: 285 EIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 316
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 3e-09
Identities = 50/290 (17%), Positives = 87/290 (30%), Gaps = 73/290 (25%)
Query: 73 VVSLNLSGLSL----------AGSISPSLGRLQSLIHLDLSSNSLTG----PIPTALSNL 118
+ S + + +L + L + LS N+ P+ LS
Sbjct: 62 LEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKH 121
Query: 119 SSLESLLLFSNQLAGTIPTQLGSLTSLRVMRIGDNWLSGSIPTSFGNLVNLGTLGLASCS 178
+ LE L L +N +G +A
Sbjct: 122 TPLEHLYLHNNG-------------------LGPQ----------------AGAKIARAL 146
Query: 179 LSGPIPPQFGQLSQLEELILQQNQLQGP----IPAELGNCSSLSIFTAAENNLN-----G 229
+ + L +I +N+L+ + L +N +
Sbjct: 147 QELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEH 206
Query: 230 SIPAALGRLQNLQLLNLGNNSLSGE----IPSELGELSQLGYLNLMGNRL--EGA--IPR 281
+ L Q L++L+L +N+ + + L L L L L GA +
Sbjct: 207 LLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVD 266
Query: 282 SFAKMGN--LQSLDLSMNRLTGGIPEEFG-----NMGQLVFLVLSNNNIS 324
+F+K+ N LQ+L L N + M L+FL L+ N S
Sbjct: 267 AFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 316
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 6e-09
Identities = 66/330 (20%), Positives = 106/330 (32%), Gaps = 76/330 (23%)
Query: 434 LELLYLYDNHLSGQ----IPSEVGNCSSLKWIDFFGNSFTGEIPTSIGR-------LKDL 482
+E L + ++ + + + + S+K I GN+ E + L+
Sbjct: 6 IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 65
Query: 483 NFLHLRQNELVGQIPA-------SLGNCHQLIILDLADNKLSG-GVPASFGFLQA---LE 531
F + + +IP +L C +L + L+DN FL LE
Sbjct: 66 EFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLE 125
Query: 532 QLMLYNNSL-------------EGNLPGSLINLRNLTRINFSKNRL-NGRIATLCSSHSF 577
L L+NN L E + N L I +NRL NG + +
Sbjct: 126 HLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKT--- 182
Query: 578 LSFDVTNNEFDHEIPPQLGNSPSLERLRLGNNKF-----IGKIPWTFGKIRELSLLDLSG 632
+ L +++ N + +EL +LDL
Sbjct: 183 -----------------FQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQD 225
Query: 633 NSLTGP----IPTQLLMCKKLSHIDLNNNLLS--GAVP----SWLGTLPQLGELKLSFNQ 682
N+ T + L L + LN+ LLS GA L L+L +N+
Sbjct: 226 NTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNE 285
Query: 683 F----VGFLPRELF-NCSKLLVLSLDGNML 707
V L + LL L L+GN
Sbjct: 286 IELDAVRTLKTVIDEKMPDLLFLELNGNRF 315
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 8e-09
Identities = 45/312 (14%), Positives = 99/312 (31%), Gaps = 62/312 (19%)
Query: 361 SLKQLDLSNNTLNG----TIPVELFQLVALTHLYLHNNSL----VGSISPFVANLSNLQE 412
S++ L + + ++ L + ++ + L N++ +S +A+ +L+
Sbjct: 5 SIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEI 64
Query: 413 LALYHNNFQGSLPREIGMLVK-----------LELLYLYDNHLSGQ----IPSEVGNCSS 457
+ F G + EI ++ L + L DN + + +
Sbjct: 65 AEF-SDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTP 123
Query: 458 LKWIDFFGNSFTGE-------------IPTSIGRLKDLNFLHLRQNEL----VGQIPASL 500
L+ + N + + L + +N L + + +
Sbjct: 124 LEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTF 183
Query: 501 GNCHQLIILDLADNKLS--GGVPASFGFLQA---LEQLMLYNNSL--EG--NLPGSLINL 551
+ L + + N + G L L+ L L +N+ G L +L +
Sbjct: 184 QSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSW 243
Query: 552 RNLTRINFSKNRLNGR----IA---TLCSSHSFLSFDVTNNEFDHEIPPQLG-----NSP 599
NL + + L+ R + + + + + NE + + L P
Sbjct: 244 PNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMP 303
Query: 600 SLERLRLGNNKF 611
L L L N+F
Sbjct: 304 DLLFLELNGNRF 315
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 2e-07
Identities = 52/327 (15%), Positives = 93/327 (28%), Gaps = 72/327 (22%)
Query: 595 LGNSPSLERLRLGNNKF-------IGKIPWTFGKIRELSLLDLSGNSLTGPIPTQ----- 642
L S++ + L N + + + + D+ + IP
Sbjct: 28 LLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLL 87
Query: 643 --LLMCKKLSHIDLNNNLLS--GAVP--SWLGTLPQLGELKLSFNQF------------- 683
LL C KL + L++N P +L L L L N
Sbjct: 88 QALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQ 147
Query: 684 VGFLPRELFNCSKLLVLSLDGNMLNG----SLPNEVGNLASLNVLTLSGNLL-----SGP 734
+ ++ N L + N L + L+ + + N +
Sbjct: 148 ELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHL 207
Query: 735 IPPAIGRLSKLYELRLSNNSL--NGVIPL--EIGQLQNLQSILDLSHNNFTGQIPPSMGT 790
+ + +L L L +N+ G L + NL+ L L+ + + G
Sbjct: 208 LLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRE-LGLNDCLLSAR-----GA 261
Query: 791 LA-----------KLEVLNLSHNQLVGELPSQLGE-----MSSLGKLNLSYNDL--QGKL 832
A L+ L L +N++ + L M L L L+ N + +
Sbjct: 262 AAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDDV 321
Query: 833 SKQFSHWPAEAFEGNLHLCGSPLDHCN 859
+ E F LD
Sbjct: 322 VDEI----REVFSTRGRGELDELDDME 344
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 68.4 bits (166), Expect = 3e-12
Identities = 36/209 (17%), Positives = 58/209 (27%), Gaps = 40/209 (19%)
Query: 933 KRDFRWEDIMGATNNLSDEFIIGSGGSGTVYKAELANGATVAVKKISCKDDHLLN----- 987
K + + T L IG G G V++ A+ VA+K I+ + L+N
Sbjct: 8 KGPVPFSHCL-PTEKLQRCEKIGEGVFGEVFQTI-ADHTPVAIKIIAIEGPDLVNGSHQK 65
Query: 988 --KSFTREVKTL---------GRIRHRHLVKLMGHCCNKGAGSNLLIYEYM----ENGSV 1032
+ E+ R + L C +G+ LL+ + GS
Sbjct: 66 TFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSA 125
Query: 1033 WDWLHKQPVN----------------IKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKI 1076
D + K I L + +
Sbjct: 126 NDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASL--RF 183
Query: 1077 LHRDIKSSNILLDSNMEAHLGDFGLAKAL 1105
HRD+ N+LL L K+
Sbjct: 184 EHRDLHWGNVLLKKTSLKKLHYTLNGKSS 212
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 3e-12
Identities = 56/223 (25%), Positives = 95/223 (42%), Gaps = 32/223 (14%)
Query: 947 NLSD-EFI--IGSGGSGTVYKAEL-ANGATVAVKKISCKDDHLLNKSFTREVKT----LG 998
++D +++ +G G G V A G A+K + + + ++ K T L
Sbjct: 3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKIL--RKEVIIAKDEVAHTVTESRVLQ 60
Query: 999 RIRHRHLVKLMGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIA 1058
RH L L + + EY G ++ L ++ R + AR A
Sbjct: 61 NTRHPFLTAL--KYAFQTHDRLCFVMEYANGGELFFHLSRE------RVFTEERARFYGA 112
Query: 1059 -VGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAH--LGDFGLAKALVEDYNSNTES 1115
+ A +EYLH +++RDIK N++LD + H + DFGL K E +
Sbjct: 113 EIVSA--LEYLHSR---DVVYRDIKLENLMLDK--DGHIKITDFGLCK---EGISDGATM 162
Query: 1116 NTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMP 1158
T F G+ Y+APE D + +G+V+ E++ G++P
Sbjct: 163 KT-FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 3e-12
Identities = 35/114 (30%), Positives = 52/114 (45%), Gaps = 10/114 (8%)
Query: 231 IPAALGRLQNLQLLNLGNNSLSGEIPSELGELSQLGYLNLMGNRLEGAIPRSFAKMGNLQ 290
IP ++ L L N + +P EL L ++L NR+ +SF+ M L
Sbjct: 29 IPR------DVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLL 81
Query: 291 SLDLSMNRLTGGIPEE-FGNMGQLVFLVLSNNNISGSIPRRICTNATSLEHLIL 343
+L LS NRL IP F + L L L N+IS +P + ++L HL +
Sbjct: 82 TLILSYNRLR-CIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAI 133
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 2e-11
Identities = 35/120 (29%), Positives = 54/120 (45%), Gaps = 10/120 (8%)
Query: 326 SIPRRICTNATSLEHLILAEIQLSGEIPVELSQCQSLKQLDLSNNTLNGTIPVELF-QLV 384
+P+ I + T L L Q + +P ELS + L +DLSNN ++ T+ + F +
Sbjct: 24 VLPKGIPRDVTELY---LDGNQFT-LVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMT 78
Query: 385 ALTHLYLHNNSLVGSISPFV-ANLSNLQELALYHNNFQGSLPREI-GMLVKLELLYLYDN 442
L L L N L I P L +L+ L+L+ N+ +P L L L + N
Sbjct: 79 QLLTLILSYNRL-RCIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 7e-11
Identities = 29/107 (27%), Positives = 47/107 (43%), Gaps = 7/107 (6%)
Query: 363 KQLDLSNNTLNGTIPVELFQLVALTHLYLHNNSLVGSISPFV-ANLSNLQELALYHNNFQ 421
+L L N +P EL LT + L NN + ++S +N++ L L L +N +
Sbjct: 34 TELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILSYNRLR 91
Query: 422 GSLPREI-GMLVKLELLYLYDNHLSGQIPSEV-GNCSSLKWIDFFGN 466
+P L L LL L+ N +S +P + S+L + N
Sbjct: 92 -CIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 4e-09
Identities = 36/128 (28%), Positives = 52/128 (40%), Gaps = 28/128 (21%)
Query: 268 LNLMGNRLEGAIPRSFAKMGNLQSLDLSMNRLTGGIPEEFGNMGQLVFLVLSNNNISGSI 327
L L GN+ +P+ + +L +DLS NR++ + F NM QL+ L+LS N + I
Sbjct: 36 LYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLR-CI 93
Query: 328 PRRICTNATSLEHLILAEIQLSGEIPVELSQCQSLKQLDLSNNTLNGTIPVELF-QLVAL 386
P R SL L L +S +P F L AL
Sbjct: 94 PPRTFDGLKSLRLLSLHGNDIS-------------------------VVPEGAFNDLSAL 128
Query: 387 THLYLHNN 394
+HL + N
Sbjct: 129 SHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 9e-06
Identities = 28/113 (24%), Positives = 50/113 (44%), Gaps = 13/113 (11%)
Query: 143 TSLRVMRIGDNWLSGSIPTSFGNLVNLGTLGLASCSLSGPIPPQ-FGQLSQLEELILQQN 201
+ + + N + +P N +L + L++ +S + Q F ++QL LIL N
Sbjct: 31 RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRIST-LSNQSFSNMTQLLTLILSYN 88
Query: 202 QLQGPIPA----ELGNCSSLSIFTAAENNLNGSIP-AALGRLQNLQLLNLGNN 249
+L+ IP L + LS+ N+++ +P A L L L +G N
Sbjct: 89 RLRC-IPPRTFDGLKSLRLLSLHG---NDIS-VVPEGAFNDLSALSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 2e-05
Identities = 28/103 (27%), Positives = 49/103 (47%), Gaps = 3/103 (2%)
Query: 75 SLNLSGLSLAGSISPSLGRLQSLIHLDLSSNSLTGPIPTALSNLSSLESLLLFSNQLAGT 134
L L G + L + L +DLS+N ++ + SN++ L +L+L N+L
Sbjct: 35 ELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCI 93
Query: 135 IPTQLGSLTSLRVMRIGDNWLSGSIPT-SFGNLVNLGTLGLAS 176
P L SLR++ + N +S +P +F +L L L + +
Sbjct: 94 PPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGA 135
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 2e-05
Identities = 31/86 (36%), Positives = 42/86 (48%), Gaps = 5/86 (5%)
Query: 675 ELKLSFNQFVGFLPRELFNCSKLLVLSLDGNMLNGSLPNEV-GNLASLNVLTLSGNLLSG 733
EL L NQF +P+EL N L ++ L N ++ +L N+ N+ L L LS N L
Sbjct: 35 ELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILSYNRLRC 92
Query: 734 PIPPAI-GRLSKLYELRLSNNSLNGV 758
IPP L L L L N ++ V
Sbjct: 93 -IPPRTFDGLKSLRLLSLHGNDISVV 117
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 4e-05
Identities = 31/103 (30%), Positives = 41/103 (39%), Gaps = 3/103 (2%)
Query: 437 LYLYDNHLSGQIPSEVGNCSSLKWIDFFGNSFTGEIPTSIGRLKDLNFLHLRQNELVGQI 496
LYL N + +P E+ N L ID N + S + L L L N L
Sbjct: 36 LYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIP 94
Query: 497 PASLGNCHQLIILDLADNKLSGGVP-ASFGFLQALEQLMLYNN 538
P + L +L L N +S VP +F L AL L + N
Sbjct: 95 PRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 4e-04
Identities = 33/130 (25%), Positives = 55/130 (42%), Gaps = 29/130 (22%)
Query: 602 ERLRLGNNKFIGKIPWTFGKIRELSLLDLSGNSLTGPIPTQLLMCKKLSHIDLNNNLLSG 661
L L N+F +P + L+L+DLS N ++ L+N S
Sbjct: 34 TELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRIS----------------TLSNQSFS- 75
Query: 662 AVPSWLGTLPQLGELKLSFNQFVGFLPRELFN-CSKLLVLSLDGNMLNGSLPNEV-GNLA 719
+ QL L LS+N+ +P F+ L +LSL GN ++ +P +L+
Sbjct: 76 -------NMTQLLTLILSYNRL-RCIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLS 126
Query: 720 SLNVLTLSGN 729
+L+ L + N
Sbjct: 127 ALSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 5e-04
Identities = 24/86 (27%), Positives = 35/86 (40%), Gaps = 10/86 (11%)
Query: 723 VLTLSGNLLSGPIPPAIGRLSKLYELRLSNNSLNGVIPLEIG---QLQNLQSILDLSHNN 779
L L GN + +P + L + LSNN ++ L + L L LS+N
Sbjct: 35 ELYLDGNQFTL-VPKELSNYKHLTLIDLSNNRIS---TLSNQSFSNMTQLL-TLILSYNR 89
Query: 780 FTGQIPPSM-GTLAKLEVLNLSHNQL 804
IPP L L +L+L N +
Sbjct: 90 LR-CIPPRTFDGLKSLRLLSLHGNDI 114
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 6e-12
Identities = 58/256 (22%), Positives = 106/256 (41%), Gaps = 54/256 (21%)
Query: 953 IIGSGGSGTVYKAE-LANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHR------HL 1005
+IG G G V KA VA+K + +++ ++ E++ L +R + ++
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMV--RNEKRFHRQAAEEIRILEHLRKQDKDNTMNV 161
Query: 1006 VKLM------GHCC--NKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKI 1057
+ ++ H C + NL YE ++ Q ++ + + K
Sbjct: 162 IHMLENFTFRNHICMTFELLSMNL--YELIKKNKF------QGFSLPLVR--------KF 205
Query: 1058 AVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAH--LGDFGLAKALVEDYNSNTES 1115
A + Q ++ LH +I+H D+K NILL + + DFG + E T
Sbjct: 206 AHSILQCLDALHK---NRIIHCDLKPENILLKQQGRSGIKVIDFGSSC--YEHQRVYTYI 260
Query: 1116 NTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGK--MPTDATFGVEMDMVRWV 1173
+ F Y APE + D++S+G +L EL++G +P + E D +
Sbjct: 261 QSRF-----YRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED----EGDQLA-- 309
Query: 1174 EMHMEMSGSAREELLD 1189
+E+ G ++LLD
Sbjct: 310 -CMIELLGMPSQKLLD 324
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 1e-11
Identities = 67/224 (29%), Positives = 102/224 (45%), Gaps = 33/224 (14%)
Query: 947 NLSD-EFI--IGSGGSGTVYKAEL-ANGATVAVKKISCKDDHLLNKSFTREVKT-----L 997
SD F+ IG G G V A A AVK + + +L K + + + L
Sbjct: 36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVL--QKKAILKKKEEKHIMSERNVLL 93
Query: 998 GRIRHRHLVKLMGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKI 1057
++H LV L H + A + +Y+ G ++ L ++ R L+ AR
Sbjct: 94 KNVKHPFLVGL--HFSFQTADKLYFVLDYINGGELFYHLQRE------RCFLEPRARFYA 145
Query: 1058 A-VGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAH--LGDFGLAKALVEDYNSNTE 1114
A + A + YLH I++RD+K NILLDS + H L DFGL K E+ N+
Sbjct: 146 AEIASA--LGYLHSL---NIVYRDLKPENILLDS--QGHIVLTDFGLCK---ENIEHNST 195
Query: 1115 SNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMP 1158
++T F G+ Y+APE + D + +G VL E++ G P
Sbjct: 196 TST-FCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPP 238
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 1e-11
Identities = 63/230 (27%), Positives = 101/230 (43%), Gaps = 35/230 (15%)
Query: 943 GATNNLS-DEF----IIGSGGSGTVYKAEL-ANGATVAVKKISCKDDHLLNKSFTREVKT 996
GA + L +F +IG G V L A+K + K + + + V+T
Sbjct: 1 GAMDPLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVV--KKELVNDDEDIDWVQT 58
Query: 997 LGRI-----RHRHLVKLMGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDW 1051
+ H LV L H C + + EY+ G + + +Q RK +
Sbjct: 59 EKHVFEQASNHPFLVGL--HSCFQTESRLFFVIEYVNGGDLMFHMQRQ------RKLPEE 110
Query: 1052 EARLKIA-VGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAH--LGDFGLAKALVED 1108
AR A + LA + YLH I++RD+K N+LLDS E H L D+G+ K E
Sbjct: 111 HARFYSAEISLA--LNYLHER---GIIYRDLKLDNVLLDS--EGHIKLTDYGMCK---EG 160
Query: 1109 YNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMP 1158
++T F G+ YIAPE D +++G+++ E+++G+ P
Sbjct: 161 LRPGDTTST-FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 209
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 1e-11
Identities = 53/224 (23%), Positives = 94/224 (41%), Gaps = 33/224 (14%)
Query: 947 NLSD-EFI--IGSGGSGTVYKAEL-ANGATVAVKKISCKDDHLLNKSFTREVKTLGRI-- 1000
L+D F+ +G G G V +E AVK + K D ++ R+
Sbjct: 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKIL--KKDVVIQDDDVECTMVEKRVLA 75
Query: 1001 ---RHRHLVKLMGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKI 1057
+ L +L H C + + EY+ G + + + + + A
Sbjct: 76 LPGKPPFLTQL--HSCFQTMDRLYFVMEYVNGGDLMYHIQQV------GRFKEPHAVFYA 127
Query: 1058 A-VGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAH--LGDFGLAKALVEDYNSNTE 1114
A + + + +L I++RD+K N++LDS E H + DFG+ K E+
Sbjct: 128 AEIAIG--LFFLQSK---GIIYRDLKLDNVMLDS--EGHIKIADFGMCK---ENIWDGVT 177
Query: 1115 SNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMP 1158
+ T F G+ YIAPE + D ++ G++L E+++G+ P
Sbjct: 178 TKT-FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 220
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 2e-11
Identities = 61/272 (22%), Positives = 108/272 (39%), Gaps = 37/272 (13%)
Query: 903 EFLRKSSQVNYTSSSSSSQAQRRLLFQAAAKRDFRWEDIMGATNN----LSD-EFI--IG 955
+ +Y ++ + + + + + L D + + IG
Sbjct: 2 SYYHHHHHHDYDIPTTENLYFQGAMGSGIEEEKEAMNTRESGKASSSLGLQDFDLLRVIG 61
Query: 956 SGGSGTVYKAEL-ANGATVAVKKISCKDDHLLNKSFTREVKTLGRI-----RHRHLVKLM 1009
G V L A++ + K + + + V+T + H LV L
Sbjct: 62 RGSYAKVLLVRLKKTDRIYAMRVV--KKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL- 118
Query: 1010 GHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIA-VGLAQGVEYL 1068
H C + + EY+ G + + +Q RK + AR A + LA + YL
Sbjct: 119 -HSCFQTESRLFFVIEYVNGGDLMFHMQRQ------RKLPEEHARFYSAEISLA--LNYL 169
Query: 1069 HHDCVPKILHRDIKSSNILLDSNMEAH--LGDFGLAKALVEDYNSNTESNTWFAGSYGYI 1126
H I++RD+K N+LLDS E H L D+G+ K E ++T F G+ YI
Sbjct: 170 HER---GIIYRDLKLDNVLLDS--EGHIKLTDYGMCK---EGLRPGDTTST-FCGTPNYI 220
Query: 1127 APEYAYSLKATEKCDVYSMGIVLMELVSGKMP 1158
APE D +++G+++ E+++G+ P
Sbjct: 221 APEILRGEDYGFSVDWWALGVLMFEMMAGRSP 252
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 65.6 bits (161), Expect = 2e-11
Identities = 60/226 (26%), Positives = 102/226 (45%), Gaps = 41/226 (18%)
Query: 947 NLSD-EFI--IGSGGSGTVYKAEL-ANGATVAVKKISCKD--------DHLLNKSFTREV 994
+L D + + +G+G G V+ NG A+K + K+ +H + E
Sbjct: 4 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLK-KEIVVRLKQVEHTND-----ER 57
Query: 995 KTLGRIRHRHLVKLMGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEAR 1054
L + H ++++ + A +I +Y+E G ++ L K ++ + A+
Sbjct: 58 LMLSIVTHPFIIRM--WGTFQDAQQIFMIMDYIEGGELFSLLRKS------QRFPNPVAK 109
Query: 1055 LKIA-VGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNT 1113
A V LA +EYLH I++RD+K NILLD N + DFG AK +
Sbjct: 110 FYAAEVCLA--LEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYV-------- 156
Query: 1114 ESNTW-FAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMP 1158
T+ G+ YIAPE + + D +S GI++ E+++G P
Sbjct: 157 PDVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTP 202
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 67.6 bits (164), Expect = 2e-11
Identities = 81/583 (13%), Positives = 164/583 (28%), Gaps = 180/583 (30%)
Query: 711 LPNEVGNLASLNVLTLSGNLLSGPIPPAIGRL-SKLYELRLSNN-SLNGVIPLEIGQ--- 765
L N+ A NV +L L ELR + N ++GV L G+
Sbjct: 119 LYNDNQVFAKYNV----------SRLQPYLKLRQALLELRPAKNVLIDGV--LGSGKTWV 166
Query: 766 -LQNLQSILDLSHNNFT------GQIPPSMGTLAKLEVLNLSHNQLVGELPSQLGEMSSL 818
L S +F L L+ L + Q+ + + SS
Sbjct: 167 ALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQ--KLLY-QIDPNW-TSRSDHSSN 222
Query: 819 GKLNLSYNDLQGKLSKQFSHWP----------------AEAFEGNLHLCGSPLDHCNGLV 862
KL + + +Q +L + P AF C L+
Sbjct: 223 IKLRI--HSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNL----------SCKILL 270
Query: 863 SNQHQSTISVSLVVAISVISTLSAIALLIAVVTLFVKRK-REFLRKSSQVNYTSSSSSSQ 921
+ + + + IS L + + L K ++ +
Sbjct: 271 TTRFKQVTDFLSAATTTHIS-------LDHHSMTLTPDEVKSLLLKY--LDCRPQDLPRE 321
Query: 922 AQRRLLFQ----AAAKRDF--RWEDIMGATNNLSDEFIIGSGGSGTVYKAELANGATVAV 975
+ A + RD W+ N
Sbjct: 322 VLTTNPRRLSIIAESIRDGLATWD-------NW--------------------------- 347
Query: 976 KKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIYEYMEN------ 1029
K ++C L + L +R + L ++ +
Sbjct: 348 KHVNCDK---LTTIIESSLNVLEPAEYRKMFD------------RLSVFP--PSAHIPTI 390
Query: 1030 --GSVWDWLHKQPVNIKM----RKSL--DWEARLKIAVGLAQGVEYLHHDCVPKILHRDI 1081
+W + K V + + + SL I + ++ ++
Sbjct: 391 LLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTI---------SIPS------IYLEL 435
Query: 1082 KSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTW-FAGSY--GYIAPEYAYSLKATE 1138
K L++ H +++V+ YN ++ Y Y + LK E
Sbjct: 436 KVK---LENEYALH-------RSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIE 485
Query: 1139 KCDVYSM-GIVLMEL--VSGKMPTDAT----FGVEMDM---VRWVEMHMEMSGSAREELL 1188
+ ++ +V ++ + K+ D+T G ++ +++ + ++ + E L+
Sbjct: 486 HPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYICDNDPKYERLV 545
Query: 1189 DDQMKPLL-PGEECAAYQ---VLEIALQCTKTSPQERPSSRQV 1227
+ + L E + +L IAL + + +QV
Sbjct: 546 NAILDFLPKIEENLICSKYTDLLRIALM-AEDEAIFEEAHKQV 587
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 60.3 bits (145), Expect = 4e-09
Identities = 72/468 (15%), Positives = 132/468 (28%), Gaps = 166/468 (35%)
Query: 818 LGKLNLSYNDLQGKLSKQFSHWPAEAFEGNLHLCGSPLDHCNGLVSNQHQSTISVSLVVA 877
G+ Y D+ S + +AF N C D ++S + I
Sbjct: 11 TGEHQYQYKDI-------LSVF-EDAFVDNFD-CKDVQDMPKSILSKEEIDHI------- 54
Query: 878 ISVISTLSAIALLIAVVTLFVKRKR---EFLRKSSQVNY--------------TSSSSSS 920
I +S L TL K++ +F+ + ++NY + +
Sbjct: 55 IMSKDAVSGTLRLF--WTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMY 112
Query: 921 QAQRRLLF---QAAAKRDF-RWEDIMGATNNL----SDEFII--GSGGSGTVYKAELANG 970
QR L+ Q AK + R + + L + ++ G GSG K +A
Sbjct: 113 IEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSG---KTWVALD 169
Query: 971 ATVAVKKISCKDDHLLNKSFTREVK--TLGRI-RHRHLVKLMGHCCNKGAGSNLLIYEYM 1027
C + K ++ L +++++ L+Y+
Sbjct: 170 V--------CLSYKVQCK-MDFKIFWLNLKNCNSPETVLEML----------QKLLYQID 210
Query: 1028 ENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNIL 1087
N W NIK+R +A L+ + + ++ ++
Sbjct: 211 PN---WTSRSDHSSNIKLRIH-SIQAELRR-----------------LLKSKPYENCLLV 249
Query: 1088 LDSNMEAHLGDFGLAKALVEDYNSNTESNTW--FAGSYGYIAPEYAYSLKATEKCDVYSM 1145
L + V++ + W F C +
Sbjct: 250 LL--------N-------VQN------AKAWNAFNL-----------------SCKI--- 268
Query: 1146 GIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSAREELLDDQMKPLLPGEECAAYQ 1205
L+ T V D + + + LD L P E
Sbjct: 269 ------LL-----TTRFKQV-TDFL--------SAATTTHISLDHHSMTLTPDE------ 302
Query: 1206 VLEIALQCTKTSPQERPSSRQVCD---LLLNVFNNRIVDFDKLHIDPY 1250
V + L+ PQ+ P R+V L++ I D D +
Sbjct: 303 VKSLLLKYLDCRPQDLP--REVLTTNPRRLSIIAESIRDG-LATWDNW 347
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 55.2 bits (132), Expect = 1e-07
Identities = 111/677 (16%), Positives = 194/677 (28%), Gaps = 209/677 (30%)
Query: 14 LLLCFSPGFVLCKDEELSVLLEIKKSFTADPENVLHAWNQSNQNLCTWRGITC-GSSSAR 72
+L F FV + + + ++ KS + E + H + T R S
Sbjct: 21 ILSVFEDAFV--DNFDCKDVQDMPKSILSKEE-IDHIIMSKDAVSGTLRLFWTLLSKQEE 77
Query: 73 VVSLNLSGLS------LAGSIS-----PSL---------GRL----QSLIHLDLSSNSLT 108
+V + + L I PS+ RL Q ++S
Sbjct: 78 MVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPY 137
Query: 109 GPIPTALSNLSSLESLLLFSNQLAGTIPTQLGSLTSLRVMRIGDNWLSGSIPTSFGNLVN 168
+ AL L +++L+ G LGS G W++ + S+
Sbjct: 138 LKLRQALLELRPAKNVLID-----G----VLGS---------GKTWVALDVCLSYKVQ-- 177
Query: 169 LGTLGLASCSLSGPIPPQF----GQLSQLEELILQQNQLQGPIPAELGNCSSLSIFTAAE 224
C + I F + E ++ +L I S + +
Sbjct: 178 --------CKMDFKI---FWLNLKNCNSPETVLEMLQKLLYQIDPNW--TSRSDHSSNIK 224
Query: 225 NNLNGSIPAALGRLQNLQ-----LLNLGN--------------------------NSLSG 253
++ SI A L RL + LL L N + LS
Sbjct: 225 LRIH-SIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSA 283
Query: 254 EIPSELGELSQLGYLNLMGNRLEGAIPRS----FAKMGNLQSLDLSMNRLTGGIPEEFGN 309
+ + + + P K + + DL P E
Sbjct: 284 ATTTHI----------SLDHHSMTLTPDEVKSLLLKYLDCRPQDL---------PRE--- 321
Query: 310 MGQLVFLVLSNNNISGSIPRRICT-------NATSLEHLILAEIQLSGEIPVELSQC-QS 361
+ LS I+ SI + T N L +I E L+ P E +
Sbjct: 322 VLTTNPRRLS--IIAESIRDGLATWDNWKHVNCDKLTTII--ESSLNVLEPAEYRKMFDR 377
Query: 362 L----KQLDLSNNTL----NGTIPVELFQLVALTHLYLHNNSLV-GSISPFVANLSNLQE 412
L + L I ++ +V LH SLV ++ ++
Sbjct: 378 LSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNK----LHKYSLVEKQPKESTISIPSIYL 433
Query: 413 LALYHNNFQGSLPREIGMLVKLELLYLYDNHLSGQIPSEVGNCSSLKWID--FFGNSFTG 470
+ +L R I + + +D+ + ++D F+ S
Sbjct: 434 ELKVKLENEYALHRSI--VDHYNIPKTFDS-----------DDLIPPYLDQYFY--SH-- 476
Query: 471 EIPTSIGRLKDLNFLHLRQNELVGQIPASLGNCHQLIILDLADNKLSGGVPASFGFLQAL 530
IG HL+ E +++ LD F FL+
Sbjct: 477 -----IGH-------HLKNIE-----HPERMTLFRMVFLD-------------FRFLEQ- 505
Query: 531 EQLMLYNNSLEGNLPGSLINLRNLTRINFSKNRLNGRIATLCSSHSFLSFDVTNNEFDHE 590
+ ++S N GS++N L ++ F K I + L + + F +
Sbjct: 506 ---KIRHDSTAWNASGSILNT--LQQLKFYKP----YICDNDPKYERLVNAILD--FLPK 554
Query: 591 IPPQLGNSPSLERLRLG 607
I L S + LR+
Sbjct: 555 IEENLICSKYTDLLRIA 571
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 51.4 bits (122), Expect = 2e-06
Identities = 90/591 (15%), Positives = 181/591 (30%), Gaps = 177/591 (29%)
Query: 327 IPRRICTNATSLEHLILAEIQLSGE----IPVELSQCQSLKQ-----LDLSNNTLNGTIP 377
+P+ I + ++H+I+++ +SG + Q + +++ L ++ L I
Sbjct: 41 MPKSILSKE-EIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIK 99
Query: 378 VELFQLVALTHLYL-HNNSLVGSISPF----VANLSNLQEL--ALYHNNFQGSLPREIGM 430
E Q +T +Y+ + L F V+ L +L AL L +
Sbjct: 100 TEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALL------ELRPAKNV 153
Query: 431 LV-------K--LELLYLYDNHLSGQIPSEVGNCSSLKWIDFFGNSFTGEIPTSIGRLKD 481
L+ K + L + ++ ++ W++ N + P ++ L+
Sbjct: 154 LIDGVLGSGKTWVALDVCLSYKVQCKMDFKI------FWLNL-KNCNS---PETV--LEM 201
Query: 482 LNFLHLRQNELVGQIPASLGNCHQLIILDLADNKLSGGVPASFGFLQALEQLMLYNNSLE 541
L L + + S + I L + + L+ L + Y N L
Sbjct: 202 LQKLLYQ----IDPNWTSRSDHSSNIKLRIHSIQ---------AELRRLLKSKPYENCL- 247
Query: 542 GNLPGSLI--NLRNLTRIN-FSKNRLNGRIATLCSSHS-----FLSFDVTNNEFDHEIPP 593
L+ N++N N F N L ++ FLS T +
Sbjct: 248 ------LVLLNVQNAKAWNAF-----NLSCKILLTTRFKQVTDFLSAATTTHISLDHHSM 296
Query: 594 QLGNSPSLERLRLGNNKFIGKIPWTFGKIRELSLLDLSGNSLTGPIPTQLLMCKKL--SH 651
L L K++ + ++L L+ N P +L + +
Sbjct: 297 TLTPDEVKSLLL----KYLDC------RPQDLPREVLTTN------PRRLSIIAESIRDG 340
Query: 652 IDLNNNLLSGAVPSWLG-TLPQLGE-LKLSFNQFVGFLPRELFNCSKLLVLSLDGNMLNG 709
+ +N W +L ++ S N R++F L +
Sbjct: 341 LATWDN--------WKHVNCDKLTTIIESSLNVLEPAEYRKMF---DRLSV--------- 380
Query: 710 SLPNEVGNLASLNVLTLSGNLLSGPIPPAIGRLSKLYELRLSNNSLNGVIPLEIGQLQNL 769
P IP + LS ++ + + + + + +L
Sbjct: 381 -FPPSA------------------HIPTIL--LSLIW-----FDVIKSDVMVVVNKLHK- 413
Query: 770 QSILDLSHNNFTGQIPPSMGTLAKLEVLNLS--HNQLV------------GELPSQL--- 812
S+++ T IP S+ K+++ N H +V +P L
Sbjct: 414 YSLVEKQPKESTISIP-SIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQY 472
Query: 813 ---------------GEMSSLGKLNLSYNDLQGKLSKQFSHWPAEAFEGNL 848
M+ + L + L+ K+ + W A N
Sbjct: 473 FYSHIGHHLKNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILNT 523
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 5e-11
Identities = 35/119 (29%), Positives = 51/119 (42%), Gaps = 2/119 (1%)
Query: 225 NNLNGSIPAALGRLQNLQLLNLGNNSLSGEIPSELGELSQLGYLNLMGNRLEGAIPRSFA 284
N + P L NL+ L LG+N L L+QL L+L N+L F
Sbjct: 50 NQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFD 109
Query: 285 KMGNLQSLDLSMNRLTGGIPEEFGNMGQLVFLVLSNNNISGSIPRRICTNATSLEHLIL 343
++ +L+ L + N+LT +P + L L L N + SIP +SL H L
Sbjct: 110 RLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLK-SIPHGAFDRLSSLTHAYL 166
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 1e-10
Identities = 42/155 (27%), Positives = 63/155 (40%), Gaps = 30/155 (19%)
Query: 290 QSLDLSMNRLTGGIPEEFGNMGQLVFLVLSNNNISGSIPRRICTNATSLEHLILAEIQLS 349
Q L L N++T P F ++ L L L +N + +L
Sbjct: 43 QILYLHDNQITKLEPGVFDSLINLKELYLGSNQL------------GALP---------V 81
Query: 350 GEIPVELSQCQSLKQLDLSNNTLNGTIPVELF-QLVALTHLYLHNNSLVGSISPFVANLS 408
G + L+Q L LDL N L +P +F +LV L L++ N L + + L+
Sbjct: 82 G-VFDSLTQ---LTVLDLGTNQLT-VLPSAVFDRLVHLKELFMCCNKL-TELPRGIERLT 135
Query: 409 NLQELALYHNNFQGSLPREI-GMLVKLELLYLYDN 442
+L LAL N + S+P L L YL+ N
Sbjct: 136 HLTHLALDQNQLK-SIPHGAFDRLSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 6e-10
Identities = 40/153 (26%), Positives = 62/153 (40%), Gaps = 12/153 (7%)
Query: 101 DLSSNSLT---GPIPTALSNLSSLESLLLFSNQLAGTIPTQLGSLTSLRVMRIGDNWLSG 157
D S IPT + + L L NQ+ P SL +L+ + +G N L
Sbjct: 25 DCRSKRHASVPAGIPT------NAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG- 77
Query: 158 SIPTS-FGNLVNLGTLGLASCSLSGPIPPQFGQLSQLEELILQQNQLQGPIPAELGNCSS 216
++P F +L L L L + L+ F +L L+EL + N+L +P + +
Sbjct: 78 ALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLTE-LPRGIERLTH 136
Query: 217 LSIFTAAENNLNGSIPAALGRLQNLQLLNLGNN 249
L+ +N L A RL +L L N
Sbjct: 137 LTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 9e-10
Identities = 40/165 (24%), Positives = 59/165 (35%), Gaps = 29/165 (17%)
Query: 158 SIPTSFGNLVNLGTLGLASCSLSGPIPPQFGQLSQLEELILQQNQLQGPIPAELGNCSSL 217
S+P G N L L ++ P F L L+EL L NQL
Sbjct: 33 SVPA--GIPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG------------- 77
Query: 218 SIFTAAENNLNGSIPAAL-GRLQNLQLLNLGNNSLSGEIPSELGELSQLGYLNLMGNRLE 276
++P + L L +L+LG N L+ + L L L + N+L
Sbjct: 78 ------------ALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT 125
Query: 277 GAIPRSFAKMGNLQSLDLSMNRLTGGIPEEFGNMGQLVFLVLSNN 321
+PR ++ +L L L N+L F + L L N
Sbjct: 126 -ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 6e-09
Identities = 40/128 (31%), Positives = 50/128 (39%), Gaps = 5/128 (3%)
Query: 628 LDLSGNSLTGPIPTQLLMCKKLSHIDLNNNLLSGAVPSWL-GTLPQLGELKLSFNQFVGF 686
L L N +T P L + L +N L A+P + +L QL L L NQ
Sbjct: 45 LYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQLTV- 102
Query: 687 LPRELFNC-SKLLVLSLDGNMLNGSLPNEVGNLASLNVLTLSGNLLSGPIPPAIGRLSKL 745
LP +F+ L L + N L LP + L L L L N L A RLS L
Sbjct: 103 LPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSL 161
Query: 746 YELRLSNN 753
L N
Sbjct: 162 THAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 1e-07
Identities = 41/153 (26%), Positives = 60/153 (39%), Gaps = 27/153 (17%)
Query: 387 THLYLHNNSLVGSISPFVANLSNLQELALYHNNFQGSLPREI-GMLVKLELLYLYDNHLS 445
LYLH+N + +L NL+EL L N +LP + L +L +L L N L+
Sbjct: 43 QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQLT 101
Query: 446 GQIPSEVGNCSSLKWIDFFGNSFTGEIPTSIGRLKDLNFLHLRQNELVGQIPASLGNCHQ 505
+PS V F RL L L + N+L ++P +
Sbjct: 102 -VLPSAV---------------F--------DRLVHLKELFMCCNKL-TELPRGIERLTH 136
Query: 506 LIILDLADNKLSGGVPASFGFLQALEQLMLYNN 538
L L L N+L +F L +L L+ N
Sbjct: 137 LTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 2e-06
Identities = 38/122 (31%), Positives = 55/122 (45%), Gaps = 5/122 (4%)
Query: 653 DLNNNLLSGAVPSWLGTLPQLGELKLSFNQFVGFLPRELFNC-SKLLVLSLDGNMLNGSL 711
L++N ++ P +L L EL L NQ LP +F+ ++L VL L N L L
Sbjct: 46 YLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQLT-VL 103
Query: 712 PNEV-GNLASLNVLTLSGNLLSGPIPPAIGRLSKLYELRLSNNSLNGVIPLEIGQLQNLQ 770
P+ V L L L + N L+ +P I RL+ L L L N L + +L +L
Sbjct: 104 PSAVFDRLVHLKELFMCCNKLTE-LPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLT 162
Query: 771 SI 772
Sbjct: 163 HA 164
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 9e-06
Identities = 34/115 (29%), Positives = 51/115 (44%), Gaps = 10/115 (8%)
Query: 719 ASLNVLTLSGNLLSGPIPPAIGRLSKLYELRLSNNSLNGVIPLEIG---QLQNLQSILDL 775
+ +L L N ++ P L L EL L +N L L +G L L +LDL
Sbjct: 40 TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGA---LPVGVFDSLTQLT-VLDL 95
Query: 776 SHNNFTGQIPPSM-GTLAKLEVLNLSHNQLVGELPSQLGEMSSLGKLNLSYNDLQ 829
N T +P ++ L L+ L + N+L ELP + ++ L L L N L+
Sbjct: 96 GTNQLT-VLPSAVFDRLVHLKELFMCCNKL-TELPRGIERLTHLTHLALDQNQLK 148
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 1e-05
Identities = 38/150 (25%), Positives = 58/150 (38%), Gaps = 24/150 (16%)
Query: 508 ILDLADNKLSGGVPASFGFLQALEQLMLYNNSLEGNLPGSLINLRNLTRINFSKNRLNGR 567
IL L DN+++ P F L L++L L +N L G +L LT ++ N+L
Sbjct: 44 ILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQL--- 100
Query: 568 IATLCSSHSFLSFDVTNNEFDHEIPPQLGNSPSLERLRLGNNKFIGKIPWTFGKIRELSL 627
+ L V FD L + L+ L + NK ++P ++ L+
Sbjct: 101 --------TVLPSAV----FDR-----LVH---LKELFMCCNKL-TELPRGIERLTHLTH 139
Query: 628 LDLSGNSLTGPIPTQLLMCKKLSHIDLNNN 657
L L N L L+H L N
Sbjct: 140 LALDQNQLKSIPHGAFDRLSSLTHAYLFGN 169
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 6e-11
Identities = 64/224 (28%), Positives = 97/224 (43%), Gaps = 33/224 (14%)
Query: 947 NLSD-EFI--IGSGGSGTVYKAEL-ANGATVAVKKISCKDDHLLNKSFTREVKTLGRI-- 1000
+ + EFI +G G G V A + G AVK + K D +L T RI
Sbjct: 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVL--KKDVILQDDDVECTMTEKRILS 78
Query: 1001 ---RHRHLVKLMGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKI 1057
H L +L CC + + E++ G + + K R+ + AR
Sbjct: 79 LARNHPFLTQL--FCCFQTPDRLFFVMEFVNGGDLMFHIQKS------RRFDEARARFYA 130
Query: 1058 A-VGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAH--LGDFGLAKALVEDYNSNTE 1114
A + A + +LH I++RD+K N+LLD E H L DFG+ K E +
Sbjct: 131 AEIISA--LMFLHDK---GIIYRDLKLDNVLLDH--EGHCKLADFGMCK---EGICNGVT 180
Query: 1115 SNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMP 1158
+ T F G+ YIAPE + D ++MG++L E++ G P
Sbjct: 181 TAT-FCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAP 223
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 7e-11
Identities = 57/224 (25%), Positives = 92/224 (41%), Gaps = 33/224 (14%)
Query: 947 NLSD-EFI--IGSGGSGTVYKAEL-ANGATVAVKKISCKDDHLLNKSFTREVKTLGRI-- 1000
+ D +G G G V+ AE A+K + K D +L R+
Sbjct: 15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKAL--KKDVVLMDDDVECTMVEKRVLS 72
Query: 1001 ---RHRHLVKLMGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKI 1057
H L + C + + + EY+ G + + K A
Sbjct: 73 LAWEHPFLTHM--FCTFQTKENLFFVMEYLNGGDLMYHIQSC------HKFDLSRATFYA 124
Query: 1058 A-VGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAH--LGDFGLAKALVEDYNSNTE 1114
A + L +++LH I++RD+K NILLD + H + DFG+ K E+ + +
Sbjct: 125 AEIILG--LQFLHSK---GIVYRDLKLDNILLDK--DGHIKIADFGMCK---ENMLGDAK 174
Query: 1115 SNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMP 1158
+NT F G+ YIAPE K D +S G++L E++ G+ P
Sbjct: 175 TNT-FCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 217
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 64.9 bits (158), Expect = 1e-10
Identities = 66/507 (13%), Positives = 142/507 (28%), Gaps = 78/507 (15%)
Query: 318 LSNNNISGSIPRRICTNATSLEHLILAEIQ---------------LSGEIPVELSQCQSL 362
+ N P + + + L + I S L
Sbjct: 48 VFIGNCYAVSPATVIRRFPKVRSVELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWL 107
Query: 363 KQLDLSNNTLNGTIPVELFQ-LVALTHLYLHNNSLVG--SISPFVANLSNLQELALYHNN 419
+++ L + + + L L + ++ A NL+EL L ++
Sbjct: 108 EEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESD 167
Query: 420 FQGSLPREIGMLVKLELLYLYDNHLSGQIPSEVGNCSSLKWIDFFG--NSFTGEIPTSIG 477
+ +SL ++ + + +
Sbjct: 168 VDDVSGHWLSHFPD--------------------TYTSLVSLNISCLASEVSFSALERLV 207
Query: 478 -RLKDLNFLHLRQNELVGQIPASLGNCHQLIILDLA------DNKLSGGVPASFGFLQAL 530
R +L L L + + ++ L QL L + G+ + + L
Sbjct: 208 TRCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKEL 267
Query: 531 EQLMLYNNSLEGNLPGSLINLRNLTRINFSKNRL--NGRIATLCSSHSFLSFDVTNNEFD 588
L + +++ LP LT +N S + + LC V + D
Sbjct: 268 RCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDYIED 327
Query: 589 HEIPPQLGNSPSLERLRLGNNKFIGKIPWTFGKIRELSLLDLSGNSLTGPIPTQLLMCKK 648
+ L LR+ ++ P + E L+ +S C K
Sbjct: 328 AGLEVLASTCKDLRELRVFPSEPFVMEP--NVALTEQGLVSVSMG------------CPK 373
Query: 649 LSHIDLNNNLLSGAVPSWLGT-LPQLGELKLSFNQFVGFLPRELF-----------NCSK 696
L + ++ A + P + +L + L +C
Sbjct: 374 LESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKD 433
Query: 697 LLVLSLDGNMLNGSLPNEVGNLASLNVLTLSGNLLSGPIPPAIGR-LSKLYELRLSN-NS 754
L LSL G + + + +L+++ S + L +L + +
Sbjct: 434 LRRLSLSGLLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPF 493
Query: 755 LNGVIPLEIGQLQNLQSILDLSHNNFT 781
+ + +L+ ++S L +S + +
Sbjct: 494 GDKALLANASKLETMRS-LWMSSCSVS 519
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 53.4 bits (128), Expect = 4e-07
Identities = 65/489 (13%), Positives = 135/489 (27%), Gaps = 62/489 (12%)
Query: 77 NLSGLSLAGSISPSLGRLQSLIHLDLSSNSLTGPIPTALSNLSSLESLLL----FSNQLA 132
+ + L G + L + S+ + LE + L ++
Sbjct: 67 KVRSVELKGKPHFADFNLVPDGWGGYVYPWIE----AMSSSYTWLEEIRLKRMVVTDDCL 122
Query: 133 GTIPTQLGSLTSLRVMRIGDNWLSGSIPTSFGNLVNLGTLGLASCSLSGPIPPQFGQLS- 191
I + L + + + + + NL L L +
Sbjct: 123 ELIAKSFKNFKVLVLSSC-EGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPD 181
Query: 192 ---QLEELILQQNQLQ---GPIPAELGNCSSLSIFTAAENNLNGSIPAALGRLQNLQLLN 245
L L + + + + C +L + L R L+ L
Sbjct: 182 TYTSLVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLEKLATLLQRAPQLEELG 241
Query: 246 LGNNSLSGEIPSELGELSQLGYLNLMGNRLEGAIPRSFAKMGNLQSLDLSMNRLTGGIPE 305
G GY + + + + + L+ L + + +P
Sbjct: 242 TG------------------GYTAEVRPDVYSGLSVALSGCKELRCLSGFWDAVPAYLPA 283
Query: 306 EFGNMGQLVFLVLSNNNISGSIPRRICTNATSLEHLILAEIQLSGEIPVELSQCQSLKQL 365
+ +L L LS + ++ L+ L + + + V S C+ L++L
Sbjct: 284 VYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDYIEDAGLEVLASTCKDLREL 343
Query: 366 DLSNNTLNGTIPVELFQLVALTHLYLHNNSLV-----------GSISPFVANLSNLQELA 414
+ + P L + + L ++ N N+
Sbjct: 344 RVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFR 403
Query: 415 LYHNNFQGSLPREIGMLVKLELLYLYDNHLSGQIPSEVGNCSSLKWIDFFGNSFTGEIPT 474
L + YL L + V +C L+ + G T ++
Sbjct: 404 LCI-------------IEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSGL-LTDKVFE 449
Query: 475 SIGR-LKDLNFLHLRQNELVGQ-IPASLGNCHQLIILDLADNKLSG-GVPASFGFLQALE 531
IG K + L + + L C L L++ D + A+ L+ +
Sbjct: 450 YIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMR 509
Query: 532 QLMLYNNSL 540
L + + S+
Sbjct: 510 SLWMSSCSV 518
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 48.0 bits (114), Expect = 2e-05
Identities = 46/274 (16%), Positives = 86/274 (31%), Gaps = 21/274 (7%)
Query: 550 NLRNLTRINFSKNRLN----GRIATLCSSHSFLSFDVTNNEFDHEIPPQLGNSPSLERLR 605
+ L I + + IA + L + +L+ L
Sbjct: 103 SYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELD 162
Query: 606 LGNNKF-------IGKIPWTFGKIRELSLLDLSGNSLTGPIPTQLLMCKKLSHIDLNNNL 658
L + + P T+ + L++ L+ + + C L + LN +
Sbjct: 163 LRESDVDDVSGHWLSHFPDTYTSLVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRAV 222
Query: 659 LSGAVPSWLGTLPQLGELKLSF------NQFVGFLPRELFNCSKLLVLSLDGNMLNGSLP 712
+ + L PQL EL L L C +L LS + + LP
Sbjct: 223 PLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRCLSGFWDAVPAYLP 282
Query: 713 NEVGNLASLNVLTLSG-NLLSGPIPPAIGRLSKLYELRLSNN-SLNGVIPLEIGQLQNLQ 770
+ L L LS + S + + + KL L + + G+ L ++L+
Sbjct: 283 AVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDYIEDAGLEVL-ASTCKDLR 341
Query: 771 SILDLSHNNFTGQIPPSMGTLAKLEVLNLSHNQL 804
L + + P T L +++ +L
Sbjct: 342 E-LRVFPSEPFVMEPNVALTEQGLVSVSMGCPKL 374
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 2e-10
Identities = 54/256 (21%), Positives = 96/256 (37%), Gaps = 52/256 (20%)
Query: 953 IIGSGGSGTVYKAE-LANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHR------HL 1005
+IG G G V KA VA+K I K+ EV+ L + ++
Sbjct: 61 LIGKGSFGQVVKAYDRVEQEWVAIKII--KNKKAFLNQAQIEVRLLELMNKHDTEMKYYI 118
Query: 1006 VKLM------GHCC--NKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKI 1057
V L H C + NL Y+ + N + + V++ + + K
Sbjct: 119 VHLKRHFMFRNHLCLVFEMLSYNL--YDLLRNTN------FRGVSLNLTR--------KF 162
Query: 1058 AVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAH--LGDFGLAKALVEDYNSNTES 1115
A + + +L + I+H D+K NILL + + + DFG +
Sbjct: 163 AQQMCTALLFLATPEL-SIIHCDLKPENILLCNPKRSAIKIVDFG--SSCQLGQRIYQYI 219
Query: 1116 NTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKM--PTDATFGVEMDMVRWV 1173
+ F Y +PE + D++S+G +L+E+ +G+ E+D +
Sbjct: 220 QSRF-----YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN----EVDQMN-- 268
Query: 1174 EMHMEMSGSAREELLD 1189
+E+ G +LD
Sbjct: 269 -KIVEVLGIPPAHILD 283
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 2e-10
Identities = 64/313 (20%), Positives = 112/313 (35%), Gaps = 65/313 (20%)
Query: 954 IGSGGSGTVYKAE-LANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRH-RHLVKLMGH 1011
IGSG G +Y +A G VA+K K H E K ++ + +
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH---PQLHIESKIYKMMQGGVGIPTI--R 71
Query: 1012 CCNKGAGSNLLIYEYMENG-SVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHH 1070
C N+++ E + G S+ D + + + L +A + +EY+H
Sbjct: 72 WCGAEGDYNVMVMELL--GPSLEDLFNFCS------RKFSLKTVLLLADQMISRIEYIHS 123
Query: 1071 DCVPKILHRDIKSSNILLDSNMEAH---LGDFGLAKALVEDYNSNTES------NTWFAG 1121
+HRD+K N L+ + + + DFGLAK ++ T N G
Sbjct: 124 KN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR---DARTHQHIPYRENKNLTG 177
Query: 1122 SYGYIAPEYAYSLKA------TEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEM 1175
+ YA S+ + + D+ S+G VLM G +P W
Sbjct: 178 T-----ARYA-SINTHLGIEQSRRDDLESLGYVLMYFNLGSLP-------------W--- 215
Query: 1176 HMEMSGSAREELLDD--QMKPLLPGEE-CAAY--QVLEIALQCTKTSPQERPSSRQVCDL 1230
+ + + + + + K P E C Y + C ++P + L
Sbjct: 216 -QGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQL 274
Query: 1231 LLNVFNNRIVDFD 1243
N+F+ + +D
Sbjct: 275 FRNLFHRQGFSYD 287
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 63.4 bits (154), Expect = 3e-10
Identities = 74/520 (14%), Positives = 156/520 (30%), Gaps = 82/520 (15%)
Query: 318 LSNNNISGSIPRRICTNATSLEHLILAEIQLSGEIPVEL---------------SQCQSL 362
++ + P R+ +L L L + + + + L
Sbjct: 55 VTMALCYTATPDRLSRRFPNLRSLKLKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQL 114
Query: 363 KQLDLSNNTL--NGTIPVELFQLVALTHLYLHNNSLVG--SISPFVANLSNLQELALYHN 418
K + + + + L L L S + V + ++ L + +
Sbjct: 115 KSVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEES 174
Query: 419 NFQGSLPREIGMLVKLELLYLYDNHLSGQIPSEVGNCSSLKWIDFFGNSFTG-------E 471
+F + + L + + +SL+ ++F+ F
Sbjct: 175 SFSEKDGKWLHELAQ--------------------HNTSLEVLNFYMTEFAKISPKDLET 214
Query: 472 IPTSIGRLKDLNFLHLRQNELVGQIPASLGNCHQLIILDLADNKLSGGVPASFGFLQALE 531
I + L + ELVG + N + L ++ + F + L
Sbjct: 215 IARNCRSLVSVKVGDFEILELVG-FFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLC 273
Query: 532 QLMLYNNSLEGNLPGSLINLRNLTRINFSKNRL--NGRIATLCSSHSFLSFDVTNNEFDH 589
+L L +P + +++ L + + + N D
Sbjct: 274 RLGLSYMGPNE-MPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETRNVIGDR 332
Query: 590 EIPPQLGNSPSLERLRLGNNKFIGKIPWTFGKIRELSLLDLSGNSLTGPIPTQLLMCKKL 649
+ L+RLR+ + G + + L+ L+ C++L
Sbjct: 333 GLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQG------------CQEL 380
Query: 650 SHIDLNNNLLSGAVPSWLGT-LPQLGELKLSFNQFVGFLPRELFNCSKLLVLSLDGNMLN 708
++ + + ++ +GT L L + +L L ++ L LD +
Sbjct: 381 EYMAVYVSDITNESLESIGTYLKNLCDFRLV----------LLDREERITDLPLDNGV-- 428
Query: 709 GSLPNEVGNLASLNVLTLSGNLLSGPIPPAIGRLSK-LYELRLSN--NSLNGVIPLEIGQ 765
SL L G L+ IG+ S + + L S G++ G
Sbjct: 429 RSLLIGCKKLRRFAFYLRQGG-LTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRG- 486
Query: 766 LQNLQSILDLSHNNFTGQ-IPPSMGTLAKLEVLNLSHNQL 804
NLQ L++ F+ + I ++ L L L + +
Sbjct: 487 CPNLQK-LEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRA 525
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 57.3 bits (138), Expect = 2e-08
Identities = 52/325 (16%), Positives = 100/325 (30%), Gaps = 44/325 (13%)
Query: 211 LGNCSSLSIFTAAENNLNGSIPAALGRLQNLQLLNLGNNSLSGEIPSELGELSQ----LG 266
L CS + + + + + ++ L + +S S + L EL+Q L
Sbjct: 145 LDKCSGFT---------TDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLE 195
Query: 267 YLNLMGNRLEG----AIPRSFAKMGNLQSLDLSMNRLTGGIPEEFGNMGQLVFLVLSNNN 322
LN + +L S+ + + + F L + N
Sbjct: 196 VLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILELV-GFFKAAANLEEFCGGSLN 254
Query: 323 ISGSIPRRI--CTNATSLEHLILAEIQLSGEIPVELSQCQSLKQLDLSNNTLNGTIPVEL 380
+P + L L L+ + + +P+ +++LDL L L
Sbjct: 255 EDIGMPEKYMNLVFPRKLCRLGLSYMGPNE-MPILFPFAAQIRKLDLLYALLETEDHCTL 313
Query: 381 FQ-LVALTHLYLHNNSLVGSISPFVANLSNLQELALYHNNFQGSLPREIGMLVKLELLYL 439
Q L L N + L+ L + + + E G++ + L+ L
Sbjct: 314 IQKCPNLEVLETRNVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIAL 373
Query: 440 YDNHLSGQIPSEVGNCSSLKWIDFFGNSFTGE----IPTSIGRLKDLNFLHLRQNELVGQ 495
C L+++ + + T E I T + L D + L + E +
Sbjct: 374 ------------AQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITD 421
Query: 496 IPASLG------NCHQLIILDLADN 514
+P G C +L
Sbjct: 422 LPLDNGVRSLLIGCKKLRRFAFYLR 446
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 49.6 bits (118), Expect = 6e-06
Identities = 45/360 (12%), Positives = 104/360 (28%), Gaps = 50/360 (13%)
Query: 68 SSSARVVSLNLSGLSLAGSISPSLGRLQSLIHLDLSSNSLTGP--IPTALSNLSSLESL- 124
++A + L+ + L L S GP +P + + L
Sbjct: 240 KAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPNEMPILFPFAAQIRKLD 299
Query: 125 LLFSNQLAGTIPTQLGSLTSLRVMRIGDNWLSGSIPTSFGNLVNLGTLGLASCSLSGPIP 184
LL++ T + +L V+ + + L L + + +
Sbjct: 300 LLYALLETEDHCTLIQKCPNLEVLETRNVIGDRGLEVLAQYCKQLKRLRIERGADEQGME 359
Query: 185 PQFGQLS------------QLEELILQQNQLQGPIPAELGNCSSLSIFTAAENNLNGSIP 232
+ G +S +LE + + + + ++ S+ +
Sbjct: 360 DEEGLVSQRGLIALAQGCQELEYMAVYVSDI-----------TNESLESIGTY------- 401
Query: 233 AALGRLQNLQLLNLGNNSLSGEIPSELG------ELSQLGYLNLMGN--RLEGAIPRSFA 284
L L + +L+ L ++P + G +L L
Sbjct: 402 --LKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIG 459
Query: 285 KMG-NLQSLDLSMNRLT-GGIPEEFGNMGQLVFLVLSNNNISGSIPRRICTNATSLEHLI 342
+ N++ + L + G+ E L L + S T SL +L
Sbjct: 460 QYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLW 519
Query: 343 LA--EIQLSGEIPVELSQ-CQSLKQLDLSNNTLNGTIPVELFQLVALTHLYLHNNSLVGS 399
+ ++G+ +++++ +++ + H+ + SL G
Sbjct: 520 VQGYRASMTGQDLMQMARPYWNIELIPSRRVPEVNQQGEIREME-HPAHILAY-YSLAGQ 577
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 62.4 bits (151), Expect = 3e-10
Identities = 18/126 (14%), Positives = 33/126 (26%), Gaps = 27/126 (21%)
Query: 273 NRLEGAIPRSFAKMGNLQSLDLSMNRLTGGIPEE-FGNMGQLVFLVLSNNNISGSIPRRI 331
NL L + + + +G+L L + + + +
Sbjct: 17 RDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDA 75
Query: 332 CTNATSLEHLILAEIQLSGEIPVELSQCQSLKQLDLSNNTLNGTIPVELFQLVALTHLYL 391
L L+LS N L ++ + Q ++L L L
Sbjct: 76 FHFTPRLSR------------------------LNLSFNALE-SLSWKTVQGLSLQELVL 110
Query: 392 HNNSLV 397
N L
Sbjct: 111 SGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 60.5 bits (146), Expect = 1e-09
Identities = 24/98 (24%), Positives = 36/98 (36%), Gaps = 2/98 (2%)
Query: 225 NNLNGSIPAALGRLQNLQLLNLGNNSLSGEIPSE-LGELSQLGYLNLMGNRLEGAIPRSF 283
+ L +NL L + N + L L +L L ++ + L P +F
Sbjct: 17 RDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAF 76
Query: 284 AKMGNLQSLDLSMNRLTGGIPEEFGNMGQLVFLVLSNN 321
L L+LS N L + + L LVLS N
Sbjct: 77 HFTPRLSRLNLSFNALESLSWKTVQGL-SLQELVLSGN 113
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 56.3 bits (135), Expect = 3e-08
Identities = 20/112 (17%), Positives = 42/112 (37%), Gaps = 3/112 (2%)
Query: 455 CSSLKWIDFFGNSFTGEIPTSIGRLKDLNFLHLRQNELVGQIPA-SLGNCHQLIILDLAD 513
+ + + + ++L L++ + + + L +L L +
Sbjct: 7 PHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVK 65
Query: 514 NKLSGGVPASFGFLQALEQLMLYNNSLEGNLPGSLINLRNLTRINFSKNRLN 565
+ L P +F F L +L L N+LE +L + +L + S N L+
Sbjct: 66 SGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 56.3 bits (135), Expect = 3e-08
Identities = 21/96 (21%), Positives = 36/96 (37%), Gaps = 2/96 (2%)
Query: 590 EIPPQLGNSPSLERLRLGNNKFIGKIPW-TFGKIRELSLLDLSGNSLTGPIPTQLLMCKK 648
+ L + +L L + N + + + + EL L + + L P +
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPR 81
Query: 649 LSHIDLNNNLLSGAVPSWLGTLPQLGELKLSFNQFV 684
LS ++L+ N L + L L EL LS N
Sbjct: 82 LSRLNLSFNALESLSWKTVQGLS-LQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 55.5 bits (133), Expect = 5e-08
Identities = 19/113 (16%), Positives = 35/113 (30%), Gaps = 5/113 (4%)
Query: 359 CQSLKQLDLSNNTLNGTIPVELFQLVALTHLYLHNNSLVGSISPFV-ANLSNLQELALYH 417
L + + L LT LY+ N + + L L+ L +
Sbjct: 7 PHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVK 65
Query: 418 NNFQGSLPREI-GMLVKLELLYLYDNHLSGQIPSEVGNCSSLKWIDFFGNSFT 469
+ + + + +L L L N L + + SL+ + GN
Sbjct: 66 SGLR-FVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 54.7 bits (131), Expect = 9e-08
Identities = 18/98 (18%), Positives = 36/98 (36%), Gaps = 5/98 (5%)
Query: 248 NNSLSGEIPSELGELSQLGYLNLMGNRLEGAIPR-SFAKMGNLQSLDLSMNRLTGGIPEE 306
+ + L L L + + + +G L++L + + L + +
Sbjct: 16 TRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPD 74
Query: 307 -FGNMGQLVFLVLSNNNISGSIPRRICTNATSLEHLIL 343
F +L L LS N + S+ + SL+ L+L
Sbjct: 75 AFHFTPRLSRLNLSFNALE-SLSWKT-VQGLSLQELVL 110
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 49.7 bits (118), Expect = 3e-06
Identities = 24/95 (25%), Positives = 36/95 (37%), Gaps = 2/95 (2%)
Query: 111 IPTALSNLSSLESLLLFSNQLAGTIPTQ-LGSLTSLRVMRIGDNWLSGSIPTSFGNLVNL 169
L +L L + + Q + + L L LR + I + L P +F L
Sbjct: 23 SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRL 82
Query: 170 GTLGLASCSLSGPIPPQFGQLSQLEELILQQNQLQ 204
L L+ +L LS L+EL+L N L
Sbjct: 83 SRLNLSFNALESLSWKTVQGLS-LQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 49.7 bits (118), Expect = 4e-06
Identities = 23/102 (22%), Positives = 38/102 (37%), Gaps = 7/102 (6%)
Query: 759 IPLEIGQLQNLQSILDLSHNNFTGQIPP-SMGTLAKLEVLNLSHNQLVGELPSQLGEMSS 817
+ +NL L + + + + L +L L + + L P
Sbjct: 23 SLHHLPGAENLTE-LYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPR 81
Query: 818 LGKLNLSYNDLQGKLSKQFSHWPAEAFEGNLHLCGSPLDHCN 859
L +LNLS+N L+ K + L L G+PL HC+
Sbjct: 82 LSRLNLSFNALESLSWKTVQGLSLQ----ELVLSGNPL-HCS 118
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 48.6 bits (115), Expect = 8e-06
Identities = 20/120 (16%), Positives = 34/120 (28%), Gaps = 28/120 (23%)
Query: 158 SIPTSFGNLVNLGTLGLASCSLSGPIPPQ-FGQLSQLEELILQQNQLQGPIPAELGNCSS 216
NL L + + + + L +L L + ++ L+
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR------------ 69
Query: 217 LSIFTAAENNLNGSIPA-ALGRLQNLQLLNLGNNSLSGEIPSELGELSQLGYLNLMGNRL 275
+ A L LNL N+L + + + L L L GN L
Sbjct: 70 -------------FVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 46.7 bits (110), Expect = 3e-05
Identities = 17/85 (20%), Positives = 29/85 (34%), Gaps = 2/85 (2%)
Query: 72 RVVSLNLSGLSLAGSISP-SLGRLQSLIHLDLSSNSLTGPIPTALSNLSSLESLLLFSNQ 130
+ L + + L L L +L + + L P A L L L N
Sbjct: 32 NLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNA 91
Query: 131 LAGTIPTQLGSLTSLRVMRIGDNWL 155
L ++ + SL+ + + N L
Sbjct: 92 LE-SLSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 45.9 bits (108), Expect = 6e-05
Identities = 27/138 (19%), Positives = 37/138 (26%), Gaps = 30/138 (21%)
Query: 646 CKKLSHIDLNNNLLSGAVPSWLGTLPQLGELKLSFNQFVGFLPRELFNCSKLLVLSLDGN 705
S + + L L EL + Q + L
Sbjct: 7 PHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDL------------- 52
Query: 706 MLNGSLPNEVGNLASLNVLTLSGNLLSGPIPP-AIGRLSKLYELRLSNNSLNGVIPLEIG 764
L L LT+ + L + P A +L L LS N+L L
Sbjct: 53 ----------RGLGELRNLTIVKSGLR-FVAPDAFHFTPRLSRLNLSFNALES---LSWK 98
Query: 765 QLQNLQ-SILDLSHNNFT 781
+Q L L LS N
Sbjct: 99 TVQGLSLQELVLSGNPLH 116
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 4e-10
Identities = 58/318 (18%), Positives = 106/318 (33%), Gaps = 73/318 (22%)
Query: 954 IGSGGSGTVYKAE-LANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMG-- 1010
IG G G +++ L N VA+K + D E +T + L G
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA---PQLRDEYRTY-----KLLAGCTGIP 69
Query: 1011 --HCCNKGAGSNLLIYEYMENG-SVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEY 1067
+ + N+L+ + + G S+ D L + + A + V+
Sbjct: 70 NVYYFGQEGLHNVLVIDLL--GPSLEDLLDLCG------RKFSVKTVAMAAKQMLARVQS 121
Query: 1068 LHHDCVPKILHRDIKSSNILL------DSNMEAHLGDFGLAKALVEDY-NSNTES----- 1115
+H +++RDIK N L+ ++NM ++ DFG+ K Y + T+
Sbjct: 122 IHEKS---LVYRDIKPDNFLIGRPNSKNANMI-YVVDFGMVK----FYRDPVTKQHIPYR 173
Query: 1116 -NTWFAGSYGYIAPEYAYSLKA---TEKC---DVYSMGIVLMELVSGKMPTDATFGVEMD 1168
+G+ Y S+ E+ D+ ++G V M + G +P
Sbjct: 174 EKKNLSGT-----ARYM-SINTHLGREQSRRDDLEALGHVFMYFLRGSLP---------- 217
Query: 1169 MVRWVEMHMEMSGSAREELLDDQMKPLLPGEE-CAAY--QVLEIALQCTKTSPQERPSSR 1225
W + + E + + K P E CA + + + + P
Sbjct: 218 ---WQGLKAATNKQKYERIG--EKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYD 272
Query: 1226 QVCDLLLNVFNNRIVDFD 1243
+ L V D
Sbjct: 273 YLQGLFSKVLERLNTTED 290
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 7e-10
Identities = 49/145 (33%), Positives = 68/145 (46%), Gaps = 11/145 (7%)
Query: 326 SIPRRICTNATSLEHLILAEIQLSGEIPVELSQCQSLKQLDLSNNTLNGTIPVELF-QLV 384
S+P I T L+ L L + SL QL L N L ++P +F +L
Sbjct: 21 SVPTGIPAQTTYLD---LETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLT 76
Query: 385 ALTHLYLHNNSLVGSISPFV-ANLSNLQELALYHNNFQGSLPREI-GMLVKLELLYLYDN 442
+LT+L L N L S+ V L+ L+ELAL N Q SLP + L +L+ L LY N
Sbjct: 77 SLTYLNLSTNQLQ-SLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQN 134
Query: 443 HLSGQIPSEV-GNCSSLKWIDFFGN 466
L +P V +SL++I N
Sbjct: 135 QLKS-VPDGVFDRLTSLQYIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 2e-09
Identities = 48/170 (28%), Positives = 72/170 (42%), Gaps = 37/170 (21%)
Query: 230 SIPAALGRLQNLQLLNLGNNSLSGEIPSELGELSQLGYLNLMGNRLEGAIPRSFAKMGNL 289
S+P G L+L NSL EL+ L L L GN+L+ F K+ +L
Sbjct: 21 SVPT--GIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSL 78
Query: 290 QSLDLSMNRLTGGIPEEFGNMGQLVFLVLSNNNISGSIPRRICTNATSLEHLILAEIQLS 349
L+LS N+L S+P + T L+ L L QL
Sbjct: 79 TYLNLSTNQLQ-------------------------SLPNGVFDKLTQLKELALNTNQLQ 113
Query: 350 GEIPV----ELSQCQSLKQLDLSNNTLNGTIPVELF-QLVALTHLYLHNN 394
+P +L+Q LK L L N L ++P +F +L +L +++LH+N
Sbjct: 114 -SLPDGVFDKLTQ---LKDLRLYQNQLK-SVPDGVFDRLTSLQYIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 7e-09
Identities = 43/136 (31%), Positives = 64/136 (47%), Gaps = 15/136 (11%)
Query: 290 QSLDLSMNRLTGGIPEEFGNMGQLVFLVLSNNNISGSIPRRICTNATSLEHLILAEIQLS 349
LDL N L F + L L L N + S+P + TSL +L L+ QL
Sbjct: 31 TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLSTNQLQ 89
Query: 350 GEIPV----ELSQCQSLKQLDLSNNTLNGTIPVELF-QLVALTHLYLHNNSLVGSISPFV 404
+P +L+Q LK+L L+ N L ++P +F +L L L L+ N L S+ P
Sbjct: 90 -SLPNGVFDKLTQ---LKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQL-KSV-PDG 142
Query: 405 A--NLSNLQELALYHN 418
L++LQ + L+ N
Sbjct: 143 VFDRLTSLQYIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 2e-08
Identities = 46/153 (30%), Positives = 63/153 (41%), Gaps = 30/153 (19%)
Query: 100 LDLSSNSLTGPIPTALSNLSSLESLLLFSNQLAGTIPTQLGSLTSLRVMRIGDNWLSGSI 159
LDL +NSL L+SL L L N+L LTSL + + N L S+
Sbjct: 33 LDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQ-SL 91
Query: 160 PTS-FGNLVNLGTLGLASCSLSGPIPP-QFGQLSQLEELILQQNQLQGPIPAELGNCSSL 217
P F L L L L + L +P F +L+QL++L L QNQL+
Sbjct: 92 PNGVFDKLTQLKELALNTNQLQS-LPDGVFDKLTQLKDLRLYQNQLK------------- 137
Query: 218 SIFTAAENNLNGSIP-AALGRLQNLQLLNLGNN 249
S+P RL +LQ + L +N
Sbjct: 138 ------------SVPDGVFDRLTSLQYIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 8e-06
Identities = 41/155 (26%), Positives = 58/155 (37%), Gaps = 30/155 (19%)
Query: 602 ERLRLGNNKFIGKIPWTFGKIRELSLLDLSGNSLTGPIPTQLLMCKKLSHIDLNNNLLSG 661
L L N F ++ L+ L L GN L
Sbjct: 31 TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ------------------------- 65
Query: 662 AVPSWL-GTLPQLGELKLSFNQFVGFLPRELFNC-SKLLVLSLDGNMLNGSLPNEV-GNL 718
++P+ + L L L LS NQ LP +F+ ++L L+L+ N L SLP+ V L
Sbjct: 66 SLPNGVFNKLTSLTYLNLSTNQLQS-LPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKL 123
Query: 719 ASLNVLTLSGNLLSGPIPPAIGRLSKLYELRLSNN 753
L L L N L RL+ L + L +N
Sbjct: 124 TQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 7e-05
Identities = 32/113 (28%), Positives = 48/113 (42%), Gaps = 5/113 (4%)
Query: 719 ASLNVLTLSGNLLSGPIPPAIGRLSKLYELRLSNNSLNGVIPLEIGQLQNLQSILDLSHN 778
A L L N L L+ L +L L N L + +L +L L+LS N
Sbjct: 28 AQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLT-YLNLSTN 86
Query: 779 NFTGQIPPSM-GTLAKLEVLNLSHNQLVGELPSQL-GEMSSLGKLNLSYNDLQ 829
+P + L +L+ L L+ NQL LP + +++ L L L N L+
Sbjct: 87 QLQ-SLPNGVFDKLTQLKELALNTNQL-QSLPDGVFDKLTQLKDLRLYQNQLK 137
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 1e-04
Identities = 42/123 (34%), Positives = 55/123 (44%), Gaps = 6/123 (4%)
Query: 653 DLNNNLLSGAVPSWLGTLPQLGELKLSFNQFVGFLPRELFNC-SKLLVLSLDGNMLNGSL 711
DL N L L L +L L N+ LP +FN + L L+L N L SL
Sbjct: 34 DLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLSTNQLQ-SL 91
Query: 712 PNEV-GNLASLNVLTLSGNLLSGPIPP-AIGRLSKLYELRLSNNSLNGVIPLEIGQLQNL 769
PN V L L L L+ N L +P +L++L +LRL N L V +L +L
Sbjct: 92 PNGVFDKLTQLKELALNTNQLQS-LPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSL 150
Query: 770 QSI 772
Q I
Sbjct: 151 QYI 153
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 3e-04
Identities = 36/133 (27%), Positives = 49/133 (36%), Gaps = 10/133 (7%)
Query: 435 ELLYLYDNHLSGQIPSEVGNCSSLKWIDFFGNSFTGEIPTSI-GRLKDLNFLHLRQNELV 493
L L N L +SL + GN +P + +L L +L+L N+L
Sbjct: 31 TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLSTNQLQ 89
Query: 494 GQIPA----SLGNCHQLIILDLADNKLSGGVPASFGFLQALEQLMLYNNSLEGNLPGSLI 549
+P L QL L L N+L F L L+ L LY N L+ G
Sbjct: 90 -SLPNGVFDKLT---QLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFD 145
Query: 550 NLRNLTRINFSKN 562
L +L I N
Sbjct: 146 RLTSLQYIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 5e-04
Identities = 44/154 (28%), Positives = 60/154 (38%), Gaps = 33/154 (21%)
Query: 509 LDLADNKLSGGVPASFGFLQALEQLMLYNNSLEGNLPGSLINLRNLTRINFSKNRLNGRI 568
LDL N L F L +L QL L N L+ G L +LT +N S N+L
Sbjct: 33 LDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQL---- 88
Query: 569 ATLCSSHSFLSFDVTNNEFDHEIPPQLGNSPSLERLRLGNNKFIGKIPW-TFGKIRELSL 627
L V FD L L+ L L N+ + +P F K+ +L
Sbjct: 89 -------QSLPNGV----FDK-----LTQ---LKELALNTNQ-LQSLPDGVFDKLTQLKD 128
Query: 628 LDLSGNSLTGPIPT----QLLMCKKLSHIDLNNN 657
L L N L +P +L L +I L++N
Sbjct: 129 LRLYQNQLKS-VPDGVFDRL---TSLQYIWLHDN 158
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 9e-10
Identities = 33/112 (29%), Positives = 49/112 (43%), Gaps = 11/112 (9%)
Query: 363 KQLDLSNNTLNGTIPVELF-QLVALTHLYLHNNSLVGSISPFV-ANLSNLQELALYHNNF 420
+L L++N L LF +L L L L N L I P S++QEL L N
Sbjct: 32 TELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGASHIQELQLGENKI 90
Query: 421 QGSLPREIGM---LVKLELLYLYDNHLSGQIPSEV-GNCSSLKWIDFFGNSF 468
+ + M L +L+ L LYDN +S + + +SL ++ N F
Sbjct: 91 K-EISN--KMFLGLHQLKTLNLYDNQISC-VMPGSFEHLNSLTSLNLASNPF 138
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 1e-09
Identities = 33/105 (31%), Positives = 46/105 (43%), Gaps = 6/105 (5%)
Query: 242 QLLNLGNNSLSGEIPSE--LGELSQLGYLNLMGNRLEGAIPRSFAKMGNLQSLDLSMNRL 299
L L +N L I S+ G L L L L N+L G P +F ++Q L L N++
Sbjct: 32 TELLLNDNELG-RISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKI 90
Query: 300 TGGIPEE-FGNMGQLVFLVLSNNNISGSIPRRICTNATSLEHLIL 343
I + F + QL L L +N IS + + SL L L
Sbjct: 91 K-EISNKMFLGLHQLKTLNLYDNQIS-CVMPGSFEHLNSLTSLNL 133
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 4e-07
Identities = 30/133 (22%), Positives = 49/133 (36%), Gaps = 32/133 (24%)
Query: 290 QSLDLSMNRLTGGIPE-EFGNMGQLVFLVLSNNNISGSIPRRICTNATSLEHLILAEIQL 348
L L+ N L + FG + LV L L N ++ I A+ ++ L L E ++
Sbjct: 32 TELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGASHIQELQLGENKI 90
Query: 349 SGEIPVELSQCQSLKQLDLSNNTLNGTIPVELF-QLVALTHLYLHNNSLVGSISP--FVA 405
I ++F L L L L++N + + P F
Sbjct: 91 K-------------------------EISNKMFLGLHQLKTLNLYDNQI-SCVMPGSF-E 123
Query: 406 NLSNLQELALYHN 418
+L++L L L N
Sbjct: 124 HLNSLTSLNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 7e-06
Identities = 39/142 (27%), Positives = 56/142 (39%), Gaps = 35/142 (24%)
Query: 159 IPTSFGNLVNLGTLGLASCSLSGPIPPQFGQLSQLEELILQQNQLQGPIPAELGNCSSLS 218
IP L L L S G FG+L L +L L++NQL
Sbjct: 27 IPLHTTEL-LLNDNELGRISSDG----LFGRLPHLVKLELKRNQLT-------------- 67
Query: 219 IFTAAENNLNGSIPA-ALGRLQNLQLLNLGNNSLSGEIPSEL-GELSQLGYLNLMGNRLE 276
I A ++Q L LG N + EI +++ L QL LNL N++
Sbjct: 68 -----------GIEPNAFEGASHIQELQLGENKIK-EISNKMFLGLHQLKTLNLYDNQIS 115
Query: 277 GAIPR-SFAKMGNLQSLDLSMN 297
+ SF + +L SL+L+ N
Sbjct: 116 -CVMPGSFEHLNSLTSLNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 1e-05
Identities = 29/114 (25%), Positives = 49/114 (42%), Gaps = 13/114 (11%)
Query: 143 TSLRVMRIGDNWLSGSIPT-SFGNLVNLGTLGLASCSLSGPIPPQ-FGQLSQLEELILQQ 200
+ + DN L FG L +L L L L+G I P F S ++EL L +
Sbjct: 29 LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTG-IEPNAFEGASHIQELQLGE 87
Query: 201 NQLQGPIPA----ELGNCSSLSIFTAAENNLNGSIP-AALGRLQNLQLLNLGNN 249
N+++ I L +L+++ N ++ + + L +L LNL +N
Sbjct: 88 NKIKE-ISNKMFLGLHQLKTLNLYD---NQIS-CVMPGSFEHLNSLTSLNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 3e-04
Identities = 30/95 (31%), Positives = 47/95 (49%), Gaps = 10/95 (10%)
Query: 93 RLQSLIHLDLSSNSLTGPIPTALSNLSSLESLLLFSNQLAGTIPTQL-GSLTSLRVMRIG 151
RL L+ L+L N LTG P A S ++ L L N++ I ++ L L+ + +
Sbjct: 52 RLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIK-EISNKMFLGLHQLKTLNLY 110
Query: 152 DNWLSGSIPT-SFGNLVNLGTLGLA------SCSL 179
DN +S + SF +L +L +L LA +C L
Sbjct: 111 DNQIS-CVMPGSFEHLNSLTSLNLASNPFNCNCHL 144
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 9e-10
Identities = 63/392 (16%), Positives = 117/392 (29%), Gaps = 92/392 (23%)
Query: 225 NNLNGS-----IPAALGRLQNLQLLNLGNNSLSGEIPSELGEL-----SQLGYLNLMGNR 274
L + + L+L N+L EL + + + LNL GN
Sbjct: 3 YKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNS 62
Query: 275 LEGAIPRSFAKM-----GNLQSLDLSMNRLTGGIPEEFGNM-----GQLVFLVLSNNNIS 324
L ++ N+ SL+LS N L+ +E + L L N+ S
Sbjct: 63 LGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFS 122
Query: 325 GSIPRRICTNATSLEHLILAEIQLSGEIPVELSQC-QSLKQLDLSNNTLNGTIPVELFQL 383
+ S A S S+ L+L N L EL Q+
Sbjct: 123 ----------SKSSSEFKQA-----------FSNLPASITSLNLRGNDLGIKSSDELIQI 161
Query: 384 VA-----LTHLYLHNNSL----VGSISPFVANL-SNLQELALYHNNFQGSLPREIGMLVK 433
+A + L L N+L ++ F+A++ +++ L L N E+ +
Sbjct: 162 LAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFS 221
Query: 434 LELLYLYDNHLSGQIPSEVGNCSSLKWIDFFGNSFTGEIPTSIGRLKDLN----FLHLRQ 489
+ + ++ N G ++ LKD ++L
Sbjct: 222 -------------------SIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDY 262
Query: 490 NEL-------VGQIPASLGNCHQLIILDLADNKLS-GGVPASFGFLQ----ALEQLMLYN 537
+ + + A+ N ++I++D ++ ++ + L N
Sbjct: 263 DIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHSIPISNLIRELSGKADVPSLLN 322
Query: 538 NSL-----EGNLPGSLINLRNLTRINFSKNRL 564
L L L + L
Sbjct: 323 QCLIFAQKHQTNIEDLNIPDELRESIQTCKPL 354
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 4e-09
Identities = 63/394 (15%), Positives = 112/394 (28%), Gaps = 89/394 (22%)
Query: 74 VSLNLSGLSLAGSISPSLGRLQSLIHLDLSSNSLTGPIPTAL-----SNLSSLESLLLFS 128
++ L+ + + + LDLS N+L L + +S+ SL L
Sbjct: 1 MNYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSG 60
Query: 129 NQLAGTIPTQLGSL-----TSLRVMRIGDNWLSGSIPTSFGNLVNLGTLGLASCSLSGPI 183
N L +L + ++ + + N+LS LA+
Sbjct: 61 NSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVK-------TLAAIP----- 108
Query: 184 PPQFGQLSQLEELILQQNQLQGPIPAELGNCSSLSIFTAAENNLNGSIPAALGRLQNLQL 243
+ L L N S + ++
Sbjct: 109 -------FTITVLDLGWNDFS-----SKS-SSEFKQAFSNLP-------------ASITS 142
Query: 244 LNLGNNSLSGEIPSELGEL-----SQLGYLNLMGNRL--EGAIPRSFAKM-----GNLQS 291
LNL N L + EL ++ + + LNL GN L + AK ++ S
Sbjct: 143 LNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNC--AELAKFLASIPASVTS 200
Query: 292 LDLSMNRLTGGIPEEFG-----NMGQLVFLVLSNNNISGSIPRRIC---TNATSLEHLIL 343
LDLS N L E +V L L N + G + + L+ + L
Sbjct: 201 LDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYL 260
Query: 344 AEIQLSGEIPVE--------LSQCQSLKQLDLSNNTLNGTIPVELFQLVALTHLYLHNNS 395
+ + E Q + +D + ++ + + + L+ S
Sbjct: 261 DYDIV-KNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHSIPISNLIRELSGKADVPS 319
Query: 396 LVGSISPFVA----------NLSNLQELALYHNN 419
L+ F L+E
Sbjct: 320 LLNQCLIFAQKHQTNIEDLNIPDELRESIQTCKP 353
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 4e-05
Identities = 52/292 (17%), Positives = 93/292 (31%), Gaps = 53/292 (18%)
Query: 595 LGNSPSLERLRLGNNKFIGKIPWTF------GKIRELSLLDLSGNSLTGPIPTQL----- 643
+ L L N + I ++ L+LSGNSL +L
Sbjct: 18 TSIPHGVTSLDLSLNN-LYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILA 76
Query: 644 LMCKKLSHIDLNNNLLSGAVPSWLGTL-----PQLGELKLSFNQF----VGFLPRELFNC 694
+ ++ ++L+ N LS L + L L +N F + N
Sbjct: 77 AIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNL 136
Query: 695 -SKLLVLSLDGNMLN--------GSLPNEVGNLASLNVLTLSGNLLSGPIPPAIGRL--- 742
+ + L+L GN L L N+ SLN L GN L+ + +
Sbjct: 137 PASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLN---LRGNNLASKNCAELAKFLAS 193
Query: 743 --SKLYELRLSNNSLN--GVIPLEIGQLQNLQSI--LDLSHNNFTGQ----IPPSMGTLA 792
+ + L LS N L L + L+L N G + +L
Sbjct: 194 IPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLK 253
Query: 793 KLEVLNLSHNQL-------VGELPSQLGEMSSLGKLNLSYNDLQGKLSKQFS 837
L+ + L ++ + L + + + ++ + ++ S S
Sbjct: 254 HLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHSIPIS 305
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 3e-04
Identities = 60/399 (15%), Positives = 116/399 (29%), Gaps = 98/399 (24%)
Query: 485 LHLRQNELVGQ--IPASLGNCHQLIILDLADNKLSG-GVPASFGFLQA----LEQLMLYN 537
++ + G + H + LDL+ N L + L L
Sbjct: 1 MNYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSG 60
Query: 538 NSLEGNLPGSLI-----NLRNLTRINFSKNRLNGRIAT-----LCSSHSFL-SFDVTNNE 586
NSL L+ N+T +N S N L+ + + L + + D+ N+
Sbjct: 61 NSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWND 120
Query: 587 FDHEIPPQLG-----NSPSLERLRLGNNKF-----------IGKIPWTFGKIRELSLLDL 630
F + + S+ L L N + IP ++ L+L
Sbjct: 121 FSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPAN------VNSLNL 174
Query: 631 SGNSLTGPIPTQLL------MCKKLSHIDLNNNLLSGAVPSWLGTL-----PQLGELKLS 679
GN+L L + ++ +DL+ NLL + L + + L L
Sbjct: 175 RGNNL-ASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLC 233
Query: 680 FNQF----VGFLPRELFNCSKLLVLSLDGNMLNGSLPNEVGNLASLNVLTLSGNLLSGPI 735
N + L + L + LD +++ + L +
Sbjct: 234 LNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGA--------------- 278
Query: 736 PPAIGRLSKLYELRLSNNSLNGVIPLEIGQLQNLQSILDLSHNNFTGQIPPSMGTLAKLE 795
A + K+ + + ++ + I L + + K +
Sbjct: 279 --AFPNIQKIILVDKNGKEIHPSHSIPISNL--------IRELSG------------KAD 316
Query: 796 VLNLSHNQLVGELPSQLGEM-----SSLGKLNLSYNDLQ 829
V +L + L+ Q L + + L
Sbjct: 317 VPSLLNQCLIFAQKHQTNIEDLNIPDELRESIQTCKPLL 355
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 56.7 bits (137), Expect = 3e-09
Identities = 33/133 (24%), Positives = 51/133 (38%), Gaps = 28/133 (21%)
Query: 238 LQNLQLLNLGNNSLSGEIPSELGELSQLGYLNLMGNRLEGAIPRSFAKMGNLQSLDLSMN 297
++ L L N +N G+I E L +L+L+ L + K+ L+ L+LS N
Sbjct: 26 VRELVLDNCKSND--GKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSEN 81
Query: 298 RLTGGIPEEFGNMGQLVFLVLSNNNISGSIPRRICTNATSLEHLILAEIQLSGEIPVELS 357
R+ GG+ + L L LS N + + L L
Sbjct: 82 RIFGGLDMLAEKLPNLTHLNLSGNKLK------------DISTLE------------PLK 117
Query: 358 QCQSLKQLDLSNN 370
+ + LK LDL N
Sbjct: 118 KLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 4e-07
Identities = 30/105 (28%), Positives = 48/105 (45%), Gaps = 5/105 (4%)
Query: 316 LVLSNNNISGSIPRRICTNATSLEHLILAEIQLSGEIPVELSQCQSLKQLDLSNNTLNGT 375
LVL N + + +LE L L + L + L + LK+L+LS N + G
Sbjct: 29 LVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SVSN-LPKLPKLKKLELSENRIFGG 86
Query: 376 IPVELFQLVALTHLYLHNNSL--VGSISPFVANLSNLQELALYHN 418
+ + +L LTHL L N L + ++ P L L+ L L++
Sbjct: 87 LDMLAEKLPNLTHLNLSGNKLKDISTLEPL-KKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 49.4 bits (118), Expect = 8e-07
Identities = 26/112 (23%), Positives = 46/112 (41%), Gaps = 6/112 (5%)
Query: 334 NATSLEHLILAEIQLS-GEIPVELSQCQSLKQLDLSNNTLNGTIPVELFQLVALTHLYLH 392
++ L+L + + G+I ++ +L+ L L N L + +L L L L
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISVSNLP--KLPKLKKLELS 79
Query: 393 NNSLVGSISPFVANLSNLQELALYHNNFQ--GSLPREIGMLVKLELLYLYDN 442
N + G + L NL L L N + +L + L L+ L L++
Sbjct: 80 ENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTL-EPLKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 2e-06
Identities = 30/113 (26%), Positives = 50/113 (44%), Gaps = 4/113 (3%)
Query: 190 LSQLEELILQQNQLQ-GPIPAELGNCSSLSIFTAAENNLNGSIPAALGRLQNLQLLNLGN 248
+ + EL+L + G I +L + L S+ + L +L L+ L L
Sbjct: 23 PAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SV-SNLPKLPKLKKLELSE 80
Query: 249 NSLSGEIPSELGELSQLGYLNLMGNRLEG-AIPRSFAKMGNLQSLDLSMNRLT 300
N + G + +L L +LNL GN+L+ + K+ L+SLDL +T
Sbjct: 81 NRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVT 133
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 5e-06
Identities = 28/111 (25%), Positives = 38/111 (34%), Gaps = 4/111 (3%)
Query: 597 NSPSLERLRLGNNKF-IGKIPWTFGKIRELSLLDLSGNSLTGPIPTQLLMCKKLSHIDLN 655
++ L L N K GKI + L L L L + L KL ++L+
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI--SVSNLPKLPKLKKLELS 79
Query: 656 NNLLSGAVPSWLGTLPQLGELKLSFNQFVGFLP-RELFNCSKLLVLSLDGN 705
N + G + LP L L LS N+ L L L L
Sbjct: 80 ENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 5e-06
Identities = 31/112 (27%), Positives = 42/112 (37%), Gaps = 9/112 (8%)
Query: 621 KIRELSLLDLSGNSLTGPIPTQLLMCKKLSHIDLNNNLLSGAVPSWLGTLPQLGELKLSF 680
+REL L D ++ G I L + L N L L LP+L +L+LS
Sbjct: 25 AVRELVL-DNCKSND-GKIEGLTAEFVNLEFLSLINVGLISVSN--LPKLPKLKKLELSE 80
Query: 681 NQFVGFLPRELFNCSKLLVLSLDGNMLNGSLPNEVGNLA---SLNVLTLSGN 729
N+ G L L L+L GN L + + L L L L
Sbjct: 81 NRIFGGLDMLAEKLPNLTHLNLSGNKL--KDISTLEPLKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 46.3 bits (110), Expect = 9e-06
Identities = 29/116 (25%), Positives = 50/116 (43%), Gaps = 7/116 (6%)
Query: 693 NCSKLLVLSLDGNMLN-GSLPNEVGNLASLNVLTLSGNLLSGPIPPAIGRLSKLYELRLS 751
+ + L LD N G + +L L+L L + + +L KL +L LS
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLIS-VSN-LPKLPKLKKLELS 79
Query: 752 NNSLNGVIPLEIGQLQNLQSILDLSHNNFT--GQIPPSMGTLAKLEVLNLSHNQLV 805
N + G + + +L NL L+LS N + P + L L+ L+L + ++
Sbjct: 80 ENRIFGGLDMLAEKLPNLT-HLNLSGNKLKDISTLEP-LKKLECLKSLDLFNCEVT 133
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 46.3 bits (110), Expect = 1e-05
Identities = 33/139 (23%), Positives = 53/139 (38%), Gaps = 13/139 (9%)
Query: 385 ALTHLYLHNNSL-VGSISPFVANLSNLQELALYHNNFQ--GSLPREIGMLVKLELLYLYD 441
A+ L L N G I A NL+ L+L + +LP+ L KL+ L L +
Sbjct: 25 AVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISVSNLPK----LPKLKKLELSE 80
Query: 442 NHLSGQIPSEVGNCSSLKWIDFFGNSFT--GEIPTSIGRLKDLNFLHLRQNELVGQI--- 496
N + G + +L ++ GN + + +L+ L L L E+
Sbjct: 81 NRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTL-EPLKKLECLKSLDLFNCEVTNLNDYR 139
Query: 497 PASLGNCHQLIILDLADNK 515
+ QL LD D +
Sbjct: 140 ESVFKLLPQLTYLDGYDRE 158
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 43.6 bits (103), Expect = 8e-05
Identities = 23/87 (26%), Positives = 37/87 (42%), Gaps = 4/87 (4%)
Query: 479 LKDLNFLHLRQNELVGQIPASLGNCHQLIILDLADNKLSGGVPASFGFLQALEQLMLYNN 538
+++L L ++ G+I L L L + L ++ L L++L L N
Sbjct: 26 VRELV-LDNCKSND-GKIEGLTAEFVNLEFLSLINVGLI--SVSNLPKLPKLKKLELSEN 81
Query: 539 SLEGNLPGSLINLRNLTRINFSKNRLN 565
+ G L L NLT +N S N+L
Sbjct: 82 RIFGGLDMLAEKLPNLTHLNLSGNKLK 108
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 3e-04
Identities = 27/90 (30%), Positives = 41/90 (45%), Gaps = 4/90 (4%)
Query: 741 RLSKLYELRLSNNSLN-GVIPLEIGQLQNLQSILDLSHNNFTGQIPPSMGTLAKLEVLNL 799
+ + EL L N N G I + NL+ L L + + + L KL+ L L
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLE-FLSLINVGLI-SVSN-LPKLPKLKKLEL 78
Query: 800 SHNQLVGELPSQLGEMSSLGKLNLSYNDLQ 829
S N++ G L ++ +L LNLS N L+
Sbjct: 79 SENRIFGGLDMLAEKLPNLTHLNLSGNKLK 108
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 60.0 bits (145), Expect = 3e-09
Identities = 53/223 (23%), Positives = 87/223 (39%), Gaps = 43/223 (19%)
Query: 954 IGSGGSGTVYKAE-LANGATVAVKKISCKDDHLLNKSFTREVKTLGRIR-HRHLVKLMGH 1011
IGSG G +Y + VA+K + K H E K ++ + +
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH---PQLLYESKIYRILQGGTGIPNV--R 69
Query: 1012 CCNKGAGSNLLIYEYMENG-SVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHH 1070
N+L+ + + G S+ D + + L + L +A + VE++H
Sbjct: 70 WFGVEGDYNVLVMDLL--GPSLEDLFNFCS------RKLSLKTVLMLADQMINRVEFVHS 121
Query: 1071 DCVPKILHRDIKSSNILLDSNMEAH---LGDFGLAKALVEDYNSNTES------NTWFAG 1121
LHRDIK N L+ A+ + DFGLAK +++T N G
Sbjct: 122 KS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY---RDTSTHQHIPYRENKNLTG 175
Query: 1122 SYGYIAPEYAYSLKA------TEKCDVYSMGIVLMELVSGKMP 1158
+ YA S+ + + D+ S+G VLM + G +P
Sbjct: 176 T-----ARYA-SVNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 59.4 bits (144), Expect = 3e-09
Identities = 44/243 (18%), Positives = 79/243 (32%), Gaps = 63/243 (25%)
Query: 954 IGSGGSGTVYKA------ELANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVK 1007
IG GG G +Y A + + A VK + L E+K R ++
Sbjct: 43 IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFT-----ELKFYQRAAKPEQIQ 97
Query: 1008 LM-----------------GHCCNKGAGSNLLIYEYMENG-SVWDWLHKQPVNIKMRKSL 1049
G G +I + G + K
Sbjct: 98 KWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQKIYEANA------KRF 149
Query: 1050 DWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNME--AHLGDFGLAKALVE 1107
+ L++++ + +EY+H +H DIK+SN+LL+ +L D+GLA
Sbjct: 150 SRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAY---R 203
Query: 1108 DYNSNTE------SNTWFAGSYGYIAPEYAYSLKATEKC------DVYSMGIVLMELVSG 1155
G+ E+ S+ A D+ +G +++ ++G
Sbjct: 204 YCPEGVHKAYAADPKRCHDGT-----IEFT-SIDAHNGVAPSRRGDLEILGYCMIQWLTG 257
Query: 1156 KMP 1158
+P
Sbjct: 258 HLP 260
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 4e-09
Identities = 54/277 (19%), Positives = 93/277 (33%), Gaps = 74/277 (26%)
Query: 953 IIGSGGSGTVYKAE-LANGATVAVKKISCKDDHLLNKSFTR----EVKTLGRIRHR---- 1003
+G G G V + + N AVK + ++ K +TR E L +I++
Sbjct: 42 KMGDGTFGRVLLCQHIDNKKYYAVKVV--RN----IKKYTRSAKIEADILKKIQNDDINN 95
Query: 1004 -HLVKLM------GHCCNKGAGSNLLIYEYMENGSVWDWL---HKQPVNIKMRKSLDWEA 1053
++VK H C LI+E + S+++ + + +I+ K
Sbjct: 96 NNIVKYHGKFMYYDHMC--------LIFEPLGP-SLYEIITRNNYNGFHIEDIK------ 140
Query: 1054 RLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNT 1113
+ + + + YL + H D+K NILLD +
Sbjct: 141 --LYCIEILKALNYLR-KM--SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYR 195
Query: 1114 ESNTW-----FAGS--------YGYI------APEYAYSLKATEKCDVYSMGIVLMELVS 1154
+T F G I APE +L D++S G VL EL +
Sbjct: 196 TKSTGIKLIDF-GCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYT 254
Query: 1155 GKM--PTDATFGVEMDMVRWVEMHMEMSGSAREELLD 1189
G + T M+ + M + + +L
Sbjct: 255 GSLLFRTHE----HMEHLA---MMESIIQPIPKNMLY 284
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 | Back alignment and structure |
|---|
Score = 58.7 bits (142), Expect = 5e-09
Identities = 51/250 (20%), Positives = 88/250 (35%), Gaps = 10/250 (4%)
Query: 171 TLGLASCSLSGPIPPQFGQLSQLEELILQQNQLQGPIPAELGNCSSLSIFTAAENNLNGS 230
TL L +L + + + ++ + P+ + + +
Sbjct: 51 TLDLTGKNLHPDVTGRLLSQGVIA-FRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVST 109
Query: 231 IPAALGRLQNLQLLNLGNNSLSGEIPSELGELSQLGYLNLMGNRL--EGAIPRSFAKMGN 288
+ L + LQ L+L LS I + L + S L LNL G E A+ +
Sbjct: 110 LHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSR 169
Query: 289 LQSLDLS-MNRLT-GGIPEEFG-NMGQLVFLVLS--NNNISGSIPRRICTNATSLEHLIL 343
L L+LS T + + L LS N+ S + +L HL L
Sbjct: 170 LDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDL 229
Query: 344 AE-IQLSGEIPVELSQCQSLKQLDLSNNT-LNGTIPVELFQLVALTHLYLHNNSLVGSIS 401
++ + L + E Q L+ L LS + +EL ++ L L + G++
Sbjct: 230 SDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQ 289
Query: 402 PFVANLSNLQ 411
L +LQ
Sbjct: 290 LLKEALPHLQ 299
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 | Back alignment and structure |
|---|
Score = 45.6 bits (108), Expect = 7e-05
Identities = 43/227 (18%), Positives = 75/227 (33%), Gaps = 28/227 (12%)
Query: 312 QLVFLVLSNNNISGSIPRRICTNATSLEHLILAEIQLSGEIPVELSQCQSLKQLDLSNNT 371
++ + LSN+ I S I + + L++L L ++LS I L++ +L +L+LS +
Sbjct: 94 RVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCS 153
Query: 372 L--NGTIPVELFQLVALTHLYLHNNSLVGSISPFVA---NLSNLQELALYHNNFQGSLPR 426
+ L L L L VA + +L L
Sbjct: 154 GFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKN----- 208
Query: 427 EIGMLVKLELLYLYDNHLSGQIPSEVGNCSSLKWIDFFGNSF-TGEIPTSIGRLKDLNFL 485
L + LS + V C +L +D + + +L L L
Sbjct: 209 ------------LQKSDLS----TLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHL 252
Query: 486 HLRQNELVG-QIPASLGNCHQLIILDLADNKLSGGVPASFGFLQALE 531
L + + + LG L L + G + L L+
Sbjct: 253 SLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEALPHLQ 299
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 | Back alignment and structure |
|---|
Score = 43.3 bits (102), Expect = 3e-04
Identities = 46/245 (18%), Positives = 80/245 (32%), Gaps = 42/245 (17%)
Query: 69 SSARVVSLNLSGLSL-AGSISPSLGRLQSLIHLDLSSNSLTGPIPTALSNLSSLESLLL- 126
S RV ++LS + ++ L + L +L L L+ PI L+ S+L L L
Sbjct: 91 SPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLS 150
Query: 127 ----FSNQLAGTIPTQLGSLTSLRV---MRIGDNWLSGSIPTSFGNLVNLGTLGLASCSL 179
FS T+ + L L + + + ++ + L L+
Sbjct: 151 GCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETIT---QLNLSGYRK 207
Query: 180 S---GPIPPQFGQLSQLEELILQQNQLQGPIPAELGNCSSLSIFTAAENNLNGSIPAALG 236
+ + + L L +L + L N
Sbjct: 208 NLQKSDLSTLVRRCPNLVHL-------------DLSDSVMLK---------NDCF-QEFF 244
Query: 237 RLQNLQLLNL-GNNSLSGEIPSELGELSQLGYLNLMGNRLEGAIPRSFAKMGNLQSLDLS 295
+L LQ L+L + E ELGE+ L L + G +G + L L ++
Sbjct: 245 QLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKE---ALPHLQIN 301
Query: 296 MNRLT 300
+ T
Sbjct: 302 CSHFT 306
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 | Back alignment and structure |
|---|
Score = 42.2 bits (99), Expect = 7e-04
Identities = 52/246 (21%), Positives = 83/246 (33%), Gaps = 13/246 (5%)
Query: 567 RIATLCSSHSFLSFDVTNNEFDHEIPPQLGNSPSLERLRLGNNKFIGKIPWTFGKIRELS 626
R L S S + H S + R + + F R +
Sbjct: 38 RWYRLASDESLWQTLDLTGKNLHPDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFR-VQ 96
Query: 627 LLDLSGNSLT-GPIPTQLLMCKKLSHIDLNNNLLSGAVPSWLGTLPQLGELKLSFNQFV- 684
+DLS + + + L C KL ++ L LS + + L L L LS
Sbjct: 97 HMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFS 156
Query: 685 -GFLPRELFNCSKLLVLSLDG------NMLNGSLPNEVGNLASLNVLTLSGNLLSGPIPP 737
L L +CS+L L+L + ++ + + LN+ NL +
Sbjct: 157 EFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLST 216
Query: 738 AIGRLSKLYELRLSN-NSLNGVIPLEIGQLQNLQSILDLSH-NNFTGQIPPSMGTLAKLE 795
+ R L L LS+ L E QL LQ L LS + + +G + L+
Sbjct: 217 LVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQH-LSLSRCYDIIPETLLELGEIPTLK 275
Query: 796 VLNLSH 801
L +
Sbjct: 276 TLQVFG 281
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 5e-09
Identities = 33/114 (28%), Positives = 50/114 (43%), Gaps = 9/114 (7%)
Query: 231 IPAALGRLQNLQLLNLGNNSLSGEIPSELGELSQLGYLNLMGNRLEGAIPRSFAKMGNLQ 290
IP+ + L L +N L +L+QL L+L N+++ F K+ L
Sbjct: 26 IPS------SATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLT 79
Query: 291 SLDLSMNRLTGGIPEE-FGNMGQLVFLVLSNNNISGSIPRRICTNATSLEHLIL 343
L L N+L +P F + QL L L N + S+P I TSL+ + L
Sbjct: 80 ILYLHENKLQ-SLPNGVFDKLTQLKELALDTNQLK-SVPDGIFDRLTSLQKIWL 131
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 55.3 bits (134), Expect = 8e-09
Identities = 41/120 (34%), Positives = 61/120 (50%), Gaps = 9/120 (7%)
Query: 326 SIPRRICTNATSLEHLILAEIQLSGEIPVELSQCQSLKQLDLSNNTLNGTIPVELF-QLV 384
S+P I ++AT LE L +L + L +L LS N + ++P +F +L
Sbjct: 21 SVPTGIPSSATRLE---LESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLT 76
Query: 385 ALTHLYLHNNSLVGSISPFV-ANLSNLQELALYHNNFQGSLPREI-GMLVKLELLYLYDN 442
LT LYLH N L S+ V L+ L+ELAL N + S+P I L L+ ++L+ N
Sbjct: 77 KLTILYLHENKL-QSLPNGVFDKLTQLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 134
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 8e-06
Identities = 43/155 (27%), Positives = 58/155 (37%), Gaps = 39/155 (25%)
Query: 101 DLSSNSLTG-P--IPTALSNLSSLESLLLFSNQLAGTIPTQLGSLTSLRVMRIGDNWLSG 157
+S LT P IP+ S L L SN+L LT L + + N +
Sbjct: 13 RCNSKGLTSVPTGIPS------SATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ- 65
Query: 158 SIPTS-FGNLVNLGTLGLASCSLSGPIPP-QFGQLSQLEELILQQNQLQGPIPAELGNCS 215
S+P F L L L L L +P F +L+QL+EL L NQL+
Sbjct: 66 SLPDGVFDKLTKLTILYLHENKLQS-LPNGVFDKLTQLKELALDTNQLK----------- 113
Query: 216 SLSIFTAAENNLNGSIP-AALGRLQNLQLLNLGNN 249
S+P RL +LQ + L N
Sbjct: 114 --------------SVPDGIFDRLTSLQKIWLHTN 134
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 7e-05
Identities = 38/118 (32%), Positives = 48/118 (40%), Gaps = 12/118 (10%)
Query: 638 PIPTQLLMCKKLSHIDLNNNLLSGAVPSWLGTLPQLGELKLSFNQFVGFLPRELFNC-SK 696
P L +L +N L L QL +L LS NQ LP +F+ +K
Sbjct: 27 PSSATRL--------ELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTK 77
Query: 697 LLVLSLDGNMLNGSLPNEV-GNLASLNVLTLSGNLLSGPIPPAIGRLSKLYELRLSNN 753
L +L L N L SLPN V L L L L N L RL+ L ++ L N
Sbjct: 78 LTILYLHENKLQ-SLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 134
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 1e-04
Identities = 32/114 (28%), Positives = 53/114 (46%), Gaps = 30/114 (26%)
Query: 187 FGQLSQLEELILQQNQLQGPIPAELGNCSSLSIFTAAENNLNGSIPAAL-GRLQNLQLLN 245
F +L+QL +L L QNQ+Q S+P + +L L +L
Sbjct: 48 FDKLTQLTKLSLSQNQIQ-------------------------SLPDGVFDKLTKLTILY 82
Query: 246 LGNNSLSGEIPSEL-GELSQLGYLNLMGNRLEGAIPR-SFAKMGNLQSLDLSMN 297
L N L +P+ + +L+QL L L N+L+ ++P F ++ +LQ + L N
Sbjct: 83 LHENKLQ-SLPNGVFDKLTQLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 134
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 5e-09
Identities = 44/239 (18%), Positives = 81/239 (33%), Gaps = 55/239 (23%)
Query: 954 IGSGGSGTVYKAE---------LANGATVAVKKISCKDDHLLN--KSFTREVK------- 995
G +Y+A ++K + KD L N F R K
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-LDAKDGRLFNEQNFFQRAAKPLQVNKW 108
Query: 996 -TLGRIRHRHLVKLMGHCCNKGAGSNLLIYEYMENG-SVWDWLHKQPVNIKMRKSLDWEA 1053
L + MG ++ L+ + G S+ L P + L +
Sbjct: 109 KKLYSTPLLAIPTCMGFGVHQDK-YRFLVLPSL--GRSLQSALDVSP-----KHVLSERS 160
Query: 1054 RLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEA--HLGDFGLAKALVEDYNS 1111
L++A L +E+LH + +H ++ + NI +D ++ L +G A S
Sbjct: 161 VLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAF---RYCPS 214
Query: 1112 NT------ESNTWFAGSYGYIAPEYAYSLKATEKC------DVYSMGIVLMELVSGKMP 1158
S + G E+ S+ + C D+ S+G +++ + G +P
Sbjct: 215 GKHVAYVEGSRSPHEG-----DLEFI-SMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLP 267
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 5e-09
Identities = 45/230 (19%), Positives = 82/230 (35%), Gaps = 55/230 (23%)
Query: 954 IGSGGSGTVYKAE-LANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMG-- 1010
IG G G + + L VA+K K E + + L G
Sbjct: 17 IGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA---PQLHLEYRFY-----KQLGSGDGIP 68
Query: 1011 --HCCNKGAGSNLLIYEYMENG-SVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEY 1067
+ N ++ E + G S+ D ++ + L IA+ L +EY
Sbjct: 69 QVYYFGPCGKYNAMVLELL--GPSLEDLFDLCD------RTFSLKTVLMIAIQLISRMEY 120
Query: 1068 LHHDCVPKILHRDIKSSNILL------DSNMEAHLGDFGLAKALVEDY-NSNTES----- 1115
+H +++RD+K N L+ + H+ DF LAK +Y + T+
Sbjct: 121 VHSKN---LIYRDVKPENFLIGRPGNKTQQV-IHIIDFALAK----EYIDPETKKHIPYR 172
Query: 1116 -NTWFAGSYGYIAPEYAYSLKA------TEKCDVYSMGIVLMELVSGKMP 1158
+ G+ Y S+ + + D+ ++G + M + G +P
Sbjct: 173 EHKSLTGT-----ARYM-SINTHLGKEQSRRDDLEALGHMFMYFLRGSLP 216
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 6e-09
Identities = 31/136 (22%), Positives = 51/136 (37%), Gaps = 34/136 (25%)
Query: 238 LQNLQLLNLGNNSLSGEIPSELGELSQLGYLNLMGN---RLEGAIPRSFAKMGNLQSLDL 294
++ L L N +N G++ E +L +L+ + + K+ L+ L+L
Sbjct: 19 VKELVLDNSRSNE--GKLEGLTDEFEELEFLSTINVGLTSIAN-----LPKLNKLKKLEL 71
Query: 295 SMNRLTGGIPEEFGNMGQLVFLVLSNNNISGSIPRRICTNATSLEHLILAEIQLSGEIPV 354
S NR++GG+ L L LS N I L +
Sbjct: 72 SDNRVSGGLEVLAEKCPNLTHLNLSGNKIK------------DLSTIE------------ 107
Query: 355 ELSQCQSLKQLDLSNN 370
L + ++LK LDL N
Sbjct: 108 PLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 3e-07
Identities = 25/111 (22%), Positives = 46/111 (41%), Gaps = 4/111 (3%)
Query: 334 NATSLEHLILAEIQLS-GEIPVELSQCQSLKQLDLSNNTLNGTIPVELFQLVALTHLYLH 392
+ ++ L+L + + G++ + + L+ L N L +I L +L L L L
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SIAN-LPKLNKLKKLELS 72
Query: 393 NNSLVGSISPFVANLSNLQELALYHNNFQG-SLPREIGMLVKLELLYLYDN 442
+N + G + NL L L N + S + L L+ L L++
Sbjct: 73 DNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 6e-07
Identities = 31/105 (29%), Positives = 50/105 (47%), Gaps = 5/105 (4%)
Query: 316 LVLSNNNISGSIPRRICTNATSLEHLILAEIQLSGEIPVELSQCQSLKQLDLSNNTLNGT 375
LVL N+ + + LE L + L+ I L + LK+L+LS+N ++G
Sbjct: 22 LVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SIAN-LPKLNKLKKLELSDNRVSGG 79
Query: 376 IPVELFQLVALTHLYLHNNSL--VGSISPFVANLSNLQELALYHN 418
+ V + LTHL L N + + +I P L NL+ L L++
Sbjct: 80 LEVLAEKCPNLTHLNLSGNKIKDLSTIEPL-KKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 6e-07
Identities = 32/113 (28%), Positives = 53/113 (46%), Gaps = 4/113 (3%)
Query: 190 LSQLEELILQQNQLQ-GPIPAELGNCSSLSIFTAAENNLNGSIPAALGRLQNLQLLNLGN 248
S ++EL+L ++ G + L + L SI A L +L L+ L L +
Sbjct: 16 PSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLELSD 73
Query: 249 NSLSGEIPSELGELSQLGYLNLMGNRLEG-AIPRSFAKMGNLQSLDLSMNRLT 300
N +SG + + L +LNL GN+++ + K+ NL+SLDL +T
Sbjct: 74 NRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVT 126
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 9e-07
Identities = 31/132 (23%), Positives = 45/132 (34%), Gaps = 7/132 (5%)
Query: 359 CQSLKQLDLSNNTLN-GTIPVELFQLVALTHLYLHNNSLVGSISPFVANLSNLQELALYH 417
+K+L L N+ N G + + L L N L SI+ L+ L++L L
Sbjct: 16 PSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SIANL-PKLNKLKKLELSD 73
Query: 418 NNFQGSLPREIGMLVKLELLYLYDNHLSG-QIPSEVGNCSSLKWIDFFGNSFTGEI---P 473
N G L L L L N + + +LK +D F T
Sbjct: 74 NRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRE 133
Query: 474 TSIGRLKDLNFL 485
L L +L
Sbjct: 134 NVFKLLPQLTYL 145
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 4e-06
Identities = 31/115 (26%), Positives = 50/115 (43%), Gaps = 11/115 (9%)
Query: 693 NCSKLLVLSLDGNMLN-GSLPNEVGNLASLNVLTLSGNLLS--GPIPPAIGRLSKLYELR 749
S + L LD + N G L L L+ L+ +P +L+KL +L
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSIANLP----KLNKLKKLE 70
Query: 750 LSNNSLNGVIPLEIGQLQNLQSILDLSHNNFT--GQIPPSMGTLAKLEVLNLSHN 802
LS+N ++G + + + NL L+LS N I P + L L+ L+L +
Sbjct: 71 LSDNRVSGGLEVLAEKCPNLT-HLNLSGNKIKDLSTIEP-LKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 7e-06
Identities = 28/115 (24%), Positives = 46/115 (40%), Gaps = 9/115 (7%)
Query: 618 TFGKIRELSLLDLSGNSLTGPIPTQLLMCKKLSHIDLNNNLLSGAVPSWLGTLPQLGELK 677
T ++EL L + N G + ++L + N L+ + L L +L +L+
Sbjct: 15 TPSDVKELVLDNSRSNE--GKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLE 70
Query: 678 LSFNQFVGFLPRELFNCSKLLVLSLDGNMLNGSLPNEVGNLA---SLNVLTLSGN 729
LS N+ G L C L L+L GN + + + L +L L L
Sbjct: 71 LSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKD--LSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 8e-06
Identities = 27/111 (24%), Positives = 40/111 (36%), Gaps = 4/111 (3%)
Query: 597 NSPSLERLRLGNNKF-IGKIPWTFGKIRELSLLDLSGNSLTGPIPTQLLMCKKLSHIDLN 655
++ L L N++ GK+ + EL L LT L KL ++L+
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT--SIANLPKLNKLKKLELS 72
Query: 656 NNLLSGAVPSWLGTLPQLGELKLSFNQFVGFL-PRELFNCSKLLVLSLDGN 705
+N +SG + P L L LS N+ L L L L
Sbjct: 73 DNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 3e-05
Identities = 26/92 (28%), Positives = 41/92 (44%), Gaps = 8/92 (8%)
Query: 741 RLSKLYELRLSNNSLN-GVIPLEIGQLQNLQSILDLSHNNFT--GQIPPSMGTLAKLEVL 797
S + EL L N+ N G + + + L+ L + T +P L KL+ L
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELE-FLSTINVGLTSIANLP----KLNKLKKL 69
Query: 798 NLSHNQLVGELPSQLGEMSSLGKLNLSYNDLQ 829
LS N++ G L + +L LNLS N ++
Sbjct: 70 ELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIK 101
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 1e-04
Identities = 23/89 (25%), Positives = 39/89 (43%), Gaps = 8/89 (8%)
Query: 479 LKDLNFLHLRQNELVGQIPASLGNCHQLIILDLADNKLS--GGVPASFGFLQALEQLMLY 536
+K+L + R NE G++ +L L + L+ +P L L++L L
Sbjct: 19 VKELVLDNSRSNE--GKLEGLTDEFEELEFLSTINVGLTSIANLPK----LNKLKKLELS 72
Query: 537 NNSLEGNLPGSLINLRNLTRINFSKNRLN 565
+N + G L NLT +N S N++
Sbjct: 73 DNRVSGGLEVLAEKCPNLTHLNLSGNKIK 101
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 4e-04
Identities = 26/111 (23%), Positives = 46/111 (41%), Gaps = 4/111 (3%)
Query: 454 NCSSLKWIDFFGNSFT-GEIPTSIGRLKDLNFLHLRQNELVGQIPASLGNCHQLIILDLA 512
S +K + + G++ ++L FL L I A+L ++L L+L+
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLELS 72
Query: 513 DNKLSGGVPASFGFLQALEQLMLYNNSLEG-NLPGSLINLRNLTRINFSKN 562
DN++SGG+ L L L N ++ + L L NL ++
Sbjct: 73 DNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 6e-04
Identities = 35/114 (30%), Positives = 51/114 (44%), Gaps = 9/114 (7%)
Query: 669 TLPQLGELKLSFNQF-VGFLPRELFNCSKLLVLSLDGNMLNGSLPNEVGNLASLNVLTLS 727
T + EL L ++ G L +L LS L S+ N + L L L LS
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SIAN-LPKLNKLKKLELS 72
Query: 728 GNLLSGPIPPAIGRLSKLYELRLSNN---SLNGVIPLEIGQLQNLQSILDLSHN 778
N +SG + + L L LS N L+ + PL+ +L+NL+S LDL +
Sbjct: 73 DNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLK--KLENLKS-LDLFNC 123
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 7e-09
Identities = 45/236 (19%), Positives = 81/236 (34%), Gaps = 52/236 (22%)
Query: 954 IGSGGSGTVYKAE-LANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLM--- 1009
IGSGG G +Y A A + + N E+K R+ + +K
Sbjct: 45 IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQE--NGPLFSELKFYQRVAKKDCIKKWIER 102
Query: 1010 --------------GHCCNKGAGSNLLIYEYMENG-SVWDWLHKQPVNIKMRKSLDWEAR 1054
G KG ++ E + G + +
Sbjct: 103 KQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQKIS-------GQNGTFKKSTV 153
Query: 1055 LKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNME--AHLGDFGLAKALVEDYNSN 1112
L++ + + +EY+H + +H DIK++N+LL +L D+GL+ ++
Sbjct: 154 LQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYC-PNGNH 209
Query: 1113 TE----SNTWFAGSYGYIAPEYAYSLKATEKC------DVYSMGIVLMELVSGKMP 1158
+ G E+ SL A + DV +G ++ + GK+P
Sbjct: 210 KQYQENPRKGHNG-----TIEFT-SLDAHKGVALSRRSDVEILGYCMLRWLCGKLP 259
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 2e-08
Identities = 53/341 (15%), Positives = 108/341 (31%), Gaps = 103/341 (30%)
Query: 953 IIGSGGSGTVYKA--ELANGATVAVKKISCKDDHLLNKSFTR----EVKTLGRIRHR--- 1003
+G G G V + + VA+K I ++ + E+ L +I+ +
Sbjct: 26 NLGEGTFGKVVECLDHARGKSQVALKII--RN----VGKYREAARLEINVLKKIKEKDKE 79
Query: 1004 ---HLVKLM------GHCC--NKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWE 1052
V + GH C + G N +E+++ + QP + +
Sbjct: 80 NKFLCVLMSDWFNFHGHMCIAFELLGKNT--FEFLKENN------FQPYPLPHVR----- 126
Query: 1053 ARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSN 1112
+A L + +LH ++ H D+K NIL ++ L + + N++
Sbjct: 127 ---HMAYQLCHALRFLHE---NQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTS 180
Query: 1113 ----------TESNTWFAGSYGYI------APEYAYSLKATEKCDVYSMGIVLMELVSGK 1156
+ + PE L + CDV+S+G +L E G
Sbjct: 181 IRVADFGSATFDHEH----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGF 236
Query: 1157 M--PTDATFGVEMDMVRWVEMHMEMSG--------------------------SAREELL 1188
T + + M ++ G S+ +
Sbjct: 237 TLFQTHE----NREHLV---MMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYV 289
Query: 1189 DDQMKPL---LPGEECAAYQVLEIALQCTKTSPQERPSSRQ 1226
+ KPL + + Q+ ++ + + P +R + +
Sbjct: 290 KENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAE 330
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 54.2 bits (129), Expect = 1e-07
Identities = 31/225 (13%), Positives = 63/225 (28%), Gaps = 32/225 (14%)
Query: 631 SGNSLTGPIPTQLLMCKKLSHIDLNNNLLSGAVPSW---------LGTLPQLGELKLSFN 681
+ + I + + SW L +P L LK+
Sbjct: 123 DCSDIADGIVENKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGT 182
Query: 682 QFVGFLPRELFNCSKLLVLSLDGNMLNGSLPNEVG-----NLASLNVLTLSGNLLSGPIP 736
+ L L + L S+ ++ NL L + +
Sbjct: 183 NNLSIGK---KPRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDM 239
Query: 737 PAI------GRLSKLYELRLSNNSLNGVIPLEIGQLQNLQS--ILDLSHNNFTG----QI 784
R L L + + V+ + L +D+S T +
Sbjct: 240 NVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLL 299
Query: 785 PPSMGTLAKLEVLNLSHNQLVGELPSQLGEMSSLGKLNLSYNDLQ 829
+ + L+ +N+ +N L E+ +L + + + +D Q
Sbjct: 300 LDHVDKIKHLKFINMKYNYLSDEMKKELQKS---LPMKIDVSDSQ 341
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 50.7 bits (120), Expect = 2e-06
Identities = 23/153 (15%), Positives = 49/153 (32%), Gaps = 18/153 (11%)
Query: 166 LVNLGTLGLASCSLSGPIPPQFGQLSQLEELILQQNQLQGPIPAELGNCS-----SLSIF 220
L + L + + L+ L + L + ++ L ++
Sbjct: 168 LDAMPLLNNLKIKGTNNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLY 227
Query: 221 TAAENNLNGSIPAAL------GRLQNLQLLNLGNNSLSGEIPSELGE---LSQLGYLNLM 271
E+ R NL+ L + + + E L QL +++
Sbjct: 228 VGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDIS 287
Query: 272 GNRL--EGA--IPRSFAKMGNLQSLDLSMNRLT 300
L EGA + K+ +L+ +++ N L+
Sbjct: 288 AGVLTDEGARLLLDHVDKIKHLKFINMKYNYLS 320
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 49.2 bits (116), Expect = 5e-06
Identities = 38/237 (16%), Positives = 73/237 (30%), Gaps = 40/237 (16%)
Query: 30 LSVLLEIKKSFTADPENVLHAWNQSNQNLCTWRGITCGSSSARVVSLNLSGLSLAGSISP 89
++E K+ F + Q + + + LN + ++S
Sbjct: 128 ADGIVENKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNLSI 187
Query: 90 SLGRLQSLIHLDLSSNSLTGPIPTAL--SNLSSLESLLLFSNQLAGTIPTQLGSLTSLRV 147
+L L++ S L + + S+L +LE L+L+ + L
Sbjct: 188 GKKPRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPL-- 245
Query: 148 MRIGDNWLSGSIPTSFGNLVNLGTLGLASCSLSGPIPPQFGQ---LSQLEELILQQNQLQ 204
S NL LG+ + F + L QLE + + L
Sbjct: 246 -------------FSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLT 292
Query: 205 GPIPAELGNCSSLSIFTAAENNLNGSIPAALGRLQNLQLLNLGNNSLSGEIPSELGE 261
L + ++++L+ +N+ N LS E+ EL +
Sbjct: 293 DEGARLL--------------------LDHVDKIKHLKFINMKYNYLSDEMKKELQK 329
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 42.6 bits (99), Expect = 6e-04
Identities = 16/130 (12%), Positives = 41/130 (31%), Gaps = 18/130 (13%)
Query: 336 TSLEHLILAEIQLSGEIPVEL--SQCQSLKQLDLSNNTLNGTIPVELFQLVA-------- 385
+L+ L + L + ++ S +L++L L + ++
Sbjct: 193 PNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFP 252
Query: 386 -LTHLYLHNNSLVGSISPFVAN---LSNLQELALYHNNFQGS----LPREIGMLVKLELL 437
L L + + + L L+ + + L + + L+ +
Sbjct: 253 NLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFI 312
Query: 438 YLYDNHLSGQ 447
+ N+LS +
Sbjct: 313 NMKYNYLSDE 322
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 54.5 bits (131), Expect = 1e-07
Identities = 43/200 (21%), Positives = 75/200 (37%), Gaps = 45/200 (22%)
Query: 954 IGSGGSGTVYKAE-LANGATVAVKKISCKDDHLLNKSFTREVKTLGRIR--------HRH 1004
+G G TV+ + + VA+K + K ++ E++ L +R
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVAMK-V-VKSAEHYTETALDEIRLLKSVRNSDPNDPNREM 102
Query: 1005 LVKLMG----------HCCNKGAGSNLLIYEYMENG-SVWDWLHKQPVNIKMRKSLDWEA 1053
+V+L+ H C +++E + G + W+ K + L
Sbjct: 103 VVQLLDDFKISGVNGTHIC--------MVFEVL--GHHLLKWIIKSN-----YQGLPLPC 147
Query: 1054 RLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNT 1113
KI + QG++YLH C +I+H DIK NILL + + + + E
Sbjct: 148 VKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILL------SVNEQYIRRLAAEATEWQR 199
Query: 1114 ESNTWFAGSYGYIAPEYAYS 1133
+GS AP A +
Sbjct: 200 SGAPPPSGSAVSTAPATAGN 219
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 1e-07
Identities = 25/139 (17%), Positives = 47/139 (33%), Gaps = 33/139 (23%)
Query: 235 LGRLQNLQLLNLGNNSLSGEIPSELGELSQLGYLNLMGN---RLEGAIPRSFAKMGNLQS 291
+ L+L + I + L Q ++ N +L+G F + L++
Sbjct: 15 YTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDG-----FPLLRRLKT 68
Query: 292 LDLSMNRLTGGIPEEFGNMGQLVFLVLSNNNISGSIPRRICTNATSLEHLILAEIQLSGE 351
L ++ NR+ + L L+L+NN++ L L
Sbjct: 69 LLVNNNRICRIGEGLDQALPDLTELILTNNSLV------------ELGDLD--------- 107
Query: 352 IPVELSQCQSLKQLDLSNN 370
L+ +SL L + N
Sbjct: 108 ---PLASLKSLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 4e-07
Identities = 24/115 (20%), Positives = 45/115 (39%), Gaps = 7/115 (6%)
Query: 690 ELFNCSKLLVLSLDGNMLNGSLPNEVGNLASLNVLTLSGNLLSGPIPPAIGRLSKLYELR 749
+ N + L L G + + N L + + S N + + L +L L
Sbjct: 14 QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLDG-FPLLRRLKTLL 70
Query: 750 LSNNSLNGVIPLEIGQLQNLQSILDLSHNNFT--GQIPPSMGTLAKLEVLNLSHN 802
++NN + + L +L L L++N+ G + P + +L L L + N
Sbjct: 71 VNNNRICRIGEGLDQALPDLT-ELILTNNSLVELGDLDP-LASLKSLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 2e-06
Identities = 23/137 (16%), Positives = 45/137 (32%), Gaps = 11/137 (8%)
Query: 355 ELSQCQSLKQLDLSNNTLNGTIPVELFQLVALTHLYLHNNSLVGSISPFVANLSNLQELA 414
+ + ++LDL + I L + +N + + F L L+ L
Sbjct: 14 QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLDGF-PLLRRLKTLL 70
Query: 415 LYHNNFQGSLPREIGMLVKLELLYLYDNHLSGQIPSEV---GNCSSLKWIDFFGNSFTGE 471
+ +N L L L L +N L ++ + SL ++ N T +
Sbjct: 71 VNNNRICRIGEGLDQALPDLTELILTNNSLVE--LGDLDPLASLKSLTYLCILRNPVTNK 128
Query: 472 I---PTSIGRLKDLNFL 485
I ++ + L
Sbjct: 129 KHYRLYVIYKVPQVRVL 145
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 2e-06
Identities = 27/131 (20%), Positives = 46/131 (35%), Gaps = 17/131 (12%)
Query: 318 LSNNNISGSIPRRI--CTNATSLEHLILAEIQLSGEIPVELSQCQSLKQLDLSNNTLNGT 375
L+ I + TNA L L ++ I + +D S+N +
Sbjct: 4 LTAELI-----EQAAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-- 55
Query: 376 IPVELFQ-LVALTHLYLHNNSLVGSISPFVANLSNLQELALYHNNFQGSLPREIGMLV-- 432
++ F L L L ++NN + L +L EL L +N+ ++ L
Sbjct: 56 -KLDGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSL--VELGDLDPLASL 112
Query: 433 -KLELLYLYDN 442
L L + N
Sbjct: 113 KSLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 3e-06
Identities = 30/139 (21%), Positives = 47/139 (33%), Gaps = 31/139 (22%)
Query: 282 SFAKMGNLQSLDLSMNRLTGGIPEEFGNMGQLVFLVLSNNNISGSIPRRICTNATSLEHL 341
+ + LDL ++ I + Q + S+N I L+
Sbjct: 14 QYTNAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEI------------RKLDGF 60
Query: 342 ILAEIQLSGEIPVELSQCQSLKQLDLSNNTLNGTIPVELFQLVALTHLYLHNNSL--VGS 399
+ LK L ++NN + L LT L L NNSL +G
Sbjct: 61 ---------------PLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGD 105
Query: 400 ISPFVANLSNLQELALYHN 418
+ P A+L +L L + N
Sbjct: 106 LDPL-ASLKSLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 3e-06
Identities = 28/152 (18%), Positives = 52/152 (34%), Gaps = 11/152 (7%)
Query: 147 VMRIGDNWLSGSIPTSFGNLVNLGTLGLASCSLSGPIPPQFGQLSQLEELILQQNQLQGP 206
++++ + + + N V L L + I L Q + + N+++
Sbjct: 1 MVKLTAELIEQA--AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-K 56
Query: 207 IPAELGNCSSLSIFTAAENNLNGSIPAALGRLQNLQLLNLGNNSLS--GEIPSELGELSQ 264
+ L N + L +L L L NNSL G++ L L
Sbjct: 57 L-DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDL-DPLASLKS 114
Query: 265 LGYLNLMGN---RLEGAIPRSFAKMGNLQSLD 293
L YL ++ N + K+ ++ LD
Sbjct: 115 LTYLCILRNPVTNKKHYRLYVIYKVPQVRVLD 146
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 4e-06
Identities = 25/129 (19%), Positives = 41/129 (31%), Gaps = 10/129 (7%)
Query: 604 LRLGNNKFIGKIPWTFGKIRELSLLDLSGNSLTGPIPTQLLMCKKLSHIDLNNNLLSGAV 663
++L I + + LDL G + I + ID ++N +
Sbjct: 2 VKLTAEL-IEQAA-QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR--K 56
Query: 664 PSWLGTLPQLGELKLSFNQFVGFLPRELFNCSKLLVLSLDGNMLNGSLPNEVGNLA---S 720
L +L L ++ N+ L L L N L ++ LA S
Sbjct: 57 LDGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSL--VELGDLDPLASLKS 114
Query: 721 LNVLTLSGN 729
L L + N
Sbjct: 115 LTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 6e-05
Identities = 22/117 (18%), Positives = 39/117 (33%), Gaps = 4/117 (3%)
Query: 185 PQFGQLSQLEELILQQNQLQGPIPAELGNCSSLSIFTAAENNLNGSIPAALGRLQNLQLL 244
Q+ + EL L+ ++ I ++N + + L+ L+ L
Sbjct: 13 AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KL-DGFPLLRRLKTL 69
Query: 245 NLGNNSLSGEIPSELGELSQLGYLNLMGNRLEG-AIPRSFAKMGNLQSLDLSMNRLT 300
+ NN + L L L L N L A + +L L + N +T
Sbjct: 70 LVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVT 126
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 1e-04
Identities = 22/115 (19%), Positives = 37/115 (32%), Gaps = 6/115 (5%)
Query: 641 TQLLMCKKLSHIDLNNNLLSGAVPSWLGTLPQLGELKLSFNQFVGFLPRELFNCSKLLVL 700
Q + +DL + + + TL Q + S N+ +L L
Sbjct: 13 AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTL 69
Query: 701 SLDGNMLNGSLPNEVGNLASLNVLTLSGNLLSGP--IPPAIGRLSKLYELRLSNN 753
++ N + L L L L+ N L + P + L L L + N
Sbjct: 70 LVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDP-LASLKSLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 6e-04
Identities = 23/114 (20%), Positives = 33/114 (28%), Gaps = 9/114 (7%)
Query: 431 LVKLELLYLYDNHLSGQIPSEVGNCSSLKWIDFFGNSFTGEIPTSIGRLKDLNFLHLRQN 490
V+ L L + I + IDF N ++ L+ L L + N
Sbjct: 18 AVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLDG-FPLLRRLKTLLVNNN 74
Query: 491 ELVGQIPASLGNCHQLIILDLADNKLSGGVPASFGFLQALEQL-MLYNNSLEGN 543
+ L L L +N L G L L L L + N
Sbjct: 75 RICRIGEGLDQALPDLTELILTNNSLV-----ELGDLDPLASLKSLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 7e-04
Identities = 18/90 (20%), Positives = 32/90 (35%), Gaps = 8/90 (8%)
Query: 742 LSKLYELRLSNNSLNGVIPLEIGQLQNLQSILDLSHNNFT--GQIPPSMGTLAKLEVLNL 799
+ EL L + + L L +D S N P L +L+ L +
Sbjct: 18 AVRDRELDLRGYKIPVIENLGA-TLDQFD-AIDFSDNEIRKLDGFP----LLRRLKTLLV 71
Query: 800 SHNQLVGELPSQLGEMSSLGKLNLSYNDLQ 829
++N++ + L +L L+ N L
Sbjct: 72 NNNRICRIGEGLDQALPDLTELILTNNSLV 101
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 8e-04
Identities = 20/107 (18%), Positives = 35/107 (32%), Gaps = 25/107 (23%)
Query: 599 PSLERLRLGNNKFIGKIPWTFGKIRELSLLDLSGNSLTGPIPTQLLMCKKLSHIDLNNNL 658
+ + +N+ I K+ F +R L L ++ N + L+ + L NN
Sbjct: 42 DQFDAIDFSDNE-IRKLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNS 99
Query: 659 LSGAVPSWLGTLPQLGELKLSFNQFVGFLPRELFNCSKLLVLSLDGN 705
L +LG+L L + L L + N
Sbjct: 100 LV-----------ELGDLD------------PLASLKSLTYLCILRN 123
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 3e-07
Identities = 56/342 (16%), Positives = 114/342 (33%), Gaps = 105/342 (30%)
Query: 953 IIGSGGSGTVYKA--ELANGATVAVKKISCKDDHLLNKSFTR----EVKTLGRIRHR--- 1003
+G G G V + A G VAVK + K+ + E++ L +
Sbjct: 21 TLGEGAFGKVVECIDHKAGGRHVAVKIV--KN----VDRYCEAARSEIQVLEHLNTTDPN 74
Query: 1004 ---HLVKLM------GHCCNKGAGSNLLIYEYMENGSVWDWL---HKQPVNIKMRKSLDW 1051
V+++ GH C +++E + S +D++ P + +
Sbjct: 75 STFRCVQMLEWFEHHGHIC--------IVFELLGL-STYDFIKENGFLPFRLDHIR---- 121
Query: 1052 EARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNS 1111
K+A + + V +LH K+ H D+K NIL + + + + N
Sbjct: 122 ----KMAYQICKSVNFLHS---NKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINP 174
Query: 1112 N----------TESNTWFAGSYGYI------APEYAYSLKATEKCDVYSMGIVLMELVSG 1155
+ + + APE +L ++ CDV+S+G +L+E G
Sbjct: 175 DIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLG 230
Query: 1156 KM--PTDATFGVEMDMVRWVEMHMEMSGSAREELLD------------------------ 1189
PT + + M + G + ++
Sbjct: 231 FTVFPTHD----SKEHLA---MMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRY 283
Query: 1190 --DQMKPL---LPGEECAAYQVLEIALQCTKTSPQERPSSRQ 1226
KPL + ++ ++ ++ + + P +R + R+
Sbjct: 284 VSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLRE 325
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 9e-07
Identities = 40/172 (23%), Positives = 68/172 (39%), Gaps = 30/172 (17%)
Query: 331 ICTNATSLE-HLILAEIQLSGEIPVELSQCQSLKQLDLSNN---TLNGTIPVELFQLVAL 386
+ T A +E H ++ I+ ++ LS ++ K L LS N ++ L + L
Sbjct: 21 VATEAEKVELHGMIPPIE---KMDATLSTLKACKHLALSTNNIEKISS-----LSGMENL 72
Query: 387 THLYLHNNSLVGSISPFVANLSNLQELALYHNNFQGSLPREIGMLVKLELLYLYDNHLSG 446
L L N + I A L+EL + +N SL I LV L +LY+ +N ++
Sbjct: 73 RILSLGRNLIK-KIENLDAVADTLEELWISYNQIA-SL-SGIEKLVNLRVLYMSNNKITN 129
Query: 447 QIPSEV---GNCSSLKWIDFFGNSFTGEIPTS----------IGRLKDLNFL 485
E+ L+ + GN + + + RL +L L
Sbjct: 130 --WGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKL 179
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 4e-06
Identities = 24/95 (25%), Positives = 42/95 (44%), Gaps = 6/95 (6%)
Query: 735 IPPAIGRLSKLYELRLSNNSLNGVIPLEIGQLQNLQSILDLSHNNFTGQIPPSMGTLAKL 794
+ + L L LS N++ + L ++NL+ IL L N +I L
Sbjct: 40 MDATLSTLKACKHLALSTNNIEKISSLS--GMENLR-ILSLGRNLIK-KIENLDAVADTL 95
Query: 795 EVLNLSHNQLVGELPSQLGEMSSLGKLNLSYNDLQ 829
E L +S+NQ+ S + ++ +L L +S N +
Sbjct: 96 EELWISYNQI--ASLSGIEKLVNLRVLYMSNNKIT 128
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 5e-06
Identities = 31/136 (22%), Positives = 55/136 (40%), Gaps = 16/136 (11%)
Query: 696 KLLVLSLDGNMLNGSLPNEVGNLASLNVLTLSGNLLSGPIPPAIGRLSKLYELR---LSN 752
+ + L + + + L + L LS N + I LS + LR L
Sbjct: 26 EKVELHGMIPPIEK-MDATLSTLKACKHLALSTNNIE-----KISSLSGMENLRILSLGR 79
Query: 753 NSLNGVIPLEIGQLQNLQSILDLSHNNFTGQIPPSMGTLAKLEVLNLSHNQL--VGELPS 810
N + + L+ L+ L +S+N + + L L VL +S+N++ GE+
Sbjct: 80 NLIKKIENLD-AVADTLE-ELWISYNQIA-SLSG-IEKLVNLRVLYMSNNKITNWGEI-D 134
Query: 811 QLGEMSSLGKLNLSYN 826
+L + L L L+ N
Sbjct: 135 KLAALDKLEDLLLAGN 150
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 2e-05
Identities = 35/137 (25%), Positives = 59/137 (43%), Gaps = 10/137 (7%)
Query: 675 ELKLSFNQFVGFLPRELFNCSKLLVLSLDGNMLNGSLPNEVGNLASLNVLTLSGNLLSGP 734
EL + L L+L N + + + + + +L +L+L NL+
Sbjct: 29 ELHGMIPPIEK-MDATLSTLKACKHLALSTNNI-EKISS-LSGMENLRILSLGRNLIKK- 84
Query: 735 IPPAIGRLSKLYELRLSNNSLNGVIPLEIGQLQNLQSILDLSHNNFT--GQIPPSMGTLA 792
I L EL +S N + + +E +L NL+ +L +S+N T G+I + L
Sbjct: 85 IENLDAVADTLEELWISYNQIASLSGIE--KLVNLR-VLYMSNNKITNWGEIDK-LAALD 140
Query: 793 KLEVLNLSHNQLVGELP 809
KLE L L+ N L +
Sbjct: 141 KLEDLLLAGNPLYNDYK 157
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 2e-04
Identities = 30/164 (18%), Positives = 59/164 (35%), Gaps = 29/164 (17%)
Query: 355 ELSQCQSLKQLDLSNNTLN-GTIPVELFQLVALTHLYLHNNSLVGSISPFVANLSNLQEL 413
+ ++++L + L L A HL L N++ IS ++ + NL+ L
Sbjct: 18 KSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIE-KISS-LSGMENLRIL 75
Query: 414 ALYHNNFQGSLPREIGMLVKLELLYLYDNHLSGQIPSEVGNCSSLKWIDFFGNSFTGEIP 473
+L N + + + LE L++ N ++ + S + +L+ + N
Sbjct: 76 SLGRNLIK-KIENLDAVADTLEELWISYNQIA-SL-SGIEKLVNLRVLYMSNNK------ 126
Query: 474 TSIGRLKDLNFLHLRQNELVGQIPASLGNCHQLIILDLADNKLS 517
I +++ L +L L LA N L
Sbjct: 127 --ITNWGEIDKL---------------AALDKLEDLLLAGNPLY 153
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 3e-04
Identities = 33/135 (24%), Positives = 63/135 (46%), Gaps = 15/135 (11%)
Query: 195 ELILQQNQLQGPIPAELGNCSSLSIFTAAENNLNGSIPAALGRLQNLQLLNLGNNSLSGE 254
EL ++ + A L + + NN+ I ++L ++NL++L+LG N + +
Sbjct: 29 ELHGMIPPIEK-MDATLSTLKACKHLALSTNNI-EKI-SSLSGMENLRILSLGRNLIK-K 84
Query: 255 IPSELGELSQLGYLNLMGNR---LEGAIPRSFAKMGNLQSLDLSMNRLT--GGIPEEFGN 309
I + L L + N+ L G K+ NL+ L +S N++T G I ++
Sbjct: 85 IENLDAVADTLEELWISYNQIASLSG-----IEKLVNLRVLYMSNNKITNWGEI-DKLAA 138
Query: 310 MGQLVFLVLSNNNIS 324
+ +L L+L+ N +
Sbjct: 139 LDKLEDLLLAGNPLY 153
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 1e-06
Identities = 28/85 (32%), Positives = 44/85 (51%), Gaps = 6/85 (7%)
Query: 361 SLKQLDLSNNTLNGTIPVELF-QLVALTHLYLHNNSLVGSISPFV-ANLSNLQELALYHN 418
++L L+NN + + +F LV L LY ++N L +I V L+ L +L L N
Sbjct: 34 DKQRLWLNNNQIT-KLEPGVFDHLVNLQQLYFNSNKL-TAIPTGVFDKLTQLTQLDLNDN 91
Query: 419 NFQGSLPREI-GMLVKLELLYLYDN 442
+ + S+PR L L +YLY+N
Sbjct: 92 HLK-SIPRGAFDNLKSLTHIYLYNN 115
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 2e-05
Identities = 31/93 (33%), Positives = 40/93 (43%), Gaps = 4/93 (4%)
Query: 230 SIPAALGRLQNLQLLNLGNNSLSGEIPSELGELSQLGYLNLMGNRLEGAIPRSFAKMGNL 289
S+PA G + Q L L NN ++ P L L L N+L F K+ L
Sbjct: 26 SVPA--GIPTDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQL 83
Query: 290 QSLDLSMNRLTGGIPE-EFGNMGQLVFLVLSNN 321
LDL+ N L IP F N+ L + L NN
Sbjct: 84 TQLDLNDNHLK-SIPRGAFDNLKSLTHIYLYNN 115
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 44.9 bits (107), Expect = 3e-05
Identities = 29/78 (37%), Positives = 40/78 (51%), Gaps = 3/78 (3%)
Query: 267 YLNLMGNRLEGAIPRSFAKMGNLQSLDLSMNRLTGGIPEE-FGNMGQLVFLVLSNNNISG 325
L L N++ P F + NLQ L + N+LT IP F + QL L L++N++
Sbjct: 37 RLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTA-IPTGVFDKLTQLTQLDLNDNHLK- 94
Query: 326 SIPRRICTNATSLEHLIL 343
SIPR N SL H+ L
Sbjct: 95 SIPRGAFDNLKSLTHIYL 112
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 3e-04
Identities = 35/117 (29%), Positives = 49/117 (41%), Gaps = 16/117 (13%)
Query: 357 SQCQ-SLKQLDLSNNTLNGT---IPVELFQLVALTHLYLHNNSLVGSISPFV-ANLSNLQ 411
SQC ++ N L IP + L+L+NN + + P V +L NLQ
Sbjct: 8 SQCSCDQTLVNCQNIRLASVPAGIPTDK------QRLWLNNNQIT-KLEPGVFDHLVNLQ 60
Query: 412 ELALYHNNFQGSLPREI-GMLVKLELLYLYDNHLSGQIPSEV-GNCSSLKWIDFFGN 466
+L N ++P + L +L L L DNHL IP N SL I + N
Sbjct: 61 QLYFNSNKLT-AIPTGVFDKLTQLTQLDLNDNHLKS-IPRGAFDNLKSLTHIYLYNN 115
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 1e-06
Identities = 25/85 (29%), Positives = 41/85 (48%), Gaps = 6/85 (7%)
Query: 361 SLKQLDLSNNTLNGTIPVELF-QLVALTHLYLHNNSLVGSISPFV-ANLSNLQELALYHN 418
+ + L L +N + + +F +L LT L L NN L + V L+ L +L+L N
Sbjct: 31 TTQVLYLYDNQIT-KLEPGVFDRLTQLTRLDLDNNQL-TVLPAGVFDKLTQLTQLSLNDN 88
Query: 419 NFQGSLPREI-GMLVKLELLYLYDN 442
+ S+PR L L ++L +N
Sbjct: 89 QLK-SIPRGAFDNLKSLTHIWLLNN 112
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 8e-06
Identities = 30/93 (32%), Positives = 43/93 (46%), Gaps = 4/93 (4%)
Query: 230 SIPAALGRLQNLQLLNLGNNSLSGEIPSELGELSQLGYLNLMGNRLEGAIPRSFAKMGNL 289
S+P G Q+L L +N ++ P L+QL L+L N+L F K+ L
Sbjct: 23 SVPT--GIPTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQL 80
Query: 290 QSLDLSMNRLTGGIPEE-FGNMGQLVFLVLSNN 321
L L+ N+L IP F N+ L + L NN
Sbjct: 81 TQLSLNDNQLK-SIPRGAFDNLKSLTHIWLLNN 112
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 45.3 bits (108), Expect = 2e-05
Identities = 28/78 (35%), Positives = 39/78 (50%), Gaps = 3/78 (3%)
Query: 267 YLNLMGNRLEGAIPRSFAKMGNLQSLDLSMNRLTGGIPEE-FGNMGQLVFLVLSNNNISG 325
L L N++ P F ++ L LDL N+LT +P F + QL L L++N +
Sbjct: 34 VLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTV-LPAGVFDKLTQLTQLSLNDNQLK- 91
Query: 326 SIPRRICTNATSLEHLIL 343
SIPR N SL H+ L
Sbjct: 92 SIPRGAFDNLKSLTHIWL 109
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 9e-05
Identities = 46/272 (16%), Positives = 86/272 (31%), Gaps = 45/272 (16%)
Query: 172 LGLASCS---LSGPIPPQFGQLSQLEELILQQNQLQGPIPAELGNCSSLSIFTAAENNLN 228
+GL S + + L LE + +L L L
Sbjct: 4 VGLLSAHNRAVLAQLGCPIKNLDALENAQAIKKKLGKLGRQVLPPSELLDHL-FFHYEFQ 62
Query: 229 GSIPAALGRLQNLQLLNLGNNSLSGEIPSELGEL-----SQLGYLNLMGNRLEGAIPRSF 283
+ L +L+ LNL ++ + + + L +NL +L+ A R+
Sbjct: 63 N-QRFSAEVLSSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTL 121
Query: 284 AKM-GNLQSLDLSMNRLTGGIPEEFG-----NMGQLVFLVLSNNNISGSIPRRICTNATS 337
+ + L L +N L ++ + Q+ L LSNN ++ A
Sbjct: 122 LPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLT----------AAG 171
Query: 338 LEHLILAEIQLSGEIPVELSQCQSLKQLDLSNNTLNGT----IPVELFQLVALTHLYLHN 393
+ L+ L+ S+ L L + L + +L + L L +
Sbjct: 172 VAVLMEG-----------LAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAY 220
Query: 394 NSL----VGSISPFVANLSNLQELALYHNNFQ 421
N +++ +L+ L LY N
Sbjct: 221 NGAGDTAALALARAAREHPSLELLHLYFNELS 252
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 1e-04
Identities = 58/356 (16%), Positives = 100/356 (28%), Gaps = 81/356 (22%)
Query: 69 SSARVVSLNLSGLSLAGSISPSLGRLQSLIHLDLSSNSLTGPIPTAL-----SNLSSLES 123
+ ++ + S L SL L+L+ +T T + S +L+
Sbjct: 47 PPSELLDHLFFHYEF-QNQRFSAEVLSSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDE 105
Query: 124 LLLFSNQL----AGTIPTQLGSLTSLRVMRIGDNWLSGSIPTSFGNLVNLGTLGLASCSL 179
+ L S QL T+ L R + + N L L L
Sbjct: 106 VNLASCQLDPAGLRTL---LPVFLRARKLGLQLNSLGPE-----------ACKDLRD-LL 150
Query: 180 SGPIPPQFGQLSQLEELILQQNQLQGPIPAELGNCSSLSIFTAAENNLNGSIPAALGRLQ 239
Q+ L L N L G + L L
Sbjct: 151 LHD-------QCQITTLRLSNNPLT-----AAG-VAVLM--------------EGLAGNT 183
Query: 240 NLQLLNLGNNSLSGE----IPSELGELSQLGYLNLMGNRLEGAIPRSFAKM----GNLQS 291
++ L+L + L E + ++L QL LN+ N + A+ +L+
Sbjct: 184 SVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLEL 243
Query: 292 LDLSMNRLT-------GGIPEEFGNMGQLVFLVLSNNNISGSIPRRICTNATSLEHLILA 344
L L N L+ + ++V + +S + +L A
Sbjct: 244 LHLYFNELSSEGRQVLRDLGGAAEGGARVVVSLTEGTAVSEYWSVILSEVQRNLNSWDRA 303
Query: 345 EIQLSGEIPVELSQCQSLKQLDLSNNTLNGTIPVELFQLVA----LTHLYLHNNSL 396
+Q + L DL ++ P QL+ + L S
Sbjct: 304 RVQ----------RHLELLLRDLEDSRGATLNPWRKAQLLRVEGEVRALLEQLGSS 349
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
No hit with probability above 80.00
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 1251 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-60 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-60 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 8e-60 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 3e-58 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 3e-57 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 3e-56 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 3e-55 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 6e-55 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 8e-55 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-54 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-54 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 5e-54 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 6e-54 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 9e-54 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-53 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-52 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-52 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 3e-52 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 5e-52 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 7e-52 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-51 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-51 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 5e-51 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-50 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-49 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 3e-47 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 3e-47 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 4e-47 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 7e-47 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 7e-47 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 9e-47 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 3e-46 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 6e-46 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-45 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 5e-45 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 4e-44 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-43 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 3e-43 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 7e-43 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-42 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 3e-42 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 8e-42 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 5e-41 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 6e-41 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 4e-40 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 4e-40 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 9e-40 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-39 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-39 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-39 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-38 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-37 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-37 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-37 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 3e-37 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 4e-37 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 3e-35 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 4e-34 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 8e-34 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-32 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 4e-31 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 6e-31 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 1e-28 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 1e-17 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 3e-17 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 5e-17 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 9e-17 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 1e-14 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 6e-05 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-24 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 5e-24 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 9e-24 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-23 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 4e-23 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-22 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 9e-22 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 8e-20 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 4e-19 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-17 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-09 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 6e-23 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 3e-22 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 3e-22 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 9e-22 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 5e-21 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 3e-19 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 3e-17 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 8e-17 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 5e-12 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 8e-08 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-06 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 5e-06 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-22 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 4e-22 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 8e-21 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 6e-18 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 8e-18 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 1e-17 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 1e-12 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 1e-06 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 6e-12 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 1e-11 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 1e-10 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-08 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-08 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 3e-08 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 5e-08 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 6e-05 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-04 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 5e-04 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 1e-11 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 1e-10 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 6e-10 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 1e-09 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 3e-07 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 0.001 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-11 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 7e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 6e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 7e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 6e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.003 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 8e-09 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 3e-08 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 4e-07 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 2e-06 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 1e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 4e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 1e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 4e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 4e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 5e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 5e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 0.002 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 0.003 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 7e-08 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 2e-07 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 2e-07 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 4e-07 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 7e-06 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 2e-05 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 5e-05 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 0.001 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 0.001 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 0.002 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 0.004 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 4e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 5e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 6e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 4e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 7e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-04 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 1e-07 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 4e-06 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 6e-06 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 2e-05 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 1e-04 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 3e-04 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 0.001 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 5e-07 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 5e-05 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 1e-04 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 0.003 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 2e-06 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 1e-04 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 2e-06 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 3e-05 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 0.001 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 0.002 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 6e-06 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 8e-06 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 6e-05 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 2e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 2e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 3e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 4e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.004 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 1e-04 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 8e-04 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 9e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 1e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 3e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 3e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 3e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 5e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 5e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 6e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 6e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.002 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.003 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.004 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 4e-04 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 5e-04 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 9e-04 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 0.001 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 0.003 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 0.004 | |
| d1m9la_ | 198 | c.10.3.1 (A:) Outer arm dynein light chain 1 {Gree | 0.003 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (526), Expect = 1e-60
Identities = 72/281 (25%), Positives = 118/281 (41%), Gaps = 32/281 (11%)
Query: 954 IGSGGSGTVYKAELANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCC 1013
IGSG GTVYK + V + ++ L ++F EV L + RH +++ MG+
Sbjct: 16 IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQL-QAFKNEVGVLRKTRHVNILLFMGYST 74
Query: 1014 NKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCV 1073
++ ++ E S++ LH + + IA AQG++YLH
Sbjct: 75 A---PQLAIVTQWCEGSSLYHHLHII------ETKFEMIKLIDIARQTAQGMDYLHA--- 122
Query: 1074 PKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYS 1133
I+HRD+KS+NI L ++ +GDFGLA S + +GS ++APE
Sbjct: 123 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW--SGSHQFEQLSGSILWMAPEVIRM 180
Query: 1134 LKA---TEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSAREELLDD 1190
+ + DVY+ GIVL EL++G++P + + ++ S
Sbjct: 181 QDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPK 240
Query: 1191 QMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLL 1231
MK + +C K ERP Q+ +
Sbjct: 241 AMK--------------RLMAECLKKKRDERPLFPQILASI 267
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (527), Expect = 2e-60
Identities = 64/294 (21%), Positives = 126/294 (42%), Gaps = 28/294 (9%)
Query: 954 IGSGGSGTVYKAELANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCC 1013
IG G G V++ + G VAVK S +++ + E+ +RH +++ +
Sbjct: 11 IGKGRFGEVWRGKW-RGEEVAVKIFSSREER--SWFREAEIYQTVMLRHENILGFIAADN 67
Query: 1014 NKGAGSN--LLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHD 1071
L+ +Y E+GS++D+L++ + E +K+A+ A G+ +LH +
Sbjct: 68 KDNGTWTQLWLVSDYHEHGSLFDYLNRYT--------VTVEGMIKLALSTASGLAHLHME 119
Query: 1072 CV-----PKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYI 1126
V P I HRD+KS NIL+ N + D GLA ++ + G+ Y+
Sbjct: 120 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 179
Query: 1127 APEYAYS------LKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMS 1180
APE ++ ++ D+Y+MG+V E+ ++ V +
Sbjct: 180 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE 239
Query: 1181 GSAREELLDDQMKPLLPGEEC---AAYQVLEIALQCTKTSPQERPSSRQVCDLL 1231
R+ + + +++P +P A + +I +C + R ++ ++ L
Sbjct: 240 -EMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTL 292
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (525), Expect = 8e-60
Identities = 62/292 (21%), Positives = 126/292 (43%), Gaps = 21/292 (7%)
Query: 944 ATNNLSDEFIIGSGGSGTVYKAE-LANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRH 1002
++ +G+G G V+K +G +A K I + + RE++ L
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63
Query: 1003 RHLVKLMGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLA 1062
++V G + G + E+M+ GS+ L K + + K+++ +
Sbjct: 64 PYIVGFYGAFYSDG--EISICMEHMDGGSLDQVLKK-------AGRIPEQILGKVSIAVI 114
Query: 1063 QGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGS 1122
+G+ YL KI+HRD+K SNIL++S E L DFG++ L ++ +N++ G+
Sbjct: 115 KGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQL-----IDSMANSF-VGT 166
Query: 1123 YGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGS 1182
Y++PE + + D++SMG+ L+E+ G+ P E++++ ++ + + +
Sbjct: 167 RSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAET 226
Query: 1183 AREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPS---SRQVCDLL 1231
+ + + E+ P + PS S + D +
Sbjct: 227 PPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFV 278
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (508), Expect = 3e-58
Identities = 65/282 (23%), Positives = 121/282 (42%), Gaps = 34/282 (12%)
Query: 954 IGSGGSGTVYKAELANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCC 1013
+G+G G V+ VAVK + K + +F E + +++H+ LV+L
Sbjct: 21 LGAGQFGEVWMGYYNGHTKVAVKSL--KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT 78
Query: 1014 NKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCV 1073
+ +I EYMENGS+ D+L L L +A +A+G+ ++
Sbjct: 79 QEPI---YIITEYMENGSLVDFLKTPS-----GIKLTINKLLDMAAQIAEGMAFIEERN- 129
Query: 1074 PKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYS 1133
+HRD++++NIL+ + + DFGLA+ + ++ + + APE
Sbjct: 130 --YIHRDLRAANILVSDTLSCKIADFGLARLI---EDNEYTAREGAKFPIKWTAPEAINY 184
Query: 1134 LKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSAREELLDDQMK 1193
T K DV+S GI+L E+V+ M+ + L+ +
Sbjct: 185 GTFTIKSDVWSFGILLTEIVTHGRIPYP----------------GMTNPEVIQNLERGYR 228
Query: 1194 PLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNVF 1235
+ P + C ++ ++ C K P++RP+ + +L + F
Sbjct: 229 MVRP-DNCPE-ELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (501), Expect = 3e-57
Identities = 64/279 (22%), Positives = 110/279 (39%), Gaps = 30/279 (10%)
Query: 953 IIGSGGSGTVYKAE-LANGATVAVKKISCKD-DHLLNKSFTREVKTLGRIRHRHLVKLMG 1010
IG+G G K ++G + K++ + EV L ++H ++V+
Sbjct: 11 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 70
Query: 1011 HCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLH- 1069
++ + ++ EY E G + + K K R+ LD E L++ L ++ H
Sbjct: 71 RIIDRTNTTLYIVMEYCEGGDLASVITK---GTKERQYLDEEFVLRVMTQLTLALKECHR 127
Query: 1070 -HDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAP 1128
D +LHRD+K +N+ LD LGDFGLA+ L N +T F G+ Y++P
Sbjct: 128 RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL----NHDTSFAKAFVGTPYYMSP 183
Query: 1129 EYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSAREELL 1188
E + EK D++S+G +L EL + P A E
Sbjct: 184 EQMNRMSYNEKSDIWSLGCLLYELCALMPPFTA-----FSQKELAGKIREGKFRRIPYRY 238
Query: 1189 DDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQV 1227
D++ ++ + RPS ++
Sbjct: 239 SDELNEII--------------TRMLNLKDYHRPSVEEI 263
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (494), Expect = 3e-56
Identities = 69/295 (23%), Positives = 127/295 (43%), Gaps = 38/295 (12%)
Query: 950 DEFIIGSGGSGTVYKAELAN---GATVAVKKISCK-DDHLLNKSFTREVKTLGRIRHRHL 1005
++ +GSG GTV K TVAVK + + +D L E + ++ + ++
Sbjct: 11 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 1006 VKLMGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGV 1065
V+++G C + S +L+ E E G + +L + + + + +++ ++ G+
Sbjct: 71 VRMIGICEAE---SWMLVMEMAELGPLNKYLQQ-------NRHVKDKNIIELVHQVSMGM 120
Query: 1066 EYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGY 1125
+YL +HRD+ + N+LL + A + DFGL+KAL D N + T +
Sbjct: 121 KYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK-AQTHGKWPVKW 176
Query: 1126 IAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMVRWVEMHMEMSGSAR 1184
APE K + K DV+S G+++ E S G+ P + M GS
Sbjct: 177 YAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP-----------------YRGMKGSEV 219
Query: 1185 EELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNVFNNRI 1239
+L+ + P C ++ ++ C + RP V L N + + +
Sbjct: 220 TAMLEKGERMGCP-AGCPR-EMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV 272
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (485), Expect = 3e-55
Identities = 61/278 (21%), Positives = 118/278 (42%), Gaps = 34/278 (12%)
Query: 954 IGSGGSGTVYKAELANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCC 1013
IGSG G V+ N VA+K I ++ + + F E + + ++ H LV+L G C
Sbjct: 13 IGSGQFGLVHLGYWLNKDKVAIKTI--REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCL 70
Query: 1014 NKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCV 1073
+ L++E+ME+G + D+L Q E L + + + +G + +
Sbjct: 71 EQA--PICLVFEFMEHGCLSDYLRTQRGLF------AAETLLGMCLDVCEG---MAYLEE 119
Query: 1074 PKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYS 1133
++HRD+ + N L+ N + DFG+ + +++D +++ T + +PE
Sbjct: 120 ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS---TGTKFPVKWASPEVFSF 176
Query: 1134 LKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSAREELLDDQMK 1193
+ + K DV+S G+++ E+ S ++V + + K
Sbjct: 177 SRYSSKSDVWSFGVLMWEVFSEGKIPYENRS-NSEVVEDISTGFRL------------YK 223
Query: 1194 PLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLL 1231
P L +I C K P++RP+ ++ L
Sbjct: 224 PRLASTHVY-----QIMNHCWKERPEDRPAFSRLLRQL 256
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 191 bits (486), Expect = 6e-55
Identities = 73/311 (23%), Positives = 124/311 (39%), Gaps = 45/311 (14%)
Query: 936 FRWEDIMGATNNLSDEF---------IIGSGGSGTVYKAELA----NGATVAVKKISCKD 982
F +ED A + E +IG+G G V L VA+K +
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 983 DHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVN 1042
+ F E +G+ H +++ L G ++I E+MENGS+ +L +
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKST--PVMIITEFMENGSLDSFLRQND-- 122
Query: 1043 IKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLA 1102
+ + G+A G++YL +HRD+ + NIL++SN+ + DFGL+
Sbjct: 123 ----GQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLS 175
Query: 1103 KALVEDYNSNTESNT-WFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTD 1160
+ L +D + T ++ + APE K T DV+S GIV+ E++S G+ P
Sbjct: 176 RFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYW 235
Query: 1161 ATFGVEMDMVRWVEMHMEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQE 1220
D++ +E LP + ++ L C +
Sbjct: 236 DM--TNQDVINAIEQD-----------------YRLPPPMDCPSALHQLMLDCWQKDRNH 276
Query: 1221 RPSSRQVCDLL 1231
RP Q+ + L
Sbjct: 277 RPKFGQIVNTL 287
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (484), Expect = 8e-55
Identities = 61/299 (20%), Positives = 124/299 (41%), Gaps = 37/299 (12%)
Query: 944 ATNNLS-DEFIIGSGGSGTVYKAELA---NGATVAVKKISCKDDHLLNKSFTREVKTLGR 999
+NL + +G G G+V + VA+K + + + RE + + +
Sbjct: 6 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQ 65
Query: 1000 IRHRHLVKLMGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAV 1059
+ + ++V+L+G C + +L+ E G + +L + R+ + ++
Sbjct: 66 LDNPYIVRLIGVCQAEAL---MLVMEMAGGGPLHKFLVGK------REEIPVSNVAELLH 116
Query: 1060 GLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWF 1119
++ G++YL +HRD+ + N+LL + A + DFGL+KAL D +S + +
Sbjct: 117 QVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD-DSYYTARSAG 172
Query: 1120 AGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMVRWVEMHME 1178
+ APE K + + DV+S G+ + E +S G+ P G +++ ++E
Sbjct: 173 KWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG--PEVMAFIEQGKR 230
Query: 1179 MSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNVFNN 1237
M + P P E + + C ++RP V + + +
Sbjct: 231 M-----------ECPPECPPE------LYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (481), Expect = 2e-54
Identities = 68/292 (23%), Positives = 124/292 (42%), Gaps = 34/292 (11%)
Query: 946 NNLSDEFIIGSGGSGTVYKAELANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHL 1005
+L E +G G G V+ VA+K + K + ++F +E + + ++RH L
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL--KPGTMSPEAFLQEAQVMKKLRHEKL 74
Query: 1006 VKLMGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGV 1065
V+L ++ EYM GS+ D+L + K L + +A +A G+
Sbjct: 75 VQLYAVVSE---EPIYIVTEYMSKGSLLDFLKG-----ETGKYLRLPQLVDMAAQIASGM 126
Query: 1066 EYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGY 1125
Y+ +HRD++++NIL+ N+ + DFGLA+ + ++ + +
Sbjct: 127 AYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLI---EDNEYTARQGAKFPIKW 180
Query: 1126 IAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSARE 1185
APE A + T K DV+S GI+L EL + + M
Sbjct: 181 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRV----------------PYPGMVNREVL 224
Query: 1186 ELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNVFNN 1237
+ ++ + P EC + ++ QC + P+ERP+ + L + F +
Sbjct: 225 DQVERGYRMPCP-PECPE-SLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 274
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (480), Expect = 2e-54
Identities = 60/282 (21%), Positives = 111/282 (39%), Gaps = 37/282 (13%)
Query: 951 EFIIGSGGSGTVYKAEL-ANGATVAVKKISCKD-DHLLNKSFTREVKTLGRIRHRHLVKL 1008
+ IG G TVYK VA ++ + + F E + L ++H ++V+
Sbjct: 14 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73
Query: 1009 MGHC--CNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVE 1066
KG +L+ E M +G++ +L + K + + + +G++
Sbjct: 74 YDSWESTVKGKKCIVLVTELMTSGTLKTYLKR-------FKVMKIKVLRSWCRQILKGLQ 126
Query: 1067 YLHHDCVPKILHRDIKSSNILLDS-NMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGY 1125
+LH P I+HRD+K NI + +GD GLA G+ +
Sbjct: 127 FLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK------RASFAKAVIGTPEF 179
Query: 1126 IAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSARE 1185
+APE Y K E DVY+ G+ ++E+ + + P + +++ ++ +
Sbjct: 180 MAPEM-YEEKYDESVDVYAFGMCMLEMATSEYPYS-------ECQNAAQIYRRVTSGVKP 231
Query: 1186 ELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQV 1227
D P +V EI C + + ER S + +
Sbjct: 232 ASFDKVAIP----------EVKEIIEGCIRQNKDERYSIKDL 263
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (480), Expect = 5e-54
Identities = 65/301 (21%), Positives = 127/301 (42%), Gaps = 33/301 (10%)
Query: 953 IIGSGGSGTVYKAELAN----GATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKL 1008
+IG G G VY L + AVK ++ D F E + H +++ L
Sbjct: 34 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 93
Query: 1009 MGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYL 1068
+G C + GS L++ YM++G + +++ + + + + + +A+G +
Sbjct: 94 LG-ICLRSEGSPLVVLPYMKHGDLRNFIRNE------THNPTVKDLIGFGLQVAKG---M 143
Query: 1069 HHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAP 1128
K +HRD+ + N +LD + DFGLA+ + + + + T ++A
Sbjct: 144 KFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 203
Query: 1129 EYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSAREELL 1188
E + K T K DV+S G++L EL++ P +++ +
Sbjct: 204 ESLQTQKFTTKSDVWSFGVLLWELMTRGAP----PYPDVNTFDITVYLL----------- 248
Query: 1189 DDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNVFNNRIVDFDKLHID 1248
Q + LL E C + E+ L+C + RPS ++ + +F+ I + +H++
Sbjct: 249 --QGRRLLQPEYCPD-PLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE-HYVHVN 304
Query: 1249 P 1249
Sbjct: 305 A 305
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (475), Expect = 6e-54
Identities = 66/282 (23%), Positives = 120/282 (42%), Gaps = 36/282 (12%)
Query: 954 IGSGGSGTVYKAELANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCC 1013
+G+G G V + VA+K I K+ + F E K + + H LV+L G C
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMI--KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 69
Query: 1014 NKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCV 1073
+ +I EYM NG + ++L + R + L++ + + +EYL
Sbjct: 70 KQR--PIFIITEYMANGCLLNYLREM------RHRFQTQQLLEMCKDVCEAMEYLES--- 118
Query: 1074 PKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYS 1133
+ LHRD+ + N L++ + DFGL++ +++D S+ + PE
Sbjct: 119 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD---EYTSSVGSKFPVRWSPPEVLMY 175
Query: 1134 LKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMVRWVEMHMEMSGSAREELLDDQM 1192
K + K D+++ G+++ E+ S GKMP + + S E + +
Sbjct: 176 SKFSSKSDIWAFGVLMWEIYSLGKMPYE-----------------RFTNSETAEHIAQGL 218
Query: 1193 KPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNV 1234
+ P A+ +V I C ERP+ + + +L+V
Sbjct: 219 RLYRP--HLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (475), Expect = 9e-54
Identities = 67/277 (24%), Positives = 102/277 (36%), Gaps = 33/277 (11%)
Query: 953 IIGSGGSGTVYKAE-LANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGH 1011
+G G G V A VAVK + K ++ +E+ + H ++VK GH
Sbjct: 12 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 71
Query: 1012 CCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHD 1071
L EY G ++D + + + L GV YLH
Sbjct: 72 RREGN--IQYLFLEYCSGGELFDRIEP-------DIGMPEPDAQRFFHQLMAGVVYLHG- 121
Query: 1072 CVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYA 1131
I HRDIK N+LLD + DFGLA YN+ G+ Y+APE
Sbjct: 122 --IGITHRDIKPENLLLDERDNLKISDFGLATVF--RYNNRERLLNKMCGTLPYVAPELL 177
Query: 1132 YSLK-ATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSAREELLDD 1190
+ E DV+S GIVL +++G++P D + W E ++ + +D
Sbjct: 178 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLN---PWKKIDS 234
Query: 1191 QMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQV 1227
LL + +P R + +
Sbjct: 235 APLALL--------------HKILVENPSARITIPDI 257
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (471), Expect = 2e-53
Identities = 66/287 (22%), Positives = 113/287 (39%), Gaps = 38/287 (13%)
Query: 953 IIGSGGSGTVYKAELANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHC 1012
IG G G V + G VAVK I ++F E + ++RH +LV+L+G
Sbjct: 14 TIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA---QAFLAEASVMTQLRHSNLVQLLG-V 68
Query: 1013 CNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDC 1072
+ G ++ EYM GS+ D+L + R L + LK ++ + + +EYL
Sbjct: 69 IVEEKGGLYIVTEYMAKGSLVDYLRSRG-----RSVLGGDCLLKFSLDVCEAMEYLEG-- 121
Query: 1073 VPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAY 1132
+HRD+ + N+L+ + A + DFGL K + + + APE
Sbjct: 122 -NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA-------SSTQDTGKLPVKWTAPEALR 173
Query: 1133 SLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSAREELLDDQM 1192
K + K DV+S GI+L E+ S + + V + + +
Sbjct: 174 EKKFSTKSDVWSFGILLWEIYSFGRVPYP----RIPLKDVVPRVEKGYKMDAPDGCPPAV 229
Query: 1193 KPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNVFNNRI 1239
E+ C RPS Q+ + L ++ + +
Sbjct: 230 Y--------------EVMKNCWHLDAAMRPSFLQLREQLEHIKTHEL 262
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (468), Expect = 1e-52
Identities = 67/291 (23%), Positives = 128/291 (43%), Gaps = 35/291 (12%)
Query: 946 NNLSDEFIIGSGGSGTVYKAELANG-----ATVAVKKISCKDDHLLNKSFTREVKTLGRI 1000
+ ++ + +IG+G G VYK L VA+K + F E +G+
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 1001 RHRHLVKLMGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVG 1060
H ++++L G ++I EYMENG++ +L ++ + + G
Sbjct: 67 SHHNIIRLEGVISKYK--PMMIITEYMENGALDKFLREK------DGEFSVLQLVGMLRG 118
Query: 1061 LAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFA 1120
+A G++YL + +HRD+ + NIL++SN+ + DFGL++ ++ED T + +
Sbjct: 119 IAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSR-VLEDDPEATYTTSGGK 174
Query: 1121 GSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMS 1180
+ APE K T DV+S GIV+ E+++ + E+S
Sbjct: 175 IPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGER----------------PYWELS 218
Query: 1181 GSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLL 1231
+ ++D + P +C + + ++ +QC + RP + +L
Sbjct: 219 NHEVMKAINDGFRLPTP-MDCPS-AIYQLMMQCWQQERARRPKFADIVSIL 267
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 184 bits (468), Expect = 1e-52
Identities = 70/286 (24%), Positives = 125/286 (43%), Gaps = 34/286 (11%)
Query: 953 IIGSGGSGTVYKAEL-ANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGH 1011
+G G G VY+ TVAVK + K+D + + F +E + I+H +LV+L+G
Sbjct: 24 KLGGGQYGEVYEGVWKKYSLTVAVKTL--KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 81
Query: 1012 CCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHD 1071
C + +I E+M G++ D+L + R+ + L +A ++ +EYL
Sbjct: 82 CTREP--PFYIITEFMTYGNLLDYLRE-----CNRQEVSAVVLLYMATQISSAMEYLEK- 133
Query: 1072 CVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYA 1131
+HRD+ + N L+ N + DFGL++ + D ++ + APE
Sbjct: 134 --KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD---TYTAHAGAKFPIKWTAPESL 188
Query: 1132 YSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSAREELLDDQ 1191
K + K DV++ G++L E+ + M + + S ELL+
Sbjct: 189 AYNKFSIKSDVWAFGVLLWEIATYGMS----------------PYPGIDLSQVYELLEKD 232
Query: 1192 MKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNVFNN 1237
+ P E C +V E+ C + +P +RPS ++ +F
Sbjct: 233 YRMERP-EGCPE-KVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 276
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 183 bits (466), Expect = 3e-52
Identities = 66/309 (21%), Positives = 119/309 (38%), Gaps = 48/309 (15%)
Query: 946 NNLSDEFIIGSGGSGTVYKAELAN------GATVAVKKISCKDDHLLNKSFTREVKTLGR 999
NN+ IG G G V++A VAVK + + + F RE +
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 72
Query: 1000 IRHRHLVKLMGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKM-------------- 1045
+ ++VKL+G C L++EYM G + ++L +
Sbjct: 73 FDNPNIVKLLGVCAVGK--PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVS 130
Query: 1046 ---RKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLA 1102
L +L IA +A G+ YL K +HRD+ + N L+ NM + DFGL+
Sbjct: 131 SPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLS 187
Query: 1103 KALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDAT 1162
+ + +++ A ++ PE + + T + DV++ G+VL E+ S +
Sbjct: 188 RNIYSA--DYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG 245
Query: 1163 FGVEMDMVRWVEMHMEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERP 1222
+++ +V + +L E ++ + C P +RP
Sbjct: 246 MA-HEEVIYYV-----------------RDGNILACPENCPLELYNLMRLCWSKLPADRP 287
Query: 1223 SSRQVCDLL 1231
S + +L
Sbjct: 288 SFCSIHRIL 296
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (465), Expect = 5e-52
Identities = 77/315 (24%), Positives = 127/315 (40%), Gaps = 45/315 (14%)
Query: 935 DFRWEDIMGATNNLSDEFIIGSGGSGTVYKAELA------NGATVAVKKISCKDDHLLNK 988
D +WE N LS +G+G G V +A TVAVK + +
Sbjct: 15 DHKWEF---PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTERE 71
Query: 989 SFTREVKTLGRI-RHRHLVKLMGHCCNKGAGSNLLIYEYMENGSVWDWLHKQ-------- 1039
+ E+K L + H ++V L+G C G L+I EY G + ++L ++
Sbjct: 72 ALMSELKVLSYLGNHMNIVNLLGACTIGG--PTLVITEYCCYGDLLNFLRRKRDSFICSK 129
Query: 1040 ---PVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHL 1096
+ +LD E L + +A+G+ +L +HRD+ + NILL +
Sbjct: 130 TSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKI 186
Query: 1097 GDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGK 1156
DFGLA+ + D SN ++APE ++ T + DV+S GI L EL S
Sbjct: 187 CDFGLARDIKND--SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLG 244
Query: 1157 MPTDATFGVEMDMVRWVEMHMEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKT 1216
V+ + + + +L E A ++ +I C
Sbjct: 245 SSPYPGMPVDSKFYKMI----------------KEGFRMLSPEHAPA-EMYDIMKTCWDA 287
Query: 1217 SPQERPSSRQVCDLL 1231
P +RP+ +Q+ L+
Sbjct: 288 DPLKRPTFKQIVQLI 302
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (465), Expect = 7e-52
Identities = 73/320 (22%), Positives = 127/320 (39%), Gaps = 50/320 (15%)
Query: 935 DFRWEDIMGATNNLSDEFIIGSGGSGTVYKA------ELANGATVAVKKISCKDDHLLNK 988
D +WE NL ++GSG G V A + VAVK + K D +
Sbjct: 29 DLKWE-F--PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSERE 85
Query: 989 SFTREVKTLGRI-RHRHLVKLMGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNI---- 1043
+ E+K + ++ H ++V L+G C G LI+EY G + ++L +
Sbjct: 86 ALMSELKMMTQLGSHENIVNLLGACTLSG--PIYLIFEYCCYGDLLNYLRSKREKFSEDE 143
Query: 1044 ------------KMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSN 1091
+ L +E L A +A+G+E+L +HRD+ + N+L+
Sbjct: 144 IEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHG 200
Query: 1092 MEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLME 1151
+ DFGLA+ ++ D SN ++APE + T K DV+S GI+L E
Sbjct: 201 KVVKICDFGLARDIMSD--SNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWE 258
Query: 1152 LVSGKMPTDATFGVEMDMVRWVEMHMEMSGSAREELLDDQMKPLLPGEECAAYQVLEIAL 1211
+ S + V+ + + ++ +M + +++ I
Sbjct: 259 IFSLGVNPYPGIPVDANFYKLIQNGFKMD---QPFYATEEIY--------------IIMQ 301
Query: 1212 QCTKTSPQERPSSRQVCDLL 1231
C ++RPS + L
Sbjct: 302 SCWAFDSRKRPSFPNLTSFL 321
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (460), Expect = 2e-51
Identities = 59/280 (21%), Positives = 109/280 (38%), Gaps = 39/280 (13%)
Query: 954 IGSGGSGTVYKAE-LANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHC 1012
+G G G VYKA+ A K I K + L + + E+ L H ++VKL+
Sbjct: 20 LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEEL-EDYMVEIDILASCDHPNIVKLLDAF 78
Query: 1013 CNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDC 1072
+ + ++ E+ G+V + + + L + + YLH
Sbjct: 79 YYE--NNLWILIEFCAGGAVDAVMLEL------ERPLTESQIQVVCKQTLDALNYLHD-- 128
Query: 1073 VPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAY 1132
KI+HRD+K+ NIL + + L DFG++ + F G+ ++APE
Sbjct: 129 -NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI----QRRDSFIGTPYWMAPEVVM 183
Query: 1133 SLKA-----TEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSAREEL 1187
+ K DV+S+GI L+E+ + P E++ +R + +
Sbjct: 184 CETSKDRPYDYKADVWSLGITLIEMAEIEPPHH-----ELNPMRVLLKIAK--------- 229
Query: 1188 LDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQV 1227
P L + + +C + + R ++ Q+
Sbjct: 230 ---SEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQL 266
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (456), Expect = 2e-51
Identities = 62/278 (22%), Positives = 106/278 (38%), Gaps = 41/278 (14%)
Query: 953 IIGSGGSGTVYKAEL-ANGATVAVKKISCK--DDHLLNKSFTREVKTLGRIRHRHLVKLM 1009
+G G G VY A + +A+K + + + REV+ +RH ++++L
Sbjct: 13 PLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 72
Query: 1010 GHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLH 1069
G+ + LI EY G+V+ L K D + LA + Y H
Sbjct: 73 GYFHDAT--RVYLILEYAPLGTVYRELQKL-------SKFDEQRTATYITELANALSYCH 123
Query: 1070 HDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPE 1129
+++HRDIK N+LL S E + DFG + + T G+ Y+ PE
Sbjct: 124 S---KRVIHRDIKPENLLLGSAGELKIADFGWSVHA------PSSRRTTLCGTLDYLPPE 174
Query: 1130 YAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSAREELLD 1189
EK D++S+G++ E + GK P + +E
Sbjct: 175 MIEGRMHDEKVDLWSLGVLCYEFLVGKPP--------------------FEANTYQETYK 214
Query: 1190 DQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQV 1227
+ + ++ + K +P +RP R+V
Sbjct: 215 RISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREV 252
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 180 bits (458), Expect = 5e-51
Identities = 68/280 (24%), Positives = 109/280 (38%), Gaps = 44/280 (15%)
Query: 954 IGSGGSGTVYKAE-LANGATVAVKKI--SCKDDHLLNKSFTREVKTLGRIRHRHLVKLMG 1010
IG G G VY A + N VA+KK+ S K + + +EV+ L ++RH + ++ G
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 1011 HCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHH 1070
+ + L+ EY + +K L + G QG+ YLH
Sbjct: 83 CYLREH--TAWLVMEYCLGSASDLLEVH-------KKPLQEVEIAAVTHGALQGLAYLHS 133
Query: 1071 DCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEY 1130
++HRD+K+ NILL LGDFG A + F G+ ++APE
Sbjct: 134 ---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIM--------APANSFVGTPYWMAPEV 182
Query: 1131 AYSL---KATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSAREEL 1187
++ + K DV+S+GI +EL K P + + +
Sbjct: 183 ILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-----LYHIAQ--------- 228
Query: 1188 LDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQV 1227
P L + C + PQ+RP+S +
Sbjct: 229 ---NESPALQSGHWSE-YFRNFVDSCLQKIPQDRPTSEVL 264
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (455), Expect = 1e-50
Identities = 73/317 (23%), Positives = 131/317 (41%), Gaps = 46/317 (14%)
Query: 946 NNLSDEFIIGSGGSGTVYKAELANGAT---VAVKKISCKDDHLLNKSFTREVKTLGRI-R 1001
N++ + +IG G G V KA + A+K++ ++ F E++ L ++
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 1002 HRHLVKLMGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVN---------IKMRKSLDWE 1052
H +++ L+G C ++G L EY +G++ D+L K V +L +
Sbjct: 70 HPNIINLLGACEHRG--YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 127
Query: 1053 ARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSN 1112
L A +A+G++YL + +HRD+ + NIL+ N A + DFGL++
Sbjct: 128 QLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRG-----QEV 179
Query: 1113 TESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRW 1172
T ++A E T DV+S G++L E+VS M
Sbjct: 180 YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT----PYCGMTCAEL 235
Query: 1173 VEMHMEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLL 1232
E + + DD++ ++ QC + P ERPS Q+ L
Sbjct: 236 YEKLPQGYRLEKPLNCDDEVY--------------DLMRQCWREKPYERPSFAQILVSL- 280
Query: 1233 NVFNNRIVDFDKLHIDP 1249
NR+++ K +++
Sbjct: 281 ----NRMLEERKTYVNT 293
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (442), Expect = 2e-49
Identities = 64/286 (22%), Positives = 116/286 (40%), Gaps = 38/286 (13%)
Query: 954 IGSGGSGTVYKAEL----ANGATVAVKKISCK--DDHLLNKSFTREVKTLGRIRHRHLVK 1007
+G G G V + E +VAVK + F REV + + HR+L++
Sbjct: 16 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 1008 LMGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEY 1067
L G ++ E GS+ D L K + + AV +A+G+ Y
Sbjct: 76 LYGVVLT---PPMKMVTELAPLGSLLDRLRKH------QGHFLLGTLSRYAVQVAEGMGY 126
Query: 1068 LHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIA 1127
L + +HRD+ + N+LL + +GDFGL +AL ++ + + + + A
Sbjct: 127 LES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN-DDHYVMQEHRKVPFAWCA 182
Query: 1128 PEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMVRWVEMHMEMSGSAREE 1186
PE + + D + G+ L E+ + G+ P G ++ +
Sbjct: 183 PESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI----------------LHK 226
Query: 1187 LLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLL 1232
+ + + P E+C + + +QC P++RP+ + D LL
Sbjct: 227 IDKEGERLPRP-EDCPQ-DIYNVMVQCWAHKPEDRPTFVALRDFLL 270
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (429), Expect = 3e-47
Identities = 58/275 (21%), Positives = 114/275 (41%), Gaps = 36/275 (13%)
Query: 954 IGSGGSGTVYKA-ELANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHC 1012
IG G SGTVY A ++A G VA+++++ + E+ + ++ ++V +
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMN-LQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 1013 CNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDC 1072
++ EY+ GS+ D + + + D + Q +E+LH +
Sbjct: 87 LVG--DELWVVMEYLAGGSLTDVVTETCM--------DEGQIAAVCRECLQALEFLHSN- 135
Query: 1073 VPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAY 1132
+++HRDIKS NILL + L DFG + + G+ ++APE
Sbjct: 136 --QVIHRDIKSDNILLGMDGSVKLTDFGFCAQI----TPEQSKRSTMVGTPYWMAPEVVT 189
Query: 1133 SLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSAREELLDDQM 1192
K D++S+GI+ +E++ G+ P ++ + L+
Sbjct: 190 RKAYGPKVDIWSLGIMAIEMIEGEPP-----------------YLNENPLRALYLIATNG 232
Query: 1193 KPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQV 1227
P L E + + +C ++R S++++
Sbjct: 233 TPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKEL 267
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 168 bits (426), Expect = 3e-47
Identities = 68/301 (22%), Positives = 129/301 (42%), Gaps = 37/301 (12%)
Query: 946 NNLSDEF----IIGSGGSGTVYKAE-LANGATVAVKKISCK--DDHLLNKSFTREVKTLG 998
++LSD + I+G GG V+ A L VAVK + D F RE +
Sbjct: 3 SHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAA 62
Query: 999 RIRHRHLVKLMGHCCNKGAGSNL--LIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLK 1056
+ H +V + + L ++ EY++ ++ D +H + + + ++
Sbjct: 63 ALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE-------GPMTPKRAIE 115
Query: 1057 IAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESN 1116
+ Q + + H I+HRD+K +NI++ + + DFG+A+A+ + NS T++
Sbjct: 116 VIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTA 172
Query: 1117 TWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMH 1176
G+ Y++PE A + DVYS+G VL E+++G+ P + +
Sbjct: 173 A-VIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGD--SPVSVAYQHVRE 229
Query: 1177 MEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSS-RQVCDLLLNVF 1235
+ SAR E L + ++ L+ +P+ R + ++ L+ V
Sbjct: 230 DPIPPSARHEGLSADLDAVV--------------LKALAKNPENRYQTAAEMRADLVRVH 275
Query: 1236 N 1236
N
Sbjct: 276 N 276
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (429), Expect = 4e-47
Identities = 63/285 (22%), Positives = 112/285 (39%), Gaps = 39/285 (13%)
Query: 953 IIGSGGSGTVYKAELAN-----GATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVK 1007
++GSG GTVYK VA+K++ NK E + + + H+ +
Sbjct: 16 VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 75
Query: 1008 LMGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEY 1067
L+G C + LI + M G + D++ + + ++ + L V +A+G+ Y
Sbjct: 76 LLGICLT---STVQLITQLMPFGCLLDYVREH------KDNIGSQYLLNWCVQIAKGMNY 126
Query: 1068 LHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIA 1127
L +++HRD+ + N+L+ + + DFGLAK L ++A
Sbjct: 127 LED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEYHAEGGKVPIKWMA 181
Query: 1128 PEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMVRWVEMHMEMSGSAREE 1186
E T + DV+S G+ + EL++ G P D + S
Sbjct: 182 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-----------------GIPASEISS 224
Query: 1187 LLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLL 1231
+L+ + P C V I ++C RP R++
Sbjct: 225 ILEKGERLPQP-PICTI-DVYMIMVKCWMIDADSRPKFRELIIEF 267
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 169 bits (430), Expect = 7e-47
Identities = 55/278 (19%), Positives = 108/278 (38%), Gaps = 36/278 (12%)
Query: 953 IIGSGGSGTVYKA-ELANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGH 1011
+G+G G V++ E A G A K + + ++ +E++T+ +RH LV L
Sbjct: 33 ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDK-ETVRKEIQTMSVLRHPTLVNLHDA 91
Query: 1012 CCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHD 1071
+ ++IYE+M G +++ + + + + ++ + +G+ ++H +
Sbjct: 92 FEDD--NEMVMIYEFMSGGELFEKVADE------HNKMSEDEAVEYMRQVCKGLCHMHEN 143
Query: 1072 CVPKILHRDIKSSNILLDS--NMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPE 1129
+H D+K NI+ + + E L DFGL L +S G+ + APE
Sbjct: 144 N---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHL-----DPKQSVKVTTGTAEFAAPE 195
Query: 1130 YAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSAREELLD 1189
A D++S+G++ L+SG P E + S +D
Sbjct: 196 VAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET-------LRNVKSCDWN---MD 245
Query: 1190 DQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQV 1227
D + + + + P R + Q
Sbjct: 246 DSAFSGISED------GKDFIRKLLLADPNTRMTIHQA 277
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (423), Expect = 7e-47
Identities = 64/284 (22%), Positives = 109/284 (38%), Gaps = 39/284 (13%)
Query: 953 IIGSGGSGTVYKAELAN----GATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKL 1008
IG G G V++ + VA+K + + F +E T+ + H H+VKL
Sbjct: 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73
Query: 1009 MGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYL 1068
+G +I E G + +L + SLD + + A L+ + YL
Sbjct: 74 IGVITE---NPVWIIMELCTLGELRSFLQVRK------YSLDLASLILYAYQLSTALAYL 124
Query: 1069 HHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAP 1128
+ +HRDI + N+L+ SN LGDFGL++ + +S + ++AP
Sbjct: 125 ES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAP 178
Query: 1129 EYAYSLKATEKCDVYSMGIVLME-LVSGKMPTDATFGVEMDMVRWVEMHMEMSGSAREEL 1187
E + T DV+ G+ + E L+ G P D++ +E +
Sbjct: 179 ESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK--NNDVIGRIENGERL-------- 228
Query: 1188 LDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLL 1231
M P P + + +C P RP ++ L
Sbjct: 229 ---PMPPNCPPT------LYSLMTKCWAYDPSRRPRFTELKAQL 263
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (424), Expect = 9e-47
Identities = 66/301 (21%), Positives = 112/301 (37%), Gaps = 43/301 (14%)
Query: 953 IIGSGGSGTVYKA-ELANGATVAVKKISCK--DDHLLNKSFTREVKTLGRIRHRHLVKLM 1009
I+G G TV A ELA A+K + + TRE + R+ H VKL
Sbjct: 15 ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY 74
Query: 1010 GHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLH 1069
+ Y +NG + ++ K S D A+ V L
Sbjct: 75 FTFQDDE--KLYFGLSYAKNGELLKYIRKI-------GSFDETCTRFYT---AEIVSALE 122
Query: 1070 HDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPE 1129
+ I+HRD+K NILL+ +M + DFG AK V S F G+ Y++PE
Sbjct: 123 YLHGKGIIHRDLKPENILLNEDMHIQITDFGTAK--VLSPESKQARANSFVGTAQYVSPE 180
Query: 1130 YAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSAREELLD 1189
A + D++++G ++ +LV+G P A + + +++ E+
Sbjct: 181 LLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLI-----FQKIIKLEYDFPEK-FF 234
Query: 1190 DQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQV--CDLLLN--VFNNRIVDFDKL 1245
+ + L+ + +R ++ L F + V ++ L
Sbjct: 235 PKARDLV--------------EKLLVLDATKRLGCEEMEGYGPLKAHPFFES--VTWENL 278
Query: 1246 H 1246
H
Sbjct: 279 H 279
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (421), Expect = 3e-46
Identities = 63/294 (21%), Positives = 118/294 (40%), Gaps = 37/294 (12%)
Query: 953 IIGSGGSGTVYKA------ELANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLV 1006
+G G G V +A + A TVAVK + H +++ E+K L I H V
Sbjct: 20 PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 79
Query: 1007 KLMGHCCNKGAGSNLLIYEYMENGSVWDWLHKQ---------PVNIKMRKSLDWEARLKI 1057
+ C K G ++I E+ + G++ +L + + L E +
Sbjct: 80 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 139
Query: 1058 AVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNT 1117
+ +A+G+E+L K +HRD+ + NILL + DFGLA+ + +D +
Sbjct: 140 SFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD--PDYVRKG 194
Query: 1118 WFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHM 1177
++APE + T + DV+S G++L E+ S ++ + R +
Sbjct: 195 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL---- 250
Query: 1178 EMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLL 1231
+ + + ++ + L C P +RP+ ++ + L
Sbjct: 251 -------------KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 291
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (419), Expect = 6e-46
Identities = 56/287 (19%), Positives = 104/287 (36%), Gaps = 34/287 (11%)
Query: 954 IGSGGSGTVYKAEL------ANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVK 1007
+G G G VY+ VA+K ++ F E + H+V+
Sbjct: 28 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 87
Query: 1008 LMGHCCNKGAGSNLLIYEYMENGSVWDWLH---KQPVNIKMRKSLDWEARLKIAVGLAQG 1064
L+G L+I E M G + +L N + +++A +A G
Sbjct: 88 LLGVVSQGQ--PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 145
Query: 1065 VEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYG 1124
+ YL+ K +HRD+ + N ++ + +GDFG+ + + E
Sbjct: 146 MAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET--DYYRKGGKGLLPVR 200
Query: 1125 YIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSAR 1184
+++PE T DV+S G+VL E+ + + + + ME
Sbjct: 201 WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQ----GLSNEQVLRFVME------ 250
Query: 1185 EELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLL 1231
LL + + E+ C + +P+ RPS ++ +
Sbjct: 251 --------GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 289
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 165 bits (418), Expect = 3e-45
Identities = 52/277 (18%), Positives = 102/277 (36%), Gaps = 36/277 (12%)
Query: 954 IGSGGSGTVYKA-ELANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHC 1012
+GSG G V++ E A G K I+ L + E+ + ++ H L+ L
Sbjct: 37 LGSGAFGVVHRCVEKATGRVFVAKFIN-TPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 95
Query: 1013 CNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDC 1072
+K +LI E++ G ++D + + + + +G++++H
Sbjct: 96 EDK--YEMVLILEFLSGGELFDRIAAE------DYKMSEAEVINYMRQACEGLKHMHE-- 145
Query: 1073 VPKILHRDIKSSNILLDSNMEAH--LGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEY 1130
I+H DIK NI+ ++ + + DFGLA L D E + + APE
Sbjct: 146 -HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD-----EIVKVTTATAEFAAPEI 199
Query: 1131 AYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSAREELLDD 1190
D++++G++ L+SG P D + ++ E+
Sbjct: 200 VDREPVGFYTDMWAIGVLGYVLLSGLSPFAG-----EDDLETLQNVKRCDWEFDEDAFSS 254
Query: 1191 QMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQV 1227
+ E + + P++R +
Sbjct: 255 -----VSPE------AKDFIKNLLQKEPRKRLTVHDA 280
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 162 bits (411), Expect = 5e-45
Identities = 56/297 (18%), Positives = 99/297 (33%), Gaps = 33/297 (11%)
Query: 954 IGSGGSGTVYKAE-LANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHC 1012
IGSG G +Y +A G VA+K K H E K ++ + + C
Sbjct: 15 IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH---PQLHIESKIYKMMQGGVGIPTIRWC 71
Query: 1013 CNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDC 1072
+G N+++ E + + + + L +A + +EY+H
Sbjct: 72 GAEG-DYNVMVMELLGPSLEDLFNFC-------SRKFSLKTVLLLADQMISRIEYIHS-- 121
Query: 1073 VPKILHRDIKSSNIL---LDSNMEAHLGDFGLAKALVEDYNS---NTESNTWFAGSYGYI 1126
+HRD+K N L ++ DFGLAK + N G+ Y
Sbjct: 122 -KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180
Query: 1127 APEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSAREE 1186
+ ++ + + D+ S+G VLM G +P E +
Sbjct: 181 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQ------GLKAATKRQKYERISEKKMS 234
Query: 1187 LLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNVFNNRIVDFD 1243
+ + P E C ++P + L N+F+ + +D
Sbjct: 235 TPIEVLCKGYPSE------FATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYD 285
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 160 bits (406), Expect = 4e-44
Identities = 53/288 (18%), Positives = 107/288 (37%), Gaps = 35/288 (12%)
Query: 945 TNNLSDEF----IIGSGGSGTVYKAE-LANGATVAVKKISCKDDHLLNKSFTREVKTLGR 999
++ D + ++G+G V AE VA+K I+ K S E+ L +
Sbjct: 4 AEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHK 63
Query: 1000 IRHRHLVKLMGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAV 1059
I+H ++V L + G LI + + G ++D + + + ++
Sbjct: 64 IKHPNIVALDDIYESGG--HLYLIMQLVSGGELFDRIVE-------KGFYTERDASRLIF 114
Query: 1060 GLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWF 1119
+ V+YLH + + LD + + + DFGL+K +T
Sbjct: 115 QVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLST-----A 169
Query: 1120 AGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEM 1179
G+ GY+APE ++ D +S+G++ L+ G P ++
Sbjct: 170 CGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKL------------ 217
Query: 1180 SGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQV 1227
E++L + + P + + + + P++R + Q
Sbjct: 218 ----FEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQA 261
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (399), Expect = 2e-43
Identities = 61/297 (20%), Positives = 117/297 (39%), Gaps = 43/297 (14%)
Query: 953 IIGSGGSGTVYKAEL--------ANGATVAVKKISCKDDHLLNKSFTREVKTLGRI-RHR 1003
+G G G V AE VAVK + E++ + I +H+
Sbjct: 20 PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 79
Query: 1004 HLVKLMGHCCNKGAGSNLLIYEYMENGSVWDWLHKQ---------PVNIKMRKSLDWEAR 1054
+++ L+G C G +I EY G++ ++L + + + L +
Sbjct: 80 NIINLLGACTQDG--PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 137
Query: 1055 LKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTE 1114
+ A +A+G+EYL K +HRD+ + N+L+ + + DFGLA+ +
Sbjct: 138 VSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 194
Query: 1115 SNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVE 1174
+N ++APE + T + DV+S G++L E+ +
Sbjct: 195 TNGR--LPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS---------------- 236
Query: 1175 MHMEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLL 1231
+ + +LL + + P C ++ + C P +RP+ +Q+ + L
Sbjct: 237 PYPGVPVEELFKLLKEGHRMDKP-SNCTN-ELYMMMRDCWHAVPSQRPTFKQLVEDL 291
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 157 bits (397), Expect = 3e-43
Identities = 66/291 (22%), Positives = 118/291 (40%), Gaps = 49/291 (16%)
Query: 953 IIGSGGSGTVYKAE-LANGATVAVKKI--------SCKDDHLLNKSFTREVKTLGRIR-H 1002
I+G G S V + AVK I S ++ L ++ +EV L ++ H
Sbjct: 10 ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGH 69
Query: 1003 RHLVKLMGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLA 1062
++++L L+++ M+ G ++D+L + + +L + KI L
Sbjct: 70 PNIIQLKDTYETNT--FFFLVFDLMKKGELFDYLTE-------KVTLSEKETRKIMRALL 120
Query: 1063 QGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGS 1122
+ + LH I+HRD+K NILLD +M L DFG + L E G+
Sbjct: 121 EVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQL-----DPGEKLREVCGT 172
Query: 1123 YGYIAPEYAYS------LKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMH 1176
Y+APE ++ D++S G+++ L++G P +M M+R +
Sbjct: 173 PSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHR--KQMLMLRMIMSG 230
Query: 1177 MEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQV 1227
GS + D +K L+ + PQ+R ++ +
Sbjct: 231 NYQFGSPEWDDYSDTVKDLV--------------SRFLVVQPQKRYTAEEA 267
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (399), Expect = 7e-43
Identities = 64/290 (22%), Positives = 120/290 (41%), Gaps = 27/290 (9%)
Query: 953 IIGSGGSGTVYKA-ELANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGH 1011
IG G G V A + N VA+KKIS + + RE+K L R RH +++ +
Sbjct: 15 YIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDI 74
Query: 1012 CCNKG--AGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLH 1069
++ + ++ ++ L Q L + + +G++Y+H
Sbjct: 75 IRAPTIEQMKDVYLVTHLMGADLYKLLKTQH--------LSNDHICYFLYQILRGLKYIH 126
Query: 1070 HDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPE 1129
+LHRD+K SN+LL++ + + DFGLA+ D++ T + + Y APE
Sbjct: 127 S---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTG-FLTEYVATRWYRAPE 182
Query: 1130 YAY-SLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEM--------DMVRWVEMHMEMS 1180
S T+ D++S+G +L E++S + ++ +++ ++
Sbjct: 183 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 242
Query: 1181 GSAREELLDDQMKPLLPGEECAAY---QVLEIALQCTKTSPQERPSSRQV 1227
AR LL K +P + L++ + +P +R Q
Sbjct: 243 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 292
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 3e-42
Identities = 46/277 (16%), Positives = 106/277 (38%), Gaps = 37/277 (13%)
Query: 954 IGSGGSGTVYKA-ELANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHC 1012
+G G G V++ E ++ T K + K +E+ L RHR+++ L
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD--QVLVKKEISILNIARHRNILHLHESF 70
Query: 1013 CNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDC 1072
+ ++I+E++ +++ ++ L+ + + + +++LH
Sbjct: 71 ESME--ELVMIFEFISGLDIFERINTS------AFELNEREIVSYVHQVCEALQFLHS-- 120
Query: 1073 VPKILHRDIKSSNILLDSNMEAH--LGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEY 1130
I H DI+ NI+ + + + +FG A+ L ++ + Y APE
Sbjct: 121 -HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL-----KPGDNFRLLFTAPEYYAPEV 174
Query: 1131 AYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSAREELLDD 1190
+ D++S+G ++ L+SG P A ++ +E M + EE +
Sbjct: 175 HQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQI-----IENIMNAEYTFDEEAFKE 229
Query: 1191 QMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQV 1227
+ + ++ + + R ++ +
Sbjct: 230 -----------ISIEAMDFVDRLLVKERKSRMTASEA 255
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 154 bits (390), Expect = 3e-42
Identities = 46/306 (15%), Positives = 94/306 (30%), Gaps = 39/306 (12%)
Query: 954 IGSGGSGTVYKAE-LANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHC 1012
IG G G +++ L N VA+K + D E +T + + + +
Sbjct: 13 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA---PQLRDEYRTYKLLAGCTGIPNVYYF 69
Query: 1013 CNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDC 1072
+G + ++ + S+ D L + + A + V+ +H
Sbjct: 70 GQEG--LHNVLVIDLLGPSLEDLLDLCG------RKFSVKTVAMAAKQMLARVQSIHE-- 119
Query: 1073 VPKILHRDIKSSNILLDSNMEAH-----LGDFGLAKALVEDYNSNT---ESNTWFAGSYG 1124
+++RDIK N L+ + + DFG+ K + +G+
Sbjct: 120 -KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTAR 178
Query: 1125 YIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSAR 1184
Y++ + + + D+ ++G V M + G +P + S R
Sbjct: 179 YMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLR 238
Query: 1185 EELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNVFNNRIVDFDK 1244
E + P E + + P + L V D
Sbjct: 239 E------LCAGFPEE------FYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTED- 285
Query: 1245 LHIDPY 1250
+ +
Sbjct: 286 ---ENF 288
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (389), Expect = 8e-42
Identities = 59/298 (19%), Positives = 105/298 (35%), Gaps = 43/298 (14%)
Query: 953 IIGSGGSGTVYKAE-LANGATVAVKKISCKDDHLLN--KSFTREVKTLGR-IRHRHLVKL 1008
++G G G V+ AE A+K + + + + E + L H L +
Sbjct: 9 MLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHM 68
Query: 1009 MGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYL 1068
K + + EY+ G + + D A + G+++L
Sbjct: 69 FCTFQTKE--NLFFVMEYLNGGDLMYHIQS-------CHKFDLSRATFYAAEIILGLQFL 119
Query: 1069 HHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAP 1128
H I++RD+K NILLD + + DFG+ K + F G+ YIAP
Sbjct: 120 HS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG----DAKTNTFCGTPDYIAP 172
Query: 1129 EYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSAREELL 1188
E K D +S G++L E++ G+ P G EEL
Sbjct: 173 EILLGQKYNHSVDWWSFGVLLYEMLIGQSP--------------------FHGQDEEELF 212
Query: 1189 DDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNVFNNRIVDFDKLH 1246
+ ++ ++ P++R R D+ + I ++++L
Sbjct: 213 HSIRMDNPFYPRWLEKEAKDLLVKLFVREPEKRLGVRG--DIRQHPLFREI-NWEELE 267
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (384), Expect = 5e-41
Identities = 58/282 (20%), Positives = 110/282 (39%), Gaps = 38/282 (13%)
Query: 953 IIGSGGSGTVYKAE-LANGATVAVKKISCKDDHLLNKSFTREVKTLGRI-RHRHLVKLMG 1010
++G G +G V + A+K + REV+ R + H+V+++
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVD 72
Query: 1011 HCCNKGAGSN--LLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYL 1068
N AG L++ E ++ G ++ + + ++ +I + + ++YL
Sbjct: 73 VYENLYAGRKCLLIVMECLDGGELFSRIQDRG-----DQAFTEREASEIMKSIGEAIQYL 127
Query: 1069 HHDCVPKILHRDIKSSNILLDSNME---AHLGDFGLAKALVEDYNSNTESNTWFAGSYGY 1125
H I HRD+K N+L S L DFG AK + T T + Y
Sbjct: 128 HS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY-----Y 179
Query: 1126 IAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSARE 1185
+APE K + CD++S+G+++ L+ G P + + +S +
Sbjct: 180 VAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYS------------NHGLAISPGMKT 227
Query: 1186 ELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQV 1227
+ Q + P + +V + KT P +R + +
Sbjct: 228 RIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEF 269
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (381), Expect = 6e-41
Identities = 71/294 (24%), Positives = 115/294 (39%), Gaps = 40/294 (13%)
Query: 953 IIGSGGSGTVYKAE-LANGATVAVKKISC----KDDHLLNKSFTREVKTLGRIRHRHLVK 1007
+G G TVYKA VA+KKI + +N++ RE+K L + H +++
Sbjct: 5 FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 64
Query: 1008 LMGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEY 1067
L+ +K + L++++ME L + QG+EY
Sbjct: 65 LLDAFGHKS--NISLVFDFMETDLEVIIKDN-------SLVLTPSHIKAYMLMTLQGLEY 115
Query: 1068 LHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIA 1127
LH ILHRD+K +N+LLD N L DFGLAK + S + T + Y A
Sbjct: 116 LHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAK----SFGSPNRAYTHQVVTRWYRA 168
Query: 1128 PEYAYSLKA-TEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSAREE 1186
PE + + D++++G +L EL+ ++ + E G+ EE
Sbjct: 169 PELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ-----LTRIFETLGTPTEE 223
Query: 1187 LLDDQMK-------------PLLPGEECAAYQVLEIALQCTKTSPQERPSSRQV 1227
D PL A +L++ +P R ++ Q
Sbjct: 224 QWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA 277
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (375), Expect = 4e-40
Identities = 60/289 (20%), Positives = 107/289 (37%), Gaps = 24/289 (8%)
Query: 954 IGSGGSGTVYKAE--LANGATVAVKKISCK-DDHLLNKSFTREV---KTLGRIRHRHLVK 1007
IG G G V+KA G VA+K++ + + + S REV + L H ++V+
Sbjct: 15 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 74
Query: 1008 LMGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEY 1067
L C + E+ + + E + L +G+++
Sbjct: 75 LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLD---KVPEPGVPTETIKDMMFQLLRGLDF 131
Query: 1068 LHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIA 1127
LH +++HRD+K NIL+ S+ + L DFGLA+ S + T + Y A
Sbjct: 132 LHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY-----SFQMALTSVVVTLWYRA 183
Query: 1128 PEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEM-------DMVRWVEMHMEMS 1180
PE D++S+G + E+ K + V+ + E
Sbjct: 184 PEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 243
Query: 1181 GSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCD 1229
R+ +P+ ++ L+C +P +R S+
Sbjct: 244 ALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (374), Expect = 4e-40
Identities = 61/295 (20%), Positives = 107/295 (36%), Gaps = 47/295 (15%)
Query: 947 NLSDEF----IIGSGGSGTVYKA-ELANGATVAVKKISCK-----DDHLLNKSFTREVKT 996
N+ D + +GSG V K E + G A K I + + + REV
Sbjct: 7 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 66
Query: 997 LGRIRHRHLVKLMGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLK 1056
L I+H +++ L NK +LI E + G ++D+L + ++SL E +
Sbjct: 67 LKEIQHPNVITLHEVYENKT--DVILILELVAGGELFDFLAE-------KESLTEEEATE 117
Query: 1057 IAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEA----HLGDFGLAKALVEDYNSN 1112
+ GV YLH I H D+K NI+L + DFGLA +
Sbjct: 118 FLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI-----DF 169
Query: 1113 TESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRW 1172
G+ ++APE + D++S+G++ L+SG P
Sbjct: 170 GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG-----DTKQET 224
Query: 1173 VEMHMEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQV 1227
+ ++ +E + + + P++R + +
Sbjct: 225 LANVSAVNYEFEDEYFSN-----TSAL------AKDFIRRLLVKDPKKRMTIQDS 268
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 148 bits (374), Expect = 9e-40
Identities = 60/299 (20%), Positives = 111/299 (37%), Gaps = 47/299 (15%)
Query: 953 IIGSGGSGTVYKAE-LANGATVAVKKISCKDDHLLN--KSFTREVKTLGRIRHRHLVKLM 1009
+G+G G V+ NG A+K + + L + E L + H ++++
Sbjct: 11 TLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMW 70
Query: 1010 GHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLH 1069
G + +I +Y+E G ++ L R A+ L
Sbjct: 71 GTFQDAQ--QIFMIMDYIEGGELFSLLR-----KSQRFPNPVAKFY-----AAEVCLALE 118
Query: 1070 HDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPE 1129
+ I++RD+K NILLD N + DFG AK + + + G+ YIAPE
Sbjct: 119 YLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYT-------LCGTPDYIAPE 171
Query: 1130 YAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSAREELLD 1189
+ + D +S GI++ E+++G P + + ++ E + +
Sbjct: 172 VVSTKPYNKSIDWWSFGILIYEMLAGYTPFY-----DSNTMKTYEKILNAELRFPPF-FN 225
Query: 1190 DQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQV-CDLLLN--VFNNRIVDFDKL 1245
+ +K LL + +R + Q + + N F V ++KL
Sbjct: 226 EDVKDLL--------------SRLITRDLSQRLGNLQNGTEDVKNHPWFKE--VVWEKL 268
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 146 bits (370), Expect = 1e-39
Identities = 62/292 (21%), Positives = 115/292 (39%), Gaps = 37/292 (12%)
Query: 954 IGSGGSGTVYKAELANGATVAVKKISC-KDDHLLNKSFTREVKTLGRIRHRHLVKLMGHC 1012
IG G G VYKA+ G T A+KKI K+D + + RE+ L ++H ++VKL
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 1013 CNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDC 1072
K +L++E+++ L+ + L G+ Y H
Sbjct: 70 HTKK--RLVLVFEHLDQDLKKLLDVC-------EGGLESVTAKSFLLQLLNGIAYCHD-- 118
Query: 1073 VPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAY 1132
++LHRD+K N+L++ E + DFGLA+A T + Y AP+
Sbjct: 119 -RRVLHRDLKPQNLLINREGELKIADFGLARAF----GIPVRKYTHEIVTLWYRAPDVLM 173
Query: 1133 SLKA-TEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSAREELLDD- 1190
K + D++S+G + E+V+G + + + G+ + +
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ-----LMRIFRILGTPNSKNWPNV 228
Query: 1191 -------------QMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCD 1229
+ P + +++ + K P +R +++Q +
Sbjct: 229 TELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (375), Expect = 1e-39
Identities = 65/293 (22%), Positives = 116/293 (39%), Gaps = 33/293 (11%)
Query: 953 IIGSGGSGTVYKAEL-ANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGH 1011
+IG+G G VY+A+L +G VA+KK+ + RE++ + ++ H ++V+L
Sbjct: 27 VIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNIVRLRYF 81
Query: 1012 CCNKGAGSNL----LIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEY 1067
+ G + L+ +Y+ H + +++L L + + Y
Sbjct: 82 FYSSGEKKDEVYLNLVLDYVPETVYRVARH----YSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 1068 LHHDCVPKILHRDIKSSNILLDSNMEAH-LGDFGLAKALVEDYNSNTESNTWFAGSYGYI 1126
+H I HRDIK N+LLD + L DFG AK LV + + + + Y
Sbjct: 138 IHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-----YR 189
Query: 1127 AP-EYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEM------DMVRWVEMHMEM 1179
AP + T DV+S G VL EL+ G+ GV+ + +
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 249
Query: 1180 SGSAREELLDDQMKPLLPGEECAAY---QVLEIALQCTKTSPQERPSSRQVCD 1229
E Q+K + + + + + + +P R + + C
Sbjct: 250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 148 bits (374), Expect = 3e-39
Identities = 57/310 (18%), Positives = 105/310 (33%), Gaps = 45/310 (14%)
Query: 946 NNLSDEFIIGSGGSGTVYKAE-LANGATVAVKKISC-----KDDHLLNKSFTREVKTLGR 999
N+ S IIG GG G VY G A+K + K L + + +
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 1000 IRHRHLVKLMGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAV 1059
+V + I + M G + L + V A
Sbjct: 64 GDCPFIVCMSYAFHTPD--KLSFILDLMNGGDLHYHLSQHGVF-------SEADMRFYAA 114
Query: 1060 GLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWF 1119
+ G+E++H+ +++RD+K +NILLD + + D GLA +
Sbjct: 115 EIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK------KPHAS 165
Query: 1120 AGSYGYIAPEYAYSLKA-TEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHME 1178
G++GY+APE A D +S+G +L +L+ G P + + + + M
Sbjct: 166 VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMA 225
Query: 1179 MSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVC--DLLLNVFN 1236
+ + +++ LL + R ++ + F
Sbjct: 226 VE---LPDSFSPELRSLL--------------EGLLQRDVNRRLGCLGRGAQEVKESPFF 268
Query: 1237 NRIVDFDKLH 1246
+ D+ +
Sbjct: 269 RSL-DWQMVF 277
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 3e-38
Identities = 61/302 (20%), Positives = 112/302 (37%), Gaps = 41/302 (13%)
Query: 954 IGSGGSGTVYKAE-LANGATVAVKKISC-KDDHLLNKSFTREVKTLGRIRHRHLVKLMGH 1011
IG G G V+KA G VA+KK+ + + RE+K L ++H ++V L+
Sbjct: 18 IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 77
Query: 1012 CCNKGA------GSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGV 1065
C K + GS L++++ E+ + ++ + +
Sbjct: 78 CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNV-------LVKFTLSEIKRV---MQMLL 127
Query: 1066 EYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGY 1125
L++ KILHRD+K++N+L+ + L DFGLA+A NS T + Y
Sbjct: 128 NGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWY 187
Query: 1126 IAPEYAYSLKA-TEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSAR 1184
PE + D++ G ++ E+ + + + ++ GS
Sbjct: 188 RPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGN-----TEQHQLALISQLCGSIT 242
Query: 1185 EELLDD-------------QMKPLLPGEECAAYQVLEIAL----QCTKTSPQERPSSRQV 1227
E+ + + + + AY AL + P +R S
Sbjct: 243 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302
Query: 1228 CD 1229
+
Sbjct: 303 LN 304
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 1e-37
Identities = 56/291 (19%), Positives = 100/291 (34%), Gaps = 37/291 (12%)
Query: 954 IGSGGSGTVYKAE-LANGATVAVKKISC-KDDHLLNKSFTREVKTLGRIRHRHLVKLMGH 1011
IG G G VYKA G VA+KKI + + + RE+ L + H ++VKL+
Sbjct: 10 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 1012 CCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHD 1071
+ L + + + ++ + L QG+ + H
Sbjct: 70 IHTEN---KLYLVFEFLHQDLKKFMDA-----SALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 1072 CVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPE-Y 1130
+LHRD+K N+L+++ L DFGLA+A + T + Y APE
Sbjct: 122 R---VLHRDLKPQNLLINTEGAIKLADFGLARAF----GVPVRTYTHEVVTLWYRAPEIL 174
Query: 1131 AYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSAREELLDD 1190
+ D++S+G + E+V+ + + + G+ E +
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPG-----DSEIDQLFRIFRTLGTPDEVVWPG 229
Query: 1191 QM--------------KPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQV 1227
+ + Q P +R S++
Sbjct: 230 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 2e-37
Identities = 58/286 (20%), Positives = 107/286 (37%), Gaps = 27/286 (9%)
Query: 954 IGSGGSGTVYKAE-LANGATVAVKKISC-KDDHLLNKSFTREVKTLGRIRHRHLVKLMGH 1011
IG G GTV+KA+ VA+K++ DD + S RE+ L ++H+++V+L
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 1012 CCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHD 1071
+ L++E+ + + LD E Q ++ L
Sbjct: 70 LHSDK--KLTLVFEFCDQDLKKYFDS-------CNGDLDPEIVKSFL---FQLLKGLGFC 117
Query: 1072 CVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYA 1131
+LHRD+K N+L++ N E L +FGLA+A + +
Sbjct: 118 HSRNVLHRDLKPQNLLINRNGELKLANFGLARAF---GIPVRCYSAEVVTLWYRPPDVLF 174
Query: 1132 YSLKATEKCDVYSMGIVLMELVSGKMP---TDATFGVEMDMVRWVEMHMEMSGSAREELL 1188
+ + D++S G + EL + P + + R + E + +L
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP 234
Query: 1189 DDQMKPLLPGEECAAY-------QVLEIALQCTKTSPQERPSSRQV 1227
D + P+ P ++ K +P +R S+ +
Sbjct: 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 2e-37
Identities = 54/316 (17%), Positives = 125/316 (39%), Gaps = 39/316 (12%)
Query: 933 KRDFRWEDIMGATNNLSDEF----IIGSGGSGTVYKA-ELANGATVAVKKISCK-DDHLL 986
+ F +++ + + +GSG G V A + GA VA+KK+ L
Sbjct: 1 RSGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELF 60
Query: 987 NKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSN----LLIYEYMENGSVWDWLHKQPVN 1042
K RE++ L +RH +++ L+ + L+ +M G+ L K
Sbjct: 61 AKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMK---- 114
Query: 1043 IKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLA 1102
+ L + + + +G+ Y+H I+HRD+K N+ ++ + E + DFGLA
Sbjct: 115 ---HEKLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLA 168
Query: 1103 KALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDAT 1162
+ +++E + + ++ T+ D++S+G ++ E+++GK +
Sbjct: 169 R------QADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGS 222
Query: 1163 FGVEMDMV-----------RWVEMHMEMSGSAREELLDDQMKPLLPGEECAAYQVLEIAL 1211
++ + + + + + L + + K A+ + +
Sbjct: 223 DHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLE 282
Query: 1212 QCTKTSPQERPSSRQV 1227
+ ++R ++ +
Sbjct: 283 KMLVLDAEQRVTAGEA 298
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (351), Expect = 3e-37
Identities = 65/286 (22%), Positives = 107/286 (37%), Gaps = 55/286 (19%)
Query: 953 IIGSGGSGTVYKA-ELANGATVAVKKISCK-----DDHLLNKSFTREVKTLGRIRHRH-- 1004
++GSGG G+VY +++ VA+K + + EV L ++
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 1005 LVKLMGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQG 1064
+++L+ S +LI E E I R +L E + +
Sbjct: 71 VIRLLDWFERPD--SFVLILERPEPVQDLFDF------ITERGALQEELARSFFWQVLEA 122
Query: 1065 VEYLHHDCVPKILHRDIKSSNILLDSN-MEAHLGDFGLAKALVEDYNSNTESNTWFAGSY 1123
V + H+ +LHRDIK NIL+D N E L DFG L T F G+
Sbjct: 123 VRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL------KDTVYTDFDGTR 173
Query: 1124 GYIAPEY-AYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRW-VEMHMEMSG 1181
Y PE+ Y V+S+GI+L ++V G +P F + +++R V +S
Sbjct: 174 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP----FEHDEEIIRGQVFFRQRVSS 229
Query: 1182 SAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQV 1227
+ + C P +RP+ ++
Sbjct: 230 ECQ-----------------------HLIRWCLALRPSDRPTFEEI 252
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 141 bits (356), Expect = 4e-37
Identities = 61/346 (17%), Positives = 120/346 (34%), Gaps = 52/346 (15%)
Query: 912 NYTSSSSSSQAQRRLLFQAAAKRDF--RWEDIMGATNNLSD-EFI--IGSGGSGTVYKAE 966
N ++ S+ + F A AK DF +WE T L + I +G+G G V +
Sbjct: 2 NAAAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVK 61
Query: 967 -LANGATVAVKKISCKDDHLLN--KSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLI 1023
+G A+K + + L + E + L + LVKL + +
Sbjct: 62 HKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM--V 119
Query: 1024 YEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKS 1083
EY+ G ++ L + A + EYLH +++RD+K
Sbjct: 120 MEYVAGGEMFSHLRR-------IGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKP 169
Query: 1084 SNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVY 1143
N+L+D + DFG AK G+ +APE S + D +
Sbjct: 170 ENLLIDQQGYIQVTDFGFAK-------RVKGRTWTLCGTPEALAPEIILSKGYNKAVDWW 222
Query: 1144 SMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSAREELLDDQMKPLLPGEECAA 1203
++G+++ E+ +G P ++ + + + +
Sbjct: 223 ALGVLIYEMAAGYPP--------------------FFADQPIQIYEKIVSGKVRFPSHFS 262
Query: 1204 YQVLEIALQCTKTSPQERPSS-RQVCDLLLN--VFNNRIVDFDKLH 1246
+ ++ + +R + + + + N F D+ ++
Sbjct: 263 SDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFAT--TDWIAIY 306
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (341), Expect = 3e-35
Identities = 55/299 (18%), Positives = 103/299 (34%), Gaps = 42/299 (14%)
Query: 953 IIGSGGSGTVYKAE-LANGATVAVKKISCK--DDHLLNKSFTREVKTLGRIRHRHLVKLM 1009
++G G G V A G A+K + + E + L RH L L
Sbjct: 12 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL- 70
Query: 1010 GHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLH 1069
+ + EY G ++ L ++ V E A+ V L
Sbjct: 71 -KYAFQTHDRLCFVMEYANGGELFFHLSRERV-------FTEERARFYG---AEIVSALE 119
Query: 1070 HDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPE 1129
+ +++RDIK N++LD + + DFGL K S+ + F G+ Y+APE
Sbjct: 120 YLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEG----ISDGATMKTFCGTPEYLAPE 175
Query: 1130 YAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSAREELLD 1189
D + +G+V+ E++ G++P E L +
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEMMCGRLP--------------------FYNQDHERLFE 215
Query: 1190 DQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQ--VCDLLLNVFNNRIVDFDKLH 1246
+ + + + + K P++R +++ + F I ++ +
Sbjct: 216 LILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI-NWQDVV 273
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 131 bits (331), Expect = 4e-34
Identities = 51/297 (17%), Positives = 106/297 (35%), Gaps = 44/297 (14%)
Query: 953 IIGSGGSGTVYKAE-LANGATVAVKKISCKDDHLLNKSFTREVKTLGRIR-HRHLVKLMG 1010
+G G V++A + N V VK + K RE+K L +R +++ L
Sbjct: 42 KLGRGKYSEVFEAINITNNEKVVVKILKPVKK----KKIKREIKILENLRGGPNIITLAD 97
Query: 1011 HCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHH 1070
+ + + L++E++ N ++L + + ++Y H
Sbjct: 98 IVKDPVSRTPALVFEHVNNTDFKQLY----------QTLTDYDIRFYMYEILKALDYCHS 147
Query: 1071 DCVPKILHRDIKSSNILLDS-NMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPE 1129
I+HRD+K N+++D + + L D+GLA+ + S + PE
Sbjct: 148 ---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG-----QEYNVRVASRYFKGPE 199
Query: 1130 YAYSLKA-TEKCDVYSMGIVLMELVSGKMPTDA-------------TFGVEMDMVRWVEM 1175
+ D++S+G +L ++ K P G E +
Sbjct: 200 LLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY 259
Query: 1176 HMEMSGSAREELLDDQMKPL-----LPGEECAAYQVLEIALQCTKTSPQERPSSRQV 1227
++E+ + L K + + + L+ + + Q R ++R+
Sbjct: 260 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREA 316
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (329), Expect = 8e-34
Identities = 67/331 (20%), Positives = 131/331 (39%), Gaps = 47/331 (14%)
Query: 932 AKRDFRWEDIMGATNNLS-DEF----IIGSGGSGTVYKAELA----NGATVAVKKI---S 979
K + R ++ G + + F ++G+G G V+ G A+K + +
Sbjct: 5 VKHELRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKAT 64
Query: 980 CKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIYEYMENGSVWDWLHKQ 1039
+ E + L IR + + + LI +Y+ G ++ L +
Sbjct: 65 IVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE-TKLHLILDYINGGELFTHLSQ- 122
Query: 1040 PVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDF 1099
+ R + + + + + V L H I++RDIK NILLDSN L DF
Sbjct: 123 ----RERFTEHE-----VQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDF 173
Query: 1100 GLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKA--TEKCDVYSMGIVLMELVSGKM 1157
GL+K V D F G+ Y+AP+ + + D +S+G+++ EL++G
Sbjct: 174 GLSKEFVADETERA---YDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGAS 230
Query: 1158 PTDATFGVEMDMVRWVEMHMEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTS 1217
P F V+ + +++ E+ +K P + + ++ +
Sbjct: 231 P----FTVDGEK------------NSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKD 274
Query: 1218 PQERPSSRQ--VCDLLLNVFNNRIVDFDKLH 1246
P++R ++ ++F +I ++D L
Sbjct: 275 PKKRLGCGPRDADEIKEHLFFQKI-NWDDLA 304
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (322), Expect = 1e-32
Identities = 54/320 (16%), Positives = 129/320 (40%), Gaps = 47/320 (14%)
Query: 933 KRDFRWEDIMGATNNLSDEF----IIGSGGSGTVYKAE-LANGATVAVKKISCKDDHLLN 987
+ F +++ + + + +GSG G+V A G VAVKK+S +++
Sbjct: 1 RPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH 60
Query: 988 -KSFTREVKTLGRIRHRHLVKLMGHCCNKGA---GSNLLIYEYMENGSVWDWLHKQPVNI 1043
K RE++ L ++H +++ L+ + +++ + ++ + + + Q
Sbjct: 61 AKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--- 117
Query: 1044 KMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAK 1103
L + + + +G++Y+H + HRD+K SN+ ++ + E + DFGLA
Sbjct: 118 -----LTDDHVQFLIYQILRGLKYIHSADII---HRDLKPSNLAVNEDCELKILDFGLA- 168
Query: 1104 ALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATF 1163
+++ E + A + + + D++S+G ++ EL++G+ T
Sbjct: 169 -----RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT- 222
Query: 1164 GVEMDMVRWVEMHMEMSGSAREELLDDQMKPLLPGEECAAYQVLEIAL------------ 1211
D + +++ + + G+ ELL + Q+ ++
Sbjct: 223 ----DHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAV 278
Query: 1212 ----QCTKTSPQERPSSRQV 1227
+ +R ++ Q
Sbjct: 279 DLLEKMLVLDSDKRITAAQA 298
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (311), Expect = 4e-31
Identities = 61/303 (20%), Positives = 113/303 (37%), Gaps = 46/303 (15%)
Query: 953 IIGSGGSGTVYKA-ELANGATVAVKKIS-CKDDHLLNKSFTREVKTLGRIRHRHLVKLMG 1010
IGSG G V A + VA+KK+S + K RE+ + + H++++ L+
Sbjct: 24 PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83
Query: 1011 HCCNKGAGSN----LLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVE 1066
+ L+ E M+ + E + + G++
Sbjct: 84 VFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD----------HERMSYLLYQMLCGIK 133
Query: 1067 YLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYI 1126
+LH I+HRD+K SNI++ S+ + DFGLA+ + T + + Y
Sbjct: 134 HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART-----AGTSFMMTPYVVTRYYR 185
Query: 1127 APEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEM------------------- 1167
APE + E D++S+G ++ E+V K+ ++
Sbjct: 186 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 245
Query: 1168 --DMVRWVEMHMEMSGSAREELLDDQMKPLL-PGEECAAYQVLEIALQCTKTSPQERPSS 1224
+ +VE + +G +L D + P + A Q ++ + P +R S
Sbjct: 246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV 305
Query: 1225 RQV 1227
Sbjct: 306 DDA 308
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 123 bits (309), Expect = 6e-31
Identities = 57/315 (18%), Positives = 113/315 (35%), Gaps = 51/315 (16%)
Query: 954 IGSGGSGTVYKAE-LANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRH---------- 1002
+G G TV+ A+ + N VA+K + + D + ++ E+K L R+
Sbjct: 21 LGWGHFSTVWLAKDMVNNTHVAMKIV--RGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 78
Query: 1003 -RHLVKLMGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGL 1061
H++KL+ H +KG ++ + G L K + + +I+ L
Sbjct: 79 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIK----KYEHRGIPLIYVKQISKQL 134
Query: 1062 AQGVEYLHHDCVPKILHRDIKSSNILLDSN-MEAHLGDFGLAKALVEDYNSNTESNTWFA 1120
G++Y+H C I+H DIK N+L++ +L +A + E T
Sbjct: 135 LLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADL--GNACWYDEHYTNSI 190
Query: 1121 GSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVE-MDMVRWVEMHMEM 1179
+ Y +PE D++S ++ EL++G + G + +E+
Sbjct: 191 QTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIEL 250
Query: 1180 SGSAREEL---------------------------LDDQMKPLLPGEECAAYQVLEIALQ 1212
G L L+D + + A ++ +
Sbjct: 251 LGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSP 310
Query: 1213 CTKTSPQERPSSRQV 1227
+ P++R + +
Sbjct: 311 MLQLDPRKRADAGGL 325
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 115 bits (288), Expect = 1e-28
Identities = 88/317 (27%), Positives = 142/317 (44%), Gaps = 12/317 (3%)
Query: 24 LCKDEELSVLLEIKKSFTADPENVLHAWNQS-NQNLCTWRGITC--GSSSARVVSLNLSG 80
LC ++ LL+IKK +P L +W + + TW G+ C + + RV +L+LSG
Sbjct: 2 LCNPQDKQALLQIKKDLG-NP-TTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSG 59
Query: 81 LSLAG--SISPSLGRLQSLIHLDLSSN-SLTGPIPTALSNLSSLESLLLFSNQLAGTIPT 137
L+L I SL L L L + +L GPIP A++ L+ L L + ++G IP
Sbjct: 60 LNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPD 119
Query: 138 QLGSLTSLRVMRIGDNWLSGSIPTSFGNLVNLGTLGLASCSLSGPIPPQFGQLSQLEE-L 196
L + +L + N LSG++P S +L NL + +SG IP +G S+L +
Sbjct: 120 FLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSM 179
Query: 197 ILQQNQLQGPIPAELGNCSSLSIFTAAENNLNGSIPAALGRLQNLQLLNLGNNSLSGEIP 256
+ +N+L G IP N + + + + +
Sbjct: 180 TISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVL--FGSDKNTQKIHLAKNSLAFDL 237
Query: 257 SELGELSQLGYLNLMGNRLEGAIPRSFAKMGNLQSLDLSMNRLTGGIPEEFGNMGQLVFL 316
++G L L+L NR+ G +P+ ++ L SL++S N L G IP + GN+ +
Sbjct: 238 GKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVS 296
Query: 317 VLSNNNISGSIPRRICT 333
+NN P CT
Sbjct: 297 AYANNKCLCGSPLPACT 313
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 83.3 bits (204), Expect = 1e-17
Identities = 70/288 (24%), Positives = 113/288 (39%), Gaps = 47/288 (16%)
Query: 596 GNSPSLERLRLGNNKFIGK--IPWTFGKIRELSLLDLSGN-SLTGPIPTQLLMCKKLSHI 652
+ + L L IP + + L+ L + G +L GPIP + +L ++
Sbjct: 47 TQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYL 106
Query: 653 DLNNNLLSGAVPSWLGTLPQLGELKLSFNQFVGFLPRELFNCSKLLVLSLDGNMLNGSLP 712
+ + +SGA+P +L + L L S+N G LP + + L+ ++ DGN ++G++P
Sbjct: 107 YITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIP 166
Query: 713 NEVGNLASLNV-LTLSGNLLSGPIPPAIGRLSKLYELRLSNNSLNG-------------- 757
+ G+ + L +T+S N L+G IPP L+ + N
Sbjct: 167 DSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKI 226
Query: 758 -------VIPLEIGQLQNLQSILDLSHNNFTGQIPPSMGTLAKLEVLNLSHNQLVGELPS 810
L L + LDL +N G +P + L L LN+S N L GE+P
Sbjct: 227 HLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ 286
Query: 811 QLGEMSSLGKLNLSYNDLQGKLSKQFSHWPAEAFEGNLHLCGSPLDHC 858
G + + N LCGSPL C
Sbjct: 287 -GGNLQRFDVSAYA---------------------NNKCLCGSPLPAC 312
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 81.7 bits (200), Expect = 3e-17
Identities = 61/266 (22%), Positives = 102/266 (38%), Gaps = 8/266 (3%)
Query: 501 GNCHQLIILDLADNKLSGG--VPASFGFLQALEQLMLYNN-SLEGNLPGSLINLRNLTRI 557
+++ LDL+ L +P+S L L L + +L G +P ++ L L +
Sbjct: 47 TQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYL 106
Query: 558 NFSKNRLNGRIATLCSSHSFLSFDVTN-NEFDHEIPPQLGNSPSLERLRLGNNKFIGKIP 616
+ ++G I S L + N +PP + + P+L + N+ G IP
Sbjct: 107 YITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIP 166
Query: 617 WTFGKIRELSL-LDLSGNSLTGPIPTQLLMCKKLSHIDLNNNLLSGAVPSWLGTLPQLGE 675
++G +L + +S N LTG IP + + S L + +
Sbjct: 167 DSYGSFSKLFTSMTISRNRLTGKIPPT--FANLNLAFVDLSRNMLEGDASVLFGSDKNTQ 224
Query: 676 LKLSFNQFVGFLPRELFNCSKLLVLSLDGNMLNGSLPNEVGNLASLNVLTLSGNLLSGPI 735
+ F ++ L L L N + G+LP + L L+ L +S N L G I
Sbjct: 225 KIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEI 284
Query: 736 PPAIGRLSKLYELRLSNNSLNGVIPL 761
P G L + +NN PL
Sbjct: 285 PQ-GGNLQRFDVSAYANNKCLCGSPL 309
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 81.3 bits (199), Expect = 5e-17
Identities = 63/261 (24%), Positives = 94/261 (36%), Gaps = 4/261 (1%)
Query: 287 GNLQSLDLSMNRLTGG--IPEEFGNMGQLVFLVLSNNNISGSIPRRICTNATSLEHLILA 344
+ +LDLS L IP N+ L FL + N T L +L +
Sbjct: 50 YRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYIT 109
Query: 345 EIQLSGEIPVELSQCQSLKQLDLSNNTLNGTIPVELFQLVALTHLYLHNNSLVGSISPFV 404
+SG IP LSQ ++L LD S N L+GT+P + L L + N + G+I
Sbjct: 110 HTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSY 169
Query: 405 ANLSNLQELALYHNNFQGSLPREIGMLVKLELLYLYDNHLSGQIPSEVGNCSSLKWIDFF 464
+ S L N + + ++ S +
Sbjct: 170 GSFSKLFTSMTISRN-RLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHL 228
Query: 465 GNSFTGEIPTSIGRLKDLNFLHLRQNELVGQIPASLGNCHQLIILDLADNKLSGGVPASF 524
+ +G K+LN L LR N + G +P L L L+++ N L G +P
Sbjct: 229 AKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QG 287
Query: 525 GFLQALEQLMLYNNSLEGNLP 545
G LQ + NN P
Sbjct: 288 GNLQRFDVSAYANNKCLCGSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 80.6 bits (197), Expect = 9e-17
Identities = 64/272 (23%), Positives = 109/272 (40%), Gaps = 10/272 (3%)
Query: 236 GRLQNLQLLNLGNNSLSG--EIPSELGELSQLGYLNLMGN-RLEGAIPRSFAKMGNLQSL 292
+ + L+L +L IPS L L L +L + G L G IP + AK+ L L
Sbjct: 47 TQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYL 106
Query: 293 DLSMNRLTGGIPEEFGNMGQLVFLVLSNNNISGSIPRRICTNATSLEHLILAEIQLSGEI 352
++ ++G IP+ + LV L S N +SG++P I + +L + ++SG I
Sbjct: 107 YITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSIS-SLPNLVGITFDGNRISGAI 165
Query: 353 PVELSQCQSLKQ-LDLSNNTLNGTIPVELFQLVALTHLYLHNNSLVGSISPFVANLSNLQ 411
P L + +S N L G IP L + +++ + +
Sbjct: 166 PDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN--LAFVDLSRNMLEGDASVLFGSDKNT 223
Query: 412 ELALYHNNFQGSLPREIGMLVKLELLYLYDNHLSGQIPSEVGNCSSLKWIDFFGNSFTGE 471
+ N ++G+ L L L +N + G +P + L ++ N+ GE
Sbjct: 224 QKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGE 283
Query: 472 IPTSIGRLKDLNFLHLRQNELVGQIPASLGNC 503
IP G L+ + N+ + P L C
Sbjct: 284 IP-QGGNLQRFDVSAYANNKCLCGSP--LPAC 312
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 74.4 bits (181), Expect = 1e-14
Identities = 64/283 (22%), Positives = 102/283 (36%), Gaps = 29/283 (10%)
Query: 530 LEQLMLYNNSLEGN--LPGSLINLRNLTRINFSKNRLNGRIATLCSSHSFLSFDVTNNEF 587
+ L L +L +P SL NL L + N
Sbjct: 52 VNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGI----------------------NNL 89
Query: 588 DHEIPPQLGNSPSLERLRLGNNKFIGKIPWTFGKIRELSLLDLSGNSLTGPIPTQLLMCK 647
IPP + L L + + G IP +I+ L LD S N+L+G +P +
Sbjct: 90 VGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLP 149
Query: 648 KLSHIDLNNNLLSGAVPSWLGTLPQLGELKLSF-NQFVGFLPRELFNCSKLLVLSLDGNM 706
L I + N +SGA+P G+ +L N+ G +P N +
Sbjct: 150 NLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNL--AFVDLSRN 207
Query: 707 LNGSLPNEVGNLASLNVLTLSGNLLSGPIPPAIGRLSKLYELRLSNNSLNGVIPLEIGQL 766
+ + + +G L L L NN + G +P + QL
Sbjct: 208 MLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQL 267
Query: 767 QNLQSILDLSHNNFTGQIPPSMGTLAKLEVLNLSHNQLVGELP 809
+ L S L++S NN G+I P G L + +V ++N+ + P
Sbjct: 268 KFLHS-LNVSFNNLCGEI-PQGGNLQRFDVSAYANNKCLCGSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 44.4 bits (103), Expect = 6e-05
Identities = 33/158 (20%), Positives = 55/158 (34%), Gaps = 10/158 (6%)
Query: 713 NEVGNLASLNVLTLSGNLLSG--PIPPAIGRLSKLYELRLSNNSLNGVIPLEIGQLQNLQ 770
+ +N L LSG L PIP ++ L L L + +
Sbjct: 44 DTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQL 103
Query: 771 SILDLSHNNFTGQIPPSMGTLAKLEVLNLSHNQLVGELPSQLGEMSSLGKLNLSYNDLQG 830
L ++H N +G IP + + L L+ S+N L G LP + + +L + N + G
Sbjct: 104 HYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISG 163
Query: 831 KLSKQFSHWPAEAFEGNLHLCGSPLDHCNGLVSNQHQS 868
+ + + L S N L +
Sbjct: 164 AIPDSYGSFS--------KLFTSMTISRNRLTGKIPPT 193
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 105 bits (261), Expect = 2e-24
Identities = 86/385 (22%), Positives = 151/385 (39%), Gaps = 36/385 (9%)
Query: 71 ARVVSLNLSGLSLAGSISPSLGRLQSLIHLDLSSNSLTGPIPTALSNLSSLESLLLFSNQ 130
A + L ++ ++S + L + L + + L++L + +NQ
Sbjct: 22 AEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQ 77
Query: 131 LAGTIPTQLGSLTSLRVMRIGDNWLSGSIPTSFGNLVNLGTLGLASCSLSGPIPPQFG-- 188
L P L +LT L + + +N ++ P + + TL + P+
Sbjct: 78 LTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLN 135
Query: 189 -------QLSQLEELILQQNQLQGPIPAELGNCSSLSIFT----AAENNLNGSIPAALGR 237
+S + L + Q ++ + L+ T ++ S + L +
Sbjct: 136 RLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAK 195
Query: 238 LQNLQLLNLGNNSLSGEIPSELGELSQLGYLNLMGNRLEGAIPRSFAKMGNLQSLDLSMN 297
L NL+ L NN +S P + + L L+L GN+L+ + A + NL LDL+ N
Sbjct: 196 LTNLESLIATNNQISDITPLGIL--TNLDELSLNGNQLKD--IGTLASLTNLTDLDLANN 251
Query: 298 RLTGGIPEEFGNMGQLVFLVLSNNNISGSIPRRICTNATSLEHLILAEIQLSGEIPVELS 357
+++ P + +L L L N IS P T T+LE + E +S
Sbjct: 252 QISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLEL-----NENQLEDISPIS 304
Query: 358 QCQSLKQLDLSNNTLNGTIPVELFQLVALTHLYLHNNSLVGSISPFVANLSNLQELALYH 417
++L L L N ++ PV L L L+ NN + S +ANL+N+ L+ H
Sbjct: 305 NLKNLTYLTLYFNNISDISPVS--SLTKLQRLFFANNKV--SDVSSLANLTNINWLSAGH 360
Query: 418 NNFQGSLPREIGMLVKLELLYLYDN 442
N P + L ++ L L D
Sbjct: 361 NQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 103 bits (257), Expect = 5e-24
Identities = 78/396 (19%), Positives = 140/396 (35%), Gaps = 33/396 (8%)
Query: 431 LVKLELLYLYDNHLSGQIPSEVGNCSSLKWIDFFGNSFTGEIPTSIGRLKDLNFLHLRQN 490
L + L +++ + + + + + L +L ++ N
Sbjct: 21 LAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKS--IDGVEYLNNLTQINFSNN 76
Query: 491 ELVGQIPASLGNCHQLIILDLADNKLSGGVPASFGFLQALEQLMLYNNSLEGNLPGSLIN 550
+L P L N +L+ + + +N+++ P + L + L
Sbjct: 77 QLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNL 134
Query: 551 LRNLTRINFSKNRLNGRIATLCSSHSFLSFDVTNNEFDHEIPPQLGNSPSLERLRLGNNK 610
R N I+ + + S + L N +LERL + +NK
Sbjct: 135 NRLELSSN--------TISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNK 186
Query: 611 FIGKIPWTFGKIRELSLLDLSGNSLTGPIPTQLLMCKKLSHIDLNNNLLSGAVPSWLGTL 670
K+ L L + N ++ P + L + LN N L L +L
Sbjct: 187 VS--DISVLAKLTNLESLIATNNQISDITPLG--ILTNLDELSLNGNQLKD--IGTLASL 240
Query: 671 PQLGELKLSFNQFVGFLPRELFNCSKLLVLSLDGNMLNGSLPNEVGNLASLNVLTLSGNL 730
L +L L+ NQ P L +KL L L N ++ P + L +L L L+ N
Sbjct: 241 TNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNEN- 295
Query: 731 LSGPIPPAIGRLSKLYELRLSNNSLNGVIPLEIGQLQNLQSILDLSHNNFTGQIPPSMGT 790
I L L L L N+++ + P + L LQ L ++N + S+
Sbjct: 296 -QLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQR-LFFANNKVSD--VSSLAN 349
Query: 791 LAKLEVLNLSHNQLVGELPSQLGEMSSLGKLNLSYN 826
L + L+ HNQ+ P L ++ + +L L+
Sbjct: 350 LTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 102 bits (255), Expect = 9e-24
Identities = 91/419 (21%), Positives = 155/419 (36%), Gaps = 42/419 (10%)
Query: 102 LSSNSLTGPIPT----ALSNLSSLESLLLFSNQLAGTIP-TQLGSLTSLRVMRIGDNWLS 156
L S ++T P + L+ +L + T+ T L +T+L+ R+G +
Sbjct: 1 LGSATITQDTPINQIFTDTALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSID 60
Query: 157 GSIPTSFGNLVNLGTLGLASCSLSGPIPPQFGQLSQLEELILQQNQLQGPIPAELGNCSS 216
G L NL + ++ L+ P L++L ++++ NQ+ P +
Sbjct: 61 G-----VEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLT 113
Query: 217 LSIFTAAENNLNGSIPAALGRLQNLQLLNLGNNSLSGEIPSELGELSQLGYLNLMGNRLE 276
+ + + N + ++S L L +
Sbjct: 114 GLTLFNNQITDIDPLKNLTNLNRLELSSN------------TISDISALSGLTSLQQLSF 161
Query: 277 GAIPRSFAKMGNLQSLDL-SMNRLTGGIPEEFGNMGQLVFLVLSNNNISGSIPRRICTNA 335
G + NL +L+ ++ + L L+ +NN IS P I TN
Sbjct: 162 GNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITPLGILTN- 220
Query: 336 TSLEHLILAEIQLSGEIPVELSQCQSLKQLDLSNNTLNGTIPVELFQLVALTHLYLHNNS 395
L+ L L QL L+ +L LDL+NN ++ P L L LT L L N
Sbjct: 221 --LDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQ 274
Query: 396 LVGSISPFVANLSNLQELALYHNNFQGSLPREIGMLVKLELLYLYDNHLSGQIPSEVGNC 455
+ L+ L L L N + I L L L LY N++S P V +
Sbjct: 275 ISNISPLA--GLTALTNLELNENQLED--ISPISNLKNLTYLTLYFNNISDISP--VSSL 328
Query: 456 SSLKWIDFFGNSFTGEIPTSIGRLKDLNFLHLRQNELVGQIPASLGNCHQLIILDLADN 514
+ L+ + F N + +S+ L ++N+L N++ P L N ++ L L D
Sbjct: 329 TKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 101 bits (251), Expect = 3e-23
Identities = 74/404 (18%), Positives = 148/404 (36%), Gaps = 36/404 (8%)
Query: 174 LASCSLSGPIPPQ----FGQLSQLEELILQQNQLQGPIP-AELGNCSSLSIFTAAENNLN 228
L S +++ P L++ + +L + + + +L ++L +++
Sbjct: 1 LGSATITQDTPINQIFTDTALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSID 60
Query: 229 GSIPAALGRLQNLQLLNLGNNSLSGEIP-SELGELSQLGYLNLMGNRLEGAIPRSFAKMG 287
G + L NL +N NN L+ P L +L + N + +
Sbjct: 61 G-----VEYLNNLTQINFSNNQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGL 115
Query: 288 NLQSLDLSMNRLTGGIPEEFGNMGQLVFLVLSNNNISGSIPRRICTNATSLEHLILAEIQ 347
L + ++ + + + + +++ + LA +
Sbjct: 116 TLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLT 175
Query: 348 LSGE---------IPVELSQCQSLKQLDLSNNTLNGTIPVELFQLVALTHLYLHNNSLVG 398
L++ +L+ L +NN ++ P+ + L L L+ N L
Sbjct: 176 TLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITPLGILT--NLDELSLNGNQLKD 233
Query: 399 SISPFVANLSNLQELALYHNNFQGSLPREIGMLVKLELLYLYDNHLSGQIPSEVGNCSSL 458
+A+L+NL +L L +N P + L KL L L N +S P + ++L
Sbjct: 234 --IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTAL 287
Query: 459 KWIDFFGNSFTGEIPTSIGRLKDLNFLHLRQNELVGQIPASLGNCHQLIILDLADNKLSG 518
++ N + I LK+L +L L N + P + + +L L A+NK+S
Sbjct: 288 TNLELNENQLE--DISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD 343
Query: 519 GVPASFGFLQALEQLMLYNNSLEGNLPGSLINLRNLTRINFSKN 562
+S L + L +N + P L NL +T++ +
Sbjct: 344 --VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 100 bits (250), Expect = 4e-23
Identities = 74/398 (18%), Positives = 128/398 (32%), Gaps = 37/398 (9%)
Query: 383 LVALTHLYLHNNSLVGSISPFVANLSNLQELALYHNNFQGSLPREIGMLVKLELLYLYDN 442
L L ++ ++S +L + L + S+ + L L + +N
Sbjct: 21 LAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK-SID-GVEYLNNLTQINFSNN 76
Query: 443 HLSGQIPSEVGNCSSLKWIDFFGNSFTGEIPTSIGRLKDLNFLHLRQNELVGQIPASLGN 502
L+ P + N + L I N P + L Q + +
Sbjct: 77 QLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNL 134
Query: 503 CHQLIILDLADNKLSGGVPASFGFLQALEQLMLYNNSLEGNLPGSLINLRNLTRINFSKN 562
+ + + + AL L GN L L NLT +
Sbjct: 135 NRLELSSN------------TISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDI 182
Query: 563 RLNGRIATLCSS--HSFLSFDVTNNEFDHEIPPQLGNSPSLERLRLGNNKFIGKIPWTFG 620
N + + S TNN+ P +L+ L L N+ T
Sbjct: 183 SSNKVSDISVLAKLTNLESLIATNNQISDITPLG--ILTNLDELSLNGNQLKD--IGTLA 238
Query: 621 KIRELSLLDLSGNSLTGPIPTQLLMCKKLSHIDLNNNLLSGAVPSWLGTLPQLGELKLSF 680
+ L+ LDL+ N ++ P L KL+ + L N +S P T
Sbjct: 239 SLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNL----EL 292
Query: 681 NQFVGFLPRELFNCSKLLVLSLDGNMLNGSLPNEVGNLASLNVLTLSGNLLSGPIPPAIG 740
N+ + N L L+L N ++ P V +L L L + N +S ++
Sbjct: 293 NENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLA 348
Query: 741 RLSKLYELRLSNNSLNGVIPLEIGQLQNLQSILDLSHN 778
L+ + L +N ++ + PL L + L L+
Sbjct: 349 NLTNINWLSAGHNQISDLTPL--ANLTRITQ-LGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 98.5 bits (244), Expect = 3e-22
Identities = 69/389 (17%), Positives = 132/389 (33%), Gaps = 32/389 (8%)
Query: 365 LDLSNNTLNGTIPVELFQLVALTHLYLHNNSLVGSISPFVANLSNLQELALYHNNFQGSL 424
L + T+ L +T L + SI L+NL ++ +N
Sbjct: 27 TVLGKTNVTDTVSQT--DLDQVTTLQADRLGIK-SIDGV-EYLNNLTQINFSNNQLTDIT 82
Query: 425 PREIGMLVKLELLYLYDNHLSGQIPSEVGNCSSLKWIDFFGNSFTGEIPTSIGRLKDLNF 484
P + L KL + + +N ++ P + + + + N
Sbjct: 83 P--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNL----NR 136
Query: 485 LHLRQNELVGQIPASLGNCHQLIILDLADNKLSGGVPASFGFLQALEQLMLYNNSLEGNL 544
L L N + S Q + L LE+L + +N +
Sbjct: 137 LELSSNTISDISALSGLTSLQQLSFGNQVTD-----LKPLANLTTLERLDISSNKVSDIS 191
Query: 545 PGSLINLRNLTRINFSKNRLNGRIATLCSSHSFLSFDVTNNEFDHEIPPQLGNSPSLERL 604
+ L NL + + N+++ + + N+ + L + +L L
Sbjct: 192 VLA--KLTNLESLIATNNQISDITPL-GILTNLDELSLNGNQL--KDIGTLASLTNLTDL 246
Query: 605 RLGNNKFIGKIPWTFGKIRELSLLDLSGNSLTGPIPTQLLMCKKLSHIDLNNNLLSGAVP 664
L NN+ P + +L+ L L N ++ P L ++ N
Sbjct: 247 DLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQL----EDI 300
Query: 665 SWLGTLPQLGELKLSFNQFVGFLPRELFNCSKLLVLSLDGNMLNGSLPNEVGNLASLNVL 724
S + L L L L FN P + + +KL L N ++ + + NL ++N L
Sbjct: 301 SPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWL 356
Query: 725 TLSGNLLSGPIPPAIGRLSKLYELRLSNN 753
+ N +S P + L+++ +L L++
Sbjct: 357 SAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 97.0 bits (240), Expect = 9e-22
Identities = 62/384 (16%), Positives = 124/384 (32%), Gaps = 31/384 (8%)
Query: 309 NMGQLVFLVLSNNNISGSIPRRICTNATSLEHLILAEIQLSGEIPVELSQCQSLKQLDLS 368
+ + + VL N++ ++ T+ + L + + I + +L Q++ S
Sbjct: 20 ALAEKMKTVLGKTNVTDTVS---QTDLDQVTTLQADRLGIK-SID-GVEYLNNLTQINFS 74
Query: 369 NNTLNGTIPVE-LFQLVALTHLYLHNNSLVGSISPFVANLSNLQELALYHNNFQGSLPRE 427
NN L P++ L +LV + + + L + + +L
Sbjct: 75 NNQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNL 134
Query: 428 IGMLVKLELLYLYDNHLSGQIPSEVGNCSSLKWIDFFGNSFTGEI----------PTSIG 477
+ + + ++ + + + N T E + +
Sbjct: 135 NRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLA 194
Query: 478 RLKDLNFLHLRQNELVGQIPASLGNCHQLIILDLADNKLSGGVPASFGFLQALEQLMLYN 537
+L +L L N++ P L L L N+L + L L L L N
Sbjct: 195 KLTNLESLIATNNQISDITPLG--ILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLAN 250
Query: 538 NSLEGNLPGSLINLRNLTRINFSKNRLNGRIATLCSSHSFLSFDVTNNEFDHEIPPQLGN 597
N + P L L LT + N+++ + N D L
Sbjct: 251 NQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNL-- 306
Query: 598 SPSLERLRLGNNKFIGKIPWTFGKIRELSLLDLSGNSLTGPIPTQLLMCKKLSHIDLNNN 657
+L L L N P + +L L + N ++ + L ++ + +N
Sbjct: 307 -KNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHN 361
Query: 658 LLSGAVPSWLGTLPQLGELKLSFN 681
+S P L L ++ +L L+
Sbjct: 362 QISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 90.8 bits (224), Expect = 8e-20
Identities = 73/396 (18%), Positives = 145/396 (36%), Gaps = 33/396 (8%)
Query: 262 LSQLGYLNLMGNRLEGAIPRSFAKMGNLQSLDLSMNRLTGGIPEEFGNMGQLVFLVLSNN 321
L++ L + + ++ + + +L + + + L + SNN
Sbjct: 21 LAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKS--IDGVEYLNNLTQINFSNN 76
Query: 322 NISGSIPRRICTNATSLEHLILAEIQLSGEIPVELSQCQSLKQLDLSNNTLNGTIPVELF 381
++ P N T L +++ Q++ P+ + L + T +
Sbjct: 77 QLTDITP---LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTN 133
Query: 382 QLVALTHLYLHNNSLVGSISPFVANLSNLQELALYHNNFQGSLPREIGMLVKLELLYLYD 441
L L +N++ ++ LS L L Q + + + L LE L +
Sbjct: 134 L----NRLELSSNTI-----SDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISS 184
Query: 442 NHLSGQIPSEVGNCSSLKWIDFFGNSFTGEIPTSIGRLKDLNFLHLRQNELVGQIPASLG 501
N S + ++L+ + N + P I +L+ L L N+L +L
Sbjct: 185 NK--VSDISVLAKLTNLESLIATNNQISDITPLGIL--TNLDELSLNGNQLKD--IGTLA 238
Query: 502 NCHQLIILDLADNKLSGGVPASFGFLQALEQLMLYNNSLEGNLPGSLINLRNLTRINFSK 561
+ L LDLA+N++S P L L +L L N + P L L LT + ++
Sbjct: 239 SLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNE 294
Query: 562 NRLNGRIATLCSSHSFLSFDVTNNEFDHEIPPQLGNSPSLERLRLGNNKFIGKIPWTFGK 621
N+ I+ + + + + N P + + L+RL NNK +
Sbjct: 295 NQ-LEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLAN 349
Query: 622 IRELSLLDLSGNSLTGPIPTQLLMCKKLSHIDLNNN 657
+ ++ L N ++ P L +++ + LN+
Sbjct: 350 LTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 88.9 bits (219), Expect = 4e-19
Identities = 71/360 (19%), Positives = 134/360 (37%), Gaps = 45/360 (12%)
Query: 502 NCHQLIILDLADNKLSGGVPASFGFLQALEQLMLYNNSLEGNLPGSLINLRNLTRINFSK 561
+ + L ++ V + L + L ++ ++ G + L NLT+INFS
Sbjct: 20 ALAEKMKTVLGKTNVTDTVSQTD--LDQVTTLQADRLGIK-SIDG-VEYLNNLTQINFSN 75
Query: 562 NRLNGRIA--------TLCSSHSFLSFDVTNNEFDHEIPPQLGNSPSLERLRLGNNKFIG 613
N+L + +++ ++ + L N+ + L N +
Sbjct: 76 NQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLN 135
Query: 614 KIPWTFGKIRELSLLDLSGNSLTGPIPTQLLMCKKLS----HIDLNNNLLSGAVPSWLGT 669
++ + I ++S L + Q+ K L+ L+ + + S L
Sbjct: 136 RLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAK 195
Query: 670 LPQLGELKLSFNQFVGFLPRELFNCSKLLVLSLDGNMLNGSLPNEVGNLASLNVLTLSGN 729
L L L + NQ P + L LSL+GN L + +L +L L L+ N
Sbjct: 196 LTNLESLIATNNQISDITPL--GILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANN 251
Query: 730 LLSGPIPPAIGRLSKLYELRLSNNSLNGVIPLEIGQLQNLQS------------------ 771
+S P + L+KL EL+L N ++ + PL
Sbjct: 252 QISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNL 309
Query: 772 -ILDLSHNNFTGQIPPSMGTLAKLEVLNLSHNQLVGELPSQLGEMSSLGKLNLSYNDLQG 830
L L NN + P + +L KL+ L ++N++ S L ++++ L+ +N +
Sbjct: 310 TYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISD 365
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 83.1 bits (204), Expect = 3e-17
Identities = 50/202 (24%), Positives = 85/202 (42%), Gaps = 14/202 (6%)
Query: 48 LHAWNQSNQNLCTWRGITCGSSSARVVSLNLSGLSLAGSISPSLGRLQSLIHLDLSSNSL 107
L IT + L+L+G L +L L +L LDL++N +
Sbjct: 196 LTNLESLIATNNQISDITPLGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQI 253
Query: 108 TGPIPTALSNLSSLESLLLFSNQLAGTIPTQLGSLTSLRVMRIGDNWLSGSIPTSFGNLV 167
+ P LS L+ L L L +NQ++ P L LT+L + + +N + NL
Sbjct: 254 SNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQ--LEDISPISNLK 307
Query: 168 NLGTLGLASCSLSGPIPPQFGQLSQLEELILQQNQLQGPIPAELGNCSSLSIFTAAENNL 227
NL L L ++S P L++L+ L N++ + L N ++++ +A N +
Sbjct: 308 NLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQI 363
Query: 228 NGSIPAALGRLQNLQLLNLGNN 249
+ P L L + L L +
Sbjct: 364 SDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 58.5 bits (140), Expect = 2e-09
Identities = 23/110 (20%), Positives = 46/110 (41%), Gaps = 6/110 (5%)
Query: 44 PENVLHAWNQSNQNLCTWRGITCGSSSARVVSLNLSGLSLAGSISPSLGRLQSLIHLDLS 103
P L A N I+ S+ + L L +++ + L L L +
Sbjct: 280 PLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFA 337
Query: 104 SNSLTGPIPTALSNLSSLESLLLFSNQLAGTIPTQLGSLTSLRVMRIGDN 153
+N ++ ++L+NL+++ L NQ++ P L +LT + + + D
Sbjct: 338 NNKVSDV--SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 98.6 bits (244), Expect = 6e-23
Identities = 67/335 (20%), Positives = 110/335 (32%), Gaps = 41/335 (12%)
Query: 59 CTWRGITCGSSSARVVSLNLSGLSLAGSISPSLGRLQSLIHLDLSSNSLTGPIPTALSNL 118
C R + C V +L LDL +N +T NL
Sbjct: 10 CHLRVVQCSDLGLEKVPKDLP---------------PDTALLDLQNNKITEIKDGDFKNL 54
Query: 119 SSLESLLLFSNQLAGTIPTQLGSLTSLRVMRIGDNWLSGSIPTSFGNLVNLGTLGLASCS 178
+L +L+L +N+++ P L L + + N L L L
Sbjct: 55 KNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITK 114
Query: 179 LSGPIPPQFGQLSQLEELILQQNQLQGPIPAELGNCSSLSIFTAAENNLNGSIPAALGRL 238
+ + Q+ + EL + G LS A+ N+ +IP L
Sbjct: 115 VRKSVFNGLNQMIVV-ELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--P 170
Query: 239 QNLQLLNLGNNSLSGEIPSELGELSQLGYLNLMGNRLEGAIPRSFAKMGNLQSLDLSMNR 298
+L L+L N ++ + L L+ L L L N + S A +L+ L L+ N+
Sbjct: 171 PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNK 230
Query: 299 LTGGIPEEFGNMGQLVFLVLSNNNISGSIPRRICTNATSLEHLILAEIQLSGEIPVELSQ 358
L +P + + + L NNNIS C P ++
Sbjct: 231 LV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFC-------------------PPGYNTK 270
Query: 359 CQSLKQLDLSNNTLN-GTIPVELFQLV-ALTHLYL 391
S + L +N + I F+ V + L
Sbjct: 271 KASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQL 305
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 96.6 bits (239), Expect = 3e-22
Identities = 53/269 (19%), Positives = 104/269 (38%), Gaps = 14/269 (5%)
Query: 230 SIPAALGRLQNLQLLNLGNNSLSGEIPSELGELSQLGYLNLMGNRLEGAIPRSFAKMGNL 289
+P L + LL+L NN ++ + L L L L+ N++ P +FA + L
Sbjct: 24 KVPKDLPP--DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 81
Query: 290 QSLDLSMNRLTGGIPEEFGNMGQLVFLVLSNNNISGSIPRRICTNATSLEHLILAEIQLS 349
+ L LS N+L + + +L + S+ N + L ++ S
Sbjct: 82 ERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFN--GLNQMIVVELGTNPLKSS 139
Query: 350 GEIPVELSQCQSLKQLDLSNNTLNGTIPVELFQLVALTHLYLHNNSLVGSISPFVANLSN 409
G + L + +++ + TIP L +LT L+L N + + + L+N
Sbjct: 140 GIENGAFQGMKKLSYIRIADTNIT-TIPQGLPP--SLTELHLDGNKITKVDAASLKGLNN 196
Query: 410 LQELALYHNNFQGSLPREIGMLVKLELLYLYDNHLSGQIPSEVGNCSSLKWIDFFGNSFT 469
L +L L N+ + L L+L +N L ++P + + ++ + N+ +
Sbjct: 197 LAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS 255
Query: 470 G------EIPTSIGRLKDLNFLHLRQNEL 492
P + + + L N +
Sbjct: 256 AIGSNDFCPPGYNTKKASYSGVSLFSNPV 284
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 96.6 bits (239), Expect = 3e-22
Identities = 58/288 (20%), Positives = 100/288 (34%), Gaps = 14/288 (4%)
Query: 471 EIPTSIGRLKDLNFLHLRQNELVGQIPASLGNCHQLIILDLADNKLSGGVPASFGFLQAL 530
++P + D L L+ N++ N L L L +NK+S P +F L L
Sbjct: 24 KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 81
Query: 531 EQLMLYNNSLEGNLPGSLINLRNLTRINFSKNRLNGRIATLCSSHSFLSFDVTNNEFDHE 590
E+L L N L+ L+ L ++ + + + +
Sbjct: 82 ERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGI 141
Query: 591 IPPQLGNSPSLERLRLGNNKFIGKIPWTFGKIRELSLLDLSGNSLTGPIPTQLLMCKKLS 650
L +R+ + + E L L GN +T L L+
Sbjct: 142 ENGAFQGMKKLSYIRIADTNITTIPQGLPPSLTE---LHLDGNKITKVDAASLKGLNNLA 198
Query: 651 HIDLNNNLLSGAVPSWLGTLPQLGELKLSFNQFVGFLPRELFNCSKLLVLSLDGNMLNG- 709
+ L+ N +S L P L EL L+ N+ V P L + + V+ L N ++
Sbjct: 199 KLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKV-PGGLADHKYIQVVYLHNNNISAI 257
Query: 710 -----SLPNEVGNLASLNVLTLSGNLLS-GPIPPAIGR-LSKLYELRL 750
P AS + ++L N + I P+ R + ++L
Sbjct: 258 GSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQL 305
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 95.1 bits (235), Expect = 9e-22
Identities = 57/269 (21%), Positives = 104/269 (38%), Gaps = 14/269 (5%)
Query: 134 TIPTQLGSLTSLRVMRIGDNWLSGSIPTSFGNLVNLGTLGLASCSLSGPIPPQFGQLSQL 193
+P L ++ + +N ++ F NL NL TL L + +S P F L +L
Sbjct: 24 KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 81
Query: 194 EELILQQNQLQGPIPAELGNCSSLSIFTAAENNLNGSIPAALGRLQNLQLLNLGNNSLSG 253
E L L +NQL+ L + + S+ L ++ ++L SG
Sbjct: 82 ERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGT-NPLKSSG 140
Query: 254 EIPSELGELSQLGYLNLMGNRLEGAIPRSFAKMGNLQSLDLSMNRLTGGIPEEFGNMGQL 313
+ +L Y+ + + IP+ +L L L N++T + L
Sbjct: 141 IENGAFQGMKKLSYIRIADTNIT-TIPQGLPP--SLTELHLDGNKITKVDAASLKGLNNL 197
Query: 314 VFLVLSNNNISGSIPRRICTNATSLEHLILAEIQLSGEIPVELSQCQSLKQLDLSNNTLN 373
L LS N+IS + N L L L +L ++P L+ + ++ + L NN ++
Sbjct: 198 AKLGLSFNSISA-VDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS 255
Query: 374 G------TIPVELFQLVALTHLYLHNNSL 396
P + + + + L +N +
Sbjct: 256 AIGSNDFCPPGYNTKKASYSGVSLFSNPV 284
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 93.2 bits (230), Expect = 5e-21
Identities = 59/288 (20%), Positives = 100/288 (34%), Gaps = 14/288 (4%)
Query: 351 EIPVELSQCQSLKQLDLSNNTLNGTIPVELFQLVALTHLYLHNNSLVGSISPFVANLSNL 410
++P +L LDL NN + + L L L L NN + A L L
Sbjct: 24 KVPKDLPP--DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 81
Query: 411 QELALYHNNFQGSLPREIGMLVKLELLYLYDNHLSGQIPSEVGNCSSLKWIDFFGNSFTG 470
+ L L N + + L +L + + + + + + + +G
Sbjct: 82 ERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVV-ELGTNPLKSSG 140
Query: 471 EIPTSIGRLKDLNFLHLRQNELVGQIPASLGNCHQLIILDLADNKLSGGVPASFGFLQAL 530
+ +K L+++ + + IP L L L L NK++ AS L L
Sbjct: 141 IENGAFQGMKKLSYIRIADTNI-TTIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNL 197
Query: 531 EQLMLYNNSLEGNLPGSLINLRNLTRINFSKNRLNGRIATLCSSHSFLSFDVTNNEF--- 587
+L L NS+ GSL N +L ++ + N+L L + NN
Sbjct: 198 AKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNNISAI 257
Query: 588 ---DHEIPPQLGNSPSLERLRLGNNK--FIGKIPWTFGKIRELSLLDL 630
D P S + L +N + P TF + + + L
Sbjct: 258 GSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQL 305
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 87.8 bits (216), Expect = 3e-19
Identities = 54/255 (21%), Positives = 100/255 (39%), Gaps = 12/255 (4%)
Query: 581 DVTNNEFDHEIPPQLGNSPSLERLRLGNNKFIGKIPWTFGKIRELSLLDLSGNSLTGPIP 640
D+ NN+ N +L L L NNK P F + +L L LS N L
Sbjct: 37 DLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKELPE 96
Query: 641 TQLLMCKKLSHIDLNNNLLSGAVPSWLGTLPQLGELKLSFNQFVGFLPRELFNCSKLLVL 700
++L + + +V + L + + EL + + G KL +
Sbjct: 97 KMPKTLQELRVHENEITKVRKSVFNGLNQMIVV-ELGTNPLKSSGIENGAFQGMKKLSYI 155
Query: 701 SLDGNMLNGSLPNEVGNLASLNVLTLSGNLLSGPIPPAIGRLSKLYELRLSNNSLNGVIP 760
+ + ++P G SL L L GN ++ ++ L+ L +L LS NS++ V
Sbjct: 156 RIADTNIT-TIPQ--GLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDN 212
Query: 761 LEIGQLQNLQSILDLSHNNFTGQIPPSMGTLAKLEVLNLSHNQL------VGELPSQLGE 814
+ +L+ + +NN ++P + ++V+ L +N + P +
Sbjct: 213 GSLANTPHLRELHL--NNNKLVKVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTK 270
Query: 815 MSSLGKLNLSYNDLQ 829
+S ++L N +Q
Sbjct: 271 KASYSGVSLFSNPVQ 285
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 82.0 bits (201), Expect = 3e-17
Identities = 58/277 (20%), Positives = 96/277 (34%), Gaps = 16/277 (5%)
Query: 589 HEIPPQLGNSPSLERLRLGNNKFIGKIPWTFGKIRELSLLDLSGNSLTGPIPTQLLMCKK 648
++P L P L L NNK F ++ L L L N ++ P K
Sbjct: 23 EKVPKDL--PPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVK 80
Query: 649 LSHIDLNNNLLSGAVPSWLGTLPQLGELKLSFNQFVGFLPRELFNCSKLLVLSLDGNMLN 708
L + L+ N L TL +L + + + L N ++ L + +
Sbjct: 81 LERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGL-NQMIVVELGTNPLKSS 139
Query: 709 GSLPNEVGNLASLNVLTLSGNLLSGPIPPAIGRLSKLYELRLSNNSLNGVIPLEIGQLQN 768
G + L+ + ++ ++ IP + L EL L N + V + L N
Sbjct: 140 GIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNN 196
Query: 769 LQSILDLSHNNFTGQIPPSMGTLAKLEVLNLSHNQLVGELPSQLGEMSSLGKLNLSYNDL 828
L L LS N+ + S+ L L+L++N+LV P L + + + L N
Sbjct: 197 LA-KLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKV-PGGLADHKYIQVVYLHNN-- 252
Query: 829 QGKLSKQFSHWPAEAFEGNLHLCGSPLDHCNGLVSNQ 865
S + F + L SN
Sbjct: 253 ------NISAIGSNDFCPPGYNTKKASYSGVSLFSNP 283
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 80.5 bits (197), Expect = 8e-17
Identities = 49/260 (18%), Positives = 92/260 (35%), Gaps = 13/260 (5%)
Query: 552 RNLTRINFSKNRLNGRIATLCSSHSFL-SFDVTNNEFDHEIPPQLGNSPSLERLRLGNNK 610
+ ++ N++ + L + + NN+ P LERL L N+
Sbjct: 31 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ 90
Query: 611 FIGKIPWTFGKIRELSLLDLSGNSLTGPIPTQLLMCKKLSHIDLNNNLLSGAVPSWLGTL 670
++EL + + + + L + N SG +
Sbjct: 91 LKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGT-NPLKSSGIENGAFQGM 149
Query: 671 PQLGELKLSFNQFVGFLPRELFNCSKLLVLSLDGNMLNGSLPNEVGNLASLNVLTLSGNL 730
+L ++++ +P+ L L L LDGN + + L +L L LS N
Sbjct: 150 KKLSYIRIADTNI-TTIPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNS 206
Query: 731 LSGPIPPAIGRLSKLYELRLSNNSLNGVIPLEIGQLQNLQSILDLSHNNFTG------QI 784
+S ++ L EL L+NN L +P + + +Q ++ L +NN +
Sbjct: 207 ISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQ-VVYLHNNNISAIGSNDFCP 264
Query: 785 PPSMGTLAKLEVLNLSHNQL 804
P A ++L N +
Sbjct: 265 PGYNTKKASYSGVSLFSNPV 284
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 65.8 bits (159), Expect = 5e-12
Identities = 39/193 (20%), Positives = 67/193 (34%), Gaps = 10/193 (5%)
Query: 649 LSHIDLNNNLLSGAVPSWLGTLPQLGELKLSFNQFVGFLPRELFNCSKLLVLSLDGNMLN 708
L + ++ L VP L L L N+ + N L L L N ++
Sbjct: 12 LRVVQCSDLGLE-KVPKDLPP--DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKIS 68
Query: 709 GSLPNEVGNLASLNVLTLSGNLLSGPIPPAIGRLSKLYELRLSNNSLNGVIPLEIGQLQN 768
P L L L LS N L +P + + + ELR+ N + V L
Sbjct: 69 KISPGAFAPLVKLERLYLSKNQLKE-LPEKMPKTLQ--ELRVHENEITKVRKSVFNGLNQ 125
Query: 769 LQSI-LDLSHNNFTGQIPPSMGTLAKLEVLNLSHNQLVGELPSQLGEMSSLGKLNLSYND 827
+ + L + +G + + KL + ++ + +P L SL +L+L N
Sbjct: 126 MIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNI-TTIPQGL--PPSLTELHLDGNK 182
Query: 828 LQGKLSKQFSHWP 840
+ +
Sbjct: 183 ITKVDAASLKGLN 195
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 53.1 bits (126), Expect = 8e-08
Identities = 44/250 (17%), Positives = 84/250 (33%), Gaps = 16/250 (6%)
Query: 9 LGLLLLLLCFSPGFVLCKDEELSVLLEIKKSFTADPENVLHAWNQ----SNQNLCTWRGI 64
L L+ + +L L K PE + + N+ + +
Sbjct: 60 LILINNKISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSV 119
Query: 65 TCGSSSARVVSLNLSGLSLAGSISPSLGRLQSLIHLDLSSNSLTGPIPTALSNLSSLESL 124
G + VV L + L +G + + ++ L ++ ++ ++T IP L SL L
Sbjct: 120 FNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTEL 176
Query: 125 LLFSNQLAGTIPTQLGSLTSLRVMRIGDNWLSGSIPTSFGNLVNLGTLGLASCSLSGPIP 184
L N++ L L +L + + N +S S N +L L L + L +P
Sbjct: 177 HLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVP 235
Query: 185 PQFGQLSQLEELILQQNQLQG------PIPAELGNCSSLSIFTAAENNLNGS--IPAALG 236
++ + L N + P +S S + N + P+
Sbjct: 236 GGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFR 295
Query: 237 RLQNLQLLNL 246
+ + L
Sbjct: 296 CVYVRAAVQL 305
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 49.7 bits (117), Expect = 1e-06
Identities = 25/137 (18%), Positives = 43/137 (31%), Gaps = 3/137 (2%)
Query: 735 IPPAIGRLSKLYELRLSNNSLNGVIPLEIGQLQNLQSILDLSHNNFTGQIPPSMGTLAKL 794
+P + L L NN + + + L+NL + L L +N + P + L KL
Sbjct: 25 VPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHT-LILINNKISKISPGAFAPLVKL 81
Query: 795 EVLNLSHNQLVGELPSQLGEMSSLGKLNLSYNDLQGKLSKQFSHWPAEAFEGNLHLCGSP 854
E L LS NQL + L ++ + + N
Sbjct: 82 ERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGI 141
Query: 855 LDHCNGLVSNQHQSTIS 871
+ + I+
Sbjct: 142 ENGAFQGMKKLSYIRIA 158
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 47.3 bits (111), Expect = 5e-06
Identities = 25/120 (20%), Positives = 43/120 (35%), Gaps = 5/120 (4%)
Query: 747 ELRLSNNSLNGVIPLEIGQLQNLQSILDLSHNNFTGQIPPSMGTLAKLEVLNLSHNQLVG 806
++ S+ L +P ++ + +LDL +N T L L L L +N++
Sbjct: 14 VVQCSDLGLE-KVPKDLPP--DTA-LLDLQNNKITEIKDGDFKNLKNLHTLILINNKISK 69
Query: 807 ELPSQLGEMSSLGKLNLSYNDLQGKLSKQFSHWPAEAFEGNLHLCGSPLDHCNGLVSNQH 866
P + L +L LS N L+ L ++ E + NGL
Sbjct: 70 ISPGAFAPLVKLERLYLSKNQLKE-LPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIV 128
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 94.5 bits (234), Expect = 1e-22
Identities = 33/217 (15%), Positives = 64/217 (29%), Gaps = 50/217 (23%)
Query: 953 IIGSGGSGTVYKAELANGATVAVKKI---------SCKDDHLLNKSFTREVKTLGRIRHR 1003
++G G V+ VK + + F+ R R
Sbjct: 7 LMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFR 66
Query: 1004 HLVKLMGHCCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQ 1063
L KL G K +Y + N + + + K + E ++ + +
Sbjct: 67 ALQKLQGLAVPK-------VYAWEGNAVLMELID-----AKELYRVRVENPDEVLDMILE 114
Query: 1064 GVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTES-------- 1115
V +H I+H D+ N+L+ + DF + VE
Sbjct: 115 EVAKFYHRG---IVHGDLSQYNVLVS-EEGIWIIDFPQS---VEVGEEGWREILERDVRN 167
Query: 1116 -NTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLME 1151
T+F+ +Y + D+ S +++
Sbjct: 168 IITYFSRTYRT-------------EKDINSAIDRILQ 191
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.0 bits (237), Expect = 4e-22
Identities = 66/275 (24%), Positives = 96/275 (34%), Gaps = 7/275 (2%)
Query: 244 LNLGNNSLSGEIPSELGELSQLGYLNLMGNRLEGAIPRSFAKMGNLQSLDLSMNRLTGGI 303
+ L +P + SQ + L GNR+ SF NL L L N L
Sbjct: 16 TSCPQQGLQ-AVPVGIPAASQ--RIFLHGNRISHVPAASFRACRNLTILWLHSNVLARID 72
Query: 304 PEEFGNMGQLVFLVLSNNNISGSIPRRICTNATSLEHLILAEIQLSGEIPVELSQCQSLK 363
F + L L LS+N S+ L L L L P +L+
Sbjct: 73 AAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQ 132
Query: 364 QLDLSNNTLNGTIPVELFQLVALTHLYLHNNSLVGSISPFVANLSNLQELALYHNNFQGS 423
L L +N L L LTHL+LH N + L +L L L+ N
Sbjct: 133 YLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHV 192
Query: 424 LPREIGMLVKLELLYLYDNHLSGQIPSEVGNCSSLKWIDFFGNSFTGEIPTSIGRLKDLN 483
P L +L LYL+ N+LS + +L+++ N + + + L
Sbjct: 193 HPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCR-ARPLWAWLQ 251
Query: 484 FLHLRQNELVGQIPASLGNCHQLIILDLADNKLSG 518
+E+ +P L + LA N L G
Sbjct: 252 KFRGSSSEVPCSLPQRLAG---RDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 91.8 bits (226), Expect = 8e-21
Identities = 58/281 (20%), Positives = 100/281 (35%), Gaps = 9/281 (3%)
Query: 95 QSLIHLDLSSNSLTGPIPTALSNLSSLESLLLFSNQLAGTIPTQLGSLTSLRVMRIGDNW 154
+ + L +P + ++ + + L N+++ + +L ++ + N
Sbjct: 11 EPKVTTSCPQQGLQA-VPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNV 67
Query: 155 LSGSIPTSFGNLVNLGTLGLASCSLSGPIPP-QFGQLSQLEELILQQNQLQGPIPAELGN 213
L+ +F L L L L+ + + P F L +L L L + LQ P
Sbjct: 68 LARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRG 127
Query: 214 CSSLSIFTAAENNLNGSIPAALGRLQNLQLLNLGNNSLSGEIPSELGELSQLGYLNLMGN 273
++L +N L L NL L L N +S L L L L N
Sbjct: 128 LAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQN 187
Query: 274 RLEGAIPRSFAKMGNLQSLDLSMNRLTGGIPEEFGNMGQLVFLVLSNNNISGSIPRRICT 333
R+ P +F +G L +L L N L+ E + L +L L++N R
Sbjct: 188 RVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDC--RARP 245
Query: 334 NATSLEHLILAEIQLSGEIPVELSQCQSLKQLDLSNNTLNG 374
L+ + ++ +P L L+ N L G
Sbjct: 246 LWAWLQKFRGSSSEVPCSLPQRL---AGRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 83.3 bits (204), Expect = 6e-18
Identities = 59/257 (22%), Positives = 85/257 (33%), Gaps = 7/257 (2%)
Query: 552 RNLTRINFSKNRLNGRIATLCSSHSFLS-FDVTNNEFDHEIPPQLGNSPSLERLRLGNNK 610
RI NR++ A + L+ + +N LE+L L +N
Sbjct: 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA 91
Query: 611 FIGKI-PWTFGKIRELSLLDLSGNSLTGPIPTQLLMCKKLSHIDLNNNLLSGAVPSWLGT 669
+ + P TF + L L L L P L ++ L +N L
Sbjct: 92 QLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRD 151
Query: 670 LPQLGELKLSFNQFVGFLPRELFNCSKLLVLSLDGNMLNGSLPNEVGNLASLNVLTLSGN 729
L L L L N+ R L L L N + P+ +L L L L N
Sbjct: 152 LGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFAN 211
Query: 730 LLSGPIPPAIGRLSKLYELRLSNNSLNGVIPLEIGQLQNLQSILDLSHNNFTGQIPPSMG 789
LS A+ L L LRL++N LQ S + +P
Sbjct: 212 NLSALPTEALAPLRALQYLRLNDNPWVCDCRA-RPLWAWLQK-FRGSSSEVPCSLPQR-- 267
Query: 790 TLAKLEVLNLSHNQLVG 806
LA ++ L+ N L G
Sbjct: 268 -LAGRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 82.9 bits (203), Expect = 8e-18
Identities = 59/284 (20%), Positives = 95/284 (33%), Gaps = 33/284 (11%)
Query: 572 CSSHSFLSFDVTNNEFDHEIPPQLGNSPSLERLRLGNNKFIGKIPWTFGKIRELSLLDLS 631
C + ++ +P + + +R+ L N+ +F R L++L L
Sbjct: 8 CYNEPKVTTSCPQQGL-QAVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLH 64
Query: 632 GNS-------------------------LTGPIPTQLLMCKKLSHIDLNNNLLSGAVPSW 666
N L P +L + L+ L P
Sbjct: 65 SNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGL 124
Query: 667 LGTLPQLGELKLSFNQFVGFLPRELFNCSKLLVLSLDGNMLNGSLPNEVGNLASLNVLTL 726
L L L L N + L L L GN ++ L SL+ L L
Sbjct: 125 FRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLL 184
Query: 727 SGNLLSGPIPPAIGRLSKLYELRLSNNSLNGVIPLEIGQLQNLQSILDLSHNNFTGQIPP 786
N ++ P A L +L L L N+L+ + + L+ LQ L L+ N +
Sbjct: 185 HQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQY-LRLNDNPWVC-DCR 242
Query: 787 SMGTLAKLEVLNLSHNQLVGELPSQLGEMSSLGKLNLSYNDLQG 830
+ A L+ S +++ LP +L L+ NDLQG
Sbjct: 243 ARPLWAWLQKFRGSSSEVPCSLPQRLAGRDL---KRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 82.6 bits (202), Expect = 1e-17
Identities = 58/288 (20%), Positives = 106/288 (36%), Gaps = 30/288 (10%)
Query: 351 EIPVELSQCQSLKQLDLSNNTLNGTIPVELFQLVALTHLYLHNNSLVGSISPFVANLSNL 410
+PV + + +++ L N ++ LT L+LH+N L + L+ L
Sbjct: 25 AVPVGIPA--ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82
Query: 411 QELALYHNNFQGSL-PREIGMLVKLELLYLYDNHLSGQIPSEVGNCSSLKWIDFFGNSFT 469
++L L N S+ P L +L L+L L P ++L+++ N+
Sbjct: 83 EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ 142
Query: 470 GEIPTSIGRLKDLNFLHLRQNELVGQIPASLGNCHQLIILDLADNKLSGGVPASFGFLQA 529
+ L +L L L N + + H L L L N+++ P +F L
Sbjct: 143 ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGR 202
Query: 530 LEQLMLYNNSLEGNLPGSLINLRNLTRINFSKNRLNGRIATLCSSHSFLSFDVTNNEFDH 589
L L L+ N+L +L LR L + + N C + ++
Sbjct: 203 LMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVC----DCRARPLWAW--------- 249
Query: 590 EIPPQLGNSPSLERLRLGNNKFIGKIPWTFGKIRELSLLDLSGNSLTG 637
L++ R +++ +P ++ L L+ N L G
Sbjct: 250 -----------LQKFRGSSSEVPCSLP---QRLAGRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 67.5 bits (163), Expect = 1e-12
Identities = 46/205 (22%), Positives = 73/205 (35%), Gaps = 4/205 (1%)
Query: 49 HAWNQSNQNLCTWRGITCGSSSARVVSLNLSGLSLAGSISPSLGRLQSLIHLDLSSNSLT 108
+ S+ R+ +L+L L L +L +L L N+L
Sbjct: 83 EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ 142
Query: 109 GPIPTALSNLSSLESLLLFSNQLAGTIPTQLGSLTSLRVMRIGDNWLSGSIPTSFGNLVN 168
+L +L L L N+++ L SL + + N ++ P +F +L
Sbjct: 143 ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGR 202
Query: 169 LGTLGLASCSLSGPIPPQFGQLSQLEELILQQNQLQGPIPAELGNCSSLSIFTAAENNLN 228
L TL L + +LS L L+ L L N A + L F + + +
Sbjct: 203 LMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA-RPLWAWLQKFRGSSSEVP 261
Query: 229 GSIPAALGRLQNLQLLNLGNNSLSG 253
S+P RL L L N L G
Sbjct: 262 CSLPQ---RLAGRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.4 bits (116), Expect = 1e-06
Identities = 45/210 (21%), Positives = 61/210 (29%), Gaps = 5/210 (2%)
Query: 651 HIDLNNNLLSGAVPSWLGTLPQLGELKLSFNQFVGFLPRELFNCSKLLVLSLDGNMLNGS 710
L AVP + Q + L N+ C L +L L N+L
Sbjct: 15 TTSCPQQGLQ-AVPVGIPAASQ--RIFLHGNRISHVPAASFRACRNLTILWLHSNVLARI 71
Query: 711 LPNEVGNLASLNVLTLSGNLLSGPIPP-AIGRLSKLYELRLSNNSLNGVIPLEIGQLQNL 769
LA L L LS N + P L +L+ L L L + P L L
Sbjct: 72 DAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAAL 131
Query: 770 QSILDLSHNNFTGQIPPSMGTLAKLEVLNLSHNQLVGELPSQLGEMSSLGKLNLSYNDLQ 829
Q + L N + L L L L N++ + SL +L L N +
Sbjct: 132 QYL-YLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVA 190
Query: 830 GKLSKQFSHWPAEAFEGNLHLCGSPLDHCN 859
F S L
Sbjct: 191 HVHPHAFRDLGRLMTLYLFANNLSALPTEA 220
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 65.5 bits (158), Expect = 6e-12
Identities = 53/208 (25%), Positives = 75/208 (36%), Gaps = 7/208 (3%)
Query: 68 SSSARVVSLNLSGLSLAGSISPSLGRLQSLIHLDLSSNSLTGPIPTALSNLSSLESLLLF 127
S A + +N +L ++ P L + L LS N L L + L L L
Sbjct: 7 SKVASHLEVNCDKRNLT-ALPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQLNLD 63
Query: 128 SNQLAGTIPTQLGSLTSLRVMRIGDNWLSGSIPTSFGNLVNLGTLGLASCSLSGPIPPQF 187
+ T G+L L + + N L L L ++ L+
Sbjct: 64 RAE--LTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTL-PALTVLDVSFNRLTSLPLGAL 120
Query: 188 GQLSQLEELILQQNQLQGPIPAELGNCSSLSIFTAAENNLNGSIPAALGRLQNLQLLNLG 247
L +L+EL L+ N+L+ P L L + A NNL L L+NL L L
Sbjct: 121 RGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQ 180
Query: 248 NNSLSGEIPSELGELSQLGYLNLMGNRL 275
NSL IP L + L GN
Sbjct: 181 ENSLY-TIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 64.7 bits (156), Expect = 1e-11
Identities = 42/211 (19%), Positives = 65/211 (30%), Gaps = 8/211 (3%)
Query: 258 ELGELSQLGYLNLMGNRLEGAIPRSFAKMGNLQSLDLSMNRLTGGIPEEFGNMGQLVFLV 317
E+ +++ +N L A+P K + L LS N L +L L
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 318 LSNNNISGSIPRRICTNATSLEHLILAEIQLSGEIPVELSQCQSLKQLDLSNNTLNGTIP 377
L ++ +L+ L + N L
Sbjct: 62 LDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVS----FNRLTSLPL 117
Query: 378 VELFQLVALTHLYLHNNSLVGSISPFVANLSNLQELALYHNNFQGSLPREIGMLVKLELL 437
L L L LYL N L + L++L+L +NN + L L+ L
Sbjct: 118 GALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTL 177
Query: 438 YLYDNHLSGQIPSEVGNCSSLKWIDFFGNSF 468
L +N L IP L + GN +
Sbjct: 178 LLQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 61.3 bits (147), Expect = 1e-10
Identities = 41/207 (19%), Positives = 68/207 (32%), Gaps = 24/207 (11%)
Query: 210 ELGNCSSLSIFTAAENNLNGSIPAALGRLQNLQLLNLGNNSLSGEIPSELGELSQLGYLN 269
E+ +S + NL ++P L + + +L+L N L + L ++L LN
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 270 LMGNRLEGAIPRSFAKMGNLQSLDLSMNRLT--------------------GGIPEEFGN 309
L L + L + + +P
Sbjct: 62 LDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALR 121
Query: 310 MGQLVFLVLSNNNISGSIPRRICTNATSLEHLILAEIQLSGEIPVELSQCQSLKQLDLSN 369
+ + N ++P + T LE L LA L+ L+ ++L L L
Sbjct: 122 GLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQE 181
Query: 370 NTLNGTIPVELFQLVALTHLYLHNNSL 396
N+L TIP F L +LH N
Sbjct: 182 NSLY-TIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.7 bits (130), Expect = 2e-08
Identities = 43/209 (20%), Positives = 68/209 (32%), Gaps = 6/209 (2%)
Query: 475 SIGRLKDLNFLHLRQNELVGQIPASLGNCHQLIILDLADNKLSGGVPASFGFLQALEQLM 534
+ ++ ++ + L +P L IL L++N L A+ L QL
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 535 LYNNSLEGNLPGSLINLRNLTRINFSKNRLNGRIATLCSSHSFLSFDVTNNEFDHEIPPQ 594
L E L L ++ S N+L + + DV+ N
Sbjct: 62 LDRA--ELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGA 119
Query: 595 LGNSPSLERLRLGNNKFIGKIPWTFGKIRELSLLDLSGNSLTGPIPTQLLMCKKLSHIDL 654
L L+ L L N+ P +L L L+ N+LT L + L + L
Sbjct: 120 LRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLL 179
Query: 655 NNNLLSGAVPSWLGTLPQLGELKLSFNQF 683
N L +P L L N +
Sbjct: 180 QENSLY-TIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.3 bits (129), Expect = 2e-08
Identities = 47/210 (22%), Positives = 62/210 (29%), Gaps = 25/210 (11%)
Query: 568 IATLCSSHSFLSFDVTNNEFDHEIPPQLGNSPSLERLRLGNNKFIGKIPWTFGKIRELSL 627
I + S L + +PP L L L N T L+
Sbjct: 3 ICEVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQ 59
Query: 628 LDLSGNSLTGPIPTQLL---------------------MCKKLSHIDLNNNLLSGAVPSW 666
L+L LT L L+ +D++ N L+
Sbjct: 60 LNLDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGA 119
Query: 667 LGTLPQLGELKLSFNQFVGFLPRELFNCSKLLVLSLDGNMLNGSLPNEVGNLASLNVLTL 726
L L +L EL L N+ P L KL LSL N L + L +L+ L L
Sbjct: 120 LRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLL 179
Query: 727 SGNLLSGPIPPAIGRLSKLYELRLSNNSLN 756
N L IP L L N
Sbjct: 180 QENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.0 bits (128), Expect = 3e-08
Identities = 52/197 (26%), Positives = 76/197 (38%), Gaps = 7/197 (3%)
Query: 608 NNKFIGKIPWTFGKIRELSLLDLSGNSLTGPIPTQLLMCKKLSHIDLNNNLLSGAVPSWL 667
+ + + +P K + ++L LS N L L+ +L+ ++L+
Sbjct: 18 DKRNLTALPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQLNLDRA--ELTKLQVD 73
Query: 668 GTLPQLGELKLSFNQFVGFLPRELFNCSKLLVLSLDGNMLNGSLPNEVGNLASLNVLTLS 727
GTLP LG L LS NQ L VL + N L + L L L L
Sbjct: 74 GTLPVLGTLDLSHNQLQSLPLLG-QTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLK 132
Query: 728 GNLLSGPIPPAIGRLSKLYELRLSNNSLNGVIPLEIGQLQNLQSILDLSHNNFTGQIPPS 787
GN L P + KL +L L+NN+L + + L+NL + L L N+ IP
Sbjct: 133 GNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDT-LLLQENSLY-TIPKG 190
Query: 788 MGTLAKLEVLNLSHNQL 804
L L N
Sbjct: 191 FFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.2 bits (126), Expect = 5e-08
Identities = 51/258 (19%), Positives = 80/258 (31%), Gaps = 54/258 (20%)
Query: 355 ELSQCQSLKQLDLSNNTLNGTIPVELFQLVALTHLYLHNNSLVGSISPFVANLSNLQELA 414
E+S+ S +++ L +P +L + T L+L N L + + L +L
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLPKD--TTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 415 LYHNNFQGSLPREIGMLVKLELLYLYDNHLSGQIPSEVGNCSSLKWIDFFGNSFTGEIPT 474
L + G L L L L N L + +D N T
Sbjct: 62 LDRAELTK--LQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPAL-TVLDVSFNRLTSLPLG 118
Query: 475 SIGRLKDLNFLHLRQNELVGQIPASLGNCHQLIILDLADNKLSGGVPASFGFLQALEQLM 534
++ L +L L+L+ NEL P L +L L LA+N L+ L+ L+ L+
Sbjct: 119 ALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLL 178
Query: 535 LYNNSLEGNLPGSLINLRNLTRINFSKNRLNGRIATLCSSHSFLSFDVTNNEFDHEIPPQ 594
L NS + IP
Sbjct: 179 LQENS------------------------------------------------LYTIPKG 190
Query: 595 LGNSPSLERLRLGNNKFI 612
S L L N ++
Sbjct: 191 FFGSHLLPFAFLHGNPWL 208
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.9 bits (102), Expect = 6e-05
Identities = 12/65 (18%), Positives = 27/65 (41%), Gaps = 4/65 (6%)
Query: 739 IGRLSKLYELRLSNNSLNGVIPLEIGQLQNLQSILDLSHNNFTGQIPPSMGTLAKLEVLN 798
+ +++ E+ +L +P ++ + + IL LS N ++ +L LN
Sbjct: 6 VSKVASHLEVNCDKRNLT-ALPPDLPK--DTT-ILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 799 LSHNQ 803
L +
Sbjct: 62 LDRAE 66
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.8 bits (99), Expect = 2e-04
Identities = 15/65 (23%), Positives = 28/65 (43%), Gaps = 4/65 (6%)
Query: 762 EIGQLQNLQSILDLSHNNFTGQIPPSMGTLAKLEVLNLSHNQLVGELPSQLGEMSSLGKL 821
E+ ++ + + + N T +PP + +L+LS N L + L + L +L
Sbjct: 5 EVSKVASHLEV-NCDKRNLT-ALPPDLPKD--TTILHLSENLLYTFSLATLMPYTRLTQL 60
Query: 822 NLSYN 826
NL
Sbjct: 61 NLDRA 65
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.2 bits (95), Expect = 5e-04
Identities = 49/218 (22%), Positives = 69/218 (31%), Gaps = 20/218 (9%)
Query: 646 CKKLSHIDLNNNLLSGAVPSWLGTLPQLGELKLSFNQFVGFLPRELFNCSKLLVLSLDGN 705
++ + L+ A+P L L LS N F L ++L L+LD
Sbjct: 9 VASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRA 65
Query: 706 MLNGSLPNEVGNLASLNVLTLSGNLLSGPIPPAIGRLSKLYELRLSNNSLNGVIPLEIGQ 765
L G L L L LS N L + N + +PL +
Sbjct: 66 ELTK--LQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTS--LPLGALR 121
Query: 766 LQNLQSILDLSHNNFTGQIPPSMGTLAKLEVLNLSHNQLVGELPSQLGEMSSLGKLNLSY 825
L L N P + KLE L+L++N L L + +L L L
Sbjct: 122 GLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQE 181
Query: 826 NDLQGKLSKQFSHWPAEAFEGN----LHLCGSPLDHCN 859
N P F + L G+P CN
Sbjct: 182 N--------SLYTIPKGFFGSHLLPFAFLHGNPW-LCN 210
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 64.7 bits (156), Expect = 1e-11
Identities = 48/277 (17%), Positives = 96/277 (34%), Gaps = 17/277 (6%)
Query: 290 QSLDLSMNRLTGGIPEEFGNMGQLVFLVLSNNNISGSIPRRICTNATSLEHLILAEIQLS 349
Q+LDL+ L + + G ++ + + + + ++H+ L+ +
Sbjct: 3 QTLDLTGKNLHPDVTGRLLSQG-VIAFRCPRSFMDQPLAE--HFSPFRVQHMDLSNSVIE 59
Query: 350 GE-IPVELSQCQSLKQLDLSNNTLNGTIPVELFQLVALTHLYLHNNSLV--GSISPFVAN 406
+ LSQC L+ L L L+ I L + L L L S ++ +++
Sbjct: 60 VSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSS 119
Query: 407 LSNLQELALYHNNFQG------SLPREIGMLVKLELLYLYDNHLSGQIPSEVGNCSSLKW 460
S L EL L ++ + +L L N + + V C +L
Sbjct: 120 CSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVH 179
Query: 461 IDFFGN-SFTGEIPTSIGRLKDLNFLHLRQ-NELVGQIPASLGNCHQLIILDLADNKLSG 518
+D + + +L L L L + +++ + LG L L + G
Sbjct: 180 LDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDG 239
Query: 519 GVPASFGFLQALEQLMLYNNSLEGNLPGSLINLRNLT 555
+ +AL L + + ++ N +N
Sbjct: 240 TLQL---LKEALPHLQINCSHFTTIARPTIGNKKNQE 273
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 61.3 bits (147), Expect = 1e-10
Identities = 52/264 (19%), Positives = 94/264 (35%), Gaps = 16/264 (6%)
Query: 160 PTSFGNLVNLGT--LGLASCSLSGPIPPQFGQLSQLEELILQQNQLQG-PIPAELGNCSS 216
P G L++ G + P+ F +++ + L + ++ + L CS
Sbjct: 14 PDVTGRLLSQGVIAFRCPRSFMDQPLAEHF-SPFRVQHMDLSNSVIEVSTLHGILSQCSK 72
Query: 217 LSIFTAAENNLNGSIPAALGRLQNLQLLNLG--NNSLSGEIPSELGELSQLGYLNLMGNR 274
L + L+ I L + NL LNL + + + L S+L LNL
Sbjct: 73 LQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCF 132
Query: 275 LEG------AIPRSFAKMGNLQSLDLSMNRLTGGIPEEFGNMGQLVFLVLSNNNISGSIP 328
A+ + L N + LV L LS++ + +
Sbjct: 133 DFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDC 192
Query: 329 RRICTNATSLEHLILAEI-QLSGEIPVELSQCQSLKQLDLSNNTLNGTIPVELFQLVALT 387
+ L+HL L+ + E +EL + +LK L + +GT+ + AL
Sbjct: 193 FQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLL---KEALP 249
Query: 388 HLYLHNNSLVGSISPFVANLSNLQ 411
HL ++ + P + N N +
Sbjct: 250 HLQINCSHFTTIARPTIGNKKNQE 273
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 59.3 bits (142), Expect = 6e-10
Identities = 43/248 (17%), Positives = 87/248 (35%), Gaps = 15/248 (6%)
Query: 73 VVSLNLSGLSLAGSISPSLGRLQSLIHLDLSSNSLTG-PIPTALSNLSSLESLLLFSNQL 131
V++ + + + H+DLS++ + + LS S L++L L +L
Sbjct: 25 VIAFRCPRSFMDQPL-AEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRL 83
Query: 132 AGTIPTQLGSLTSLRV--MRIGDNWLSGSIPTSFGNLVNLGTL------GLASCSLSGPI 183
+ I L ++L + + ++ T + L L + +
Sbjct: 84 SDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAV 143
Query: 184 PPQFGQLSQLEELILQQNQLQGPIPAELGNCSSLSIFTAAEN-NLNGSIPAALGRLQNLQ 242
++QL ++N + + + C +L +++ L +L LQ
Sbjct: 144 AHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQ 203
Query: 243 LLNLGN-NSLSGEIPSELGELSQLGYLNLMGNRLEGAIPRSFAKMGNLQSLDLSMNRLTG 301
L+L + E ELGE+ L L + G +G + L L ++ + T
Sbjct: 204 HLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKE---ALPHLQINCSHFTT 260
Query: 302 GIPEEFGN 309
GN
Sbjct: 261 IARPTIGN 268
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 58.6 bits (140), Expect = 1e-09
Identities = 42/278 (15%), Positives = 87/278 (31%), Gaps = 17/278 (6%)
Query: 242 QLLNLGNNSLSGEIPSELGELSQLGYLNLMGNRLEGAIPRSFAKMGNLQSLDLSMNRLTG 301
Q L+L +L ++ L + + ++ + F +Q +DLS + +
Sbjct: 3 QTLDLTGKNLHPDVTGRLLSQ-GVIAFRCPRSFMDQPLAEHF-SPFRVQHMDLSNSVIEV 60
Query: 302 -GIPEEFGNMGQLVFLVLSNNNISGSIPRRICTNATSLEHLILAEIQLSGEIPVELSQCQ 360
+ +L L L +S I + N ++L L L+ E ++
Sbjct: 61 STLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKN-SNLVRLNLSGCSGFSEFALQTLLSS 119
Query: 361 SLKQLDLSNNTLNGTIPVELFQLVALTHLYLHNNSLVGSISPFVANLSNLQELALYHN-- 418
+ +L+ + + VA + +L G + + +
Sbjct: 120 CSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVH 179
Query: 419 -------NFQGSLPREIGMLVKLELLYLYD-NHLSGQIPSEVGNCSSLKWIDFFGNSFTG 470
+ +E L L+ L L + + E+G +LK + FG G
Sbjct: 180 LDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDG 239
Query: 471 EIPTSIGRLKDLNFLHLRQNELVGQIPASLGNCHQLII 508
+ L L + + ++GN I
Sbjct: 240 TLQLLKEALPHLQ---INCSHFTTIARPTIGNKKNQEI 274
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.3 bits (121), Expect = 3e-07
Identities = 50/276 (18%), Positives = 96/276 (34%), Gaps = 16/276 (5%)
Query: 535 LYNNSLEGNLPGSLINLRNLTRINFSKNRLNGRIATLCSSHSFLSFDVTNNEFDHE-IPP 593
L +L ++ G L++ + + ++ ++ +A S D++N+ + +
Sbjct: 7 LTGKNLHPDVTGRLLS-QGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHG 65
Query: 594 QLGNSPSLERLRLGNNKFIGKIPWTFGKIRELSLLDL--------SGNSLTGPIPTQLLM 645
L L+ L L + I T K L L+L ++L
Sbjct: 66 ILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDE 125
Query: 646 CKKLSHIDLNNNLLSGAVPSWLGTLPQLGELKLSFNQFVGFLPRELFNCSKLLVLSLDGN 705
D + AV T+ QL N L + C L+ L L +
Sbjct: 126 LNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDS 185
Query: 706 ML-NGSLPNEVGNLASLNVLTLSG-NLLSGPIPPAIGRLSKLYELRLSNNSLNGVIPLEI 763
++ E L L L+LS + +G + L L++ +G + L
Sbjct: 186 VMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLK 245
Query: 764 GQLQNLQSILDLSHNNFTGQIPPSMGTLAKLEVLNL 799
L +LQ ++ ++FT P++G E+ +
Sbjct: 246 EALPHLQ----INCSHFTTIARPTIGNKKNQEIWGI 277
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.7 bits (91), Expect = 0.001
Identities = 18/94 (19%), Positives = 37/94 (39%), Gaps = 4/94 (4%)
Query: 748 LRLSNNSLNGVIPLEIGQLQNLQSILDLSHNNFTGQIPPSMGTLAKLEVLNLSHNQLVGE 807
L L+ +L+ P G+L + I +F Q + +++ ++LS++ +
Sbjct: 5 LDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVS 61
Query: 808 -LPSQLGEMSSLGKLNLSYNDLQGKLSKQFSHWP 840
L L + S L L+L L + +
Sbjct: 62 TLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNS 95
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 65.4 bits (157), Expect = 2e-11
Identities = 58/451 (12%), Positives = 111/451 (24%), Gaps = 20/451 (4%)
Query: 361 SLKQLDLSNNTLNGTIPVELF-QLVALTHLYLHNNSL----VGSISPFVANLSNLQELAL 415
++ LD+ L+ EL L + L + L IS + L EL L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 416 YHNNFQGSLPREIG-----MLVKLELLYLYDNHLSGQIPSEVGNCSSLKWIDFFGNSFTG 470
N + K++ L L + L+G + + +
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDN 122
Query: 471 EIPTSIGRLKDLNFLHLRQNELVGQIPASLGNCHQLIILDLADNKLSGGVPASFGFLQAL 530
+ + +L L + Q+ + L +
Sbjct: 123 LLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDIN 182
Query: 531 EQLMLYNNSLEGNLPGSLINLRNLTRINFSKNRLNGRIATLCSSHSFLSFDVTNNEFDHE 590
E + + P L L+ + S N + + +N D
Sbjct: 183 EAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVG 242
Query: 591 IPPQLGNSPSLERLRLGNNKFIGKIPWTFGKIRELSLLDLSGNSLTGPIPTQLLMCKKLS 650
+ + I L +L
Sbjct: 243 MAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARL 302
Query: 651 HIDLNNNLLSGAVPSWLGTLPQLGELKLSFNQFVGFLPRELFNCSKLLVLSLDGNMLNGS 710
+ W+ + F+ + L L G
Sbjct: 303 LCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQ 362
Query: 711 LPNEVGNLASLNVLTLSGNLLSG----PIPPAIGRLSKLYELRLSNNSLNGVIPLEIGQ- 765
+ + L VL L+ +S + + L EL LSNN L L++ +
Sbjct: 363 GLGQ--PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVES 420
Query: 766 LQNLQS---ILDLSHNNFTGQIPPSMGTLAK 793
++ L L ++ ++ + L K
Sbjct: 421 VRQPGCLLEQLVLYDIYWSEEMEDRLQALEK 451
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.1 bits (120), Expect = 5e-07
Identities = 18/110 (16%), Positives = 37/110 (33%), Gaps = 22/110 (20%)
Query: 288 NLQSLDLSMNRLT-GGIPEEFGNMGQLVFLVLSNNNISGSIPRRICTNATSLEHLILAEI 346
++QSLD+ L+ E + Q + L + ++ + + I +
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSA------------ 50
Query: 347 QLSGEIPVELSQCQSLKQLDLSNNTLNGTIPVELFQLVALTHLYLHNNSL 396
L +L +L+L +N L + Q + + SL
Sbjct: 51 ---------LRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSL 91
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.7 bits (119), Expect = 7e-07
Identities = 18/112 (16%), Positives = 30/112 (26%), Gaps = 6/112 (5%)
Query: 745 LYELRLSNNSLNGVIPLEI-GQLQNLQSILDLSHNNFTGQ----IPPSMGTLAKLEVLNL 799
+ L + L+ E+ LQ Q + L T I ++ L LNL
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQV-VRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 800 SHNQLVGELPSQLGEMSSLGKLNLSYNDLQGKLSKQFSHWPAEAFEGNLHLC 851
N+L + + + LQ + L
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTL 114
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.0 bits (112), Expect = 6e-06
Identities = 17/98 (17%), Positives = 28/98 (28%), Gaps = 5/98 (5%)
Query: 240 NLQLLNLGNNSLSGEIPSELGE-LSQLGYLNLMGNRLEG----AIPRSFAKMGNLQSLDL 294
++Q L++ LS +EL L Q + L L I + L L+L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 295 SMNRLTGGIPEEFGNMGQLVFLVLSNNNISGSIPRRIC 332
N L Q + ++
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAG 100
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.7 bits (111), Expect = 7e-06
Identities = 19/95 (20%), Positives = 34/95 (35%), Gaps = 14/95 (14%)
Query: 286 MGNLQSLDLSMNRLTG----GIPEEFGNMGQLVFLVLSNNNISGSIPRRIC----TNATS 337
L+ L L+ ++ + L L LSNN + + ++
Sbjct: 368 GSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCL 427
Query: 338 LEHLILAEIQLSGEIPVELSQCQSLKQLDLSNNTL 372
LE L+L +I S E+ L+ L+ +L
Sbjct: 428 LEQLVLYDIYWSEEME------DRLQALEKDKPSL 456
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.5 bits (108), Expect = 2e-05
Identities = 21/103 (20%), Positives = 37/103 (35%), Gaps = 9/103 (8%)
Query: 49 HAWNQSNQNLCTWRGITCGSSSARVVSLNLSGLSL----AGSISPSLGRLQSLIHLDLSS 104
+ N+ G + + L L+ + S++ +L SL LDLS+
Sbjct: 347 ISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSN 406
Query: 105 NSLTGPIPTALS-----NLSSLESLLLFSNQLAGTIPTQLGSL 142
N L L LE L+L+ + + +L +L
Sbjct: 407 NCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQAL 449
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.5 bits (108), Expect = 2e-05
Identities = 57/440 (12%), Positives = 107/440 (24%), Gaps = 16/440 (3%)
Query: 193 LEELILQQNQLQGPIPAEL-GNCSSLSIFTAAENNLNG----SIPAALGRLQNLQLLNLG 247
++ L +Q +L AEL + + L I +AL L LNL
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 248 NNSLSGEIPSELGELSQLGYLNLMGNRLEGAIP-RSFAKMGNLQSLDLSMNRLTGGIPEE 306
+N L + + Q + L+ + + + L +
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNL 123
Query: 307 FGNMGQLVFLVLSNNNISGSIPRRICTNATSLEHLILAEIQLSGEIPVELSQCQSLKQLD 366
G+ G + + ++ + S L + + + +
Sbjct: 124 LGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINE 183
Query: 367 LSNNTLNGTIPVELFQLVALTHLYLHNNSLVGSISPFVANLSNLQELALYHNNFQGSLPR 426
L + QL AL S + +N G +
Sbjct: 184 AGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGM 243
Query: 427 EIGMLVKLELLYLYDNHLSGQIPSEVGNCSSLKWIDFFGNSFTGEIPTSIGRLKDLNFLH 486
L + C L + S + L
Sbjct: 244 AELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLL 303
Query: 487 LRQNELVGQIPASLGNCHQLIILDLADNKLSGGVPASFGFLQALEQLMLYNNSLEGNLPG 546
G SL + S F + L + + G
Sbjct: 304 CETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQG 363
Query: 547 SLINLRNLTRINFSKNRLNGRIA-----TLCSSHSFLSFDVTNNEFDHEIPPQLG----- 596
L + + ++ TL ++HS D++NN QL
Sbjct: 364 LGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQ 423
Query: 597 NSPSLERLRLGNNKFIGKIP 616
LE+L L + + ++
Sbjct: 424 PGCLLEQLVLYDIYWSEEME 443
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.0 bits (104), Expect = 5e-05
Identities = 18/88 (20%), Positives = 28/88 (31%), Gaps = 9/88 (10%)
Query: 263 SQLGYLNLMGNRLEG----AIPRSFAKMGNLQSLDLSMNRLTGGIPEEFG-----NMGQL 313
S L L L + ++ + +L+ LDLS N L + L
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428
Query: 314 VFLVLSNNNISGSIPRRICTNATSLEHL 341
LVL + S + R+ L
Sbjct: 429 EQLVLYDIYWSEEMEDRLQALEKDKPSL 456
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.8 bits (101), Expect = 1e-04
Identities = 17/85 (20%), Positives = 30/85 (35%), Gaps = 8/85 (9%)
Query: 307 FGNMGQLVFLVLSNNNISGSIPRRIC---TNATSLEHLILAEIQLSGEIPVELSQ----- 358
L L L++ ++S S + SL L L+ L ++L +
Sbjct: 365 GQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQP 424
Query: 359 CQSLKQLDLSNNTLNGTIPVELFQL 383
L+QL L + + + L L
Sbjct: 425 GCLLEQLVLYDIYWSEEMEDRLQAL 449
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.4 bits (100), Expect = 2e-04
Identities = 20/88 (22%), Positives = 31/88 (35%), Gaps = 5/88 (5%)
Query: 75 SLNLSGLSLAGS-ISPSLGRLQSLIHLDLSSNSLTG----PIPTALSNLSSLESLLLFSN 129
SL++ L+ + + L LQ + L LT I +AL +L L L SN
Sbjct: 6 SLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSN 65
Query: 130 QLAGTIPTQLGSLTSLRVMRIGDNWLSG 157
+L + +I L
Sbjct: 66 ELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.0 bits (99), Expect = 2e-04
Identities = 23/104 (22%), Positives = 37/104 (35%), Gaps = 23/104 (22%)
Query: 334 NATSLEHLILAEIQLSGE----IPVELSQCQSLKQLDLSNNTLNGTIPVELFQLVALTHL 389
+ L L LA+ +S + L SL++LDLSNN L ++L + V
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQ--- 423
Query: 390 YLHNNSLVGSISPFVANLSNLQELALYHNNFQGSLPREIGMLVK 433
L++L LY + + + L K
Sbjct: 424 ----------------PGCLLEQLVLYDIYWSEEMEDRLQALEK 451
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.3 bits (97), Expect = 3e-04
Identities = 13/86 (15%), Positives = 30/86 (34%), Gaps = 5/86 (5%)
Query: 598 SPSLERLRLGNNKFIGK-IPWTFGKIRELSLLDLSGNSLTG----PIPTQLLMCKKLSHI 652
S ++ L + + +++ ++ L LT I + L + L+ +
Sbjct: 1 SLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAEL 60
Query: 653 DLNNNLLSGAVPSWLGTLPQLGELKL 678
+L +N L + Q K+
Sbjct: 61 NLRSNELGDVGVHCVLQGLQTPSCKI 86
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.3 bits (97), Expect = 3e-04
Identities = 21/102 (20%), Positives = 34/102 (33%), Gaps = 15/102 (14%)
Query: 208 PAELGNCSSLSIFTAAENNLNG----SIPAALGRLQNLQLLNLGNNSLSGEIPSELGE-- 261
S L + A+ +++ S+ A L +L+ L+L NN L +L E
Sbjct: 362 QGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESV 421
Query: 262 ---LSQLGYLNLMGNRLEGAIPRSFAKMGNLQSLDLSMNRLT 300
L L L + LQ+L+ L
Sbjct: 422 RQPGCLLEQLVLYDIYWSEEMEDR------LQALEKDKPSLR 457
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.9 bits (96), Expect = 4e-04
Identities = 15/80 (18%), Positives = 30/80 (37%), Gaps = 9/80 (11%)
Query: 765 QLQNLQSILDLSHNNFTGQ----IPPSMGTLAKLEVLNLSHNQLVGELPSQLGE-----M 815
Q ++ +L L+ + + + ++ L L+LS+N L QL E
Sbjct: 366 QPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPG 425
Query: 816 SSLGKLNLSYNDLQGKLSKQ 835
L +L L ++ +
Sbjct: 426 CLLEQLVLYDIYWSEEMEDR 445
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.5 bits (95), Expect = 6e-04
Identities = 14/87 (16%), Positives = 28/87 (32%), Gaps = 9/87 (10%)
Query: 406 NLSNLQELALYHNNFQG----SLPREIGMLVKLELLYLYDNHLSGQIPSEVG-----NCS 456
S L+ L L + SL + L L L +N L ++
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426
Query: 457 SLKWIDFFGNSFTGEIPTSIGRLKDLN 483
L+ + + ++ E+ + L+
Sbjct: 427 LLEQLVLYDIYWSEEMEDRLQALEKDK 453
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.2 bits (89), Expect = 0.003
Identities = 14/90 (15%), Positives = 30/90 (33%), Gaps = 13/90 (14%)
Query: 433 KLELLYLYDNHLSGQ----IPSEVGNCSSLKWIDFFGNSFTGEIPTSIGR-LKD----LN 483
L +L+L D +S + + + SL+ +D N + ++ L
Sbjct: 370 VLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLE 429
Query: 484 FLHLRQNELVGQIPASLG----NCHQLIIL 509
L L ++ L + L ++
Sbjct: 430 QLVLYDIYWSEEMEDRLQALEKDKPSLRVI 459
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 55.4 bits (132), Expect = 8e-09
Identities = 34/227 (14%), Positives = 68/227 (29%), Gaps = 18/227 (7%)
Query: 94 LQSLIHLDLSSNSLTGPIPTALSNLSSLESLLLFSNQLAGTIPTQLGSLTSLRVMRIGDN 153
L + I + +++T + ++L + +L F + + L +L + + DN
Sbjct: 18 LANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDN 73
Query: 154 WLSGSIPTSFGNLVNLGTLGLASCSLSGPIPPQFGQLSQLEELILQQNQLQGPIPAELGN 213
++ P L + +S + L +
Sbjct: 74 QITDLAPLK----------NLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVT 123
Query: 214 CSSLSIFTAAENNLNGSIPAALGRLQNLQLLNLGNNSLSGEIPSELGELSQLGYLNLMGN 273
+ I L L + + L LS+L L N
Sbjct: 124 PLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDN 183
Query: 274 RLEGAIPRSFAKMGNLQSLDLSMNRLTGGIPEEFGNMGQLVFLVLSN 320
++ P A + NL + L N+++ P N L + L+N
Sbjct: 184 KISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 53.5 bits (127), Expect = 3e-08
Identities = 36/225 (16%), Positives = 66/225 (29%), Gaps = 18/225 (8%)
Query: 71 ARVVSLNLSGLSLAGSISPSLGRLQSLIHLDLSSNSLTGPIPTALSNLSSLESLLLFSNQ 130
A + + ++ +++ L + L +T + L++L L L NQ
Sbjct: 19 ANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTT--IEGVQYLNNLIGLELKDNQ 74
Query: 131 LAGTIPTQLGSLTSLRVMRIGDNWLSGSIPTSFGNLVNLGTLGLASCSLSGPIPPQFGQL 190
+ P + + + + +I T + L
Sbjct: 75 ITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVL 134
Query: 191 SQLEELILQQNQLQGPIPAELGNCSSLSIFTAAENNLNGSIPAALGRLQNLQLLNLGNNS 250
I + L G + + N S L L L L +N
Sbjct: 135 YLDLNQITNISPLAGLTNLQYLSI----------GNAQVSDLTPLANLSKLTTLKADDNK 184
Query: 251 LSGEIPSELGELSQLGYLNLMGNRLEGAIPRSFAKMGNLQSLDLS 295
+S P L L L ++L N++ P A NL + L+
Sbjct: 185 ISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 50.4 bits (119), Expect = 4e-07
Identities = 40/226 (17%), Positives = 74/226 (32%), Gaps = 19/226 (8%)
Query: 238 LQNLQLLNLGNNSLSGEIPSELGELSQLGYLNLMGNRLEGAIPRSFAKMGNLQSLDLSMN 297
L N + G ++++ + +L + L+ G + + NL L+L N
Sbjct: 18 LANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDN 73
Query: 298 RLTGGIPEEFGNMGQLVFLVLSNNNISGSIPRRICTNATSLEHLILAEIQLSGEIPVELS 357
++T P + + L + +I L L+
Sbjct: 74 QITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQ-------ITDVTPLA 126
Query: 358 QCQSLKQLDLSNNTLNGTIPVELFQLVALTHLYLHNNSLVGSISPFVANLSNLQELALYH 417
+L+ L L N + P+ + + S +ANLS L L
Sbjct: 127 GLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQV----SDLTPLANLSKLTTLKADD 182
Query: 418 NNFQGSLPREIGMLVKLELLYLYDNHLSGQIPSEVGNCSSLKWIDF 463
N P + L L ++L +N +S P + N S+L +
Sbjct: 183 NKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTL 224
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 48.1 bits (113), Expect = 2e-06
Identities = 32/219 (14%), Positives = 76/219 (34%), Gaps = 23/219 (10%)
Query: 309 NMGQLVFLVLSNNNISGSIPRRICTNATSLEHLILAEIQLSGEIPVELSQCQSLKQLDLS 368
+ + + +N++ ++ + + + L ++ I + +L L+L
Sbjct: 17 ALANAIKIAAGKSNVTDTVTQ---ADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELK 71
Query: 369 NNTLNGTIPVELFQLVALTHLYLHNNSLVGSISPFVANLSN-------LQELALYHNNFQ 421
+N + P++ + L + V +I+ + + L +
Sbjct: 72 DNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNL 131
Query: 422 GSLPREIGMLVKLELL-------YLYDNHLSGQIPSEVGNCSSLKWIDFFGNSFTGEIPT 474
L ++ + + L YL + + + N S L + N + P
Sbjct: 132 QVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP- 190
Query: 475 SIGRLKDLNFLHLRQNELVGQIPASLGNCHQLIILDLAD 513
+ L +L +HL+ N++ P L N L I+ L +
Sbjct: 191 -LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 45.4 bits (106), Expect = 1e-05
Identities = 39/228 (17%), Positives = 66/228 (28%), Gaps = 18/228 (7%)
Query: 550 NLRNLTRINFSKNRLNGRIATLCSSHSFLSFDVTNNEFDHEIPPQLGNSPSLERLRLGNN 609
L N +I K+ + + T + I + +L L L +N
Sbjct: 17 ALANAIKIAAGKSNVTDTV-TQADLDGITTLSAFGTGVT-TIEG-VQYLNNLIGLELKDN 73
Query: 610 KFIGKIPWTFGKIRELSLLDLSGNSLTGPIPTQLLMCKKLSHIDLNNNLLSGAVPSWLGT 669
+ P L + I + ++ A S L
Sbjct: 74 QITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQV 133
Query: 670 LPQLGELKLSFNQFVGFLPRELFNCSKLLVLSLDGNMLNGSLPNEVGNLASLNVLTLSGN 729
L + + G + + S + NL+ L L N
Sbjct: 134 LYLDLNQITNISPLAGLTNLQYLSI----------GNAQVSDLTPLANLSKLTTLKADDN 183
Query: 730 LLSGPIPPAIGRLSKLYELRLSNNSLNGVIPLEIGQLQNLQSILDLSH 777
+S P + L L E+ L NN ++ V PL NL I+ L++
Sbjct: 184 KISDISP--LASLPNLIEVHLKNNQISDVSPL--ANTSNLF-IVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 44.3 bits (103), Expect = 4e-05
Identities = 34/226 (15%), Positives = 70/226 (30%), Gaps = 17/226 (7%)
Query: 502 NCHQLIILDLADNKLSGGVPASFGFLQALEQLMLYNNSLEGNLPGSLINLRNLTRINFSK 561
I + + ++ + L + L + + + G + L NL +
Sbjct: 17 ALANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVT-TIEG-VQYLNNLIGLELKD 72
Query: 562 NRLNGRIATLCSSHSFLSFDVTNNEFDHEIPPQLGNSPSLERLRLGNNKFIGKIPWTFGK 621
N++ + L+ + + + L
Sbjct: 73 NQITD-----LAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAG 127
Query: 622 IRELSLLDLSGNSLTGPIPTQLLMCKKLSHIDLNNNLLSGAVPSWLGTLPQLGELKLSFN 681
+ L +L L N +T P L + I + L L +L LK N
Sbjct: 128 LSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVS----DLTPLANLSKLTTLKADDN 183
Query: 682 QFVGFLPRELFNCSKLLVLSLDGNMLNGSLPNEVGNLASLNVLTLS 727
+ P L + L+ + L N ++ P + N ++L ++TL+
Sbjct: 184 KISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 42.3 bits (98), Expect = 1e-04
Identities = 16/66 (24%), Positives = 31/66 (46%), Gaps = 5/66 (7%)
Query: 736 PPAIGRLSKLYELRLSNNSLNGVIPLEIGQLQNLQSILDLSHNNFTGQIPPSMGTLAKLE 795
+ LSKL L+ +N ++ + PL L NL + L +N + P + + L
Sbjct: 166 LTPLANLSKLTTLKADDNKISDISPL--ASLPNLIE-VHLKNNQISDVSP--LANTSNLF 220
Query: 796 VLNLSH 801
++ L++
Sbjct: 221 IVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 41.2 bits (95), Expect = 4e-04
Identities = 30/219 (13%), Positives = 57/219 (26%), Gaps = 23/219 (10%)
Query: 165 NLVNLGTLGLASCSLSGPIPPQFGQLSQLEELILQQNQLQGPIPAELGNCSSLSIFTAAE 224
L N + +++ + L + L + I + ++L +
Sbjct: 17 ALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTT-IEG-VQYLNNLIGLELKD 72
Query: 225 NNLNGSIPAALGRLQNLQLLNLGNNSLSGEIPSELGELSQLGYLNLMG------------ 272
N + P L+ I + +
Sbjct: 73 NQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQ 132
Query: 273 --NRLEGAIPRSFAKMGNLQSLDLSMNRLTGGIPEEFGNMGQLVFLVLSNNNISGSIPRR 330
I G LS+ N+ +L L +N IS P
Sbjct: 133 VLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP-- 190
Query: 331 ICTNATSLEHLILAEIQLSGEIPVELSQCQSLKQLDLSN 369
+ +L + L Q+S P L+ +L + L+N
Sbjct: 191 -LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 40.8 bits (94), Expect = 4e-04
Identities = 34/249 (13%), Positives = 66/249 (26%), Gaps = 41/249 (16%)
Query: 360 QSLKQLDLSNNTLNGTIPVELFQLVALTHLYLHNNSLVGSISPFVANLSNLQELALYHNN 419
+ ++ + + T+ L +T L + +I L+NL L L N
Sbjct: 19 ANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVT-TIEGV-QYLNNLIGLELKDNQ 74
Query: 420 FQGSLPREIGMLVKLELLYLYDNHLSGQIPSEVGNCSSLKWIDFFGNSFTGEIPTSIGRL 479
P + + L I + + +++ L
Sbjct: 75 ITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVL 134
Query: 480 KDLNFLHLRQNELVGQIPASLGNCHQLIILDLADNKLSGGVPASFGFLQALEQLMLYNNS 539
+ L G + + D L L L +N
Sbjct: 135 YLDLNQITNISPLAGLTNLQYLSIGNAQVSD----------LTPLANLSKLTTLKADDNK 184
Query: 540 LEGNLPGSLINLRNLTRINFSKNRLNGRIATLCSSHSFLSFDVTNNEFDHEIPPQLGNSP 599
+ P L +L NL ++ N+++ + P L N+
Sbjct: 185 ISDISP--LASLPNLIEVHLKNNQISD------------------------VSP-LANTS 217
Query: 600 SLERLRLGN 608
+L + L N
Sbjct: 218 NLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 40.8 bits (94), Expect = 5e-04
Identities = 32/215 (14%), Positives = 67/215 (31%), Gaps = 21/215 (9%)
Query: 623 RELSLLDLSGNSLTGPIPTQLLMCKKLSHIDLNNNLLSGAVPSWLGTLPQLGELKLSFNQ 682
+ +++T + L ++ + ++ + L L L+L NQ
Sbjct: 19 ANAIKIAAGKSNVTDTVTQADL--DGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDNQ 74
Query: 683 FVGFLPRELFNCSKLLVLSLDGNMLNGSLPNEVGNLASLNVLTLSGNLLSGPIPPAIGRL 742
P + L LS + ++ T ++ + L
Sbjct: 75 ITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVL 134
Query: 743 SKLYELRLSNNSLNGVIPLEIGQLQNLQ-------------SILDLSHNNFTGQIPPSMG 789
+ + L G+ L+ + N Q + L N + P +
Sbjct: 135 YLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--LA 192
Query: 790 TLAKLEVLNLSHNQLVGELPSQLGEMSSLGKLNLS 824
+L L ++L +NQ+ P L S+L + L+
Sbjct: 193 SLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 40.8 bits (94), Expect = 5e-04
Identities = 14/42 (33%), Positives = 23/42 (54%), Gaps = 3/42 (7%)
Query: 89 PSLGRLQSLIHLDLSSNSLTGPIPTALSNLSSLESLLLFSNQ 130
L L +LI + L +N ++ P L+N S+L + L +NQ
Sbjct: 189 SPLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTL-TNQ 227
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 38.9 bits (89), Expect = 0.002
Identities = 36/235 (15%), Positives = 77/235 (32%), Gaps = 25/235 (10%)
Query: 175 ASCSLSGPIPPQF--GQLSQLEELILQQNQLQGPIP-AELGNCSSLSIFTAAENNLNGSI 231
S + I F L+ ++ ++ + + A+L ++LS F + G
Sbjct: 1 GSITQPTAINVIFPDPALANAIKIAAGKSNVTDTVTQADLDGITTLSAFGTGVTTIEG-- 58
Query: 232 PAALGRLQNLQLLNLGNNSLSGEIPSELGELSQLGYLNLMGNRLEGAIPRSFAKMGNLQS 291
+ L NL L L +N ++ P + L+ + AI + +
Sbjct: 59 ---VQYLNNLIGLELKDNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLT 115
Query: 292 LDLSMNRLTGGIPEEFGNMGQLVFLVLSNNNISGSIPRRIC-------------TNATSL 338
+ + + + + + ++G + N + L
Sbjct: 116 STQITDVTPLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKL 175
Query: 339 EHLILAEIQLSGEIPVELSQCQSLKQLDLSNNTLNGTIPVELFQLVALTHLYLHN 393
L + ++S P L+ +L ++ L NN ++ P L L + L N
Sbjct: 176 TTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 38.5 bits (88), Expect = 0.003
Identities = 16/67 (23%), Positives = 32/67 (47%), Gaps = 4/67 (5%)
Query: 86 SISPSLGRLQSLIHLDLSSNSLTGPIPTALSNLSSLESLLLFSNQLAGTIPTQLGSLTSL 145
S L L L L N ++ P L++L +L + L +NQ++ P L + ++L
Sbjct: 164 SDLTPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNL 219
Query: 146 RVMRIGD 152
++ + +
Sbjct: 220 FIVTLTN 226
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 50.1 bits (119), Expect = 7e-08
Identities = 26/110 (23%), Positives = 40/110 (36%), Gaps = 7/110 (6%)
Query: 699 VLSLDGNMLNGSLPNEVGNLASLNVLTLSGNLLSGPIPPAIGRLSKLYELRLSNNSLNGV 758
VL L L ++ + L + L LS N L P L+ L L + S N +
Sbjct: 2 VLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPPA----LAALRCLEVLQASDNAL 55
Query: 759 IPLEIGQLQNLQSILDLSHNNFTG-QIPPSMGTLAKLEVLNLSHNQLVGE 807
++ L L +N + + +L +LNL N L E
Sbjct: 56 ENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 48.9 bits (116), Expect = 2e-07
Identities = 27/110 (24%), Positives = 46/110 (41%), Gaps = 7/110 (6%)
Query: 723 VLTLSGNLLSGPIPPAIGRLSKLYELRLSNNSLNGVIPLEIGQLQNLQSILDLSHNNFTG 782
VL L+ L+ + + +L + L LS+N L + P L L+ + L ++
Sbjct: 2 VLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPP----ALAALRCLEVLQASDNAL 55
Query: 783 QIPPSMGTLAKLEVLNLSHNQLVG-ELPSQLGEMSSLGKLNLSYNDLQGK 831
+ + L +L+ L L +N+L L L LNL N L +
Sbjct: 56 ENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 48.6 bits (115), Expect = 2e-07
Identities = 27/124 (21%), Positives = 52/124 (41%), Gaps = 5/124 (4%)
Query: 242 QLLNLGNNSLSGEIPSELGELSQLGYLNLMGNRLEGAIPRSFAKMGNLQSLDLSMNRLTG 301
++L+L + L+ + L +L + +L+L NRL P + A + L+ L +
Sbjct: 1 RVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQ--ASDNAL 55
Query: 302 GIPEEFGNMGQLVFLVLSNNNISGSIPRRICTNATSLEHLILAEIQLSGEIPVELSQCQS 361
+ N+ +L L+L NN + S + + L L L L E ++ +
Sbjct: 56 ENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEM 115
Query: 362 LKQL 365
L +
Sbjct: 116 LPSV 119
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 47.8 bits (113), Expect = 4e-07
Identities = 29/121 (23%), Positives = 48/121 (39%), Gaps = 7/121 (5%)
Query: 363 KQLDLSNNTLNGTIPVELFQLVALTHLYLHNNSLVGSISPFVANLSNLQELALYHNNFQG 422
+ L L++ L T+ L QL+ +THL L +N L A L L+ L N +
Sbjct: 1 RVLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPPAL-AALRCLEVLQASDNALEN 57
Query: 423 SLPREIGMLVKLELLYLYDNHL-SGQIPSEVGNCSSLKWIDFFGNSFTGEIPTSIGRLKD 481
++ L L +N L + +C L ++ GNS + RL +
Sbjct: 58 VDGVANLPRLQ--ELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC-QEEGIQERLAE 114
Query: 482 L 482
+
Sbjct: 115 M 115
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 44.3 bits (104), Expect = 7e-06
Identities = 32/126 (25%), Positives = 45/126 (35%), Gaps = 9/126 (7%)
Query: 652 IDLNNNLLSGAVPSWLGTLPQLGELKLSFNQFVGFLPRELFNCSKLLVLSLDGNMLNGSL 711
+ L + L+ V L L + L LS N+ P L L VL +
Sbjct: 3 LHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVL--QASDNALEN 57
Query: 712 PNEVGNLASLNVLTLSGNLL-SGPIPPAIGRLSKLYELRLSNNSLNGVIPLE---IGQLQ 767
+ V NL L L L N L + +L L L NSL ++ L
Sbjct: 58 VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLP 117
Query: 768 NLQSIL 773
++ SIL
Sbjct: 118 SVSSIL 123
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 42.8 bits (100), Expect = 2e-05
Identities = 27/106 (25%), Positives = 38/106 (35%), Gaps = 5/106 (4%)
Query: 533 LMLYNNSLEGNLPGSLINLRNLTRINFSKNRLNGRIATLCSSHSFLSFDVTNNEFDHEIP 592
L L + L L L +T ++ S NRL L + ++ E
Sbjct: 3 LHLAHKDLTV--LCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQ--ASDNALENV 58
Query: 593 PQLGNSPSLERLRLGNNKFIG-KIPWTFGKIRELSLLDLSGNSLTG 637
+ N P L+ L L NN+ L LL+L GNSL
Sbjct: 59 DGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 42.0 bits (98), Expect = 5e-05
Identities = 24/109 (22%), Positives = 42/109 (38%), Gaps = 6/109 (5%)
Query: 411 QELALYHNNFQGSLPREIGMLVKLELLYLYDNHLSGQIPSEVGNCSSLKWIDFFGNSFTG 470
+ L L H + ++ + L+ + L L N L P+ + L+ + N+
Sbjct: 1 RVLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDNALE- 56
Query: 471 EIPTSIGRLKDLNFLHLRQNELVG-QIPASLGNCHQLIILDLADNKLSG 518
+ L L L L N L L +C +L++L+L N L
Sbjct: 57 -NVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 38.2 bits (88), Expect = 0.001
Identities = 22/105 (20%), Positives = 36/105 (34%), Gaps = 4/105 (3%)
Query: 581 DVTNNEFDHEIPPQLGNSPSLERLRLGNNKFIGKIPWTFGKIRELSLLDLSGNSLTGPIP 640
+ + + + L + L L +N+ P +R L +L S N+L
Sbjct: 4 HLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALENVDG 60
Query: 641 TQLLMCKKLSHIDLNNNLLSGAVPSWLGTLPQLGELKLSFNQFVG 685
L + + NN L A L + P+L L L N
Sbjct: 61 VANLPRLQELLLC-NNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 37.8 bits (87), Expect = 0.001
Identities = 29/121 (23%), Positives = 42/121 (34%), Gaps = 7/121 (5%)
Query: 146 RVMRIGDNWLSGSIPTSFGNLVNLGTLGLASCSLSGPIPPQFGQLSQLEELILQQNQLQG 205
RV+ + L+ + L+ + L L+ L PP L LE L N L+
Sbjct: 1 RVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRAL-PPALAALRCLEVLQASDNALEN 57
Query: 206 PIPAELGNCSSLSIFTAAENNLNG-SIPAALGRLQNLQLLNLGNNSLSGEIPSELGELSQ 264
N L N L + L L LLNL NSL + L++
Sbjct: 58 VDGVA--NLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC-QEEGIQERLAE 114
Query: 265 L 265
+
Sbjct: 115 M 115
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 37.4 bits (86), Expect = 0.002
Identities = 26/125 (20%), Positives = 42/125 (33%), Gaps = 7/125 (5%)
Query: 76 LNLSGLSLAGSISPSLGRLQSLIHLDLSSNSLTGPIPTALSNLSSLESLLLFSNQLAGTI 135
L+L+ L ++ L +L + HLDLS N L P AL+ L LE L N +
Sbjct: 3 LHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNA-LENV 58
Query: 136 PTQLGSLTSLRVMRIGDNWLSGSIPTSFGNLVNLGTLGLAS---CSLSGPIPPQFGQLSQ 192
++ + + + L L L C G L
Sbjct: 59 DGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPS 118
Query: 193 LEELI 197
+ ++
Sbjct: 119 VSSIL 123
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 36.6 bits (84), Expect = 0.004
Identities = 28/97 (28%), Positives = 38/97 (39%), Gaps = 4/97 (4%)
Query: 351 EIPVELSQCQSLKQLDLSNNTLNGTIPVELFQLVALTHLYLHNNSLVGSISPFVANLSNL 410
+ L Q + LDLS+N L P L L L L +N+L L
Sbjct: 11 TVLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALENVDGVANLP--RL 67
Query: 411 QELALYHNNFQG-SLPREIGMLVKLELLYLYDNHLSG 446
QEL L +N Q + + + +L LL L N L
Sbjct: 68 QELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 52.9 bits (125), Expect = 1e-07
Identities = 22/89 (24%), Positives = 35/89 (39%), Gaps = 9/89 (10%)
Query: 225 NNLNGSIPAALGRLQNLQLLNLGNNSLSGEIPSELGELSQLGYLNLMGNRLEGAIPRSFA 284
N + I + +L+ LN+ NN L E+P+ L L N L +P
Sbjct: 270 NASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLE---RLIASFNHLA-EVPEL-- 322
Query: 285 KMGNLQSLDLSMNRLTGGIPEEFGNMGQL 313
NL+ L + N L P+ ++ L
Sbjct: 323 -PQNLKQLHVEYNPLR-EFPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 52.1 bits (123), Expect = 2e-07
Identities = 24/97 (24%), Positives = 38/97 (39%), Gaps = 11/97 (11%)
Query: 726 LSGNLLSGPIPPAIGRLSKLYELRLSNNSLNGVIPLEIGQLQNLQSILDLSHNNFTGQIP 785
N S I L EL +SNN L +P +L+ L S N+ ++P
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALPPRLERL----IASFNHLA-EVP 320
Query: 786 PSMGTLAKLEVLNLSHNQLVGELPSQLGEMSSLGKLN 822
L+ L++ +N L E P + L ++N
Sbjct: 321 ELPQ---NLKQLHVEYNPLR-EFPDIPESVEDL-RMN 352
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 52.1 bits (123), Expect = 2e-07
Identities = 58/328 (17%), Positives = 97/328 (29%), Gaps = 31/328 (9%)
Query: 240 NLQLLNLGNNSLSGEIPSELGELSQLGYLNLMGNRLEGAIPRSFAKMGNLQSLDLSMNRL 299
L L N LS +P L L N L +P +L+SL + N L
Sbjct: 39 QAHELELNNLGLS-SLPELPP---HLESLVASCNSLT-ELPELP---QSLKSLLVDNNNL 90
Query: 300 TGGIPEEFGNMGQLVFLVLSNNNISGSIPRRICTNATSLEHLILAEIQLSGEIPVELSQC 359
V + L +
Sbjct: 91 KALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNN 150
Query: 360 QSLKQLDLSNNTLNGTIPVELFQLVALTHLYLHNNSLVGSISPFVANLSNLQELALYHNN 419
Q + +L N I + L L L L S+V + L
Sbjct: 151 QLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIY 210
Query: 420 FQGSLPREIGMLVKLELLYLYDNHLSGQIPSEVGNCSSLKWI-------------DFFGN 466
+L + + L ++ +P + + L ++ N
Sbjct: 211 ADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLN 270
Query: 467 SFTGEIPTSIGRLKDLNFLHLRQNELVGQIPASLGNCHQLIILDLADNKLSGGVPASFGF 526
+ + EI + L L++ N+L+ ++PA L L + N L+ VP
Sbjct: 271 ASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPR---LERLIASFNHLA-EVP---EL 322
Query: 527 LQALEQLMLYNNSLEG--NLPGSLINLR 552
Q L+QL + N L ++P S+ +LR
Sbjct: 323 PQNLKQLHVEYNPLREFPDIPESVEDLR 350
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 49.1 bits (115), Expect = 2e-06
Identities = 23/94 (24%), Positives = 37/94 (39%), Gaps = 10/94 (10%)
Query: 705 NMLNGSLPNEVGNLASLNVLTLSGNLLSGPIPPAIGRLSKLYELRLSNNSLNGVIPLEIG 764
N + + + SL L +S N L +P RL +L S N L V L
Sbjct: 270 NASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALPPRLERLI---ASFNHLAEVPEL--- 322
Query: 765 QLQNLQSILDLSHNNFTGQIPPSMGTLAKLEVLN 798
QNL+ L + +N + P ++ L + +
Sbjct: 323 -PQNLKQ-LHVEYNPLR-EFPDIPESVEDLRMNS 353
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 48.3 bits (113), Expect = 4e-06
Identities = 20/81 (24%), Positives = 36/81 (44%), Gaps = 9/81 (11%)
Query: 750 LSNNSLNGVIPLEIGQLQNLQSILDLSHNNFTGQIPPSMGTLAKLEVLNLSHNQLVGELP 809
N+ + I +L+ L++S+N ++P +LE L S N L E+P
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEE-LNVSNNKLI-ELPALPP---RLERLIASFNHL-AEVP 320
Query: 810 SQLGEMSSLGKLNLSYNDLQG 830
+L +L++ YN L+
Sbjct: 321 E---LPQNLKQLHVEYNPLRE 338
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 47.9 bits (112), Expect = 5e-06
Identities = 55/330 (16%), Positives = 92/330 (27%), Gaps = 32/330 (9%)
Query: 359 CQSLKQLDLSNNTLNGTIPVELFQLVALTHLYLHNNSLVGSISPFVANLSNLQELALYHN 418
+ +L+L+N L+ ++P L L NSL + +L+ L + +N
Sbjct: 37 DRQAHELELNNLGLS-SLPELPPHL---ESLVASCNSL----TELPELPQSLKSLLVDNN 88
Query: 419 NFQG------SLPREIGMLVKLELLYLYDNHLSGQIPSEVGNCSSLKWIDFFGNSFTGEI 472
N + L +LE L N +I N F
Sbjct: 89 NLKALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAG 148
Query: 473 PTSIGRLKDLNFLHLRQNELVGQIPASLGNCHQLIILDLADNKLSGGVPASFGFLQALEQ 532
+ L +L L L + + L L
Sbjct: 149 NNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTT 208
Query: 533 L---------MLYNNSLEGNLPGSLINLRNLTRINFSKNRLNGRIATLCSSHSFLSFDVT 583
+ + L L +L + S L+
Sbjct: 209 IYADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYY 268
Query: 584 NNEFDHEIPPQLGNSPSLERLRLGNNKFIGKIPWTFGKIRELSLLDLSGNSLTGPIPTQL 643
N +EI PSLE L + NNK + ++P ++ L S N L +P
Sbjct: 269 LNASSNEIRSLCDLPPSLEELNVSNNK-LIELPALPPRLER---LIASFNHLAE-VPELP 323
Query: 644 LMCKKLSHIDLNNNLLSGAVPSWLGTLPQL 673
+ L + + N L P ++ L
Sbjct: 324 ---QNLKQLHVEYNPLRE-FPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 47.5 bits (111), Expect = 6e-06
Identities = 47/338 (13%), Positives = 91/338 (26%), Gaps = 26/338 (7%)
Query: 386 LTHLYLHNNSLVGSISPFVANLSNLQELALYHNNFQGSLPREIGMLVKLELLYLYDNHLS 445
L L+N L S +L+ L N+ LP L L +
Sbjct: 40 AHELELNNLGL----SSLPELPPHLESLVASCNSLT-ELPELPQSLKSLLVDNN------ 88
Query: 446 GQIPSEVGNCSSLKWIDFFGNSFTGEIPTSIGRLKDLNFLHLRQNELVGQIPASLGNCHQ 505
+ + L+++ N + + + + +P SL
Sbjct: 89 -NLKALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAA 147
Query: 506 LIILDLADNKLSGGVPASFGFLQALEQLMLYNNSLEGNLPGSLINLRNLTRINFSKNRLN 565
+L + + L + L + N+ + L
Sbjct: 148 GNNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLT 207
Query: 566 GRIATLCSSHSFLSFDVTNNEFDHEIPPQLGNSPSLERLRLGNNKFIGKIPWTFGKIREL 625
A + + + + F+ F + EL
Sbjct: 208 TIYADNNLLKTLPDLPPSLEALNVRDNYLTDLPELP-----QSLTFLDVSENIFSGLSEL 262
Query: 626 SLLDLSGNSLTGPIPTQLLMCKKLSHIDLNNNLLSGAVPSWLGTLPQLGELKLSFNQFVG 685
N+ + I + + L ++++NN L P+L L SFN
Sbjct: 263 PPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI----ELPALPPRLERLIASFNHL-A 317
Query: 686 FLPRELFNCSKLLVLSLDGNMLNGSLPNEVGNLASLNV 723
+P N L L ++ N L P+ ++ L +
Sbjct: 318 EVPELPQN---LKQLHVEYNPLR-EFPDIPESVEDLRM 351
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 46.7 bits (109), Expect = 1e-05
Identities = 20/101 (19%), Positives = 39/101 (38%), Gaps = 13/101 (12%)
Query: 269 NLMGNRLEGAIPRSFAKMGNLQSLDLSMNRLTGGIPEEFGNMGQLVFLVLSNNNISGSIP 328
N I +L+ L++S N+L +P L L+ S N+++ +P
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPR---LERLIASFNHLA-EVP 320
Query: 329 RRICTNATSLEHLILAEIQLSGEIPVELSQCQSLKQLDLSN 369
+L+ L + L E P S++ L +++
Sbjct: 321 ELP----QNLKQLHVEYNPLR-EFPDIPE---SVEDLRMNS 353
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 46.4 bits (108), Expect = 2e-05
Identities = 55/314 (17%), Positives = 104/314 (33%), Gaps = 23/314 (7%)
Query: 263 SQLGYLNLMGNRLEGAIPRSFAKMGNLQSLDLSMNRLTGGIPEEFGNMGQLVFLVLSNNN 322
Q L L L ++P +L+SL S N LT +PE ++ L+ +
Sbjct: 38 RQAHELELNNLGLS-SLPELP---PHLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKA 92
Query: 323 ISGSIPRRICTNATSLEHLILAEIQLSGEIPVELSQCQSLKQLDLSNNTLNGTIPVELFQ 382
+S P ++ + L E+Q S + + SLK+L +L
Sbjct: 93 LSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQL 152
Query: 383 LVALTHLYLHNNSLVGSISPFVANLSNLQELALYHNNFQGSLPREIGMLVKLELLYLYDN 442
L + + + + + L +L L + L +Y +
Sbjct: 153 EELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYAD 212
Query: 443 HLSGQIPSEVGNCSSLKWIDFFGNSFTGEIPT----------SIGRLKDLNFLHLRQNEL 492
+ + ++ + + E+P L +L N
Sbjct: 213 NNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNAS 272
Query: 493 VGQIPASLGNCHQLIILDLADNKLSGGVPASFGFLQALEQLMLYNNSLEGNLPGSLINLR 552
+I + L L++++NKL +PA LE+L+ N L +P +
Sbjct: 273 SNEIRSLCDLPPSLEELNVSNNKLI-ELPALPP---RLERLIASFNHLA-EVPEL---PQ 324
Query: 553 NLTRINFSKNRLNG 566
NL +++ N L
Sbjct: 325 NLKQLHVEYNPLRE 338
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 46.4 bits (108), Expect = 2e-05
Identities = 21/90 (23%), Positives = 35/90 (38%), Gaps = 9/90 (10%)
Query: 347 QLSGEIPVELSQCQSLKQLDLSNNTLNGTIPVELFQLVALTHLYLHNNSLVGSISPFVAN 406
S EI SL++L++SNN L +P + L L N L +
Sbjct: 271 ASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPR---LERLIASFNHL-AEVPEL--- 322
Query: 407 LSNLQELALYHNNFQGSLPREIGMLVKLEL 436
NL++L + +N + P + L +
Sbjct: 323 PQNLKQLHVEYNPLR-EFPDIPESVEDLRM 351
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 46.0 bits (107), Expect = 2e-05
Identities = 23/93 (24%), Positives = 33/93 (35%), Gaps = 10/93 (10%)
Query: 177 CSLSGPIPPQFGQLSQLEELILQQNQLQGPIPAELGNCSSLSIFTAAENNLNGSIPAALG 236
+ S I LEEL + N+L +PA L N +P
Sbjct: 270 NASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALPPRLERLIA----SFNHLAEVPEL-- 322
Query: 237 RLQNLQLLNLGNNSLSGEIPSELGELSQLGYLN 269
QNL+ L++ N L E P + L +N
Sbjct: 323 -PQNLKQLHVEYNPLR-EFPDIPESVEDL-RMN 352
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 44.8 bits (104), Expect = 4e-05
Identities = 19/76 (25%), Positives = 31/76 (40%), Gaps = 9/76 (11%)
Query: 94 LQSLIHLDLSSNSLTGPIPTALSNLSSLESLLLFSNQLAGTIPTQLGSLTSLRVMRIGDN 153
SL L++S+N L +P + LE L+ N L +P +L L + N
Sbjct: 283 PPSLEELNVSNNKLIE-LP---ALPPRLERLIASFNHL-AEVPELPQNLKQL---HVEYN 334
Query: 154 WLSGSIPTSFGNLVNL 169
L P ++ +L
Sbjct: 335 PLR-EFPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 44.0 bits (102), Expect = 7e-05
Identities = 20/93 (21%), Positives = 35/93 (37%), Gaps = 9/93 (9%)
Query: 153 NWLSGSIPTSFGNLVNLGTLGLASCSLSGPIPPQFGQLSQLEELILQQNQLQGPIPAELG 212
N S I + +L L +++ L +P +L E LI N L +P
Sbjct: 270 NASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALPPRL---ERLIASFNHLAE-VPELPQ 324
Query: 213 NCSSLSIFTAAENNLNGSIPAALGRLQNLQLLN 245
N L + E N P +++L++ +
Sbjct: 325 NLKQLHV----EYNPLREFPDIPESVEDLRMNS 353
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 42.9 bits (99), Expect = 2e-04
Identities = 22/99 (22%), Positives = 32/99 (32%), Gaps = 9/99 (9%)
Query: 49 HAWNQSNQNLCTWRGITCGSSSARVVSLNLSGLSLAGSISPSLGRLQSLIHLDLSSNSLT 108
N N + + + LN+S L + RL+ L S N L
Sbjct: 262 LPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLE---RLIASFNHLA 317
Query: 109 GPIPTALSNLSSLESLLLFSNQLAGTIPTQLGSLTSLRV 147
+P NL L + N L P S+ LR+
Sbjct: 318 E-VPELPQNLKQLH---VEYNPLR-EFPDIPESVEDLRM 351
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 51.2 bits (121), Expect = 1e-07
Identities = 34/203 (16%), Positives = 69/203 (33%), Gaps = 17/203 (8%)
Query: 238 LQNLQLLNLGNNSLSGEIPSELGELSQLGYLNLMGNRLEGAIPRSFAKMGNLQSLDLSMN 297
NL S++ + EL+ + + + ++ + N+ L L+ N
Sbjct: 23 FAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNGN 78
Query: 298 RLTGGIPEEFGNMGQLVFLVLSNNNISGSIPRRICTNATSLEHLILAEIQLSGEIPVELS 357
+LT P L N ++ ++ + L + L +++
Sbjct: 79 KLTDIKPLAN----------LKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDIN 128
Query: 358 QCQSLKQLDLSNNTLNGTIPVELFQLVALTHLYLHNNSLVGSISPFVANLSNLQELALYH 417
L QL+ N + + + ++ + I P A L+ LQ L L
Sbjct: 129 GLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVPL-AGLTKLQNLYLSK 187
Query: 418 NNFQGSLPREIGMLVKLELLYLY 440
N+ R + L L++L L+
Sbjct: 188 NHISD--LRALAGLKNLDVLELF 208
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 46.9 bits (110), Expect = 4e-06
Identities = 36/224 (16%), Positives = 65/224 (29%), Gaps = 20/224 (8%)
Query: 101 DLSSNSLTGPIP----TALSNLSSLESLLLFSNQLAGTIPTQLGSLTSLRVMRIGDNWLS 156
L S ++T P P + + L + + L S+ + ++ +
Sbjct: 2 PLGSETITVPTPIKQIFSDDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIK 59
Query: 157 GSIPTSFGNLVNLGTLGLASCSLSGPIPPQFGQLSQLEELILQQNQLQGPIPAELGNCSS 216
L N+ L L L+ L+ L+ L
Sbjct: 60 SVQG--IQYLPNVTKLFLNGNKLTDIK-----PLANLKNLGWLFLDENKVKDLSSLKDLK 112
Query: 217 LSIFTAAENNLNGSIPAALGRLQNLQLLNLGNNSLSGEIPSELGELSQLGYLNLMGNRLE 276
+ E+N I + Q L N + S L +L L + + +
Sbjct: 113 KLKSLSLEHNGISDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIV 172
Query: 277 GAIPRSFAKMGNLQSLDLSMNRLTGGIPEEFGNMGQLVFLVLSN 320
A + LQ+L LS N ++ + L L L +
Sbjct: 173 -----PLAGLTKLQNLYLSKNHISD--LRALAGLKNLDVLELFS 209
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 46.5 bits (109), Expect = 6e-06
Identities = 40/221 (18%), Positives = 82/221 (37%), Gaps = 15/221 (6%)
Query: 318 LSNNNISGSIPRRICTNATSLEHLILAEIQL-SGEIPVELSQCQSLKQLDLSNNTLNGTI 376
L + I+ P + + + I ++ S V ++ S+ Q+ +N+ +
Sbjct: 3 LGSETITVPTPIKQIFSDDAFAETIKDNLKKKSVTDAVTQNELNSIDQIIANNSDIKSVQ 62
Query: 377 PVELFQLVALTHLYLHNNSLVGSISPFVANLSNLQELALYHNNFQGSLPREIGMLVKLEL 436
++ L +T L+L+ N L L+NL+ L + +K
Sbjct: 63 GIQ--YLPNVTKLFLNGNKLTDIK-----PLANLKNLGWLFLDENKVKDLSSLKDLKKLK 115
Query: 437 LYLYDNHLSGQIPSEVGNCSSLKWIDFFGNSFTGEIPTSIGRLKDLNFLHLRQNELVGQI 496
+++ I V + + + T + RL L+ L L N++ +
Sbjct: 116 SLSLEHNGISDINGLVHLP---QLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIV 172
Query: 497 PASLGNCHQLIILDLADNKLSGGVPASFGFLQALEQLMLYN 537
P L +L L L+ N +S + L+ L+ L L++
Sbjct: 173 P--LAGLTKLQNLYLSKNHISD--LRALAGLKNLDVLELFS 209
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 44.6 bits (104), Expect = 2e-05
Identities = 39/202 (19%), Positives = 62/202 (30%), Gaps = 17/202 (8%)
Query: 623 RELSLLDLSGNSLTGPIPTQLLMCKKLSHIDLNNNLLSGAVPSWLGTLPQLGELKLSFNQ 682
E +L S+T + L + I NN+ + + LP + +L L+ N+
Sbjct: 24 AETIKDNLKKKSVTDAVTQNEL--NSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNGNK 79
Query: 683 FVGFLPRELFNCSKLLVLSLDGNMLNGSLPNEVGNLASLNVLTLSGNLLSGPIPPAIGRL 742
P L L + SL + + I L
Sbjct: 80 LTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLE---------HNGISDINGL 130
Query: 743 SKLYELRLSNNSLNGVIPLEIGQLQNLQSILDLSHNNFTGQIPPSMGTLAKLEVLNLSHN 802
L +L N +I L L + LS + + L KL+ L LS N
Sbjct: 131 VHLPQLESLYLGNN--KITDITVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKN 188
Query: 803 QLVGELPSQLGEMSSLGKLNLS 824
+ L + +L L L
Sbjct: 189 HISD--LRALAGLKNLDVLELF 208
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 42.3 bits (98), Expect = 1e-04
Identities = 28/203 (13%), Positives = 54/203 (26%), Gaps = 15/203 (7%)
Query: 550 NLRNLTRINFSKNRLNGRIATLCSSHSFLSFDVTNNEFDHEIPPQLGNSPSLERLRLGNN 609
+ N K + + T +S N++ + P++ +L L N
Sbjct: 22 AFAETIKDNLKKKSVTDAV-TQNELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNGN 78
Query: 610 KFIGKIPWTFGKIRELSLLDLSGNSLTGPIPTQLLMCKKLSHIDLNNNLLSGAVPSWLGT 669
K P K LD + + + + +++ L +
Sbjct: 79 KLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQLES 138
Query: 670 LPQLGELKLSFNQFVGFLPRELFNCSKLLVLSLDGNMLNGSLPNEVGNLASLNVLTLSGN 729
L + + + + + L L L LS N
Sbjct: 139 LYLGNNKITDITVLSRLTKLDTLSLEDNQISDIV----------PLAGLTKLQNLYLSKN 188
Query: 730 LLSGPIPPAIGRLSKLYELRLSN 752
+S A+ L L L L +
Sbjct: 189 HISD--LRALAGLKNLDVLELFS 209
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 41.1 bits (95), Expect = 3e-04
Identities = 36/201 (17%), Positives = 68/201 (33%), Gaps = 15/201 (7%)
Query: 502 NCHQLIILDLADNKLSGGVPASFGFLQALEQLMLYNNSLEGNLPGSLINLRNLTRINFSK 561
+ I +L ++ V + L +++Q++ N+ ++ + L N+T++ +
Sbjct: 22 AFAETIKDNLKKKSVTDAVTQNE--LNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNG 77
Query: 562 NRLNGRIATLCSSHSFLSFDVTNNEFDHEIPPQLGNSPSLERLRLGNNKFIGKIPWTFGK 621
N+L + L ++++ + L
Sbjct: 78 NKLTD-----IKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVH 132
Query: 622 IRELSLLDLSGNSLTGPIPTQLLMCKKLSHIDLNNNLLSGAVPSWLGTLPQLGELKLSFN 681
+ +L L L N +T L + +N +S VP L L +L L LS N
Sbjct: 133 LPQLESLYLGNNKITDITVLSRLTKLDTLSL--EDNQISDIVP--LAGLTKLQNLYLSKN 188
Query: 682 QFVGFLPRELFNCSKLLVLSL 702
R L L VL L
Sbjct: 189 HISDL--RALAGLKNLDVLEL 207
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 39.2 bits (90), Expect = 0.001
Identities = 30/216 (13%), Positives = 59/216 (27%), Gaps = 21/216 (9%)
Query: 423 SLPREIG------MLVKLELLYLYDNHLSGQIPSEVGNCSSLKWIDFFGNSFTGEIPTSI 476
++P I + L ++ + +S+ I + I
Sbjct: 9 TVPTPIKQIFSDDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQG--I 64
Query: 477 GRLKDLNFLHLRQNELVGQIPASLGNCHQLIILDLADNKLSGGVPASFGFLQALEQLMLY 536
L ++ L L N+L P + + + L
Sbjct: 65 QYLPNVTKLFLNGNKLTDIKPLANLKNLGWLF---------LDENKVKDLSSLKDLKKLK 115
Query: 537 NNSLEGNLPGSLINLRNLTRINFSKNRLNGRIATLCSSHSFLSFDVTNNEFDHEIPPQLG 596
+ SLE N + L +L ++ N S ++ + L
Sbjct: 116 SLSLEHNGISDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVPLA 175
Query: 597 NSPSLERLRLGNNKFIGKIPWTFGKIRELSLLDLSG 632
L+ L L N I + ++ L +L+L
Sbjct: 176 GLTKLQNLYLSKNH-ISDLRA-LAGLKNLDVLELFS 209
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.6 bits (114), Expect = 5e-07
Identities = 23/145 (15%), Positives = 43/145 (29%), Gaps = 4/145 (2%)
Query: 358 QCQSLKQLDLSNNTLNGTIPVELFQLVALTHLYLHNNSLVGSISPFV-ANLSNLQELALY 416
L + + L LT LY+ N + + L L+ L +
Sbjct: 6 CPHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIV 64
Query: 417 HNNFQGSLPREIGMLVKLELLYLYDNHLSGQIPSEVGNCSSLKWIDFFGNSFT-GEIPTS 475
+ + P +L L L N L + + SL+ + GN
Sbjct: 65 KSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLHCSCALRW 123
Query: 476 IGRLKDLNFLHLRQNELVGQIPASL 500
+ R ++ + + +L L
Sbjct: 124 LQRWEEEGLGGVPEQKLQCHGQGPL 148
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.9 bits (99), Expect = 5e-05
Identities = 19/142 (13%), Positives = 41/142 (28%), Gaps = 1/142 (0%)
Query: 553 NLTRINFSKNRLNGRIATLCSSHSFLSFDVTNNEFDHEIPPQL-GNSPSLERLRLGNNKF 611
+ + +++ + L + + + N + + + L L + +
Sbjct: 9 GSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGL 68
Query: 612 IGKIPWTFGKIRELSLLDLSGNSLTGPIPTQLLMCKKLSHIDLNNNLLSGAVPSWLGTLP 671
P F LS L+LS N+L + + N L WL
Sbjct: 69 RFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWE 128
Query: 672 QLGELKLSFNQFVGFLPRELFN 693
+ G + + L +
Sbjct: 129 EEGLGGVPEQKLQCHGQGPLAH 150
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.7 bits (96), Expect = 1e-04
Identities = 22/139 (15%), Positives = 40/139 (28%), Gaps = 3/139 (2%)
Query: 288 NLQSLDLSMNRLTGGIPEEFGNMGQLVFLVLSNNNISGSIPRRICTNATSLEHLILAEIQ 347
L + + L L + N + R L +L + +
Sbjct: 9 GSSGLRCTRDGALD-SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSG 67
Query: 348 LSGEIPVELSQCQSLKQLDLSNNTLNGTIPVELFQLVALTHLYLHNNSLVGSISP-FVAN 406
L P L +L+LS N ++ + Q ++L L L N L S + ++
Sbjct: 68 LRFVAPDAFHFTPRLSRLNLSFN-ALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQR 126
Query: 407 LSNLQELALYHNNFQGSLP 425
+ Q
Sbjct: 127 WEEEGLGGVPEQKLQCHGQ 145
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.5 bits (85), Expect = 0.003
Identities = 29/156 (18%), Positives = 47/156 (30%), Gaps = 4/156 (2%)
Query: 89 PSLGRLQSLIHLDLSSNSLTGPIPTALSNLSSLESLLLFSNQLAGTIPTQL-GSLTSLRV 147
P L + + L +L L + + Q + + L LR
Sbjct: 2 PDACCPHGSSGLRCTRDGALD-SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRN 60
Query: 148 MRIGDNWLSGSIPTSFGNLVNLGTLGLASCSLSGPIPPQFGQLSQLEELILQQNQLQGPI 207
+ I + L P +F L L L+ +L + + Q L+EL+L N L
Sbjct: 61 LTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALES-LSWKTVQGLSLQELVLSGNPLHCSC 119
Query: 208 -PAELGNCSSLSIFTAAENNLNGSIPAALGRLQNLQ 242
L + E L L + N
Sbjct: 120 ALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNAS 155
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.1 bits (111), Expect = 2e-06
Identities = 25/125 (20%), Positives = 47/125 (37%), Gaps = 6/125 (4%)
Query: 279 IPRSFAKMGNLQSLDLSMNRLTGGIPEEFGNMGQLVFLVLSNNNISGSIPRRICTNATSL 338
+ +K + L + L + V L ++ + R I N L
Sbjct: 12 LKLIMSKRYDGSQQALDLKGLR--SDPDLVAQNIDVVLNRRSSMAA--TLRIIEENIPEL 67
Query: 339 EHLILAEIQLSG--EIPVELSQCQSLKQLDLSNNTLNGTIPVELFQLVALTHLYLHNNSL 396
L L+ +L ++ + + +LK L+LS N L ++ + + L L+L NSL
Sbjct: 68 LSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSL 127
Query: 397 VGSIS 401
+
Sbjct: 128 SDTFR 132
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.7 bits (97), Expect = 1e-04
Identities = 24/109 (22%), Positives = 41/109 (37%), Gaps = 3/109 (2%)
Query: 235 LGRLQNLQLLNLGNNSLSGEIPSELGELSQLGYLNLMGNRLEG--AIPRSFAKMGNLQSL 292
L +LN ++ + + + +L LNL NRL + K NL+ L
Sbjct: 38 LVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKIL 96
Query: 293 DLSMNRLTGGIPEEFGNMGQLVFLVLSNNNISGSIPRRICTNATSLEHL 341
+LS N L + +L L L N++S + + + E
Sbjct: 97 NLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRERF 145
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 47.5 bits (111), Expect = 2e-06
Identities = 43/187 (22%), Positives = 68/187 (36%), Gaps = 9/187 (4%)
Query: 628 LDLSGNSLTGPIPTQLLMCKKLSHIDLNNNLLSGAVPSWL-GTLPQLGELKLSFNQFVGF 686
+D +G L IP + + + LN+N L L G LP L +L+L NQ G
Sbjct: 13 VDCTGRGLKE-IPRDI--PLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGI 69
Query: 687 LPRELFNCSKLLVLSLDGNMLNGSLPNEVGNLASLNVLTLSGNLLSGPIPPAIGRLSKLY 746
P S + L L N + L L L L N +S +P + L+ L
Sbjct: 70 EPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLT 129
Query: 747 ELRLSNNSLNGVIPLEIGQLQNLQSILDLSHNNFTGQIPPSMGTLAKLEVLNLSHNQLVG 806
L L++N N L L+ P + +++ +L H++
Sbjct: 130 SLNLASNPFNCNCHLAW--FAEWLRKKSLNGGAARCGAPSK---VRDVQIKDLPHSEFKC 184
Query: 807 ELPSQLG 813
+ G
Sbjct: 185 SSENSEG 191
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 44.0 bits (102), Expect = 3e-05
Identities = 35/188 (18%), Positives = 61/188 (32%), Gaps = 7/188 (3%)
Query: 290 QSLDLSMNRLTGGIPEEFGNMGQLVFLVLSNNNISGSIPRRICTNATSLEHLILAEIQLS 349
++D + L IP + L+L++N + + L L L QL+
Sbjct: 11 TTVDCTGRGLKE-IPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT 67
Query: 350 GEIPVELSQCQSLKQLDLSNNTLNGTIPVELFQLVALTHLYLHNNSLVGSISPFVANLSN 409
G P +++L L N + L L L L++N + + +L++
Sbjct: 68 GIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNS 127
Query: 410 LQELALYHNNFQGSLPREIGMLVKLELLYLYDNHLSGQIPSEVGNCSSLKWIDFFGNSFT 469
L L +N L L PS+V ++ D + F
Sbjct: 128 LTSLN-LASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAPSKV---RDVQIKDLPHSEFK 183
Query: 470 GEIPTSIG 477
S G
Sbjct: 184 CSSENSEG 191
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 39.4 bits (90), Expect = 0.001
Identities = 18/103 (17%), Positives = 44/103 (42%), Gaps = 5/103 (4%)
Query: 271 MGNRLEGAIPRSFAKMGNLQSLDLSMNRLTGGIPEEFGNMGQLVFLVLSNNNISGSIPRR 330
N+++ + F + L++L+L N+++ +P F ++ L L L++N + +
Sbjct: 86 GENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH-- 143
Query: 331 ICTNATSLEHLILAEIQLSGEIPVELSQCQSLKQLDLSNNTLN 373
+ A L L P ++ + ++ DL ++
Sbjct: 144 LAWFAEWLRKKSLNGGAARCGAPSKV---RDVQIKDLPHSEFK 183
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 38.6 bits (88), Expect = 0.002
Identities = 39/193 (20%), Positives = 61/193 (31%), Gaps = 32/193 (16%)
Query: 590 EIPPQLGNSPSLERLRLGNNKFIGKIPWTF-GKIRELSLLDLSGNSLTGPIPTQLLMCKK 648
EIP + L L +N+ G++ L L+L N LTG P
Sbjct: 22 EIPRDI--PLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASH 79
Query: 649 LSHIDLNNNLLSGAVPSWLGTLPQLGELKLSFNQFVGFLPRELFNCSKLLVLSLDGNMLN 708
+ + L N + L QL L L NQ +P + + L L+L N N
Sbjct: 80 IQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFN 139
Query: 709 GSLPNEVGNLASLNVLTLSGNLLSGPIPPAIGRLSKLYELRLSNNSLNGVIPLEIGQLQN 768
L + L+ + P ++++
Sbjct: 140 C-------------------------NCHLAWFAEWLRKKSLNGGAARCGAP---SKVRD 171
Query: 769 LQSILDLSHNNFT 781
+Q I DL H+ F
Sbjct: 172 VQ-IKDLPHSEFK 183
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 47.6 bits (111), Expect = 6e-06
Identities = 39/333 (11%), Positives = 92/333 (27%), Gaps = 32/333 (9%)
Query: 239 QNLQLLNLGNNSLSGEIPSELGELSQLGYLNLMGNRLEG----AIPRSFAKMGNLQSLDL 294
++L+L + + + L E + + L GN + + + A +L+ +
Sbjct: 8 KSLKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEF 66
Query: 295 SMNRLTGGIPEEFGNMGQLVFLVLSNNNIS--GSIPRRICTNATSLEHLILAEIQLSGEI 352
S E + L+ +L + A L++ +
Sbjct: 67 SDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHL 126
Query: 353 PVELSQCQSLKQLDLSNNTLNGTIPVELFQLVALTHLYLHNNSL-VGSISPFVANLSNLQ 411
+ + ++ + + L + N L GS+ + + +
Sbjct: 127 YLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHR 186
Query: 412 ELALYHNNFQGSLPREIGMLVKLEL------------LYLYDNHLSGQIPSEVGNCSSLK 459
L G P I L+ L + + S + + + +L+
Sbjct: 187 LLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLR 246
Query: 460 WIDFFGNSFTGEIPTSIGR------LKDLNFLHLRQNELVGQIPASL-----GNCHQLII 508
+ + ++ L L L+ NE+ +L L+
Sbjct: 247 ELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLF 306
Query: 509 LDLADNKLSGGVPASFGFLQALEQLMLYNNSLE 541
L+L N+ ++ + E
Sbjct: 307 LELNGNRF-SEEDDVVDEIREVFSTRGRGELDE 338
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 47.2 bits (110), Expect = 8e-06
Identities = 37/330 (11%), Positives = 90/330 (27%), Gaps = 32/330 (9%)
Query: 95 QSLIHLDLSSNSLTGPIPTALSNLSSLESLLLFSNQL----AGTIPTQLGSLTSLRVMRI 150
+SL +++ + L S++ ++L N + A + + S L +
Sbjct: 8 KSLKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEF 66
Query: 151 GDNW---LSGSIPTSFGNLVNLGTLGLASCSLSGPIPPQFGQLSQLEELILQQNQLQGPI 207
D + + IP + L+ ++ + L ++ +
Sbjct: 67 SDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHL 126
Query: 208 PAELGNCSSLSIFTAAENNLNGSIPAALGRLQNLQLLNLGNNSLSGEIPSELGELSQLGY 267
+ A ++ L+ + G N L E + Q
Sbjct: 127 YLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHR 186
Query: 268 LNLMGNRLEGAIPRSFAKMGNLQSL-------------DLSMNRLTGGIPEEFGNMGQLV 314
L ++ I + L+ L + + + + + L
Sbjct: 187 LLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLR 246
Query: 315 FLVLSNNNISGSIPRRICT-----NATSLEHLILAEIQLSGEIPVEL-----SQCQSLKQ 364
L L++ +S + L+ L L ++ + L + L
Sbjct: 247 ELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLF 306
Query: 365 LDLSNNTLNGTIPVELFQLVALTHLYLHNN 394
L+L+ N + ++ +
Sbjct: 307 LELNGNRF-SEEDDVVDEIREVFSTRGRGE 335
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 44.5 bits (103), Expect = 6e-05
Identities = 37/357 (10%), Positives = 97/357 (27%), Gaps = 34/357 (9%)
Query: 358 QCQSLKQLDLSNNTLNGTIPVELFQLVALTHLYLHNNSL----VGSISPFVANLSNLQEL 413
+ +SLK ++ ++ L + ++ + L N++ +S +A+ +L+
Sbjct: 6 EGKSLKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 64
Query: 414 ALYHN---NFQGSLPREIGMLVKLELLYLYDNHLSGQIPSEVGNCSSLKWIDFFGNSFTG 470
+ +P + +L++ L + + + ++
Sbjct: 65 EFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLE 124
Query: 471 EIPTSIGRLKDLNFLHLRQNELVGQIPASLGNCHQLIILDLADNKLS-GGVPASFGFLQA 529
+ L + + + N L + N+L G + Q+
Sbjct: 125 HLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQS 184
Query: 530 LEQLMLYNNSLEGNLPGSLINLRNLTRINFSKNRLNGRIATLCSSHSFLSFDVTNNEFDH 589
L G P + +L + ++ + + + + +
Sbjct: 185 HRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPN 244
Query: 590 EIPPQLGNSPSLERLRLGNNKFIGKIPWTFGKIRELSLLDLSGNSLTGPIPTQLLMCKKL 649
L + L + ++ + L L L N + L
Sbjct: 245 LRELGLNDC----LLSARGAAAVVD-AFSKLENIGLQTLRLQYNEIELDAVRTL------ 293
Query: 650 SHIDLNNNLLSGAVPSWLGTLPQLGELKLSFNQFVGFLPRELFNCSKLLVLSLDGNM 706
+P L L+L+ N+F + ++ G +
Sbjct: 294 -------------KTVIDEKMPDLLFLELNGNRF-SEEDDVVDEIREVFSTRGRGEL 336
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 42.9 bits (99), Expect = 2e-04
Identities = 39/349 (11%), Positives = 87/349 (24%), Gaps = 39/349 (11%)
Query: 480 KDLNFLHLRQNELVGQIPASLGNCHQLIILDLADNKLSGGVPASFGFLQALEQLMLYNNS 539
K L + + + A L + + L+ N +
Sbjct: 8 KSLKLDAITTEDE-KSVFAVLLEDDSVKEIVLSGNTIGTEAARW---------------- 50
Query: 540 LEGNLPGSLINLRNLTRINFSKNRLNGRIATLCSSHSFLSFDVTNNEFDHEIPPQLGNSP 599
L ++ + ++L FS + + L + P+L
Sbjct: 51 ----LSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKC-------PKLHTVR 99
Query: 600 SLERLRLGNNKFIGKIPWTFGKIRELSLLDLSGNSLTGPIPTQLLMCKKLSHIDLNNNLL 659
+ + + E L +G + + + N
Sbjct: 100 LSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPP 159
Query: 660 SGAVPSWLGTLPQLGELKLSFNQFVGFLPRELFNCSKLLVLSLDGNMLNGSLPNEVGNLA 719
++ L + + L + + ++L L
Sbjct: 160 LRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKV 219
Query: 720 SLNVLTLSGNLLSGPIPPAIGRLSKLYELRLSNNSLNGVIPLEIGQLQNLQS-----ILD 774
+L S + A+ L EL L++ L+ + + L
Sbjct: 220 LDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLR 279
Query: 775 LSHNNFTGQIPPSMGT-----LAKLEVLNLSHNQLVGELPSQLGEMSSL 818
L +N ++ T + L L L+ N+ E + E+ +
Sbjct: 280 LQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRF-SEEDDVVDEIREV 327
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 42.6 bits (98), Expect = 2e-04
Identities = 43/350 (12%), Positives = 89/350 (25%), Gaps = 38/350 (10%)
Query: 288 NLQSLDLSMNRLTG----GIPEEFGNMGQLVFLVLSNNNISGSIPRRICTNATSLEHLIL 343
+++ L ++ +T + + +VLS N I R + N
Sbjct: 4 SIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSEN--------- 54
Query: 344 AEIQLSGEIPVELSQCQSLKQLDLSNNT---LNGTIPVELFQLVALTHLYLHNNSLVGSI 400
++ + L+ + S+ + IP L L+ +++ S
Sbjct: 55 ------------IASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSD 102
Query: 401 SPFVANLSNLQELALYHNNFQGSLPREIGMLVKLELLYLYDNHLSGQIPSEVGNCSSLKW 460
+ F L + L L + + + N L+
Sbjct: 103 NAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRS 162
Query: 461 IDFFGNSFTGEIPTSIGRLKDLNFLHLRQNELVGQIPASLGNCHQLIILDLADNKLSGGV 520
I N + + L + I L L +
Sbjct: 163 IICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDL 222
Query: 521 PASFGFLQALEQLMLYNNSLEGNLPGSLINLRNLTRINFSKNRLNGRIATLCSSHSFLSF 580
+ L + S L + ++ + + +
Sbjct: 223 QDNTFTHLGSSALAIALKSWPNLRELGLND----CLLSARGAAAVVDAFSKLENIGLQTL 278
Query: 581 DVTNNEFDHEIPPQL-----GNSPSLERLRLGNNKFIGKIPWTFGKIREL 625
+ NE + + L P L L L N+F + +IRE+
Sbjct: 279 RLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRF-SEEDDVVDEIREV 327
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 42.2 bits (97), Expect = 3e-04
Identities = 36/307 (11%), Positives = 76/307 (24%), Gaps = 18/307 (5%)
Query: 351 EIPVELSQCQSLKQLDLSNNTLNG----TIPVELFQLVALTHLYLHNNS---LVGSISPF 403
+ L + S+K++ LS NT+ + + L + + I
Sbjct: 22 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEA 81
Query: 404 VANLSNLQELALYHNNFQGSLPREIGMLVKLELLYLYDNHLSGQIPSEVGNCSSLKWIDF 463
+ L + + S + + +L + +
Sbjct: 82 LRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKI 141
Query: 464 FGNSFTGEIPTSIGRLKDLNFLHLRQNELVGQIPASLGNCHQLIILDLADNKLSGGVPAS 523
+ L + +N L L K+
Sbjct: 142 ARALQELAVNKKAKNAPPLRSIICGRNRL-ENGSMKEWAKTFQSHRLLHTVKMVQNGIRP 200
Query: 524 FGFLQALEQLMLYNNSLEGNLPGSLINLRNLTRINFSKNRLNGRIATLCSSHSFLSFDVT 583
G L + + Y L+ + + + L + LS
Sbjct: 201 EGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGA 260
Query: 584 NNEFDHEIPPQLGNSPSLERLRLGNNKFIGKIP-----WTFGKIRELSLLDLSGNSLT-- 636
D + L+ LRL N+ K+ +L L+L+GN +
Sbjct: 261 AAVVDA---FSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEE 317
Query: 637 GPIPTQL 643
+ ++
Sbjct: 318 DDVVDEI 324
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 41.8 bits (96), Expect = 4e-04
Identities = 42/334 (12%), Positives = 88/334 (26%), Gaps = 20/334 (5%)
Query: 457 SLKWIDFFGNSFTGEIPTSIGRLKDLNFLHLRQNEL----VGQIPASLGNCHQLIILDLA 512
SLK + + + + L N + + ++ + L I + +
Sbjct: 9 SLKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFS 67
Query: 513 DNKLSGGVPASFGFLQALEQLMLYNNSLEGNLPGSL----INLRNLTRINFSKNRLNGRI 568
D L+ L Q +L L L L
Sbjct: 68 DIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLY 127
Query: 569 ATLCSSHSFLSFDVTNNEFDHEIPPQLGNSPSLERLRLGNNKFIGKIPWTFGKIRELSLL 628
+ + + + N+P L + G N+ + K + L
Sbjct: 128 LHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRL 187
Query: 629 DLSGNSLTGPIPTQLLMCKKLSHIDLNNNLLSGAVPSWLGTLPQLGELKLSFNQFVGFLP 688
+ + I + + L + L + T L ++ +
Sbjct: 188 LHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRE 247
Query: 689 RELFNCSKLLVLSLDGNMLNGSLPNEVGNLASLNVLTLSGNLLSGPIPPAI-----GRLS 743
L +C LS G +++ N+ L L L N + + ++
Sbjct: 248 LGLNDCL----LSARGAAAVVDAFSKLENI-GLQTLRLQYNEIELDAVRTLKTVIDEKMP 302
Query: 744 KLYELRLSNNSLNGVIPLEIGQLQNLQSILDLSH 777
L L L+ N + +++ + S
Sbjct: 303 DLLFLELNGNRF-SEEDDVVDEIREVFSTRGRGE 335
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 38.3 bits (87), Expect = 0.004
Identities = 42/340 (12%), Positives = 82/340 (24%), Gaps = 32/340 (9%)
Query: 433 KLELLYLYDNHLSGQIPSEVGNCSSLKWIDFFGNSFTGE----IPTSIGRLKDLNFLHLR 488
L+L + + + + S+K I GN+ E + +I KDL
Sbjct: 9 SLKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFS 67
Query: 489 QN----------ELVGQIPASLGNCHQLIILDLADNKLSGGVPASFGFLQALEQLMLYNN 538
E + + +L C +L + L+DN + + +
Sbjct: 68 DIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLY 127
Query: 539 SLEGNLPGSLINLRNLTRINFSKNRLNGRIATLCSSHSFLSFDVTNNEFDHEIPPQLGNS 598
L + N+ ++ S N ++ + +
Sbjct: 128 LHNNGLGPQAGAKIARALQELAVNK------KAKNAPPLRSIICGRNRLENGSMKEWAKT 181
Query: 599 PSLERLRLGNNKFIGKIPWTFGKIRELSLLDLSGNSLTGPIPTQLLMCKKLSHIDLNNNL 658
RL I + L L + S + +
Sbjct: 182 FQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKS 241
Query: 659 LSGAVPSWLGTLPQLGELKLSFNQFVGFLPRELFNCSKLLVLSLDGNMLNGSLPNEV--- 715
L + L L L L N + +
Sbjct: 242 WPNLRELGLNDCLLSARGAAAVVDAFSKL-----ENIGLQTLRLQYNEIELDAVRTLKTV 296
Query: 716 --GNLASLNVLTLSGNLLSGPIPPAIGRLSKLYELRLSNN 753
+ L L L+GN S + + +++ R
Sbjct: 297 IDEKMPDLLFLELNGNRFSE-EDDVVDEIREVFSTRGRGE 335
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 42.3 bits (98), Expect = 1e-04
Identities = 24/189 (12%), Positives = 54/189 (28%), Gaps = 20/189 (10%)
Query: 94 LQSLIHLDLSSNSLTGPIPTALSNLSSLESLLLFSNQLAGTIPTQLGSLTSLRVMRIGDN 153
L + L ++T + ++L + +L + + L +L + +N
Sbjct: 17 LAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGI--KSIDGVEYLNNLTQINFSNN 72
Query: 154 WLSGSIPTSFGNLVNLGTLGLASCSLSGPIPPQFGQLSQLEELILQQNQLQGPIPAELG- 212
L+ P + + + P+ + L
Sbjct: 73 QLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNR 132
Query: 213 -------------NCSSLSIFTAAENNLNGSIPAALGRLQNLQLLNLGNNSLSGEIPSEL 259
S+ ++ + L L L+ L++ +N +S S L
Sbjct: 133 LELSSNTISDISALSGLTSLQQLNFSSNQVTDLKPLANLTTLERLDISSNKVSD--ISVL 190
Query: 260 GELSQLGYL 268
+L+ L L
Sbjct: 191 AKLTNLESL 199
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 39.6 bits (91), Expect = 8e-04
Identities = 30/188 (15%), Positives = 57/188 (30%), Gaps = 20/188 (10%)
Query: 360 QSLKQLDLSNNTLNGTIPVELFQLVALTHLYLHNNSLVGSISPFVANLSNLQELALYHNN 419
+ L + T+ L +T L + SI L+NL ++ +N
Sbjct: 18 AEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIK-SIDGV-EYLNNLTQINFSNNQ 73
Query: 420 FQGSLPREIGMLVKLELLYLYDNHLSGQIPSEVGNCSSLKWIDFFGNSFTGEIPTSIGRL 479
P + + L+ + + + + + + T++ RL
Sbjct: 74 LTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRL 133
Query: 480 KDLNFLHLRQNELVGQI--------------PASLGNCHQLIILDLADNKLSGGVPASFG 525
+ + + L G L N L LD++ NK+S +
Sbjct: 134 ELSSNTISDISALSGLTSLQQLNFSSNQVTDLKPLANLTTLERLDISSNKVSD--ISVLA 191
Query: 526 FLQALEQL 533
L LE L
Sbjct: 192 KLTNLESL 199
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 39.6 bits (91), Expect = 9e-04
Identities = 29/200 (14%), Positives = 60/200 (30%), Gaps = 17/200 (8%)
Query: 238 LQNLQLLNLGNNSLSGEIPSELGELSQLGYLNLMGNRLEGAIPRSFAKMGNLQSLDLSMN 297
L LG +++ + +L Q+ L ++ + NL ++ S N
Sbjct: 17 LAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNN 72
Query: 298 RLTGGIPEEFGNMGQLVFLVLSNNNISGSIPRRICTNATSLEHLILAEIQLSGEIPVELS 357
+ L+ +I L + L ++
Sbjct: 73 Q----------LTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDID 122
Query: 358 QCQSLKQLDLSNNTLNGTIPVELFQLVALTHLYLHNNSLVGSISPFVANLSNLQELALYH 417
++L L+ + N + + +++ V + P ANL+ L+ L +
Sbjct: 123 PLKNLTNLNRLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKPL-ANLTTLERLDISS 181
Query: 418 NNFQGSLPREIGMLVKLELL 437
N + L LE L
Sbjct: 182 NKVSD--ISVLAKLTNLESL 199
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.0 bits (99), Expect = 1e-04
Identities = 35/227 (15%), Positives = 62/227 (27%), Gaps = 6/227 (2%)
Query: 268 LNLMGNRLEGAIPRSFAKMGNLQSLDLSMNRLTGGIPEEFGNMGQLVFLVLSNNNISGSI 327
+++ IP + N L + +L F G L + +S N++ I
Sbjct: 13 FLCQESKVT-EIPSDLPR--NAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVI 69
Query: 328 PRRICTNATSLEHLILAEIQLSGEIPVELSQCQSLKQLDLSNNTLNGTIPVELFQLVALT 387
+ +N L + + + I E Q Q L +NT +P
Sbjct: 70 EADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQK 129
Query: 388 HLYLHNNSLVGSISPFVANLSNLQ---ELALYHNNFQGSLPREIGMLVKLELLYLYDNHL 444
L +++ + + L L N Q EL +N+L
Sbjct: 130 VLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNL 189
Query: 445 SGQIPSEVGNCSSLKWIDFFGNSFTGEIPTSIGRLKDLNFLHLRQNE 491
S +D + LK L +
Sbjct: 190 EELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 236
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.8 bits (96), Expect = 3e-04
Identities = 33/241 (13%), Positives = 62/241 (25%), Gaps = 10/241 (4%)
Query: 214 CS-SLSIFTAAENNLNGSIPAALGRLQNLQLLNLGNNSLSGEIPSELGELSQLGYLNLMG 272
C S +F E+ + IP+ L +N L L L + +
Sbjct: 6 CHCSNRVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQ 62
Query: 273 NRLEGAI---PRSFAKMGNLQSLDLSMNRLTGGIPEEFGNMGQLVFLVLSNNNISGSIPR 329
N + I S + ++ + N L L+ +
Sbjct: 63 NDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVH 122
Query: 330 RICTNATSLEHLILAEIQLSGEIPVELSQCQSLKQLDLSNNTLNGTIPVELFQLVALTHL 389
+I + L + + E + L L+ N +
Sbjct: 123 KIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELN 182
Query: 390 YLHNNSLVGSISPFVANLSNLQELALYHNNFQGSLPREIGMLVKLELLYLYDNHLSGQIP 449
NN+L + S L + + L KL Y+ ++P
Sbjct: 183 LSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNL---KKLP 239
Query: 450 S 450
+
Sbjct: 240 T 240
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.4 bits (95), Expect = 3e-04
Identities = 32/240 (13%), Positives = 54/240 (22%), Gaps = 36/240 (15%)
Query: 59 CTWRGITCGSSSARVVSLNLSGLSLAGSISPSLGRLQSLIHLDLSSNSLTGPIPTALSNL 118
C R C S RV S ++ I L ++ I L L A S
Sbjct: 1 CHHRICHC---SNRVFLCQESKVT---EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGF 52
Query: 119 SSLESLLLFSNQLAGTIPTQLGSLTSLRVMRIGDNWLSGSIPTSFGNLVNLGTLGLA--- 175
LE + + N + I + S + + L
Sbjct: 53 GDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISN 112
Query: 176 -------------------------SCSLSGPIPPQFGQLSQLEELILQQNQLQGPIPAE 210
+ G + L L +N +Q
Sbjct: 113 TGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCA 172
Query: 211 LGNCSSLSIFTAAENNLNGSIPAALGRLQNLQLLNLGNNSLSGEIPSELGELSQLGYLNL 270
+ + NNL +L++ + L L +L +
Sbjct: 173 FNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST 232
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.4 bits (95), Expect = 3e-04
Identities = 9/48 (18%), Positives = 17/48 (35%), Gaps = 3/48 (6%)
Query: 90 SLGRLQSLIHLDLSSNSLTGPIPTALSNLSSLESLLLFSNQLAGTIPT 137
+ LD+S + L NL L + ++ + +PT
Sbjct: 196 VFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK---KLPT 240
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.0 bits (94), Expect = 5e-04
Identities = 37/240 (15%), Positives = 69/240 (28%), Gaps = 9/240 (3%)
Query: 328 PRRICTNATSLEHLILAEIQLSGEIPVELSQCQSLKQLDLSNNTLNGTIPVELFQLVALT 387
RIC S + E +++ EIP +L + + +L L L
Sbjct: 2 HHRICH--CSNRVFLCQESKVT-EIPSDLPR--NAIELRFVLTKLRVIQKGAFSGFGDLE 56
Query: 388 HLYLHNNSLVGSISPFVANLSNLQELALYH--NNFQGSLPREIGMLVKLELLYLYDNHLS 445
+ + N ++ I V + NN P L L+ L + + +
Sbjct: 57 KIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIK 116
Query: 446 GQIPSEVGNCSSLKWIDFFG--NSFTGEIPTSIGRLKDLNFLHLRQNELVGQIPASLGNC 503
+ +D N T E + +G + L L +N + +
Sbjct: 117 HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGT 176
Query: 504 HQLIILDLADNKLSGGVPASFGFLQALEQLMLYNNSLEGNLPGSLINLRNLTRINFSKNR 563
+ +N L F L + + L NL+ L + +
Sbjct: 177 QLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 236
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.0 bits (94), Expect = 5e-04
Identities = 39/244 (15%), Positives = 72/244 (29%), Gaps = 12/244 (4%)
Query: 571 LCSSHSFLSFDVTNNEFDHEIPPQLGNSPSLERLRLGNNKFIGKIPWTFGKIRELSLLDL 630
+C + F ++ EIP L + LR K F +L +++
Sbjct: 5 ICHCSN-RVFLCQESKV-TEIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEI 60
Query: 631 SGNSLTGPIPTQLLMCKKLSHIDL----NNNLLSGAVPSWLGTLPQLGELKLSFNQFVGF 686
S N + I + H NN L Q + + + +
Sbjct: 61 SQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPD 120
Query: 687 LPRELFNCSKLLVLSLDGNMLNGSLPNEVGNLASLNVLTLSGNLLSGPIPPAIGRLSKLY 746
+ + LL + + N+ + VG +L L+ N + A
Sbjct: 121 VHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDE 180
Query: 747 ELRLSNNSLNGVIPLEIGQLQNLQSILDLSHNNFTGQIPPSMGTLAKLEVLNLSHNQLVG 806
NN+L + LD+S + L KL + + +
Sbjct: 181 LNLSDNNNLEELPNDVFHGASGPVI-LDISRTRIHSLPSYGLENLKKLRARSTYNLK--- 236
Query: 807 ELPS 810
+LP+
Sbjct: 237 KLPT 240
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.7 bits (93), Expect = 6e-04
Identities = 29/234 (12%), Positives = 73/234 (31%), Gaps = 9/234 (3%)
Query: 244 LNLGNNSLSGEIPSELGELSQLGYLNLMGNRLEGAIPRSFAKMGNLQSLDLSMNRLTGGI 303
+ ++ EIPS+L L + +L +F+ G+L+ +++S N + I
Sbjct: 13 FLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVI 69
Query: 304 PEEFGNMGQLVFLVL---SNNNISGSIPRRICTNATSLEHLILAEIQLSGEIPVELSQCQ 360
+ + + + +NN + + + I+ ++ S +
Sbjct: 70 EADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQK 129
Query: 361 SLKQLDLSNNTLNGTIPVELFQLVALTHLYLHNNSLVGSISPFVANLSNLQELALYHNNF 420
L + + N + L+L+ N + + + +NN
Sbjct: 130 VLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNL 189
Query: 421 QGSLPREIGMLVKLELLYLYDNHLSGQIPSEVGNCSSLKWIDFFGNSFTGEIPT 474
+ +L + + + N L+ + ++PT
Sbjct: 190 EELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK---KLPT 240
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.7 bits (93), Expect = 6e-04
Identities = 31/237 (13%), Positives = 55/237 (23%), Gaps = 10/237 (4%)
Query: 96 SLIHLDLSSNSLTGPIPTALSNLSSLESLLLFSNQLAGTIPTQLGSLTSLRVMRIGDNWL 155
S + +T IP+ L + L +L L + I N +
Sbjct: 9 SNRVFLCQESKVTE-IPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDV 65
Query: 156 SGSIPTSFGNLVNLGTLGLASCSLSGPIPPQFGQLSQLEELILQQNQLQ----GPIPAEL 211
I + + + + + L + +
Sbjct: 66 LEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIH 125
Query: 212 GNCSSLSIFTAAENNLNGSIPAALGRLQNLQLLNLGNNSLSGEIPSELGELSQLGYLNLM 271
L N + +G +L L N +
Sbjct: 126 SLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSD 185
Query: 272 GNRLEGAIPRSFAKMGNLQSLDLSMNRLTGGIPEEFGNMGQLVFLVLSNNNISGSIP 328
N LE F LD+S R+ N+ +L S N+ +P
Sbjct: 186 NNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLR--ARSTYNLK-KLP 239
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.1 bits (89), Expect = 0.002
Identities = 28/225 (12%), Positives = 62/225 (27%), Gaps = 8/225 (3%)
Query: 319 SNNNISGSIPRRICTNATSLEHLILAEIQLSGEIPVELSQCQSLKQLDLSNNTLNGTIPV 378
+ ++ IP + N L +L S L+++++S N + I
Sbjct: 16 QESKVT-EIPSDLPRN---AIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEA 71
Query: 379 ELFQLVALTHLYL----HNNSLVGSISPFVANLSNLQELALYHNNFQGSLPREIGMLVKL 434
++F + H +N + + ++ + + + L
Sbjct: 72 DVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVL 131
Query: 435 ELLYLYDNHLSGQIPSEVGNCSSLKWIDFFGNSFTGEIPTSIGRLKDLNFLHLRQNELVG 494
+ N + + S VG + N + + N L
Sbjct: 132 LDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEE 191
Query: 495 QIPASLGNCHQLIILDLADNKLSGGVPASFGFLQALEQLMLYNNS 539
+ILD++ ++ L+ L YN
Sbjct: 192 LPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 236
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.4 bits (87), Expect = 0.003
Identities = 33/242 (13%), Positives = 64/242 (26%), Gaps = 18/242 (7%)
Query: 437 LYLYDNHLSGQIPSEVGNCSSLKWIDFFGNSFTGEIPTSIGRLKDLNFLHLRQNELVGQI 496
++ ++ +IPS++ + + F + DL + + QN+++ I
Sbjct: 13 FLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVI 69
Query: 497 PASLGNCHQLIILDLADNKLSGGVPASFGFLQALEQLMLYNN-----SLEGNLPGSLINL 551
A + + + + + F L + L +
Sbjct: 70 EADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQK 129
Query: 552 RNLTRINFSKNRLNGRIATLCSSHSFLSFDVTNNEFDHEIPPQLGNSPSLERLRLGNNKF 611
L + R + + S + + N + E NN
Sbjct: 130 VLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNL 189
Query: 612 IGKIPWTFGKIRELSLLDLSGNSLTGPIPTQLLMCKKLSHIDLNNNLLSGAVPSWLGTLP 671
F +LD+S + L KKL N L LP
Sbjct: 190 EELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYN----------LKKLP 239
Query: 672 QL 673
L
Sbjct: 240 TL 241
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.0 bits (86), Expect = 0.004
Identities = 31/224 (13%), Positives = 57/224 (25%), Gaps = 10/224 (4%)
Query: 495 QIPASLGNCHQLIILDLADNKLSGGVPASFGFLQALEQLMLYNNSLEGNLPGSLINLRNL 554
+IP+ L I L KL +F LE++ + N + + + +
Sbjct: 22 EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPK 79
Query: 555 TRINFSKNRLNGRIATLCSSHSFLSFDVTNNEFDH-----EIPPQLGNSPSLERLRLGNN 609
+ N + + + ++ L ++ N
Sbjct: 80 LHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNIN 139
Query: 610 KFIGKIPWTFGKIRELSLLDLSGNSLTGPIPTQLLMCKKLSHIDLNNNLLSGAVPSWLGT 669
+ G E +L L+ N + + +NN L
Sbjct: 140 IHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHG 199
Query: 670 LPQLGELKLSFNQFVGFLPRELFNCSKLLVLSLDGNMLNGSLPN 713
L +S + L N KL S LP
Sbjct: 200 ASGPVILDISRTRIHSLPSYGLENLKKLRARSTYN---LKKLPT 240
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.3 bits (93), Expect = 4e-04
Identities = 26/152 (17%), Positives = 46/152 (30%), Gaps = 9/152 (5%)
Query: 148 MRIGDNWLSGSIPTSFGNLVNLGTLGLASCSLSGPIPPQFGQLSQLEELILQQNQLQGPI 207
+++ + + + N V L L + I L Q + + N+++
Sbjct: 1 VKLTAELIEQA--AQYTNAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIRKLD 57
Query: 208 PAELGNCSSLSIFTAAENNLNGSIPAALGRLQNLQLLNLGNNSLSG-EIPSELGELSQLG 266
L N + L +L L L NNSL L L L
Sbjct: 58 GFP--LLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLT 115
Query: 267 YLNLMG---NRLEGAIPRSFAKMGNLQSLDLS 295
YL ++ + K+ ++ LD
Sbjct: 116 YLCILRNPVTNKKHYRLYVIYKVPQVRVLDFQ 147
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.9 bits (92), Expect = 5e-04
Identities = 25/137 (18%), Positives = 37/137 (27%), Gaps = 7/137 (5%)
Query: 401 SPFVANLSNLQELALYHNNFQGSLPREIGMLVKLELLYLYDNHLSGQIPSEVGNCSSLKW 460
+ N +EL L + L + + + DN + + LK
Sbjct: 11 AAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEI--RKLDGFPLLRRLKT 67
Query: 461 IDFFGNSFTGEIPTSIGRLKDLNFLHLRQNELVG----QIPASLGNCHQLIILDLADNKL 516
+ N L DL L L N LV ASL + L IL
Sbjct: 68 LLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNK 127
Query: 517 SGGVPASFGFLQALEQL 533
+ + L
Sbjct: 128 KHYRLYVIYKVPQVRVL 144
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.2 bits (90), Expect = 9e-04
Identities = 15/94 (15%), Positives = 29/94 (30%), Gaps = 10/94 (10%)
Query: 749 RLSNNSLNGVIPLEIGQLQNLQSI--LDLSHNNFTGQIPPSMGTLAKLEVLNLSHNQLVG 806
+L+ + + Q N LDL I TL + + ++ S N++
Sbjct: 2 KLTAELIE-----QAAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRK 55
Query: 807 ELPSQLGEMSSLGKLNLSYNDLQGKLSKQFSHWP 840
+ L L ++ N + P
Sbjct: 56 --LDGFPLLRRLKTLLVNNNRICRIGEGLDQALP 87
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.2 bits (90), Expect = 0.001
Identities = 22/136 (16%), Positives = 49/136 (36%), Gaps = 3/136 (2%)
Query: 262 LSQLGYLNLMGNRLEGAIPRSFAKMGNLQSLDLSMNRLTGGIPEEFGNMGQLVFLVLSNN 321
+ L+L G ++ I A + ++D S N + + F + +L L+++NN
Sbjct: 17 AVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR--KLDGFPLLRRLKTLLVNNN 73
Query: 322 NISGSIPRRICTNATSLEHLILAEIQLSGEIPVELSQCQSLKQLDLSNNTLNGTIPVELF 381
I E ++ + L+ +SL L + N + L+
Sbjct: 74 RICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLY 133
Query: 382 QLVALTHLYLHNNSLV 397
+ + + + + V
Sbjct: 134 VIYKVPQVRVLDFQKV 149
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.6 bits (86), Expect = 0.003
Identities = 28/136 (20%), Positives = 45/136 (33%), Gaps = 7/136 (5%)
Query: 593 PQLGNSPSLERLRLGNNKFIGKIPWTFGKIRELSLLDLSGNSLTGPIPTQLLMCKKLSHI 652
Q N+ L L K I I + + +D S N + LL ++L +
Sbjct: 12 AQYTNAVRDRELDLRGYK-IPVIENLGATLDQFDAIDFSDNEIRKLDGFPLL--RRLKTL 68
Query: 653 DLNNNLLSGAVPSWLGTLPQLGELKLSFNQFVGFLPRELFNCSKLLVLSLDGNMLNGSLP 712
+NNN + LP L EL L+ N V + K L +
Sbjct: 69 LVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKK 128
Query: 713 NE----VGNLASLNVL 724
+ + + + VL
Sbjct: 129 HYRLYVIYKVPQVRVL 144
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.2 bits (85), Expect = 0.004
Identities = 20/132 (15%), Positives = 48/132 (36%), Gaps = 3/132 (2%)
Query: 690 ELFNCSKLLVLSLDGNMLNGSLPNEVGNLASLNVLTLSGNLLSGPIPPAIGRLSKLYELR 749
+ N + L L G + + N L + + S N + L +L L
Sbjct: 13 QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEI--RKLDGFPLLRRLKTLL 69
Query: 750 LSNNSLNGVIPLEIGQLQNLQSILDLSHNNFTGQIPPSMGTLAKLEVLNLSHNQLVGELP 809
++NN + + L +L ++ +++ + +L L L + N + +
Sbjct: 70 VNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKH 129
Query: 810 SQLGEMSSLGKL 821
+L + + ++
Sbjct: 130 YRLYVIYKVPQV 141
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} Length = 198 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Score = 38.1 bits (87), Expect = 0.003
Identities = 34/181 (18%), Positives = 62/181 (34%), Gaps = 26/181 (14%)
Query: 72 RVVSLNLSGLSLAGSISP------SLGRLQSLIHLDLSSNSLTGPIPTALSNLSSLESL- 124
VV+ + L G I P +L L++ HL LS+N++ +S+LS +E+L
Sbjct: 19 SVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNI-----EKISSLSGMENLR 73
Query: 125 LLFSNQLAGTIPTQLGSLTSLRVMRIGDNWLSGSIPTSFGNLVNLGTLGLASCSLSGPIP 184
+L + L ++ S+ + + +
Sbjct: 74 ILSLGRNLIKKIENLDAVADTLEELWISYNQIASLSGIEKLVNLRVLYMSNNKITNWGEI 133
Query: 185 PQFGQLSQLEELILQQNQLQGPIPAELGNCSSLSIFTAAENNLNGSIPAALGRLQNLQLL 244
+ L +LE+L+L N L N + + RL NL+ L
Sbjct: 134 DKLAALDKLEDLLLAGNPLYNDYK--------------ENNATSEYRIEVVKRLPNLKKL 179
Query: 245 N 245
+
Sbjct: 180 D 180
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 1251 | |||
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 100.0 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 100.0 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 100.0 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 100.0 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 100.0 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.98 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.97 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.95 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.94 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.93 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.92 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.91 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.89 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.88 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.88 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.88 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.8 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.78 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.7 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.61 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.6 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.57 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 99.02 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.87 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.79 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.69 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 98.3 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 98.22 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 98.08 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 97.65 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 97.45 |
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=376.67 Aligned_cols=263 Identities=26% Similarity=0.397 Sum_probs=214.2
Q ss_pred CCCCCCCEECCCCCCEEEEEEEC-CC---CEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCCCEECEEEECCCCCEE
Q ss_conf 29996853223588039999965-99---589999811577145569999999998710477743130215405998116
Q 000859 946 NNLSDEFIIGSGGSGTVYKAELA-NG---ATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNL 1021 (1251)
Q Consensus 946 ~~~~~~~~lg~G~~g~V~~~~~~-~~---~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~ 1021 (1251)
.+|+..+.||+|+||+||+|.++ ++ ..||||.+.........+.|.+|+.++++++|||||+++|++... ...+
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~--~~~~ 103 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKS--TPVM 103 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS--SSCE
T ss_pred HHCEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEEC--CEEE
T ss_conf 04278569802788299999995799788999999978445989999999999999857998886189999628--8779
Q ss_pred EEEEECCCCCHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEECCCCC
Q ss_conf 99950589995776302887732478999999999999999997986306999915249999995546898758744456
Q 000859 1022 LIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGL 1101 (1251)
Q Consensus 1022 lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nili~~~~~~ki~DfG~ 1101 (1251)
+||||+++|+|.+++... .+.+++.++..++.|+++||+|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 104 iv~Ey~~~g~L~~~~~~~------~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGl 174 (299)
T d1jpaa_ 104 IITEFMENGSLDSFLRQN------DGQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGL 174 (299)
T ss_dssp EEEECCTTEEHHHHHHTT------TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC--
T ss_pred EEEEECCCCCCEEEECCC------CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCEEEECCCCCEEECCCCC
T ss_conf 999722798530021045------67999999999999999988988527---983576150448988999199888443
Q ss_pred CCCCCCCCCCC-CCCCCEEECCCCEECCCCCCCCCCCCCCCEEEHHHHHHHHHH-CCCCCCCCCCCCHHHHHHHHHHHHC
Q ss_conf 42221235888-754310001000005310024798986455303599999860-9999997664102479999997811
Q 000859 1102 AKALVEDYNSN-TESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMVRWVEMHMEM 1179 (1251)
Q Consensus 1102 a~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diws~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 1179 (1251)
|+......... ........||+.|+|||.+.+..++.++|||||||++|||+| |+.||.+....+. ...+
T Consensus 175 a~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~--~~~i------ 246 (299)
T d1jpaa_ 175 SRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDV--INAI------ 246 (299)
T ss_dssp ---------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH--HHHH------
T ss_pred CEECCCCCCCCEEEECCCCCCCCCCCCHHHHHCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHH--HHHH------
T ss_conf 15756777765365025666883003878883699786121445357899998679999999999999--9999------
Q ss_pred CCHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHCCCC
Q ss_conf 40125542002479999922799999999998745359999999999999997210997
Q 000859 1180 SGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNVFNNR 1238 (1251)
Q Consensus 1180 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~ 1238 (1251)
... ...+.+..++.++.+++.+||+.||++|||++++++.|+++.++.
T Consensus 247 ---------~~~--~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~p 294 (299)
T d1jpaa_ 247 ---------EQD--YRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNP 294 (299)
T ss_dssp ---------HTT--CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred ---------HCC--CCCCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHCCH
T ss_conf ---------737--889997422699999999975879768929999999999984186
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=375.87 Aligned_cols=269 Identities=24% Similarity=0.400 Sum_probs=215.2
Q ss_pred HHHHHHCCCCCCCEECCCCCCEEEEEEEC-CCCEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCCCEECEEEECCCC
Q ss_conf 99996129996853223588039999965-99589999811577145569999999998710477743130215405998
Q 000859 940 DIMGATNNLSDEFIIGSGGSGTVYKAELA-NGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAG 1018 (1251)
Q Consensus 940 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~ 1018 (1251)
+++...++|...+.||+|+||+||+|.++ +++.||||++.... ...+.|.+|+.++++++||||++++|++.+. .
T Consensus 11 ~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~--~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~--~ 86 (287)
T d1opja_ 11 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE--P 86 (287)
T ss_dssp TTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC--SCHHHHHHHHHHHHHCCCTTBCCEEEEECSS--S
T ss_pred CCEECHHHEEEEEEEEECCCEEEEEEEECCCCEEEEEEEECCCC--CHHHHHHHHHHHHHHCCCCCEECCCCCEEEC--C
T ss_conf 51745799398659820888089999999999699999977761--0399999999999867999882677527457--8
Q ss_pred CEEEEEEECCCCCHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEECC
Q ss_conf 11699950589995776302887732478999999999999999997986306999915249999995546898758744
Q 000859 1019 SNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGD 1098 (1251)
Q Consensus 1019 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nili~~~~~~ki~D 1098 (1251)
..++||||+++|+|.+++.+.. ...+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|
T Consensus 87 ~~~iv~E~~~~g~l~~~l~~~~-----~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~D 158 (287)
T d1opja_ 87 PFYIITEFMTYGNLLDYLRECN-----RQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVAD 158 (287)
T ss_dssp SCEEEEECCTTCBHHHHHHHSC-----TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECC
T ss_pred EEEEEEECCCCCCHHHHHHHCC-----CCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCEEEECCCCCEEECC
T ss_conf 5478763146760677753035-----54157999999999999978889878---930576045768998999289832
Q ss_pred CCCCCCCCCCCCCCCCCCCEEECCCCEECCCCCCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHH
Q ss_conf 45642221235888754310001000005310024798986455303599999860999999766410247999999781
Q 000859 1099 FGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHME 1178 (1251)
Q Consensus 1099 fG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~ 1178 (1251)
||+|+..... .........|+..|+|||++.+..++.++||||||+++|||++|+.|+........ ...
T Consensus 159 FG~a~~~~~~---~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~-~~~------- 227 (287)
T d1opja_ 159 FGLSRLMTGD---TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-VYE------- 227 (287)
T ss_dssp CCCTTTCCSS---SSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-HHH-------
T ss_pred CCCEEECCCC---CCEEECCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHH-HHH-------
T ss_conf 4454653788---72210355665466692787279998104302178999999867998877425999-999-------
Q ss_pred CCCHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHCCCCCCC
Q ss_conf 140125542002479999922799999999998745359999999999999997210997334
Q 000859 1179 MSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNVFNNRIVD 1241 (1251)
Q Consensus 1179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~~~ 1241 (1251)
.+....++ +.+..+++++.+++.+||+.||++|||++++++.|+.++++..+.
T Consensus 228 --------~i~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~~~~~ 280 (287)
T d1opja_ 228 --------LLEKDYRM--ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSIS 280 (287)
T ss_dssp --------HHHTTCCC--CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSSSCHH
T ss_pred --------HHHCCCCC--CCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHHCCCC
T ss_conf --------98558888--887433099999999975779768939999999999998757777
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=373.81 Aligned_cols=263 Identities=28% Similarity=0.403 Sum_probs=209.1
Q ss_pred HHHCCCCCCCEECCCCCCEEEEEEECCCCEEEEEEECCCC-CHHHHHHHHHHHHHHHHCCCCCCCCEECEEEECCCCCEE
Q ss_conf 9612999685322358803999996599589999811577-145569999999998710477743130215405998116
Q 000859 943 GATNNLSDEFIIGSGGSGTVYKAELANGATVAVKKISCKD-DHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNL 1021 (1251)
Q Consensus 943 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~ 1021 (1251)
...++|...+.||+|+||+||+|+++ ..||||+++... .....+.|.+|+.++++++||||++++|++.+ ...+
T Consensus 5 i~~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~---~~~~ 79 (276)
T d1uwha_ 5 IPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA---PQLA 79 (276)
T ss_dssp CCTTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS---SSCE
T ss_pred CCCCCEEEEEEEEECCCCEEEEEEEC--CEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEC---CEEE
T ss_conf 15451899889830788589999999--989999997346998999999999999984799878645679715---5899
Q ss_pred EEEEECCCCCHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEECCCCC
Q ss_conf 99950589995776302887732478999999999999999997986306999915249999995546898758744456
Q 000859 1022 LIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGL 1101 (1251)
Q Consensus 1022 lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nili~~~~~~ki~DfG~ 1101 (1251)
+||||+++|+|.+++... ...+++..+..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 80 lv~Ey~~~g~L~~~l~~~------~~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGl 150 (276)
T d1uwha_ 80 IVTQWCEGSSLYHHLHII------ETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGL 150 (276)
T ss_dssp EEEECCCEEEHHHHHHTS------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCC
T ss_pred EEEECCCCCCHHHHHHHC------CCCCCHHHHHHHHHHHHHHHHHHHCC---CEECCCCCHHHEEECCCCCEEECCCCC
T ss_conf 999658998889998523------57899999999999999998887509---995161478997981899788750022
Q ss_pred CCCCCCCCCCCCCCCCEEECCCCEECCCCCCC---CCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHH
Q ss_conf 42221235888754310001000005310024---798986455303599999860999999766410247999999781
Q 000859 1102 AKALVEDYNSNTESNTWFAGSYGYIAPEYAYS---LKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHME 1178 (1251)
Q Consensus 1102 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Diws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~ 1178 (1251)
|+....... ........||+.|+|||++.+ ..++.++|||||||++|||+||+.||.+.......... +..
T Consensus 151 a~~~~~~~~--~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~-~~~--- 224 (276)
T d1uwha_ 151 ATVKSRWSG--SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFM-VGR--- 224 (276)
T ss_dssp SCC--------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHH-HHH---
T ss_pred EEECCCCCC--CCCCCCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH-HHC---
T ss_conf 133355677--63125665574317999995056899995315163599999999788998998969999999-965---
Q ss_pred CCCHHHHHHHCCCCCCCC-CCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHCC
Q ss_conf 140125542002479999-9227999999999987453599999999999999972109
Q 000859 1179 MSGSAREELLDDQMKPLL-PGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNVFN 1236 (1251)
Q Consensus 1179 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~ 1236 (1251)
....+.. .....+++++.+++.+||+.||.+||||+++++.|+.+..
T Consensus 225 -----------~~~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~ 272 (276)
T d1uwha_ 225 -----------GYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR 272 (276)
T ss_dssp -----------TSCCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----------CCCCCCCHHCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf -----------888986000365554999999999758897689299999999999997
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=373.50 Aligned_cols=261 Identities=23% Similarity=0.375 Sum_probs=209.0
Q ss_pred HHHCCCCCCCEECCCCCCEEEEEEECCCCEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCCCEECEEEECCCCCEEE
Q ss_conf 96129996853223588039999965995899998115771455699999999987104777431302154059981169
Q 000859 943 GATNNLSDEFIIGSGGSGTVYKAELANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLL 1022 (1251)
Q Consensus 943 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~l 1022 (1251)
...++|+..+.||+|+||+||+|.++++..||||++.... ...+.|.+|+.++++++|||||+++|++.+ ...++
T Consensus 10 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~---~~~~i 84 (272)
T d1qpca_ 10 VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS--MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ---EPIYI 84 (272)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS---SSCEE
T ss_pred CCHHHEEEEEEEECCCCCEEEEEEECCCCEEEEEEECCCC--CCHHHHHHHHHHHHHCCCCCEEEEEEEECC---CCEEE
T ss_conf 3889938867981079828999999999999999986476--888999999999986799988578731045---97699
Q ss_pred EEEECCCCCHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEECCCCCC
Q ss_conf 99505899957763028877324789999999999999999979863069999152499999955468987587444564
Q 000859 1023 IYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLA 1102 (1251)
Q Consensus 1023 v~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nili~~~~~~ki~DfG~a 1102 (1251)
||||+++|+|.+++.... ...+++..+++++.||++||+|||++ +|+||||||+||++++++.+||+|||+|
T Consensus 85 v~Ey~~~g~L~~~~~~~~-----~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla 156 (272)
T d1qpca_ 85 ITEYMENGSLVDFLKTPS-----GIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLA 156 (272)
T ss_dssp EEECCTTCBHHHHTTSHH-----HHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred EEEECCCCCHHHHHHHCC-----CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHEEEECCCCEEECCCCCE
T ss_conf 999578982888875147-----89887889999999999999999748---9546756422515620244042341014
Q ss_pred CCCCCCCCCCCCCCCEEECCCCEECCCCCCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHCCCH
Q ss_conf 22212358887543100010000053100247989864553035999998609999997664102479999997811401
Q 000859 1103 KALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGS 1182 (1251)
Q Consensus 1103 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 1182 (1251)
+...... ........|+..|+|||++.+..++.++||||||+++|||+||+.|+....... .....+
T Consensus 157 ~~~~~~~---~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~-~~~~~i--------- 223 (272)
T d1qpca_ 157 RLIEDNE---YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP-EVIQNL--------- 223 (272)
T ss_dssp EECSSSC---EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-HHHHHH---------
T ss_pred EECCCCC---CCCCCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCHH-HHHHHH---------
T ss_conf 7735886---442035677444458289837999824564525799999996898888888999-999999---------
Q ss_pred HHHHHHCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHCCC
Q ss_conf 2554200247999992279999999999874535999999999999999721099
Q 000859 1183 AREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNVFNN 1237 (1251)
Q Consensus 1183 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~ 1237 (1251)
....++ +.+..+++++.+++.+||+.||++|||++++++.|++++..
T Consensus 224 ------~~~~~~--~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 224 ------ERGYRM--VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp ------HTTCCC--CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ------HHCCCC--CCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHC
T ss_conf ------706888--89655719999999997588976893999999986113213
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=369.22 Aligned_cols=257 Identities=26% Similarity=0.423 Sum_probs=208.7
Q ss_pred HCCCCCCCEECCCCCCEEEEEEECCCCEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCCCEECEEEECCCCCEEEEE
Q ss_conf 12999685322358803999996599589999811577145569999999998710477743130215405998116999
Q 000859 945 TNNLSDEFIIGSGGSGTVYKAELANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIY 1024 (1251)
Q Consensus 945 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv~ 1024 (1251)
.++|...+.||+|+||+||+|.+.+++.||||++.... ...+.|.+|+.++++++||||++++|+|... ...++||
T Consensus 4 p~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~--~~~~lv~ 79 (263)
T d1sm2a_ 4 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA--MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ--APICLVF 79 (263)
T ss_dssp CSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECSS--SSCEEEE
T ss_pred HHHCEEEEEEEECCCEEEEEEEECCCCEEEEEEECCCC--CCHHHHHHHHHHHHHCCCCCCCCCCCEECCC--CCEEEEE
T ss_conf 69958888982088829999998899999999987886--7689999999999966899756535243159--9337999
Q ss_pred EECCCCCHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEECCCCCCCC
Q ss_conf 50589995776302887732478999999999999999997986306999915249999995546898758744456422
Q 000859 1025 EYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKA 1104 (1251)
Q Consensus 1025 e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nili~~~~~~ki~DfG~a~~ 1104 (1251)
||+++|+|.+++... ...+++..+..++.|++.||+|+|+. +|+||||||+||++++++.+||+|||+|+.
T Consensus 80 E~~~~g~L~~~l~~~------~~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~ 150 (263)
T d1sm2a_ 80 EFMEHGCLSDYLRTQ------RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRF 150 (263)
T ss_dssp ECCTTCBHHHHHHTT------TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC----
T ss_pred EECCCCCHHHHHHCC------CCCCCHHHHHHHHHHHHHHHHHHHCC---CEEECCCCHHHEEECCCCCEEECCCCHHEE
T ss_conf 836999189975201------34788999999999999987765316---431044315326666887768655321002
Q ss_pred CCCCCCCCCCCCCEEECCCCEECCCCCCCCCCCCCCCEEEHHHHHHHHHHC-CCCCCCCCCCCHHHHHHHHHHHHCCCHH
Q ss_conf 212358887543100010000053100247989864553035999998609-9999976641024799999978114012
Q 000859 1105 LVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSG-KMPTDATFGVEMDMVRWVEMHMEMSGSA 1183 (1251)
Q Consensus 1105 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diws~Gvil~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1183 (1251)
...... .......||..|+|||++.+..++.++||||||+++|||+|+ ++||......+ ....+.
T Consensus 151 ~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~--~~~~i~--------- 216 (263)
T d1sm2a_ 151 VLDDQY---TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE--VVEDIS--------- 216 (263)
T ss_dssp -----------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHH--HHHHHH---------
T ss_pred CCCCCC---EEECCEECCCCCCCHHHHCCCCCCCHHHHCCHHHHHHHHHHCCCCCCCCCCHHH--HHHHHH---------
T ss_conf 368873---350430017666785786079998403321059999999878988877899999--999998---------
Q ss_pred HHHHHCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHCC
Q ss_conf 55420024799999227999999999987453599999999999999972109
Q 000859 1184 REELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNVFN 1236 (1251)
Q Consensus 1184 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~ 1236 (1251)
...+. +.+..+++++.+++.+||+.||++|||++++++.|+++.+
T Consensus 217 ------~~~~~--~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 217 ------TGFRL--YKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp ------HTCCC--CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ------HCCCC--CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf ------06888--9954367999999999765797689199999999999985
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=365.18 Aligned_cols=265 Identities=27% Similarity=0.390 Sum_probs=212.2
Q ss_pred HHCCCCCCCEECCCCCCEEEEEEECC-C-----CEEEEEEECCCCCHHHHHHHHHHHHHHHHC-CCCCCCCEECEEEECC
Q ss_conf 61299968532235880399999659-9-----589999811577145569999999998710-4777431302154059
Q 000859 944 ATNNLSDEFIIGSGGSGTVYKAELAN-G-----ATVAVKKISCKDDHLLNKSFTREVKTLGRI-RHRHLVKLMGHCCNKG 1016 (1251)
Q Consensus 944 ~~~~~~~~~~lg~G~~g~V~~~~~~~-~-----~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~ 1016 (1251)
..++|...+.||+|+||+||+|.+.. + ..||+|.+...........+.+|+.+++++ +|||||+++|++...
T Consensus 35 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~- 113 (325)
T d1rjba_ 35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS- 113 (325)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS-
T ss_pred CHHHEEEEEEEEECCCEEEEEEEECCCCCCCCEEEEEEEEECCCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEEC-
T ss_conf 7899397019830788199999985788554204999999663358789999999999999715899686877888629-
Q ss_pred CCCEEEEEEECCCCCHHHHHHCCCCCC----------------CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECC
Q ss_conf 981169995058999577630288773----------------2478999999999999999997986306999915249
Q 000859 1017 AGSNLLIYEYMENGSVWDWLHKQPVNI----------------KMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRD 1080 (1251)
Q Consensus 1017 ~~~~~lv~e~~~~gsL~~~l~~~~~~~----------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~D 1080 (1251)
...++||||+++|+|.++++..+... .....+++..++.++.|++.||+|||++ +|+|||
T Consensus 114 -~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRD 189 (325)
T d1rjba_ 114 -GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRD 189 (325)
T ss_dssp -SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETT
T ss_pred -CEEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECC
T ss_conf -9589999727999599999862577751022100001222001257789999999999999999999739---905052
Q ss_pred CCCCCEEECCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCEECCCCCCCCCCCCCCCEEEHHHHHHHHHH-CCCCC
Q ss_conf 99999554689875874445642221235888754310001000005310024798986455303599999860-99999
Q 000859 1081 IKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMPT 1159 (1251)
Q Consensus 1081 lk~~Nili~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diws~Gvil~ellt-g~~p~ 1159 (1251)
|||+||+++.++.+||+|||+|+....... ........||+.|+|||++.+..++.++|||||||++|||+| |+.||
T Consensus 190 lKp~Nill~~~~~~Kl~DFGla~~~~~~~~--~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf 267 (325)
T d1rjba_ 190 LAARNVLVTHGKVVKICDFGLARDIMSDSN--YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY 267 (325)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCGGGCTT--SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred CCHHCCCCCCCCEEEEEECCCCCCCCCCCC--EEEECCCCCCCCCCCHHHHCCCCCCCCEECCCHHHHHHHHHHCCCCCC
T ss_conf 703214434598289851422220457786--156234357876578388727999963303000399999983899999
Q ss_pred CCCCCCCHHHHHHHHHHHHCCCHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHH
Q ss_conf 97664102479999997811401255420024799999227999999999987453599999999999999972
Q 000859 1160 DATFGVEMDMVRWVEMHMEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLN 1233 (1251)
Q Consensus 1160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 1233 (1251)
.+....+. .... +....+ .+.+..+++++.+++.+||+.||++|||++||++.|..
T Consensus 268 ~~~~~~~~-~~~~---------------~~~~~~--~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 323 (325)
T d1rjba_ 268 PGIPVDAN-FYKL---------------IQNGFK--MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC 323 (325)
T ss_dssp TTCCCSHH-HHHH---------------HHTTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCCHHHH-HHHH---------------HHCCCC--CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHC
T ss_conf 99898999-9999---------------856998--99887678999999999758896689399999999748
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=365.94 Aligned_cols=259 Identities=22% Similarity=0.344 Sum_probs=209.8
Q ss_pred CCCCCCC-EECCCCCCEEEEEEEC---CCCEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCCCEECEEEECCCCCEE
Q ss_conf 2999685-3223588039999965---99589999811577145569999999998710477743130215405998116
Q 000859 946 NNLSDEF-IIGSGGSGTVYKAELA---NGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNL 1021 (1251)
Q Consensus 946 ~~~~~~~-~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~ 1021 (1251)
++|.... +||+|+||+||+|.++ ++..||||++.........+.|.+|+.++++++|||||+++|++.. ...+
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~---~~~~ 84 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA---EALM 84 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES---SSEE
T ss_pred CCEEECCCEEECCCCEEEEEEEEECCCCCEEEEEEEECHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECC---CEEE
T ss_conf 4718878487306080999999960897689999998820397899999999999986799888068656036---8079
Q ss_pred EEEEECCCCCHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEECCCCC
Q ss_conf 99950589995776302887732478999999999999999997986306999915249999995546898758744456
Q 000859 1022 LIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGL 1101 (1251)
Q Consensus 1022 lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nili~~~~~~ki~DfG~ 1101 (1251)
+||||+++|+|.+++... ...+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 85 lvmE~~~~g~L~~~l~~~------~~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGl 155 (285)
T d1u59a_ 85 LVMEMAGGGPLHKFLVGK------REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGL 155 (285)
T ss_dssp EEEECCTTEEHHHHHTTC------TTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTT
T ss_pred EEEEECCCCCHHHHHHCC------CCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEECCCCCEEECCCHH
T ss_conf 999807899689975212------56999999999999999987899868---810576764660454688542033134
Q ss_pred CCCCCCCCCCCCCCCCEEECCCCEECCCCCCCCCCCCCCCEEEHHHHHHHHHH-CCCCCCCCCCCCHHHHHHHHHHHHCC
Q ss_conf 42221235888754310001000005310024798986455303599999860-99999976641024799999978114
Q 000859 1102 AKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMVRWVEMHMEMS 1180 (1251)
Q Consensus 1102 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diws~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 1180 (1251)
|+.+...... ........||+.|+|||++.+..++.++|||||||++|||+| |+.||.+....+. ...+
T Consensus 156 a~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~--~~~i------- 225 (285)
T d1u59a_ 156 SKALGADDSY-YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV--MAFI------- 225 (285)
T ss_dssp CEECTTCSCE-ECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHH--HHHH-------
T ss_pred HHCCCCCCCC-CCCCCCCCCCCCCCCHHHHHCCCCCCCCHHHCCHHHHHHHHHCCCCCCCCCCHHHH--HHHH-------
T ss_conf 2115543432-11356211374335868872799995412322017899999389999999799999--9999-------
Q ss_pred CHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHCC
Q ss_conf 01255420024799999227999999999987453599999999999999972109
Q 000859 1181 GSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNVFN 1236 (1251)
Q Consensus 1181 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~ 1236 (1251)
....+ .+.+..+++++.+++.+||+.||++||+|.+|.+.|+.++.
T Consensus 226 --------~~~~~--~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~ 271 (285)
T d1u59a_ 226 --------EQGKR--MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 271 (285)
T ss_dssp --------HTTCC--CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --------HCCCC--CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf --------81899--99997678999999999757797689099999999999999
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=367.36 Aligned_cols=268 Identities=24% Similarity=0.408 Sum_probs=209.1
Q ss_pred HHCCCCCCCEECCCCCCEEEEEEE-CCCCEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCCCEECEEEECCCCCEEE
Q ss_conf 612999685322358803999996-5995899998115771455699999999987104777431302154059981169
Q 000859 944 ATNNLSDEFIIGSGGSGTVYKAEL-ANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLL 1022 (1251)
Q Consensus 944 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~l 1022 (1251)
..++|+..+.||+|+||+||+|.. .+++.||+|+++........+.+.+|+.+++.++|||||++++++.+ +...++
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~~~i 81 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS--DGEISI 81 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEEC--SSEEEE
T ss_pred CCCCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEE--CCEEEE
T ss_conf 756888978971277809999999899969999998754097899999999999986799999949999998--999999
Q ss_pred EEEECCCCCHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCCCEEECCCCCCCEEECCCCCEEECCCCC
Q ss_conf 995058999577630288773247899999999999999999798630-6999915249999995546898758744456
Q 000859 1023 IYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHH-DCVPKILHRDIKSSNILLDSNMEAHLGDFGL 1101 (1251)
Q Consensus 1023 v~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~Dlk~~Nili~~~~~~ki~DfG~ 1101 (1251)
||||+++|+|.+++.+ .+.+++..++.++.|++.|+.|||+ + +|+||||||+|||++.++.+||+|||+
T Consensus 82 VmEy~~gg~L~~~l~~-------~~~l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vkl~DFGl 151 (322)
T d1s9ja_ 82 CMEHMDGGSLDQVLKK-------AGRIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGV 151 (322)
T ss_dssp EEECCTTEEHHHHHHH-------HSSCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCC
T ss_pred EEECCCCCCHHHHHHH-------CCCCCHHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEECCCCCEEEEECCC
T ss_conf 9976799868998742-------499999999999999999999999859---997144577994687899899954877
Q ss_pred CCCCCCCCCCCCCCCCEEECCCCEECCCCCCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHCCC
Q ss_conf 42221235888754310001000005310024798986455303599999860999999766410247999999781140
Q 000859 1102 AKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSG 1181 (1251)
Q Consensus 1102 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 1181 (1251)
|+.+.... ....+||+.|+|||++.+..|+.++||||+||++|||++|+.||.+....+...............
T Consensus 152 a~~~~~~~------~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~ 225 (322)
T d1s9ja_ 152 SGQLIDSM------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAE 225 (322)
T ss_dssp CHHHHHHT------C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC----------
T ss_pred CCCCCCCC------CCCCCCCCCCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCCC
T ss_conf 62567886------211137714119468758998948889989999999998889989988789999998875177545
Q ss_pred ----------------------HH---HHHHHCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf ----------------------12---55420024799999227999999999987453599999999999999
Q 000859 1182 ----------------------SA---REELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDL 1230 (1251)
Q Consensus 1182 ----------------------~~---~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 1230 (1251)
.. ..........+..+ ....+.++.+++.+|++.||.+|||++|+++.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H 298 (322)
T d1s9ja_ 226 TPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLP-SGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 298 (322)
T ss_dssp --------------------CCCCHHHHHHHHHTSCCCCCC-BTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCC-CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHC
T ss_conf 77421233322111122235413477887665026876676-44489999999999868994679089999609
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=363.28 Aligned_cols=264 Identities=24% Similarity=0.404 Sum_probs=211.5
Q ss_pred HCCCCCCCEECCCCCCEEEEEEECCC-----CEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCCCEECEEEECCCCC
Q ss_conf 12999685322358803999996599-----5899998115771455699999999987104777431302154059981
Q 000859 945 TNNLSDEFIIGSGGSGTVYKAELANG-----ATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGS 1019 (1251)
Q Consensus 945 ~~~~~~~~~lg~G~~g~V~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 1019 (1251)
..+|+..++||+|+||+||+|.++.. ..||||++.........+.|.+|+.++++++|||||+++|++... ..
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~--~~ 83 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY--KP 83 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS--SS
T ss_pred HHHEEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECC--CC
T ss_conf 8996861598117790999999968998787999999988445968999999999999856898783236778338--80
Q ss_pred EEEEEEECCCCCHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEECCC
Q ss_conf 16999505899957763028877324789999999999999999979863069999152499999955468987587444
Q 000859 1020 NLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDF 1099 (1251)
Q Consensus 1020 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nili~~~~~~ki~Df 1099 (1251)
.++|+||+.+|++.+++... ...+++..+..++.|++.|++|||+. +|+||||||+|||++.++.+||+||
T Consensus 84 ~~~v~e~~~~~~l~~~~~~~------~~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DF 154 (283)
T d1mqba_ 84 MMIITEYMENGALDKFLREK------DGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDF 154 (283)
T ss_dssp EEEEEECCTTEEHHHHHHHT------TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC
T ss_pred EEEEEEECCCCCCHHHHHCC------CCCCCHHHHHHHHHHHHHHHHHCCCC---CCCCCCCCCCEEEECCCCEEEECCC
T ss_conf 38999721357402221023------45420899999999999854121212---3425765644278889984998455
Q ss_pred CCCCCCCCCCCCCCCCCCEEECCCCEECCCCCCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHC
Q ss_conf 56422212358887543100010000053100247989864553035999998609999997664102479999997811
Q 000859 1100 GLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEM 1179 (1251)
Q Consensus 1100 G~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 1179 (1251)
|+|+........ ........||..|+|||++.+..++.++||||||+++|||++|+.|+....... .....
T Consensus 155 Gla~~~~~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~-~~~~~------- 225 (283)
T d1mqba_ 155 GLSRVLEDDPEA-TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH-EVMKA------- 225 (283)
T ss_dssp CC------------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-HHHHH-------
T ss_pred CHHHCCCCCCCC-CEEECCCCCCCCCCCHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHH-HHHHH-------
T ss_conf 103003578765-267426777734348888704999973556344898999996798865568999-99999-------
Q ss_pred CCHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHCCCC
Q ss_conf 40125542002479999922799999999998745359999999999999997210997
Q 000859 1180 SGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNVFNNR 1238 (1251)
Q Consensus 1180 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~ 1238 (1251)
+....++ +.+..++.++.+++.+||+.||++||+|++|++.|+.+.+.+
T Consensus 226 --------i~~~~~~--~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~p 274 (283)
T d1mqba_ 226 --------INDGFRL--PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 274 (283)
T ss_dssp --------HHTTCCC--CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred --------HHCCCCC--CCCHHHHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHCC
T ss_conf --------8635789--985045799999999977679768939999999999986695
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=365.51 Aligned_cols=253 Identities=26% Similarity=0.348 Sum_probs=205.9
Q ss_pred CCCCCCCEECCCCCCEEEEEEE-CCCCEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCCCEECEEEECCCCCEEEEE
Q ss_conf 2999685322358803999996-599589999811577145569999999998710477743130215405998116999
Q 000859 946 NNLSDEFIIGSGGSGTVYKAEL-ANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIY 1024 (1251)
Q Consensus 946 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv~ 1024 (1251)
++|+..+.||+|+||+||+|.. .+++.||+|++.........+.+.+|+.++++++||||+++++++.+ +...++||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~--~~~~~ivm 82 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE--GNIQYLFL 82 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEE--TTEEEEEE
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHCCCCCEEEEEEEECC--CCEEEEEE
T ss_conf 4608998972174809999999999979999998456641279999999999985799888469654046--74367988
Q ss_pred EECCCCCHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEECCCCCCCC
Q ss_conf 50589995776302887732478999999999999999997986306999915249999995546898758744456422
Q 000859 1025 EYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKA 1104 (1251)
Q Consensus 1025 e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nili~~~~~~ki~DfG~a~~ 1104 (1251)
||+++|+|.+++.. ...+++.+++.++.|++.|++|||++ +|+||||||+||++++++.+||+|||+|+.
T Consensus 83 Ey~~gg~L~~~l~~-------~~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~ 152 (271)
T d1nvra_ 83 EYCSGGELFDRIEP-------DIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATV 152 (271)
T ss_dssp ECCTTEEGGGGSBT-------TTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred ECCCCCCHHHHHHC-------CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHEEECCCCCEEECCCHHHEE
T ss_conf 64589808999753-------79999999999999999999999975---983575468997887899879832314224
Q ss_pred CCCCCCCCCCCCCEEECCCCEECCCCCCCCCC-CCCCCEEEHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHCCCHH
Q ss_conf 21235888754310001000005310024798-98645530359999986099999976641024799999978114012
Q 000859 1105 LVEDYNSNTESNTWFAGSYGYIAPEYAYSLKA-TEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSA 1183 (1251)
Q Consensus 1105 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Diws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1183 (1251)
..... ........+||+.|+|||++.+..+ +.++||||+||++|||++|+.||............+..
T Consensus 153 ~~~~~--~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~--------- 221 (271)
T d1nvra_ 153 FRYNN--RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE--------- 221 (271)
T ss_dssp CEETT--EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHT---------
T ss_pred ECCCC--CCCCCCCEEECCCCCCHHHHCCCCCCCCCEEEEHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHC---------
T ss_conf 04688--6531113255747428728618999997101617379999998299788889859999999863---------
Q ss_pred HHHHHCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 5542002479999922799999999998745359999999999999
Q 000859 1184 REELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCD 1229 (1251)
Q Consensus 1184 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1229 (1251)
.....+.....++++.+++.+||+.||++|||++|+++
T Consensus 222 --------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 222 --------KKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp --------TCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --------CCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf --------88878864469999999999976799668909999961
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=359.62 Aligned_cols=250 Identities=23% Similarity=0.367 Sum_probs=205.4
Q ss_pred CCCCCCCEECCCCCCEEEEEEE-CCCCEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCCCEECEEEECCCCCEEEEE
Q ss_conf 2999685322358803999996-599589999811577145569999999998710477743130215405998116999
Q 000859 946 NNLSDEFIIGSGGSGTVYKAEL-ANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIY 1024 (1251)
Q Consensus 946 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv~ 1024 (1251)
.+|+..+.||+|+||+||+|.. .+++.||+|++..... ...+.+.+|+.+++.++||||+++++++.. ....++||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~--~~~~~ivm 96 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ-PKKELIINEILVMRENKNPNIVNYLDSYLV--GDELWVVM 96 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGC-SCHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEEEE
T ss_pred CCCEEEEEEECCCCCEEEEEEECCCCCEEEEEEEECCCC-HHHHHHHHHHHHHHHCCCCCEEEEEEEEEE--CCEEEEEE
T ss_conf 053887898128582999999989998999999843017-279999999999986799988058577988--99989999
Q ss_pred EECCCCCHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEECCCCCCCC
Q ss_conf 50589995776302887732478999999999999999997986306999915249999995546898758744456422
Q 000859 1025 EYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKA 1104 (1251)
Q Consensus 1025 e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nili~~~~~~ki~DfG~a~~ 1104 (1251)
||+++|+|.+++.+ ..+++..+..++.|++.||+|||++ ||+||||||+|||++.++.+||+|||+|+.
T Consensus 97 Ey~~gg~L~~~~~~--------~~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~ 165 (293)
T d1yhwa1 97 EYLAGGSLTDVVTE--------TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQ 165 (293)
T ss_dssp ECCTTCBHHHHHHH--------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EECCCCCHHHHHHC--------CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHEEECCCCCEEECCCHHHEE
T ss_conf 70379808988641--------5999999999999999999999987---972267768886887899686425156413
Q ss_pred CCCCCCCCCCCCCEEECCCCEECCCCCCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHCCCHHH
Q ss_conf 21235888754310001000005310024798986455303599999860999999766410247999999781140125
Q 000859 1105 LVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSAR 1184 (1251)
Q Consensus 1105 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1184 (1251)
+... ........||+.|+|||++.+..++.++||||+||++|||++|+.||.+....+. .. ...
T Consensus 166 ~~~~----~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~--~~---~~~------- 229 (293)
T d1yhwa1 166 ITPE----QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA--LY---LIA------- 229 (293)
T ss_dssp CCST----TCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH--HH---HHH-------
T ss_pred ECCC----CCCCCCCCCCCCCCCHHHHCCCCCCCHHCEEHHHHHHHHHHHCCCCCCCCCHHHH--HH---HHH-------
T ss_conf 2136----6644444447773682664479988012031372999998048899899799999--99---998-------
Q ss_pred HHHHCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 5420024799999227999999999987453599999999999999
Q 000859 1185 EELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDL 1230 (1251)
Q Consensus 1185 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 1230 (1251)
....+..+.+...++++.+++.+||+.||.+|||++|+++.
T Consensus 230 -----~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 230 -----TNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (293)
T ss_dssp -----HHCSCCCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred -----HCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf -----57999888855379999999999866996689099999649
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=361.50 Aligned_cols=253 Identities=22% Similarity=0.293 Sum_probs=206.2
Q ss_pred HCCCCCCCEECCCCCCEEEEEEE-CCCCEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCCCEECEEEECCCCCEEEE
Q ss_conf 12999685322358803999996-59958999981157714556999999999871047774313021540599811699
Q 000859 945 TNNLSDEFIIGSGGSGTVYKAEL-ANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLI 1023 (1251)
Q Consensus 945 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv 1023 (1251)
.+.|...+.||+|+||+||+|.. .+++.||+|++.........+.+.+|+.+++.++||||+++++++.+ +...++|
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~~~lv 85 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYES--GGHLYLI 85 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEEC--SSEEEEE
T ss_pred CCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEE--CCEEEEE
T ss_conf 66669988994065839999999999989999998157731289999999999986799899919899998--9988898
Q ss_pred EEECCCCCHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEEC---CCCCEEECCCC
Q ss_conf 950589995776302887732478999999999999999997986306999915249999995546---89875874445
Q 000859 1024 YEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLD---SNMEAHLGDFG 1100 (1251)
Q Consensus 1024 ~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nili~---~~~~~ki~DfG 1100 (1251)
|||+++|+|.+++.. ...+++..+..++.|++.|++|||++ +|+||||||+||++. .++.+||+|||
T Consensus 86 mE~~~gg~L~~~l~~-------~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG 155 (307)
T d1a06a_ 86 MQLVSGGELFDRIVE-------KGFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFG 155 (307)
T ss_dssp ECCCCSCBHHHHHHT-------CSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC-
T ss_pred EECCCCCCHHHHHHC-------CCCCCHHHHHHHHHHHHHHHHHHHHC---EEEEEEECCCCEEECCCCCCCEEEEECCC
T ss_conf 852689848886530-------36788789999999999998752413---05568704630011046888249983154
Q ss_pred CCCCCCCCCCCCCCCCCEEECCCCEECCCCCCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHCC
Q ss_conf 64222123588875431000100000531002479898645530359999986099999976641024799999978114
Q 000859 1101 LAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMS 1180 (1251)
Q Consensus 1101 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 1180 (1251)
+|+..... .......||+.|+|||++.+..++.++||||+||++|||++|+.||.+....+. .
T Consensus 156 ~a~~~~~~-----~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~--~---------- 218 (307)
T d1a06a_ 156 LSKMEDPG-----SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKL--F---------- 218 (307)
T ss_dssp ----------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--H----------
T ss_pred EEEECCCC-----CEEEEEEECCCCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHH--H----------
T ss_conf 35872589-----704400328422591887379998078734515999999859799999899999--9----------
Q ss_pred CHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 01255420024799999227999999999987453599999999999999
Q 000859 1181 GSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDL 1230 (1251)
Q Consensus 1181 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 1230 (1251)
..+.........+.....++++.+++.+||+.||++|||++|+++.
T Consensus 219 ----~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 219 ----EQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp ----HHHHTTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred ----HHHHCCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf ----9986168777876666789999999999760897579189998629
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=361.51 Aligned_cols=246 Identities=26% Similarity=0.380 Sum_probs=203.0
Q ss_pred CCCCCCCEECCCCCCEEEEEEE-CCCCEEEEEEECCCC--CHHHHHHHHHHHHHHHHCCCCCCCCEECEEEECCCCCEEE
Q ss_conf 2999685322358803999996-599589999811577--1455699999999987104777431302154059981169
Q 000859 946 NNLSDEFIIGSGGSGTVYKAEL-ANGATVAVKKISCKD--DHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLL 1022 (1251)
Q Consensus 946 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~l 1022 (1251)
++|++.+.||+|+||+||+|.. .+++.||+|++.... .....+.+.+|+.+++.++||||+++++++.+ +...++
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~--~~~~~i 83 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHD--ATRVYL 83 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SSEEEE
T ss_pred HHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEE--CCEEEE
T ss_conf 376998898517785899999989994999999816885676899999999999985688888859999998--999899
Q ss_pred EEEECCCCCHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEECCCCCC
Q ss_conf 99505899957763028877324789999999999999999979863069999152499999955468987587444564
Q 000859 1023 IYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLA 1102 (1251)
Q Consensus 1023 v~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nili~~~~~~ki~DfG~a 1102 (1251)
||||+++|+|.+++.+ ...+++..+..++.||+.|++|||++ +|+||||||+||+++.++.+||+|||+|
T Consensus 84 vmEy~~~g~L~~~l~~-------~~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a 153 (263)
T d2j4za1 84 ILEYAPLGTVYRELQK-------LSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS 153 (263)
T ss_dssp EEECCTTCBHHHHHHH-------HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSC
T ss_pred EEEECCCCCHHHHHHH-------CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEEEECCCCCEECCCCCEEECCCCEE
T ss_conf 9850479858988750-------48999999999999999999999988---9465220234414668998711555633
Q ss_pred CCCCCCCCCCCCCCCEEECCCCEECCCCCCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHCCCH
Q ss_conf 22212358887543100010000053100247989864553035999998609999997664102479999997811401
Q 000859 1103 KALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGS 1182 (1251)
Q Consensus 1103 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 1182 (1251)
...... ......||+.|+|||++.+..++.++||||+||++|||++|+.||.+....+. .....
T Consensus 154 ~~~~~~------~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~-----~~~i~----- 217 (263)
T d2j4za1 154 VHAPSS------RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET-----YKRIS----- 217 (263)
T ss_dssp SCCCCC------CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH-----HHHHH-----
T ss_pred EECCCC------CCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHH-----HHHHH-----
T ss_conf 544888------52355788763499997589989314404675999998329999888999999-----99997-----
Q ss_pred HHHHHHCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 25542002479999922799999999998745359999999999999
Q 000859 1183 AREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCD 1229 (1251)
Q Consensus 1183 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1229 (1251)
. ...+.+...++++.+++.+||+.||++|||++|+++
T Consensus 218 ------~----~~~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 218 ------R----VEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp ------T----TCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ------C----CCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf ------1----899998668999999999976479768909999971
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=357.32 Aligned_cols=255 Identities=25% Similarity=0.413 Sum_probs=211.1
Q ss_pred HCCCCCCCEECCCCCCEEEEEEECCCCEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCCCEECEEEECCCCCEEEEE
Q ss_conf 12999685322358803999996599589999811577145569999999998710477743130215405998116999
Q 000859 945 TNNLSDEFIIGSGGSGTVYKAELANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIY 1024 (1251)
Q Consensus 945 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv~ 1024 (1251)
.++|+..+.||+|+||+||+|+++++..||||+++.... ..++|.+|+.++++++||||++++|+|.+. ...++||
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~--~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~--~~~~iv~ 78 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM--SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ--RPIFIIT 78 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS--CHHHHHHHHHHHHTCCCTTBCCEEEEECCS--SSEEEEE
T ss_pred HHHCEEEEEEECCCCEEEEEEEECCCCEEEEEEECCCCC--CHHHHHHHHHHHHHCCCCCEEEEEEEEEEC--CCEEEEE
T ss_conf 699799689820788399999988998999999874757--789999999999966898601588998507--8169999
Q ss_pred EECCCCCHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEECCCCCCCC
Q ss_conf 50589995776302887732478999999999999999997986306999915249999995546898758744456422
Q 000859 1025 EYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKA 1104 (1251)
Q Consensus 1025 e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nili~~~~~~ki~DfG~a~~ 1104 (1251)
||+++|++.+++... ...+++..+.+++.|+++||+|||+. +|+||||||+||++++++.+||+|||+|+.
T Consensus 79 Ey~~~g~l~~~~~~~------~~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~ 149 (258)
T d1k2pa_ 79 EYMANGCLLNYLREM------RHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRY 149 (258)
T ss_dssp ECCTTEEHHHHHHSG------GGCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCB
T ss_pred ECCCCCCHHHHHHCC------CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCEEEEECCCCCEEECCCHHHEE
T ss_conf 704899388864102------46776899999999999999987546---843466541358876998479886144202
Q ss_pred CCCCCCCCCCCCCEEECCCCEECCCCCCCCCCCCCCCEEEHHHHHHHHHH-CCCCCCCCCCCCHHHHHHHHHHHHCCCHH
Q ss_conf 21235888754310001000005310024798986455303599999860-99999976641024799999978114012
Q 000859 1105 LVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMVRWVEMHMEMSGSA 1183 (1251)
Q Consensus 1105 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diws~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1183 (1251)
...... .......||..|+|||.+.+..++.++||||||+++|||+| |+.||......+. .. .
T Consensus 150 ~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~--~~---~-------- 213 (258)
T d1k2pa_ 150 VLDDEY---TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSET--AE---H-------- 213 (258)
T ss_dssp CSSSSC---CCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHH--HH---H--------
T ss_pred CCCCCC---EEECCCCCCCCCCCCHHHCCCCCCCCEEECCCCHHHHHHHHCCCCCCCCCCHHHH--HH---H--------
T ss_conf 357872---2524657887757807863799885210336432467397559999889999999--99---9--------
Q ss_pred HHHHHCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHH
Q ss_conf 554200247999992279999999999874535999999999999999721
Q 000859 1184 REELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNV 1234 (1251)
Q Consensus 1184 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 1234 (1251)
+. ... ..+.+..+++++.+++.+||+.||++|||++++++.|.++
T Consensus 214 ---i~-~~~--~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 214 ---IA-QGL--RLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp ---HH-TTC--CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred ---HH-HCC--CCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHCC
T ss_conf ---98-079--7899654659999999997668976893999999874188
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=364.87 Aligned_cols=258 Identities=24% Similarity=0.370 Sum_probs=207.8
Q ss_pred CCCCCCCEECCCCCCEEEEEEE-CCCCEEEEEEECCCC-CHHHHHHHHHHHHHHHHCCCCCCCCEECEEEECCCCCEEEE
Q ss_conf 2999685322358803999996-599589999811577-14556999999999871047774313021540599811699
Q 000859 946 NNLSDEFIIGSGGSGTVYKAEL-ANGATVAVKKISCKD-DHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLI 1023 (1251)
Q Consensus 946 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv 1023 (1251)
++|++.+.||+|+||+||+|.. .+++.||+|.+.... .+...+.+.+|+.++++++||||+++++++.+......++|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEE
T ss_conf 33799679830889199999999999799999987465797999999999999997789998248999991789989999
Q ss_pred EEECCCCCHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCC--CCEEECCCCCCCEEECCCCCEEECCCCC
Q ss_conf 95058999577630288773247899999999999999999798630699--9915249999995546898758744456
Q 000859 1024 YEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCV--PKILHRDIKSSNILLDSNMEAHLGDFGL 1101 (1251)
Q Consensus 1024 ~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~--~~ivH~Dlk~~Nili~~~~~~ki~DfG~ 1101 (1251)
|||+++|+|.+++.+.. .....+++..++.++.|++.||+|||+++. .+|+||||||+|||++.++.+||+|||+
T Consensus 84 mEy~~~g~L~~~i~~~~---~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~ 160 (269)
T d2java1 84 MEYCEGGDLASVITKGT---KERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL 160 (269)
T ss_dssp EECCTTEEHHHHHHHHH---HHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHH
T ss_pred EECCCCCCHHHHHHHCC---CCCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCHHHCCCCCCCCEEEEECCC
T ss_conf 95689993899998515---457899999999999999999999997167788788586765425747888579800100
Q ss_pred CCCCCCCCCCCCCCCCEEECCCCEECCCCCCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHCCC
Q ss_conf 42221235888754310001000005310024798986455303599999860999999766410247999999781140
Q 000859 1102 AKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSG 1181 (1251)
Q Consensus 1102 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 1181 (1251)
|+.+.... .......||+.|+|||++.+..++.++||||+||++|||+||+.||.+....+. . ..
T Consensus 161 a~~~~~~~----~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~--~---~~------ 225 (269)
T d2java1 161 ARILNHDT----SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKEL--A---GK------ 225 (269)
T ss_dssp HHHC---------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--H---HH------
T ss_pred EEECCCCC----CCCCCCCCCCCCCCHHHHCCCCCCHHHHHHHHCHHHHHHHHCCCCCCCCCHHHH--H---HH------
T ss_conf 03224577----755667788232799998399999389887527899998018899899899999--9---99------
Q ss_pred HHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 125542002479999922799999999998745359999999999999
Q 000859 1182 SAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCD 1229 (1251)
Q Consensus 1182 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1229 (1251)
+..... + +.+...++++.+++.+||+.||.+|||++|+++
T Consensus 226 -----i~~~~~-~--~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 226 -----IREGKF-R--RIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp -----HHHTCC-C--CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -----HHCCCC-C--CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf -----971899-8--897435999999999976799557918999972
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=354.99 Aligned_cols=262 Identities=24% Similarity=0.406 Sum_probs=212.1
Q ss_pred CCEECCCCCCEEEEEEECCC----CEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCCCEECEEEECCCCCEEEEEEE
Q ss_conf 85322358803999996599----58999981157714556999999999871047774313021540599811699950
Q 000859 951 EFIIGSGGSGTVYKAELANG----ATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIYEY 1026 (1251)
Q Consensus 951 ~~~lg~G~~g~V~~~~~~~~----~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv~e~ 1026 (1251)
.++||+|+||+||+|.+..+ ..||||++.........+.|.+|++++++++||||++++|++... +...++||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~-~~~~~lv~E~ 110 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS-EGSPLVVLPY 110 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEET-TTEEEEEEEC
T ss_pred CEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEEC-CCCEEEEEEE
T ss_conf 669813688099999997799879999999988436978999999999999867899986786789806-9943899987
Q ss_pred CCCCCHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEECCCCCCCCCC
Q ss_conf 58999577630288773247899999999999999999798630699991524999999554689875874445642221
Q 000859 1027 MENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALV 1106 (1251)
Q Consensus 1027 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nili~~~~~~ki~DfG~a~~~~ 1106 (1251)
+++|+|.+++... ....++..+.+++.|++.||.|+|+. +|+||||||+||++++++.+||+|||+++...
T Consensus 111 ~~~g~l~~~~~~~------~~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~ 181 (311)
T d1r0pa_ 111 MKHGDLRNFIRNE------THNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMY 181 (311)
T ss_dssp CTTCBHHHHHHCT------TCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTT
T ss_pred EECCCHHHHHCCC------CCCCHHHHHHHHHHHHHHHHHHHCCC---CCCCCCCCHHHEEECCCCCEEEECCCCHHHCC
T ss_conf 4067414421013------45404899999999988765200336---76257766875767799988991065232255
Q ss_pred CCCCCCCCCCCEEECCCCEECCCCCCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHCCCHHHHH
Q ss_conf 23588875431000100000531002479898645530359999986099999976641024799999978114012554
Q 000859 1107 EDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSAREE 1186 (1251)
Q Consensus 1107 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1186 (1251)
..............||..|+|||......++.++||||||+++|||+||+.||....... +...++
T Consensus 182 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~-~~~~~i------------- 247 (311)
T d1r0pa_ 182 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF-DITVYL------------- 247 (311)
T ss_dssp TTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-------CHHHH-------------
T ss_pred CCCCCCCEECCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCHH-HHHHHH-------------
T ss_conf 665553100256555645567688743799974574661999999997899998889999-999999-------------
Q ss_pred HHCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHCCCCCC
Q ss_conf 200247999992279999999999874535999999999999999721099733
Q 000859 1187 LLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNVFNNRIV 1240 (1251)
Q Consensus 1187 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~~ 1240 (1251)
.. ..++ +.+..+++++.+++.+||+.||++||+++||++.|+.+....+.
T Consensus 248 -~~-g~~~--~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~~ 297 (311)
T d1r0pa_ 248 -LQ-GRRL--LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 297 (311)
T ss_dssp -HT-TCCC--CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCS
T ss_pred -HC-CCCC--CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHHHHH
T ss_conf -80-8988--99644759999999997688976893999999999999975201
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=0 Score=356.80 Aligned_cols=253 Identities=20% Similarity=0.276 Sum_probs=205.1
Q ss_pred HCCCCCCCEECCCCCCEEEEEEE-CCCCEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCCCEECEEEECCCCCEEEE
Q ss_conf 12999685322358803999996-59958999981157714556999999999871047774313021540599811699
Q 000859 945 TNNLSDEFIIGSGGSGTVYKAEL-ANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLI 1023 (1251)
Q Consensus 945 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv 1023 (1251)
-++|.+.+.||+|+||.||+|.. .+|+.||||++.... ....+.+.+|+.++++++||||+++++++.+ ....++|
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~--~~~~~iv 101 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH-ESDKETVRKEIQTMSVLRHPTLVNLHDAFED--DNEMVMI 101 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS-HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEE--TTEEEEE
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCC-HHHHHHHHHHHHHHHHCCCCCCCCEEEEEEE--CCEEEEE
T ss_conf 657589889840768199999988999899999984524-3169999999999986799799929999998--9999999
Q ss_pred EEECCCCCHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECC--CCCEEECCCCC
Q ss_conf 9505899957763028877324789999999999999999979863069999152499999955468--98758744456
Q 000859 1024 YEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDS--NMEAHLGDFGL 1101 (1251)
Q Consensus 1024 ~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nili~~--~~~~ki~DfG~ 1101 (1251)
|||+++|+|.+++.+. ...+++..+..++.||+.||+|||++ +|+||||||+|||++. ++.+||+|||+
T Consensus 102 mE~~~gg~L~~~l~~~------~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~ 172 (350)
T d1koaa2 102 YEFMSGGELFEKVADE------HNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGL 172 (350)
T ss_dssp ECCCCSCBHHHHHTCT------TSCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTT
T ss_pred EECCCCCCHHHHHHHH------CCCCCHHHHHHHHHHHHHHHHHHHHC---CCEEEEECHHHEEECCCCCCEEEEEECCH
T ss_conf 9857998899999762------37899999999999999999999756---97600015467364168898699954521
Q ss_pred CCCCCCCCCCCCCCCCEEECCCCEECCCCCCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHCCC
Q ss_conf 42221235888754310001000005310024798986455303599999860999999766410247999999781140
Q 000859 1102 AKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSG 1181 (1251)
Q Consensus 1102 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 1181 (1251)
|+.+.. ........||+.|+|||++.+..++.++||||+||++|||++|+.||.+....+. .....
T Consensus 173 a~~~~~-----~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~-----~~~i~---- 238 (350)
T d1koaa2 173 TAHLDP-----KQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET-----LRNVK---- 238 (350)
T ss_dssp CEECCT-----TSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-----HHHHH----
T ss_pred HEECCC-----CCCCCEECCCCCCCCHHHHCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHHHH-----HHHHH----
T ss_conf 044256-----5432000686242188997589987267655465999999859899899799999-----99998----
Q ss_pred HHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 1255420024799999227999999999987453599999999999999
Q 000859 1182 SAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDL 1230 (1251)
Q Consensus 1182 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 1230 (1251)
..............++++.+++.+||+.||++|||++|+++.
T Consensus 239 -------~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 239 -------SCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp -------HTCCCSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred -------HCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf -------478898942235899999999999756896679089998629
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=359.40 Aligned_cols=253 Identities=26% Similarity=0.373 Sum_probs=204.6
Q ss_pred CEECCCCCCEEEEEEECC---CCEEEEEEECCCC-CHHHHHHHHHHHHHHHHCCCCCCCCEECEEEECCCCCEEEEEEEC
Q ss_conf 532235880399999659---9589999811577-145569999999998710477743130215405998116999505
Q 000859 952 FIIGSGGSGTVYKAELAN---GATVAVKKISCKD-DHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIYEYM 1027 (1251)
Q Consensus 952 ~~lg~G~~g~V~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv~e~~ 1027 (1251)
+.||+|+||+||+|.++. ++.||||++.... .....+.+.+|+.++++++||||++++|+|.. ...++||||+
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~---~~~~lvmE~~ 89 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA---ESWMLVMEMA 89 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES---SSEEEEEECC
T ss_pred CCCCCCCCEEEEEEEECCCCCCEEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEECC---CCEEEEEECC
T ss_conf 7834587829999998169738599999988010898999999999999986799898527777505---9779999747
Q ss_pred CCCCHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEECCCCCCCCCCC
Q ss_conf 89995776302887732478999999999999999997986306999915249999995546898758744456422212
Q 000859 1028 ENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKALVE 1107 (1251)
Q Consensus 1028 ~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nili~~~~~~ki~DfG~a~~~~~ 1107 (1251)
++|+|.+++++ ...+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+|++|||+|+.+..
T Consensus 90 ~~g~L~~~l~~-------~~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~ 159 (277)
T d1xbba_ 90 ELGPLNKYLQQ-------NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRA 159 (277)
T ss_dssp TTEEHHHHHHH-------CTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCT
T ss_pred CCCCHHHHHHH-------CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCHHHCCCCCCCCCCCCHHHHHHCCC
T ss_conf 88968999752-------25789999999999999997668747---955677761131023567512341345331343
Q ss_pred CCCCCCCCCCEEECCCCEECCCCCCCCCCCCCCCEEEHHHHHHHHHH-CCCCCCCCCCCCHHHHHHHHHHHHCCCHHHHH
Q ss_conf 35888754310001000005310024798986455303599999860-99999976641024799999978114012554
Q 000859 1108 DYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMVRWVEMHMEMSGSAREE 1186 (1251)
Q Consensus 1108 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diws~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1186 (1251)
.... ........||+.|+|||.+.+..++.++||||||+++|||+| |+.||.+....+. ...+
T Consensus 160 ~~~~-~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~--~~~i------------- 223 (277)
T d1xbba_ 160 DENY-YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV--TAML------------- 223 (277)
T ss_dssp TCSE-EEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH--HHHH-------------
T ss_pred CCCC-CCCCCCCCCCCEECCCHHHCCCCCCCHHHHCCCHHHHHHHHHCCCCCCCCCCHHHH--HHHH-------------
T ss_conf 2344-32244567784203916653799984344303403132896589999999899999--9999-------------
Q ss_pred HHCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHCCC
Q ss_conf 200247999992279999999999874535999999999999999721099
Q 000859 1187 LLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNVFNN 1237 (1251)
Q Consensus 1187 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~ 1237 (1251)
.... ..+.+..+++++.+++.+||+.||++|||+++|.+.|+..+.+
T Consensus 224 --~~~~--~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 270 (277)
T d1xbba_ 224 --EKGE--RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 270 (277)
T ss_dssp --HTTC--CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred --HCCC--CCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHCHHHH
T ss_conf --8289--9999865679999999997588976890989999985288750
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=0 Score=354.77 Aligned_cols=252 Identities=19% Similarity=0.244 Sum_probs=204.7
Q ss_pred CCCCCCCEECCCCCCEEEEEEE-CCCCEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCCCEECEEEECCCCCEEEEE
Q ss_conf 2999685322358803999996-599589999811577145569999999998710477743130215405998116999
Q 000859 946 NNLSDEFIIGSGGSGTVYKAEL-ANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIY 1024 (1251)
Q Consensus 946 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv~ 1024 (1251)
++|++.+.||+|+||.||+|.. .+++.||+|++.... ....+.+.+|+.++++++||||+++++++.+ +...++||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~--~~~~~ivm 105 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY-PLDKYTVKNEISIMNQLHHPKLINLHDAFED--KYEMVLIL 105 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-HHHHHHHHHHHHHHTTCCSTTBCCEEEEEEC--SSEEEEEE
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCC-HHHHHHHHHHHHHHHHCCCCCCCCEEEEEEE--CCEEEEEE
T ss_conf 03599899931778299999998999799999988726-4679999999999986799798919999998--99999999
Q ss_pred EECCCCCHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEEC--CCCCEEECCCCCC
Q ss_conf 50589995776302887732478999999999999999997986306999915249999995546--8987587444564
Q 000859 1025 EYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLD--SNMEAHLGDFGLA 1102 (1251)
Q Consensus 1025 e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nili~--~~~~~ki~DfG~a 1102 (1251)
||+++|+|.+++... ...+++.+++.++.||+.|++|||++ ||+||||||+|||++ .++.+||+|||+|
T Consensus 106 E~~~gg~L~~~~~~~------~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla 176 (352)
T d1koba_ 106 EFLSGGELFDRIAAE------DYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLA 176 (352)
T ss_dssp ECCCCCBHHHHTTCT------TCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTC
T ss_pred ECCCCCHHHHHHHHC------CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCCCCCCCCCCCCCCCEEEEEECCCC
T ss_conf 828998088889863------89989999999999999999999977---926513144553113467884899525630
Q ss_pred CCCCCCCCCCCCCCCEEECCCCEECCCCCCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHCCCH
Q ss_conf 22212358887543100010000053100247989864553035999998609999997664102479999997811401
Q 000859 1103 KALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGS 1182 (1251)
Q Consensus 1103 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 1182 (1251)
+.+... .......|++.|+|||++.+..++.++||||+||++|||++|+.||.+....+. ....
T Consensus 177 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~-----~~~i------ 240 (352)
T d1koba_ 177 TKLNPD-----EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLET-----LQNV------ 240 (352)
T ss_dssp EECCTT-----SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH-----HHHH------
T ss_pred EECCCC-----CCEEECCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHHH-----HHHH------
T ss_conf 343788-----720100476453489997479989763338989999999968899899799999-----9999------
Q ss_pred HHHHHHCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 255420024799999227999999999987453599999999999999
Q 000859 1183 AREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDL 1230 (1251)
Q Consensus 1183 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 1230 (1251)
...............++++.+++.+||+.||.+|||++|+++.
T Consensus 241 -----~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 241 -----KRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp -----HHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred -----HHCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf -----8478898930024799999999999756996689189999609
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=358.45 Aligned_cols=252 Identities=22% Similarity=0.320 Sum_probs=204.3
Q ss_pred CCCCCCCEECCCCCCEEEEEEE-CCCCEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCCCEECEEEECCCCCEEEEE
Q ss_conf 2999685322358803999996-599589999811577145569999999998710477743130215405998116999
Q 000859 946 NNLSDEFIIGSGGSGTVYKAEL-ANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIY 1024 (1251)
Q Consensus 946 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv~ 1024 (1251)
+.|++.+.||+|+||+||+|.. .++..||+|++.... ....+.+.+|++++++++||||+++++++.+ +...++||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~--~~~~~lvm 88 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS-EEELEDYMVEIDILASCDHPNIVKLLDAFYY--ENNLWILI 88 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS-SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEEEE
T ss_pred CCEEEEEEEEECCCCEEEEEEECCCCEEEEEEEECCCC-HHHHHHHHHHHHHHHHCCCCCCCEEEEEEEE--CCEEEEEE
T ss_conf 37598479930778199999999999399999987289-9999999999999986799998849889800--99589999
Q ss_pred EECCCCCHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEECCCCCCCC
Q ss_conf 50589995776302887732478999999999999999997986306999915249999995546898758744456422
Q 000859 1025 EYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKA 1104 (1251)
Q Consensus 1025 e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nili~~~~~~ki~DfG~a~~ 1104 (1251)
||+++|+|.+++.+. ...+++..+..++.|++.|++|||++ +|+||||||+|||++.++.+||+|||+|+.
T Consensus 89 Ey~~~g~L~~~~~~~------~~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~ 159 (288)
T d2jfla1 89 EFCAGGAVDAVMLEL------ERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAK 159 (288)
T ss_dssp ECCTTEEHHHHHHHH------TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred ECCCCCCHHHHHHHC------CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEEECCHHHEEECCCCCEEEEECHHHHC
T ss_conf 627998188999862------89999999999999999999999988---988714070031487899989971612303
Q ss_pred CCCCCCCCCCCCCEEECCCCEECCCCCC-----CCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHC
Q ss_conf 2123588875431000100000531002-----47989864553035999998609999997664102479999997811
Q 000859 1105 LVEDYNSNTESNTWFAGSYGYIAPEYAY-----SLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEM 1179 (1251)
Q Consensus 1105 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Diws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 1179 (1251)
..... .......||+.|+|||++. ...|+.++||||+||++|||++|+.||.+....+.-. .
T Consensus 160 ~~~~~----~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~-~-------- 226 (288)
T d2jfla1 160 NTRTI----QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLL-K-------- 226 (288)
T ss_dssp CHHHH----HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHH-H--------
T ss_pred CCCCC----CCCCCCCCCCCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHH-H--------
T ss_conf 57786----4100102562647999983202578888806657878999999820889999989999999-9--------
Q ss_pred CCHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 401255420024799999227999999999987453599999999999999
Q 000859 1180 SGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDL 1230 (1251)
Q Consensus 1180 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 1230 (1251)
+.. ...+..+.+...++++.+++.+||+.||.+|||++|+++.
T Consensus 227 -------i~~-~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 227 -------IAK-SEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp -------HHH-SCCCCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred -------HHC-CCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf -------970-7998777656699999999999766996689199999629
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=360.53 Aligned_cols=262 Identities=25% Similarity=0.395 Sum_probs=211.7
Q ss_pred HHCCCCCCCEECCCCCCEEEEEEECCCCEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCCCEECEEEECCCCCEEEE
Q ss_conf 61299968532235880399999659958999981157714556999999999871047774313021540599811699
Q 000859 944 ATNNLSDEFIIGSGGSGTVYKAELANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLI 1023 (1251)
Q Consensus 944 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv 1023 (1251)
..++|++.+.||+|+||+||+|.++++..||||++.... ...+.|.+|+.++++++|||||+++|++.+ ...++|
T Consensus 15 ~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~---~~~~lv 89 (285)
T d1fmka3 15 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT--MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE---EPIYIV 89 (285)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS---SSCEEE
T ss_pred CHHHEEEEEEEEECCCEEEEEEEECCCCEEEEEEECCCC--CCHHHHHHHHHHHHHCCCCCEEEEEEEEEC---CCEEEE
T ss_conf 779979846993079809999999999999999988044--888999999999986666788689999823---975999
Q ss_pred EEECCCCCHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEECCCCCCC
Q ss_conf 95058999577630288773247899999999999999999798630699991524999999554689875874445642
Q 000859 1024 YEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAK 1103 (1251)
Q Consensus 1024 ~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nili~~~~~~ki~DfG~a~ 1103 (1251)
|||+++|++..++.... ...+++..++.++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+|+
T Consensus 90 ~Ey~~~g~l~~~~~~~~-----~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~ 161 (285)
T d1fmka3 90 TEYMSKGSLLDFLKGET-----GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLAR 161 (285)
T ss_dssp ECCCTTCBHHHHHSHHH-----HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC
T ss_pred EEECCCCCHHHHHHHCC-----CCCCHHHHHHHHHHHHHHHHHHHHHH---HEECCCCCCEEEEECCCCCEEECCCCHHH
T ss_conf 99447994354200003-----55305999999999999999987541---14335312307999899929984425554
Q ss_pred CCCCCCCCCCCCCCEEECCCCEECCCCCCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHCCCHH
Q ss_conf 22123588875431000100000531002479898645530359999986099999976641024799999978114012
Q 000859 1104 ALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSA 1183 (1251)
Q Consensus 1104 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1183 (1251)
....... .......|++.|+|||++....++.++||||||+++|||++|+.|+........ ....+
T Consensus 162 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~-~~~~i---------- 227 (285)
T d1fmka3 162 LIEDNEY---TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-VLDQV---------- 227 (285)
T ss_dssp -----------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-HHHHH----------
T ss_pred HCCCCCC---EEECCCCCCCCCCCHHHHHCCCCCCHHHHHCCHHHHHHHHHCCCCCCCCCCHHH-HHHHH----------
T ss_conf 2568873---352454556654580898379989177413235899999868999998888999-99999----------
Q ss_pred HHHHHCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHCCCCC
Q ss_conf 55420024799999227999999999987453599999999999999972109973
Q 000859 1184 REELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNVFNNRI 1239 (1251)
Q Consensus 1184 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~ 1239 (1251)
.... ..+.+..++.++.+++.+||+.||++||++++|++.|++++.+..
T Consensus 228 -----~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~ 276 (285)
T d1fmka3 228 -----ERGY--RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 276 (285)
T ss_dssp -----HTTC--CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred -----HHCC--CCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHCCCC
T ss_conf -----8268--999983237999999999756697589199999998766623899
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=356.01 Aligned_cols=270 Identities=25% Similarity=0.387 Sum_probs=215.0
Q ss_pred HHHHHCCCCCCCEECCCCCCEEEEEEEC------CCCEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCCCEECEEEE
Q ss_conf 9996129996853223588039999965------9958999981157714556999999999871047774313021540
Q 000859 941 IMGATNNLSDEFIIGSGGSGTVYKAELA------NGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCN 1014 (1251)
Q Consensus 941 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~ 1014 (1251)
++...++|+..+.||+|+||+||+|+++ +++.||||++.........+.|.+|+.++++++||||+++++++..
T Consensus 8 ~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~ 87 (301)
T d1lufa_ 8 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV 87 (301)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred CCCCHHHCEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECHHCCHHHHHHHHHHHHHHHHCCCCCCCCCEEEECC
T ss_conf 13898893886798207883999999888765778829999998821085799999999999996689976552466605
Q ss_pred CCCCCEEEEEEECCCCCHHHHHHCCCC-----------------CCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEE
Q ss_conf 599811699950589995776302887-----------------732478999999999999999997986306999915
Q 000859 1015 KGAGSNLLIYEYMENGSVWDWLHKQPV-----------------NIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKIL 1077 (1251)
Q Consensus 1015 ~~~~~~~lv~e~~~~gsL~~~l~~~~~-----------------~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iv 1077 (1251)
. ...++++||+++|+|.+++..... .......+++..+..++.|++.||+|||+. +++
T Consensus 88 ~--~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~iv 162 (301)
T d1lufa_ 88 G--KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFV 162 (301)
T ss_dssp S--SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCC
T ss_pred C--CCEEEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCC---CEE
T ss_conf 9--80389998158992999998527554210000111001210346788989999999999999985541357---868
Q ss_pred ECCCCCCCEEECCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCEECCCCCCCCCCCCCCCEEEHHHHHHHHHHCC-
Q ss_conf 2499999955468987587444564222123588875431000100000531002479898645530359999986099-
Q 000859 1078 HRDIKSSNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGK- 1156 (1251)
Q Consensus 1078 H~Dlk~~Nili~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diws~Gvil~elltg~- 1156 (1251)
||||||+||+++.++.+||+|||+|+....... ........|+..|+|||.+.+..++.++||||||+++|||++|.
T Consensus 163 HrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~ 240 (301)
T d1lufa_ 163 HRDLATRNCLVGENMVVKIADFGLSRNIYSADY--YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 240 (301)
T ss_dssp CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGC--BC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTC
T ss_pred EEEECCCCEEECCCCCEEECCCHHHEECCCCCC--CCCCCCCCCCCCCCCHHHHCCCCCCHHHHHCCCHHHHHHHHCCCC
T ss_conf 548840116898999289833144211367764--111577776767679899726889805630252362999980689
Q ss_pred CCCCCCCCCCHHHHHHHHHHHHCCCHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHCC
Q ss_conf 99997664102479999997811401255420024799999227999999999987453599999999999999972109
Q 000859 1157 MPTDATFGVEMDMVRWVEMHMEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNVFN 1236 (1251)
Q Consensus 1157 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~ 1236 (1251)
.||......+. ... +.... ..+.+..+++++.+++.+||+.||++||||.||++.|+++.+
T Consensus 241 ~p~~~~~~~e~--~~~--------------v~~~~---~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~~ 301 (301)
T d1lufa_ 241 QPYYGMAHEEV--IYY--------------VRDGN---ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 301 (301)
T ss_dssp CTTTTSCHHHH--HHH--------------HHTTC---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred CCCCCCCHHHH--HHH--------------HHCCC---CCCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHCC
T ss_conf 99999899999--999--------------97399---788873252999999999748896579399999999998429
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=354.83 Aligned_cols=258 Identities=24% Similarity=0.396 Sum_probs=210.2
Q ss_pred CCCCCCCEECCCCCCEEEEEEEC-CCC----EEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCCCEECEEEECCCCCE
Q ss_conf 29996853223588039999965-995----8999981157714556999999999871047774313021540599811
Q 000859 946 NNLSDEFIIGSGGSGTVYKAELA-NGA----TVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSN 1020 (1251)
Q Consensus 946 ~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~ 1020 (1251)
.+|+..+.||+|+||+||+|.+. +++ .||+|++.........+.+.+|+.++++++|||||+++|+|.+. ..
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~---~~ 85 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS---TV 85 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS---SE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECC---CE
T ss_conf 999783198208992999999958998898999999965134979999999999999867998881589999619---83
Q ss_pred EEEEEECCCCCHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEECCCC
Q ss_conf 69995058999577630288773247899999999999999999798630699991524999999554689875874445
Q 000859 1021 LLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFG 1100 (1251)
Q Consensus 1021 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nili~~~~~~ki~DfG 1100 (1251)
++++|++.+|+|.+++... ...+++..++.++.||+.||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 86 ~~v~e~~~~~~l~~~~~~~------~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFG 156 (317)
T d1xkka_ 86 QLITQLMPFGCLLDYVREH------KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFG 156 (317)
T ss_dssp EEEEECCTTCBHHHHHHHT------SSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCS
T ss_pred EEEEEECCCCCCCCCCCCC------CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCHHHCCEECCCCCEEEECCC
T ss_conf 6999842687401011133------45799999999999999999999876---95047621203116799875860255
Q ss_pred CCCCCCCCCCCCCCCCCEEECCCCEECCCCCCCCCCCCCCCEEEHHHHHHHHHH-CCCCCCCCCCCCHHHHHHHHHHHHC
Q ss_conf 642221235888754310001000005310024798986455303599999860-9999997664102479999997811
Q 000859 1101 LAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMVRWVEMHMEM 1179 (1251)
Q Consensus 1101 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diws~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 1179 (1251)
+|+....... ........||..|+|||++.+..++.++||||||+++|||+| |+.||.+....+. ...+
T Consensus 157 la~~~~~~~~--~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~--~~~i------ 226 (317)
T d1xkka_ 157 LAKLLGAEEK--EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI--SSIL------ 226 (317)
T ss_dssp HHHHTTTTCC----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGH--HHHH------
T ss_pred CCEECCCCCC--CCCCCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHH--HHHH------
T ss_conf 2223354445--32236510586446708874699983565440799999999779999999998999--9999------
Q ss_pred CCHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHCC
Q ss_conf 401255420024799999227999999999987453599999999999999972109
Q 000859 1180 SGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNVFN 1236 (1251)
Q Consensus 1180 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~ 1236 (1251)
.... ..+.+..+++++.+++.+||+.||.+|||++++++.++.+..
T Consensus 227 ---------~~~~--~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 227 ---------EKGE--RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272 (317)
T ss_dssp ---------HHTC--CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---------HCCC--CCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf ---------7599--899985568999999998478993469199999999999875
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=357.89 Aligned_cols=251 Identities=23% Similarity=0.319 Sum_probs=203.9
Q ss_pred CCCCCCCEECCCCCCEEEEEEE-CCCCEEEEEEECCCC--CHHHHHHHHHHHHHHHHCCCCCCCCEECEEEECCCCCEEE
Q ss_conf 2999685322358803999996-599589999811577--1455699999999987104777431302154059981169
Q 000859 946 NNLSDEFIIGSGGSGTVYKAEL-ANGATVAVKKISCKD--DHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLL 1022 (1251)
Q Consensus 946 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~l 1022 (1251)
++|++.+.||+|+||+||+|.. .+++.||||++.... .....+.+.+|++++++++||||+++++++.+ ....++
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~--~~~~~i 85 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQD--DEKLYF 85 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEEC--SSEEEE
T ss_pred CCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEE--CCEEEE
T ss_conf 877898898508790999999989997999999865775577789999999999987688886179999998--998899
Q ss_pred EEEECCCCCHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEECCCCCC
Q ss_conf 99505899957763028877324789999999999999999979863069999152499999955468987587444564
Q 000859 1023 IYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLA 1102 (1251)
Q Consensus 1023 v~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nili~~~~~~ki~DfG~a 1102 (1251)
||||+++|+|.+++.. .+.+++..++.++.|++.|++|||+. +|+||||||+||++++++.+||+|||+|
T Consensus 86 vmEy~~gg~L~~~~~~-------~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a 155 (288)
T d1uu3a_ 86 GLSYAKNGELLKYIRK-------IGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTA 155 (288)
T ss_dssp EECCCTTEEHHHHHHH-------HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred EEECCCCCCHHHHHHC-------CCCCCHHHHHHHHHHHHHHHHHHCCC---CEECCCCCCCCCCCCCCCEEEECCCCCC
T ss_conf 9970489877776531-------59999999999999999999762165---0884767741236688853886032102
Q ss_pred CCCCCCCCCCCCCCCEEECCCCEECCCCCCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHCCCH
Q ss_conf 22212358887543100010000053100247989864553035999998609999997664102479999997811401
Q 000859 1103 KALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGS 1182 (1251)
Q Consensus 1103 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 1182 (1251)
+.+.... .........||+.|+|||++.+..++.++||||+||++|||++|+.||.+....+. ...
T Consensus 156 ~~~~~~~--~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~-----~~~------- 221 (288)
T d1uu3a_ 156 KVLSPES--KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLI-----FQK------- 221 (288)
T ss_dssp EECC------------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-----HHH-------
T ss_pred EECCCCC--CCCCCCCCCCCCCCCCCEEECCCCCCCCCCEEHHHHHHHHHHHCCCCCCCCCHHHH-----HHH-------
T ss_conf 4225677--64333555677552584400268989666230456999998038899899599999-----999-------
Q ss_pred HHHHHHCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 255420024799999227999999999987453599999999999999
Q 000859 1183 AREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDL 1230 (1251)
Q Consensus 1183 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 1230 (1251)
+.. .....+...++++.+++.+||+.||.+|||++|+++.
T Consensus 222 ----i~~----~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~ 261 (288)
T d1uu3a_ 222 ----IIK----LEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY 261 (288)
T ss_dssp ----HHT----TCCCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred ----HHC----CCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHCCC
T ss_conf ----971----8999985479999999999855797689197897377
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=351.65 Aligned_cols=273 Identities=25% Similarity=0.363 Sum_probs=213.5
Q ss_pred HHHHHHCCCCCCCEECCCCCCEEEEEEEC------CCCEEEEEEECCCCCHHHHHHHHHHHHHHHHC-CCCCCCCEECEE
Q ss_conf 99996129996853223588039999965------99589999811577145569999999998710-477743130215
Q 000859 940 DIMGATNNLSDEFIIGSGGSGTVYKAELA------NGATVAVKKISCKDDHLLNKSFTREVKTLGRI-RHRHLVKLMGHC 1012 (1251)
Q Consensus 940 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~ 1012 (1251)
.++...++|...+.||+|+||.||+|.+. +++.||||++.........+.+.+|..++.++ +|+||+.+++++
T Consensus 7 ~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~ 86 (299)
T d1ywna1 7 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC 86 (299)
T ss_dssp HHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CCCCCHHHEEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCEEEEEEEEE
T ss_conf 52616799798449841678399999986777555783999999860017178999999999988614998499741154
Q ss_pred EECCCCCEEEEEEECCCCCHHHHHHCCCCCC---------CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCC
Q ss_conf 4059981169995058999577630288773---------2478999999999999999997986306999915249999
Q 000859 1013 CNKGAGSNLLIYEYMENGSVWDWLHKQPVNI---------KMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKS 1083 (1251)
Q Consensus 1013 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~---------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~ 1083 (1251)
... ....++||||+++|+|.++++...... .....+++..+..++.|++.||+|||++ +|+||||||
T Consensus 87 ~~~-~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp 162 (299)
T d1ywna1 87 TKP-GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAA 162 (299)
T ss_dssp CST-TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCG
T ss_pred CCC-CCEEEEEEEECCCCCHHHHHHHCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCC
T ss_conf 047-9757999984589929999985366666532220233214689999999999999999988737---971786773
Q ss_pred CCEEECCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCEECCCCCCCCCCCCCCCEEEHHHHHHHHHHC-CCCCCCC
Q ss_conf 995546898758744456422212358887543100010000053100247989864553035999998609-9999976
Q 000859 1084 SNILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSG-KMPTDAT 1162 (1251)
Q Consensus 1084 ~Nili~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diws~Gvil~elltg-~~p~~~~ 1162 (1251)
+||+++.++.+||+|||+|+....... ........||+.|+|||++.+..++.++|||||||++|||+|| ..||...
T Consensus 163 ~NILl~~~~~~Kl~DFGla~~~~~~~~--~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~ 240 (299)
T d1ywna1 163 RNILLSEKNVVKICDFGLARDIYKDPD--YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 240 (299)
T ss_dssp GGEEECGGGCEEECC------CCSCTT--SCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred CCEEECCCCCEEECCCCCHHHCCCCCC--CCCCCCEEECCCCCCHHHHHCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCC
T ss_conf 106577998289845752001135665--222475166721020368646889966322136789999986889999899
Q ss_pred CCCCHHHHHHHHHHHHCCCHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHCC
Q ss_conf 64102479999997811401255420024799999227999999999987453599999999999999972109
Q 000859 1163 FGVEMDMVRWVEMHMEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNVFN 1236 (1251)
Q Consensus 1163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~ 1236 (1251)
...+. ....+ ....++ +.+..+++++.+++.+||+.||++|||++|+++.|+++++
T Consensus 241 ~~~~~-~~~~~---------------~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq 296 (299)
T d1ywna1 241 KIDEE-FCRRL---------------KEGTRM--RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296 (299)
T ss_dssp CCSHH-HHHHH---------------HHTCCC--CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CHHHH-HHHHH---------------HCCCCC--CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf 98999-99999---------------638988--8886578999999999767796679199999999979986
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=353.44 Aligned_cols=245 Identities=28% Similarity=0.385 Sum_probs=198.2
Q ss_pred CCCCCCEECCCCCCEEEEEEE-CCCCEEEEEEECCCC--CHHHHHHHHHHHHHHHHCCCCCCCCEECEEEECCCCCEEEE
Q ss_conf 999685322358803999996-599589999811577--14556999999999871047774313021540599811699
Q 000859 947 NLSDEFIIGSGGSGTVYKAEL-ANGATVAVKKISCKD--DHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLI 1023 (1251)
Q Consensus 947 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv 1023 (1251)
.|+..+.||+|+||+||+|.. .+++.||||++.... .....+.+.+|+.++++++|||||++++++.+ +...++|
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~--~~~~~iv 93 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR--EHTAWLV 93 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE--TTEEEEE
T ss_pred HCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEE--CCEEEEE
T ss_conf 56762797018880999999989993999999844443588999999999999997789998238999998--9988999
Q ss_pred EEECCCCCHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEECCCCCCC
Q ss_conf 95058999577630288773247899999999999999999798630699991524999999554689875874445642
Q 000859 1024 YEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAK 1103 (1251)
Q Consensus 1024 ~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nili~~~~~~ki~DfG~a~ 1103 (1251)
|||+++|++..+... ...+++..++.++.|++.||+|||++ ||+||||||+|||++.++.+||+|||+|.
T Consensus 94 ~E~~~~g~l~~~~~~-------~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~ 163 (309)
T d1u5ra_ 94 MEYCLGSASDLLEVH-------KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSAS 163 (309)
T ss_dssp EECCSEEHHHHHHHH-------TSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCB
T ss_pred EEECCCCCHHHHHHH-------CCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCCCEEEECCCCCEEEEECCCCC
T ss_conf 980699945789973-------79999999999999999999999868---97666788421798799978984436533
Q ss_pred CCCCCCCCCCCCCCEEECCCCEECCCCCCC---CCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHCC
Q ss_conf 221235888754310001000005310024---79898645530359999986099999976641024799999978114
Q 000859 1104 ALVEDYNSNTESNTWFAGSYGYIAPEYAYS---LKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMS 1180 (1251)
Q Consensus 1104 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Diws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 1180 (1251)
..... ....||+.|+|||++.+ ..|+.++||||+||++|||++|+.||.+....+. ...
T Consensus 164 ~~~~~--------~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~-----~~~----- 225 (309)
T d1u5ra_ 164 IMAPA--------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-----LYH----- 225 (309)
T ss_dssp SSSSB--------CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-----HHH-----
T ss_pred CCCCC--------CCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHH-----HHH-----
T ss_conf 46778--------731347663688998346788867214545589999999878899999799999-----999-----
Q ss_pred CHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 0125542002479999922799999999998745359999999999999
Q 000859 1181 GSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCD 1229 (1251)
Q Consensus 1181 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1229 (1251)
...... +.. .....++++.+++.+||+.||.+|||++|+++
T Consensus 226 ------i~~~~~-~~~-~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 226 ------IAQNES-PAL-QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp ------HHHSCC-CCC-SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ------HHHCCC-CCC-CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf ------982899-988-87888999999999977379657918999971
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=349.94 Aligned_cols=247 Identities=23% Similarity=0.362 Sum_probs=196.0
Q ss_pred CCCCEECCCCCCEEEEEEE-CCCCEEEEEEECCCC-CHHHHHHHHHHHHHHHHCCCCCCCCEECEEEEC--CCCCEEEEE
Q ss_conf 9685322358803999996-599589999811577-145569999999998710477743130215405--998116999
Q 000859 949 SDEFIIGSGGSGTVYKAEL-ANGATVAVKKISCKD-DHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNK--GAGSNLLIY 1024 (1251)
Q Consensus 949 ~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~~~lv~ 1024 (1251)
+..+.||+|+||+||+|.. .++..||+|++.... .....+.+.+|++++++++||||+++++++... +....++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EEEEEEECCCCCEEEEEEECCCCEEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCEEEEEE
T ss_conf 85169700828499999999999599999985122798999999999999985799985069999840334588899999
Q ss_pred EECCCCCHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCC--EEECCCCCCCEEEC-CCCCEEECCCCC
Q ss_conf 505899957763028877324789999999999999999979863069999--15249999995546-898758744456
Q 000859 1025 EYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPK--ILHRDIKSSNILLD-SNMEAHLGDFGL 1101 (1251)
Q Consensus 1025 e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~Dlk~~Nili~-~~~~~ki~DfG~ 1101 (1251)
||+++|+|.+++.+ ...+++..++.++.|++.|++|||++ + |+||||||+||+++ .++.+||+|||+
T Consensus 92 E~~~~g~L~~~l~~-------~~~~~~~~~~~~~~qi~~gl~yLH~~---~~~IiHrDiKp~NILl~~~~~~~Kl~DFGl 161 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKR-------FKVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGL 161 (270)
T ss_dssp ECCCSCBHHHHHHH-------HSSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTG
T ss_pred ECCCCCCHHHHHHC-------CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCEEECCCCHHHCEEECCCCCEEEEECCC
T ss_conf 57898948999751-------35546999999999999999999978---997996876743511667999889800576
Q ss_pred CCCCCCCCCCCCCCCCEEECCCCEECCCCCCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHCCC
Q ss_conf 42221235888754310001000005310024798986455303599999860999999766410247999999781140
Q 000859 1102 AKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSG 1181 (1251)
Q Consensus 1102 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 1181 (1251)
|+.... .......||+.|+|||++.+ .++.++||||+||++|||++|+.||.+....+.-.. ..
T Consensus 162 a~~~~~------~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~----~i----- 225 (270)
T d1t4ha_ 162 ATLKRA------SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYR----RV----- 225 (270)
T ss_dssp GGGCCT------TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHH----HH-----
T ss_pred CEECCC------CCCCCCCCCCCCCCHHHHCC-CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCHHHHHH----HH-----
T ss_conf 542368------76677553813008988478-999867110079999999878899987655999999----99-----
Q ss_pred HHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 125542002479999922799999999998745359999999999999
Q 000859 1182 SAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCD 1229 (1251)
Q Consensus 1182 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1229 (1251)
.. ...+ .......++++.+++.+||+.||++|||++|+++
T Consensus 226 ------~~-~~~~-~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 226 ------TS-GVKP-ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp ------TT-TCCC-GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ------HC-CCCC-CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf ------73-8998-6567557899999999976379758929999967
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=350.06 Aligned_cols=250 Identities=22% Similarity=0.304 Sum_probs=204.4
Q ss_pred HCCCCCCCEECCCCCCEEEEEEE-CCCCEEEEEEECCCC--CHHHHHHHHHHHHHHHHCCCCCCCCEECEEEECCCCCEE
Q ss_conf 12999685322358803999996-599589999811577--145569999999998710477743130215405998116
Q 000859 945 TNNLSDEFIIGSGGSGTVYKAEL-ANGATVAVKKISCKD--DHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNL 1021 (1251)
Q Consensus 945 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~ 1021 (1251)
.++|.+.+.||+|+||.||+|.. .+++.||+|++.... .....+.+.+|+.+++.++||||+++++++.+ ....+
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~--~~~~~ 81 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT--HDRLC 81 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC--SSEEE
T ss_pred HHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECC--CCCCC
T ss_conf 4742898898317684999999989998999999815654497999999999999986799988778764035--64211
Q ss_pred EEEEECCCCCHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEECCCCC
Q ss_conf 99950589995776302887732478999999999999999997986306999915249999995546898758744456
Q 000859 1022 LIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGL 1101 (1251)
Q Consensus 1022 lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nili~~~~~~ki~DfG~ 1101 (1251)
+||||+++|+|.+++.+ .+.+++..++.++.|++.|++|+|++ +|+||||||+||+++.++.+||+|||+
T Consensus 82 iv~ey~~gg~L~~~~~~-------~~~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~ 151 (337)
T d1o6la_ 82 FVMEYANGGELFFHLSR-------ERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGL 151 (337)
T ss_dssp EEEECCTTCBHHHHHHH-------HSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTT
T ss_pred CCEECCCCCCHHHHHHC-------CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHEEECCCCCEEEEECCC
T ss_conf 10003579860555532-------56775999999999996521134315---962246477784765899888820565
Q ss_pred CCCCCCCCCCCCCCCCEEECCCCEECCCCCCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHCCC
Q ss_conf 42221235888754310001000005310024798986455303599999860999999766410247999999781140
Q 000859 1102 AKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSG 1181 (1251)
Q Consensus 1102 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 1181 (1251)
|+..... .......+||+.|+|||++.+..|+.++||||+||++|||++|+.||.+....+. .+..
T Consensus 152 a~~~~~~----~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~-----~~~i----- 217 (337)
T d1o6la_ 152 CKEGISD----GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL-----FELI----- 217 (337)
T ss_dssp CBCSCCT----TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-----HHHH-----
T ss_pred CCCCCCC----CCCCCCCEECHHHHHHHHCCCCCCCHHHCCCCHHHHHHHHHHCCCCCCCCCHHHH-----HHHH-----
T ss_conf 2003567----8620551008899666650489888333102230678899878999999699999-----9998-----
Q ss_pred HHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCC-----HHHHHHH
Q ss_conf 125542002479999922799999999998745359999999-----9999999
Q 000859 1182 SAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPS-----SRQVCDL 1230 (1251)
Q Consensus 1182 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~eil~~ 1230 (1251)
.. .....+...++++.+++.+||++||.+|++ ++|+++.
T Consensus 218 ------~~----~~~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 218 ------LM----EEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp ------HH----CCCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred ------HC----CCCCCCCCCCHHHHHHHHHHCCCCCHHHCCCCCCCHHHHHCC
T ss_conf ------52----899898668999999998666389344225652349999729
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=349.20 Aligned_cols=252 Identities=23% Similarity=0.260 Sum_probs=202.7
Q ss_pred CCCCCCCEECCCCCCEEEEEEE-CCCCEEEEEEECCCCC-----HHHHHHHHHHHHHHHHCCCCCCCCEECEEEECCCCC
Q ss_conf 2999685322358803999996-5995899998115771-----455699999999987104777431302154059981
Q 000859 946 NNLSDEFIIGSGGSGTVYKAEL-ANGATVAVKKISCKDD-----HLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGS 1019 (1251)
Q Consensus 946 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 1019 (1251)
++|...+.||+|+||+||+|.. .+++.||||++..... ....+.+.+|+.++++++||||+++++++.+ ...
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~--~~~ 87 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN--KTD 87 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSE
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEE--CCE
T ss_conf 677982798117895999999999998999999875663213406899999999999986799899938899997--998
Q ss_pred EEEEEEECCCCCHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCC----CEE
Q ss_conf 1699950589995776302887732478999999999999999997986306999915249999995546898----758
Q 000859 1020 NLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNM----EAH 1095 (1251)
Q Consensus 1020 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nili~~~~----~~k 1095 (1251)
.++||||+++|+|.+++.. .+.+++..++.++.|++.|++|||+. +|+||||||+||+++.++ .+|
T Consensus 88 ~~iv~E~~~gg~L~~~i~~-------~~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vk 157 (293)
T d1jksa_ 88 VILILELVAGGELFDFLAE-------KESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIK 157 (293)
T ss_dssp EEEEEECCCSCBHHHHHHH-------HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEE
T ss_pred EEEEEECCCCCCCCCHHCC-------CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCCCCCEEEEECCCCCCCCEE
T ss_conf 9999986778643100103-------56421557899999999998766625---4221133301279825898666469
Q ss_pred ECCCCCCCCCCCCCCCCCCCCCEEECCCCEECCCCCCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHH
Q ss_conf 74445642221235888754310001000005310024798986455303599999860999999766410247999999
Q 000859 1096 LGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEM 1175 (1251)
Q Consensus 1096 i~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~ 1175 (1251)
++|||+|...... .......|++.|+|||++.+..++.++||||+||++|||++|+.||.+....+. ...
T Consensus 158 l~DfG~a~~~~~~-----~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~-----~~~ 227 (293)
T d1jksa_ 158 IIDFGLAHKIDFG-----NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET-----LAN 227 (293)
T ss_dssp ECCCTTCEECTTS-----CBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-----HHH
T ss_pred ECCHHHHHHCCCC-----CCCCCCCCCCCCCCHHHHCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHHH-----HHH
T ss_conf 6433442105777-----631224777743099998189999766522140999999708899889999999-----999
Q ss_pred HHHCCCHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 7811401255420024799999227999999999987453599999999999999
Q 000859 1176 HMEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDL 1230 (1251)
Q Consensus 1176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 1230 (1251)
... .......+.....+.++.+++.+||+.||++|||++|+++.
T Consensus 228 i~~-----------~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 228 VSA-----------VNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp HHT-----------TCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHH-----------CCCCCCCHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 981-----------68888701047889999999999863896689199999619
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=354.91 Aligned_cols=260 Identities=23% Similarity=0.350 Sum_probs=212.7
Q ss_pred HHCCCCCCCEECCCCCCEEEEEEECC----CCEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCCCEECEEEECCCCC
Q ss_conf 61299968532235880399999659----95899998115771455699999999987104777431302154059981
Q 000859 944 ATNNLSDEFIIGSGGSGTVYKAELAN----GATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGS 1019 (1251)
Q Consensus 944 ~~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 1019 (1251)
..++|...+.||+|+||.||+|.+.. +..||||.+.........+.+.+|+.++++++||||++++|++.+ ..
T Consensus 5 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~---~~ 81 (273)
T d1mp8a_ 5 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE---NP 81 (273)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS---SS
T ss_pred CHHHEEEEEEEEECCCCEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEC---CE
T ss_conf 889969877993078829999999369964499999993656687999999999999986899998569889953---74
Q ss_pred EEEEEEECCCCCHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEECCC
Q ss_conf 16999505899957763028877324789999999999999999979863069999152499999955468987587444
Q 000859 1020 NLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDF 1099 (1251)
Q Consensus 1020 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nili~~~~~~ki~Df 1099 (1251)
.++||||+++|++.+++... ...+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+||
T Consensus 82 ~~iv~E~~~~g~l~~~~~~~------~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~Df 152 (273)
T d1mp8a_ 82 VWIIMELCTLGELRSFLQVR------KYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDF 152 (273)
T ss_dssp CEEEEECCTTEEHHHHHHHT------TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-
T ss_pred EEEEEEECCCCCHHHHHHCC------CCCCCHHHHHHHHHHHHHHHHHHCCC---CEECCCCCHHHEEECCCCCEEECCC
T ss_conf 79999840698077654224------78999999999999998775230226---7441410265532067896787650
Q ss_pred CCCCCCCCCCCCCCCCCCEEECCCCEECCCCCCCCCCCCCCCEEEHHHHHHHHHH-CCCCCCCCCCCCHHHHHHHHHHHH
Q ss_conf 5642221235888754310001000005310024798986455303599999860-999999766410247999999781
Q 000859 1100 GLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMVRWVEMHME 1178 (1251)
Q Consensus 1100 G~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diws~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 1178 (1251)
|+|+....... .......||+.|+|||++.+..++.++||||||+++|||++ |..||......+. ...
T Consensus 153 G~a~~~~~~~~---~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~--~~~------ 221 (273)
T d1mp8a_ 153 GLSRYMEDSTY---YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV--IGR------ 221 (273)
T ss_dssp ---------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH--HHH------
T ss_pred HHHEECCCCCC---EECCCEECCCCCCHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHH--HHH------
T ss_conf 34213367762---3305400583103266751699887452444247899998269999888999999--999------
Q ss_pred CCCHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHCCC
Q ss_conf 14012554200247999992279999999999874535999999999999999721099
Q 000859 1179 MSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNVFNN 1237 (1251)
Q Consensus 1179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~ 1237 (1251)
+... ...+.+..+++++.+++.+||+.||++|||++||++.|+++.++
T Consensus 222 --------i~~~---~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 269 (273)
T d1mp8a_ 222 --------IENG---ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269 (273)
T ss_dssp --------HHTT---CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --------HHCC---CCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHH
T ss_conf --------9818---99989877799999999997687976892999999999999778
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=352.52 Aligned_cols=282 Identities=22% Similarity=0.324 Sum_probs=207.2
Q ss_pred CCCCCCCEECCCCCCEEEEEEECCCCEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCCCEECEEEECCCC--CEEEE
Q ss_conf 2999685322358803999996599589999811577145569999999998710477743130215405998--11699
Q 000859 946 NNLSDEFIIGSGGSGTVYKAELANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAG--SNLLI 1023 (1251)
Q Consensus 946 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~--~~~lv 1023 (1251)
.+|...+.||+|+||.||+|++. +..||||++..... .......|+..+..++||||++++|++...... ..++|
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~-g~~vAvK~~~~~~~--~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv 79 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREE--RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEEECGGGH--HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred CEEEEEEEEEECCCEEEEEEEEC-CEEEEEEEECCCCH--HHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCEEEEEE
T ss_conf 68999889820788199999999-98999999872004--6799999999996279986832688998379860489999
Q ss_pred EEECCCCCHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC-----CCCCEEECCCCCCCEEECCCCCEEECC
Q ss_conf 950589995776302887732478999999999999999997986306-----999915249999995546898758744
Q 000859 1024 YEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHD-----CVPKILHRDIKSSNILLDSNMEAHLGD 1098 (1251)
Q Consensus 1024 ~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-----~~~~ivH~Dlk~~Nili~~~~~~ki~D 1098 (1251)
|||+++|+|.+++++. .++|..+++++.|++.||+|+|+. +.++|+||||||+|||++.++.+||+|
T Consensus 80 ~Ey~~~g~L~~~l~~~--------~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~D 151 (303)
T d1vjya_ 80 SDYHEHGSLFDYLNRY--------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 151 (303)
T ss_dssp EECCTTCBHHHHHHHC--------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECC
T ss_pred EECCCCCCHHHHHHCC--------CCCHHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCCEEECCCCCEEEEE
T ss_conf 9646698989998658--------99989999999999999999887665204689866153173135786887768876
Q ss_pred CCCCCCCCCCCCCCCCCCCEEECCCCEECCCCCCCCC------CCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCHHHHHH
Q ss_conf 4564222123588875431000100000531002479------8986455303599999860999999766410247999
Q 000859 1099 FGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLK------ATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRW 1172 (1251)
Q Consensus 1099 fG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~~Diws~Gvil~elltg~~p~~~~~~~~~~~~~~ 1172 (1251)
||+++.................||+.|+|||++.+.. ++.++||||||+++|||+||..|+.............
T Consensus 152 FGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~ 231 (303)
T d1vjya_ 152 LGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL 231 (303)
T ss_dssp CTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTT
T ss_pred CCCCCCCCCCCCCEECCCCCEECCCCCCCHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHC
T ss_conf 38662346777620013552503547678221056545467776750122015999999962899887663112410122
Q ss_pred HHHHHHCCCHHHHHHHCCCCCCCCCC---HHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHCCCCC
Q ss_conf 99978114012554200247999992---27999999999987453599999999999999972109973
Q 000859 1173 VEMHMEMSGSAREELLDDQMKPLLPG---EECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNVFNNRI 1239 (1251)
Q Consensus 1173 ~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~ 1239 (1251)
... ................++..+. .......+.+++.+||+.||++|||+.||++.|+++.++.-
T Consensus 232 ~~~-~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~~ 300 (303)
T d1vjya_ 232 VPS-DPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG 300 (303)
T ss_dssp SCS-SCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred CCC-CCHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHHCC
T ss_conf 556-430999999875024688877655776899999999999760698589599999999998888659
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=348.14 Aligned_cols=268 Identities=28% Similarity=0.420 Sum_probs=212.7
Q ss_pred CCCCCCCEECCCCCCEEEEEEEC-CCC--EEEEEEECCCCCHHHHHHHHHHHHHHHHC-CCCCCCCEECEEEECCCCCEE
Q ss_conf 29996853223588039999965-995--89999811577145569999999998710-477743130215405998116
Q 000859 946 NNLSDEFIIGSGGSGTVYKAELA-NGA--TVAVKKISCKDDHLLNKSFTREVKTLGRI-RHRHLVKLMGHCCNKGAGSNL 1021 (1251)
Q Consensus 946 ~~~~~~~~lg~G~~g~V~~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~~~ 1021 (1251)
++|+..+.||+|+||+||+|.++ ++. .||||++.........+.+.+|+++++++ +||||++++|++.+. ...+
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~--~~~~ 87 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR--GYLY 87 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEET--TEEE
T ss_pred HHCEEEEEEEECCCCEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECC--CEEE
T ss_conf 99688779820788289999998999699999999782338579999999999998622899883678888418--7369
Q ss_pred EEEEECCCCCHHHHHHCCCC---------CCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCC
Q ss_conf 99950589995776302887---------732478999999999999999997986306999915249999995546898
Q 000859 1022 LIYEYMENGSVWDWLHKQPV---------NIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNM 1092 (1251)
Q Consensus 1022 lv~e~~~~gsL~~~l~~~~~---------~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nili~~~~ 1092 (1251)
+||||+++|+|.++++.... .......+++..+.+++.||+.|+.|+|+. +|+||||||+||+++.++
T Consensus 88 iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~ 164 (309)
T d1fvra_ 88 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENY 164 (309)
T ss_dssp EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGG
T ss_pred EEEEECCCCCHHHHHHHCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCEEEECCCC
T ss_conf 99980289869999864035555512310123457899999999999999998766308---954555052048986887
Q ss_pred CEEECCCCCCCCCCCCCCCCCCCCCEEECCCCEECCCCCCCCCCCCCCCEEEHHHHHHHHHHCC-CCCCCCCCCCHHHHH
Q ss_conf 7587444564222123588875431000100000531002479898645530359999986099-999976641024799
Q 000859 1093 EAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGK-MPTDATFGVEMDMVR 1171 (1251)
Q Consensus 1093 ~~ki~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diws~Gvil~elltg~-~p~~~~~~~~~~~~~ 1171 (1251)
.+||+|||+|+....... .....||..|+|||.+.+..++.++||||||+++|||++|. .||.+....+.
T Consensus 165 ~~kl~DfG~a~~~~~~~~-----~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~---- 235 (309)
T d1fvra_ 165 VAKIADFGLSRGQEVYVK-----KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL---- 235 (309)
T ss_dssp CEEECCTTCEESSCEECC-----C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH----
T ss_pred CEEECCCCCCCCCCCCCC-----CCCEECCCCCCCHHHHCCCCCCCCCEEEHHHHHHHHHHHCCCCCCCCCCHHHH----
T ss_conf 638743443224442234-----55301377555538752699996221531388999998368999999999999----
Q ss_pred HHHHHHHCCCHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHCCCCCCCC
Q ss_conf 99997811401255420024799999227999999999987453599999999999999972109973344
Q 000859 1172 WVEMHMEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNVFNNRIVDF 1242 (1251)
Q Consensus 1172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~~~~ 1242 (1251)
.. . +....+ .+.+..+++++.+++.+||+.||++|||+++|++.|+++.++.....
T Consensus 236 -~~-----------~-i~~~~~--~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~~~~~ 291 (309)
T d1fvra_ 236 -YE-----------K-LPQGYR--LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYV 291 (309)
T ss_dssp -HH-----------H-GGGTCC--CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSCSB
T ss_pred -HH-----------H-HHHCCC--CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHCCCCCC
T ss_conf -99-----------9-982688--88876678999999999767896689499999999999986186778
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=0 Score=347.44 Aligned_cols=265 Identities=23% Similarity=0.362 Sum_probs=212.2
Q ss_pred HCCCCCCCEECCCCCCEEEEEEE-CCCCEEEEEEECCCC--CHHHHHHHHHHHHHHHHCCCCCCCCEECEEEECCCC--C
Q ss_conf 12999685322358803999996-599589999811577--145569999999998710477743130215405998--1
Q 000859 945 TNNLSDEFIIGSGGSGTVYKAEL-ANGATVAVKKISCKD--DHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAG--S 1019 (1251)
Q Consensus 945 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~--~ 1019 (1251)
.++|.+.+.||+|+||+||+|.. .+++.||+|++.... .....+.+.+|+.+++.++||||+++++++...... .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred CCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCCCCE
T ss_conf 62069868996089929999999999989999998556646989999999999999856999887311435432688766
Q ss_pred EEEEEEECCCCCHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEECCC
Q ss_conf 16999505899957763028877324789999999999999999979863069999152499999955468987587444
Q 000859 1020 NLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDF 1099 (1251)
Q Consensus 1020 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nili~~~~~~ki~Df 1099 (1251)
.++||||+++|+|.+++.. .+.+++.+++.++.|++.|++|||+. +|+||||||+||+++.++..+++||
T Consensus 86 ~~lvmE~~~g~~L~~~~~~-------~~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~ 155 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHT-------EGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDF 155 (277)
T ss_dssp EEEEEECCCEEEHHHHHHH-------HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCC
T ss_pred EEEEEECCCCCEEHHHHCC-------CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCCCCCCCCCCEEEHH
T ss_conf 9999977889871011203-------58999999999999999999999857---9527634675566575432010034
Q ss_pred CCCCCCCCCCCCCCCCCCEEECCCCEECCCCCCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHC
Q ss_conf 56422212358887543100010000053100247989864553035999998609999997664102479999997811
Q 000859 1100 GLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEM 1179 (1251)
Q Consensus 1100 G~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 1179 (1251)
|.+........ .........||+.|+|||++.+..++.++||||+||++|||+||+.||.+....+. ......
T Consensus 156 ~~~~~~~~~~~-~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~-----~~~~~~- 228 (277)
T d1o6ya_ 156 GIARAIADSGN-SVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV-----AYQHVR- 228 (277)
T ss_dssp TTCEECC-----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-----HHHHHH-
T ss_pred HHHHHHCCCCC-CCCCCCCCCCCCCCCCHHHHCCCCCCCCEECCCCHHHHHHHHHCCCCCCCCCHHHH-----HHHHHH-
T ss_conf 44322123544-33334642576243699998399999663202652899999769799899699999-----999984-
Q ss_pred CCHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCC-CHHHHHHHHHHHCC
Q ss_conf 4012554200247999992279999999999874535999999-99999999972109
Q 000859 1180 SGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERP-SSRQVCDLLLNVFN 1236 (1251)
Q Consensus 1180 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~eil~~L~~~~~ 1236 (1251)
....+........++++.+++.+|++.||.+|| |++++++.|.++.+
T Consensus 229 ----------~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~n 276 (277)
T d1o6ya_ 229 ----------EDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 276 (277)
T ss_dssp ----------CCCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHC
T ss_pred ----------CCCCCCCHHCCCCCHHHHHHHHHHCCCCHHHCHHHHHHHHHHHHHHHC
T ss_conf ----------699997100347899999999998667976777399999999999758
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=0 Score=345.11 Aligned_cols=251 Identities=20% Similarity=0.234 Sum_probs=196.6
Q ss_pred HCCCCCCCEECCCCCCEEEEEEE-CCCCEEEEEEECCCCC--HHHHHHHHH---HHHHHHHCCCCCCCCEECEEEECCCC
Q ss_conf 12999685322358803999996-5995899998115771--455699999---99998710477743130215405998
Q 000859 945 TNNLSDEFIIGSGGSGTVYKAEL-ANGATVAVKKISCKDD--HLLNKSFTR---EVKTLGRIRHRHLVKLMGHCCNKGAG 1018 (1251)
Q Consensus 945 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~---E~~~l~~l~h~niv~l~g~~~~~~~~ 1018 (1251)
.++|.+.+.||+|+||.||+|.. .+++.||+|++..... ......+.+ ++.+++.++||||+++++++.. +.
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~--~~ 80 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT--PD 80 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC--SS
T ss_pred HHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEE--CC
T ss_conf 7768510188428890999999999997999999845875426679999999999999850899858899999998--99
Q ss_pred CEEEEEEECCCCCHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEECC
Q ss_conf 11699950589995776302887732478999999999999999997986306999915249999995546898758744
Q 000859 1019 SNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGD 1098 (1251)
Q Consensus 1019 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nili~~~~~~ki~D 1098 (1251)
..++||||+++|+|.+++.+ ...+++..++.++.||+.|++|||++ +|+||||||+|||++.++.+||+|
T Consensus 81 ~~~ivmE~~~gg~L~~~l~~-------~~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~D 150 (364)
T d1omwa3 81 KLSFILDLMNGGDLHYHLSQ-------HGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISD 150 (364)
T ss_dssp EEEEEECCCCSCBHHHHHHH-------HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECC
T ss_pred EEEEEEEECCCCCHHHHHHH-------CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCEEECCCEEEECCCCCEEEEE
T ss_conf 88999991489838999873-------25532789999999999999999977---962204442216785889679822
Q ss_pred CCCCCCCCCCCCCCCCCCCEEECCCCEECCCCCCC-CCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHH
Q ss_conf 45642221235888754310001000005310024-79898645530359999986099999976641024799999978
Q 000859 1099 FGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYS-LKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHM 1177 (1251)
Q Consensus 1099 fG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Diws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~ 1177 (1251)
||+|+.+... ......||+.|+|||++.. ..|+.++||||+||++|||+||+.||.+....+... .
T Consensus 151 FGla~~~~~~------~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~--~----- 217 (364)
T d1omwa3 151 LGLACDFSKK------KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE--I----- 217 (364)
T ss_dssp CTTCEECSSS------CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHH--H-----
T ss_pred ECEEEECCCC------CCCCCCCCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHHHHH--H-----
T ss_conf 0102333788------64331134554216876038999844104677899999985999888899899999--9-----
Q ss_pred HCCCHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCC-----HHHHHHH
Q ss_conf 1140125542002479999922799999999998745359999999-----9999999
Q 000859 1178 EMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPS-----SRQVCDL 1230 (1251)
Q Consensus 1178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~eil~~ 1230 (1251)
...........+...++++.+++.+||+.||.+||+ ++|+++.
T Consensus 218 ----------~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 218 ----------DRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp ----------HHHSSSCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred ----------HHHCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHHCCCCCCCHHHHHCC
T ss_conf ----------986046888788778999999999985669888088743579999749
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=347.41 Aligned_cols=245 Identities=19% Similarity=0.245 Sum_probs=201.7
Q ss_pred CCCCCCCEECCCCCCEEEEEEE-CCCCEEEEEEECCCC--CHHHHHHHHHHHHHHHHCCCCCCCCEECEEEECCCCCEEE
Q ss_conf 2999685322358803999996-599589999811577--1455699999999987104777431302154059981169
Q 000859 946 NNLSDEFIIGSGGSGTVYKAEL-ANGATVAVKKISCKD--DHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLL 1022 (1251)
Q Consensus 946 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~l 1022 (1251)
++|++.+.||+|+||.||+|.. .+++.||||++.... .....+.+.+|+.+++.++||||+++++++.. ....++
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~--~~~~~~ 118 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD--NSNLYM 118 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEEEE
T ss_pred CCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEECCCCCCC--CCCCCC
T ss_conf 370898896117680899999989998999999826774588999999999999997487727403444432--222232
Q ss_pred EEEECCCCCHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEECCCCCC
Q ss_conf 99505899957763028877324789999999999999999979863069999152499999955468987587444564
Q 000859 1023 IYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLA 1102 (1251)
Q Consensus 1023 v~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nili~~~~~~ki~DfG~a 1102 (1251)
|+||+.+|+|.+++.+ .+.+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+|
T Consensus 119 v~e~~~~g~l~~~l~~-------~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a 188 (350)
T d1rdqe_ 119 VMEYVAGGEMFSHLRR-------IGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFA 188 (350)
T ss_dssp EEECCTTCBHHHHHHH-------HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred CCCCCCCCCHHHHHHH-------CCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHCCCCCCCCEEEEECEEE
T ss_conf 2223346622666751-------58989999999999999989999859---9861767999936077897886101033
Q ss_pred CCCCCCCCCCCCCCCEEECCCCEECCCCCCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHCCCH
Q ss_conf 22212358887543100010000053100247989864553035999998609999997664102479999997811401
Q 000859 1103 KALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGS 1182 (1251)
Q Consensus 1103 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 1182 (1251)
+..... .....||+.|+|||++.+..++.++||||+||++|||+||+.||.+..... .....
T Consensus 189 ~~~~~~-------~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~-----~~~~i------ 250 (350)
T d1rdqe_ 189 KRVKGR-------TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ-----IYEKI------ 250 (350)
T ss_dssp EECSSC-------BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----HHHHH------
T ss_pred EECCCC-------CCCCCCCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCHHH-----HHHHH------
T ss_conf 322566-------643367635678899717998853311450078999975889989959999-----99998------
Q ss_pred HHHHHHCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCC-----CHHHHHH
Q ss_conf 2554200247999992279999999999874535999999-----9999999
Q 000859 1183 AREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERP-----SSRQVCD 1229 (1251)
Q Consensus 1183 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~ 1229 (1251)
.. .....+...++++.+++.+||+.||.+|+ +++++++
T Consensus 251 -----~~----~~~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 251 -----VS----GKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp -----HH----CCCCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred -----HC----CCCCCCCCCCHHHHHHHHHHHHHCHHHCCCCCCCCHHHHHC
T ss_conf -----61----79889766899999999998340998606553454999971
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=343.99 Aligned_cols=269 Identities=28% Similarity=0.406 Sum_probs=214.4
Q ss_pred HHCCCCCCCEECCCCCCEEEEEEEC------CCCEEEEEEECCCCCHHHHHHHHHHHHHHHHC-CCCCCCCEECEEEECC
Q ss_conf 6129996853223588039999965------99589999811577145569999999998710-4777431302154059
Q 000859 944 ATNNLSDEFIIGSGGSGTVYKAELA------NGATVAVKKISCKDDHLLNKSFTREVKTLGRI-RHRHLVKLMGHCCNKG 1016 (1251)
Q Consensus 944 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~ 1016 (1251)
..++|...+.||+|+||.||+|.+. ++..||||+++..........+.+|+.+++.+ +||||++++|++.+.
T Consensus 21 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~- 99 (311)
T d1t46a_ 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG- 99 (311)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-
T ss_pred CHHHEEEEEEEEECCCEEEEEEEEECCCCCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEEC-
T ss_conf 7899698549820688299999980664477886999999874248779999999999987626999887899898319-
Q ss_pred CCCEEEEEEECCCCCHHHHHHCCCCC-----------CCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCC
Q ss_conf 98116999505899957763028877-----------3247899999999999999999798630699991524999999
Q 000859 1017 AGSNLLIYEYMENGSVWDWLHKQPVN-----------IKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSN 1085 (1251)
Q Consensus 1017 ~~~~~lv~e~~~~gsL~~~l~~~~~~-----------~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~N 1085 (1251)
...++||||+++|+|.+++++.... ......+++..+.+++.||+.|++|||++ +++||||||+|
T Consensus 100 -~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~N 175 (311)
T d1t46a_ 100 -GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARN 175 (311)
T ss_dssp -SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGG
T ss_pred -CEEEEEEECCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCCCCCC
T ss_conf -97899997379987999998535665444445332223345889999999999999999988757---92666241021
Q ss_pred EEECCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCEECCCCCCCCCCCCCCCEEEHHHHHHHHHH-CCCCCCCCCC
Q ss_conf 554689875874445642221235888754310001000005310024798986455303599999860-9999997664
Q 000859 1086 ILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFG 1164 (1251)
Q Consensus 1086 ili~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diws~Gvil~ellt-g~~p~~~~~~ 1164 (1251)
|+++.++.+|++|||.++...... .........||+.|+|||++.+..++.++||||||+++|||+| |.+||.....
T Consensus 176 Il~~~~~~~ki~DfG~~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~ 253 (311)
T d1t46a_ 176 ILLTHGRITKICDFGLARDIKNDS--NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV 253 (311)
T ss_dssp EEEETTTEEEECCCGGGSCTTSCT--TSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred CCCCCCCCCCCCCCCHHEECCCCC--CCEEEEECCCCHHHCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCH
T ss_conf 000025752102340102336788--615862013596876778861799997400102589999998589988778998
Q ss_pred CCHHHHHHHHHHHHCCCHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHCCC
Q ss_conf 1024799999978114012554200247999992279999999999874535999999999999999721099
Q 000859 1165 VEMDMVRWVEMHMEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNVFNN 1237 (1251)
Q Consensus 1165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~ 1237 (1251)
.+ ..... +....++.. +...+.++.+++.+||+.||.+||||+++++.|++++..
T Consensus 254 ~~-~~~~~---------------i~~~~~~~~--~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~ 308 (311)
T d1t46a_ 254 DS-KFYKM---------------IKEGFRMLS--PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (311)
T ss_dssp SH-HHHHH---------------HHHTCCCCC--CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HH-HHHHH---------------HHCCCCCCC--CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHCC
T ss_conf 99-99999---------------866898898--543659999999997577965792999999999876534
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=0 Score=346.04 Aligned_cols=246 Identities=24% Similarity=0.323 Sum_probs=201.9
Q ss_pred CCCCCCCEECCCCCCEEEEEEE-CCCCEEEEEEECCCC--CHHHHHHHHHHHHHHHHCCCCCCCCEECEEEECCCCCEEE
Q ss_conf 2999685322358803999996-599589999811577--1455699999999987104777431302154059981169
Q 000859 946 NNLSDEFIIGSGGSGTVYKAEL-ANGATVAVKKISCKD--DHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLL 1022 (1251)
Q Consensus 946 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~l 1022 (1251)
++|++.+.||+|+||+||+|+. .+++.||||++.... .....+.+.+|+.+++.++||||+++++++.+ +...++
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~--~~~~~i 81 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQD--AQQIFM 81 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEEC--SSEEEE
T ss_pred HHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCHHHEEEEEEE--CCEEEE
T ss_conf 470888897207680899999989997999999845775488999999999999986369675330356852--880056
Q ss_pred EEEECCCCCHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEECCCCCC
Q ss_conf 99505899957763028877324789999999999999999979863069999152499999955468987587444564
Q 000859 1023 IYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLA 1102 (1251)
Q Consensus 1023 v~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nili~~~~~~ki~DfG~a 1102 (1251)
||||++||++..++.. ...+++..++.++.|++.|++|||++ +|+||||||+|||++.++.+||+|||+|
T Consensus 82 vmE~~~gg~l~~~~~~-------~~~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a 151 (316)
T d1fota_ 82 IMDYIEGGELFSLLRK-------SQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFA 151 (316)
T ss_dssp EECCCCSCBHHHHHHH-------TSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSC
T ss_pred EEEECCCCCCCCCCCC-------CCCCCCCHHHHHHHHHHHHHHHHCCC---CEECCCCCCHHEEECCCCCEEEECCCCC
T ss_conf 7650378632234322-------22111007999999998765541247---6770556810503868998898317521
Q ss_pred CCCCCCCCCCCCCCCEEECCCCEECCCCCCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHCCCH
Q ss_conf 22212358887543100010000053100247989864553035999998609999997664102479999997811401
Q 000859 1103 KALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGS 1182 (1251)
Q Consensus 1103 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 1182 (1251)
+..... .....||+.|+|||++.+..|+.++||||+||++|||++|+.||.+....+. ...
T Consensus 152 ~~~~~~-------~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-----~~~------- 212 (316)
T d1fota_ 152 KYVPDV-------TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT-----YEK------- 212 (316)
T ss_dssp EECSSC-------BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH-----HHH-------
T ss_pred EEECCC-------CCCCCCCCCCCCHHHHCCCCCCCHHHCCCCCHHHHHHHHCCCCCCCCCHHHH-----HHH-------
T ss_conf 671245-------6434576343599998389998043046533368999759899999699999-----999-------
Q ss_pred HHHHHHCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCC-----CHHHHHHH
Q ss_conf 2554200247999992279999999999874535999999-----99999999
Q 000859 1183 AREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERP-----SSRQVCDL 1230 (1251)
Q Consensus 1183 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~~ 1230 (1251)
+... ....+...++++.+++.+|+..||.+|+ +++++++.
T Consensus 213 ----i~~~----~~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 213 ----ILNA----ELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp ----HHHC----CCCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred ----HHCC----CCCCCCCCCHHHHHHHHHHHHHCHHHCCCCCHHHHHHHHCC
T ss_conf ----9708----98899778999999999995449976664310219999819
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=347.92 Aligned_cols=275 Identities=20% Similarity=0.323 Sum_probs=217.7
Q ss_pred HHHHHCCCCCCCEECCCCCCEEEEEEEC------CCCEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCCCEECEEEE
Q ss_conf 9996129996853223588039999965------9958999981157714556999999999871047774313021540
Q 000859 941 IMGATNNLSDEFIIGSGGSGTVYKAELA------NGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCN 1014 (1251)
Q Consensus 941 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~ 1014 (1251)
++...++|...+.||+|+||+||+|.++ +++.||||+++..........|.+|+.++++++||||++++|++..
T Consensus 15 ~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~ 94 (308)
T d1p4oa_ 15 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 94 (308)
T ss_dssp TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS
T ss_pred EEECHHHEEEEEEEEECCCEEEEEEEECCCCCCCCCCEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEC
T ss_conf 04268991883598207881899999878644778968999998701286899999999999997699988412547842
Q ss_pred CCCCCEEEEEEECCCCCHHHHHHCCCCCC---CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCC
Q ss_conf 59981169995058999577630288773---247899999999999999999798630699991524999999554689
Q 000859 1015 KGAGSNLLIYEYMENGSVWDWLHKQPVNI---KMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSN 1091 (1251)
Q Consensus 1015 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~---~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nili~~~ 1091 (1251)
. ...++|+||+++|+|.+++....... .....+++..+.+++.|+++||.|||++ +|+||||||+||+++++
T Consensus 95 ~--~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~ 169 (308)
T d1p4oa_ 95 G--QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAED 169 (308)
T ss_dssp S--SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTT
T ss_pred C--CCEEEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECEECCCCEEECCC
T ss_conf 8--810677760489988999875033211344468879999999999999999987647---96543286775403599
Q ss_pred CCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCEECCCCCCCCCCCCCCCEEEHHHHHHHHHHC-CCCCCCCCCCCHHHH
Q ss_conf 8758744456422212358887543100010000053100247989864553035999998609-999997664102479
Q 000859 1092 MEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSG-KMPTDATFGVEMDMV 1170 (1251)
Q Consensus 1092 ~~~ki~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diws~Gvil~elltg-~~p~~~~~~~~~~~~ 1170 (1251)
+.+||+|||+|+....... ........|++.|+|||.+.+..++.++||||||+++|||+|| +.||.+....+
T Consensus 170 ~~~Kl~DFGla~~~~~~~~--~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~---- 243 (308)
T d1p4oa_ 170 FTVKIGDFGMTRDIYETDY--YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ---- 243 (308)
T ss_dssp CCEEECCTTCCCGGGGGGC--EEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH----
T ss_pred CEEEEEECCCCEECCCCCC--EEECCCEECCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHH----
T ss_conf 6499942454202357763--0313402316323788887369988333444378999999968999999989999----
Q ss_pred HHHHHHHHCCCHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHCCCCCCC
Q ss_conf 99999781140125542002479999922799999999998745359999999999999997210997334
Q 000859 1171 RWVEMHMEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNVFNNRIVD 1241 (1251)
Q Consensus 1171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~~~ 1241 (1251)
+... +.+. ...+.+..+++.+.+++.+||+.+|.+|||+++|++.|++..+.....
T Consensus 244 -~~~~-----------i~~~---~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~~~~ 299 (308)
T d1p4oa_ 244 -VLRF-----------VMEG---GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFRE 299 (308)
T ss_dssp -HHHH-----------HHTT---CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHH
T ss_pred -HHHH-----------HHHC---CCCCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHCCCCCCC
T ss_conf -9999-----------9808---888886335399999999975779658939999999978761778757
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=342.62 Aligned_cols=267 Identities=23% Similarity=0.373 Sum_probs=214.6
Q ss_pred HHCCCCCCCEECCCCCCEEEEEEECC--------CCEEEEEEECCCCCHHHHHHHHHHHHHHHHC-CCCCCCCEECEEEE
Q ss_conf 61299968532235880399999659--------9589999811577145569999999998710-47774313021540
Q 000859 944 ATNNLSDEFIIGSGGSGTVYKAELAN--------GATVAVKKISCKDDHLLNKSFTREVKTLGRI-RHRHLVKLMGHCCN 1014 (1251)
Q Consensus 944 ~~~~~~~~~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~ 1014 (1251)
..++|...+.||+|+||.||+|+... +..||||+++..........+.+|...+.++ +||||++++|+|.+
T Consensus 11 ~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~ 90 (299)
T d1fgka_ 11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 90 (299)
T ss_dssp CGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHHHEEEEEEEEECCCCEEEEEEECCCCCCCCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCC
T ss_conf 58996970098516782899999857875556675499999988112868899999999999981399969734652201
Q ss_pred CCCCCEEEEEEECCCCCHHHHHHCCCCC---------CCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCC
Q ss_conf 5998116999505899957763028877---------3247899999999999999999798630699991524999999
Q 000859 1015 KGAGSNLLIYEYMENGSVWDWLHKQPVN---------IKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSN 1085 (1251)
Q Consensus 1015 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~---------~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~N 1085 (1251)
. ...++||||+++|+|.+++...... ......+++.++++++.|++.||+|||+. +|+||||||+|
T Consensus 91 ~--~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~N 165 (299)
T d1fgka_ 91 D--GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARN 165 (299)
T ss_dssp S--SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGG
T ss_pred C--CEEEEEEECCCCCCHHHHHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEEEECCCC
T ss_conf 8--868999973699909999986067764322233457434679999999999999999876637---97863022102
Q ss_pred EEECCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCEECCCCCCCCCCCCCCCEEEHHHHHHHHHH-CCCCCCCCCC
Q ss_conf 554689875874445642221235888754310001000005310024798986455303599999860-9999997664
Q 000859 1086 ILLDSNMEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFG 1164 (1251)
Q Consensus 1086 ili~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diws~Gvil~ellt-g~~p~~~~~~ 1164 (1251)
|+++.++.+||+|||.++........ .......|++.|+|||.+.+..|+.++||||||+++|||++ |..||.+...
T Consensus 166 iLl~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~ 243 (299)
T d1fgka_ 166 VLVTEDNVMKIADFGLARDIHHIDYY--KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 243 (299)
T ss_dssp EEECTTCCEEECSTTCCCCGGGCCTT--CCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred EEECCCCCEEECCCHHHCCCCCCCCC--CCCCCCCCCHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCH
T ss_conf 24547897676221110113555554--3146678884663266751798882555477588888740179898999999
Q ss_pred CCHHHHHHHHHHHHCCCHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHCC
Q ss_conf 102479999997811401255420024799999227999999999987453599999999999999972109
Q 000859 1165 VEMDMVRWVEMHMEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNVFN 1236 (1251)
Q Consensus 1165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~ 1236 (1251)
.. .... +....++ +.+...++++.+++.+||+.||.+|||+.||++.|+++..
T Consensus 244 ~~--~~~~---------------i~~~~~~--~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 244 EE--LFKL---------------LKEGHRM--DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp HH--HHHH---------------HHTTCCC--CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HH--HHHH---------------HHCCCCC--CCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf 99--9999---------------9728888--9874352999999999766797679399999999988860
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=342.17 Aligned_cols=252 Identities=17% Similarity=0.235 Sum_probs=202.2
Q ss_pred HCCCCCCCEECCCCCCEEEEEEE-CCCCEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCCCEECEEEECCCCCEEEE
Q ss_conf 12999685322358803999996-59958999981157714556999999999871047774313021540599811699
Q 000859 945 TNNLSDEFIIGSGGSGTVYKAEL-ANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLI 1023 (1251)
Q Consensus 945 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv 1023 (1251)
.++|.+.+.||+|+||+||+|.. .+++.||+|++.... .....+.+|+++++.++||||+++++++.+ ....|+|
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~--~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~--~~~~~lv 79 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG--TDQVLVKKEISILNIARHRNILHLHESFES--MEELVMI 79 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT--HHHHHHHHHHHHHHHSCCTTBCCEEEEEEE--TTEEEEE
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCC--CCHHHHHHHHHHHHHCCCCCCCEEEEEEEE--CCEEEEE
T ss_conf 010588789831778399999998999699999975786--659999999999985799798909899988--9988999
Q ss_pred EEECCCCCHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCC--CCEEECCCCC
Q ss_conf 95058999577630288773247899999999999999999798630699991524999999554689--8758744456
Q 000859 1024 YEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSN--MEAHLGDFGL 1101 (1251)
Q Consensus 1024 ~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nili~~~--~~~ki~DfG~ 1101 (1251)
|||+++|+|.+++... ...+++.+++.++.||+.|++|||+. +|+||||||+||+++.+ ..+|++|||.
T Consensus 80 mE~~~gg~L~~~i~~~------~~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~ 150 (321)
T d1tkia_ 80 FEFISGLDIFERINTS------AFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQ 150 (321)
T ss_dssp ECCCCCCBHHHHHTSS------SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTT
T ss_pred EECCCCCCHHHHHHHC------CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCEEECCCCCEEEEECCCCH
T ss_conf 9538998088998753------89999999999999999999999876---99751355444344378851899764411
Q ss_pred CCCCCCCCCCCCCCCCEEECCCCEECCCCCCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHCCC
Q ss_conf 42221235888754310001000005310024798986455303599999860999999766410247999999781140
Q 000859 1102 AKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSG 1181 (1251)
Q Consensus 1102 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 1181 (1251)
++.... ........|++.|+|||...+..++.++||||+||++|+|++|+.||......+. ...
T Consensus 151 ~~~~~~-----~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~-----~~~------ 214 (321)
T d1tkia_ 151 ARQLKP-----GDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQI-----IEN------ 214 (321)
T ss_dssp CEECCT-----TCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-----HHH------
T ss_pred HHCCCC-----CCCCCCCCCCCCCCCCHHCCCCCCCCHHHCCCHHHHHHHHHHCCCCCCCCCHHHH-----HHH------
T ss_conf 100346-----7753212233222340210487778401130279999999828999999899999-----999------
Q ss_pred HHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 1255420024799999227999999999987453599999999999999
Q 000859 1182 SAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDL 1230 (1251)
Q Consensus 1182 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 1230 (1251)
+.........+.....++++.+++.+|+..||.+|||++|+++.
T Consensus 215 -----i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 215 -----IMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp -----HHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred -----HHHCCCCCCHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf -----98389998802236789999999999866996689099999639
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=349.03 Aligned_cols=252 Identities=29% Similarity=0.412 Sum_probs=206.7
Q ss_pred HCCCCCCCEECCCCCCEEEEEEECCCCEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCCCEECEEEECCCCCEEEEE
Q ss_conf 12999685322358803999996599589999811577145569999999998710477743130215405998116999
Q 000859 945 TNNLSDEFIIGSGGSGTVYKAELANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIY 1024 (1251)
Q Consensus 945 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv~ 1024 (1251)
.++|+..+.||+|+||.||+|.++ +..||||+++... ..+.+.+|++++++++||||++++|++.+.. ...++||
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~~---~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~-~~~~lv~ 80 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEK-GGLYIVT 80 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC-----HHHHHTHHHHTTCCCTTBCCEEEEECCC---CCEEEE
T ss_pred HHHEEEEEEEECCCCEEEEEEEEC-CEEEEEEEECCHH---HHHHHHHHHHHHHHCCCCCEEEEEEEEEECC-CCEEEEE
T ss_conf 899488579820798089999999-9099999988577---7999999999998678989854987887238-9289999
Q ss_pred EECCCCCHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEECCCCCCCC
Q ss_conf 50589995776302887732478999999999999999997986306999915249999995546898758744456422
Q 000859 1025 EYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKA 1104 (1251)
Q Consensus 1025 e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nili~~~~~~ki~DfG~a~~ 1104 (1251)
||+++|+|.+++.... ...+++..+++++.|++.||+|||+. +|+||||||+||+++.++.+|++|||.++.
T Consensus 81 ey~~~g~L~~~l~~~~-----~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~ 152 (262)
T d1byga_ 81 EYMAKGSLVDYLRSRG-----RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKE 152 (262)
T ss_dssp CCCTTEEHHHHHHHHH-----HHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC---
T ss_pred ECCCCCCHHHHHHHCC-----CCCCCHHHHHHHHHHHHHHCCCCCCC---CEECCCCCHHHHEECCCCCEEECCCCCCEE
T ss_conf 6369998999987457-----88889999999999998523211337---655366656760146899776324560034
Q ss_pred CCCCCCCCCCCCCEEECCCCEECCCCCCCCCCCCCCCEEEHHHHHHHHHH-CCCCCCCCCCCCHHHHHHHHHHHHCCCHH
Q ss_conf 21235888754310001000005310024798986455303599999860-99999976641024799999978114012
Q 000859 1105 LVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMVRWVEMHMEMSGSA 1183 (1251)
Q Consensus 1105 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diws~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1183 (1251)
.... .....++..|+|||++.+..++.++||||||+++|||+| |+.||......+. ...+
T Consensus 153 ~~~~-------~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~--~~~i---------- 213 (262)
T d1byga_ 153 ASST-------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV--VPRV---------- 213 (262)
T ss_dssp ----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGH--HHHH----------
T ss_pred CCCC-------CCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHH--HHHH----------
T ss_conf 4787-------76556664677817872798885887775799999999789999999999999--9999----------
Q ss_pred HHHHHCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHC
Q ss_conf 5542002479999922799999999998745359999999999999997210
Q 000859 1184 REELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNVF 1235 (1251)
Q Consensus 1184 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~ 1235 (1251)
....++.. +...++++.+++.+||+.||.+||||+++++.|+++.
T Consensus 214 -----~~~~~~~~--~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~ 258 (262)
T d1byga_ 214 -----EKGYKMDA--PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 258 (262)
T ss_dssp -----TTTCCCCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -----HCCCCCCC--CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHH
T ss_conf -----80899999--7657999999999975669768939999999999998
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=346.72 Aligned_cols=258 Identities=26% Similarity=0.407 Sum_probs=206.3
Q ss_pred CCCCCCCEECCCCCCEEEEEEECC--C--CEEEEEEECCCC--CHHHHHHHHHHHHHHHHCCCCCCCCEECEEEECCCCC
Q ss_conf 299968532235880399999659--9--589999811577--1455699999999987104777431302154059981
Q 000859 946 NNLSDEFIIGSGGSGTVYKAELAN--G--ATVAVKKISCKD--DHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGS 1019 (1251)
Q Consensus 946 ~~~~~~~~lg~G~~g~V~~~~~~~--~--~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 1019 (1251)
.+|+..+.||+|+||.||+|.+.. + ..||||++.... .....+.|.+|+.++++++||||++++|++.+. .
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~---~ 84 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP---P 84 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS---S
T ss_pred HHEEEEEEEECCCCEEEEEEEEECCCCCEEEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEEC---C
T ss_conf 8919978980388839999999889990799999999835557989999999999999868999987898777401---0
Q ss_pred EEEEEEECCCCCHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEECCC
Q ss_conf 16999505899957763028877324789999999999999999979863069999152499999955468987587444
Q 000859 1020 NLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDF 1099 (1251)
Q Consensus 1020 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nili~~~~~~ki~Df 1099 (1251)
.++|+||+++|++.+++... ...+++..++.++.|++.||.|||++ +|+||||||+||+++.++.+|++||
T Consensus 85 ~~lv~e~~~~~~l~~~~~~~------~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~Df 155 (273)
T d1u46a_ 85 MKMVTELAPLGSLLDRLRKH------QGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDF 155 (273)
T ss_dssp CEEEEECCTTCBHHHHHHHH------GGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCC
T ss_pred HHEEEEEECCCCHHHHHHCC------CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEEEECHHHHCCCCCCCEEECCC
T ss_conf 01146542386125444212------68999999999999999999875217---8752056688815655654332561
Q ss_pred CCCCCCCCCCCCCCCCCCEEECCCCEECCCCCCCCCCCCCCCEEEHHHHHHHHHH-CCCCCCCCCCCCHHHHHHHHHHHH
Q ss_conf 5642221235888754310001000005310024798986455303599999860-999999766410247999999781
Q 000859 1100 GLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVS-GKMPTDATFGVEMDMVRWVEMHME 1178 (1251)
Q Consensus 1100 G~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diws~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 1178 (1251)
|+++........ ........|+..|+|||++.+..++.++||||||+++|||+| |+.||.+....+. ..+
T Consensus 156 Gl~~~~~~~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~--~~~------ 226 (273)
T d1u46a_ 156 GLMRALPQNDDH-YVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI--LHK------ 226 (273)
T ss_dssp TTCEECCC-CCE-EEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH--HHH------
T ss_pred HHHHHCCCCCCC-CEECCCCCCCCCCCCHHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHH--HHH------
T ss_conf 155530358875-26547632573107999983799994215661489999999689999999699999--999------
Q ss_pred CCCHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHH
Q ss_conf 14012554200247999992279999999999874535999999999999999721
Q 000859 1179 MSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNV 1234 (1251)
Q Consensus 1179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 1234 (1251)
+..... ..+.+..++.++.+++.+||+.||++||||++|.+.|.+.
T Consensus 227 --------i~~~~~--~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 227 --------IDKEGE--RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp --------HHTSCC--CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --------HHHCCC--CCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHC
T ss_conf --------984799--9998544539999999997688966792999999999964
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=340.18 Aligned_cols=254 Identities=23% Similarity=0.311 Sum_probs=198.4
Q ss_pred CCCCCCC-EECCCCCCEEEEEEE-CCCCEEEEEEECCCCCHHHHHHHHHHHHHHHHC-CCCCCCCEECEEEEC--CCCCE
Q ss_conf 2999685-322358803999996-599589999811577145569999999998710-477743130215405--99811
Q 000859 946 NNLSDEF-IIGSGGSGTVYKAEL-ANGATVAVKKISCKDDHLLNKSFTREVKTLGRI-RHRHLVKLMGHCCNK--GAGSN 1020 (1251)
Q Consensus 946 ~~~~~~~-~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~--~~~~~ 1020 (1251)
++|.+.. .||+|+||.||+|.. .+++.||||++... ..+.+|+.++.++ +||||+++++++.+. .....
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred CCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECCC------HHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCCCEE
T ss_conf 48798107965454869999998899989999998974------779999999998669999782989995034689789
Q ss_pred EEEEEECCCCCHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECC---CCCEEEC
Q ss_conf 6999505899957763028877324789999999999999999979863069999152499999955468---9875874
Q 000859 1021 LLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDS---NMEAHLG 1097 (1251)
Q Consensus 1021 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nili~~---~~~~ki~ 1097 (1251)
|+||||++||+|.+++.+.. ...+++..++.++.|++.|++|||+. +|+||||||+||+++. .+.+||+
T Consensus 85 ~ivmEy~~gg~L~~~i~~~~-----~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~ 156 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDRG-----DQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLT 156 (335)
T ss_dssp EEEEECCCSEEHHHHHHSCS-----CCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEEC
T ss_pred EEEEECCCCCCHHHHHHHCC-----CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 99997789984999998627-----87757999999999999999999976---98644410022011355556631135
Q ss_pred CCCCCCCCCCCCCCCCCCCCEEECCCCEECCCCCCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHH
Q ss_conf 44564222123588875431000100000531002479898645530359999986099999976641024799999978
Q 000859 1098 DFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHM 1177 (1251)
Q Consensus 1098 DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~ 1177 (1251)
|||+|+...... ......||+.|+|||++.+..|+.++||||+||++|+|+||+.||.+........ .
T Consensus 157 DFG~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~--~----- 224 (335)
T d2ozaa1 157 DFGFAKETTSHN-----SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP--G----- 224 (335)
T ss_dssp CCTTCEECCCCC-----CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC------------
T ss_pred CCCEEEECCCCC-----CCCCCCCCCCCCCCHHHCCCCCCHHHHHHHHCHHHHHHHHCCCCCCCCCHHHHHH--H-----
T ss_conf 455123336888-----6432267756379277748988888888764516778865889988988778899--9-----
Q ss_pred HCCCHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 11401255420024799999227999999999987453599999999999999
Q 000859 1178 EMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDL 1230 (1251)
Q Consensus 1178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 1230 (1251)
..............+.....++++.+++.+|++.||++|||++|+++.
T Consensus 225 -----~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 225 -----MKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp --------CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred -----HHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf -----999985388888985434699999999999756996579099999709
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=0 Score=337.86 Aligned_cols=252 Identities=24% Similarity=0.341 Sum_probs=203.5
Q ss_pred CCCCCCCEECCCCCCEEEEEEE-CCCCEEEEEEECCCCC--------HHHHHHHHHHHHHHHHCC-CCCCCCEECEEEEC
Q ss_conf 2999685322358803999996-5995899998115771--------455699999999987104-77743130215405
Q 000859 946 NNLSDEFIIGSGGSGTVYKAEL-ANGATVAVKKISCKDD--------HLLNKSFTREVKTLGRIR-HRHLVKLMGHCCNK 1015 (1251)
Q Consensus 946 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~--------~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~ 1015 (1251)
++|+..+.||+|+||+||+|+. .+++.||||++..... ....+.+.+|+.++++++ ||||+++++++.+
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~- 81 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET- 81 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC-
T ss_pred CCCEECEEEECCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEECCC-
T ss_conf 6388852884176849999999999989999999624464114788899999999999999985079974799762146-
Q ss_pred CCCCEEEEEEECCCCCHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEE
Q ss_conf 99811699950589995776302887732478999999999999999997986306999915249999995546898758
Q 000859 1016 GAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAH 1095 (1251)
Q Consensus 1016 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nili~~~~~~k 1095 (1251)
....|+||||+++|+|.++++. .+.+++..++.++.||+.|++|||++ +|+||||||+||+++.++.+|
T Consensus 82 -~~~~~ivmE~~~~g~L~~~l~~-------~~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~k 150 (277)
T d1phka_ 82 -NTFFFLVFDLMKKGELFDYLTE-------KVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIK 150 (277)
T ss_dssp -SSEEEEEEECCTTCBHHHHHHH-------HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEE
T ss_pred -CCCEEEEEECCCCCHHHHHHHH-------CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCEEEECCCCCEE
T ss_conf -7605999976898668999986-------59999999999999999999999875---994323462548986899838
Q ss_pred ECCCCCCCCCCCCCCCCCCCCCEEECCCCEECCCCCCC------CCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCHHH
Q ss_conf 74445642221235888754310001000005310024------798986455303599999860999999766410247
Q 000859 1096 LGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYS------LKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDM 1169 (1251)
Q Consensus 1096 i~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~Diws~Gvil~elltg~~p~~~~~~~~~~~ 1169 (1251)
|+|||.|+...... ......||..|+|||.+.+ ..++.++||||+||++|||++|+.||.+....+.
T Consensus 151 l~DFG~a~~~~~~~-----~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~-- 223 (277)
T d1phka_ 151 LTDFGFSCQLDPGE-----KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLM-- 223 (277)
T ss_dssp ECCCTTCEECCTTC-----CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--
T ss_pred ECCCHHEEECCCCC-----CEEEEECCCCCCCHHHHHCCCCCCCCCCCCHHEECCCCHHHHHHCCCCCCCCCCCHHHH--
T ss_conf 71240316726887-----21345246788898886053445678899233185656023103228889889999999--
Q ss_pred HHHHHHHHHCCCHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 9999997811401255420024799999227999999999987453599999999999999
Q 000859 1170 VRWVEMHMEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDL 1230 (1251)
Q Consensus 1170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 1230 (1251)
. ..+.........+.....++++.+++.+||+.||.+|||++|+++.
T Consensus 224 ~--------------~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 224 L--------------RMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp H--------------HHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred H--------------HHHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 9--------------9998189888985434689999999999765896689199999739
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=343.20 Aligned_cols=248 Identities=22% Similarity=0.329 Sum_probs=198.6
Q ss_pred CCCCCCCEECCCCCCEEEEEEE-CCCCEEEEEEECCCC--CHHHHHHHHHHHHHHH-HCCCCCCCCEECEEEECCCCCEE
Q ss_conf 2999685322358803999996-599589999811577--1455699999999987-10477743130215405998116
Q 000859 946 NNLSDEFIIGSGGSGTVYKAEL-ANGATVAVKKISCKD--DHLLNKSFTREVKTLG-RIRHRHLVKLMGHCCNKGAGSNL 1021 (1251)
Q Consensus 946 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~-~l~h~niv~l~g~~~~~~~~~~~ 1021 (1251)
++|...+.||+|+||+||+|.. .+++.||||++.... .....+.+..|..++. .++||||+++++++.+ ....+
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~--~~~~y 79 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT--KENLF 79 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC--SSEEE
T ss_pred CCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECC--CCCEE
T ss_conf 9718865894087828999999999989999998055533848999999999999984799968789889704--98316
Q ss_pred EEEEECCCCCHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEECCCCC
Q ss_conf 99950589995776302887732478999999999999999997986306999915249999995546898758744456
Q 000859 1022 LIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGL 1101 (1251)
Q Consensus 1022 lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nili~~~~~~ki~DfG~ 1101 (1251)
+||||+++|+|.++++. ...+++..++.++.||+.|++|||++ +|+||||||+|||++.++.+|++|||.
T Consensus 80 ivmEy~~~g~L~~~i~~-------~~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~ 149 (320)
T d1xjda_ 80 FVMEYLNGGDLMYHIQS-------CHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGM 149 (320)
T ss_dssp EEEECCTTCBHHHHHHH-------HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTT
T ss_pred EEEEECCCCCHHHHHHC-------CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCCCCCCEEECCCCCEECCCCCH
T ss_conf 77750379808998640-------47899999999999999999999868---934034765404444899630155530
Q ss_pred CCCCCCCCCCCCCCCCEEECCCCEECCCCCCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHCCC
Q ss_conf 42221235888754310001000005310024798986455303599999860999999766410247999999781140
Q 000859 1102 AKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSG 1181 (1251)
Q Consensus 1102 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 1181 (1251)
|+..... ........||+.|+|||++.+..++.++||||+||++|||++|+.||.+....+. .. ..
T Consensus 150 a~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~--~~---~i----- 215 (320)
T d1xjda_ 150 CKENMLG----DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEEL--FH---SI----- 215 (320)
T ss_dssp CBCCCCT----TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HH---HH-----
T ss_pred HHHCCCC----CCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHH--HH---HH-----
T ss_conf 2323566----5334545787776899998279988323201122789898738899999899999--99---99-----
Q ss_pred HHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHH-HHHH
Q ss_conf 12554200247999992279999999999874535999999999-9999
Q 000859 1182 SAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSR-QVCD 1229 (1251)
Q Consensus 1182 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-eil~ 1229 (1251)
... .+ ..+...++++.+++.+||..||++||+++ ++++
T Consensus 216 ------~~~--~~--~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 216 ------RMD--NP--FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp ------HHC--CC--CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred ------HCC--CC--CCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHHH
T ss_conf ------718--99--8975679999999999654489878388999980
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=0 Score=335.98 Aligned_cols=293 Identities=33% Similarity=0.593 Sum_probs=217.2
Q ss_pred CCCHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCC--CCCCEEECCCC--CEEEEECCCCCCCCC--CCCCCCCCCCCC
Q ss_conf 789776999999999758799778789889999998--63017994999--737980047766788--878887888950
Q 000859 24 LCKDEELSVLLEIKKSFTADPENVLHAWNQSNQNLC--TWRGITCGSSS--ARVVSLNLSGLSLAG--SISPSLGRLQSL 97 (1251)
Q Consensus 24 ~~~~~~~~~l~~~k~~~~~~~~~~~~sw~~~~~~~c--~w~gv~C~~~~--~~v~~l~l~~~~l~g--~~~~~l~~l~~L 97 (1251)
.|+++|++||++||++++ ||. .+++|+. +.||| +|+||+|+..+ +||+.|+|.+.++.| .+|++++++++|
T Consensus 2 ~c~~~e~~aLl~~k~~~~-~~~-~l~sW~~-~~d~C~~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~~l~~L~~L 78 (313)
T d1ogqa_ 2 LCNPQDKQALLQIKKDLG-NPT-TLSSWLP-TTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYL 78 (313)
T ss_dssp CSCHHHHHHHHHHHHHTT-CCG-GGTTCCT-TSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTC
T ss_pred CCCHHHHHHHHHHHHHCC-CCC-CCCCCCC-CCCCCCCCCCCEEEECCCCCEEEEEEECCCCCCCCCCCCCHHHHCCCCC
T ss_conf 989899999999999779-998-6778899-9999889488969748999479889989899888888798478467533
Q ss_pred CEEECCC-CCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 1998658-988898674322667663886224454588875357875555788126778899898656544434223456
Q 000859 98 IHLDLSS-NSLTGPIPTALSNLSSLESLLLFSNQLAGTIPTQLGSLTSLRVMRIGDNWLSGSIPTSFGNLVNLGTLGLAS 176 (1251)
Q Consensus 98 ~~L~l~~-n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~ 176 (1251)
++|+|++ |.+.|.+|.+|+++++|++|+|++|++.+..+..+..+..|++++++.|.+.+.+|.++++++.|+.+++++
T Consensus 79 ~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~ 158 (313)
T d1ogqa_ 79 NFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDG 158 (313)
T ss_dssp SEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCS
T ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCHHHCCCCCCCEEECCC
T ss_conf 52020265433300243114542001102035643443322222011100111122455556851220674000000235
Q ss_pred CCCCCCCCCCCCCCCCC-CEEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCHHHHCCCCCCCEEECCCCCCCCCC
Q ss_conf 78899999976733445-13321133356877844389888753330142368870222026445864654476688878
Q 000859 177 CSLSGPIPPQFGQLSQL-EELILQQNQLQGPIPAELGNCSSLSIFTAAENNLNGSIPAALGRLQNLQLLNLGNNSLSGEI 255 (1251)
Q Consensus 177 n~l~~~~p~~~~~l~~L-~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~ 255 (1251)
|.+++.+|..+..+.++ +.+++++|++++..|..+..+..+ .++++.+...+.+|..+..+++++.+++++|.+.+.+
T Consensus 159 n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~ 237 (313)
T d1ogqa_ 159 NRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-FVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDL 237 (313)
T ss_dssp SCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-EEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBG
T ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 533562031214431123231022464353324332222222-3333334332222222222222111222222222222
Q ss_pred CCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCEEEEECCCCC
Q ss_conf 9553687766555344762468677232357873589801542249989742445533799902750
Q 000859 256 PSELGELSQLGYLNLMGNRLEGAIPRSFAKMGNLQSLDLSMNRLTGGIPEEFGNMGQLVFLVLSNNN 322 (1251)
Q Consensus 256 ~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~Ls~N~ 322 (1251)
+ .+..+++|+.|++++|++++.+|..+.++++|+.|+|++|++++.+|. ++.+++|+.+++++|+
T Consensus 238 ~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~-~~~L~~L~~l~l~~N~ 302 (313)
T d1ogqa_ 238 G-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNK 302 (313)
T ss_dssp G-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCC-STTGGGSCGGGTCSSS
T ss_pred C-CCCCCCCCCCCCCCCCEECCCCCHHHHCCCCCCEEECCCCCCCCCCCC-CCCCCCCCHHHHCCCC
T ss_conf 2-222455444444765706660876884799999897958835166898-6667998978868895
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=330.13 Aligned_cols=269 Identities=23% Similarity=0.329 Sum_probs=200.5
Q ss_pred CCCCCCCEECCCCCCEEEEEEE-CCCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCCCCCCEECEEEECCCCCEEEE
Q ss_conf 2999685322358803999996-5995899998115771-4556999999999871047774313021540599811699
Q 000859 946 NNLSDEFIIGSGGSGTVYKAEL-ANGATVAVKKISCKDD-HLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLI 1023 (1251)
Q Consensus 946 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv 1023 (1251)
++|+..+.||+|+||+||+|.. .+++.||+|++..... ....+.+.+|+.++++++||||+++++++.+ ....++|
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~--~~~~~iv 79 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT--ENKLYLV 79 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEE--TTEEEEE
T ss_pred CCCEECCEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEECCCCCC--CCCEEEE
T ss_conf 99776517723768099999999999799999980222575899999999999986799838874453322--4320378
Q ss_pred EEECCCCCHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEECCCCCCC
Q ss_conf 95058999577630288773247899999999999999999798630699991524999999554689875874445642
Q 000859 1024 YEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAK 1103 (1251)
Q Consensus 1024 ~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nili~~~~~~ki~DfG~a~ 1103 (1251)
|||+.+ ++.+++.... ...+++..++.++.|++.|++|||++ +|+||||||+||+++.++.+|++|||.|+
T Consensus 80 ~e~~~~-~~~~~~~~~~-----~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~ 150 (298)
T d1gz8a_ 80 FEFLHQ-DLKKFMDASA-----LTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR 150 (298)
T ss_dssp EECCSE-EHHHHHHHTT-----TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHH
T ss_pred EEECCC-CHHHHHHHHC-----CCCCCHHHHHHHHHHHHHHHHHHHCC---CEECCCCCCHHEEECCCCCCEECCCCCCE
T ss_conf 862377-4455544202-----56888899999999999999986528---89921357114011346762103578613
Q ss_pred CCCCCCCCCCCCCCEEECCCCEECCCCCCCCC-CCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHCCCH
Q ss_conf 22123588875431000100000531002479-89864553035999998609999997664102479999997811401
Q 000859 1104 ALVEDYNSNTESNTWFAGSYGYIAPEYAYSLK-ATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGS 1182 (1251)
Q Consensus 1104 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Diws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 1182 (1251)
..... ........|++.|+|||...... ++.++||||+||++|+|++|+.||.+....+. ..............
T Consensus 151 ~~~~~----~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~-~~~i~~~~~~~~~~ 225 (298)
T d1gz8a_ 151 AFGVP----VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ-LFRIFRTLGTPDEV 225 (298)
T ss_dssp HHCCC----SBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCCCCTT
T ss_pred ECCCC----CCCCEEECCCCEEEEHHHHCCCCCCCCCCCCCCCCHHHHHHHHCCCCCCCCCHHHH-HHHHHHHCCCCCHH
T ss_conf 43688----64100103652154112213665777422103333134279668799898899999-99999832898333
Q ss_pred HHHHH-HCCCCCCCCC-----C----HHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 25542-0024799999-----2----27999999999987453599999999999999
Q 000859 1183 AREEL-LDDQMKPLLP-----G----EECAAYQVLEIALQCTKTSPQERPSSRQVCDL 1230 (1251)
Q Consensus 1183 ~~~~~-~~~~~~~~~~-----~----~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 1230 (1251)
..... .........+ . ....+.++.+++.+|++.||.+|||++|+++.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 226 VWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp TSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 1444222421243454322220444166789999999999763995579189999678
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=330.73 Aligned_cols=270 Identities=27% Similarity=0.310 Sum_probs=196.9
Q ss_pred CCEECCCCCCEEEEEEE-CCCCEEEEEEECCCCCH----HHHHHHHHHHHHHHHCCCCCCCCEECEEEECCCCCEEEEEE
Q ss_conf 85322358803999996-59958999981157714----55699999999987104777431302154059981169995
Q 000859 951 EFIIGSGGSGTVYKAEL-ANGATVAVKKISCKDDH----LLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIYE 1025 (1251)
Q Consensus 951 ~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv~e 1025 (1251)
.++||+|+||+||+|.. .+++.||||++...... ...+.+.+|+.+++.++||||+++++++... ...++|||
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~--~~~~ivmE 80 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHK--SNISLVFD 80 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCT--TCCEEEEE
T ss_pred CEEECCCCCEEEEEEEECCCCCEEEEEEEEHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCC--CCEEEHHH
T ss_conf 6385127282999999999996999999842021245679999999999999867999986898542258--74022045
Q ss_pred ECCCCCHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEECCCCCCCCC
Q ss_conf 05899957763028877324789999999999999999979863069999152499999955468987587444564222
Q 000859 1026 YMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKAL 1105 (1251)
Q Consensus 1026 ~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nili~~~~~~ki~DfG~a~~~ 1105 (1251)
|++++++..+... ...+++..+..++.||+.|++|||++ +|+||||||+||+++.++.+||+|||.|+..
T Consensus 81 ~~~~~~~~~~~~~-------~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~ 150 (299)
T d1ua2a_ 81 FMETDLEVIIKDN-------SLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSF 150 (299)
T ss_dssp CCSEEHHHHHTTC-------CSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTT
T ss_pred HHCCHHHHHHHHC-------CCCCCHHHHHHHHHHHHHHHHHHHCC---CEECCCCCCCEEEECCCCCCCCCCCCCCCCC
T ss_conf 5345077655412-------66778999999999999999886316---3550357762588537784114657610005
Q ss_pred CCCCCCCCCCCCEEECCCCEECCCCCCC-CCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHCCCHHH
Q ss_conf 1235888754310001000005310024-798986455303599999860999999766410247999999781140125
Q 000859 1106 VEDYNSNTESNTWFAGSYGYIAPEYAYS-LKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGSAR 1184 (1251)
Q Consensus 1106 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Diws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1184 (1251)
.... .......||+.|+|||++.. ..++.++||||+||++|||++|+.||.+....+. +....+..........
T Consensus 151 ~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~-l~~i~~~~~~~~~~~~ 225 (299)
T d1ua2a_ 151 GSPN----RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ-LTRIFETLGTPTEEQW 225 (299)
T ss_dssp TSCC----CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHHHCCCCTTTS
T ss_pred CCCC----CCCCCEECCHHHCCHHHHCCCCCCCHHHHHHHCCHHHHHHHHCCCCCCCCCHHHH-HHHHHHHCCCCCHHHC
T ss_conf 7875----5433020473336399972677888056436304289999859699999999999-9999985189972545
Q ss_pred H---HHHCCC---CCCCCCCH---HHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHCCCCC
Q ss_conf 5---420024---79999922---7999999999987453599999999999999972109973
Q 000859 1185 E---ELLDDQ---MKPLLPGE---ECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNVFNNRI 1239 (1251)
Q Consensus 1185 ~---~~~~~~---~~~~~~~~---~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~ 1239 (1251)
. ...... ..+..+.. ...++++.+++.+|++.||++|||++|+++. .++.+..
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H--p~f~~~p 287 (299)
T d1ua2a_ 226 PDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM--KYFSNRP 287 (299)
T ss_dssp SSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS--GGGTSSS
T ss_pred CCHHCCCHHHHHCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC--HHHCCCC
T ss_conf 2100021344303478988678565689999999999763894569089999679--9657899
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=323.10 Aligned_cols=273 Identities=24% Similarity=0.297 Sum_probs=203.4
Q ss_pred HCCCCCCCEECCCCCCEEEEEE-ECCCCEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCCCEECEEEECCCC--CEE
Q ss_conf 1299968532235880399999-6599589999811577145569999999998710477743130215405998--116
Q 000859 945 TNNLSDEFIIGSGGSGTVYKAE-LANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAG--SNL 1021 (1251)
Q Consensus 945 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~--~~~ 1021 (1251)
..+|+..+.||+|+||+||+|. ..+++.||||++.........+.+.+|+.+++.++||||+++++++...... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCEE
T ss_conf 89859978994064809999999999949999998031095899999999999997689898858889950564554149
Q ss_pred EEEEECCCCCHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEECCCCC
Q ss_conf 99950589995776302887732478999999999999999997986306999915249999995546898758744456
Q 000859 1022 LIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGL 1101 (1251)
Q Consensus 1022 lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nili~~~~~~ki~DfG~ 1101 (1251)
++++++.+|+|.+++... .+++..++.++.|++.||+|||++ ||+||||||+||+++.++.+||+|||.
T Consensus 87 ~l~~~~~~g~L~~~l~~~--------~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~ 155 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKTQ--------HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGL 155 (345)
T ss_dssp EEEEECCCEEHHHHHHHC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred EEEEEECCCCHHHHHHCC--------CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCEEEECCCCCEEECCCCC
T ss_conf 999962598656644058--------999999999999999999999978---986777876437887999778754570
Q ss_pred CCCCCCCCCCCCCCCCEEECCCCEECCCCCC-CCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHCC
Q ss_conf 4222123588875431000100000531002-479898645530359999986099999976641024799999978114
Q 000859 1102 AKALVEDYNSNTESNTWFAGSYGYIAPEYAY-SLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMS 1180 (1251)
Q Consensus 1102 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Diws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 1180 (1251)
|.......... .......|++.|+|||++. ...++.++||||+|+++|||++|+.||.+....+..... ........
T Consensus 156 a~~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~-~~~~~~~~ 233 (345)
T d1pmea_ 156 ARVADPDHDHT-GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI-LGILGSPS 233 (345)
T ss_dssp CEECCGGGCBC-CTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH-HHHHCSCC
T ss_pred EEECCCCCCCC-EEECCCCCCCEECHHHHHHCCCCCCCHHHHHCCCCEEHHHHHCCCCCCCCCHHHHHHHH-HHHCCCCC
T ss_conf 56504777641-01011026520003878604788874101004670133776697997888889999987-65206997
Q ss_pred C---------HHHHHHHCCCCCCCCCCH---HHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 0---------125542002479999922---7999999999987453599999999999999
Q 000859 1181 G---------SAREELLDDQMKPLLPGE---ECAAYQVLEIALQCTKTSPQERPSSRQVCDL 1230 (1251)
Q Consensus 1181 ~---------~~~~~~~~~~~~~~~~~~---~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 1230 (1251)
. ...............+.. ...++++.+++.+|++.||.+|||++|+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 234 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp HHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHHHHHHHCCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 56642343322220244677557787778378999999999999764895679089998619
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=325.65 Aligned_cols=270 Identities=21% Similarity=0.293 Sum_probs=204.6
Q ss_pred CCCCCCCEECCCCCCEEEEEEE-CCCCEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCCCEECEEEECCCCCEEEEE
Q ss_conf 2999685322358803999996-599589999811577145569999999998710477743130215405998116999
Q 000859 946 NNLSDEFIIGSGGSGTVYKAEL-ANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIY 1024 (1251)
Q Consensus 946 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv~ 1024 (1251)
++|+..+.||+|+||.||+|.. .+++.||||++..... .+.+..|+++++.++|++++..++.+... ....++||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~---~~~~~~E~~i~~~l~~~~~i~~~~~~~~~-~~~~~ivm 82 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK---HPQLHIESKIYKMMQGGVGIPTIRWCGAE-GDYNVMVM 82 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT---SCCHHHHHHHHHHSTTSTTCCCEEEEEEE-TTEEEEEE
T ss_pred CEEEEEEEEEECCCCEEEEEEECCCCCEEEEEEECHHCC---CHHHHHHHHHHHHCCCCCCCCEEEEEEEC-CCEEEEEE
T ss_conf 889996898507880999999988998999999721005---88899999999970389960179999951-98778999
Q ss_pred EECCCCCHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECC---CCCEEECCCCC
Q ss_conf 505899957763028877324789999999999999999979863069999152499999955468---98758744456
Q 000859 1025 EYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDS---NMEAHLGDFGL 1101 (1251)
Q Consensus 1025 e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nili~~---~~~~ki~DfG~ 1101 (1251)
||+ +|++.+.+... ...+++..+..++.|++.|++|||++ +|+||||||+||+++. +..+|++|||+
T Consensus 83 e~~-~~~l~~~~~~~------~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~ 152 (299)
T d1ckia_ 83 ELL-GPSLEDLFNFC------SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGL 152 (299)
T ss_dssp ECC-CCBHHHHHHHT------TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSS
T ss_pred EEC-CCCHHHHHHHC------CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCCCHHHCCCCCCCCCCEEEEECCCC
T ss_conf 873-87133324430------68876899999999999999999979---944266787660643357776156504675
Q ss_pred CCCCCCCCCCC---CCCCCEEECCCCEECCCCCCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCHHHHH--HHHHH
Q ss_conf 42221235888---75431000100000531002479898645530359999986099999976641024799--99997
Q 000859 1102 AKALVEDYNSN---TESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVR--WVEMH 1176 (1251)
Q Consensus 1102 a~~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diws~Gvil~elltg~~p~~~~~~~~~~~~~--~~~~~ 1176 (1251)
|+.+....... ........||+.|+|||.+.+..++.++||||||+++|||++|+.||............ +....
T Consensus 153 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~ 232 (299)
T d1ckia_ 153 AKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK 232 (299)
T ss_dssp CEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHH
T ss_pred CEECCCCCCCCCEECCCCCCCCCCCCCCCHHHHHCCCCCCHHHEEECCHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCC
T ss_conf 13425544554100013577678735329999918998983218861778999984987665530577999999852356
Q ss_pred HHCCCHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCC
Q ss_conf 8114012554200247999992279999999999874535999999999999999721099733445
Q 000859 1177 MEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNVFNNRIVDFD 1243 (1251)
Q Consensus 1177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~~~~~ 1243 (1251)
.. ...... ...+++++.+++..||+.+|++||+++++.+.|++++.+.....+
T Consensus 233 ~~---~~~~~~-----------~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~~~~~ 285 (299)
T d1ckia_ 233 MS---TPIEVL-----------CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYD 285 (299)
T ss_dssp HH---SCHHHH-----------TTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHTCCCS
T ss_pred CC---CCHHHH-----------CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHHCCCCCC
T ss_conf 78---983575-----------347889999999998439955791999999999999997699978
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=328.34 Aligned_cols=271 Identities=22% Similarity=0.292 Sum_probs=197.7
Q ss_pred HCCCCCCCEECCCCCCEEEEEEE-CC-CCEEEEEEECCCCC-HHHHHHHHHHHHHHHHC---CCCCCCCEECEEEEC---
Q ss_conf 12999685322358803999996-59-95899998115771-45569999999998710---477743130215405---
Q 000859 945 TNNLSDEFIIGSGGSGTVYKAEL-AN-GATVAVKKISCKDD-HLLNKSFTREVKTLGRI---RHRHLVKLMGHCCNK--- 1015 (1251)
Q Consensus 945 ~~~~~~~~~lg~G~~g~V~~~~~-~~-~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l---~h~niv~l~g~~~~~--- 1015 (1251)
.++|++.+.||+|+||+||+|.. ++ ++.||||++..... ......+.+|+.+++.+ +||||+++++++...
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred CCCEEEEEEEECCCCEEEEEEEEECCCCEEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCCC
T ss_conf 58979888992155869999999888998999999802324516799999999999987425898802366322146666
Q ss_pred CCCCEEEEEEECCCCCHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEE
Q ss_conf 99811699950589995776302887732478999999999999999997986306999915249999995546898758
Q 000859 1016 GAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAH 1095 (1251)
Q Consensus 1016 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nili~~~~~~k 1095 (1251)
.....++++|+++++++....... ...+++..++.++.|++.||+|||++ +|+||||||+|||++..+.+|
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~------~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~k 156 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVP------EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIK 156 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSC------TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEE
T ss_pred CCCEEEEEEEECCCCCHHHHHHCC------CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCCCCCEEEECCCCCEE
T ss_conf 674699999740587144444303------78999899999999999999999758---898357986278985899754
Q ss_pred ECCCCCCCCCCCCCCCCCCCCCEEECCCCEECCCCCCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHH
Q ss_conf 74445642221235888754310001000005310024798986455303599999860999999766410247999999
Q 000859 1096 LGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEM 1175 (1251)
Q Consensus 1096 i~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~ 1175 (1251)
++|||.+...... .......||+.|+|||++.+..|+.++||||+||++|||++|+.||.+....+. .......
T Consensus 157 l~dfg~~~~~~~~-----~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~-~~~i~~~ 230 (305)
T d1blxa_ 157 LADFGLARIYSFQ-----MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ-LGKILDV 230 (305)
T ss_dssp ECSCCSCCCCCGG-----GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHH
T ss_pred ECCHHHHHHHCCC-----CCCCCCCCCHHHCCCCHHCCCCCCHHEHHHCHHHHHHHHHHCCCCCCCCCHHHH-HHHHHHH
T ss_conf 2100010110023-----457776548511483100179888111000328999999878799899898999-9999984
Q ss_pred HHHCCCH-H-------HHHHHCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 7811401-2-------55420024799999227999999999987453599999999999999
Q 000859 1176 HMEMSGS-A-------REELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDL 1230 (1251)
Q Consensus 1176 ~~~~~~~-~-------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 1230 (1251)
....... + ..........+........++.+.+++.+|++.||++|||++|+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 231 IGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp HCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HCCCCHHCCCCCCCCHHHHHCCCCCCCHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 079961105321111033302234564544044589999999999874896679189999669
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=0 Score=326.74 Aligned_cols=267 Identities=23% Similarity=0.301 Sum_probs=200.8
Q ss_pred CCCCCCCEECCCCCCEEEEEEECCCCEEEEEEECCCC-CHHHHHHHHHHHHHHHHCCCCCCCCEECEEEECCCCCEEEEE
Q ss_conf 2999685322358803999996599589999811577-145569999999998710477743130215405998116999
Q 000859 946 NNLSDEFIIGSGGSGTVYKAELANGATVAVKKISCKD-DHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLIY 1024 (1251)
Q Consensus 946 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv~ 1024 (1251)
++|...+.||+|+||+||+|..++++.||||++.... .....+.+.+|+.++++++||||+++++++... ...++++
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~--~~~~i~~ 79 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTK--KRLVLVF 79 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECS--SCEEEEE
T ss_pred CCCEECCEEECCCCCEEEEEEECCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEECCCC--CCEEEEE
T ss_conf 99634318722778189999968999999999812326858999999999999867998687660120467--7315899
Q ss_pred EECCCCCHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEECCCCCCCC
Q ss_conf 50589995776302887732478999999999999999997986306999915249999995546898758744456422
Q 000859 1025 EYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAKA 1104 (1251)
Q Consensus 1025 e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nili~~~~~~ki~DfG~a~~ 1104 (1251)
|++.++.+..+... .+.+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+|++|||.|..
T Consensus 80 e~~~~~~~~~~~~~-------~~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~ 149 (286)
T d1ob3a_ 80 EHLDQDLKKLLDVC-------EGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARA 149 (286)
T ss_dssp ECCSEEHHHHHHTS-------TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHH
T ss_pred EEEHHHHHHHHHHH-------CCCCCHHHHHHHHHHHHHHHHHHCCC---CEEECCCCCCEEEECCCCCEEECCCCCCEE
T ss_conf 74004567899860-------47751445689999999999986057---488267877505686899787323664301
Q ss_pred CCCCCCCCCCCCCEEECCCCEECCCCCCCC-CCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHCCCH-
Q ss_conf 212358887543100010000053100247-989864553035999998609999997664102479999997811401-
Q 000859 1105 LVEDYNSNTESNTWFAGSYGYIAPEYAYSL-KATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGS- 1182 (1251)
Q Consensus 1105 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Diws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~- 1182 (1251)
..... .......|++.|+|||.+.+. .++.++||||+|+++|||++|+.||.+....+. ..............
T Consensus 150 ~~~~~----~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~-~~~i~~~~~~~~~~~ 224 (286)
T d1ob3a_ 150 FGIPV----RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ-LMRIFRILGTPNSKN 224 (286)
T ss_dssp HCC-------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCCCCTTT
T ss_pred CCCCC----CCCCEECCCCHHHHHHHHHCCCCCCCCEEEHHCCCHHHHHHHCCCCCCCCCHHHH-HHHHHHHHCCCCHHH
T ss_conf 14676----5410102431101378871788888410021117589999779799898898999-999998638997110
Q ss_pred HHHHHHCCC----C--CCCCC---CHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 255420024----7--99999---22799999999998745359999999999999
Q 000859 1183 AREELLDDQ----M--KPLLP---GEECAAYQVLEIALQCTKTSPQERPSSRQVCD 1229 (1251)
Q Consensus 1183 ~~~~~~~~~----~--~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1229 (1251)
+........ . ....+ .....++.+.+++.+|++.||++|||++|+++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 225 WPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp STTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCHHHHHHCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 42123332214333335676466651258999999999986689668909999856
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=322.89 Aligned_cols=274 Identities=22% Similarity=0.289 Sum_probs=202.9
Q ss_pred HCCCCCCCEECCCCCCEEEEEEE-CCCCEEEEEEECCCC-CHHHHHHHHHHHHHHHHCCCCCCCCEECEEEECC------
Q ss_conf 12999685322358803999996-599589999811577-1455699999999987104777431302154059------
Q 000859 945 TNNLSDEFIIGSGGSGTVYKAEL-ANGATVAVKKISCKD-DHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKG------ 1016 (1251)
Q Consensus 945 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~------ 1016 (1251)
..+|++.+.||+|+||+||+|.. .+++.||||++.... .....+.+.+|+.+++.++|||++++++++....
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCCCCCC
T ss_conf 27988999972274829999999899979999998422246378999999999999835999660676540246544445
Q ss_pred CCCEEEEEEECCCCCHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEE
Q ss_conf 98116999505899957763028877324789999999999999999979863069999152499999955468987587
Q 000859 1017 AGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHL 1096 (1251)
Q Consensus 1017 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nili~~~~~~ki 1096 (1251)
....++|+|++.++.+..+... ...++...++.++.|++.||.|||+. ||+||||||+||+++.++.+|+
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~-------~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl 158 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNV-------LVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKL 158 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCT-------TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEE
T ss_pred CCEEEEEEECCCCCCCCHHHHC-------CCCCCCHHHHHHHHHHHHHHHHHCCC---CEEECCCCCHHEEECCCCCEEE
T ss_conf 7638999853578741012220-------34433089999999999999885229---9885676722203668996876
Q ss_pred CCCCCCCCCCCCCCCCCCCCCEEECCCCEECCCCCCCC-CCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHH
Q ss_conf 44456422212358887543100010000053100247-98986455303599999860999999766410247999999
Q 000859 1097 GDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSL-KATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEM 1175 (1251)
Q Consensus 1097 ~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Diws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~ 1175 (1251)
+|||++..+...............||+.|+|||++.+. .++.++||||+||++|||++|+.||.+....+. ......
T Consensus 159 ~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~--~~~i~~ 236 (318)
T d3blha1 159 ADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQ--LALISQ 236 (318)
T ss_dssp CCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHH
T ss_pred EECCEEEECCCCCCCCCCCCCCEECCHHHHHHHHHCCCCCCCCHHHCCCCCCEEEEHHHCCCCCCCCCHHHH--HHHHHH
T ss_conf 313500223554443211356602497874289970799989178700678646617448799899899999--999998
Q ss_pred HH-HCCCHHHHHH--------HCCCCCCCCCCHH-----HHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 78-1140125542--------0024799999227-----999999999987453599999999999999
Q 000859 1176 HM-EMSGSAREEL--------LDDQMKPLLPGEE-----CAAYQVLEIALQCTKTSPQERPSSRQVCDL 1230 (1251)
Q Consensus 1176 ~~-~~~~~~~~~~--------~~~~~~~~~~~~~-----~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 1230 (1251)
.. .......... .........+... ...+.+.+++.+|++.||++|||++|+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 237 LCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp HHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HCCCCCHHHCCCCCHHHHHHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 418998255344320344433201334455503340444599899999999873896589099999749
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=319.60 Aligned_cols=271 Identities=20% Similarity=0.292 Sum_probs=201.8
Q ss_pred HCCCCCCCEECCCCCCEEEEEEE-CCCCEEEEEEECCCC-CHHHHHHHHHHHHHHHHCCCCCCCCEECEEEECCC----C
Q ss_conf 12999685322358803999996-599589999811577-14556999999999871047774313021540599----8
Q 000859 945 TNNLSDEFIIGSGGSGTVYKAEL-ANGATVAVKKISCKD-DHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGA----G 1018 (1251)
Q Consensus 945 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~----~ 1018 (1251)
.++|+..+.||+|+||+||+|.. .+++.||||++.... .....+.+.+|+.+++.++||||+++++++...+. .
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCCCCCC
T ss_conf 77189988980177819999999999989999998522259699999999999998668987547999863576555541
Q ss_pred CEEEEEEECCCCCHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEECC
Q ss_conf 11699950589995776302887732478999999999999999997986306999915249999995546898758744
Q 000859 1019 SNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGD 1098 (1251)
Q Consensus 1019 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nili~~~~~~ki~D 1098 (1251)
..++||||+ ++++..+.+. ..+++..++.++.|++.||+|||++ ||+||||||+||+++.++.+|++|
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~--------~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~D 164 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKH--------EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILD 164 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHH--------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECC
T ss_pred EEEEEEECC-CCCHHHHHHH--------CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCHHHCCCCCCCCCCC
T ss_conf 599998405-5218999874--------0226999999999999999998737---876456685111121001221134
Q ss_pred CCCCCCCCCCCCCCCCCCCEEECCCCEECCCCCCCC-CCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHH
Q ss_conf 456422212358887543100010000053100247-9898645530359999986099999976641024799999978
Q 000859 1099 FGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSL-KATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHM 1177 (1251)
Q Consensus 1099 fG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Diws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~ 1177 (1251)
||.|+..... .....|++.|+|||++.+. .++.++||||+||++|||++|+.||.+...... .........
T Consensus 165 fg~a~~~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~-~~~~~~~~~ 236 (346)
T d1cm8a_ 165 FGLARQADSE-------MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQ-LKEIMKVTG 236 (346)
T ss_dssp CTTCEECCSS-------CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHHHC
T ss_pred CCCEECCCCC-------CCCCCCCCCCCCHHHHCCCCCCCCCCHHHCCHHHHHHHHHCCCCCCCCCHHHH-HHHHHHCCC
T ss_conf 3102206876-------31024553335889981787899650103003899999978699888976899-999985037
Q ss_pred HCC--------CHHHHHHHC---CCCCCC-CCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH--HHHHC
Q ss_conf 114--------012554200---247999-99227999999999987453599999999999999--97210
Q 000859 1178 EMS--------GSAREELLD---DQMKPL-LPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDL--LLNVF 1235 (1251)
Q Consensus 1178 ~~~--------~~~~~~~~~---~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~--L~~~~ 1235 (1251)
... ......... ...... .......++.+.+++.+|+..||.+|||++|+++. ++++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 237 TPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308 (346)
T ss_dssp CCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred CCCHHHHHHHCCHHHHHHHCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCCC
T ss_conf 884888865300034433115786665566775568999999999997729955792999996396237587
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=330.12 Aligned_cols=242 Identities=25% Similarity=0.372 Sum_probs=192.7
Q ss_pred HCCCCCCCEECCCCCCEEEEEEE-CCCCEEEEEEECCCCCH-----HHHHHHHHHHHHHHHCC--CCCCCCEECEEEECC
Q ss_conf 12999685322358803999996-59958999981157714-----55699999999987104--777431302154059
Q 000859 945 TNNLSDEFIIGSGGSGTVYKAEL-ANGATVAVKKISCKDDH-----LLNKSFTREVKTLGRIR--HRHLVKLMGHCCNKG 1016 (1251)
Q Consensus 945 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l~--h~niv~l~g~~~~~~ 1016 (1251)
.++|++.+.||+|+||+||+|.. .+++.||||++...... .....+.+|+.++++++ ||||+++++++.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~-- 80 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER-- 80 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC--
T ss_pred CCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEEE--
T ss_conf 883799679840878399999999999799999985688443345567999999999999743589881279999830--
Q ss_pred CCCEEEEEEECCC-CCHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCC-CCE
Q ss_conf 9811699950589-99577630288773247899999999999999999798630699991524999999554689-875
Q 000859 1017 AGSNLLIYEYMEN-GSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSN-MEA 1094 (1251)
Q Consensus 1017 ~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nili~~~-~~~ 1094 (1251)
+...++|||++.+ +++.+++.. ...+++..++.++.|++.|++|||+. +|+||||||+||+++.+ +.+
T Consensus 81 ~~~~~lv~e~~~~~~~l~~~~~~-------~~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~v 150 (273)
T d1xwsa_ 81 PDSFVLILERPEPVQDLFDFITE-------RGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGEL 150 (273)
T ss_dssp SSEEEEEEECCSSEEEHHHHHHH-------HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEE
T ss_pred CCEEEEEEEECCCCCHHHHHHHC-------CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCEEEECCCCEE
T ss_conf 99689999833686228999861-------58999999999999999999999877---975566761114774478848
Q ss_pred EECCCCCCCCCCCCCCCCCCCCCEEECCCCEECCCCCCCCCC-CCCCCEEEHHHHHHHHHHCCCCCCCCCCCCHHHHHHH
Q ss_conf 874445642221235888754310001000005310024798-9864553035999998609999997664102479999
Q 000859 1095 HLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKA-TEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWV 1173 (1251)
Q Consensus 1095 ki~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Diws~Gvil~elltg~~p~~~~~~~~~~~~~~~ 1173 (1251)
||+|||.|+..... ......||+.|+|||++.+..+ +.++||||+||++|||++|+.||..... .
T Consensus 151 kl~DFG~a~~~~~~------~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-------i- 216 (273)
T d1xwsa_ 151 KLIDFGSGALLKDT------VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-------I- 216 (273)
T ss_dssp EECCCTTCEECCSS------CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-------H-
T ss_pred EECCCCCCEECCCC------CCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCEEEEHHHHHCCCCCCCCHH-------H-
T ss_conf 97754653532444------556656587747999984899788653325540345367568899887367-------7-
Q ss_pred HHHHHCCCHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 997811401255420024799999227999999999987453599999999999999
Q 000859 1174 EMHMEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDL 1230 (1251)
Q Consensus 1174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 1230 (1251)
.. . .... +...++++.+++.+||+.||++|||++|+++.
T Consensus 217 ---~~--~-------~~~~------~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 217 ---IR--G-------QVFF------RQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp ---HH--C-------CCCC------SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ---HH--C-------CCCC------CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf ---61--5-------4477------87799999999999760897589399998539
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=0 Score=317.73 Aligned_cols=271 Identities=16% Similarity=0.188 Sum_probs=208.7
Q ss_pred HCCCCCCCEECCCCCCEEEEEEE-CCCCEEEEEEECCCCCHHHHHHHHHHHHHHHHCC-CCCCCCEECEEEECCCCCEEE
Q ss_conf 12999685322358803999996-5995899998115771455699999999987104-777431302154059981169
Q 000859 945 TNNLSDEFIIGSGGSGTVYKAEL-ANGATVAVKKISCKDDHLLNKSFTREVKTLGRIR-HRHLVKLMGHCCNKGAGSNLL 1022 (1251)
Q Consensus 945 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~~~l 1022 (1251)
.++|.+.+.||+|+||+||+|.. .+++.||||++..... ...+.+|++.++.+. |+|++.+++++.. ....++
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~---~~~~~~e~~~~~~l~~~~~i~~~~~~~~~--~~~~~~ 78 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD---APQLRDEYRTYKLLAGCTGIPNVYYFGQE--GLHNVL 78 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT---SCCHHHHHHHHHHTTTCTTCCCEEEEEEE--TTEEEE
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCC---CHHHHHHHHHHHHHCCCCCCCEEEEEEEC--CCCCEE
T ss_conf 9806997998417882999999988997999999750258---29999999999996489998779999601--881179
Q ss_pred EEEECCCCCHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECC-----CCCEEEC
Q ss_conf 99505899957763028877324789999999999999999979863069999152499999955468-----9875874
Q 000859 1023 IYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDS-----NMEAHLG 1097 (1251)
Q Consensus 1023 v~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nili~~-----~~~~ki~ 1097 (1251)
|||++ +|+|.+++... ...+++.++..++.|++.|++|+|+. ||+||||||+||+++. .+.+|++
T Consensus 79 vme~~-~~~l~~~~~~~------~~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~ 148 (293)
T d1csna_ 79 VIDLL-GPSLEDLLDLC------GRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVV 148 (293)
T ss_dssp EEECC-CCBHHHHHHHT------TTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEEC
T ss_pred EEEEC-CCCHHHHHHHH------CCCHHHHHHHHHHHHHHHHHHHHHHC---CCEECCCCCCCEEECCCCCCCCCCEEEC
T ss_conf 99964-88879999752------03110689999999999999999977---9662667713152347543447956872
Q ss_pred CCCCCCCCCCCCCCC---CCCCCEEECCCCEECCCCCCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCHHHH-HHH
Q ss_conf 445642221235888---7543100010000053100247989864553035999998609999997664102479-999
Q 000859 1098 DFGLAKALVEDYNSN---TESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMV-RWV 1173 (1251)
Q Consensus 1098 DfG~a~~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diws~Gvil~elltg~~p~~~~~~~~~~~~-~~~ 1173 (1251)
|||+|+.+....... ........||+.|+|||++.+..++.++||||+|+++|||++|+.||.+......... ..+
T Consensus 149 DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i 228 (293)
T d1csna_ 149 DFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERI 228 (293)
T ss_dssp CCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHH
T ss_pred CCCEEEECCCCCCCCCEEECCCCCEEECHHHCCHHHHCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHH
T ss_conf 36605771467665411102467627751026798964888886999898319999998698767885302199999999
Q ss_pred HHHHHCCCHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCC
Q ss_conf 9978114012554200247999992279999999999874535999999999999999721099733445
Q 000859 1174 EMHMEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDLLLNVFNNRIVDFD 1243 (1251)
Q Consensus 1174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~~~~~ 1243 (1251)
..... .....+.. ..+++++.+++..|++.+|++||+++.+.+.+++++++....++
T Consensus 229 ~~~~~--~~~~~~l~-----------~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~~~~~ 285 (293)
T d1csna_ 229 GEKKQ--STPLRELC-----------AGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTED 285 (293)
T ss_dssp HHHHH--HSCHHHHT-----------TTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSC
T ss_pred HHCCC--CCCHHHHC-----------CCCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHCCCCCC
T ss_conf 70567--99958965-----------79989999999998439930085999999999999997599999
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=0 Score=317.83 Aligned_cols=262 Identities=18% Similarity=0.238 Sum_probs=197.3
Q ss_pred CCCCCCCEECCCCCCEEEEEEE-CCCCEEEEEEECCCCCHHHHHHHHHHHHHHHHC-CCCCCCCEECEEEECCCCCEEEE
Q ss_conf 2999685322358803999996-599589999811577145569999999998710-47774313021540599811699
Q 000859 946 NNLSDEFIIGSGGSGTVYKAEL-ANGATVAVKKISCKDDHLLNKSFTREVKTLGRI-RHRHLVKLMGHCCNKGAGSNLLI 1023 (1251)
Q Consensus 946 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~~~lv 1023 (1251)
++|++.+.||+|+||+||+|+. .+++.||+|++.... .+.+.+|+.+++.+ .||||+++++++........++|
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~----~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v 110 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 110 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEE
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHH----HHHHHHHHHHHHHCCCCCCCCEEEEEEEECCCCCEEEE
T ss_conf 67189789831748199999988999799999988899----99999999999851579987679999981687712688
Q ss_pred EEECCCCCHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCC-CEEECCCCCC
Q ss_conf 950589995776302887732478999999999999999997986306999915249999995546898-7587444564
Q 000859 1024 YEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNM-EAHLGDFGLA 1102 (1251)
Q Consensus 1024 ~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nili~~~~-~~ki~DfG~a 1102 (1251)
|||+++|+|..+. +.+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+|++|||.|
T Consensus 111 ~e~~~~~~L~~~~----------~~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a 177 (328)
T d3bqca1 111 FEHVNNTDFKQLY----------QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLA 177 (328)
T ss_dssp EECCCSCBGGGTT----------TSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGC
T ss_pred EEECCCCCHHHHH----------CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCEEECCCCCEEEECCCCCC
T ss_conf 8631798589974----------6899999999999999999887643---34434564412377489983664156542
Q ss_pred CCCCCCCCCCCCCCCEEECCCCEECCCCCCCC-CCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHH-----
Q ss_conf 22212358887543100010000053100247-989864553035999998609999997664102479999997-----
Q 000859 1103 KALVEDYNSNTESNTWFAGSYGYIAPEYAYSL-KATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMH----- 1176 (1251)
Q Consensus 1103 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Diws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~----- 1176 (1251)
+...... ......+|..|+|||...+. .++.++||||+|+++||+++|+.||.................
T Consensus 178 ~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~ 252 (328)
T d3bqca1 178 EFYHPGQ-----EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDL 252 (328)
T ss_dssp EECCTTC-----CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHH
T ss_pred EECCCCC-----CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCHH
T ss_conf 6646887-----44432248642476102688888845232335455587604889998876018999999998788415
Q ss_pred ---HH-CC---CHHHHHHHCCCCC------CCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf ---81-14---0125542002479------999922799999999998745359999999999999
Q 000859 1177 ---ME-MS---GSAREELLDDQMK------PLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCD 1229 (1251)
Q Consensus 1177 ---~~-~~---~~~~~~~~~~~~~------~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1229 (1251)
.. .. ............. .........++++.+++.+|++.||.+|||++|+++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 253 YDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp HHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHCCCCCCCCCCHHCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 555542254447430000033343311211552112448999999999986699568908999964
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=318.72 Aligned_cols=272 Identities=25% Similarity=0.350 Sum_probs=194.7
Q ss_pred CCCCCCEECCCCCCEEEEEEE-CCCCEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCCCEECEEEECC----CCCEE
Q ss_conf 999685322358803999996-5995899998115771455699999999987104777431302154059----98116
Q 000859 947 NLSDEFIIGSGGSGTVYKAEL-ANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKG----AGSNL 1021 (1251)
Q Consensus 947 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~----~~~~~ 1021 (1251)
+|...++||+|+||+||+|.. .+++.||||++..... ...+|+.++++++||||+++++++.... ....+
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~ 95 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 95 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEE
T ss_pred CCEEEEEEEECCCEEEEEEEECCCCCEEEEEEECCCCH-----HHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCEEEE
T ss_conf 76751698217683999999999997999999881606-----8999999998668989873878997447657731899
Q ss_pred EEEEECCCCCHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCC-CEEECCCC
Q ss_conf 99950589995776302887732478999999999999999997986306999915249999995546898-75874445
Q 000859 1022 LIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNM-EAHLGDFG 1100 (1251)
Q Consensus 1022 lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nili~~~~-~~ki~DfG 1100 (1251)
+||||++++ +.+.+.... .....+++..++.++.|++.||+|||++ ||+||||||+|||++.++ .+||+|||
T Consensus 96 lv~Ey~~~~-~~~~l~~~~---~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG 168 (350)
T d1q5ka_ 96 LVLDYVPET-VYRVARHYS---RAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFG 168 (350)
T ss_dssp EEEECCSEE-HHHHHHHHH---HTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCT
T ss_pred EEEECCCCC-CHHHHHHHH---HCCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCEEEEECCCCCEEEECCC
T ss_conf 998416886-078888631---0368999999999999999999999866---876457886037873589711673366
Q ss_pred CCCCCCCCCCCCCCCCCEEECCCCEECCCCCCC-CCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHC
Q ss_conf 642221235888754310001000005310024-7989864553035999998609999997664102479999997811
Q 000859 1101 LAKALVEDYNSNTESNTWFAGSYGYIAPEYAYS-LKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEM 1179 (1251)
Q Consensus 1101 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Diws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 1179 (1251)
+|....... ......|+..|+|||.+.+ ..++.++||||+||++|||++|+.||......+. +..........
T Consensus 169 ~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~-l~~i~~~~g~~ 242 (350)
T d1q5ka_ 169 SAKQLVRGE-----PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ-LVEIIKVLGTP 242 (350)
T ss_dssp TCEECCTTS-----CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHH-HHHHHHHHCCC
T ss_pred CHHHCCCCC-----CCCCCCCCCCCCCHHHHHCCCCCCCCEEECCCCEEEEEHHHCCCCCCCCCHHHH-HHHHHHHHCCC
T ss_conf 054404776-----532002555556827764046888210002465277855028799898799999-99999974898
Q ss_pred CCHHHHHHHCCCCCCCCC----------CHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH--HHHHCC
Q ss_conf 401255420024799999----------227999999999987453599999999999999--972109
Q 000859 1180 SGSAREELLDDQMKPLLP----------GEECAAYQVLEIALQCTKTSPQERPSSRQVCDL--LLNVFN 1236 (1251)
Q Consensus 1180 ~~~~~~~~~~~~~~~~~~----------~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~--L~~~~~ 1236 (1251)
................++ .....++++.+++.+|+..||++|||++|+++. ++++.+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~ 311 (350)
T d1q5ka_ 243 TREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD 311 (350)
T ss_dssp CHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred HHHHHHHHCCCHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCCCC
T ss_conf 177654306210110355445674444315689999999999976589557929999966984524667
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=315.37 Aligned_cols=266 Identities=23% Similarity=0.267 Sum_probs=201.6
Q ss_pred CCCCCCCEECCCCCCEEEEEEE-CCCCEEEEEEECCCC-CHHHHHHHHHHHHHHHHCCCCCCCCEECEEEECC----CCC
Q ss_conf 2999685322358803999996-599589999811577-1455699999999987104777431302154059----981
Q 000859 946 NNLSDEFIIGSGGSGTVYKAEL-ANGATVAVKKISCKD-DHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKG----AGS 1019 (1251)
Q Consensus 946 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~----~~~ 1019 (1251)
++|+..++||+|+||+||+|.. .+++.||||++.... .....+.+.+|+.++++++||||+++++++...+ ...
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCCCCCCE
T ss_conf 77599889621758599999999999899999988233697999999999999986489876489989702564345762
Q ss_pred EEEEEEECCCCCHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEECCC
Q ss_conf 16999505899957763028877324789999999999999999979863069999152499999955468987587444
Q 000859 1020 NLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDF 1099 (1251)
Q Consensus 1020 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nili~~~~~~ki~Df 1099 (1251)
.|+||||+.+ ++.+.+. ..+++..++.++.|++.|++|||+. ||+||||||+||+++.++.+|++||
T Consensus 97 ~~iv~Ey~~~-~l~~~~~---------~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df 163 (355)
T d2b1pa1 97 VYLVMELMDA-NLCQVIQ---------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDF 163 (355)
T ss_dssp EEEEEECCSE-EHHHHHT---------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC
T ss_pred EEEEEECCCH-HHHHHHH---------CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCCCCCCCCCEEEECH
T ss_conf 6999841446-7787650---------3899999999999999999886522---1124567763211365443132010
Q ss_pred CCCCCCCCCCCCCCCCCCEEECCCCEECCCCCCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHH---
Q ss_conf 56422212358887543100010000053100247989864553035999998609999997664102479999997---
Q 000859 1100 GLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMH--- 1176 (1251)
Q Consensus 1100 G~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~--- 1176 (1251)
|.++.... ........||..|+|||++.+..++.++||||+||++|||++|+.||.+...... ........
T Consensus 164 ~~~~~~~~-----~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~-~~~i~~~~~~~ 237 (355)
T d2b1pa1 164 GLARTAGT-----SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ-WNKVIEQLGTP 237 (355)
T ss_dssp CC--------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHHHCCC
T ss_pred HHHHCCCC-----CCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCCHHHH-HHHHHHHCCCC
T ss_conf 23211466-----6553322146555581331477778774333566257898659899888977889-99999720589
Q ss_pred ----HHCCCHHHHHH---------------H-CCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf ----81140125542---------------0-024799999227999999999987453599999999999999
Q 000859 1177 ----MEMSGSAREEL---------------L-DDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDL 1230 (1251)
Q Consensus 1177 ----~~~~~~~~~~~---------------~-~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 1230 (1251)
........... . ..............+.++.+++.+|++.||++|||++|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 238 CPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp CHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 87999876566777764175435666421264333543210133379999999999876994579089999669
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=310.55 Aligned_cols=269 Identities=23% Similarity=0.283 Sum_probs=201.5
Q ss_pred CCCCCCCEECCCCCCEEEEEEE-CCCCEEEEEEECCCC-CHHHHHHHHHHHHHHHHCCCCCCCCEECEEEECCCCCEEEE
Q ss_conf 2999685322358803999996-599589999811577-14556999999999871047774313021540599811699
Q 000859 946 NNLSDEFIIGSGGSGTVYKAEL-ANGATVAVKKISCKD-DHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKGAGSNLLI 1023 (1251)
Q Consensus 946 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~~lv 1023 (1251)
++|+..+.||+|+||+||+|.. .+++.||||+++... .....+.+.+|+.+++.++||||+++++++.. +...+++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~--~~~~~iv 79 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS--DKKLTLV 79 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEEEEE
T ss_pred CCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEECCCCCC--CCCEEEE
T ss_conf 99786269712868199999999999699999980321786899999999999985675788821354444--4311588
Q ss_pred EEECCCCCHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEECCCCCCC
Q ss_conf 95058999577630288773247899999999999999999798630699991524999999554689875874445642
Q 000859 1024 YEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDFGLAK 1103 (1251)
Q Consensus 1024 ~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nili~~~~~~ki~DfG~a~ 1103 (1251)
+|++.++++..+... .+.+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+|++|||.|+
T Consensus 80 ~~~~~~~~l~~~~~~-------~~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~ 149 (292)
T d1unla_ 80 FEFCDQDLKKYFDSC-------NGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLAR 149 (292)
T ss_dssp EECCSEEHHHHHHHT-------TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEECCCCCCCCCCCC-------CCCCCHHHHHHHHHHHHHHHHHHHCC---CEEEECCCCCCCCCCCCCCEEEEECCHHH
T ss_conf 630233222112123-------56540367899999999998774339---98600146761211337826652046011
Q ss_pred CCCCCCCCCCCCCCEEECCCCEECCCCCCCCC-CCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHCCCH
Q ss_conf 22123588875431000100000531002479-89864553035999998609999997664102479999997811401
Q 000859 1104 ALVEDYNSNTESNTWFAGSYGYIAPEYAYSLK-ATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHMEMSGS 1182 (1251)
Q Consensus 1104 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Diws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 1182 (1251)
....... ......++..|+|||.+.... ++.++||||+||++|||++|+.||.......................
T Consensus 150 ~~~~~~~----~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 225 (292)
T d1unla_ 150 AFGIPVR----CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEE 225 (292)
T ss_dssp ECCSCCS----CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred CCCCCCC----CCEEECCCCCHHHHHHHCCCCCCCCHHHCCCCCHHHHHHHHCCCCCCCCCCHHHHHHHHHHHCCCCCHH
T ss_conf 0468875----100103443101466750698888044402654188998518999988999999999998611899735
Q ss_pred H---HHHHHCCCC-------CCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 2---554200247-------99999227999999999987453599999999999999
Q 000859 1183 A---REELLDDQM-------KPLLPGEECAAYQVLEIALQCTKTSPQERPSSRQVCDL 1230 (1251)
Q Consensus 1183 ~---~~~~~~~~~-------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 1230 (1251)
. .....+... ..........++.+.+++.+|++.||.+|||++|+++.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 226 QWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp TCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred HHHHHHHCCCCCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 5134432221133444544310433065689999999999864996689099999649
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=306.76 Aligned_cols=266 Identities=20% Similarity=0.292 Sum_probs=199.6
Q ss_pred HCCCCCCCEECCCCCCEEEEEE-ECCCCEEEEEEECCCC-CHHHHHHHHHHHHHHHHCCCCCCCCEECEEEECC---CCC
Q ss_conf 1299968532235880399999-6599589999811577-1455699999999987104777431302154059---981
Q 000859 945 TNNLSDEFIIGSGGSGTVYKAE-LANGATVAVKKISCKD-DHLLNKSFTREVKTLGRIRHRHLVKLMGHCCNKG---AGS 1019 (1251)
Q Consensus 945 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~---~~~ 1019 (1251)
.++|+..+.||+|+||+||+|. ..+++.||||++.... .....+.+.+|+.++++++|||++++++++.... ...
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCCC
T ss_conf 98718888983178839999999999979999998820028689999999999998668987425999996346456686
Q ss_pred EEEEEEECCCCCHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEECCC
Q ss_conf 16999505899957763028877324789999999999999999979863069999152499999955468987587444
Q 000859 1020 NLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLGDF 1099 (1251)
Q Consensus 1020 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nili~~~~~~ki~Df 1099 (1251)
.+++++++.+|+|.+++.. +.+++..++.++.|++.|++|||++ ||+||||||+||+++.++.+|++||
T Consensus 97 ~~~i~~~~~gg~L~~~~~~--------~~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~df 165 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC--------QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDF 165 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT--------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC
T ss_pred EEEEEEEECCCCHHHHCCC--------CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 4999996258862320022--------4530999999999999999999738---8765166776334554322001321
Q ss_pred CCCCCCCCCCCCCCCCCCEEECCCCEECCCCCCCC-CCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHH
Q ss_conf 56422212358887543100010000053100247-98986455303599999860999999766410247999999781
Q 000859 1100 GLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSL-KATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEMHME 1178 (1251)
Q Consensus 1100 G~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Diws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~ 1178 (1251)
|.|..... ......|+..|+|||...+. .++.++||||+||++|+|++|+.||.+...... ...+.....
T Consensus 166 g~a~~~~~-------~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~--~~~i~~~~~ 236 (348)
T d2gfsa1 166 GLARHTDD-------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ--LKLILRLVG 236 (348)
T ss_dssp ----CCTG-------GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHHHC
T ss_pred CHHCCCCC-------CCCCCCCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHHH--HHHHHHHCC
T ss_conf 00012575-------444434543555835533775678551243205899999768899788988999--999997307
Q ss_pred CCC---------HHHHHHHCCC-CCCCCCCH---HHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 140---------1255420024-79999922---7999999999987453599999999999999
Q 000859 1179 MSG---------SAREELLDDQ-MKPLLPGE---ECAAYQVLEIALQCTKTSPQERPSSRQVCDL 1230 (1251)
Q Consensus 1179 ~~~---------~~~~~~~~~~-~~~~~~~~---~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 1230 (1251)
... .......... ..+..... ...++++.+++.+|++.||.+|||++|+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H 301 (348)
T d2gfsa1 237 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301 (348)
T ss_dssp CCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCCHHHHHHCCCHHHHHHHHHCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 99757732001024454443035578755566267899999999999775883459389998559
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=316.70 Aligned_cols=253 Identities=24% Similarity=0.312 Sum_probs=198.6
Q ss_pred CCCCCCCEECCCCCCEEEEEEE----CCCCEEEEEEECCCC---CHHHHHHHHHHHHHHHHCCC-CCCCCEECEEEECCC
Q ss_conf 2999685322358803999996----599589999811577---14556999999999871047-774313021540599
Q 000859 946 NNLSDEFIIGSGGSGTVYKAEL----ANGATVAVKKISCKD---DHLLNKSFTREVKTLGRIRH-RHLVKLMGHCCNKGA 1017 (1251)
Q Consensus 946 ~~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h-~niv~l~g~~~~~~~ 1017 (1251)
++|++.+.||+|+||+||+|.. .+|+.||+|++.... .....+.+.+|+.++++++| |||+++++++.+ .
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~--~ 101 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT--E 101 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE--T
T ss_pred HCEEEEEEEECCCCEEEEEEEECCCCCCCCEEEEEEEEHHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECC--C
T ss_conf 02599989832878399999987658879489999983677210168999999999999864679839996200024--8
Q ss_pred CCEEEEEEECCCCCHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEC
Q ss_conf 81169995058999577630288773247899999999999999999798630699991524999999554689875874
Q 000859 1018 GSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSNMEAHLG 1097 (1251)
Q Consensus 1018 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nili~~~~~~ki~ 1097 (1251)
...++++||+.+|+|.+++.. ...++...+..++.|++.|++|+|+. +|+||||||+||+++.++.+||+
T Consensus 102 ~~~~~v~e~~~~~~L~~~i~~-------~~~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~ 171 (322)
T d1vzoa_ 102 TKLHLILDYINGGELFTHLSQ-------RERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLT 171 (322)
T ss_dssp TEEEEEECCCCSCBHHHHHHH-------HSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEES
T ss_pred CCEEEEEECCCCCHHHHHHHH-------CCCCCHHHHHHHHHHHHHHHHHHHCC---CEEECCCCCCCEEECCCCCEEEE
T ss_conf 730012312341179999873-------04543788888899999999885149---98965477320124699988874
Q ss_pred CCCCCCCCCCCCCCCCCCCCEEECCCCEECCCCCCCC--CCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHH
Q ss_conf 4456422212358887543100010000053100247--98986455303599999860999999766410247999999
Q 000859 1098 DFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSL--KATEKCDVYSMGIVLMELVSGKMPTDATFGVEMDMVRWVEM 1175 (1251)
Q Consensus 1098 DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Diws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~ 1175 (1251)
|||.|+.+..... .......|++.|+|||.+.+. .++.++||||+||++|||++|+.||......+........
T Consensus 172 DFG~a~~~~~~~~---~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~- 247 (322)
T d1vzoa_ 172 DFGLSKEFVADET---ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRR- 247 (322)
T ss_dssp CSSEEEECCGGGG---GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHH-
T ss_pred ECCCHHHHCCCCC---CCCCCCCCCCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHH-
T ss_conf 1320222034444---322122233333106876057768871325177779999997689998888777799999983-
Q ss_pred HHHCCCHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCC-----HHHHHH
Q ss_conf 781140125542002479999922799999999998745359999999-----999999
Q 000859 1176 HMEMSGSAREELLDDQMKPLLPGEECAAYQVLEIALQCTKTSPQERPS-----SRQVCD 1229 (1251)
Q Consensus 1176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~eil~ 1229 (1251)
.. ....+.+...++++.+++.+||+.||.+||| ++|+++
T Consensus 248 ~~---------------~~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 248 IL---------------KSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp HH---------------HCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred CC---------------CCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCCCCCCHHHHHC
T ss_conf 35---------------689988654799999999997445898819997450999974
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=0 Score=283.82 Aligned_cols=268 Identities=19% Similarity=0.256 Sum_probs=193.8
Q ss_pred CCCCCCCEECCCCCCEEEEEEE-CCCCEEEEEEECCCCCHHHHHHHHHHHHHHHHCC-----------CCCCCCEECEEE
Q ss_conf 2999685322358803999996-5995899998115771455699999999987104-----------777431302154
Q 000859 946 NNLSDEFIIGSGGSGTVYKAEL-ANGATVAVKKISCKDDHLLNKSFTREVKTLGRIR-----------HRHLVKLMGHCC 1013 (1251)
Q Consensus 946 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~g~~~ 1013 (1251)
.+|++.+.||+|+||+||+|.. .+++.||||+++.. ....+.+.+|+.+++.++ |+||+++++++.
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~--~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~ 90 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD--KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 90 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECC--CCCHHHHHHHHHHHHHHCCHHHHHHHHCCCCCEEEEEEEEE
T ss_conf 8579989975077818999999999979999998343--13368999999999984014555554227676478998763
Q ss_pred ECCCCCEEEEEEECCCCCHHHH-HHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCCCEEECCCCCCCEEECCC
Q ss_conf 0599811699950589995776-30288773247899999999999999999798630-699991524999999554689
Q 000859 1014 NKGAGSNLLIYEYMENGSVWDW-LHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHH-DCVPKILHRDIKSSNILLDSN 1091 (1251)
Q Consensus 1014 ~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~Dlk~~Nili~~~ 1091 (1251)
...+...++++++...+..... ..... ...+++..+..++.|++.|++|||+ . ||+||||||+|||++.+
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~~ 162 (362)
T d1q8ya_ 91 HKGPNGVHVVMVFEVLGENLLALIKKYE-----HRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIV 162 (362)
T ss_dssp EEETTEEEEEEEECCCCEEHHHHHHHTT-----TSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEEE
T ss_pred ECCCCCEEEEEEECCCCCCCCCCCCCCC-----CCCCCHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHEEEECC
T ss_conf 1256520234320003542000001223-----467868999999999999988876405---86465677057056305
Q ss_pred CC------EEECCCCCCCCCCCCCCCCCCCCCEEECCCCEECCCCCCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCC
Q ss_conf 87------587444564222123588875431000100000531002479898645530359999986099999976641
Q 000859 1092 ME------AHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPEYAYSLKATEKCDVYSMGIVLMELVSGKMPTDATFGV 1165 (1251)
Q Consensus 1092 ~~------~ki~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diws~Gvil~elltg~~p~~~~~~~ 1165 (1251)
+. ++++|||.|...... .....|++.|+|||++....++.++||||+|+++++|++|+.||......
T Consensus 163 ~~~~~~~~~kl~dfg~s~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~ 235 (362)
T d1q8ya_ 163 DSPENLIQIKIADLGNACWYDEH-------YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGH 235 (362)
T ss_dssp ETTTTEEEEEECCCTTCEETTBC-------CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC------
T ss_pred CCCCCCCEEEEEECCCCCCCCCC-------CCCCCCCCCCCCHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCC
T ss_conf 76564430567531442123445-------42236652105713214667776432012378999998788998987554
Q ss_pred CH-HHHHHHHHHHHCCCHHH----------HHHHCC-----CCC------------CCCCCHHHHHHHHHHHHHHCCCCC
Q ss_conf 02-47999999781140125----------542002-----479------------999922799999999998745359
Q 000859 1166 EM-DMVRWVEMHMEMSGSAR----------EELLDD-----QMK------------PLLPGEECAAYQVLEIALQCTKTS 1217 (1251)
Q Consensus 1166 ~~-~~~~~~~~~~~~~~~~~----------~~~~~~-----~~~------------~~~~~~~~~~~~l~~li~~cl~~d 1217 (1251)
.. .............+... ....+. ... .........+.++.+++.+|+..|
T Consensus 236 ~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~d 315 (362)
T d1q8ya_ 236 SYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLD 315 (362)
T ss_dssp ---CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSS
T ss_pred CCCCHHHHHHHHHHHHCCCCHHHHHCCCCCCCCCCCCHHHHCCCCCCCCCHHHHCCCCCCCCCCCCHHHHHHHHHHCCCC
T ss_conf 32102689999999837998788624532200013201220243235776444210001567435899999999987799
Q ss_pred CCCCCCHHHHHHH
Q ss_conf 9999999999999
Q 000859 1218 PQERPSSRQVCDL 1230 (1251)
Q Consensus 1218 P~~RPs~~eil~~ 1230 (1251)
|.+|||++|+++.
T Consensus 316 P~~Rpta~e~L~H 328 (362)
T d1q8ya_ 316 PRKRADAGGLVNH 328 (362)
T ss_dssp TTTCBCHHHHHTC
T ss_pred HHHCCCHHHHHCC
T ss_conf 4579089999669
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=100.00 E-value=2.3e-38 Score=226.44 Aligned_cols=355 Identities=26% Similarity=0.310 Sum_probs=0.0
Q ss_pred ECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCC
Q ss_conf 12677889989865654443422345678899999976733445133211333568778443898887533301423688
Q 000859 150 IGDNWLSGSIPTSFGNLVNLGTLGLASCSLSGPIPPQFGQLSQLEELILQQNQLQGPIPAELGNCSSLSIFTAAENNLNG 229 (1251)
Q Consensus 150 L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~ 229 (1251)
++.+.+++.+.. ..+.+|+.|++++|.++.. +.+..+++|++|++++|++++..+ ++++++|+.|++++|++.+
T Consensus 29 l~~~~~~~~~~~--~~l~~l~~L~l~~~~I~~l--~gl~~L~nL~~L~Ls~N~l~~l~~--l~~L~~L~~L~L~~n~i~~ 102 (384)
T d2omza2 29 LGKTNVTDTVSQ--TDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIAD 102 (384)
T ss_dssp TTCSSTTSEECH--HHHTTCCEEECCSSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC
T ss_pred HCCCCCCCCCCH--HHHCCCCEEECCCCCCCCC--CCCCCCCCCCEEECCCCCCCCCCC--CCCCCCCCCCCCCCCCCCC
T ss_conf 677777886398--8957878998999898776--242458999989681881798863--3477110103013433322
Q ss_pred CCHHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCC
Q ss_conf 70222026445864654476688878955368776655534476246867723235787358980154224998974244
Q 000859 230 SIPAALGRLQNLQLLNLGNNSLSGEIPSELGELSQLGYLNLMGNRLEGAIPRSFAKMGNLQSLDLSMNRLTGGIPEEFGN 309 (1251)
Q Consensus 230 ~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~l~~ 309 (1251)
..+ ++.+++|+.|+++++.+++. ........+..+....|.+....+..................+. .+..
T Consensus 103 i~~--l~~l~~L~~L~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~ 173 (384)
T d2omza2 103 ITP--LANLTNLTGLTLFNNQITDI--DPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLK-----PLAN 173 (384)
T ss_dssp CGG--GTTCTTCCEEECCSSCCCCC--GGGTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCCG-----GGTT
T ss_pred CCC--CCCCCCCCCCCCCCCCCCCC--CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHH-----HHCC
T ss_conf 221--11233433344332222222--22222222211213466313100232222112222212322011-----1124
Q ss_pred CCCEEEEECCCCCCCCCCCCCCCCCCCCHHHHHCCCHHCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEE
Q ss_conf 55337999027504676661001463310244400100136789576677878658855873557865111123456489
Q 000859 310 MGQLVFLVLSNNNISGSIPRRICTNATSLEHLILAEIQLSGEIPVELSQCQSLKQLDLSNNTLNGTIPVELFQLVALTHL 389 (1251)
Q Consensus 310 l~~L~~L~Ls~N~l~~~i~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L 389 (1251)
...........|.. .....+..+++++.+++++|.+.+..+ .....+|+.|
T Consensus 174 ~~~~~~~~~~~~~~---------------------------~~~~~~~~l~~~~~l~l~~n~i~~~~~--~~~~~~L~~L 224 (384)
T d2omza2 174 LTTLERLDISSNKV---------------------------SDISVLAKLTNLESLIATNNQISDITP--LGILTNLDEL 224 (384)
T ss_dssp CTTCCEEECCSSCC---------------------------CCCGGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEE
T ss_pred CCCCCCCCCCCCCC---------------------------CCCCCCCCCCCCCEEECCCCCCCCCCC--CCCCCCCCEE
T ss_conf 54211011222433---------------------------321100223532333035774478786--4445778788
Q ss_pred EEECCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCHHHHCCCCCCHHHCCCCCCCCCCCCCCCCCCCCCEEECCCCCCC
Q ss_conf 96256433665100024455637870145568997332100000003202568102312577678775645760488555
Q 000859 390 YLHNNSLVGSISPFVANLSNLQELALYHNNFQGSLPREIGMLVKLELLYLYDNHLSGQIPSEVGNCSSLKWIDFFGNSFT 469 (1251)
Q Consensus 390 ~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~l~~N~l~ 469 (1251)
++++|.+.... .+..+++|+.+++++|.+++..+ +..+++|+.|++++|.+++..+ +..+..++.+.+..|.++
T Consensus 225 ~l~~n~l~~~~--~l~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~~~l~~~~~--~~~~~~l~~l~~~~n~l~ 298 (384)
T d2omza2 225 SLNGNQLKDIG--TLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLE 298 (384)
T ss_dssp ECCSSCCCCCG--GGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCS
T ss_pred ECCCCCCCCCC--HHHCCCCCCHHCCCCCCCCCCCC--CCCCCCCCEEECCCCCCCCCCC--CCCCCCCCCCCCCCCCCC
T ss_conf 88777778961--34325653410044674478775--3554668775456744578773--235652222332323333
Q ss_pred CCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCHHCCCHHHHHHCCCCCCCCCCCHHHH
Q ss_conf 78899543558776895557735788670001544587662688858645995100101015652037855667733444
Q 000859 470 GEIPTSIGRLKDLNFLHLRQNELVGQIPASLGNCHQLIILDLADNKLSGGVPASFGFLQALEQLMLYNNSLEGNLPGSLI 549 (1251)
Q Consensus 470 ~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~ 549 (1251)
+ ...+..+++++.|++++|++++..+ +..+++|+.|++++|+|++.. .+..+++|++|++++|.+++..+ +.
T Consensus 299 ~--~~~~~~~~~l~~L~ls~n~l~~l~~--l~~l~~L~~L~L~~n~l~~l~--~l~~l~~L~~L~l~~N~l~~l~~--l~ 370 (384)
T d2omza2 299 D--ISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSDVS--SLANLTNINWLSAGHNQISDLTP--LA 370 (384)
T ss_dssp C--CGGGGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCCCG--GGGGCTTCCEEECCSSCCCBCGG--GT
T ss_pred C--CCCCCHHCCCCEEECCCCCCCCCCC--CCCCCCCCEEECCCCCCCCCH--HHCCCCCCCEEECCCCCCCCCHH--HC
T ss_conf 3--2210000246767777887789845--366898898989899899974--67089999989897995899800--00
Q ss_pred HHCCCCEEECCCC
Q ss_conf 1037771430255
Q 000859 550 NLRNLTRINFSKN 562 (1251)
Q Consensus 550 ~l~~L~~L~l~~N 562 (1251)
++++|+.|++++|
T Consensus 371 ~l~~L~~L~L~~N 383 (384)
T d2omza2 371 NLTRITQLGLNDQ 383 (384)
T ss_dssp TCTTCSEEECCCE
T ss_pred CCCCCCEEECCCC
T ss_conf 3999999639789
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=2.8e-40 Score=237.05 Aligned_cols=249 Identities=31% Similarity=0.474 Sum_probs=198.8
Q ss_pred CCCCEEECCCCCCCC--CCCCCCCCCCCCCEEECCC-CCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCC
Q ss_conf 950199865898889--8674322667663886224-4545888753578755557881267788998986565444342
Q 000859 95 QSLIHLDLSSNSLTG--PIPTALSNLSSLESLLLFS-NQLAGTIPTQLGSLTSLRVMRIGDNWLSGSIPTSFGNLVNLGT 171 (1251)
Q Consensus 95 ~~L~~L~l~~n~~~~--~~p~~~~~l~~L~~L~L~~-n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~ 171 (1251)
.+++.|+|+++++.| .+|.++++|++|++|+|++ |.++|.+|..|+++++|++|+|++|++.+..+..+..+..|+.
T Consensus 50 ~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~ 129 (313)
T d1ogqa_ 50 YRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVT 129 (313)
T ss_dssp CCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCE
T ss_pred EEEEEEECCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCHHHHCC
T ss_conf 79889989899888888798478467533520202654333002431145420011020356434433222220111001
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCC-CEEECCCCCCCCCCHHHHCCCCCCCEEECCCCC
Q ss_conf 2345678899999976733445133211333568778443898887-533301423688702220264458646544766
Q 000859 172 LGLASCSLSGPIPPQFGQLSQLEELILQQNQLQGPIPAELGNCSSL-SIFTAAENNLNGSIPAALGRLQNLQLLNLGNNS 250 (1251)
Q Consensus 172 L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L-~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~ 250 (1251)
+++++|.+.+.+|..+++++.++++++++|.+.+.+|..+..+.++ +.+.++.|++++..+..+..+..+ .++++.+.
T Consensus 130 l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~~ 208 (313)
T d1ogqa_ 130 LDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-FVDLSRNM 208 (313)
T ss_dssp EECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-EEECCSSE
T ss_pred CCCCCCCCCCCCCHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCC
T ss_conf 11122455556851220674000000235533562031214431123231022464353324332222222-33333343
Q ss_pred CCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCEEEEECCCCCCCCCCCCC
Q ss_conf 88878955368776655534476246867723235787358980154224998974244553379990275046766610
Q 000859 251 LSGEIPSELGELSQLGYLNLMGNRLEGAIPRSFAKMGNLQSLDLSMNRLTGGIPEEFGNMGQLVFLVLSNNNISGSIPRR 330 (1251)
Q Consensus 251 l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~i~~~ 330 (1251)
..+.++..+..++.++.+++++|.+.+.++ .+..+++|+.|++++|++++.+|..++.+++|++|+|++|+++|.+|.
T Consensus 209 ~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~- 286 (313)
T d1ogqa_ 209 LEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ- 286 (313)
T ss_dssp EEECCGGGCCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCC-
T ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCEECCCCCHHHHCCCCCCEEECCCCCCCCCCCC-
T ss_conf 322222222222221112222222222222-222455444444765706660876884799999897958835166898-
Q ss_pred CCCCCCCHHHHHCCCHH
Q ss_conf 01463310244400100
Q 000859 331 ICTNATSLEHLILAEIQ 347 (1251)
Q Consensus 331 ~~~~~~~L~~L~L~~n~ 347 (1251)
+..+.+|+.+++.+|+
T Consensus 287 -~~~L~~L~~l~l~~N~ 302 (313)
T d1ogqa_ 287 -GGNLQRFDVSAYANNK 302 (313)
T ss_dssp -STTGGGSCGGGTCSSS
T ss_pred -CCCCCCCCHHHHCCCC
T ss_conf -6667998978868895
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=9.1e-35 Score=206.44 Aligned_cols=244 Identities=24% Similarity=0.340 Sum_probs=99.4
Q ss_pred CCCCCCEEECCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCC
Q ss_conf 98630179949997379800477667888788878889501998658988898674322667663886224454588875
Q 000859 58 LCTWRGITCGSSSARVVSLNLSGLSLAGSISPSLGRLQSLIHLDLSSNSLTGPIPTALSNLSSLESLLLFSNQLAGTIPT 137 (1251)
Q Consensus 58 ~c~w~gv~C~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~ 137 (1251)
-|.|++|.|+.. ++. .+|+.+. +.+++|+|++|+++...+.+|.++++|++|++++|.+....|.
T Consensus 9 ~c~~~~~~C~~~------------~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~ 73 (305)
T d1xkua_ 9 QCHLRVVQCSDL------------GLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPG 73 (305)
T ss_dssp EEETTEEECTTS------------CCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTT
T ss_pred EECCCEEEECCC------------CCC-CCCCCCC--CCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCHH
T ss_conf 955999985599------------988-5198889--9979897849918986965760465652311234434452356
Q ss_pred CCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEECCCCC--CCCCCCCCCCCC
Q ss_conf 357875555788126778899898656544434223456788999999767334451332113335--687784438988
Q 000859 138 QLGSLTSLRVMRIGDNWLSGSIPTSFGNLVNLGTLGLASCSLSGPIPPQFGQLSQLEELILQQNQL--QGPIPAELGNCS 215 (1251)
Q Consensus 138 ~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l--~~~~p~~~~~l~ 215 (1251)
.|.++++|++|++++|+++. +|..+. ..+..|.+..|.+.+..+..+.....+..+....|.. ....+..+..++
T Consensus 74 ~f~~l~~L~~L~l~~n~l~~-l~~~~~--~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~ 150 (305)
T d1xkua_ 74 AFAPLVKLERLYLSKNQLKE-LPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMK 150 (305)
T ss_dssp TTTTCTTCCEEECCSSCCSB-CCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCT
T ss_pred HHHCCCCCCEECCCCCCCCC-CCCCHH--HHHHHHHCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 65279855783156875676-764001--113232102461023444454013311000012333334677764223456
Q ss_pred CCCEEECCCCCCCCCCHHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEEC
Q ss_conf 87533301423688702220264458646544766888789553687766555344762468677232357873589801
Q 000859 216 SLSIFTAAENNLNGSIPAALGRLQNLQLLNLGNNSLSGEIPSELGELSQLGYLNLMGNRLEGAIPRSFAKMGNLQSLDLS 295 (1251)
Q Consensus 216 ~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls 295 (1251)
+|+.+++++|.+... +.. .+++|+.|++++|.+....+..+..++.++.|++++|.+....+..+.++++|+.|+++
T Consensus 151 ~L~~l~l~~n~l~~l-~~~--~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~ 227 (305)
T d1xkua_ 151 KLSYIRIADTNITTI-PQG--LPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLN 227 (305)
T ss_dssp TCCEEECCSSCCCSC-CSS--CCTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECC
T ss_pred CCCCCCCCCCCCCCC-CCC--CCCCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEECC
T ss_conf 567120346774516-710--17766789897886778882676413413301544553322234543344332243025
Q ss_pred CCCCCCCCCCCCCCCCCEEEEECCCCCC
Q ss_conf 5422499897424455337999027504
Q 000859 296 MNRLTGGIPEEFGNMGQLVFLVLSNNNI 323 (1251)
Q Consensus 296 ~n~l~~~~~~~l~~l~~L~~L~Ls~N~l 323 (1251)
+|++. .+|.++..+++|++|++++|++
T Consensus 228 ~N~L~-~lp~~l~~l~~L~~L~Ls~N~i 254 (305)
T d1xkua_ 228 NNKLV-KVPGGLADHKYIQVVYLHNNNI 254 (305)
T ss_dssp SSCCS-SCCTTTTTCSSCCEEECCSSCC
T ss_pred CCCCC-CCCCCCCCCCCCCEEECCCCCC
T ss_conf 54002-4631103346789898989865
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=2.5e-34 Score=203.97 Aligned_cols=40 Identities=25% Similarity=0.363 Sum_probs=12.8
Q ss_pred CCCCCCCCEECCCCCCCCCCCCCCCCCCCCCCEEECCCCCC
Q ss_conf 47987784511478767799873225456555565037515
Q 000859 715 VGNLASLNVLTLSGNLLSGPIPPAIGRLSKLYELRLSNNSL 755 (1251)
Q Consensus 715 ~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l 755 (1251)
+..+++|++|+|++|+++ .+|..+..+++|+.|++++|+|
T Consensus 215 ~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i 254 (305)
T d1xkua_ 215 LANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNI 254 (305)
T ss_dssp GGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCC
T ss_pred CCCCCCCEEEECCCCCCC-CCCCCCCCCCCCCEEECCCCCC
T ss_conf 334433224302554002-4631103346789898989865
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-34 Score=201.43 Aligned_cols=234 Identities=24% Similarity=0.284 Sum_probs=119.3
Q ss_pred CEEECCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCC
Q ss_conf 17994999737980047766788878887888950199865898889867432266766388622445458887535787
Q 000859 63 GITCGSSSARVVSLNLSGLSLAGSISPSLGRLQSLIHLDLSSNSLTGPIPTALSNLSSLESLLLFSNQLAGTIPTQLGSL 142 (1251)
Q Consensus 63 gv~C~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l 142 (1251)
++.|.....-++ +.++.++. .+|..+. +.+++|+|++|+|+..-+.+|.++++|++|++++|.+.+..+..+..+
T Consensus 5 ~C~C~~~~~~~v--~c~~~~L~-~iP~~ip--~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~ 79 (284)
T d1ozna_ 5 ACVCYNEPKVTT--SCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGL 79 (284)
T ss_dssp TCEEECSSSCEE--ECCSSCCS-SCCTTCC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTC
T ss_pred CCEECCCCCEEE--ECCCCCCC-CCCCCCC--CCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 889869999699--84799989-4497889--998889774881798797786414213000013445433211121222
Q ss_pred CCCCEEEEC-CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCEEE
Q ss_conf 555578812-6778899898656544434223456788999999767334451332113335687784438988875333
Q 000859 143 TSLRVMRIG-DNWLSGSIPTSFGNLVNLGTLGLASCSLSGPIPPQFGQLSQLEELILQQNQLQGPIPAELGNCSSLSIFT 221 (1251)
Q Consensus 143 ~~L~~L~L~-~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~ 221 (1251)
..++.+... .|.++...+.+|+++++|+.|++++|.+....+..+....+|+.+++++|.+++..+..|..+++
T Consensus 80 ~~~~~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~----- 154 (284)
T d1ozna_ 80 ALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGN----- 154 (284)
T ss_dssp TTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTT-----
T ss_pred CCCCCCCCCCCCCCCCCCCHHHCCCCCCCEEECCCCCCCCCCCCCCCHHCCCCHHHHCCCCCCCCCHHHHCCCCC-----
T ss_conf 222222222102235446201010102778756885443201353320001211020014314458057404340-----
Q ss_pred CCCCCCCCCCHHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEECCCCCCC
Q ss_conf 01423688702220264458646544766888789553687766555344762468677232357873589801542249
Q 000859 222 AAENNLNGSIPAALGRLQNLQLLNLGNNSLSGEIPSELGELSQLGYLNLMGNRLEGAIPRSFAKMGNLQSLDLSMNRLTG 301 (1251)
Q Consensus 222 l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~ 301 (1251)
|+.|++++|.++...+..|.++++|+++++++|++.+..|..|..+++|+.|++++|++.+
T Consensus 155 -------------------L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~ 215 (284)
T d1ozna_ 155 -------------------LTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSA 215 (284)
T ss_dssp -------------------CCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSC
T ss_pred -------------------HHHCCCCCCCCCCCCHHHHCCCCCCCHHHHHHCCCCCCCHHHHHHHHHCCCCCCCCCCCCC
T ss_conf -------------------5022314176566256665465634131421143466281676653200023333352210
Q ss_pred CCCCCCCCCCCEEEEECCCCCCCC
Q ss_conf 989742445533799902750467
Q 000859 302 GIPEEFGNMGQLVFLVLSNNNISG 325 (1251)
Q Consensus 302 ~~~~~l~~l~~L~~L~Ls~N~l~~ 325 (1251)
..+..|..+++|++|++++|++.+
T Consensus 216 ~~~~~~~~~~~L~~L~l~~N~l~C 239 (284)
T d1ozna_ 216 LPTEALAPLRALQYLRLNDNPWVC 239 (284)
T ss_dssp CCHHHHTTCTTCCEEECCSSCEEC
T ss_pred CCCCCCCCCCCCCEEEECCCCCCC
T ss_conf 000023554656889811998878
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-34 Score=201.46 Aligned_cols=141 Identities=26% Similarity=0.211 Sum_probs=66.4
Q ss_pred CCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 75322344456687027734388983000257753898579946899863149976534112447311488830013644
Q 000859 616 PWTFGKIRELSLLDLSGNSLTGPIPTQLLMCKKLSHIDLNNNLLSGAVPSWLGTLPQLGELKLSFNQFVGFLPRELFNCS 695 (1251)
Q Consensus 616 ~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~ 695 (1251)
+..|..+++|+.|++++|.+....+..+...++|+.+++++|.++.+.+..+..+++|+.|++++|.+.++.+..+..++
T Consensus 98 ~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~ 177 (284)
T d1ozna_ 98 PATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLH 177 (284)
T ss_dssp TTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCT
T ss_pred CHHHCCCCCCCEEECCCCCCCCCCCCCCCHHCCCCHHHHCCCCCCCCCHHHHCCCCCHHHCCCCCCCCCCCCHHHHCCCC
T ss_conf 20101010277875688544320135332000121102001431445805740434050223141765662566654656
Q ss_pred CCCEEECCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCCCCCCCCCCCCEEECCCCCCC
Q ss_conf 4525520373212456823479877845114787677998732254565555650375155
Q 000859 696 KLLVLSLDGNMLNGSLPNEVGNLASLNVLTLSGNLLSGPIPPAIGRLSKLYELRLSNNSLN 756 (1251)
Q Consensus 696 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~ 756 (1251)
+|+.+++++|+++...|..|..+++|++|++++|++.+..+..++.+++|++|++++|++.
T Consensus 178 ~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~ 238 (284)
T d1ozna_ 178 SLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWV 238 (284)
T ss_dssp TCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEE
T ss_pred CCCHHHHHHCCCCCCCHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCEEEECCCCCC
T ss_conf 3413142114346628167665320002333335221000002355465688981199887
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=5.1e-32 Score=191.14 Aligned_cols=20 Identities=20% Similarity=-0.064 Sum_probs=6.2
Q ss_pred CHHHHHCCCCCCEEECCCCC
Q ss_conf 35553016889376103667
Q 000859 809 PSQLGEMSSLGKLNLSYNDL 828 (1251)
Q Consensus 809 p~~l~~l~~l~~l~l~~N~l 828 (1251)
|..+..+++|+.|+|++||+
T Consensus 188 p~~~~~~~~L~~L~L~~Np~ 207 (266)
T d1p9ag_ 188 PKGFFGSHLLPFAFLHGNPW 207 (266)
T ss_dssp CTTTTTTCCCSEEECCSCCB
T ss_pred CHHHCCCCCCCEEEECCCCC
T ss_conf 86677788899998369998
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.4e-29 Score=177.55 Aligned_cols=36 Identities=28% Similarity=0.151 Sum_probs=12.6
Q ss_pred CCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCC
Q ss_conf 019986589888986743226676638862244545
Q 000859 97 LIHLDLSSNSLTGPIPTALSNLSSLESLLLFSNQLA 132 (1251)
Q Consensus 97 L~~L~l~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~ 132 (1251)
+++|+|++|.+++..+.+|.++++|++|+|++|.++
T Consensus 33 l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~ 68 (266)
T d1p9ag_ 33 TTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT 68 (266)
T ss_dssp CCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC
T ss_pred CCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCC
T ss_conf 898988499289859778634565522135665444
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.95 E-value=2.2e-26 Score=159.81 Aligned_cols=13 Identities=46% Similarity=0.516 Sum_probs=4.4
Q ss_pred CCCEEECCCCCCC
Q ss_conf 6638862244545
Q 000859 120 SLESLLLFSNQLA 132 (1251)
Q Consensus 120 ~L~~L~L~~n~~~ 132 (1251)
+|++|+|++|+++
T Consensus 59 ~L~~L~Ls~N~l~ 71 (353)
T d1jl5a_ 59 HLESLVASCNSLT 71 (353)
T ss_dssp TCSEEECCSSCCS
T ss_pred CCCEEECCCCCCC
T ss_conf 9888989999796
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.94 E-value=2.4e-27 Score=165.20 Aligned_cols=166 Identities=16% Similarity=0.173 Sum_probs=118.7
Q ss_pred CCCCEECCCCCCEEEEEEECCCCEEEEEEECCCCC-----------------HHHHHHHHHHHHHHHHCCCCCCCCEECE
Q ss_conf 96853223588039999965995899998115771-----------------4556999999999871047774313021
Q 000859 949 SDEFIIGSGGSGTVYKAELANGATVAVKKISCKDD-----------------HLLNKSFTREVKTLGRIRHRHLVKLMGH 1011 (1251)
Q Consensus 949 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-----------------~~~~~~~~~E~~~l~~l~h~niv~l~g~ 1011 (1251)
.+.++||+|+||+||+|...+|+.||||+++.... .........|...+.++.|.+++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred HHCCEEEECCCEEEEEEECCCCCEEEEEEEECCCCHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEE
T ss_conf 22778024856599999979999999999860443466655656300088899999977899999998169991449986
Q ss_pred EEECCCCCEEEEEEECCCCCHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCC
Q ss_conf 54059981169995058999577630288773247899999999999999999798630699991524999999554689
Q 000859 1012 CCNKGAGSNLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHDCVPKILHRDIKSSNILLDSN 1091 (1251)
Q Consensus 1012 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nili~~~ 1091 (1251)
. . .+++||+++++...+ ++.....+++.|++.+++|||++ ||+||||||+|||++++
T Consensus 83 ~----~--~~lvme~~~~~~~~~--------------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~ 139 (191)
T d1zara2 83 E----G--NAVLMELIDAKELYR--------------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE 139 (191)
T ss_dssp E----T--TEEEEECCCCEEGGG--------------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT
T ss_pred C----C--CEEEEEEECCCCCCC--------------HHHHHHHHHHHHHHHHHHHHHHC---CEEECCCCHHHEEEECC
T ss_conf 2----8--889999504565420--------------01578999999999999998268---88983689036114289
Q ss_pred CCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCEECCC-----CCCCCCCCCCCCEEEHHHHHH
Q ss_conf 87587444564222123588875431000100000531-----002479898645530359999
Q 000859 1092 MEAHLGDFGLAKALVEDYNSNTESNTWFAGSYGYIAPE-----YAYSLKATEKCDVYSMGIVLM 1150 (1251)
Q Consensus 1092 ~~~ki~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE-----~~~~~~~~~~~Diws~Gvil~ 1150 (1251)
.++++|||.|+....+. ...|.... .+..+.|+.++|+||..--+.
T Consensus 140 -~~~liDFG~a~~~~~~~------------~~~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~~ 190 (191)
T d1zara2 140 -GIWIIDFPQSVEVGEEG------------WREILERDVRNIITYFSRTYRTEKDINSAIDRIL 190 (191)
T ss_dssp -EEEECCCTTCEETTSTT------------HHHHHHHHHHHHHHHHHHHHCCCCCHHHHHHHHH
T ss_pred -CEEEEECCCCCCCCCCC------------CHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH
T ss_conf -89998778843089987------------0999987799999997578998446899999874
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=2.9e-30 Score=181.41 Aligned_cols=11 Identities=36% Similarity=0.159 Sum_probs=3.7
Q ss_pred CCEEECCCCCC
Q ss_conf 30798368812
Q 000859 794 LEVLNLSHNQL 804 (1251)
Q Consensus 794 L~~L~l~~N~l 804 (1251)
|+.|++++|.+
T Consensus 428 L~~l~l~~~~~ 438 (460)
T d1z7xw1 428 LEQLVLYDIYW 438 (460)
T ss_dssp CCEEECTTCCC
T ss_pred CCEEECCCCCC
T ss_conf 67898989878
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=2e-24 Score=148.88 Aligned_cols=221 Identities=21% Similarity=0.177 Sum_probs=105.1
Q ss_pred CCCCCEEECCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCC-CC
Q ss_conf 86301799499973798004776678887888788895019986589888986743226676638862244545888-75
Q 000859 59 CTWRGITCGSSSARVVSLNLSGLSLAGSISPSLGRLQSLIHLDLSSNSLTGPIPTALSNLSSLESLLLFSNQLAGTI-PT 137 (1251)
Q Consensus 59 c~w~gv~C~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~-p~ 137 (1251)
|+++.|.|.. .++. .+|+.+. +.+++|++++|.++...+.+|.++++|++|++++|.+...+ +.
T Consensus 8 C~~~~i~c~~------------~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~ 72 (242)
T d1xwdc1 8 CSNRVFLCQE------------SKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEAD 72 (242)
T ss_dssp ECSSEEEEES------------CSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSS
T ss_pred CCCCEEEEEC------------CCCC-CCCCCCC--CCCCEEECCCCCCCCCCHHHHHCCCHHHHHHHCCCCCCCEEECC
T ss_conf 7399999818------------9988-7688889--98899987699189649668614643232110221124201001
Q ss_pred CCCCCCCCCEEEECC-CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCEEEECCCCCCCCCCCCCCCCC
Q ss_conf 357875555788126-778899898656544434223456788999999-767334451332113335687784438988
Q 000859 138 QLGSLTSLRVMRIGD-NWLSGSIPTSFGNLVNLGTLGLASCSLSGPIPP-QFGQLSQLEELILQQNQLQGPIPAELGNCS 215 (1251)
Q Consensus 138 ~~~~l~~L~~L~L~~-n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~-~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~ 215 (1251)
.|.+++.++++.+.. |.+....+..|.++++|+.+++++|.+....+. .+..+..+..+...++.+....+..|.+++
T Consensus 73 ~f~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~ 152 (242)
T d1xwdc1 73 VFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLS 152 (242)
T ss_dssp SEESCTTCCEEEEECCTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSB
T ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 12222222221111123432222221222222222234211112554333222111122222221211122222222223
Q ss_pred CCCEEECCCCCCCCCCHHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEE-ECCCCCCCCCCCCCCCCCCCCCEEEE
Q ss_conf 87533301423688702220264458646544766888789553687766555-34476246867723235787358980
Q 000859 216 SLSIFTAAENNLNGSIPAALGRLQNLQLLNLGNNSLSGEIPSELGELSQLGYL-NLMGNRLEGAIPRSFAKMGNLQSLDL 294 (1251)
Q Consensus 216 ~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L-~L~~n~l~~~~~~~~~~l~~L~~L~L 294 (1251)
..++.|++++|.++...+..+ ..+++..+ ++++|.++.+.+..|.++++|+.|++
T Consensus 153 -----------------------~~l~~L~l~~n~l~~i~~~~~-~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~L 208 (242)
T d1xwdc1 153 -----------------------FESVILWLNKNGIQEIHNCAF-NGTQLDELNLSDNNNLEELPNDVFHGASGPVILDI 208 (242)
T ss_dssp -----------------------SSCEEEECCSSCCCEECTTTT-TTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEEC
T ss_pred -----------------------CCCEEEECCCCCCCCCCCCCC-CCHHHHCCCCCCCCCCCCCCHHHHCCCCCCCEEEC
T ss_conf -----------------------310012200123333222222-20111012123543246424788668999998989
Q ss_pred CCCCCCCCCCCCCCCCCCEEEEEC
Q ss_conf 154224998974244553379990
Q 000859 295 SMNRLTGGIPEEFGNMGQLVFLVL 318 (1251)
Q Consensus 295 s~n~l~~~~~~~l~~l~~L~~L~L 318 (1251)
++|++....+..|.++++|+.+++
T Consensus 209 s~N~l~~l~~~~~~~l~~L~~l~~ 232 (242)
T d1xwdc1 209 SRTRIHSLPSYGLENLKKLRARST 232 (242)
T ss_dssp TTSCCCCCCSSSCTTCCEEESSSE
T ss_pred CCCCCCCCCHHHHCCCCCCCCCCC
T ss_conf 799289459779737713414767
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.91 E-value=6.8e-24 Score=145.96 Aligned_cols=206 Identities=24% Similarity=0.356 Sum_probs=0.0
Q ss_pred EEEECCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEECC
Q ss_conf 79800477667888788878889501998658988898674322667663886224454588875357875555788126
Q 000859 73 VVSLNLSGLSLAGSISPSLGRLQSLIHLDLSSNSLTGPIPTALSNLSSLESLLLFSNQLAGTIPTQLGSLTSLRVMRIGD 152 (1251)
Q Consensus 73 v~~l~l~~~~l~g~~~~~l~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~ 152 (1251)
|+.+++....+.+.+ .++.+..|+.|++.+|+++.. ..+..+++|++|++++|.+++..| +..+++|+++++++
T Consensus 21 ~~~~~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~~l--~~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~ 94 (227)
T d1h6ua2 21 AIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSG 94 (227)
T ss_dssp HHHHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCS
T ss_pred HHHHHHCCCCCCCCC--CHHHCCCCCEEECCCCCCCCC--HHHHCCCCCCEEECCCCEEECCCC--CCCCCCCCCCCCCC
T ss_conf 999984888767757--987848868997779999766--457448888376357853202543--11233432012111
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCH
Q ss_conf 77889989865654443422345678899999976733445133211333568778443898887533301423688702
Q 000859 153 NWLSGSIPTSFGNLVNLGTLGLASCSLSGPIPPQFGQLSQLEELILQQNQLQGPIPAELGNCSSLSIFTAAENNLNGSIP 232 (1251)
Q Consensus 153 n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~ 232 (1251)
|.++... .+.++++|+.+++++|...+..+ +...+.+..+.++.+.+....+ +.++++|+.|++++|.+....+
T Consensus 95 n~~~~i~--~l~~l~~L~~l~l~~~~~~~~~~--~~~~~~~~~l~~~~~~~~~~~~--~~~~~~L~~L~l~~n~~~~~~~ 168 (227)
T d1h6ua2 95 NPLKNVS--AIAGLQSIKTLDLTSTQITDVTP--LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP 168 (227)
T ss_dssp CCCSCCG--GGTTCTTCCEEECTTSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG
T ss_pred CCCCCCC--CCCCCCCCCCCCCCCCCCCCCCH--HCCCCCHHHHHCHHHHHCHHHH--HCCCCCCCCCCCCCCCCCCCHH
T ss_conf 2222222--22222222122122244331100--0002301222000000000000--0102111002333333331001
Q ss_pred HHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEECC
Q ss_conf 2202644586465447668887895536877665553447624686772323578735898015
Q 000859 233 AALGRLQNLQLLNLGNNSLSGEIPSELGELSQLGYLNLMGNRLEGAIPRSFAKMGNLQSLDLSM 296 (1251)
Q Consensus 233 ~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~ 296 (1251)
++++++|+.|++++|.+++..+ +..+++|++|++++|+++.+.+ +..+++|+.|++++
T Consensus 169 --l~~l~~L~~L~Ls~n~l~~l~~--l~~l~~L~~L~Ls~N~lt~i~~--l~~l~~L~~L~lsn 226 (227)
T d1h6ua2 169 --LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226 (227)
T ss_dssp --GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEEE
T ss_pred --HCCCCCCEECCCCCCCCCCCHH--HCCCCCCCEEECCCCCCCCCCC--CCCCCCCCEEEEEC
T ss_conf --0564633564458884177853--4479999989795996899802--03699989897129
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.89 E-value=6.8e-23 Score=140.41 Aligned_cols=117 Identities=26% Similarity=0.316 Sum_probs=65.1
Q ss_pred CCCCCCCCCCCCCEEECCCCCCCCCC-CCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCC
Q ss_conf 87888788895019986589888986-74322667663886224454588875357875555788126778899898656
Q 000859 86 SISPSLGRLQSLIHLDLSSNSLTGPI-PTALSNLSSLESLLLFSNQLAGTIPTQLGSLTSLRVMRIGDNWLSGSIPTSFG 164 (1251)
Q Consensus 86 ~~~~~l~~l~~L~~L~l~~n~~~~~~-p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~ 164 (1251)
.+|+.+. +.+++|+|++|.|++.+ +..|.++++|++|+|++|.+.+..+..|..+++|++|+|++|++....|.+|.
T Consensus 22 ~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~ 99 (192)
T d1w8aa_ 22 EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFL 99 (192)
T ss_dssp SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSST
T ss_pred CCCCCCC--CCCCEEEECCCCCCCCCCCCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCHHHHH
T ss_conf 0298989--78788984898775530200257876272130136322121212221122221010035534434979980
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEECCCCCC
Q ss_conf 5444342234567889999997673344513321133356
Q 000859 165 NLVNLGTLGLASCSLSGPIPPQFGQLSQLEELILQQNQLQ 204 (1251)
Q Consensus 165 ~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~ 204 (1251)
++++|++|+|++|.+++..+.+|..+++|++|+|++|.+.
T Consensus 100 ~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~ 139 (192)
T d1w8aa_ 100 GLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFN 139 (192)
T ss_dssp TCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBC
T ss_pred CCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCC
T ss_conf 7974655245774535359778568753342000364434
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.88 E-value=8.7e-23 Score=139.80 Aligned_cols=108 Identities=26% Similarity=0.333 Sum_probs=38.6
Q ss_pred CCCEEECCCCCCCC-CCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEE
Q ss_conf 66388622445458-88753578755557881267788998986565444342234567889999997673344513321
Q 000859 120 SLESLLLFSNQLAG-TIPTQLGSLTSLRVMRIGDNWLSGSIPTSFGNLVNLGTLGLASCSLSGPIPPQFGQLSQLEELIL 198 (1251)
Q Consensus 120 ~L~~L~L~~n~~~~-~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L 198 (1251)
++++|+|++|.+++ ..+..|+++++|++|+|++|.+....+..|..+++|+.|+|++|+++...|..|.++++|++|+|
T Consensus 30 ~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L 109 (192)
T d1w8aa_ 30 HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNL 109 (192)
T ss_dssp TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEEC
T ss_pred CCCEEEECCCCCCCCCCCCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCHHHHHCCCCCCCCCC
T ss_conf 87889848987755302002578762721301363221212122211222210100355344349799807974655245
Q ss_pred CCCCCCCCCCCCCCCCCCCCEEECCCCCC
Q ss_conf 13335687784438988875333014236
Q 000859 199 QQNQLQGPIPAELGNCSSLSIFTAAENNL 227 (1251)
Q Consensus 199 ~~n~l~~~~p~~~~~l~~L~~L~l~~n~l 227 (1251)
++|++++..+..|.++++|+++++++|.+
T Consensus 110 ~~N~l~~i~~~~f~~l~~L~~l~L~~N~~ 138 (192)
T d1w8aa_ 110 YDNQISCVMPGSFEHLNSLTSLNLASNPF 138 (192)
T ss_dssp CSSCCCEECTTSSTTCTTCCEEECTTCCB
T ss_pred CCCCCCCCCHHHHCCCCCCCCCCCCCCCC
T ss_conf 77453535977856875334200036443
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.88 E-value=1.2e-21 Score=133.56 Aligned_cols=15 Identities=40% Similarity=0.434 Sum_probs=4.8
Q ss_pred CCCCCCEECCCCCCC
Q ss_conf 987784511478767
Q 000859 717 NLASLNVLTLSGNLL 731 (1251)
Q Consensus 717 ~l~~L~~L~ls~N~l 731 (1251)
.+++|+.|+|++|++
T Consensus 176 ~l~~L~~L~Ls~N~i 190 (210)
T d1h6ta2 176 GLTKLQNLYLSKNHI 190 (210)
T ss_dssp TCTTCCEEECCSSCC
T ss_pred CCCCCCEEECCCCCC
T ss_conf 789899998979989
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.88 E-value=9.6e-22 Score=134.01 Aligned_cols=14 Identities=14% Similarity=0.280 Sum_probs=4.8
Q ss_pred HCCCCEEECCCCCC
Q ss_conf 03777143025544
Q 000859 551 LRNLTRINFSKNRL 564 (1251)
Q Consensus 551 l~~L~~L~l~~N~l 564 (1251)
+.+++.|++++|.+
T Consensus 39 l~~l~~L~l~~~~i 52 (199)
T d2omxa2 39 LDQVTTLQADRLGI 52 (199)
T ss_dssp HTTCCEEECTTSCC
T ss_pred HCCCCEEECCCCCC
T ss_conf 46878998999999
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.80 E-value=3e-22 Score=136.82 Aligned_cols=13 Identities=31% Similarity=0.419 Sum_probs=5.3
Q ss_pred CCCCEEECCCCCC
Q ss_conf 6555565037515
Q 000859 743 SKLYELRLSNNSL 755 (1251)
Q Consensus 743 ~~L~~L~l~~N~l 755 (1251)
++|+.|++++|++
T Consensus 302 ~~L~~L~l~~N~~ 314 (344)
T d2ca6a1 302 PDLLFLELNGNRF 314 (344)
T ss_dssp TTCCEEECTTSBS
T ss_pred CCCCEEECCCCCC
T ss_conf 9999897879808
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.78 E-value=2.4e-21 Score=131.78 Aligned_cols=261 Identities=16% Similarity=0.131 Sum_probs=0.0
Q ss_pred CEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCC-CCCCCCCCCCCCCCCCCC
Q ss_conf 1998658988898674322667663886224454588875357875555788126778899-898656544434223456
Q 000859 98 IHLDLSSNSLTGPIPTALSNLSSLESLLLFSNQLAGTIPTQLGSLTSLRVMRIGDNWLSGS-IPTSFGNLVNLGTLGLAS 176 (1251)
Q Consensus 98 ~~L~l~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~-~p~~~~~l~~L~~L~L~~ 176 (1251)
+++|++++.+.......+... .+..+.++...+. ..........+|++|+++++.+++. ++..+..+++|++|++++
T Consensus 3 ~~lDLs~~~l~~~~l~~l~~~-~~~~lrl~~~~~~-~~~~~~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~ 80 (284)
T d2astb2 3 QTLDLTGKNLHPDVTGRLLSQ-GVIAFRCPRSFMD-QPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEG 80 (284)
T ss_dssp SEEECTTCBCCHHHHHHHHHT-TCSEEECTTCEEC-SCCCSCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTT
T ss_pred CEEECCCCCCCCHHHHHHHHC-CCEEEECCCCCCC-CCHHHHCCCCCCCEEECCCCCCCHHHHHHHHHHCCCCCCCCCCC
T ss_conf 779789997881479998745-5427465233345-52244256787887889898457779999997487765145234
Q ss_pred CCCCCCCCCCCCCCCCCCEEEECC-CCCCCCCCCCC-CCCCCCCEEECCCCCC---CCCCHHHHCCCCCCCEEECCCCCC
Q ss_conf 788999999767334451332113-33568778443-8988875333014236---887022202644586465447668
Q 000859 177 CSLSGPIPPQFGQLSQLEELILQQ-NQLQGPIPAEL-GNCSSLSIFTAAENNL---NGSIPAALGRLQNLQLLNLGNNSL 251 (1251)
Q Consensus 177 n~l~~~~p~~~~~l~~L~~L~L~~-n~l~~~~p~~~-~~l~~L~~L~l~~n~l---~~~~~~~l~~l~~L~~L~L~~n~l 251 (1251)
|.++...+..++.+++|++|++++ +.++...-..+ .++++|+.|+++++.. .+.........++|+.|+++++..
T Consensus 81 ~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~ 160 (284)
T d2astb2 81 LRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRK 160 (284)
T ss_dssp CBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGG
T ss_pred CCCCCHHHHHHHCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHCCCCCCCCCCCCCCCCCHHHHCCCCCCCCHHHHCCCCC
T ss_conf 67986789998518997571510013412355403657887435652245332333220001000111110122135542
Q ss_pred C---CCCCCCCCCCCCCCEEECCCCC-CCCCCCCCCCCCCCCCEEEECC-CCCCCCCCCCCCCCCCEEEEECCCCCCCCC
Q ss_conf 8---8789553687766555344762-4686772323578735898015-422499897424455337999027504676
Q 000859 252 S---GEIPSELGELSQLGYLNLMGNR-LEGAIPRSFAKMGNLQSLDLSM-NRLTGGIPEEFGNMGQLVFLVLSNNNISGS 326 (1251)
Q Consensus 252 ~---~~~~~~~~~l~~L~~L~L~~n~-l~~~~~~~~~~l~~L~~L~Ls~-n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~ 326 (1251)
. ..+...+..+++|++|++++|. +++.....+.++++|++|++++ +.+++.....++.+++|++|+++++ +++.
T Consensus 161 ~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~-~~d~ 239 (284)
T d2astb2 161 NLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI-VPDG 239 (284)
T ss_dssp GSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS-SCTT
T ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHCCCCCCCEEECCCCCCCCHHHHHHHHCCCCCCEEEEECC-CCHH
T ss_conf 444443434232322212355322347783033332135768779899999787378999726999898964488-8989
Q ss_pred CCCCCCCCCCCHHHHHCCCHHCCCCCCCCCCCCCCCCE
Q ss_conf 66100146331024440010013678957667787865
Q 000859 327 IPRRICTNATSLEHLILAEIQLSGEIPVELSQCQSLKQ 364 (1251)
Q Consensus 327 i~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 364 (1251)
....+...+++|+ +..+.++...+..++..+.-..
T Consensus 240 ~l~~l~~~lp~L~---i~~~~ls~~~~~~~~~~~~~~i 274 (284)
T d2astb2 240 TLQLLKEALPHLQ---INCSHFTTIARPTIGNKKNQEI 274 (284)
T ss_dssp CHHHHHHHSTTSE---ESCCCSCCTTCSSCSSTTCCCB
T ss_pred HHHHHHHHCCCCC---CCCCCCCCCCCCCCCCCCCCHH
T ss_conf 9999997684366---1686587777885476664001
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.70 E-value=9.9e-18 Score=111.69 Aligned_cols=130 Identities=18% Similarity=0.126 Sum_probs=0.0
Q ss_pred CCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 75322344456687027734388983000257753898579946899863149976534112447311488830013644
Q 000859 616 PWTFGKIRELSLLDLSGNSLTGPIPTQLLMCKKLSHIDLNNNLLSGAVPSWLGTLPQLGELKLSFNQFVGFLPRELFNCS 695 (1251)
Q Consensus 616 ~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~ 695 (1251)
...|....+++.|+|++|+|+ .++..+..+++|++|++++|.|+.. +.+..+++|++|++++|++.++.+..+..++
T Consensus 11 ~~~~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~~l--~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~ 87 (162)
T d1a9na_ 11 AAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALP 87 (162)
T ss_dssp SCEEECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCT
T ss_pred HHHCCCCCCCCEEECCCCCCC-CCCCCCCCCCCCCEEECCCCCCCCC--CCCCCCCCHHHHHCCCCCCCCCCCCCCCCCC
T ss_conf 175168574848978899788-6576200414599898979978764--7744576130643102134577763223345
Q ss_pred CCCEEECCCCCCCCCCC-CCCCCCCCCCEECCCCCCCCCCCCC----CCCCCCCCCEEE
Q ss_conf 45255203732124568-2347987784511478767799873----225456555565
Q 000859 696 KLLVLSLDGNMLNGSLP-NEVGNLASLNVLTLSGNLLSGPIPP----AIGRLSKLYELR 749 (1251)
Q Consensus 696 ~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~ls~N~l~~~~~~----~~~~l~~L~~L~ 749 (1251)
+|+.|++++|+++.... ..+..+++|++|++++|.++ ..|. .+..+++|+.||
T Consensus 88 ~L~~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~-~~~~~r~~~i~~lp~L~~LD 145 (162)
T d1a9na_ 88 DLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLD 145 (162)
T ss_dssp TCCEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEET
T ss_pred CCCCCEECCCCCCCCCCCCCCCCCCCCCHHHCCCCCCC-CCCCHHHHHHHHCCCCCEEC
T ss_conf 34434203000166542110013653206640799634-56106999998789958337
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.61 E-value=9.8e-16 Score=100.60 Aligned_cols=118 Identities=21% Similarity=0.232 Sum_probs=0.0
Q ss_pred CHHHCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCC
Q ss_conf 03202568102312577678775645760488555788995435587768955577357886700015445876626888
Q 000859 435 ELLYLYDNHLSGQIPSEVGNCSSLKWIDFFGNSFTGEIPTSIGRLKDLNFLHLRQNELVGQIPASLGNCHQLIILDLADN 514 (1251)
Q Consensus 435 ~~L~L~~N~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N 514 (1251)
+.|++++|+++ ..+. +..+++|++|++++|.++ .+|..+..+++|+.|++++|.++ .++. +..+++|+.|++++|
T Consensus 1 R~L~Ls~n~l~-~l~~-l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~-~l~~-~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 1 RVLHLAHKDLT-VLCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVDG-VANLPRLQELLLCNN 75 (124)
T ss_dssp SEEECTTSCCS-SCCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCGG-GTTCSSCCEEECCSS
T ss_pred CEEECCCCCCC-CCCC-CCCCCCCCEEECCCCCCC-CCHHHHHHHHCCCCCCCCCCCCC-CCCC-CCCCCCCCEEECCCC
T ss_conf 98986899898-8710-105898898979787168-65215655431354532432112-3574-123355576888898
Q ss_pred CCCCCCC-CCHHCCCHHHHHHCCCCCCCCCC---CHHHHHHCCCCEE
Q ss_conf 5864599-51001010156520378556677---3344410377714
Q 000859 515 KLSGGVP-ASFGFLQALEQLMLYNNSLEGNL---PGSLINLRNLTRI 557 (1251)
Q Consensus 515 ~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~---~~~l~~l~~L~~L 557 (1251)
+|++... ..+..+++|+.|++++|+++... ......+++|+.|
T Consensus 76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~~~~~~~~~l~~~lp~L~~L 122 (124)
T d1dcea3 76 RLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI 122 (124)
T ss_dssp CCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCSEE
T ss_pred CCCCCCCCHHHCCCCCCCEEECCCCCCCCCCCHHHHHHHHCCCCCEE
T ss_conf 65888882565379999999897996886826799999989673138
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.60 E-value=6.8e-18 Score=112.62 Aligned_cols=148 Identities=23% Similarity=0.265 Sum_probs=0.0
Q ss_pred CCCCCCCEEECCCC--CCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCC
Q ss_conf 77565755560267--5100367532234445668702773438898300025775389857994689986314997653
Q 000859 596 GNSPSLERLRLGNN--KFIGKIPWTFGKIRELSLLDLSGNSLTGPIPTQLLMCKKLSHIDLNNNLLSGAVPSWLGTLPQL 673 (1251)
Q Consensus 596 ~~l~~L~~L~L~~n--~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L 673 (1251)
.....++.+.+.++ .+. ..+..+..+++|+.|++++|.|+...+ +..+++|+.|++++|.|+ .++..+..+++|
T Consensus 20 ~~~~~~~~~~l~~~~~~i~-~l~~sl~~L~~L~~L~Ls~n~I~~i~~--l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L 95 (198)
T d1m9la_ 20 VVATEAEKVELHGMIPPIE-KMDATLSTLKACKHLALSTNNIEKISS--LSGMENLRILSLGRNLIK-KIENLDAVADTL 95 (198)
T ss_dssp CCCTTCSCEECCBCCTTCC-CCHHHHHHTTTCCEEECSEEEESCCCC--HHHHTTCCEEECCEEEEC-SCSSHHHHHHHC
T ss_pred CCCCCCCEEEEECCCCCHH-HHHHHHHCCCCCCEEECCCCCCCCCCC--CCCCCCCCCHHHCCCCCC-CCCCCCCCCCCC
T ss_conf 8545331002555568520-024677626046151994468998644--247825357341353432-100003322123
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCC-CCCCCCCCCCEECCCCCCCCCCCCCC----------CCCC
Q ss_conf 411244731148883001364445255203732124568-23479877845114787677998732----------2545
Q 000859 674 GELKLSFNQFVGFLPRELFNCSKLLVLSLDGNMLNGSLP-NEVGNLASLNVLTLSGNLLSGPIPPA----------IGRL 742 (1251)
Q Consensus 674 ~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~ls~N~l~~~~~~~----------~~~l 742 (1251)
++|++++|++..+ ..+..+++|+.|++++|+++.... ..+..+++|+.|++++|++....+.. +..+
T Consensus 96 ~~L~l~~N~i~~l--~~~~~l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~r~~vi~~l 173 (198)
T d1m9la_ 96 EELWISYNQIASL--SGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRL 173 (198)
T ss_dssp CEEECSEEECCCH--HHHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHHHCTTTTHHHHHHHHHHHC
T ss_pred CCCCCCCCCCCCC--CCCCCCCCCCCCCCCCCHHCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCHHHHHHHHHHHC
T ss_conf 3333333222222--22222223411123410212554221236777630234279843467632222055899999878
Q ss_pred CCCCEEE
Q ss_conf 6555565
Q 000859 743 SKLYELR 749 (1251)
Q Consensus 743 ~~L~~L~ 749 (1251)
|+|+.||
T Consensus 174 p~L~~LD 180 (198)
T d1m9la_ 174 PNLKKLD 180 (198)
T ss_dssp SSCCEES
T ss_pred CCCCEEC
T ss_conf 8958769
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.57 E-value=3.7e-15 Score=97.41 Aligned_cols=66 Identities=20% Similarity=0.183 Sum_probs=26.4
Q ss_pred CCCCCCCCEEECCCC-CCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEECCCCCC
Q ss_conf 788895019986589-888986743226676638862244545888753578755557881267788
Q 000859 91 LGRLQSLIHLDLSSN-SLTGPIPTALSNLSSLESLLLFSNQLAGTIPTQLGSLTSLRVMRIGDNWLS 156 (1251)
Q Consensus 91 l~~l~~L~~L~l~~n-~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~ 156 (1251)
+..++.|++|++++| .++..-+.+|.++++|+.|+|++|+++...|.+|..+++|++|+|++|+++
T Consensus 27 l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~ 93 (156)
T d2ifga3 27 LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE 93 (156)
T ss_dssp SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCS
T ss_pred CCCCCCCCEEECCCCCCCCCCCCHHHCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEECCCCCCC
T ss_conf 2576565743168986644369212256666672162021247742011124554333322678785
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=99.02 E-value=1.4e-09 Score=66.36 Aligned_cols=147 Identities=14% Similarity=0.052 Sum_probs=93.8
Q ss_pred HHHHHCCCCCCCEECCCCCCEEEEEEECCCCEEEEEEECCCCCHHHHHHHHHHHHHHHHCC-CCCCCCEECEEEECCCCC
Q ss_conf 9996129996853223588039999965995899998115771455699999999987104-777431302154059981
Q 000859 941 IMGATNNLSDEFIIGSGGSGTVYKAELANGATVAVKKISCKDDHLLNKSFTREVKTLGRIR-HRHLVKLMGHCCNKGAGS 1019 (1251)
Q Consensus 941 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~ 1019 (1251)
+...-..|+..+..+.++.+.||+.... +..+++|+...... .....+.+|...++.+. +--+.+++++... ++.
T Consensus 9 l~~~~~~~~~~~~~~G~s~~~v~rv~~~-~~~~vlk~~~~~~~-~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~--~~~ 84 (263)
T d1j7la_ 9 LKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYK-GTTYDVEREKDMMLWLEGKLPVPKVLHFERH--DGW 84 (263)
T ss_dssp HHHHHTTSEEEECSCCCSSSEEEEEECS-SCEEEEEEECGGGT-TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEE--TTE
T ss_pred HHHHHHCEEEEECCCCCCCCCEEEEEEC-CCEEEEEECCCCCC-CCHHHHHHHHHHHHHHHCCCCCCCEEEEEEC--CCC
T ss_conf 9975135279976789987718999908-98699998488765-3255699999999987606998728999750--896
Q ss_pred EEEEEEECCCCCHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC----------------------------
Q ss_conf 1699950589995776302887732478999999999999999997986306----------------------------
Q 000859 1020 NLLIYEYMENGSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHD---------------------------- 1071 (1251)
Q Consensus 1020 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---------------------------- 1071 (1251)
.++||++++|.++.+..... .. ...++.++++.++.+|+.
T Consensus 85 ~~lv~~~l~G~~~~~~~~~~---------~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 152 (263)
T d1j7la_ 85 SNLLMSEADGVLCSEEYEDE---------QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLAD 152 (263)
T ss_dssp EEEEEECCSSEEHHHHTTTC---------SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSC
T ss_pred EEEEEEECCCCCCCCCCCCC---------CC---HHHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHH
T ss_conf 49999860433435433440---------26---9999998999999985568421435764465655577899877655
Q ss_pred ----------------------------CCCCEEECCCCCCCEEECCCCCEEECCCCCCC
Q ss_conf ----------------------------99991524999999554689875874445642
Q 000859 1072 ----------------------------CVPKILHRDIKSSNILLDSNMEAHLGDFGLAK 1103 (1251)
Q Consensus 1072 ----------------------------~~~~ivH~Dlk~~Nili~~~~~~ki~DfG~a~ 1103 (1251)
..+.++|+|+.+.||++++++.+.++||+.+.
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 153 VDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp CCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHCCCCCCCCHHHHHHHHHHHHCCCCCCCEEEEEECCCCCEEECCCCEEEEEECHHCC
T ss_conf 554303323200579999999984498678178986004764236499659996023144
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.87 E-value=9.6e-11 Score=72.84 Aligned_cols=124 Identities=23% Similarity=0.168 Sum_probs=0.0
Q ss_pred CCCCEEECCCCCCCCCCCCCHHCCCHHHHHHCCCCCCCCCCCHHHHHHCCCCEEECCCCCCCCCCCCCCCCCCCEEEECC
Q ss_conf 45876626888586459951001010156520378556677334441037771430255446610101467641011012
Q 000859 504 HQLIILDLADNKLSGGVPASFGFLQALEQLMLYNNSLEGNLPGSLINLRNLTRINFSKNRLNGRIATLCSSHSFLSFDVT 583 (1251)
Q Consensus 504 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~l~~~~~l~~l~l~ 583 (1251)
...+.|++++++.. ..+..+..+..++..++... ..+..+..+++|++|++++|+|++.
T Consensus 22 ~~~~~Ldls~l~~~----~~l~~~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l---------------- 80 (162)
T d1koha1 22 GSQQALDLKGLRSD----PDLVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRL---------------- 80 (162)
T ss_dssp SSSCCBCCCCCSSC----TTTTTTTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCC----------------
T ss_pred HHHCEEECCCCCCC----CHHHHCCCHHHCCHHHHHHH-HHHHHHHHCCCCCEEECCCCCCCCC----------------
T ss_conf 33086534359898----21554664011225556766-6078897487878863777666677----------------
Q ss_pred CCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCC-------CCCCCCCCEEE
Q ss_conf 57655578988777565755560267510036753223444566870277343889830-------00257753898
Q 000859 584 NNEFDHEIPPQLGNSPSLERLRLGNNKFIGKIPWTFGKIRELSLLDLSGNSLTGPIPTQ-------LLMCKKLSHID 653 (1251)
Q Consensus 584 ~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~-------~~~l~~L~~L~ 653 (1251)
..++..+..+++|+.|++++|.+.......+....+|+.+++++|.+....... +..+|+|+.||
T Consensus 81 -----~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~~i~~~~P~L~~LD 152 (162)
T d1koha1 81 -----DDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLD 152 (162)
T ss_dssp -----SGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHHHHHTTSTTCCEET
T ss_pred -----CHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHCCCCCEEECCCCCCCCCCCCCHHHHHHHHHHCCCCCEEC
T ss_conf -----315889865885610004357213423442220331042664899767676661569999999889978799
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.79 E-value=1.5e-08 Score=60.72 Aligned_cols=130 Identities=15% Similarity=0.104 Sum_probs=82.8
Q ss_pred EECCCCC-CEEEEEEECCCCEEEEEEECCCCCHHHHHHHHHHHHHHHHCC--CCCCCCEECEEEECCCCCEEEEEEECCC
Q ss_conf 3223588-039999965995899998115771455699999999987104--7774313021540599811699950589
Q 000859 953 IIGSGGS-GTVYKAELANGATVAVKKISCKDDHLLNKSFTREVKTLGRIR--HRHLVKLMGHCCNKGAGSNLLIYEYMEN 1029 (1251)
Q Consensus 953 ~lg~G~~-g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~g~~~~~~~~~~~lv~e~~~~ 1029 (1251)
.+..|.. +.||+....++..+++|...... ...+..|...++.+. .-.+.+++++..+ +...++||++++|
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~----~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~--~~~~~~v~~~i~G 90 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA----LNELQDEAARLSWLATTGVPCAAVLDVVTE--AGRDWLLLGEVPG 90 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCT----TSCHHHHHHHHHHHHTTTCCBCCEEEEEEC--SSCEEEEEECCSS
T ss_pred ECCCCCCCCEEEEEEECCCCEEEEEECCCCC----HHHHHHHHHHHHHHHHCCCCCCCEEEECCC--CCCEEEEEEEEEC
T ss_conf 7678654775899993898789999589667----768999999999998659998861322245--6615999874413
Q ss_pred CCHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC--------------------------------------
Q ss_conf 995776302887732478999999999999999997986306--------------------------------------
Q 000859 1030 GSVWDWLHKQPVNIKMRKSLDWEARLKIAVGLAQGVEYLHHD-------------------------------------- 1071 (1251)
Q Consensus 1030 gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-------------------------------------- 1071 (1251)
.++.+.. .... ..+.+++..++-||+.
T Consensus 91 ~~~~~~~------------~~~~---~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (255)
T d1nd4a_ 91 QDLLSSH------------LAPA---EKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQG 155 (255)
T ss_dssp EETTTSC------------CCHH---HHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTT
T ss_pred CCCCCCC------------CCHH---HHHHHHHHHHHHHCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCHHHH
T ss_conf 5543221------------2689---999999999998736885448875541246889999998754110113401121
Q ss_pred -----------------CCCCEEECCCCCCCEEECCCCCEEECCCCCCC
Q ss_conf -----------------99991524999999554689875874445642
Q 000859 1072 -----------------CVPKILHRDIKSSNILLDSNMEAHLGDFGLAK 1103 (1251)
Q Consensus 1072 -----------------~~~~ivH~Dlk~~Nili~~~~~~ki~DfG~a~ 1103 (1251)
..+.++|+|+.+.||+++.+..+.|+||+.+.
T Consensus 156 ~~~~~~~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 156 LAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp CCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHHHHHHCCCCCCCEEEECCCCCCCEEEECCCEEEEEECHHCC
T ss_conf 3799999999871876579567867888763577379658999853326
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.69 E-value=6.7e-08 Score=57.04 Aligned_cols=77 Identities=14% Similarity=0.068 Sum_probs=47.7
Q ss_pred CEECCCCCCEEEEEEEC-CCCEEEEEEECCCC------CHHHHHHHHHHHHHHHHCC-C--CCCCCEECEEEECCCCCEE
Q ss_conf 53223588039999965-99589999811577------1455699999999987104-7--7743130215405998116
Q 000859 952 FIIGSGGSGTVYKAELA-NGATVAVKKISCKD------DHLLNKSFTREVKTLGRIR-H--RHLVKLMGHCCNKGAGSNL 1021 (1251)
Q Consensus 952 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~------~~~~~~~~~~E~~~l~~l~-h--~niv~l~g~~~~~~~~~~~ 1021 (1251)
+.+|.|....||++... +++.|++|.-.... -+........|.+.++.+. + ..+++++.+. . ...+
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d--~--~~~~ 107 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--T--EMAV 107 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--T--TTTE
T ss_pred EEECCCCEEEEEEEEECCCCEEEEEECCCCHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCEEEEEC--C--CCCE
T ss_conf 98079852768999957998489996177130346777888778999999999986505798855289985--9--8877
Q ss_pred EEEEECCCCCH
Q ss_conf 99950589995
Q 000859 1022 LIYEYMENGSV 1032 (1251)
Q Consensus 1022 lv~e~~~~gsL 1032 (1251)
+|||++++...
T Consensus 108 lvmE~L~~~~~ 118 (392)
T d2pula1 108 TVMEDLSHLKI 118 (392)
T ss_dssp EEECCCTTSEE
T ss_pred EEEECCCCCCC
T ss_conf 98713577653
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=98.30 E-value=7.6e-06 Score=45.61 Aligned_cols=144 Identities=17% Similarity=0.127 Sum_probs=75.6
Q ss_pred CCCCEEEEEEECCCCEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCC-----CCEECEEEECCCCCEEEEEEECCCCC
Q ss_conf 5880399999659958999981157714556999999999871047774-----31302154059981169995058999
Q 000859 957 GGSGTVYKAELANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRHL-----VKLMGHCCNKGAGSNLLIYEYMENGS 1031 (1251)
Q Consensus 957 G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-----v~l~g~~~~~~~~~~~lv~e~~~~gs 1031 (1251)
+.--.||++...+|..|++|+.+... ...+.+..|...+..+....+ +..-|-.........+.++++++|..
T Consensus 33 s~EN~vy~v~~~dg~~~VlK~~rp~~--~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~ 110 (325)
T d1zyla1 33 SYENRVYQFQDEDRRRFVVKFYRPER--WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQ 110 (325)
T ss_dssp CSSSEEEEECCTTCCCEEEEEECTTT--SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEE
T ss_pred CCCCEEEEEECCCCCEEEEEEECCCC--CCHHHHHHHHHHHHHHHHCCCCCCCCEECCCCEEEEEEEEEEEEEEECCCCC
T ss_conf 61202699983899979999847877--8899999999999999855998787520689805665347999986527768
Q ss_pred HH-----HHH---------HC--CCCCCCCCCCCC----------------------HHHHHHHHHHHHHHHHHH-HHCC
Q ss_conf 57-----763---------02--887732478999----------------------999999999999997986-3069
Q 000859 1032 VW-----DWL---------HK--QPVNIKMRKSLD----------------------WEARLKIAVGLAQGVEYL-HHDC 1072 (1251)
Q Consensus 1032 L~-----~~l---------~~--~~~~~~~~~~l~----------------------~~~~~~i~~~i~~~l~~L-H~~~ 1072 (1251)
+. .+- +. ...........+ .......+..+...+.-. .+..
T Consensus 111 ~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~ 190 (325)
T d1zyla1 111 FEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDF 190 (325)
T ss_dssp CCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCS
T ss_pred CCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCC
T ss_conf 89999999999899999988630357865567789788766568999874769988989999999999999998454568
Q ss_pred CCCEEECCCCCCCEEECCCCCEEECCCCCCCC
Q ss_conf 99915249999995546898758744456422
Q 000859 1073 VPKILHRDIKSSNILLDSNMEAHLGDFGLAKA 1104 (1251)
Q Consensus 1073 ~~~ivH~Dlk~~Nili~~~~~~ki~DfG~a~~ 1104 (1251)
..+++|+|+.+.||+++.+ ..++||+.+..
T Consensus 191 p~~liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 191 TVLRLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CCEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred CCEEECCCCCCCCEEEECC--CEEEECHHCCC
T ss_conf 7120247888042878389--35886520146
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=98.22 E-value=1e-05 Score=44.95 Aligned_cols=73 Identities=16% Similarity=0.171 Sum_probs=48.3
Q ss_pred CEECCCCCCEEEEEEECC--------CCEEEEEEECCCCCHHHHHHHHHHHHHHHHCC-CCCCCCEECEEEECCCCCEEE
Q ss_conf 532235880399999659--------95899998115771455699999999987104-777431302154059981169
Q 000859 952 FIIGSGGSGTVYKAELAN--------GATVAVKKISCKDDHLLNKSFTREVKTLGRIR-HRHLVKLMGHCCNKGAGSNLL 1022 (1251)
Q Consensus 952 ~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~~~l 1022 (1251)
+.++.|-.-.+|++...+ ...|.+++.. ... ...+..+|..+++.+. +.-..++++++ ++ +.
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~~--~~idr~~E~~i~~~ls~~gl~Pkll~~~----~~--g~ 118 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NPE--TESHLVAESVIFTLLSERHLGPKLYGIF----SG--GR 118 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEE----TT--EE
T ss_pred EECCCCCCCCEEEEEECCCCCCCCCCCCCEEEEECC-CCC--HHHHHHHHHHHHHHHHHCCCCCEEEEEC----CC--CE
T ss_conf 991785334348999688775445789817999659-961--1658999999999997579998089981----89--56
Q ss_pred EEEECCCCCHH
Q ss_conf 99505899957
Q 000859 1023 IYEYMENGSVW 1033 (1251)
Q Consensus 1023 v~e~~~~gsL~ 1033 (1251)
|+||++|.++.
T Consensus 119 I~efi~g~~l~ 129 (395)
T d1nw1a_ 119 LEEYIPSRPLS 129 (395)
T ss_dssp EECCCCEEECC
T ss_pred EEEEECCCCCC
T ss_conf 99973455488
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=98.08 E-value=6.6e-07 Score=51.49 Aligned_cols=111 Identities=12% Similarity=0.151 Sum_probs=0.0
Q ss_pred CCCCCCCEEEECC-CCCCCC----CCCCCCCCCCCCEEECCCCCCC----CCCHHHHCCCCCCCEEECCCCCCC----CC
Q ss_conf 7334451332113-335687----7844389888753330142368----870222026445864654476688----87
Q 000859 188 GQLSQLEELILQQ-NQLQGP----IPAELGNCSSLSIFTAAENNLN----GSIPAALGRLQNLQLLNLGNNSLS----GE 254 (1251)
Q Consensus 188 ~~l~~L~~L~L~~-n~l~~~----~p~~~~~l~~L~~L~l~~n~l~----~~~~~~l~~l~~L~~L~L~~n~l~----~~ 254 (1251)
.+.++|++|+|++ +.+... +...+...+.|+.|++++|.+. ..+...+...+.|+.|+|++|.++ ..
T Consensus 12 ~n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~ 91 (167)
T d1pgva_ 12 EDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLAR 91 (167)
T ss_dssp TTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHH
T ss_pred HCCCCCCEEEECCCCCCCHHHHHHHHHHHHHCCCCCEEECCCCCCCHHHHHHHHHHHHHCCCCCCEEEEHHHCCHHHHHH
T ss_conf 28999819782799998989999999997637764540120156215679887531000234330033010214599999
Q ss_pred CCCCCCCCCCCCEEECCCCCCCCC-------CCCCCCCCCCCCEEEECCCC
Q ss_conf 895536877665553447624686-------77232357873589801542
Q 000859 255 IPSELGELSQLGYLNLMGNRLEGA-------IPRSFAKMGNLQSLDLSMNR 298 (1251)
Q Consensus 255 ~~~~~~~l~~L~~L~L~~n~l~~~-------~~~~~~~l~~L~~L~Ls~n~ 298 (1251)
+...+...++|++|++++|.+... +...+...+.|+.|+++.+.
T Consensus 92 l~~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~~ 142 (167)
T d1pgva_ 92 LLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFAS 142 (167)
T ss_dssp HHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCC
T ss_pred HHHHHHHCCCCCEEECCCCCCCCCCHHHHHHHHHHHHHCCCCCEEECCCCC
T ss_conf 999998489389877887768886579999999999729985386486888
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=97.65 E-value=0.00078 Score=34.43 Aligned_cols=164 Identities=10% Similarity=0.063 Sum_probs=80.4
Q ss_pred CCHHHHHHHHCCCCCCCE-----ECCCCCCEEEEEEECCCCEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCC--CCCE
Q ss_conf 789899996129996853-----223588039999965995899998115771455699999999987104777--4313
Q 000859 936 FRWEDIMGATNNLSDEFI-----IGSGGSGTVYKAELANGATVAVKKISCKDDHLLNKSFTREVKTLGRIRHRH--LVKL 1008 (1251)
Q Consensus 936 ~~~~~~~~~~~~~~~~~~-----lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l 1008 (1251)
.+.++++....+|..++. +..|.--+.|+....++ .+++|++..... .+....|.+++..+...+ +...
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~~---~~~l~~~~~~l~~L~~~g~pvp~p 78 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRVE---KNDLPFFLGLMQHLAAKGLSCPLP 78 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC------CCHHHHHHHHHHHHHHTTCCCCCB
T ss_pred CCHHHHHHHHHHCCCCCCEEEECCCCCCCCCEEEEEECCC-CEEEEECCCCCC---HHHHHHHHHHHHHHHHCCCCCCCC
T ss_conf 8999999999867999856852378885267389997897-289998078999---889999999987543025554556
Q ss_pred E----CEEEECCCCCEEEEEEECCCCCHHHH--------------HHCCCCCC--CCCCCC------------------C
Q ss_conf 0----21540599811699950589995776--------------30288773--247899------------------9
Q 000859 1009 M----GHCCNKGAGSNLLIYEYMENGSVWDW--------------LHKQPVNI--KMRKSL------------------D 1050 (1251)
Q Consensus 1009 ~----g~~~~~~~~~~~lv~e~~~~gsL~~~--------------l~~~~~~~--~~~~~l------------------~ 1050 (1251)
. |.....-....+.++.+..+...... ++...... ...... .
T Consensus 79 i~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (316)
T d2ppqa1 79 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV 158 (316)
T ss_dssp CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred CEECCCCCCEEEECCCCEEEEECCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHCCHHHHHHHHHHHHC
T ss_conf 41048976213412550245311465533320467888889987645444320245310111012002456777765311
Q ss_pred HHHHHHHHHHHHHHHHHHHH-CCCCCEEECCCCCCCEEECCCCCEEECCCCCCC
Q ss_conf 99999999999999798630-699991524999999554689875874445642
Q 000859 1051 WEARLKIAVGLAQGVEYLHH-DCVPKILHRDIKSSNILLDSNMEAHLGDFGLAK 1103 (1251)
Q Consensus 1051 ~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~Dlk~~Nili~~~~~~ki~DfG~a~ 1103 (1251)
.......+......+..... ....|++|+|+.+.||+++.+...-++||+.+.
T Consensus 159 ~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 159 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred CHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHCCCCCCEEEECCCCCC
T ss_conf 412799999998764204855454503337863656402045412674222123
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=97.45 E-value=4.7e-06 Score=46.77 Aligned_cols=115 Identities=13% Similarity=0.072 Sum_probs=0.0
Q ss_pred CCCCCCCEEECCC-CCCCCCCCCCHH----CCCHHHHHHCCCCCCCC----CCCHHHHHHCCCCEEECCCCCCCCCCCCC
Q ss_conf 1544587662688-858645995100----10101565203785566----77334441037771430255446610101
Q 000859 501 GNCHQLIILDLAD-NKLSGGVPASFG----FLQALEQLMLYNNSLEG----NLPGSLINLRNLTRINFSKNRLNGRIATL 571 (1251)
Q Consensus 501 ~~l~~L~~L~L~~-N~l~~~~~~~~~----~l~~L~~L~L~~N~l~~----~~~~~l~~l~~L~~L~l~~N~l~~~~~~l 571 (1251)
.+.+.|+.|++++ +.++......+. ..+.|++|++++|.++. .+...+...++++.+++++|.+......
T Consensus 14 ~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~- 92 (166)
T d1io0a_ 14 NNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGIL- 92 (166)
T ss_dssp TTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHH-
T ss_pred HCCCCCCEEECCCCCCCCHHHHHHHHHHHHCCCCCCEEECCCCCCCHHHHHHHHHHHHHCCCCHHHHHCCCCCCCHHHH-
T ss_conf 5599986887689999898999999988841982574301589611778999998775212210121025432201478-
Q ss_pred CCCCCCEEEECCCCCCCCCCCCCCCCCCCCCE--EECCCCCCCC----CCCCCCCCCCCCCEEECCCCC
Q ss_conf 46764101101257655578988777565755--5602675100----367532234445668702773
Q 000859 572 CSSHSFLSFDVTNNEFDHEIPPQLGNSPSLER--LRLGNNKFIG----KIPWTFGKIRELSLLDLSGNS 634 (1251)
Q Consensus 572 ~~~~~l~~l~l~~n~l~~~~~~~l~~l~~L~~--L~L~~n~l~~----~~~~~~~~l~~L~~L~ls~N~ 634 (1251)
.+...+...++|+. |++.+|.+.. .+...+...+.|+.|+++.+.
T Consensus 93 ------------------~l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~ 143 (166)
T d1io0a_ 93 ------------------ALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQ 143 (166)
T ss_dssp ------------------HHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSS
T ss_pred ------------------HHHHHHHHCCCCCEEEECCCCCCCCHHHHHHHHHHHHHCCCCCEEECCCCC
T ss_conf ------------------899999848652477321677867679999999999849984788581898
|